Citrus Sinensis ID: 035761
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 560 | 2.2.26 [Sep-21-2011] | |||||||
| Q8VZG8 | 1045 | Probable LRR receptor-lik | yes | no | 0.976 | 0.523 | 0.435 | 1e-118 | |
| Q9LP24 | 1120 | Probable leucine-rich rep | no | no | 0.962 | 0.481 | 0.396 | 1e-109 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.955 | 0.485 | 0.382 | 6e-94 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.948 | 0.481 | 0.387 | 7e-92 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.991 | 0.493 | 0.373 | 1e-89 | |
| C0LGW6 | 966 | LRR receptor-like serine/ | no | no | 0.912 | 0.528 | 0.390 | 2e-87 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.978 | 0.437 | 0.352 | 2e-87 | |
| Q6XAT2 | 967 | LRR receptor-like serine/ | no | no | 0.903 | 0.523 | 0.373 | 3e-87 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.960 | 0.430 | 0.351 | 3e-86 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.896 | 0.439 | 0.360 | 5e-84 |
| >sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3 | Back alignment and function desciption |
|---|
Score = 424 bits (1091), Expect = e-118, Method: Compositional matrix adjust.
Identities = 249/572 (43%), Positives = 351/572 (61%), Gaps = 25/572 (4%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAI 60
G L +DLS+N+F G + + +L LS NS+ G IP + ++TQL+ L +
Sbjct: 450 FGVYPTLNFIDLSNNNFHGQLSANWEQSQKLVAFILSNNSITGAIPPEIWNMTQLSQLDL 509
Query: 61 ASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSS 120
+SNR+ G + I ++ + L L+ N + G IPS + L L +DLS N+ IP +
Sbjct: 510 SSNRITGELPESISNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNRFSSEIPPT 569
Query: 121 LGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDL 180
L +L +L +N+ N LD IP L S+L++L L N L G I SQ LQ L LDL
Sbjct: 570 LNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLERLDL 629
Query: 181 SGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIP--VFVRKVPHLDVSGNQ-FGGEIPTT 237
S N ++G+IP + + VD+S NNL G IP R P GN+ G + TT
Sbjct: 630 SHNNLSGQIPPSFKDMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTT 689
Query: 238 LANVP------PPHHKT---IATGLVAIILAMVAFLALIFGILIIRRRRDKEIEPTGTVE 288
P HK I LV II A++ L++ GI I R+R K+IE E
Sbjct: 690 QGLKPCSITSSKKSHKDRNLIIYILVPIIGAII-ILSVCAGIFICFRKRTKQIEEHTDSE 748
Query: 289 ITKCADEIAIWNYDGRITFQDMIEATEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLH 348
+ ++I+++DG++ +Q++I+AT +FD KY IGTGG+G VY+A+LP+ ++A+KKL+
Sbjct: 749 --SGGETLSIFSFDGKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNA-IMAVKKLN 805
Query: 349 RLETELASL------ESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFC 402
ET +S+ + F NE R L++IRHRN+VKL+GFC H + FL+YEYME GSL
Sbjct: 806 --ETTDSSISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRK 863
Query: 403 ILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVAD 462
+L D+EA LDW KR+N+VKG+AHALSY+HH +P I+HRDISS NILL ++EA ++D
Sbjct: 864 VLENDDEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISD 923
Query: 463 FGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELL 522
FG A+LL DSSN + +AGTYG +APELAY M VTEK DVYSFGV+ LEV+ G+HPG+L+
Sbjct: 924 FGTAKLLKPDSSNWSAVAGTYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGDLV 983
Query: 523 SS-SSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553
S+ SSS D + L + D RLP P ++ +
Sbjct: 984 STLSSSPPDATLSLKSISDHRLPEPTPEIKEE 1015
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 394 bits (1012), Expect = e-109, Method: Compositional matrix adjust.
Identities = 231/583 (39%), Positives = 340/583 (58%), Gaps = 44/583 (7%)
Query: 5 RNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNR 64
++L+ N F G I G +L ++ S N G I SN +L L +++N
Sbjct: 510 KSLIRARFLGNKFTGDIFEAFGIYPDLNFIDFSHNKFHGEISSNWEKSPKLGALIMSNNN 569
Query: 65 MNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHL 124
+ G+I I ++ L LDLS N + G +P +G+L L + L+ N+L G +P+ L L
Sbjct: 570 ITGAIPTEIWNMTQLVELDLSTNNLFGELPEAIGNLTNLSRLRLNGNQLSGRVPAGLSFL 629
Query: 125 TQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNF 184
T L +L++ +N IP + KL + L N GSIP ++ KL +L LDLS N
Sbjct: 630 TNLESLDLSSNNFSSEIPQTFDSFLKLHDMNLSRNKFDGSIP-RLSKLTQLTQLDLSHNQ 688
Query: 185 INGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVR---KVPHLDVSGNQFGGEIPTT---- 237
++G+IPSQL +D +DLS NNLSG IP + ++D+S N+ G +P T
Sbjct: 689 LDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTFEGMIALTNVDISNNKLEGPLPDTPTFR 748
Query: 238 -------------LANVP------------PPHHKTIATGLVAIILAMVAFLALIFGILI 272
+N+P P + + ++ IL ++ L++
Sbjct: 749 KATADALEENIGLCSNIPKQRLKPCRELKKPKKNGNLVVWILVPILGVLVILSICANTFT 808
Query: 273 --IRRRRDKEIEPTGTVEITKCADEIAIWNYDGRITFQDMIEATEDFDIKYCIGTGGYGS 330
IR+R+ + G + + ++I++ DG+ +QD+IE+T +FD + IGTGGY
Sbjct: 809 YCIRKRKLQN----GRNTDPETGENMSIFSVDGKFKYQDIIESTNEFDPTHLIGTGGYSK 864
Query: 331 VYRARLPSGKVVALKKLH-RLETELAS---LESFQNEARLLSQIRHRNIVKLYGFCLHEK 386
VYRA L ++A+K+LH ++ E++ + F NE + L++IRHRN+VKL+GFC H +
Sbjct: 865 VYRANL-QDTIIAVKRLHDTIDEEISKPVVKQEFLNEVKALTEIRHRNVVKLFGFCSHRR 923
Query: 387 CMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDIS 446
FLIYEYME GSL +L DEEA L WTKR+N+VKG+AHALSY+HH PI+HRDIS
Sbjct: 924 HTFLIYEYMEKGSLNKLLANDEEAKRLTWTKRINVVKGVAHALSYMHHDRITPIVHRDIS 983
Query: 447 SNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFG 506
S NILL++++ A ++DFG A+LL DSSN + +AGTYG +APE AYTM VTEK DVYSFG
Sbjct: 984 SGNILLDNDYTAKISDFGTAKLLKTDSSNWSAVAGTYGYVAPEFAYTMKVTEKCDVYSFG 1043
Query: 507 VVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRLPPPGDQ 549
V+ LE+++GKHPG+L+SS SSS + + L + D R+ P Q
Sbjct: 1044 VLILELIIGKHPGDLVSSLSSSPGEALSLRSISDERVLEPRGQ 1086
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 345 bits (884), Expect = 6e-94, Method: Compositional matrix adjust.
Identities = 216/565 (38%), Positives = 313/565 (55%), Gaps = 30/565 (5%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASN 63
L+NL L+L N G+I LG+L L+ L L+ N+ G IP +G+LT++ I+SN
Sbjct: 474 LQNLTALELHQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSN 533
Query: 64 RMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGH 123
++ G I +GS +Q LDLS N+ G I LG L +L + LS N+L G IP S G
Sbjct: 534 QLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGD 593
Query: 124 LTQLTTLNMYNNKLDGPIPPELMNCSKLRI-LKLGNNLLSGSIPSQIGKLQELYYLDLSG 182
LT+L L + N L IP EL + L+I L + +N LSG+IP +G LQ L L L+
Sbjct: 594 LTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLND 653
Query: 183 NFINGKIPSQLGEFSCIDTVDLSMNNLSGGIP--VFVRKVPHLDVSGNQFGGEIPTTLAN 240
N ++G+IP+ +G + ++S NNL G +P +++ + +GN G + ++
Sbjct: 654 NKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNH--GLCNSQRSH 711
Query: 241 VPP--PHHKTIATGLV-----------AIILAMVAFLALIFGILIIRRRRDKEIEPTGTV 287
P PH + L+ I+ FL G+ +RR+ +
Sbjct: 712 CQPLVPHSDSKLNWLINGSQRQKILTITCIVIGSVFLITFLGLCWTIKRREPAFV---AL 768
Query: 288 EITKCADEIAIWNYDGR-ITFQDMIEATEDFDIKYCIGTGGYGSVYRARLPSGKVVALKK 346
E D + + + + T+Q +++AT +F +G G G+VY+A + G+V+A+KK
Sbjct: 769 EDQTKPDVMDSYYFPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKK 828
Query: 347 LHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRT 406
L+ +S SF+ E L +IRHRNIVKLYGFC H+ L+YEYM GSL L+
Sbjct: 829 LNSRGEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQR 888
Query: 407 DEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIA 466
E+ LDW R I G A L YLHH C P I+HRDI SNNILL+ F+A V DFG+A
Sbjct: 889 GEKNCLLDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLA 948
Query: 467 RLLNYD-SSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHP------- 518
+L++ S + + +AG+YG IAPE AYTM VTEK D+YSFGVV LE++ GK P
Sbjct: 949 KLIDLSYSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQG 1008
Query: 519 GELLSSSSSSLDKNIKLIDLLDPRL 543
G+L++ S+ I I++ D RL
Sbjct: 1009 GDLVNWVRRSIRNMIPTIEMFDARL 1033
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 338 bits (867), Expect = 7e-92, Method: Compositional matrix adjust.
Identities = 219/565 (38%), Positives = 318/565 (56%), Gaps = 34/565 (6%)
Query: 6 NLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRM 65
N+ ++L N F G IP +G S L+ L L+ N G +P +G L+QL TL I+SN++
Sbjct: 482 NVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPREIGMLSQLGTLNISSNKL 541
Query: 66 NGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLT 125
G + I + K+LQ LD+ N G++PS +G L L + LS N L G IP +LG+L+
Sbjct: 542 TGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLS 601
Query: 126 QLTTLNMYNNKLDGPIPPELMNCSKLRI-LKLGNNLLSGSIPSQIGKLQELYYLDLSGNF 184
+LT L M N +G IP EL + + L+I L L N L+G IP ++ L L +L L+ N
Sbjct: 602 RLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNN 661
Query: 185 INGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHLDVSGNQFGGEIPTTLANVPPP 244
++G+IPS S + + S N+L+G IP+ +R + GN+ P P
Sbjct: 662 LSGEIPSSFANLSSLLGYNFSYNSLTGPIPL-LRNISMSSFIGNEGLCGPPLNQCIQTQP 720
Query: 245 HHKTIATG---------LVAIILAMVAFLALIFGILIIRRRRDKEIEPTGTVEITKCADE 295
+ +TG ++AI A++ ++L+ LI+ R P TV + +
Sbjct: 721 FAPSQSTGKPGGMRSSKIIAITAAVIGGVSLMLIALIVYLMR----RPVRTVASSAQDGQ 776
Query: 296 IAIWNYD------GRITFQDMIEATEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKL-- 347
+ + D TFQD++ AT++FD + +G G G+VY+A LP+G +A+KKL
Sbjct: 777 PSEMSLDIYFPPKEGFTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLAS 836
Query: 348 -HRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRT 406
H SF+ E L IRHRNIVKL+GFC H+ L+YEYM GSL IL
Sbjct: 837 NHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILH- 895
Query: 407 DEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIA 466
+ + LDW+KR I G A L+YLHH C P I HRDI SNNILL+ +FEA V DFG+A
Sbjct: 896 -DPSCNLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLA 954
Query: 467 RLLNY-DSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHP------- 518
++++ S + + +AG+YG IAPE AYTM VTEK D+YS+GVV LE+L GK P
Sbjct: 955 KVIDMPHSKSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQG 1014
Query: 519 GELLSSSSSSLDKNIKLIDLLDPRL 543
G++++ S + ++ +LD RL
Sbjct: 1015 GDVVNWVRSYIRRDALSSGVLDARL 1039
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 331 bits (848), Expect = 1e-89, Method: Compositional matrix adjust.
Identities = 219/587 (37%), Positives = 328/587 (55%), Gaps = 32/587 (5%)
Query: 3 RLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIAS 62
+L NL ++L N F G +PP +G +L+ L+L+ N N+P+ + L+ L T ++S
Sbjct: 491 KLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSS 550
Query: 63 NRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLG 122
N + G I I + K+LQ LDLSRN GS+P LG L L + LS+N+ G IP ++G
Sbjct: 551 NSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIG 610
Query: 123 HLTQLTTLNMYNNKLDGPIPPELMNCSKLRI-LKLGNNLLSGSIPSQIGKLQELYYLDLS 181
+LT LT L M N G IPP+L S L+I + L N SG IP +IG L L YL L+
Sbjct: 611 NLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLN 670
Query: 182 GNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIP--VFVRKVPHLDVSGNQ--FGGEIPTT 237
N ++G+IP+ S + + S NNL+G +P + + GN+ GG + +
Sbjct: 671 NNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGGHLRSC 730
Query: 238 -LANVPPPHHKTIATG------LVAIILAMVAFLALIFGILIIRRRRDKEIEPTGTVEIT 290
++ PH ++ G ++ I+ +++ ++L+ +++ R+ +EPT
Sbjct: 731 DPSHSSWPHISSLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHFLRNP-VEPTAPYVHD 789
Query: 291 K--CADEIAIWNY-DGRITFQDMIEATEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKL 347
K E I+ R T +D++EAT+ F Y +G G G+VY+A +PSGK +A+KKL
Sbjct: 790 KEPFFQESDIYFVPKERFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKL 849
Query: 348 H-----RLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHE--KCMFLIYEYMEMGSL 400
+ SF+ E L +IRHRNIV+LY FC H+ L+YEYM GSL
Sbjct: 850 ESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSL 909
Query: 401 FCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFV 460
+L ++ +DW R I G A L+YLHH C P I+HRDI SNNIL++ FEA V
Sbjct: 910 GELLHGG-KSHSMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHV 968
Query: 461 ADFGIARLLNYD-SSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHP- 518
DFG+A++++ S + + +AG+YG IAPE AYTM VTEK D+YSFGVV LE+L GK P
Sbjct: 969 GDFGLAKVIDMPLSKSVSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPV 1028
Query: 519 ------GELLSSSSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILIS 559
G+L + + + + + ++LDP L D +I +I ++
Sbjct: 1029 QPLEQGGDLATWTRNHIRDHSLTSEILDPYLTKVEDDVILNHMITVT 1075
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGW6|ERL1_ARATH LRR receptor-like serine/threonine-protein kinase ERL1 OS=Arabidopsis thaliana GN=ERL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 323 bits (828), Expect = 2e-87, Method: Compositional matrix adjust.
Identities = 204/522 (39%), Positives = 297/522 (56%), Gaps = 11/522 (2%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAI 60
+G + L +L L+DN +G IPP LG+L +L LNL+ N LVG IPSN+ L +
Sbjct: 330 LGNMSRLSYLQLNDNKLVGTIPPELGKLEQLFELNLANNRLVGPIPSNISSCAALNQFNV 389
Query: 61 ASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSS 120
N ++GSI L +L L L+LS N G IP LGH+ L +DLS N G IP +
Sbjct: 390 HGNLLSGSIPLAFRNLGSLTYLNLSSNNFKGKIPVELGHIINLDKLDLSGNNFSGSIPLT 449
Query: 121 LGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDL 180
LG L L LN+ N L G +P E N ++++ + NLLSG IP+++G+LQ L L L
Sbjct: 450 LGDLEHLLILNLSRNHLSGQLPAEFGNLRSIQMIDVSFNLLSGVIPTELGQLQNLNSLIL 509
Query: 181 SGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPV---FVRKVPHLDVSGNQFGGEIPTT 237
+ N ++GKIP QL + +++S NNLSG +P F R P V G +
Sbjct: 510 NNNKLHGKIPDQLTNCFTLVNLNVSFNNLSGIVPPMKNFSRFAPASFVGNPYLCGNWVGS 569
Query: 238 LANVPPPHHKTIATG-LVAIILAMVAFLALIFGILIIRRRRDKEIEPTGTVEITKCADEI 296
+ P P + + G L+ I+L ++ L +IF + + + + K+I G+ + + ++
Sbjct: 570 ICG-PLPKSRVFSRGALICIVLGVITLLCMIF-LAVYKSMQQKKIL-QGSSKQAEGLTKL 626
Query: 297 AIWNYDGRI-TFQDMIEATEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELA 355
I + D I TF D++ TE+ + K+ IG G +VY+ L S + +A+K+L+
Sbjct: 627 VILHMDMAIHTFDDIMRVTENLNEKFIIGYGASSTVYKCALKSSRPIAIKRLYNQYPH-- 684
Query: 356 SLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDW 415
+L F+ E + IRHRNIV L+G+ L L Y+YME GSL+ +L + V LDW
Sbjct: 685 NLREFETELETIGSIRHRNIVSLHGYALSPTGNLLFYDYMENGSLWDLLHGSLKKVKLDW 744
Query: 416 TKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSN 475
R+ I G A L+YLHH CTP I+HRDI S+NILL+ FEA ++DFGIA+ + ++
Sbjct: 745 ETRLKIAVGAAQGLAYLHHDCTPRIIHRDIKSSNILLDENFEAHLSDFGIAKSIPASKTH 804
Query: 476 -RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGK 516
T + GT G I PE A T + EK D+YSFG+V LE+L GK
Sbjct: 805 ASTYVLGTIGYIDPEYARTSRINEKSDIYSFGIVLLELLTGK 846
|
Receptor kinase that regulates inflorescence architecture and organ shape as well as stomatal patterning, including density and clustering, together with ER and ERL2. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 323 bits (828), Expect = 2e-87, Method: Compositional matrix adjust.
Identities = 212/602 (35%), Positives = 331/602 (54%), Gaps = 54/602 (8%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAI 60
+G+ NL L L N F G IP T G++SEL +L++S NSL G IP +G +LT + +
Sbjct: 596 LGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHIDL 655
Query: 61 ASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSS 120
+N ++G I +G L +L L LS N+ GS+P+ + L + ++ L N L G IP
Sbjct: 656 NNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQE 715
Query: 121 LGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELY-YLD 179
+G+L L LN+ N+L GP+P + SKL L+L N L+G IP +IG+LQ+L LD
Sbjct: 716 IGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALD 775
Query: 180 LSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFV---RKVPHLDVSGNQFGGEIPT 236
LS N G+IPS + ++++DLS N L G +P + + + +L++S N G++
Sbjct: 776 LSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKK 835
Query: 237 T--------------LANVPPPH--------HKTIATGLVAII-----LAMVAFLALIFG 269
L P H ++++ V II LA +A + L+
Sbjct: 836 QFSRWQADAFVGNAGLCGSPLSHCNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVI- 894
Query: 270 ILIIRRRRD--KEIEPTGTVEITKCADEIAIWNYDG----RITFQDMIEATEDFDIKYCI 323
IL ++ D K++ + + + A +G I + D++EAT + ++ I
Sbjct: 895 ILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMI 954
Query: 324 GTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCL 383
G+GG G VY+A L +G+ +A+KK+ + +L S +SF E + L IRHR++VKL G+C
Sbjct: 955 GSGGSGKVYKAELKNGETIAVKKI-LWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCS 1013
Query: 384 HEK--CMFLIYEYMEMGSLFCILRTDEEAVG---LDWTKRVNIVKGMAHALSYLHHHCTP 438
+ LIYEYM GS++ L +E L W R+ I G+A + YLH+ C P
Sbjct: 1014 SKADGLNLLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVP 1073
Query: 439 PILHRDISSNNILLNSEFEAFVADFGIARLL--NYDSS--NRTLLAGTYGSIAPELAYTM 494
PI+HRDI S+N+LL+S EA + DFG+A++L NYD++ + T+ AG+YG IAPE AY++
Sbjct: 1074 PIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSL 1133
Query: 495 VVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRLPPPGDQMIRQG 554
TEK DVYS G+V +E++ GK P E + D+ ++ ++ L P R+
Sbjct: 1134 KATEKSDVYSMGIVLMEIVTGKMPTEAM------FDEETDMVRWVETVLDTPPGSEAREK 1187
Query: 555 II 556
+I
Sbjct: 1188 LI 1189
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6XAT2|ERL2_ARATH LRR receptor-like serine/threonine-protein kinase ERL2 OS=Arabidopsis thaliana GN=ERL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 323 bits (827), Expect = 3e-87, Method: Compositional matrix adjust.
Identities = 197/528 (37%), Positives = 295/528 (55%), Gaps = 22/528 (4%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAI 60
+G + L +L L+DN +G IPP LG+L +L LNL+ N+LVG IPSN+ L +
Sbjct: 332 LGNMSRLSYLQLNDNELVGKIPPELGKLEQLFELNLANNNLVGLIPSNISSCAALNQFNV 391
Query: 61 ASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSS 120
N ++G++ L +L L L+LS N G IP+ LGH+ L ++DLS N G IP +
Sbjct: 392 HGNFLSGAVPLEFRNLGSLTYLNLSSNSFKGKIPAELGHIINLDTLDLSGNNFSGSIPLT 451
Query: 121 LGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDL 180
LG L L LN+ N L+G +P E N ++I+ + N L+G IP+++G+LQ + L L
Sbjct: 452 LGDLEHLLILNLSRNHLNGTLPAEFGNLRSIQIIDVSFNFLAGVIPTELGQLQNINSLIL 511
Query: 181 SGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPV---FVRKVPHLDVSGNQF--GGEIP 235
+ N I+GKIP QL + +++S NNLSG IP F R P GN F G +
Sbjct: 512 NNNKIHGKIPDQLTNCFSLANLNISFNNLSGIIPPMKNFTRFSPA-SFFGNPFLCGNWVG 570
Query: 236 TTLANVPPPHHKTIATGLVAIILAMVAFLALIFGILIIRRRRDKEI------EPTGTVEI 289
+ P ++ ++L + + +IF I + + ++ K + +P G+ ++
Sbjct: 571 SICGPSLPKSQVFTRVAVICMVLGFITLICMIF-IAVYKSKQQKPVLKGSSKQPEGSTKL 629
Query: 290 TKCADEIAIWNYDGRITFQDMIEATEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHR 349
++AI TF D++ TE+ D KY IG G +VY+ + + +A+K+++
Sbjct: 630 VILHMDMAIH------TFDDIMRVTENLDEKYIIGYGASSTVYKCTSKTSRPIAIKRIYN 683
Query: 350 LETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEE 409
++ F+ E + IRHRNIV L+G+ L L Y+YME GSL+ +L +
Sbjct: 684 QYP--SNFREFETELETIGSIRHRNIVSLHGYALSPFGNLLFYDYMENGSLWDLLHGPGK 741
Query: 410 AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL 469
V LDW R+ I G A L+YLHH CTP I+HRDI S+NILL+ FEA ++DFGIA+ +
Sbjct: 742 KVKLDWETRLKIAVGAAQGLAYLHHDCTPRIIHRDIKSSNILLDGNFEARLSDFGIAKSI 801
Query: 470 NYDSS-NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGK 516
+ T + GT G I PE A T + EK D+YSFG+V LE+L GK
Sbjct: 802 PATKTYASTYVLGTIGYIDPEYARTSRLNEKSDIYSFGIVLLELLTGK 849
|
Receptor kinase that regulates inflorescence architecture and organ shape as well as stomatal patterning, including density and clustering, together with ERL1 and ER. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 320 bits (819), Expect = 3e-86, Method: Compositional matrix adjust.
Identities = 215/611 (35%), Positives = 325/611 (53%), Gaps = 73/611 (11%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAI 60
+G +NL L L N G IP TLG++ EL +L++S N+L G IP + +LT + +
Sbjct: 595 LGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDL 654
Query: 61 ASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSS 120
+N ++G I +G L L L LS N+ S+P+ L + L + L N L G IP
Sbjct: 655 NNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQE 714
Query: 121 LGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELY-YLD 179
+G+L L LN+ N+ G +P + SKL L+L N L+G IP +IG+LQ+L LD
Sbjct: 715 IGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALD 774
Query: 180 LSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFV---RKVPHLDVSGNQFGGEIPT 236
LS N G IPS +G S ++T+DLS N L+G +P V + + +L+VS N GG++
Sbjct: 775 LSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKK 834
Query: 237 TLANVPPP-----------------------HHKTIATGLVAIILAMVAFLALIFGILII 273
+ P + ++ V II A+ A A+ IL+I
Sbjct: 835 QFSRWPADSFLGNTGLCGSPLSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVI 894
Query: 274 ----RRRRD--KEIEPTGTVEITKCADEIAIWN-------YDGRITFQDMIEATEDFDIK 320
++R D K++ T + + A I ++D++EAT + +
Sbjct: 895 ALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEE 954
Query: 321 YCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYG 380
+ IG+GG G VY+A L +G+ VA+KK+ + +L S +SF E + L +IRHR++VKL G
Sbjct: 955 FMIGSGGSGKVYKAELENGETVAVKKI-LWKDDLMSNKSFSREVKTLGRIRHRHLVKLMG 1013
Query: 381 FC--LHEKCMFLIYEYMEMGSLFCILRTDEEAVG-----LDWTKRVNIVKGMAHALSYLH 433
+C E LIYEYM+ GS++ L D+ + LDW R+ I G+A + YLH
Sbjct: 1014 YCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLH 1073
Query: 434 HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL----NYDSSNRTLLAGTYGSIAPE 489
H C PPI+HRDI S+N+LL+S EA + DFG+A++L + ++ + T A +YG IAPE
Sbjct: 1074 HDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPE 1133
Query: 490 LAYTMVVTEKYDVYSFGVVALEVLMGKHPGEL---------------LSSSSSSLDKNIK 534
AY++ TEK DVYS G+V +E++ GK P + L + S+ DK
Sbjct: 1134 YAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLEVAGSARDK--- 1190
Query: 535 LIDLLDPRLPP 545
L+DP+L P
Sbjct: 1191 ---LIDPKLKP 1198
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 312 bits (799), Expect = 5e-84, Method: Compositional matrix adjust.
Identities = 205/568 (36%), Positives = 296/568 (52%), Gaps = 66/568 (11%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASN 63
LRNL L L N G IP +G S L L L N + G IPS +G L ++ L +SN
Sbjct: 441 LRNLTKLLLISNSLSGFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSN 500
Query: 64 RMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGH 123
R++G + IGS LQ++DLS N + GS+P+ + L L+ +D+S N+ G IP+SLG
Sbjct: 501 RLHGKVPDEIGSCSELQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGR 560
Query: 124 LTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQEL-YYLDLSG 182
L L L + N G IP L CS L++L LG+N LSG IPS++G ++ L L+LS
Sbjct: 561 LVSLNKLILSKNLFSGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSS 620
Query: 183 NFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVF--VRKVPHLDVSGNQFGGEIPTT--L 238
N + GKIPS++ + + +DLS N L G + + + L++S N F G +P
Sbjct: 621 NRLTGKIPSKIASLNKLSILDLSHNMLEGDLAPLANIENLVSLNISYNSFSGYLPDNKLF 680
Query: 239 ANVPPP----HHKTIATGLVAIILA----------------------------MVAFLAL 266
+ P + K ++ + L + L +
Sbjct: 681 RQLSPQDLEGNKKLCSSTQDSCFLTYRKGNGLGDDGDASRTRKLRLTLALLITLTVVLMI 740
Query: 267 IFGILIIRRRRDKEIEPTGTVEITKCADEIAIWNYDGRITFQDMIEATEDFDIKYC---- 322
+ + +IR RR+ + E + E W + FQ + + + I C
Sbjct: 741 LGAVAVIRARRNIDNERDSEL------GETYKWQF---TPFQKLNFSVDQ--IIRCLVEP 789
Query: 323 --IGTGGYGSVYRARLPSGKVVALKKL--------HRLETELASLESFQNEARLLSQIRH 372
IG G G VYRA + +G+V+A+KKL H +T+ +SF E + L IRH
Sbjct: 790 NVIGKGCSGVVYRADVDNGEVIAVKKLWPAMVNGGHDEKTKNVR-DSFSAEVKTLGTIRH 848
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYL 432
+NIV+ G C + L+Y+YM GSL +L + LDW R I+ G A L+YL
Sbjct: 849 KNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLH-ERRGSSLDWDLRYRILLGAAQGLAYL 907
Query: 433 HHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNR--TLLAGTYGSIAPEL 490
HH C PPI+HRDI +NNIL+ +FE ++ADFG+A+L++ R +AG+YG IAPE
Sbjct: 908 HHDCLPPIVHRDIKANNILIGLDFEPYIADFGLAKLVDEGDIGRCSNTVAGSYGYIAPEY 967
Query: 491 AYTMVVTEKYDVYSFGVVALEVLMGKHP 518
Y+M +TEK DVYS+GVV LEVL GK P
Sbjct: 968 GYSMKITEKSDVYSYGVVVLEVLTGKQP 995
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 560 | ||||||
| 359484068 | 868 | PREDICTED: probable leucine-rich repeat | 0.989 | 0.638 | 0.500 | 1e-154 | |
| 296085307 | 874 | unnamed protein product [Vitis vinifera] | 0.989 | 0.633 | 0.500 | 1e-153 | |
| 225466223 | 736 | PREDICTED: probable leucine-rich repeat | 0.992 | 0.755 | 0.526 | 1e-153 | |
| 225465647 | 820 | PREDICTED: probable LRR receptor-like se | 0.983 | 0.671 | 0.503 | 1e-153 | |
| 359484066 | 843 | PREDICTED: probable LRR receptor-like se | 0.991 | 0.658 | 0.5 | 1e-152 | |
| 225452694 | 783 | PREDICTED: probable LRR receptor-like se | 0.967 | 0.692 | 0.533 | 1e-152 | |
| 296085303 | 789 | unnamed protein product [Vitis vinifera] | 0.991 | 0.703 | 0.5 | 1e-152 | |
| 225452698 | 727 | PREDICTED: probable LRR receptor-like se | 0.996 | 0.767 | 0.494 | 1e-149 | |
| 359484063 | 1003 | PREDICTED: probable LRR receptor-like se | 0.994 | 0.555 | 0.494 | 1e-149 | |
| 224110024 | 827 | predicted protein [Populus trichocarpa] | 0.989 | 0.669 | 0.490 | 1e-148 |
| >gi|359484068|ref|XP_002271708.2| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At1g35710-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 550 bits (1417), Expect = e-154, Method: Compositional matrix adjust.
Identities = 303/605 (50%), Positives = 404/605 (66%), Gaps = 51/605 (8%)
Query: 1 MGRLRNLVHLDLSDNHFM-GHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLA 59
+G L+NL+HLDLS N+++ G IP ++G L L L+L NSL IPS++G LT L L
Sbjct: 220 IGNLKNLIHLDLSYNYYLSGAIPSSIGYLKNLIHLDLGSNSLSSVIPSSLGSLTNLEYLY 279
Query: 60 IASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPS 119
+ NR+NGSI IG+LK L L LS N + G+IPS+LG+L L L N++ G IP
Sbjct: 280 LNFNRINGSIPSEIGNLKNLVQLSLSHNALLGTIPSSLGNLINLTYFHLIDNQIQGLIPL 339
Query: 120 SLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSG---------------- 163
S G+LT LT L + N+++G IPP + N L L+L +N L+G
Sbjct: 340 SFGNLTNLTHLYLRYNQINGSIPPVIWNLKNLIHLRLDHNNLTGVIPSLGYLIHLNVFNI 399
Query: 164 -------SIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIP-- 214
IPS+IG L L LDLS N I+GKIPSQL +++++LS N LSG IP
Sbjct: 400 RRNRIRGHIPSKIGNLNNLTSLDLSDNLIDGKIPSQLQNLKSLESLNLSHNKLSGHIPPL 459
Query: 215 -VFVRKVPHLDVSGNQFGGEIPTTLANVPPP-----------------HHKTIATGLVAI 256
+++ K +D S N F G IP L V PP H K ++ I
Sbjct: 460 SIYIHKGSSIDFSHNDFEGHIPHELQFVYPPRVFGHNKGLCGEREGLPHCKRGHKTILII 519
Query: 257 ILAMVAFLALI-FGILIIRRR-RDKEIEPTGTVEITKCADEIAIWNYDGRITFQDMIEAT 314
L+ + FL+ + GIL++ R+ R + + T T K D ++WNYDG+I ++D+IEAT
Sbjct: 520 SLSTILFLSFVALGILLLSRKTRRNQTKATST----KNGDIFSVWNYDGKIAYEDIIEAT 575
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELAS-LESFQNEARLLSQIRHR 373
EDFDIKYCIGTGGYGSVY+A+LP+G VVALKKLH E + A+ L+SFQNE ++LS+I+HR
Sbjct: 576 EDFDIKYCIGTGGYGSVYKAQLPTGNVVALKKLHGWERDEATYLKSFQNEVQVLSKIQHR 635
Query: 374 NIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLH 433
NI+KL+G+CLH++CMFLIY+YME GSL+C+L + EA+ LDW KRVN++K + HAL Y+H
Sbjct: 636 NIIKLHGYCLHKRCMFLIYKYMERGSLYCVLSNEVEALELDWIKRVNVIKSIVHALCYMH 695
Query: 434 HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYT 493
H TPPI+HRD+SSNNILL+ + +AF++DFG ARLL+ DSSN+TLLAGTYG IAPELAYT
Sbjct: 696 HDSTPPIIHRDVSSNNILLDFKLDAFLSDFGTARLLHPDSSNQTLLAGTYGYIAPELAYT 755
Query: 494 MVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553
M VTEK DVYSFGVVALE +MG+HP EL + SSS +NI L D+LD RLP P D+ + +
Sbjct: 756 MAVTEKCDVYSFGVVALETMMGRHPRELFTLLSSSSAQNIMLTDILDSRLPSPQDRQVAR 815
Query: 554 GIILI 558
++L+
Sbjct: 816 DVVLV 820
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296085307|emb|CBI29039.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 549 bits (1415), Expect = e-153, Method: Compositional matrix adjust.
Identities = 303/605 (50%), Positives = 404/605 (66%), Gaps = 51/605 (8%)
Query: 1 MGRLRNLVHLDLSDNHFM-GHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLA 59
+G L+NL+HLDLS N+++ G IP ++G L L L+L NSL IPS++G LT L L
Sbjct: 226 IGNLKNLIHLDLSYNYYLSGAIPSSIGYLKNLIHLDLGSNSLSSVIPSSLGSLTNLEYLY 285
Query: 60 IASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPS 119
+ NR+NGSI IG+LK L L LS N + G+IPS+LG+L L L N++ G IP
Sbjct: 286 LNFNRINGSIPSEIGNLKNLVQLSLSHNALLGTIPSSLGNLINLTYFHLIDNQIQGLIPL 345
Query: 120 SLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSG---------------- 163
S G+LT LT L + N+++G IPP + N L L+L +N L+G
Sbjct: 346 SFGNLTNLTHLYLRYNQINGSIPPVIWNLKNLIHLRLDHNNLTGVIPSLGYLIHLNVFNI 405
Query: 164 -------SIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIP-- 214
IPS+IG L L LDLS N I+GKIPSQL +++++LS N LSG IP
Sbjct: 406 RRNRIRGHIPSKIGNLNNLTSLDLSDNLIDGKIPSQLQNLKSLESLNLSHNKLSGHIPPL 465
Query: 215 -VFVRKVPHLDVSGNQFGGEIPTTLANVPPP-----------------HHKTIATGLVAI 256
+++ K +D S N F G IP L V PP H K ++ I
Sbjct: 466 SIYIHKGSSIDFSHNDFEGHIPHELQFVYPPRVFGHNKGLCGEREGLPHCKRGHKTILII 525
Query: 257 ILAMVAFLALI-FGILIIRRR-RDKEIEPTGTVEITKCADEIAIWNYDGRITFQDMIEAT 314
L+ + FL+ + GIL++ R+ R + + T T K D ++WNYDG+I ++D+IEAT
Sbjct: 526 SLSTILFLSFVALGILLLSRKTRRNQTKATST----KNGDIFSVWNYDGKIAYEDIIEAT 581
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELAS-LESFQNEARLLSQIRHR 373
EDFDIKYCIGTGGYGSVY+A+LP+G VVALKKLH E + A+ L+SFQNE ++LS+I+HR
Sbjct: 582 EDFDIKYCIGTGGYGSVYKAQLPTGNVVALKKLHGWERDEATYLKSFQNEVQVLSKIQHR 641
Query: 374 NIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLH 433
NI+KL+G+CLH++CMFLIY+YME GSL+C+L + EA+ LDW KRVN++K + HAL Y+H
Sbjct: 642 NIIKLHGYCLHKRCMFLIYKYMERGSLYCVLSNEVEALELDWIKRVNVIKSIVHALCYMH 701
Query: 434 HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYT 493
H TPPI+HRD+SSNNILL+ + +AF++DFG ARLL+ DSSN+TLLAGTYG IAPELAYT
Sbjct: 702 HDSTPPIIHRDVSSNNILLDFKLDAFLSDFGTARLLHPDSSNQTLLAGTYGYIAPELAYT 761
Query: 494 MVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553
M VTEK DVYSFGVVALE +MG+HP EL + SSS +NI L D+LD RLP P D+ + +
Sbjct: 762 MAVTEKCDVYSFGVVALETMMGRHPRELFTLLSSSSAQNIMLTDILDSRLPSPQDRQVAR 821
Query: 554 GIILI 558
++L+
Sbjct: 822 DVVLV 826
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225466223|ref|XP_002267065.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At1g35710 [Vitis vinifera] gi|147859823|emb|CAN79273.1| hypothetical protein VITISV_014885 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 548 bits (1411), Expect = e-153, Method: Compositional matrix adjust.
Identities = 296/562 (52%), Positives = 390/562 (69%), Gaps = 6/562 (1%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAI 60
+ L LV L+L NH G IP +G L L L L N L G IPS++G LT+LT+L I
Sbjct: 129 LTNLTKLVELNLGYNHISGQIPSEIGNLRNLVGLVLDCNYLNGVIPSSLGQLTRLTSLYI 188
Query: 61 ASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSS 120
N+M GSI I SLK L + N + G IPS++G+L L S+ L+ N++ G IPS
Sbjct: 189 GWNQMEGSIPPEIWSLKSLVDIYFDHNILTGVIPSSVGNLTNLTSLHLASNQITGSIPSE 248
Query: 121 LGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDL 180
+G L +L L + NNKL G IP EL NC LR L + N L+GSIPS+IG L L LDL
Sbjct: 249 IGSLKKLVDLALDNNKLVGVIPKELGNCHSLRYLSMKFNRLNGSIPSEIGGLVALRKLDL 308
Query: 181 SGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHLDVSGNQFGGEIPTTLAN 240
S N I+G IP Q F+ ++ +DLS N L G +P F +P L + G T
Sbjct: 309 SVNNISGTIPLQFQNFNSLEYLDLSYNYLEGYVP-FELHLPSLFRAFEHNKGLCGDTKFG 367
Query: 241 VPPPHHKTIATGLVAIILAMVAFL---ALIFGILIIRRRRDKEIEPTGTVEITKCADEIA 297
+PP + T ++ +++ + + L ++IFG+L+I RR+ ++++P T+ D +
Sbjct: 368 IPPCRKRNRITIIIIVVICLCSALLISSIIFGVLLIWRRKTRKLQPE-EATTTQNGDIFS 426
Query: 298 IWNYDGRITFQDMIEATEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELAS- 356
IW+YDG+I ++D+IEATEDFDIKYCIGTGGYGSVYRA+L +GK VALKKLH LE++ +
Sbjct: 427 IWDYDGKIAYEDIIEATEDFDIKYCIGTGGYGSVYRAKLTNGKEVALKKLHTLESQNPTY 486
Query: 357 LESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWT 416
++SF NE R+LS+IRHRNIVKLYGFCLH++CMFL+YEYME GSL C+L + EA+ DW
Sbjct: 487 MKSFTNEVRVLSKIRHRNIVKLYGFCLHKRCMFLVYEYMERGSLHCVLSDEIEALEFDWI 546
Query: 417 KRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNR 476
KRVN+VK +A+ALSY+H+ C PP+LHRDISS NILL+SEF A V+DFG ARLL+ DSSN+
Sbjct: 547 KRVNVVKSIANALSYMHNDCIPPLLHRDISSGNILLDSEFRAVVSDFGTARLLDPDSSNQ 606
Query: 477 TLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLI 536
TLLAGTYG +APELAYTMVVTEK DVYSFGV+ LE++MGKHP EL++ S+S +NI L+
Sbjct: 607 TLLAGTYGYVAPELAYTMVVTEKCDVYSFGVLTLEIMMGKHPRELVTILSTSSSQNIMLV 666
Query: 537 DLLDPRLPPPGDQMIRQGIILI 558
D+LDPRL P D + ++LI
Sbjct: 667 DILDPRLAPHIDPEVIDNVVLI 688
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225465647|ref|XP_002270862.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 548 bits (1411), Expect = e-153, Method: Compositional matrix adjust.
Identities = 308/612 (50%), Positives = 397/612 (64%), Gaps = 61/612 (9%)
Query: 1 MGRLRNLVHLDLSDNH-FMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLA 59
+G L+NL+HLDLS N+ G IPP+LG L LK L+LS+N + G+IPS +G+L LT L
Sbjct: 168 LGYLKNLIHLDLSFNYGLSGVIPPSLGYLKNLKYLDLSINEINGSIPSQIGNLKNLTHLY 227
Query: 60 IASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPS 119
+ SN ++G I + +L L+ L L+ N I GSIPS +G+LK L + LS N L+G IPS
Sbjct: 228 LVSNSLSGVIPSPLANLSNLEYLFLNFNRINGSIPSEIGNLKNLVQLCLSHNSLIGAIPS 287
Query: 120 SLGHLTQLTTLNMYNNKL------------------------DGPIPPELMNCSKLRILK 155
SLGHLT LT L+++NN++ +G IPP + N L L+
Sbjct: 288 SLGHLTNLTYLHLFNNQIQGGIPLSFGHLTNLTDLYLCYNQINGSIPPIIWNLKNLIHLR 347
Query: 156 LGNNLL------------------------SGSIPSQIGKLQELYYLDLSGNFINGKIPS 191
L +N L SG IPS IG L L LDLS N I+GKIPS
Sbjct: 348 LDHNNLTGVIPSSLGYLIHLHEFNISGNQISGQIPSSIGNLNNLTRLDLSDNLIHGKIPS 407
Query: 192 QLGEFSCIDTVDLSMNNLSGGIP---VFVRKVPHLDVSGNQFGGEIPTTLANVPPPHHKT 248
Q+ + ++LS N LSG IP ++ P LD+S N G IP L +
Sbjct: 408 QVQNLKRLVYLNLSHNKLSGSIPTLLIYDHIRPSLDLSYNDLEGHIPFELQSKFSQGSFD 467
Query: 249 IATGLVAIILAMVAFLALIFGILIIRRR-RDKEIEPTGTVEITKCADEIAIWNYDGRITF 307
GL I + II R+ + KEI TK D ++WNYDG+I +
Sbjct: 468 NNKGLCGDIKGLPHCKEEYKTTRIITRKIQTKEIP-------TKNGDIFSVWNYDGKIAY 520
Query: 308 QDMIEATEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELAS-LESFQNEARL 366
+D+I+ATEDFDIKYCIGTGGYGSVY+A+LP+G VVALKKLH ET+ A+ L+SFQNE ++
Sbjct: 521 EDIIKATEDFDIKYCIGTGGYGSVYKAQLPTGNVVALKKLHGWETDEATYLKSFQNEVQI 580
Query: 367 LSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMA 426
LS+IRHRNIVKL G+CLH++CMFLIY YM GSL+C+L + EA+ LDW KRVN+VK +
Sbjct: 581 LSKIRHRNIVKLQGYCLHKRCMFLIYNYMGRGSLYCVLSNEVEALELDWIKRVNVVKSIV 640
Query: 427 HALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI 486
HA+ Y+HH CTPPI+HRDISSNNILL+S+ +AF++DFG +RLL+ DSSN+TLL+GTYG I
Sbjct: 641 HAVCYMHHDCTPPIIHRDISSNNILLDSKLDAFLSDFGTSRLLHPDSSNQTLLSGTYGYI 700
Query: 487 APELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRLPPP 546
APELAYTMVVTEK DVYSFGVVALE +MGKHPGEL + SSS +NI L D+LD RLP P
Sbjct: 701 APELAYTMVVTEKCDVYSFGVVALETMMGKHPGELFTLLSSSSTQNIMLTDMLDSRLPSP 760
Query: 547 GDQMIRQGIILI 558
DQ + + ++L+
Sbjct: 761 QDQQVARDVVLV 772
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484066|ref|XP_002271307.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 545 bits (1405), Expect = e-152, Method: Compositional matrix adjust.
Identities = 303/606 (50%), Positives = 395/606 (65%), Gaps = 51/606 (8%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAI 60
+G L+NL +LDLS N G IP +G L L L L NSL G IPS++ +L+ L L +
Sbjct: 193 LGYLKNLKYLDLSINEINGSIPYQIGNLKNLTHLYLVSNSLSGVIPSSLANLSNLEYLFL 252
Query: 61 ASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSS 120
NR+NGSI IG+LK L L S N + G+IP +LGHL L + L N++ G IP S
Sbjct: 253 NFNRINGSIPSEIGNLKNLVQLCFSHNSLIGTIPPSLGHLTNLTYLHLFNNQIQGGIPLS 312
Query: 121 LGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSG----------------- 163
GHLT+LT LN+ +N+++G IPP + N L L+L +N L+G
Sbjct: 313 FGHLTKLTDLNLCDNQINGSIPPIIWNLKNLIHLRLDHNNLTGVIPSSLGYLIHLNEFNI 372
Query: 164 -------SIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIP-- 214
IPS IG L L LDLS N I+GKIPSQ+ + ++LS N LSG IP
Sbjct: 373 SGNRINGHIPSTIGNLNNLTRLDLSANLIHGKIPSQVQNLKRLTYLNLSHNKLSGSIPTL 432
Query: 215 -VFVRKVPHLDVSGNQFGGEIPTTLAN-------------------VPPPHHKTIATGLV 254
++ P LD+S N G IP L + +P + T ++
Sbjct: 433 LIYDHIKPSLDLSHNDLEGHIPFELQSKFSQGSFDNNKGLCGDIKGLPHCKEEYKTTRII 492
Query: 255 AIILAMVAFLALIFGILIIRRRRDKEIEPTGTVEI-TKCADEIAIWNYDGRITFQDMIEA 313
I L+ FL + ++ R+ ++I+ T EI TK D ++WNYDG+I ++D+I+A
Sbjct: 493 VISLSTTLFLFFVVLGFLLLSRKTRKIQ---TKEIPTKNGDIFSVWNYDGKIAYEDIIKA 549
Query: 314 TEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELA-SLESFQNEARLLSQIRH 372
TEDFDIKYCIGTGGYGSVY+A+LP+G VVALKKLH E + A L+SFQNE ++LS+IRH
Sbjct: 550 TEDFDIKYCIGTGGYGSVYKAQLPTGNVVALKKLHGWERDEAIYLKSFQNEVQILSKIRH 609
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYL 432
RNIVKL G+CLH++CMFLIY YM GSL+C+L + EA+ LDW KRVN+VK + HA+ Y+
Sbjct: 610 RNIVKLQGYCLHKRCMFLIYNYMGRGSLYCVLSNEVEALELDWIKRVNVVKSIVHAVCYM 669
Query: 433 HHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAY 492
HH CTPPI+HRDISSNNILL+S+ +AF++DFG ARLL+ DSSN+TLLAGTYG IAPELAY
Sbjct: 670 HHDCTPPIIHRDISSNNILLDSKLDAFLSDFGTARLLHPDSSNQTLLAGTYGYIAPELAY 729
Query: 493 TMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRLPPPGDQMIR 552
TMVVTEK DVYSFGVVALE +MGKHPGEL + SSS +NI L ++LD RLP P DQ +
Sbjct: 730 TMVVTEKCDVYSFGVVALETMMGKHPGELFTLLSSSSTQNIMLTNILDSRLPSPQDQQVA 789
Query: 553 QGIILI 558
+ ++L+
Sbjct: 790 RDVVLV 795
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225452694|ref|XP_002276873.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 545 bits (1404), Expect = e-152, Method: Compositional matrix adjust.
Identities = 298/559 (53%), Positives = 385/559 (68%), Gaps = 17/559 (3%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAI 60
GRL L HLDLS N G IP +G L+EL L+LS L G IPS++GHLT+LT L +
Sbjct: 192 FGRLTKLTHLDLSSNQLTGPIPHPIGTLTELIFLHLSWTELTGAIPSSLGHLTKLTHLDL 251
Query: 61 ASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSS 120
+ N++NGSI + +L L LDLS N++ GSIP +G L L +DLS ++L G +PSS
Sbjct: 252 SYNQLNGSISHQMYTLTELTHLDLSNNQLSGSIPHQIGTLTELTYLDLSWSELTGAMPSS 311
Query: 121 LGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDL 180
LG LT+LT+LN+ N+++G IPPE+ N L L L NL+SG IPS++ KL+ L LDL
Sbjct: 312 LGSLTKLTSLNLCMNQINGSIPPEIGNIKDLVSLDLHRNLISGEIPSKLKKLKRLECLDL 371
Query: 181 SGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHLDVSGNQFGGEIPTTLAN 240
S N ++GKIP L S + +DLS N+ G FV G + G ++PT +
Sbjct: 372 SYNRLSGKIPPFLTNNSDWEKLDLSHNDDLEGYTPFVHN------GGEKTGAQVPT--RD 423
Query: 241 VPPPHHKTIATGLVAIILAMVAFLALIFGILIIRRRRDKEIEPTGTVEITKCADEIAIWN 300
H TI T L+ ++ + L L L ++R+ ++P ++ K D +IW+
Sbjct: 424 TTSQH--TIITPLLLTLVFVTLILGL--ACLWWKKRK---VQPE-SMATKKNGDLFSIWD 475
Query: 301 YDGRITFQDMIEATEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLE-TELASLES 359
YDGRI F+D+I ATEDFDI+YCIG GGYGSVYRA+LPSG VV +KKLHR E E L S
Sbjct: 476 YDGRIAFEDIISATEDFDIRYCIGVGGYGSVYRAQLPSGNVVVVKKLHRSEIDEPTYLRS 535
Query: 360 FQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRV 419
F+NE ++L +IRHRNIVKL+G+CLH +CMFLI YME GSL C+L + EAV LDW KRV
Sbjct: 536 FKNEVQMLEEIRHRNIVKLHGYCLHNRCMFLICMYMERGSLNCMLSNEVEAVELDWVKRV 595
Query: 420 NIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLL 479
NIVK MAHALSY+HH CTPPI+HRDISSNNILL+S+ E FV+DFG ARLL+ SSN+TL+
Sbjct: 596 NIVKNMAHALSYMHHDCTPPIIHRDISSNNILLDSKLEGFVSDFGTARLLDPSSSNQTLI 655
Query: 480 AGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLL 539
AGTYG IAPE AYTM+VTEK DVYSFGVVALE ++GKHPGEL++S SSL ++I L D+L
Sbjct: 656 AGTYGYIAPEFAYTMIVTEKCDVYSFGVVALETMIGKHPGELITSLLSSLCQDIMLRDVL 715
Query: 540 DPRLPPPGDQMIRQGIILI 558
D RL P D + + ++ +
Sbjct: 716 DSRLSLPEDLQVAKDVVFV 734
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296085303|emb|CBI29035.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 545 bits (1403), Expect = e-152, Method: Compositional matrix adjust.
Identities = 303/606 (50%), Positives = 395/606 (65%), Gaps = 51/606 (8%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAI 60
+G L+NL +LDLS N G IP +G L L L L NSL G IPS++ +L+ L L +
Sbjct: 139 LGYLKNLKYLDLSINEINGSIPYQIGNLKNLTHLYLVSNSLSGVIPSSLANLSNLEYLFL 198
Query: 61 ASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSS 120
NR+NGSI IG+LK L L S N + G+IP +LGHL L + L N++ G IP S
Sbjct: 199 NFNRINGSIPSEIGNLKNLVQLCFSHNSLIGTIPPSLGHLTNLTYLHLFNNQIQGGIPLS 258
Query: 121 LGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSG----------------- 163
GHLT+LT LN+ +N+++G IPP + N L L+L +N L+G
Sbjct: 259 FGHLTKLTDLNLCDNQINGSIPPIIWNLKNLIHLRLDHNNLTGVIPSSLGYLIHLNEFNI 318
Query: 164 -------SIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIP-- 214
IPS IG L L LDLS N I+GKIPSQ+ + ++LS N LSG IP
Sbjct: 319 SGNRINGHIPSTIGNLNNLTRLDLSANLIHGKIPSQVQNLKRLTYLNLSHNKLSGSIPTL 378
Query: 215 -VFVRKVPHLDVSGNQFGGEIPTTLAN-------------------VPPPHHKTIATGLV 254
++ P LD+S N G IP L + +P + T ++
Sbjct: 379 LIYDHIKPSLDLSHNDLEGHIPFELQSKFSQGSFDNNKGLCGDIKGLPHCKEEYKTTRII 438
Query: 255 AIILAMVAFLALIFGILIIRRRRDKEIEPTGTVEI-TKCADEIAIWNYDGRITFQDMIEA 313
I L+ FL + ++ R+ ++I+ T EI TK D ++WNYDG+I ++D+I+A
Sbjct: 439 VISLSTTLFLFFVVLGFLLLSRKTRKIQ---TKEIPTKNGDIFSVWNYDGKIAYEDIIKA 495
Query: 314 TEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELA-SLESFQNEARLLSQIRH 372
TEDFDIKYCIGTGGYGSVY+A+LP+G VVALKKLH E + A L+SFQNE ++LS+IRH
Sbjct: 496 TEDFDIKYCIGTGGYGSVYKAQLPTGNVVALKKLHGWERDEAIYLKSFQNEVQILSKIRH 555
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYL 432
RNIVKL G+CLH++CMFLIY YM GSL+C+L + EA+ LDW KRVN+VK + HA+ Y+
Sbjct: 556 RNIVKLQGYCLHKRCMFLIYNYMGRGSLYCVLSNEVEALELDWIKRVNVVKSIVHAVCYM 615
Query: 433 HHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAY 492
HH CTPPI+HRDISSNNILL+S+ +AF++DFG ARLL+ DSSN+TLLAGTYG IAPELAY
Sbjct: 616 HHDCTPPIIHRDISSNNILLDSKLDAFLSDFGTARLLHPDSSNQTLLAGTYGYIAPELAY 675
Query: 493 TMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRLPPPGDQMIR 552
TMVVTEK DVYSFGVVALE +MGKHPGEL + SSS +NI L ++LD RLP P DQ +
Sbjct: 676 TMVVTEKCDVYSFGVVALETMMGKHPGELFTLLSSSSTQNIMLTNILDSRLPSPQDQQVA 735
Query: 553 QGIILI 558
+ ++L+
Sbjct: 736 RDVVLV 741
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225452698|ref|XP_002276923.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 535 bits (1378), Expect = e-149, Method: Compositional matrix adjust.
Identities = 288/582 (49%), Positives = 385/582 (66%), Gaps = 24/582 (4%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAI 60
+G L +++LDLS N G IP + L++L L+LS N L G+IP + LT L L +
Sbjct: 95 IGSLTKVIYLDLSRNELSGSIPDQIATLTKLTYLDLSRNELSGSIPPQINTLTSLNYLDL 154
Query: 61 ASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSS 120
+ N +NG I IG+L L LDL NE+ GSIP + L L +DLS N L G IP
Sbjct: 155 SHNELNGRIPQQIGTLIRLTHLDLYSNELSGSIPDEIDTLTELAYLDLSNNVLNGSIPHQ 214
Query: 121 LGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDL 180
LG L +LT ++ N+L G IP + S L L L NN ++G IP IG L++L LDL
Sbjct: 215 LGALAKLTYFDLSWNELSGDIPSSFGHLSNLISLCLNNNQINGPIPEDIGNLEDLVDLDL 274
Query: 181 SGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIP---VFVRKVPHLDVSGNQFGGEIPTT 237
S N I+GKIPSQ+ ++ ++LS N LSG IP + K +D+S N G IP
Sbjct: 275 SSNSISGKIPSQIQNLKRLENLNLSRNKLSGAIPPSLTYDYKWTSIDLSYNDLEGHIPFE 334
Query: 238 LA-NVPP----------------PHHKTIATGLVAIILAMVAFLALIFGIL---IIRRRR 277
L PP PH K + ++++++A L + F L ++ R+
Sbjct: 335 LQFESPPGVFEHNKHLCGEIRHWPHCKKGQKITLILVISLLATLCIAFAFLKFLLLPRKM 394
Query: 278 DKEIEPTGTVEITKCADEIAIWNYDGRITFQDMIEATEDFDIKYCIGTGGYGSVYRARLP 337
K + + T+ D ++W+YDG I +QD+I++TE+FDIKYC+G GGYGSVYRA+LP
Sbjct: 395 RKMRHMSASAAETRRGDLFSVWDYDGTIAYQDIIQSTENFDIKYCVGVGGYGSVYRAQLP 454
Query: 338 SGKVVALKKLHRLETELAS-LESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYME 396
GKVVALKKLH E E + L+SF+NEA++LS+IRHRNIVKL+GFCLH + MFL+Y++ME
Sbjct: 455 CGKVVALKKLHGWEREEPTYLKSFENEAQILSKIRHRNIVKLHGFCLHRRSMFLVYQFME 514
Query: 397 MGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEF 456
GSLFC+L + EA+ LDWTKR+N+VK +AHALSY+HH C+PPI+HRDISSNN+LLNS+
Sbjct: 515 RGSLFCMLSHEVEALELDWTKRLNVVKSIAHALSYMHHDCSPPIIHRDISSNNVLLNSQL 574
Query: 457 EAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGK 516
EAFV+DFG ARLL+ DSS +TLL GTYG IAPELAYTM VT+K DVYSFGVVALE +MGK
Sbjct: 575 EAFVSDFGTARLLDPDSSIQTLLVGTYGYIAPELAYTMTVTKKCDVYSFGVVALETMMGK 634
Query: 517 HPGELLSSSSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558
HP E+++S SSS ++I L D+LDPRL P + + + I+ +
Sbjct: 635 HPREVITSLSSSSGQDILLRDVLDPRLALPENPQVAKDIVFV 676
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484063|ref|XP_002270651.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 533 bits (1374), Expect = e-149, Method: Compositional matrix adjust.
Identities = 299/605 (49%), Positives = 392/605 (64%), Gaps = 48/605 (7%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAI 60
+G L NL +LDLS N G IP +G L + LNLS NSL IPS++G+LT L L +
Sbjct: 352 LGNLTNLEYLDLSFNSINGSIPFEIGNLRNVVALNLSYNSLSSVIPSSLGNLTNLEYLDL 411
Query: 61 ASNRMNGSILLGIGSLKV------------------------LQVLDLSRNEIGGSIPST 96
+ N +NGSI IG+L+ L+ LDLS N I GSIPS
Sbjct: 412 SFNSINGSIPFEIGNLRNVVALNLSSNSLSSVIPSFLGNLTNLEYLDLSFNSINGSIPSE 471
Query: 97 LGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKL 156
+G+LK L +++LS N L IPSSLG+LT L TL++ N L G IP + N L +
Sbjct: 472 IGNLKNLAALNLSSNYLSSVIPSSLGNLTNLVTLSLTLNSLVGAIPSSVGNLINLTEFNI 531
Query: 157 GNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVF 216
N + G IP +IG L+ + LDLS N IN KIPSQL ++ ++LS N LSG IP
Sbjct: 532 CGNQIRGCIPFEIGNLKNMASLDLSDNLINVKIPSQLQNLESLENLNLSHNKLSGHIPTL 591
Query: 217 VRK-VPHLDVSGNQFGGEIPT--TLANVPP---------------PH----HKTIATGLV 254
+ +D+S N G IP L + P PH HKT+ +
Sbjct: 592 PKYGWLSIDLSYNDLEGHIPIELQLEHSPEVFSYNKGLCGEIKGWPHCKRGHKTMLITTI 651
Query: 255 AIILAMVAFLALIFGILIIRRRRDKEIEPTGTVEITKCADEIAIWNYDGRITFQDMIEAT 314
AI + A +FG L++ R+ + T + K D +IWNYDG+I ++D+IEAT
Sbjct: 652 AISTILFLLFA-VFGFLLLSRKMRQNQTKTPLKKNEKNGDIFSIWNYDGKIAYEDIIEAT 710
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELAS-LESFQNEARLLSQIRHR 373
EDFDIKYCIGTGGYG+VY+A+LP+G VVALKKLH E + A+ +SFQNE ++LS+I+HR
Sbjct: 711 EDFDIKYCIGTGGYGTVYKAQLPTGNVVALKKLHGWERDEATYFKSFQNEVQVLSKIQHR 770
Query: 374 NIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLH 433
NI+KL+G+CLH++CMFLIY+YME GSLF +L + EA+ LDW KRVN+VK + HAL Y+H
Sbjct: 771 NIIKLHGYCLHKRCMFLIYKYMERGSLFGVLSNEVEALELDWIKRVNVVKSIVHALCYMH 830
Query: 434 HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYT 493
H T PI+HRDISS+NILL+S+ +AF++DFG ARLL++DSSN+T+LAGTYG IAPELAYT
Sbjct: 831 HDYTLPIIHRDISSSNILLDSKLDAFLSDFGTARLLHHDSSNQTVLAGTYGYIAPELAYT 890
Query: 494 MVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553
MVVTEK DVYSFGVVALE +MGKHP EL + SSS ++I L D+LD RLP P DQ + +
Sbjct: 891 MVVTEKCDVYSFGVVALETMMGKHPRELFTLLSSSSAQSIMLTDILDSRLPSPQDQQVAR 950
Query: 554 GIILI 558
++L+
Sbjct: 951 DVVLV 955
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224110024|ref|XP_002333161.1| predicted protein [Populus trichocarpa] gi|222835014|gb|EEE73463.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 532 bits (1370), Expect = e-148, Method: Compositional matrix adjust.
Identities = 298/607 (49%), Positives = 385/607 (63%), Gaps = 53/607 (8%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAI 60
+G L+NL LD S+N G IP T+G L++L+ L LS N++ G IP +G+LT L L +
Sbjct: 171 LGNLKNLEILDASNNRLNGPIPRTMGSLAKLRSLILSRNAINGFIPLEIGNLTNLKDLQL 230
Query: 61 ASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSS 120
SN + GSI IG L L LDLS N I GSIP +G+L L +DLS N L G IPS+
Sbjct: 231 ISNILVGSIPSTIGFLSDLTNLDLSYNVINGSIPLQIGNLTNLEHLDLSSNILAGSIPST 290
Query: 121 LGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDL 180
G L+ L L++++N+++G I E+ N + L L L N +SGSIP +G L+ L +LDL
Sbjct: 291 FGFLSNLILLHLFDNQINGSISLEIGNLTNLCRLFLKGNKISGSIPISLGDLRNLAFLDL 350
Query: 181 SGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVP---HLDVSGNQFGGEIPTT 237
S N ING I S L + +DLS NNLSG IP + +P +++ N G +P
Sbjct: 351 SNNQINGSIASSLKNCKYLTYLDLSYNNLSGQIPSQLHNLPSLSYVNFRYNNLSGFVPLQ 410
Query: 238 L-----------------ANVPPPHHKTIATG--------------------------LV 254
L N P T+ G +
Sbjct: 411 LPQPFDVSFTCDSLHGQRTNSPEIFQATVFEGNKDLHPDFSRCSSIYSPPSKDNRIIHSI 470
Query: 255 AIILAMVAFLALIFGILIIRRRRDKEIEPTGTVEITKCADEIAIWNYDGRITFQDMIEAT 314
I L + + + R K +P T K D +IWNYDGRI ++D+I AT
Sbjct: 471 KIFLPITTISLCLLCLGCCYLSRCKATQPEATS--LKNGDLFSIWNYDGRIAYEDIIAAT 528
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLE-SFQNEARLLSQIRHR 373
E+FD++YCIG+GGYGSVYRA+LPSGK+VALKKLH E E + + S +NE LL+QIRHR
Sbjct: 529 ENFDLRYCIGSGGYGSVYRAQLPSGKLVALKKLHHREAEEPAFDKSLKNEVELLTQIRHR 588
Query: 374 NIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLH 433
+IVKLYGFCLH++CMFL+YEYME GSLFC LR D AV L W KR +I+K +AHALSYLH
Sbjct: 589 SIVKLYGFCLHQRCMFLVYEYMEKGSLFCALRNDVGAVELKWMKRAHIIKDIAHALSYLH 648
Query: 434 HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYT 493
H C PPI+HRDISS+N+LLNSEF++FVADFG+ARLL+ DSSN T+LAGTYG IAPELAYT
Sbjct: 649 HDCNPPIVHRDISSSNVLLNSEFKSFVADFGVARLLDPDSSNHTVLAGTYGYIAPELAYT 708
Query: 494 MVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553
M VTEK DVYSFGVVALE LMG+HPG++LSSS+ + I L ++LDPRLPPP ++++ Q
Sbjct: 709 MAVTEKCDVYSFGVVALETLMGRHPGDILSSSAQA----ITLKEVLDPRLPPPTNEIVIQ 764
Query: 554 GIILIST 560
I I++
Sbjct: 765 NICTIAS 771
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 560 | ||||||
| TAIR|locus:2138268 | 1045 | AT4G08850 [Arabidopsis thalian | 0.905 | 0.485 | 0.428 | 6.2e-101 | |
| TAIR|locus:2011339 | 1120 | AT1G35710 [Arabidopsis thalian | 0.912 | 0.456 | 0.415 | 5.9e-96 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.382 | 0.190 | 0.493 | 1.8e-95 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.380 | 0.170 | 0.448 | 4.5e-89 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.380 | 0.193 | 0.504 | 7.4e-89 | |
| TAIR|locus:2156349 | 1252 | GSO2 "GASSHO 2" [Arabidopsis t | 0.383 | 0.171 | 0.444 | 9.3e-89 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.907 | 0.460 | 0.399 | 1.3e-86 | |
| TAIR|locus:2167948 | 966 | ERL1 "ERECTA-like 1" [Arabidop | 0.912 | 0.528 | 0.383 | 8.9e-86 | |
| TAIR|locus:2161825 | 1090 | AT5G56040 [Arabidopsis thalian | 0.907 | 0.466 | 0.373 | 1.7e-84 | |
| TAIR|locus:2085949 | 1141 | AT3G24240 [Arabidopsis thalian | 0.346 | 0.170 | 0.466 | 6.7e-84 |
| TAIR|locus:2138268 AT4G08850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1001 (357.4 bits), Expect = 6.2e-101, P = 6.2e-101
Identities = 226/527 (42%), Positives = 321/527 (60%)
Query: 10 LDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSI 69
+DLS+N+F G + + +L LS NS+ G IP + ++TQL+ L ++SNR+ G +
Sbjct: 459 IDLSNNNFHGQLSANWEQSQKLVAFILSNNSITGAIPPEIWNMTQLSQLDLSSNRITGEL 518
Query: 70 LLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTT 129
I ++ + L L+ N + G IPS + L L +DLS N+ IP +L +L +L
Sbjct: 519 PESISNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNRFSSEIPPTLNNLPRLYY 578
Query: 130 LNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKI 189
+N+ N LD IP L S+L++L L N L G I SQ LQ L LDLS N ++G+I
Sbjct: 579 MNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLERLDLSHNNLSGQI 638
Query: 190 PSQLGEFSCIDTVDLSMNNLSGGIP--VFVRKVPHLDVSGNQ-FGGEIPTTLANVP---- 242
P + + VD+S NNL G IP R P GN+ G + TT P
Sbjct: 639 PPSFKDMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQGLKPCSIT 698
Query: 243 --PPHHKT---IATGLVAIILAMVXXXXXXXXXXXXXXXXDKEIEPTGTVEITKCADEIA 297
HK I LV II A++ K+IE E + ++
Sbjct: 699 SSKKSHKDRNLIIYILVPIIGAIIILSVCAGIFICFRKRT-KQIEEHTDSE--SGGETLS 755
Query: 298 IWNYDGRITFQDMIEATEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRL-ETELAS 356
I+++DG++ +Q++I+AT +FD KY IGTGG+G VY+A+LP+ ++A+KKL+ ++ +++
Sbjct: 756 IFSFDGKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNA-IMAVKKLNETTDSSISN 814
Query: 357 ---LESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGL 413
+ F NE R L++IRHRN+VKL+GFC H + FL+YEYME GSL +L D+EA L
Sbjct: 815 PSTKQEFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKL 874
Query: 414 DWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473
DW KR+N+VKG+AHALSY+HH +P I+HRDISS NILL ++EA ++DFG A+LL DS
Sbjct: 875 DWGKRINVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDS 934
Query: 474 SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGE 520
SN + +AGTYG +APELAY M VTEK DVYSFGV+ LEV+ G+HPG+
Sbjct: 935 SNWSAVAGTYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGD 981
|
|
| TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 954 (340.9 bits), Expect = 5.9e-96, P = 5.9e-96
Identities = 219/527 (41%), Positives = 305/527 (57%)
Query: 6 NLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRM 65
+L +D S N F G I + +L L +S N++ G IP+ + ++TQL L +++N +
Sbjct: 535 DLNFIDFSHNKFHGEISSNWEKSPKLGALIMSNNNITGAIPTEIWNMTQLVELDLSTNNL 594
Query: 66 NGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLT 125
G + IG+L L L L+ N++ G +P+ L L L S+DLS N IP +
Sbjct: 595 FGELPEAIGNLTNLSRLRLNGNQLSGRVPAGLSFLTNLESLDLSSNNFSSEIPQTFDSFL 654
Query: 126 QLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFI 185
+L +N+ NK DG IP L ++L L L +N L G IPSQ+ LQ L LDLS N +
Sbjct: 655 KLHDMNLSRNKFDGSIP-RLSKLTQLTQLDLSHNQLDGEIPSQLSSLQSLDKLDLSHNNL 713
Query: 186 NGKIPSQLGEFSCIDTVDLSMNNLSGGIP---VFVRKVPHLDVSGNQFG--GEIPTTLAN 240
+G IP+ + VD+S N L G +P F RK D G IP
Sbjct: 714 SGLIPTTFEGMIALTNVDISNNKLEGPLPDTPTF-RKAT-ADALEENIGLCSNIPKQRLK 771
Query: 241 VPPPHHKTIATG-LVAIILAMVXXXXXXXXXXXXXXXX--DKEIEPTGTVEITKCADEIA 297
K G LV IL + K G + + ++
Sbjct: 772 PCRELKKPKKNGNLVVWILVPILGVLVILSICANTFTYCIRKRKLQNGRNTDPETGENMS 831
Query: 298 IWNYDGRITFQDMIEATEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLH-RLETELAS 356
I++ DG+ +QD+IE+T +FD + IGTGGY VYRA L ++A+K+LH ++ E++
Sbjct: 832 IFSVDGKFKYQDIIESTNEFDPTHLIGTGGYSKVYRANLQD-TIIAVKRLHDTIDEEISK 890
Query: 357 ---LESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGL 413
+ F NE + L++IRHRN+VKL+GFC H + FLIYEYME GSL +L DEEA L
Sbjct: 891 PVVKQEFLNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEEAKRL 950
Query: 414 DWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473
WTKR+N+VKG+AHALSY+HH PI+HRDISS NILL++++ A ++DFG A+LL DS
Sbjct: 951 TWTKRINVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTAKLLKTDS 1010
Query: 474 SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGE 520
SN + +AGTYG +APE AYTM VTEK DVYSFGV+ LE+++GKHPG+
Sbjct: 1011 SNWSAVAGTYGYVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHPGD 1057
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 511 (184.9 bits), Expect = 1.8e-95, Sum P(2) = 1.8e-95
Identities = 110/223 (49%), Positives = 144/223 (64%)
Query: 304 RITFQDMIEATEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKL--HRLETELASLE--- 358
R T +D++EAT+ F Y +G G G+VY+A +PSGK +A+KKL +R S
Sbjct: 806 RFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDN 865
Query: 359 SFQNEARLLSQIRHRNIVKLYGFCLHE--KCMFLIYEYMEMGSLFCILRTDEEAVGLDWT 416
SF+ E L +IRHRNIV+LY FC H+ L+YEYM GSL +L + +DW
Sbjct: 866 SFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLHGGKSH-SMDWP 924
Query: 417 KRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD-SSN 475
R I G A L+YLHH C P I+HRDI SNNIL++ FEA V DFG+A++++ S +
Sbjct: 925 TRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDMPLSKS 984
Query: 476 RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHP 518
+ +AG+YG IAPE AYTM VTEK D+YSFGVV LE+L GK P
Sbjct: 985 VSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAP 1027
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 484 (175.4 bits), Expect = 4.5e-89, Sum P(2) = 4.5e-89
Identities = 101/225 (44%), Positives = 148/225 (65%)
Query: 305 ITFQDMIEATEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEA 364
I ++D++EAT + ++ IG+GG G VY+A L +G+ VA+KK+ + +L S +SF E
Sbjct: 939 IRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKI-LWKDDLMSNKSFSREV 997
Query: 365 RLLSQIRHRNIVKLYGFCLH--EKCMFLIYEYMEMGSLFCILRTDEEAVG-----LDWTK 417
+ L +IRHR++VKL G+C E LIYEYM+ GS++ L D+ + LDW
Sbjct: 998 KTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEA 1057
Query: 418 RVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL--NYDSS- 474
R+ I G+A + YLHH C PPI+HRDI S+N+LL+S EA + DFG+A++L N D++
Sbjct: 1058 RLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNT 1117
Query: 475 -NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHP 518
+ T A +YG IAPE AY++ TEK DVYS G+V +E++ GK P
Sbjct: 1118 DSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMP 1162
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 542 (195.9 bits), Expect = 7.4e-89, Sum P(2) = 7.4e-89
Identities = 108/214 (50%), Positives = 142/214 (66%)
Query: 306 TFQDMIEATEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEAR 365
T+Q +++AT +F +G G G+VY+A + G+V+A+KKL+ +S SF+ E
Sbjct: 788 TYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASSDNSFRAEIS 847
Query: 366 LLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGM 425
L +IRHRNIVKLYGFC H+ L+YEYM GSL L+ E+ LDW R I G
Sbjct: 848 TLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGA 907
Query: 426 AHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD-SSNRTLLAGTYG 484
A L YLHH C P I+HRDI SNNILL+ F+A V DFG+A+L++ S + + +AG+YG
Sbjct: 908 AEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGSYG 967
Query: 485 SIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHP 518
IAPE AYTM VTEK D+YSFGVV LE++ GK P
Sbjct: 968 YIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPP 1001
|
|
| TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 485 (175.8 bits), Expect = 9.3e-89, Sum P(2) = 9.3e-89
Identities = 100/225 (44%), Positives = 147/225 (65%)
Query: 305 ITFQDMIEATEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEA 364
I + D++EAT + ++ IG+GG G VY+A L +G+ +A+KK+ + +L S +SF E
Sbjct: 936 IKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKI-LWKDDLMSNKSFNREV 994
Query: 365 RLLSQIRHRNIVKLYGFCLHEK--CMFLIYEYMEMGSLFCILRTDEEAVG---LDWTKRV 419
+ L IRHR++VKL G+C + LIYEYM GS++ L +E L W R+
Sbjct: 995 KTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEVLGWETRL 1054
Query: 420 NIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL--NYDSS--N 475
I G+A + YLH+ C PPI+HRDI S+N+LL+S EA + DFG+A++L NYD++ +
Sbjct: 1055 KIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTES 1114
Query: 476 RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGE 520
T+ AG+YG IAPE AY++ TEK DVYS G+V +E++ GK P E
Sbjct: 1115 NTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTE 1159
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 866 (309.9 bits), Expect = 1.3e-86, P = 1.3e-86
Identities = 212/531 (39%), Positives = 300/531 (56%)
Query: 6 NLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRM 65
N+ ++L N F G IP +G S L+ L L+ N G +P +G L+QL TL I+SN++
Sbjct: 482 NVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPREIGMLSQLGTLNISSNKL 541
Query: 66 NGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLT 125
G + I + K+LQ LD+ N G++PS +G L L + LS N L G IP +LG+L+
Sbjct: 542 TGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLS 601
Query: 126 QLTTLNMYNNKLDGPIPPELMNCSKLRI-LKLGNNLLSGSIPSQIGKLQELYYLDLSGNF 184
+LT L M N +G IP EL + + L+I L L N L+G IP ++ L L +L L+ N
Sbjct: 602 RLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNN 661
Query: 185 INGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHLDVSGNQ--FGGEIPTTLANVP 242
++G+IPS S + + S N+L+G IP+ +R + GN+ G + + P
Sbjct: 662 LSGEIPSSFANLSSLLGYNFSYNSLTGPIPL-LRNISMSSFIGNEGLCGPPLNQCIQTQP 720
Query: 243 -PPHHKTIATGLV--AIILAMVXXXXXXXXXXXXXXXXDKEIEPTGTVEITKCAD----E 295
P T G + + I+A+ P TV + D E
Sbjct: 721 FAPSQSTGKPGGMRSSKIIAITAAVIGGVSLMLIALIVYLMRRPVRTVA-SSAQDGQPSE 779
Query: 296 IAIWNY----DGRITFQDMIEATEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKL---H 348
+++ Y +G TFQD++ AT++FD + +G G G+VY+A LP+G +A+KKL H
Sbjct: 780 MSLDIYFPPKEG-FTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNH 838
Query: 349 RLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDE 408
SF+ E L IRHRNIVKL+GFC H+ L+YEYM GSL IL +
Sbjct: 839 EGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILH--D 896
Query: 409 EAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARL 468
+ LDW+KR I G A L+YLHH C P I HRDI SNNILL+ +FEA V DFG+A++
Sbjct: 897 PSCNLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 956
Query: 469 LNYD-SSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHP 518
++ S + + +AG+YG IAPE AYTM VTEK D+YS+GVV LE+L GK P
Sbjct: 957 IDMPHSKSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAP 1007
|
|
| TAIR|locus:2167948 ERL1 "ERECTA-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 858 (307.1 bits), Expect = 8.9e-86, P = 8.9e-86
Identities = 200/522 (38%), Positives = 289/522 (55%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAI 60
+G + L +L L+DN +G IPP LG+L +L LNL+ N LVG IPSN+ L +
Sbjct: 330 LGNMSRLSYLQLNDNKLVGTIPPELGKLEQLFELNLANNRLVGPIPSNISSCAALNQFNV 389
Query: 61 ASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSS 120
N ++GSI L +L L L+LS N G IP LGH+ L +DLS N G IP +
Sbjct: 390 HGNLLSGSIPLAFRNLGSLTYLNLSSNNFKGKIPVELGHIINLDKLDLSGNNFSGSIPLT 449
Query: 121 LGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDL 180
LG L L LN+ N L G +P E N ++++ + NLLSG IP+++G+LQ L L L
Sbjct: 450 LGDLEHLLILNLSRNHLSGQLPAEFGNLRSIQMIDVSFNLLSGVIPTELGQLQNLNSLIL 509
Query: 181 SGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPV---FVRKVPHLDVSGNQFGGEIPTT 237
+ N ++GKIP QL + +++S NNLSG +P F R P V G +
Sbjct: 510 NNNKLHGKIPDQLTNCFTLVNLNVSFNNLSGIVPPMKNFSRFAPASFVGNPYLCGNWVGS 569
Query: 238 LANVPPPHHKTIATG-LVAIILAMVXXXXXXXXXXXXXXXXDKEIEPTGTVEITKCADEI 296
+ P P + + G L+ I+L ++ K ++ G+ + + ++
Sbjct: 570 ICG-PLPKSRVFSRGALICIVLGVITLLCMIFLAVYKSMQQKKILQ--GSSKQAEGLTKL 626
Query: 297 AIWNYDGRI-TFQDMIEATEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELA 355
I + D I TF D++ TE+ + K+ IG G +VY+ L S + +A+K+L+
Sbjct: 627 VILHMDMAIHTFDDIMRVTENLNEKFIIGYGASSTVYKCALKSSRPIAIKRLYNQYPH-- 684
Query: 356 SLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDW 415
+L F+ E + IRHRNIV L+G+ L L Y+YME GSL+ +L + V LDW
Sbjct: 685 NLREFETELETIGSIRHRNIVSLHGYALSPTGNLLFYDYMENGSLWDLLHGSLKKVKLDW 744
Query: 416 TKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSN 475
R+ I G A L+YLHH CTP I+HRDI S+NILL+ FEA ++DFGIA+ + ++
Sbjct: 745 ETRLKIAVGAAQGLAYLHHDCTPRIIHRDIKSSNILLDENFEAHLSDFGIAKSIPASKTH 804
Query: 476 R-TLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGK 516
T + GT G I PE A T + EK D+YSFG+V LE+L GK
Sbjct: 805 ASTYVLGTIGYIDPEYARTSRINEKSDIYSFGIVLLELLTGK 846
|
|
| TAIR|locus:2161825 AT5G56040 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 846 (302.9 bits), Expect = 1.7e-84, P = 1.7e-84
Identities = 202/541 (37%), Positives = 301/541 (55%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASN 63
+RNL L L N+ G IPP +G + L L L+ N L GNIP+ +G+L L + I+ N
Sbjct: 432 IRNLTKLLLLSNYLSGFIPPDIGNCTNLYRLRLNGNRLAGNIPAEIGNLKNLNFIDISEN 491
Query: 64 RMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGH 123
R+ G+I I L+ +DL N + G +P TL K L+ +DLS N L G +P+ +G
Sbjct: 492 RLIGNIPPEISGCTSLEFVDLHSNGLTGGLPGTLP--KSLQFIDLSDNSLTGSLPTGIGS 549
Query: 124 LTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYY-LDLSG 182
LT+LT LN+ N+ G IP E+ +C L++L LG+N +G IP+++G++ L L+LS
Sbjct: 550 LTELTKLNLAKNRFSGEIPREISSCRSLQLLNLGDNGFTGEIPNELGRIPSLAISLNLSC 609
Query: 183 NFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVF--VRKVPHLDVSGNQFGGEIPTTL-- 238
N G+IPS+ + + T+D+S N L+G + V ++ + L++S N+F GE+P TL
Sbjct: 610 NHFTGEIPSRFSSLTNLGTLDVSHNKLAGNLNVLADLQNLVSLNISFNEFSGELPNTLFF 669
Query: 239 ANVPPPHHKT-----IAT----GLVAIILAMVXXXXXXXXXXXXXXXXDKEIEPTGTVEI 289
+P ++ I+T G+ + V I
Sbjct: 670 RKLPLSVLESNKGLFISTRPENGIQTRHRSAVKVTMSILVAASVVLVLMAVYTLVKAQRI 729
Query: 290 TKCADEIAIWNYD--GRITFQDMIEATEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKL 347
T +E+ W ++ F + + ++ IGTG G VYR +PSG+ +A+KK+
Sbjct: 730 TGKQEELDSWEVTLYQKLDFS-IDDIVKNLTSANVIGTGSSGVVYRVTIPSGETLAVKKM 788
Query: 348 HRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILR-T 406
E A F +E L IRHRNI++L G+C + L Y+Y+ GSL +L
Sbjct: 789 WSKEENRA----FNSEINTLGSIRHRNIIRLLGWCSNRNLKLLFYDYLPNGSLSSLLHGA 844
Query: 407 DEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIA 466
+ + G DW R ++V G+AHAL+YLHH C PPILH D+ + N+LL S FE+++ADFG+A
Sbjct: 845 GKGSGGADWEARYDVVLGVAHALAYLHHDCLPPILHGDVKAMNVLLGSRFESYLADFGLA 904
Query: 467 RLLNY------DSS---NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKH 517
++++ DSS NR LAG+YG +APE A +TEK DVYS+GVV LEVL GKH
Sbjct: 905 KIVSGEGVTDGDSSKLSNRPPLAGSYGYMAPEHASMQHITEKSDVYSYGVVLLEVLTGKH 964
Query: 518 P 518
P
Sbjct: 965 P 965
|
|
| TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 452 (164.2 bits), Expect = 6.7e-84, Sum P(2) = 6.7e-84
Identities = 96/206 (46%), Positives = 129/206 (62%)
Query: 323 IGTGGYGSVYRARLPSGKVVALKKL--------HRLETELASLESFQNEARLLSQIRHRN 374
IG G G VYRA + +G+V+A+KKL H +T+ +SF E + L IRH+N
Sbjct: 792 IGKGCSGVVYRADVDNGEVIAVKKLWPAMVNGGHDEKTKNVR-DSFSAEVKTLGTIRHKN 850
Query: 375 IVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHH 434
IV+ G C + L+Y+YM GSL +L + LDW R I+ G A L+YLHH
Sbjct: 851 IVRFLGCCWNRNTRLLMYDYMPNGSLGSLLH-ERRGSSLDWDLRYRILLGAAQGLAYLHH 909
Query: 435 HCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNR--TLLAGTYGSIAPELAY 492
C PPI+HRDI +NNIL+ +FE ++ADFG+A+L++ R +AG+YG IAPE Y
Sbjct: 910 DCLPPIVHRDIKANNILIGLDFEPYIADFGLAKLVDEGDIGRCSNTVAGSYGYIAPEYGY 969
Query: 493 TMVVTEKYDVYSFGVVALEVLMGKHP 518
+M +TEK DVYS+GVV LEVL GK P
Sbjct: 970 SMKITEKSDVYSYGVVVLEVLTGKQP 995
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 560 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-65 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-48 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-46 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-46 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-45 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-42 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-42 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-42 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-41 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-40 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-39 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-38 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-38 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-37 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-35 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-35 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-32 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 9e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-30 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-29 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-29 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-29 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-29 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-29 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-28 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-27 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-26 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-26 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-26 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-25 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-25 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-24 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-24 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-24 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-24 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-23 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-23 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-23 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-22 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-22 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-22 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-22 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-21 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-21 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-21 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-21 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-21 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-20 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-20 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-20 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-20 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-20 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-20 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-19 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-19 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-19 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-19 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-19 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-19 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-19 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-19 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-18 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-18 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-18 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-18 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-18 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-18 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 9e-18 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-17 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-17 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-17 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-17 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-17 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-17 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-16 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-16 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-16 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-16 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-16 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-16 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-15 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-15 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-15 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-15 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-15 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-15 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-14 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-14 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-14 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-14 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 4e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-14 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-14 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 9e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 9e-14 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-13 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-13 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-13 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-12 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-12 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-12 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-12 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-12 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-12 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 9e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-11 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-11 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-11 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-11 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 7e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 9e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 9e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 8e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-09 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 7e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 9e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-08 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-08 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 8e-08 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 8e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-07 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-06 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-06 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-06 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 9e-06 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 1e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 3e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 4e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.003 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.003 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 228 bits (583), Expect = 5e-65
Identities = 168/542 (30%), Positives = 269/542 (49%), Gaps = 52/542 (9%)
Query: 6 NLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRM 65
NL L L N G IP +LG L+ + L NS G +PS L + L I++N +
Sbjct: 381 NLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNL 440
Query: 66 NGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLT 125
G I + LQ+L L+RN+ G +P + G K L ++DLS+N+ G +P LG L+
Sbjct: 441 QGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLS 499
Query: 126 QLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFI 185
+L L + NKL G IP EL +C KL L L +N LSG IP+ ++ L LDLS N +
Sbjct: 500 ELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQL 559
Query: 186 NGKIPSQLGEFSCIDTVDLSMNNLSGGIP---VFVRKVPHLDVSGNQF--GGEIPTTLAN 240
+G+IP LG + V++S N+L G +P F+ + V+GN GG+ + L
Sbjct: 560 SGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFL-AINASAVAGNIDLCGGDTTSGL-- 616
Query: 241 VPPPHHKTIATGLVAIILA--MVAFLALI---FGILIIRRRRDKEIEPTGTVEITKCADE 295
PP + T + + AFL L FG + IR R + +E+ + +E
Sbjct: 617 --PPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNN--------LELKRVENE 666
Query: 296 IAIWN---YDGR----ITFQDMIEATEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLH 348
W +D + IT D++ + ++ ++ I G G+ Y+ + +
Sbjct: 667 DGTWELQFFDSKVSKSITINDILSSLKEENV---ISRGKKGASYKGKSIKNGM------Q 717
Query: 349 RLETELASLESF-QNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTD 407
+ E+ + S +E + +++H NIVKL G C EK +LI+EY+E +L +LR
Sbjct: 718 FVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-- 775
Query: 408 EEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIAR 467
L W +R I G+A AL +LH C+P ++ ++S I+++ + E + +
Sbjct: 776 ----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPG 830
Query: 468 LLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSS 527
LL D + ++ Y +APE T +TEK D+Y FG++ +E+L GK P +
Sbjct: 831 LLCTD--TKCFISSAY--VAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG 886
Query: 528 SL 529
S+
Sbjct: 887 SI 888
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 180 bits (457), Expect = 3e-48
Identities = 104/242 (42%), Positives = 136/242 (56%), Gaps = 3/242 (1%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIA 61
G + NL LDLS+N G IP +G S LK+L+L N LVG IP+++ +LT L L +A
Sbjct: 137 GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLA 196
Query: 62 SNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSL 121
SN++ G I +G +K L+ + L N + G IP +G L L +DL N L GPIPSSL
Sbjct: 197 SNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSL 256
Query: 122 GHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLS 181
G+L L L +Y NKL GPIPP + + KL L L +N LSG IP + +LQ L L L
Sbjct: 257 GNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLF 316
Query: 182 GNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRK---VPHLDVSGNQFGGEIPTTL 238
N GKIP L + + L N SG IP + K + LD+S N GEIP L
Sbjct: 317 SNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGL 376
Query: 239 AN 240
+
Sbjct: 377 CS 378
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 1e-46
Identities = 72/192 (37%), Positives = 107/192 (55%), Gaps = 9/192 (4%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGF 381
+G GG+G+VY AR +GK VA+K + + E + LE E +L ++ H NIVKLYG
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKII-KKEDSSSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 382 CLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPIL 441
E ++L+ EY E GSL +L+ E L + + I+ + L YLH + I+
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLK--ENEGKLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 442 HRDISSNNILLNS-EFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPE-LAYTMVVTEK 499
HRD+ NILL+S + +ADFG+++LL D S + GT +APE L +EK
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEK 174
Query: 500 YDVYSFGVVALE 511
D++S GV+ E
Sbjct: 175 SDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 6e-46
Identities = 76/244 (31%), Positives = 119/244 (48%), Gaps = 13/244 (5%)
Query: 317 FDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNI 375
++I +G G +G VY AR +GK+VA+K + + + E E ++L +++H NI
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVI-KKKKIKKDRERILREIKILKKLKHPNI 59
Query: 376 VKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHH 435
V+LY E ++L+ EY E G LF +L+ + D + ++ + AL YLH
Sbjct: 60 VRLYDVFEDEDKLYLVMEYCEGGDLFDLLK-KRGRLSEDEARF--YLRQILSALEYLHSK 116
Query: 436 CTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMV 495
I+HRD+ NILL+ + +ADFG+AR L+ T GT +APE+
Sbjct: 117 G---IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT-FVGTPEYMAPEVLLGKG 172
Query: 496 VTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRLPPPGDQMIRQGI 555
+ D++S GV+ E+L GK P L + K I P PPP + +
Sbjct: 173 YGKAVDIWSLGVILYELLTGKPP----FPGDDQLLELFKKIGKPKPPFPPPEWDISPEAK 228
Query: 556 ILIS 559
LI
Sbjct: 229 DLIR 232
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 1e-45
Identities = 94/244 (38%), Positives = 133/244 (54%), Gaps = 2/244 (0%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAI 60
+G L+NL +L L N G IPP++ L +L L+LS NSL G IP V L L L +
Sbjct: 256 LGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHL 315
Query: 61 ASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSS 120
SN G I + + SL LQVL L N+ G IP LG L +DLS N L G IP
Sbjct: 316 FSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEG 375
Query: 121 LGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDL 180
L L L +++N L+G IP L C LR ++L +N SG +PS+ KL +Y+LD+
Sbjct: 376 LCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDI 435
Query: 181 SGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVR--KVPHLDVSGNQFGGEIPTTL 238
S N + G+I S+ + + + L+ N GG+P ++ +LD+S NQF G +P L
Sbjct: 436 SNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKL 495
Query: 239 ANVP 242
++
Sbjct: 496 GSLS 499
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 163 bits (413), Expect = 1e-42
Identities = 94/236 (39%), Positives = 134/236 (56%), Gaps = 5/236 (2%)
Query: 6 NLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRM 65
+L +L+LS+N+F G IP G + L+ L+LS N L G IP+++G + L L + N +
Sbjct: 119 SLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVL 176
Query: 66 NGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLT 125
G I + +L L+ L L+ N++ G IP LG +K L+ + L N L G IP +G LT
Sbjct: 177 VGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLT 236
Query: 126 QLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFI 185
L L++ N L GPIP L N L+ L L N LSG IP I LQ+L LDLS N +
Sbjct: 237 SLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSL 296
Query: 186 NGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHLDVS---GNQFGGEIPTTL 238
+G+IP + + ++ + L NN +G IPV + +P L V N+F GEIP L
Sbjct: 297 SGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNL 352
|
Length = 968 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 6e-42
Identities = 68/204 (33%), Positives = 106/204 (51%), Gaps = 8/204 (3%)
Query: 317 FDIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNI 375
+++ +G+G +G+VY+A+ GK+VA+K L + + ++ + E R+L ++ H NI
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 376 VKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHH 435
V+L + ++L+ EY E G LF L L + I + L YLH +
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG---GPLSEDEAKKIALQILRGLEYLHSN 117
Query: 436 CTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPE-LAYTM 494
I+HRD+ NILL+ +ADFG+A+ L SS+ T GT +APE L
Sbjct: 118 ---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGN 174
Query: 495 VVTEKYDVYSFGVVALEVLMGKHP 518
K DV+S GV+ E+L GK P
Sbjct: 175 GYGPKVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 161 bits (408), Expect = 8e-42
Identities = 94/242 (38%), Positives = 134/242 (55%), Gaps = 3/242 (1%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAI 60
+G +L LDL N +G IP +L L+ L+ L L+ N LVG IP +G + L + +
Sbjct: 160 IGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYL 219
Query: 61 ASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSS 120
N ++G I IG L L LDL N + G IPS+LG+LK L+ + L QNKL GPIP S
Sbjct: 220 GYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPS 279
Query: 121 LGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDL 180
+ L +L +L++ +N L G IP ++ L IL L +N +G IP + L L L L
Sbjct: 280 IFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQL 339
Query: 181 SGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHLD---VSGNQFGGEIPTT 237
N +G+IP LG+ + + +DLS NNL+G IP + +L + N GEIP +
Sbjct: 340 WSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKS 399
Query: 238 LA 239
L
Sbjct: 400 LG 401
|
Length = 968 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 2e-41
Identities = 67/235 (28%), Positives = 110/235 (46%), Gaps = 26/235 (11%)
Query: 323 IGTGGYGSVYRARL-----PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVK 377
+G G +G VY+ L + VA+K L + E F EA ++ ++ H NIV+
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTL-KEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 378 LYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCT 437
L G C + ++++ EYM G L LR E + L + + +A + YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD--LLQMALQIAKGMEYLESK-- 121
Query: 438 PPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI---APELAYTM 494
+HRD+++ N L+ ++DFG++R + Y+ G I APE
Sbjct: 122 -NFVHRDLAARNCLVTENLVVKISDFGLSRDI-YEDDYYRKRGGGKLPIKWMAPESLKDG 179
Query: 495 VVTEKYDVYSFGVVALEVL-MGKHPGELLSSSSSSLDKNIKLIDLLD--PRLPPP 546
T K DV+SFGV+ E+ +G+ P +S N ++++LL+ RLP P
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMS--------NEEVLELLEDGYRLPRP 226
|
Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 6e-40
Identities = 76/241 (31%), Positives = 114/241 (47%), Gaps = 30/241 (12%)
Query: 316 DFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRN 374
F+I IG GG+G VY+AR +GK VA+K + E NE ++L + +H N
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIK--LESKEKKEKIINEIQILKKCKHPN 58
Query: 375 IVKLYGFCLHEKCMFLIYEYMEMGSL-----FCILRTDEEAVGLDWTKRVNIVKGMAHAL 429
IVK YG L + ++++ E+ GSL E + + K + L
Sbjct: 59 IVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAY-------VCKELLKGL 111
Query: 430 SYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPE 489
YLH + I+HRDI + NILL S+ E + DFG++ L+ D+ R + GT +APE
Sbjct: 112 EYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLS-DTKARNTMVGTPYWMAPE 167
Query: 490 LAYTMVVTEKYDVYSFGVVALEVLMGKHP-GELLSSSSSSLDKNIKLIDLLDPRLPPPGD 548
+ K D++S G+ A+E+ GK P EL K + I PPG
Sbjct: 168 VINGKPYDYKADIWSLGITAIELAEGKPPYSELPP------MKALFKI----ATNGPPGL 217
Query: 549 Q 549
+
Sbjct: 218 R 218
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 5e-39
Identities = 96/237 (40%), Positives = 134/237 (56%), Gaps = 6/237 (2%)
Query: 7 LVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLT-QLTTLAIASNRM 65
+V +DLS + G I + RL ++ +NLS N L G IP ++ + L L +++N
Sbjct: 71 VVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNF 130
Query: 66 NGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLT 125
GSI GS+ L+ LDLS N + G IP+ +G L+ +DL N LVG IP+SL +LT
Sbjct: 131 TGSI--PRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLT 188
Query: 126 QLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFI 185
L L + +N+L G IP EL L+ + LG N LSG IP +IG L L +LDL N +
Sbjct: 189 SLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNL 248
Query: 186 NGKIPSQLGEFSCIDTVDLSMNNLSGGIP--VF-VRKVPHLDVSGNQFGGEIPTTLA 239
G IPS LG + + L N LSG IP +F ++K+ LD+S N GEIP +
Sbjct: 249 TGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVI 305
|
Length = 968 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 4e-38
Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 16/205 (7%)
Query: 323 IGTGGYGSVYRARL-----PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVK 377
+G G +G VY+ L VA+K L + + +E F EAR++ ++ H NIVK
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTL-KEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 378 LYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCT 437
L G C E+ + ++ EYM G L LR + L + ++ +A + YL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE-LSLSDLLSFALQIARGMEYLESK-- 122
Query: 438 PPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI---APELAYTM 494
+HRD+++ N L+ ++DFG++R L D + G I APE
Sbjct: 123 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKV--KGGKLPIRWMAPESLKEG 179
Query: 495 VVTEKYDVYSFGVVALEVL-MGKHP 518
T K DV+SFGV+ E+ +G+ P
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEEP 204
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 139 bits (354), Expect = 6e-38
Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 323 IGTGGYGSVYRARL--PSGKV---VALKKLHRLETELASLESFQNEARLLSQIRHRNIVK 377
+G G +G VY+ +L GK VA+K L + + +E F EAR++ ++ H N+VK
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTL-KEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 378 LYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCT 437
L G C E+ ++++ EYME G L LR + + L ++ +A + YL
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLS--DLLSFALQIARGMEYLESK-- 121
Query: 438 PPILHRDISSNNILLNSEFEAFVADFGIARLL-NYDSSNRTLLAGTYGSIAPELAYTMVV 496
+HRD+++ N L+ ++DFG++R L + D + +APE
Sbjct: 122 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKF 180
Query: 497 TEKYDVYSFGVVALEVL-MGKHP 518
T K DV+SFGV+ E+ +G+ P
Sbjct: 181 TSKSDVWSFGVLLWEIFTLGEQP 203
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 7e-37
Identities = 67/205 (32%), Positives = 105/205 (51%), Gaps = 17/205 (8%)
Query: 322 CIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYG 380
+G G +GSVY A +G+++A+K + LE+ + E R+LS ++H NIV+ YG
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 381 FCLH-EKCMFLIY-EYMEMGSLFCILRTD---EEAVGLDWTKRVNIVKGMAHALSYLHHH 435
EK I+ EY+ GSL +L+ E V +T++ I++G L+YLH +
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQ--ILEG----LAYLHSN 120
Query: 436 CTPPILHRDISSNNILLNSEFEAFVADFGIARLL--NYDSSNRTLLAGTYGSIAPELAYT 493
I+HRDI NIL++S+ +ADFG A+ L + GT +APE+
Sbjct: 121 G---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 494 MVVTEKYDVYSFGVVALEVLMGKHP 518
D++S G +E+ GK P
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 1e-35
Identities = 86/245 (35%), Positives = 129/245 (52%), Gaps = 3/245 (1%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAI 60
+G++++L + L N+ G IP +G L+ L L+L N+L G IPS++G+L L L +
Sbjct: 208 LGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFL 267
Query: 61 ASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSS 120
N+++G I I SL+ L LDLS N + G IP + L+ L + L N G IP +
Sbjct: 268 YQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVA 327
Query: 121 LGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDL 180
L L +L L +++NK G IP L + L +L L N L+G IP + L+ L L
Sbjct: 328 LTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLIL 387
Query: 181 SGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVP---HLDVSGNQFGGEIPTT 237
N + G+IP LG + V L N+ SG +P K+P LD+S N G I +
Sbjct: 388 FSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSR 447
Query: 238 LANVP 242
++P
Sbjct: 448 KWDMP 452
|
Length = 968 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 2e-35
Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 323 IGTGGYGSVYRARL---PSGKV-VALKKLHRLETELASLESFQNEARLLSQIRHRNIVKL 378
+G G +G VY+ +L VA+K L + + + F EAR++ ++ H N+V+L
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTL-KEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 379 YGFCLHEKCMFLIYEYMEMGSL------FCILRTDEEAVGLDWTKRVNIVKGMAHALSYL 432
G C E+ ++L+ EYME G L + E L ++ +A + YL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 433 HHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI---APE 489
+HRD+++ N L+ + ++DFG++R + YD G I APE
Sbjct: 122 ASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDV-YDDDYYRKKTGGKLPIRWMAPE 177
Query: 490 LAYTMVVTEKYDVYSFGVVALEVL-MGKHP 518
+ T K DV+SFGV+ E+ +G P
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATP 207
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 6e-32
Identities = 68/219 (31%), Positives = 103/219 (47%), Gaps = 35/219 (15%)
Query: 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHR 373
D + +G G G VY+ R P+GK+ ALKK+H E + E + L
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESP 59
Query: 374 NIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTD----EEAVGLDWTKRVNIVKGMAHAL 429
+VK YG E + ++ EYM+ GSL +L+ E + I + + L
Sbjct: 60 YVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY-------IARQILKGL 112
Query: 430 SYLH--HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTY-GSI 486
YLH H I+HRDI +N+L+NS+ E +ADFGI+++L N T+ G++
Sbjct: 113 DYLHTKRH----IIHRDIKPSNLLINSKGEVKIADFGISKVL----ENTLDQCNTFVGTV 164
Query: 487 A---PELAYTMVVTEKY----DVYSFGVVALEVLMGKHP 518
PE + E Y D++S G+ LE +GK P
Sbjct: 165 TYMSPE----RIQGESYSYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 6e-31
Identities = 80/239 (33%), Positives = 123/239 (51%), Gaps = 41/239 (17%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRH---RNIVKL 378
IG G YG+VYR + +P+G+VVALK ++ L+T + Q E LLSQ+R NI K
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIIN-LDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 379 YGFCLHEKCMFLIYEYMEMGSLFCILRT---DEEAVGLDWTKRVNIVKGMAHALSYLHHH 435
YG L +++I EY E GS+ +++ E+ + + I++ + AL Y+H
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV-------IIREVLVALKYIHKV 120
Query: 436 CTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMV 495
++HRDI + NIL+ + + DFG+A LLN +SS R+ GT +APE V
Sbjct: 121 ---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPE-----V 172
Query: 496 VTE------KYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLL----DPRLP 544
+TE K D++S G+ E+ G P S +D + + L+ PRL
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMATGNPP-------YSDVDA-FRAMMLIPKSKPPRLE 223
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 9e-31
Identities = 80/243 (32%), Positives = 126/243 (51%), Gaps = 17/243 (6%)
Query: 316 DFDIKYCIGTGGYGSVYRARLPSGKVVALKKL-HRLETELASLESFQNEARLLSQIRH-R 373
+ I +G G +G VY AR K+VALK L +LE++ +E F E ++L+ + H
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 374 NIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLH 433
NIVKLY F E ++L+ EY++ GSL +L+ L ++ + I+ + AL YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 434 HHCTPPILHRDISSNNILLNSE-FEAFVADFGIARLLNYDSSNRTLLA------GTYGSI 486
I+HRDI NILL+ + + DFG+A+LL S ++ A GT G +
Sbjct: 119 SKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 487 APELAYTMV---VTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRL 543
APE+ + + D++S G+ E+L G P E +SS++ +++L P L
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235
Query: 544 PPP 546
P
Sbjct: 236 ASP 238
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 4e-30
Identities = 67/219 (30%), Positives = 98/219 (44%), Gaps = 33/219 (15%)
Query: 316 DFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRN 374
++I IG G +G VY R GK+ LK++ E NE ++L ++ H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 375 IVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTD--------EEAVGLDWTKRVNIVKGMA 426
I+K Y + + ++ EY + G L ++ EE + LDW V +
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQI-LDWF--VQLCL--- 114
Query: 427 HALSYLH-HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGT--Y 483
AL YLH ILHRDI NI L S + DFGI+++L+ + GT Y
Sbjct: 115 -ALKYLHSRK----ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYY 169
Query: 484 GSIAPEL----AYTMVVTEKYDVYSFGVVALEVLMGKHP 518
++PEL Y K D++S G V E+ KHP
Sbjct: 170 --LSPELCQNKPY----NYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 316 DFDIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRN 374
++ + IG G +G VY+ L +G VA+K++ + + +L+S E LL ++H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 375 IVKLYGFCLHEKCMFLIYEYMEMGSLFCILRT----DEEAVGLDWTKRVNIVKGMAHALS 430
IVK G +++I EY E GSL I++ E V V + L+
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVA-------VYVYQVLQGLA 113
Query: 431 YLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPEL 490
YLH ++HRDI + NIL + +ADFG+A LN S + + GT +APE+
Sbjct: 114 YLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEV 170
Query: 491 AYTMVVTEKYDVYSFGVVALEVLMGKHP 518
+ D++S G +E+L G P
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 2e-29
Identities = 65/202 (32%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 323 IGTGGYGSVYRA-RLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGF 381
IG G G VY+A +GK VA+KK+ RL + + E NE ++ +H NIV Y
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKM-RLRKQ--NKELIINEILIMKDCKHPNIVDYYDS 83
Query: 382 CLHEKCMFLIYEYMEMGSL-----FCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHC 436
L ++++ EYM+ GSL +R +E + + + + L YLH
Sbjct: 84 YLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAY-------VCREVLQGLEYLHSQ- 135
Query: 437 TPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVV 496
++HRDI S+NILL+ + +ADFG A L + S R + GT +APE+
Sbjct: 136 --NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDY 193
Query: 497 TEKYDVYSFGVVALEVLMGKHP 518
K D++S G++ +E+ G+ P
Sbjct: 194 GPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 83/243 (34%), Positives = 121/243 (49%), Gaps = 39/243 (16%)
Query: 323 IGTGGYGSVYRARL--PSGKV--VALKKLHRLETELASLESFQNEARLLSQIRHRNIVKL 378
IG G +G V R RL P K VA+K L ++ L+ F EA ++ Q H NI++L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD-FLTEASIMGQFDHPNIIRL 70
Query: 379 YGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTP 438
G + + +I EYME GSL LR ++ + V +++G+A + YL
Sbjct: 71 EGVVTKSRPVMIITEYMENGSLDKFLRENDGK--FTVGQLVGMLRGIASGMKYLSEMNY- 127
Query: 439 PILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTY----GSI-----APE 489
+HRD+++ NIL+NS V+DFG++R L + S TY G I APE
Sbjct: 128 --VHRDLAARNILVNSNLVCKVSDFGLSRRL--EDSE-----ATYTTKGGKIPIRWTAPE 178
Query: 490 -LAYTMVVTEKYDVYSFGVVALEVL-MGKHPGELLSSSSSSLDKNIKLIDLLDP--RLPP 545
+AY T DV+SFG+V EV+ G+ P +S N +I ++ RLPP
Sbjct: 179 AIAYR-KFTSASDVWSFGIVMWEVMSYGERPYWDMS--------NQDVIKAVEDGYRLPP 229
Query: 546 PGD 548
P D
Sbjct: 230 PMD 232
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 4e-29
Identities = 76/239 (31%), Positives = 115/239 (48%), Gaps = 29/239 (12%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHR 373
E FDI +G G YGSVY+A +G+VVA+K + +E +L + E +L Q
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDLQEII---KEISILKQCDSP 58
Query: 374 NIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRT-----DEEAVGLDWTKRVNIVKGMAHA 428
IVK YG ++++ EY GS+ I++ EE + I+
Sbjct: 59 YIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAA-------ILYQTLKG 111
Query: 429 LSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAP 488
L YLH + +HRDI + NILLN E +A +ADFG++ L + R + GT +AP
Sbjct: 112 LEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAP 168
Query: 489 ELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRLPPPG 547
E+ + K D++S G+ A+E+ GK P + + I +I P PPP
Sbjct: 169 EVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA-----IFMI----PNKPPPT 218
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 7e-29
Identities = 66/193 (34%), Positives = 108/193 (55%), Gaps = 6/193 (3%)
Query: 53 TQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKW-LRSVDLSQN 111
+++ ++ ++ ++G I I L +Q ++LS N++ G IP + LR ++LS N
Sbjct: 69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNN 128
Query: 112 KLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGK 171
G IP G + L TL++ NN L G IP ++ + S L++L LG N+L G IP+ +
Sbjct: 129 NFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTN 186
Query: 172 LQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVP---HLDVSGN 228
L L +L L+ N + G+IP +LG+ + + L NNLSG IP + + HLD+ N
Sbjct: 187 LTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYN 246
Query: 229 QFGGEIPTTLANV 241
G IP++L N+
Sbjct: 247 NLTGPIPSSLGNL 259
|
Length = 968 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 67/215 (31%), Positives = 108/215 (50%), Gaps = 18/215 (8%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHR 373
+D+++ IG G VY A LP+ + VA+K++ LE S++ + E + +SQ H
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRID-LEKCQTSVDELRKEVQAMSQCNHP 59
Query: 374 NIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLH 433
N+VK Y + ++L+ Y+ GSL I+++ GLD ++K + L YLH
Sbjct: 60 NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119
Query: 434 HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL--NYDSSN--RTLLAGTYGSIAPE 489
+ +HRDI + NILL + +ADFG++ L D + R GT +APE
Sbjct: 120 SNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176
Query: 490 L-----AYTMVVTEKYDVYSFGVVALEVLMGKHPG 519
+ Y K D++SFG+ A+E+ G P
Sbjct: 177 VMEQVHGY----DFKADIWSFGITAIELATGAAPY 207
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 78/238 (32%), Positives = 114/238 (47%), Gaps = 28/238 (11%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHR 373
E F + CIG G +G VY+A + +VVA+K + LE +E Q E + LSQ R
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID-LEEAEDEIEDIQQEIQFLSQCRSP 59
Query: 374 NIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRT---DEEAVGLDWTKRVNIVKGMAHALS 430
I K YG L +++I EY GS +L+ DE + I++ + L
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF-------ILREVLLGLE 112
Query: 431 YLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPEL 490
YLH +HRDI + NILL+ E + +ADFG++ L S R GT +APE+
Sbjct: 113 YLHEEGK---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEV 169
Query: 491 AYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLD--KNIKLIDLLDPRLPPP 546
EK D++S G+ A+E+ G+ P S L + + LI P+ PP
Sbjct: 170 IKQSGYDEKADIWSLGITAIELAKGEPP-------LSDLHPMRVLFLI----PKNNPP 216
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 65/210 (30%), Positives = 108/210 (51%), Gaps = 17/210 (8%)
Query: 316 DFDIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRN 374
DF+I IG G +G V++ R +V A+K++ + E +EAR+L+++
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 375 IVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTD------EEAVGLDWTKRVNIVKGMAHA 428
I++ Y L + + ++ EY E G L +L+ E+ V W + I+ G
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQV---WRFFIQILLG---- 113
Query: 429 LSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAP 488
L++LH + ILHRDI S N+ L++ + D G+A+LL+ +++ + GT ++P
Sbjct: 114 LAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSP 170
Query: 489 ELAYTMVVTEKYDVYSFGVVALEVLMGKHP 518
EL EK DV++ GVV E GKHP
Sbjct: 171 ELCEDKPYNEKSDVWALGVVLYECCTGKHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 68/215 (31%), Positives = 106/215 (49%), Gaps = 43/215 (20%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETE-----LASLESFQNEARLLSQIRHRNIV 376
IG G YG VY+AR +G++VALKK+ R+E E + ++ E +LL ++RH NIV
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKI-RMENEKEGFPITAIR----EIKLLQKLRHPNIV 61
Query: 377 KLYGFCLHEKC--MFLIYEYME---MGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSY 431
+L + +++++EYM+ G +L + E K +K + L Y
Sbjct: 62 RLKEIVTSKGKGSIYMVFEYMDHDLTG----LLDSPEVKFTESQIKC--YMKQLLEGLQY 115
Query: 432 LHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI----- 486
LH + ILHRDI +NIL+N++ +ADFG+AR +S T I
Sbjct: 116 LHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY----TNRVITLWYR 168
Query: 487 APEL-----AYTMVVTEKYDVYSFGVVALEVLMGK 516
PEL Y + D++S G + E+ +GK
Sbjct: 169 PPELLLGATRY----GPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-26
Identities = 68/233 (29%), Positives = 116/233 (49%), Gaps = 25/233 (10%)
Query: 323 IGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFC 382
+G+G +G V+ + VA+K + E ++ + F EA+++ ++ H N+V+LYG C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIR--EGAMSE-DDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 383 LHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRV--NIVKGMAHALSYLHHHCTPPI 440
++ +F++ EYM G L LR + +G +W + ++ + M YL +
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAME----YLESNG---F 121
Query: 441 LHRDISSNNILLNSEFEAFVADFGIARLL---NYDSSNRTLLAGTYGSI---APELAYTM 494
+HRD+++ N L+ + V+DFG+AR + Y SS GT + PE+
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS-----QGTKFPVKWAPPEVFDYS 176
Query: 495 VVTEKYDVYSFGVVALEVL-MGKHPGELLSSSSSSLDKNIKLIDLLDPRLPPP 546
+ K DV+SFGV+ EV GK P E S+S ++ L P+L P
Sbjct: 177 RFSSKSDVWSFGVLMWEVFSEGKMPYERF-SNSEVVESVSAGYRLYRPKLAPT 228
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 4e-26
Identities = 81/240 (33%), Positives = 122/240 (50%), Gaps = 22/240 (9%)
Query: 319 IKYCIGTGGYGSVYRARL-PSGK---VVALKKLHRLETELASLESFQNEARLLSQIRHRN 374
I+ IG G +G V R RL GK VA+K L TE + F +EA ++ Q H N
Sbjct: 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRD-FLSEASIMGQFDHPN 66
Query: 375 IVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHH 434
I+ L G + + +I E+ME G+L LR ++ + + V +++G+A + YL
Sbjct: 67 IIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTV--IQLVGMLRGIAAGMKYLSE 124
Query: 435 HCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI-----APE 489
+HRD+++ NIL+NS V+DFG++R L D+S+ T + G I APE
Sbjct: 125 M---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE 181
Query: 490 LAYTMVVTEKYDVYSFGVVALEVL-MGKHPGELLSSSSSSLDKNIKLIDLLDPRLPPPGD 548
T DV+S+G+V EV+ G+ P +S+ I I+ D RLPPP D
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV-----INAIE-QDYRLPPPMD 235
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 69/210 (32%), Positives = 104/210 (49%), Gaps = 34/210 (16%)
Query: 322 CIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQ----NEARLLSQIRHRNIV 376
+G G YG VY+AR +G++VALKK+ RL+ E E E LL +++H NIV
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKI-RLDNEE---EGIPSTALREISLLKELKHPNIV 61
Query: 377 KLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHC 436
KL E+ ++L++EY +M L L + + K I+ + L+Y H H
Sbjct: 62 KLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKS--IMYQLLRGLAYCHSHR 118
Query: 437 TPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI-----APEL- 490
ILHRD+ NIL+N + +ADFG+AR RT T+ + APE+
Sbjct: 119 ---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPL--RTY---THEVVTLWYRAPEIL 170
Query: 491 ----AYTMVVTEKYDVYSFGVVALEVLMGK 516
Y+ V D++S G + E++ GK
Sbjct: 171 LGSKHYSTAV----DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 20/216 (9%)
Query: 316 DFDIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRN 374
D+++ IG G +G+V + R GK++ K++ + +E +L +++H N
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPN 60
Query: 375 IVKLYGFCLHE--KCMFLIYEYMEMGSLFCIL--------RTDEEAVGLDWTKRVNIVKG 424
IV+ Y + + ++++ EY E G L ++ +EE + W I+
Sbjct: 61 IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI---W----RILTQ 113
Query: 425 MAHALSYLHH--HCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGT 482
+ AL H+ +LHRD+ NI L++ + DFG+A++L +DSS GT
Sbjct: 114 LLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGT 173
Query: 483 YGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHP 518
++PE M EK D++S G + E+ P
Sbjct: 174 PYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 66/223 (29%), Positives = 106/223 (47%), Gaps = 27/223 (12%)
Query: 317 FDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLE-TELASLESFQNEARLLSQIRHRN 374
F++ IG G +G V + + K+ A+K +++ + E S+ + NE R+L ++ H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 375 IVKL-YGFCLHEKCMFLIYEYMEMGSL-FCILRT---DEEAVGLDWTKRVNIVKGMAHAL 429
+V L Y F E M+L+ + + G L + + + EE V + + AL
Sbjct: 62 LVNLWYSFQDEEN-MYLVVDLLLGGDLRYHLSQKVKFSEEQVKF-------WICEIVLAL 113
Query: 430 SYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPE 489
YLH I+HRDI +NILL+ + + DF IA + D + T +GT G +APE
Sbjct: 114 EYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD-TLTTSTSGTPGYMAPE 169
Query: 490 LAYTMVVTEKY----DVYSFGVVALEVLMGKHPGELLSSSSSS 528
++ + Y D +S GV A E L GK P S +
Sbjct: 170 ----VLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD 208
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 70/238 (29%), Positives = 123/238 (51%), Gaps = 23/238 (9%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRN 374
E+F ++ +G+G +G V+ + VA+K L +L + FQ E + L ++RH++
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKS--DDLLKQQDFQKEVQALKRLRHKH 63
Query: 375 IVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHH 434
++ L+ C + +++I E ME GSL LR+ E V L +++ +A ++YL
Sbjct: 64 LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQV-LPVASLIDMACQVAEGMAYLEE 122
Query: 435 HCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN---YDSSNRTLLAGTYGSIAPELA 491
+HRD+++ NIL+ + VADFG+ARL+ Y SS++ + Y APE A
Sbjct: 123 Q---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI---PYKWTAPEAA 176
Query: 492 YTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSSSSLDKNIKLIDLLDP--RLPPP 546
+ K DV+SFG++ E+ G+ P ++ N ++ D + R+P P
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN--------NHEVYDQITAGYRMPCP 226
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 57/206 (27%), Positives = 102/206 (49%), Gaps = 27/206 (13%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRN 374
++ + IG G +G V G+ VA+K L + + ++F EA +++ +RH N
Sbjct: 6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKD---DSTAAQAFLAEASVMTTLRHPN 61
Query: 375 IVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKR------VNIVKGMAHA 428
+V+L G L ++++ EYM GSL LR+ AV T +++ +GM
Sbjct: 62 LVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAV---ITLAQQLGFALDVCEGME-- 116
Query: 429 LSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGS--I 486
YL +HRD+++ N+L++ + A V+DFG+A+ +++ +G
Sbjct: 117 --YLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWT 166
Query: 487 APELAYTMVVTEKYDVYSFGVVALEV 512
APE + K DV+SFG++ E+
Sbjct: 167 APEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 66/203 (32%), Positives = 98/203 (48%), Gaps = 18/203 (8%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLH-RLETELASLESFQNEARLLSQIRHRNIVKL-Y 379
+G G +G V R +GK+ A+K L + + +E E +LS+I H IVKL Y
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 380 GFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPP 439
F EK ++L+ EY G LF L E + + + AL YLH
Sbjct: 61 AFQTEEK-LYLVLEYAPGGELFSHLS-KEGRFSEERARF--YAAEIVLALEYLHSL---G 113
Query: 440 ILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPEL----AYTMV 495
I++RD+ NILL+++ + DFG+A+ L+ + S GT +APE+ Y
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKA 173
Query: 496 VTEKYDVYSFGVVALEVLMGKHP 518
V D +S GV+ E+L GK P
Sbjct: 174 V----DWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 8e-24
Identities = 71/229 (31%), Positives = 114/229 (49%), Gaps = 20/229 (8%)
Query: 316 DFDIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRLETELASLESFQNEARLLSQIRHRN 374
D +K+ +G G YG VY VA+K L + + +E F EA ++ +I+H N
Sbjct: 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPN 63
Query: 375 IVKLYGFCLHEKCMFLIYEYMEMGSLFCILR-TDEEAVGLDWTKRVNIVKGMAHALSYLH 433
+V+L G C E ++I E+M G+L LR + + ++ + + ++ A+ YL
Sbjct: 64 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLE 121
Query: 434 HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI---APE- 489
+HRD+++ N L+ VADFG++RL+ D+ T AG I APE
Sbjct: 122 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPES 176
Query: 490 LAYTMVVTEKYDVYSFGVVALEVL---MGKHPGELLSSSSSSLDKNIKL 535
LAY K DV++FGV+ E+ M +PG LS L+K ++
Sbjct: 177 LAYNKFSI-KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRM 224
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 64/212 (30%), Positives = 105/212 (49%), Gaps = 30/212 (14%)
Query: 323 IGTGGYGSVYRA-RLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGF 381
IG G +G VY A L +G+++A+K++ + + +++ +E ++L ++H N+VK YG
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 382 CLHEKCMFLIYEYMEMGSLFCILR----TDEEAVGLDWTKRVNIVKGMAHALSYLHHHCT 437
+H + +++ EY G+L +L DE + + + L+YLH H
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRV-------YTLQLLEGLAYLHSH-- 118
Query: 438 PPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTL-------LAGTYGSIAPEL 490
I+HRDI NI L+ + DFG A L +N T LAGT +APE+
Sbjct: 119 -GIVHRDIKPANIFLDHNGVIKLGDFGCAVKL---KNNTTTMGEEVQSLAGTPAYMAPEV 174
Query: 491 AYTMVVTEKY----DVYSFGVVALEVLMGKHP 518
T + + D++S G V LE+ GK P
Sbjct: 175 -ITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 1e-23
Identities = 66/215 (30%), Positives = 108/215 (50%), Gaps = 25/215 (11%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHR 373
ED+++ IG+G YG VY+AR + +G++VA+K + + E Q E +L + RH
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHP 60
Query: 374 NIVKLYGFCLHEKCMFLIYEYMEMGSL---FCILRTDEEAVGLDWTKRVNIVKGMAHALS 430
NIV +G L ++++ EY GSL + + R + + + R +KG L+
Sbjct: 61 NIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCR-ETLKG----LA 115
Query: 431 YLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPEL 490
YLH +HRDI NILL + + +ADFG++ L + R GT +APE+
Sbjct: 116 YLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEV 172
Query: 491 A-------YTMVVTEKYDVYSFGVVALEVLMGKHP 518
A Y K D+++ G+ A+E+ + P
Sbjct: 173 AAVERKGGY----DGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 2e-23
Identities = 76/251 (30%), Positives = 110/251 (43%), Gaps = 41/251 (16%)
Query: 323 IGTGGYGSVYRARLP-----SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVK 377
+G G +G V R +G+ VA+K L+ E F+ E +L + H NIVK
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNH-SGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 378 LYGFC--LHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKR-----VNIVKGMAHALS 430
G C + + LI EY+ GSL L+ + + L KR I KGM
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINL---KRLLLFSSQICKGMD---- 123
Query: 431 YLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS------SNRTLLAGTYG 484
YL + +HRD+++ NIL+ SE ++DFG+A++L D Y
Sbjct: 124 YLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY- 179
Query: 485 SIAPELAYTMVVTEKYDVYSFGVVALEVL-MGKH----PGELLSSSSSSLDKNI--KLID 537
APE T + DV+SFGV E+ G P E L + + I +L++
Sbjct: 180 --APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237
Query: 538 LLDP--RLPPP 546
LL RLP P
Sbjct: 238 LLKEGERLPRP 248
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 4e-23
Identities = 64/230 (27%), Positives = 106/230 (46%), Gaps = 21/230 (9%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGF 381
+G G G V + P+GK++A+K + LE A + E +L + IV YG
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIR-LEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 382 CLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPIL 441
+ + + EYM+ GSL IL+ + + ++ + + L+YLH I+
Sbjct: 68 FYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAV--AVLKGLTYLHE--KHKII 123
Query: 442 HRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYD 501
HRD+ +NIL+NS + + DFG++ L +S +T GT +APE + K D
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVSGQL-VNSLAKT-FVGTSSYMAPERIQGNDYSVKSD 181
Query: 502 VYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLD-------PRLP 544
++S G+ +E+ G+ P D + +LL PRLP
Sbjct: 182 IWSLGLSLIELATGRFP------YPPENDPPDGIFELLQYIVNEPPPRLP 225
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 65/210 (30%), Positives = 109/210 (51%), Gaps = 23/210 (10%)
Query: 323 IGTGGYGSVYRAR-LPSGK----VVALKKLHRLETELASLESFQNEARLLSQIRHRNIVK 377
+G+G +G+VY+ +P G+ VA+K L R ET + + +EA +++ + H ++V+
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVL-REETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 378 LYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVG----LDWTKRVNIVKGMAHALSYLH 433
L G CL + LI + M +G L +R ++ +G L+W V I KGM SYL
Sbjct: 74 LLGICLSSQVQ-LITQLMPLGCLLDYVRNHKDNIGSQYLLNWC--VQIAKGM----SYLE 126
Query: 434 HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGS--IAPELA 491
++HRD+++ N+L+ + + DFG+A+LL+ D G +A E
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 492 YTMVVTEKYDVYSFGVVALEVL-MGKHPGE 520
+ T K DV+S+GV E++ G P E
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 2e-22
Identities = 73/207 (35%), Positives = 106/207 (51%), Gaps = 20/207 (9%)
Query: 323 IGTGGYGSVYRA--RLPSGK--VVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKL 378
IG G +G V+R ++P K VA+K L TE + F +EA ++ Q H NI++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE-KQRQDFLSEASIMGQFSHHNIIRL 71
Query: 379 YGFCLHEKCMFLIYEYMEMGSLFCILR-TDEEAVGLDWTKRVNIVKGMAHALSYLHHHCT 437
G K +I EYME G+L LR D E + V +++G+A + YL
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSY---QLVGMLRGIAAGMKYLSDM-- 126
Query: 438 PPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI-----APELAY 492
+HRD+++ NIL+NS E V+DFG++R+L D +G G I APE
Sbjct: 127 -NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSG--GKIPIRWTAPEAIA 183
Query: 493 TMVVTEKYDVYSFGVVALEVL-MGKHP 518
T DV+SFG+V EV+ G+ P
Sbjct: 184 YRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 5e-22
Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 16/200 (8%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQN----EARLLSQIRHRNIVK 377
IG G YG VY+AR +G++VA+KK+ E E +LL ++ H NI+K
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFES----EGIPKTALREIKLLKELNHPNIIK 62
Query: 378 LYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCT 437
L H+ ++L++E+M+ L+ +++ GL + + + + L++ H H
Sbjct: 63 LLDVFRHKGDLYLVFEFMDT-DLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSH-- 117
Query: 438 PPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTM-VV 496
ILHRD+ N+L+N+E +ADFG+AR T T APEL
Sbjct: 118 -GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGY 176
Query: 497 TEKYDVYSFGVVALEVLMGK 516
+ D++S G + E+L +
Sbjct: 177 STPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 5e-22
Identities = 70/259 (27%), Positives = 122/259 (47%), Gaps = 39/259 (15%)
Query: 323 IGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFC 382
+G G +G VY+A+ + A K+ ++E+E LE F E +LS+ +H NIV LY
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESE-EELEDFMVEIDILSECKHPNIVGLYEAY 71
Query: 383 LHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILH 442
+E ++++ E+ + G+L I+ E GL + + + M AL++LH H ++H
Sbjct: 72 FYENKLWILIEFCDGGALDSIM--LELERGLTEPQIRYVCRQMLEALNFLHSH---KVIH 126
Query: 443 RDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTE---- 498
RD+ + NILL + + +ADFG++ R GT +APE+ V E
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEV----VACETFKD 182
Query: 499 -----KYDVYSFGVVALEVLMGKHPG----------ELLSSSSSSLDK----NIKLIDLL 539
K D++S G+ +E+ + P ++L S +LD+ + D L
Sbjct: 183 NPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFL 242
Query: 540 ------DPRLPPPGDQMIR 552
DP P ++++
Sbjct: 243 KSCLVKDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 78/241 (32%), Positives = 114/241 (47%), Gaps = 36/241 (14%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETE-----LASLESFQNEARLLSQIRHRNIV 376
IG G YG VYRAR SG++VALKK+ R++ E ++SL E LL +RH NIV
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKV-RMDNERDGIPISSLR----EITLLLNLRHPNIV 69
Query: 377 KLYGFCL--HEKCMFLIYEYME--MGSLFCILRT--DEEAVGLDWTKRVNIVKGMAHALS 430
+L + H +FL+ EY E + SL + T E V ++ + L
Sbjct: 70 ELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKC-------LMLQLLRGLQ 122
Query: 431 YLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPEL 490
YLH + I+HRD+ +N+LL + +ADFG+AR + T T APEL
Sbjct: 123 YLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPEL 179
Query: 491 AYTMVV-TEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRLPPPGDQ 549
T D+++ G + E+L K LL S I+ +DL+ L P +
Sbjct: 180 LLGCTTYTTAIDMWAVGCILAELLAHK---PLLPGKSE-----IEQLDLIIQLLGTPNES 231
Query: 550 M 550
+
Sbjct: 232 I 232
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 1e-21
Identities = 76/269 (28%), Positives = 115/269 (42%), Gaps = 43/269 (15%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGK------VVALKKLHRLETELASLESFQNEARLLS 368
+ +K +G G +G V+ + +VA+K L + A + F+ EA LL+
Sbjct: 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDAR-KDFEREAELLT 63
Query: 369 QIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRT-DEEAVGLDWTKR--------- 418
+H NIVK YG C +++EYME G L LR+ +A L
Sbjct: 64 NFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQ 123
Query: 419 -VNIVKGMAHALSYL--HHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL----NY 471
+ I +A + YL H +HRD+++ N L+ + + DFG++R + Y
Sbjct: 124 LLQIAVQIASGMVYLASQH-----FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY 178
Query: 472 DSSNRTLLAGTYGSIAPE-LAYTMVVTEKYDVYSFGVVALEVL-MGKHPGELLSSSSSSL 529
T+L + + PE + Y TE DV+SFGVV E+ GK P LS+
Sbjct: 179 RVGGHTMLPIRW--MPPESIMYRKFTTES-DVWSFGVVLWEIFTYGKQPWYGLSNEEV-- 233
Query: 530 DKNIKLID----LLDPRLPPPGDQMIRQG 554
I+ I L PR P I G
Sbjct: 234 ---IECITQGRLLQRPRTCPSEVYDIMLG 259
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 65/227 (28%), Positives = 101/227 (44%), Gaps = 32/227 (14%)
Query: 312 EATEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQI 370
+ T F++ IG G YG VY+AR +G++VA+K + +E E ++ N R S
Sbjct: 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSN- 61
Query: 371 RHRNIVKLYGFCL------HEKCMFLIYEYMEMGS--------LFCILRTDEEAVGLDWT 416
H NI YG + ++ ++L+ E GS R EE +
Sbjct: 62 -HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY--- 117
Query: 417 KRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNR 476
I++ L+YLH + ++HRDI NILL E + DFG++ L+ R
Sbjct: 118 ----ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRR 170
Query: 477 TLLAGTYGSIAPEL-----AYTMVVTEKYDVYSFGVVALEVLMGKHP 518
GT +APE+ + DV+S G+ A+E+ GK P
Sbjct: 171 NTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 3e-21
Identities = 75/241 (31%), Positives = 114/241 (47%), Gaps = 40/241 (16%)
Query: 323 IGTGGYGSVYRA--RLPSGKV--VALKKLHRLETELASLESFQNEARLLSQIRHRNIVKL 378
+G G +GSV + + SGK VA+K L + E A + F EA +++Q+ H IV+L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQ-EHIAAGKKEFLREASVMAQLDHPCIVRL 61
Query: 379 YGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALS----YLHH 434
G C E M L+ E +G L L+ E D +K +AH ++ YL
Sbjct: 62 IGVCKGEPLM-LVMELAPLGPLLKYLKKRREIPVSD-------LKELAHQVAMGMAYLE- 112
Query: 435 HCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGS-----IAPE 489
+ +HRD+++ N+LL + +A ++DFG++R L S A T G APE
Sbjct: 113 --SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR--ATTAGRWPLKWYAPE 168
Query: 490 LAYTMVVTEKYDVYSFGVVALEVL-MGKHP-GELLSSSSSSLDKNIKLIDLLDP--RLPP 545
+ K DV+S+GV E G P GE+ K ++I +L+ RLP
Sbjct: 169 CINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM---------KGAEVIAMLESGERLPR 219
Query: 546 P 546
P
Sbjct: 220 P 220
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 4e-21
Identities = 79/240 (32%), Positives = 116/240 (48%), Gaps = 24/240 (10%)
Query: 319 IKYCIGTGGYGSVY--RARLPSGK--VVALKKLHRLETELASLESFQNEARLLSQIRHRN 374
I+ IG G +G V R +LP + VA+K L TE F +EA ++ Q H N
Sbjct: 8 IEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTE-KQRRDFLSEASIMGQFDHPN 66
Query: 375 IVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHH 434
I+ L G K + ++ EYME GSL LR + + + V +++G+A + YL
Sbjct: 67 IIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTV--IQLVGMLRGIASGMKYLSD 124
Query: 435 HCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI-----APE 489
+HRD+++ NIL+NS V+DFG++R+L D G G I APE
Sbjct: 125 M---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRG--GKIPIRWTAPE 179
Query: 490 LAYTMVVTEKYDVYSFGVVALEVL-MGKHPGELLSSSSSSLDKNIKLIDLLDPRLPPPGD 548
T DV+S+G+V EV+ G+ P +S+ IK I+ RLP P D
Sbjct: 180 AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV-----IKAIE-EGYRLPAPMD 233
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 9e-21
Identities = 71/233 (30%), Positives = 109/233 (46%), Gaps = 27/233 (11%)
Query: 323 IGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFC 382
IG+G +G V+ + VA+K + S E F EA+++ ++ H +V+LYG C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIRE---GAMSEEDFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 383 LHEKCMFLIYEYMEMGSLFCILRTD------EEAVGLDWTKRVNIVKGMAHALSYLHHHC 436
+ L++E+ME G L LR E +G+ +++ +GMA YL
Sbjct: 69 TERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGM----CLDVCEGMA----YLESSN 120
Query: 437 TPPILHRDISSNNILLNSEFEAFVADFGIARLL---NYDSSNRTLLAGTYGSIAPELAYT 493
++HRD+++ N L+ V+DFG+ R + Y SS T + S PE+
Sbjct: 121 ---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSS--PEVFSF 175
Query: 494 MVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSSSSLDKNIKLIDLLDPRLPP 545
+ K DV+SFGV+ EV GK P E S+S N L PRL
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF-RLYKPRLAS 227
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 1e-20
Identities = 65/197 (32%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 323 IGTGGYGSVYRA-RLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGF 381
IG G +G V++ + KVVA+K + E E +E Q E +LSQ + K YG
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 382 CLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPIL 441
L + +++I EY+ GS +L E LD T+ I++ + L YLH + +
Sbjct: 71 YLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLH---SEKKI 123
Query: 442 HRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYD 501
HRDI + N+LL+ E +ADFG+A L R GT +APE+ K D
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKAD 183
Query: 502 VYSFGVVALEVLMGKHP 518
++S G+ A+E+ G+ P
Sbjct: 184 IWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (229), Expect = 1e-20
Identities = 69/213 (32%), Positives = 102/213 (47%), Gaps = 25/213 (11%)
Query: 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLE-TELASLESFQNEARLLSQIRH 372
+DF+ +GTG +G V R SGK ALK L + + +L +E NE R+L IRH
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTK--RVNIVKGMAHALS 430
+V LYG + ++L+ EY+ G LF LR + +V AL
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVL----ALE 115
Query: 431 YLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRT-LLAGTYGSIAPE 489
YLH I++RD+ N+LL+S+ + DFG A+ + RT L GT +APE
Sbjct: 116 YLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRV----KGRTYTLCGTPEYLAPE 168
Query: 490 L----AYTMVVTEKYDVYSFGVVALEVLMGKHP 518
+ Y V D ++ G++ E+L G P
Sbjct: 169 IILSKGYGKAV----DWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 61/230 (26%), Positives = 111/230 (48%), Gaps = 23/230 (10%)
Query: 323 IGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFC 382
+G G +G V+ + VA+K L + + F EA+++ ++RH +++LY C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTL---KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 383 LHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILH 442
E+ ++++ E M+ GSL L+ L + +++ +A ++YL +H
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQGGAGRA-LKLPQLIDMAAQVASGMAYLEAQ---NYIH 126
Query: 443 RDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI---APELAYTMVVTEK 499
RD+++ N+L+ VADFG+AR++ D G I APE A + K
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAR--EGAKFPIKWTAPEAALYNRFSIK 184
Query: 500 YDVYSFGVVALE-VLMGKHPGELLSSSSSSLDKNIKLIDLLDP--RLPPP 546
DV+SFG++ E V G+ P ++ N +++ +D R+P P
Sbjct: 185 SDVWSFGILLTEIVTYGRMPYPGMT--------NAEVLQQVDQGYRMPCP 226
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 2e-20
Identities = 57/211 (27%), Positives = 107/211 (50%), Gaps = 14/211 (6%)
Query: 323 IGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFC 382
+GTG +G V + VA+K + E ++ E + EA+++ ++ H +V+LYG C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIK--EGSMSEDEFIE-EAKVMMKLSHEKLVQLYGVC 68
Query: 383 LHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILH 442
++ ++++ EYM G L LR E ++ + + K + ++YL +H
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYLR--EHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIH 123
Query: 443 RDISSNNILLNSEFEAFVADFGIARLL---NYDSSNRTLLAGTYGSIAPELAYTMVVTEK 499
RD+++ N L++ + V+DFG++R + Y SS + + PE+ + K
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS--PPEVLLYSKFSSK 181
Query: 500 YDVYSFGVVALEVL-MGKHPGELLSSSSSSL 529
DV++FGV+ EV +GK P E ++S +
Sbjct: 182 SDVWAFGVLMWEVYSLGKMPYERFNNSETVE 212
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 3e-20
Identities = 70/240 (29%), Positives = 106/240 (44%), Gaps = 31/240 (12%)
Query: 323 IGTGGYGSVYRARL--PSGKV--VALKKLHRLETELASLESFQNEARLLSQIRHRNIVKL 378
+G G +G V R GKV VA+K L + + ++ F EA ++ + H N+++L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCL-KSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 379 YGFCLHEKCMFLIYEYMEMGSLFCILRTDEEA---VGLDWTKRVNIVKGMAHALSYLHHH 435
YG L M ++ E +GSL LR D + V I GM YL
Sbjct: 62 YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMR----YLE-- 114
Query: 436 CTPPILHRDISSNNILLNSEFEAFVADFGIARLL-----NYDSS-NRTLLAGTYGSIAPE 489
+ +HRD+++ NILL S+ + + DFG+ R L +Y + + + APE
Sbjct: 115 -SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV---PFAWCAPE 170
Query: 490 LAYTMVVTEKYDVYSFGVVALEVL-MGKHPGELLSSSSSSLDKNIKLIDLLDPRLPPPGD 548
T + DV+ FGV E+ G+ P LS S + +K ID RL P
Sbjct: 171 SLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS-----QILKKIDKEGERLERPEA 225
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 6e-20
Identities = 67/225 (29%), Positives = 106/225 (47%), Gaps = 18/225 (8%)
Query: 323 IGTGGYGSVYRA-RLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGF 381
IG G +G V++ + +VVA+K + E E +E Q E +LSQ + K YG
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 382 CLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPIL 441
L +++I EY+ GS +LR A D + ++K + L YLH + +
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLH---SEKKI 123
Query: 442 HRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYD 501
HRDI + N+LL+ + + +ADFG+A L R GT +APE+ K D
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKAD 183
Query: 502 VYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRLPPP 546
++S G+ A+E+ G+ P D + + L P+ PP
Sbjct: 184 IWSLGITAIELAKGEPPNS---------DMHPMRVLFLIPKNNPP 219
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 7e-20
Identities = 78/264 (29%), Positives = 130/264 (49%), Gaps = 33/264 (12%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR----LPSGK--VVALKKLHRLETELASLESFQNEARLLS 368
D +K+ +G G +G V+ A LP +VA+K L E ++ + FQ EA LL+
Sbjct: 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK--EASESARQDFQREAELLT 62
Query: 369 QIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRT-----------DEEAVG-LDWT 416
++H++IV+ YG C + + +++EYM G L LR+ ++ A G L
Sbjct: 63 VLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLG 122
Query: 417 KRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL----NYD 472
+ + I +A + YL + +HRD+++ N L+ + DFG++R + Y
Sbjct: 123 QMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR 179
Query: 473 SSNRTLLAGTYGSIAPE-LAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSSSSLD 530
RT+L + + PE + Y TE D++SFGVV E+ GK P L S++ +++
Sbjct: 180 VGGRTMLPIRW--MPPESILYRKFTTES-DIWSFGVVLWEIFTYGKQPWYQL-SNTEAIE 235
Query: 531 KNIKLIDLLDPRLPPPGDQMIRQG 554
+ +L PR PP I QG
Sbjct: 236 CITQGRELERPRTCPPEVYAIMQG 259
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 8e-20
Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 33/215 (15%)
Query: 323 IGTGGYGSVYRARL--PSGK----VVALKKLHRLETELASLESFQNEARLLSQIRHRNIV 376
+G G +G VY+ L P+ + VA+K L + E + F+ EA L+S ++H NIV
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTL-KENAEPKVQQEFRQEAELMSDLQHPNIV 71
Query: 377 KLYGFCLHEKCMFLIYEYMEMGSL--FCILRTDEEAVG-----------LDWTKRVNIVK 423
L G C E+ +++EY+ G L F + + VG LD + ++I
Sbjct: 72 CLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131
Query: 424 GMAHALSYL--HHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL----NYDSSNRT 477
+A + YL HH HRD+++ N L+ ++DFG++R + Y +++
Sbjct: 132 QIAAGMEYLSSHHFV-----HRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186
Query: 478 LLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEV 512
LL + + PE T + D++SFGVV E+
Sbjct: 187 LLPVRW--MPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 9e-20
Identities = 62/193 (32%), Positives = 100/193 (51%), Gaps = 12/193 (6%)
Query: 323 IGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFC 382
+G G +G V+ VA+K L + S E+F EA+++ ++RH +V+LY C
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTL---KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70
Query: 383 LHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILH 442
E+ ++++ EYM GSL L++ E L + V++ +A ++YL +H
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIH 126
Query: 443 RDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI---APELAYTMVVTEK 499
RD+++ NIL+ +ADFG+ARL+ D T G I APE A T K
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDDEY--TAREGAKFPIKWTAPEAANYGRFTIK 184
Query: 500 YDVYSFGVVALEV 512
DV+SFG++ E+
Sbjct: 185 SDVWSFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 1e-19
Identities = 48/118 (40%), Positives = 70/118 (59%)
Query: 3 RLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIAS 62
+ L +LDLS N F G +P LG LSEL L LS N L G IP + +L +L ++
Sbjct: 473 GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSH 532
Query: 63 NRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSS 120
N+++G I + VL LDLS+N++ G IP LG+++ L V++S N L G +PS+
Sbjct: 533 NQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPST 590
|
Length = 968 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 62/206 (30%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGF 381
+G G YG V + R +G++VA+KK E + ++ E ++L Q+RH NIV L
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68
Query: 382 CLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPIL 441
+ ++L++EY+E +L +L + D + + + A++Y H H I+
Sbjct: 69 FRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRS--YIWQLLQAIAYCHSH---NII 122
Query: 442 HRDISSNNILLNSEFEAFVADFGIARLLNYDSSNR-TLLAGTYGSIAPELAYTMVVTEKY 500
HRDI NIL++ + DFG AR L ++ T T APEL +V Y
Sbjct: 123 HRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPEL---LVGDTNY 179
Query: 501 ----DVYSFGVVALEVLMGK--HPGE 520
DV++ G + E+L G+ PG+
Sbjct: 180 GKPVDVWAIGCIMAELLDGEPLFPGD 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 1e-19
Identities = 62/233 (26%), Positives = 99/233 (42%), Gaps = 27/233 (11%)
Query: 323 IGTGGYGSVYRARLPSGKVVALKKLHRLETELASL-ESFQNEARLLSQIRHRNIVKLYGF 381
IG G +G VY+ L VA+K T L F EA +L Q H NIVKL G
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCR--STLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 382 CLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPIL 441
C+ ++ ++++ E + GSL LR + L K + + A + YL +
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRK--KKNRLTVKKLLQMSLDAAAGMEYLESKNC---I 115
Query: 442 HRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI-----APELAYTMVV 496
HRD+++ N L+ ++DFG++R + T+ G I APE
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGL-KQIPIKWTAPEALNYGRY 172
Query: 497 TEKYDVYSFGVVALEVLM---GKHPGELLSSSSSSLDKNIKLIDLLDPRLPPP 546
T + DV+S+G++ E +PG + ++ R+P P
Sbjct: 173 TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY--------RMPAP 217
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 19/210 (9%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLET-ELASLESFQNEARLLSQIRH 372
+D + +GTG +G V+ R S ALK + E L + NE R+L ++ H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTD---EEAVGLDWTKRVNIVKGMAHAL 429
I++L+ ++ ++++ EY+ G LF LR + GL + + AL
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEI------VCAL 114
Query: 430 SYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRT-LLAGTYGSIAP 488
YLH I++RD+ NILL+ E + DFG A+ L +RT L GT +AP
Sbjct: 115 EYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKL----RDRTWTLCGTPEYLAP 167
Query: 489 ELAYTMVVTEKYDVYSFGVVALEVLMGKHP 518
E+ + + D ++ G++ E+L+G P
Sbjct: 168 EVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 51/151 (33%), Positives = 83/151 (54%), Gaps = 16/151 (10%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQ-NEARLLSQIRHRNIVKLYG 380
IG G YG VY+AR +G++VALKK+ RLETE + S E LL ++ H NIV+L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI-RLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 381 FCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKG----MAHALSYLHHHC 436
E ++L++E++++ L+ ++ L ++K + ++Y H H
Sbjct: 66 VVHSENKLYLVFEFLDLD-----LKKYMDSSPLTGLDP-PLIKSYLYQLLQGIAYCHSH- 118
Query: 437 TPPILHRDISSNNILLNSEFEAFVADFGIAR 467
+LHRD+ N+L++ E +ADFG+AR
Sbjct: 119 --RVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 73/219 (33%), Positives = 106/219 (48%), Gaps = 29/219 (13%)
Query: 307 FQDMIEATEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQN--- 362
F D+ E IG G +G+VY AR + + +VVA+KK+ + S E +Q+
Sbjct: 17 FTDLRE----------IGHGSFGAVYFARDVRTNEVVAIKKM--SYSGKQSNEKWQDIIK 64
Query: 363 EARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIV 422
E R L Q+RH N ++ G L E +L+ EY +GS IL ++ L + I
Sbjct: 65 EVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDILEVHKK--PLQEVEIAAIC 121
Query: 423 KGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGT 482
G L+YLH H +HRDI + NILL +ADFG A L++ +S GT
Sbjct: 122 HGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANS----FVGT 174
Query: 483 YGSIAPELAYTM---VVTEKYDVYSFGVVALEVLMGKHP 518
+APE+ M K DV+S G+ +E+ K P
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 52/164 (31%), Positives = 85/164 (51%), Gaps = 20/164 (12%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIR---HRNIVKL 378
IG G YG+VY+AR L +G+ VALKK+ +E S E LL Q+ H NIV+L
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 379 YGFCL-----HEKCMFLIYEYMEMGSLFCILRTDEEAV---GLDWTKRVNIVKGMAHALS 430
C E + L++E+++ L T GL ++++ + +
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHVD-----QDLATYLSKCPKPGLPPETIKDLMRQLLRGVD 121
Query: 431 YLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474
+LH H I+HRD+ NIL+ S+ + +ADFG+AR+ +++ +
Sbjct: 122 FLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA 162
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 4e-19
Identities = 64/210 (30%), Positives = 109/210 (51%), Gaps = 20/210 (9%)
Query: 323 IGTGGYGSVYRA-RLPSGKVVALKKL-------HRLETELASLESFQNEARLLSQIRHRN 374
IG+G +GSVY SG+++A+K++ + + + L++ E LL +++H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 375 IVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHH 434
IV+ G L + + EY+ GS+ +L + T N V+ + L+YLH+
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALL---NNYGAFEETLVRNFVRQILKGLNYLHN 124
Query: 435 HCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS------SNRTLLAGTYGSIAP 488
I+HRDI NIL++++ ++DFGI++ L +S R L G+ +AP
Sbjct: 125 R---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 489 ELAYTMVVTEKYDVYSFGVVALEVLMGKHP 518
E+ T K D++S G + +E+L GKHP
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 4e-19
Identities = 59/208 (28%), Positives = 105/208 (50%), Gaps = 16/208 (7%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHR 373
D IG G G V A +G+ VA+KK+ + + L NE ++ +H
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRREL--LFNEVVIMRDYQHP 76
Query: 374 NIVKLYGFCLHEKCMFLIYEYMEMGSLFCIL---RTDEEAVGLDWTKRVNIVKGMAHALS 430
NIV++Y L ++++ E++E G+L I+ R +EE + + + ALS
Sbjct: 77 NIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-------TVCLAVLKALS 129
Query: 431 YLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPEL 490
+LH ++HRDI S++ILL S+ ++DFG ++ + R L GT +APE+
Sbjct: 130 FLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEV 186
Query: 491 AYTMVVTEKYDVYSFGVVALEVLMGKHP 518
+ + D++S G++ +E++ G+ P
Sbjct: 187 ISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 6e-19
Identities = 63/219 (28%), Positives = 112/219 (51%), Gaps = 15/219 (6%)
Query: 323 IGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFC 382
+G G +G V+ + VA+K L + S+++F EA L+ ++H +V+LY
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTL---KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 383 LHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILH 442
E+ +++I EYM GSL L++DE + K ++ +A ++Y+ +H
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLKSDEGG-KVLLPKLIDFSAQIAEGMAYIERK---NYIH 126
Query: 443 RDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI---APELAYTMVVTEK 499
RD+ + N+L++ +ADFG+AR++ + + T G I APE T K
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGSFTIK 184
Query: 500 YDVYSFGVVALEVLM-GK--HPGELLSSSSSSLDKNIKL 535
DV+SFG++ E++ GK +PG S S+L + ++
Sbjct: 185 SDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM 223
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 6e-19
Identities = 67/224 (29%), Positives = 104/224 (46%), Gaps = 51/224 (22%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQN--------EARLLSQIRHR 373
+G G Y VY+AR +G++VA+KK+ +L + ++ E +LL +++H
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKI-----KLGERKEAKDGINFTALREIKLLQELKHP 62
Query: 374 NIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAH------ 427
NI+ L H+ + L++E+ME TD E V K +IV A
Sbjct: 63 NIIGLLDVFGHKSNINLVFEFME---------TDLEKV----IKDKSIVLTPADIKSYML 109
Query: 428 ----ALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTY 483
L YLH + ILHRD+ NN+L+ S+ +ADFG+AR + T T
Sbjct: 110 MTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTR 166
Query: 484 GSIAPEL-----AYTMVVTEKYDVYSFGVVALEVLMGKH--PGE 520
APEL Y + V D++S G + E+L+ PG+
Sbjct: 167 WYRAPELLFGARHYGVGV----DMWSVGCIFAELLLRVPFLPGD 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 7e-19
Identities = 64/212 (30%), Positives = 117/212 (55%), Gaps = 25/212 (11%)
Query: 323 IGTGGYGSVYRA-RLPSGKVVALKKLHRLETE--------LASLESFQNEARLLSQIRHR 373
IG G YG VY A + +G+++A+K++ T +++ ++E L + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 374 NIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTD---EEAVGLDWTKRVNIVKGMAHALS 430
NIV+ GF E+ + + EY+ GS+ LRT EE + +T++V ++G L+
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQV--LEG----LA 122
Query: 431 YLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN--YDSSNRTLLAGTYGSIAP 488
YLH + ILHRD+ ++N+L++++ ++DFGI++ + YD+ + G+ +AP
Sbjct: 123 YLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179
Query: 489 EL--AYTMVVTEKYDVYSFGVVALEVLMGKHP 518
E+ +Y+ + K D++S G V LE+ G+ P
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 8e-19
Identities = 58/202 (28%), Positives = 104/202 (51%), Gaps = 14/202 (6%)
Query: 323 IGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFC 382
+G+G +G V+ + + VA+K ++ S E F EA+++ ++ H +V+LYG C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINE---GAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 383 LHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILH 442
+K ++++ E+ME G L LR + + D +++ + + + YL + +H
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML--LSMCQDVCEGMEYLERN---SFIH 123
Query: 443 RDISSNNILLNSEFEAFVADFGIARLL---NYDSSNRTLLAGTYGSIAPELAYTMVVTEK 499
RD+++ N L++S V+DFG+ R + Y SS+ + PE+ + K
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSP--PEVFNFSKYSSK 181
Query: 500 YDVYSFGVVALEVLM-GKHPGE 520
DV+SFGV+ EV GK P E
Sbjct: 182 SDVWSFGVLMWEVFTEGKMPFE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 9e-19
Identities = 61/196 (31%), Positives = 94/196 (47%), Gaps = 7/196 (3%)
Query: 323 IGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFC 382
IG G +G VY+ K V K+ LE +E Q E +LSQ I + YG
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 383 LHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILH 442
L +++I EY+ GS +L+ L+ T I++ + L YLH + +H
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLKPGP----LEETYIATILREILKGLDYLH---SERKIH 124
Query: 443 RDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDV 502
RDI + N+LL+ + + +ADFG+A L R GT +APE+ K D+
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADI 184
Query: 503 YSFGVVALEVLMGKHP 518
+S G+ A+E+ G+ P
Sbjct: 185 WSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 58/230 (25%), Positives = 96/230 (41%), Gaps = 35/230 (15%)
Query: 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLE----SFQNEARLLSQ 369
+DF IG G + +V A+ + K A+K L+ E + E +L++
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIK---ILDKRQLIKEKKVKYVKIEKEVLTR 57
Query: 370 I-RHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHA 428
+ H I+KLY E+ ++ + EY G L +R LD + A
Sbjct: 58 LNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLA 114
Query: 429 LSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLA-------- 480
L YLH I+HRD+ NILL+ + + DFG A++L+ +SS +
Sbjct: 115 LEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171
Query: 481 ------------GTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHP 518
GT ++PEL + D+++ G + ++L GK P
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 77/231 (33%), Positives = 112/231 (48%), Gaps = 55/231 (23%)
Query: 317 FDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQ----NEARLLSQIR 371
FDI IG G YG VY+AR +G++VALKK+ RL+ E E F E ++L Q+
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKV-RLDNEK---EGFPITAIREIKILRQLN 64
Query: 372 HRNIVKLY----------GFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVN- 420
HRNIV L F + +L++EYM D + +GL + V+
Sbjct: 65 HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----------DHDLMGLLESGLVHF 113
Query: 421 -------IVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473
+K + L+Y H LHRDI +NILLN++ + +ADFG+ARL N +
Sbjct: 114 SEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEE 170
Query: 474 S----NRTLLAGTYGSIAPELAYTMVVTEKY----DVYSFGVVALEVLMGK 516
S N+ + T PEL ++ E+Y DV+S G + E+ K
Sbjct: 171 SRPYTNKVI---TLWYRPPEL---LLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 1e-18
Identities = 65/200 (32%), Positives = 102/200 (51%), Gaps = 14/200 (7%)
Query: 323 IGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFC 382
+G G +G V+ VA+K L + S ESF EA+++ ++RH +V+LY
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTL---KPGTMSPESFLEEAQIMKKLRHDKLVQLYA-V 69
Query: 383 LHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILH 442
+ E+ ++++ EYM GSL L+ D E L V++ +A ++Y+ +H
Sbjct: 70 VSEEPIYIVTEYMSKGSLLDFLK-DGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIH 125
Query: 443 RDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI---APELAYTMVVTEK 499
RD+ S NIL+ +ADFG+ARL+ + + T G I APE A T K
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 500 YDVYSFGVVALE-VLMGKHP 518
DV+SFG++ E V G+ P
Sbjct: 184 SDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGF 381
IG G +G V++A+ +G+ VALKK+ E E + L +H +VKL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 382 CLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPIL 441
H L+ EYM L +LR +E + K ++ + ++Y+H + I+
Sbjct: 68 FPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKS--YMRMLLKGVAYMHAN---GIM 121
Query: 442 HRDISSNNILLNSEFEAFVADFGIARLLNYDSSNR-TLLAGTYGSIAPELAYTMVVTEKY 500
HRD+ N+L++++ +ADFG+ARL + + + T APEL Y KY
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG---ARKY 178
Query: 501 ----DVYSFGVVALEVLMGK--HPGE 520
D+++ G + E+L G PGE
Sbjct: 179 DPGVDLWAVGCIFAELLNGSPLFPGE 204
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 2e-18
Identities = 61/194 (31%), Positives = 100/194 (51%), Gaps = 13/194 (6%)
Query: 323 IGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFC 382
+G G +G V+ VA+K L + S E+F EA L+ Q++H +V+LY
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSL---KQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV 70
Query: 383 LHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILH 442
E +++I EYME GSL L+T E + L K +++ +A ++++ +H
Sbjct: 71 TQEP-IYIITEYMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERK---NYIH 125
Query: 443 RDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI---APELAYTMVVTEK 499
RD+ + NIL++ +ADFG+ARL+ + + T G I APE T K
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183
Query: 500 YDVYSFGVVALEVL 513
DV+SFG++ E++
Sbjct: 184 SDVWSFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 2e-18
Identities = 63/211 (29%), Positives = 96/211 (45%), Gaps = 16/211 (7%)
Query: 317 FDIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNI 375
++I IG G +G +Y A+ S + +K++ + + E+ + E LL++++H NI
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 376 VKLYGFCLHEKCMFLIYEYMEMGSLFCILRTD-----EEAVGLDWTKRVNIVKGMAHALS 430
V + +F++ EY + G L + E L W V I G+ H
Sbjct: 62 VTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF--VQISLGLKH--- 116
Query: 431 YLHHHCTPPILHRDISSNNILLNSE-FEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPE 489
+H ILHRDI S NI L+ A + DFGIAR LN GT ++PE
Sbjct: 117 -IHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPE 172
Query: 490 LAYTMVVTEKYDVYSFGVVALEVLMGKHPGE 520
+ K D++S G V E+ KHP E
Sbjct: 173 ICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 67/204 (32%), Positives = 96/204 (47%), Gaps = 25/204 (12%)
Query: 323 IGTGGYGSVYRARLP-----SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVK 377
+G G +GSV R +G+VVA+KKL E L F+ E +L ++H NIVK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAE--HLRDFEREIEILKSLQHDNIVK 69
Query: 378 LYGFCLH--EKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRV----NIVKGMAHALSY 431
G C + + L+ EY+ GSL L+ E LD K + I KGM Y
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER--LDHRKLLLYASQICKGM----EY 123
Query: 432 LHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI---AP 488
L + +HRD+++ NIL+ SE + DFG+ ++L D + I AP
Sbjct: 124 LG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAP 180
Query: 489 ELAYTMVVTEKYDVYSFGVVALEV 512
E + DV+SFGVV E+
Sbjct: 181 ESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 3e-18
Identities = 72/245 (29%), Positives = 116/245 (47%), Gaps = 30/245 (12%)
Query: 315 EDFDIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHR 373
ED + +G G GSV + +P+G V+A K +H + + + + E +++ + R
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVH-IGAKSSVRKQILRELQIMHECRSP 63
Query: 374 NIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRT----DEEAVGLDWTKRVNIVKGMAHAL 429
IV YG L+E + + E+M+ GSL I + E +G I + L
Sbjct: 64 YIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-------KIAVAVVEGL 116
Query: 430 SYLH--HHCTPPILHRDISSNNILLNSEFEAFVADFGIA-RLLNYDSSNRTLLAGTYGSI 486
+YL+ H I+HRDI +NIL+NS + + DFG++ L+N S GT +
Sbjct: 117 TYLYNVHR----IMHRDIKPSNILVNSRGQIKLCDFGVSGELIN---SIADTFVGTSTYM 169
Query: 487 APELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLD------ 540
+PE T K DV+S G+ +E+ +GK P + D + ++DLL
Sbjct: 170 SPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP 229
Query: 541 -PRLP 544
PRLP
Sbjct: 230 PPRLP 234
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 4e-18
Identities = 61/201 (30%), Positives = 102/201 (50%), Gaps = 13/201 (6%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRN 374
E ++ +G G +G V+ VA+K L + S E+F EA+++ ++RH
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEK 62
Query: 375 IVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHH 434
+V+LY + E+ ++++ EYM GSL L+ E L + V++ +A ++Y+
Sbjct: 63 LVQLYA-VVSEEPIYIVTEYMSKGSLLDFLK-GEMGKYLRLPQLVDMAAQIASGMAYVER 120
Query: 435 HCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI---APELA 491
+HRD+ + NIL+ VADFG+ARL+ + + T G I APE A
Sbjct: 121 M---NYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAA 175
Query: 492 YTMVVTEKYDVYSFGVVALEV 512
T K DV+SFG++ E+
Sbjct: 176 LYGRFTIKSDVWSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 4e-18
Identities = 53/196 (27%), Positives = 83/196 (42%), Gaps = 40/196 (20%)
Query: 342 VALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLF 401
VA+K L ++ + E F E ++LS++ NI +L G C + + +I EYME G L
Sbjct: 49 VAVKVLRPDASD-NAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLN 107
Query: 402 CILRTDE-EAVGLDWTKR-----------VNIVKGMAHALSYLHHHCTPPILHRDISSNN 449
L+ E GL + I GM + L L+ +HRD+++ N
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRY-LESLN------FVHRDLATRN 160
Query: 450 ILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI-----------APELAYTMVVTE 498
L+ + +ADFG+ +R L + Y + A E T
Sbjct: 161 CLVGKNYTIKIADFGM---------SRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTT 211
Query: 499 KYDVYSFGVVALEVLM 514
K DV++FGV E+L
Sbjct: 212 KSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 6e-18
Identities = 68/244 (27%), Positives = 116/244 (47%), Gaps = 31/244 (12%)
Query: 315 EDFDIKYCIGTGGYGSVYRA--RLPSGKVVALK-KLHRLETELASLESFQNEARLLSQIR 371
ED + CIG G +G VY+ P + +A+ K + T + E F EA ++ Q
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65
Query: 372 HRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVK---GMAHA 428
H +IVKL G E ++++ E +G L L+ ++ +++ ++ A
Sbjct: 66 HPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKY-----SLDLASLILYSYQLSTA 119
Query: 429 LSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS---SNRTLLAGTYGS 485
L+YL + +HRDI++ N+L++S + DFG++R L +S +++ L +
Sbjct: 120 LAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKW-- 174
Query: 486 IAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSSSSLDKNIKLIDLLD--PR 542
+APE T DV+ FGV E+LM G P + + KN +I ++ R
Sbjct: 175 MAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGV--------KNNDVIGRIENGER 226
Query: 543 LPPP 546
LP P
Sbjct: 227 LPMP 230
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 6e-18
Identities = 66/210 (31%), Positives = 105/210 (50%), Gaps = 24/210 (11%)
Query: 323 IGTGGYGSVYRARLPSGKVVALKKL-----HRLETELASLESFQNEARLLSQIRHRNIVK 377
+G G YG+VY G+++A+K++ + L E E Q E LL ++H NIV+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAE-KEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 378 LYGFCLHEKCMFLIYEYMEMGSLFCILR---TDEEAVGLDWTKRVNIVKGMAHALSYLHH 434
G CL + + + E++ GS+ IL E V +TK+ I+ G+A YLH+
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQ--ILDGVA----YLHN 120
Query: 435 HCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRT---LLAGTYGS---IAP 488
+C ++HRDI NN++L + DFG AR L + + T +L +G+ +AP
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 489 ELAYTMVVTEKYDVYSFGVVALEVLMGKHP 518
E+ K D++S G E+ GK P
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 6e-18
Identities = 65/207 (31%), Positives = 103/207 (49%), Gaps = 19/207 (9%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQ-NEARLLSQIRHRNIVKLYG 380
IG G YG VY+AR +G+VVALKK+ RL+TE + S E LL ++ H NIVKL
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66
Query: 381 FCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPI 440
E ++L++E++ + + + L K + + + L++ H H +
Sbjct: 67 VIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIK--SYLFQLLQGLAFCHSH---RV 121
Query: 441 LHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELA-----YTMV 495
LHRD+ N+L+N+E +ADFG+AR T T APE+ Y+
Sbjct: 122 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 181
Query: 496 VTEKYDVYSFGVVALEVLMGK--HPGE 520
V D++S G + E++ + PG+
Sbjct: 182 V----DIWSLGCIFAEMVTRRALFPGD 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 9e-18
Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 18/207 (8%)
Query: 323 IGTGGYGSVYRARLPS-GKVVALKKLHRLETEL-ASLESFQNEARLLSQIRHRNIVKLYG 380
I G YG V+ A+ S G + A+K + + + ++ E +LSQ + +VKLY
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 381 FCLHEKCMFLIYEYMEMGSLFCILRTDEEAVG-LDWTKRVNIVKGMAHALSYLHHHCTPP 439
+K ++L+ EY+ G L +L E VG LD + + AL YLH +
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLL----ENVGSLDEDVARIYIAEIVLALEYLHSN---G 113
Query: 440 ILHRDISSNNILLNSEFEAFVADFGIARL--------LNYDSSNRTLLAGTYGSIAPELA 491
I+HRD+ +NIL++S + DFG++++ LN D + GT IAPE+
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 492 YTMVVTEKYDVYSFGVVALEVLMGKHP 518
++ D +S G + E L+G P
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 70/246 (28%), Positives = 114/246 (46%), Gaps = 35/246 (14%)
Query: 317 FDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRN 374
F++ +G G YG VY+ R + +G++ A+K + E E E + E +L + HRN
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE---EEIKLEINMLKKYSHHRN 74
Query: 375 IVKLYGFCL------HEKCMFLIYEYMEMGSLFCILR-TDEEAVGLDWTKRV--NIVKGM 425
I YG + H+ ++L+ E+ GS+ +++ T A+ DW + I++G+
Sbjct: 75 IATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGL 134
Query: 426 AHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGS 485
AH LH H ++HRDI N+LL E + DFG++ L+ R GT
Sbjct: 135 AH----LHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYW 187
Query: 486 IAPELAYT-----MVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLD 540
+APE+ + D++S G+ A+E+ G P D + L
Sbjct: 188 MAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPP---------LCDMHPMRALFLI 238
Query: 541 PRLPPP 546
PR PPP
Sbjct: 239 PRNPPP 244
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 62/236 (26%), Positives = 106/236 (44%), Gaps = 25/236 (10%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGF 381
+G G YGSVY+ P+G +A+K++ RLE + + E +L + IV YG
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEI-RLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 382 CLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPIL 441
E +++ EYM+ GSL + G+ I + L +L I+
Sbjct: 68 FFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--II 125
Query: 442 HRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPE----------LA 491
HRD+ N+L+N + + DFG++ L + + +Y +APE
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSY--MAPERIKSGGPNQNPT 183
Query: 492 YTMVVTEKYDVYSFGVVALEVLMGK--HPGELLSSSSSSLDKNIKLIDLLDPRLPP 545
YT+ + DV+S G+ LE+ +G+ +P E ++ + L ++D P LP
Sbjct: 184 YTV----QSDVWSLGLSILEMALGRYPYPPETYANIFAQLS---AIVDGDPPTLPS 232
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 56/212 (26%), Positives = 92/212 (43%), Gaps = 31/212 (14%)
Query: 323 IGTGGYGSVYR---ARLPSGKV---VALKKLHRLETELASLESFQNEARLLSQIRHRNIV 376
+G G +G VY + G+ VA+K ++ + +E F NEA ++ + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIE-FLNEASVMKEFNCHHVV 72
Query: 377 KLYGFCLHEKCMFLIYEYMEMGSLFCILRT----DEEAVGLDWTKR-------VNIVKGM 425
+L G + ++ E M G L LR+ E GL I GM
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 426 AHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN----YDSSNRTLLAG 481
A+ L+ +HRD+++ N ++ + + DFG+ R + Y + LL
Sbjct: 133 AY-LAAKK------FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 482 TYGSIAPELAYTMVVTEKYDVYSFGVVALEVL 513
+ +APE V T K DV+SFGVV E+
Sbjct: 186 RW--MAPESLKDGVFTTKSDVWSFGVVLWEMA 215
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 28/209 (13%)
Query: 323 IGTGGYGSVYRA-RLPSGKVVALKKLHRLETELASLESFQN---EARLLSQIRHRNIVKL 378
+G+G +GSVY L G A+K++ + E+ + E LLS+++H NIV+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 379 YGFCLHEKCMFLIYEYMEMGSLFCILRT----DEEAVGLDWTKRVNIVKGMAHALSYLHH 434
G E +++ E + GSL +L+ E + L +T++ I+ G L YLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRL-YTRQ--ILLG----LEYLHD 120
Query: 435 HCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPEL---- 490
+HRDI NIL+++ +ADFG+A+ + S ++ G+ +APE+
Sbjct: 121 R---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS-FKGSPYWMAPEVIAQQ 176
Query: 491 -AYTMVVTEKYDVYSFGVVALEVLMGKHP 518
Y + D++S G LE+ GK P
Sbjct: 177 GGYGLAA----DIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 44/225 (19%)
Query: 317 FDIKYCIGTGGYGSVYRARL---PSGKVVALKKLHRLETELASL-ESFQNEARLLSQIRH 372
++I+ CIG G YG VY+A+ GK A+KK + + + +S E LL +++H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 373 RNIVKLYGFCLH--EKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMA---- 426
N+V L L +K ++L+++Y E L+ I++ + KRV+I M
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQ------AKRVSIPPSMVKSLL 114
Query: 427 ----HALSYLHHHCTPPILHRDISSNNILLNSEFEAF----VADFGIARLLNYDSSNRTL 478
+ + YLH + +LHRD+ NIL+ E + D G+ARL +++ + L
Sbjct: 115 WQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARL--FNAPLKPL 169
Query: 479 LAG-----TYGSIAPELA-----YTMVVTEKYDVYSFGVVALEVL 513
T APEL YT + D+++ G + E+L
Sbjct: 170 ADLDPVVVTIWYRAPELLLGARHYTKAI----DIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 2e-17
Identities = 46/156 (29%), Positives = 80/156 (51%), Gaps = 24/156 (15%)
Query: 322 CIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQN--EARLLSQI-RHRNIVK 377
+G G +GSVY AR +G++VA+KK+ + + S E N E + L ++ H NIVK
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKK---KFYSWEECMNLREVKSLRKLNEHPNIVK 62
Query: 378 LYGFCLHEKCMFLIYEYMEMGSLFCILRT------DEEAVGLDWTKRVNIVKGMAHALSY 431
L ++ ++EYME G+L+ +++ E + +I+ + L++
Sbjct: 63 LKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIR-------SIIYQILQGLAH 114
Query: 432 LHHHCTPPILHRDISSNNILLNSEFEAFVADFGIAR 467
+H H HRD+ N+L++ +ADFG+AR
Sbjct: 115 IHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 51/205 (24%), Positives = 97/205 (47%), Gaps = 21/205 (10%)
Query: 323 IGTGGYGSVYRARLPSG------KVVALKKLHRLETELASLESFQNEARLLSQIRHRNIV 376
+G G +G V+ A+ +V +K L + + E E F+ E + ++ H+N+V
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSE-FRRELDMFRKLSHKNVV 71
Query: 377 KLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVG------LDWTKRVNIVKGMAHALS 430
+L G C + ++I EY ++G L LR + L ++V + +A +
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 431 YLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL---NYDSSNRTLLAGTYGSIA 487
+L + +HRD+++ N L++S+ E V+ +++ + Y L+ + +A
Sbjct: 132 HLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRW--LA 186
Query: 488 PELAYTMVVTEKYDVYSFGVVALEV 512
PE + K DV+SFGV+ EV
Sbjct: 187 PEAVQEDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 21/204 (10%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGF 381
IG+G G+VY+ P+G++ ALK ++ E E +L + H N+VK +
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYG-NHEDTVRRQICREIEILRDVNHPNVVKCHDM 140
Query: 382 CLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPIL 441
H + ++ E+M+ GSL DE+ + ++ + + ++YLH I+
Sbjct: 141 FDHNGEIQVLLEFMDGGSLEGTHIADEQFLA-------DVARQILSGIAYLHRR---HIV 190
Query: 442 HRDISSNNILLNSEFEAFVADFGIARLLN--YDSSNRTLLAGTYGSIAPELAYTMVVTEK 499
HRDI +N+L+NS +ADFG++R+L D N ++ GT ++PE T +
Sbjct: 191 HRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV--GTIAYMSPERINTDLNHGA 248
Query: 500 Y-----DVYSFGVVALEVLMGKHP 518
Y D++S GV LE +G+ P
Sbjct: 249 YDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 57/200 (28%), Positives = 105/200 (52%), Gaps = 16/200 (8%)
Query: 323 IGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGF 381
IG G G V AR SG+ VA+K + + + L NE ++ +H+N+V++Y
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRREL--LFNEVVIMRDYQHQNVVEMYKS 86
Query: 382 CLHEKCMFLIYEYMEMGSLFCIL---RTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTP 438
L + ++++ E+++ G+L I+ R +EE + + + + AL YLH +
Sbjct: 87 YLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIA-------TVCESVLQALCYLH---SQ 136
Query: 439 PILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTE 498
++HRDI S++ILL + ++DFG ++ D R L GT +APE+
Sbjct: 137 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGT 196
Query: 499 KYDVYSFGVVALEVLMGKHP 518
+ D++S G++ +E++ G+ P
Sbjct: 197 EVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-17
Identities = 60/209 (28%), Positives = 110/209 (52%), Gaps = 22/209 (10%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELAS----LESFQNEARLLSQIRHRNIVK 377
+GTG + S Y+AR + +G ++A+K++ + + +E+ + E RL++++ H +I++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 378 LYGFCLHEKCMFLIYEYMEMGSLFCILRTD---EEAVGLDWTKRVNIVKGMAHALSYLHH 434
+ G + L E+M GS+ +L +EAV +++T++ +++G LSYLH
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQ--LLRG----LSYLHE 121
Query: 435 HCTPPILHRDISSNNILLNSEFEAF-VADFGIARLLNYDSSNRTL----LAGTYGSIAPE 489
+ I+HRD+ N+L++S + +ADFG A L + L GT +APE
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178
Query: 490 LAYTMVVTEKYDVYSFGVVALEVLMGKHP 518
+ DV+S G V +E+ K P
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 4e-17
Identities = 80/254 (31%), Positives = 123/254 (48%), Gaps = 67/254 (26%)
Query: 317 FDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQN---------EARL 366
++I +G G YG V++A + +VVALKK+ ++F+N E
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKI---------FDAFRNATDAQRTFREIMF 59
Query: 367 LSQIR-HRNIVKLYGFCLHE--KCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVK 423
L ++ H NIVKL E K ++L++EYME TD AV R NI++
Sbjct: 60 LQELGDHPNIVKLLNVIKAENDKDIYLVFEYME---------TDLHAV-----IRANILE 105
Query: 424 GMAH---------ALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474
+ AL Y+H + ++HRD+ +NILLNS+ +ADFG+AR L+
Sbjct: 106 DVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162
Query: 475 NRTLLAGT-YGSI----APEL-----AYTMVVTEKYDVYSFGVVALEVLMGK--HPGELL 522
N T Y + APE+ YT V D++S G + E+L+GK PG
Sbjct: 163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGV----DMWSVGCILGEMLLGKPLFPG--- 215
Query: 523 SSSSSSLDKNIKLI 536
+S+ + L+K I++I
Sbjct: 216 TSTLNQLEKIIEVI 229
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 5e-17
Identities = 69/231 (29%), Positives = 114/231 (49%), Gaps = 34/231 (14%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQ-NEARLLSQIRHRNIVKLYG 380
IG G YG VY+AR + + +ALKK+ RLE E + S E LL +++H NIV+L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 381 FCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKG----MAHALSYLHHHC 436
EK ++L++EY+++ L+ ++ D+ K ++K + ++Y H H
Sbjct: 69 VVHSEKRLYLVFEYLDLD-----LKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSH- 121
Query: 437 TPPILHRDISSNNILLNSEFEAF-VADFGIARLLNYDSSNRTLLAGTYGSIAPEL----- 490
+LHRD+ N+L++ A +ADFG+AR T T APE+
Sbjct: 122 --RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSR 179
Query: 491 AYTMVVTEKYDVYSFGVVALEVLMGK--HPGELLSSSSSSLDKNIKLIDLL 539
Y+ V D++S G + E++ K PG+ S +D+ K+ +L
Sbjct: 180 HYSTPV----DIWSVGCIFAEMVNQKPLFPGD------SEIDELFKIFRIL 220
|
Length = 294 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 7e-17
Identities = 68/234 (29%), Positives = 114/234 (48%), Gaps = 31/234 (13%)
Query: 316 DFDIKYCIGTGGYGSVYRARL----PSGK--VVALKKLHRLETELASLESFQNEARLLSQ 369
D +K +G G +G V+ A P+ +VA+K L + LA+ + FQ EA LL+
Sbjct: 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK--DPTLAARKDFQREAELLTN 63
Query: 370 IRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTD------------EEAVG-LDWT 416
++H +IVK YG C + +++EYM+ G L LR +A G L +
Sbjct: 64 LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 123
Query: 417 KRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL----NYD 472
+ ++I +A + YL + +HRD+++ N L+ + + DFG++R + Y
Sbjct: 124 QMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR 180
Query: 473 SSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS 525
T+L + + PE T + DV+SFGV+ E+ GK P LS++
Sbjct: 181 VGGHTMLPIRW--MPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 232
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 7e-17
Identities = 59/200 (29%), Positives = 104/200 (52%), Gaps = 16/200 (8%)
Query: 323 IGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGF 381
IG G G V A + SGK+VA+KK+ + + L NE ++ +H N+V++Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRREL--LFNEVVIMRDYQHENVVEMYNS 85
Query: 382 CLHEKCMFLIYEYMEMGSLFCIL---RTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTP 438
L ++++ E++E G+L I+ R +EE + + + ALS LH
Sbjct: 86 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-------AVCLAVLKALSVLH---AQ 135
Query: 439 PILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTE 498
++HRDI S++ILL + ++DFG ++ + R L GT +APEL +
Sbjct: 136 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGP 195
Query: 499 KYDVYSFGVVALEVLMGKHP 518
+ D++S G++ +E++ G+ P
Sbjct: 196 EVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 8e-17
Identities = 68/229 (29%), Positives = 107/229 (46%), Gaps = 43/229 (18%)
Query: 318 DIKYC--IGTGGYGSVYRARLPS------GKVVALKKLHRLETELASLE---SFQNEARL 366
+I+Y IG G +G V++AR P +VA+K L E AS + FQ EA L
Sbjct: 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKML----KEEASADMQADFQREAAL 61
Query: 367 LSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRT-------------------D 407
+++ H NIVKL G C K M L++EYM G L LR
Sbjct: 62 MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121
Query: 408 EEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIAR 467
+ L T+++ I K +A ++YL +HRD+++ N L+ +ADFG++R
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSR 178
Query: 468 LL----NYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEV 512
+ Y +S + + + PE + T + DV+++GVV E+
Sbjct: 179 NIYSADYYKASENDAIPIRW--MPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 9e-17
Identities = 54/148 (36%), Positives = 78/148 (52%), Gaps = 24/148 (16%)
Query: 105 SVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMN-CSKLRILKLGNNLLSG 163
S+DLS + G I S++ L + T+N+ NN+L GPIP ++ S LR L L NN +G
Sbjct: 73 SIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTG 132
Query: 164 SIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHL 223
SIP G + L LDLS N ++G+IP+ +G FS + KV L
Sbjct: 133 SIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSL-------------------KV--L 169
Query: 224 DVSGNQFGGEIPTTLANVPPPHHKTIAT 251
D+ GN G+IP +L N+ T+A+
Sbjct: 170 DLGGNVLVGKIPNSLTNLTSLEFLTLAS 197
|
Length = 968 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 65/203 (32%), Positives = 99/203 (48%), Gaps = 19/203 (9%)
Query: 323 IGTGGYGSVYRA-RLPSGKVVALKKLHRLETELASLESFQN---EARLLSQIRHRNIVKL 378
IG G +G+VY A + +VVA+KK+ + E +Q+ E + L Q++H N ++
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTN--EKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 379 YGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTP 438
G L E +L+ EY +GS +L ++ L + I G L+YLH H
Sbjct: 87 KGCYLKEHTAWLVMEYC-LGSASDLLEVHKKP--LQEVEIAAITHGALQGLAYLHSHN-- 141
Query: 439 PILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTE 498
++HRDI + NILL + +ADFG A SS GT +APE+ M +
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSASK----SSPANSFVGTPYWMAPEVILAMDEGQ 196
Query: 499 ---KYDVYSFGVVALEVLMGKHP 518
K DV+S G+ +E+ K P
Sbjct: 197 YDGKVDVWSLGITCIELAERKPP 219
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 21/203 (10%)
Query: 315 EDFDIKYCIGTGGYGSV----YRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQI 370
++ + IG G +G V YR G VA+K + A+ ++F EA +++Q+
Sbjct: 6 KELKLLQTIGKGEFGDVMLGDYR-----GNKVAVKCI----KNDATAQAFLAEASVMTQL 56
Query: 371 RHRNIVKLYGFCLHEK-CMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHAL 429
RH N+V+L G + EK ++++ EYM GSL LR+ +V L + + A+
Sbjct: 57 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAM 115
Query: 430 SYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPE 489
YL + +HRD+++ N+L++ + A V+DFG+ + SS + APE
Sbjct: 116 EYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPE 169
Query: 490 LAYTMVVTEKYDVYSFGVVALEV 512
+ K DV+SFG++ E+
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 66/203 (32%), Positives = 104/203 (51%), Gaps = 19/203 (9%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQN---EARLLSQIRHRNIVKL 378
IG G +G+VY AR + + +VVA+KK+ + S E +Q+ E + L +I+H N ++
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ--SNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 379 YGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTP 438
G L E +L+ EY +GS +L ++ L + I G L+YLH H
Sbjct: 91 KGCYLREHTAWLVMEYC-LGSASDLLEVHKKP--LQEVEIAAITHGALQGLAYLHSH--- 144
Query: 439 PILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTE 498
++HRDI + NILL + +ADFG A + + +S GT +APE+ M +
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS----FVGTPYWMAPEVILAMDEGQ 200
Query: 499 ---KYDVYSFGVVALEVLMGKHP 518
K DV+S G+ +E+ K P
Sbjct: 201 YDGKVDVWSLGITCIELAERKPP 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 59/203 (29%), Positives = 93/203 (45%), Gaps = 27/203 (13%)
Query: 323 IGTGGYGS--VYRARLPSGKVV----ALKKLHRLETELASLESFQNEARLLSQIRHRNIV 376
+G G +G +YR VV L +L E A NE +LS ++H NI+
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDA-----LNEIVILSLLQHPNII 62
Query: 377 KLYGFCLHEKCMFLIYEYMEMGSLF-CILRT-----DEEAVGLDWTKRVNIVKGMAHALS 430
Y + + + + EY G+L+ I+R +EE V W + + A+S
Sbjct: 63 AYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVL--W-----YLFQIVSAVS 115
Query: 431 YLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPEL 490
Y+H ILHRDI + NI L + DFGI+++L + S + GT ++PEL
Sbjct: 116 YIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPEL 172
Query: 491 AYTMVVTEKYDVYSFGVVALEVL 513
+ K D+++ G V E+L
Sbjct: 173 CQGVKYNFKSDIWALGCVLYELL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 67/249 (26%), Positives = 108/249 (43%), Gaps = 25/249 (10%)
Query: 316 DFDIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRN 374
DF + +G G YGSVY+ RL + ALK++ E NE R+L+ + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 375 IVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTD--------EEAVGLDWTKRVNIVKGMA 426
I+ L + ++ EY G L + E+ + W + +++G
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEI---WRIFIQLLRG-- 115
Query: 427 HALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI 486
L LH ILHRD+ S NILL + + D GI+++L + + + GT +
Sbjct: 116 --LQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI--GTPHYM 168
Query: 487 APELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRLPPP 546
APE+ + K D++S G + E+ P E + S D K+ P +PP
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE----ARSMQDLRYKVQRGKYPPIPPI 224
Query: 547 GDQMIRQGI 555
Q ++ I
Sbjct: 225 YSQDLQNFI 233
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-16
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 322 CIGTGGYGSVYRAR-LPSGKVVALKKLH--RLETELAS-LESFQNEARLLSQIRHRNIVK 377
+G G +G VY + +G+ +A+K++ E + + + E +LL ++H IV+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 378 LYGFCLHEKCMFLIY-EYMEMGSLFCILRTD---EEAVGLDWTKRVNIVKGMAHALSYLH 433
YG CL + I+ EYM GS+ L+ E V +T+++ + YLH
Sbjct: 69 YYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQI------LEGVEYLH 121
Query: 434 HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGS---IAPEL 490
+ I+HRDI NIL +S + DFG ++ L S+ T + G+ ++PE+
Sbjct: 122 SN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEV 178
Query: 491 AYTMVVTEKYDVYSFGVVALEVLMGKHP 518
K DV+S G +E+L K P
Sbjct: 179 ISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 60/216 (27%), Positives = 102/216 (47%), Gaps = 31/216 (14%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGF 381
IG+G YG V A +G+ VA+KK+ + +L + E +LL +RH NI+ L
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDI 67
Query: 382 CLHEKCM-----FLIYEYMEMGSLFCILRTDEEAVGLDWTKRVN-IVKGMAHALSYLHHH 435
+++ E ME L ++++ + L + + + L YLH
Sbjct: 68 LRPPSPEDFNDVYIVTELMET-DLHKVIKSPQP---LT-DDHIQYFLYQILRGLKYLH-- 120
Query: 436 CTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAG---T--YGSIAPEL 490
+ ++HRD+ +NIL+NS + + DFG+AR ++ D + L T Y APEL
Sbjct: 121 -SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR--APEL 177
Query: 491 AYTMVVTEKY----DVYSFGVVALEVLMGKH--PGE 520
++ + +Y D++S G + E+L K PG
Sbjct: 178 ---LLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGR 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 67/241 (27%), Positives = 100/241 (41%), Gaps = 40/241 (16%)
Query: 323 IGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFC 382
+G G GSV + RL + ++ K + + E + + IVK YG
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 383 LHEK-CMFLI-YEYMEMGSLFCIL--------RTDEEAVGLDWTKRVNIVKGMAHALSYL 432
L E I EY E GSL I R E+ +G I + + LSYL
Sbjct: 69 LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG-------KIAESVLKGLSYL 121
Query: 433 HHHCTPPILHRDISSNNILLNSEFEAFVADFGIA-RLLNYDSSNRTLLAGTYGSIAPE-- 489
H + I+HRDI +NILL + + + DFG++ L+N + T GT +APE
Sbjct: 122 H---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT---GTSFYMAPERI 175
Query: 490 --LAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLD--PRLPP 545
Y++ DV+S G+ LEV + P + + I+LL +P
Sbjct: 176 QGKPYSI----TSDVWSLGLTLLEVAQNRFPFP------PEGEPPLGPIELLSYIVNMPN 225
Query: 546 P 546
P
Sbjct: 226 P 226
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 3e-16
Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 23/205 (11%)
Query: 323 IGTGGYGSVYRARL-PSGKVVALKKLHRLE-TELASLESFQNEARLLSQIRHRNIVKLYG 380
+G GG+G V ++ + ALK + + E E +E +L + H IVKLY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 381 FCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGL--DWTKRVNIVKGMAHALSYLHHHCTP 438
+K ++++ EY G L+ ILR GL ++T R + + A YLH+
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILR----DRGLFDEYTARF-YIACVVLAFEYLHNR--- 112
Query: 439 PILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTL-LAGTYGSIAPEL----AYT 493
I++RD+ N+LL+S + DFG A+ L S +T GT +APE+ Y
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLK--SGQKTWTFCGTPEYVAPEIILNKGYD 170
Query: 494 MVVTEKYDVYSFGVVALEVLMGKHP 518
V D +S G++ E+L G+ P
Sbjct: 171 FSV----DYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQN---EARLLSQIRHRNIVKL 378
IG G +G+VY AR + + +VVA+KK+ + S E +Q+ E R L ++RH N ++
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ--SNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 379 YGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTP 438
G L E +L+ EY +GS +L ++ L + + G L+YLH H
Sbjct: 81 RGCYLREHTAWLVMEYC-LGSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYLHSH--- 134
Query: 439 PILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTE 498
++HRD+ + NILL+ + DFG A ++ + GT +APE+ M +
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----FVGTPYWMAPEVILAMDEGQ 190
Query: 499 ---KYDVYSFGVVALEVLMGKHP 518
K DV+S G+ +E+ K P
Sbjct: 191 YDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 3e-16
Identities = 55/197 (27%), Positives = 104/197 (52%), Gaps = 10/197 (5%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGF 381
IG G G+V+ A + +G+ VA+K+++ L+ + E NE ++ ++++ NIV
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQIN-LQKQ-PKKELIINEILVMKELKNPNIVNFLDS 84
Query: 382 CLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPIL 441
L +F++ EY+ GSL ++ +D + + + AL +LH + ++
Sbjct: 85 FLVGDELFVVMEYLAGGSLTDVV----TETCMDEAQIAAVCRECLQALEFLHAN---QVI 137
Query: 442 HRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYD 501
HRDI S+N+LL + + DFG + + S R+ + GT +APE+ K D
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 197
Query: 502 VYSFGVVALEVLMGKHP 518
++S G++A+E++ G+ P
Sbjct: 198 IWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 3e-16
Identities = 56/193 (29%), Positives = 97/193 (50%), Gaps = 7/193 (3%)
Query: 323 IGTGGYGSVYRA-RLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGF 381
+G G +G V+ R K+V +K++ + + QNE ++L + H NI++ Y
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 382 CLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPIL 441
L +K + ++ EY G+L ++ ++ + T I+ L LHH T IL
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDT----ILHFFVQILLALHHVHTKLIL 123
Query: 442 HRDISSNNILLNSEFEAF-VADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKY 500
HRD+ + NILL+ + DFGI+++L+ S T++ GT I+PEL +K
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV-GTPCYISPELCEGKPYNQKS 182
Query: 501 DVYSFGVVALEVL 513
D+++ G V E+
Sbjct: 183 DIWALGCVLYELA 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-16
Identities = 57/200 (28%), Positives = 103/200 (51%), Gaps = 14/200 (7%)
Query: 323 IGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFC 382
+G G +G V+ A VA+K + + S+E+F EA ++ ++H +VKL+
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTM---KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 70
Query: 383 LHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILH 442
E +++I E+M GSL L++DE K ++ +A ++++ +H
Sbjct: 71 TKEP-IYIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIH 125
Query: 443 RDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI---APELAYTMVVTEK 499
RD+ + NIL+++ +ADFG+AR++ + + T G I APE T K
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGSFTIK 183
Query: 500 YDVYSFGVVALEVL-MGKHP 518
DV+SFG++ +E++ G+ P
Sbjct: 184 SDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-16
Identities = 70/240 (29%), Positives = 110/240 (45%), Gaps = 28/240 (11%)
Query: 321 YC----IGTGGYGSVYRARLPS-GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNI 375
YC +G G YG V R + GK +KKL+ ++ + EA+LLSQ++H NI
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 376 VKLYGFCLHEKCM-FLIYEYMEMGSLFCILRTDE-----EAVGLDWTKRVNIVKGMAHAL 429
V E + +++ + E G L+ L+ + E ++W ++ A AL
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQI------AMAL 115
Query: 430 SYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPE 489
YLH ILHRD+ + N+ L V D GIAR+L + L GT ++PE
Sbjct: 116 QYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPE 172
Query: 490 LAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRLPP-PGD 548
L K DV++ G E+ KH + ++ D N + +++ +LPP P D
Sbjct: 173 LFSNKPYNYKSDVWALGCCVYEMATLKH-------AFNAKDMNSLVYRIIEGKLPPMPKD 225
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 59/200 (29%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 323 IGTGGYGSVYRA-RLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGF 381
IG G G V A +GK VA+KK+ + + L NE ++ H N+V +Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRREL--LFNEVVIMRDYHHENVVDMYNS 87
Query: 382 CLHEKCMFLIYEYMEMGSLFCIL---RTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTP 438
L ++++ E++E G+L I+ R +EE + + + ALSYLH
Sbjct: 88 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-------TVCLSVLRALSYLH---NQ 137
Query: 439 PILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTE 498
++HRDI S++ILL S+ ++DFG ++ + R L GT +APE+ +
Sbjct: 138 GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGT 197
Query: 499 KYDVYSFGVVALEVLMGKHP 518
+ D++S G++ +E++ G+ P
Sbjct: 198 EVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 5e-16
Identities = 58/199 (29%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGF 381
IG G YG V++ R +G++VA+KK E + + E R+L Q++H N+V L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 382 CLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLH-HHCTPPI 440
++ + L++EY + L ++ G+ I+ A+++ H H+C
Sbjct: 69 FRRKRKLHLVFEYCDHTVLN---ELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNC---- 121
Query: 441 LHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKY 500
+HRD+ NIL+ + + + DFG AR+L + T T APEL +V +Y
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPEL---LVGDTQY 178
Query: 501 ----DVYSFGVVALEVLMG 515
DV++ G V E+L G
Sbjct: 179 GPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 76/239 (31%), Positives = 114/239 (47%), Gaps = 29/239 (12%)
Query: 323 IGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLE-SFQNEARLL---SQIRHRNIVK 377
IG G YG+VY+AR P SG VALK + R++T L S E LL H NIV+
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSV-RVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 378 LYGFCL-----HEKCMFLIYEYMEMGSLFCILRTDEEAV---GLDWTKRVNIVKGMAHAL 429
L C E + L++E+++ LRT + V GL ++++ L
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQD-----LRTYLDKVPPPGLPAETIKDLMRQFLRGL 121
Query: 430 SYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPE 489
+LH +C I+HRD+ NIL+ S + +ADFG+AR+ + + T + T APE
Sbjct: 122 DFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA-LTPVVVTLWYRAPE 177
Query: 490 LAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRLPPPGD 548
+ D++S G + E+ K L +S D+ K+ DL+ LPP D
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEMFRRKP----LFCGNSEADQLGKIFDLIG--LPPEDD 230
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 7e-16
Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 323 IGTGGYGSVYRARL--PSGKVVALKK--LHRLETELASLESFQNEARLLS-------QIR 371
+G+G +G VY+ R ++ALK+ +H E ++ ++S Q+R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 372 HRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRV-NIVKGMAHALS 430
H NIV+ Y L ++++ + +E L + +E +R+ NI M AL
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 431 YLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPEL 490
YLH I+HRD++ NNI+L + + + DFG+A+ S T + GT PE+
Sbjct: 128 YLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ-PESKLTSVVGTILYSCPEI 184
Query: 491 AYTMVVTEKYDVYSFGVVALEVLMGKHP 518
EK DV++FG + ++ + P
Sbjct: 185 VKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 7e-16
Identities = 58/198 (29%), Positives = 101/198 (51%), Gaps = 12/198 (6%)
Query: 323 IGTGGYGSVYRA-RLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGF 381
IG G G+VY A + +G+ VA+K+++ + E NE ++ + +H NIV
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNL--QQQPKKELIINEILVMRENKHPNIVNYLDS 84
Query: 382 CLHEKCMFLIYEYMEMGSLFCILRTDE-EAVGLDWTKRVNIVKGMAHALSYLHHHCTPPI 440
L ++++ EY+ GSL TD +D + + + AL +LH + +
Sbjct: 85 YLVGDELWVVMEYLAGGSL-----TDVVTETCMDEGQIAAVCRECLQALEFLHSN---QV 136
Query: 441 LHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKY 500
+HRDI S+NILL + + DFG + + S R+ + GT +APE+ K
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 501 DVYSFGVVALEVLMGKHP 518
D++S G++A+E++ G+ P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 8e-16
Identities = 63/216 (29%), Positives = 101/216 (46%), Gaps = 22/216 (10%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGF 381
+G G YG V + + +G++VA+KK E + + E R+L Q+RH N+V L
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68
Query: 382 CLHEKCMFLIYEYMEMGSLFCILRTDEEAV--GLDWTKRVNIVKGMAHALSYLHHHCTPP 439
+K ++L++E+++ L D E GLD ++ + + + + H H
Sbjct: 69 FRRKKRLYLVFEFVDHTVL-----DDLEKYPNGLDESRVRKYLFQILRGIEFCHSH---N 120
Query: 440 ILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEK 499
I+HRDI NIL++ + DFG AR L T T APEL +V K
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPEL---LVGDTK 177
Query: 500 Y----DVYSFGVVALEVLMGKHPGELLSSSSSSLDK 531
Y D+++ G + E+L GE L S +D+
Sbjct: 178 YGRAVDIWAVGCLVTEMLT----GEPLFPGDSDIDQ 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 58/200 (29%), Positives = 107/200 (53%), Gaps = 20/200 (10%)
Query: 323 IGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFC 382
IG G +G+V + +G+ VA+K + T A LE E +++++ H+N+V+L G
Sbjct: 14 IGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQAFLE----ETAVMTKLHHKNLVRLLGVI 68
Query: 383 LHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSY---LHHHCTPP 439
LH ++++ E M G+L LRT A+ V++++ + +L + + +
Sbjct: 69 LHNG-LYIVMELMSKGNLVNFLRTRGRAL-------VSVIQLLQFSLDVAEGMEYLESKK 120
Query: 440 ILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEK 499
++HRD+++ NIL++ + A V+DFG+AR + + + L + APE + K
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNSKLPVKW--TAPEALKHKKFSSK 177
Query: 500 YDVYSFGVVALEVL-MGKHP 518
DV+S+GV+ EV G+ P
Sbjct: 178 SDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 68/218 (31%), Positives = 101/218 (46%), Gaps = 29/218 (13%)
Query: 323 IGTGGYGSVYRARLP------SGKV-VALKKLHRLETELASLESFQNEARLLSQIRHRNI 375
+G+G +G VY SG + VA+K L + T+ E F EA L+S H NI
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKE-FLKEAHLMSNFNHPNI 61
Query: 376 VKLYGFCLHEKCMFLIYEYMEMGSLFCILR----TDEEAVGLDWTKRVNIVKGMAHALSY 431
VKL G CL + ++I E ME G L LR L + ++I +A Y
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 432 LHH-HCTPPILHRDISSNNILLNSEFEAF-----VADFGIARLL----NYDSSNRTLLAG 481
L H +HRD+++ N L++ + + DFG+AR + Y LL
Sbjct: 122 LEQMH----FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 482 TYGSIAPELAYTMVVTEKYDVYSFGVVALEVL-MGKHP 518
+ +APE T + DV+SFGV+ E+L +G+ P
Sbjct: 178 RW--MAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 70/238 (29%), Positives = 114/238 (47%), Gaps = 36/238 (15%)
Query: 323 IGTGGYGSVYRARLPSGKV-VALKKLHR-LETELASLESFQNEARLLSQIRHRNIVKLYG 380
IG G +G V+ RL + VA+K L +L + F EAR+L Q H NIV+L G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA--KFLQEARILKQYSHPNIVRLIG 60
Query: 381 FCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLH-HHCTPP 439
C ++ ++++ E ++ G LRT E L + + +V+ A + YL HC
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKHC--- 115
Query: 440 ILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGS-------IAPE-LA 491
+HRD+++ N L+ + ++DFG++R + A T G APE L
Sbjct: 116 -IHRDLAARNCLVTEKNVLKISDFGMSR-----EEEDGVYASTGGMKQIPVKWTAPEALN 169
Query: 492 YTMVVTEKYDVYSFGVVALEVL-MGKHPGELLSSSSS--SLDKNIKLIDLLDPRLPPP 546
Y +E DV+SFG++ E +G P LS+ + ++++ + RLP P
Sbjct: 170 YGRYSSES-DVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV--------RLPCP 218
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 49/153 (32%), Positives = 82/153 (53%), Gaps = 21/153 (13%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQ-NEARLLSQIRHRNIVKLYG 380
IG G YG+V++A+ + ++VALK++ RL+ + + S E LL +++H+NIV+LY
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 381 FCLHEKCMFLIYEYME--MGSLFCILRTDEEAVGLDWTKRVNIVKG----MAHALSYLHH 434
+K + L++EY + + F D + IVK + L++ H
Sbjct: 67 VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDP---------EIVKSFMFQLLKGLAFCHS 117
Query: 435 HCTPPILHRDISSNNILLNSEFEAFVADFGIAR 467
H +LHRD+ N+L+N E +ADFG+AR
Sbjct: 118 H---NVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 62/213 (29%), Positives = 106/213 (49%), Gaps = 24/213 (11%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETE-----LASLESFQNEARLLS 368
++++ I G YG VYRAR +G++VALKKL ++E E + SL +L
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL-KMEKEKEGFPITSLREIN----ILL 59
Query: 369 QIRHRNIVKL----YGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKG 424
+++H NIV + G L + ++++ EY+E L ++ T ++ K ++
Sbjct: 60 KLQHPNIVTVKEVVVGSNLDK--IYMVMEYVEH-DLKSLMETMKQPFLQSEVK--CLMLQ 114
Query: 425 MAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYG 484
+ +++LH + ILHRD+ ++N+LLN+ + DFG+AR T L T
Sbjct: 115 LLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLW 171
Query: 485 SIAPELAY-TMVVTEKYDVYSFGVVALEVLMGK 516
APEL + D++S G + E+L K
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-15
Identities = 79/238 (33%), Positives = 119/238 (50%), Gaps = 8/238 (3%)
Query: 3 RLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIAS 62
RL +L L S + L L L L+L+LN L NI S + LT LT+L + +
Sbjct: 68 RLLSLDLLSPSGISSLDGSE-NLLNLLPLPSLDLNLNRLRSNI-SELLELTNLTSLDLDN 125
Query: 63 NRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLG 122
N + L L+ LDLS N+I S+PS L +L L+++DLS N L +P L
Sbjct: 126 NNITDIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNLKNLDLSFNDLSD-LPKLLS 183
Query: 123 HLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSG 182
+L+ L L++ NK+ +PPE+ S L L L NN + + S + L+ L L+LS
Sbjct: 184 NLSNLNNLDLSGNKI-SDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSN 241
Query: 183 NFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVR-KVPHLDVSGNQFGGEIPTTLA 239
N + +P +G S ++T+DLS N +S + + LD+SGN +P
Sbjct: 242 NKLE-DLPESIGNLSNLETLDLSNNQISSISSLGSLTNLRELDLSGNSLSNALPLIAL 298
|
Length = 394 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 14/208 (6%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRN 374
E + +G G +G V+ VA+K L + E+F EA+++ ++RH
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTL---KPGTMMPEAFLQEAQIMKKLRHDK 62
Query: 375 IVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHH 434
+V LY + E+ ++++ E+M GSL L+ + + L + V++ +A ++Y+
Sbjct: 63 LVPLYA-VVSEEPIYIVTEFMGKGSLLDFLK-EGDGKYLKLPQLVDMAAQIADGMAYIER 120
Query: 435 HCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI---APELA 491
+HRD+ + NIL+ +ADFG+ARL+ + + T G I APE A
Sbjct: 121 M---NYIHRDLRAANILVGDNLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAA 175
Query: 492 YTMVVTEKYDVYSFGVVALE-VLMGKHP 518
T K DV+SFG++ E V G+ P
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 2e-15
Identities = 55/197 (27%), Positives = 101/197 (51%), Gaps = 10/197 (5%)
Query: 323 IGTGGYGSVYRA-RLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGF 381
IG G G+VY A + +G+ VA+K+++ + L NE ++ + ++ NIV
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKEL--IINEILVMRENKNPNIVNYLDS 84
Query: 382 CLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPIL 441
L ++++ EY+ GSL ++ +D + + + AL +LH + ++
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALDFLHSN---QVI 137
Query: 442 HRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYD 501
HRDI S+NILL + + DFG + + S R+ + GT +APE+ K D
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 197
Query: 502 VYSFGVVALEVLMGKHP 518
++S G++A+E++ G+ P
Sbjct: 198 IWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 2e-15
Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 22/216 (10%)
Query: 317 FDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRN 374
F++ +G G YG VY+ R + +G++ A+K + E E + E +L + HRN
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE---EEIKQEINMLKKYSHHRN 64
Query: 375 IVKLYGFCLH------EKCMFLIYEYMEMGSLFCILR-TDEEAVGLDWTKRVNIVKGMAH 427
I YG + + ++L+ E+ GS+ +++ T + +W I + +
Sbjct: 65 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AYICREILR 122
Query: 428 ALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIA 487
LS+LH H ++HRDI N+LL E + DFG++ L+ R GT +A
Sbjct: 123 GLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 179
Query: 488 PELAYT-----MVVTEKYDVYSFGVVALEVLMGKHP 518
PE+ K D++S G+ A+E+ G P
Sbjct: 180 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 3e-15
Identities = 61/207 (29%), Positives = 89/207 (42%), Gaps = 23/207 (11%)
Query: 323 IGTGGYGSVY------RARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIV 376
+G G +G VY R VA+K L +E F EA ++S+ H+NIV
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE-QDESDFLMEALIMSKFNHQNIV 72
Query: 377 KLYGFCLHEKCMFLIYEYMEMGSLFCILR----TDEEAVGLDWTKRVNIVKGMAHALSYL 432
+L G F++ E M G L LR E L + + +A YL
Sbjct: 73 RLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL 132
Query: 433 HHHCTPPILHRDISSNNILLNSEFE---AFVADFGIARLL----NYDSSNRTLLAGTYGS 485
+HRDI++ N LL + A +ADFG+AR + Y R +L +
Sbjct: 133 E---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKW-- 187
Query: 486 IAPELAYTMVVTEKYDVYSFGVVALEV 512
+ PE + T K DV+SFGV+ E+
Sbjct: 188 MPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 3e-15
Identities = 69/238 (28%), Positives = 118/238 (49%), Gaps = 33/238 (13%)
Query: 323 IGTGGYGSVYRA-RLPSGKVV----ALKKLHRLETELASLESFQNEARLLSQIRHRNIVK 377
+G+G +G+VY+ +P G+ V A+K L+ A++E F +EA +++ + H ++V+
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEALIMASMDHPHLVR 73
Query: 378 LYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVG----LDWTKRVNIVKGMAHALSYLH 433
L G CL + L+ + M G L + ++ +G L+W V I KGM YL
Sbjct: 74 LLGVCL-SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWC--VQIAKGMM----YLE 126
Query: 434 HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTY--GSIAPELA 491
++HRD+++ N+L+ S + DFG+ARLL D G +A E
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 492 YTMVVTEKYDVYSFGVVALEVL-MGKHPGELLSSSSSSLDKNIKLIDLLDP--RLPPP 546
+ T + DV+S+GV E++ G P + + + ++ DLL+ RLP P
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR--------EIPDLLEKGERLPQP 233
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 4e-15
Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 41/208 (19%)
Query: 313 ATEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKL--HRLETELASLESFQNEARLLSQ 369
D++I +G G +G VY+AR + +G+VVALKK+ H E + + + + E ++L +
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHN-EKDGFPITALR-EIKILKK 63
Query: 370 IRHRNIVKLYGFCLHE--------KCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVN- 420
++H N+V L + ++++ YM D + GL V
Sbjct: 64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYM-----------DHDLSGLLENPSVKL 112
Query: 421 -------IVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473
+ + ++YLH + ILHRDI + NIL++++ +ADFG+AR YD
Sbjct: 113 TESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLAR--PYDG 167
Query: 474 SNRTLLAGTYGSIAPELAYT-MVVTEKY 500
G YT +VVT Y
Sbjct: 168 PPPNP---KGGGGGGTRKYTNLVVTRWY 192
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 4e-15
Identities = 70/267 (26%), Positives = 121/267 (45%), Gaps = 42/267 (15%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHR 373
D+++ +G+G YG VY+AR L +G++ A+K + + SL Q E ++ + +H
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL--IQQEIFMVKECKHC 66
Query: 374 NIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLH 433
NIV +G L + +++ EY GSL I L + + + L+YLH
Sbjct: 67 NIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGP---LSELQIAYVCRETLQGLAYLH 123
Query: 434 HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYT 493
+ +HRDI NILL + +ADFG+A + + R GT +APE+A
Sbjct: 124 ---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVA-- 178
Query: 494 MVVTEKY-------DVYSFGVVALEV------LMGKHPGE---LLSSS------------ 525
EK D+++ G+ A+E+ + HP L+S S
Sbjct: 179 --AVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTK 236
Query: 526 -SSSLDKNIKLIDLLDPRLPPPGDQMI 551
SS+ +K+ +P+ P ++++
Sbjct: 237 WSSTFHNFVKISLTKNPKKRPTAERLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 5e-15
Identities = 67/233 (28%), Positives = 104/233 (44%), Gaps = 31/233 (13%)
Query: 305 ITFQDMIEATEDFDIKYCIGTGGYGSVYR-ARLPSGKVVALKKLHRLETELASLESFQNE 363
+ + + + T+ ++I IG G YG VY+ G + A+K L + +E+ N
Sbjct: 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNI 71
Query: 364 ARLLSQIRHRNIVKLYG-FCLHEKC----MFLIYEYMEMGS--------LFCILRTDEEA 410
+ L H N+VK YG F +K ++L+ E GS L C R DE
Sbjct: 72 LQSLPN--HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAM 129
Query: 411 VGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN 470
+ I+ G L +LH++ I+HRD+ NNILL +E + DFG++ L
Sbjct: 130 ISY-------ILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 179
Query: 471 YDSSNRTLLAGTYGSIAPEL-----AYTMVVTEKYDVYSFGVVALEVLMGKHP 518
R GT +APE+ Y + DV+S G+ A+E+ G P
Sbjct: 180 STRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPP 232
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 5e-15
Identities = 54/197 (27%), Positives = 101/197 (51%), Gaps = 10/197 (5%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGF 381
IG G G+VY A + +G+ VA+++++ + L NE ++ + ++ NIV
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNPNIVNYLDS 85
Query: 382 CLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPIL 441
L ++++ EY+ GSL ++ +D + + + AL +LH + ++
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 442 HRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYD 501
HRDI S+NILL + + DFG + + S R+ + GT +APE+ K D
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 198
Query: 502 VYSFGVVALEVLMGKHP 518
++S G++A+E++ G+ P
Sbjct: 199 IWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 6e-15
Identities = 45/134 (33%), Positives = 66/134 (49%), Gaps = 14/134 (10%)
Query: 101 KWLRS-VDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNN 159
KW + L L G IP+ + L L ++N+ N + G IPP L + + L +L L N
Sbjct: 417 KWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYN 476
Query: 160 LLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLG-------EFSCIDTVDLSMNNLSGG 212
+GSIP +G+L L L+L+GN ++G++P+ LG F+ D L G
Sbjct: 477 SFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLC------G 530
Query: 213 IPVFVRKVPHLDVS 226
IP PHL V
Sbjct: 531 IPGLRACGPHLSVG 544
|
Length = 623 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 6e-15
Identities = 47/151 (31%), Positives = 81/151 (53%), Gaps = 15/151 (9%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQ-NEARLLSQIRHRNIVKLYG 380
IG G YG VY+ R +G++VA+KK+ RLE+E + S E LL +++H NIV L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 381 FCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKG----MAHALSYLHHHC 436
+ E ++LI+E++ M L+ +++ +VK + + + H
Sbjct: 67 VLMQESRLYLIFEFLSMD-----LKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR- 120
Query: 437 TPPILHRDISSNNILLNSEFEAFVADFGIAR 467
+LHRD+ N+L++++ +ADFG+AR
Sbjct: 121 --RVLHRDLKPQNLLIDNKGVIKLADFGLAR 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 7e-15
Identities = 39/103 (37%), Positives = 60/103 (58%), Gaps = 1/103 (0%)
Query: 34 LNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSI 93
L L L G IP+++ L L ++ ++ N + G+I +GS+ L+VLDLS N GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 94 PSTLGHLKWLRSVDLSQNKLVGPIPSSLG-HLTQLTTLNMYNN 135
P +LG L LR ++L+ N L G +P++LG L + N +N
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 45/146 (30%), Positives = 79/146 (54%), Gaps = 6/146 (4%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGF 381
+G G Y +VY+ R +G++VALK++H L+ E + + E L+ +++H NIV+L+
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIH-LDAEEGTPSTAIREISLMKELKHENIVRLHDV 66
Query: 382 CLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPIL 441
E + L++EYM+ L + T LD + + +++ H + +L
Sbjct: 67 IHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVL 122
Query: 442 HRDISSNNILLNSEFEAFVADFGIAR 467
HRD+ N+L+N E +ADFG+AR
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 64/228 (28%), Positives = 109/228 (47%), Gaps = 28/228 (12%)
Query: 319 IKYCIGTGGYGSVYRARL----PSGK--VVALKKLHRLETELASLESFQNEARLLSQIRH 372
+K +G G +G V+ A P +VA+K L + + + F EA LL+ ++H
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLK--DASDNARKDFHREAELLTNLQH 66
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTD-EEAV---------GLDWTKRVNIV 422
+IVK YG C+ + +++EYM+ G L LR +AV L ++ ++I
Sbjct: 67 EHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIA 126
Query: 423 KGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL----NYDSSNRTL 478
+ +A + YL + +HRD+++ N L+ + DFG++R + Y T+
Sbjct: 127 QQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTM 183
Query: 479 LAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS 525
L + + PE T + DV+S GVV E+ GK P LS++
Sbjct: 184 LPIRW--MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN 229
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 25/205 (12%)
Query: 323 IGTGGYGSV-YRARLPSGKVVALKKLHR-LETELASLESFQNEARLLSQIRHRNIVKLYG 380
+G+G YG+V +G VA+KKL+R ++EL + +++ E RLL ++H N++ L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMKHENVIGLLD 81
Query: 381 FCLHEKCM------FLIYEYM--EMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYL 432
+ + +L+ +M ++G L + E+ + +V M L Y+
Sbjct: 82 VFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQF-------LVYQMLKGLKYI 134
Query: 433 HHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAY 492
H I+HRD+ N+ +N + E + DFG+AR S T T APE+
Sbjct: 135 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMTGYVVTRWYRAPEVIL 188
Query: 493 T-MVVTEKYDVYSFGVVALEVLMGK 516
M T+ D++S G + E+L GK
Sbjct: 189 NWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 22/212 (10%)
Query: 316 DFDIKYCIGTGGYGSVYRARL----PSGKVVALKKLHRLETELASLESFQNEARLLSQIR 371
+++ +G G +G RA L S + A+K++ RL +++E + EA LL++++
Sbjct: 1 QYNVLRVVGEGSFG---RALLVQHVNSDQKYAMKEI-RLPKSSSAVEDSRKEAVLLAKMK 56
Query: 372 HRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDE-----EAVGLDWTKRVNIVKGMA 426
H NIV + ++++ EY + G L ++ E L W + M
Sbjct: 57 HPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ------MC 110
Query: 427 HALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI 486
+ ++H +LHRDI S NI L + + DFG ARLL + GT +
Sbjct: 111 LGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYV 167
Query: 487 APELAYTMVVTEKYDVYSFGVVALEVLMGKHP 518
PE+ M K D++S G + E+ KHP
Sbjct: 168 PPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 63/247 (25%), Positives = 105/247 (42%), Gaps = 26/247 (10%)
Query: 314 TEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELA-SLESFQNEARLLSQIR 371
+F I+ IG G + VY+A L G+VVALKK+ E A + + E LL Q+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 372 HRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILR--------TDEEAVGLDWTKRVNIVK 423
H N++K + + ++ E + G L +++ E + W V +
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTI---WKYFVQL-- 115
Query: 424 GMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTY 483
AL ++H I+HRDI N+ + + + D G+ R + ++ L GT
Sbjct: 116 --CSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTP 170
Query: 484 GSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRL 543
++PE + K D++S G + E+ + P + SL K I+ D
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD-----Y 225
Query: 544 PP-PGDQ 549
PP P D
Sbjct: 226 PPLPADH 232
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 72/251 (28%), Positives = 124/251 (49%), Gaps = 34/251 (13%)
Query: 310 MIEATEDFDIKYCIGTGGYGSVYRAR-LPSGK----VVALKKLHRLETELASLESFQNEA 364
+++ TE IK +G+G +G+VY+ +P G+ VA+K+L + A+ E +EA
Sbjct: 3 ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEA 60
Query: 365 RLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVG----LDWTKRVN 420
+++ + + ++ +L G CL LI + M G L +R ++ +G L+W V
Sbjct: 61 YVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQ 117
Query: 421 IVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLA 480
I KGM +YL ++HRD+++ N+L+ + + DFG+A+LL D
Sbjct: 118 IAKGM----NYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEG 170
Query: 481 GTY--GSIAPELAYTMVVTEKYDVYSFGVVALEVL-MGKHPGELLSSS--SSSLDKNIKL 535
G +A E + T + DV+S+GV E++ G P + + +S SS L+K
Sbjct: 171 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG--- 227
Query: 536 IDLLDPRLPPP 546
RLP P
Sbjct: 228 -----ERLPQP 233
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 64/235 (27%), Positives = 107/235 (45%), Gaps = 52/235 (22%)
Query: 323 IGTGGYGSVYRAR------LPSGKVVALKKLHR--LETELASLESFQNEARLLSQIRHRN 374
+G G +G V +A VA+K L +EL L S E LL Q+ H +
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLS---EFNLLKQVNHPH 64
Query: 375 IVKLYGFCLHEKCMFLIYEYMEMGSLFCILRT-----------------------DEEAV 411
++KLYG C + + LI EY + GSL LR DE A+
Sbjct: 65 VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 412 --GLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL 469
G + I +GM + L+ + ++HRD+++ N+L+ + ++DFG++R +
Sbjct: 125 TMGDLISFAWQISRGMQY-LAEMK------LVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 470 NYDSSNRTLLAGTYGSI-----APELAYTMVVTEKYDVYSFGVVALEVL-MGKHP 518
+ S + + G I A E + + T + DV+SFGV+ E++ +G +P
Sbjct: 178 YEEDS---YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 229
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 57/195 (29%), Positives = 96/195 (49%), Gaps = 11/195 (5%)
Query: 323 IGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFC 382
+G G +G VY+A+ +A K+ ++E LE + E +L+ H IVKL G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSE-EELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 383 LHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILH 442
+ ++++ E+ G++ I+ E GL + I + M AL YLH + I+H
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIML--ELDRGLTEPQIQVICRQMLEALQYLH---SMKIIH 133
Query: 443 RDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAY--TMVVTE-- 498
RD+ + N+LL + + +ADFG++ R GT +APE+ TM T
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYD 193
Query: 499 -KYDVYSFGVVALEV 512
K D++S G+ +E+
Sbjct: 194 YKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 67/213 (31%), Positives = 105/213 (49%), Gaps = 35/213 (16%)
Query: 323 IGTGGYGSVYRARLPSGKV-VALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGF 381
+G G YG VY AR S +V +A+K++ E + ++ E L S ++HRNIV+ G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIP--ERDSRYVQPLHEEIALHSYLKHRNIVQYLGS 73
Query: 382 CLHEKCMFLIY-EYMEMGSLFCILRT------DEEAVGLDWTKRVNIVKGMAHALSYLHH 434
E F I+ E + GSL +LR+ D E + +TK+ I++G L YLH
Sbjct: 74 DS-ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ--ILEG----LKYLHD 126
Query: 435 HCTPPILHRDISSNNILLNSEFEAF-VADFGIARLLNYDSSNRTLLAGTYGSIAPELAYT 493
+ I+HRDI +N+L+N+ ++DFG ++ L + GT +APE
Sbjct: 127 N---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPE---- 179
Query: 494 MVVTEK--------YDVYSFGVVALEVLMGKHP 518
V +K D++S G +E+ GK P
Sbjct: 180 --VIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 64/236 (27%), Positives = 114/236 (48%), Gaps = 22/236 (9%)
Query: 323 IGTGGYGSVYRAR--LPSGKVVALKKLH-RLETELASLESFQNEA--RLLSQIRHRNIVK 377
IG G YG V++AR G+ VALK++ + E L + + A R L H N+V+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 378 LYGFCL-----HEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYL 432
L+ C E + L++E+++ + + E V + K +++ + L +L
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK--DMMFQLLRGLDFL 126
Query: 433 HHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAY 492
H H ++HRD+ NIL+ S + +ADFG+AR+ ++ + +++ T APE+
Sbjct: 127 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV-TLWYRAPEVLL 182
Query: 493 TMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRLPPPGD 548
D++S G + E+ K L SS +D+ K++D++ LP D
Sbjct: 183 QSSYATPVDLWSVGCIFAEMFRRKP----LFRGSSDVDQLGKILDVIG--LPGEED 232
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 29/214 (13%)
Query: 323 IGTGGYGSVYRARL-----PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVK 377
+G +G +Y+ L ++VA+K L + E FQ EA L++++ H NIV
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGE-FQQEASLMAELHHPNIVC 71
Query: 378 LYGFCLHEKCMFLIYEYMEMGSL--FCILRTDEEAVG------------LDWTKRVNIVK 423
L G E+ + +++EY+ G L F I+R+ VG LD ++I
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 424 GMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL----NYDSSNRTLL 479
+A + YL H +H+D+++ NIL+ + ++D G++R + Y ++LL
Sbjct: 132 QIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 480 AGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVL 513
+ + PE + D++SFGVV E+
Sbjct: 189 PIRW--MPPEAIMYGKFSSDSDIWSFGVVLWEIF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 4e-14
Identities = 69/197 (35%), Positives = 102/197 (51%), Gaps = 9/197 (4%)
Query: 3 RLRNLVHLDLSDNHFMGHIPPTLGRL-SELKILNLSLNSLVGNIPSNVGHLTQLTTLAIA 61
L NL LDL +N+ IPP +G L S LK L+LS N + ++PS + +L L L ++
Sbjct: 114 ELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNLKNLDLS 171
Query: 62 SNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSL 121
N ++ + + +L L LDLS N+I +P + L L +DLS N ++ + SSL
Sbjct: 172 FNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSL 228
Query: 122 GHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLS 181
+L L+ L + NNKL+ + N S L L L NN +S S +G L L LDLS
Sbjct: 229 SNLKNLSGLELSNNKLEDLPES-IGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLS 285
Query: 182 GNFINGKIPSQLGEFSC 198
GN ++ +P
Sbjct: 286 GNSLSNALPLIALLLLL 302
|
Length = 394 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 4e-14
Identities = 58/208 (27%), Positives = 103/208 (49%), Gaps = 24/208 (11%)
Query: 318 DIKY--CIGTGGYGSVYRA-RLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRN 374
DI+Y +G G G+VY+A L + +++A+K + L+ + + +E +L +
Sbjct: 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVI-PLDITVELQKQIMSELEILYKCDSPY 60
Query: 375 IVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHH 434
I+ YG E + + E+M+ GSL + E +G V +VKG+ + S
Sbjct: 61 IIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLG---RIAVAVVKGLTYLWSL--- 114
Query: 435 HCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTM 494
ILHRD+ +N+L+N+ + + DFG++ L +S GT +APE
Sbjct: 115 ----KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV--NSIAKTYVGTNAYMAPE----R 164
Query: 495 VVTEKY----DVYSFGVVALEVLMGKHP 518
+ E+Y DV+S G+ +E+ +G+ P
Sbjct: 165 ISGEQYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 4e-14
Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 29/207 (14%)
Query: 323 IGTGGYGSVYRARL----PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKL 378
IG G +G VY L A+K L+R+ T+L +E F E ++ H N++ L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 379 YGFCL-HEKCMFLIYEYMEMGSLFCILR------TDEEAVGLDWTKRVNIVKGMAHALSY 431
G CL E ++ YM+ G L +R T ++ +G + + KGM Y
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFG----LQVAKGM----EY 113
Query: 432 LHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI----- 486
L + +HRD+++ N +L+ F VADFG+AR + YD ++ T +
Sbjct: 114 L---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDI-YDKEYYSVHNHTGAKLPVKWM 169
Query: 487 APELAYTMVVTEKYDVYSFGVVALEVL 513
A E T T K DV+SFGV+ E++
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 5e-14
Identities = 60/223 (26%), Positives = 105/223 (47%), Gaps = 22/223 (9%)
Query: 323 IGTGGYGSVYRARLPSGKVVALKKLHR-LETELASLESFQNEARLLSQIRHRNIVKLYGF 381
+G G +G V++ L VA+K L EL F +EAR+L Q H NIVKL G
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKI--KFLSEARILKQYDHPNIVKLIGV 60
Query: 382 CLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKR--VNIVKGMAHALSYLHHHCTPP 439
C + ++++ E + G LR ++ + + ++ GMA+ S +C
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLES---KNC--- 114
Query: 440 ILHRDISSNNILLNSEFEAFVADFGIARLLN---YDSSNRTLLAGTYGSIAPE-LAYTMV 495
+HRD+++ N L+ ++DFG++R + Y SS + + APE L Y
Sbjct: 115 -IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKW--TAPEALNYGRY 171
Query: 496 VTEKYDVYSFGVVALEVL---MGKHPGELLSSSSSSLDKNIKL 535
+E DV+S+G++ E + +PG + ++K ++
Sbjct: 172 SSES-DVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM 213
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 6e-14
Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 18/205 (8%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHR 373
EDF++ IG+G YG VY+AR + +G++ A+K + +LE Q E ++ +H
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVI-KLEPG-EDFAVVQQEIIMMKDCKHS 66
Query: 374 NIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLH 433
NIV +G L +++ E+ GSL I L ++ + + L YLH
Sbjct: 67 NIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP---LSESQIAYVSRETLQGLYYLH 123
Query: 434 HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYT 493
+HRDI NILL +ADFG++ + + R GT +APE+A
Sbjct: 124 SKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVA-- 178
Query: 494 MVVTEK------YDVYSFGVVALEV 512
V K D+++ G+ A+E+
Sbjct: 179 -AVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 7e-14
Identities = 65/278 (23%), Positives = 115/278 (41%), Gaps = 54/278 (19%)
Query: 316 DFDIKY----CIGTGGYGSVYRA-RLPSGKVVALKKLHRLETELASLESFQNEARLLSQI 370
D +Y IG+G YG V A SGK VA+KK+ + E ++L
Sbjct: 2 DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF 61
Query: 371 RHRNIVKLYGFCL----HEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVN-----I 421
+H NI+ + K ++++ + ME L I+ +D+ + + +
Sbjct: 62 KHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQPLT----EEHIRYFLYQL 116
Query: 422 VKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAG 481
++G L Y+H ++HRD+ +N+L+N + E + DFG+AR L+ +
Sbjct: 117 LRG----LKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMT 169
Query: 482 TYGSI----APELAYTMV-VTEKYDVYSFGVVALEVLM------GKH------------- 517
Y + APEL ++ T D++S G + E+L GK+
Sbjct: 170 EYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLG 229
Query: 518 --PGELLSSSSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553
E+L+ S + K I L + P P ++ +
Sbjct: 230 SPSEEVLNRIGSDRVR--KYIQNLPRKQPVPWSKIFPK 265
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 8e-14
Identities = 36/93 (38%), Positives = 53/93 (56%)
Query: 78 VLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKL 137
+ L L + G IP+ + L+ L+S++LS N + G IP SLG +T L L++ N
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478
Query: 138 DGPIPPELMNCSKLRILKLGNNLLSGSIPSQIG 170
+G IP L + LRIL L N LSG +P+ +G
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 8e-14
Identities = 54/195 (27%), Positives = 94/195 (48%), Gaps = 11/195 (5%)
Query: 323 IGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFC 382
+G G +G VY+A+ V+A K+ ++E LE + E +L+ H NIVKL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSE-EELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 383 LHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILH 442
+E ++++ E+ G++ ++ E + + V K AL+YLH + I+H
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVV--CKQTLEALNYLHEN---KIIH 126
Query: 443 RDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTE---- 498
RD+ + NIL + + +ADFG++ R GT +APE+ +
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 186
Query: 499 -KYDVYSFGVVALEV 512
K DV+S G+ +E+
Sbjct: 187 YKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 8e-14
Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 17/197 (8%)
Query: 323 IGTGGYGSVYRA---RLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLY 379
+G+G +G+V + S K VA+K L + A + EA ++ Q+ + IV++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 380 GFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPP 439
G C E M L+ E E+G L L+ ++ + T+ V+ V + + YL
Sbjct: 63 GICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNITELVHQV---SMGMKYLEET---N 115
Query: 440 ILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGS-----IAPELAYTM 494
+HRD+++ N+LL ++ A ++DFG+++ L D + A T+G APE
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK--AKTHGKWPVKWYAPECMNYY 173
Query: 495 VVTEKYDVYSFGVVALE 511
+ K DV+SFGV+ E
Sbjct: 174 KFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 9e-14
Identities = 66/233 (28%), Positives = 103/233 (44%), Gaps = 39/233 (16%)
Query: 323 IGTGGYGSVYRA------RLPSGKVVALKKL----HRLETELASLESFQNEARLLSQI-R 371
+G G +G V A + + VA+K L H E E + +E +++S +
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSERE-----ALMSELKIMSHLGN 97
Query: 372 HRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVG-----LDWTKRVNIVKGMA 426
H NIV L G C + +I EY G L LR E+ L ++ +V KGMA
Sbjct: 98 HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQV--AKGMA 155
Query: 427 HALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL----NYDSSNRTLLAGT 482
S +C +HRD+++ N+LL + DFG+AR + NY L
Sbjct: 156 FLAS---KNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK 208
Query: 483 YGSIAPELAYTMVVTEKYDVYSFGVVALEVL---MGKHPGELLSSSSSSLDKN 532
+ +APE + V T + DV+S+G++ E+ +PG + S L K
Sbjct: 209 W--MAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE 259
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 9e-14
Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 19/206 (9%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGF 381
IG G +G + GK +K+++ + E + E +LS ++H NIV+ Y
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ-YQE 66
Query: 382 CLHEK-CMFLIYEYMEMGSLFCILRTD------EEAVGLDWTKRVNIVKGMAHALSYLHH 434
E ++++ +Y E G L+ + E+ + LDW ++ + AL ++H
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQI-LDWFVQICL------ALKHVHD 119
Query: 435 HCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTM 494
ILHRDI S NI L + + DFGIAR+LN GT ++PE+
Sbjct: 120 R---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENR 176
Query: 495 VVTEKYDVYSFGVVALEVLMGKHPGE 520
K D+++ G V E+ KH E
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 9e-14
Identities = 62/230 (26%), Positives = 103/230 (44%), Gaps = 41/230 (17%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQN------------EARLLSQ 369
+G G YG V +A +GK+VA+KK+ +E + Q E +++++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 370 IRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHAL 429
I+H NI+ L + + L+ + M L ++ + + L ++ I+ + + L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVV---DRKIRLTESQVKCILLQILNGL 132
Query: 430 SYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPE 489
+ LH +HRD+S NI +NS+ +ADFG+AR Y + TL +
Sbjct: 133 NVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDET--MQRR 187
Query: 490 LAYT-MVVT------------EKY----DVYSFGVVALEVLMGK--HPGE 520
T VVT EKY D++S G + E+L GK PGE
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237
|
Length = 335 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 57/211 (27%), Positives = 98/211 (46%), Gaps = 23/211 (10%)
Query: 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHR 373
DF++ +GTG +G V A+ +G+ A+K L + E ++ ++ E +L ++ H
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 374 NIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHA----- 428
IV + E ++ + E++ G LF LR + N V HA
Sbjct: 79 FIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKA--------GRFPNDVAKFYHAELVLA 130
Query: 429 LSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTL-LAGTYGSIA 487
YLH I++RD+ N+LL+++ V DFG A+ + +RT L GT +A
Sbjct: 131 FEYLHS-KD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKV----PDRTFTLCGTPEYLA 183
Query: 488 PELAYTMVVTEKYDVYSFGVVALEVLMGKHP 518
PE+ + + D ++ GV+ E + G P
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 32/216 (14%)
Query: 323 IGTGGYGSVYRARL-----PSGKV-VALKKL--HRLETELASLESFQNEARLLSQI-RHR 373
+G G +G V +A P+ VA+K L E +L+ L S E ++ I +H+
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVS---EMEMMKMIGKHK 76
Query: 374 NIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKG--------- 424
NI+ L G C E ++++ EY G+L LR G +
Sbjct: 77 NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLR-ARRPPGEYASPDDPRPPEETLTQKDLV 135
Query: 425 -----MAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLL 479
+A + +L + +HRD+++ N+L+ + +ADFG+AR +++ R
Sbjct: 136 SFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTT 192
Query: 480 AG--TYGSIAPELAYTMVVTEKYDVYSFGVVALEVL 513
G +APE + V T + DV+SFGV+ E+
Sbjct: 193 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 2e-13
Identities = 65/212 (30%), Positives = 105/212 (49%), Gaps = 29/212 (13%)
Query: 323 IGTGGYGSVYRA-RLPSGKVVALKKLH------RLETELASLESFQNEARLLSQIRHRNI 375
+G G +G VY + +G+ +A K++ E+++LE E +LL ++H I
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALEC---EIQLLKNLQHERI 66
Query: 376 VKLYGFCLH---EKCMFLIYEYMEMGSLFCILRTD---EEAVGLDWTKRVNIVKGMAHAL 429
V+ YG CL EK + + EYM GS+ L+ E+V +T++ I++GM
Sbjct: 67 VQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQ--ILEGM---- 119
Query: 430 SYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGS---I 486
SYLH + I+HRDI NIL +S + DFG ++ L + T + G+ +
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWM 176
Query: 487 APELAYTMVVTEKYDVYSFGVVALEVLMGKHP 518
+PE+ K DV+S G +E+L K P
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 60/224 (26%), Positives = 101/224 (45%), Gaps = 35/224 (15%)
Query: 323 IGTGGYGSVYRA--------RLPSGKVVALKKLHRLETELASLESFQNEARLLSQI-RHR 373
+G G +G V A + VA+K L TE L +E ++ I +H+
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATE-KDLSDLVSEMEMMKMIGKHK 81
Query: 374 NIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKG--------- 424
NI+ L G C + +++I EY G+L LR G++++ + V
Sbjct: 82 NIINLLGACTQDGPLYVIVEYASKGNLREYLRA-RRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 425 -----MAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN----YDSSN 475
+A + YL + +HRD+++ N+L+ +ADFG+AR +N Y +
Sbjct: 141 SCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTT 197
Query: 476 RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVL-MGKHP 518
L + +APE + V T + DV+SFGV+ E+ +G P
Sbjct: 198 NGRLPVKW--MAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 17/209 (8%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHR 373
+DF+ +G G G V + + PSG ++A K +H LE + A E ++L +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIH-LEIKPAIRNQIIRELQVLHECNSP 63
Query: 374 NIVKLYGFCLHEKCMFLIYEYMEMGSLFCIL----RTDEEAVGLDWTKRVNIVKGMAHAL 429
IV YG + + + E+M+ GSL +L R EE +G + +++G+A+ L
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG---KVSIAVLRGLAY-L 119
Query: 430 SYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPE 489
H I+HRD+ +NIL+NS E + DFG++ L +N GT ++PE
Sbjct: 120 REKHQ-----IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMSPE 172
Query: 490 LAYTMVVTEKYDVYSFGVVALEVLMGKHP 518
+ + D++S G+ +E+ +G++P
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 4e-13
Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 28/206 (13%)
Query: 323 IGTGGYGSVYRA-RLPSGKVVALKKLHR-LETELASLESFQNEARLLSQIRHRNIVKLY- 379
+G+G YGSV A +G+ VA+KKL R ++E+ + +++ E LL ++H N++ L
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGLLD 81
Query: 380 ----GFCLHE-KCMFLIYEYMEMGSLFCILRTDEEAV-GLDWT--KRVNIVKGMAHALSY 431
E + +L+ YM +TD + + G + K +V M L Y
Sbjct: 82 VFTSAVSGDEFQDFYLVMPYM---------QTDLQKIMGHPLSEDKVQYLVYQMLCGLKY 132
Query: 432 LHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELA 491
+H + I+HRD+ N+ +N + E + DFG+AR + + T T APE+
Sbjct: 133 IH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVVTRWYRAPEVI 186
Query: 492 YT-MVVTEKYDVYSFGVVALEVLMGK 516
M + D++S G + E+L GK
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 55/213 (25%), Positives = 101/213 (47%), Gaps = 27/213 (12%)
Query: 323 IGTGGYGSVYRARL------PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIV 376
+G +G VY+ L + VA+K L + + E E F++EA + S+++H NIV
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 377 KLYGFCLHEKCMFLIYEYMEMGSL--FCILRTDEEAVG-----------LDWTKRVNIVK 423
L G E+ + +I+ Y L F ++R+ VG L+ V+IV
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 424 GMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTY 483
+A + +L H ++H+D+++ N+L+ + ++D G+ R + Y + L+ +
Sbjct: 132 QIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREV-YAADYYKLMGNSL 187
Query: 484 GSI---APELAYTMVVTEKYDVYSFGVVALEVL 513
I +PE + D++S+GVV EV
Sbjct: 188 LPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-13
Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 22/207 (10%)
Query: 323 IGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQN---EARLLSQIRHRNIVKL 378
+G GG+G V ++ +GK+ A KKL++ L + ++ E R+L+++ R IV L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNK--KRLKKRKGYEGAMVEKRILAKVHSRFIVSL 58
Query: 379 -YGF-CLHEKCMFLIYEYMEMGSL-FCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHH 435
Y F + C L+ M G L + I DEE G + + L +LH
Sbjct: 59 AYAFQTKTDLC--LVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR 116
Query: 436 CTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPEL----A 491
I++RD+ N+LL+++ ++D G+A L S AGT G +APEL
Sbjct: 117 ---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEE 173
Query: 492 YTMVVTEKYDVYSFGVVALEVLMGKHP 518
Y V D ++ GV E++ + P
Sbjct: 174 YDFSV----DYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 5e-13
Identities = 65/227 (28%), Positives = 107/227 (47%), Gaps = 41/227 (18%)
Query: 323 IGTGGYGSVYRA--------RLPSGKVVALKKL--HRLETELASLESFQNEARLLSQI-R 371
+G G +G V RA R VA+K L + + +LA L S E L+ I +
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLIS---EMELMKLIGK 76
Query: 372 HRNIVKLYGFCLHEKCMFLIYEYMEMGSL---------------FCILRTDEEAVGLDWT 416
H+NI+ L G C E +++I EY G+L F I + EE L +
Sbjct: 77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQ--LSFK 134
Query: 417 KRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN----YD 472
V+ +A + YL + +HRD+++ N+L+ + +ADFG+AR ++ Y
Sbjct: 135 DLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYK 191
Query: 473 SSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVL-MGKHP 518
++ L + +APE + V T + DV+SFG++ E+ +G P
Sbjct: 192 KTSNGRLPVKW--MAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 7e-13
Identities = 64/226 (28%), Positives = 102/226 (45%), Gaps = 35/226 (15%)
Query: 318 DIKY--CIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLES---FQNEARLLSQI-R 371
DIK+ IG G +G V +AR+ + + R++ E AS + F E +L ++
Sbjct: 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGH 66
Query: 372 HRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILR------TD-------EEAVGLDWTKR 418
H NI+ L G C H ++L EY G+L LR TD A L +
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 419 VNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTL 478
++ +A + YL +HRD+++ NIL+ + A +ADFG++R
Sbjct: 127 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR------GQEVY 177
Query: 479 LAGTYGSI-----APELAYTMVVTEKYDVYSFGVVALEVL-MGKHP 518
+ T G + A E V T DV+S+GV+ E++ +G P
Sbjct: 178 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 7e-13
Identities = 56/208 (26%), Positives = 99/208 (47%), Gaps = 23/208 (11%)
Query: 323 IGTGGYGSVYRA-RLPSGKVVALKKLHRLETELASLESFQ---NEARLLSQIRHRNIVKL 378
+G+G +G+V++ +P G + + + + + ++FQ + + + H IV+L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 379 YGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVG----LDWTKRVNIVKGMAHALSYLHH 434
G C + L+ + +GSL +R +++ L+W V I KGM YL
Sbjct: 75 LGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWC--VQIAKGM----YYLEE 127
Query: 435 HCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI---APELA 491
H ++HR++++ NILL S+ +ADFG+A LL Y + + I A E
Sbjct: 128 HR---MVHRNLAARNILLKSDSIVQIADFGVADLL-YPDDKKYFYSEHKTPIKWMALESI 183
Query: 492 YTMVVTEKYDVYSFGVVALEVL-MGKHP 518
T + DV+S+GV E++ G P
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 7e-13
Identities = 62/211 (29%), Positives = 106/211 (50%), Gaps = 21/211 (9%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHR 373
+DF+ +G G G V + PSG ++A K +H LE + A E ++L +
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIH-LEIKPAIRNQIIRELKVLHECNSP 59
Query: 374 NIVKLYGFCLHEKCMFLIYEYMEMGSLFCIL----RTDEEAVGLDWTKRVNI--VKGMAH 427
IV YG + + + E+M+ GSL +L R E +G +++I ++G
Sbjct: 60 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILG-----KISIAVLRG--- 111
Query: 428 ALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIA 487
L+YL I+HRD+ +NIL+NS E + DFG++ L DS + + GT ++
Sbjct: 112 -LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFV-GTRSYMS 166
Query: 488 PELAYTMVVTEKYDVYSFGVVALEVLMGKHP 518
PE T + D++S G+ +E+ +G++P
Sbjct: 167 PERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 8e-13
Identities = 49/156 (31%), Positives = 77/156 (49%), Gaps = 28/156 (17%)
Query: 323 IGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGF 381
+G G Y +V++ R + +VALK++ RLE E + + E LL ++H NIV L+
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEI-RLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 382 CLHEKCMFLIYEYME---------MGSLFCILRTDEEAVGLDWTKRVNIVK-GMAHALSY 431
E+C+ L++EY++ G+L + V I + LSY
Sbjct: 72 IHTERCLTLVFEYLDSDLKQYLDNCGNLMSM-------------HNVKIFMFQLLRGLSY 118
Query: 432 LHHHCTPPILHRDISSNNILLNSEFEAFVADFGIAR 467
H ILHRD+ N+L+N + E +ADFG+AR
Sbjct: 119 CHKR---KILHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 55/211 (26%), Positives = 103/211 (48%), Gaps = 20/211 (9%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGKV--VALKKLHRLET-ELASLESFQNEARLLSQIR 371
EDF+ +GTG +G V A + VA+K+ + + + ++ +E ++L+ I
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 372 HRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEE---AVGLDWTKRVNIVKGMAHA 428
H V LYG E ++L+ E++ G F LR ++ VG + ++ ++ +
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS 149
Query: 429 LSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTL-LAGTYGSIA 487
L+ I++RD+ N+LL+ + + DFG A++++ RT L GT IA
Sbjct: 150 LN---------IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD----TRTYTLCGTPEYIA 196
Query: 488 PELAYTMVVTEKYDVYSFGVVALEVLMGKHP 518
PE+ + + D ++ G+ E+L+G P
Sbjct: 197 PEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 66/237 (27%), Positives = 115/237 (48%), Gaps = 31/237 (13%)
Query: 323 IGTGGYGSVYRA-RLPSGKVVALK---KLHRLETELASLESFQNEARLLSQIRHRNIVKL 378
+G+G +G+VY+ +P G+ V + K+ R T + + +EA +++ + + +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 379 YGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVG----LDWTKRVNIVKGMAHALSYLHH 434
G CL L+ + M G L +R +++ +G L+W V I KGM SYL
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWC--VQIAKGM----SYLEE 127
Query: 435 HCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTY--GSIAPELAY 492
++HRD+++ N+L+ S + DFG+ARLL+ D + G +A E
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 493 TMVVTEKYDVYSFGVVALEVL-MGKHPGELLSSSSSSLDKNIKLIDLLDP--RLPPP 546
T + DV+S+GV E++ G P + + + ++ DLL+ RLP P
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--------EIPDLLEKGERLPQP 233
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 58/226 (25%), Positives = 99/226 (43%), Gaps = 33/226 (14%)
Query: 308 QDMIEATEDFDIKY----CIGTGGYGSVYRARLPSGKV-VALKKLHR-LETELASLESFQ 361
Q++ + + +Y +G+G YG V A VA+KKL R ++ + + +++
Sbjct: 4 QELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR 63
Query: 362 NEARLLSQIRHRNIVKLYG-FCLHEKCM-----FLIYEYMEMGSLFCILR----TDEEAV 411
E RLL + H N++ L F +L+ M L I++ +D+
Sbjct: 64 -ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMG-ADLNNIVKCQKLSDDHIQ 121
Query: 412 GLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471
L V + L Y+H + I+HRD+ +NI +N + E + DFG+AR +
Sbjct: 122 FL--------VYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD- 169
Query: 472 DSSNRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGK 516
T T APE+ M + D++S G + E+L GK
Sbjct: 170 --DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 54/217 (24%), Positives = 102/217 (47%), Gaps = 29/217 (13%)
Query: 315 EDFDIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHR 373
+ IG G YG V A P+G VA+KK+ E + + + E ++L + +H
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR-EIKILRRFKHE 63
Query: 374 NIVKLY------GFC-LHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMA 426
NI+ + F ++ ++++ E ME L+ +++T L + +
Sbjct: 64 NIIGILDIIRPPSFESFND--VYIVQELMET-DLYKLIKTQH----LSNDHIQYFLYQIL 116
Query: 427 HALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLA---GTY 483
L Y+H + +LHRD+ +N+LLN+ + + DFG+AR+ + + + L T
Sbjct: 117 RGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 484 GSIAPELAYTMVVTEKY----DVYSFGVVALEVLMGK 516
APE+ M+ ++ Y D++S G + E+L +
Sbjct: 174 WYRAPEI---MLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 58/204 (28%), Positives = 93/204 (45%), Gaps = 17/204 (8%)
Query: 323 IGTGGYGSVYRARLPSGKV---VALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLY 379
+G G +GSV +L VA+K + + +E F +EA + + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 380 GFCLH--EKCMF----LIYEYMEMGSLFCIL---RTDEEAVGLDWTKRVNIVKGMAHALS 430
G CL E + +I +M+ G L L R + L V + +A +
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 431 YLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIA-RLLNYDSSNRTLLAGT-YGSIAP 488
YL + +HRD+++ N +LN VADFG++ ++ N D + +A IA
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 489 ELAYTMVVTEKYDVYSFGVVALEV 512
E V T K DV+SFGV E+
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 74/265 (27%), Positives = 117/265 (44%), Gaps = 46/265 (17%)
Query: 303 GRITFQDMIEATEDFDIKYC--IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLES 359
G +T + D++ IG+G G VY+ R +G V+A+K++ R +
Sbjct: 1 GYLTIDGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK------ 54
Query: 360 FQNEARLLSQIR-----HR--NIVKLYGFCLHEKCMFLIYEYME-MGSLFCILRT----- 406
+ R+L + H IVK YG+ + + +F+ ME M + L
Sbjct: 55 -EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC---MELMSTCLDKLLKRIQGP 110
Query: 407 -DEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGI 465
E+ +G V IVK AL YL ++HRD+ +NILL++ + DFGI
Sbjct: 111 IPEDILG---KMTVAIVK----ALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGI 161
Query: 466 A-RLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKY----DVYSFGVVALEVLMGKHPGE 520
+ RL+ DS +T AG +APE KY DV+S G+ +E+ G+ P +
Sbjct: 162 SGRLV--DSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYK 219
Query: 521 LLSSSSSSLDKNIKLIDLLDPRLPP 545
+ L K++ P LPP
Sbjct: 220 NCKTEFEVLT---KILQEEPPSLPP 241
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 3e-12
Identities = 34/73 (46%), Positives = 43/73 (58%)
Query: 73 IGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNM 132
I L+ LQ ++LS N I G+IP +LG + L +DLS N G IP SLG LT L LN+
Sbjct: 438 ISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNL 497
Query: 133 YNNKLDGPIPPEL 145
N L G +P L
Sbjct: 498 NGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-12
Identities = 68/252 (26%), Positives = 110/252 (43%), Gaps = 41/252 (16%)
Query: 323 IGTGGYGSV--YR---ARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVK 377
+G G +G V Y A +G++VA+K L R E + ++ E +L + H NIVK
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKR-ECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 378 LYGFCLH--EKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHH 435
G C K + LI EY+ +GSL L + + I +GMA YLH
Sbjct: 71 YKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMA----YLH-- 124
Query: 436 CTPPILHRDISSNNILLNSEFEAFVADFGIARLL---------NYDSSNRTLLAGTYGSI 486
+ +HRD+++ N+LL+++ + DFG+A+ + D +
Sbjct: 125 -SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW------Y 177
Query: 487 APELAYTMVVTEKYDVYSFGVVALEVLMGKHPG--------ELLSSSSSSLDKNIKLIDL 538
A E + DV+SFGV E+L E++ + ++LI+L
Sbjct: 178 AVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTV-VRLIEL 236
Query: 539 LD--PRLPPPGD 548
L+ RLP P +
Sbjct: 237 LERGMRLPCPKN 248
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-12
Identities = 56/212 (26%), Positives = 92/212 (43%), Gaps = 19/212 (8%)
Query: 323 IGTGGYGSVYRARL--PSGKV--VALKKLHRLETELASLESFQNEARLLSQIRHRNIVKL 378
+G G +GSV +L G VA+K + + +E F +EA + H N++KL
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 379 YGFCLHEKCM------FLIYEYMEMGSLFCIL---RTDEEAVGLDWTKRVNIVKGMAHAL 429
G C + +I +M+ G L L R L + + +A +
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 430 SYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIAR-LLNYDSSNRTLLAGT-YGSIA 487
YL +HRD+++ N +L + VADFG+++ + + D + +A IA
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183
Query: 488 PELAYTMVVTEKYDVYSFGVVALEVL-MGKHP 518
E V T K DV++FGV E+ G+ P
Sbjct: 184 IESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 3e-12
Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 36/214 (16%)
Query: 323 IGTGGYGSVYRA--RLPSGKV-VALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLY 379
+G+G +G V + ++ ++ VA+K L + E E + + EA ++ Q+ + IV++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVL-KNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 380 GFCLHEKCMFLIYEYMEMGS-----LFCILRTDEEAVGLDWTKRVNIVKGMAHALS---- 430
G C E M + MEM S F + DE V N+V+ M H +S
Sbjct: 62 GVCEAEALMLV----MEMASGGPLNKFLSGKKDEITVS-------NVVELM-HQVSMGMK 109
Query: 431 YLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGS----- 485
YL +HRD+++ N+LL ++ A ++DFG+++ L D S A + G
Sbjct: 110 YLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK--ARSAGKWPLKW 164
Query: 486 IAPELAYTMVVTEKYDVYSFGVVALEVL-MGKHP 518
APE + + DV+S+G+ E G+ P
Sbjct: 165 YAPECINFRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 61/210 (29%), Positives = 94/210 (44%), Gaps = 31/210 (14%)
Query: 323 IGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGF 381
IG G +G V+ P GK VALKK+ + L S + E ++L +H N++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 382 -------CLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTK--RVNIVKGMAHALSYL 432
E ++++ E M+ I+ + + D K I++G L YL
Sbjct: 68 LQPPHIDPFEE--IYVVTELMQSDLHKIIVS--PQPLSSDHVKVFLYQILRG----LKYL 119
Query: 433 HHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS-NRTLLAGTYGSIAPELA 491
H + ILHRDI N+L+NS + DFG+AR+ D S + T T APE+
Sbjct: 120 H---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEIL 176
Query: 492 -----YTMVVTEKYDVYSFGVVALEVLMGK 516
YT V D++S G + E+L +
Sbjct: 177 MGSRHYTSAV----DIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 5e-12
Identities = 61/231 (26%), Positives = 103/231 (44%), Gaps = 6/231 (2%)
Query: 316 DFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLE-TELASLESFQNEARLLSQIRHR 373
+F I+ IG G + VYRA L G VALKK+ + + + E LL Q+ H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 374 NIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLH 433
N++K Y + + + ++ E + G L +++ ++ L K V K S L
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTV--WKYFVQLCSALE 120
Query: 434 HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYT 493
H + ++HRDI N+ + + + D G+ R + ++ L GT ++PE +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 494 MVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRLP 544
K D++S G + E+ + P + SL K I+ D P LP
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY--PPLP 229
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 5e-12
Identities = 63/220 (28%), Positives = 101/220 (45%), Gaps = 46/220 (20%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQ--IRHR-----N 374
+G G YG V + R +P+G ++A+K++ A++ S Q + RLL I R
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIR------ATVNS-QEQKRLLMDLDISMRSVDCPY 61
Query: 375 IVKLYGFCLHEKCMFLIYEYMEMGSLFCI--------LRTDEEAVGLDWTKRVNIVKGMA 426
V YG E +++ E M+ SL L E+ +G I +
Sbjct: 62 TVTFYGALFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILG-------KIAVSIV 113
Query: 427 HALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI 486
AL YLH + ++HRD+ +N+L+N + + DFGI+ L DS +T+ AG +
Sbjct: 114 KALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYL-VDSVAKTIDAGCKPYM 170
Query: 487 APEL--------AYTMVVTEKYDVYSFGVVALEVLMGKHP 518
APE Y + K DV+S G+ +E+ G+ P
Sbjct: 171 APERINPELNQKGYDV----KSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 6e-12
Identities = 71/236 (30%), Positives = 106/236 (44%), Gaps = 38/236 (16%)
Query: 316 DFDIKYCIGTGGYGSVYRARLPS----GKVVALKKLH--RLETELASLESFQNEARLLSQ 369
+F++ +GTG YG V+ R GK+ A+K L + + + E + E ++L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 370 IRHRN-IVKL-YGFCLHEKCMFLIYEYMEMGSLFCIL----RTDEEAVGLDWTKRVNIVK 423
+R +V L Y F K + LI +Y+ G LF L E V RV I +
Sbjct: 61 VRRCPFLVTLHYAFQTDTK-LHLILDYVNGGELFTHLYQREHFTESEV------RVYIAE 113
Query: 424 GMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTL-LAGT 482
+ AL +LH I++RDI NILL+SE + DFG+++ + R GT
Sbjct: 114 -IVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGT 169
Query: 483 YGSIAPEL------AYTMVVTEKYDVYSFGVVALEVLMGKHP----GELLSSSSSS 528
+APE+ + V D +S GV+ E+L G P GE S S S
Sbjct: 170 IEYMAPEVIRGGSGGHDKAV----DWWSLGVLTFELLTGASPFTVDGEQNSQSEIS 221
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 7e-12
Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 19/215 (8%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQIRH 372
+DF+I IG G +G V ++ +G+V A+K L++ E + A F+ E +L
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 373 RNIVKL-YGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSY 431
R I L Y F E ++L+ +Y G L +L E+ + D + + M A+
Sbjct: 61 RWITNLHYAF-QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY--LAEMVLAIDS 117
Query: 432 LH--HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLA-GTYGSIAP 488
+H + +HRDI +N+LL+ +ADFG L D + ++ +A GT I+P
Sbjct: 118 VHQLGY-----VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISP 172
Query: 489 ELAYTMVV-TEKY----DVYSFGVVALEVLMGKHP 518
E+ M +Y D +S GV E+L G+ P
Sbjct: 173 EILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 67/244 (27%), Positives = 116/244 (47%), Gaps = 24/244 (9%)
Query: 315 EDFDIKYCIGTGGYGSVYR-ARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHR 373
+DF+ +G G G V++ + PSG ++A K +H LE + A E ++L +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIH-LEIKPAIRNQIIRELQVLHECNSP 63
Query: 374 NIVKLYGFCLHEKCMFLIYEYMEMGSLFCIL----RTDEEAVGLDWTKRVNIVKGMAHAL 429
IV YG + + + E+M+ GSL +L R E+ +G + ++KG L
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG---KVSIAVIKG----L 116
Query: 430 SYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPE 489
+YL I+HRD+ +NIL+NS E + DFG++ L +N GT ++PE
Sbjct: 117 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMSPE 172
Query: 490 LAYTMVVTEKYDVYSFGVVALEVLMGKHP------GELLSSSSSSLDKNIKLIDLLDPRL 543
+ + D++S G+ +E+ +G++P EL ++ + + PR
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESE-TSPRP 231
Query: 544 PPPG 547
PPG
Sbjct: 232 RPPG 235
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 9e-12
Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 22/213 (10%)
Query: 317 FDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNI 375
+ I+ IG G YG V A +G+ VA+KK++ + ++ E +LL +RH +I
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61
Query: 376 VKLYGFCLHE-----KCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVN--IVKGMAHA 428
V++ L K +++++E ME L +++ ++ D T + + + A
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKAND-----DLTPEHHQFFLYQLLRA 115
Query: 429 LSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTL---LAGTYGS 485
L Y+H T + HRD+ NIL N++ + + DFG+AR+ D+ T
Sbjct: 116 LKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 172
Query: 486 IAPEL--AYTMVVTEKYDVYSFGVVALEVLMGK 516
APEL ++ T D++S G + EVL GK
Sbjct: 173 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 51/163 (31%), Positives = 76/163 (46%), Gaps = 33/163 (20%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQ----NEARLLSQIRHRNIVK 377
IG G +G V++AR + ++VALKK+ +E E E F E ++L ++H N+V
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKV-LMENEK---EGFPITALREIKILQLLKHENVVN 75
Query: 378 LYGFCLHEKCMF-----LIYEYMEMGSLFCILRTDEEAVGLDWTKRVN-----IVKGMAH 427
L C + + Y E FC + + GL K V I K M
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFE----FC----EHDLAGLLSNKNVKFTLSEIKKVMKM 127
Query: 428 ALS---YLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIAR 467
L+ Y+H ILHRD+ + NIL+ + +ADFG+AR
Sbjct: 128 LLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 1e-11
Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 19/218 (8%)
Query: 317 FDIKYCIGTGGYGSVYRARLP----SGKVVALKKLHRLETELASLESFQNEARLLSQIRH 372
F + +G G +GSV A+L S + VA+K L + +E F EA + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 373 RNIVKLYGFCLHEKCM------FLIYEYMEMGSLFCIL---RTDEEAVGLDWTKRVNIVK 423
N++KL G L + +I +M+ G L L R EE L V +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 424 GMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTY 483
+A + YL + +HRD+++ N +LN VADFG+++ + R A
Sbjct: 121 DIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 484 GS--IAPELAYTMVVTEKYDVYSFGVVALEVL-MGKHP 518
+A E V T DV++FGV E++ G+ P
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 67/217 (30%), Positives = 99/217 (45%), Gaps = 40/217 (18%)
Query: 323 IGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRN---IVKL 378
IG G +G+V + PSG ++A+K++ R + + + L +R + IVK
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQKRLLMD--LDVVMRSSDCPYIVKF 68
Query: 379 YGFCLHEK----CMFLIYEYMEMGSL-------FCILRT--DEEAVGLDWTKRVNIVKGM 425
YG E CM E M++ SL + +L++ EE +G V VK
Sbjct: 69 YGALFREGDCWICM----ELMDI-SLDKFYKYVYEVLKSVIPEEILG---KIAVATVK-- 118
Query: 426 AHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGS 485
AL+YL I+HRD+ +NILL+ + DFGI+ L DS +T AG
Sbjct: 119 --ALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL-VDSIAKTRDAGCRPY 173
Query: 486 IAPELAYTMVVTEKYD----VYSFGVVALEVLMGKHP 518
+APE + YD V+S G+ EV GK P
Sbjct: 174 MAPERIDPS-ARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 44/187 (23%), Positives = 74/187 (39%), Gaps = 39/187 (20%)
Query: 363 EARLLSQIRHRNIVKL-----YG--FCL---HEKCMFLIYEYMEMGSL-----FCILRTD 407
EA LL + H +++++ G C+ H Y L I +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEK-- 164
Query: 408 EEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIAR 467
I++G L YLH I+HRD+ + NI +N + + D G A+
Sbjct: 165 ------------QILEG----LRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQ 205
Query: 468 LLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSS 527
+ LAGT + APE+ K D++S G+V E+L +P + S
Sbjct: 206 -FPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML--AYPSTIFEDPPS 262
Query: 528 SLDKNIK 534
+ ++ +K
Sbjct: 263 TPEEYVK 269
|
Length = 357 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 65/238 (27%), Positives = 112/238 (47%), Gaps = 19/238 (7%)
Query: 317 FDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNI 375
F++ +G G YG V + R + ++VA+KK E E+ E ++L ++ NI
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62
Query: 376 VKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHH 435
V+L ++L++EY+E L + +E G+ K + + + A+ + H +
Sbjct: 63 VELKEAFRRRGKLYLVFEYVEKNMLELL---EEMPNGVPPEKVRSYIYQLIKAIHWCHKN 119
Query: 436 CTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS-SNRTLLAGTYGSIAPELAYTM 494
I+HRDI N+L++ + DFG AR L+ S +N T T +PEL
Sbjct: 120 ---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA 176
Query: 495 VVTEKYDVYSFGVVALEVLMGK--HPGELLSSSSSSLDKNIKLIDLLDPRLPPPGDQM 550
+ D++S G + E+ G+ PGE S +D+ + +L P LP +QM
Sbjct: 177 PYGKAVDMWSVGCILGELSDGQPLFPGE------SEIDQLFTIQKVLGP-LPA--EQM 225
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 48/148 (32%), Positives = 79/148 (53%), Gaps = 12/148 (8%)
Query: 323 IGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGF 381
+G G Y +VY+ R +G++VALK++ RLE E + + EA LL ++H NIV L+
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEI-RLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 382 CLHEKCMFLIYEYMEMGSLFCILRT--DEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPP 439
+K + L++EY++ L+ D+ GL + + L+Y H
Sbjct: 72 IHTKKTLTLVFEYLDTD-----LKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---R 123
Query: 440 ILHRDISSNNILLNSEFEAFVADFGIAR 467
+LHRD+ N+L++ E +ADFG+AR
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 29/225 (12%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGKV---VALKKLHRLETELASLESFQNEARLLSQI- 370
ED + IG G +G V RA + + A+K L +E F E +L ++
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASE-NDHRDFAGELEVLCKLG 60
Query: 371 RHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILR------TD-----EEAVGLDWTKRV 419
H NI+ L G C + +++ EY G+L LR TD E T +
Sbjct: 61 HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ- 119
Query: 420 NIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLL 479
+++ + + + + +HRD+++ N+L+ + +ADFG++R +
Sbjct: 120 QLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR------GEEVYV 173
Query: 480 AGTYGSI-----APELAYTMVVTEKYDVYSFGVVALEVL-MGKHP 518
T G + A E V T K DV+SFGV+ E++ +G P
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 63/226 (27%), Positives = 101/226 (44%), Gaps = 26/226 (11%)
Query: 323 IGTGGYGSVYRARLP-----SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVK 377
+G G +G V R +G+ VA+K L + E+ + + E +L + H NIVK
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 378 LYGFCLHE--KCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKR--VNIVKGMAHALSYLH 433
G C + + LI E++ GSL L ++ + L + V I KGM + S +
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQY 130
Query: 434 HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTL---LAGTYGSIAPEL 490
+HRD+++ N+L+ SE + + DFG+ + + D T+ L APE
Sbjct: 131 -------VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC 183
Query: 491 AYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLI 536
DV+SFGV E+L S SS + +K+I
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT------YCDSESSPMTLFLKMI 223
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 61/226 (26%), Positives = 103/226 (45%), Gaps = 39/226 (17%)
Query: 323 IGTGGYGSVYRA--------RLPSGKVVALKKLHRLETELASLESFQNEARLLSQI-RHR 373
+G G +G V A + VA+K L T+ L +E ++ I +H+
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD-KDLSDLVSEMEMMKMIGKHK 78
Query: 374 NIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWT--------------KRV 419
NI+ L G C + ++++ EY G+L LR G+D++ V
Sbjct: 79 NIINLLGACTQDGPLYVLVEYASKGNLREYLRA-RRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 420 NIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIAR-LLNYDSSNRTL 478
+ +A + YL + +HRD+++ N+L+ + +ADFG+AR + N D +T
Sbjct: 138 SCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT- 193
Query: 479 LAGTYGSI-----APELAYTMVVTEKYDVYSFGVVALEVL-MGKHP 518
T G + APE + V T + DV+SFGV+ E+ +G P
Sbjct: 194 ---TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (158), Expect = 2e-11
Identities = 44/153 (28%), Positives = 74/153 (48%), Gaps = 21/153 (13%)
Query: 372 HRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSY 431
+ N +KLY K LI +Y++ G LF +L+ + + L + I++ + AL+
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK---LSEAEVKKIIRQLVEALND 124
Query: 432 LHHHCTPPILHRDISSNNILLN-SEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPEL 490
LH H I+H DI N+L + ++ ++ D+G+ +++ S GT +PE
Sbjct: 125 LHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS----CYDGTLDYFSPE- 176
Query: 491 AYTMVVTEKYDVYSF-----GVVALEVLMGKHP 518
+ YD SF GV+ E+L GKHP
Sbjct: 177 ---KIKGHNYD-VSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 40/201 (19%)
Query: 341 VVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSL 400
+VA+K L R + + F E ++LS+++ NI++L G C+ E + +I EYME G L
Sbjct: 48 LVAVKIL-RPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL 106
Query: 401 FCILRT----DEEAVGLD------------WTKRVNIVKGMAHALSYLHHHCTPPILHRD 444
L + D+E G D ++ +++ +A + YL + +HRD
Sbjct: 107 NQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRD 163
Query: 445 ISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPE-------LAYTMVVT 497
+++ N L+ +ADFG++ R L AG Y I +A+ ++
Sbjct: 164 LATRNCLVGENLTIKIADFGMS---------RNLYAGDYYRIQGRAVLPIRWMAWECILM 214
Query: 498 EKY----DVYSFGVVALEVLM 514
K+ DV++FGV E+LM
Sbjct: 215 GKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 22/206 (10%)
Query: 323 IGTGGYGSVYRAR----LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKL 378
+G G +G V+ R +G++ A+K L + ++ + E +L+++ H IVKL
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 379 -YGFCLHEKCMFLIYEYMEMGSLFCILRTD----EEAVGLDWTKRVNIVKGMAHALSYLH 433
Y F K ++LI +++ G LF L + EE V + +A AL +LH
Sbjct: 64 HYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKF-------YLAELALALDHLH 115
Query: 434 HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTL-LAGTYGSIAPELAY 492
+ I++RD+ NILL+ E + DFG+++ + D + GT +APE+
Sbjct: 116 ---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPEVVN 171
Query: 493 TMVVTEKYDVYSFGVVALEVLMGKHP 518
T+ D +SFGV+ E+L G P
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 21/203 (10%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQN----EARLLSQIRHRNIVK 377
I G +GSVY A+ +G A+K L + +++ + N A ++ Q + K
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKK--SDMIAKNQVTNVKAERAIMMIQGESPYVAK 61
Query: 378 LYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCT 437
LY + ++L+ EY+ G +++T + DW K + + + LH
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCASLIKT-LGGLPEDWAK--QYIAEVVLGVEDLHQR-- 116
Query: 438 PPILHRDISSNNILLNSEFEAFVADFGIAR--LLNYDSSNRTLLAGTYGSIAPELAYTMV 495
I+HRDI N+L++ + DFG++R L N GT +APE +
Sbjct: 117 -GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK------FVGTPDYLAPETILGVG 169
Query: 496 VTEKYDVYSFGVVALEVLMGKHP 518
+ D +S G V E L G P
Sbjct: 170 DDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 3e-11
Identities = 63/229 (27%), Positives = 101/229 (44%), Gaps = 29/229 (12%)
Query: 317 FDIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRLETELASLES-FQNEARLLSQIRHRN 374
+DI IG GG G VY A P + VALKK+ +E L+ F EA++ + + H
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63
Query: 375 IVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHH 434
IV +Y C ++ Y+E +L +L++ + L +K + + LS H
Sbjct: 64 IVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESL--SKELAEKTSVGAFLSIFHK 121
Query: 435 HC-------TPPILHRDISSNNILLNSEFEAFVADFGIA---------------RLLNYD 472
C + +LHRD+ +NILL E + D+G A N
Sbjct: 122 ICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 473 SSNRTL---LAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHP 518
S+ T+ + GT +APE + +E D+Y+ GV+ ++L P
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 71/256 (27%), Positives = 109/256 (42%), Gaps = 30/256 (11%)
Query: 305 ITFQDMIEATEDFDIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRLETELASLESFQNE 363
I F + ++ ++I IG G YG V++ +G A+K L + +E+ N
Sbjct: 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNI 67
Query: 364 ARLLSQIRHRNIVKLYGFCLHEKC-----MFLIYEYMEMGSLFCILRTDEEAVGLDWTKR 418
+ LS H N+VK YG + ++L+ E GS+ TD L +R
Sbjct: 68 LKALSD--HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSV-----TDLVKGFLKRGER 120
Query: 419 VN--IVKGMAH-ALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSN 475
+ I+ + H AL L H +HRD+ NNILL +E + DFG++ L
Sbjct: 121 MEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR 180
Query: 476 RTLLAGTYGSIAPEL-----AYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLD 530
R GT +APE+ + DV+S G+ A+E+ G P + L
Sbjct: 181 RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPP-------LADLH 233
Query: 531 KNIKLIDLLDPRLPPP 546
L + PR PPP
Sbjct: 234 PMRALFKI--PRNPPP 247
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 71/245 (28%), Positives = 110/245 (44%), Gaps = 28/245 (11%)
Query: 316 DFDIKYCIGTGGYGSVYRARLPSG----KVVALKKLHR--LETELASLESFQNEARLLSQ 369
+F++ +GTG YG V+ R +G K+ A+K L + L + ++E + E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 370 IRHRN-IVKL-YGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKG-MA 426
+R +V L Y F K + LI +Y+ G +F L + V G +
Sbjct: 61 VRQSPFLVTLHYAFQTEAK-LHLILDYVSGGEMFTHLYQRDNFS----EDEVRFYSGEII 115
Query: 427 HALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTL-LAGTYGS 485
AL +LH I++RDI NILL+SE + DFG+++ + RT GT
Sbjct: 116 LALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEY 172
Query: 486 IAPELAYTMVVTEK-YDVYSFGVVALEVLMGKHP----GELLSSSSSSLDKNIKLIDLLD 540
+APE+ K D +S G++ E+L G P GE + S S + I D
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS-----RRILKCD 227
Query: 541 PRLPP 545
P P
Sbjct: 228 PPFPS 232
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 64/214 (29%), Positives = 97/214 (45%), Gaps = 16/214 (7%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEAR-LLSQIRH 372
+DFD+K +G G +G V R +G + A+K + + SF E R +LS
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 373 RNIVKL-YGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSY 431
I +L Y F + ++L+ EY G L +L E+ D + +A +
Sbjct: 61 PWIPQLQYAF-QDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFY-----LAELVLA 114
Query: 432 LHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS-NRTLLAGTYGSIAPEL 490
+H +HRDI N+L++ +ADFG A L + N L GT IAPE+
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEV 174
Query: 491 AYTMVVTEK--YDV----YSFGVVALEVLMGKHP 518
TM K Y V +S GV+A E++ G+ P
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 57/202 (28%), Positives = 101/202 (50%), Gaps = 23/202 (11%)
Query: 323 IGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGF 381
+G G Y +VY+ + +GK+VALK + RL+ E + + EA LL ++H NIV L+
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVI-RLQEEEGTPFTAIREASLLKGLKHANIVLLHDI 71
Query: 382 CLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPIL 441
++ + L++EY+ C D+ GL + + LSY+H IL
Sbjct: 72 IHTKETLTLVFEYVHTD--LC-QYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---IL 125
Query: 442 HRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAY----TMVVT 497
HRD+ N+L++ E +ADFG+AR +++ + TY + L Y ++ +
Sbjct: 126 HRDLKPQNLLISDTGELKLADFGLARA-------KSVPSHTYSNEVVTLWYRPPDVLLGS 178
Query: 498 EKY----DVYSFGVVALEVLMG 515
+Y D++ G + +E++ G
Sbjct: 179 TEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 18/209 (8%)
Query: 319 IKYCIGTGGYGSVYRA--RLPSGK--VVALKKLHRLETELASLESFQNEARLLSQIRHRN 374
I+ +GTG +G + R +LPS + VA+ L R F EA L Q H N
Sbjct: 9 IERILGTGRFGELCRGCLKLPSKRELPVAIHTL-RAGCSDKQRRGFLAEALTLGQFDHSN 67
Query: 375 IVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHH 434
IV+L G M ++ EYM G+L LR E L + + ++ G+A + YL
Sbjct: 68 IVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ--LVAGQLMGMLPGLASGMKYLSE 125
Query: 435 HCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNR--TLLAGTYGSI--APEL 490
+H+ ++++ +L+NS+ ++ F R L D S T ++G + APE
Sbjct: 126 M---GYVHKGLAAHKVLVNSDLVCKISGF---RRLQEDKSEAIYTTMSGKSPVLWAAPEA 179
Query: 491 AYTMVVTEKYDVYSFGVVALEVL-MGKHP 518
+ DV+SFG+V EV+ G+ P
Sbjct: 180 IQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 64/216 (29%), Positives = 101/216 (46%), Gaps = 21/216 (9%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSG-KVVALKKLHRLET-ELASLESFQNEARLLSQIRH 372
EDF+I IG G +G V +L + KV A+K L++ E + A F+ E +L +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTK----RVNIVKGMAHA 428
+ I L+ E ++L+ +Y G L +L E+ + D + + I H
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 429 LSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLA-GTYGSIA 487
L Y+H RDI +NIL++ +ADFG L D + ++ +A GT I+
Sbjct: 121 LHYVH---------RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 171
Query: 488 PELAYTMVVTE-KY----DVYSFGVVALEVLMGKHP 518
PE+ M + KY D +S GV E+L G+ P
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 13/212 (6%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSG-KVVALKKLHRLET-ELASLESFQNEARLLSQIRH 372
+DF+I IG G +G V ++ ++ A+K L++ E + A F+ E +L
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYL 432
+ I L+ E ++L+ +Y G L +L E+ + D + + M A+ +
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY--IAEMVLAIHSI 118
Query: 433 HHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLA-GTYGSIAPELA 491
H +HRDI +N+LL+ +ADFG +N D + ++ +A GT I+PE+
Sbjct: 119 HQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEIL 175
Query: 492 YTMV-VTEKY----DVYSFGVVALEVLMGKHP 518
M KY D +S GV E+L G+ P
Sbjct: 176 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 55/198 (27%), Positives = 94/198 (47%), Gaps = 29/198 (14%)
Query: 342 VALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKCMFLIYEYMEMGSL 400
VA+K L TE L +E ++ I +H+NI+ L G C + +++I EY G+L
Sbjct: 53 VAVKMLKSDATE-KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 111
Query: 401 -------------FCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISS 447
+C T L + V+ +A + YL + +HRD+++
Sbjct: 112 REYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 168
Query: 448 NNILLNSEFEAFVADFGIARLLNY-DSSNRTLLAGTYGSI-----APELAYTMVVTEKYD 501
N+L+ + +ADFG+AR +++ D +T T G + APE + + T + D
Sbjct: 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKT----TNGRLPVKWMAPEALFDRIYTHQSD 224
Query: 502 VYSFGVVALEVL-MGKHP 518
V+SFGV+ E+ +G P
Sbjct: 225 VWSFGVLLWEIFTLGGSP 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 51/195 (26%), Positives = 95/195 (48%), Gaps = 15/195 (7%)
Query: 341 VVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSL 400
+VA+K L R + + F E +++S++++ NI++L G C+ + + +I EYME G L
Sbjct: 46 LVAVKML-RADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL 104
Query: 401 FCILRTDE------EAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNS 454
L E A + N++ S + + + +HRD+++ N L+ +
Sbjct: 105 NQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN 164
Query: 455 EFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKY----DVYSFGVVAL 510
+ +ADFG++R N S + + G +A+ ++ K+ DV++FGV
Sbjct: 165 HYTIKIADFGMSR--NLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLW 222
Query: 511 EV--LMGKHPGELLS 523
E+ L + P LLS
Sbjct: 223 EMFTLCKEQPYSLLS 237
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 9e-11
Identities = 65/215 (30%), Positives = 101/215 (46%), Gaps = 20/215 (9%)
Query: 316 DFDIKYCIGTGGYGSVYRARLPSG----KVVALKKLHR--LETELASLESFQNEARLLSQ 369
+F++ +GTG YG V+ R SG K+ A+K L + + + + E + E ++L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 370 IRHRN-IVKL-YGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKG-MA 426
IR +V L Y F K + LI +Y+ G LF L E + V I G +
Sbjct: 61 IRQSPFLVTLHYAFQTDTK-LHLILDYINGGELFTHLSQRERFK----EQEVQIYSGEIV 115
Query: 427 HALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTL-LAGTYGS 485
AL +LH I++RDI NILL+S + DFG+++ + D R GT
Sbjct: 116 LALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEY 172
Query: 486 IAPELAYTMVV--TEKYDVYSFGVVALEVLMGKHP 518
+AP++ + D +S GV+ E+L G P
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 9e-11
Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 25/209 (11%)
Query: 323 IGTGGYGSVYRARLPSGK----VVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVK 377
+G G +G V A L V LKK L+ + +E E R+L+ +H + +
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDD--DVECTMTEKRVLALAGKHPFLTQ 60
Query: 378 LYGFCLHEKC-MFLIYEYMEMGSL-FCILRTD--EEAVGLDWTKRVNIVKGMAHALSYLH 433
L+ C K +F + EY+ G L F I R+ +E + + + L +LH
Sbjct: 61 LHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVL------GLQFLH 113
Query: 434 HHCTPPILHRDISSNNILLNSEFEAFVADFGIAR--LLNYDSSNRTLLAGTYGSIAPELA 491
I++RD+ +N+LL+SE +ADFG+ + +L +++ GT IAPE+
Sbjct: 114 ER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST--FCGTPDYIAPEIL 168
Query: 492 YTMVVTEKYDVYSFGVVALEVLMGKHPGE 520
D ++ GV+ E+L G+ P E
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 29/76 (38%), Positives = 49/76 (64%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAI 60
+ +LR+L ++LS N G+IPP+LG ++ L++L+LS NS G+IP ++G LT L L +
Sbjct: 438 ISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNL 497
Query: 61 ASNRMNGSILLGIGSL 76
N ++G + +G
Sbjct: 498 NGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 29/212 (13%)
Query: 323 IGTGGYGSVYRA-RLPSGKVVALKKL------HRLETELASLESFQNEARLLSQIRHRNI 375
+G G +G VY +G+ +A+K++ E+ +LE E +LL +RH I
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALEC---EIQLLKNLRHDRI 66
Query: 376 VKLYGFCLH---EKCMFLIYEYMEMGSLFCILRTD---EEAVGLDWTKRVNIVKGMAHAL 429
V+ YG CL EK + + EYM GS+ L+ E V +T++ I++G +
Sbjct: 67 VQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQ--ILQG----V 119
Query: 430 SYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGS---I 486
SYLH + I+HRDI NIL +S + DFG ++ + + T + G+ +
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWM 176
Query: 487 APELAYTMVVTEKYDVYSFGVVALEVLMGKHP 518
+PE+ K DV+S +E+L K P
Sbjct: 177 SPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 50/205 (24%), Positives = 92/205 (44%), Gaps = 4/205 (1%)
Query: 316 DFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHR 373
+F I+ IG G + VYRA L K VALKK+ E + + + E LL Q+ H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 374 NIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLH 433
N++K + + + ++ E + G L +++ ++ L + K S +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRL--IPERTVWKYFVQLCSAVE 120
Query: 434 HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYT 493
H + ++HRDI N+ + + + D G+ R + ++ L GT ++PE +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 494 MVVTEKYDVYSFGVVALEVLMGKHP 518
K D++S G + E+ + P
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 47/152 (30%), Positives = 77/152 (50%), Gaps = 20/152 (13%)
Query: 323 IGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGF 381
+G G Y +V++ R + +VALK++ RLE E + + E LL ++H NIV L+
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEI-RLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 382 CLHEKCMFLIYEYME------MGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHH 435
+K + L++EY++ M I+ + L I++G+A Y H
Sbjct: 73 VHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFL-----YQILRGLA----YCHRR 123
Query: 436 CTPPILHRDISSNNILLNSEFEAFVADFGIAR 467
+LHRD+ N+L+N E +ADFG+AR
Sbjct: 124 ---KVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 61/231 (26%), Positives = 97/231 (41%), Gaps = 21/231 (9%)
Query: 323 IGTGGYGSVY---------RARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHR 373
+G G +G+VY RL K + + +L+ ET A+ E A+LLS++ H
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQE-----AQLLSKLDHP 62
Query: 374 NIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLH 433
IVK + L +I EY E L C L + + + L +H
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKT--LSENQVCEWFIQLLLGVH 120
Query: 434 HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYT 493
+ ILHRD+ + NI L + + DFG++RLL T GT ++PE
Sbjct: 121 YMHQRRILHRDLKAKNIFLKNNLLK-IGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH 179
Query: 494 MVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRLP 544
K D++S G + E+ H E + L +++++ P LP
Sbjct: 180 QGYDSKSDIWSLGCILYEMCCLAHAFE----GQNFLSVVLRIVEGPTPSLP 226
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 33/219 (15%)
Query: 323 IGTGGYGSVYRARLPSGKV---VALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKL 378
IG G +G V +AR+ + A+K++ ++ F E +L ++ H NI+ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCKLGHHPNIINL 61
Query: 379 YGFCLHEKCMFLIYEYMEMGSLFCILR------TDE-------EAVGLDWTKRVNIVKGM 425
G C H ++L EY G+L LR TD A L + ++ +
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 426 AHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGS 485
A + YL +HRD+++ NIL+ + A +ADFG++R + T G
Sbjct: 122 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR------GQEVYVKKTMGR 172
Query: 486 I-----APELAYTMVVTEKYDVYSFGVVALEVL-MGKHP 518
+ A E V T DV+S+GV+ E++ +G P
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 49/152 (32%), Positives = 77/152 (50%), Gaps = 20/152 (13%)
Query: 323 IGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGF 381
+G G Y +VY+ R + +VALK++ RLE E + + E LL ++H NIV L+
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEI-RLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 382 CLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNI--VK----GMAHALSYLHHH 435
EK + L++EY++ D + D +N+ VK + L+Y H
Sbjct: 73 IHTEKSLTLVFEYLD---------KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR 123
Query: 436 CTPPILHRDISSNNILLNSEFEAFVADFGIAR 467
+LHRD+ N+L+N E +ADFG+AR
Sbjct: 124 ---KVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 33/216 (15%)
Query: 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLH-RLETELASLESFQNEARLLSQIRHR 373
DF I +G GGYG V+ A+ +G++VALK++ L +L + E +L+ +
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61
Query: 374 NIVKL-YGFCLHEKCMFLIYEYMEMG---SLFCILRT--DEEAVGLDWTKRVNIVKGMAH 427
+VKL Y F E ++L EY+ G +L L ++ A R + + M
Sbjct: 62 WLVKLLYAFQDDEY-LYLAMEYVPGGDFRTLLNNLGVLSEDHA-------RFYMAE-MFE 112
Query: 428 ALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIAR-LLNYDSSNRTLLAGTYGSI 486
A+ LH +HRD+ N L+++ + DFG+++ ++ Y +S + G+ +
Sbjct: 113 AVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS----VVGSPDYM 165
Query: 487 APELAYTMVVTEKY----DVYSFGVVALEVLMGKHP 518
APE ++ + Y D +S G + E L G P
Sbjct: 166 APE----VLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 26/217 (11%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHR 373
EDFD+ IG G +G V R S +V A+K L + E S +F E R + + H
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDI--MAHA 100
Query: 374 N---IVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTK--RVNIVKGMA-- 426
N IV+L+ +K ++++ EYM G L ++ + + W + +V +
Sbjct: 101 NSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD--IPEKWARFYTAEVVLALDAI 158
Query: 427 HALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLA-GTYGS 485
H++ ++H RD+ +N+LL+ +ADFG ++ + R A GT
Sbjct: 159 HSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDY 209
Query: 486 IAPELAYTMVVTEKY----DVYSFGVVALEVLMGKHP 518
I+PE+ + Y D +S GV E+L+G P
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 58/200 (29%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQN--EARLLSQIRHRNIVKL- 378
+G G +G V R SGK A+K L + E +A E E+R+L RH + L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKK-EVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 379 YGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTP 438
Y F ++ F++ EY+ G LF L + E D T+ + AL YLH +
Sbjct: 62 YSFQTKDRLCFVM-EYVNGGELFFHL-SRERVFSEDRTRFYG--AEIVSALDYLH---SG 114
Query: 439 PILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTE 498
I++RD+ N++L+ + + DFG+ + D++ GT +APE+
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 499 KYDVYSFGVVALEVLMGKHP 518
D + GVV E++ G+ P
Sbjct: 175 AVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 29/212 (13%)
Query: 323 IGTGGYGSVYRA-RLPSGKVVALKKLH------RLETELASLESFQNEARLLSQIRHRNI 375
+G G +G VY +G+ +A+K++ E+ +LE E +LL + H I
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALEC---EIQLLKNLLHERI 66
Query: 376 VKLYGFCLH---EKCMFLIYEYMEMGSLFCILRTD---EEAVGLDWTKRVNIVKGMAHAL 429
V+ YG CL E+ + + E+M GS+ L++ E V +T++ I++G +
Sbjct: 67 VQYYG-CLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQ--ILEG----V 119
Query: 430 SYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGS---I 486
SYLH + I+HRDI NIL +S + DFG ++ L + T + G+ +
Sbjct: 120 SYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWM 176
Query: 487 APELAYTMVVTEKYDVYSFGVVALEVLMGKHP 518
+PE+ K D++S G +E+L K P
Sbjct: 177 SPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 52/199 (26%), Positives = 93/199 (46%), Gaps = 9/199 (4%)
Query: 323 IGTGGYGSVYRARLP-SGKVVALKKLHRLETELAS-LESFQNEARLLS-QIRHRNIVKLY 379
+G G +G V+ A L + + A+K L + + +E E R+LS H + LY
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 380 GFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPP 439
++ +F + EY+ G L +++ + D + + L +LH +
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQSCHK---FDLPRATFYAAEIICGLQFLH---SKG 116
Query: 440 ILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEK 499
I++RD+ +NILL+++ +ADFG+ + + GT IAPE+
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTS 176
Query: 500 YDVYSFGVVALEVLMGKHP 518
D +SFGV+ E+L+G+ P
Sbjct: 177 VDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 37/210 (17%)
Query: 323 IGTGGYGSVYR--ARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYG 380
+G G Y +VY+ +R+ +G++VALK + ++TE + EA LL ++H NIV L+
Sbjct: 13 LGEGSYATVYKGISRI-NGQLVALKVIS-MKTEEGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 381 FCLHEKCMFLIYEYMEMGSLFCILRTD------EEAVGLDWTKRVNIVKGMAHALSYLHH 434
++ + ++EYM TD + GL + + L+Y+H
Sbjct: 71 IIHTKETLTFVFEYMH---------TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG 121
Query: 435 HCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYT- 493
ILHRD+ N+L++ E +ADFG+AR +++ + TY S L Y
Sbjct: 122 Q---HILHRDLKPQNLLISYLGELKLADFGLAR-------AKSIPSQTYSSEVVTLWYRP 171
Query: 494 ----MVVTE---KYDVYSFGVVALEVLMGK 516
+ T+ D++ G + +E+L G+
Sbjct: 172 PDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 36/141 (25%), Positives = 70/141 (49%), Gaps = 15/141 (10%)
Query: 323 IGTGGYGSVYRARLPSGKVVALKKLHRLETELASL--------ESFQNEARLLSQIRHRN 374
+G G + +++ +V +LH+ E L L ESF A ++SQ+ H++
Sbjct: 3 LGQGTFTKIFKGI--RREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60
Query: 375 IVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHH 434
+V YG C+ ++ EY++ GSL L+ ++ + + W ++ + K +A AL +L
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLED 118
Query: 435 HCTPPILHRDISSNNILLNSE 455
+ H ++ + N+LL E
Sbjct: 119 K---GLTHGNVCAKNVLLIRE 136
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 4e-10
Identities = 48/187 (25%), Positives = 87/187 (46%), Gaps = 22/187 (11%)
Query: 341 VVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSL 400
+VA+K L R + + F E +++S+++ NI++L C+ + +I EYME G L
Sbjct: 48 LVAVKML-REDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL 106
Query: 401 FCILR--------TDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILL 452
L + V + ++ + + +A + YL + +HRD+++ N L+
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLV 163
Query: 453 NSEFEAFVADFGIARLL----NYDSSNRTLLAGTYGSIAPEL--AYTMVVTEKYDVYSFG 506
+ +ADFG++R L Y R +L + S L +T DV++FG
Sbjct: 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTAS----DVWAFG 219
Query: 507 VVALEVL 513
V E+L
Sbjct: 220 VTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 18/220 (8%)
Query: 308 QDMIEATEDFDIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRLETELASLESFQNEAR- 365
+D+ ED+++ IG G +G V R S KV A+K L + E S +F E R
Sbjct: 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 366 LLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDE--EAVGLDWTKRVNIVK 423
+++ +V+L+ ++ ++++ EYM G L ++ + E +T V +
Sbjct: 96 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLAL 155
Query: 424 GMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLA-GT 482
H++ ++H RD+ +N+LL+ +ADFG +N + R A GT
Sbjct: 156 DAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGT 206
Query: 483 YGSIAPELAYTMVVTEKY----DVYSFGVVALEVLMGKHP 518
I+PE+ + Y D +S GV E+L+G P
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 14/211 (6%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEAR-LLSQIRH 372
ED+D+ IG G +G V R S KV A+K L + E S +F E R +++
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYL 432
+V+L+ +K ++++ EYM G L ++ + V W K + AL +
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD--VPEKWAKFYT--AEVVLALDAI 158
Query: 433 HHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLA-GTYGSIAPELA 491
H + ++HRD+ +N+LL+ +ADFG ++ R A GT I+PE+
Sbjct: 159 H---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVL 215
Query: 492 YTMVVTEKY----DVYSFGVVALEVLMGKHP 518
+ Y D +S GV E+L+G P
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 6e-10
Identities = 55/218 (25%), Positives = 101/218 (46%), Gaps = 16/218 (7%)
Query: 323 IGTGGYGSVYRARLP-SGKVVALKKLHR-LETELASLESFQNEARLLSQI-RHRNIVKLY 379
IG G Y V RL + ++ A+K + + L + ++ Q E + Q H +V L+
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 380 GFCLHEKCMFLIYEYMEMGSLFCIL---RTDEEAVGLDWTKRVNIVKGMAHALSYLHHHC 436
E +F + EY+ G L + R E ++ +++ AL+YLH
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL------ALNYLHER- 115
Query: 437 TPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVV 496
I++RD+ +N+LL+SE + D+G+ + + GT IAPE+
Sbjct: 116 --GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 497 TEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIK 534
D ++ GV+ E++ G+ P +++ SS + D+N +
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP-DQNTE 210
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 8e-10
Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 323 IGTGGYGSVYRARLPSGKV-------VALKKLHRLETELASLESFQNEARLLSQIRHRNI 375
+G G +G VY + G V VA+K ++ + +E F NEA ++ + ++
Sbjct: 14 LGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFNCHHV 71
Query: 376 VKLYGFCLHEKCMFLIYEYMEMGSLFCILRT---DEEAVGL----DWTKRVNIVKGMAHA 428
V+L G + +I E M G L LR+ + E + K + + +A
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 429 LSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL----NYDSSNRTLLAGTYG 484
++YL+ + +HRD+++ N ++ +F + DFG+ R + Y + LL +
Sbjct: 132 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW- 187
Query: 485 SIAPELAYTMVVTEKYDVYSFGVVALEV 512
++PE V T DV+SFGVV E+
Sbjct: 188 -MSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 9e-10
Identities = 66/243 (27%), Positives = 119/243 (48%), Gaps = 25/243 (10%)
Query: 323 IGTGGYGSVYRARL----PSGKVVALKKLH-----RLETELASLESFQNEARLLSQIRHR 373
+G GGYG V++ R +GK+ A+K L R + + A ++ +N +L ++H
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERN---ILEAVKHP 60
Query: 374 NIVKL-YGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYL 432
IV L Y F K ++LI EY+ G LF L + E + ++ T + + ++ AL +L
Sbjct: 61 FIVDLIYAFQTGGK-LYLILEYLSGGELFMHL--EREGIFMEDTACFYLSE-ISLALEHL 116
Query: 433 HHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAY 492
H I++RD+ NILL+++ + DFG+ + ++ + GT +APE+
Sbjct: 117 HQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILM 173
Query: 493 TMVVTEKYDVYSFGVVALEVLMGKHP--GELLSSSSSSLDKNIKLIDLLDPRLPPPGDQM 550
+ D +S G + ++L G P E + ++DK +K L P L P +
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLTGAPPFTAE---NRKKTIDKILKGKLNLPPYLTPEARDL 230
Query: 551 IRQ 553
+++
Sbjct: 231 LKK 233
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 323 IGTGGYGSVYRARLP-SGKVVALKKLHR---LETELASLESFQNEARLLSQIR-HRNIVK 377
+G G +G V ARL SG++ A+K L + L+ + +E E R+LS R H + +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDD--DVECTMTEKRILSLARNHPFLTQ 60
Query: 378 LYGFCLHE-KCMFLIYEYMEMGSL-FCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHH 435
LY C +F + E++ G L F I ++ D + + AL +LH
Sbjct: 61 LY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRR----FDEARARFYAAEITSALMFLH-- 113
Query: 436 CTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMV 495
I++RD+ +N+LL+ E +ADFG+ + ++ + GT IAPE+ M+
Sbjct: 114 -DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEML 172
Query: 496 VTEKYDVYSFGVVALEVLMGKHPGE 520
D ++ GV+ E+L G P E
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 19/204 (9%)
Query: 323 IGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQ-NEARLLSQIRHRNIVKL-Y 379
+G GG+G V ++ +GK+ A KKL + + E NE ++L ++ R IV L Y
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 380 GFCLHEKCMFLIYEYMEMGSL-FCILRTDEEAVGLDWTKRV----NIVKGMAHALSYLHH 434
F + + L+ M G L + I E G + + I+ G+ H LH
Sbjct: 61 AFETKDD-LCLVMTLMNGGDLKYHIYNVGEP--GFPEARAIFYAAQIICGLEH----LHQ 113
Query: 435 HCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTM 494
I++RD+ N+LL+ ++D G+A L AGT G +APE+
Sbjct: 114 R---RIVYRDLKPENVLLDDHGNVRISDLGLAVELK-GGKKIKGRAGTPGYMAPEVLQGE 169
Query: 495 VVTEKYDVYSFGVVALEVLMGKHP 518
V D ++ G E++ G+ P
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 21/205 (10%)
Query: 323 IGTGGYGSVYRARLPSGK----VVALKKLHRLETELASLESFQNEARLLS-QIRHRNIVK 377
+G G +G V A L + ALKK LE + +E E R+L+ H +
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDD--DVECTMVERRVLALAWEHPFLTH 60
Query: 378 LYGFCLHEKCMFLIYEYMEMGSLF----CILRTDEEAVGLDWTKRVNIVKGMAHALSYLH 433
L+ ++ +F + EY+ G L R DE I+ G L +LH
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARF---YAAEIICG----LQFLH 113
Query: 434 HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYT 493
I++RD+ +N+LL+ + +ADFG+ + + GT IAPE+
Sbjct: 114 ---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKG 170
Query: 494 MVVTEKYDVYSFGVVALEVLMGKHP 518
E D +SFGV+ E+L+G+ P
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 323 IGTGGYGSVYRA-RLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGF 381
+G+G YGSV A +G VA+KKL R + + E RLL ++H N++ L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 382 CLHEKCM------FLIYEYM--EMGSLF-CILRTDEEAVGLDWTKRVNIVKGMAHALSYL 432
+ + +L+ M ++ ++ C TD+ L + I++G L Y+
Sbjct: 85 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----QILRG----LKYI 136
Query: 433 HHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAY 492
H + I+HRD+ +N+ +N + E + DFG+AR + T T APE+
Sbjct: 137 H---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIML 190
Query: 493 T-MVVTEKYDVYSFGVVALEVLMGK 516
M + D++S G + E+L G+
Sbjct: 191 NWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 57/197 (28%), Positives = 82/197 (41%), Gaps = 30/197 (15%)
Query: 338 SGKVVALKKLHRLETELASLES-FQNEARLLSQIRHRNIVKLY--GFCLHEKCMFLIYEY 394
+G VA+K L E + F+ E L +++ H NIV L G +F ++EY
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEY 60
Query: 395 MEMGSLFCILRTD-----EEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNN 449
+ +L +L D E L M L L I+HRD+ N
Sbjct: 61 VPGRTLREVLAADGALPAGETGRL-----------MLQVLDALACAHNQGIVHRDLKPQN 109
Query: 450 ILLNS---EFEAFVADFGIARLLN--YDSSNRTLLA-----GTYGSIAPELAYTMVVTEK 499
I+++ A V DFGI LL D+ TL GT APE VT
Sbjct: 110 IMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPN 169
Query: 500 YDVYSFGVVALEVLMGK 516
D+Y++G++ LE L G+
Sbjct: 170 SDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 53/184 (28%), Positives = 82/184 (44%), Gaps = 27/184 (14%)
Query: 363 EARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY-------MEMGSLFCILRTDEEAVG-LD 414
E +L I HR I+ L I+ Y M M C L T + G L
Sbjct: 136 EIDILKTISHRAIINL------------IHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLP 183
Query: 415 WTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIA-RLLNYDS 473
+ + I + + AL+YLH I+HRD+ + NI L+ A + DFG A +L +
Sbjct: 184 LEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240
Query: 474 SNRTL-LAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHP--GELLSSSSSSLD 530
+ + +GT + +PEL K D++S G+V E+ + G+ + SSSS L
Sbjct: 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLR 300
Query: 531 KNIK 534
I+
Sbjct: 301 SIIR 304
|
Length = 392 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 46/210 (21%), Positives = 91/210 (43%), Gaps = 22/210 (10%)
Query: 322 CIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESF---QNEARLLSQIRHRNIVKL 378
C + + + P+ +VA+KK+ + S E Q E Q++H NI+
Sbjct: 9 CFEDLMIVHLAKHK-PTNTLVAVKKI---NLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 379 YGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHH-HCT 437
+ + ++++ M GS +L+T GL I+K + +AL Y+H
Sbjct: 65 VTSFIVDSELYVVSPLMAYGSCEDLLKT-HFPEGLPELAIAFILKDVLNALDYIHSKGF- 122
Query: 438 PPILHRDISSNNILLNSEFEAFVADFGIAR-LLNYDSSNRTLLAGTYGSI------APEL 490
+HR + +++ILL+ + + ++ + ++ + R + S+ +PE+
Sbjct: 123 ---IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEV 179
Query: 491 AYTMV--VTEKYDVYSFGVVALEVLMGKHP 518
+ EK D+YS G+ A E+ G P
Sbjct: 180 LQQNLQGYNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 37/138 (26%), Positives = 72/138 (52%), Gaps = 14/138 (10%)
Query: 323 IGTGGYGSVYRARL---PSGKVVALKK-----LHRLETELASLESFQNEARLLSQIRHRN 374
+G G + ++Y+ L +V + L L ++ +F A L+SQ+ H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 375 IVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHH 434
+VKLYG C+ ++ + ++ EY++ G L L ++ V L W ++++ K +A AL YL
Sbjct: 63 LVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119
Query: 435 HCTPPILHRDISSNNILL 452
++H ++ NIL+
Sbjct: 120 K---KLVHGNVCGKNILV 134
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 61/201 (30%), Positives = 91/201 (45%), Gaps = 13/201 (6%)
Query: 323 IGTGGYGSVYRA-RLPSGKVVALKKLHRLETELASLESFQNEAR---LLSQIRHRNIVKL 378
IG G +G V A R GK A+K L + + L E A LL ++H +V L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQK-KIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 379 -YGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCT 437
Y F EK ++ + +++ G LF L+ E + R + +A AL YLH +
Sbjct: 62 HYSFQTTEK-LYFVLDFVNGGELFFHLQ--RERSFPEPRARFYAAE-IASALGYLH---S 114
Query: 438 PPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVT 497
I++RD+ NILL+S+ + DFG+ + S T GT +APE+
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 498 EKYDVYSFGVVALEVLMGKHP 518
D + G V E+L G P
Sbjct: 175 NTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 59/201 (29%), Positives = 90/201 (44%), Gaps = 13/201 (6%)
Query: 323 IGTGGYGSVYRARLPS-GKVVALKKLHRLETELASLESFQNEAR---LLSQIRHRNIVKL 378
IG G +G V A+ S G A+K L + +T L E A LL ++H +V L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQK-KTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 379 -YGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCT 437
Y F EK ++ + +Y+ G LF E L+ R + +A A+ YLH +
Sbjct: 62 HYSFQTAEK-LYFVLDYVNGGELF--FHLQRERCFLEPRARFYAAE-VASAIGYLH---S 114
Query: 438 PPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVT 497
I++RD+ NILL+S+ + DFG+ + + GT +APE+
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYD 174
Query: 498 EKYDVYSFGVVALEVLMGKHP 518
D + G V E+L G P
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 13/215 (6%)
Query: 323 IGTGGYGSVYRARLPSG-KVVALKKLHRLETELASLESFQNEAR--LLSQIRHRNIVKL- 378
IG G +G V AR + K A+K L + E R LL ++H +V L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 379 YGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTP 438
+ F +K ++ + +Y+ G LF L+ E L+ R + +A AL YLH +
Sbjct: 63 FSFQTADK-LYFVLDYINGGELFYHLQ--RERCFLEPRARFYAAE-IASALGYLH---SL 115
Query: 439 PILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTE 498
I++RD+ NILL+S+ + DFG+ + + + GT +APE+ +
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDR 175
Query: 499 KYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNI 533
D + G V E+L G P S +++ + NI
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP--FYSRNTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 5e-09
Identities = 56/229 (24%), Positives = 92/229 (40%), Gaps = 41/229 (17%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLES--FQNEARLLSQIR 371
+DF++ IG G +G V+ R +G+V A+K L R + + + E +L+
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVL-RKSDMIKRNQIAHVRAERDILADAD 59
Query: 372 HRNIVKLYGFCLHEKCMFLIYEYM---EMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHA 428
IVKLY E+ ++L+ EYM ++ +L E + R I + + A
Sbjct: 60 SPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE----ETA-RFYIAE-LVLA 113
Query: 429 LSYLH--HHCTPPILHRDISSNNILLNSEFEAFVADFGIA--------------RLLNYD 472
L +H +HRDI +NIL++++ +ADFG+ N
Sbjct: 114 LDSVHKLGF-----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168
Query: 473 SSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGEL 521
+ L+ A + V T Y +A EVL G G
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDY-------IAPEVLRGTPYGLE 210
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 57/200 (28%), Positives = 91/200 (45%), Gaps = 12/200 (6%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQN--EARLLSQIRHRNIVKL- 378
+G G +G V R +G+ A+K L R E +A E E+R+L RH + L
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKIL-RKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 379 YGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTP 438
Y F H++ F++ EY G LF E V + R + + AL YLH +
Sbjct: 62 YAFQTHDRLCFVM-EYANGGELF--FHLSRERVFTEERARFYGAE-IVSALEYLH---SR 114
Query: 439 PILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTE 498
+++RDI N++L+ + + DFG+ + D + GT +APE+
Sbjct: 115 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 499 KYDVYSFGVVALEVLMGKHP 518
D + GVV E++ G+ P
Sbjct: 175 AVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 7e-09
Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 27/206 (13%)
Query: 323 IGTGGYGSV---YRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLY 379
+G+G YGSV Y RL + VA+KKL R L E RLL ++H N++ L
Sbjct: 23 VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 380 GFCLHEKCM------FLIYEYM--EMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSY 431
+ +L+ M ++ ++ + +E V ++ + L Y
Sbjct: 81 DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF-------LIYQLLRGLKY 133
Query: 432 LHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELA 491
+H + I+HRD+ +N+ +N + E + DFG+AR + T T APE+
Sbjct: 134 IH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD---DEMTGYVATRWYRAPEIM 187
Query: 492 YT-MVVTEKYDVYSFGVVALEVLMGK 516
M + D++S G + E+L GK
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 7e-09
Identities = 61/230 (26%), Positives = 100/230 (43%), Gaps = 55/230 (23%)
Query: 318 DIKY----CIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQN---------E 363
D KY IG G YG V A+ + + VA+KK+ +F N E
Sbjct: 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIAN---------AFDNRIDAKRTLRE 54
Query: 364 ARLLSQIRHRNIVKLYGFCLHE-----KCMFLIYEYMEMGSLFCILR-----TDEEAVGL 413
+LL + H N++ + ++++YE M+ L I+R +D+
Sbjct: 55 IKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYF 113
Query: 414 DWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473
+ +++G L Y+H + +LHRD+ +N+LLN+ + + DFG+AR +
Sbjct: 114 LY----QLLRG----LKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG 162
Query: 474 SNRTLLAGTYGSIAPEL-----AYTMVVTEKYDVYSFGVVALEVLMGKHP 518
T T APEL YT + DV+S G + E L+G+ P
Sbjct: 163 DFMTEYVVTRWYRAPELLLNCSEYTTAI----DVWSVGCIFAE-LLGRKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 9e-09
Identities = 51/216 (23%), Positives = 87/216 (40%), Gaps = 37/216 (17%)
Query: 349 RLETELASLESFQNEARLLSQIRHRNIVKL--------YGFCLHEKCMFLIYEYMEMGSL 400
+ + A +NE L ++ H NI+K+ + + +K F +Y +M +
Sbjct: 201 KAGSRAAI--QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF 258
Query: 401 FCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFV 460
D + L R I+K + A+ Y+H ++HRDI NI LN + + +
Sbjct: 259 ------DWKDRPLLKQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVL 308
Query: 461 ADFGIARLLNYDSSNRTL-LAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM----- 514
DFG A + GT + +PE+ E D++S G++ L++L
Sbjct: 309 GDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368
Query: 515 ----GKHPGELLSSSSSSLDKNIKLIDLLDPRLPPP 546
G PG+ L K I + + D P P
Sbjct: 369 IGDGGGKPGK-------QLLKIIDSLSVCDEEFPDP 397
|
Length = 501 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 24/215 (11%)
Query: 317 FDIKYC-IGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNI 375
F+ + C +G G YG VY+A+ GK L ++E S+ + + E LL +++H N+
Sbjct: 2 FEYEGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACR-EIALLRELKHPNV 60
Query: 376 VKLYG-FCLH-EKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSY-- 431
+ L F H ++ ++L+++Y E L+ I++ + K V + +GM +L Y
Sbjct: 61 ISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKAN--KKPVQLPRGMVKSLLYQI 117
Query: 432 ---LHHHCTPPILHRDISSNNILLNSE----FEAFVADFGIARLLNYDSSNRTL-----L 479
+H+ +LHRD+ NIL+ E +AD G ARL N S + L +
Sbjct: 118 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN--SPLKPLADLDPV 175
Query: 480 AGTYGSIAPELAY-TMVVTEKYDVYSFGVVALEVL 513
T+ APEL T+ D+++ G + E+L
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 66/256 (25%), Positives = 114/256 (44%), Gaps = 41/256 (16%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHR-LETELASLESFQNEARLLSQIRHRNIVKLYG 380
+G G +G V AR +G+ VA+KK+ + T + + +++ E +LL +RH NI+ L
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLRHENIISLSD 76
Query: 381 -FCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPP 439
F + ++ + E + L +L + I++G L Y+H +
Sbjct: 77 IFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQYFLYQILRG----LKYVH---SAG 128
Query: 440 ILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEK 499
++HRD+ +NIL+N + + DFG+AR+ T T APE+ M+ +K
Sbjct: 129 VVHRDLKPSNILINENCDLKICDFGLARI---QDPQMTGYVSTRYYRAPEI---MLTWQK 182
Query: 500 YDV----YSFGVVALEVLMGK--HPG-----------ELLSSSSSSLDKNI------KLI 536
YDV +S G + E+L GK PG +LL + + I + +
Sbjct: 183 YDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFV 242
Query: 537 DLLDPRLPPPGDQMIR 552
L R P P + +
Sbjct: 243 QSLPKREPVPFSEKFK 258
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 53/199 (26%), Positives = 91/199 (45%), Gaps = 9/199 (4%)
Query: 323 IGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQ-NEARLLSQIRHRNIVKLYG 380
+G GG+G V ++ +GK+ A KKL + + ES NE ++L ++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 381 FCLHEKCMFLIYEYMEMGSL-FCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPP 439
+ + L+ M G L F I E G + + V + L LH
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLHQE---R 122
Query: 440 ILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEK 499
I++RD+ NILL+ ++D G+A + + + + GT G +APE+ T
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV-GTVGYMAPEVVKNERYTFS 181
Query: 500 YDVYSFGVVALEVLMGKHP 518
D ++ G + E++ G+ P
Sbjct: 182 PDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 56/206 (27%), Positives = 98/206 (47%), Gaps = 19/206 (9%)
Query: 323 IGTGGYGSVYRARLP-SGKVVALKKLHR---LETELASLESFQNEARLLSQIR-HRNIVK 377
+G G +G V A L + +V A+K L + L+ + ++ E R+L+ H +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDD--DVDCTMTEKRILALAAKHPFLTA 60
Query: 378 LYGFCLHEKCMFLIYEYMEMGSL-FCILRTD--EEAVGLDWTKRVNIVKGMAHALSYLHH 434
L+ + +F + EY+ G L F I R+ +E + V + AL +LH
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTL------ALMFLHR 114
Query: 435 HCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTM 494
H +++RD+ +NILL++E +ADFG+ + + T GT IAPE+ +
Sbjct: 115 H---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQEL 171
Query: 495 VVTEKYDVYSFGVVALEVLMGKHPGE 520
D ++ GV+ E++ G+ P E
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 53/197 (26%), Positives = 93/197 (47%), Gaps = 16/197 (8%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIR-HRNIVKLYG 380
IG G + V +A+ +GK A+K + + L + + E + L ++ H NI++L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL-REIQALRRLSPHPNILRLIE 65
Query: 381 FCLHEK--CMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRV-NIVKGMAHALSYLHHHCT 437
K + L++E M+M +L+ +++ + + KRV + + + +L ++H +
Sbjct: 66 VLFDRKTGRLALVFELMDM-NLYELIKGRKRPLP---EKRVKSYMYQLLKSLDHMHRN-- 119
Query: 438 PPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTM-VV 496
I HRDI NIL+ + +ADFG R + Y T T APE T
Sbjct: 120 -GIFHRDIKPENILIKDD-ILKLADFGSCRGI-YSKPPYTEYISTRWYRAPECLLTDGYY 176
Query: 497 TEKYDVYSFGVVALEVL 513
K D+++ G V E+L
Sbjct: 177 GPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 22/159 (13%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQ-NEARLLSQIRHRN-IVKLY 379
IG G YG VY+AR +GK+VALKK RLE + + E LL + IV+L
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKT-RLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 380 GFCLHEK-----CMFLIYEYMEMG-SLFCILRTDEEAVGLDWTKRVN----IVKGMAHAL 429
E+ ++L++EY++ F L + ++KG+AH
Sbjct: 68 DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAH-- 125
Query: 430 SYLHHHCTPPILHRDISSNNILLNSEFEAF-VADFGIAR 467
H H ++HRD+ N+L++ + +AD G+ R
Sbjct: 126 --CHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 52/178 (29%), Positives = 79/178 (44%), Gaps = 12/178 (6%)
Query: 363 EARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIV 422
EA +L I H +I++L G + K LI + L+C L D + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDI---LAIE 188
Query: 423 KGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTL-LAG 481
+ + A+ YLH + I+HRDI + NI +N + + DFG A ++N+ AG
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAG 245
Query: 482 TYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHP---GELLSSSSSSLDKNIKLI 536
T + APEL D++S G+V E+ + L S D+ IKLI
Sbjct: 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDS-DRQIKLI 302
|
Length = 391 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 4e-08
Identities = 49/204 (24%), Positives = 80/204 (39%), Gaps = 18/204 (8%)
Query: 323 IGTGGYGSVYRARLPSGKVVALKKLHRLETELASLE--SFQNEARLLSQIRHRNIVKLYG 380
IG G +G V G A + L E F E + ++ H N+++ G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 381 FCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAH--ALSYLHHHCTP 438
C+ L+ E+ +G L LR++ V K V ++ MA A L H
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDV--LQRMACEVASGLLWLH-QA 119
Query: 439 PILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS---NRTLLAGTYGSIAPELA---- 491
+H D++ N L ++ + D+G+A L Y + A +APEL
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 492 ---YTMVVTEKYDVYSFGVVALEV 512
T+K +++S GV E+
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 4e-08
Identities = 59/215 (27%), Positives = 104/215 (48%), Gaps = 24/215 (11%)
Query: 317 FDIKYC-IGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNI 375
F+ + C +G G YG VY+A+ GK L ++E S+ + + E LL +++H N+
Sbjct: 2 FEYEGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACR-EIALLRELKHPNV 60
Query: 376 VKLYG-FCLH-EKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSY-- 431
+ L F H ++ ++L+++Y E L+ I++ + K + + + M +L Y
Sbjct: 61 IALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKAN--KKPMQLPRSMVKSLLYQI 117
Query: 432 ---LHHHCTPPILHRDISSNNILLNSE----FEAFVADFGIARLLNYDSSNRTL-----L 479
+H+ +LHRD+ NIL+ E +AD G ARL N S + L +
Sbjct: 118 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN--SPLKPLADLDPV 175
Query: 480 AGTYGSIAPELAY-TMVVTEKYDVYSFGVVALEVL 513
T+ APEL T+ D+++ G + E+L
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 4e-08
Identities = 45/160 (28%), Positives = 77/160 (48%), Gaps = 16/160 (10%)
Query: 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASL-ESFQNEARLLSQIRH 372
E+F I I G +G VY R + K+ A+K + + + ++ Q E L+ +
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRT----DEEAVGLDWTKRVNIVKGMAHA 428
IV LY ++L+ EY+ G + +L DEE V + +A A
Sbjct: 64 PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA-------VKYISEVALA 116
Query: 429 LSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARL 468
L YLH H I+HRD+ +N+L+++E + DFG++++
Sbjct: 117 LDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 8e-08
Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 34/212 (16%)
Query: 323 IGTGGYGSVYRARL-PSGKVVALKKLHRLE-TELASLESFQNEARLL---SQIRHRNIVK 377
+G G +G V A +G++ A+K L + + +ES E R+ + RH +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 378 LYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHA------LSY 431
L+ E + + EY G L + TD + + + +A L Y
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHIHTD----------VFSEPRAVFYAACVVLGLQY 116
Query: 432 LHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARL-LNYDSSNRTLLAGTYGSIAPEL 490
LH + I++RD+ +N+LL++E +ADFG+ + + + T GT +APE+
Sbjct: 117 LHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-FCGTPEFLAPEV 172
Query: 491 ----AYTMVVTEKYDVYSFGVVALEVLMGKHP 518
+YT V D + GV+ E+L+G+ P
Sbjct: 173 LTETSYTRAV----DWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 8e-08
Identities = 34/114 (29%), Positives = 59/114 (51%), Gaps = 7/114 (6%)
Query: 342 VALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLF 401
V LK L ++ SL F+ A ++ Q+ H++IV LYG C+ + ++ E++E G L
Sbjct: 35 VILKVLDPSHRDI-SLAFFET-ASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD 92
Query: 402 CILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSE 455
+ + + W + + K +A ALSYL ++H ++ + NILL E
Sbjct: 93 LFMHRKSDVLTTPW--KFKVAKQLASALSYLEDK---DLVHGNVCTKNILLARE 141
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 8e-08
Identities = 57/224 (25%), Positives = 101/224 (45%), Gaps = 21/224 (9%)
Query: 323 IGTGGYGSVYRA-RLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGF 381
IG+G G V A G VA+KKL R + E LL + H+NI+ L
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88
Query: 382 CLHEKCM------FLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHH 435
+K + +L+ E M+ +L ++ + LD + ++ M + +LH
Sbjct: 89 FTPQKSLEEFQDVYLVMELMD-ANLCQVIHME-----LDHERMSYLLYQMLCGIKHLH-- 140
Query: 436 CTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMV 495
+ I+HRD+ +NI++ S+ + DFG+AR + + Y APE+ M
Sbjct: 141 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYR-APEVILGMG 198
Query: 496 VTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLL 539
E D++S G + E++ G ++ + +D+ K+I+ L
Sbjct: 199 YKENVDIWSVGCIMGELV----KGSVIFQGTDHIDQWNKVIEQL 238
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 9e-08
Identities = 28/90 (31%), Positives = 51/90 (56%), Gaps = 3/90 (3%)
Query: 429 LSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAP 488
L +LH + I++RD+ +N++L+ + +ADFG+ + + + + GT IAP
Sbjct: 109 LQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAP 165
Query: 489 ELAYTMVVTEKYDVYSFGVVALEVLMGKHP 518
E+ + T D +SFGV+ E+L+G+ P
Sbjct: 166 EILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 44/155 (28%), Positives = 73/155 (47%), Gaps = 19/155 (12%)
Query: 301 YDGRITFQDMIEATEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKL---HRLETELASL 357
YDGR+ + E ED G + R V LK L HR + LA
Sbjct: 12 YDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELR------VVLKVLDPSHR-DIALAFF 64
Query: 358 ESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTK 417
E+ A L+SQ+ H ++ ++G C+ ++ E++E G L LR ++ V + W
Sbjct: 65 ET----ASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW-- 118
Query: 418 RVNIVKGMAHALSYLHHHCTPPILHRDISSNNILL 452
++ + + +A ALSYL ++H ++ + NILL
Sbjct: 119 KITVAQQLASALSYLEDK---NLVHGNVCAKNILL 150
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 69/261 (26%), Positives = 108/261 (41%), Gaps = 80/261 (30%)
Query: 315 EDFDIKYCIGTGGYGSVYRARL----PSGKVVALKKLHRLET-ELASLESFQNEARLLSQ 369
+DF+ IG G +G V RL +G + A+KKL + E E + + E +L++
Sbjct: 1 DDFESIKVIGRGAFGEV---RLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAE 57
Query: 370 IRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILR-----TDEEAVGLDWTKRVNIVKG 424
+ +VKLY E ++LI EY+ G + +L T+EE R I +
Sbjct: 58 ADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEET-------RFYIAET 110
Query: 425 -MA----HALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGI------------AR 467
+A H L Y+H RDI +N+LL+++ ++DFG+ R
Sbjct: 111 ILAIDSIHKLGYIH---------RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYR 161
Query: 468 LLNYDSS----------------------NRTLLA----GTYGSIAPEL----AYTMVVT 497
+L++ NR LA GT IAPE+ Y
Sbjct: 162 ILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKEC- 220
Query: 498 EKYDVYSFGVVALEVLMGKHP 518
D +S GV+ E+L+G P
Sbjct: 221 ---DWWSLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 323 IGTGGYGSVYRARLPS-GKVVALKKLH----RLETELASLESFQNEARLLSQIRHRNIVK 377
IG G +G V A+ + GK A+K L + E + + +N LL ++H +V
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNV--LLKNVKHPFLVG 60
Query: 378 L-YGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHC 436
L Y F +K F++ +Y+ G LF L+ E + R + +A AL YLH
Sbjct: 61 LHYSFQTADKLYFVL-DYVNGGELFFHLQ--RERSFPEPRARFYAAE-IASALGYLH--- 113
Query: 437 TPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVV 496
+ I++RD+ NILL+S+ + DFG+ + S + GT +APE+
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPY 173
Query: 497 TEKYDVYSFGVVALEVLMGKHP 518
D + G V E+L G P
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 53/200 (26%), Positives = 89/200 (44%), Gaps = 11/200 (5%)
Query: 323 IGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQ-NEARLLSQIRHRNIVKLYG 380
+G GG+G V ++ +GK+ A KKL + + E+ NE R+L ++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66
Query: 381 FCLHEK-CMFLIYEYMEMGSL-FCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTP 438
+ K + L+ M G L F I G D + + + L L
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNP--GFDEQRAIFYAAELCCGLEDLQRE--- 121
Query: 439 PILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTE 498
I++RD+ NILL+ ++D G+A + + R + GT G +APE+ T
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV-GTVGYMAPEVINNEKYTF 180
Query: 499 KYDVYSFGVVALEVLMGKHP 518
D + G + E++ G+ P
Sbjct: 181 SPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 60/242 (24%), Positives = 105/242 (43%), Gaps = 21/242 (8%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQN--EARLLSQIRHRNIVKL- 378
+G G +G V + +G+ A+K L + E +A E E R+L RH + L
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKK-EVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 379 YGFCLHEKCMFLIYEYMEMGSLFCILRTD----EEAVGLDWTKRVNIVKGMAHALSYLHH 434
Y F H++ F++ EY G LF L + E+ + V+ AL YLH
Sbjct: 62 YSFQTHDRLCFVM-EYANGGELFFHLSRERVFSEDRARFYGAEIVS-------ALDYLHS 113
Query: 435 HCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTM 494
+++RD+ N++L+ + + DFG+ + D + GT +APE+
Sbjct: 114 E--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN 171
Query: 495 VVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRLPPPGDQMIRQG 554
D + GVV E++ G+ P + L + I + ++ PR P + + G
Sbjct: 172 DYGRAVDWWGLGVVMYEMMCGRLP--FYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSG 229
Query: 555 II 556
++
Sbjct: 230 LL 231
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 51/207 (24%), Positives = 93/207 (44%), Gaps = 11/207 (5%)
Query: 316 DFDIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHR-LETELASLESFQNEARLLSQIRHR 373
DF+ +G G +G V A R + ++ A+K L + + + +E E R+L+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 374 NIVKLYGFCLHE-KCMFLIYEYMEMGSLFCILRTDEEAVG-LDWTKRVNIVKGMAHALSY 431
+ C ++ + EY+ G L + + VG + V ++ L +
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI----QQVGKFKEPQAVFYAAEISVGLFF 116
Query: 432 LHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELA 491
LH I++RD+ +N++L+SE +ADFG+ + D GT IAPE+
Sbjct: 117 LHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEII 173
Query: 492 YTMVVTEKYDVYSFGVVALEVLMGKHP 518
+ D +++GV+ E+L G+ P
Sbjct: 174 AYQPYGKSVDWWAYGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 22/207 (10%)
Query: 323 IGTGGYGSVYRARLP-SGKVVALKKLHRLE----TELASLESFQNEARLLSQIRHRNIVK 377
IG G +G VY+ R + ++ A+K L + E E+A +N IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 378 LYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNI-VKGMAHALSYLHHHC 436
L + ++L+ +YM G LF L+ + G R + + AL +LH +
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKE----GRFSEDRAKFYIAELVLALEHLHKY- 115
Query: 437 TPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPEL-----A 491
I++RD+ NILL++ + DFG+++ D+ GT +APE+
Sbjct: 116 --DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKG 173
Query: 492 YTMVVTEKYDVYSFGVVALEVLMGKHP 518
YT V D +S GV+ E+ G P
Sbjct: 174 YTKHV----DFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 54/244 (22%), Positives = 105/244 (43%), Gaps = 40/244 (16%)
Query: 308 QDMIEATEDFDIKY------------CIGTGGYGSVYRARLPSGKVV--ALKKLHRLETE 353
Q++I + DIK I S+Y+ + +V+ KK H+
Sbjct: 1 QNIITRSYINDIKCIESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKV 60
Query: 354 LASLESFQNEARLLSQIRHRNIVKLYGFCLHEKC-----MFLIYEYMEMGSLFCILRTDE 408
L ++ +NE + L +I NI+K+YGF + + + LI EY G L +L ++
Sbjct: 61 L--IDITENEIKNLRRIDSNNILKIYGFII-DIVDDLPRLSLILEYCTRGYLREVLDKEK 117
Query: 409 EAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARL 468
+ L + ++++ L L+ + P +++++S + L+ ++ + G+ ++
Sbjct: 118 D---LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKI 172
Query: 469 LNYDSSNRTLLAGTYGSIAPELAYTMVV------TEKYDVYSFGVVALEVLMGKHPGELL 522
L+ + +Y M+ T K D+YS GVV E+ GK P E L
Sbjct: 173 LSSPPFKNV-------NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL 225
Query: 523 SSSS 526
++
Sbjct: 226 TTKE 229
|
Length = 283 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 53/199 (26%), Positives = 91/199 (45%), Gaps = 10/199 (5%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLE-TELASLESFQNEARLLSQIRHRNIVKL-Y 379
IG G +G V + R + ++ ALK + + + + E +L+Q+ IV L +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 380 GFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPP 439
F EK ++L+ ++ G LF L+ + D ++ + AL LH
Sbjct: 61 SFQSPEK-LYLVLAFINGGELFHHLQREGR---FDLSRARFYTAELLCALENLHKF---N 113
Query: 440 ILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEK 499
+++RD+ NILL+ + + DFG+ +L D GT +APEL T+
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKA 173
Query: 500 YDVYSFGVVALEVLMGKHP 518
D ++ GV+ E+L G P
Sbjct: 174 VDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 62/251 (24%), Positives = 109/251 (43%), Gaps = 28/251 (11%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQ-NEARLLSQIRHRN---IVK 377
IG GG+G VY R +GK+ A+K L + ++ E+ NE +LS + + IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 378 L-YGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKR---VNIVKGMAHALSYLH 433
+ Y F +K F I + M G L L + V + R I+ G+ H +H
Sbjct: 62 MSYAFHTPDKLSF-ILDLMNGGDLHYHL--SQHGVFSEAEMRFYAAEIILGLEH----MH 114
Query: 434 HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPE-LAY 492
+ +++RD+ NILL+ ++D G+A ++ GT+G +APE L
Sbjct: 115 NRF---VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGTHGYMAPEVLQK 169
Query: 493 TMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSS------SLDKNIKLIDLLDPRLPPP 546
+ D +S G + ++L G P + +L ++L D P L
Sbjct: 170 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 229
Query: 547 GDQMIRQGIIL 557
+ ++++ +
Sbjct: 230 LEGLLQRDVNR 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 3e-07
Identities = 59/231 (25%), Positives = 103/231 (44%), Gaps = 25/231 (10%)
Query: 323 IGTGGYGSV---YRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLY 379
IG+G G V Y A L + VA+KKL R + E L+ + H+NI+ L
Sbjct: 25 IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 380 GFCLHEKCM------FLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLH 433
+K + +L+ E M+ +L +++ + LD + ++ M + +LH
Sbjct: 83 NVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQME-----LDHERMSYLLYQMLCGIKHLH 136
Query: 434 HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYT 493
+ I+HRD+ +NI++ S+ + DFG+AR + Y APE+
Sbjct: 137 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR-APEVILG 192
Query: 494 MVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRLP 544
M E D++S G + E++ K +L +D+ K+I+ L P
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHK----ILFPGRDYIDQWNKVIEQLGTPCP 239
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 5e-07
Identities = 61/237 (25%), Positives = 101/237 (42%), Gaps = 28/237 (11%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQ-NEARLLSQIRHRN----IV 376
IG GG+G VY R +GK+ A+K L + ++ E+ NE +LS + + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 377 KLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKR---VNIVKGMAHALSYLH 433
Y F +K F I + M G L L + V + R I+ G+ H +H
Sbjct: 62 MTYAFHTPDKLCF-ILDLMNGGDLHYHL--SQHGVFSEKEMRFYATEIILGLEH----MH 114
Query: 434 HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPE-LAY 492
+ +++RD+ NILL+ ++D G+A ++ GT+G +APE L
Sbjct: 115 NRF---VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGTHGYMAPEVLQK 169
Query: 493 TMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSS------SLDKNIKLIDLLDPRL 543
D +S G + ++L G P + +L N++L D P L
Sbjct: 170 GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPEL 226
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 52/210 (24%), Positives = 101/210 (48%), Gaps = 17/210 (8%)
Query: 316 DFDIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHR-LETELASLESFQNEARLLS-QIRH 372
DF+ +G G +G V A R + ++ A+K L + + + +E E R+L+ +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSL-FCILRTDE--EAVGLDWTKRVNIVKGMAHAL 429
+ +L+ ++ + EY+ G L + I + + E + + + I L
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAI------GL 114
Query: 430 SYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARL-LNYDSSNRTLLAGTYGSIAP 488
+LH + I++RD+ +N++L++E +ADFG+ + + + RT GT IAP
Sbjct: 115 FFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT-FCGTPDYIAP 170
Query: 489 ELAYTMVVTEKYDVYSFGVVALEVLMGKHP 518
E+ + D ++FGV+ E+L G+ P
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 6e-07
Identities = 50/199 (25%), Positives = 88/199 (44%), Gaps = 9/199 (4%)
Query: 323 IGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQ-NEARLLSQIRHRNIVKLYG 380
+G GG+G V ++ +GK+ A K+L + + ES NE ++L ++ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 381 FCLHEKCMFLIYEYMEMGSL-FCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPP 439
+ + L+ M G L F I G + + + + L LH
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNP--GFEEERALFYAAEILCGLEDLHRE---N 122
Query: 440 ILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEK 499
++RD+ NILL+ ++D G+A + S R + GT G +APE+ T
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV-GTVGYMAPEVLNNQRYTLS 181
Query: 500 YDVYSFGVVALEVLMGKHP 518
D + G + E++ G+ P
Sbjct: 182 PDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 7e-07
Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 3/96 (3%)
Query: 425 MAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYG 484
+A L +LH + I++RD+ +N++L+SE +ADFG+ + +D GT
Sbjct: 110 IAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPD 166
Query: 485 SIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGE 520
IAPE+ + D ++FGV+ E+L G+ P E
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 7e-07
Identities = 58/223 (26%), Positives = 101/223 (45%), Gaps = 30/223 (13%)
Query: 323 IGTGGYGSVYRA---RLPSGKV---VALKKLHRLETELASLES---FQNEARLLSQIRHR 373
+G G +G VY + G+ VA+K ++ E ASL F NEA ++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN----ESASLRERIEFLNEASVMKGFTCH 69
Query: 374 NIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRT----DEEAVGL---DWTKRVNIVKGMA 426
++V+L G + ++ E M G L LR+ E G + + + +A
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129
Query: 427 HALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL----NYDSSNRTLLAGT 482
++YL+ +HRD+++ N ++ +F + DFG+ R + Y + LL
Sbjct: 130 DGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 483 YGSIAPELAYTMVVTEKYDVYSFGVVALEV-LMGKHPGELLSS 524
+ +APE V T D++SFGVV E+ + + P + LS+
Sbjct: 187 W--MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN 227
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 7e-07
Identities = 61/235 (25%), Positives = 105/235 (44%), Gaps = 54/235 (22%)
Query: 317 FDI--KYC----IGTGGYGSVYRA-RLPSGKVVALKKLHRLETELASLESFQNEARLLSQ 369
FD+ +Y +G G G V+ A K VA+KK+ + T+ S++ E +++ +
Sbjct: 1 FDLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKI--VLTDPQSVKHALREIKIIRR 58
Query: 370 IRHRNIVKLY--------------GFCLHEKCMFLIYEYMEMGSLFCIL---RTDEEAVG 412
+ H NIVK+Y G ++++ EYME L +L EE
Sbjct: 59 LDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHAR 117
Query: 413 LDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAF-VADFGIARLLNY 471
L + + L Y+H + +LHRD+ N+ +N+E + DFG+AR+++
Sbjct: 118 L-------FMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDP 167
Query: 472 DSSNRTLLAGT-----YGSIAPELA-----YTMVVTEKYDVYSFGVVALEVLMGK 516
S++ L+ Y S P L YT + D+++ G + E+L GK
Sbjct: 168 HYSHKGYLSEGLVTKWYRS--PRLLLSPNNYTKAI----DMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 7e-07
Identities = 57/226 (25%), Positives = 103/226 (45%), Gaps = 25/226 (11%)
Query: 323 IGTGGYGSV---YRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLY 379
IG+G G V Y A L + VA+KKL R + E L+ + H+NI+ L
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 380 GFCLHEKCM------FLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLH 433
+K + +++ E M+ +L +++ + LD + ++ M + +LH
Sbjct: 90 NVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQME-----LDHERMSYLLYQMLCGIKHLH 143
Query: 434 HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYT 493
+ I+HRD+ +NI++ S+ + DFG+AR + Y APE+
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR-APEVILG 199
Query: 494 MVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLL 539
M E D++S G + E++ G +L + +D+ K+I+ L
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKGG----VLFPGTDHIDQWNKVIEQL 241
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 7e-07
Identities = 61/233 (26%), Positives = 105/233 (45%), Gaps = 39/233 (16%)
Query: 323 IGTGGYGSVYRA-RLPSGKVVALKKLHRLETELASLESFQN---------EARLLSQIRH 372
IG+G G V A +G+ VA+KKL R FQN E L+ + H
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLSR---------PFQNVTHAKRAYRELVLMKLVNH 74
Query: 373 RNIVKLYGFCLHEKCM------FLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMA 426
+NI+ L +K + +L+ E M+ +L +++ D LD + ++ M
Sbjct: 75 KNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD-----LDHERMSYLLYQML 128
Query: 427 HALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI 486
+ +LH + I+HRD+ +NI++ S+ + DFG+AR + Y
Sbjct: 129 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR- 184
Query: 487 APELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLL 539
APE+ M E D++S G + E++ G +L + +D+ K+I+ L
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT----VLFPGTDHIDQWNKIIEQL 233
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 29/85 (34%), Positives = 40/85 (47%), Gaps = 21/85 (24%)
Query: 154 LKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGI 213
L L N L G IP+ I KL+ L ++LSGN I G IP LG + ++ +DLS N+ +G
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNG-- 480
Query: 214 PVFVRKVPHLDVSGNQFGGEIPTTL 238
IP +L
Sbjct: 481 -------------------SIPESL 486
|
Length = 623 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 16/202 (7%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQN--EARLLSQIRHRNIVKL- 378
+G G +G V R +GK A+K L + E +A E E+R+L RH + L
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKK-EVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 379 YGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTK--RVNIVKGMAHALSYLHHHC 436
Y F H++ F++ EY G LF L E D + IV AL YLH
Sbjct: 62 YSFQTHDRLCFVM-EYANGGELFFHLSR-ERVFSEDRARFYGAEIVS----ALGYLH--- 112
Query: 437 TPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVV 496
+ +++RD+ N++L+ + + DFG+ + D + GT +APE+
Sbjct: 113 SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 172
Query: 497 TEKYDVYSFGVVALEVLMGKHP 518
D + GVV E++ G+ P
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 62/246 (25%), Positives = 104/246 (42%), Gaps = 53/246 (21%)
Query: 315 EDFDIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRLET-ELASLESFQNEARLLSQIRH 372
EDF+ IG G +G V + +G V A+K L + + E + + E +L +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 373 RNIVKLYGFCLHEKC-MFLIYEYMEMGSLFCIL-RTD---EEAVGLDWTKRVNIVKGMAH 427
+VK++ + +K ++LI E++ G + +L + D EE + V + + H
Sbjct: 61 LWVVKMF-YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSI-H 118
Query: 428 ALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIA------------RLLNYD--- 472
L ++H RDI +N+LL+S+ ++DFG+ R LN+
Sbjct: 119 QLGFIH---------RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPS 169
Query: 473 ----------------SSNRTLLA----GTYGSIAPELAYTMVVTEKYDVYSFGVVALEV 512
NR LA GT IAPE+ + D +S GV+ E+
Sbjct: 170 DFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
Query: 513 LMGKHP 518
L+G P
Sbjct: 230 LIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 11/200 (5%)
Query: 323 IGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQN-EARLLSQIRHRNIVKLYG 380
+G GG+G V ++ +GK+ A KKL + + S E E +L ++ IV L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 381 FCLHEKC-MFLIYEYMEMGSL-FCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTP 438
+ K + L+ M G L + I E GL+ + ++ + + +LH +
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGE--RGLEMERVIHYSAQITCGILHLH---SM 114
Query: 439 PILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTE 498
I++RD+ N+LL+ + ++D G+A L D T AGT G +APE+ +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELK-DGKTITQRAGTNGYMAPEILKEEPYSY 173
Query: 499 KYDVYSFGVVALEVLMGKHP 518
D ++ G E++ G+ P
Sbjct: 174 PVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 55/215 (25%), Positives = 98/215 (45%), Gaps = 34/215 (15%)
Query: 326 GGYGSVYRARLPSGKV-----VALKKL--HRLETELASLESFQNEARLLSQIRHRNIVKL 378
G +G ++ L K V +K + H E ++ L E+ LL + H+NI+ +
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQ---ESCLLYGLSHQNILPI 73
Query: 379 YGFC--LHEKCMFLIYEYMEMGSLFCIL---RTDEEAVGLDWTKR--VNIVKGMAHALSY 431
C E F++Y YM G+L L R E + + V++ +A +SY
Sbjct: 74 LHVCIEDGEP-PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSY 132
Query: 432 LHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL---NY----DSSNRTLLAGTYG 484
LH ++H+DI++ N +++ E + + D ++R L +Y D+ NR +
Sbjct: 133 LHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV-----K 184
Query: 485 SIAPELAYTMVVTEKYDVYSFGVVALE-VLMGKHP 518
+A E + DV+SFGV+ E + +G+ P
Sbjct: 185 WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 32/90 (35%), Positives = 48/90 (53%), Gaps = 4/90 (4%)
Query: 432 LHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN---YDSSNRTLLAGTYGSIAP 488
+HH + ++HRDI S NILL S + DFG +++ D RT GT +AP
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT-FCGTPYYVAP 214
Query: 489 ELAYTMVVTEKYDVYSFGVVALEVLMGKHP 518
E+ ++K D++S GV+ E+L K P
Sbjct: 215 EIWRRKPYSKKADMFSLGVLLYELLTLKRP 244
|
Length = 496 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 21/205 (10%)
Query: 323 IGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQ-NEARLLSQIRHRNIVKL-Y 379
+G GG+G V ++ +GK+ A KKL + + E+ NE ++L ++ R +V L Y
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67
Query: 380 GFCLHEK-CMFLIYEYMEMGSL-FCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCT 437
+ + C+ L M G L F I G D + V + L LH
Sbjct: 68 AYETKDALCLVLTL--MNGGDLKFHIYNMGNP--GFDEERAVFYAAEITCGLEDLHRE-- 121
Query: 438 PPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVT 497
I++RD+ NILL+ ++D G+A + + R + GT G +APE+ V
Sbjct: 122 -RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV-GTVGYMAPEV----VKN 175
Query: 498 EKY----DVYSFGVVALEVLMGKHP 518
E+Y D + G + E++ GK P
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-06
Identities = 31/91 (34%), Positives = 49/91 (53%), Gaps = 2/91 (2%)
Query: 147 NCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFS-CIDTVDLS 205
N S++ + L +SG I S I +L + ++LS N ++G IP + S + ++LS
Sbjct: 67 NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLS 126
Query: 206 MNNLSGGIPV-FVRKVPHLDVSGNQFGGEIP 235
NN +G IP + + LD+S N GEIP
Sbjct: 127 NNNFTGSIPRGSIPNLETLDLSNNMLSGEIP 157
|
Length = 968 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 45/154 (29%), Positives = 66/154 (42%), Gaps = 22/154 (14%)
Query: 374 NIVKLYGFCLHEKCMFLIYEYMEMGSLFC----ILRTDEEAVGLDWTKRVNIVKGMAHAL 429
N+V L+ + + E +FL+ ++ E G L+ L EE V W M AL
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVK-RWAAE------MVVAL 98
Query: 430 SYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPE 489
LH I+ RD++ NNILL+ + F + DS + + Y APE
Sbjct: 99 DALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVE-DSCDGEAVENMY--CAPE 152
Query: 490 LAYTMVVTEKYDVYSFGVVALEVLMGK-----HP 518
+ TE D +S G + E+L GK HP
Sbjct: 153 VGGISEETEACDWWSLGAILFELLTGKTLVECHP 186
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 55/213 (25%), Positives = 94/213 (44%), Gaps = 23/213 (10%)
Query: 323 IGTGGYGSVYRARLPSGKVVALKKLHRLETELASLES--FQNEARLLSQIRHRNIVKLYG 380
IG G +G V + SG A + L + E F EA+ ++H N+++ G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 381 FCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAH--ALSYLHHHCTP 438
C L+ E+ +G L LR+ +A + T ++ MA AL LH H
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELM--TPDPTTLQRMACEIALGLLHLH-KN 119
Query: 439 PILHRDISSNNILLNSEFEAFVADFGIARLLNYD-----SSNRTLLAGTYGSIAPEL--- 490
+H D++ N LL ++ + D+G++ Y + ++ + + IAPEL
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSH-NKYKEDYYVTPDQLWVPLRW--IAPELVDE 176
Query: 491 --AYTMVV--TEKYDVYSFGVVALEVL-MGKHP 518
+VV T++ +V+S GV E+ +G P
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 42/154 (27%), Positives = 66/154 (42%), Gaps = 22/154 (14%)
Query: 323 IGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQ------IRHRNIV 376
IG G +G V + + + VA + L+ +S E QNE L Q ++H NI+
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKE--QNE--FLQQGDPYRILQHPNIL 58
Query: 377 KLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVN-----IVKGMAHALSY 431
+ G C+ L++EY E+G L L ++ + I G+ H
Sbjct: 59 QCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTH---- 114
Query: 432 LHHHCTPPILHRDISSNNILLNSEFEAFVADFGI 465
+H H LH D++ N L S+ V D+GI
Sbjct: 115 MHKH---NFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 3e-06
Identities = 19/59 (32%), Positives = 27/59 (45%)
Query: 79 LQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKL 137
L+ LDLS N + L L+ +DLS N L P + L L +L++ N L
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (117), Expect = 5e-06
Identities = 43/182 (23%), Positives = 88/182 (48%), Gaps = 27/182 (14%)
Query: 363 EARLLSQIRHRNIVKLYGFCLHE--KCMFLIYEYMEMGSLFCILRTDEEAVG-LDWTKRV 419
E ++ +++H+NIV+ L++ + ++++ E+ + G L ++ + G ++ V
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121
Query: 420 NIVKGMAHALSYLHHHCTPP----ILHRDISSNNILLNSEFE-----------------A 458
+I + + HAL+Y H+ P +LHRD+ NI L++ A
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA 181
Query: 459 FVADFGIARLLNYDSSNRTLLAGTYGSIAPELAY--TMVVTEKYDVYSFGVVALEVLMGK 516
+ DFG+++ + +S + + GT +PEL T +K D+++ G + E+ GK
Sbjct: 182 KIGDFGLSKNIGIESMAHSCV-GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
Query: 517 HP 518
P
Sbjct: 241 TP 242
|
Length = 1021 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 8e-06
Identities = 48/209 (22%), Positives = 92/209 (44%), Gaps = 15/209 (7%)
Query: 323 IGTGGYGSVYRARLPSG-KVVALKKLHR-LETELASLESFQNEARLLSQIRHRN-IVKLY 379
IG G Y V RL ++ A+K + + L + ++ Q E + Q +V L+
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 380 GFCLHEKCMFLIYEYMEMGSLFCIL---RTDEEAVGLDWTKRVNIVKGMAHALSYLHHHC 436
+FL+ EY+ G L + R E + + I AL++LH
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICI------ALNFLHER- 115
Query: 437 TPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVV 496
I++RD+ +N+LL+++ + D+G+ + + GT IAPE+
Sbjct: 116 --GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY 173
Query: 497 TEKYDVYSFGVVALEVLMGKHPGELLSSS 525
D ++ GV+ E++ G+ P ++++ +
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIITDN 202
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 9e-06
Identities = 55/245 (22%), Positives = 102/245 (41%), Gaps = 51/245 (20%)
Query: 315 EDFDIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRLET-ELASLESFQNEARLLSQIRH 372
+DF+ IG G +G V + +G + A+K L + + E + + E +L +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRT----DEEAVGLDWTKRVNIVKGMAHA 428
+VK++ ++ ++LI E++ G + +L EEA + V + + H
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAI-HQ 119
Query: 429 LSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL------------------- 469
L ++H RDI +N+LL+++ ++DFG+ L
Sbjct: 120 LGFIH---------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSD 170
Query: 470 -NYDSSNRTLLAGTYGSIAPELAYTMVVTEKY---------------DVYSFGVVALEVL 513
++ + N A T+ +LAY+ V T Y D +S GV+ E+L
Sbjct: 171 FSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
Query: 514 MGKHP 518
+G P
Sbjct: 231 IGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 59/238 (24%), Positives = 91/238 (38%), Gaps = 41/238 (17%)
Query: 319 IKYCIGTGGYGSVYRARLPSGKVV---ALKKLHRLETELASLESFQ----------NEAR 365
I IG GG+G VY + S + A+ K+ LE E +E+ +
Sbjct: 16 IDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWK 75
Query: 366 LLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRV------ 419
+ I H I K YG C K + Y ++ + L T E KR+
Sbjct: 76 NIHNIDHLGIPKYYG-CGSFKRCRMYYRFILLEKLV--ENTKE------IFKRIKCKNKK 126
Query: 420 ---NIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIA-------RLL 469
NI+K M L Y+H H I H DI NI+++ ++ D+GIA + +
Sbjct: 127 LIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHI 183
Query: 470 NYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSS 527
Y + L GT + VT + D+ S G L+ K P + + +
Sbjct: 184 EYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241
|
Length = 294 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 30/207 (14%)
Query: 330 SVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCM 388
SVY AR P+G +V ++ L++ QNE L RH NI+ + +
Sbjct: 15 SVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWL 74
Query: 389 FLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSN 448
++I +M GS +L+T G+ NI+ G L+YLH + +HR+I ++
Sbjct: 75 WVISPFMAYGSANSLLKTYFPE-GMSEALIGNILFGALRGLNYLHQN---GYIHRNIKAS 130
Query: 449 NILLNSEFEAFVADFGIARLLN-----------YDSSNRTLLAGTYGSIAPEL------A 491
+IL++ + V+ G++ L + YD + + ++PEL
Sbjct: 131 HILISG--DGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPW--LSPELLRQDLYG 186
Query: 492 YTMVVTEKYDVYSFGVVALEVLMGKHP 518
Y + K D+YS G+ A E+ G+ P
Sbjct: 187 YNV----KSDIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 55/221 (24%), Positives = 106/221 (47%), Gaps = 23/221 (10%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGKV-VALKKLHRLETELAS-LESFQNEARLLSQIRH 372
EDF+ I G YG+VY R + A+KK+++ L + ++ E +L+ +
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYL 432
+V ++ ++ + ++ EY+E G +L+ + A+ +D R+ + + AL YL
Sbjct: 61 PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLK-NIGALPVD-MARMYFAETVL-ALEYL 117
Query: 433 HHHCTPPILHRDISSNNILLNSEFEAFVADFGIAR--LLNY---------DSSNRTLL-- 479
H++ I+HRD+ +N+L+ S + DFG+++ L++ + R L
Sbjct: 118 HNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDK 174
Query: 480 --AGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHP 518
GT IAPE+ + D ++ G++ E L+G P
Sbjct: 175 QVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 44/219 (20%)
Query: 323 IGTGGYGSVYRARLPS---GKVVALKKLHRLETELASLESFQNEARLLSQIR-HRNIVKL 378
+G G YG V AR + VA+KK+ + ++ + E +LL R H+NI L
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67
Query: 379 YGFCLHEKCMF-LIYEYMEM--GSLFCILRTDEEAVGLDWTKRVNIVKGMAH-------- 427
Y + F +Y Y E+ L I+R+ + AH
Sbjct: 68 YDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPL-------------TDAHFQSFIYQI 114
Query: 428 --ALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS-SNRTLLAGTYG 484
L Y+H + +LHRD+ N+L+N++ E + DFG+AR + + N +
Sbjct: 115 LCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA 171
Query: 485 SI---APELAYTMVVTEKY----DVYSFGVVALEVLMGK 516
+ APE+ M+ + Y DV+S G + E+L K
Sbjct: 172 TRWYRAPEI---MLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 51/221 (23%), Positives = 100/221 (45%), Gaps = 26/221 (11%)
Query: 323 IGTGGYGSVYRARLPSG-KVVALKKLHR-LETELASLESFQNEARLLSQI-RHRNIVKLY 379
IG G Y V L ++ A+K + + L + ++ Q E + H +V L+
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 380 GFCLHEKCMFLIYEYMEMGSLFCIL----RTDEEAVGLDWTKRVNIVKGMAHALSYLHHH 435
E +F + E++ G L + + EE ++ +++ AL++LH
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARF-YSAEISL------ALNFLHER 115
Query: 436 CTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMV 495
I++RD+ +N+LL++E + D+G+ + + GT IAPE+ +
Sbjct: 116 ---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEI----L 168
Query: 496 VTEKY----DVYSFGVVALEVLMGKHPGELLSSSSSSLDKN 532
E Y D ++ GV+ E++ G+ P +++ S + D+N
Sbjct: 169 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNP-DQN 208
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 3e-05
Identities = 57/245 (23%), Positives = 88/245 (35%), Gaps = 71/245 (28%)
Query: 323 IGTGGYGSVYRARLP-SGKVVALK-----------KLHRLETELASLESFQNEARLLSQI 370
+G G G V+ RL +GK+ ALK K+ R+ TE +L+ +
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTE----------QEILATL 58
Query: 371 RHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAH--- 427
H + LY E + L+ +Y G LF +L+ + + A
Sbjct: 59 DHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKC-----LSEEVARFYAAEVL 113
Query: 428 -ALSYLHHHCTPPILHRDISSNNILLN-------SEF------------EAFVADFGIAR 467
AL YLH I++RD+ NILL+ S+F + G R
Sbjct: 114 LALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRR 170
Query: 468 LLNYDSSNRTLLA----------GTYGSIAPEL----AYTMVVTEKYDVYSFGVVALEVL 513
+ T GT IAPE+ + V D ++ G++ E+L
Sbjct: 171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV----DWWTLGILLYEML 226
Query: 514 MGKHP 518
G P
Sbjct: 227 YGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 35/119 (29%), Positives = 61/119 (51%), Gaps = 14/119 (11%)
Query: 407 DEEAVGLDWTKRVNIVKGMAHALSYL-HHHCTPPILHRDISSNNILLNSEFEAFVADFGI 465
+E+ + LD ++ +A +S+L +C +HRD+++ NILL + DFG+
Sbjct: 205 EEDELALDTEDLLSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGL 260
Query: 466 ARLLNYDSS-----NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVL-MGKHP 518
AR + DS+ N L +APE + V T + DV+S+G++ E+ +G P
Sbjct: 261 ARDIRNDSNYVVKGNARL---PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 30/85 (35%), Positives = 45/85 (52%), Gaps = 11/85 (12%)
Query: 441 LHRDISSNNILLNSEFEAFVADFGIARLLNYD------SSNRTLLAGTYGSIAPELAYTM 494
+HRD+++ NILL+ + DFG+AR + D S R L +APE +
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW----MAPESIFDK 251
Query: 495 VVTEKYDVYSFGVVALEVL-MGKHP 518
V T + DV+SFGV+ E+ +G P
Sbjct: 252 VYTTQSDVWSFGVLLWEIFSLGASP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 29/84 (34%), Positives = 47/84 (55%), Gaps = 9/84 (10%)
Query: 441 LHRDISSNNILLNSEFEAFVADFGIARLLNYDSS-----NRTLLAGTYGSIAPELAYTMV 495
+HRD+++ N+LL A + DFG+AR + DS+ N L +APE + V
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL---PVKWMAPESIFDCV 290
Query: 496 VTEKYDVYSFGVVALEVL-MGKHP 518
T + DV+S+G++ E+ +GK P
Sbjct: 291 YTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-05
Identities = 56/198 (28%), Positives = 81/198 (40%), Gaps = 27/198 (13%)
Query: 333 RARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392
R P KVVA + E + A S E L+ H IVK + + + LI
Sbjct: 88 RGSDPKEKVVAKFVMLNDERQAAYARS---ELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144
Query: 393 EYMEMGSLFCILRT--------DEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRD 444
EY G L ++ E VGL + + V AL +H ++HRD
Sbjct: 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIV-------LALDEVHSRK---MMHRD 194
Query: 445 ISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLA----GTYGSIAPELAYTMVVTEKY 500
+ S NI L + DFG ++ Y S +A GT +APEL ++K
Sbjct: 195 LKSANIFLMPTGIIKLGDFGFSK--QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKA 252
Query: 501 DVYSFGVVALEVLMGKHP 518
D++S GV+ E+L P
Sbjct: 253 DMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 28/83 (33%), Positives = 45/83 (54%), Gaps = 7/83 (8%)
Query: 441 LHRDISSNNILLNSEFEAFVADFGIARLL----NYDSSNRTLLAGTYGSIAPELAYTMVV 496
+HRD+++ NILL+ + DFG+AR + +Y L + +APE + V
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW--MAPETIFDRVY 258
Query: 497 TEKYDVYSFGVVALEVL-MGKHP 518
T + DV+SFGV+ E+ +G P
Sbjct: 259 TIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 28/83 (33%), Positives = 45/83 (54%), Gaps = 7/83 (8%)
Query: 441 LHRDISSNNILLNSEFEAFVADFGIARLL----NYDSSNRTLLAGTYGSIAPELAYTMVV 496
+HRD+++ NILL+ + DFG+AR + +Y L + +APE + V
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW--MAPESIFDKVY 252
Query: 497 TEKYDVYSFGVVALEVL-MGKHP 518
T + DV+SFGV+ E+ +G P
Sbjct: 253 TTQSDVWSFGVLLWEIFSLGASP 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 29/92 (31%), Positives = 51/92 (55%), Gaps = 9/92 (9%)
Query: 441 LHRDISSNNILLNSEFEAFVADFGIARLL----NYDSSNRTLLAGTYGSIAPELAYTMVV 496
+HRD+++ N+LL + DFG+AR + NY S T L + +APE + +
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKW--MAPESIFDNLY 316
Query: 497 TEKYDVYSFGVVALEVL-MG--KHPGELLSSS 525
T DV+S+G++ E+ +G +PG ++ S+
Sbjct: 317 TTLSDVWSYGILLWEIFSLGGTPYPGMIVDST 348
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 2e-04
Identities = 21/60 (35%), Positives = 27/60 (45%), Gaps = 2/60 (3%)
Query: 103 LRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPE-LMNCSKLRILKLGNNLL 161
L+S+DLS N+L + L L L++ N L I PE LR L L N L
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTS-ISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 15/104 (14%)
Query: 428 ALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL--NYDSSNRTLLAGTYGS 485
A+ Y+H I+HRDI + N+L+N + + DFG A ++ + +AGT +
Sbjct: 272 AIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDT 328
Query: 486 IAPE-LA---YTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS 525
APE LA YT V D++S G+V E + H L S+S
Sbjct: 329 NAPEVLAGDPYTPSV----DIWSAGLVIFEAAV--HTASLFSAS 366
|
Length = 461 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 26/148 (17%), Positives = 51/148 (34%), Gaps = 17/148 (11%)
Query: 323 IGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIV--KLYG 380
+ G VY V LK E + E +L + + + K+
Sbjct: 6 LKGGLTNRVYLLGTKDEDYV-LKINPSREKGAD----REREVAILQLLARKGLPVPKVLA 60
Query: 381 FCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPI 440
+ +L+ E++E E + ++ +I + +A L+ LH +
Sbjct: 61 SGESDGWSYLLMEWIE----------GETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVL 110
Query: 441 LHRDISSNNILLNSEFEAFVADFGIARL 468
H D+ NIL++ + D+ A
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 54/228 (23%), Positives = 82/228 (35%), Gaps = 37/228 (16%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRL---SELKILNLSLNSLVGNIPSNVG-----HL 52
+ + L LDLSDN L L S L+ L L+ N L +
Sbjct: 77 LTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLP 136
Query: 53 TQLTTLAIASNRMNG----SILLGIGSLKVLQVLDLSRNEIGGS-IPST---LGHLKWLR 104
L L + NR+ G ++ + + + L+ L+L+ N IG + I + L L
Sbjct: 137 PALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLE 196
Query: 105 SVDLSQNKL----VGPIPSSLGHLTQLTTLNMYNNKLDGPIPPEL-----MNCSKLRILK 155
+DL+ N L + +L L L LN+ +N L L L L
Sbjct: 197 VLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLS 256
Query: 156 LGNN--------LLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGE 195
L N L+ + + + L LDL GN + L E
Sbjct: 257 LSCNDITDDGAKDLAEVLAEK----ESLLELDLRGNKFGEEGAQLLAE 300
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 69/301 (22%), Positives = 98/301 (32%), Gaps = 88/301 (29%)
Query: 4 LRNLVHLDLSDNHFMGH----IPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLA 59
L L L L N + L LK L LSLN G IP + L Q
Sbjct: 22 LLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNET-GRIPRGLQSLLQ----- 75
Query: 60 IASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIP---------STLGHLKW-------- 102
G+ LQ LDLS N +G S+L LK
Sbjct: 76 ------------GLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDR 123
Query: 103 ---------------LRSVDLSQNKLVG----PIPSSLGHLTQLTTLNMYNNKLDGP--- 140
L + L +N+L G + +L L LN+ NN +
Sbjct: 124 GLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIR 183
Query: 141 -IPPELMNCSKLRILKLGNN--------LLSGSIPSQIGKLQELYYLDLSGNFINGKI-- 189
+ L L +L L NN L+ ++ S L+ L+L N +
Sbjct: 184 ALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLK-SLEV---LNLGDNNLTDAGAA 239
Query: 190 ---PSQLGEFSCIDTVDLSMNN--------LSGGIPVFVRKVPHLDVSGNQFGGEIPTTL 238
+ L + T+ LS N+ L+ + + LD+ GN+FG E L
Sbjct: 240 ALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLL-ELDLRGNKFGEEGAQLL 298
Query: 239 A 239
A
Sbjct: 299 A 299
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 62/258 (24%), Positives = 101/258 (39%), Gaps = 65/258 (25%)
Query: 315 EDFDIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRLETEL---ASLESFQNEARLLSQI 370
EDF IG G +G V + +GK+ A+K L L++E+ L + E +L++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTL--LKSEMFKKDQLAHVKAERDVLAES 58
Query: 371 RHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCIL---RTDEEAVGLDWTKRVNIVKGMAH 427
+V LY + ++LI E++ G L +L T E V + + H
Sbjct: 59 DSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVH 118
Query: 428 ALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIA-------------RLLNYDSS 474
L ++H RDI +NIL++ ++DFG++ +LL S+
Sbjct: 119 KLGFIH---------RDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSN 169
Query: 475 ------------------------------NRTLLA----GTYGSIAPELAYTMVVTEKY 500
NR L+A GT IAPE+ ++
Sbjct: 170 KNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQEC 229
Query: 501 DVYSFGVVALEVLMGKHP 518
D +S G + E L+G P
Sbjct: 230 DWWSLGAIMFECLIGWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 27/83 (32%), Positives = 45/83 (54%), Gaps = 7/83 (8%)
Query: 441 LHRDISSNNILLNSEFEAFVADFGIARLL----NYDSSNRTLLAGTYGSIAPELAYTMVV 496
+HRD+++ N+L+ + DFG+AR + NY S T L + +APE + +
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKW--MAPESIFNNLY 318
Query: 497 TEKYDVYSFGVVALEVL-MGKHP 518
T DV+SFG++ E+ +G P
Sbjct: 319 TTLSDVWSFGILLWEIFTLGGTP 341
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.002
Identities = 21/59 (35%), Positives = 28/59 (47%), Gaps = 2/59 (3%)
Query: 126 QLTTLNMYNNKLDGPIPPE-LMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGN 183
L +L++ NN+L IP L++L L N L+ P L L LDLSGN
Sbjct: 1 NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58
|
Length = 60 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 51/230 (22%), Positives = 105/230 (45%), Gaps = 22/230 (9%)
Query: 337 PSGKVVALKKLHRLETELASLESF-QNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYM 395
P+G+ V +++++ LE + +F Q E + H NIV + + ++++ +M
Sbjct: 23 PTGEYVTVRRIN-LEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81
Query: 396 EMGS---LFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILL 452
GS L C D G+ I++G+ AL Y+HH +HR + +++IL+
Sbjct: 82 AYGSAKDLICTHFMD----GMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILI 134
Query: 453 NSEFEAFVADF-GIARLLNYDSSNRTLLAGTYGSI------APELAYTMV--VTEKYDVY 503
+ + + +++ ++N+ R + S+ +PE+ + K D+Y
Sbjct: 135 SVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIY 194
Query: 504 SFGVVALEVLMGKHPGELLSSSSSSLDK-NIKLIDLLDPRLPPPGDQMIR 552
S G+ A E+ G P + + ++ L+K N + LLD P + ++
Sbjct: 195 SVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMK 244
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 35.6 bits (83), Expect = 0.003
Identities = 24/65 (36%), Positives = 31/65 (47%), Gaps = 10/65 (15%)
Query: 54 QLTTLAIASNRMNGSILLGIG-----SLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDL 108
L +L +++NR L I L L+VLDLS N + P L LRS+DL
Sbjct: 1 NLKSLDLSNNR-----LTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDL 55
Query: 109 SQNKL 113
S N L
Sbjct: 56 SGNNL 60
|
Length = 60 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 52/251 (20%), Positives = 99/251 (39%), Gaps = 67/251 (26%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHR----LETELASLESFQNEARLLSQIRHRNIVK 377
+G G +G V AR + + + A+K L + L ++A +++ E +L++ + +V+
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKA---ERDILAEADNEWVVR 65
Query: 378 LYGFCLHEKCMFLIYEYM---EMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHH 434
LY + ++ + +Y+ +M SL + E + + + H + ++H
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIH- 124
Query: 435 HCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY----------------------- 471
RDI +NIL++ + + DFG+ +
Sbjct: 125 --------RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNE 176
Query: 472 --DSSN-------------------RTL---LAGTYGSIAPELAYTMVVTEKYDVYSFGV 507
D +N R L L GT IAPE+ T+ D +S GV
Sbjct: 177 WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236
Query: 508 VALEVLMGKHP 518
+ E+L+G+ P
Sbjct: 237 ILYEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 55/248 (22%), Positives = 100/248 (40%), Gaps = 65/248 (26%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLET----ELASLESFQNEARLLSQIRHRNIVK 377
IG G +G V R + + + A+K L + + + A +++ E +L++ + +VK
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKA---ERDILAEADNEWVVK 65
Query: 378 LYGFCLHEK-CMFLIYEYM---EMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLH 433
LY + +K ++ + +Y+ +M SL L EE + R I + + A+ +H
Sbjct: 66 LY-YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA-----RFYIAE-LTCAIESVH 118
Query: 434 HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY---------------------- 471
+HRDI +NIL++ + + DFG+ +
Sbjct: 119 KM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175
Query: 472 ---DSSNRTL------------------LAGTYGSIAPELAYTMVVTEKYDVYSFGVVAL 510
+ L L GT IAPE+ T+ D +S GV+
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235
Query: 511 EVLMGKHP 518
E+L+G+ P
Sbjct: 236 EMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 560 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.98 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.98 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.95 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.89 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.89 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.87 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.86 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.83 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.83 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.8 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.79 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.79 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.77 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.76 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.76 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.76 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.76 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.75 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.74 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.74 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.73 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.73 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.73 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.73 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.72 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.71 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.71 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.7 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.69 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.68 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.65 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.63 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.6 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.59 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.57 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.51 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.5 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.48 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.46 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.45 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.41 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.4 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.39 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.39 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.38 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.37 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.36 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.36 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.33 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.32 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.32 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.3 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.29 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.27 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.21 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.2 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.2 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.18 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.14 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 99.12 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.12 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 99.09 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.98 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.97 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.88 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.87 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.86 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.84 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.81 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.78 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.78 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.77 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.73 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.73 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.73 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.69 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.67 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.66 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-68 Score=601.27 Aligned_cols=528 Identities=30% Similarity=0.492 Sum_probs=383.1
Q ss_pred CCCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCE
Q 035761 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQV 81 (560)
Q Consensus 2 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~ 81 (560)
+.+++|+.|+|++|++++..|..+..+++|+.|++++|++.+..|..+..+++|+.|+|++|++++..|..|.++++|+.
T Consensus 353 ~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 432 (968)
T PLN00113 353 GKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYF 432 (968)
T ss_pred hCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCE
Confidence 45778889999999888888888888888888888888888888888888888888888888888778888888888888
Q ss_pred EEeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCccc
Q 035761 82 LDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLL 161 (560)
Q Consensus 82 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 161 (560)
|++++|.+++..+..+..+++|+.|+|++|++.+..|..+ ..++|+.|++++|++++..|..+.++++|+.|++++|++
T Consensus 433 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 511 (968)
T PLN00113 433 LDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKL 511 (968)
T ss_pred EECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcc
Confidence 8888888888777777778888888888888877666655 357788888888888777777777788888888888888
Q ss_pred ccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCccc---ccCCCCcCCCCCCCCcCCccc
Q 035761 162 SGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFV---RKVPHLDVSGNQFGGEIPTTL 238 (560)
Q Consensus 162 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~~---~~l~~l~l~~n~~~~~~p~~~ 238 (560)
++.+|..+..+++|++|+|++|.+++.+|..+..+++|+.|+|++|++++.+|..+ ..+..+++++|++.|.+|...
T Consensus 512 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~ 591 (968)
T PLN00113 512 SGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTG 591 (968)
T ss_pred eeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcc
Confidence 77777777788888888888888887777777778888888888888887777644 446667777777776554321
Q ss_pred C----------------C------CCCC----CCCcchhhhhHHHHHHHHHHHHHHhheeeEeccCCCCCCCCccccccc
Q 035761 239 A----------------N------VPPP----HHKTIATGLVAIILAMVAFLALIFGILIIRRRRDKEIEPTGTVEITKC 292 (560)
Q Consensus 239 ~----------------~------~~~~----~~~~~~~~~~~~~~~~v~~~~l~~~~~~~rr~r~k~~~~~~~~~~~~~ 292 (560)
. . .++. ....+..++++++.+++++++++++++++|++++.+.+..+ ....
T Consensus 592 ~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 668 (968)
T PLN00113 592 AFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVE---NEDG 668 (968)
T ss_pred hhcccChhhhcCCccccCCccccCCCCCccccccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccc---cccc
Confidence 0 0 0000 01111112222222222222233333333333322111100 0000
Q ss_pred ccceeeec--CCCCcCHHHHHHHhcCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhc
Q 035761 293 ADEIAIWN--YDGRITFQDMIEATEDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQ 369 (560)
Q Consensus 293 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~ 369 (560)
..+..... ....++++++ ...+...+.||+|+||.||+|.. .++..||||++..... ...+|++.+++
T Consensus 669 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~ 739 (968)
T PLN00113 669 TWELQFFDSKVSKSITINDI---LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGK 739 (968)
T ss_pred cccccccccccchhhhHHHH---HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhh
Confidence 00111111 0112334443 34577788999999999999986 5789999999864332 11346888999
Q ss_pred cCCCCcceeeeEEEeCCEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCC
Q 035761 370 IRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNN 449 (560)
Q Consensus 370 l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~N 449 (560)
++|||||+++|+|.+++..++||||+++|+|.++++. ++|.++.+|+.|||+||+|||..+.++|+|||+||+|
T Consensus 740 l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~N 813 (968)
T PLN00113 740 LQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEK 813 (968)
T ss_pred CCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHh
Confidence 9999999999999999999999999999999999963 8999999999999999999996656699999999999
Q ss_pred eEeCCCCcEEEeeeccccccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccccc--
Q 035761 450 ILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSS-- 527 (560)
Q Consensus 450 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~~-- 527 (560)
|+++.++.+++. ||.+...... ....+++.|||||++.+..++.++|||||||++|||+||+.||+.......
T Consensus 814 il~~~~~~~~~~-~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~ 888 (968)
T PLN00113 814 IIIDGKDEPHLR-LSLPGLLCTD----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSI 888 (968)
T ss_pred EEECCCCceEEE-eccccccccC----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcH
Confidence 999999888875 6655433211 123578999999999999999999999999999999999999853211000
Q ss_pred ---------------------------------ccccccccccccCCCCCCChhHHHhh
Q 035761 528 ---------------------------------SLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 528 ---------------------------------~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
++.+.+..|...||+.||+++++++.
T Consensus 889 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 889 VEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred HHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 01122335667799999999998875
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-49 Score=389.54 Aligned_cols=241 Identities=41% Similarity=0.691 Sum_probs=204.7
Q ss_pred CCCCcCHHHHHHHhcCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeee
Q 035761 301 YDGRITFQDMIEATEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYG 380 (560)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 380 (560)
....+++.++..+|++|+..+.||+|+||.||+|.+.+|+.||||++....... .++|.+|++++.+++|||+|+++|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlG 138 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLG 138 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEE
Confidence 344689999999999999999999999999999999999999999887654321 456999999999999999999999
Q ss_pred EEEeCC-EEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEE
Q 035761 381 FCLHEK-CMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAF 459 (560)
Q Consensus 381 ~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 459 (560)
||.+.+ ..+||||||++|+|.++++..... .++|.+|++||.++|+||+|||+.+.|+||||||||+|||+|+++++|
T Consensus 139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred EEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 999998 599999999999999999986543 699999999999999999999999888999999999999999999999
Q ss_pred EeeeccccccCCCCCCceee-ccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc-c-------cccc
Q 035761 460 VADFGIARLLNYDSSNRTLL-AGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS-S-------SSLD 530 (560)
Q Consensus 460 l~Dfg~~~~~~~~~~~~~~~-~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~-~-------~~~~ 530 (560)
|+|||+|+............ .||.+|+|||+...+..++|+|||||||++.|++||+.|.+..... . ....
T Consensus 218 lsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred ccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 99999997654312222222 7999999999999999999999999999999999999887643211 1 1122
Q ss_pred cccccccccCCCCC
Q 035761 531 KNIKLIDLLDPRLP 544 (560)
Q Consensus 531 ~~~~~~~~~dp~~~ 544 (560)
+..+..+.+||++.
T Consensus 298 ~~~~~~eiiD~~l~ 311 (361)
T KOG1187|consen 298 EEGKLREIVDPRLK 311 (361)
T ss_pred HCcchhheeCCCcc
Confidence 23356677787764
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-48 Score=363.18 Aligned_cols=200 Identities=31% Similarity=0.504 Sum_probs=181.8
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
.+|...+.||+|+||+||+|+++ ++.+||||.+....-.....+.+..|+++++.++|||||.++++++.++..|+|||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 56888888999999999999875 58999999998765345566778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCC------CcEEEeeecccc
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSE------FEAFVADFGIAR 467 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~------~~~kl~Dfg~~~ 467 (560)
||.+|+|.+|+++.+. +++.....++.|+|.||++||++ +||||||||.|||++.. -.+||+|||+|+
T Consensus 90 yC~gGDLs~yi~~~~~---l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRGR---LPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred eCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 9999999999998754 99999999999999999999999 99999999999999865 457999999999
Q ss_pred ccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCc
Q 035761 468 LLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGEL 521 (560)
Q Consensus 468 ~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~ 521 (560)
.+. +.......+|++-|||||++...+|+.|+|+||.|+++||+++|+.||+.
T Consensus 164 ~L~-~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 164 FLQ-PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred hCC-chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 987 34455667899999999999999999999999999999999999999983
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-47 Score=373.82 Aligned_cols=237 Identities=27% Similarity=0.450 Sum_probs=213.5
Q ss_pred cCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
..|...+.||+|+|+.+|+++. ..|+.||+|++.+..- .....+...+|+++.+.++|||||+++++|++..+.|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688899999999999999987 7899999999987542 2344567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
|+|++++|..++++.. .+++.+++.++.||+.||.|||+. +|+|||||..|++++++.++||+|||+|..+..+
T Consensus 98 ELC~~~sL~el~Krrk---~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRK---PLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHHhcC---CCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999998543 399999999999999999999999 9999999999999999999999999999999888
Q ss_pred CCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------ccccccccccc
Q 035761 473 SSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNIKL 535 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~~~ 535 (560)
.+.....+|||.|.|||++....++..+||||+||+||.|+.|++||+...- .+.+..+.++.
T Consensus 172 ~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~ 251 (592)
T KOG0575|consen 172 GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRK 251 (592)
T ss_pred ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHH
Confidence 7888888999999999999999999999999999999999999999985531 12234567778
Q ss_pred ccccCCCCCCChhHHHhhceee
Q 035761 536 IDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 536 ~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
+...+|..||+++++++|.|+.
T Consensus 252 lL~~~P~~Rpsl~~vL~h~Ff~ 273 (592)
T KOG0575|consen 252 LLRPNPSERPSLDEVLDHPFFK 273 (592)
T ss_pred HhcCCcccCCCHHHHhcCHhhh
Confidence 8888999999999999999983
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-47 Score=372.07 Aligned_cols=205 Identities=37% Similarity=0.591 Sum_probs=179.1
Q ss_pred CCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCC-EEEEEEec
Q 035761 316 DFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEK-CMFLIYEY 394 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~ 394 (560)
++...+.+|+|+||.||+|.++....||||++..........+.|.+|+.+|++++|||||+++|+|.+.. ..++||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 34455669999999999999975555999999876543333778999999999999999999999999987 79999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEEeCCCCCCeEeCCCC-cEEEeeeccccccCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPP-ILHRDISSNNILLNSEF-EAFVADFGIARLLNYD 472 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~-ivH~dlk~~Nill~~~~-~~kl~Dfg~~~~~~~~ 472 (560)
|++|+|.++++.. ....+++..+++||.|||+||+|||++ + ||||||||+|||++.++ ++||+|||+++.....
T Consensus 122 ~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 122 MPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred CCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 9999999999874 234599999999999999999999999 7 99999999999999997 9999999999876533
Q ss_pred CCCceeeccccCccCccccc--cCccCcchhHHHHHHHHHHHHhCCCCCCcccc
Q 035761 473 SSNRTLLAGTYGSIAPELAY--TMVVTEKYDVYSFGVVALEVLMGKHPGELLSS 524 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~--~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~ 524 (560)
........||+.|||||++. ...|+.|+|||||||++|||+||+.||+....
T Consensus 198 ~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~ 251 (362)
T KOG0192|consen 198 KTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP 251 (362)
T ss_pred cccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence 23333467999999999999 66999999999999999999999999987764
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-47 Score=353.39 Aligned_cols=233 Identities=27% Similarity=0.386 Sum_probs=204.0
Q ss_pred CcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCC-EEEEEEec
Q 035761 317 FDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEK-CMFLIYEY 394 (560)
Q Consensus 317 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~ 394 (560)
++..+.||+|+.|+|||++++ +++.+|+|.+... .+....+++.+|+++++..+|||||.++|.|+.+. ...++|||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~-~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN-IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc-CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 455678999999999999876 5788999999433 33455678899999999999999999999999999 59999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHH-HCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|++|+|..++...+. +++...-+|+.+|++||.|||+ . +||||||||+|||++..|++||||||.+..+...
T Consensus 160 MDgGSLd~~~k~~g~---i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRVGR---IPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred cCCCCHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 999999999986543 8999999999999999999996 5 9999999999999999999999999999887532
Q ss_pred CCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc------------------------ccccc
Q 035761 474 SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS------------------------SSSSL 529 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~------------------------~~~~~ 529 (560)
.....+||..|||||.+.+..|+.++||||||+.++|+.+|++||..... .+.++
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef 311 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEF 311 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHH
Confidence 45567899999999999999999999999999999999999999875310 22345
Q ss_pred ccccccccccCCCCCCChhHHHhhceeee
Q 035761 530 DKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 530 ~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
...+..|..-||+.||++++++.|+||..
T Consensus 312 ~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~ 340 (364)
T KOG0581|consen 312 RSFVSCCLRKDPSERPSAKQLLQHPFIKK 340 (364)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCHHHhh
Confidence 66677888999999999999999999874
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=357.27 Aligned_cols=239 Identities=28% Similarity=0.403 Sum_probs=203.5
Q ss_pred hcCCcccceeeccCCeeEEEEE-eCCCcEEEEEEccchhhhhh-----hHHHHHHHHHHHhccCCCCcceeeeEEEeCCE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELA-----SLESFQNEARLLSQIRHRNIVKLYGFCLHEKC 387 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 387 (560)
.+.|.+.+.+|+|+||.|-.|. -++|+.||||++++...... ......+|+++|++++|||||++.+++..++.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 4567888999999999999996 45799999999986552211 12234799999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCC---CcEEEeeec
Q 035761 388 MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSE---FEAFVADFG 464 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg 464 (560)
.|||||||+||+|.+++-.+.. +.+..-..+++|++.|+.|||++ ||+||||||+|||+..+ -.+||+|||
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk~---l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANKY---LREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred eEEEEEEecCccHHHHHHhccc---cccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccc
Confidence 9999999999999999987654 77777788999999999999999 99999999999999766 668999999
Q ss_pred cccccCCCCCCceeeccccCccCccccccCcc--Cc-chhHHHHHHHHHHHHhCCCCCCcccc-----------------
Q 035761 465 IARLLNYDSSNRTLLAGTYGSIAPELAYTMVV--TE-KYDVYSFGVVALEVLMGKHPGELLSS----------------- 524 (560)
Q Consensus 465 ~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~--~~-~~Dv~s~G~il~el~~g~~P~~~~~~----------------- 524 (560)
+|+... ........+||+.|.|||++.+..+ ++ ++|+||+||++|-+++|.+||...-.
T Consensus 325 lAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p 403 (475)
T KOG0615|consen 325 LAKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGP 403 (475)
T ss_pred hhhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccC
Confidence 999876 5566777899999999999887653 33 78999999999999999999953321
Q ss_pred -----cccccccccccccccCCCCCCChhHHHhhceeeec
Q 035761 525 -----SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILIS 559 (560)
Q Consensus 525 -----~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~~ 559 (560)
.+++....+..+..+||+.||++++.++|+|+.-+
T Consensus 404 ~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 404 LQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 23345566788899999999999999999999743
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-46 Score=347.25 Aligned_cols=236 Identities=28% Similarity=0.422 Sum_probs=198.6
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLI 391 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 391 (560)
.++|++.++||+|+||.||.++.+ +++.+|+|++++... .....+...+|..++.+++||.||+++-.+++.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 467999999999999999999764 588999999987663 233567788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 471 (560)
+||+.||.|..++++.+. +++..+.-++..|+.||.|||+. ||||||+||+|||+|.+|+++|+|||+++..-.
T Consensus 104 ld~~~GGeLf~hL~~eg~---F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGR---FSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHHhcCC---cchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 999999999999987655 89999999999999999999999 999999999999999999999999999997655
Q ss_pred CCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccccccCCC-CCCChhHH
Q 035761 472 DSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPR-LPPPGDQM 550 (560)
Q Consensus 472 ~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~~~~~~~~~~~~~~dp~-~~p~~~~~ 550 (560)
.+......+||+.|||||++.+..|+..+|+||+|+++|||++|.+||...+. ....+.+.+......|. +.++++++
T Consensus 178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~-~~~~~~I~~~k~~~~p~~ls~~ardl 256 (357)
T KOG0598|consen 178 DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV-KKMYDKILKGKLPLPPGYLSEEARDL 256 (357)
T ss_pred CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH-HHHHHHHhcCcCCCCCccCCHHHHHH
Confidence 55566668999999999999999999999999999999999999999985542 22222232222233333 55666666
Q ss_pred Hhhcee
Q 035761 551 IRQGII 556 (560)
Q Consensus 551 ~~~~~~ 556 (560)
++..+-
T Consensus 257 l~~LL~ 262 (357)
T KOG0598|consen 257 LKKLLK 262 (357)
T ss_pred HHHHhc
Confidence 655443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-46 Score=335.97 Aligned_cols=236 Identities=25% Similarity=0.338 Sum_probs=206.2
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
++|+....+|+|+||+|||++.+ +|+.||||+|...++.+.-.+-.++|+.++++++|||+|.++.+|......+||||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 45777888999999999999976 49999999998877766666778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|++. ++.+-+...+.+ ++.+.+.++++|+++|+.|+|++ ++|||||||+|||++.++.+||||||+|+.+..++
T Consensus 82 ~~dh-TvL~eLe~~p~G--~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNG--VPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred ecch-HHHHHHHhccCC--CCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 9988 444555544433 89999999999999999999999 99999999999999999999999999999998788
Q ss_pred CCceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCcccccc--------------------------
Q 035761 474 SNRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSSSS-------------------------- 526 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~-------------------------- 526 (560)
...+..+.|.+|.|||++.+ .+|...+||||.||++.||++|.+-|...++.+
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 88888999999999999887 789999999999999999999998886555311
Q ss_pred ----------------------cccccccccccccCCCCCCChhHHHhhcee
Q 035761 527 ----------------------SSLDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 527 ----------------------~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
.-+....+.|..+||.-|.++++++.|.++
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yF 287 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYF 287 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHH
Confidence 112345577889999999999999988765
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=358.57 Aligned_cols=231 Identities=29% Similarity=0.461 Sum_probs=192.0
Q ss_pred hcCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
.+.+.+.+.||+|.||.||.|.++....||+|.++... ...+.|.+|+++|++++|++||+++|+|..++..+||||
T Consensus 205 r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~---m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE 281 (468)
T KOG0197|consen 205 REELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS---MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTE 281 (468)
T ss_pred HHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc---cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEE
Confidence 34456678899999999999999888899999998653 334688999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
||+.|+|.+|++.. ....+...+.+.++.|||+||+||+++ ++|||||.++|||++++..+||+|||+|+...++.
T Consensus 282 ~m~~GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~ 357 (468)
T KOG0197|consen 282 YMPKGSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE 357 (468)
T ss_pred ecccCcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence 99999999999973 334489999999999999999999999 99999999999999999999999999999654333
Q ss_pred CCc-eeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccccc------------------ccccccc
Q 035761 474 SNR-TLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSS------------------SSLDKNI 533 (560)
Q Consensus 474 ~~~-~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~~------------------~~~~~~~ 533 (560)
+.. ....-+..|+|||.+....++.|||||||||+||||+| |+.||+.....+ ..+.+++
T Consensus 358 Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM 437 (468)
T KOG0197|consen 358 YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELM 437 (468)
T ss_pred eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHH
Confidence 322 22234679999999999999999999999999999999 999998666421 1233344
Q ss_pred ccccccCCCCCCChhHHH
Q 035761 534 KLIDLLDPRLPPPGDQMI 551 (560)
Q Consensus 534 ~~~~~~dp~~~p~~~~~~ 551 (560)
..|=..+|+-||+++.+.
T Consensus 438 ~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 438 KSCWHEDPEDRPTFETLR 455 (468)
T ss_pred HHHhhCCcccCCCHHHHH
Confidence 444555666666666543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-46 Score=330.56 Aligned_cols=233 Identities=26% Similarity=0.347 Sum_probs=200.7
Q ss_pred cCCcccceeeccCCeeEEEEE-eCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeE-EEeCCE-EEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGF-CLHEKC-MFLI 391 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~-~~~~~~-~~lv 391 (560)
.+|++.++||+|.||.|||+. ..+|..||.|.++-........+....|+.++++++|||||+++++ +.++.. .++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 347788899999999999996 5689999999998665555667788999999999999999999994 444444 7899
Q ss_pred EeccCCCCHHHHhhcCC-cccCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEEeCCCCCCeEeCCCCcEEEeeecccccc
Q 035761 392 YEYMEMGSLFCILRTDE-EAVGLDWTKRVNIVKGMAHALSYLHHHCTPP-ILHRDISSNNILLNSEFEAFVADFGIARLL 469 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~-ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 469 (560)
|||+..|+|.++++... ....+++..+.+++.|++.||..+|..+..+ |+||||||.||+++.+|.+|++|||+++++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999999987532 2345899999999999999999999954322 889999999999999999999999999999
Q ss_pred CCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-------------------cccccc
Q 035761 470 NYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-------------------SSSSLD 530 (560)
Q Consensus 470 ~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-------------------~~~~~~ 530 (560)
..........+|||.||+||.+.+..|+.||||||+||++|||..-.+||...+- .+..+.
T Consensus 179 ~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~~l~ 258 (375)
T KOG0591|consen 179 SSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYSTDLR 258 (375)
T ss_pred cchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhhhHHH
Confidence 8777777778999999999999999999999999999999999999999965431 234567
Q ss_pred cccccccccCCCCCCCh
Q 035761 531 KNIKLIDLLDPRLPPPG 547 (560)
Q Consensus 531 ~~~~~~~~~dp~~~p~~ 547 (560)
+++..|..+||..||+.
T Consensus 259 ~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 259 ELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHHHHccCCcccCCCc
Confidence 77888999999999984
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=349.99 Aligned_cols=237 Identities=26% Similarity=0.400 Sum_probs=210.9
Q ss_pred hcCCcccceeeccCCeeEEEEE-eCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
...|.....||+|+.|.||.|. ..+++.||||++..... ...+-..+|+.+|+..+|+|||.+++.|...+..|+||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q--~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ--PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC--CchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 3456667889999999999995 45688999999976442 23346789999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
|||++|+|.+.+.... +++.++..|++.+++||+|||.+ ||+|||||..|||++.+|.+||+|||++..+...
T Consensus 350 Eym~ggsLTDvVt~~~----~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTKTR----MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE 422 (550)
T ss_pred eecCCCchhhhhhccc----ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence 9999999999987544 89999999999999999999999 9999999999999999999999999999999887
Q ss_pred CCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccc--------------------ccccccccc
Q 035761 473 SSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLS--------------------SSSSSLDKN 532 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~--------------------~~~~~~~~~ 532 (560)
...+...+||+.|||||+.....|++|+||||||++++||+-|.+||-... ..+..+.+.
T Consensus 423 ~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdF 502 (550)
T KOG0578|consen 423 QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDF 502 (550)
T ss_pred cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHH
Confidence 778888999999999999999999999999999999999999999985332 133456677
Q ss_pred cccccccCCCCCCChhHHHhhceeeec
Q 035761 533 IKLIDLLDPRLPPPGDQMIRQGIILIS 559 (560)
Q Consensus 533 ~~~~~~~dp~~~p~~~~~~~~~~~~~~ 559 (560)
...|.++|+.-|+++.++++|+|+.-|
T Consensus 503 L~~cL~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 503 LDRCLVVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred HHHHhhcchhcCCCHHHHhcChhhhhc
Confidence 788999999999999999999998643
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=332.66 Aligned_cols=241 Identities=28% Similarity=0.440 Sum_probs=208.3
Q ss_pred hcCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
.++|++.+.||.|..++||+|+. +.++.||||++.-...+.. .+.+++|+..|+.++||||++++..|..+...|+||
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 36799999999999999999975 5689999999987665433 678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
.||.+|++.+.++..-. ..+++..+..|.+++++||.|||.+ |.||||||+.||||+.+|.|||+|||.+..+...
T Consensus 104 pfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 99999999999987543 3399999999999999999999999 9999999999999999999999999988776544
Q ss_pred CCCc----eeeccccCccCcccccc--CccCcchhHHHHHHHHHHHHhCCCCCCccccc---------------------
Q 035761 473 SSNR----TLLAGTYGSIAPELAYT--MVVTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------------- 525 (560)
Q Consensus 473 ~~~~----~~~~g~~~~~aPE~~~~--~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------------- 525 (560)
+... ...+||+.|||||++.. ..|+.|+||||||+...|+.+|..||....-.
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~ 259 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDK 259 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCCh
Confidence 4332 33479999999999553 35889999999999999999999999755511
Q ss_pred ------ccccccccccccccCCCCCCChhHHHhhceeeec
Q 035761 526 ------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILIS 559 (560)
Q Consensus 526 ------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~~ 559 (560)
...+.+.+..|.+-||+.||++.++++|.|+.++
T Consensus 260 d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 260 DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence 1124466778889999999999999999998764
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=365.85 Aligned_cols=241 Identities=26% Similarity=0.382 Sum_probs=194.2
Q ss_pred hcCCcccceeeccCCeeEEEEEeC------CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKC 387 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 387 (560)
..+....+.||+|+||.||+|+.. +.+.||||.++...+ .+..++|++|+++++.++|||||+++|+|.+++.
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~-~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAE-NQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccccc-HHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 345566788999999999999753 356799999987554 3456799999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhcCCc-----------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCC
Q 035761 388 MFLIYEYMEMGSLFCILRTDEE-----------AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEF 456 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~ 456 (560)
.+||+|||..|||.+||....+ +.+|+..+.+.||.|||.||+||-++ .+|||||.++|+|+.++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccce
Confidence 9999999999999999975321 22389999999999999999999999 999999999999999999
Q ss_pred cEEEeeeccccccCCCCCCce--eeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccccc-ccccc
Q 035761 457 EAFVADFGIARLLNYDSSNRT--LLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSSS-SLDKN 532 (560)
Q Consensus 457 ~~kl~Dfg~~~~~~~~~~~~~--~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~~~-~~~~~ 532 (560)
.|||+|||+++.....++.+- ...-+.+|||||.+..++|+++||||||||++||+++ |+.||......+. +..+.
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~ 720 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA 720 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc
Confidence 999999999998754433321 2335789999999999999999999999999999999 9999986664321 22222
Q ss_pred cccccccCCCCCCChhHHHhhceeeec
Q 035761 533 IKLIDLLDPRLPPPGDQMIRQGIILIS 559 (560)
Q Consensus 533 ~~~~~~~dp~~~p~~~~~~~~~~~~~~ 559 (560)
.+. ..-....|+++..+++.||--+|
T Consensus 721 g~l-L~~Pe~CP~~vY~LM~~CW~~~P 746 (774)
T KOG1026|consen 721 GQL-LSCPENCPTEVYSLMLECWNENP 746 (774)
T ss_pred CCc-ccCCCCCCHHHHHHHHHHhhcCc
Confidence 222 33344455666666666665443
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=315.56 Aligned_cols=230 Identities=27% Similarity=0.394 Sum_probs=200.9
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchh-hhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLE-TELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|+..+.+|.|+||.|..++.+ +|..+|+|++.+.. ....+.+...+|..+++.+.||.++++++.+.+.+..+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 45888999999999999999875 47889999998765 34455677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||++||.|.+++++.++ +++..++-+|.||+.|++|||+. +|++||+||+|||+|.+|.+||+|||+|+....
T Consensus 124 eyv~GGElFS~Lrk~~r---F~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~- 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGR---FSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG- 196 (355)
T ss_pred eccCCccHHHHHHhcCC---CCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC-
Confidence 99999999999987665 99999999999999999999999 999999999999999999999999999998643
Q ss_pred CCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccccccCCCCCCChhHHHh
Q 035761 473 SSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRLPPPGDQMIR 552 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~~~~~~~~~~~~~~dp~~~p~~~~~~~ 552 (560)
.....+|||.|+|||++....|...+|.|||||++|||+.|.+||..... ...+.++......+++-..|.++++++
T Consensus 197 --rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-~~iY~KI~~~~v~fP~~fs~~~kdLl~ 273 (355)
T KOG0616|consen 197 --RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-IQIYEKILEGKVKFPSYFSSDAKDLLK 273 (355)
T ss_pred --cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-HHHHHHHHhCcccCCcccCHHHHHHHH
Confidence 35567899999999999999999999999999999999999999974443 333455555556667777777777776
Q ss_pred hc
Q 035761 553 QG 554 (560)
Q Consensus 553 ~~ 554 (560)
+.
T Consensus 274 ~L 275 (355)
T KOG0616|consen 274 KL 275 (355)
T ss_pred HH
Confidence 63
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=343.80 Aligned_cols=236 Identities=29% Similarity=0.418 Sum_probs=210.1
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+......+.+.+++|+++++.++||||+.++++|+....+|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46778889999999999999765 57899999998877666778889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+.+ +|.+++..+.. ++++.+..|+.|++.||.|||+. +|.|||+||+|||++..+.+|+||||+|+.+....
T Consensus 82 ~a~g-~L~~il~~d~~---lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGK---LPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9977 99999987655 99999999999999999999999 99999999999999999999999999999987776
Q ss_pred CCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccc-----------------ccccccccccccc
Q 035761 474 SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLS-----------------SSSSSLDKNIKLI 536 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~-----------------~~~~~~~~~~~~~ 536 (560)
...+...|||-|||||+..+..|+..+|+||+||++||+++|++||-... ..+..+.......
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gL 234 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGL 234 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHH
Confidence 66777889999999999999999999999999999999999999994222 1222344555666
Q ss_pred cccCCCCCCChhHHHhhceee
Q 035761 537 DLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 537 ~~~dp~~~p~~~~~~~~~~~~ 557 (560)
..-||..|-++.+++.|+|+.
T Consensus 235 L~kdP~~RltW~~Ll~HpF~k 255 (808)
T KOG0597|consen 235 LIKDPAQRLTWTDLLGHPFWK 255 (808)
T ss_pred hhcChhhcccHHHHhcChHHh
Confidence 777999999999999998864
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=339.79 Aligned_cols=239 Identities=26% Similarity=0.390 Sum_probs=205.1
Q ss_pred HhcCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhh-hhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCEEE
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETE-LASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKCMF 389 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 389 (560)
...+|.+.+.||.|+|++|++|+. .+++++|||++.+.--. ....+....|-+.|.++ +||.|++++-.|.++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 346799999999999999999975 46899999998765422 23334567899999999 8999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccccc
Q 035761 390 LIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL 469 (560)
Q Consensus 390 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 469 (560)
.|+||+++|+|.++++..+. |++...+.++.+|+.|++|||+. |||||||||+|||+|+|++++|+|||.|+.+
T Consensus 151 FvLe~A~nGdll~~i~K~Gs---fde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYGS---FDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEecCCCcHHHHHHHhCc---chHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccC
Confidence 99999999999999997654 99999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCC-------------CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc-----------
Q 035761 470 NYDSS-------------NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS----------- 525 (560)
Q Consensus 470 ~~~~~-------------~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~----------- 525 (560)
.+... .+...+||..|.+||++.+...+..+|+|||||++|+|+.|.+||...+..
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y 304 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDY 304 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcc
Confidence 53211 123478999999999999999999999999999999999999999766531
Q ss_pred ------ccccccccccccccCCCCCCChhHHHhhceee
Q 035761 526 ------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 526 ------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
.+...++++...++||.-|.++.+|-+|+|+.
T Consensus 305 ~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~ 342 (604)
T KOG0592|consen 305 EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFE 342 (604)
T ss_pred cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccc
Confidence 12235566777788999999999998888864
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=335.12 Aligned_cols=236 Identities=28% Similarity=0.381 Sum_probs=199.8
Q ss_pred cCCcccceeeccCCeeEEEEE-eCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC--CEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHE--KCMFLI 391 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv 391 (560)
+.|+..+.||+|.||.||+|+ ..+|+.||+|++.-.....+...-..+|+.++++++||||+++.+...+. +.+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 457778889999999999996 46799999999987665566667788999999999999999999999887 689999
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 471 (560)
||||+. +|.-++... ...|+..++..++.|++.||+|+|.+ ||+|||||.+|||||.+|.+||+|||+|+++..
T Consensus 197 FeYMdh-DL~GLl~~p--~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSP--GVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred Eecccc-hhhhhhcCC--CcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 999988 888888753 34599999999999999999999999 999999999999999999999999999998865
Q ss_pred CCCC-ceeeccccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCCCCCcccc------------------cc---c-
Q 035761 472 DSSN-RTLLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKHPGELLSS------------------SS---S- 527 (560)
Q Consensus 472 ~~~~-~~~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~P~~~~~~------------------~~---~- 527 (560)
.... .+..+.|.+|.|||++.+. .|+..+|+||.|||+.||++|++.|+.... +. .
T Consensus 271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP 350 (560)
T ss_pred CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence 5433 5667789999999998875 589999999999999999999998864432 00 0
Q ss_pred ------------------------ccccccccccccCCCCCCChhHHHhhcee
Q 035761 528 ------------------------SLDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 528 ------------------------~~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
....+...+..+||.-|.++.+.+++.|+
T Consensus 351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF 403 (560)
T KOG0600|consen 351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF 403 (560)
T ss_pred cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence 01112234467899999999999999887
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=332.23 Aligned_cols=237 Identities=27% Similarity=0.416 Sum_probs=198.6
Q ss_pred cCCcccceeeccCCeeEEEEEeCC-CcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCC--EEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEK--CMFLI 391 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv 391 (560)
.++...+.||+|+||.||.+...+ |+..|||.+....... .+.+.+|+.++++++|||||+.+|...... ...++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 346677889999999999998654 8999999987653222 567899999999999999999999854443 68999
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCC-CCcEEEeeeccccccC
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNS-EFEAFVADFGIARLLN 470 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~~~~~~ 470 (560)
|||+++|+|.+++...+. .+++..+..+++||++||+|||++ |||||||||+|||++. ++.+||+|||++....
T Consensus 95 mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 999999999999998764 499999999999999999999999 9999999999999999 7999999999998765
Q ss_pred C---CCCCceeeccccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCCCCCcc-cc-------------------cc
Q 035761 471 Y---DSSNRTLLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKHPGELL-SS-------------------SS 526 (560)
Q Consensus 471 ~---~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~P~~~~-~~-------------------~~ 526 (560)
. .........||+.|||||++..+ ....++||||+||++.||+||+.||... .. .+
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls 249 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLS 249 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccC
Confidence 3 11223346799999999999964 3445899999999999999999999862 10 11
Q ss_pred cccccccccccccCCCCCCChhHHHhhceeee
Q 035761 527 SSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 527 ~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
.+..+....|...||..||++++++.|+|+..
T Consensus 250 ~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 250 DEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred HHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 23456678889999999999999999999854
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=339.18 Aligned_cols=239 Identities=23% Similarity=0.346 Sum_probs=206.1
Q ss_pred hcCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhh---hhhHHHHHHHHHHHhccC-CCCcceeeeEEEeCCEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETE---LASLESFQNEARLLSQIR-HRNIVKLYGFCLHEKCM 388 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~ 388 (560)
...|.+.+.||+|+||.|+.|.. .+++.||+|.+.+.... ....+...+|+.+++.++ ||||++++.++......
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 46789999999999999999965 46899999977664211 123345668999999998 99999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCC-CcEEEeeecccc
Q 035761 389 FLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSE-FEAFVADFGIAR 467 (560)
Q Consensus 389 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~~~ 467 (560)
++||||+.+|+|.+++...+. +.+.++..++.|++.|++|+|+. ||+||||||+|||++.+ +++||+|||++.
T Consensus 96 ~ivmEy~~gGdL~~~i~~~g~---l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVNKGR---LKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred EEEEEecCCccHHHHHHHcCC---CChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 999999999999999987433 88899999999999999999999 99999999999999999 999999999999
Q ss_pred ccCCCCCCceeeccccCccCccccccCc-cC-cchhHHHHHHHHHHHHhCCCCCCcccc-----------------c-cc
Q 035761 468 LLNYDSSNRTLLAGTYGSIAPELAYTMV-VT-EKYDVYSFGVVALEVLMGKHPGELLSS-----------------S-SS 527 (560)
Q Consensus 468 ~~~~~~~~~~~~~g~~~~~aPE~~~~~~-~~-~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~-~~ 527 (560)
............+|++.|+|||++.+.. |+ .++||||+||++|.|++|+.||+.... . +.
T Consensus 170 ~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~ 249 (370)
T KOG0583|consen 170 ISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSP 249 (370)
T ss_pred ccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCH
Confidence 8743444556678999999999999987 86 579999999999999999999986541 1 33
Q ss_pred ccccccccccccCCCCCCChhHHHhhceeee
Q 035761 528 SLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 528 ~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
+....++.|...||.-|+++.+++.|+|++.
T Consensus 250 ~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 250 EARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 4456667788899999999999999999874
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=304.64 Aligned_cols=238 Identities=25% Similarity=0.338 Sum_probs=198.4
Q ss_pred cCCcccceeeccCCeeEEEEE-eCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
++|...+.+|+|.||.||+|+ .++|+.||||+++.......-.....+|++.++.++|+||+.+++++.+.+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 356777889999999999996 4679999999998765433334567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
||+. +|...++... ..++..++..++.++++|++|||.+ .|+|||+||.|+|++.+|.+||+|||+|+.+..+.
T Consensus 82 fm~t-dLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred eccc-cHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 9986 9999888654 3499999999999999999999999 89999999999999999999999999999987766
Q ss_pred CCceeeccccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCCCCCcccc----------------------------
Q 035761 474 SNRTLLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------------- 524 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------------- 524 (560)
......+-|..|.|||++.+. .|+..+||||.|||+.||+-|.+-|...++
T Consensus 156 ~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 156 RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence 666666889999999988764 689999999999999999999866643332
Q ss_pred -----------------cccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 525 -----------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 525 -----------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
...+..+....+...+|.-|.++.+.+++.++..
T Consensus 236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 0111223334455668888888888888877664
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=348.12 Aligned_cols=216 Identities=33% Similarity=0.474 Sum_probs=183.9
Q ss_pred CCCcCHHHHHHHhcC---------CcccceeeccCCeeEEEEEeCC----CcEEEEEEccchhhhhhhHHHHHHHHHHHh
Q 035761 302 DGRITFQDMIEATED---------FDIKYCIGTGGYGSVYRARLPS----GKVVALKKLHRLETELASLESFQNEARLLS 368 (560)
Q Consensus 302 ~~~~~~~~~~~~~~~---------~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~ 368 (560)
-..++|+|-..+..+ ..+.++||.|.||.|++|+++- ...||||.++....+ .+..+|..|+.+|.
T Consensus 607 iDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyte-kqrrdFL~EAsIMG 685 (996)
T KOG0196|consen 607 IDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTE-KQRRDFLSEASIMG 685 (996)
T ss_pred cCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccH-HHHhhhhhhhhhcc
Confidence 334566655444333 3456789999999999998752 457999999876654 45678999999999
Q ss_pred ccCCCCcceeeeEEEeCCEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 035761 369 QIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSN 448 (560)
Q Consensus 369 ~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~ 448 (560)
+++||||+++-|+....+...+|.|||++|+|..||+.+.. ++++.++..|.++||.||.||-+. ++|||||.++
T Consensus 686 QFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DG--qftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAAR 760 (996)
T KOG0196|consen 686 QFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDG--QFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAAR 760 (996)
T ss_pred cCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCC--ceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhhhh
Confidence 99999999999999999999999999999999999997654 399999999999999999999999 9999999999
Q ss_pred CeEeCCCCcEEEeeeccccccCCCCCC-cee--eccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccc
Q 035761 449 NILLNSEFEAFVADFGIARLLNYDSSN-RTL--LAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLS 523 (560)
Q Consensus 449 Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~--~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~ 523 (560)
|||++.+..+|++|||+++.++++... .+. ..-+.+|.|||.+..++++..||||||||+|||.++ |.+||=.+.
T Consensus 761 NILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS 839 (996)
T KOG0196|consen 761 NILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 839 (996)
T ss_pred heeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc
Confidence 999999999999999999988655422 222 223679999999999999999999999999999998 999975444
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=329.72 Aligned_cols=239 Identities=29% Similarity=0.424 Sum_probs=213.0
Q ss_pred cCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
..|...+.||+|+||.||+|.. ..++.||+|++.-... ....+..++|+.++..++++||.++||.+..+..+|++||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 3466678899999999999975 4688999999976543 3456788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
||.+|++.+.++.... +++.++.-|++++..|+.|||.+ +.+|||||+.||++..+|.+|++|||.+..+....
T Consensus 92 y~~gGsv~~lL~~~~~---~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSGNI---LDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HhcCcchhhhhccCCC---CccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 9999999999986543 58888888999999999999999 99999999999999999999999999999988777
Q ss_pred CCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccc------------------cccccccccccc
Q 035761 474 SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLS------------------SSSSSLDKNIKL 535 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~------------------~~~~~~~~~~~~ 535 (560)
..+...+||+.|||||++.+..|+.|+||||+|++++||.+|.+||.... ..+..+++.+..
T Consensus 166 ~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~ 245 (467)
T KOG0201|consen 166 KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEA 245 (467)
T ss_pred hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHH
Confidence 77778899999999999999999999999999999999999999985444 233447788899
Q ss_pred ccccCCCCCCChhHHHhhceeeecC
Q 035761 536 IDLLDPRLPPPGDQMIRQGIILIST 560 (560)
Q Consensus 536 ~~~~dp~~~p~~~~~~~~~~~~~~~ 560 (560)
|...+|..||++.++++|.||+.++
T Consensus 246 CL~k~P~~RpsA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 246 CLDKNPEFRPSAKELLKHKFIKRAK 270 (467)
T ss_pred HhhcCcccCcCHHHHhhhHHHHhcC
Confidence 9999999999999999999998763
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=326.79 Aligned_cols=235 Identities=24% Similarity=0.362 Sum_probs=191.9
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchh-hhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLE-TELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLI 391 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 391 (560)
.++|+....||+|+||.||.|+-+ +|..+|+|++++.. ....+++..+.|-.+|...++|+||+++-.|++.+++|||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 478999999999999999999754 69999999998876 3456677889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 471 (560)
|||++||++.++|.+.+. |++..+..++.+++.|++-+|+. |+|||||||+|+|||..|++||+|||++.-+..
T Consensus 220 MEylPGGD~mTLL~~~~~---L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRKDT---LTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEecCCccHHHHHHhcCc---CchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhh
Confidence 999999999999987554 99999999999999999999999 999999999999999999999999999853210
Q ss_pred -----------------------CCC-----Cc-------------------eeeccccCccCccccccCccCcchhHHH
Q 035761 472 -----------------------DSS-----NR-------------------TLLAGTYGSIAPELAYTMVVTEKYDVYS 504 (560)
Q Consensus 472 -----------------------~~~-----~~-------------------~~~~g~~~~~aPE~~~~~~~~~~~Dv~s 504 (560)
+.. .. -..+|||.|||||++.+..|+..+|+||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 000 00 0146999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCcccccccccccccccc----cccCCCCCCChhHHHhhce
Q 035761 505 FGVVALEVLMGKHPGELLSSSSSSLDKNIKLI----DLLDPRLPPPGDQMIRQGI 555 (560)
Q Consensus 505 ~G~il~el~~g~~P~~~~~~~~~~~~~~~~~~----~~~dp~~~p~~~~~~~~~~ 555 (560)
+|||+|||+.|.+||.... ......++.... ...+..+++++.++|.+++
T Consensus 374 LG~ImyEmLvGyPPF~s~t-p~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll 427 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSET-PQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLL 427 (550)
T ss_pred HHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHh
Confidence 9999999999999997433 222222222111 1223445566666665543
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=336.34 Aligned_cols=235 Identities=23% Similarity=0.366 Sum_probs=206.1
Q ss_pred CCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchh-hhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 316 DFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLE-TELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
-|++.+.+|.|+.|.|..|++ .+|+.+|||++.+.. ..........+|+-+|+-+.||||+++|++++..+++|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 467888999999999999975 579999999998763 222333457789999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++|.|.+|+...+. +++.+..+++.||+.|++|+|.. +|+|||+||+|+|+|..+++||+|||+|..- .++
T Consensus 93 yv~gGELFdylv~kG~---l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe-~~g 165 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKGP---LPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLE-VPG 165 (786)
T ss_pred ecCCchhHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecc-cCC
Confidence 9999999999987665 99999999999999999999999 9999999999999999999999999999764 345
Q ss_pred CCceeeccccCccCccccccCccCc-chhHHHHHHHHHHHHhCCCCCCcccc-----------------ccccccccccc
Q 035761 474 SNRTLLAGTYGSIAPELAYTMVVTE-KYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNIKL 535 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~~~~~~-~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~~~ 535 (560)
......+|.+-|.|||++.+..|+- ++||||+|||+|.|+||+.||++.+- ...+...+++.
T Consensus 166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ 245 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRR 245 (786)
T ss_pred ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHH
Confidence 5666778999999999999999876 79999999999999999999984441 23345667788
Q ss_pred ccccCCCCCCChhHHHhhceee
Q 035761 536 IDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 536 ~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
|..+||.-|=+.++|++|+|+.
T Consensus 246 ml~VDp~~RiT~~eI~kHP~l~ 267 (786)
T KOG0588|consen 246 MLDVDPSTRITTEEILKHPFLS 267 (786)
T ss_pred HhccCccccccHHHHhhCchhh
Confidence 8899999999999999999975
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=333.70 Aligned_cols=239 Identities=28% Similarity=0.456 Sum_probs=199.8
Q ss_pred CHHHHHHHhcCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC
Q 035761 306 TFQDMIEATEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHE 385 (560)
Q Consensus 306 ~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 385 (560)
+.+++....+++.+.+.||+|.||+||+|.|-+ .||||++.......+..+.|+.|+.++++-||.||+-+.|||..+
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 345666666778888999999999999999854 699999987776667889999999999999999999999999988
Q ss_pred CEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecc
Q 035761 386 KCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGI 465 (560)
Q Consensus 386 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 465 (560)
.. .+|+.||+|-+|+.+++..+. +|+..+.+.||.|||+||.|||.+ +|||||||+.||++.++++|||+|||+
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~et--kfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQET--KFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred ce-eeeehhccCchhhhhccchhh--hhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccc
Confidence 77 999999999999999997654 499999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCC--CCCceeeccccCccCcccccc---CccCcchhHHHHHHHHHHHHhCCCCCCcccccc--------------
Q 035761 466 ARLLNYD--SSNRTLLAGTYGSIAPELAYT---MVVTEKYDVYSFGVVALEVLMGKHPGELLSSSS-------------- 526 (560)
Q Consensus 466 ~~~~~~~--~~~~~~~~g~~~~~aPE~~~~---~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~-------------- 526 (560)
+..-..- ........|...|||||+++. ..|+..+||||||+|+|||+||..||. ....+
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmVGrG~l~pd 613 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMVGRGYLMPD 613 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEecccccCcc
Confidence 9754321 111223347788999999874 458889999999999999999999997 32211
Q ss_pred ---------cccccccccccccCCCCCCChhHHHhh
Q 035761 527 ---------SSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 527 ---------~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
..++++...|-..+++.||.+.+++..
T Consensus 614 ~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~ 649 (678)
T KOG0193|consen 614 LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSK 649 (678)
T ss_pred chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHH
Confidence 134445555667789999999888764
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=326.28 Aligned_cols=238 Identities=23% Similarity=0.356 Sum_probs=198.6
Q ss_pred hcCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccC-CCCcceeeeEEEeCC-EEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIR-HRNIVKLYGFCLHEK-CMFL 390 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~l 390 (560)
.++|.+.+.+|.|.||.||+|+- .+|..||||++++.-...++. .-.+|+..+++++ ||||+++.+++.+.+ ..++
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~-~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHH-HHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 46788899999999999999974 468999999998755432322 2358999999998 999999999999988 9999
Q ss_pred EEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccC
Q 035761 391 IYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN 470 (560)
Q Consensus 391 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 470 (560)
|||||+. +|.++++.. ...|++.++..|+.||.+||+|+|.+ |+.|||+||+|||+.....+||+|||+||.+.
T Consensus 88 VfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccc
Confidence 9999976 999999875 44599999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCceeeccccCccCccccc-cCccCcchhHHHHHHHHHHHHhCCCCCCcccc-------------------------
Q 035761 471 YDSSNRTLLAGTYGSIAPELAY-TMVVTEKYDVYSFGVVALEVLMGKHPGELLSS------------------------- 524 (560)
Q Consensus 471 ~~~~~~~~~~g~~~~~aPE~~~-~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~------------------------- 524 (560)
.. ...+..+.|.+|.|||++. ...|+.+.||||+|||++|+.+=++-|...+.
T Consensus 162 Sk-pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 162 SK-PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred cC-CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence 43 3345567899999999755 56788999999999999999999887765442
Q ss_pred ----------------------cccccccccccccccCCCCCCChhHHHhhceeeec
Q 035761 525 ----------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILIS 559 (560)
Q Consensus 525 ----------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~~ 559 (560)
...+..+.++.|..=||..||++.+.++++|++.+
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 11112233344455599999999999999998765
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=354.12 Aligned_cols=236 Identities=29% Similarity=0.426 Sum_probs=194.1
Q ss_pred hcCCcccceeeccCCeeEEEEEeCC--C----cEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLPS--G----KVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKC 387 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~~--~----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 387 (560)
.+..+..+.||+|+||.||+|...+ | ..||||.+++..+ .+...+|.+|..+|++++|||||+++|+|.+...
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~-~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSS-EQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCC-HHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence 3456677889999999999998643 3 3499999987543 4667789999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhcCCc----ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeee
Q 035761 388 MFLIYEYMEMGSLFCILRTDEE----AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADF 463 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 463 (560)
.++++|||++|+|..|++..+. ...++..+.+.|+.|||+|+.||+++ ++|||||.++|+|++....+||+||
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEccc
Confidence 9999999999999999987632 33599999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCceee--ccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccccccc------------
Q 035761 464 GIARLLNYDSSNRTLL--AGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSSSS------------ 528 (560)
Q Consensus 464 g~~~~~~~~~~~~~~~--~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~~~~------------ 528 (560)
|+|+.+....+.+... .-+.+|||||.+.++.++.|+|||||||++||++| |..||...+..+..
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P 926 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPP 926 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCC
Confidence 9999665444433221 23569999999999999999999999999999999 99999876653322
Q ss_pred ------cccccccccccCCCCCCChhHHHhh
Q 035761 529 ------LDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 529 ------~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
+.+.+..|-.=+|..||++..++.+
T Consensus 927 ~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q 957 (1025)
T KOG1095|consen 927 SYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQ 957 (1025)
T ss_pred CCCChHHHHHHHHHccCChhhCccHHHHHhh
Confidence 2233344444566677776666653
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=330.32 Aligned_cols=232 Identities=22% Similarity=0.285 Sum_probs=197.7
Q ss_pred ceeeccCCeeEEEEEe-CCCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEeccCCC
Q 035761 321 YCIGTGGYGSVYRARL-PSGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMG 398 (560)
Q Consensus 321 ~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (560)
+.||+|+||.||+|.. .+|+.||+|+++.... .......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999976 4689999999875432 2234456788999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCcee
Q 035761 399 SLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTL 478 (560)
Q Consensus 399 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 478 (560)
+|.+++..... +++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...........
T Consensus 81 ~L~~~l~~~~~---~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 154 (323)
T cd05571 81 ELFFHLSRERV---FSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred cHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccc
Confidence 99999876443 89999999999999999999999 9999999999999999999999999999764333333444
Q ss_pred eccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------cccccccccccccccCC
Q 035761 479 LAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNIKLIDLLDP 541 (560)
Q Consensus 479 ~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~~~~~~~dp 541 (560)
..|++.|+|||++.+..++.++||||+||++|||++|+.||...+. ....+.+.++.|...||
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP 234 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP 234 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCH
Confidence 6799999999999999999999999999999999999999964331 11234556677788899
Q ss_pred CCCC-----ChhHHHhhceeee
Q 035761 542 RLPP-----PGDQMIRQGIILI 558 (560)
Q Consensus 542 ~~~p-----~~~~~~~~~~~~~ 558 (560)
+.|| +++++++|+|+..
T Consensus 235 ~~R~~~~~~~~~~ll~h~~f~~ 256 (323)
T cd05571 235 KQRLGGGPEDAKEIMEHRFFAS 256 (323)
T ss_pred HHcCCCCCCCHHHHHcCCCcCC
Confidence 9999 8999999999754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=330.58 Aligned_cols=222 Identities=32% Similarity=0.505 Sum_probs=192.6
Q ss_pred cccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEeccCC
Q 035761 318 DIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEM 397 (560)
Q Consensus 318 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (560)
...+.+|.|+.|.||.|+++ ++.||||+++... ..+++-+++++||||+.|.|+|....+++||||||+.
T Consensus 127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~elk---------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~ 196 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK---------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQ 196 (904)
T ss_pred hhhhhhccCcccceeeeecc-CceehhHHHhhhh---------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecccc
Confidence 44677999999999999985 7899999886422 2578889999999999999999999999999999999
Q ss_pred CCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCce
Q 035761 398 GSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRT 477 (560)
Q Consensus 398 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 477 (560)
|-|.+.++..+. ++......+..+||.||.|||.+ .|||||||+-||||+.+..+||+|||-++...+. ...-
T Consensus 197 GqL~~VLka~~~---itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STkM 269 (904)
T KOG4721|consen 197 GQLYEVLKAGRP---ITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STKM 269 (904)
T ss_pred ccHHHHHhccCc---cCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh-hhhh
Confidence 999999987554 88889999999999999999999 9999999999999999999999999999887644 3344
Q ss_pred eeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccccc-------------------ccccccccccc
Q 035761 478 LLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSS-------------------SLDKNIKLIDL 538 (560)
Q Consensus 478 ~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~~-------------------~~~~~~~~~~~ 538 (560)
.++||..|||||+++....++|+||||||||+|||+||..||.+.++... -++-+++.|-.
T Consensus 270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~ 349 (904)
T KOG4721|consen 270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWN 349 (904)
T ss_pred hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHh
Confidence 56899999999999999999999999999999999999999987765221 13344566666
Q ss_pred cCCCCCCChhHHHhhcee
Q 035761 539 LDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 539 ~dp~~~p~~~~~~~~~~~ 556 (560)
=-|+.||.+++|++|-=|
T Consensus 350 sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 350 SKPRNRPSFRQILLHLDI 367 (904)
T ss_pred cCCCCCccHHHHHHHHhh
Confidence 689999999999998544
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=325.42 Aligned_cols=235 Identities=26% Similarity=0.349 Sum_probs=201.8
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|++.+.||+|+||.||+|..+ +++.||+|++..... .....+.+.+|+++++.++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888899999999999999865 688999999875432 2234556889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++|+|.+++...+. +++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRNSGR---FSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 99999999999976543 89999999999999999999999 9999999999999999999999999999875432
Q ss_pred CCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------ccccccccccc
Q 035761 473 SSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNIKL 535 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~~~ 535 (560)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||..... ....+.+.++.
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~ 231 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKK 231 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHH
Confidence 2234689999999999999999999999999999999999999965432 12234566778
Q ss_pred ccccCCCCCCC-----hhHHHhhceeee
Q 035761 536 IDLLDPRLPPP-----GDQMIRQGIILI 558 (560)
Q Consensus 536 ~~~~dp~~~p~-----~~~~~~~~~~~~ 558 (560)
|...||..|++ ++++++|.|+..
T Consensus 232 ~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 232 LLVVDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred HcCCCHHHccCCccCCHHHHhcCccccC
Confidence 88899999995 999999999853
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=313.80 Aligned_cols=236 Identities=22% Similarity=0.380 Sum_probs=209.3
Q ss_pred cCCcccceeeccCCeeEEEEE-eCCCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
.+|++.+.+|+|.||.|-+|. +..|+.||||.+++... ..+..-.+++|+++|+.++||||+.++.+|+..+...+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 468888999999999999996 47899999999987652 3344456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||..+|.|.+|+...+. |++.+...+++||+.|+.|+|.+ +++|||||.+|||+|+++++||+|||++..+. +
T Consensus 133 EYaS~GeLYDYiSer~~---LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~-~ 205 (668)
T KOG0611|consen 133 EYASGGELYDYISERGS---LSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYA-D 205 (668)
T ss_pred EecCCccHHHHHHHhcc---ccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhc-c
Confidence 99999999999987654 99999999999999999999999 99999999999999999999999999998875 4
Q ss_pred CCCceeeccccCccCccccccCccC-cchhHHHHHHHHHHHHhCCCCCCcccc----------------ccccccccccc
Q 035761 473 SSNRTLLAGTYGSIAPELAYTMVVT-EKYDVYSFGVVALEVLMGKHPGELLSS----------------SSSSLDKNIKL 535 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~~~~~-~~~Dv~s~G~il~el~~g~~P~~~~~~----------------~~~~~~~~~~~ 535 (560)
......++|++-|.+||+..+..|. +.+|-||+||++|.|+.|..||+..+- .-.....+++.
T Consensus 206 ~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~PSdA~gLIRw 285 (668)
T KOG0611|consen 206 KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPETPSDASGLIRW 285 (668)
T ss_pred ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCCCchHHHHHHH
Confidence 4556678999999999999999885 579999999999999999999986652 11234667889
Q ss_pred ccccCCCCCCChhHHHhhceee
Q 035761 536 IDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 536 ~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
|..+.|..|.++.+|..|-|++
T Consensus 286 mLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 286 MLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred HHhcCcccchhHHHHhhhheee
Confidence 9999999999999999998875
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=308.06 Aligned_cols=195 Identities=27% Similarity=0.446 Sum_probs=165.1
Q ss_pred HHHhcCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc--CCCCcceeeeEEEeC---
Q 035761 311 IEATEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQI--RHRNIVKLYGFCLHE--- 385 (560)
Q Consensus 311 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~--- 385 (560)
........+.+.||+|.||.||+|+|+ |+.||||+|...+. +++.+|.+++..+ ||+||+.+++.-..+
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE-----~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs 280 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE-----RSWFRETEIYQTVMLRHENILGFIAADNKDNGS 280 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc-CCceEEEEecccch-----hhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence 334567888999999999999999996 88999999986543 4788999999874 999999999876543
Q ss_pred -CEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCeEEeCCCCCCeEeCCCCcEE
Q 035761 386 -KCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHH-----HCTPPILHRDISSNNILLNSEFEAF 459 (560)
Q Consensus 386 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-----~~~~~ivH~dlk~~Nill~~~~~~k 459 (560)
.++|||.+|.+.|||.+||.+.. ++....++++..+|.||++||. +.+|.|.|||||+.|||+..++.+.
T Consensus 281 ~TQLwLvTdYHe~GSL~DyL~r~t----v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~ 356 (513)
T KOG2052|consen 281 WTQLWLVTDYHEHGSLYDYLNRNT----VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 356 (513)
T ss_pred eEEEEEeeecccCCcHHHHHhhcc----CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence 36899999999999999998743 8999999999999999999995 3589999999999999999999999
Q ss_pred EeeeccccccCCCCC----CceeeccccCccCccccccCc------cCcchhHHHHHHHHHHHHhC
Q 035761 460 VADFGIARLLNYDSS----NRTLLAGTYGSIAPELAYTMV------VTEKYDVYSFGVVALEVLMG 515 (560)
Q Consensus 460 l~Dfg~~~~~~~~~~----~~~~~~g~~~~~aPE~~~~~~------~~~~~Dv~s~G~il~el~~g 515 (560)
|+|+|+|.....+.. .....+||.+|||||++...- ....+||||||.|+||+..+
T Consensus 357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarR 422 (513)
T KOG2052|consen 357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARR 422 (513)
T ss_pred EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHH
Confidence 999999988754422 234568999999999976432 22368999999999999864
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=294.26 Aligned_cols=237 Identities=31% Similarity=0.440 Sum_probs=202.9
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhh-hhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETE-LASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|++.+.+|+|.||.||.|+.+ ++-.||+|++.+..-. .+-.+++.+|+++-+.++||||+++|+++.++...||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 57899999999999999999864 5789999999876532 233457899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||.+.|++...+...+. ..+++.....++.|+|.|+.|+|.. +|+||||||+|+|++..+..||+|||-+..- +
T Consensus 102 Eya~~gel~k~L~~~~~-~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~--p 175 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRM-KRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA--P 175 (281)
T ss_pred EecCCchHHHHHHhccc-ccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeec--C
Confidence 99999999999985433 2388888999999999999999998 9999999999999999999999999988753 3
Q ss_pred CCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------ccccccccccc
Q 035761 473 SSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNIKL 535 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~~~ 535 (560)
...+...+||..|.+||...+..++..+|+|++|++.||++.|.+||+.... ......+.+..
T Consensus 176 ~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dlI~~ 255 (281)
T KOG0580|consen 176 SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADLISR 255 (281)
T ss_pred CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHHHHH
Confidence 5567778999999999999999999999999999999999999999986551 11223344455
Q ss_pred ccccCCCCCCChhHHHhhceee
Q 035761 536 IDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 536 ~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
+...+|..|.+..+++.|.||.
T Consensus 256 ll~~~p~~r~~l~~v~~hpwI~ 277 (281)
T KOG0580|consen 256 LLVKNPIERLALTEVMDHPWIV 277 (281)
T ss_pred HhccCccccccHHHHhhhHHHH
Confidence 6667888888888888888874
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=312.69 Aligned_cols=195 Identities=30% Similarity=0.526 Sum_probs=167.6
Q ss_pred cCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhc--cCCCCcceeeeEEEeCC----EE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQ--IRHRNIVKLYGFCLHEK----CM 388 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~----~~ 388 (560)
+..++.+.||+|+||.||||.+. ++.||||+|.. +..+.|++|-++++. ++|+||++++++-...+ ..
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey 283 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY 283 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence 44566788999999999999985 59999999974 345689999999886 48999999999877655 78
Q ss_pred EEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhc------CCCCeEEeCCCCCCeEeCCCCcEEEee
Q 035761 389 FLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHH------CTPPILHRDISSNNILLNSEFEAFVAD 462 (560)
Q Consensus 389 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~------~~~~ivH~dlk~~Nill~~~~~~kl~D 462 (560)
+||++|.+.|+|.+|+..+- .+|.+..+|+..+++||+|||+. .+|+|+|||||++|||+.+|+++.|+|
T Consensus 284 wLVt~fh~kGsL~dyL~~nt----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKANT----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred eEEeeeccCCcHHHHHHhcc----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 99999999999999998765 89999999999999999999964 478999999999999999999999999
Q ss_pred eccccccCCCCC--CceeeccccCccCccccccCc------cCcchhHHHHHHHHHHHHhCCCCC
Q 035761 463 FGIARLLNYDSS--NRTLLAGTYGSIAPELAYTMV------VTEKYDVYSFGVVALEVLMGKHPG 519 (560)
Q Consensus 463 fg~~~~~~~~~~--~~~~~~g~~~~~aPE~~~~~~------~~~~~Dv~s~G~il~el~~g~~P~ 519 (560)
||+|..+.+... .....+||.+|||||++.+.. .-.+.||||+|.|+|||+++..-+
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 999998864322 223368999999999987653 223789999999999999987554
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=320.92 Aligned_cols=237 Identities=22% Similarity=0.284 Sum_probs=198.1
Q ss_pred CcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 317 FDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 317 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
|+..+.||+|+||.||+|.. .+|+.||+|.+..... .......+.+|+.+++.++|+|++++++++.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 67788999999999999976 4689999999875432 223334678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
+++|+|.+++..... ..+++.++..++.|++.|++|||+. +|+||||||+||++++++.++|+|||++...... .
T Consensus 82 ~~~g~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-~ 156 (285)
T cd05631 82 MNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-E 156 (285)
T ss_pred cCCCcHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-C
Confidence 999999888764322 2489999999999999999999999 9999999999999999999999999999875422 2
Q ss_pred CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------ccccccccc
Q 035761 475 NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------SSSSLDKNI 533 (560)
Q Consensus 475 ~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------~~~~~~~~~ 533 (560)
......|+..|+|||++.+..++.++|||||||++|||++|+.||..... ....+..++
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 236 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC 236 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence 22334689999999999999999999999999999999999999974322 111234455
Q ss_pred ccccccCCCCCCC-----hhHHHhhceeee
Q 035761 534 KLIDLLDPRLPPP-----GDQMIRQGIILI 558 (560)
Q Consensus 534 ~~~~~~dp~~~p~-----~~~~~~~~~~~~ 558 (560)
+.|...||..||+ ++++++|+|+..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~ 266 (285)
T cd05631 237 RMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266 (285)
T ss_pred HHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence 6777889999986 899999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=303.45 Aligned_cols=238 Identities=25% Similarity=0.279 Sum_probs=198.5
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC--CEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHE--KCMFLI 391 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv 391 (560)
++|+..+.|++|.||.||+|+.+ +++.||+|+++-......-.-...+|+.++.+++|||||.+-.+.... +..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 45778889999999999999864 688999999986553333333467999999999999999999988754 579999
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 471 (560)
||||+. +|...+++-. +.+...++..++.|+++|++|||.+ .|+|||||++|+|+.+.|.+||+|||+|+.+..
T Consensus 156 Me~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcC
Confidence 999987 9999998755 3489999999999999999999999 899999999999999999999999999999988
Q ss_pred CCCCceeeccccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCCCCCcccccc------------------------
Q 035761 472 DSSNRTLLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKHPGELLSSSS------------------------ 526 (560)
Q Consensus 472 ~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~------------------------ 526 (560)
+....+..+-|..|.|||++.+. .|++..||||+|||+.|++++++-|...+..+
T Consensus 230 p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 230 PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 77778888899999999988765 58999999999999999999998775333100
Q ss_pred -------------------------cccccccccccccCCCCCCChhHHHhhceeee
Q 035761 527 -------------------------SSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 527 -------------------------~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
+.-..........||+-|-++.+-++|.|+.-
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e 366 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE 366 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence 00011123345679999999999999998753
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=321.81 Aligned_cols=236 Identities=25% Similarity=0.317 Sum_probs=198.4
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
++|++.+.||+|+||.||+|+.+ +++.||+|++..........+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888999999999999999875 57899999987654333445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|++++.+..+.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEEMP---NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 99987776554332 2389999999999999999999998 99999999999999999999999999998764322
Q ss_pred C-CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc---------------------------
Q 035761 474 S-NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------------------- 525 (560)
Q Consensus 474 ~-~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------------------- 525 (560)
. ......|++.|+|||++.+..++.++||||+||++|||++|+.||...+..
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence 2 223346899999999999988999999999999999999999999743210
Q ss_pred ----------------------ccccccccccccccCCCCCCChhHHHhhcee
Q 035761 526 ----------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 526 ----------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
+..+.+.++.|...||+.||+++++++|+|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 1123456677788999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=335.48 Aligned_cols=206 Identities=29% Similarity=0.456 Sum_probs=176.4
Q ss_pred hcCCcccceeeccCCeeEEEEEeCC--C--cE-EEEEEccchh-hhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLPS--G--KV-VALKKLHRLE-TELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKC 387 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~~--~--~~-vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 387 (560)
-++..+.+.||+|+||.||+|.++. + .. ||||..+... .......+|++|+.+|+.++|||||+++|++..+..
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 3455666889999999999998643 2 23 8999988532 445667899999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccc
Q 035761 388 MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIAR 467 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~ 467 (560)
.++|||+|+||+|.+|++..++ .++..+++.++.+.|+||+|||++ ++|||||.++|+|++.++.+||+|||+++
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCcccccc
Confidence 9999999999999999998654 489999999999999999999999 99999999999999999999999999988
Q ss_pred ccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc
Q 035761 468 LLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS 524 (560)
Q Consensus 468 ~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~ 524 (560)
.-...........-+.+|+|||.+....|++++|||||||++||+++ |..||.....
T Consensus 311 ~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~ 368 (474)
T KOG0194|consen 311 AGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN 368 (474)
T ss_pred CCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH
Confidence 64311111112234679999999999999999999999999999999 8999976653
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=328.11 Aligned_cols=235 Identities=23% Similarity=0.300 Sum_probs=201.7
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|++.+.||+|+||.||+|+.+ +++.||+|.+..... .....+.+.+|+.++++++||||+++++++..++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888999999999999999875 588999999875432 2234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++|+|.+++..... +++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKAGR---FPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999999976543 88899999999999999999999 9999999999999999999999999999876432
Q ss_pred CCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------ccccccccccc
Q 035761 473 SSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNIKL 535 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~~~ 535 (560)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||..... .+..+.+.++.
T Consensus 172 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 248 (329)
T PTZ00263 172 ---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKG 248 (329)
T ss_pred ---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHH
Confidence 2234689999999999999999999999999999999999999964431 11234456677
Q ss_pred ccccCCCCCCC-----hhHHHhhceeee
Q 035761 536 IDLLDPRLPPP-----GDQMIRQGIILI 558 (560)
Q Consensus 536 ~~~~dp~~~p~-----~~~~~~~~~~~~ 558 (560)
|...||..|++ +++++.|+|+..
T Consensus 249 ~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 249 LLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred HhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 88889999986 799999999754
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=328.80 Aligned_cols=235 Identities=23% Similarity=0.334 Sum_probs=199.0
Q ss_pred cCCcccceeeccCCeeEEEEEeCC--CcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPS--GKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLI 391 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 391 (560)
++|++.+.||+|+||.||+|.++. +..||+|++..... .....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 468889999999999999997543 36899999865432 223455788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 471 (560)
|||+++|+|.+++..... +++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 110 ~Ey~~~g~L~~~i~~~~~---~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNKR---FPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 999999999999976543 89999999999999999999999 999999999999999999999999999987542
Q ss_pred CCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc-----------------ccccccccc
Q 035761 472 DSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS-----------------SSSLDKNIK 534 (560)
Q Consensus 472 ~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~-----------------~~~~~~~~~ 534 (560)
. .....||+.|+|||++.+..++.++||||+||++|||++|+.||...... .......++
T Consensus 184 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 260 (340)
T PTZ00426 184 R---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMK 260 (340)
T ss_pred C---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 2 23456899999999999988999999999999999999999999754321 112344556
Q ss_pred cccccCCCCC-----CChhHHHhhceeee
Q 035761 535 LIDLLDPRLP-----PPGDQMIRQGIILI 558 (560)
Q Consensus 535 ~~~~~dp~~~-----p~~~~~~~~~~~~~ 558 (560)
.|...||..| |+++++++|+|+.+
T Consensus 261 ~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 261 KLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred HHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 6677788888 48999999999864
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=320.13 Aligned_cols=235 Identities=22% Similarity=0.312 Sum_probs=194.9
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
++|+..+.||+|+||.||+|..+ +++.||+|.++.... ......+.+|+.+++.++||||+++++++..++..++|||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 46888999999999999999765 688999999865432 2233467789999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++ +|.+++..... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~~~-~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 84 YLDS-DLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CCCc-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 9975 99998865432 378899999999999999999999 99999999999999999999999999997654333
Q ss_pred CCceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCccccc---------------------------
Q 035761 474 SNRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------------------- 525 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------------------- 525 (560)
.......+++.|+|||++.+ ..++.++||||+||++|||++|+.||......
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 33334567899999998865 56888999999999999999999998543210
Q ss_pred --------------------ccccccccccccccCCCCCCChhHHHhhcee
Q 035761 526 --------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 526 --------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
+.+..+.++.|...||+.||+++++++|+|+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 1112345566788899999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=298.33 Aligned_cols=238 Identities=25% Similarity=0.358 Sum_probs=204.6
Q ss_pred HHhcCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhh------hhhHHHHHHHHHHHhcc-CCCCcceeeeEEE
Q 035761 312 EATEDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETE------LASLESFQNEARLLSQI-RHRNIVKLYGFCL 383 (560)
Q Consensus 312 ~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 383 (560)
.....|+..+.+|+|..+.|.++.+ ++|.+.|+|++....+. .+-.+.-.+|+++++++ .||+|+++.++++
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 3456788889999999999999865 46889999988654321 12234567899999998 7999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeee
Q 035761 384 HEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADF 463 (560)
Q Consensus 384 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 463 (560)
.+...++|+|.|+.|.|.+|+...- .+++++..+|++|+.+|++|||.. .|||||+||+|||+|++.++||+||
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecc
Confidence 9999999999999999999997643 499999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCceeeccccCccCccccccC------ccCcchhHHHHHHHHHHHHhCCCCCC-----------------
Q 035761 464 GIARLLNYDSSNRTLLAGTYGSIAPELAYTM------VVTEKYDVYSFGVVALEVLMGKHPGE----------------- 520 (560)
Q Consensus 464 g~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~------~~~~~~Dv~s~G~il~el~~g~~P~~----------------- 520 (560)
|+|+.+. +++..+..+|||+|.|||.+... .|+..+|+||+||+||.++.|.+||-
T Consensus 168 GFa~~l~-~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyq 246 (411)
T KOG0599|consen 168 GFACQLE-PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQ 246 (411)
T ss_pred ceeeccC-CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccc
Confidence 9999986 44556667899999999988743 36668999999999999999999972
Q ss_pred ----cccccccccccccccccccCCCCCCChhHHHhhcee
Q 035761 521 ----LLSSSSSSLDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 521 ----~~~~~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
.+.+.+...+..+..+.++||.-|=++++.+.|+|+
T Consensus 247 F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff 286 (411)
T KOG0599|consen 247 FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFF 286 (411)
T ss_pred cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence 222345567888899999999999999999999986
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=325.07 Aligned_cols=232 Identities=22% Similarity=0.294 Sum_probs=195.5
Q ss_pred ceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEeccCCC
Q 035761 321 YCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMG 398 (560)
Q Consensus 321 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (560)
+.||+|+||.||++... +|+.||+|++..... .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36899999999999764 689999999876432 2234456788999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCcee
Q 035761 399 SLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTL 478 (560)
Q Consensus 399 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 478 (560)
+|..++.... .+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++............
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 154 (323)
T cd05595 81 ELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcccc
Confidence 9998887644 389999999999999999999999 9999999999999999999999999998764333333344
Q ss_pred eccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc-----------------ccccccccccccccCC
Q 035761 479 LAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS-----------------SSSLDKNIKLIDLLDP 541 (560)
Q Consensus 479 ~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~-----------------~~~~~~~~~~~~~~dp 541 (560)
..|++.|+|||++.+..++.++|||||||++|||++|+.||...+.. ...+.+.++.|...||
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP 234 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP 234 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCH
Confidence 56899999999999999999999999999999999999999644321 1223445567778899
Q ss_pred CCCC-----ChhHHHhhceeee
Q 035761 542 RLPP-----PGDQMIRQGIILI 558 (560)
Q Consensus 542 ~~~p-----~~~~~~~~~~~~~ 558 (560)
+.|+ +++++++|.|+..
T Consensus 235 ~~R~~~~~~~~~~~l~h~~~~~ 256 (323)
T cd05595 235 KQRLGGGPSDAKEVMEHRFFLS 256 (323)
T ss_pred HHhCCCCCCCHHHHHcCCCcCC
Confidence 9997 8999999998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=324.43 Aligned_cols=230 Identities=23% Similarity=0.310 Sum_probs=195.6
Q ss_pred eeccCCeeEEEEEeC-CCcEEEEEEccchh-hhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEeccCCCCH
Q 035761 323 IGTGGYGSVYRARLP-SGKVVALKKLHRLE-TELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSL 400 (560)
Q Consensus 323 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 400 (560)
||+|+||.||+|... +++.||+|++.... ........+.+|++++++++||||+++++++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999865 57899999987543 2233456788999999999999999999999999999999999999999
Q ss_pred HHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCceeec
Q 035761 401 FCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLA 480 (560)
Q Consensus 401 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 480 (560)
.+++..... +++.++..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||+++.............
T Consensus 81 ~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 154 (312)
T cd05585 81 FHHLQREGR---FDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC 154 (312)
T ss_pred HHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcccccc
Confidence 999976443 89999999999999999999999 999999999999999999999999999986543333344457
Q ss_pred cccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------cccccccccccccccCCCC
Q 035761 481 GTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNIKLIDLLDPRL 543 (560)
Q Consensus 481 g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~~~~~~~dp~~ 543 (560)
||+.|+|||++.+..++.++||||+||++|||++|+.||..... ....+.+.++.|...||..
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~ 234 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTR 234 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHH
Confidence 89999999999999999999999999999999999999964321 1223455667788889999
Q ss_pred CC---ChhHHHhhceeee
Q 035761 544 PP---PGDQMIRQGIILI 558 (560)
Q Consensus 544 ~p---~~~~~~~~~~~~~ 558 (560)
|| ++.+++.|+|+..
T Consensus 235 R~~~~~~~e~l~hp~~~~ 252 (312)
T cd05585 235 RLGYNGAQEIKNHPFFSQ 252 (312)
T ss_pred cCCCCCHHHHHcCCCcCC
Confidence 96 5789999998753
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=322.11 Aligned_cols=238 Identities=23% Similarity=0.311 Sum_probs=197.1
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
.++|++.+.||+|+||.||+|..+ +++.||||++...... .....+.+|+.+++.++||||+++++++..+...++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 367899999999999999999875 6889999998754322 22345678999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||++ +++.+++..... .+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 83 EYVH-TDLCQYMDKHPG--GLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred ECCC-cCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 9996 588888765432 388999999999999999999999 9999999999999999999999999999765433
Q ss_pred CCCceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCcccccc-------------------------
Q 035761 473 SSNRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSSSS------------------------- 526 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~------------------------- 526 (560)
........+++.|+|||++.+ ..++.++||||+||++|||++|+.||....+..
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence 333334567899999998765 457889999999999999999999996532110
Q ss_pred -------------------------cccccccccccccCCCCCCChhHHHhhceeee
Q 035761 527 -------------------------SSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 527 -------------------------~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
....+.++.|...||+.||++++++.|+|+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~ 293 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSD 293 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccccc
Confidence 11234556778889999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=328.23 Aligned_cols=235 Identities=23% Similarity=0.293 Sum_probs=201.0
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|++.+.||+|+||.||+|+.. +++.||+|+++.... .....+.+.+|++++..++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999875 588999999976432 2234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++|+|.+++..... +++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~~---l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLGV---LSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 99999999999976443 89999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc-------------------------cc
Q 035761 473 SSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS-------------------------SS 527 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~-------------------------~~ 527 (560)
......|++.|+|||++.+..++.++|||||||++|||++|+.||...... ..
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~ 231 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSD 231 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCH
Confidence 223456899999999999999999999999999999999999999643310 12
Q ss_pred ccccccccccccCCCCCCChhHHHhhceeee
Q 035761 528 SLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 528 ~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
.+...+..|...+|..||+++++++|+|+..
T Consensus 232 ~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~ 262 (333)
T cd05600 232 EAWDLITKLINDPSRRFGSLEDIKNHPFFKE 262 (333)
T ss_pred HHHHHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence 2334555667779999999999999999764
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=326.31 Aligned_cols=232 Identities=23% Similarity=0.303 Sum_probs=196.1
Q ss_pred ceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEeccCCC
Q 035761 321 YCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMG 398 (560)
Q Consensus 321 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (560)
+.||+|+||.||++... +++.||+|++..... .......+.+|+.+++.++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 35899999999999764 689999999975432 2234567788999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCcee
Q 035761 399 SLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTL 478 (560)
Q Consensus 399 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 478 (560)
+|..++.... .+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...........
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~ 154 (328)
T cd05593 81 ELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT 154 (328)
T ss_pred CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccccccc
Confidence 9999887644 389999999999999999999999 9999999999999999999999999998764333333344
Q ss_pred eccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc-----------------ccccccccccccccCC
Q 035761 479 LAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS-----------------SSSLDKNIKLIDLLDP 541 (560)
Q Consensus 479 ~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~-----------------~~~~~~~~~~~~~~dp 541 (560)
..|++.|+|||++.+..++.++|||||||++|||++|+.||...+.. ...+...++.|...||
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP 234 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDP 234 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCH
Confidence 56899999999999999999999999999999999999999644321 1223455566778899
Q ss_pred CCCC-----ChhHHHhhceeee
Q 035761 542 RLPP-----PGDQMIRQGIILI 558 (560)
Q Consensus 542 ~~~p-----~~~~~~~~~~~~~ 558 (560)
+.|+ ++.++++|+|+..
T Consensus 235 ~~R~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 235 NKRLGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred HHcCCCCCCCHHHHhcCCCcCC
Confidence 9996 8999999999754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=328.01 Aligned_cols=238 Identities=23% Similarity=0.298 Sum_probs=192.0
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|+..+.||+|+||.||+|... +++.||+|++..... .......+.+|+.++..++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999764 588999999976432 2334457888999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++|+|.+++..... +++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMKKDT---LTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 99999999999976443 89999999999999999999999 9999999999999999999999999998754321
Q ss_pred CC-----------------------------------CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCC
Q 035761 473 SS-----------------------------------NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKH 517 (560)
Q Consensus 473 ~~-----------------------------------~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~ 517 (560)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 00 0113469999999999999999999999999999999999999
Q ss_pred CCCcccccc---------------------cccccccccccc--cCCCCCCChhHHHhhceeee
Q 035761 518 PGELLSSSS---------------------SSLDKNIKLIDL--LDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 518 P~~~~~~~~---------------------~~~~~~~~~~~~--~dp~~~p~~~~~~~~~~~~~ 558 (560)
||....... ......+..+.. -++..||+++++++|+|+..
T Consensus 235 Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~ 298 (363)
T cd05628 235 PFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEG 298 (363)
T ss_pred CCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCC
Confidence 997433210 001111111111 12234689999999999854
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=322.12 Aligned_cols=232 Identities=23% Similarity=0.334 Sum_probs=195.1
Q ss_pred ceeeccCCeeEEEEEe----CCCcEEEEEEccchhh--hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 321 YCIGTGGYGSVYRARL----PSGKVVALKKLHRLET--ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 321 ~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
+.||+|+||.||+++. .+++.||+|.++.... .......+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999975 3578999999876432 223344677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
+++|+|.+++..... +.+..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLEREGI---FMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 999999999976443 78888999999999999999999 999999999999999999999999999875433333
Q ss_pred CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------ccccccccccccc
Q 035761 475 NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNIKLID 537 (560)
Q Consensus 475 ~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~~~~~ 537 (560)
......|++.|+|||++.+..++.++|||||||++|||++|+.||..... ....+.+.++.|.
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 235 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLL 235 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHc
Confidence 33445689999999999998899999999999999999999999975432 1122345567777
Q ss_pred ccCCCCCC-----ChhHHHhhceeee
Q 035761 538 LLDPRLPP-----PGDQMIRQGIILI 558 (560)
Q Consensus 538 ~~dp~~~p-----~~~~~~~~~~~~~ 558 (560)
..||..|| .+++++.|+|+..
T Consensus 236 ~~~p~~R~~~~~~~~~~l~~h~~~~~ 261 (323)
T cd05584 236 KRNPSSRLGAGPGDAAEVQSHPFFRH 261 (323)
T ss_pred ccCHhHcCCCCCCCHHHHhcCCCcCC
Confidence 88999999 8999999998754
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=321.73 Aligned_cols=232 Identities=25% Similarity=0.392 Sum_probs=196.2
Q ss_pred ceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCEEEEEEeccCC
Q 035761 321 YCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKCMFLIYEYMEM 397 (560)
Q Consensus 321 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (560)
+.||+|+||.||+|+.+ +++.||||++..... .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 35899999999999875 578999999875431 223445677888888876 799999999999999999999999999
Q ss_pred CCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCce
Q 035761 398 GSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRT 477 (560)
Q Consensus 398 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 477 (560)
|+|.+++..... +++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~i~~~~~---l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (320)
T cd05590 81 GDLMFHIQKSRR---FDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTS 154 (320)
T ss_pred chHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccc
Confidence 999999876543 89999999999999999999999 999999999999999999999999999876433333344
Q ss_pred eeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------cccccccccccccccC
Q 035761 478 LLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNIKLIDLLD 540 (560)
Q Consensus 478 ~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~~~~~~~d 540 (560)
...|++.|+|||++.+..++.++||||+||++|||++|+.||..... ....+.+.++.|...|
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~d 234 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKN 234 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccC
Confidence 45789999999999999999999999999999999999999975432 1223445667788889
Q ss_pred CCCCCCh------hHHHhhceeee
Q 035761 541 PRLPPPG------DQMIRQGIILI 558 (560)
Q Consensus 541 p~~~p~~------~~~~~~~~~~~ 558 (560)
|..|+++ +++++|+|+..
T Consensus 235 P~~R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 235 PTMRLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred HHHCCCCCCCCCHHHHHcCCCcCC
Confidence 9999998 89999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=326.02 Aligned_cols=203 Identities=26% Similarity=0.398 Sum_probs=181.1
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchh-hhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLE-TELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKCMFL 390 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 390 (560)
-++|.+.+++|+|+||.|+.+..+ +++.+|||.+++.. -+.+.+++.+.|..++... +||.++.++..++.++..+.
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 467999999999999999999876 47899999998866 3445677889999999887 59999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccC
Q 035761 391 IYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN 470 (560)
Q Consensus 391 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 470 (560)
||||+.||++..+.+. ..+++..+.-+|..|+.||.|||++ |||+||||..|||+|.+|.+||+|||+++..-
T Consensus 447 vmey~~Ggdm~~~~~~----~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIHT----DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEecCCCcEEEEEec----ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccC
Confidence 9999999995444433 2399999999999999999999999 99999999999999999999999999998754
Q ss_pred CCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccc
Q 035761 471 YDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLS 523 (560)
Q Consensus 471 ~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~ 523 (560)
..+...+..+||+.|||||++.+..|+..+|+|||||+||||+.|..||...+
T Consensus 520 ~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd 572 (694)
T KOG0694|consen 520 GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD 572 (694)
T ss_pred CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 44556677899999999999999999999999999999999999999998554
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=322.25 Aligned_cols=232 Identities=21% Similarity=0.298 Sum_probs=194.7
Q ss_pred ceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCEEEEEEeccCC
Q 035761 321 YCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKCMFLIYEYMEM 397 (560)
Q Consensus 321 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (560)
+.||+|+||.||+|..+ +++.||+|+++.... .....+.+.+|..++..+ +||||+++++++..+...++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999865 588999999976432 223445678899999988 799999999999999999999999999
Q ss_pred CCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCce
Q 035761 398 GSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRT 477 (560)
Q Consensus 398 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 477 (560)
|+|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (329)
T cd05588 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTS 154 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCCccc
Confidence 99999887543 389999999999999999999999 999999999999999999999999999875433333344
Q ss_pred eeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc--------------------------cccccc
Q 035761 478 LLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------------------SSSLDK 531 (560)
Q Consensus 478 ~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------------------~~~~~~ 531 (560)
...||+.|+|||++.+..++.++|||||||++|||++|+.||+..... ...+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 234 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASS 234 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 457899999999999999999999999999999999999999632211 112334
Q ss_pred ccccccccCCCCCCC------hhHHHhhceeee
Q 035761 532 NIKLIDLLDPRLPPP------GDQMIRQGIILI 558 (560)
Q Consensus 532 ~~~~~~~~dp~~~p~------~~~~~~~~~~~~ 558 (560)
.++.|...||..|++ +++++.|+|+.+
T Consensus 235 li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 235 VLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 566777889999987 689999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=325.06 Aligned_cols=236 Identities=25% Similarity=0.387 Sum_probs=189.7
Q ss_pred hcCCcccceeeccCCeeEEEEEe------CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCC
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEK 386 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 386 (560)
.++|++.+.||+|+||.||+|.+ .+++.||||+++.... ....+.+.+|+.+++.+ +||||+++++++...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT-ASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc-hHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 46789999999999999999974 2356899999875332 23345788999999999 8999999999987654
Q ss_pred -EEEEEEeccCCCCHHHHhhcCCc--------------------------------------------------------
Q 035761 387 -CMFLIYEYMEMGSLFCILRTDEE-------------------------------------------------------- 409 (560)
Q Consensus 387 -~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------- 409 (560)
..++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 57899999999999999875321
Q ss_pred ---ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCC--ceeeccccC
Q 035761 410 ---AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSN--RTLLAGTYG 484 (560)
Q Consensus 410 ---~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~ 484 (560)
...+++.++..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++........ .....++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 12478899999999999999999998 9999999999999999999999999999865332211 122345678
Q ss_pred ccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc-------------------ccccccccccccccCCCCC
Q 035761 485 SIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS-------------------SSSLDKNIKLIDLLDPRLP 544 (560)
Q Consensus 485 ~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~-------------------~~~~~~~~~~~~~~dp~~~ 544 (560)
|+|||++.+..++.++|||||||++|||++ |..||...... ...+.+.+..|...||..|
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 321 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKER 321 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhC
Confidence 999999999999999999999999999997 99999754321 1123445556677788888
Q ss_pred CChhHHHhh
Q 035761 545 PPGDQMIRQ 553 (560)
Q Consensus 545 p~~~~~~~~ 553 (560)
|++.++++.
T Consensus 322 Ps~~el~~~ 330 (338)
T cd05102 322 PTFSALVEI 330 (338)
T ss_pred cCHHHHHHH
Confidence 888888753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=323.69 Aligned_cols=236 Identities=26% Similarity=0.392 Sum_probs=193.9
Q ss_pred CCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC-----CEEE
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHE-----KCMF 389 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~ 389 (560)
+|++.+.||+|+||.||+|... +++.||||++............+.+|+++++.++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788899999999999999864 689999999875433333345688999999999999999999988643 2479
Q ss_pred EEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccccc
Q 035761 390 LIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL 469 (560)
Q Consensus 390 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 469 (560)
+||||+. ++|.+++..... +++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~~~~---~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKANDD---LTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHhccc---CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 689988875433 89999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCC---CceeeccccCccCcccccc--CccCcchhHHHHHHHHHHHHhCCCCCCccccc-------------------
Q 035761 470 NYDSS---NRTLLAGTYGSIAPELAYT--MVVTEKYDVYSFGVVALEVLMGKHPGELLSSS------------------- 525 (560)
Q Consensus 470 ~~~~~---~~~~~~g~~~~~aPE~~~~--~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~------------------- 525 (560)
..... ......|++.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 32221 1233568999999999876 67889999999999999999999999643210
Q ss_pred -----------------------------ccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 526 -----------------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 526 -----------------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
...+.+.++.|...||..||++++++.|+|+..
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~ 295 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKG 295 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhh
Confidence 111234566778889999999999999999854
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=323.89 Aligned_cols=232 Identities=21% Similarity=0.276 Sum_probs=195.2
Q ss_pred ceeeccCCeeEEEEEe-CCCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEeccCCC
Q 035761 321 YCIGTGGYGSVYRARL-PSGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMG 398 (560)
Q Consensus 321 ~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (560)
+.||+|+||.||++.. .+|+.||+|.+..... .......+.+|+++++.++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3589999999999975 4688999999975432 2233456778999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCce
Q 035761 399 SLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHH-HCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRT 477 (560)
Q Consensus 399 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 477 (560)
+|..++.... .+++.++..++.||+.||+|||+ . +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (325)
T cd05594 81 ELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 154 (325)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccc
Confidence 9999887544 38999999999999999999997 6 999999999999999999999999999876433333334
Q ss_pred eeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------cccccccccccccccC
Q 035761 478 LLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNIKLIDLLD 540 (560)
Q Consensus 478 ~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~~~~~~~d 540 (560)
...|++.|+|||++.+..++.++|||||||++|||++|+.||..... ....+.+.++.|...|
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~d 234 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKD 234 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcC
Confidence 45699999999999999999999999999999999999999964432 1122345556778889
Q ss_pred CCCCC-----ChhHHHhhceeee
Q 035761 541 PRLPP-----PGDQMIRQGIILI 558 (560)
Q Consensus 541 p~~~p-----~~~~~~~~~~~~~ 558 (560)
|+.|+ ++.++++|.|+..
T Consensus 235 P~~R~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 235 PKQRLGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred HHHhCCCCCCCHHHHhcCCCcCC
Confidence 99996 8999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=327.67 Aligned_cols=237 Identities=24% Similarity=0.336 Sum_probs=195.1
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchh-hhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLE-TELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|++.+.||+|+||.||+|+.. +++.||||++.... ........+.+|+++++.++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36888999999999999999865 58999999997543 22234456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++|+|.+++..... +++.++..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||++..+...
T Consensus 81 E~~~~g~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKKDT---FTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 99999999999976443 89999999999999999999999 9999999999999999999999999998754321
Q ss_pred CC--------------------------------------CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh
Q 035761 473 SS--------------------------------------NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM 514 (560)
Q Consensus 473 ~~--------------------------------------~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~ 514 (560)
.. .....+||+.|+|||++....++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 10 0012358999999999999999999999999999999999
Q ss_pred CCCCCCccccc---------------------ccccccccccccccCCCCCCC---hhHHHhhceeee
Q 035761 515 GKHPGELLSSS---------------------SSSLDKNIKLIDLLDPRLPPP---GDQMIRQGIILI 558 (560)
Q Consensus 515 g~~P~~~~~~~---------------------~~~~~~~~~~~~~~dp~~~p~---~~~~~~~~~~~~ 558 (560)
|+.||...... +....+.++.+.. +|..|+. +++++.|+|+..
T Consensus 235 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~ 301 (364)
T cd05599 235 GYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKG 301 (364)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 99999644311 1112223333333 7888887 999999999753
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=319.68 Aligned_cols=235 Identities=24% Similarity=0.327 Sum_probs=195.2
Q ss_pred CcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHH---hccCCCCcceeeeEEEeCCEEEEE
Q 035761 317 FDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLL---SQIRHRNIVKLYGFCLHEKCMFLI 391 (560)
Q Consensus 317 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lv 391 (560)
|++.+.||+|+||.||+|... +++.||||+++.... .....+.+.+|..++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567789999999999999764 589999999975431 223344566666554 567899999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 471 (560)
|||+++|+|..+++.. .+++.++..++.||+.||+|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 9999999999888643 389999999999999999999999 999999999999999999999999999876433
Q ss_pred CCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------cccccccccc
Q 035761 472 DSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNIK 534 (560)
Q Consensus 472 ~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~~ 534 (560)
.........|++.|+|||.+.+..++.++|||||||++|||++|+.||..... ....+...++
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 233 (324)
T cd05589 154 FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMR 233 (324)
T ss_pred CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 33334446789999999999999999999999999999999999999975431 1122345667
Q ss_pred cccccCCCCCC-----ChhHHHhhceeee
Q 035761 535 LIDLLDPRLPP-----PGDQMIRQGIILI 558 (560)
Q Consensus 535 ~~~~~dp~~~p-----~~~~~~~~~~~~~ 558 (560)
.|...||..|| .+.++++|+|+.+
T Consensus 234 ~~L~~dP~~R~~~~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 234 RLLRRNPERRLGSGEKDAEDVKKQPFFRD 262 (324)
T ss_pred HHhhcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence 77888999998 6889999988754
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=321.42 Aligned_cols=239 Identities=26% Similarity=0.372 Sum_probs=213.0
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCE-EEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKC-MFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv~ 392 (560)
++|...+.+|+|+||.++.++++ +++.+++|.+.-........+...+|+.++++++|||||.+.+.|..++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56888999999999999999765 57789999987665444445577899999999999999999999999988 99999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
+|++||++.+.+.+.+ +..++++++..++.|++.|+.|||++ .|+|||||+.||+++.+..|+|+|||+|+.+..+
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999998765 45699999999999999999999998 9999999999999999999999999999999877
Q ss_pred CCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc------------------cccccccccc
Q 035761 473 SSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS------------------SSSSLDKNIK 534 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~------------------~~~~~~~~~~ 534 (560)
.......+||+.||.||.+.+..|..|+|+||+||++|||++=+++|...+. .+..+...++
T Consensus 160 ~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~ 239 (426)
T KOG0589|consen 160 DSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVK 239 (426)
T ss_pred hhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHH
Confidence 7677788999999999999999999999999999999999999999975542 2345677788
Q ss_pred cccccCCCCCCChhHHHhhceee
Q 035761 535 LIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 535 ~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
.+...+|..||++.+++.++.++
T Consensus 240 ~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 240 SMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred HHhhcCCccCCCHHHHhhChhhh
Confidence 88999999999999999986654
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=319.60 Aligned_cols=236 Identities=22% Similarity=0.298 Sum_probs=200.2
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
++|++.+.||+|+||.||+++.+ ++..||+|.+..... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 57899999999999999999865 578899998875432 2334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++|+|.+++..... +++..+..++.|++.||+|||+.. +|+||||||+||+++.++.++|+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 84 HMDGGSLDQVLKEAKR---IPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred cCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 9999999999976443 889999999999999999999851 5999999999999999999999999999765322
Q ss_pred CCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------------------
Q 035761 474 SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS----------------------------- 524 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~----------------------------- 524 (560)
......|++.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence 22334689999999999999999999999999999999999999953211
Q ss_pred ------------------------------------cccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 525 ------------------------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 525 ------------------------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
...++.+.++.|...||..||+++++++|+|+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~ 306 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKR 306 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhh
Confidence 0112345566788889999999999999999853
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=318.32 Aligned_cols=238 Identities=27% Similarity=0.375 Sum_probs=209.9
Q ss_pred hcCCcccceeeccCCeeEEEEEeCC-CcEEEEEEccchhhh-hhhHHHHHHHHHHHhccC-CCCcceeeeEEEeCCEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRLETE-LASLESFQNEARLLSQIR-HRNIVKLYGFCLHEKCMFL 390 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 390 (560)
.+.|++.+.||+|.||.||+++.+. |+.+|+|.+.+.... ........+|+.+|+++. |||||.+.+++++....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 3568888999999999999998765 999999999765532 224567889999999997 9999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCC----CcEEEeeeccc
Q 035761 391 IYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSE----FEAFVADFGIA 466 (560)
Q Consensus 391 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg~~ 466 (560)
|||++.||.|.+.+... .+++.+...++.|++.++.|||+. ||+|||+||+|+|+... +.+|++|||++
T Consensus 114 vmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 99999999999998765 289999999999999999999998 99999999999999643 47999999999
Q ss_pred cccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------c
Q 035761 467 RLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------S 525 (560)
Q Consensus 467 ~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------~ 525 (560)
..... .......+||+.|+|||++....|+..+||||+||++|.|++|.+||....+ .
T Consensus 187 ~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~i 265 (382)
T KOG0032|consen 187 KFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDI 265 (382)
T ss_pred eEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCcccc
Confidence 99876 5566778999999999999999999999999999999999999999975552 2
Q ss_pred ccccccccccccccCCCCCCChhHHHhhceeeec
Q 035761 526 SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILIS 559 (560)
Q Consensus 526 ~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~~ 559 (560)
+......++.+...||..|.++.++++|+||...
T Consensus 266 s~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 266 SESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred CHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 3345667788889999999999999999999863
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=314.71 Aligned_cols=235 Identities=25% Similarity=0.339 Sum_probs=191.0
Q ss_pred CCcccceeeccCCeeEEEEEeC--CCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc---CCCCcceeeeEEEe-----C
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP--SGKVVALKKLHRLETELASLESFQNEARLLSQI---RHRNIVKLYGFCLH-----E 385 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----~ 385 (560)
+|++.+.||+|+||.||+|+.. +++.||+|.++...........+.+|+.+++.+ +||||+++++++.. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 6888899999999999999763 468899998875443323334556777777665 69999999999863 3
Q ss_pred CEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecc
Q 035761 386 KCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGI 465 (560)
Q Consensus 386 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 465 (560)
...++||||++ ++|.+++..... ..+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 46899999997 599999875432 3389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------
Q 035761 466 ARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS--------------------- 524 (560)
Q Consensus 466 ~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~--------------------- 524 (560)
++..... .......|++.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 157 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (290)
T cd07862 157 ARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 235 (290)
T ss_pred eEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence 9876433 223345689999999999988999999999999999999999999974321
Q ss_pred -----------------------cccccccccccccccCCCCCCChhHHHhhcee
Q 035761 525 -----------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 525 -----------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
.+..+.+.+..|...||+.||++.++++|+|+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 01112345567788899999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=327.32 Aligned_cols=237 Identities=26% Similarity=0.335 Sum_probs=200.4
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhh-hhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETE-LASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|++.+.||+|+||.||+|... +++.||+|+++..... ......+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888999999999999999865 6899999999765422 244567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++|+|.+++.... .+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRKD---VFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 9999999999998653 389999999999999999999998 9999999999999999999999999999876433
Q ss_pred C-----------------------------CCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccc
Q 035761 473 S-----------------------------SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLS 523 (560)
Q Consensus 473 ~-----------------------------~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~ 523 (560)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 12233568999999999999999999999999999999999999996543
Q ss_pred cc---------------------ccccccccccccccCCCCCCC-hhHHHhhceeee
Q 035761 524 SS---------------------SSSLDKNIKLIDLLDPRLPPP-GDQMIRQGIILI 558 (560)
Q Consensus 524 ~~---------------------~~~~~~~~~~~~~~dp~~~p~-~~~~~~~~~~~~ 558 (560)
.. ...+...++.|.. ||..||+ +++++.|+|+..
T Consensus 235 ~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 235 LQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred HHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 21 1122334444555 9999999 999999999853
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=294.55 Aligned_cols=238 Identities=24% Similarity=0.372 Sum_probs=204.0
Q ss_pred hcCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++.|++.+.||+|.|+.||++.. .+|+.+|+|.+....-.....+.+.+|+.+-+.++||||+++...+.+.+..++||
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 45688889999999999999854 56899999988655534446678889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCC---CcEEEeeecccccc
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSE---FEAFVADFGIARLL 469 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~~~~~ 469 (560)
|+|.|++|..-+-.. ...++..+-..++||++++.|+|.+ +|||||+||+|+++... .-+|++|||+|..+
T Consensus 90 e~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 999999996444322 2378888899999999999999999 99999999999999533 45899999999988
Q ss_pred CCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccc---------------------ccccc
Q 035761 470 NYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLS---------------------SSSSS 528 (560)
Q Consensus 470 ~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~---------------------~~~~~ 528 (560)
. +.......+|||+|||||+++...|+..+||||.||++|-++.|++||-..+ ...+.
T Consensus 164 ~-~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~ 242 (355)
T KOG0033|consen 164 N-DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPE 242 (355)
T ss_pred C-CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHH
Confidence 7 5555666789999999999999999999999999999999999999996532 13344
Q ss_pred cccccccccccCCCCCCChhHHHhhceeee
Q 035761 529 LDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 529 ~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
.+.+++.|..+||..|=++.+.+.|+||.+
T Consensus 243 Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 243 AKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred HHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 567778899999999999999999999864
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=320.30 Aligned_cols=231 Identities=24% Similarity=0.346 Sum_probs=194.7
Q ss_pred ceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCEEEEEEeccCC
Q 035761 321 YCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKCMFLIYEYMEM 397 (560)
Q Consensus 321 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (560)
+.||+|+||.||+|+.+ +++.||+|++..... .....+.+..|.+++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 35899999999999865 478999999876432 223445677888888866 899999999999999999999999999
Q ss_pred CCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCce
Q 035761 398 GSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRT 477 (560)
Q Consensus 398 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 477 (560)
|+|..++..... +++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++...........
T Consensus 81 ~~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05591 81 GDLMFQIQRSRK---FDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTT 154 (321)
T ss_pred CcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCcccc
Confidence 999998876543 89999999999999999999999 999999999999999999999999999976543333344
Q ss_pred eeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------cccccccccccccccC
Q 035761 478 LLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNIKLIDLLD 540 (560)
Q Consensus 478 ~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~~~~~~~d 540 (560)
...|++.|+|||++.+..++.++||||+||++|||++|+.||..... ....+.+.++.|...|
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~d 234 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKN 234 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccC
Confidence 45689999999999999999999999999999999999999975432 1223445667777889
Q ss_pred CCCCC-------ChhHHHhhceee
Q 035761 541 PRLPP-------PGDQMIRQGIIL 557 (560)
Q Consensus 541 p~~~p-------~~~~~~~~~~~~ 557 (560)
|+.|+ .+++++.|+|+.
T Consensus 235 p~~R~~~~~~~~~~~~~~~hp~~~ 258 (321)
T cd05591 235 PNKRLGCVASQGGEDAIKQHPFFK 258 (321)
T ss_pred HHHcCCCCCCCCCHHHHhcCCccC
Confidence 99999 888999999874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=323.96 Aligned_cols=233 Identities=26% Similarity=0.349 Sum_probs=192.7
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
++|+..+.||+|+||.||+|... +++.||||++..... ......+.+|+++++.++|+||+++++++...+..++|||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE-DTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCc-HHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 34566788999999999999865 689999999865332 2334578899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++|+|.... ..++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.+....
T Consensus 153 ~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 153 FMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred cCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 99999986432 156777889999999999999999 99999999999999999999999999998765433
Q ss_pred CCceeeccccCccCcccccc-----CccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------ccc
Q 035761 474 SNRTLLAGTYGSIAPELAYT-----MVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------SSS 527 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~-----~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------~~~ 527 (560)
.......|+..|+|||++.. ...+.++|||||||++|||++|+.||..... ...
T Consensus 223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (353)
T PLN00034 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASR 302 (353)
T ss_pred ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCH
Confidence 33344578999999998743 2334589999999999999999999963221 112
Q ss_pred ccccccccccccCCCCCCChhHHHhhceeee
Q 035761 528 SLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 528 ~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
.+.+.++.|...||..||++.++++|.|+.-
T Consensus 303 ~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~ 333 (353)
T PLN00034 303 EFRHFISCCLQREPAKRWSAMQLLQHPFILR 333 (353)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCccccc
Confidence 3456677888899999999999999999864
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=305.23 Aligned_cols=235 Identities=29% Similarity=0.421 Sum_probs=211.4
Q ss_pred CCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
-|.+.+.+|+|+||.||||.++ +|+.+|+|++.... ..++..+|+.+|.+++.|+||++||.+.....+|+||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 3677888999999999999765 69999999987543 356788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
|-.|+..+.++..++ .+++.++..+++..++||+|||.. .-||||||+-|||++.+|.+|++|||.|-.+.+.-.
T Consensus 110 CGAGSiSDI~R~R~K--~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA 184 (502)
T KOG0574|consen 110 CGAGSISDIMRARRK--PLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA 184 (502)
T ss_pred cCCCcHHHHHHHhcC--CccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence 999999999986543 499999999999999999999998 889999999999999999999999999988876555
Q ss_pred CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc--------------------cccccccccc
Q 035761 475 NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS--------------------SSSSLDKNIK 534 (560)
Q Consensus 475 ~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~--------------------~~~~~~~~~~ 534 (560)
.+..+.||+.|||||++..-.|+.++|+||+|+...||..|++||.+..- +++++...++
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~ 264 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIR 264 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHH
Confidence 66677899999999999999999999999999999999999999875552 4556778888
Q ss_pred cccccCCCCCCChhHHHhhceeeec
Q 035761 535 LIDLLDPRLPPPGDQMIRQGIILIS 559 (560)
Q Consensus 535 ~~~~~dp~~~p~~~~~~~~~~~~~~ 559 (560)
.|..-.|..|.++.++++|.||.||
T Consensus 265 ~CLiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 265 SCLIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred HHhcCCHHHHHHHHHHhhhhhhcCC
Confidence 9999999999999999999999987
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=319.80 Aligned_cols=232 Identities=24% Similarity=0.331 Sum_probs=192.6
Q ss_pred ceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCEEEEEEeccCC
Q 035761 321 YCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKCMFLIYEYMEM 397 (560)
Q Consensus 321 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (560)
+.||+|+||.||+|..+ +++.||+|++++... .....+.+.+|..++.++ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999865 578999999976432 223445677888888776 899999999999999999999999999
Q ss_pred CCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCce
Q 035761 398 GSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRT 477 (560)
Q Consensus 398 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 477 (560)
|+|..++..... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~~~~---l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (329)
T cd05618 81 GDLMFHMQRQRK---LPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS 154 (329)
T ss_pred CCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccc
Confidence 999988875433 89999999999999999999999 999999999999999999999999999976433333334
Q ss_pred eeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc--------------------------cccccc
Q 035761 478 LLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------------------SSSLDK 531 (560)
Q Consensus 478 ~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------------------~~~~~~ 531 (560)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 234 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAAS 234 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence 457899999999999999999999999999999999999999532111 111224
Q ss_pred ccccccccCCCCCCCh------hHHHhhceeee
Q 035761 532 NIKLIDLLDPRLPPPG------DQMIRQGIILI 558 (560)
Q Consensus 532 ~~~~~~~~dp~~~p~~------~~~~~~~~~~~ 558 (560)
.++.|...||+.|+++ ++++.|+|+.+
T Consensus 235 ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 235 VLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred HHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 4566778899999984 79999998854
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=317.36 Aligned_cols=236 Identities=22% Similarity=0.290 Sum_probs=195.5
Q ss_pred CCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCC-CCcceeeeEEEeCCEEEEEE
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQIRH-RNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 392 (560)
+|++.+.||+|+||.||+|+.+ +++.||||++..... .....+.+..|.+++..++| ++|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999865 478899999875432 22345567889999999976 56888999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++|+|.+++..... +++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~~~~---~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQVGK---FKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 99999999999876443 89999999999999999999999 9999999999999999999999999998754333
Q ss_pred CCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------ccccccccccc
Q 035761 473 SSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNIKL 535 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~~~ 535 (560)
........|++.|+|||++.+..++.++||||+||++|||++|+.||..... ....+...++.
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~ 234 (324)
T cd05587 155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKG 234 (324)
T ss_pred CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 3334455789999999999999999999999999999999999999964432 11122345566
Q ss_pred ccccCCCCCCCh-----hHHHhhceee
Q 035761 536 IDLLDPRLPPPG-----DQMIRQGIIL 557 (560)
Q Consensus 536 ~~~~dp~~~p~~-----~~~~~~~~~~ 557 (560)
|...||..|++. +++.+|+|+.
T Consensus 235 ~l~~~P~~R~~~~~~~~~~~~~hp~~~ 261 (324)
T cd05587 235 LLTKHPAKRLGCGPTGERDIREHAFFR 261 (324)
T ss_pred HhhcCHHHcCCCCCCCHHHHhcCCCcC
Confidence 778899999876 7888888764
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=316.37 Aligned_cols=206 Identities=30% Similarity=0.430 Sum_probs=180.6
Q ss_pred hcCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
.+...+.+.||+|.||.|..+....+..||||.++... ......+|.+|+++|.+++||||++++|+|..++..++++|
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 34566778899999999999999888999999998654 34556899999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
||++|+|.+|+..+..+. .+.....+|+.|||.||+||.+. .+||||+.++|+|+|.++++||+|||+++.+....
T Consensus 616 YmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCC
Confidence 999999999998875432 56677788999999999999998 99999999999999999999999999999765444
Q ss_pred CCc--eeeccccCccCccccccCccCcchhHHHHHHHHHHHHh--CCCCCCcccc
Q 035761 474 SNR--TLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM--GKHPGELLSS 524 (560)
Q Consensus 474 ~~~--~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~--g~~P~~~~~~ 524 (560)
+.. ...+-+.+|||||.+.-++++++||||+||+.+||+++ ...||+...+
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~ 746 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD 746 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH
Confidence 432 23456789999999999999999999999999999975 7899976654
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=325.79 Aligned_cols=237 Identities=21% Similarity=0.282 Sum_probs=191.6
Q ss_pred CCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchh-hhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 316 DFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLE-TELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
.|+..+.||+|+||.||+|+. .+++.||+|++.... ......+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 478889999999999999975 457899999997643 223345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++|+|.+++..... +++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~~~---~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIRMEV---FPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999999976543 88999999999999999999999 99999999999999999999999999976431100
Q ss_pred C-----------------------------------------------CceeeccccCccCccccccCccCcchhHHHHH
Q 035761 474 S-----------------------------------------------NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFG 506 (560)
Q Consensus 474 ~-----------------------------------------------~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G 506 (560)
. .....+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 00124689999999999998999999999999
Q ss_pred HHHHHHHhCCCCCCcccccc---------------------ccccccccc--ccccCCCCCCChhHHHhhceeee
Q 035761 507 VVALEVLMGKHPGELLSSSS---------------------SSLDKNIKL--IDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 507 ~il~el~~g~~P~~~~~~~~---------------------~~~~~~~~~--~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
|++|||++|+.||....... .+....++. +...++..|+++++++.|+|+..
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~ 310 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE 310 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCC
Confidence 99999999999996443211 011122222 22234445999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=318.17 Aligned_cols=236 Identities=23% Similarity=0.304 Sum_probs=195.2
Q ss_pred CCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCEEEEEE
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 392 (560)
+|++.+.||+|+||.||+|... +++.||+|.+..... .....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999865 578999999876432 223344567788888777 5899999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++|+|.+++..... +++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~~---~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQVGR---FKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 99999999999876443 89999999999999999999999 9999999999999999999999999999764433
Q ss_pred CCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------ccccccccccc
Q 035761 473 SSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNIKL 535 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~~~ 535 (560)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...+. ....+...++.
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 234 (323)
T cd05616 155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKG 234 (323)
T ss_pred CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHH
Confidence 3333445789999999999999999999999999999999999999975432 11223445566
Q ss_pred ccccCCCCCCCh-----hHHHhhceee
Q 035761 536 IDLLDPRLPPPG-----DQMIRQGIIL 557 (560)
Q Consensus 536 ~~~~dp~~~p~~-----~~~~~~~~~~ 557 (560)
|...||..|++. +++..|+|+.
T Consensus 235 ~l~~~p~~R~~~~~~~~~~i~~h~~~~ 261 (323)
T cd05616 235 LMTKHPGKRLGCGPEGERDIKEHAFFR 261 (323)
T ss_pred HcccCHHhcCCCCCCCHHHHhcCCCcC
Confidence 777899988875 7788887764
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=324.88 Aligned_cols=239 Identities=23% Similarity=0.283 Sum_probs=192.7
Q ss_pred HhcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEE
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFL 390 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 390 (560)
..++|++.+.||+|+||.||+++.. +++.+|+|.+.+... .....+.+.+|+.+++.++||||+++++++..++..++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3467999999999999999999875 578999999875332 22334567899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccC
Q 035761 391 IYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN 470 (560)
Q Consensus 391 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 470 (560)
||||+++|+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 121 VMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 99999999999999753 278889999999999999999999 99999999999999999999999999998764
Q ss_pred CCCC-CceeeccccCccCccccccCc----cCcchhHHHHHHHHHHHHhCCCCCCccccc--------------------
Q 035761 471 YDSS-NRTLLAGTYGSIAPELAYTMV----VTEKYDVYSFGVVALEVLMGKHPGELLSSS-------------------- 525 (560)
Q Consensus 471 ~~~~-~~~~~~g~~~~~aPE~~~~~~----~~~~~Dv~s~G~il~el~~g~~P~~~~~~~-------------------- 525 (560)
.... ......||+.|+|||++.+.. ++.++||||+||++|||++|+.||...+..
T Consensus 194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 273 (370)
T cd05621 194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVE 273 (370)
T ss_pred cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCccc
Confidence 3222 223456999999999987543 778999999999999999999999644310
Q ss_pred -ccccccccccccccCCC--CCCChhHHHhhceeee
Q 035761 526 -SSSLDKNIKLIDLLDPR--LPPPGDQMIRQGIILI 558 (560)
Q Consensus 526 -~~~~~~~~~~~~~~dp~--~~p~~~~~~~~~~~~~ 558 (560)
+......++.+..-++. -|++++++++|+|+.+
T Consensus 274 ~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 274 ISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN 309 (370)
T ss_pred CCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence 00112222222222332 2789999999999865
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=316.59 Aligned_cols=231 Identities=24% Similarity=0.350 Sum_probs=190.3
Q ss_pred ceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCEEEEEEeccCC
Q 035761 321 YCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKCMFLIYEYMEM 397 (560)
Q Consensus 321 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (560)
+.||+|+||.||+|... +++.||+|.++.... .....+.+..|..++... +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 35899999999999865 578899999876432 223344556677777654 899999999999999999999999999
Q ss_pred CCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCce
Q 035761 398 GSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRT 477 (560)
Q Consensus 398 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 477 (560)
|+|.+++..... +++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~~~~~~~---~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 154 (316)
T cd05592 81 GDLMFHIQSSGR---FDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAS 154 (316)
T ss_pred CcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccc
Confidence 999999876443 89999999999999999999999 999999999999999999999999999986543333344
Q ss_pred eeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------cccccccccccccccC
Q 035761 478 LLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNIKLIDLLD 540 (560)
Q Consensus 478 ~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~~~~~~~d 540 (560)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...+. ....+...++.|...|
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~ 234 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERD 234 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCC
Confidence 45789999999999999999999999999999999999999974432 1122345556777889
Q ss_pred CCCCCChh-HHHhhceee
Q 035761 541 PRLPPPGD-QMIRQGIIL 557 (560)
Q Consensus 541 p~~~p~~~-~~~~~~~~~ 557 (560)
|..||+.. ++..|+|+.
T Consensus 235 P~~R~~~~~~l~~h~~~~ 252 (316)
T cd05592 235 PTKRLGVDGDIRQHPFFR 252 (316)
T ss_pred HHHcCCChHHHHcCcccC
Confidence 99999875 677788764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=311.18 Aligned_cols=233 Identities=24% Similarity=0.307 Sum_probs=193.9
Q ss_pred eeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEeccCCCCH
Q 035761 323 IGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSL 400 (560)
Q Consensus 323 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 400 (560)
||+|+||.||++... +++.||+|.+..... .....+.+..|+++++.++||||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999764 688999999875432 222345678899999999999999999999999999999999999999
Q ss_pred HHHhhcC-CcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCceee
Q 035761 401 FCILRTD-EEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLL 479 (560)
Q Consensus 401 ~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 479 (560)
.+++... .....+++.++..++.||+.||+|||+. +|+||||||+||++++++.++|+|||++..+..........
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence 8887532 2233489999999999999999999999 99999999999999999999999999998765433333445
Q ss_pred ccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc---------------------ccccccccccccc
Q 035761 480 AGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS---------------------SSSLDKNIKLIDL 538 (560)
Q Consensus 480 ~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~---------------------~~~~~~~~~~~~~ 538 (560)
.|++.|+|||++.+..++.++||||||+++|||++|+.||...+.. ...+.+..+.|..
T Consensus 158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 237 (280)
T cd05608 158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLA 237 (280)
T ss_pred CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhc
Confidence 6899999999999999999999999999999999999999743211 1123455567778
Q ss_pred cCCCCCC-----ChhHHHhhceeee
Q 035761 539 LDPRLPP-----PGDQMIRQGIILI 558 (560)
Q Consensus 539 ~dp~~~p-----~~~~~~~~~~~~~ 558 (560)
.||..|| ++++++.|+|+..
T Consensus 238 ~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 238 KDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred CCHHHhcCCCCCCHHHHhcChhhhc
Confidence 8999999 7788999988753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=324.03 Aligned_cols=238 Identities=24% Similarity=0.290 Sum_probs=195.7
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLI 391 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 391 (560)
.++|++.+.||+|+||.||+|+.+ +++.||+|++..... .....+.+.+|+.+++.++||||+++++++.++...++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 457899999999999999999865 588999999875432 223344578899999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 471 (560)
|||+++|+|.+++.... ++...+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 122 ~Ey~~gg~L~~~l~~~~----l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 122 MEYMPGGDLVNLMSNYD----IPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EcCCCCCcHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999987532 78888899999999999999999 999999999999999999999999999987643
Q ss_pred CCC-CceeeccccCccCccccccC----ccCcchhHHHHHHHHHHHHhCCCCCCccccc---------------------
Q 035761 472 DSS-NRTLLAGTYGSIAPELAYTM----VVTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------------- 525 (560)
Q Consensus 472 ~~~-~~~~~~g~~~~~aPE~~~~~----~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------------- 525 (560)
... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...+..
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 274 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEI 274 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCC
Confidence 222 22345689999999988653 3788999999999999999999999754321
Q ss_pred ccccccccccccccCCCC--CCChhHHHhhceeee
Q 035761 526 SSSLDKNIKLIDLLDPRL--PPPGDQMIRQGIILI 558 (560)
Q Consensus 526 ~~~~~~~~~~~~~~dp~~--~p~~~~~~~~~~~~~ 558 (560)
+..+...++.|...+|.. |+++++++.|+|+.+
T Consensus 275 s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 275 SKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred CHHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 112233345555567776 999999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=317.41 Aligned_cols=237 Identities=23% Similarity=0.309 Sum_probs=200.1
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
.++|+..+.||+|+||.||++... +++.+|+|.+..... ......+.+|+++++.++||||+++++++..++..++||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 367899999999999999999875 578899998765432 233456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++|+|.+++..... +++..+..++.|++.|++|||+.. +++||||||+||+++.++.+||+|||++......
T Consensus 83 e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 83 EHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred ecCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 99999999999976433 789999999999999999999741 6999999999999999999999999999765322
Q ss_pred CCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc---------------------------
Q 035761 473 SSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------------------- 525 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------------------- 525 (560)
......|+..|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence 223346889999999999988999999999999999999999998632210
Q ss_pred ------------------------------------ccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 526 ------------------------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 526 ------------------------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
..++.+.+..|...||..||++.++++|+|+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~ 304 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 304 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhc
Confidence 112335667788999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=321.03 Aligned_cols=231 Identities=25% Similarity=0.325 Sum_probs=195.6
Q ss_pred ceeeccCCeeEEEEEe----CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEeccC
Q 035761 321 YCIGTGGYGSVYRARL----PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYME 396 (560)
Q Consensus 321 ~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 396 (560)
+.||+|+||.||+++. .+|+.||+|++............+..|++++++++||||+++++++..++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5699999999999864 357899999998654333344567789999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCc
Q 035761 397 MGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNR 476 (560)
Q Consensus 397 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 476 (560)
+|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..........
T Consensus 82 ~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 155 (318)
T cd05582 82 GGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 155 (318)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCce
Confidence 999999997543 389999999999999999999999 99999999999999999999999999998654333333
Q ss_pred eeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------ccccccccccccccc
Q 035761 477 TLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNIKLIDLL 539 (560)
Q Consensus 477 ~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~~~~~~~ 539 (560)
....|++.|+|||.+.+..++.++|||||||++|||++|+.||..... ....+...++.|...
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~ 235 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKR 235 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhc
Confidence 445689999999999988899999999999999999999999975431 112335566778888
Q ss_pred CCCCCCC-----hhHHHhhceee
Q 035761 540 DPRLPPP-----GDQMIRQGIIL 557 (560)
Q Consensus 540 dp~~~p~-----~~~~~~~~~~~ 557 (560)
||..||+ +++++.++|+.
T Consensus 236 ~P~~R~~a~~~~~~~~~~~~~~~ 258 (318)
T cd05582 236 NPANRLGAGPDGVEEIKRHPFFS 258 (318)
T ss_pred CHhHcCCCCCCCHHHHhCCCCcC
Confidence 9999999 67788888874
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=316.35 Aligned_cols=232 Identities=23% Similarity=0.310 Sum_probs=196.5
Q ss_pred ceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCEEEEEEeccCC
Q 035761 321 YCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKCMFLIYEYMEM 397 (560)
Q Consensus 321 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (560)
+.||+|+||.||+|..+ +++.||||+++.... .......+..|.++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999875 478999999976432 223445677888998887 799999999999999999999999999
Q ss_pred CCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCce
Q 035761 398 GSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRT 477 (560)
Q Consensus 398 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 477 (560)
|+|..++..... +++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~~~~---l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (318)
T cd05570 81 GDLMFHIQRSGR---FDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS 154 (318)
T ss_pred CCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccc
Confidence 999998876533 89999999999999999999999 999999999999999999999999999875433333334
Q ss_pred eeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------cccccccccccccccC
Q 035761 478 LLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNIKLIDLLD 540 (560)
Q Consensus 478 ~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~~~~~~~d 540 (560)
...|++.|+|||++.+..++.++|||||||++|||++|+.||..... ....+.+.++.|...|
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~d 234 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKN 234 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCC
Confidence 45689999999999999999999999999999999999999964432 1223446667888899
Q ss_pred CCCCCCh-----hHHHhhceeee
Q 035761 541 PRLPPPG-----DQMIRQGIILI 558 (560)
Q Consensus 541 p~~~p~~-----~~~~~~~~~~~ 558 (560)
|..||++ .+++.+.|+.+
T Consensus 235 P~~R~s~~~~~~~~ll~~~~~~~ 257 (318)
T cd05570 235 PEKRLGCLPTGEQDIKGHPFFRE 257 (318)
T ss_pred HHHcCCCCCCCHHHHhcCCCcCC
Confidence 9999999 99999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=307.85 Aligned_cols=240 Identities=25% Similarity=0.319 Sum_probs=195.5
Q ss_pred hcCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhh------------hhHHHHHHHHHHHhccCCCCcceeee
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETEL------------ASLESFQNEARLLSQIRHRNIVKLYG 380 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~niv~l~~ 380 (560)
-+.|++.+.||+|.||.|-+|+. .+++.||||++.+..... ...+...+|+.+|++++|||||+++.
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 46789999999999999999975 468999999997654211 12356789999999999999999999
Q ss_pred EEEeC--CEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcE
Q 035761 381 FCLHE--KCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEA 458 (560)
Q Consensus 381 ~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 458 (560)
+..+. +..|||+|||..|.+.+.=.. ...++..++.+++++++.||+|||.+ |||||||||+|+|++++|++
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p~d---~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCPPD---KPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCCCC---cccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcE
Confidence 98764 579999999999887543222 12289999999999999999999999 99999999999999999999
Q ss_pred EEeeeccccccCCC-----CCCceeeccccCccCccccccCc----cCcchhHHHHHHHHHHHHhCCCCCCcccc-----
Q 035761 459 FVADFGIARLLNYD-----SSNRTLLAGTYGSIAPELAYTMV----VTEKYDVYSFGVVALEVLMGKHPGELLSS----- 524 (560)
Q Consensus 459 kl~Dfg~~~~~~~~-----~~~~~~~~g~~~~~aPE~~~~~~----~~~~~Dv~s~G~il~el~~g~~P~~~~~~----- 524 (560)
||+|||.+...... .......+|||.|+|||...+.. ...+.||||+||.+|-|+.|+.||-....
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~ 329 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFD 329 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHH
Confidence 99999999866221 11123468999999999987733 23478999999999999999999953321
Q ss_pred --------------cccccccccccccccCCCCCCChhHHHhhceeeec
Q 035761 525 --------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILIS 559 (560)
Q Consensus 525 --------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~~ 559 (560)
....++.+++.+..-||..|-++.++..|+|+...
T Consensus 330 KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 330 KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 23345677788888899999999999999998753
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=315.21 Aligned_cols=232 Identities=22% Similarity=0.333 Sum_probs=192.2
Q ss_pred ceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCEEEEEEeccCC
Q 035761 321 YCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKCMFLIYEYMEM 397 (560)
Q Consensus 321 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (560)
+.||+|+||.||+|+.+ +|+.||+|.++.... .....+....|..++... +||||+++++++..++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36899999999999875 588999999976432 122344566788887754 899999999999999999999999999
Q ss_pred CCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCce
Q 035761 398 GSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRT 477 (560)
Q Consensus 398 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 477 (560)
|+|.+++..... +++.++..++.|+++||+|||+. +|+||||||+||+++.++.++|+|||+++..........
T Consensus 81 g~L~~~i~~~~~---~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05620 81 GDLMFHIQDKGR---FDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAS 154 (316)
T ss_pred CcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCcee
Confidence 999999876433 89999999999999999999999 999999999999999999999999999875432333334
Q ss_pred eeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc-----------------ccccccccccccccC
Q 035761 478 LLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS-----------------SSSLDKNIKLIDLLD 540 (560)
Q Consensus 478 ~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~-----------------~~~~~~~~~~~~~~d 540 (560)
...|++.|+|||++.+..++.++||||+||++|||++|+.||...+.. ...+...++.|...|
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 234 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERD 234 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCC
Confidence 467899999999999999999999999999999999999999744321 122345567788889
Q ss_pred CCCCCCh-hHHHhhceeee
Q 035761 541 PRLPPPG-DQMIRQGIILI 558 (560)
Q Consensus 541 p~~~p~~-~~~~~~~~~~~ 558 (560)
|..|+++ +++..|+|+..
T Consensus 235 P~~R~~~~~~~~~h~~f~~ 253 (316)
T cd05620 235 PTRRLGVVGNIRGHPFFKT 253 (316)
T ss_pred HHHcCCChHHHHcCCCcCC
Confidence 9999998 47777888753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=299.00 Aligned_cols=205 Identities=28% Similarity=0.376 Sum_probs=177.5
Q ss_pred cCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCC-cceeeeEEEeCC------
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRN-IVKLYGFCLHEK------ 386 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~------ 386 (560)
..|+..+.+|+|+||.||+|+. .+|+.||+|++.-..++........+|+.+++.++|+| ||++++++....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 4466677899999999999975 46899999999866543334445679999999999999 999999998877
Q ss_pred EEEEEEeccCCCCHHHHhhcCCcc-cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecc
Q 035761 387 CMFLIYEYMEMGSLFCILRTDEEA-VGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGI 465 (560)
Q Consensus 387 ~~~lv~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 465 (560)
..++||||++. +|..|+...... ..++...+..+++||++||+|||++ +|+||||||.|||++++|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence 78999999976 999999875532 3477888999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCceeeccccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCCCCCccc
Q 035761 466 ARLLNYDSSNRTLLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKHPGELLS 523 (560)
Q Consensus 466 ~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~P~~~~~ 523 (560)
|+...-+....+..++|..|.|||++.+. .|++..||||+||+++||++++.-|....
T Consensus 167 Ara~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~s 225 (323)
T KOG0594|consen 167 ARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDS 225 (323)
T ss_pred HHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCc
Confidence 99876555556677899999999998877 79999999999999999999998886544
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=313.79 Aligned_cols=231 Identities=23% Similarity=0.352 Sum_probs=191.0
Q ss_pred ceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCEEEEEEeccCC
Q 035761 321 YCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKCMFLIYEYMEM 397 (560)
Q Consensus 321 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (560)
+.||+|+||.||+|... +++.||||.++.... .....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36899999999999875 478999999876432 122334566777787764 999999999999999999999999999
Q ss_pred CCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCce
Q 035761 398 GSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRT 477 (560)
Q Consensus 398 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 477 (560)
|+|.+++..... +++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~l~~~~~---~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05619 81 GDLMFHIQSCHK---FDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTC 154 (316)
T ss_pred CcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCcee
Confidence 999999976432 89999999999999999999999 999999999999999999999999999875432333334
Q ss_pred eeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------cccccccccccccccC
Q 035761 478 LLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNIKLIDLLD 540 (560)
Q Consensus 478 ~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~~~~~~~d 540 (560)
...||+.|+|||++.+..++.++||||+||++|||++|+.||..... ....+.+.+..|...|
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~ 234 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVRE 234 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccC
Confidence 45789999999999999999999999999999999999999964431 1112345556677789
Q ss_pred CCCCCChh-HHHhhceee
Q 035761 541 PRLPPPGD-QMIRQGIIL 557 (560)
Q Consensus 541 p~~~p~~~-~~~~~~~~~ 557 (560)
|+.|+++. ++.+|+|+.
T Consensus 235 P~~R~~~~~~l~~h~~~~ 252 (316)
T cd05619 235 PERRLGVKGDIRQHPFFR 252 (316)
T ss_pred HhhcCCChHHHHcCcccC
Confidence 99999996 788888864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=318.52 Aligned_cols=237 Identities=24% Similarity=0.346 Sum_probs=196.3
Q ss_pred CCcccceeeccCCeeEEEEEe----CCCcEEEEEEccchhh--hhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCEE
Q 035761 316 DFDIKYCIGTGGYGSVYRARL----PSGKVVALKKLHRLET--ELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKCM 388 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 388 (560)
+|++.+.||+|+||.||+++. .+++.||+|++.+... .....+.+..|+.+++.+ +||||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478889999999999999875 3578999999875432 223345678899999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccc
Q 035761 389 FLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARL 468 (560)
Q Consensus 389 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 468 (560)
++||||+++|+|.+++..... +++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDN---FSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999999875433 89999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCC-CceeeccccCccCccccccCc-cCcchhHHHHHHHHHHHHhCCCCCCccccc---------------------
Q 035761 469 LNYDSS-NRTLLAGTYGSIAPELAYTMV-VTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------------- 525 (560)
Q Consensus 469 ~~~~~~-~~~~~~g~~~~~aPE~~~~~~-~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------------- 525 (560)
...... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||......
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFI 234 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Confidence 533222 223356899999999988654 788999999999999999999999643211
Q ss_pred ccccccccccccccCCCCCC-----ChhHHHhhceeee
Q 035761 526 SSSLDKNIKLIDLLDPRLPP-----PGDQMIRQGIILI 558 (560)
Q Consensus 526 ~~~~~~~~~~~~~~dp~~~p-----~~~~~~~~~~~~~ 558 (560)
...+.+.++.|...||+.|| .+++++.|+|+..
T Consensus 235 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 272 (332)
T cd05614 235 GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272 (332)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 11234556677888999999 7889999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=324.95 Aligned_cols=236 Identities=23% Similarity=0.315 Sum_probs=190.5
Q ss_pred cCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|++.+.||+|+||.||++.. .+++.||||++..... .....+.+.+|+++++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3688899999999999999975 4688999999865432 2334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999999999997643 388999999999999999999999 9999999999999999999999999998643110
Q ss_pred CC------------C-----------------------------------ceeeccccCccCccccccCccCcchhHHHH
Q 035761 473 SS------------N-----------------------------------RTLLAGTYGSIAPELAYTMVVTEKYDVYSF 505 (560)
Q Consensus 473 ~~------------~-----------------------------------~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~ 505 (560)
.. . ....+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 00 0 001358999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCcccccc---------------------cccccccccccccCCCC---CCChhHHHhhceee
Q 035761 506 GVVALEVLMGKHPGELLSSSS---------------------SSLDKNIKLIDLLDPRL---PPPGDQMIRQGIIL 557 (560)
Q Consensus 506 G~il~el~~g~~P~~~~~~~~---------------------~~~~~~~~~~~~~dp~~---~p~~~~~~~~~~~~ 557 (560)
||++|||++|+.||....... ......++.+.. +|.. |+++.+++.|+|+.
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~ 309 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFR 309 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcC
Confidence 999999999999996433210 011122222333 4443 57999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=325.52 Aligned_cols=236 Identities=21% Similarity=0.284 Sum_probs=192.3
Q ss_pred CCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
+|++.+.||+|+||.||+|+.. +++.||||.+..... .....+.+.+|+++++.++||||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 5888999999999999999764 588999999875432 22334568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+|..+....
T Consensus 82 ~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 82 YIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 999999999997643 378888999999999999999999 99999999999999999999999999975321000
Q ss_pred -------------------------------------------CCceeeccccCccCccccccCccCcchhHHHHHHHHH
Q 035761 474 -------------------------------------------SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVAL 510 (560)
Q Consensus 474 -------------------------------------------~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~ 510 (560)
.......||+.|||||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 0001246899999999999999999999999999999
Q ss_pred HHHhCCCCCCcccccc---------------------cccccccccccccCCCCCC---ChhHHHhhceeee
Q 035761 511 EVLMGKHPGELLSSSS---------------------SSLDKNIKLIDLLDPRLPP---PGDQMIRQGIILI 558 (560)
Q Consensus 511 el~~g~~P~~~~~~~~---------------------~~~~~~~~~~~~~dp~~~p---~~~~~~~~~~~~~ 558 (560)
||++|+.||....... ....+.+..+ ..+|.-|+ ++.+++.|+|+..
T Consensus 236 ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l-~~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 236 EMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRL-CCGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred ehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHH-hcCHhhcCCCCCHHHHhCCCCcCC
Confidence 9999999997543210 0111122222 24888888 8999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=324.41 Aligned_cols=235 Identities=21% Similarity=0.297 Sum_probs=190.5
Q ss_pred CCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
.|+..+.||+|+||.||+|+.. +++.||+|++..... .....+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788999999999999999764 578999999875432 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 999999999997643 378889999999999999999999 99999999999999999999999999975321000
Q ss_pred -----------------------------------------------CCceeeccccCccCccccccCccCcchhHHHHH
Q 035761 474 -----------------------------------------------SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFG 506 (560)
Q Consensus 474 -----------------------------------------------~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G 506 (560)
......+||+.|+|||++.+..++.++||||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 001123689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCcccccc---------------------cccccccccccccCCCCCCC---hhHHHhhceee
Q 035761 507 VVALEVLMGKHPGELLSSSS---------------------SSLDKNIKLIDLLDPRLPPP---GDQMIRQGIIL 557 (560)
Q Consensus 507 ~il~el~~g~~P~~~~~~~~---------------------~~~~~~~~~~~~~dp~~~p~---~~~~~~~~~~~ 557 (560)
|++|||++|+.||....... ....+.+..+ ..+|.-|+. ++++++|+|+.
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l-~~~p~~R~~~~~~~ei~~hp~f~ 309 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKL-CRGPEDRLGKNGADEIKAHPFFK 309 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHH-ccCHhHcCCCCCHHHHhcCCCcC
Confidence 99999999999997543210 0111112222 237777776 89999999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=319.29 Aligned_cols=238 Identities=25% Similarity=0.317 Sum_probs=197.6
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|++.+.||+|+||.||+|..+ +++.||+|+++.... .....+.+.+|+.+++.++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36888999999999999999764 688999999986542 2334556889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++|+|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRYED--QFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 99999999999976522 389999999999999999999999 9999999999999999999999999999876433
Q ss_pred CCC-ceeeccccCccCccccc------cCccCcchhHHHHHHHHHHHHhCCCCCCccccc--------------------
Q 035761 473 SSN-RTLLAGTYGSIAPELAY------TMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS-------------------- 525 (560)
Q Consensus 473 ~~~-~~~~~g~~~~~aPE~~~------~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~-------------------- 525 (560)
... .....||+.|+|||++. ...++.++|||||||++|||++|+.||......
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPK 235 (330)
T ss_pred CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCC
Confidence 222 22346899999999987 456778999999999999999999999643321
Q ss_pred -ccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 526 -SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 526 -~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
...+...++.|.. +|..||++++++.|+|+..
T Consensus 236 ~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 236 VSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred CCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 1112233344555 9999999999999999753
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=320.32 Aligned_cols=242 Identities=23% Similarity=0.306 Sum_probs=194.0
Q ss_pred HHHHHhcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCC
Q 035761 309 DMIEATEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEK 386 (560)
Q Consensus 309 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 386 (560)
+.....++|++.+.||+|+||.||+|..+ +++.+|+|.+..... .....+.+.+|..+++.++||||+++++++..++
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34445578999999999999999999875 578999999865332 2233456788999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccc
Q 035761 387 CMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIA 466 (560)
Q Consensus 387 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~ 466 (560)
..++||||+++|+|.+++.... ++...+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~~----~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNYD----VPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 9999999999999999987532 78888999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC-CceeeccccCccCccccccCc----cCcchhHHHHHHHHHHHHhCCCCCCccccc----------------
Q 035761 467 RLLNYDSS-NRTLLAGTYGSIAPELAYTMV----VTEKYDVYSFGVVALEVLMGKHPGELLSSS---------------- 525 (560)
Q Consensus 467 ~~~~~~~~-~~~~~~g~~~~~aPE~~~~~~----~~~~~Dv~s~G~il~el~~g~~P~~~~~~~---------------- 525 (560)
+....... ......||+.|+|||++.... ++.++|||||||++|||++|+.||...+..
T Consensus 190 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~ 269 (371)
T cd05622 190 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFP 269 (371)
T ss_pred eEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCC
Confidence 87643322 223456999999999987543 778999999999999999999999754320
Q ss_pred -----ccccccccccccccCCCC---CCChhHHHhhceeee
Q 035761 526 -----SSSLDKNIKLIDLLDPRL---PPPGDQMIRQGIILI 558 (560)
Q Consensus 526 -----~~~~~~~~~~~~~~dp~~---~p~~~~~~~~~~~~~ 558 (560)
+......+..+.. +|.. |++++++++|.|+.+
T Consensus 270 ~~~~~s~~~~~li~~~L~-~~~~r~~r~~~~ei~~h~~~~~ 309 (371)
T cd05622 270 DDNDISKEAKNLICAFLT-DREVRLGRNGVEEIKRHLFFKN 309 (371)
T ss_pred CcCCCCHHHHHHHHHHcC-ChhhhcCCCCHHHHhcCcccCC
Confidence 0011122233333 3332 678999999998864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=307.00 Aligned_cols=224 Identities=20% Similarity=0.299 Sum_probs=184.5
Q ss_pred ceeeccCCeeEEEEEeCCCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEe----CCEEEEEEecc
Q 035761 321 YCIGTGGYGSVYRARLPSGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLH----EKCMFLIYEYM 395 (560)
Q Consensus 321 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~ 395 (560)
..||+|++|.||+|.+ +|+.||||+++.... .....+.+.+|+.++++++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 689999999976432 22234678899999999999999999999877 34689999999
Q ss_pred CCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCC
Q 035761 396 EMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSN 475 (560)
Q Consensus 396 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 475 (560)
++|+|.++++... .+++.....++.|++.|++|||+.. +++||||||+||++++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 105 TRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence 9999999998653 3899999999999999999999732 78899999999999999999999999998654322
Q ss_pred ceeeccccCccCcccccc--CccCcchhHHHHHHHHHHHHhCCCCCCccccc-------------------ccccccccc
Q 035761 476 RTLLAGTYGSIAPELAYT--MVVTEKYDVYSFGVVALEVLMGKHPGELLSSS-------------------SSSLDKNIK 534 (560)
Q Consensus 476 ~~~~~g~~~~~aPE~~~~--~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~-------------------~~~~~~~~~ 534 (560)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...... ...+.+.+.
T Consensus 178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~ 256 (283)
T PHA02988 178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVE 256 (283)
T ss_pred -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHH
Confidence 22357889999999876 67899999999999999999999999755321 112345556
Q ss_pred cccccCCCCCCChhHHHhh
Q 035761 535 LIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 535 ~~~~~dp~~~p~~~~~~~~ 553 (560)
.|...||..||++++++..
T Consensus 257 ~cl~~dp~~Rps~~ell~~ 275 (283)
T PHA02988 257 ACTSHDSIKRPNIKEILYN 275 (283)
T ss_pred HHhcCCcccCcCHHHHHHH
Confidence 6667788888888777653
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=301.96 Aligned_cols=237 Identities=29% Similarity=0.396 Sum_probs=202.2
Q ss_pred CCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
+|+..+.||+|++|.||+|..+ +++.|++|.+..........+.+.+|+++++.++|||++++++++..++..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4777889999999999999865 588999999875443344556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
+++++|.+++.... ...+++.++..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 99999999997642 23489999999999999999999998 999999999999999999999999999987654433
Q ss_pred CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc------------------cccccccccccc
Q 035761 475 NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS------------------SSSSLDKNIKLI 536 (560)
Q Consensus 475 ~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~------------------~~~~~~~~~~~~ 536 (560)
......|++.|+|||+..+..++.++|+||||+++|||++|+.||..... ....+.+.++.|
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQC 236 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 33445688899999999999999999999999999999999999964442 112244555667
Q ss_pred cccCCCCCCChhHHHhhcee
Q 035761 537 DLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 537 ~~~dp~~~p~~~~~~~~~~~ 556 (560)
...+|+.||++.++++++|+
T Consensus 237 l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 237 LTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ccCCcccCcCHHHHhhCCCC
Confidence 77899999999999999885
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=314.58 Aligned_cols=231 Identities=21% Similarity=0.317 Sum_probs=192.1
Q ss_pred ceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCEEEEEEeccCC
Q 035761 321 YCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKCMFLIYEYMEM 397 (560)
Q Consensus 321 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (560)
+.||+|+||.||+|... +++.||+|+++.... .....+.+.+|..++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999864 578999999976432 223455688899999888 699999999999999999999999999
Q ss_pred CCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCce
Q 035761 398 GSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRT 477 (560)
Q Consensus 398 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 477 (560)
|+|..++..... +++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~~~~---l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (327)
T cd05617 81 GDLMFHMQRQRK---LPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTS 154 (327)
T ss_pred CcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCcee
Confidence 999998875433 89999999999999999999999 999999999999999999999999999976433333344
Q ss_pred eeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc------------------------cccccccc
Q 035761 478 LLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS------------------------SSSLDKNI 533 (560)
Q Consensus 478 ~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~------------------------~~~~~~~~ 533 (560)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... +......+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li 234 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVL 234 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 567999999999999999999999999999999999999999632211 11233445
Q ss_pred ccccccCCCCCCCh------hHHHhhceee
Q 035761 534 KLIDLLDPRLPPPG------DQMIRQGIIL 557 (560)
Q Consensus 534 ~~~~~~dp~~~p~~------~~~~~~~~~~ 557 (560)
+.|...||+.|+++ .++..|+|+.
T Consensus 235 ~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~ 264 (327)
T cd05617 235 KGFLNKDPKERLGCQPQTGFSDIKSHTFFR 264 (327)
T ss_pred HHHhccCHHHcCCCCCCCCHHHHHcCCCCC
Confidence 66677799999874 5888888864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=307.86 Aligned_cols=237 Identities=23% Similarity=0.281 Sum_probs=198.1
Q ss_pred CcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 317 FDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 317 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
|+..+.||+|+||.||++... +++.||||++..... .......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 677889999999999999864 688999999875432 222334577899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
+++|+|.+++.... ...+++.++..++.|++.|++|||+. +++||||||+||++++++.++|+|||++...... .
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-~ 156 (285)
T cd05605 82 MNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG-E 156 (285)
T ss_pred cCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC-C
Confidence 99999998886532 23489999999999999999999999 9999999999999999999999999999875422 2
Q ss_pred CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------ccccccccc
Q 035761 475 NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------SSSSLDKNI 533 (560)
Q Consensus 475 ~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------~~~~~~~~~ 533 (560)
......|+..|+|||++.+..++.++||||+|+++||+++|+.||..... ....+.+.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC 236 (285)
T ss_pred ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence 22334688999999999988999999999999999999999999975322 112234556
Q ss_pred ccccccCCCCCC-----ChhHHHhhceeee
Q 035761 534 KLIDLLDPRLPP-----PGDQMIRQGIILI 558 (560)
Q Consensus 534 ~~~~~~dp~~~p-----~~~~~~~~~~~~~ 558 (560)
+.|...||..|| +++++++|.|+..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred HHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 677788999999 8889999998864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=312.77 Aligned_cols=236 Identities=22% Similarity=0.295 Sum_probs=193.3
Q ss_pred CCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccC-CCCcceeeeEEEeCCEEEEEE
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQIR-HRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 392 (560)
+|+..+.||+|+||.||+|... +|+.||+|++..... .....+.+..|..+++.+. |++|+++.+++..++..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677889999999999999864 588999999875432 2233456778888888885 578888999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++|+|.+++..... +++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~~~---l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQVGK---FKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 99999999999876443 89999999999999999999999 9999999999999999999999999999765433
Q ss_pred CCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc-----------------cccccccccc
Q 035761 473 SSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS-----------------SSSLDKNIKL 535 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~-----------------~~~~~~~~~~ 535 (560)
........|++.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.++.
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 234 (323)
T cd05615 155 GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKG 234 (323)
T ss_pred CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHH
Confidence 33334456899999999999989999999999999999999999999754321 1122344555
Q ss_pred ccccCCCCCCCh-----hHHHhhceee
Q 035761 536 IDLLDPRLPPPG-----DQMIRQGIIL 557 (560)
Q Consensus 536 ~~~~dp~~~p~~-----~~~~~~~~~~ 557 (560)
|...+|..|+.. +++.+|+|+.
T Consensus 235 ~l~~~p~~R~~~~~~~~~~i~~h~~f~ 261 (323)
T cd05615 235 LMTKHPSKRLGCGPEGERDIREHAFFR 261 (323)
T ss_pred HcccCHhhCCCCCCCCHHHHhcCcccC
Confidence 667788888864 5777777764
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=313.65 Aligned_cols=231 Identities=22% Similarity=0.284 Sum_probs=187.5
Q ss_pred ceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHH-HHHhccCCCCcceeeeEEEeCCEEEEEEeccCC
Q 035761 321 YCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEA-RLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEM 397 (560)
Q Consensus 321 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (560)
+.||+|+||.||+|+.. +++.||+|++..... .......+.+|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999875 578999999875432 222233444554 467889999999999999999999999999999
Q ss_pred CCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCce
Q 035761 398 GSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRT 477 (560)
Q Consensus 398 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 477 (560)
|+|..++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05603 81 GELFFHLQRER---CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTS 154 (321)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccc
Confidence 99998887543 378889999999999999999998 999999999999999999999999999876433333334
Q ss_pred eeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------cccccccccccccccC
Q 035761 478 LLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNIKLIDLLD 540 (560)
Q Consensus 478 ~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~~~~~~~d 540 (560)
...|++.|+|||++.+..++.++|||||||++|||++|+.||...+. ....+.+.+..|...|
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~ 234 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKD 234 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCC
Confidence 45689999999999999999999999999999999999999965431 1112345566777778
Q ss_pred CCCCCChh----HHHhhceee
Q 035761 541 PRLPPPGD----QMIRQGIIL 557 (560)
Q Consensus 541 p~~~p~~~----~~~~~~~~~ 557 (560)
|..|++.. +++.|.|+.
T Consensus 235 p~~R~~~~~~~~~~~~~~~~~ 255 (321)
T cd05603 235 QRRRLGAKADFLEIKNHVFFS 255 (321)
T ss_pred HhhcCCCCCCHHHHhCCCCcC
Confidence 88887654 777777764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=317.69 Aligned_cols=235 Identities=26% Similarity=0.301 Sum_probs=194.7
Q ss_pred HhcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCC-----
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEK----- 386 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 386 (560)
..++|++.+.||+|+||.||++... +|+.||||++............+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3478999999999999999999764 5889999998754433344556789999999999999999999986543
Q ss_pred -EEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecc
Q 035761 387 -CMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGI 465 (560)
Q Consensus 387 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 465 (560)
..++||||+++ ++.+.+.. .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCC
Confidence 47999999975 66666643 278899999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc--------------------
Q 035761 466 ARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS-------------------- 525 (560)
Q Consensus 466 ~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~-------------------- 525 (560)
++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...+..
T Consensus 170 a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (359)
T cd07876 170 ARTACTN-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR 248 (359)
T ss_pred ccccccC-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence 9765322 2223346889999999999999999999999999999999999999643210
Q ss_pred ---------------------------------------ccccccccccccccCCCCCCChhHHHhhceee
Q 035761 526 ---------------------------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 526 ---------------------------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
...+.+.+..|...||+.||++++++.|+|+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 319 (359)
T cd07876 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT 319 (359)
T ss_pred HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhh
Confidence 01234555677888999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=314.25 Aligned_cols=232 Identities=24% Similarity=0.302 Sum_probs=189.2
Q ss_pred ceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHH-HHhccCCCCcceeeeEEEeCCEEEEEEeccCC
Q 035761 321 YCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEAR-LLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEM 397 (560)
Q Consensus 321 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (560)
+.||+|+||.||+|... +|+.||+|++..... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36899999999999875 689999999875432 1222334445544 56789999999999999999999999999999
Q ss_pred CCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCce
Q 035761 398 GSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRT 477 (560)
Q Consensus 398 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 477 (560)
|+|.+++..... +++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..........
T Consensus 81 g~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (323)
T cd05575 81 GELFFHLQRERS---FPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTS 154 (323)
T ss_pred CCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccc
Confidence 999999876443 88999999999999999999999 999999999999999999999999999876433333334
Q ss_pred eeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------cccccccccccccccC
Q 035761 478 LLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNIKLIDLLD 540 (560)
Q Consensus 478 ~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~~~~~~~d 540 (560)
...|++.|+|||++.+..++.++|||||||++|||++|+.||...+. ....+.+.++.|...|
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~ 234 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKD 234 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcC
Confidence 45689999999999999999999999999999999999999975432 1112344456667778
Q ss_pred CCCCCCh----hHHHhhceeee
Q 035761 541 PRLPPPG----DQMIRQGIILI 558 (560)
Q Consensus 541 p~~~p~~----~~~~~~~~~~~ 558 (560)
|..||++ .+++.|+|+..
T Consensus 235 p~~R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 235 RTKRLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred HHhCCCCCCCHHHHHcCCCcCC
Confidence 8988877 58888888743
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=319.33 Aligned_cols=236 Identities=25% Similarity=0.305 Sum_probs=194.9
Q ss_pred CCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCC-----EEE
Q 035761 316 DFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEK-----CMF 389 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 389 (560)
+|+..+.||+|+||.||+|.. .+++.||+|++..........+.+.+|+++++.++||||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999986 46899999998754333334557889999999999999999999998776 789
Q ss_pred EEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccccc
Q 035761 390 LIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL 469 (560)
Q Consensus 390 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 469 (560)
+|+||+. ++|.+++.... .+++..+..++.||+.||+|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ---PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999997 58888876543 389999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCC-CceeeccccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCCCCCccccc----------------------
Q 035761 470 NYDSS-NRTLLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKHPGELLSSS---------------------- 525 (560)
Q Consensus 470 ~~~~~-~~~~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~---------------------- 525 (560)
..... ......+++.|+|||++.+. .++.++||||+||++|||++|+.||...+..
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC 233 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 43222 22234578899999998774 4788999999999999999999999643210
Q ss_pred ---------------------------ccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 526 ---------------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 526 ---------------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
...+.+.+..|...||..||++.+++.|+|+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 293 (372)
T cd07853 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE 293 (372)
T ss_pred HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence 112234556778889999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=313.78 Aligned_cols=230 Identities=23% Similarity=0.298 Sum_probs=181.5
Q ss_pred ceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHH-HHHHhccCCCCcceeeeEEEeCCEEEEEEeccCC
Q 035761 321 YCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNE-ARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEM 397 (560)
Q Consensus 321 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e-~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (560)
+.||+|+||.||+|+.. +++.||+|++..... .......+..| ..+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36899999999999865 567899999875432 11222333444 4456788999999999999999999999999999
Q ss_pred CCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCce
Q 035761 398 GSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRT 477 (560)
Q Consensus 398 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 477 (560)
|+|.+++..... +++.++..++.||++||+|||+. ||+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~~~~---~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~ 154 (325)
T cd05602 81 GELFYHLQRERC---FLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTS 154 (325)
T ss_pred CcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcc
Confidence 999999976443 78888889999999999999999 999999999999999999999999999976533333344
Q ss_pred eeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc-----------------ccccccccccccccC
Q 035761 478 LLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS-----------------SSSLDKNIKLIDLLD 540 (560)
Q Consensus 478 ~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~-----------------~~~~~~~~~~~~~~d 540 (560)
...|++.|+|||++.+..++.++||||+||++|||++|+.||...... ...+.+.++.|...|
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~ 234 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKD 234 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccC
Confidence 557999999999999999999999999999999999999999644321 111223334455566
Q ss_pred CCCCCChh----HHHhhcee
Q 035761 541 PRLPPPGD----QMIRQGII 556 (560)
Q Consensus 541 p~~~p~~~----~~~~~~~~ 556 (560)
|..|+++. ++..|.|+
T Consensus 235 p~~R~~~~~~~~~i~~~~~~ 254 (325)
T cd05602 235 RTKRLGAKDDFMEIKNHIFF 254 (325)
T ss_pred HHHCCCCCCCHHHHhcCccc
Confidence 66666554 55555554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=318.91 Aligned_cols=229 Identities=24% Similarity=0.296 Sum_probs=191.8
Q ss_pred cCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
.+|++.+.||+|+||.||+|.. .+++.||+|.... +.+.+|++++++++||||+++++++..+...++|+|
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 5799999999999999999975 4688999997532 246789999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
++. ++|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 164 ~~~-~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 164 RYK-TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred cCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 995 68988886543 389999999999999999999999 99999999999999999999999999997543221
Q ss_pred -CCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc----------------------------
Q 035761 474 -SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------------- 524 (560)
Q Consensus 474 -~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------------- 524 (560)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||.....
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 222345799999999999999999999999999999999999987632110
Q ss_pred -------------------------------cccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 525 -------------------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 525 -------------------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
....+...++.|...||..||++++++.|+|+..
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD 381 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence 0012233456677889999999999999999864
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=312.57 Aligned_cols=238 Identities=26% Similarity=0.303 Sum_probs=191.3
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchh-hhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLE-TELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|++.+.||+|+||.||+++.. +++.||+|++.+.. ......+.+.+|..++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999865 58899999987533 22234456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++|+|.+++.... ..+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 9999999999997532 2388999999999999999999999 9999999999999999999999999999765433
Q ss_pred CCC-ceeeccccCccCcccccc-----CccCcchhHHHHHHHHHHHHhCCCCCCccccc---------------------
Q 035761 473 SSN-RTLLAGTYGSIAPELAYT-----MVVTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------------- 525 (560)
Q Consensus 473 ~~~-~~~~~g~~~~~aPE~~~~-----~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------------- 525 (560)
... .....||+.|+|||++.. ..++.++||||+||++|||++|+.||......
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 235 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTD 235 (331)
T ss_pred CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCC
Confidence 222 223468999999999863 45778999999999999999999999643210
Q ss_pred -ccccccccccccccCCC--CCCChhHHHhhceee
Q 035761 526 -SSSLDKNIKLIDLLDPR--LPPPGDQMIRQGIIL 557 (560)
Q Consensus 526 -~~~~~~~~~~~~~~dp~--~~p~~~~~~~~~~~~ 557 (560)
...+...++.+...++. -|+++++++.|+|+.
T Consensus 236 ~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~ 270 (331)
T cd05597 236 VSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFE 270 (331)
T ss_pred CCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCC
Confidence 11112222333333333 377999999999974
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=320.08 Aligned_cols=237 Identities=22% Similarity=0.308 Sum_probs=192.9
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|+..+.||+|+||.||++..+ +++.||+|+++.... .......+.+|..++..++||||+++++++.+++..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888999999999999999865 588999999875432 2334567888999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++|+|.+++..... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++..+...
T Consensus 81 E~~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMKKDT---LSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 99999999999976443 89999999999999999999999 9999999999999999999999999998754211
Q ss_pred CC-----------------------------------CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCC
Q 035761 473 SS-----------------------------------NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKH 517 (560)
Q Consensus 473 ~~-----------------------------------~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~ 517 (560)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 00 0112468999999999999999999999999999999999999
Q ss_pred CCCcccccc---------------------cccccccccccccCCCCCC---ChhHHHhhceeee
Q 035761 518 PGELLSSSS---------------------SSLDKNIKLIDLLDPRLPP---PGDQMIRQGIILI 558 (560)
Q Consensus 518 P~~~~~~~~---------------------~~~~~~~~~~~~~dp~~~p---~~~~~~~~~~~~~ 558 (560)
||....... ......+..+ ..||.-|+ +++++++|+|+..
T Consensus 235 Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l-~~~p~~R~~~~~~~ei~~hp~f~~ 298 (360)
T cd05627 235 PFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRF-CTDSENRIGSNGVEEIKSHPFFEG 298 (360)
T ss_pred CCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHh-ccChhhcCCCCCHHHHhcCCCCCC
Confidence 996443210 0111112222 23777776 4789999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=309.74 Aligned_cols=237 Identities=20% Similarity=0.285 Sum_probs=195.8
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
++|.+.+.||+|+||.||+|..+ +++.||+|.++..... .....+.+|++++++++||||+++++++..++..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 56888999999999999999865 5788999998754322 223457789999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++ ++.+++..... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 85 YLDK-DLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCCC-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 9975 88888765432 378999999999999999999999 99999999999999999999999999997654333
Q ss_pred CCceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCccccc---------------------------
Q 035761 474 SNRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------------------- 525 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------------------- 525 (560)
.......+++.|+|||.+.+ ..++.++||||+|+++|||++|+.||...+..
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 33334467899999998765 45788999999999999999999999643210
Q ss_pred --------------------ccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 526 --------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 526 --------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
+....+.++.|...||..||+++++++|+|+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 291 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS 291 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhh
Confidence 112234556677889999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=305.72 Aligned_cols=237 Identities=24% Similarity=0.296 Sum_probs=196.8
Q ss_pred CCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
+|++.+.||+|++|.||+|... +++.||+|+++...........+.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778889999999999999865 689999999875443333345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
++ ++|.+++........+++.++..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 68988887644434589999999999999999999999 999999999999999999999999999976543333
Q ss_pred CceeeccccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------------------
Q 035761 475 NRTLLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKHPGELLSS----------------------------- 524 (560)
Q Consensus 475 ~~~~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~P~~~~~~----------------------------- 524 (560)
......+++.|+|||.+.+. .++.++||||||+++|||++|+.||.....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 23334568899999987654 468899999999999999999999964321
Q ss_pred -----------------cccccccccccccccCCCCCCChhHHHhhcee
Q 035761 525 -----------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 525 -----------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
.+..+.+.++.|...||..||++++++.+.|+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 01122346677888899999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=307.99 Aligned_cols=234 Identities=25% Similarity=0.345 Sum_probs=186.7
Q ss_pred cCCcccceeeccCCeeEEEEEeCC-----------------CcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcce
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPS-----------------GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVK 377 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 377 (560)
++|.+.+.||+|+||.||+|.+++ +..||+|.+..... ......+.+|++++++++||||++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN-KNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC-HHHHHHHHHHHHHHhhcCCCCeeE
Confidence 568888999999999999997532 33699999875432 234567899999999999999999
Q ss_pred eeeEEEeCCEEEEEEeccCCCCHHHHhhcCC----------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 035761 378 LYGFCLHEKCMFLIYEYMEMGSLFCILRTDE----------------EAVGLDWTKRVNIVKGMAHALSYLHHHCTPPIL 441 (560)
Q Consensus 378 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iv 441 (560)
+++++...+..++||||+++|+|.+++.... ....+++.++..++.||+.||+|||+. +|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 9999999999999999999999999986431 112478899999999999999999999 999
Q ss_pred EeCCCCCCeEeCCCCcEEEeeeccccccCCCCCC--ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh--CCC
Q 035761 442 HRDISSNNILLNSEFEAFVADFGIARLLNYDSSN--RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM--GKH 517 (560)
Q Consensus 442 H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~--g~~ 517 (560)
||||||+||+++.++.+||+|||+++........ .....++..|+|||++....++.++||||||+++|||++ |..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999865432211 122345778999999998899999999999999999987 567
Q ss_pred CCCcccccc-------------------------cccccccccccccCCCCCCChhHHHh
Q 035761 518 PGELLSSSS-------------------------SSLDKNIKLIDLLDPRLPPPGDQMIR 552 (560)
Q Consensus 518 P~~~~~~~~-------------------------~~~~~~~~~~~~~dp~~~p~~~~~~~ 552 (560)
||....... ..+.+.+..|...||..||++.++.+
T Consensus 241 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 241 PYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 776433210 12334555566667777777777743
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=292.47 Aligned_cols=238 Identities=23% Similarity=0.309 Sum_probs=193.5
Q ss_pred cCCcccceeeccCCeeEEEEEeCC-CcEEEEEEccchhhh-hhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRLETE-LASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|++.+.||+|.-|.||.++.++ +..+|+|++.+..-. .......+.|.++++.++||.++.+|+.++.++..++||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 457778899999999999999865 588999999876632 344556788999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC-
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY- 471 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~- 471 (560)
|||+||+|....+++... .+++..+.-++..++-||+|||-. |||.|||||+|||+.++|++.|+||.++.....
T Consensus 157 eyCpGGdL~~LrqkQp~~-~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGK-RFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhhCCCC-ccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 999999999999886654 499999999999999999999999 999999999999999999999999998753210
Q ss_pred --------------------------------CCC-----------------------CceeeccccCccCccccccCcc
Q 035761 472 --------------------------------DSS-----------------------NRTLLAGTYGSIAPELAYTMVV 496 (560)
Q Consensus 472 --------------------------------~~~-----------------------~~~~~~g~~~~~aPE~~~~~~~ 496 (560)
... .....+||-.|.|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 000 0112468999999999999999
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCcccccc-------------------cccccccccccccCCCCCCC----hhHHHhh
Q 035761 497 TEKYDVYSFGVVALEVLMGKHPGELLSSSS-------------------SSLDKNIKLIDLLDPRLPPP----GDQMIRQ 553 (560)
Q Consensus 497 ~~~~Dv~s~G~il~el~~g~~P~~~~~~~~-------------------~~~~~~~~~~~~~dp~~~p~----~~~~~~~ 553 (560)
+.++|+|+|||++|||+.|+-||...+... .....+++...+-||+.|-. +.+|-+|
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcC
Confidence 999999999999999999999998665321 12334444445555555555 5555555
Q ss_pred cee
Q 035761 554 GII 556 (560)
Q Consensus 554 ~~~ 556 (560)
+|+
T Consensus 393 pFF 395 (459)
T KOG0610|consen 393 PFF 395 (459)
T ss_pred ccc
Confidence 554
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=311.12 Aligned_cols=239 Identities=26% Similarity=0.306 Sum_probs=190.5
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchh-hhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLE-TELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|++.+.||+|+||.||++..+ +++.+|+|.+.+.. ......+.+.+|..++..++|++|+++++++.++...++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36888999999999999999875 46789999986533 22233456888999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++|+|.++++.... .+++..+..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||++..+...
T Consensus 81 ey~~~g~L~~~l~~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 99999999999976322 389999999999999999999999 9999999999999999999999999999765432
Q ss_pred CCC-ceeeccccCccCccccc-----cCccCcchhHHHHHHHHHHHHhCCCCCCccccc---------------------
Q 035761 473 SSN-RTLLAGTYGSIAPELAY-----TMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------------- 525 (560)
Q Consensus 473 ~~~-~~~~~g~~~~~aPE~~~-----~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------------- 525 (560)
... .....||+.|+|||++. ...++.++|||||||++|||++|+.||...+..
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 235 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTD 235 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCcccc
Confidence 222 22356899999999886 345788999999999999999999999644310
Q ss_pred -ccccccccccccccCCC--CCCChhHHHhhceeee
Q 035761 526 -SSSLDKNIKLIDLLDPR--LPPPGDQMIRQGIILI 558 (560)
Q Consensus 526 -~~~~~~~~~~~~~~dp~--~~p~~~~~~~~~~~~~ 558 (560)
.......++.+...++. -|++++++++|+|+.+
T Consensus 236 ~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 236 VSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred CCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 11112222222223333 3678999999998754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=324.22 Aligned_cols=237 Identities=22% Similarity=0.238 Sum_probs=197.0
Q ss_pred CCcccceeeccCCeeEEEEEeC-C-CcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-S-GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
.|.+.+.||+|+||.||+|... + ++.||+|.+.... ......+.+|+.+++.++||||+++++++..++..++|||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND--ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 4888999999999999999754 3 5778888764432 2334567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcC-CcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 394 YMEMGSLFCILRTD-EEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 394 ~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
|+++|+|.++++.. .....+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.+...
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 99999999887642 1223488999999999999999999998 9999999999999999999999999999876432
Q ss_pred CC--CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc------------------cccccccc
Q 035761 473 SS--NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS------------------SSSSLDKN 532 (560)
Q Consensus 473 ~~--~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~------------------~~~~~~~~ 532 (560)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+.+.
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 302 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKAL 302 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHH
Confidence 21 12345689999999999999999999999999999999999999964321 11234555
Q ss_pred cccccccCCCCCCChhHHHhhceee
Q 035761 533 IKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 533 ~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
+..|...||..||++++++.+.|+.
T Consensus 303 i~~~L~~dP~~Rps~~~~l~~~~~~ 327 (478)
T PTZ00267 303 LDPLLSKNPALRPTTQQLLHTEFLK 327 (478)
T ss_pred HHHHhccChhhCcCHHHHHhCHHHH
Confidence 6777888999999999999887753
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=303.98 Aligned_cols=238 Identities=23% Similarity=0.356 Sum_probs=209.0
Q ss_pred cCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
.-|.+.+.||+|.|+.|-.|++ -+|..||||++.+..-.......+.+|+..|+.++|||||++|.+.......|||.|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 3477788899999999999964 479999999999877555666778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEe-CCCCcEEEeeeccccccCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILL-NSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill-~~~~~~kl~Dfg~~~~~~~~ 472 (560)
.-++|+|++|+-.+..+ +.+.-..+++.||+.|+.|+|+. .+|||||||+||.+ ..-|-+|++|||++..+.+
T Consensus 98 LGD~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P- 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP- 171 (864)
T ss_pred ecCCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC-
Confidence 99999999999876554 89999999999999999999999 99999999999766 5668999999999988764
Q ss_pred CCCceeeccccCccCccccccCccCc-chhHHHHHHHHHHHHhCCCCCCcccccc-----------------cccccccc
Q 035761 473 SSNRTLLAGTYGSIAPELAYTMVVTE-KYDVYSFGVVALEVLMGKHPGELLSSSS-----------------SSLDKNIK 534 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~~~~~~-~~Dv~s~G~il~el~~g~~P~~~~~~~~-----------------~~~~~~~~ 534 (560)
+......+|...|-|||++.+..|+. .+||||+|||+|-|++|++||+..++.+ .+...++.
T Consensus 172 G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~ 251 (864)
T KOG4717|consen 172 GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQ 251 (864)
T ss_pred cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHH
Confidence 45556678999999999999988875 7899999999999999999999777522 23456778
Q ss_pred cccccCCCCCCChhHHHhhceeee
Q 035761 535 LIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 535 ~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
.|.+.||+.|.++++|..+.|++-
T Consensus 252 sMLvRdPkkRAslEeI~s~~Wlq~ 275 (864)
T KOG4717|consen 252 SMLVRDPKKRASLEEIVSTSWLQA 275 (864)
T ss_pred HHHhcCchhhccHHHHhccccccC
Confidence 888999999999999999999873
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=314.81 Aligned_cols=235 Identities=24% Similarity=0.277 Sum_probs=195.0
Q ss_pred HhcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC------
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHE------ 385 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 385 (560)
..++|+..+.||+|+||.||++... .++.||||++..........+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999754 588999999876543334456778899999999999999999988653
Q ss_pred CEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecc
Q 035761 386 KCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGI 465 (560)
Q Consensus 386 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 465 (560)
...++||||+++ ++.+++.. .+++.++..++.|+++||+|||+. ||+||||||+||+++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcc
Confidence 347999999975 67666653 278899999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc--------------------
Q 035761 466 ARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS-------------------- 525 (560)
Q Consensus 466 ~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~-------------------- 525 (560)
++..... .......||..|+|||++.+..++.++|||||||++|||++|+.||...+..
T Consensus 166 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (355)
T cd07874 166 ARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_pred cccCCCc-cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 9865422 2223346899999999999999999999999999999999999999643210
Q ss_pred ---------------------------------------ccccccccccccccCCCCCCChhHHHhhceee
Q 035761 526 ---------------------------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 526 ---------------------------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
...+.+.+..|...||+.||+++++++|+|+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~ 315 (355)
T cd07874 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYIN 315 (355)
T ss_pred hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchh
Confidence 01123456677888999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=301.40 Aligned_cols=234 Identities=32% Similarity=0.488 Sum_probs=201.8
Q ss_pred CcccceeeccCCeeEEEEEeCC-CcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEecc
Q 035761 317 FDIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYM 395 (560)
Q Consensus 317 ~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 395 (560)
|++.+.||+|+||.||+++... ++.+|+|.+..............+|+.++++++||||+++++++..+...++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5678899999999999998764 568999999877655444445567999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCC
Q 035761 396 EMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSN 475 (560)
Q Consensus 396 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 475 (560)
++++|.+++.... .+++.++..++.|+++||++||+. +++||||||+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQKNK---PLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNEN 154 (260)
T ss_dssp TTEBHHHHHHHHS---SBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSE
T ss_pred ccccccccccccc---cccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9999999998332 389999999999999999999999 9999999999999999999999999999865333333
Q ss_pred ceeeccccCccCccccc-cCccCcchhHHHHHHHHHHHHhCCCCCCcccc------------------c------ccccc
Q 035761 476 RTLLAGTYGSIAPELAY-TMVVTEKYDVYSFGVVALEVLMGKHPGELLSS------------------S------SSSLD 530 (560)
Q Consensus 476 ~~~~~g~~~~~aPE~~~-~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~------------------~------~~~~~ 530 (560)
.....++..|+|||++. +..++.++||||+|+++|+|++|+.||..... . ...+.
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELR 234 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHH
Confidence 44556889999999998 88899999999999999999999999986620 0 13456
Q ss_pred cccccccccCCCCCCChhHHHhhcee
Q 035761 531 KNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 531 ~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
+.++.|...||+.||+++++++|+|+
T Consensus 235 ~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 235 DLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHHccCChhHCcCHHHHhcCCCC
Confidence 67778889999999999999999996
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=293.26 Aligned_cols=236 Identities=25% Similarity=0.362 Sum_probs=192.9
Q ss_pred hcCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEe-----CCE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLH-----EKC 387 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~~ 387 (560)
...|...+.||+|+||.|.++.. .+|+.||||++...-......+.-.+|+.+++.++|+||+.+++.+.. -..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 44566678899999999999975 468999999987554444455677899999999999999999998865 246
Q ss_pred EEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccc
Q 035761 388 MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIAR 467 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~ 467 (560)
.|+|+|+|+ .+|...++.... ++......+++|+++||.|+|+. +|+|||+||+|++++.+...||+|||+|+
T Consensus 101 vYiV~elMe-tDL~~iik~~~~---L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 101 VYLVFELME-TDLHQIIKSQQD---LTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eEEehhHHh-hHHHHHHHcCcc---ccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccccee
Confidence 899999994 599999987543 89999999999999999999998 99999999999999999999999999999
Q ss_pred ccCCC--CCCceeeccccCccCccccc-cCccCcchhHHHHHHHHHHHHhCCCCCCccccc-------------------
Q 035761 468 LLNYD--SSNRTLLAGTYGSIAPELAY-TMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS------------------- 525 (560)
Q Consensus 468 ~~~~~--~~~~~~~~g~~~~~aPE~~~-~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~------------------- 525 (560)
..... ....+..+.|..|.|||++. ...|+...||||.|||+.||++|++-|...+..
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 87542 23345567899999999765 467899999999999999999999888644420
Q ss_pred -----------------------------ccccccccccccccCCCCCCChhHHHhhcee
Q 035761 526 -----------------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 526 -----------------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
..........|..+||.-|.++++.++|+++
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl 313 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYL 313 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhh
Confidence 0011223344667788888888888888765
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=314.77 Aligned_cols=234 Identities=23% Similarity=0.275 Sum_probs=194.4
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC------C
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHE------K 386 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 386 (560)
.++|++.+.||+|+||.||+|... .++.||||++..........+.+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 467999999999999999999754 588999999876443334445678899999999999999999987643 3
Q ss_pred EEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccc
Q 035761 387 CMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIA 466 (560)
Q Consensus 387 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~ 466 (560)
..++||||+++ ++.+++.. .+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 57999999975 77777753 278899999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc---------------------
Q 035761 467 RLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------------- 525 (560)
Q Consensus 467 ~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------------- 525 (560)
+..... .......+++.|+|||++.+..++.++|||||||++|||++|+.||...+..
T Consensus 174 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 174 RTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred cccCCC-CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 875432 2223346899999999999999999999999999999999999999643210
Q ss_pred --------------------------------------ccccccccccccccCCCCCCChhHHHhhceee
Q 035761 526 --------------------------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 526 --------------------------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
...+.+.+..|...||..||+++++++|+|+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~ 322 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence 01223456777888999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=297.11 Aligned_cols=197 Identities=28% Similarity=0.402 Sum_probs=163.3
Q ss_pred CCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCC-----EEE
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEK-----CMF 389 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 389 (560)
.|...+.+|+|+||.||+|... +++.||||+...... .-.+|.++|+.++|||||++.-++.... +..
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 4666788999999999999865 468999998764331 2247999999999999999999987643 346
Q ss_pred EEEeccCCCCHHHHhhcC-CcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCC-CcEEEeeecccc
Q 035761 390 LIYEYMEMGSLFCILRTD-EEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSE-FEAFVADFGIAR 467 (560)
Q Consensus 390 lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~~~ 467 (560)
+||||||. +|.++++.. .....++.-.+.-+..||.+||+|||+. +|+||||||+|+|+|.+ |.+||||||.|+
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcce
Confidence 89999998 898888742 1223478888888999999999999998 99999999999999987 899999999999
Q ss_pred ccCCCCCCceeeccccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCCCCCccc
Q 035761 468 LLNYDSSNRTLLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKHPGELLS 523 (560)
Q Consensus 468 ~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~P~~~~~ 523 (560)
.+...... .....+..|.|||++.+. .|+.+.||||.|||+.||+-|++-|...+
T Consensus 175 ~L~~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s 230 (364)
T KOG0658|consen 175 VLVKGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS 230 (364)
T ss_pred eeccCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC
Confidence 98754444 444567789999988875 58999999999999999999998887544
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=316.18 Aligned_cols=237 Identities=27% Similarity=0.416 Sum_probs=191.2
Q ss_pred HhcCCcccceeeccCCeeEEEEEeC------CCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeC
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLHE 385 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 385 (560)
..++|++.+.||+|+||.||+|... ++..||||+++..... ...+.+.+|+++++.+ +|+||+++++++...
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT-DEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH-HHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 3467899999999999999998742 2457999999754322 3345688999999999 899999999999999
Q ss_pred CEEEEEEeccCCCCHHHHhhcCCc--------------------------------------------------------
Q 035761 386 KCMFLIYEYMEMGSLFCILRTDEE-------------------------------------------------------- 409 (560)
Q Consensus 386 ~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------- 409 (560)
+..++||||+++|+|.++++....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 999999999999999998854210
Q ss_pred -----------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCC--c
Q 035761 410 -----------AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSN--R 476 (560)
Q Consensus 410 -----------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~ 476 (560)
...+++.++.+++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++........ .
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 12378899999999999999999998 9999999999999999999999999999865432211 1
Q ss_pred eeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc-------------------ccccccccccc
Q 035761 477 TLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS-------------------SSSLDKNIKLI 536 (560)
Q Consensus 477 ~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~-------------------~~~~~~~~~~~ 536 (560)
....++..|||||++.+..++.++|||||||++|||++ |+.||...... ...+.+.++.|
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 351 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMC 351 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHH
Confidence 11234568999999999999999999999999999997 99999654321 12334555667
Q ss_pred cccCCCCCCChhHHHhh
Q 035761 537 DLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 537 ~~~dp~~~p~~~~~~~~ 553 (560)
...||..||++.++++.
T Consensus 352 l~~dp~~RPs~~~l~~~ 368 (374)
T cd05106 352 WNLEPTERPTFSQISQL 368 (374)
T ss_pred cCCChhhCcCHHHHHHH
Confidence 77788888888887753
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=308.17 Aligned_cols=239 Identities=27% Similarity=0.362 Sum_probs=196.8
Q ss_pred hcCCcccceeeccCCeeEEEEEeC---CCc--EEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP---SGK--VVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCM 388 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~---~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 388 (560)
.+.....++||.|-||.||+|.+. .|+ .||||..+... ..+..+.|+.|..+|+.++||||++++|+|.+. ..
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~ 465 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PM 465 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ce
Confidence 345566788999999999999753 233 58889887643 345578899999999999999999999999764 58
Q ss_pred EEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccc
Q 035761 389 FLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARL 468 (560)
Q Consensus 389 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 468 (560)
|+|||.++-|.|+.|++.+.. .++......++.||..+|+|||+. .+|||||.++|||+.....+|++|||+++.
T Consensus 466 WivmEL~~~GELr~yLq~nk~--sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNKD--SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred eEEEecccchhHHHHHHhccc--cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhh
Confidence 999999999999999997644 489999999999999999999999 999999999999999999999999999999
Q ss_pred cCCCCCCcee-eccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccccccccccccccccccCCCCCCC
Q 035761 469 LNYDSSNRTL-LAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSSSSLDKNIKLIDLLDPRLPPP 546 (560)
Q Consensus 469 ~~~~~~~~~~-~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~~~~~~~~~~~~~~~dp~~~p~ 546 (560)
++++...... ..-+..|||||.+.-+.++.+||||.|||+|||+++ |..||......+.-..-..--....+|.+||.
T Consensus 541 ~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~ 620 (974)
T KOG4257|consen 541 LEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPA 620 (974)
T ss_pred ccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChH
Confidence 9876655433 334679999999999999999999999999999998 99999876654433221112234556778888
Q ss_pred hhHHHhhceeeec
Q 035761 547 GDQMIRQGIILIS 559 (560)
Q Consensus 547 ~~~~~~~~~~~~~ 559 (560)
+-.+..+||.-.|
T Consensus 621 LYslmskcWayeP 633 (974)
T KOG4257|consen 621 LYSLMSKCWAYEP 633 (974)
T ss_pred HHHHHHHHhccCc
Confidence 8888888886543
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=302.59 Aligned_cols=236 Identities=26% Similarity=0.355 Sum_probs=197.0
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
++|+..+.||+|++|.||+|+.+ +++.||+|++..........+.+.+|++++++++|||++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36888899999999999999876 58999999987544332334567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|++++.+..+..... .+++.++..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999988888775433 389999999999999999999998 99999999999999999999999999998775443
Q ss_pred CCceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCccccc---------------------------
Q 035761 474 SNRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------------------- 525 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------------------- 525 (560)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 155 DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence 33334457889999998876 45788999999999999999999999643310
Q ss_pred ---------------------ccccccccccccccCCCCCCChhHHHhhcee
Q 035761 526 ---------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 526 ---------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
...+.+.+..|...||..||++.+++.|+|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 1112345566778899999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=325.64 Aligned_cols=241 Identities=22% Similarity=0.266 Sum_probs=199.1
Q ss_pred HhcCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCC-----
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEK----- 386 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 386 (560)
..++|.+.+.||+|+||.||+|+. .+|+.||||++............+.+|+..+..++|+|++++.+.+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 346899999999999999999975 46899999998754433344567889999999999999999988775432
Q ss_pred ---EEEEEEeccCCCCHHHHhhcCC-cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEee
Q 035761 387 ---CMFLIYEYMEMGSLFCILRTDE-EAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVAD 462 (560)
Q Consensus 387 ---~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 462 (560)
..++||||+++|+|.++++... ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEe
Confidence 3689999999999999986532 233589999999999999999999999 999999999999999999999999
Q ss_pred eccccccCCCC--CCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc----------------
Q 035761 463 FGIARLLNYDS--SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------- 524 (560)
Q Consensus 463 fg~~~~~~~~~--~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------- 524 (560)
||+++.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 266 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLP 266 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCC
Confidence 99998754321 122345689999999999999999999999999999999999999964331
Q ss_pred --cccccccccccccccCCCCCCChhHHHhhcee
Q 035761 525 --SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 525 --~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
....+...++.|...||..||++.+++.++|.
T Consensus 267 ~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~ 300 (496)
T PTZ00283 267 PSISPEMQEIVTALLSSDPKRRPSSSKLLNMPIC 300 (496)
T ss_pred CCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHH
Confidence 11234455667778899999999999998764
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=300.59 Aligned_cols=230 Identities=22% Similarity=0.281 Sum_probs=189.2
Q ss_pred eeccCCeeEEEEEeC-CCcEEEEEEccchhhh-hhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEeccCCCCH
Q 035761 323 IGTGGYGSVYRARLP-SGKVVALKKLHRLETE-LASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSL 400 (560)
Q Consensus 323 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 400 (560)
||+|+||.||+++.+ +|+.||+|.+...... ......+..|++++++++||||+++++++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999864 5899999998653321 12233456799999999999999999999999999999999999999
Q ss_pred HHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCceeec
Q 035761 401 FCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLA 480 (560)
Q Consensus 401 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 480 (560)
.+++.... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||++...... .......
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~-~~~~~~~ 155 (277)
T cd05607 81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG-KTITQRA 155 (277)
T ss_pred HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC-ceeeccC
Confidence 98886533 23389999999999999999999998 9999999999999999999999999999876432 2223346
Q ss_pred cccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc----------------------cccccccccccccc
Q 035761 481 GTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS----------------------SSSSLDKNIKLIDL 538 (560)
Q Consensus 481 g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~----------------------~~~~~~~~~~~~~~ 538 (560)
|+..|+|||++.+..++.++||||+||++|||++|+.||..... ....+.+.++.|..
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 235 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLA 235 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhc
Confidence 88999999999998899999999999999999999999964321 11223455567778
Q ss_pred cCCCCCCCh----hHHHhhceee
Q 035761 539 LDPRLPPPG----DQMIRQGIIL 557 (560)
Q Consensus 539 ~dp~~~p~~----~~~~~~~~~~ 557 (560)
.||..||++ ++++.|.|+.
T Consensus 236 ~~P~~R~~~~~~~~~~~~h~~f~ 258 (277)
T cd05607 236 KKPEDRLGSREKNDDPRKHEFFK 258 (277)
T ss_pred cCHhhCCCCccchhhhhcChhhc
Confidence 899999999 5666787764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=311.25 Aligned_cols=232 Identities=23% Similarity=0.294 Sum_probs=187.6
Q ss_pred ceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHH-HHhccCCCCcceeeeEEEeCCEEEEEEeccCC
Q 035761 321 YCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEAR-LLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEM 397 (560)
Q Consensus 321 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (560)
+.||+|+||.||+|+.. +|+.||+|++..... .......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 35899999999999764 689999999875432 2223344555554 56778999999999999999999999999999
Q ss_pred CCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCce
Q 035761 398 GSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRT 477 (560)
Q Consensus 398 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 477 (560)
|+|..++.... .+++.++..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (325)
T cd05604 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT 154 (325)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcc
Confidence 99998887544 389999999999999999999999 999999999999999999999999999876433333334
Q ss_pred eeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc-----------------ccccccccccccccC
Q 035761 478 LLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS-----------------SSSLDKNIKLIDLLD 540 (560)
Q Consensus 478 ~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~-----------------~~~~~~~~~~~~~~d 540 (560)
...|++.|+|||++.+..++.++|||||||++|||++|+.||...+.. ...+.+.++.|...|
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~ 234 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKD 234 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccC
Confidence 456899999999999999999999999999999999999999754321 111223445566678
Q ss_pred CCCCCCh----hHHHhhceeee
Q 035761 541 PRLPPPG----DQMIRQGIILI 558 (560)
Q Consensus 541 p~~~p~~----~~~~~~~~~~~ 558 (560)
|..||+. .+++.|+|+..
T Consensus 235 p~~R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 235 RQRRLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred HHhcCCCCCCHHHHhcCCCcCC
Confidence 8888766 48888888753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=315.02 Aligned_cols=237 Identities=27% Similarity=0.389 Sum_probs=193.6
Q ss_pred HhcCCcccceeeccCCeeEEEEEe------CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeC
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLHE 385 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 385 (560)
..++|++.+.||+|+||.||+|.+ .++..||||+++.... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 345788999999999999999963 2356899999875432 23345788999999999 899999999999999
Q ss_pred CEEEEEEeccCCCCHHHHhhcCCc--------------------------------------------------------
Q 035761 386 KCMFLIYEYMEMGSLFCILRTDEE-------------------------------------------------------- 409 (560)
Q Consensus 386 ~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------- 409 (560)
+..++||||+++|+|.++++....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 999999999999999999864321
Q ss_pred ----------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 410 ----------------AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 410 ----------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
...+++..+.+++.||++||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 12478999999999999999999998 99999999999999999999999999998764322
Q ss_pred CCc--eeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc-------------------ccccccc
Q 035761 474 SNR--TLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS-------------------SSSSLDK 531 (560)
Q Consensus 474 ~~~--~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~-------------------~~~~~~~ 531 (560)
... ....++..|+|||++.+..++.++|||||||++|||++ |..||..... ...++.+
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 348 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYD 348 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHH
Confidence 211 11234567999999999999999999999999999998 8999864431 1123456
Q ss_pred ccccccccCCCCCCChhHHHhh
Q 035761 532 NIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 532 ~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
++..|...||..||+++++++.
T Consensus 349 li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 349 IMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHHHccCChhHCcCHHHHHHH
Confidence 6677788899999999998864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=320.70 Aligned_cols=233 Identities=21% Similarity=0.253 Sum_probs=187.1
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC-------
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHE------- 385 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------- 385 (560)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 457999999999999999999864 58899999885422 1335799999999999999999987532
Q ss_pred -CEEEEEEeccCCCCHHHHhhcC-CcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCC-cEEEee
Q 035761 386 -KCMFLIYEYMEMGSLFCILRTD-EEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEF-EAFVAD 462 (560)
Q Consensus 386 -~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~D 462 (560)
...++||||+++ ++.+++... .....+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|
T Consensus 139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeec
Confidence 246799999985 676666432 2233489999999999999999999999 999999999999999664 699999
Q ss_pred eccccccCCCCCCceeeccccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCCCCCccccc----------------
Q 035761 463 FGIARLLNYDSSNRTLLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKHPGELLSSS---------------- 525 (560)
Q Consensus 463 fg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~---------------- 525 (560)
||+|+.+.... ......|++.|+|||++.+. .++.++|||||||++|||++|++||......
T Consensus 215 FGla~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 215 FGSAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred cccchhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 99998764322 22334688999999987654 6899999999999999999999999643210
Q ss_pred ------------------------------ccccccccccccccCCCCCCChhHHHhhceee
Q 035761 526 ------------------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 526 ------------------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
..+..+.++.|...||..||++.+++.|+|+.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~ 355 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFD 355 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHH
Confidence 11234556677888999999999999999974
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=299.28 Aligned_cols=232 Identities=25% Similarity=0.300 Sum_probs=186.8
Q ss_pred cCCcccceeeccCCeeEEEEEeC----CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP----SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFL 390 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 390 (560)
++|++.+.||+|+||.||+|.++ .+..||+|.++.... ......+.+|+.++++++||||++++|++..++..++
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS-DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 46888999999999999999753 356899999876432 2334578899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccC
Q 035761 391 IYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN 470 (560)
Q Consensus 391 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 470 (560)
||||+++|+|.+++.... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||.+....
T Consensus 84 v~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 999999999999997643 2489999999999999999999999 99999999999999999999999999876542
Q ss_pred CCCCC-ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------------ccccc
Q 035761 471 YDSSN-RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------------SSSLD 530 (560)
Q Consensus 471 ~~~~~-~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------------~~~~~ 530 (560)
..... .....++..|+|||.+.+..++.++|||||||++||+++ |+.||...... ...+.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLH 238 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence 21111 111234578999999999999999999999999999885 99999644321 11223
Q ss_pred cccccccccCCCCCCChhHHHh
Q 035761 531 KNIKLIDLLDPRLPPPGDQMIR 552 (560)
Q Consensus 531 ~~~~~~~~~dp~~~p~~~~~~~ 552 (560)
+.+..|...+|..||+++++.+
T Consensus 239 ~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 239 QLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHcCCCchhCCCHHHHHH
Confidence 3444555667777777776655
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=309.54 Aligned_cols=203 Identities=27% Similarity=0.385 Sum_probs=174.0
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchh-hhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLE-TELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|++.+.||+|+||.||+++.+ +++.||+|.+.+.. ......+.+.+|..++..++|+||+++++++.+++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999865 57889999987533 22233456888999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 Ey~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFED--RLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999999976322 388999999999999999999999 9999999999999999999999999999876433
Q ss_pred CCC-ceeeccccCccCcccccc-----CccCcchhHHHHHHHHHHHHhCCCCCCcc
Q 035761 473 SSN-RTLLAGTYGSIAPELAYT-----MVVTEKYDVYSFGVVALEVLMGKHPGELL 522 (560)
Q Consensus 473 ~~~-~~~~~g~~~~~aPE~~~~-----~~~~~~~Dv~s~G~il~el~~g~~P~~~~ 522 (560)
... .....|++.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 211 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence 222 223468999999998875 45788999999999999999999999643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=297.00 Aligned_cols=233 Identities=33% Similarity=0.467 Sum_probs=201.1
Q ss_pred cCCcccceeeccCCeeEEEEEeCC-CcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
++|+..+.||+|+||.||+|...+ ++.+++|.+..... .+.+.+|+++++.++||||+++++++..+...++++|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 568888999999999999998765 78999999865432 5678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++++|.+++.... ..+++..+..++.|+++|+.|||+. +++|||++|+||+++.++.++|+|||++.......
T Consensus 79 ~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 79 YCGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred cCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence 999999999986533 2489999999999999999999999 99999999999999999999999999998765443
Q ss_pred CCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc--------------------cccccccc
Q 035761 474 SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------------SSSLDKNI 533 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------------~~~~~~~~ 533 (560)
.......++..|+|||++.+..++.++||||||+++|||++|+.||...... ...+.+.+
T Consensus 154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 233 (256)
T cd06612 154 AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFV 233 (256)
T ss_pred cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHH
Confidence 3333455788999999999989999999999999999999999998643311 12344566
Q ss_pred ccccccCCCCCCChhHHHhhcee
Q 035761 534 KLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 534 ~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
..|...||..||++.+++.++|+
T Consensus 234 ~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 234 KKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHhcChhhCcCHHHHhcCCCC
Confidence 77778899999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=302.92 Aligned_cols=235 Identities=27% Similarity=0.351 Sum_probs=188.7
Q ss_pred CCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc---CCCCcceeeeEEEe-----CC
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQI---RHRNIVKLYGFCLH-----EK 386 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----~~ 386 (560)
+|++.+.||+|+||.||+|..+ +++.||+|.++...........+.+|+++++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999765 588999998875432222223455677776655 79999999998864 24
Q ss_pred EEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccc
Q 035761 387 CMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIA 466 (560)
Q Consensus 387 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~ 466 (560)
..++||||+++ +|.+++..... ..+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcc
Confidence 57899999985 88888875432 3389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc---------------------
Q 035761 467 RLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------------- 525 (560)
Q Consensus 467 ~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------------- 525 (560)
+..... .......++..|+|||++.+..++.++||||+||++|||++|++||......
T Consensus 156 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 156 RIYSCQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred ccccCc-ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 876432 2223346788999999999999999999999999999999999998533210
Q ss_pred -----------------------ccccccccccccccCCCCCCChhHHHhhcee
Q 035761 526 -----------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 526 -----------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
...+.+.+..|...||+.||++.+++.|+|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 1112344566788899999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=296.26 Aligned_cols=236 Identities=24% Similarity=0.357 Sum_probs=198.4
Q ss_pred cCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhh---hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLET---ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFL 390 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 390 (560)
++|+..+.||+|++|.||+|.. .+++.||+|.+..... .....+.+.+|++++++++||||+++++++..+...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688899999999999999975 4689999998865432 22334578899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccC
Q 035761 391 IYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN 470 (560)
Q Consensus 391 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 470 (560)
|+||+++++|.+++..... +++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGA---LTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999999876433 88999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCCCc---eeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-------------------cccc
Q 035761 471 YDSSNR---TLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-------------------SSSS 528 (560)
Q Consensus 471 ~~~~~~---~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-------------------~~~~ 528 (560)
...... ....++..|+|||.+.+..++.++||||+|+++||+++|+.||..... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPD 235 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHH
Confidence 321111 234577899999999999999999999999999999999999864321 1122
Q ss_pred cccccccccccCCCCCCChhHHHhhcee
Q 035761 529 LDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 529 ~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
+...++.|...+|..||++.+++.+.|+
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 236 ARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 3455577778899999999999999885
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=312.85 Aligned_cols=230 Identities=23% Similarity=0.314 Sum_probs=187.8
Q ss_pred eeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhcc---CCCCcceeeeEEEeCCEEEEEEeccCC
Q 035761 323 IGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQI---RHRNIVKLYGFCLHEKCMFLIYEYMEM 397 (560)
Q Consensus 323 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (560)
||+|+||.||+|+.. +++.||||++..... .......+..|..++... +||||+++++++..+...++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999865 589999999865431 222333455666676655 799999999999999999999999999
Q ss_pred CCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCce
Q 035761 398 GSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRT 477 (560)
Q Consensus 398 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 477 (560)
|+|.+++..... +++.++..++.||+.||+|||+. +|+||||||+|||++.++.++|+|||+++..........
T Consensus 81 g~L~~~l~~~~~---~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~ 154 (330)
T cd05586 81 GELFWHLQKEGR---FSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTN 154 (330)
T ss_pred ChHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCcc
Confidence 999999875433 89999999999999999999999 999999999999999999999999999976433333334
Q ss_pred eeccccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCCCCCccccc------------------ccccccccccccc
Q 035761 478 LLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKHPGELLSSS------------------SSSLDKNIKLIDL 538 (560)
Q Consensus 478 ~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~------------------~~~~~~~~~~~~~ 538 (560)
...||..|+|||++.+. .++.++||||+||++|||++|+.||...... .......++.|..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~ 234 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLN 234 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcC
Confidence 45789999999998754 4788999999999999999999999644311 1223345567788
Q ss_pred cCCCCCC----ChhHHHhhceeee
Q 035761 539 LDPRLPP----PGDQMIRQGIILI 558 (560)
Q Consensus 539 ~dp~~~p----~~~~~~~~~~~~~ 558 (560)
.||..|| ++.++++|+|+..
T Consensus 235 ~~P~~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 235 RNPQHRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred CCHHHCCCCCCCHHHHhcCccccC
Confidence 8999997 7899999999854
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=301.49 Aligned_cols=239 Identities=28% Similarity=0.421 Sum_probs=201.9
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
.++|++.+.||.|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++..+...++||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES--EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC--HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 456888999999999999999874 58899999986533 234467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++++|.+++..... .+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||.+......
T Consensus 82 e~~~~~~L~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 82 EFCDGGALDSIMLELER--GLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred eccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 99999999999875432 389999999999999999999999 9999999999999999999999999998766444
Q ss_pred CCCceeeccccCccCccccc-----cCccCcchhHHHHHHHHHHHHhCCCCCCccccc--------------------cc
Q 035761 473 SSNRTLLAGTYGSIAPELAY-----TMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------------SS 527 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~-----~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------------~~ 527 (560)
........+++.|+|||.+. ...++.++||||||+++|||++|+.||...... ..
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (280)
T cd06611 157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSS 236 (280)
T ss_pred ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCH
Confidence 33444556889999999875 344677999999999999999999999654311 12
Q ss_pred ccccccccccccCCCCCCChhHHHhhceeeec
Q 035761 528 SLDKNIKLIDLLDPRLPPPGDQMIRQGIILIS 559 (560)
Q Consensus 528 ~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~~ 559 (560)
.+.+.++.|...+|+.||+++++++++|+.+.
T Consensus 237 ~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 237 SFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 23445577788899999999999999999765
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=307.83 Aligned_cols=238 Identities=25% Similarity=0.376 Sum_probs=208.7
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
...|.+...||+|.|+.|..|++. ++..||+|.+++..-+....+.+.+|+++|+.++|||||+++.+...+...++||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 356888899999999999999754 6899999999887766566667899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+.+|.+++|+..++. ....+...+..|+..+++|||++ .|||||||++|||++.+.++||+|||++.++. .
T Consensus 135 eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-~ 207 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD-Y 207 (596)
T ss_pred EeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec-c
Confidence 99999999999998765 55688889999999999999999 99999999999999999999999999999987 3
Q ss_pred CCCceeeccccCccCccccccCccC-cchhHHHHHHHHHHHHhCCCCCCcccc-----------------cccccccccc
Q 035761 473 SSNRTLLAGTYGSIAPELAYTMVVT-EKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNIK 534 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~~~~~-~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~~ 534 (560)
.......+|++.|.|||++.+..|+ +++|+||+|+++|.|+.|..||+...- .+.+.+.+++
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLr 287 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLR 287 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHH
Confidence 4445567899999999999998765 589999999999999999999984442 2223456666
Q ss_pred cccccCCCCCCChhHHHhhceeee
Q 035761 535 LIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 535 ~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
-+..++|+.|+++++|..++|+..
T Consensus 288 k~lvl~Pskr~~~dqim~~~W~n~ 311 (596)
T KOG0586|consen 288 KFLVLNPSKRGPCDQIMKDRWRND 311 (596)
T ss_pred HhhccCccccCCHHHhhhhcccch
Confidence 777899999999999999999863
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=302.67 Aligned_cols=237 Identities=22% Similarity=0.303 Sum_probs=195.8
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
++|+..+.||+|+||.||+|..+ +++.||+|.+...... .....+.+|+.+++.++||||+++++++..+...++|||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 46888999999999999999865 5789999998644322 233457789999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|++ ++|.+++..... .+++..+..++.||++||+|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 85 YLD-KDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred ccc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 997 589888875432 388999999999999999999999 99999999999999999999999999997654333
Q ss_pred CCceeeccccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCCCCCcccc----------------------------
Q 035761 474 SNRTLLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------------- 524 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------------- 524 (560)
.......+++.|+|||.+.+. .++.++||||||+++|||++|+.||...+.
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 333334578899999987654 477899999999999999999999864321
Q ss_pred -------------------cccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 525 -------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 525 -------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
....+.+.+..|...||..||+++++++|.|+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC 291 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 0111234667778889999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=298.00 Aligned_cols=231 Identities=23% Similarity=0.329 Sum_probs=195.0
Q ss_pred cCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
++|+..+.||+|+||.||+|.. .+++.||+|.+..... ....+.+.+|++++++++||||+++++++..+...++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 3577889999999999999975 4688999998865422 2334578899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|++++++..+. .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~- 148 (279)
T cd06619 80 FMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS- 148 (279)
T ss_pred cCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence 99999997653 268888899999999999999999 9999999999999999999999999999765322
Q ss_pred CCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc--------------------------ccc
Q 035761 474 SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS--------------------------SSS 527 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~--------------------------~~~ 527 (560)
......|+..|+|||++.+..++.++||||||+++|||++|+.||..... ...
T Consensus 149 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (279)
T cd06619 149 -IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSE 227 (279)
T ss_pred -cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCH
Confidence 22335688999999999998999999999999999999999999954221 111
Q ss_pred ccccccccccccCCCCCCChhHHHhhceeee
Q 035761 528 SLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 528 ~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
.+.+.+..|...+|..||++++++.+.|+..
T Consensus 228 ~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~ 258 (279)
T cd06619 228 KFVHFITQCMRKQPKERPAPENLMDHPFIVQ 258 (279)
T ss_pred HHHHHHHHHhhCChhhCCCHHHHhcCccccc
Confidence 2334556677889999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=301.65 Aligned_cols=235 Identities=24% Similarity=0.373 Sum_probs=199.4
Q ss_pred cCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
.+|+..+.||+|+||.||+|.. .+++.|++|.+..... ...+.+.+|+.+++.++||||+++++.+..+...++|||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc--chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 5788889999999999999975 4688999998875332 234568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++++|.+++... .+++.++..++.|++.|++|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 98 YLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred ccCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 99999999998643 278999999999999999999999 99999999999999999999999999988764433
Q ss_pred CCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc--------------------cccccccc
Q 035761 474 SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------------SSSLDKNI 533 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------------~~~~~~~~ 533 (560)
.......+++.|+|||.+.+..++.++|||||||++|||++|+.||...... ...+.+.+
T Consensus 171 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 250 (296)
T cd06654 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL 250 (296)
T ss_pred cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHH
Confidence 3333456888999999999888999999999999999999999999644320 01133445
Q ss_pred ccccccCCCCCCChhHHHhhceeee
Q 035761 534 KLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 534 ~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
+.|...||..||++.+++.++|+..
T Consensus 251 ~~~l~~~p~~Rpt~~eil~~~~~~~ 275 (296)
T cd06654 251 NRCLDMDVEKRGSAKELLQHQFLKI 275 (296)
T ss_pred HHHCcCCcccCcCHHHHhhChhhhc
Confidence 6677789999999999999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=309.25 Aligned_cols=238 Identities=24% Similarity=0.304 Sum_probs=195.6
Q ss_pred HHHHhcCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC---
Q 035761 310 MIEATEDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHE--- 385 (560)
Q Consensus 310 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--- 385 (560)
..+..++|+..+.||+|+||.||+|.. .+++.||||++..........+.+.+|+.+++.++||||+++++++...
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 344567899999999999999999975 4678999999876543334445677899999999999999999987543
Q ss_pred ---CEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEee
Q 035761 386 ---KCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVAD 462 (560)
Q Consensus 386 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 462 (560)
...++++|++ +++|.+++... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~D 161 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILD 161 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcC
Confidence 3468999988 77998887642 389999999999999999999999 999999999999999999999999
Q ss_pred eccccccCCCCCCceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCccccc----------------
Q 035761 463 FGIARLLNYDSSNRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSSS---------------- 525 (560)
Q Consensus 463 fg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~---------------- 525 (560)
||+++..... .....|++.|+|||++.+ ..++.++||||+||++|||++|+.||......
T Consensus 162 fg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07878 162 FGLARQADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPE 238 (343)
T ss_pred CccceecCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 9999875432 233468999999999877 56888999999999999999999999643210
Q ss_pred --------------------------------ccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 526 --------------------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 526 --------------------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
...+.+.++.|...||..||++.+++.|+|+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~ 303 (343)
T cd07878 239 VLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303 (343)
T ss_pred HHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence 001224455678889999999999999999863
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=300.63 Aligned_cols=230 Identities=34% Similarity=0.511 Sum_probs=182.4
Q ss_pred ccceeeccCCeeEEEEEeC-----CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 319 IKYCIGTGGYGSVYRARLP-----SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 319 ~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
..+.||.|+||.||+|.+. .+..|+||.++... .....+.+.+|++.+++++||||++++|++...+..++|+|
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS-SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS-SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc-ccccceeeeeccccccccccccccccccccccccccccccc
Confidence 4578999999999999876 25789999996532 23346789999999999999999999999998888999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++|+|.++++... ...+++.++.+|+.|||+||+|||+. +++|+||+++||+++.++.+||+|||++.......
T Consensus 82 ~~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp --TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccccc-cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 999999999998762 23489999999999999999999999 99999999999999999999999999998763221
Q ss_pred CC--ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------------ccccccc
Q 035761 474 SN--RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------------SSSLDKN 532 (560)
Q Consensus 474 ~~--~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------------~~~~~~~ 532 (560)
.. .........|+|||.+.+..++.++||||||+++||+++ |+.||...... ...+...
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSL 237 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHH
Confidence 11 122346778999999999999999999999999999999 78998754321 1123445
Q ss_pred cccccccCCCCCCChhHHHhh
Q 035761 533 IKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 533 ~~~~~~~dp~~~p~~~~~~~~ 553 (560)
+..|...||..||++.++++.
T Consensus 238 i~~C~~~~p~~RPs~~~i~~~ 258 (259)
T PF07714_consen 238 IQQCWSHDPEKRPSFQEILQE 258 (259)
T ss_dssp HHHHT-SSGGGS--HHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHhc
Confidence 566667788888888887753
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=327.43 Aligned_cols=236 Identities=26% Similarity=0.359 Sum_probs=189.8
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|++.+.||+|+||.||+|... +|+.||+|++..... .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46889999999999999999865 589999999875332 2233457899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCC--------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeec
Q 035761 393 EYMEMGSLFCILRTDE--------EAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFG 464 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 464 (560)
||+++|+|.+++.... ....+++..+.+++.||++||+|||+. +|+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999986421 122367788899999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCC------------------CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccccc
Q 035761 465 IARLLNYDSS------------------NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSS 526 (560)
Q Consensus 465 ~~~~~~~~~~------------------~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~ 526 (560)
+++....... .....+||+.|||||++.+..++.++|||||||++|||++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9987621110 0112468999999999999999999999999999999999999996533211
Q ss_pred --------------------cccccccccccccCCCCCCChhHHHhh
Q 035761 527 --------------------SSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 527 --------------------~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
..+.+.+..|...||+.|++..+.+.+
T Consensus 239 i~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 239 ISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 112334455666677777665555443
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=306.56 Aligned_cols=236 Identities=19% Similarity=0.301 Sum_probs=192.5
Q ss_pred ccceeecc--CCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEecc
Q 035761 319 IKYCIGTG--GYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYM 395 (560)
Q Consensus 319 ~~~~ig~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 395 (560)
+.++||+| +|+.||++.. .+|+.||+|++..........+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45679999 6789999976 46899999998765433344557788999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCC
Q 035761 396 EMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSN 475 (560)
Q Consensus 396 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 475 (560)
++|+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+.........
T Consensus 82 ~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 99999999965422 2389999999999999999999998 9999999999999999999999999876543211111
Q ss_pred -------ceeeccccCccCcccccc--CccCcchhHHHHHHHHHHHHhCCCCCCccccc---------------------
Q 035761 476 -------RTLLAGTYGSIAPELAYT--MVVTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------------- 525 (560)
Q Consensus 476 -------~~~~~g~~~~~aPE~~~~--~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------------- 525 (560)
.....++..|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP 237 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence 112346678999999876 45889999999999999999999999643210
Q ss_pred ------------------------------------------ccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 526 ------------------------------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 526 ------------------------------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
+..+.+.++.|...||..||+++++++|+|+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 012334567888899999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=299.77 Aligned_cols=236 Identities=22% Similarity=0.293 Sum_probs=196.7
Q ss_pred CcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhh-hhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 317 FDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETE-LASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 317 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
|+..+.||+|+||.||++... +++.||||.+...... ......+.+|+.+++.++|++++++++.+..++..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667788999999999999764 6889999998654321 22234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
+++++|.+++.... ...+++.++..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05630 82 MNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ- 156 (285)
T ss_pred cCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence 99999999886533 23489999999999999999999998 99999999999999999999999999987654222
Q ss_pred CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------ccccccccc
Q 035761 475 NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------SSSSLDKNI 533 (560)
Q Consensus 475 ~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------~~~~~~~~~ 533 (560)
......|+..|+|||++.+..++.++||||+|+++|||++|+.||..... ....+.+.+
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLC 236 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHH
Confidence 22234689999999999999999999999999999999999999974321 111234556
Q ss_pred ccccccCCCCCCC-----hhHHHhhceee
Q 035761 534 KLIDLLDPRLPPP-----GDQMIRQGIIL 557 (560)
Q Consensus 534 ~~~~~~dp~~~p~-----~~~~~~~~~~~ 557 (560)
+.|...||..||+ +++++.|+|+.
T Consensus 237 ~~~l~~~p~~R~s~~~~~~~~~~~h~~~~ 265 (285)
T cd05630 237 KMLLCKDPKERLGCQGGGAREVKEHPLFK 265 (285)
T ss_pred HHHhhcCHHHccCCCCCchHHHHcChhhh
Confidence 7778889999998 88999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=294.92 Aligned_cols=231 Identities=26% Similarity=0.396 Sum_probs=191.0
Q ss_pred cCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
++|++.+.||+|+||.||+|.++++..+|+|.+..... ..+.+.+|++++++++||||+++++++..++..++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM---SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc---cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 45788899999999999999998888999998864332 234688899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
+++|+|.++++.... .+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||.++.......
T Consensus 81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 81 MENGCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred CCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 999999999875432 389999999999999999999999 999999999999999999999999999886532221
Q ss_pred Cc-eeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccccc------------------cccccccc
Q 035761 475 NR-TLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSS------------------SSLDKNIK 534 (560)
Q Consensus 475 ~~-~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~~------------------~~~~~~~~ 534 (560)
.. ....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ..+...++
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMY 235 (256)
T ss_pred eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence 11 12234568999999988889999999999999999999 999996543211 11334445
Q ss_pred cccccCCCCCCChhHHHhh
Q 035761 535 LIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 535 ~~~~~dp~~~p~~~~~~~~ 553 (560)
.|...+|..||+++++++.
T Consensus 236 ~c~~~~p~~Rps~~~l~~~ 254 (256)
T cd05114 236 SCWHEKPEGRPTFAELLRA 254 (256)
T ss_pred HHccCCcccCcCHHHHHHh
Confidence 6667788888888888764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=313.17 Aligned_cols=239 Identities=26% Similarity=0.364 Sum_probs=203.6
Q ss_pred cCCcccceeeccCCeeEEEEEeCCCcE-EEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPSGKV-VALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~-vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
+.|++...+|.|+||.||+|..++... .|-|++... +.+..+.|+-|+++++.++||+||++++.|+.+..+|+..|
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 345556678999999999998775443 455666543 34567789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
||.||-....+-.-+ ..|++.++.-+++|++.||.|||++ .|||||||+-|||++-+|.++++|||.+.......
T Consensus 110 FC~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~ 184 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR 184 (1187)
T ss_pred ecCCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHH
Confidence 999999988775433 2399999999999999999999999 99999999999999999999999999987765444
Q ss_pred CCceeeccccCccCcccc-----ccCccCcchhHHHHHHHHHHHHhCCCCCCccc--------------------ccccc
Q 035761 474 SNRTLLAGTYGSIAPELA-----YTMVVTEKYDVYSFGVVALEVLMGKHPGELLS--------------------SSSSS 528 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~-----~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~--------------------~~~~~ 528 (560)
..+..+.|||.|||||+. .+..|+.++||||||+.+.||..+.+|....+ .|+..
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~ 264 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRS 264 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhH
Confidence 556667899999999974 46779999999999999999999999975443 24455
Q ss_pred cccccccccccCCCCCCChhHHHhhceeeecC
Q 035761 529 LDKNIKLIDLLDPRLPPPGDQMIRQGIILIST 560 (560)
Q Consensus 529 ~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~~~ 560 (560)
+....+.|..-+|+-||++.++++|+|+.|++
T Consensus 265 F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 265 FSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP 296 (1187)
T ss_pred HHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence 67778889999999999999999999999874
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=298.84 Aligned_cols=237 Identities=26% Similarity=0.430 Sum_probs=195.5
Q ss_pred HhcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeC-----
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLHE----- 385 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----- 385 (560)
+.+.|+..+.||+|+||.||+|... +++.||+|.+.... .....+.+|+.+++++ +||||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 4567888889999999999999764 57889999986533 2234678899999998 799999999998753
Q ss_pred -CEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeec
Q 035761 386 -KCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFG 464 (560)
Q Consensus 386 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 464 (560)
...++||||+++|+|.+++.... ...+++..+..++.|++.|++|||+. +++|||++|+||++++++.++|+|||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCC
Confidence 46899999999999999987643 23489999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCceeeccccCccCccccc-----cCccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------
Q 035761 465 IARLLNYDSSNRTLLAGTYGSIAPELAY-----TMVVTEKYDVYSFGVVALEVLMGKHPGELLSS--------------- 524 (560)
Q Consensus 465 ~~~~~~~~~~~~~~~~g~~~~~aPE~~~-----~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~--------------- 524 (560)
++..............|+..|+|||++. +..++.++|||||||++|||++|+.||.....
T Consensus 157 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 236 (272)
T cd06637 157 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL 236 (272)
T ss_pred CceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCC
Confidence 9987643333334456889999999876 34578899999999999999999999864321
Q ss_pred ----cccccccccccccccCCCCCCChhHHHhhcee
Q 035761 525 ----SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 525 ----~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
....+.+.+..|...||..||++++++.|+|+
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 237 KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 11234455567778899999999999999986
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=301.39 Aligned_cols=236 Identities=26% Similarity=0.364 Sum_probs=196.9
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
++|+..+.||+|+||.||+|..+ +++.||+|++..........+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 35788899999999999999875 58999999987654333344568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|++++++..+..... .+++.++..++.||++|++|||+. +++|||++|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 999999888765432 289999999999999999999998 99999999999999999999999999998764433
Q ss_pred CCceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCcccc----------------------------
Q 035761 474 SNRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------------- 524 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------------- 524 (560)
.......++..|+|||++.+ ..++.++||||||+++|||++|+.||.....
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence 33334457889999998875 4467899999999999999999999863321
Q ss_pred --------------------cccccccccccccccCCCCCCChhHHHhhcee
Q 035761 525 --------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 525 --------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
....+.+.++.|...+|..||++.+++++.|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 01123445667778899999999999999884
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=304.78 Aligned_cols=232 Identities=23% Similarity=0.405 Sum_probs=189.3
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCc----EEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGK----VVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMF 389 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 389 (560)
.+|+..+.||+|+||.||+|.+. +++ .||+|.++... .....+.+.+|+.+++.++||||++++|+|... ..+
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 46888999999999999999864 333 48999986432 223456788999999999999999999999765 567
Q ss_pred EEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccccc
Q 035761 390 LIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL 469 (560)
Q Consensus 390 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 469 (560)
+++||+++|+|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeeecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccc
Confidence 99999999999999986432 388999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCce--eeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------------ccc
Q 035761 470 NYDSSNRT--LLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------------SSS 528 (560)
Q Consensus 470 ~~~~~~~~--~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------------~~~ 528 (560)
........ ...++..|+|||.+.+..++.++||||||+++|||++ |+.||+..... ...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 239 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHH
Confidence 53322211 1234668999999999999999999999999999998 99999754321 112
Q ss_pred cccccccccccCCCCCCChhHHHhh
Q 035761 529 LDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 529 ~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
+...+..|...+|..||++.+++.+
T Consensus 240 ~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 240 VYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHH
Confidence 3344566777899999999988875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=298.80 Aligned_cols=238 Identities=26% Similarity=0.381 Sum_probs=198.9
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
.+.|++.+.||+|+||.||+|... +++.|++|.+.... ....+.+.+|+++++.++|||++++++++..++..++||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 356888999999999999999875 48899999986533 334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||++++++.+++..... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 89 e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 89 EFCPGGAVDAIMLELDR--GLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163 (292)
T ss_pred ecCCCCcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence 99999999888764332 389999999999999999999998 9999999999999999999999999998764333
Q ss_pred CCCceeeccccCccCccccc-----cCccCcchhHHHHHHHHHHHHhCCCCCCccccc--------------------cc
Q 035761 473 SSNRTLLAGTYGSIAPELAY-----TMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------------SS 527 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~-----~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------------~~ 527 (560)
........+++.|+|||++. ...++.++|||||||++|||++|+.||...... ..
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (292)
T cd06644 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSM 243 (292)
T ss_pred ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCH
Confidence 23333456788999999874 345678999999999999999999998654310 11
Q ss_pred ccccccccccccCCCCCCChhHHHhhceeee
Q 035761 528 SLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 528 ~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
.+...++.|...+|+.||+++++++++|+..
T Consensus 244 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 274 (292)
T cd06644 244 EFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274 (292)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 2344567778889999999999999999864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=295.33 Aligned_cols=233 Identities=27% Similarity=0.407 Sum_probs=193.5
Q ss_pred cCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
++|++.+.||+|+||.||+|.. .+++.||+|++..... .....+.+|+.++++++||||+++++++..+...++|||
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 5688999999999999999986 4688999999864322 223467789999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++++|.++++... .+++.++..++.|++.|++|||+. +|+|||++|+||+++.++.++|+|||++.......
T Consensus 87 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 87 YCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 999999999987543 389999999999999999999998 99999999999999999999999999998764333
Q ss_pred CCceeeccccCccCccccc---cCccCcchhHHHHHHHHHHHHhCCCCCCccccc----------------------ccc
Q 035761 474 SNRTLLAGTYGSIAPELAY---TMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS----------------------SSS 528 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~---~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~----------------------~~~ 528 (560)
.......++..|+|||.+. ...++.++||||||+++|||++|+.||...... ...
T Consensus 161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06646 161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSST 240 (267)
T ss_pred cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHH
Confidence 3333456888999999874 344778999999999999999999998533211 112
Q ss_pred cccccccccccCCCCCCChhHHHhhce
Q 035761 529 LDKNIKLIDLLDPRLPPPGDQMIRQGI 555 (560)
Q Consensus 529 ~~~~~~~~~~~dp~~~p~~~~~~~~~~ 555 (560)
+.+.++.|...||..||++++++.+.|
T Consensus 241 ~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 241 FHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 334556667789999999999998865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=319.31 Aligned_cols=237 Identities=24% Similarity=0.327 Sum_probs=197.6
Q ss_pred cCCcccceeeccCCeeEEEEEeCCC-cEEEEEEccchhhhhhhHHHHHHHHHHHhccC-CCCcceeeeE-EEeC------
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPSG-KVVALKKLHRLETELASLESFQNEARLLSQIR-HRNIVKLYGF-CLHE------ 385 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~-~~~~------ 385 (560)
.++++.+.|.+|||+.||.|....+ .++|+|++-.. +....+...+|+++|+.+. |+|||.+++. ....
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 3567788899999999999987665 99999998765 3466788999999999995 9999999993 3221
Q ss_pred CEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecc
Q 035761 386 KCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGI 465 (560)
Q Consensus 386 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 465 (560)
.+.+|.||||++|.|-+++...-. ..|++.++++|+.|+++|+++||.. +|+|||||||.+||||+.+++.||||||.
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq-~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQ-TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHh-ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 357899999999999999975432 2399999999999999999999986 78899999999999999999999999999
Q ss_pred ccccCCCC-CCce--------eeccccCccCccc---cccCccCcchhHHHHHHHHHHHHhCCCCCCcccc---------
Q 035761 466 ARLLNYDS-SNRT--------LLAGTYGSIAPEL---AYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS--------- 524 (560)
Q Consensus 466 ~~~~~~~~-~~~~--------~~~g~~~~~aPE~---~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~--------- 524 (560)
|.-..... .... ...-|+.|.|||. ..+...++|+||||+||+||-|+....||+..+.
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~Y~ 272 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGNYS 272 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEecccc
Confidence 87532211 1111 1235889999996 4577899999999999999999999999997742
Q ss_pred ------cccccccccccccccCCCCCCChhHHHhhce
Q 035761 525 ------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGI 555 (560)
Q Consensus 525 ------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~ 555 (560)
....+..+++.|...+|..||.+.+++.+.+
T Consensus 273 ~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 273 FPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred CCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 3456789999999999999999999988744
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=292.62 Aligned_cols=237 Identities=29% Similarity=0.376 Sum_probs=198.1
Q ss_pred CCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEe-CCEEEEEEe
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLH-EKCMFLIYE 393 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 393 (560)
+|++.+.||+|++|.||++..+ +++.||+|++..........+.+.+|++++++++|+|++++++.+.. +...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999764 57889999987544333445678899999999999999999998764 446789999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++++|.+++.... ...+++.++..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 999999999987532 23489999999999999999999999 99999999999999999999999999998764433
Q ss_pred CCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc------------------cccccccccc
Q 035761 474 SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS------------------SSSLDKNIKL 535 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~------------------~~~~~~~~~~ 535 (560)
.......+++.|+|||+..+..++.++||||+|+++||+++|+.||...+.. ...+.+.++.
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIAT 236 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 3334456888999999999999999999999999999999999998643311 1223445566
Q ss_pred ccccCCCCCCChhHHHhhcee
Q 035761 536 IDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 536 ~~~~dp~~~p~~~~~~~~~~~ 556 (560)
|...+|..||++.++++|+|+
T Consensus 237 ~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 237 MLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HhccCcccCCCHHHHhcCCCC
Confidence 777899999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=274.74 Aligned_cols=237 Identities=25% Similarity=0.357 Sum_probs=195.8
Q ss_pred hcCCcccceeeccCCeeEEEEE-eCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC-----CE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHE-----KC 387 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 387 (560)
.++|.+.+.+|+|+|+.||.++ ..++..+|+|++.... .+..+..++|++..++++||||+++++++..+ ..
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 4679999999999999999997 5578899999987644 34456788999999999999999999987653 35
Q ss_pred EEEEEeccCCCCHHHHhhcCC-cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccc
Q 035761 388 MFLIYEYMEMGSLFCILRTDE-EAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIA 466 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~ 466 (560)
.|++++|...|+|.+.+.... ++..+++.+.+.|+.+|++||++||+. .|+++||||||.||++++++.+++.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCc
Confidence 899999999999999987543 233599999999999999999999997 456999999999999999999999999999
Q ss_pred cccCCCCCCc---------eeeccccCccCccccc---cCccCcchhHHHHHHHHHHHHhCCCCCCcccc----------
Q 035761 467 RLLNYDSSNR---------TLLAGTYGSIAPELAY---TMVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------- 524 (560)
Q Consensus 467 ~~~~~~~~~~---------~~~~g~~~~~aPE~~~---~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------- 524 (560)
+...-.-... .....|..|.|||++. +...++++|||||||++|+|+.|..||+..-.
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~ 256 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQ 256 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeee
Confidence 8653221111 1123688999999876 34567899999999999999999999963321
Q ss_pred -----------cccccccccccccccCCCCCCChhHHHhh
Q 035761 525 -----------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 525 -----------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
.++.+.+.++.|.++||..||++.+++.+
T Consensus 257 n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 257 NAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred ccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 23446778899999999999999999875
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=317.94 Aligned_cols=229 Identities=24% Similarity=0.404 Sum_probs=189.1
Q ss_pred CcccceeeccCCeeEEEEEe-CCCc----EEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEE
Q 035761 317 FDIKYCIGTGGYGSVYRARL-PSGK----VVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLI 391 (560)
Q Consensus 317 ~~~~~~ig~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 391 (560)
....++||.|+||.||+|.| ++|+ +||+|++.... ..+...++.+|+-.|.+++|||+++++|+|..+. ..||
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 34467899999999999975 4443 68888886543 3455678999999999999999999999998876 7899
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 471 (560)
++||+.|+|.+|++.++.. +-.+..+.|..|||+||.|||++ ++|||||.++|||+..-..+||+|||+++.+..
T Consensus 776 tq~mP~G~LlDyvr~hr~~--igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDN--IGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HHhcccchHHHHHHHhhcc--ccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 9999999999999987654 77889999999999999999999 999999999999999999999999999998876
Q ss_pred CCCCcee--eccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccccc--cc----------------c
Q 035761 472 DSSNRTL--LAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSSS--SL----------------D 530 (560)
Q Consensus 472 ~~~~~~~--~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~~~--~~----------------~ 530 (560)
+...... ..-.+.|||=|.+....|+.++|||||||.+||++| |..|++.....+. .+ .
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy 930 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVY 930 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHH
Confidence 5544433 334678999999999999999999999999999999 9999986653221 11 1
Q ss_pred cccccccccCCCCCCChhHHHh
Q 035761 531 KNIKLIDLLDPRLPPPGDQMIR 552 (560)
Q Consensus 531 ~~~~~~~~~dp~~~p~~~~~~~ 552 (560)
.....|-.+|++.||.++++..
T Consensus 931 ~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 931 MVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHHHhccCcccCccHHHHHH
Confidence 1122344679999999887654
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=301.03 Aligned_cols=235 Identities=23% Similarity=0.342 Sum_probs=192.8
Q ss_pred CCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
+|+..+.||+|+||.||+|... +|+.||+|.++...........+.+|+++++.++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4777889999999999999875 688999999875433323335677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
++ +++.+++..... .+++..+..++.||++||+|||+. +++||||||+||+++.++.++|+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CD-QDLKKYFDSCNG--DIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 97 488887765332 389999999999999999999999 999999999999999999999999999986643333
Q ss_pred CceeeccccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCCCCCccccc----------------------------
Q 035761 475 NRTLLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKHPGELLSSS---------------------------- 525 (560)
Q Consensus 475 ~~~~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~---------------------------- 525 (560)
......++..|+|||.+.+. .++.++|||||||++|||++|+.|+....+.
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 33334578899999988764 4688999999999999999999886322210
Q ss_pred -------------------ccccccccccccccCCCCCCChhHHHhhcee
Q 035761 526 -------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 526 -------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
...+.+.++.|...||..||++++++.|.|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 1122345677778899999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=294.98 Aligned_cols=238 Identities=29% Similarity=0.455 Sum_probs=201.3
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
++|++.+.||.|+||.||+|... ++..+++|++....... ..+.+.+|++.++.++|+|++++++.+..+...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 36888999999999999999864 57899999986543322 55678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++++|.++++.......+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||++..+....
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999997643334589999999999999999999998 99999999999999999999999999998765433
Q ss_pred CC----ceeeccccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCCCCCccccc-----------------------
Q 035761 474 SN----RTLLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKHPGELLSSS----------------------- 525 (560)
Q Consensus 474 ~~----~~~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~----------------------- 525 (560)
.. .....|+..|+|||.+... .++.++|+||||+++|||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKY 236 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccc
Confidence 22 1334688899999998877 7888999999999999999999999654321
Q ss_pred ccccccccccccccCCCCCCChhHHHhhcee
Q 035761 526 SSSLDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 526 ~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
...+.+.++.|...||..||++.+++.|+|+
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 237 SKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred cHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 1223456677778899999999999999985
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=297.80 Aligned_cols=237 Identities=21% Similarity=0.271 Sum_probs=195.7
Q ss_pred CcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhh-hhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 317 FDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETE-LASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 317 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
|+..+.||+|+||.||+|... +++.||+|.+...... ......+.+|+++++.++|+|++++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566788999999999999764 6889999998654321 22234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
+++++|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred ccCccHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 999999988865332 2489999999999999999999998 99999999999999999999999999997654222
Q ss_pred CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------ccccccccc
Q 035761 475 NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------SSSSLDKNI 533 (560)
Q Consensus 475 ~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------~~~~~~~~~ 533 (560)
......|+..|+|||++.+..++.++|+||+|+++|||++|+.||..... ....+.+.+
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC 236 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence 22234689999999999988999999999999999999999999974321 111234455
Q ss_pred ccccccCCCCCCC-----hhHHHhhceeee
Q 035761 534 KLIDLLDPRLPPP-----GDQMIRQGIILI 558 (560)
Q Consensus 534 ~~~~~~dp~~~p~-----~~~~~~~~~~~~ 558 (560)
..|...||..||+ +++++.+.|+..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05632 237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRN 266 (285)
T ss_pred HHHccCCHhHcCCCcccChHHHHcChhhhc
Confidence 6677789999999 778888888754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=303.16 Aligned_cols=229 Identities=24% Similarity=0.363 Sum_probs=182.5
Q ss_pred cceeeccCCeeEEEEEeC---CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEe--CCEEEEEEec
Q 035761 320 KYCIGTGGYGSVYRARLP---SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLH--EKCMFLIYEY 394 (560)
Q Consensus 320 ~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~ 394 (560)
.+.||+|+||.||+|+.+ +++.||+|.+..... ...+.+|++++++++||||+++++++.. +...+++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 357999999999999864 467899999865322 2356789999999999999999998864 4568999999
Q ss_pred cCCCCHHHHhhcCC------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEe----CCCCcEEEeeec
Q 035761 395 MEMGSLFCILRTDE------EAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILL----NSEFEAFVADFG 464 (560)
Q Consensus 395 ~~~g~L~~~l~~~~------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfg 464 (560)
+.+ ++.+++.... ....+++..+..++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 82 AEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred cCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 965 8887775321 123488999999999999999999999 99999999999999 456789999999
Q ss_pred cccccCCCCC---CceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCccccc---------------
Q 035761 465 IARLLNYDSS---NRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------- 525 (560)
Q Consensus 465 ~~~~~~~~~~---~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------- 525 (560)
+++....... ......||+.|+|||++.+ ..++.++||||+||++|||++|++||......
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 237 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence 9987643221 1233568999999999876 45888999999999999999999999532210
Q ss_pred -------------------------------------------------ccccccccccccccCCCCCCChhHHHhhcee
Q 035761 526 -------------------------------------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 526 -------------------------------------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
+....+.++.|...||..||+++++++|+|+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 238 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0011234567788899999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=310.01 Aligned_cols=232 Identities=24% Similarity=0.385 Sum_probs=193.5
Q ss_pred cccceeeccCCeeEEEEEeC-CCcEEEEEEccchh--hhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCC--EEEEEE
Q 035761 318 DIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLE--TELASLESFQNEARLLSQIRHRNIVKLYGFCLHEK--CMFLIY 392 (560)
Q Consensus 318 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 392 (560)
.....||+|+|-+||||... +|.+||--.++..+ ..+...+.|..|+++++.++||||++++.+|.+.. +..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 34567999999999999653 57778765444332 33455688999999999999999999999998765 478899
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCC-CcEEEeeeccccccCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSE-FEAFVADFGIARLLNY 471 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~~~~~~~ 471 (560)
|.|..|+|+.|.++.+. .+.+.+..|++||++||.|||++ .|+|||||||-.||+|+.+ |.|||+|+|+|.....
T Consensus 123 EL~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ecccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 99999999999998776 88999999999999999999997 8899999999999999865 8999999999998653
Q ss_pred CCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc--------------------ccccccc
Q 035761 472 DSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS--------------------SSSSLDK 531 (560)
Q Consensus 472 ~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~--------------------~~~~~~~ 531 (560)
.......|||.|||||+.. ..|++.+||||||++|.||+|+..||..=.. ...+..+
T Consensus 199 --s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~ 275 (632)
T KOG0584|consen 199 --SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVRE 275 (632)
T ss_pred --cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHH
Confidence 3333478999999999877 7799999999999999999999999841111 1234566
Q ss_pred ccccccccCCCCCCChhHHHhhceee
Q 035761 532 NIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 532 ~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
++..|... ...|+++.+++.+.|+.
T Consensus 276 fIekCl~~-~~~R~sa~eLL~d~Ff~ 300 (632)
T KOG0584|consen 276 FIEKCLAT-KSERLSAKELLKDPFFD 300 (632)
T ss_pred HHHHHhcC-chhccCHHHHhhChhhc
Confidence 67777766 88899999999998874
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=299.51 Aligned_cols=236 Identities=24% Similarity=0.369 Sum_probs=200.9
Q ss_pred hcCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
.++|+..+.||+|+||.||+|.. .+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 36788899999999999999985 4689999999865332 23356788999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++++|.+++... .+++.++..++.|++.||+|||+. +++||||||+||+++.++.++|+|||.+......
T Consensus 96 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 96 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred cccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 999999999998643 278999999999999999999998 9999999999999999999999999999876544
Q ss_pred CCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc--------------------ccccccc
Q 035761 473 SSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------------SSSLDKN 532 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------------~~~~~~~ 532 (560)
........+++.|+|||...+..++.++|+||||+++|++++|+.||...+.. ...+.+.
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 248 (297)
T cd06656 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDF 248 (297)
T ss_pred ccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHH
Confidence 33334456888999999999988999999999999999999999999643311 0112345
Q ss_pred cccccccCCCCCCChhHHHhhceeee
Q 035761 533 IKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 533 ~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
+..|...+|..||++++++.++|+..
T Consensus 249 i~~~l~~~p~~Rps~~~il~~~~~~~ 274 (297)
T cd06656 249 LNRCLEMDVDRRGSAKELLQHPFLKL 274 (297)
T ss_pred HHHHccCChhhCcCHHHHhcCchhcc
Confidence 56677789999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=294.16 Aligned_cols=240 Identities=25% Similarity=0.336 Sum_probs=195.1
Q ss_pred HHhcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEE
Q 035761 312 EATEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFL 390 (560)
Q Consensus 312 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 390 (560)
.+++++.....||+|+||.||+|... ++..|++|.+..... ...+.+.+|+++++.++|+||+++++++..++..++
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS--RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH--HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 34555666778999999999999854 577899998865432 334578899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCC-CCcEEEeeecccccc
Q 035761 391 IYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNS-EFEAFVADFGIARLL 469 (560)
Q Consensus 391 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~~~~~ 469 (560)
|+||+++++|.+++.........++..+..++.||+.|++|||+. +|+||||||+||+++. ++.++|+|||.+...
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 999999999999997643222237888899999999999999998 9999999999999976 678999999998765
Q ss_pred CCCCCCceeeccccCccCccccccCc--cCcchhHHHHHHHHHHHHhCCCCCCccccc--------------------cc
Q 035761 470 NYDSSNRTLLAGTYGSIAPELAYTMV--VTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------------SS 527 (560)
Q Consensus 470 ~~~~~~~~~~~g~~~~~aPE~~~~~~--~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------------~~ 527 (560)
...........+++.|+|||++.... ++.++||||||+++|||++|+.||...... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd06624 160 AGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSA 239 (268)
T ss_pred ccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCH
Confidence 43333233345788999999986543 788999999999999999999998643221 11
Q ss_pred ccccccccccccCCCCCCChhHHHhhcee
Q 035761 528 SLDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 528 ~~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
.+...++.|...+|+.||++.+++.|+|+
T Consensus 240 ~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 240 EAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 23345566777899999999999999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=312.01 Aligned_cols=231 Identities=22% Similarity=0.294 Sum_probs=193.1
Q ss_pred hcCCcccceeeccCCeeEEEEEeC---CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP---SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFL 390 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 390 (560)
..+|++.+.||+|+||.||++... .+..||+|.+.... ...+|++++++++||||+++++++......++
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 357999999999999999999753 35789999876432 34579999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccC
Q 035761 391 IYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN 470 (560)
Q Consensus 391 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 470 (560)
|||++. ++|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||++.++.++|+|||+++...
T Consensus 164 v~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 164 VMPKYK-CDLFTYVDRSG---PLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred EehhcC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 999996 68888885433 389999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCC--ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc-----------------------
Q 035761 471 YDSSN--RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS----------------------- 525 (560)
Q Consensus 471 ~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~----------------------- 525 (560)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~ 316 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN 316 (392)
T ss_pred cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence 32221 22356899999999999999999999999999999999999998543210
Q ss_pred -------------------------------ccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 526 -------------------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 526 -------------------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
...+...++.|...||+.||++.+++.|+|+..
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~ 380 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380 (392)
T ss_pred cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence 011223456778889999999999999999863
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=312.91 Aligned_cols=230 Identities=23% Similarity=0.290 Sum_probs=190.5
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
..|.+.+.||+|+||.||+|... .++.||||.... ..+.+|++++++++|+||+++++++..++..++|||
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 36888899999999999999875 478899996432 235689999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
++. ++|.+++..... .+++.++..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 241 ~~~-~~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 241 KYR-SDLYTYLGARLR--PLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred ccC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 995 689888865322 489999999999999999999999 99999999999999999999999999998754322
Q ss_pred CC--ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------------
Q 035761 474 SN--RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS--------------------------- 524 (560)
Q Consensus 474 ~~--~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~--------------------------- 524 (560)
.. .....||..|+|||++.+..++.++|||||||++|||++|..|+.....
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 11 2235689999999999999999999999999999999998755421110
Q ss_pred --------------------------------cccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 525 --------------------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 525 --------------------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
.+..+.+.+..|...||+.||++.++++|.|+..
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0012233556678889999999999999999864
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=330.17 Aligned_cols=245 Identities=22% Similarity=0.345 Sum_probs=197.7
Q ss_pred HhcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEe--CCEEE
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLH--EKCMF 389 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~ 389 (560)
..++|++.+.||+|+||.||+|... ++..||+|.+............+..|+.+++.++||||+++++++.. ....+
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 4467999999999999999999865 46788999887544333445678899999999999999999998865 35689
Q ss_pred EEEeccCCCCHHHHhhcCCc-ccCCCHHHHHHHHHHHHHHHHHHHhcCC----CCeEEeCCCCCCeEeCC----------
Q 035761 390 LIYEYMEMGSLFCILRTDEE-AVGLDWTKRVNIVKGMAHALSYLHHHCT----PPILHRDISSNNILLNS---------- 454 (560)
Q Consensus 390 lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~----~~ivH~dlk~~Nill~~---------- 454 (560)
+||||+++|+|.+++..... ...+++..+..|+.||+.||+|||+... .+||||||||+|||++.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 99999999999999875321 2348999999999999999999998521 25999999999999964
Q ss_pred -------CCcEEEeeeccccccCCCCCCceeeccccCccCcccccc--CccCcchhHHHHHHHHHHHHhCCCCCCcccc-
Q 035761 455 -------EFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYT--MVVTEKYDVYSFGVVALEVLMGKHPGELLSS- 524 (560)
Q Consensus 455 -------~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~--~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~- 524 (560)
.+.+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~ 249 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF 249 (1021)
T ss_pred cccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH
Confidence 2348999999998764322 2234468999999998854 4588899999999999999999999964332
Q ss_pred -----------------cccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 525 -----------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 525 -----------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
....+..++..|...+|..||++.+++.+.|+.+
T Consensus 250 ~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~ 300 (1021)
T PTZ00266 250 SQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN 300 (1021)
T ss_pred HHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhh
Confidence 1223455667788889999999999999999864
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=320.16 Aligned_cols=233 Identities=19% Similarity=0.235 Sum_probs=187.1
Q ss_pred HhcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCC------CCcceeeeEEEeC
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRH------RNIVKLYGFCLHE 385 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~l~~~~~~~ 385 (560)
..++|++.+.||+|+||.||+|... .++.||||+++.... ..+.+..|+++++.++| ++++++++++..+
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK---YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh---hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 4578999999999999999999764 578899999864321 22344567777766654 4588898988765
Q ss_pred -CEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEeCCCCCCeEeCCCC-------
Q 035761 386 -KCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHH-HCTPPILHRDISSNNILLNSEF------- 456 (560)
Q Consensus 386 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~------- 456 (560)
+..++|||++ +++|.+++.... .+++.++..|+.||+.||+|||+ . +||||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccccccc
Confidence 4688999988 678988887543 38999999999999999999997 5 999999999999998765
Q ss_pred ---------cEEEeeeccccccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc--
Q 035761 457 ---------EAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS-- 525 (560)
Q Consensus 457 ---------~~kl~Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~-- 525 (560)
.+||+|||.+.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~ 353 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH 353 (467)
T ss_pred ccccCCCCceEEECCCCccccCc---cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 49999999886432 2233457899999999999999999999999999999999999999643310
Q ss_pred ---------------------------------------------------------ccccccccccccccCCCCCCChh
Q 035761 526 ---------------------------------------------------------SSSLDKNIKLIDLLDPRLPPPGD 548 (560)
Q Consensus 526 ---------------------------------------------------------~~~~~~~~~~~~~~dp~~~p~~~ 548 (560)
+..+.+.++.|...||..||+++
T Consensus 354 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~ 433 (467)
T PTZ00284 354 LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNAR 433 (467)
T ss_pred HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHH
Confidence 00112455677889999999999
Q ss_pred HHHhhceeee
Q 035761 549 QMIRQGIILI 558 (560)
Q Consensus 549 ~~~~~~~~~~ 558 (560)
++++|+|+..
T Consensus 434 e~L~Hp~~~~ 443 (467)
T PTZ00284 434 QMTTHPYVLK 443 (467)
T ss_pred HHhcCccccc
Confidence 9999999864
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=295.66 Aligned_cols=233 Identities=27% Similarity=0.419 Sum_probs=195.0
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
++|+..+.||+|+||.||+|... +++.||+|.++.... .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 46778888999999999999764 588999998865432 233467889999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++++|.+++..... +++.++..++.|++.|++|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 87 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 87 FCGGGSLQDIYHVTGP---LSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred ccCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence 9999999999876443 89999999999999999999999 99999999999999999999999999987664333
Q ss_pred CCceeeccccCccCccccc---cCccCcchhHHHHHHHHHHHHhCCCCCCccccc----------------------ccc
Q 035761 474 SNRTLLAGTYGSIAPELAY---TMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS----------------------SSS 528 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~---~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~----------------------~~~ 528 (560)
.......|+..|+|||++. ...++.++||||+||++|||++|+.||...... ...
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNS 240 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHH
Confidence 3334456899999999874 455788999999999999999999998533210 112
Q ss_pred cccccccccccCCCCCCChhHHHhhce
Q 035761 529 LDKNIKLIDLLDPRLPPPGDQMIRQGI 555 (560)
Q Consensus 529 ~~~~~~~~~~~dp~~~p~~~~~~~~~~ 555 (560)
+.+.++.|...+|..||++++++.|+|
T Consensus 241 ~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 241 FHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 334566777889999999999999887
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=293.00 Aligned_cols=235 Identities=27% Similarity=0.393 Sum_probs=197.3
Q ss_pred CCcccceeeccCCeeEEEEEeCCCcEEEEEEccchh----hhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEE
Q 035761 316 DFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLE----TELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLI 391 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 391 (560)
+|...+.||+|+||.||+|...+++.+|+|.+.... ......+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 367788999999999999988889999999886432 1223345688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 471 (560)
+||+++++|.+++..... +++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRFGP---LPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 999999999999976433 78999999999999999999998 999999999999999999999999999876532
Q ss_pred C------CCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc--------------------
Q 035761 472 D------SSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS-------------------- 525 (560)
Q Consensus 472 ~------~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~-------------------- 525 (560)
. ........++..|+|||++.+..++.++||||||+++||+++|+.||......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSF 234 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCC
Confidence 1 11122345788999999999988999999999999999999999999643321
Q ss_pred ccccccccccccccCCCCCCChhHHHhhcee
Q 035761 526 SSSLDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 526 ~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
...+...++.|...+|..||++.++++++|+
T Consensus 235 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 235 SAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 1123345566777899999999999999986
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=291.28 Aligned_cols=237 Identities=24% Similarity=0.338 Sum_probs=201.1
Q ss_pred CCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 316 DFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
+|+..+.||.|+||.||.++. .+++.+++|.+..........+.+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 478889999999999999875 4588999999875543344556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
+++|+|.+++.... ...+++.++..++.|+++|++|||+. +++||||+|+||++++++.+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999997643 23489999999999999999999998 999999999999999999999999999987654443
Q ss_pred CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc------------------cccccccccccc
Q 035761 475 NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS------------------SSSSLDKNIKLI 536 (560)
Q Consensus 475 ~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~------------------~~~~~~~~~~~~ 536 (560)
......+++.|+|||...+..++.++||||||+++|||++|+.||+.... ....+.+.+..|
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSL 236 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 33445688999999999888889999999999999999999999864321 112234555667
Q ss_pred cccCCCCCCChhHHHhhcee
Q 035761 537 DLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 537 ~~~dp~~~p~~~~~~~~~~~ 556 (560)
...+|..||++.+++.+.|+
T Consensus 237 l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 237 LQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred cccCcccCCCHHHHhhCcCC
Confidence 77899999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=298.89 Aligned_cols=235 Identities=24% Similarity=0.380 Sum_probs=201.4
Q ss_pred cCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
++|++.+.||.|++|.||+|.. .+++.|++|.+.... ....+.+.+|+++++.++|||++++++++......++|+|
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK--QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc--CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 4688899999999999999975 568999999886533 2234578899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++++|.+++... .+++.++..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||++.......
T Consensus 97 ~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 97 YLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred ecCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 99999999998653 289999999999999999999999 99999999999999999999999999988765443
Q ss_pred CCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc--------------------cccccccc
Q 035761 474 SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------------SSSLDKNI 533 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------------~~~~~~~~ 533 (560)
.......++..|+|||.+.+..++.++|||||||++||+++|+.||...... ...+.+.+
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 249 (296)
T cd06655 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFL 249 (296)
T ss_pred ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHH
Confidence 3334456888999999999888999999999999999999999999654320 11234556
Q ss_pred ccccccCCCCCCChhHHHhhceeee
Q 035761 534 KLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 534 ~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
+.|...||..||++.+++.++|+.-
T Consensus 250 ~~~l~~dp~~Rpt~~~il~~~~~~~ 274 (296)
T cd06655 250 NRCLEMDVEKRGSAKELLQHPFLKL 274 (296)
T ss_pred HHHhhcChhhCCCHHHHhhChHhhh
Confidence 7778889999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=295.80 Aligned_cols=236 Identities=33% Similarity=0.467 Sum_probs=201.9
Q ss_pred CCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
+|+..+.||.|++|.||+|... +++.||+|.+..... ......+.+|+++++.++|+|++++++++..+...++|+||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA-EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc-chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 5778889999999999999865 588999999875432 23445788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
+++++|.+++... .+++.++..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.++.......
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 9999999999764 389999999999999999999998 999999999999999999999999999988754433
Q ss_pred CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-------------------ccccccccccc
Q 035761 475 NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-------------------SSSSLDKNIKL 535 (560)
Q Consensus 475 ~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-------------------~~~~~~~~~~~ 535 (560)
......++..|+|||.+.+..++.++||||||+++|||++|+.||..... ....+.+.+..
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 233 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSL 233 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHH
Confidence 33445688899999999988899999999999999999999999964321 11123445556
Q ss_pred ccccCCCCCCChhHHHhhceeeec
Q 035761 536 IDLLDPRLPPPGDQMIRQGIILIS 559 (560)
Q Consensus 536 ~~~~dp~~~p~~~~~~~~~~~~~~ 559 (560)
|...||+.||+++++++++|+..+
T Consensus 234 ~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 234 CLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred HhhCChhhCcCHHHHhhChhhcCC
Confidence 677899999999999999998753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=295.74 Aligned_cols=235 Identities=26% Similarity=0.347 Sum_probs=196.0
Q ss_pred CcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEecc
Q 035761 317 FDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYM 395 (560)
Q Consensus 317 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 395 (560)
|++.+.||+|+||.||+|... ++..+++|.+.... ....+.+.+|+++++.++|||++++++++..+...++|+||+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 566788999999999999875 47788888886433 234567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCC
Q 035761 396 EMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSN 475 (560)
Q Consensus 396 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 475 (560)
++++|..++.... ..+++.++..++.|+++||+|||+. +++||||||+||+++.++.++++|||++.........
T Consensus 85 ~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~ 159 (282)
T cd06643 85 AGGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 159 (282)
T ss_pred CCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccccc
Confidence 9999998876532 2389999999999999999999998 9999999999999999999999999999765433333
Q ss_pred ceeeccccCccCccccc-----cCccCcchhHHHHHHHHHHHHhCCCCCCcccc--------------------cccccc
Q 035761 476 RTLLAGTYGSIAPELAY-----TMVVTEKYDVYSFGVVALEVLMGKHPGELLSS--------------------SSSSLD 530 (560)
Q Consensus 476 ~~~~~g~~~~~aPE~~~-----~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~--------------------~~~~~~ 530 (560)
.....++..|+|||++. +..++.++|||||||++|||++|+.||..... ....+.
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFK 239 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHH
Confidence 33456889999999874 44577899999999999999999999864431 112345
Q ss_pred cccccccccCCCCCCChhHHHhhceeee
Q 035761 531 KNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 531 ~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
+.++.|...||..||+++++++++|+..
T Consensus 240 ~li~~~l~~~p~~Rp~~~~il~~~~~~~ 267 (282)
T cd06643 240 DFLKKCLEKNVDARWTTTQLLQHPFVTV 267 (282)
T ss_pred HHHHHHccCChhhCcCHHHHhcCCCEec
Confidence 5667777889999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=294.25 Aligned_cols=236 Identities=22% Similarity=0.294 Sum_probs=194.8
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchh-hhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLE-TELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|++.+.||+|+||.||+|+.. +++.||||.++... ........+.+|+++++.++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46888999999999999999864 68999999876432 22344457889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCC-cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC
Q 035761 393 EYMEMGSLFCILRTDE-EAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 471 (560)
||+++|+|.+++.... ....+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998885422 123478899999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------cccccc
Q 035761 472 DSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------SSSSLD 530 (560)
Q Consensus 472 ~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------~~~~~~ 530 (560)
.........++..|+|||.+.+..++.++|+||||+++|||++|+.||..... ....+.
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLR 238 (267)
T ss_pred hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHH
Confidence 33323334678899999999888899999999999999999999999853321 112245
Q ss_pred cccccccccCCCCCCChhHHHhh
Q 035761 531 KNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 531 ~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
+.++.|...+|+.||++.++++.
T Consensus 239 ~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 239 ELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHCCCCcccCcCHHHHHHH
Confidence 55666777789999998888764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=308.62 Aligned_cols=233 Identities=29% Similarity=0.405 Sum_probs=199.7
Q ss_pred CCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhh-hhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 316 DFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETE-LASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
-|+..+.||.|+||.||-|+. .+.+.||||++.-...+ .+.-+.+.+|+..+.+++|||.+.+-|+|..+...|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 355567799999999999975 46789999999754422 2233578899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
||- |+-.+.+..+.++ +-+.++..|+.+.+.||+|||+. +.||||||+-|||+++.|.||++|||.|....+.
T Consensus 107 YCl-GSAsDlleVhkKp--lqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA- 179 (948)
T KOG0577|consen 107 YCL-GSASDLLEVHKKP--LQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA- 179 (948)
T ss_pred HHh-ccHHHHHHHHhcc--chHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence 995 4888887765543 88899999999999999999999 9999999999999999999999999999886543
Q ss_pred CCceeeccccCccCccccc---cCccCcchhHHHHHHHHHHHHhCCCCCCccc-------------------cccccccc
Q 035761 474 SNRTLLAGTYGSIAPELAY---TMVVTEKYDVYSFGVVALEVLMGKHPGELLS-------------------SSSSSLDK 531 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~---~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~-------------------~~~~~~~~ 531 (560)
..++|||.|||||++. .+.|+.|+||||+|+...|+.-+++|...++ .|++.+..
T Consensus 180 ---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~ 256 (948)
T KOG0577|consen 180 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRN 256 (948)
T ss_pred ---hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHH
Confidence 3458999999999876 4679999999999999999999999975444 24555677
Q ss_pred ccccccccCCCCCCChhHHHhhceeee
Q 035761 532 NIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 532 ~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
.+-.|..--|..||+.+.+++|.|++-
T Consensus 257 Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 257 FVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred HHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 778888999999999999999999874
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=305.65 Aligned_cols=231 Identities=22% Similarity=0.292 Sum_probs=188.7
Q ss_pred HhcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEE
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLI 391 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 391 (560)
...+|++.+.||+|+||.||+|... +++.||+|..... ....|+.++++++||||+++++++......++|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 3457999999999999999999875 4678999975432 234689999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 471 (560)
+||+. ++|.+++.... ..+++.++..|+.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 136 ~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 209 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV 209 (357)
T ss_pred EEccC-CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence 99995 58888886533 2389999999999999999999999 999999999999999999999999999975432
Q ss_pred CCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCC-CCccccc-------------------------
Q 035761 472 DSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHP-GELLSSS------------------------- 525 (560)
Q Consensus 472 ~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P-~~~~~~~------------------------- 525 (560)
. .......||+.|+|||++.+..++.++|||||||++|||+++..| |+.....
T Consensus 210 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 288 (357)
T PHA03209 210 A-PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEE 288 (357)
T ss_pred C-cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhh
Confidence 2 222345689999999999999999999999999999999985444 3321110
Q ss_pred -----------------------------------ccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 526 -----------------------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 526 -----------------------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
.......++.|...||..||+++++++|+|+.+
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 289 FPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred cCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 000111445677889999999999999999864
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=293.28 Aligned_cols=232 Identities=27% Similarity=0.414 Sum_probs=193.5
Q ss_pred hcCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
.++|++.+.||+|+||.||+|...+++.||+|.+..... ..+.+.+|+.++++++|+||+++++++......+++||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 356889999999999999999988888999998865332 24578899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++|+|.++++... ...+++.++..++.|++.|++|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 82 YMAKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred cCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 999999999997643 23488999999999999999999998 99999999999999999999999999998764322
Q ss_pred CC-ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc------------------ccccccccc
Q 035761 474 SN-RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS------------------SSSSLDKNI 533 (560)
Q Consensus 474 ~~-~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~------------------~~~~~~~~~ 533 (560)
.. .....++..|+|||+.....++.++||||||+++|||++ |+.||..... ....+.+.+
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 237 (261)
T cd05072 158 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIM 237 (261)
T ss_pred eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 11 122335678999999988889999999999999999998 9999964321 112344556
Q ss_pred ccccccCCCCCCChhHHHh
Q 035761 534 KLIDLLDPRLPPPGDQMIR 552 (560)
Q Consensus 534 ~~~~~~dp~~~p~~~~~~~ 552 (560)
..|...+|+.||+++++.+
T Consensus 238 ~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 238 KTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHccCCcccCcCHHHHHH
Confidence 6677778888888888764
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=298.82 Aligned_cols=237 Identities=24% Similarity=0.291 Sum_probs=198.0
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
++|++.+.||+|+||.||++... ++..+|+|.+..... ......+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK-PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 36888999999999999999765 578889998764322 2334568889999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++++|.++++... .+++..+..++.|+++||+|||+.. +++||||||+||++++++.++|+|||++......
T Consensus 80 y~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 80 HMDGGSLDQVLKKAG---RIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred ccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 999999999997653 3889999999999999999999731 8999999999999999999999999998765322
Q ss_pred CCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------------------
Q 035761 474 SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS----------------------------- 524 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~----------------------------- 524 (560)
......++..|+|||.+.+..++.++|+||||+++|||++|+.||.....
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
T cd06615 154 -MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPD 232 (308)
T ss_pred -ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCC
Confidence 22334688899999999888899999999999999999999999852211
Q ss_pred --------------------------cccccccccccccccCCCCCCChhHHHhhceeeec
Q 035761 525 --------------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILIS 559 (560)
Q Consensus 525 --------------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~~ 559 (560)
....+.+.+..|...+|+.||++.+++++.|+.++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 233 SPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred ccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 01123455667888899999999999999998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=297.04 Aligned_cols=235 Identities=23% Similarity=0.326 Sum_probs=192.4
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
++|+..+.||+|++|.||+|..+ +++.||+|.+...... .....+.+|+++++.++||||+++++++..++..++|||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 56888999999999999999865 6889999998653322 222356789999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++ +|.+++..... .+++.....++.|+++||+|||+. +++||||||+||+++.++.++|+|||+++......
T Consensus 84 ~~~~-~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 84 YLDT-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred cCCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 9985 99998875433 489999999999999999999999 99999999999999999999999999987653322
Q ss_pred CCceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCccccc---------------------------
Q 035761 474 SNRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------------------- 525 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------------------- 525 (560)
.......++..|+|||++.+ ..++.++||||+|+++|||++|+.||......
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 22222346788999998875 45788999999999999999999999644310
Q ss_pred ---------------------c--cccccccccccccCCCCCCChhHHHhhcee
Q 035761 526 ---------------------S--SSLDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 526 ---------------------~--~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
. ....+.+..|...+|+.||++.+++.+.|+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0 111244455677799999999999999885
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=296.58 Aligned_cols=237 Identities=24% Similarity=0.368 Sum_probs=191.4
Q ss_pred HhcCCcccceeeccCCeeEEEEEeC------CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCC
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEK 386 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 386 (560)
..++|++.+.||+|+||.||+|.+. .+..||+|++..... ......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 3567999999999999999999753 246799999865332 233456889999999999999999999999989
Q ss_pred EEEEEEeccCCCCHHHHhhcCCc-------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEE
Q 035761 387 CMFLIYEYMEMGSLFCILRTDEE-------AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAF 459 (560)
Q Consensus 387 ~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 459 (560)
..++||||+++|+|.++++.... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEE
Confidence 99999999999999999875322 22468899999999999999999998 999999999999999999999
Q ss_pred EeeeccccccCCCCCCc--eeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc-----------
Q 035761 460 VADFGIARLLNYDSSNR--TLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS----------- 525 (560)
Q Consensus 460 l~Dfg~~~~~~~~~~~~--~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~----------- 525 (560)
|+|||+++......... ....+++.|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~ 239 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL 239 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence 99999987653322111 11235678999999998889999999999999999999 78898644321
Q ss_pred -------ccccccccccccccCCCCCCChhHHHhh
Q 035761 526 -------SSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 526 -------~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
...+.+.+..|...+|+.||++.++++.
T Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 240 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1123445666777788888888887764
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=296.73 Aligned_cols=235 Identities=27% Similarity=0.394 Sum_probs=191.6
Q ss_pred cCCcccceeeccCCeeEEEEEeCC------CcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPS------GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCM 388 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 388 (560)
++|.+.+.||+|+||.||+|...+ ++.||||.++.... .+..+.+.+|+++++.++||||+++++++......
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 457888999999999999997643 47899999875432 23456889999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCCc-----------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCc
Q 035761 389 FLIYEYMEMGSLFCILRTDEE-----------AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFE 457 (560)
Q Consensus 389 ~lv~e~~~~g~L~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~ 457 (560)
++||||+++|+|.+++..... ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 999999999999999975421 23488999999999999999999999 9999999999999999999
Q ss_pred EEEeeeccccccCCCCCC--ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc---------
Q 035761 458 AFVADFGIARLLNYDSSN--RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS--------- 525 (560)
Q Consensus 458 ~kl~Dfg~~~~~~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~--------- 525 (560)
++|+|||+++........ .....+++.|+|||++.+..++.++||||||+++|||++ |+.||......
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG 240 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 999999999765322211 122345678999999999999999999999999999998 99998643321
Q ss_pred ---------ccccccccccccccCCCCCCChhHHHhh
Q 035761 526 ---------SSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 526 ---------~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
...+.+.++.|...||..||++++++..
T Consensus 241 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 277 (280)
T cd05049 241 RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHER 277 (280)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 1223445555666788888888777653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=291.32 Aligned_cols=235 Identities=25% Similarity=0.370 Sum_probs=197.9
Q ss_pred CCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
+|++.+.||+|+||.||++... +++.+|+|.++.... ....+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 4778899999999999999865 588999998864332 23456778899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
+++|++.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.++++|||.+........
T Consensus 80 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 80 CDGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 99999999886532 23378999999999999999999999 999999999999999999999999999987654433
Q ss_pred CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc------------------ccccccccccc
Q 035761 475 NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS------------------SSSLDKNIKLI 536 (560)
Q Consensus 475 ~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~------------------~~~~~~~~~~~ 536 (560)
......|++.|+|||++.+..++.++|+||||+++|+|++|+.||...+.. ...+...++.|
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 235 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM 235 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHH
Confidence 334456888999999999988999999999999999999999999754311 11234456677
Q ss_pred cccCCCCCCChhHHHhhce
Q 035761 537 DLLDPRLPPPGDQMIRQGI 555 (560)
Q Consensus 537 ~~~dp~~~p~~~~~~~~~~ 555 (560)
...||..||++.+++...+
T Consensus 236 l~~~P~~Rp~~~~il~~~~ 254 (255)
T cd08219 236 FKRNPRSRPSATTILSRGS 254 (255)
T ss_pred HhCCcccCCCHHHHhhccC
Confidence 7889999999999988754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=291.40 Aligned_cols=237 Identities=25% Similarity=0.338 Sum_probs=200.1
Q ss_pred CCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
+|+..+.||+|+||.||++... +|+.||+|.+..........+.+.+|+.++++++||||+++++++......++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778899999999999999754 688999999875433334456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
+++++|.+++..... ..+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++........
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 999999999875332 2378999999999999999999998 999999999999999999999999999987644333
Q ss_pred CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc------------------cccccccccccc
Q 035761 475 NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS------------------SSSSLDKNIKLI 536 (560)
Q Consensus 475 ~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~------------------~~~~~~~~~~~~ 536 (560)
......|++.|+|||+..+..++.++|+||||+++||+++|+.||..... ....+...++.|
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 236 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQL 236 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHH
Confidence 23334578899999999988899999999999999999999999864321 112344566677
Q ss_pred cccCCCCCCChhHHHhhcee
Q 035761 537 DLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 537 ~~~dp~~~p~~~~~~~~~~~ 556 (560)
...+|..||+++++++|+|+
T Consensus 237 l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 237 FKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred hhCChhhCcCHHHHhhCcCC
Confidence 78899999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=291.64 Aligned_cols=234 Identities=30% Similarity=0.440 Sum_probs=199.2
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
++|+..+.+|+|+||.||+|... +++.+++|.+..... ...+.+.+|++++++++||||+++++++......+++||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 57888999999999999999864 578899999875432 245678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++++|.+++.... ..+++.++..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 81 YCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred CCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 999999999987642 2389999999999999999999998 99999999999999999999999999998765433
Q ss_pred CCceeeccccCccCccccccC---ccCcchhHHHHHHHHHHHHhCCCCCCccccc----------------------ccc
Q 035761 474 SNRTLLAGTYGSIAPELAYTM---VVTEKYDVYSFGVVALEVLMGKHPGELLSSS----------------------SSS 528 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~~---~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~----------------------~~~ 528 (560)
.......++..|+|||.+... .++.++||||||+++|||++|+.||...... ...
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (262)
T cd06613 156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPV 235 (262)
T ss_pred hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHH
Confidence 233345678899999998877 7889999999999999999999998644310 122
Q ss_pred cccccccccccCCCCCCChhHHHhhce
Q 035761 529 LDKNIKLIDLLDPRLPPPGDQMIRQGI 555 (560)
Q Consensus 529 ~~~~~~~~~~~dp~~~p~~~~~~~~~~ 555 (560)
+.+.++.|...+|..||++.+++.+.|
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 236 FHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 456667778889999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=291.72 Aligned_cols=231 Identities=25% Similarity=0.396 Sum_probs=192.1
Q ss_pred cCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
++|.+.+.||+|+||.||.|++.++..+|+|.+..... ..+.+.+|+.++++++||||+++++++......++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc---cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 45788889999999999999987777899998874332 235688999999999999999999999988889999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
+++|+|.+++..... .+++.++..++.||+.|++|||+. +++|+||||+||+++.++.+||+|||.++.......
T Consensus 81 ~~~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 81 MSNGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred CCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 999999999976432 489999999999999999999999 999999999999999999999999999886543222
Q ss_pred Cc-eeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------------ccccccccc
Q 035761 475 NR-TLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------------SSSLDKNIK 534 (560)
Q Consensus 475 ~~-~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------------~~~~~~~~~ 534 (560)
.. ....++..|+|||...+..++.++||||||+++|||++ |+.||...... ...+.+.+.
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMY 235 (256)
T ss_pred eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 11 11235568999999988889999999999999999998 99998644321 112344555
Q ss_pred cccccCCCCCCChhHHHhh
Q 035761 535 LIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 535 ~~~~~dp~~~p~~~~~~~~ 553 (560)
.|...+|..||++.+++.+
T Consensus 236 ~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 236 SCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHcCCCcccCCCHHHHHHh
Confidence 6777899999999988764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=308.41 Aligned_cols=236 Identities=22% Similarity=0.334 Sum_probs=188.7
Q ss_pred HhcCCcccceeeccCCeeEEEEEeC------CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccC-CCCcceeeeEEEeC
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRLETELASLESFQNEARLLSQIR-HRNIVKLYGFCLHE 385 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~ 385 (560)
..++|.+.+.||+|+||.||+|... .+..||||+++.... ....+.+.+|++++++++ ||||+++++++.+.
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR-SSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 4567889999999999999999753 234799999975432 233467899999999996 99999999999999
Q ss_pred CEEEEEEeccCCCCHHHHhhcCCc--------------------------------------------------------
Q 035761 386 KCMFLIYEYMEMGSLFCILRTDEE-------------------------------------------------------- 409 (560)
Q Consensus 386 ~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------- 409 (560)
...++||||+++|+|.++++....
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 999999999999999998864311
Q ss_pred -------------------------------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEe
Q 035761 410 -------------------------------------AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILL 452 (560)
Q Consensus 410 -------------------------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill 452 (560)
...+++.++..++.||++|++|||+. +++||||||+||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEE
Confidence 12478899999999999999999998 99999999999999
Q ss_pred CCCCcEEEeeeccccccCCCCCC--ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc----
Q 035761 453 NSEFEAFVADFGIARLLNYDSSN--RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS---- 525 (560)
Q Consensus 453 ~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~---- 525 (560)
++++.+||+|||+++........ .....++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~ 350 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY 350 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence 99999999999999865432221 122346778999999999899999999999999999997 99998653211
Q ss_pred ---------------ccccccccccccccCCCCCCChhHHHh
Q 035761 526 ---------------SSSLDKNIKLIDLLDPRLPPPGDQMIR 552 (560)
Q Consensus 526 ---------------~~~~~~~~~~~~~~dp~~~p~~~~~~~ 552 (560)
...+.+.+..|...||+-||++.++.+
T Consensus 351 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 351 NKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 112334455566667777777666654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=294.76 Aligned_cols=235 Identities=29% Similarity=0.439 Sum_probs=200.1
Q ss_pred CCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
.|+..+.||.|+||.||+|... +++.||+|.+..... ......+.+|++++++++||||+++++++.++...++||||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 4667788999999999999865 588999998875432 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
+++|+|.+++... .+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++........
T Consensus 84 ~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 9999999998753 288999999999999999999998 999999999999999999999999999987654333
Q ss_pred CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc------------------ccccccccccc
Q 035761 475 NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS------------------SSSLDKNIKLI 536 (560)
Q Consensus 475 ~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~------------------~~~~~~~~~~~ 536 (560)
......++..|+|||++.+..++.++|+||||+++|||++|+.||...... ...+.+.++.|
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 236 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDAC 236 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHH
Confidence 333456788999999998888999999999999999999999998643311 11234566678
Q ss_pred cccCCCCCCChhHHHhhceeee
Q 035761 537 DLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 537 ~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
...+|..||++.+++++.|+.+
T Consensus 237 l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06640 237 LNKDPSFRPTAKELLKHKFIVK 258 (277)
T ss_pred cccCcccCcCHHHHHhChHhhh
Confidence 8889999999999999999865
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=304.78 Aligned_cols=244 Identities=27% Similarity=0.383 Sum_probs=195.7
Q ss_pred HHHHHHhcCCcccceeeccCCeeEEEEEeCC-CcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCC
Q 035761 308 QDMIEATEDFDIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEK 386 (560)
Q Consensus 308 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 386 (560)
++|+-...+..+...+|-|.||.||.|.|+. .-.||||.++... ...++|.+|+.+|+.++|||+|+++|+|..+.
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt---MeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP 336 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc---hhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence 3343344567778899999999999999875 5679999997543 45679999999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccc
Q 035761 387 CMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIA 466 (560)
Q Consensus 387 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~ 466 (560)
.+|||.|||..|+|.+|+++... ..++.-..+.||.||+.||+||... .+|||||.++|+|+.++..+|++|||++
T Consensus 337 PFYIiTEfM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLs 412 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLS 412 (1157)
T ss_pred CeEEEEecccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchh
Confidence 99999999999999999987543 3377778899999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCCcee-eccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccccc-ccccccccccccCCCC
Q 035761 467 RLLNYDSSNRTL-LAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSSS-SLDKNIKLIDLLDPRL 543 (560)
Q Consensus 467 ~~~~~~~~~~~~-~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~~~-~~~~~~~~~~~~dp~~ 543 (560)
+++..+.+.... ..-++.|.|||.+....++.|+|||+|||++|||.| |-.||...+-.+. .+.+..-.|+ -...+
T Consensus 413 RlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~-~PeGC 491 (1157)
T KOG4278|consen 413 RLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMD-GPEGC 491 (1157)
T ss_pred hhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcccccc-CCCCC
Confidence 998765443221 123578999999999999999999999999999998 9999986653211 1111111111 13456
Q ss_pred CCChhHHHhhceeeec
Q 035761 544 PPPGDQMIRQGIILIS 559 (560)
Q Consensus 544 ~p~~~~~~~~~~~~~~ 559 (560)
||.+-++++.||=-+|
T Consensus 492 PpkVYeLMraCW~WsP 507 (1157)
T KOG4278|consen 492 PPKVYELMRACWNWSP 507 (1157)
T ss_pred CHHHHHHHHHHhcCCc
Confidence 7777777777775443
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=298.22 Aligned_cols=238 Identities=26% Similarity=0.300 Sum_probs=197.2
Q ss_pred CCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhh---hhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEE
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETE---LASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLI 391 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 391 (560)
+|+..+.||+|+||.||+|... +++.||||.+...... ......+..|+++++.++|+||+++++++.++...++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3677888999999999999864 6899999998754422 22334577899999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 471 (560)
|||+ +|+|.+++.... ..+++.++..++.||++||+|||+. +++||||+|+||+++.++.++|+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999997654 2489999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCccccc-------------------------
Q 035761 472 DSSNRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSSS------------------------- 525 (560)
Q Consensus 472 ~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~------------------------- 525 (560)
.........++..|+|||.+.+ ..++.++|||||||++|||++|.+||......
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (298)
T cd07841 155 PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP 234 (298)
T ss_pred CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence 3333333456788999998764 45788999999999999999998877533211
Q ss_pred --------------------ccccccccccccccCCCCCCChhHHHhhceeeec
Q 035761 526 --------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILIS 559 (560)
Q Consensus 526 --------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~~ 559 (560)
...+.+.+..|...||+.||++.+++.+.|+.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~ 288 (298)
T cd07841 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND 288 (298)
T ss_pred ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCC
Confidence 1112234566788899999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=291.38 Aligned_cols=236 Identities=23% Similarity=0.302 Sum_probs=196.7
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchh-hhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLE-TELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|++.+.||+|+||.||+|... +|+.||+|.++... ......+.+.+|++++++++|+|++++++++..++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 46888999999999999999876 78999999886433 22233567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCC-cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC
Q 035761 393 EYMEMGSLFCILRTDE-EAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 471 (560)
||+++|+|.+++.... ....+++.++..++.|+++|++|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999986432 234489999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------cccccc
Q 035761 472 DSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------SSSSLD 530 (560)
Q Consensus 472 ~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------~~~~~~ 530 (560)
.........+++.|+|||.+.+..++.++||||||+++|||++|+.||..... ....+.
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELR 238 (267)
T ss_pred CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHH
Confidence 33333445688899999999988899999999999999999999999853321 111344
Q ss_pred cccccccccCCCCCCChhHHHhh
Q 035761 531 KNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 531 ~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
+.+..|...+|+.||++.++++.
T Consensus 239 ~~i~~cl~~~p~~Rp~~~~il~~ 261 (267)
T cd08224 239 DLVSRCINPDPEKRPDISYVLQV 261 (267)
T ss_pred HHHHHHcCCCcccCCCHHHHHHH
Confidence 55566777889999998887653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=294.82 Aligned_cols=235 Identities=27% Similarity=0.437 Sum_probs=196.7
Q ss_pred HhcCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
+..+|++.+.||.|+||.||+|...+++.+++|.+..... .....+.+|+.+++.++||||+++++++......++||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL--LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch--hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence 3456888999999999999999988899999999875432 23456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++|+|.+++.... ...+++.++..++.|++.|++|||+. +++||||+|+||++++++.+||+|||.+......
T Consensus 82 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 82 ELMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred eecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 9999999999997643 23489999999999999999999998 9999999999999999999999999999876433
Q ss_pred CCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------------cccccccc
Q 035761 473 SSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------------SSSLDKNI 533 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------------~~~~~~~~ 533 (560)
........++..|+|||.+....++.++||||||+++|+|++ |+.||...... ...+.+.+
T Consensus 158 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 237 (261)
T cd05148 158 VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIM 237 (261)
T ss_pred cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHH
Confidence 322233345678999999988889999999999999999998 89999654321 11234455
Q ss_pred ccccccCCCCCCChhHHHhh
Q 035761 534 KLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 534 ~~~~~~dp~~~p~~~~~~~~ 553 (560)
..|...||+.||++++++..
T Consensus 238 ~~~l~~~p~~Rpt~~~l~~~ 257 (261)
T cd05148 238 LECWAAEPEDRPSFKALREE 257 (261)
T ss_pred HHHcCCCchhCcCHHHHHHH
Confidence 66777888888888888754
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=300.21 Aligned_cols=192 Identities=27% Similarity=0.423 Sum_probs=157.6
Q ss_pred ceeeccCCeeEEEEEeC---CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEe--CCEEEEEEecc
Q 035761 321 YCIGTGGYGSVYRARLP---SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLH--EKCMFLIYEYM 395 (560)
Q Consensus 321 ~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~ 395 (560)
..||+|+||.||+|+.+ ++..||+|.+..... ...+.+|+++++.++||||+++++++.. +...++||||+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 56999999999999865 357899998865332 2356789999999999999999999854 45789999998
Q ss_pred CCCCHHHHhhcCC------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEe----CCCCcEEEeeecc
Q 035761 396 EMGSLFCILRTDE------EAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILL----NSEFEAFVADFGI 465 (560)
Q Consensus 396 ~~g~L~~~l~~~~------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfg~ 465 (560)
++ ++.+++.... ....+++..+..++.||+.||+|||+. +|+||||||+||++ +.++.+||+|||+
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 75 7777764321 123488999999999999999999999 99999999999999 5667899999999
Q ss_pred ccccCCCCC---CceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCC
Q 035761 466 ARLLNYDSS---NRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGE 520 (560)
Q Consensus 466 ~~~~~~~~~---~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~ 520 (560)
++....... ......+|+.|+|||++.+ ..++.++|||||||++|||+||+.||.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~ 217 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcc
Confidence 987643221 1223468899999999876 457889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=295.38 Aligned_cols=235 Identities=25% Similarity=0.381 Sum_probs=191.1
Q ss_pred cCCcccceeeccCCeeEEEEEeCC------CcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPS------GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCM 388 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 388 (560)
++|++.+.||+|+||.||+|.... ...||+|.+..... ....+.+.+|++.+++++||||+++++++...+..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE-PKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC-HHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 457888999999999999997643 25799999875432 23345788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCCc-------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCC
Q 035761 389 FLIYEYMEMGSLFCILRTDEE-------------AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSE 455 (560)
Q Consensus 389 ~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~ 455 (560)
+++|||+++|+|.+++..... ...+++.++..++.|++.||+|||+. +++||||||+||+++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCC
Confidence 999999999999999975421 13488999999999999999999999 99999999999999999
Q ss_pred CcEEEeeeccccccCCCCC--CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc-------
Q 035761 456 FEAFVADFGIARLLNYDSS--NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------- 525 (560)
Q Consensus 456 ~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------- 525 (560)
+.++|+|||+++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999976532221 1223346788999999998899999999999999999998 99998643321
Q ss_pred -----------ccccccccccccccCCCCCCChhHHHhh
Q 035761 526 -----------SSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 526 -----------~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
...+.++++.|...||..||++++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 241 SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1233455566677788888888887764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=291.57 Aligned_cols=233 Identities=30% Similarity=0.392 Sum_probs=193.5
Q ss_pred cCCcccceeeccCCeeEEEEEeCC----CcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPS----GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFL 390 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 390 (560)
++|+..+.||+|+||.||+|.++. ...||||.++.... ......|.+|+.++++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS-DKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC-hHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 568889999999999999998742 45799998875432 2345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccC
Q 035761 391 IYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN 470 (560)
Q Consensus 391 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 470 (560)
||||+++++|.+++..... .+++.++.+++.|++.|++|||+. +|+||||||+||++++++.++|+|||+++...
T Consensus 83 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 83 ITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999999976433 489999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCCCc--eeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------------cccc
Q 035761 471 YDSSNR--TLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------------SSSL 529 (560)
Q Consensus 471 ~~~~~~--~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------------~~~~ 529 (560)
...... ....++..|+|||.+.+..++.++||||||+++||+++ |+.||...... ...+
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSAL 237 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 222211 12234578999999999999999999999999999998 99998543311 1234
Q ss_pred ccccccccccCCCCCCChhHHHhh
Q 035761 530 DKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 530 ~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
.+.+..|...+|+.||++++++.+
T Consensus 238 ~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 238 YQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHHHcCCCcccCcCHHHHHHH
Confidence 556677778899999999888765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=297.23 Aligned_cols=234 Identities=30% Similarity=0.453 Sum_probs=197.6
Q ss_pred CCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
.|+..+.||+|+||.||+|... +++.||+|.+...... ...+.+.+|++++++++||||+++++++..+...++||||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccch-HHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 3556677999999999999764 5788999988644322 3446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
+++++|.+++... .+++..+..++.|+++|++|||+. +++|+||+|+||++++++.++++|||++..+.....
T Consensus 84 ~~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 84 LGGGSALDLLKPG----PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred cCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 9999999998643 389999999999999999999998 999999999999999999999999999987654333
Q ss_pred CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc------------------cccccccccccc
Q 035761 475 NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS------------------SSSSLDKNIKLI 536 (560)
Q Consensus 475 ~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~------------------~~~~~~~~~~~~ 536 (560)
......++..|+|||++.+..++.++||||||+++|||++|+.||..... ....+.+.+..|
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 236 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEAC 236 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHH
Confidence 33334578899999999998899999999999999999999999864321 112244556678
Q ss_pred cccCCCCCCChhHHHhhceee
Q 035761 537 DLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 537 ~~~dp~~~p~~~~~~~~~~~~ 557 (560)
...+|..||++.+++.++|+.
T Consensus 237 l~~~p~~Rp~~~~il~~~~~~ 257 (277)
T cd06642 237 LNKDPRFRPTAKELLKHKFIT 257 (277)
T ss_pred ccCCcccCcCHHHHHHhHHHH
Confidence 888999999999999999875
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=295.06 Aligned_cols=235 Identities=23% Similarity=0.372 Sum_probs=191.7
Q ss_pred cCCcccceeeccCCeeEEEEEe-----CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-----PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMF 389 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 389 (560)
++|++.+.||+|+||.||+|.. .++..|++|.+..... ......+.+|++++++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN-PQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 4578889999999999999974 2467899999875432 234467889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCc--------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCC
Q 035761 390 LIYEYMEMGSLFCILRTDEE--------------AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSE 455 (560)
Q Consensus 390 lv~e~~~~g~L~~~l~~~~~--------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~ 455 (560)
+||||+++|+|.+++..... ...+++.++..++.|++.||+|||+. +++||||||+||+++++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCC
Confidence 99999999999999853211 23478999999999999999999999 99999999999999999
Q ss_pred CcEEEeeeccccccCCCCC--CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc--------
Q 035761 456 FEAFVADFGIARLLNYDSS--NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS-------- 524 (560)
Q Consensus 456 ~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~-------- 524 (560)
+.+||+|||+++....... ......++..|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 240 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999986533221 1122335678999999988889999999999999999998 9999854321
Q ss_pred ----------cccccccccccccccCCCCCCChhHHHhh
Q 035761 525 ----------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 525 ----------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
....+...+..|...||..||+++++.++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 241 KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 11223455566778899999999998765
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=280.64 Aligned_cols=239 Identities=25% Similarity=0.363 Sum_probs=195.1
Q ss_pred CHHHHHHHhcCCcccceeeccCCeeEEEEE-eCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEE
Q 035761 306 TFQDMIEATEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCL 383 (560)
Q Consensus 306 ~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 383 (560)
+++|+...++ +.+|+|+|+.|.-++ ..+|.++|||++.+.. ........+|++++.+. .|+||++++.+++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFE 146 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFE 146 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhc
Confidence 4677777665 459999999999985 6789999999998764 34455677899999998 6999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCc---EEE
Q 035761 384 HEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFE---AFV 460 (560)
Q Consensus 384 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl 460 (560)
+++..|||||-|.||+|.++++...- +++.++.++..+||.||.|||.+ ||.|||+||+|||...... +||
T Consensus 147 dd~~FYLVfEKm~GGplLshI~~~~~---F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKi 220 (463)
T KOG0607|consen 147 DDTRFYLVFEKMRGGPLLSHIQKRKH---FNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKI 220 (463)
T ss_pred ccceEEEEEecccCchHHHHHHHhhh---ccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceee
Confidence 99999999999999999999986544 99999999999999999999999 9999999999999976544 799
Q ss_pred eeeccccccCCCCC-------CceeeccccCccCccccc-----cCccCcchhHHHHHHHHHHHHhCCCCCCcccc----
Q 035761 461 ADFGIARLLNYDSS-------NRTLLAGTYGSIAPELAY-----TMVVTEKYDVYSFGVVALEVLMGKHPGELLSS---- 524 (560)
Q Consensus 461 ~Dfg~~~~~~~~~~-------~~~~~~g~~~~~aPE~~~-----~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---- 524 (560)
+||.++.-+..... .....+|+..|||||+.. ...|+.++|.||+|||+|-|++|.+||.....
T Consensus 221 CDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG 300 (463)
T KOG0607|consen 221 CDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG 300 (463)
T ss_pred eccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC
Confidence 99998865422111 122356889999999743 23588899999999999999999999964432
Q ss_pred --------------------------------cccccccccccccccCCCCCCChhHHHhhceee
Q 035761 525 --------------------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 525 --------------------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
.+.+.++.++.....|+.-|-.+.+++.|+|+.
T Consensus 301 WdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~ 365 (463)
T KOG0607|consen 301 WDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQ 365 (463)
T ss_pred ccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccc
Confidence 122334555566678999999999999999875
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=291.91 Aligned_cols=234 Identities=29% Similarity=0.444 Sum_probs=196.4
Q ss_pred CcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhh-------hhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEE
Q 035761 317 FDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETE-------LASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCM 388 (560)
Q Consensus 317 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 388 (560)
|.+...||+|++|.||+|... +++.+|+|.+...... ....+.+.+|++++++++||||+++++++..++..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 667788999999999999764 5789999988643311 12335688999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccc
Q 035761 389 FLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARL 468 (560)
Q Consensus 389 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 468 (560)
++||||+++++|.+++..... +++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.++.
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNYGA---FEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred EEEEEecCCCCHHHHHHhccC---ccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 999999999999999976533 88999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCC------CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc------------------
Q 035761 469 LNYDSS------NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS------------------ 524 (560)
Q Consensus 469 ~~~~~~------~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~------------------ 524 (560)
...... ......|+..|+|||.+.+..++.++||||+|+++|||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSN 235 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcc
Confidence 642211 11223578899999999988899999999999999999999999964321
Q ss_pred cccccccccccccccCCCCCCChhHHHhhcee
Q 035761 525 SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 525 ~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
....+...++.|...||..||+++++++++|+
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 236 ISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred cCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 11223455677788899999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=295.89 Aligned_cols=236 Identities=25% Similarity=0.341 Sum_probs=194.1
Q ss_pred CCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
+|+..+.||.|++|.||+|... +++.||||++............+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 3778889999999999999864 688999998875443333345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
++ ++|.+++..... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASPL-SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 689888865432 3489999999999999999999998 999999999999999999999999999886643332
Q ss_pred CceeeccccCccCccccccCc-cCcchhHHHHHHHHHHHHhCCCCCCccccc----------------------------
Q 035761 475 NRTLLAGTYGSIAPELAYTMV-VTEKYDVYSFGVVALEVLMGKHPGELLSSS---------------------------- 525 (560)
Q Consensus 475 ~~~~~~g~~~~~aPE~~~~~~-~~~~~Dv~s~G~il~el~~g~~P~~~~~~~---------------------------- 525 (560)
......++..|+|||.+.+.. ++.++||||||+++|||+||+.||......
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK 235 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence 233345678899999877644 578899999999999999999998533210
Q ss_pred ------------------ccccccccccccccCCCCCCChhHHHhhcee
Q 035761 526 ------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 526 ------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
...+.+.+..|...||..||+++++++|+|+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0112235567778899999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=295.68 Aligned_cols=236 Identities=22% Similarity=0.293 Sum_probs=192.3
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
+++|.+.+.||+|+||.||+|... +++.||+|.+...... .....+.+|+++++.++|+||+++.+++..++..++||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 467899999999999999999754 6889999998654322 22335678999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+. +++.+++..... .+++.++..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQHPG--GLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 677777654322 378888999999999999999999 9999999999999999999999999999765433
Q ss_pred CCCceeeccccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCCCCCccccc--------------------------
Q 035761 473 SSNRTLLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKHPGELLSSS-------------------------- 525 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~-------------------------- 525 (560)
........+++.|+|||.+.+. .++.++||||||+++|||++|+.||+.....
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 157 SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence 3233334578899999998754 4788999999999999999999999643210
Q ss_pred ------------------------ccccccccccccccCCCCCCChhHHHhhcee
Q 035761 526 ------------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 526 ------------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
...+.+.++.|...||+.||++++++.|+|+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0122345566777899999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=290.86 Aligned_cols=235 Identities=24% Similarity=0.371 Sum_probs=191.0
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchh---hhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC--CEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLE---TELASLESFQNEARLLSQIRHRNIVKLYGFCLHE--KCM 388 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 388 (560)
.+|++.+.||+|+||.||+|... ++..||+|.+.... ......+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888999999999999999864 58899999875322 1223456788999999999999999999988764 467
Q ss_pred EEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccc
Q 035761 389 FLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARL 468 (560)
Q Consensus 389 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 468 (560)
++||||+++++|.+++..... +++.....++.|++.||+|||+. +++|+||||+||+++.++.++|+|||.++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGA---LTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 899999999999999875433 78889999999999999999999 999999999999999999999999999986
Q ss_pred cCCCC---CCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccccc-------------------
Q 035761 469 LNYDS---SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSS------------------- 526 (560)
Q Consensus 469 ~~~~~---~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~------------------- 526 (560)
..... .......++..|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVS 235 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhC
Confidence 53211 11223457889999999988889999999999999999999999996432100
Q ss_pred cccccccccccccCCCCCCChhHHHhhcee
Q 035761 527 SSLDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 527 ~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
......++.|. .+|..||+++++++++|+
T Consensus 236 ~~~~~~i~~~l-~~p~~Rp~~~~il~~~~~ 264 (265)
T cd06652 236 DHCRDFLKRIF-VEAKLRPSADELLRHTFV 264 (265)
T ss_pred HHHHHHHHHHh-cChhhCCCHHHHhcCccc
Confidence 11122223333 499999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=297.58 Aligned_cols=234 Identities=26% Similarity=0.408 Sum_probs=195.7
Q ss_pred CcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEecc
Q 035761 317 FDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYM 395 (560)
Q Consensus 317 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 395 (560)
|.....||+|+||.||++... ++..||||.+.... ....+.+.+|+.+++.++|||++++++.+...+..++||||+
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 333466999999999999764 58899999886433 233456889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCC
Q 035761 396 EMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSN 475 (560)
Q Consensus 396 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 475 (560)
++++|.+++... .+++.++..++.||+.|++|||+. +++||||||+||++++++.++|+|||++.........
T Consensus 102 ~~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~ 174 (292)
T cd06658 102 EGGALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK 174 (292)
T ss_pred CCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc
Confidence 999999988543 289999999999999999999999 9999999999999999999999999999765433333
Q ss_pred ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc--------------------cccccccccc
Q 035761 476 RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------------SSSLDKNIKL 535 (560)
Q Consensus 476 ~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------------~~~~~~~~~~ 535 (560)
.....|+..|+|||.+.+..++.++||||||+++||+++|+.||...... ...+...+..
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 254 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDL 254 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHH
Confidence 34456889999999998888999999999999999999999998643321 1112334456
Q ss_pred ccccCCCCCCChhHHHhhceeeec
Q 035761 536 IDLLDPRLPPPGDQMIRQGIILIS 559 (560)
Q Consensus 536 ~~~~dp~~~p~~~~~~~~~~~~~~ 559 (560)
|...||..||+++++++++|+...
T Consensus 255 ~l~~~P~~Rpt~~~il~~~~~~~~ 278 (292)
T cd06658 255 MLVREPSQRATAQELLQHPFLKLA 278 (292)
T ss_pred HccCChhHCcCHHHHhhChhhhcc
Confidence 677899999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=297.66 Aligned_cols=233 Identities=26% Similarity=0.393 Sum_probs=196.8
Q ss_pred cccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEeccC
Q 035761 318 DIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYME 396 (560)
Q Consensus 318 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 396 (560)
+....||+|+||.||+|... +++.||+|.+..... ...+.+.+|+.+++.++|||++++++++..++..++|+||++
T Consensus 24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~ 101 (297)
T cd06659 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ 101 (297)
T ss_pred HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence 33456999999999999764 689999999865332 234567899999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCc
Q 035761 397 MGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNR 476 (560)
Q Consensus 397 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 476 (560)
+++|.+++... .+++.++..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||++..........
T Consensus 102 ~~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~ 174 (297)
T cd06659 102 GGALTDIVSQT----RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR 174 (297)
T ss_pred CCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccccc
Confidence 99999987642 289999999999999999999999 99999999999999999999999999997654433333
Q ss_pred eeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc--------------------cccccccccccc
Q 035761 477 TLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS--------------------SSSSLDKNIKLI 536 (560)
Q Consensus 477 ~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~--------------------~~~~~~~~~~~~ 536 (560)
....|+..|+|||++.+..++.++||||||+++|||++|+.||..... ....+.+.++.|
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~ 254 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERM 254 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHH
Confidence 445688999999999988899999999999999999999999864331 112234566777
Q ss_pred cccCCCCCCChhHHHhhceeeec
Q 035761 537 DLLDPRLPPPGDQMIRQGIILIS 559 (560)
Q Consensus 537 ~~~dp~~~p~~~~~~~~~~~~~~ 559 (560)
...+|..||++++++++.|+..+
T Consensus 255 l~~~P~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 255 LTREPQERATAQELLDHPFLLQT 277 (297)
T ss_pred hcCCcccCcCHHHHhhChhhccC
Confidence 78899999999999999988764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=289.89 Aligned_cols=233 Identities=24% Similarity=0.392 Sum_probs=193.2
Q ss_pred hcCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
.++|++.+.||+|++|.||+|...+++.||+|.++.... ..+.+.+|+.++++++||||+++++++......++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc---cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 356888999999999999999987888999999875332 24568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++++|.+++.... ...+++.++..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 82 LMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred cccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 999999999997643 23489999999999999999999998 99999999999999999999999999998765322
Q ss_pred CCc-eeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------------cccccccc
Q 035761 474 SNR-TLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------------SSSLDKNI 533 (560)
Q Consensus 474 ~~~-~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------------~~~~~~~~ 533 (560)
... .....+..|+|||++.+..++.++||||||+++|||++ |+.||...... ...+.+.+
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 237 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIM 237 (261)
T ss_pred ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence 111 11223457999999998899999999999999999999 99998643321 12334455
Q ss_pred ccccccCCCCCCChhHHHhh
Q 035761 534 KLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 534 ~~~~~~dp~~~p~~~~~~~~ 553 (560)
..|...+|..||++++++..
T Consensus 238 ~~~l~~~P~~Rp~~~~l~~~ 257 (261)
T cd05068 238 LDCWKEDPDDRPTFETLQWK 257 (261)
T ss_pred HHHhhcCcccCCCHHHHHHH
Confidence 66677788888888888764
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=291.03 Aligned_cols=231 Identities=27% Similarity=0.403 Sum_probs=190.6
Q ss_pred cCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
.+|++.+.||+|+||.||+|.++++..+|+|.+..... ....+.+|+++++.++||||+++++++...+..++||||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 34778889999999999999988778899999864332 234678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
+++++|.+++..... .+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||.++.......
T Consensus 81 ~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 81 MANGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred CCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 999999999975432 489999999999999999999999 999999999999999999999999999976542221
Q ss_pred Cc-eeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------------ccccccccc
Q 035761 475 NR-TLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------------SSSLDKNIK 534 (560)
Q Consensus 475 ~~-~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------------~~~~~~~~~ 534 (560)
.. ....++..|+|||.+.+..++.++||||||+++||+++ |+.||...... ...+.+.+.
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05059 156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMY 235 (256)
T ss_pred cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHH
Confidence 11 11223457999999998899999999999999999999 89998644321 122445556
Q ss_pred cccccCCCCCCChhHHHhh
Q 035761 535 LIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 535 ~~~~~dp~~~p~~~~~~~~ 553 (560)
.|...+|+.||++.++++.
T Consensus 236 ~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 236 SCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHhcCChhhCcCHHHHHHH
Confidence 6677788888888888764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=289.71 Aligned_cols=235 Identities=28% Similarity=0.426 Sum_probs=199.7
Q ss_pred CCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
+|+..+.||+|+||.||+|... +++.|++|.++.........+.+.+|+++++.++|+||+++++++......++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4777889999999999999764 688999999876554334567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
+++++|.+++.... .+++..+..++.|+++|++|||+. +++|+||+|+||++++++.+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 99999999997643 278999999999999999999999 999999999999999999999999999987643322
Q ss_pred Cce----eeccccCccCccccccCc---cCcchhHHHHHHHHHHHHhCCCCCCccccc---------------------c
Q 035761 475 NRT----LLAGTYGSIAPELAYTMV---VTEKYDVYSFGVVALEVLMGKHPGELLSSS---------------------S 526 (560)
Q Consensus 475 ~~~----~~~g~~~~~aPE~~~~~~---~~~~~Dv~s~G~il~el~~g~~P~~~~~~~---------------------~ 526 (560)
... ...++..|+|||++.+.. .+.++||||||+++||+++|+.||...... .
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLS 234 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccC
Confidence 211 245788999999988766 788999999999999999999999644210 2
Q ss_pred cccccccccccccCCCCCCChhHHHhhcee
Q 035761 527 SSLDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 527 ~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
..+...++.|...+|+.||++.+++.++|+
T Consensus 235 ~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 235 PEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 233456677788899999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=288.89 Aligned_cols=224 Identities=25% Similarity=0.365 Sum_probs=182.5
Q ss_pred eeeccCCeeEEEEEe---CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEeccCCC
Q 035761 322 CIGTGGYGSVYRARL---PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMG 398 (560)
Q Consensus 322 ~ig~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (560)
.||+|+||.||+|.+ +++..+|+|+++.........+.+.+|+.+++.++||||+++++++.. +..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 489999999999965 357889999987554444556788999999999999999999998864 4678999999999
Q ss_pred CHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCc--
Q 035761 399 SLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNR-- 476 (560)
Q Consensus 399 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-- 476 (560)
+|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 9999997543 389999999999999999999998 99999999999999999999999999998764332211
Q ss_pred -eeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc------------------cccccccccccc
Q 035761 477 -TLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS------------------SSSSLDKNIKLI 536 (560)
Q Consensus 477 -~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~------------------~~~~~~~~~~~~ 536 (560)
....++..|+|||.+....++.++||||||+++|||++ |+.||..... ....+.+.++.|
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~ 234 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLC 234 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH
Confidence 11223578999999988888999999999999999998 9999975432 112344555666
Q ss_pred cccCCCCCCChhHHHh
Q 035761 537 DLLDPRLPPPGDQMIR 552 (560)
Q Consensus 537 ~~~dp~~~p~~~~~~~ 552 (560)
...||..||+++.|.+
T Consensus 235 ~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 235 WTYGVDERPGFAVVEL 250 (257)
T ss_pred hccCchhCcCHHHHHH
Confidence 6777777777777654
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=291.41 Aligned_cols=235 Identities=23% Similarity=0.311 Sum_probs=193.7
Q ss_pred cCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchh-hhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLE-TELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|++.+.||+|+||.||+|.. .+++.+|||.+.... ......+.+.+|+.+++.++||||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 3577888999999999999985 478999999886533 22334467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcC-CcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC
Q 035761 393 EYMEMGSLFCILRTD-EEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471 (560)
Q Consensus 393 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 471 (560)
||+++++|.+++... .....+++.++..++.||+.|++|||+. +++|+||||+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988642 2223489999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------cccccc
Q 035761 472 DSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------SSSSLD 530 (560)
Q Consensus 472 ~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------~~~~~~ 530 (560)
.........++..|+|||.+.+..++.++||||||+++|||++|..||..... ....+.
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR 238 (267)
T ss_pred CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHH
Confidence 33333345688899999999988899999999999999999999999853321 111234
Q ss_pred cccccccccCCCCCCChhHHHh
Q 035761 531 KNIKLIDLLDPRLPPPGDQMIR 552 (560)
Q Consensus 531 ~~~~~~~~~dp~~~p~~~~~~~ 552 (560)
..+..|...||..||+++++.+
T Consensus 239 ~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 239 QLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHhcCCCcccCCCHHHHHH
Confidence 4455566778888888886554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=303.09 Aligned_cols=236 Identities=25% Similarity=0.377 Sum_probs=189.7
Q ss_pred hcCCcccceeeccCCeeEEEEEeC------CCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeC-
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLHE- 385 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~- 385 (560)
.++|++.+.||+|+||.||+|... +++.||+|+++..... ...+.+.+|++++.++ +|+||++++++|...
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~-~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATA-SEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCH-HHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 357889999999999999999642 3478999998754322 3345678899999999 899999999988754
Q ss_pred CEEEEEEeccCCCCHHHHhhcCCc--------------------------------------------------------
Q 035761 386 KCMFLIYEYMEMGSLFCILRTDEE-------------------------------------------------------- 409 (560)
Q Consensus 386 ~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------- 409 (560)
...+++|||+++|+|.+++.....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 567899999999999999864221
Q ss_pred --ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCC--ceeeccccCc
Q 035761 410 --AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSN--RTLLAGTYGS 485 (560)
Q Consensus 410 --~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~~ 485 (560)
...++|..+..++.||+.||+|||+. +|+||||||+||++++++.++|+|||+++.+...... .....++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 12589999999999999999999999 9999999999999999999999999999876433221 1223456789
Q ss_pred cCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc-------------------ccccccccccccccCCCCCC
Q 035761 486 IAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS-------------------SSSLDKNIKLIDLLDPRLPP 545 (560)
Q Consensus 486 ~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~-------------------~~~~~~~~~~~~~~dp~~~p 545 (560)
+|||++.+..++.++|||||||++|||++ |+.||...... ...+.+++..|...+|..||
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RP 321 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRP 321 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCc
Confidence 99999999999999999999999999998 99999642211 11223444566778999999
Q ss_pred ChhHHHhh
Q 035761 546 PGDQMIRQ 553 (560)
Q Consensus 546 ~~~~~~~~ 553 (560)
++.+++++
T Consensus 322 s~~ell~~ 329 (337)
T cd05054 322 TFSELVEI 329 (337)
T ss_pred CHHHHHHH
Confidence 99998875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=295.43 Aligned_cols=235 Identities=28% Similarity=0.363 Sum_probs=196.8
Q ss_pred CCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
+|++.+.||+|+||.||+|..+ +++.||+|.++.........+.+.+|+++++.++|+||+++++++..++..++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 5888999999999999999875 578999999876544444456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
++++.+..+..... .+++.++..++.||+.|++|||+. +++|||++|+||++++++.++|+|||++........
T Consensus 82 ~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 82 VERTLLELLEASPG---GLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred CCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 99877766654432 289999999999999999999999 999999999999999999999999999987654332
Q ss_pred -CceeeccccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCCCCCccccc---------------------------
Q 035761 475 -NRTLLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------------------- 525 (560)
Q Consensus 475 -~~~~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------------------- 525 (560)
......++..|+|||++.+. .++.++||||||+++|||++|+.||......
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence 23335678899999999888 7889999999999999999999998632110
Q ss_pred ----------------------ccccccccccccccCCCCCCChhHHHhhcee
Q 035761 526 ----------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 526 ----------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
...+.+.++.|...+|+.||++++++++.|+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 1223345667778899999999999998874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=290.38 Aligned_cols=237 Identities=29% Similarity=0.414 Sum_probs=204.9
Q ss_pred CCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
+|++.+.||+|++|.||+|... +++.|+||++...... ...+.+.+|+.++..++|+|++++++++......++||||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 5788899999999999999876 4899999998765432 4456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHH-HCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
+++++|.+++.... .+++..+..++.|+++|++|||+ . +++||||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKVG---KIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 99999999997653 38999999999999999999999 8 99999999999999999999999999998775444
Q ss_pred CCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc----------------------ccccccc
Q 035761 474 SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS----------------------SSSSLDK 531 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~----------------------~~~~~~~ 531 (560)
.......++..|+|||.+.+..++.++|+||||+++|||++|+.||..... ....+.+
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 234 (264)
T cd06623 155 DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRD 234 (264)
T ss_pred CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHH
Confidence 433345678899999999999899999999999999999999999976631 1123455
Q ss_pred ccccccccCCCCCCChhHHHhhceeeec
Q 035761 532 NIKLIDLLDPRLPPPGDQMIRQGIILIS 559 (560)
Q Consensus 532 ~~~~~~~~dp~~~p~~~~~~~~~~~~~~ 559 (560)
.++.|...+|+.||++.++++++|+.++
T Consensus 235 li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 235 FISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 5666777899999999999999998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=294.87 Aligned_cols=237 Identities=23% Similarity=0.329 Sum_probs=195.3
Q ss_pred CCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
+|++.+.||+|+||.||+|..+ +++.||+|.+..... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELD-ESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 5788899999999999999875 689999998864322 23345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
+++++|.++++.......+++..+..++.|++.|++|||+.. +++||||||+||+++.++.++|+|||.+..+...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 999999999876432335899999999999999999999632 8999999999999999999999999998765322
Q ss_pred CceeeccccCccCccccccCc------cCcchhHHHHHHHHHHHHhCCCCCCccccc---------------------cc
Q 035761 475 NRTLLAGTYGSIAPELAYTMV------VTEKYDVYSFGVVALEVLMGKHPGELLSSS---------------------SS 527 (560)
Q Consensus 475 ~~~~~~g~~~~~aPE~~~~~~------~~~~~Dv~s~G~il~el~~g~~P~~~~~~~---------------------~~ 527 (560)
......+++.|+|||.+.+.. ++.++|+|||||++|||++|+.||...... ..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd06622 157 LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSD 236 (286)
T ss_pred ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCH
Confidence 222345788999999886543 477999999999999999999999643221 11
Q ss_pred ccccccccccccCCCCCCChhHHHhhceee
Q 035761 528 SLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 528 ~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
.+...++.|...+|..||++++++.++|+.
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~ 266 (286)
T cd06622 237 DAQDFVAKCLNKIPNRRPTYAQLLEHPWLV 266 (286)
T ss_pred HHHHHHHHHcccCcccCCCHHHHhcChhhh
Confidence 223445667788999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=288.95 Aligned_cols=235 Identities=25% Similarity=0.356 Sum_probs=192.0
Q ss_pred CCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchh---hhhhhHHHHHHHHHHHhccCCCCcceeeeEEEe--CCEEE
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLE---TELASLESFQNEARLLSQIRHRNIVKLYGFCLH--EKCMF 389 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~ 389 (560)
+|+..+.||+|+||.||+|... ++..|++|++.... ......+.+.+|+.+++.++||||+++++++.. ....+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 5888899999999999999764 58899999886432 122344578899999999999999999998875 35788
Q ss_pred EEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccccc
Q 035761 390 LIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL 469 (560)
Q Consensus 390 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 469 (560)
+++||+++++|.+++..... +++.....++.|++.||+|||+. +++||||+|+||+++.++.++|+|||+++..
T Consensus 83 l~~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGA---LTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 99999999999999976433 88999999999999999999998 9999999999999999999999999999765
Q ss_pred CCCC---CCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccccc-------------------c
Q 035761 470 NYDS---SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSS-------------------S 527 (560)
Q Consensus 470 ~~~~---~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~-------------------~ 527 (560)
.... .......++..|+|||.+.+..++.++||||+||++||+++|+.||....... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISE 236 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCH
Confidence 3211 11122457889999999998889999999999999999999999996443111 1
Q ss_pred ccccccccccccCCCCCCChhHHHhhceee
Q 035761 528 SLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 528 ~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
.+...+ .|...+|+-||+++++++|+|+.
T Consensus 237 ~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 237 HARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 112222 24446999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=289.55 Aligned_cols=238 Identities=26% Similarity=0.423 Sum_probs=199.6
Q ss_pred CCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEe--CCEEEEEE
Q 035761 316 DFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLH--EKCMFLIY 392 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 392 (560)
+|++.+.+|.|+||.||++.. .+++.||+|.+..........+.+..|++++++++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477788999999999999975 467899999987544334445678899999999999999999998764 34679999
Q ss_pred eccCCCCHHHHhhcCC-cccCCCHHHHHHHHHHHHHHHHHHH-----hcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccc
Q 035761 393 EYMEMGSLFCILRTDE-EAVGLDWTKRVNIVKGMAHALSYLH-----HHCTPPILHRDISSNNILLNSEFEAFVADFGIA 466 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH-----~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~ 466 (560)
||+++++|.+++.... ....+++.++..++.|++.|++||| +. +++||||+|+||+++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 9999999999987532 2345899999999999999999999 66 9999999999999999999999999999
Q ss_pred cccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc------------------cccc
Q 035761 467 RLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS------------------SSSS 528 (560)
Q Consensus 467 ~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~------------------~~~~ 528 (560)
..............+++.|+|||.+.+..++.++|+||||+++|+|++|+.||..... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (265)
T cd08217 158 KILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSE 237 (265)
T ss_pred ccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHH
Confidence 8875444333445688999999999998899999999999999999999999975421 1123
Q ss_pred cccccccccccCCCCCCChhHHHhhcee
Q 035761 529 LDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 529 ~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
+....+.|...+|+.||+++++++++|+
T Consensus 238 ~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 238 LNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 4456677788899999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=293.92 Aligned_cols=244 Identities=25% Similarity=0.417 Sum_probs=199.9
Q ss_pred CHHHHHHHhcCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEE
Q 035761 306 TFQDMIEATEDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCL 383 (560)
Q Consensus 306 ~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 383 (560)
++.++..+.+.|++.+.+|+|+||.||+|.. .+++.+|+|.+.... .....+..|+.+++++ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 83 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFI 83 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence 4556666778899999999999999999986 457899999886533 2234677899999988 7999999999985
Q ss_pred e------CCEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCc
Q 035761 384 H------EKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFE 457 (560)
Q Consensus 384 ~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~ 457 (560)
. ....+++|||+++|+|.+++.... ...+++..+..++.|++.|++|||+. +++|||++|+||++++++.
T Consensus 84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAE 159 (282)
T ss_pred cccccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCC
Confidence 3 457899999999999999987543 23378888999999999999999999 9999999999999999999
Q ss_pred EEEeeeccccccCCCCCCceeeccccCccCccccc-----cCccCcchhHHHHHHHHHHHHhCCCCCCcccc--------
Q 035761 458 AFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAY-----TMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-------- 524 (560)
Q Consensus 458 ~kl~Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~~-----~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-------- 524 (560)
++|+|||++..............|+..|+|||.+. ...++.++||||||+++|||++|+.||.....
T Consensus 160 ~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~ 239 (282)
T cd06636 160 VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP 239 (282)
T ss_pred EEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHh
Confidence 99999999876543322333456889999999876 34578899999999999999999999954321
Q ss_pred -----------cccccccccccccccCCCCCCChhHHHhhcee
Q 035761 525 -----------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 525 -----------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
....+.+.++.|...||..||++.+++.++|+
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 240 RNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred hCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 11234566677888999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=291.12 Aligned_cols=236 Identities=30% Similarity=0.443 Sum_probs=200.0
Q ss_pred CCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 316 DFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
-|+..+.||+|+||.||+|.. .+++.||+|.+..... ....+.+.+|+..+++++||||+++++++..+...++||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 366778899999999999976 4678999998764432 23446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
+++++|.+++... .+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 84 LGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 9999999998743 389999999999999999999998 999999999999999999999999999877654333
Q ss_pred CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc------------------ccccccccccc
Q 035761 475 NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS------------------SSSLDKNIKLI 536 (560)
Q Consensus 475 ~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~------------------~~~~~~~~~~~ 536 (560)
......++..|+|||.+.+..++.++|+|||||++|||++|..||...... ...+.+.+..|
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEAC 236 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHH
Confidence 333346788999999998888899999999999999999999998643311 12344556677
Q ss_pred cccCCCCCCChhHHHhhceeeec
Q 035761 537 DLLDPRLPPPGDQMIRQGIILIS 559 (560)
Q Consensus 537 ~~~dp~~~p~~~~~~~~~~~~~~ 559 (560)
...+|..||++.++++++|+..+
T Consensus 237 l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 237 LNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred ccCChhhCcCHHHHHhCHHHhhh
Confidence 88899999999999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=287.42 Aligned_cols=236 Identities=28% Similarity=0.371 Sum_probs=198.5
Q ss_pred CCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
+|+..+.||+|+||.||++... +++.+|+|.+..........+.+.+|+++++.++|||++++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778899999999999999764 678999999876543344566788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCC-CcEEEeeeccccccCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSE-FEAFVADFGIARLLNYDS 473 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~~~~~~~~~ 473 (560)
+++++|.+++.... ...+++..+..++.|+++|++|||+. +++||||+|+||+++++ +.++++|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999997643 23489999999999999999999999 99999999999999865 457999999998764322
Q ss_pred CCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc------------------ccccccccccc
Q 035761 474 SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS------------------SSSSLDKNIKL 535 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~------------------~~~~~~~~~~~ 535 (560)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+. ....+...+..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 235 (256)
T cd08220 157 -KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS 235 (256)
T ss_pred -cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHH
Confidence 22234678899999999988889999999999999999999999975431 11234455667
Q ss_pred ccccCCCCCCChhHHHhhcee
Q 035761 536 IDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 536 ~~~~dp~~~p~~~~~~~~~~~ 556 (560)
|...+|..||+++++++|+|+
T Consensus 236 ~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 236 MLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HccCChhhCCCHHHHhhCCCC
Confidence 777899999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=294.54 Aligned_cols=236 Identities=25% Similarity=0.309 Sum_probs=195.3
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC--CEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHE--KCMFLI 391 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv 391 (560)
++|+..+.||+|+||.||+|..+ +++.+|+|.++...........+.+|++++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999875 588999999875443323334567899999999999999999999877 889999
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 471 (560)
|||+++ +|.+++..... .+++.++..++.|++.||+|||+. +++||||||+||+++.++.++|+|||.+.....
T Consensus 85 ~e~~~~-~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcCc-CHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999974 99988876432 489999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCceeeccccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCCCCCcccc--------------------------
Q 035761 472 DSSNRTLLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKHPGELLSS-------------------------- 524 (560)
Q Consensus 472 ~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-------------------------- 524 (560)
.........+++.|+|||.+.+. .++.++|+||+|+++|||++|+.||.....
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 33333344578899999988754 468899999999999999999999863321
Q ss_pred -----------------------cccccccccccccccCCCCCCChhHHHhhcee
Q 035761 525 -----------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 525 -----------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
....+.+.++.|...||+.||++++++.+.|+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 01223345677788899999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=291.34 Aligned_cols=234 Identities=24% Similarity=0.368 Sum_probs=190.3
Q ss_pred CcccceeeccCCeeEEEEEeCC----CcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCE-----
Q 035761 317 FDIKYCIGTGGYGSVYRARLPS----GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKC----- 387 (560)
Q Consensus 317 ~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 387 (560)
|.+.+.||+|+||.||+|.... +..||+|+++...........+.+|++.++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567889999999999998642 3679999987544333445678999999999999999999999876554
Q ss_pred -EEEEEeccCCCCHHHHhhcCC---cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeee
Q 035761 388 -MFLIYEYMEMGSLFCILRTDE---EAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADF 463 (560)
Q Consensus 388 -~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 463 (560)
.++++||+++|+|.+++.... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 789999999999999985432 223589999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCCCc--eeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc----------------
Q 035761 464 GIARLLNYDSSNR--TLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS---------------- 524 (560)
Q Consensus 464 g~~~~~~~~~~~~--~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~---------------- 524 (560)
|+++......... ....++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 237 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQP 237 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 9998764332211 12234678999999988889999999999999999999 9999864432
Q ss_pred --cccccccccccccccCCCCCCChhHHHhh
Q 035761 525 --SSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 525 --~~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
....+.+.++.|...||+.||++.+++.+
T Consensus 238 ~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 238 EDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred cCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11234556677888899999999988765
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=292.15 Aligned_cols=236 Identities=26% Similarity=0.332 Sum_probs=197.1
Q ss_pred CCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
+|++.+.||+|+||.||+|... +|+.||+|++............+.+|+.++++++|||++++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778889999999999999864 689999999876543334456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
+ +++|.+++.... ..+++.++..++.||++||+|||+. +++|+||||+||+++.++.++|+|||.+........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999987543 3389999999999999999999998 999999999999999999999999999987653321
Q ss_pred -CceeeccccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCCCCCcccc----------------------------
Q 035761 475 -NRTLLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------------- 524 (560)
Q Consensus 475 -~~~~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------------- 524 (560)
......++..|+|||.+.+. .++.++||||+|+++|||++|++||.....
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence 12234588899999988654 468899999999999999999888753221
Q ss_pred -------------------cccccccccccccccCCCCCCChhHHHhhceee
Q 035761 525 -------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 525 -------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
....+.+.++.|...+|..||+++++++|+|+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 112233455777788999999999999999974
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=305.78 Aligned_cols=233 Identities=26% Similarity=0.357 Sum_probs=199.9
Q ss_pred eeeccCCeeEEEEEeCCC-cEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEeccCCCCH
Q 035761 322 CIGTGGYGSVYRARLPSG-KVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSL 400 (560)
Q Consensus 322 ~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 400 (560)
++|+|.||+||.|+..+. ..+|||.+.... .+..+.+.+|+...++++|.|||+++|.+.+++..-+.||-+|||+|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd--sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD--SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc--chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 599999999999987654 468999887544 34556789999999999999999999999999999999999999999
Q ss_pred HHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeC-CCCcEEEeeeccccccCCCCCCceee
Q 035761 401 FCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLN-SEFEAFVADFGIARLLNYDSSNRTLL 479 (560)
Q Consensus 401 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~ 479 (560)
.+.++..-++.+=.+.+.-.+..||++||.|||++ .|||||||-.|||++ -.|.+||+|||-++.+..-+......
T Consensus 660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETF 736 (1226)
T KOG4279|consen 660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETF 736 (1226)
T ss_pred HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCcccccc
Confidence 99999876554346777788899999999999999 999999999999995 56899999999998886655666777
Q ss_pred ccccCccCccccccC--ccCcchhHHHHHHHHHHHHhCCCCCCccccccc--------------------cccccccccc
Q 035761 480 AGTYGSIAPELAYTM--VVTEKYDVYSFGVVALEVLMGKHPGELLSSSSS--------------------SLDKNIKLID 537 (560)
Q Consensus 480 ~g~~~~~aPE~~~~~--~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~~--------------------~~~~~~~~~~ 537 (560)
.||..|||||++..+ .|...+|||||||.+.||.||++||-..++..- +.+..+..|.
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcF 816 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCF 816 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHc
Confidence 899999999998765 488899999999999999999999976665321 2344556678
Q ss_pred ccCCCCCCChhHHHhhceeeec
Q 035761 538 LLDPRLPPPGDQMIRQGIILIS 559 (560)
Q Consensus 538 ~~dp~~~p~~~~~~~~~~~~~~ 559 (560)
..||..||.+.+++.++|+++.
T Consensus 817 epd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 817 EPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred CCCcccCccHHHhccCcccccC
Confidence 8899999999999999999864
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=294.25 Aligned_cols=239 Identities=22% Similarity=0.252 Sum_probs=193.7
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccC-CCCcceeeeEEEeCCE-----
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIR-HRNIVKLYGFCLHEKC----- 387 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~----- 387 (560)
++|+..+.||+|+||.||+|... +++.||+|.++...........+.+|+.+++.++ ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36888899999999999999865 6899999988754433333456788999999995 6999999999987665
Q ss_pred EEEEEeccCCCCHHHHhhcCCc--ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCC-CCcEEEeeec
Q 035761 388 MFLIYEYMEMGSLFCILRTDEE--AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNS-EFEAFVADFG 464 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg 464 (560)
.++||||+++ ++.+++..... ...+++..+..++.||++||+|||+. +++||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 89888765332 23489999999999999999999999 9999999999999998 8899999999
Q ss_pred cccccCCCCCCceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCcccc-------------------
Q 035761 465 IARLLNYDSSNRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSS------------------- 524 (560)
Q Consensus 465 ~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~------------------- 524 (560)
.++.+...........+++.|+|||.+.+ ..++.++||||||+++|||++|..||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 99866433332333456788999998765 4578899999999999999999999864321
Q ss_pred --------------------------cccccccccccccccCCCCCCChhHHHhhceee
Q 035761 525 --------------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 525 --------------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
....+.+.+..|...||..||++++++.|+|+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 112233455677788999999999999999973
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=296.55 Aligned_cols=240 Identities=25% Similarity=0.332 Sum_probs=202.2
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhh-hhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETE-LASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|+..+.||+|++|.||+|... +++.||+|.+...... ....+.+.+|+++++.++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999875 4899999998764422 234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++++|.+++.... ...+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 9999999999987543 23489999999999999999999998 9999999999999999999999999998765321
Q ss_pred CC-----------------------------CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccc
Q 035761 473 SS-----------------------------NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLS 523 (560)
Q Consensus 473 ~~-----------------------------~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~ 523 (560)
.. ......|+..|+|||++.+..++.++||||||+++|+|++|+.||...+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 11 1112357889999999999889999999999999999999999996443
Q ss_pred c-------------------cccccccccccccccCCCCCCC----hhHHHhhceeee
Q 035761 524 S-------------------SSSSLDKNIKLIDLLDPRLPPP----GDQMIRQGIILI 558 (560)
Q Consensus 524 ~-------------------~~~~~~~~~~~~~~~dp~~~p~----~~~~~~~~~~~~ 558 (560)
. ....+.+.++.|...||..||+ +++++.+.|+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~ 294 (316)
T cd05574 237 RDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294 (316)
T ss_pred hHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhc
Confidence 1 1233566778888899999999 999999999764
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=289.33 Aligned_cols=233 Identities=26% Similarity=0.385 Sum_probs=186.1
Q ss_pred cccceeeccCCeeEEEEEeCCC-c--EEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC------CEE
Q 035761 318 DIKYCIGTGGYGSVYRARLPSG-K--VVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHE------KCM 388 (560)
Q Consensus 318 ~~~~~ig~G~~g~Vy~~~~~~~-~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~ 388 (560)
.+.+.||+|+||.||+|.+.+. . .||+|.++.........+.+.+|+++++.++||||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 4567899999999999987543 2 589998876543444567889999999999999999999988542 246
Q ss_pred EEEEeccCCCCHHHHhhcCC---cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecc
Q 035761 389 FLIYEYMEMGSLFCILRTDE---EAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGI 465 (560)
Q Consensus 389 ~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 465 (560)
+++|||+++|+|.+++.... ....+++.....++.|++.|++|||+. +|+||||||+||++++++.++|+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999998874321 223489999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCC--ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc-----------------
Q 035761 466 ARLLNYDSSN--RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS----------------- 525 (560)
Q Consensus 466 ~~~~~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~----------------- 525 (560)
++........ .....+++.|+|||...+..++.++||||||+++|||++ |+.||......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPD 238 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 9876432211 112235678999999999999999999999999999999 89998643221
Q ss_pred -ccccccccccccccCCCCCCChhHHHhh
Q 035761 526 -SSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 526 -~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
...+.+.+..|...||..||+++++++.
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 239 CLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1123445567777788888888888764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=289.85 Aligned_cols=232 Identities=28% Similarity=0.432 Sum_probs=192.4
Q ss_pred hcCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
.++|++.+.||+|+||.||+|..++++.||+|.+..... ..+.+.+|+.++++++|+|++++++++. .+..+++||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 456888999999999999999988899999999875432 2357889999999999999999999874 456899999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++|+|.+++..... ..+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 81 YMENGSLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 9999999999876432 3489999999999999999999998 99999999999999999999999999998764222
Q ss_pred C-CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------------cccccccc
Q 035761 474 S-NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------------SSSLDKNI 533 (560)
Q Consensus 474 ~-~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------------~~~~~~~~ 533 (560)
. ......++..|+|||++....++.++||||||+++||+++ |+.||...... ...+.+.+
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELM 236 (260)
T ss_pred cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 1 1122345678999999998889999999999999999999 99999644321 12345556
Q ss_pred ccccccCCCCCCChhHHHhh
Q 035761 534 KLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 534 ~~~~~~dp~~~p~~~~~~~~ 553 (560)
+.|...+|+.||++++++..
T Consensus 237 ~~~l~~~p~~Rp~~~~l~~~ 256 (260)
T cd05067 237 RLCWKEKPEERPTFEYLRSV 256 (260)
T ss_pred HHHccCChhhCCCHHHHHHH
Confidence 67777788999988887653
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=294.40 Aligned_cols=244 Identities=25% Similarity=0.377 Sum_probs=196.7
Q ss_pred HHHHHHHhcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEE-
Q 035761 307 FQDMIEATEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCL- 383 (560)
Q Consensus 307 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~- 383 (560)
++.+..+.++|++.+.||+|+||.||+|... +++.+|+|.+..... ....+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD---IDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc---hHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 3445556788999999999999999999764 578999998764322 224577899999999 7999999999885
Q ss_pred ----eCCEEEEEEeccCCCCHHHHhhcC-CcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcE
Q 035761 384 ----HEKCMFLIYEYMEMGSLFCILRTD-EEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEA 458 (560)
Q Consensus 384 ----~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 458 (560)
.+...++||||+++++|.+++... .....+++..+..++.|+++|+.|||+. +++||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCE
Confidence 345689999999999999887632 1223488999999999999999999998 99999999999999999999
Q ss_pred EEeeeccccccCCCCCCceeeccccCccCcccccc-----CccCcchhHHHHHHHHHHHHhCCCCCCccccc--------
Q 035761 459 FVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYT-----MVVTEKYDVYSFGVVALEVLMGKHPGELLSSS-------- 525 (560)
Q Consensus 459 kl~Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-----~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~-------- 525 (560)
+|+|||+++.............|++.|+|||++.. ..++.++||||+||++|||++|+.||......
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~ 243 (286)
T cd06638 164 KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR 243 (286)
T ss_pred EEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccc
Confidence 99999999876433333334468899999998753 44788999999999999999999998644321
Q ss_pred ------------ccccccccccccccCCCCCCChhHHHhhcee
Q 035761 526 ------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 526 ------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
...+...+..|...||+.||++++++.+.|+
T Consensus 244 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 244 NPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred cCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 1123445566777899999999999999885
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=293.41 Aligned_cols=236 Identities=25% Similarity=0.377 Sum_probs=201.1
Q ss_pred cCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
++|+..+.||+|+||.||+|.. .+++.|++|.+.... ....+.+.+|+.+++.++|||++++++++......++|+|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 5788899999999999999975 467899999986432 2234568889999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++++|.+++... .+++.++..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||++.......
T Consensus 97 ~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 97 YLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred cCCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 99999999998753 278999999999999999999999 99999999999999999999999999987765444
Q ss_pred CCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc--------------------cccccccc
Q 035761 474 SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------------SSSLDKNI 533 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------------~~~~~~~~ 533 (560)
.......+++.|+|||.+....++.++||||||+++||+++|+.||...... ...+...+
T Consensus 170 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 249 (293)
T cd06647 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL 249 (293)
T ss_pred cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHH
Confidence 3344456888999999998888999999999999999999999999643320 01234556
Q ss_pred ccccccCCCCCCChhHHHhhceeeec
Q 035761 534 KLIDLLDPRLPPPGDQMIRQGIILIS 559 (560)
Q Consensus 534 ~~~~~~dp~~~p~~~~~~~~~~~~~~ 559 (560)
+.|...+|..||++++++.|.|+.++
T Consensus 250 ~~~l~~~p~~Rp~~~~il~h~~~~~~ 275 (293)
T cd06647 250 NRCLEMDVEKRGSAKELLQHPFLKIA 275 (293)
T ss_pred HHHccCChhhCcCHHHHhcCHHHhcC
Confidence 77788899999999999999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=288.16 Aligned_cols=237 Identities=27% Similarity=0.379 Sum_probs=198.8
Q ss_pred CCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
+|+..+.||+|+||.||+|..+ +|..||+|.+..........+.+.+|+++++.++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778889999999999999875 578999999876433233445778999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCc-EEEeeeccccccCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFE-AFVADFGIARLLNYDS 473 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-~kl~Dfg~~~~~~~~~ 473 (560)
+++++|.+++..... ..+++..+..++.|+++|++|||+. +++|+||+|+||++++++. ++++|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 999999999875432 3479999999999999999999998 9999999999999998864 6999999998765433
Q ss_pred CCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc------------------ccccccccccc
Q 035761 474 SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS------------------SSSSLDKNIKL 535 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~------------------~~~~~~~~~~~ 535 (560)
.......|++.|+|||...+..++.++||||||+++||+++|..||..... ....+.+.++.
T Consensus 157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 236 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQ 236 (257)
T ss_pred ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHH
Confidence 333334588899999999888899999999999999999999999864321 12234455667
Q ss_pred ccccCCCCCCChhHHHhhcee
Q 035761 536 IDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 536 ~~~~dp~~~p~~~~~~~~~~~ 556 (560)
|...+|+.||++++++.+.|+
T Consensus 237 ~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 237 LFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HhccChhhCcCHHHHhhCCCC
Confidence 778899999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=305.52 Aligned_cols=204 Identities=32% Similarity=0.476 Sum_probs=177.6
Q ss_pred CcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCC------EEE
Q 035761 317 FDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEK------CMF 389 (560)
Q Consensus 317 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~ 389 (560)
+...+.+|+|+||.||+|+. .+|+.||||.++... .....+...+|+++|++++|||||++++.-++.. ...
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 45567799999999999995 579999999998654 3445667899999999999999999999765543 468
Q ss_pred EEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeC--CCCc--EEEeeecc
Q 035761 390 LIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLN--SEFE--AFVADFGI 465 (560)
Q Consensus 390 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~~--~kl~Dfg~ 465 (560)
+|||||.+|||+..+....+...|++.+.+.+..+++.||.|||++ +||||||||.||++- .+|. -||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 9999999999999999988888899999999999999999999999 999999999999984 3343 58999999
Q ss_pred ccccCCCCCCceeeccccCccCccccc-cCccCcchhHHHHHHHHHHHHhCCCCCCccccc
Q 035761 466 ARLLNYDSSNRTLLAGTYGSIAPELAY-TMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS 525 (560)
Q Consensus 466 ~~~~~~~~~~~~~~~g~~~~~aPE~~~-~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~ 525 (560)
|+.++++. .....+||..|.+||+.. .+.|+..+|.|||||++||.+||..||......
T Consensus 171 Arel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 171 ARELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred cccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 99987544 566678999999999999 488899999999999999999999999755543
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=291.09 Aligned_cols=236 Identities=24% Similarity=0.356 Sum_probs=195.2
Q ss_pred CCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
+|+..+.||.|++|.||+|... +|+.||||.++..... .....+.+|+++++.++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 4788899999999999999875 5889999998754322 2335677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
+++ +|.+++........+++.++..++.|++.||+|||+. +++||||+|+||++++++.++++|||++........
T Consensus 80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 985 8888887654344589999999999999999999998 999999999999999999999999999986543333
Q ss_pred CceeeccccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCCCCCccccc----------------------------
Q 035761 475 NRTLLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKHPGELLSSS---------------------------- 525 (560)
Q Consensus 475 ~~~~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~---------------------------- 525 (560)
......++..|+|||.+.+. .++.++||||||+++||+++|+.||...+..
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 33334578899999987654 5688999999999999999999999744311
Q ss_pred ------------------ccccccccccccccCCCCCCChhHHHhhcee
Q 035761 526 ------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 526 ------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
...+.+.++.|...||..||++.++++++|+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 1122345567778899999999999999885
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=289.76 Aligned_cols=234 Identities=28% Similarity=0.375 Sum_probs=199.5
Q ss_pred CCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
+|++.+.||.|+||.||+|... +++.||+|.+..... .....+.+.+|++++++++||||+++++++..+...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999875 589999999875432 22445688999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++++|.+++... ..+++.++..++.|+++||+|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999999765 2389999999999999999999999 99999999999999999999999999998764332
Q ss_pred CCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc--------------------ccccccccc
Q 035761 474 SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS--------------------SSSSLDKNI 533 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~--------------------~~~~~~~~~ 533 (560)
......|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||..... ....+.+.+
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 233 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAI 233 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHH
Confidence 22334578899999999988899999999999999999999999986542 122345556
Q ss_pred ccccccCCCCCCCh--hHHHhhcee
Q 035761 534 KLIDLLDPRLPPPG--DQMIRQGII 556 (560)
Q Consensus 534 ~~~~~~dp~~~p~~--~~~~~~~~~ 556 (560)
..|...||..||+. ++++.++|+
T Consensus 234 ~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 234 NKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHccCChhHcCCccHHHHhcCCCC
Confidence 66777789999998 888888875
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=286.48 Aligned_cols=234 Identities=26% Similarity=0.357 Sum_probs=195.9
Q ss_pred CCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh---hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEE
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET---ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLI 391 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 391 (560)
+|+..+.||+|++|.||+|... +++.|++|.+..... ..+..+.+.+|+++++.++|+||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667788999999999999876 789999998865431 123456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 471 (560)
+||+++++|.+++.... .+++..+..++.|+++|++|||+. +++|+||+|+||+++.++.+||+|||.+.....
T Consensus 81 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 99999999999997653 388999999999999999999999 999999999999999999999999999877543
Q ss_pred CCCCceeeccccCccCccccccCc-cCcchhHHHHHHHHHHHHhCCCCCCccccc-------------------cccccc
Q 035761 472 DSSNRTLLAGTYGSIAPELAYTMV-VTEKYDVYSFGVVALEVLMGKHPGELLSSS-------------------SSSLDK 531 (560)
Q Consensus 472 ~~~~~~~~~g~~~~~aPE~~~~~~-~~~~~Dv~s~G~il~el~~g~~P~~~~~~~-------------------~~~~~~ 531 (560)
.. ......++..|+|||.+.... ++.++|+||||+++||+++|+.||...... ...+.+
T Consensus 155 ~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (258)
T cd06632 155 FS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKD 233 (258)
T ss_pred cc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHH
Confidence 22 223345788999999987766 888999999999999999999998644310 112233
Q ss_pred ccccccccCCCCCCChhHHHhhcee
Q 035761 532 NIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 532 ~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
.++.|...+|..||++.++++++|+
T Consensus 234 li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 234 FILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHHhhcCcccCcCHHHHhcCCCC
Confidence 4556677799999999999999885
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=290.52 Aligned_cols=235 Identities=27% Similarity=0.369 Sum_probs=200.1
Q ss_pred CCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
+|+..+.||+|++|.||++..+ +++.||+|.+...... ...+.+.+|+++++.++||||+++++++..+...++++||
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE-AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh-HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 5777889999999999999875 5889999998765432 3446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHH-HCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
+++++|.+++.... ..+++..+..++.|++.|++|||+ . +++||||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999998653 348899999999999999999999 7 99999999999999999999999999987653222
Q ss_pred CCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc------------------------ccccc
Q 035761 474 SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS------------------------SSSSL 529 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~------------------------~~~~~ 529 (560)
.. ...++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ....+
T Consensus 156 ~~--~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd06605 156 AK--TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDF 233 (265)
T ss_pred hh--cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence 11 15678899999999999999999999999999999999999965420 11224
Q ss_pred ccccccccccCCCCCCChhHHHhhceeee
Q 035761 530 DKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 530 ~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
...+..|...||+.||++.+++.++|++.
T Consensus 234 ~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 234 QDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred HHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 45566778889999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=291.30 Aligned_cols=234 Identities=29% Similarity=0.388 Sum_probs=197.7
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|++.+.||+|+||.||++... +++.||+|.+..... .....+.+.+|++++++++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36888899999999999999865 589999999875432 2234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 9999999999997653 389999999999999999999998 9999999999999999999999999999876433
Q ss_pred CCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------ccccccccccc
Q 035761 473 SSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNIKL 535 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~~~ 535 (560)
.....+++.|+|||.+.+...+.++||||||+++|||++|+.||..... ....+.+.++.
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 231 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRN 231 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHH
Confidence 2334688999999999888888999999999999999999999964431 11233455566
Q ss_pred ccccCCCCCC-----ChhHHHhhceee
Q 035761 536 IDLLDPRLPP-----PGDQMIRQGIIL 557 (560)
Q Consensus 536 ~~~~dp~~~p-----~~~~~~~~~~~~ 557 (560)
|...||..|+ .+++++.++|+.
T Consensus 232 ~l~~~p~~R~~~~~~~~~~l~~~~~~~ 258 (290)
T cd05580 232 LLQVDLTKRLGNLKNGVNDIKNHPWFA 258 (290)
T ss_pred HccCCHHHccCcccCCHHHHHcCcccc
Confidence 6777888887 788888888764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=292.92 Aligned_cols=234 Identities=27% Similarity=0.409 Sum_probs=188.6
Q ss_pred cCCcccceeeccCCeeEEEEEeCC-Cc--EEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPS-GK--VVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKCMFL 390 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 390 (560)
++|++.+.||+|+||.||+|..++ +. .+++|.++.... ....+.+.+|+++++++ +||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFAS-ENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCC-HHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 468889999999999999998753 33 478888764322 23345788999999999 79999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCc-------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCc
Q 035761 391 IYEYMEMGSLFCILRTDEE-------------AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFE 457 (560)
Q Consensus 391 v~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~ 457 (560)
|+||+++|+|.+++..... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCe
Confidence 9999999999999975321 12488999999999999999999998 9999999999999999999
Q ss_pred EEEeeeccccccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc------------
Q 035761 458 AFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS------------ 524 (560)
Q Consensus 458 ~kl~Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~------------ 524 (560)
+||+|||++........ ......+..|+|||+..+..++.++|||||||++|||++ |+.||.....
T Consensus 158 ~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~ 236 (297)
T cd05089 158 SKIADFGLSRGEEVYVK-KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 236 (297)
T ss_pred EEECCcCCCccccceec-cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Confidence 99999999864321111 111123457999999998889999999999999999998 9999964432
Q ss_pred ------cccccccccccccccCCCCCCChhHHHhh
Q 035761 525 ------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 525 ------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
....+.+++..|...+|..||+++++++.
T Consensus 237 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 237 MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11234456667778899999999998765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=292.55 Aligned_cols=236 Identities=22% Similarity=0.362 Sum_probs=192.4
Q ss_pred HhcCCcccceeeccCCeeEEEEEeC------CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCC
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEK 386 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 386 (560)
..++|++.+.||+|+||.||+|..+ .+..||+|.+..... ......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS-LRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 3567999999999999999999653 245799998864432 223446788999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHhhcCCc-------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEE
Q 035761 387 CMFLIYEYMEMGSLFCILRTDEE-------AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAF 459 (560)
Q Consensus 387 ~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 459 (560)
..++||||+++|+|.++++.... ....++..+..++.|++.||+|||+. +++||||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEE
Confidence 99999999999999999975321 12357788899999999999999999 999999999999999999999
Q ss_pred EeeeccccccCCCCCCc--eeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc------------
Q 035761 460 VADFGIARLLNYDSSNR--TLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS------------ 524 (560)
Q Consensus 460 l~Dfg~~~~~~~~~~~~--~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~------------ 524 (560)
|+|||+++......... ....++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~ 239 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY 239 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 99999998654322211 11234678999999998899999999999999999998 7889854321
Q ss_pred ------cccccccccccccccCCCCCCChhHHHh
Q 035761 525 ------SSSSLDKNIKLIDLLDPRLPPPGDQMIR 552 (560)
Q Consensus 525 ------~~~~~~~~~~~~~~~dp~~~p~~~~~~~ 552 (560)
....+.+.++.|...||+.||++.++++
T Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 273 (288)
T cd05061 240 LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVN 273 (288)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1123556677788889999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=290.59 Aligned_cols=238 Identities=28% Similarity=0.425 Sum_probs=197.8
Q ss_pred HhcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCC----
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEK---- 386 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~---- 386 (560)
++++|++.+.||+|++|.||+|..+ +++.+++|.+..... ..+.+.+|+++++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 4578999999999999999999875 578899998875432 235788999999999 7999999999997644
Q ss_pred --EEEEEEeccCCCCHHHHhhcCC-cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeee
Q 035761 387 --CMFLIYEYMEMGSLFCILRTDE-EAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADF 463 (560)
Q Consensus 387 --~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 463 (560)
..++||||+++++|.+++.... ....+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCC
Confidence 4899999999999999886532 123489999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCceeeccccCccCcccccc-----CccCcchhHHHHHHHHHHHHhCCCCCCcccc--------------
Q 035761 464 GIARLLNYDSSNRTLLAGTYGSIAPELAYT-----MVVTEKYDVYSFGVVALEVLMGKHPGELLSS-------------- 524 (560)
Q Consensus 464 g~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-----~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-------------- 524 (560)
|++..............++..|+|||++.. ..++.++||||||+++||+++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 237 (275)
T cd06608 158 GVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPT 237 (275)
T ss_pred ccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCC
Confidence 999876443333344568889999998753 3467789999999999999999999964331
Q ss_pred ------cccccccccccccccCCCCCCChhHHHhhcee
Q 035761 525 ------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 525 ------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
....+.+.++.|...||..||++.++++++|+
T Consensus 238 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 238 LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 11234566677888899999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=290.86 Aligned_cols=236 Identities=25% Similarity=0.340 Sum_probs=190.6
Q ss_pred hcCCcccceeeccCCeeEEEEEeCC------CcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLPS------GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKC 387 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 387 (560)
.++|.+.+.||+|++|.||+|.+.+ +..||+|.+..... ......+.+|+.+++.++|+||+++++++.+...
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS-EQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 4568889999999999999998753 56789998764332 2233568899999999999999999999999989
Q ss_pred EEEEEeccCCCCHHHHhhcCCc----ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCC---cEEE
Q 035761 388 MFLIYEYMEMGSLFCILRTDEE----AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEF---EAFV 460 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl 460 (560)
.++||||+++++|.++++.... ...+++.++++++.||+.|++|||+. +++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999876432 12489999999999999999999999 999999999999998654 5899
Q ss_pred eeeccccccCCCCCC--ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------
Q 035761 461 ADFGIARLLNYDSSN--RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------ 525 (560)
Q Consensus 461 ~Dfg~~~~~~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------ 525 (560)
+|||+++........ ......+..|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL 240 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 999999876322111 111223567999999999999999999999999999997 99999754311
Q ss_pred ------ccccccccccccccCCCCCCChhHHHhh
Q 035761 526 ------SSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 526 ------~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
...+.+.+..|...+|+.||++.+++++
T Consensus 241 ~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 241 DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1123455667777889999999888875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=290.01 Aligned_cols=235 Identities=31% Similarity=0.452 Sum_probs=197.0
Q ss_pred CCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccC---CCCcceeeeEEEeCCEEEEE
Q 035761 316 DFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIR---HRNIVKLYGFCLHEKCMFLI 391 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv 391 (560)
.|+..+.||+|+||.||+|.. .+++.||+|.+..... ......+.+|+++++.++ |||++++++++..+...++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP-DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 366778899999999999986 5689999998865322 233456788999999986 99999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 471 (560)
|||+++++|.++++.. .+++.....++.|++.|++|||+. +++||||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 81 MEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred EecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 9999999999998653 389999999999999999999999 999999999999999999999999999987754
Q ss_pred CCCCceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCccccc-------------------cccccc
Q 035761 472 DSSNRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSSS-------------------SSSLDK 531 (560)
Q Consensus 472 ~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~-------------------~~~~~~ 531 (560)
.........|+..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ...+.+
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (277)
T cd06917 154 NSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLRE 233 (277)
T ss_pred CccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHH
Confidence 4433444568889999998765 44688999999999999999999999644321 112334
Q ss_pred ccccccccCCCCCCChhHHHhhceeee
Q 035761 532 NIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 532 ~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
.++.|...||+.||++.+++.++|+.+
T Consensus 234 ~i~~~l~~~p~~R~~~~~il~~~~~~~ 260 (277)
T cd06917 234 FVAACLDEEPKERLSAEELLKSKWIKA 260 (277)
T ss_pred HHHHHcCCCcccCcCHHHHhhChHhhc
Confidence 456677789999999999999999864
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=283.46 Aligned_cols=226 Identities=24% Similarity=0.361 Sum_probs=185.7
Q ss_pred eeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEeccCCCCHH
Q 035761 322 CIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLF 401 (560)
Q Consensus 322 ~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 401 (560)
.||+|+||.||+|..++++.+|+|.+...... .....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQ-ELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCH-HHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 58999999999999888999999998754322 33346889999999999999999999999999999999999999999
Q ss_pred HHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCc-eeec
Q 035761 402 CILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNR-TLLA 480 (560)
Q Consensus 402 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~ 480 (560)
+++.... ..+++.++..++.|++.|+.|+|+. +++||||+|+||+++.++.++++|||++.......... ....
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 81 SFLRKKK--DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 9987543 2389999999999999999999998 99999999999999999999999999987643221111 1123
Q ss_pred cccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc------------------cccccccccccccccCC
Q 035761 481 GTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS------------------SSSSLDKNIKLIDLLDP 541 (560)
Q Consensus 481 g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~------------------~~~~~~~~~~~~~~~dp 541 (560)
+++.|+|||++.+..++.++||||||+++||+++ |..||..... ....+.+.+..|...+|
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKP 235 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCc
Confidence 4567999999998889999999999999999998 9999864321 11233445566667788
Q ss_pred CCCCChhHHHhh
Q 035761 542 RLPPPGDQMIRQ 553 (560)
Q Consensus 542 ~~~p~~~~~~~~ 553 (560)
+.||++.++++.
T Consensus 236 ~~Rp~~~~l~~~ 247 (250)
T cd05085 236 ENRPKFSELQKE 247 (250)
T ss_pred ccCCCHHHHHHH
Confidence 888888877764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=287.39 Aligned_cols=230 Identities=27% Similarity=0.400 Sum_probs=188.8
Q ss_pred cCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
++|++.+.||+|+||.||+|...++..||+|+++.... ..+.+.+|++++++++||||+++++++.. ...++||||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 81 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEc
Confidence 56888999999999999999887777899999875332 23468899999999999999999998754 557999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
+++|+|.+++.... ...+++..+..++.|+++||+|||+. +++||||||+||++++++.++|+|||.++.+.....
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 82 MSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred CCCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 99999999997643 23479999999999999999999998 999999999999999999999999999987643322
Q ss_pred Cc-eeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------------ccccccccc
Q 035761 475 NR-TLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------------SSSLDKNIK 534 (560)
Q Consensus 475 ~~-~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------------~~~~~~~~~ 534 (560)
.. ....++..|+|||+..+..++.++||||||+++|||++ |+.||...... ...+.+.++
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 237 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC 237 (262)
T ss_pred ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHH
Confidence 11 12345678999999988889999999999999999999 88898644321 122445566
Q ss_pred cccccCCCCCCChhHHHh
Q 035761 535 LIDLLDPRLPPPGDQMIR 552 (560)
Q Consensus 535 ~~~~~dp~~~p~~~~~~~ 552 (560)
.|...||+.||++.+++.
T Consensus 238 ~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 238 QCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHccCCcccCCCHHHHHH
Confidence 677778888888887764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=302.23 Aligned_cols=238 Identities=24% Similarity=0.374 Sum_probs=192.7
Q ss_pred HHhcCCcccceeeccCCeeEEEEEeC------CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccC-CCCcceeeeEEEe
Q 035761 312 EATEDFDIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRLETELASLESFQNEARLLSQIR-HRNIVKLYGFCLH 384 (560)
Q Consensus 312 ~~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~ 384 (560)
...++|.+.+.||+|+||.||+|++. .++.||+|+++..... ...+.+.+|++++.++. ||||+++++++..
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS-SEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh-hHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 34456888899999999999999863 3468999999754322 33457889999999997 9999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHhhcCCc-------------------------------------------------------
Q 035761 385 EKCMFLIYEYMEMGSLFCILRTDEE------------------------------------------------------- 409 (560)
Q Consensus 385 ~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------- 409 (560)
++..++||||+++|+|.++++..+.
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 9999999999999999999975321
Q ss_pred ----------------------------------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCC
Q 035761 410 ----------------------------------------AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNN 449 (560)
Q Consensus 410 ----------------------------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~N 449 (560)
...+++.++..++.|++.||+|||+. +++||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcce
Confidence 12378888999999999999999998 99999999999
Q ss_pred eEeCCCCcEEEeeeccccccCCCCC--CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc-
Q 035761 450 ILLNSEFEAFVADFGIARLLNYDSS--NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS- 525 (560)
Q Consensus 450 ill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~- 525 (560)
|++++++.+||+|||+++....... ......++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 9999999999999999986532221 1122346788999999998889999999999999999998 89998643211
Q ss_pred ------------------ccccccccccccccCCCCCCChhHHHhh
Q 035761 526 ------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 526 ------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
...+.++++.|...+|..||++++++..
T Consensus 350 ~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 350 QFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 1233456677777788888888888764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=285.54 Aligned_cols=227 Identities=26% Similarity=0.386 Sum_probs=185.4
Q ss_pred ceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEeccCCCC
Q 035761 321 YCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGS 399 (560)
Q Consensus 321 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 399 (560)
+.||+|+||.||+|... +++.||+|.+..... ......+.+|++++++++||||+++++++......++||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLP-PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 35899999999999864 688999998764322 2334578899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCc--e
Q 035761 400 LFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNR--T 477 (560)
Q Consensus 400 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~ 477 (560)
|.+++.... ..+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||.+.......... .
T Consensus 80 L~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 80 FLTFLRTEG--PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 999997543 2389999999999999999999999 99999999999999999999999999987643211111 1
Q ss_pred eeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------------ccccccccccccc
Q 035761 478 LLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------------SSSLDKNIKLIDL 538 (560)
Q Consensus 478 ~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------------~~~~~~~~~~~~~ 538 (560)
....+..|+|||.+.+..++.++||||||+++|||++ |..||...... ...+.+.++.|..
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 234 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWE 234 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcC
Confidence 1123457999999998889999999999999999998 99998643321 1223445567778
Q ss_pred cCCCCCCChhHHHhh
Q 035761 539 LDPRLPPPGDQMIRQ 553 (560)
Q Consensus 539 ~dp~~~p~~~~~~~~ 553 (560)
.+|..||+++++.+.
T Consensus 235 ~~p~~Rps~~~~~~~ 249 (252)
T cd05084 235 YDPGQRPSFSTVHQE 249 (252)
T ss_pred CChhhCcCHHHHHHH
Confidence 899999999888764
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=289.17 Aligned_cols=232 Identities=23% Similarity=0.356 Sum_probs=185.8
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCc----EEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGK----VVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMF 389 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 389 (560)
++|+..+.||+|+||.||+|.+. +++ .+++|.+..... ......+..|+..+++++||||+++++++.. ...+
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~ 84 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSG-RQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ 84 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccc-hHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence 46788899999999999999864 344 477787753322 2334567788889999999999999998854 4578
Q ss_pred EEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccccc
Q 035761 390 LIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL 469 (560)
Q Consensus 390 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 469 (560)
+++||+++|+|.+++..... .+++..+..++.||+.||+|||+. +++||||||+||++++++.+||+|||.++..
T Consensus 85 ~i~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHRD--SLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEEeCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 89999999999999975432 389999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCC--CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccccc------------------cc
Q 035761 470 NYDSS--NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSS------------------SS 528 (560)
Q Consensus 470 ~~~~~--~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~~------------------~~ 528 (560)
..... ......++..|+|||.+.+..++.++||||||+++||+++ |+.||....... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTID 239 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHH
Confidence 43221 1223346778999999998899999999999999999998 999996543210 11
Q ss_pred cccccccccccCCCCCCChhHHHhh
Q 035761 529 LDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 529 ~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
+...+..|...+|..||++.+++..
T Consensus 240 ~~~li~~c~~~~p~~Rps~~el~~~ 264 (279)
T cd05111 240 VYMVMVKCWMIDENVRPTFKELANE 264 (279)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHH
Confidence 2234456777899999999998764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=285.53 Aligned_cols=224 Identities=21% Similarity=0.334 Sum_probs=179.4
Q ss_pred eeccCCeeEEEEEeC---CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEeccCCCC
Q 035761 323 IGTGGYGSVYRARLP---SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGS 399 (560)
Q Consensus 323 ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 399 (560)
||+|+||.||+|.+. .+..||+|.+..... ....+.+.+|+.++++++||||+++++++.. ...++||||+++|+
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE-KSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccC-hHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 899999999999764 355799999875432 2344678899999999999999999998854 56899999999999
Q ss_pred HHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCce--
Q 035761 400 LFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRT-- 477 (560)
Q Consensus 400 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-- 477 (560)
|.+++.... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++...........
T Consensus 81 L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 999987533 2389999999999999999999999 999999999999999999999999999986543322211
Q ss_pred -eeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------------cccccccccccc
Q 035761 478 -LLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------------SSSLDKNIKLID 537 (560)
Q Consensus 478 -~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------------~~~~~~~~~~~~ 537 (560)
...++..|+|||.+....++.++||||||+++||+++ |..||...... ...+.+.+..|.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~ 235 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCW 235 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHc
Confidence 1223568999999988889999999999999999996 99999754321 123344556666
Q ss_pred ccCCCCCCChhHHHhh
Q 035761 538 LLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 538 ~~dp~~~p~~~~~~~~ 553 (560)
..+|+.||++.++.+.
T Consensus 236 ~~~~~~Rp~~~~i~~~ 251 (257)
T cd05115 236 IYKWEDRPNFAKVEER 251 (257)
T ss_pred CCChhhCcCHHHHHHH
Confidence 6677777777776543
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=291.20 Aligned_cols=239 Identities=28% Similarity=0.422 Sum_probs=204.2
Q ss_pred HhcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEE
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLI 391 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 391 (560)
.++.|+..+.+|+|++|.||+|..+ +++.+++|++..... ..+.+.+|+++++.++|+|++++++++..+...++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 3456788889999999999999876 688999999875432 345688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 471 (560)
+||+++++|.+++.... ..+++.++..++.|++.||+|||+. |++|+|++|+||+++.++.++|+|||.+.....
T Consensus 94 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 94 MEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred EeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 99999999999998754 2489999999999999999999998 999999999999999999999999999876543
Q ss_pred CCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc--------------------ccccccc
Q 035761 472 DSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS--------------------SSSSLDK 531 (560)
Q Consensus 472 ~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~--------------------~~~~~~~ 531 (560)
.........++..|+|||.+.+..++.++||||||+++|||++|+.||..... ....+.+
T Consensus 169 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 248 (286)
T cd06614 169 EKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKD 248 (286)
T ss_pred chhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHH
Confidence 33333334578899999999888899999999999999999999999864332 1122455
Q ss_pred ccccccccCCCCCCChhHHHhhceeeec
Q 035761 532 NIKLIDLLDPRLPPPGDQMIRQGIILIS 559 (560)
Q Consensus 532 ~~~~~~~~dp~~~p~~~~~~~~~~~~~~ 559 (560)
.++.|...+|..||++.+++.+.|+..+
T Consensus 249 li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 249 FLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred HHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 6677888899999999999999998763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=291.28 Aligned_cols=236 Identities=27% Similarity=0.358 Sum_probs=197.5
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
++|++.+.||+|+||.||++... +++.||+|++..... ....+.+.+|+++++.++||||+++++++......++|||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK-SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc-chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 45778889999999999999764 588999998765432 2334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++++|.+++.... .+++..+..++.|++.|+.|||+.. +++||||+|+||++++++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 84 FMDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS- 157 (284)
T ss_pred cCCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence 999999999987643 3899999999999999999999731 8999999999999999999999999998764321
Q ss_pred CCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc----------------------------
Q 035761 474 SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS---------------------------- 525 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~---------------------------- 525 (560)
......|+..|+|||++.+..++.++|+|||||++||+++|+.||......
T Consensus 158 -~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd06620 158 -IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSS 236 (284)
T ss_pred -ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCch
Confidence 122346889999999998888999999999999999999999999743321
Q ss_pred --ccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 526 --SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 526 --~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
...+.+.++.|...||..||++++++++.|+..
T Consensus 237 ~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 237 DFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred hcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 012344567778889999999999999987653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=290.33 Aligned_cols=233 Identities=25% Similarity=0.401 Sum_probs=189.9
Q ss_pred cCCcccceeeccCCeeEEEEEeC------CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCM 388 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 388 (560)
.+|.+.+.||+|+||.||++... ++..+|+|.+.... ....+.+.+|++++++++||||+++++++...+..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 46888899999999999999742 34568999887543 23345788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCC----------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcE
Q 035761 389 FLIYEYMEMGSLFCILRTDE----------EAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEA 458 (560)
Q Consensus 389 ~lv~e~~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 458 (560)
++||||+++++|.+++.... ....+++.++..++.|++.||+|||+. +++||||||+||++++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence 99999999999999987532 123489999999999999999999998 99999999999999999999
Q ss_pred EEeeeccccccCCCCCC--ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc-----------
Q 035761 459 FVADFGIARLLNYDSSN--RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS----------- 524 (560)
Q Consensus 459 kl~Dfg~~~~~~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~----------- 524 (560)
+|+|||+++........ .....++..|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~ 239 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 239 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999999865432211 122335678999999998899999999999999999998 9999864432
Q ss_pred -------cccccccccccccccCCCCCCChhHHHh
Q 035761 525 -------SSSSLDKNIKLIDLLDPRLPPPGDQMIR 552 (560)
Q Consensus 525 -------~~~~~~~~~~~~~~~dp~~~p~~~~~~~ 552 (560)
....+.+++..|...+|..||+++++..
T Consensus 240 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 240 VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 1123445556677778888888887754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=292.18 Aligned_cols=245 Identities=27% Similarity=0.383 Sum_probs=197.9
Q ss_pred HHHHHHHhcCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEe
Q 035761 307 FQDMIEATEDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLH 384 (560)
Q Consensus 307 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 384 (560)
+.++..+.++|++.+.||+|+||.||+|.. .+++.+|+|.+..... ....+.+|+.+++++ +|||++++++++..
T Consensus 14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD---VDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc---HHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 344455678899999999999999999986 4688999999865322 234567889999988 89999999999875
Q ss_pred C-----CEEEEEEeccCCCCHHHHhhcCC-cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcE
Q 035761 385 E-----KCMFLIYEYMEMGSLFCILRTDE-EAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEA 458 (560)
Q Consensus 385 ~-----~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 458 (560)
. ...++||||+++|+|.++++... ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCE
Confidence 4 35899999999999999886421 123489999999999999999999998 99999999999999999999
Q ss_pred EEeeeccccccCCCCCCceeeccccCccCccccccC-----ccCcchhHHHHHHHHHHHHhCCCCCCcccccc-------
Q 035761 459 FVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTM-----VVTEKYDVYSFGVVALEVLMGKHPGELLSSSS------- 526 (560)
Q Consensus 459 kl~Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-----~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~------- 526 (560)
+|+|||++..............|+..|+|||.+... .++.++|||||||++|||++|+.||.......
T Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~ 247 (291)
T cd06639 168 KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR 247 (291)
T ss_pred EEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc
Confidence 999999998765433333345688899999987543 36789999999999999999999986543210
Q ss_pred -------------cccccccccccccCCCCCCChhHHHhhceee
Q 035761 527 -------------SSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 527 -------------~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
..+...+..|...+|..||++.+++.|+|+.
T Consensus 248 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 248 NPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 1123456667778999999999999999973
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=286.07 Aligned_cols=230 Identities=29% Similarity=0.428 Sum_probs=189.1
Q ss_pred cCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
++|++.+.||+|+||.||+|..+++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. +...+++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 46888899999999999999988888999999875432 2346889999999999999999999885 4567899999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
+++++|.++++... ...+++.++..++.|++.|++|||+. +++||||||+||++++++.++|+|||.+........
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 82 MSKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 99999999997543 23489999999999999999999999 999999999999999999999999999987643221
Q ss_pred Cc-eeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------------ccccccccc
Q 035761 475 NR-TLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------------SSSLDKNIK 534 (560)
Q Consensus 475 ~~-~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------------~~~~~~~~~ 534 (560)
.. ....++..|+|||...+..++.++|+||||+++|||++ |+.||...... ...+.+.++
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELML 237 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHH
Confidence 11 12235668999999988889999999999999999999 99998654321 122345556
Q ss_pred cccccCCCCCCChhHHHh
Q 035761 535 LIDLLDPRLPPPGDQMIR 552 (560)
Q Consensus 535 ~~~~~dp~~~p~~~~~~~ 552 (560)
.|...+|+.||+++++..
T Consensus 238 ~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 238 QCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHcccCcccCcCHHHHHH
Confidence 677778888888887754
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=288.08 Aligned_cols=235 Identities=26% Similarity=0.380 Sum_probs=198.3
Q ss_pred CCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 316 DFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
.|...+.||+|++|.||++.. .+++.+++|++.... ....+.+.+|+.+++.++||||+++++++...+..++|+||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 345557899999999999985 468899999886432 22345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
+++++|.+++... .+++.++..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||.+........
T Consensus 98 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 98 LEGGALTDIVTHT----RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred cCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence 9999999998762 289999999999999999999999 999999999999999999999999998876543333
Q ss_pred CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc--------------------cccccccccc
Q 035761 475 NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS--------------------SSSSLDKNIK 534 (560)
Q Consensus 475 ~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~--------------------~~~~~~~~~~ 534 (560)
......|++.|+|||...+..++.++||||||+++|||++|+.||..... ....+...++
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 250 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLD 250 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHH
Confidence 33345688999999999888899999999999999999999999854321 1123456667
Q ss_pred cccccCCCCCCChhHHHhhceeeec
Q 035761 535 LIDLLDPRLPPPGDQMIRQGIILIS 559 (560)
Q Consensus 535 ~~~~~dp~~~p~~~~~~~~~~~~~~ 559 (560)
.|...+|+.||++.++++++|+.++
T Consensus 251 ~~l~~~p~~Rpt~~~il~~~~~~~~ 275 (285)
T cd06648 251 RMLVRDPAQRATAAELLNHPFLAKA 275 (285)
T ss_pred HHcccChhhCcCHHHHccCcccccC
Confidence 7788899999999999999998765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=288.86 Aligned_cols=232 Identities=23% Similarity=0.388 Sum_probs=188.6
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCc----EEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGK----VVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMF 389 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 389 (560)
++|+..+.||+|+||.||+|.+. +++ .||+|.+..... ....+.+.+|+.+++.++||||+++++++... ..+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS-PKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC-HHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 56888899999999999999753 444 489998865332 23345788999999999999999999999754 467
Q ss_pred EEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccccc
Q 035761 390 LIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL 469 (560)
Q Consensus 390 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 469 (560)
+++||+++|+|.++++.... .+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++..
T Consensus 85 l~~~~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKD--RIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeec
Confidence 99999999999999976432 389999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCc--eeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------------ccc
Q 035761 470 NYDSSNR--TLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------------SSS 528 (560)
Q Consensus 470 ~~~~~~~--~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------------~~~ 528 (560)
....... ....++..|+|||...+..++.++||||||+++|||++ |..||...... ...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTID 239 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHH
Confidence 4322211 11234678999999998899999999999999999998 99998643311 112
Q ss_pred cccccccccccCCCCCCChhHHHhh
Q 035761 529 LDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 529 ~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
+...+..|...||..||++.+++..
T Consensus 240 ~~~li~~~l~~dp~~Rp~~~~l~~~ 264 (279)
T cd05109 240 VYMIMVKCWMIDSECRPRFRELVDE 264 (279)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3345567788899999999998854
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=286.67 Aligned_cols=232 Identities=27% Similarity=0.400 Sum_probs=189.5
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
.+|++.+.||+|+||.||+|..+ .++.||+|.+.... .....+.+|+++++.++||||+++++++..++..+++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 45788899999999999999865 48899999987432 234578899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++++|.+++.... ...+++..+..++.|+++||+|||+. +++||||||+||++++++.+||+|||++.......
T Consensus 83 ~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 83 FMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred eCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 999999999987543 23489999999999999999999998 99999999999999999999999999998764322
Q ss_pred CCc-eeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------------cccccccc
Q 035761 474 SNR-TLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------------SSSLDKNI 533 (560)
Q Consensus 474 ~~~-~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------------~~~~~~~~ 533 (560)
... ....++..|+|||.+.+..++.++||||||+++|||++ |..||...... ...+.+.+
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (263)
T cd05052 159 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELM 238 (263)
T ss_pred eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHH
Confidence 111 11224568999999998999999999999999999998 99998643211 11233455
Q ss_pred ccccccCCCCCCChhHHHhh
Q 035761 534 KLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 534 ~~~~~~dp~~~p~~~~~~~~ 553 (560)
..|...||+-||++.++++.
T Consensus 239 ~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 239 RACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred HHHccCCcccCCCHHHHHHH
Confidence 55666788888888877654
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=290.35 Aligned_cols=239 Identities=21% Similarity=0.351 Sum_probs=190.4
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHH-HhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARL-LSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|++.+.||+|+||.||+|..+ +|+.||+|+++........ ..+..|... ++..+|||++++++++..++..++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHH-HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 36888899999999999999875 5899999998754322222 344455554 66679999999999999999999999
Q ss_pred eccCCCCHHHHhhcC-CcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC
Q 035761 393 EYMEMGSLFCILRTD-EEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471 (560)
Q Consensus 393 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 471 (560)
||++ |+|.+++... .....+++..+..++.||+.|++|||++. +++||||||+||+++.++.+||+|||.+..+..
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9997 6888777542 22345899999999999999999999742 799999999999999999999999999987542
Q ss_pred CCCCceeeccccCccCcccccc----CccCcchhHHHHHHHHHHHHhCCCCCCccccc--------------------cc
Q 035761 472 DSSNRTLLAGTYGSIAPELAYT----MVVTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------------SS 527 (560)
Q Consensus 472 ~~~~~~~~~g~~~~~aPE~~~~----~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------------~~ 527 (560)
. .......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||...... ..
T Consensus 157 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd06617 157 S-VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSP 235 (283)
T ss_pred c-cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCH
Confidence 2 22233457889999998765 44678999999999999999999999643211 12
Q ss_pred ccccccccccccCCCCCCChhHHHhhceeee
Q 035761 528 SLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 528 ~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
.+...+..|...+|..||++++++.+.|+..
T Consensus 236 ~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 266 (283)
T cd06617 236 EFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266 (283)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCchhhh
Confidence 2344556677889999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=291.53 Aligned_cols=235 Identities=26% Similarity=0.376 Sum_probs=192.5
Q ss_pred hcCCcccceeeccCCeeEEEEEeC------CCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCC
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEK 386 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 386 (560)
.++|.+.+.||+|+||.||+|... .+..||||.++.... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 356888999999999999999641 345799999875432 23346788999999999 7999999999999999
Q ss_pred EEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccc
Q 035761 387 CMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIA 466 (560)
Q Consensus 387 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~ 466 (560)
..++||||+++|+|.++++.... ..+++.++..++.|++.|++|||+. +++|+||||+||+++.++.++++|||++
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccc
Confidence 99999999999999999975432 2389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCC--ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------------
Q 035761 467 RLLNYDSSN--RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------------ 525 (560)
Q Consensus 467 ~~~~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------------ 525 (560)
+........ .....++..|+|||.+.+..++.++||||+||++|||++ |+.||......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEH 268 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCC
Confidence 865432211 112235678999999999999999999999999999998 99998643311
Q ss_pred -ccccccccccccccCCCCCCChhHHHhh
Q 035761 526 -SSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 526 -~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
...+.+.+..|...+|+-||+++++++.
T Consensus 269 ~~~~~~~li~~cl~~~p~~Rpt~~ell~~ 297 (302)
T cd05055 269 APAEIYDIMKTCWDADPLKRPTFKQIVQL 297 (302)
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 1223455667777889999999988764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=293.80 Aligned_cols=239 Identities=28% Similarity=0.357 Sum_probs=194.1
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC--CEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHE--KCMFL 390 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 390 (560)
.++|+..+.||+|+||.||+|..+ +|+.||+|.++...........+.+|+.++++++|+|++++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 357889999999999999999864 589999999875432222233456899999999999999999998765 46899
Q ss_pred EEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccC
Q 035761 391 IYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN 470 (560)
Q Consensus 391 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 470 (560)
||||+++ +|.+++.... ..+++.++..++.||++|++|||+. +++||||||+||++++++.+||+|||.+....
T Consensus 86 v~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999975 8888887543 3489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCccccc------------------------
Q 035761 471 YDSSNRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSSS------------------------ 525 (560)
Q Consensus 471 ~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~------------------------ 525 (560)
..........++..|+|||.+.+ ..++.++||||+|+++|||++|+.||...+..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07845 160 LPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL 239 (309)
T ss_pred CccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence 43333333345788999998865 45788999999999999999999998633210
Q ss_pred -----------------------ccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 526 -----------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 526 -----------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
.......++.|...||+.||+++++++|.|+.-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~ 295 (309)
T cd07845 240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295 (309)
T ss_pred cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 111123456677889999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=286.49 Aligned_cols=233 Identities=30% Similarity=0.415 Sum_probs=190.2
Q ss_pred cCCcccceeeccCCeeEEEEEeC----CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP----SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFL 390 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 390 (560)
.+|++.+.||+|+||.||+|... .+..+|+|.++..... ...+.+.+|+.++++++||||+++++++..++..++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTE-KQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46788899999999999999763 2347999988654322 334678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccC
Q 035761 391 IYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN 470 (560)
Q Consensus 391 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 470 (560)
||||+++++|.+++..... .+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||++....
T Consensus 83 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDG--QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 9999999999999976432 389999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCCce---eeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------------ccc
Q 035761 471 YDSSNRT---LLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------------SSS 528 (560)
Q Consensus 471 ~~~~~~~---~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------------~~~ 528 (560)
....... ...++..|+|||.+.+..++.++|+||||+++||+++ |+.||...... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAA 237 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHH
Confidence 3322111 1123567999999998889999999999999999987 99998644321 113
Q ss_pred cccccccccccCCCCCCChhHHHhh
Q 035761 529 LDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 529 ~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
+.+.+..|...+|..||++.++++.
T Consensus 238 ~~~li~~~l~~~p~~Rp~~~~i~~~ 262 (267)
T cd05066 238 LHQLMLDCWQKDRNERPKFEQIVSI 262 (267)
T ss_pred HHHHHHHHcccCchhCCCHHHHHHH
Confidence 3455566677788888888887754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=290.65 Aligned_cols=239 Identities=23% Similarity=0.303 Sum_probs=193.3
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
++|+..+.||+|++|.||+|..+ +++.||+|.+..........+.+.+|++++++++||||+++++++..+...++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888999999999999999865 68899999986543322334568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCC-CCcEEEeeeccccccCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNS-EFEAFVADFGIARLLNYD 472 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~~~~~~~~ 472 (560)
|++ +++.+++..... ..+++..+..++.||+.||+|||+. +++||||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 588887765332 2367888889999999999999999 9999999999999985 567899999999765433
Q ss_pred CCCceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------------
Q 035761 473 SSNRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSS--------------------------- 524 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~--------------------------- 524 (560)
........+++.|+|||.+.+ ..++.++||||+|+++|||++|+.||.....
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 222233457889999998766 4578899999999999999999999963321
Q ss_pred -------------------cccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 525 -------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 525 -------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
.+..+.+.+..|...+|+.||+..+++++.|+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~ 289 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence 0112234555677789999999999999999764
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=286.78 Aligned_cols=235 Identities=26% Similarity=0.382 Sum_probs=192.5
Q ss_pred CCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhh--------hhhHHHHHHHHHHHhccCCCCcceeeeEEEeCC
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETE--------LASLESFQNEARLLSQIRHRNIVKLYGFCLHEK 386 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 386 (560)
+|...+.||.|+||.||+|... +|+.||+|.++..... ....+.+.+|+++++.++|||++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 3667788999999999999754 6889999987542211 112346788999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccc
Q 035761 387 CMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIA 466 (560)
Q Consensus 387 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~ 466 (560)
..++||||+++|+|.++++... .+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++++|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccc
Confidence 9999999999999999997653 389999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCC--CceeeccccCccCccccccCc--cCcchhHHHHHHHHHHHHhCCCCCCccccc-----------------
Q 035761 467 RLLNYDSS--NRTLLAGTYGSIAPELAYTMV--VTEKYDVYSFGVVALEVLMGKHPGELLSSS----------------- 525 (560)
Q Consensus 467 ~~~~~~~~--~~~~~~g~~~~~aPE~~~~~~--~~~~~Dv~s~G~il~el~~g~~P~~~~~~~----------------- 525 (560)
+....... ......++..|+|||.+.... ++.++||||||+++||+++|+.||......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPP 235 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCc
Confidence 76532211 122345788999999987654 788999999999999999999998643210
Q ss_pred ------ccccccccccccccCCCCCCChhHHHhhcee
Q 035761 526 ------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 526 ------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
...+.+.+..|...||..||+++++++|+|+
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 236 DVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 1123334455677899999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=289.56 Aligned_cols=234 Identities=27% Similarity=0.411 Sum_probs=190.2
Q ss_pred cCCcccceeeccCCeeEEEEEeC------CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCM 388 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 388 (560)
.+|.+.+.||+|+||.||+|... ++..+++|.+.... ....+.+.+|++++++++||||+++++++...+..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 45778889999999999999742 34568899886433 23345788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCCc-------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCC
Q 035761 389 FLIYEYMEMGSLFCILRTDEE-------------AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSE 455 (560)
Q Consensus 389 ~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~ 455 (560)
++||||+++++|.+++..... ...+++.++..++.||+.|++|||+. +++||||||+||+++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGAN 159 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC
Confidence 999999999999999975421 23489999999999999999999999 99999999999999999
Q ss_pred CcEEEeeeccccccCCCCCC--ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc-------
Q 035761 456 FEAFVADFGIARLLNYDSSN--RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------- 525 (560)
Q Consensus 456 ~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------- 525 (560)
+.++|+|||++......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 239 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 239 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence 99999999999765432211 122345778999999999999999999999999999999 99998543321
Q ss_pred -----------ccccccccccccccCCCCCCChhHHHhh
Q 035761 526 -----------SSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 526 -----------~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
...+.+.+..|...||..||++++++..
T Consensus 240 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~ 278 (291)
T cd05094 240 QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKI 278 (291)
T ss_pred CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 1123445566677788888888887654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=289.13 Aligned_cols=235 Identities=25% Similarity=0.335 Sum_probs=193.5
Q ss_pred CcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEecc
Q 035761 317 FDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYM 395 (560)
Q Consensus 317 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 395 (560)
|+..+.||.|++|.||+|... +|+.||+|++............+.+|+++++.++|||++++++++..++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566788999999999999764 6899999998754433333456788999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCC
Q 035761 396 EMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSN 475 (560)
Q Consensus 396 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 475 (560)
+ ++|.+++..... ..+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 5 689999876542 3489999999999999999999998 9999999999999999999999999999765433222
Q ss_pred ceeeccccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCCCCCccccc-----------------------------
Q 035761 476 RTLLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKHPGELLSSS----------------------------- 525 (560)
Q Consensus 476 ~~~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~----------------------------- 525 (560)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||...+..
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP 235 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence 2333568899999987654 5688999999999999999999998633210
Q ss_pred -----------------ccccccccccccccCCCCCCChhHHHhhcee
Q 035761 526 -----------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 526 -----------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
...+.+.+..|...||..||+.++++.+.|+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0123345567888899999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=294.09 Aligned_cols=234 Identities=26% Similarity=0.419 Sum_probs=189.3
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCc--EEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGK--VVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKCMFL 390 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 390 (560)
++|++.+.||+|+||.||+|.++ ++. .+++|.++... .....+.+.+|++++.++ +||||+++++++..++..++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC-CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 46888899999999999999864 344 46777776432 223446788999999999 89999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCc-------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCc
Q 035761 391 IYEYMEMGSLFCILRTDEE-------------AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFE 457 (560)
Q Consensus 391 v~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~ 457 (560)
||||+++|+|.++++.... ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence 9999999999999975421 12488999999999999999999998 9999999999999999999
Q ss_pred EEEeeeccccccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc------------
Q 035761 458 AFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS------------ 524 (560)
Q Consensus 458 ~kl~Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~------------ 524 (560)
+||+|||++...... .......++..|+|||.+.+..++.++||||||+++|||+| |..||.....
T Consensus 163 ~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~ 241 (303)
T cd05088 163 AKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 241 (303)
T ss_pred EEeCccccCcccchh-hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCc
Confidence 999999998643211 11111234567999999988889999999999999999998 9999864321
Q ss_pred ------cccccccccccccccCCCCCCChhHHHhh
Q 035761 525 ------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 525 ------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
....+.+.+..|...+|+-||+++++++.
T Consensus 242 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 242 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11233456677788899999999998875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=290.18 Aligned_cols=234 Identities=25% Similarity=0.399 Sum_probs=190.6
Q ss_pred CCcccceeeccCCeeEEEEEeC------CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEE
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMF 389 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 389 (560)
+|++.+.||+|+||.||+|... ....+++|.+...... ...+.+.+|+.+++.++||||+++++.+..++..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASS-SELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 4677889999999999999753 2357888888654322 33467889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCC---------------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 035761 390 LIYEYMEMGSLFCILRTDE---------------------EAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSN 448 (560)
Q Consensus 390 lv~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~ 448 (560)
+++||+++|+|.+++.... ....+++.++..++.|++.|++|||+. +++||||||+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~ 156 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAAR 156 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhh
Confidence 9999999999999986421 113488999999999999999999998 9999999999
Q ss_pred CeEeCCCCcEEEeeeccccccCCCCCC--ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc-
Q 035761 449 NILLNSEFEAFVADFGIARLLNYDSSN--RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS- 524 (560)
Q Consensus 449 Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~- 524 (560)
||++++++.++|+|||+++........ .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 999999999999999999865332221 122335678999999988889999999999999999998 9999864321
Q ss_pred -----------------cccccccccccccccCCCCCCChhHHHhh
Q 035761 525 -----------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 525 -----------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
....+.+.+..|...+|..||++++++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~ 282 (290)
T cd05045 237 RLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKE 282 (290)
T ss_pred HHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 11234456677788899999999988764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=286.02 Aligned_cols=235 Identities=27% Similarity=0.421 Sum_probs=195.1
Q ss_pred CCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhh----hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEE
Q 035761 316 DFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLET----ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFL 390 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 390 (560)
+|+..+.||+|++|.||+|.. .+++.||+|.+..... .....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 367778899999999999975 5689999999864331 12234678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCC-cEEEeeecccccc
Q 035761 391 IYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEF-EAFVADFGIARLL 469 (560)
Q Consensus 391 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~~~~~ 469 (560)
||||+++++|.+++.... .+++..+..++.|++.|++|||+. +++||||+|+||+++.++ .++|+|||.+..+
T Consensus 81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 999999999999997643 389999999999999999999999 999999999999998776 5899999999876
Q ss_pred CCCCC----CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc--------------------
Q 035761 470 NYDSS----NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS-------------------- 525 (560)
Q Consensus 470 ~~~~~----~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~-------------------- 525 (560)
..... ......++..|+|||.+.+..++.++||||+|+++||+++|+.||......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPE 234 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCch
Confidence 43211 122345788999999998888999999999999999999999999643311
Q ss_pred --ccccccccccccccCCCCCCChhHHHhhcee
Q 035761 526 --SSSLDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 526 --~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
...+.+.+..|...+|..||++.+++.++|+
T Consensus 235 ~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~ 267 (268)
T cd06630 235 HLSPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267 (268)
T ss_pred hhCHHHHHHHHHHcCCCcccCcCHHHHhcCccc
Confidence 1122334456677899999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=302.22 Aligned_cols=237 Identities=23% Similarity=0.323 Sum_probs=190.6
Q ss_pred CCcccceeeccCCeeEEEEEeC--CCc--EEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEE
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP--SGK--VVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLI 391 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 391 (560)
+..+.+.||+|.||.|++|.|. +|+ .||||.++..... .....|.+|+.+|.+++|||++++||+..+ ....||
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~-~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN-AIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc-hhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 3455678999999999999875 343 5899999865533 256789999999999999999999999987 678899
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 471 (560)
||.++.|+|.+.|+. .....|-......++.|||.||.||..+ ++|||||.++|+++.....+||+|||+.+.+..
T Consensus 189 ~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 999999999999988 3344588899999999999999999999 999999999999999999999999999998865
Q ss_pred CCCCcee---eccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccccccccccc-cccccccCCCCCCC
Q 035761 472 DSSNRTL---LAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSSSSLDKN-IKLIDLLDPRLPPP 546 (560)
Q Consensus 472 ~~~~~~~---~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~~~~~~~~-~~~~~~~dp~~~p~ 546 (560)
....+.. ..-.+.|+|||.+....++.++|||+|||.+|||+| |..||......... ..+ .+......+.++.+
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL-~~iD~~erLpRPk~csed 343 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQIL-KNIDAGERLPRPKYCSED 343 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHH-HhccccccCCCCCCChHH
Confidence 4444322 224568999999999999999999999999999999 99999755432211 111 12222334556666
Q ss_pred hhHHHhhceeeec
Q 035761 547 GDQMIRQGIILIS 559 (560)
Q Consensus 547 ~~~~~~~~~~~~~ 559 (560)
+-+|+.+||..|+
T Consensus 344 IY~imk~cWah~p 356 (1039)
T KOG0199|consen 344 IYQIMKNCWAHNP 356 (1039)
T ss_pred HHHHHHHhccCCc
Confidence 7777777776654
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=288.02 Aligned_cols=236 Identities=22% Similarity=0.322 Sum_probs=192.8
Q ss_pred hcCCcccceeeccCCeeEEEEEeCC-----CcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEe-CCE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLPS-----GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLH-EKC 387 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~ 387 (560)
.++|++.+.||+|+||.||+|.+.+ +..|++|++.... .....+.+.+|+.++++++||||+++++++.. ...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 4578889999999999999998765 6889999886433 23445678899999999999999999999876 467
Q ss_pred EEEEEeccCCCCHHHHhhcCCcc-----cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEee
Q 035761 388 MFLIYEYMEMGSLFCILRTDEEA-----VGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVAD 462 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~~-----~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 462 (560)
.++++||+++|+|.+++...... ..+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998764322 4589999999999999999999998 999999999999999999999999
Q ss_pred eccccccCCCCCCc--eeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc---------------
Q 035761 463 FGIARLLNYDSSNR--TLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS--------------- 524 (560)
Q Consensus 463 fg~~~~~~~~~~~~--~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~--------------- 524 (560)
||+++.+....... ....++..|+|||++.+..++.++||||||+++||+++ |+.||.....
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 240 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQ 240 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCC
Confidence 99998654322111 11235668999999998889999999999999999999 9999964321
Q ss_pred ---cccccccccccccccCCCCCCChhHHHhh
Q 035761 525 ---SSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 525 ---~~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
....+.+.+..|...||+.||++.++++.
T Consensus 241 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~ 272 (280)
T cd05043 241 PINCPDELFAVMACCWALDPEERPSFSQLVQC 272 (280)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 01224455566777789999998888764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=291.71 Aligned_cols=236 Identities=25% Similarity=0.368 Sum_probs=189.8
Q ss_pred hcCCcccceeeccCCeeEEEEEeC--------CCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEe
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP--------SGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLH 384 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 384 (560)
.++|.+.+.||+|+||.||+|... ++..+|+|.++.... ......+.+|+++++.+ +||||+++++++..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC-hHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 356889999999999999999752 235799999875432 23345688899999999 79999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHhhcCCc-------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeE
Q 035761 385 EKCMFLIYEYMEMGSLFCILRTDEE-------------AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNIL 451 (560)
Q Consensus 385 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nil 451 (560)
.+..++||||+++|+|.+++..... ...+++.+++.++.|++.||+|||+. +++||||||+||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nil 172 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 172 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheE
Confidence 9999999999999999999976421 13489999999999999999999998 9999999999999
Q ss_pred eCCCCcEEEeeeccccccCCCCCCc--eeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc----
Q 035761 452 LNSEFEAFVADFGIARLLNYDSSNR--TLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS---- 524 (560)
Q Consensus 452 l~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~---- 524 (560)
++.++.++|+|||.++......... ....+++.|+|||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~ 252 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 252 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence 9999999999999987654221111 11224468999999999889999999999999999998 8888853321
Q ss_pred --------------cccccccccccccccCCCCCCChhHHHhh
Q 035761 525 --------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 525 --------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
....+.+.+..|...+|+.||++.+++..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 253 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 11223445566667788888888888765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=283.67 Aligned_cols=229 Identities=29% Similarity=0.468 Sum_probs=191.9
Q ss_pred ceeeccCCeeEEEEEeCC----CcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEeccC
Q 035761 321 YCIGTGGYGSVYRARLPS----GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYME 396 (560)
Q Consensus 321 ~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 396 (560)
+.||+|+||.||+|.... +..|++|.++...... ..+.+.+|+++++.++|+|++++++++......++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 358999999999998754 7889999987655432 45678899999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCc------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccC
Q 035761 397 MGSLFCILRTDEE------AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN 470 (560)
Q Consensus 397 ~g~L~~~l~~~~~------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 470 (560)
+++|.+++..... ...+++.++..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||.+....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccccccc
Confidence 9999999986521 24489999999999999999999998 99999999999999999999999999998765
Q ss_pred CCC--CCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc------------------ccccc
Q 035761 471 YDS--SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS------------------SSSSL 529 (560)
Q Consensus 471 ~~~--~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~------------------~~~~~ 529 (560)
... .......++..|+|||.+....++.++||||+|+++|||++ |+.||..... ....+
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDEL 236 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHH
Confidence 432 11223457889999999988889999999999999999999 6999975432 11234
Q ss_pred ccccccccccCCCCCCChhHHHhh
Q 035761 530 DKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 530 ~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
...++.|...+|+.||++.+++.+
T Consensus 237 ~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 237 YELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHHHccCCcccCcCHHHHHHh
Confidence 455566777889999999888764
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=292.53 Aligned_cols=236 Identities=26% Similarity=0.391 Sum_probs=193.1
Q ss_pred hcCCcccceeeccCCeeEEEEEeCC------CcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCC
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLPS------GKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEK 386 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 386 (560)
.++|+..+.||+|+||.||++.... ...+|+|.+..... ......+.+|+++++++ +|+||+++++++..++
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 4568889999999999999997642 36799998875432 23345688999999999 8999999999999999
Q ss_pred EEEEEEeccCCCCHHHHhhcC-------------CcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeC
Q 035761 387 CMFLIYEYMEMGSLFCILRTD-------------EEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLN 453 (560)
Q Consensus 387 ~~~lv~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~ 453 (560)
..+++|||+++|+|.++++.. .....+++..++.++.|++.|++|||+. +++||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEc
Confidence 999999999999999998642 1234589999999999999999999998 999999999999999
Q ss_pred CCCcEEEeeeccccccCCCCCCc--eeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc-----
Q 035761 454 SEFEAFVADFGIARLLNYDSSNR--TLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS----- 525 (560)
Q Consensus 454 ~~~~~kl~Dfg~~~~~~~~~~~~--~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~----- 525 (560)
+++.+||+|||+++.+....... ....++..|+|||+..+..++.++|||||||++||+++ |..||......
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 246 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 99999999999998764322111 11234568999999988899999999999999999998 99998643311
Q ss_pred -------------ccccccccccccccCCCCCCChhHHHhh
Q 035761 526 -------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 526 -------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
...+.+.+..|...||+.||++.+++.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 247 LKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 1233445566777799999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=283.13 Aligned_cols=228 Identities=27% Similarity=0.431 Sum_probs=192.1
Q ss_pred cCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
++|++.+.||+|+||.||+|... |+.||+|.+..... ..+.+.+|+.+++.++|+||+++++++......++||||
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 56888999999999999999875 78999999976443 456788999999999999999999999988899999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
+++++|.+++..... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||.++.......
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 82 MAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred cCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence 999999999976432 2489999999999999999999999 999999999999999999999999999987632211
Q ss_pred CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------------cccccccccc
Q 035761 475 NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------------SSSLDKNIKL 535 (560)
Q Consensus 475 ~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------------~~~~~~~~~~ 535 (560)
....+..|+|||.+....++.++||||||+++||+++ |+.||...... ...+.+.++.
T Consensus 158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 234 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKD 234 (256)
T ss_pred ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHH
Confidence 2234567999999998889999999999999999997 99998644321 1234455566
Q ss_pred ccccCCCCCCChhHHHhh
Q 035761 536 IDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 536 ~~~~dp~~~p~~~~~~~~ 553 (560)
|...+|..||++.+++..
T Consensus 235 ~l~~~p~~Rp~~~~l~~~ 252 (256)
T cd05039 235 CWELDPAKRPTFKQLREQ 252 (256)
T ss_pred HhccChhhCcCHHHHHHH
Confidence 777788888888887754
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=282.37 Aligned_cols=235 Identities=29% Similarity=0.415 Sum_probs=203.2
Q ss_pred CCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC--CEEEEEE
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHE--KCMFLIY 392 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 392 (560)
+|...+.||+|++|.||+|... +++.|++|++..........+.+.+|++++++++||||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3667788999999999999876 688999999876554345567889999999999999999999999988 8899999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++++|.+++.... .+++.++..++.|+++|++|||+. +++|+|++|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999997654 489999999999999999999998 9999999999999999999999999999876543
Q ss_pred CC--CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc--------------------cccccc
Q 035761 473 SS--NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS--------------------SSSSLD 530 (560)
Q Consensus 473 ~~--~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~--------------------~~~~~~ 530 (560)
.. ......++..|+|||...+...+.++||||||+++|+|++|+.||..... ....+.
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAK 234 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHH
Confidence 32 13345688899999999888899999999999999999999999975541 112355
Q ss_pred cccccccccCCCCCCChhHHHhhcee
Q 035761 531 KNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 531 ~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
+.+..|...+|+.||++.+++.++|+
T Consensus 235 ~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 235 DFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 66677888899999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=287.70 Aligned_cols=228 Identities=25% Similarity=0.335 Sum_probs=183.1
Q ss_pred CcccceeeccCCeeEEEEEe-----CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC--CEEE
Q 035761 317 FDIKYCIGTGGYGSVYRARL-----PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHE--KCMF 389 (560)
Q Consensus 317 ~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 389 (560)
|+..+.||+|+||.||.+.. .+++.||+|.++.... ......+.+|++++++++||||+++++++... ...+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence 37788999999999988653 3578899999875432 22345788999999999999999999998764 4688
Q ss_pred EEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccccc
Q 035761 390 LIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL 469 (560)
Q Consensus 390 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 469 (560)
+||||+++|+|.+++... .+++.++..++.|++.|++|||+. +++||||||+||++++++.++|+|||+++..
T Consensus 85 lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 85 LIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccccc
Confidence 999999999999999753 289999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCC---ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc---------------------
Q 035761 470 NYDSSN---RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------------- 525 (560)
Q Consensus 470 ~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------------- 525 (560)
...... .....++..|+|||...+..++.++||||||+++|||++|+.||......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence 432221 11123456799999999888999999999999999999999998543210
Q ss_pred ------------ccccccccccccccCCCCCCChhHHHh
Q 035761 526 ------------SSSLDKNIKLIDLLDPRLPPPGDQMIR 552 (560)
Q Consensus 526 ------------~~~~~~~~~~~~~~dp~~~p~~~~~~~ 552 (560)
...+.+.+..|...+|+.||++++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 012334455566667777887777765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=282.47 Aligned_cols=238 Identities=29% Similarity=0.400 Sum_probs=204.2
Q ss_pred CCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
+|++.+.||+|+||.||++... +++.+++|++..........+.+.+|+++++.++|||++++.+.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778889999999999999865 588999999876544445566788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCC-cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 395 MEMGSLFCILRTDE-EAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 395 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
+++++|.+++.... ....+++.++..++.|++.|++|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999997642 124489999999999999999999999 99999999999999999999999999998765443
Q ss_pred CCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc------------------ccccccccccc
Q 035761 474 SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS------------------SSSSLDKNIKL 535 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~------------------~~~~~~~~~~~ 535 (560)
.......|++.|+|||...+..++.++||||+|+++|+|++|+.||..... ....+...++.
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSS 237 (258)
T ss_pred ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 333345688899999999888899999999999999999999999965431 12234556677
Q ss_pred ccccCCCCCCChhHHHhhcee
Q 035761 536 IDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 536 ~~~~dp~~~p~~~~~~~~~~~ 556 (560)
|...+|+.||++.+++.++|+
T Consensus 238 ~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 238 LLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HcCCChhhCcCHHHHhcCCCC
Confidence 888899999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=284.22 Aligned_cols=227 Identities=26% Similarity=0.399 Sum_probs=188.3
Q ss_pred ceeeccCCeeEEEEEeCC--C--cEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEeccC
Q 035761 321 YCIGTGGYGSVYRARLPS--G--KVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYME 396 (560)
Q Consensus 321 ~~ig~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 396 (560)
+.||+|++|.||+|.+.+ + ..||+|.+...... ...+.+.+|+.++++++||||+++++++.. ...++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 358999999999998643 3 36899998765543 556788999999999999999999999988 88999999999
Q ss_pred CCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCC-
Q 035761 397 MGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSN- 475 (560)
Q Consensus 397 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 475 (560)
+|+|.+++..... ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||+|||+++.+......
T Consensus 79 ~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 79 LGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 9999999976542 3489999999999999999999999 9999999999999999999999999999876432221
Q ss_pred --ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc-------------------cccccccc
Q 035761 476 --RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS-------------------SSSLDKNI 533 (560)
Q Consensus 476 --~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~-------------------~~~~~~~~ 533 (560)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ...+...+
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 234 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVM 234 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHH
Confidence 112346778999999998899999999999999999999 99999533211 12334455
Q ss_pred ccccccCCCCCCChhHHHhh
Q 035761 534 KLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 534 ~~~~~~dp~~~p~~~~~~~~ 553 (560)
..|...+|..||++++++..
T Consensus 235 ~~~l~~~p~~Rps~~~~~~~ 254 (257)
T cd05040 235 LQCWAHNPADRPTFAALREF 254 (257)
T ss_pred HHHCCCCcccCCCHHHHHHH
Confidence 66778899999999988764
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=287.55 Aligned_cols=238 Identities=28% Similarity=0.313 Sum_probs=196.1
Q ss_pred CCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC--CEEEEEE
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHE--KCMFLIY 392 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 392 (560)
+|+..+.||.|++|.||+|... +++.+|+|.+...... .....+.+|+++++.++||||+++++++... +..++||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP-DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch-HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 5788899999999999999874 5789999988754322 3446788999999999999999999998653 4689999
Q ss_pred eccCCCCHHHHhhcCC-cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC
Q 035761 393 EYMEMGSLFCILRTDE-EAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 471 (560)
||+++++|.+++.... ....+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999998875421 223488999999999999999999998 999999999999999999999999999876532
Q ss_pred CCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------c-----------
Q 035761 472 DSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------S----------- 525 (560)
Q Consensus 472 ~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------~----------- 525 (560)
.. .....++..|+|||.+.+..++.++||||+|+++|||++|+.||..... .
T Consensus 158 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd06621 158 SL--AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNG 235 (287)
T ss_pred cc--cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCC
Confidence 21 1234577889999999999999999999999999999999999975521 0
Q ss_pred ---ccccccccccccccCCCCCCChhHHHhhceeeec
Q 035761 526 ---SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILIS 559 (560)
Q Consensus 526 ---~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~~ 559 (560)
...+.+.+..|...+|..||++.+++++.|+.+.
T Consensus 236 ~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 236 IKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred CchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 0012344456777899999999999999999764
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=283.48 Aligned_cols=230 Identities=28% Similarity=0.432 Sum_probs=188.6
Q ss_pred cCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
++|++.+.||+|++|.||+|...++..+|+|.+..... ..+.+.+|+.++++++|||++++++++. .+..++||||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 45888899999999999999987777899998764332 2356888999999999999999999875 4567899999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
+++|+|.++++... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.++|+|||.+........
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 82 MGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 99999999997643 23479999999999999999999998 999999999999999999999999999987643221
Q ss_pred C-ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------------ccccccccc
Q 035761 475 N-RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------------SSSLDKNIK 534 (560)
Q Consensus 475 ~-~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------------~~~~~~~~~ 534 (560)
. .....++..|+|||...+..++.++||||||+++|||++ |+.||...... ...+...++
T Consensus 158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (260)
T cd05069 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMK 237 (260)
T ss_pred cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHH
Confidence 1 112335678999999988889999999999999999999 99998654321 112345556
Q ss_pred cccccCCCCCCChhHHHh
Q 035761 535 LIDLLDPRLPPPGDQMIR 552 (560)
Q Consensus 535 ~~~~~dp~~~p~~~~~~~ 552 (560)
.|...||..||+++++++
T Consensus 238 ~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 238 LCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHccCCcccCcCHHHHHH
Confidence 677778889988888765
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=290.80 Aligned_cols=235 Identities=24% Similarity=0.342 Sum_probs=192.0
Q ss_pred cCCcccceeeccCCeeEEEEEeCC-----------------CcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcce
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPS-----------------GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVK 377 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 377 (560)
++|++.+.||+|+||.||+|...+ +..||+|.+...... ...+.+.+|++++++++||||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD-NAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH-HHHHHHHHHHHHHHhcCCCCEeE
Confidence 568889999999999999987542 246899998754332 44567889999999999999999
Q ss_pred eeeEEEeCCEEEEEEeccCCCCHHHHhhcCCc--------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCC
Q 035761 378 LYGFCLHEKCMFLIYEYMEMGSLFCILRTDEE--------AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNN 449 (560)
Q Consensus 378 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~N 449 (560)
+++++..++..+++|||+++++|.+++..... ...+++..+..++.|++.||+|||+. +++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 99999999999999999999999999876431 12489999999999999999999998 99999999999
Q ss_pred eEeCCCCcEEEeeeccccccCCCCCC--ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh--CCCCCCccccc
Q 035761 450 ILLNSEFEAFVADFGIARLLNYDSSN--RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM--GKHPGELLSSS 525 (560)
Q Consensus 450 ill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~--g~~P~~~~~~~ 525 (560)
|+++.++.++|+|||+++........ .....++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 99999999999999999865432211 122345678999999988889999999999999999998 77887643211
Q ss_pred -------------------------ccccccccccccccCCCCCCChhHHHhh
Q 035761 526 -------------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 526 -------------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
..++.+.+..|...||..||++.++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~ 293 (296)
T cd05051 241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLF 293 (296)
T ss_pred HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHH
Confidence 1234556666777889999998888653
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=288.80 Aligned_cols=234 Identities=23% Similarity=0.285 Sum_probs=189.6
Q ss_pred CCcccceeeccCCeeEEEEEeC------CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEE
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMF 389 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 389 (560)
+|.+.+.||+|+||.||+|... .++.||+|+++.... ....+.+.+|+.+++.++||||+++++++......+
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 4667788999999999999753 247899999875432 223456889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCC-------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCC
Q 035761 390 LIYEYMEMGSLFCILRTDE-------------EAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEF 456 (560)
Q Consensus 390 lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~ 456 (560)
+++||+++++|.+++.... ....+++..+..++.|++.||+|||+. +++||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence 9999999999999985321 112488899999999999999999999 999999999999999999
Q ss_pred cEEEeeeccccccCCCCCC--ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc--------
Q 035761 457 EAFVADFGIARLLNYDSSN--RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS-------- 525 (560)
Q Consensus 457 ~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~-------- 525 (560)
.+||+|||+++........ .....+++.|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~ 241 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN 241 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 9999999998865432211 122345678999999988889999999999999999998 88888643321
Q ss_pred ----------ccccccccccccccCCCCCCChhHHHhh
Q 035761 526 ----------SSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 526 ----------~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
...+...+..|...+|..||+++++++.
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 242 RQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred CCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 1123455566778899999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=287.51 Aligned_cols=232 Identities=23% Similarity=0.342 Sum_probs=189.1
Q ss_pred CCcccceeeccCCeeEEEEEe-----CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC--CEE
Q 035761 316 DFDIKYCIGTGGYGSVYRARL-----PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHE--KCM 388 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 388 (560)
-|++.+.||+|+||.||.+.+ .++..||+|.++.... ....+.+.+|+++++.++|||++++.+++... ...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 367788999999999999974 3578899999875432 33456789999999999999999999999875 568
Q ss_pred EEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccc
Q 035761 389 FLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARL 468 (560)
Q Consensus 389 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 468 (560)
++||||+++++|.+++..... .+++.++..++.|++.||+|||+. |++||||||+||+++.++.++|+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKN--KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccc
Confidence 999999999999999865432 389999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCC---ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccc----------------------
Q 035761 469 LNYDSSN---RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLS---------------------- 523 (560)
Q Consensus 469 ~~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~---------------------- 523 (560)
+...... .....++..|+|||.+.+..++.++||||||+++||+++++.|+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 6433221 112346678999999988889999999999999999999876642110
Q ss_pred -----------ccccccccccccccccCCCCCCChhHHHhh
Q 035761 524 -----------SSSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 524 -----------~~~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
.....+.+.+..|...+|+.||++++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 239 LEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 011234456677778899999999998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=283.65 Aligned_cols=222 Identities=25% Similarity=0.319 Sum_probs=180.5
Q ss_pred ceeeccCCeeEEEEEeCC-------------CcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCE
Q 035761 321 YCIGTGGYGSVYRARLPS-------------GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKC 387 (560)
Q Consensus 321 ~~ig~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 387 (560)
+.||+|+||.||+|.+.+ ...|++|.+.... ......+.+|+.+++.++||||+++++++..+..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 358999999999997532 2358888876533 2334578889999999999999999999999989
Q ss_pred EEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCc-------EEE
Q 035761 388 MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFE-------AFV 460 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-------~kl 460 (560)
.++||||+++|+|..+++.... .+++..+.+++.||++||+|||+. +++||||||+||+++.++. +++
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSD--VLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEe
Confidence 9999999999999998875432 389999999999999999999999 9999999999999987664 899
Q ss_pred eeeccccccCCCCCCceeeccccCccCccccc-cCccCcchhHHHHHHHHHHHH-hCCCCCCcccc--------------
Q 035761 461 ADFGIARLLNYDSSNRTLLAGTYGSIAPELAY-TMVVTEKYDVYSFGVVALEVL-MGKHPGELLSS-------------- 524 (560)
Q Consensus 461 ~Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~~-~~~~~~~~Dv~s~G~il~el~-~g~~P~~~~~~-------------- 524 (560)
+|||++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|+.||.....
T Consensus 154 ~d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~ 229 (262)
T cd05077 154 SDPGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLV 229 (262)
T ss_pred CCCCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcCccCC
Confidence 999998765322 2235778899999886 466888999999999999998 58888864321
Q ss_pred --cccccccccccccccCCCCCCChhHHHhh
Q 035761 525 --SSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 525 --~~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
....+..+++.|...||..||++.+++++
T Consensus 230 ~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 230 TPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred CCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 11234566778888899999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=281.81 Aligned_cols=224 Identities=25% Similarity=0.356 Sum_probs=183.2
Q ss_pred ceeeccCCeeEEEEEeCC----CcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEeccC
Q 035761 321 YCIGTGGYGSVYRARLPS----GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYME 396 (560)
Q Consensus 321 ~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 396 (560)
+.||+|+||.||+|.+.. +..+|+|.+...... ...+.+.+|+++++.++||||+++++++.. ...++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCC
Confidence 358999999999997532 268999998765432 345678899999999999999999998764 45799999999
Q ss_pred CCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCc
Q 035761 397 MGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNR 476 (560)
Q Consensus 397 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 476 (560)
+|+|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++.........
T Consensus 79 ~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 79 LGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 999999998654 389999999999999999999998 99999999999999999999999999998764332221
Q ss_pred e---eeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------------ccccccccc
Q 035761 477 T---LLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------------SSSLDKNIK 534 (560)
Q Consensus 477 ~---~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------------~~~~~~~~~ 534 (560)
. ...++..|+|||.+.+..++.++||||||+++||+++ |+.||...+.. ...+.+.+.
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 232 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIML 232 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHH
Confidence 1 1123467999999998899999999999999999998 99999654321 123445667
Q ss_pred cccccCCCCCCChhHHHh
Q 035761 535 LIDLLDPRLPPPGDQMIR 552 (560)
Q Consensus 535 ~~~~~dp~~~p~~~~~~~ 552 (560)
.|...+|..||++.+++.
T Consensus 233 ~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 233 SCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHhcCChhhCcCHHHHHH
Confidence 777788888888888765
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=290.87 Aligned_cols=238 Identities=26% Similarity=0.427 Sum_probs=200.0
Q ss_pred hcCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCEEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 392 (560)
...|+..+.||+||.+.||++...+.+.+|+|++.......+..+.|..|+..+.++ .|.+|+++++|-..++..||||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 356888899999999999999988888999998876665567778999999999999 5999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||-+ .+|..+++..... ..+| .+..+..||+.++.++|.. ||||.||||.|+|+- .|.+||+|||.|..+..+
T Consensus 440 E~Gd-~DL~kiL~k~~~~-~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 440 ECGD-IDLNKILKKKKSI-DPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD 512 (677)
T ss_pred eccc-ccHHHHHHhccCC-CchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence 9875 4999999865432 2345 6778999999999999999 999999999999985 468999999999988654
Q ss_pred CCC--ceeeccccCccCccccccCc-----------cCcchhHHHHHHHHHHHHhCCCCCCcccc---------------
Q 035761 473 SSN--RTLLAGTYGSIAPELAYTMV-----------VTEKYDVYSFGVVALEVLMGKHPGELLSS--------------- 524 (560)
Q Consensus 473 ~~~--~~~~~g~~~~~aPE~~~~~~-----------~~~~~Dv~s~G~il~el~~g~~P~~~~~~--------------- 524 (560)
... ....+||+.||+||.+.... .++++||||+|||+|+|+.|+.||.....
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~I 592 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEI 592 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccc
Confidence 432 34467999999999987554 34689999999999999999999964441
Q ss_pred ------cccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 525 ------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 525 ------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
...++.+..+-|...||+-||+++++++|.|++.
T Consensus 593 efp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 593 EFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred cccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 1112456668889999999999999999999876
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=286.69 Aligned_cols=235 Identities=23% Similarity=0.348 Sum_probs=192.5
Q ss_pred cCCcccceeeccCCeeEEEEEeCC------CcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPS------GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCM 388 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 388 (560)
++|.+.+.||+|+||.||+|..++ +..||+|.+..... ......+.+|+.+++.++||||+++++++......
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 568889999999999999997642 36899999865432 23345788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCCc-------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEe
Q 035761 389 FLIYEYMEMGSLFCILRTDEE-------AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVA 461 (560)
Q Consensus 389 ~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 461 (560)
++||||+++|+|.+++..... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 999999999999999875322 12378999999999999999999998 99999999999999999999999
Q ss_pred eeccccccCCCCCC--ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc--------------
Q 035761 462 DFGIARLLNYDSSN--RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS-------------- 524 (560)
Q Consensus 462 Dfg~~~~~~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~-------------- 524 (560)
|||+++........ .....++..|+|||.+.+..++.++||||||+++||+++ |+.||.....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 241 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLD 241 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCC
Confidence 99999865432211 122346788999999988889999999999999999998 9999864321
Q ss_pred ----cccccccccccccccCCCCCCChhHHHhh
Q 035761 525 ----SSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 525 ----~~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
....+.+.+..|...+|+.||++.+++..
T Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~ 274 (277)
T cd05032 242 LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSS 274 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 11234456667778888999988888754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=288.49 Aligned_cols=237 Identities=22% Similarity=0.274 Sum_probs=195.8
Q ss_pred CCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
+|+..+.||+|+||.||++..+ +++.|++|.+..... .....+.+.+|+++++.++||||+++++.+..++..++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888899999999999999865 478999998875432 22344578899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++++|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.++++|||+++......
T Consensus 82 ~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 82 YVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 999999999997643 389999999999999999999998 99999999999999999999999999986421100
Q ss_pred ---------------CCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc--------------
Q 035761 474 ---------------SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-------------- 524 (560)
Q Consensus 474 ---------------~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-------------- 524 (560)
.......++..|+|||.+.+..++.++|+||||+++||+++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 235 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW 235 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC
Confidence 001123467889999999988899999999999999999999999863221
Q ss_pred ------cccccccccccccccCCCCCCC---hhHHHhhceeee
Q 035761 525 ------SSSSLDKNIKLIDLLDPRLPPP---GDQMIRQGIILI 558 (560)
Q Consensus 525 ------~~~~~~~~~~~~~~~dp~~~p~---~~~~~~~~~~~~ 558 (560)
....+...++.|...||+.||+ +.+++.++|+..
T Consensus 236 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 236 PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 1122455667778889999997 688889988754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=283.78 Aligned_cols=228 Identities=25% Similarity=0.352 Sum_probs=193.5
Q ss_pred eeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEeccCCCCH
Q 035761 323 IGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSL 400 (560)
Q Consensus 323 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 400 (560)
||.|++|.||+|... +++.||+|.+..... .....+.+.+|+++++.++||||+++++++.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999875 488999999875432 223446789999999999999999999999999999999999999999
Q ss_pred HHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCceeec
Q 035761 401 FCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLA 480 (560)
Q Consensus 401 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 480 (560)
.+++..... +++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus 81 ~~~l~~~~~---l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~ 153 (262)
T cd05572 81 WTILRDRGL---FDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFC 153 (262)
T ss_pred HHHHhhcCC---CCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-cccccc
Confidence 999976533 89999999999999999999998 99999999999999999999999999998765332 222346
Q ss_pred cccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------ccccccccccccccc
Q 035761 481 GTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------SSSSLDKNIKLIDLL 539 (560)
Q Consensus 481 g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------~~~~~~~~~~~~~~~ 539 (560)
++..|+|||.+.+..++.++|+||+|+++|||++|+.||..... ....+...++.|...
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 233 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRR 233 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccC
Confidence 78899999999888899999999999999999999999975541 012234455667778
Q ss_pred CCCCCCC-----hhHHHhhceee
Q 035761 540 DPRLPPP-----GDQMIRQGIIL 557 (560)
Q Consensus 540 dp~~~p~-----~~~~~~~~~~~ 557 (560)
+|+.||+ ++++++|+|+.
T Consensus 234 ~p~~R~~~~~~~~~~l~~~~~~~ 256 (262)
T cd05572 234 NPEERLGNLKGGIKDIKKHKWFN 256 (262)
T ss_pred ChhhCcCCcccCHHHHhcChhhh
Confidence 9999999 99999999975
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=268.62 Aligned_cols=235 Identities=22% Similarity=0.312 Sum_probs=190.3
Q ss_pred CcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCEEEEEEec
Q 035761 317 FDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 317 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
.+....+|.|..|.||+++++ +|..+|||.+.+.... ++.+.....+.++..- ++|+||+.+|||..+...++.||.
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nk-ee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCH-HHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 445566999999999999876 4899999999876543 4445556666666655 599999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
|.. .+..++++-.. ++++.-+-++...+.+||.||-++. +|+|||+||+|||+|+.|++|+||||.+-++.+ ..
T Consensus 173 Ms~-C~ekLlkrik~--piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd-Sk 246 (391)
T KOG0983|consen 173 MST-CAEKLLKRIKG--PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVD-SK 246 (391)
T ss_pred HHH-HHHHHHHHhcC--CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeec-cc
Confidence 954 56666655433 3778888899999999999998765 999999999999999999999999999987753 23
Q ss_pred CceeeccccCccCccccccC---ccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------cccccc
Q 035761 475 NRTLLAGTYGSIAPELAYTM---VVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------SSSSLD 530 (560)
Q Consensus 475 ~~~~~~g~~~~~aPE~~~~~---~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------~~~~~~ 530 (560)
..+..+|.+.|||||-+... .|+-++||||||+.++||.||..||..-+. -+.++.
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~ 326 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQ 326 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHH
Confidence 33445799999999987644 588899999999999999999999975221 112345
Q ss_pred cccccccccCCCCCCChhHHHhhceeee
Q 035761 531 KNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 531 ~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
+....|..-|++.||..+++++|.|+.+
T Consensus 327 ~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ 354 (391)
T KOG0983|consen 327 SFVKDCLTKDHRKRPKYNKLLEHPFIKR 354 (391)
T ss_pred HHHHHHhhcCcccCcchHHHhcCcceee
Confidence 5567788889999999999999999875
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=295.09 Aligned_cols=236 Identities=24% Similarity=0.368 Sum_probs=187.8
Q ss_pred hcCCcccceeeccCCeeEEEEEe------CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeC-
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLHE- 385 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~- 385 (560)
.++|++.+.||+|+||.||+|.+ .+++.||||+++.... ....+.+.+|+.++.++ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 35789999999999999999963 3467899999875432 23345688999999999 689999999988764
Q ss_pred CEEEEEEeccCCCCHHHHhhcCCc--------------------------------------------------------
Q 035761 386 KCMFLIYEYMEMGSLFCILRTDEE-------------------------------------------------------- 409 (560)
Q Consensus 386 ~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------- 409 (560)
...++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 467899999999999999864321
Q ss_pred --------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCC--ceee
Q 035761 410 --------AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSN--RTLL 479 (560)
Q Consensus 410 --------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~ 479 (560)
...+++.++..++.||++|++|||+. +|+||||||+||+++.++.+||+|||++......... ....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 12378889999999999999999999 9999999999999999999999999999865322221 1122
Q ss_pred ccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc-------------------cccccccccccccc
Q 035761 480 AGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS-------------------SSSLDKNIKLIDLL 539 (560)
Q Consensus 480 ~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~-------------------~~~~~~~~~~~~~~ 539 (560)
.++..|+|||.+.+..++.++||||||+++|||++ |..||...... ...+.+.+..|...
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~ 321 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG 321 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccC
Confidence 35677999999988889999999999999999997 99998643311 11122333445666
Q ss_pred CCCCCCChhHHHhh
Q 035761 540 DPRLPPPGDQMIRQ 553 (560)
Q Consensus 540 dp~~~p~~~~~~~~ 553 (560)
||..||++.+++++
T Consensus 322 ~p~~Rps~~eil~~ 335 (343)
T cd05103 322 EPSQRPTFSELVEH 335 (343)
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=290.03 Aligned_cols=236 Identities=26% Similarity=0.376 Sum_probs=191.4
Q ss_pred hcCCcccceeeccCCeeEEEEEeC--------CCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEe
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP--------SGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLH 384 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 384 (560)
.++|.+.+.||+|+||.||+|++. ++..||+|.+..... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc-hHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 356788899999999999999641 245799998865322 23456788999999999 89999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHhhcCCc-------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeE
Q 035761 385 EKCMFLIYEYMEMGSLFCILRTDEE-------------AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNIL 451 (560)
Q Consensus 385 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nil 451 (560)
....++||||+++|+|.+++..... ...+++.++..++.||++||+|||+. +++||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEE
Confidence 9999999999999999999975321 13488999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeeeccccccCCCCCC--ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc---
Q 035761 452 LNSEFEAFVADFGIARLLNYDSSN--RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS--- 525 (560)
Q Consensus 452 l~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~--- 525 (560)
+++++.+||+|||.++........ .....+++.|+|||++.+..++.++||||||+++||+++ |..||......
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 249 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 999999999999999876432221 112235678999999998889999999999999999998 88887543211
Q ss_pred ---------------ccccccccccccccCCCCCCChhHHHhh
Q 035761 526 ---------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 526 ---------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
...+...+..|...+|+.||++.++++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 250 KLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 1223455566777789999999888765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=284.44 Aligned_cols=197 Identities=23% Similarity=0.327 Sum_probs=160.7
Q ss_pred eeeccCCeeEEEEEeCC---CcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEeccCCC
Q 035761 322 CIGTGGYGSVYRARLPS---GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMG 398 (560)
Q Consensus 322 ~ig~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (560)
.||+|+||.||+|...+ ...+++|.+..... ......+.+|++.++.++||||+++++++......++||||+++|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASAT-PDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCC-hHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 48999999999997543 34688887764332 233457889999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCc--ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCC-
Q 035761 399 SLFCILRTDEE--AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSN- 475 (560)
Q Consensus 399 ~L~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 475 (560)
+|.+++..... ....++.....++.||+.|++|||+. +|+||||||+||+++.++.+||+|||++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999976432 12356788899999999999999999 9999999999999999999999999998754322111
Q ss_pred -ceeeccccCccCcccccc-------CccCcchhHHHHHHHHHHHHh-CCCCCCcc
Q 035761 476 -RTLLAGTYGSIAPELAYT-------MVVTEKYDVYSFGVVALEVLM-GKHPGELL 522 (560)
Q Consensus 476 -~~~~~g~~~~~aPE~~~~-------~~~~~~~Dv~s~G~il~el~~-g~~P~~~~ 522 (560)
.....++..|+|||+... ..++.++|||||||++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL 213 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 122345678999998643 456779999999999999999 88898644
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=296.04 Aligned_cols=235 Identities=25% Similarity=0.317 Sum_probs=194.1
Q ss_pred HhcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCC-----
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEK----- 386 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 386 (560)
..++|+..+.||+|+||.||+|... +++.||+|.+............+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4577999999999999999999764 6899999998654333334456778999999999999999999886442
Q ss_pred -EEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecc
Q 035761 387 -CMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGI 465 (560)
Q Consensus 387 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 465 (560)
..++||||+.+ +|.+++... +++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCcc
Confidence 46999999964 888887542 78899999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc--------------------
Q 035761 466 ARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS-------------------- 525 (560)
Q Consensus 466 ~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~-------------------- 525 (560)
++....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+..
T Consensus 165 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 165 ARTAGTSFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred ceeCCCCCC-CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 987643222 22345788999999999999999999999999999999999998633210
Q ss_pred ----------------------------------------ccccccccccccccCCCCCCChhHHHhhceee
Q 035761 526 ----------------------------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 526 ----------------------------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
.....+.++.|...||+.||++++++.++|+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~ 315 (353)
T cd07850 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN 315 (353)
T ss_pred hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHh
Confidence 00123456777888999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=285.96 Aligned_cols=230 Identities=23% Similarity=0.303 Sum_probs=191.6
Q ss_pred eeccCCeeEEEEEeC-CCcEEEEEEccchhhh-hhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEeccCCCCH
Q 035761 323 IGTGGYGSVYRARLP-SGKVVALKKLHRLETE-LASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSL 400 (560)
Q Consensus 323 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 400 (560)
||+|+||.||+|..+ +|+.||+|.+...... ....+.+..|+++++.++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999754 6889999998754321 22344567899999999999999999999999999999999999999
Q ss_pred HHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCceeec
Q 035761 401 FCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLA 480 (560)
Q Consensus 401 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 480 (560)
.+++..... ..+++.++..++.|++.|+.|||+. +++||||+|+||++++++.++|+|||.+...... .......
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRA 155 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC-Ccccccc
Confidence 999876442 3489999999999999999999999 9999999999999999999999999998765432 2222345
Q ss_pred cccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------ccccccccccccccc
Q 035761 481 GTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------SSSSLDKNIKLIDLL 539 (560)
Q Consensus 481 g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------~~~~~~~~~~~~~~~ 539 (560)
++..|+|||.+.+..++.++||||+|+++|+|++|+.||..... ....+...++.|...
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 235 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQK 235 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccC
Confidence 77899999999888899999999999999999999999965432 112345566777788
Q ss_pred CCCCCC-----ChhHHHhhceee
Q 035761 540 DPRLPP-----PGDQMIRQGIIL 557 (560)
Q Consensus 540 dp~~~p-----~~~~~~~~~~~~ 557 (560)
||..|| ++.+++.|+|+.
T Consensus 236 ~p~~R~~~~~~~~~~ll~h~~~~ 258 (277)
T cd05577 236 DPEKRLGCRGGSADEVREHPLFK 258 (277)
T ss_pred ChhHccCCCcccHHHHHhChhhh
Confidence 999999 888899998874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=289.19 Aligned_cols=234 Identities=30% Similarity=0.406 Sum_probs=194.4
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchh-hhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLE-TELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
+.|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+.+|+++++.++|||++++.+++..++..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45788889999999999999864 68899999886433 22233457889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||++ |++.+++..... .+++.++..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~~--~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEVHKK--PLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHHccc--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9997 577777654332 389999999999999999999998 9999999999999999999999999998765432
Q ss_pred CCCceeeccccCccCccccc---cCccCcchhHHHHHHHHHHHHhCCCCCCcccc-------------------cccccc
Q 035761 473 SSNRTLLAGTYGSIAPELAY---TMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-------------------SSSSLD 530 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~---~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-------------------~~~~~~ 530 (560)
....+++.|+|||++. ...++.++||||||+++|||++|+.||..... ....+.
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFR 244 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHH
Confidence 2235788999999874 45678899999999999999999999864331 112345
Q ss_pred cccccccccCCCCCCChhHHHhhceeee
Q 035761 531 KNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 531 ~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
..+..|...+|..||++.+++.++|+..
T Consensus 245 ~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 245 NFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred HHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 6667788889999999999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=285.95 Aligned_cols=232 Identities=28% Similarity=0.399 Sum_probs=185.0
Q ss_pred cCCcccceeeccCCeeEEEEEeC-----CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC--CE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-----SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHE--KC 387 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~ 387 (560)
++|++.+.||+|+||.||+|..+ +++.||+|.+.... ....+.+.+|+++++.++||||+++++++... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 46788899999999999999743 57899999987543 23346788999999999999999999987543 46
Q ss_pred EEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccc
Q 035761 388 MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIAR 467 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~ 467 (560)
.++||||+++|+|.+++..... .+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||+++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRE--RLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCc--CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccc
Confidence 8999999999999999975432 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCc---eeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc--------------------
Q 035761 468 LLNYDSSNR---TLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-------------------- 524 (560)
Q Consensus 468 ~~~~~~~~~---~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-------------------- 524 (560)
......... ....++..|+|||.+.+..++.++||||||+++|||++|..|+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence 764322211 111234469999999988899999999999999999998776532211
Q ss_pred --------------cccccccccccccccCCCCCCChhHHHhh
Q 035761 525 --------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 525 --------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
....+.+.+..|...+|..||++++++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05081 237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ 279 (284)
T ss_pred HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 01134455566666778888888777654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=316.69 Aligned_cols=238 Identities=27% Similarity=0.346 Sum_probs=193.5
Q ss_pred HHHHHhcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhh-hhhHHHHHHHHHHHhccCCCCcceeeeEEEeCC
Q 035761 309 DMIEATEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETE-LASLESFQNEARLLSQIRHRNIVKLYGFCLHEK 386 (560)
Q Consensus 309 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 386 (560)
++.-..++|++.++||+|+||.|..++++ +++.+|+|++.+-..- ......|..|-.+|...+.+.|+.+.-+|+++.
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 44445688999999999999999999875 5788999998764321 234568999999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccc
Q 035761 387 CMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIA 466 (560)
Q Consensus 387 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~ 466 (560)
+.|+|||||+||+|..++.... .+++.-+..++..|+-||+-||+. |+|||||||.|||+|..|++||+|||.+
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSC 222 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhH
Confidence 9999999999999999998765 278888888999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCc-eeeccccCccCcccccc-----CccCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccc----cc
Q 035761 467 RLLNYDSSNR-TLLAGTYGSIAPELAYT-----MVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIK----LI 536 (560)
Q Consensus 467 ~~~~~~~~~~-~~~~g~~~~~aPE~~~~-----~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~~~~~~~~~----~~ 536 (560)
-.+..++... ...+|||.|.+||++.. +.|++.+|+||+||++|||+.|.-||.. ++..+.+.++.. +.
T Consensus 223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa-dslveTY~KIm~hk~~l~ 301 (1317)
T KOG0612|consen 223 LKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA-DSLVETYGKIMNHKESLS 301 (1317)
T ss_pred HhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH-HHHHHHHHHHhchhhhcC
Confidence 8887655544 45789999999999863 5688899999999999999999999963 222222222221 11
Q ss_pred cccCCCCCCChhHHHhh
Q 035761 537 DLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 537 ~~~dp~~~p~~~~~~~~ 553 (560)
..-+..++++++++|+.
T Consensus 302 FP~~~~VSeeakdLI~~ 318 (1317)
T KOG0612|consen 302 FPDETDVSEEAKDLIEA 318 (1317)
T ss_pred CCcccccCHHHHHHHHH
Confidence 11234466666666654
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=280.07 Aligned_cols=235 Identities=30% Similarity=0.428 Sum_probs=201.0
Q ss_pred CCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
+|+..+.||+|++|.||+|... +++.|++|.+..........+.+.+|++++++++|||++++++++..+...+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677889999999999999765 578999999976654334566889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
+++++|.+++.... .+++..+..++.|++.|+.|||+. |++||||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 99999999997653 389999999999999999999999 999999999999999999999999999987754443
Q ss_pred CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc------------------cccccccccccc
Q 035761 475 NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS------------------SSSSLDKNIKLI 536 (560)
Q Consensus 475 ~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~------------------~~~~~~~~~~~~ 536 (560)
......++..|+|||...+..++.++||||+|+++|+|++|+.||..... ....+...+..|
T Consensus 155 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 234 (254)
T cd06627 155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQC 234 (254)
T ss_pred cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHH
Confidence 33445688899999998888888999999999999999999999864332 112344555666
Q ss_pred cccCCCCCCChhHHHhhcee
Q 035761 537 DLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 537 ~~~dp~~~p~~~~~~~~~~~ 556 (560)
...+|+.||++.+++.+.|+
T Consensus 235 l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 235 FQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HhCChhhCcCHHHHhcCCCC
Confidence 77899999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=279.20 Aligned_cols=232 Identities=32% Similarity=0.497 Sum_probs=200.5
Q ss_pred CCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
+|+..+.||+|++|.||++... +++.+++|++..... ...+.+.+|+++++.++|+|++++++++..+...++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 3677889999999999999875 688999999876443 3456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
+++++|.+++.... ..+++.++..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.+........
T Consensus 79 ~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 79 CSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred CCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 99999999987643 3489999999999999999999998 999999999999999999999999999987654332
Q ss_pred CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc------------------c--ccccccccc
Q 035761 475 NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS------------------S--SSSLDKNIK 534 (560)
Q Consensus 475 ~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~------------------~--~~~~~~~~~ 534 (560)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+. . ...+.+.++
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 232 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLK 232 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHH
Confidence 3345688899999999888889999999999999999999999975511 1 234566777
Q ss_pred cccccCCCCCCChhHHHhhce
Q 035761 535 LIDLLDPRLPPPGDQMIRQGI 555 (560)
Q Consensus 535 ~~~~~dp~~~p~~~~~~~~~~ 555 (560)
.|...||+.||++.++++|+|
T Consensus 233 ~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 233 KCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHccCChhhCCCHHHHhcCCC
Confidence 888889999999999999987
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=283.25 Aligned_cols=227 Identities=24% Similarity=0.330 Sum_probs=176.8
Q ss_pred eeeccCCeeEEEEEeCC---CcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEeccCCC
Q 035761 322 CIGTGGYGSVYRARLPS---GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMG 398 (560)
Q Consensus 322 ~ig~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (560)
.||+|+||.||+|.+.+ +..+|+|.++..... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV-QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 58999999999997643 457899988654322 23346888999999999999999999999988999999999999
Q ss_pred CHHHHhhcCCc--ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCC-
Q 035761 399 SLFCILRTDEE--AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSN- 475 (560)
Q Consensus 399 ~L~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 475 (560)
+|.+++..... ....++..+..++.|+++|++|||+. +++||||||+||+++.+++++++|||.+.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999975322 23467788889999999999999999 9999999999999999999999999998754322111
Q ss_pred -ceeeccccCccCccccccC-------ccCcchhHHHHHHHHHHHHh-CCCCCCccccccc-------------------
Q 035761 476 -RTLLAGTYGSIAPELAYTM-------VVTEKYDVYSFGVVALEVLM-GKHPGELLSSSSS------------------- 527 (560)
Q Consensus 476 -~~~~~g~~~~~aPE~~~~~-------~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~~~------------------- 527 (560)
.....++..|+|||++.+. .++.++||||||+++|||++ |+.||........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKL 237 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCC
Confidence 1223467889999987642 35779999999999999996 9999964432110
Q ss_pred ----ccccccccccccCCCCCCChhHHHhh
Q 035761 528 ----SLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 528 ----~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
.+...++.|. .+|..||+++++.+.
T Consensus 238 ~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~ 266 (269)
T cd05087 238 PLSDRWYEVMQFCW-LQPEQRPSAEEVHLL 266 (269)
T ss_pred CCChHHHHHHHHHh-cCcccCCCHHHHHHH
Confidence 1112333343 578888888887653
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=286.93 Aligned_cols=235 Identities=29% Similarity=0.428 Sum_probs=192.5
Q ss_pred hcCCcccceeeccCCeeEEEEEeC------CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKC 387 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 387 (560)
.++|+..+.||+|+||.||+|..+ ++..||+|.+..... ....+.+.+|+.++++++||||+++++++..+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC-HHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 356888999999999999999863 467899999875432 2334678899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhcCC-------------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 035761 388 MFLIYEYMEMGSLFCILRTDE-------------------EAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSN 448 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~ 448 (560)
.++||||+++|+|.+++.... ....+++.++..++.|++.||+|||+. +++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHh
Confidence 999999999999999997421 113478899999999999999999998 9999999999
Q ss_pred CeEeCCCCcEEEeeeccccccCCCCCC--ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc-
Q 035761 449 NILLNSEFEAFVADFGIARLLNYDSSN--RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS- 524 (560)
Q Consensus 449 Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~- 524 (560)
||++++++.++|+|||+++........ ......+..|+|||...+..++.++|||||||++|||++ |..||.....
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999998765332211 112234567999999998899999999999999999998 8889853321
Q ss_pred -----------------cccccccccccccccCCCCCCChhHHHh
Q 035761 525 -----------------SSSSLDKNIKLIDLLDPRLPPPGDQMIR 552 (560)
Q Consensus 525 -----------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~ 552 (560)
....+.+.+..|...||..||++.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 240 EVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 1234556677788889999999998875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=288.71 Aligned_cols=234 Identities=25% Similarity=0.346 Sum_probs=186.8
Q ss_pred cCCcccceeeccCCeeEEEEEeCC---------------CcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceee
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPS---------------GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLY 379 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 379 (560)
.+|++.+.||+|+||.||++...+ ...||+|.++.... ....+.+.+|++++++++|||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT-KTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 468889999999999999987532 23589999875432 23445788999999999999999999
Q ss_pred eEEEeCCEEEEEEeccCCCCHHHHhhcCCc---------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCe
Q 035761 380 GFCLHEKCMFLIYEYMEMGSLFCILRTDEE---------AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNI 450 (560)
Q Consensus 380 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Ni 450 (560)
+++......++||||+++++|.+++..... ...+++.++..++.|+++|++|||+. +++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 999999999999999999999999864321 12378899999999999999999999 999999999999
Q ss_pred EeCCCCcEEEeeeccccccCCCCCC--ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh--CCCCCCccccc-
Q 035761 451 LLNSEFEAFVADFGIARLLNYDSSN--RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM--GKHPGELLSSS- 525 (560)
Q Consensus 451 ll~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~--g~~P~~~~~~~- 525 (560)
++++++.+||+|||++......... .....++..|+|||......++.++||||||+++|||++ |..||......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 9999999999999999765332211 112234678999999998889999999999999999998 66787643210
Q ss_pred ------------------------ccccccccccccccCCCCCCChhHHHh
Q 035761 526 ------------------------SSSLDKNIKLIDLLDPRLPPPGDQMIR 552 (560)
Q Consensus 526 ------------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~ 552 (560)
...+.++++.|...||..||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 012345556677778888888877765
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=290.21 Aligned_cols=236 Identities=26% Similarity=0.384 Sum_probs=191.2
Q ss_pred hcCCcccceeeccCCeeEEEEEeC--------CCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEe
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP--------SGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLH 384 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 384 (560)
.++|.+.+.||+|+||.||+|... ....+|+|.++.... ......+.+|+++++++ +||||+++++++..
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-DKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC-hHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 356888999999999999999642 245789998875432 23355788999999999 69999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHhhcCCc-------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeE
Q 035761 385 EKCMFLIYEYMEMGSLFCILRTDEE-------------AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNIL 451 (560)
Q Consensus 385 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nil 451 (560)
++..++||||+++|+|.+++..... ...+++.++..++.|++.||+|||+. |++||||||+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEE
Confidence 9999999999999999999975321 13489999999999999999999998 9999999999999
Q ss_pred eCCCCcEEEeeeccccccCCCCCCc--eeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc----
Q 035761 452 LNSEFEAFVADFGIARLLNYDSSNR--TLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS---- 524 (560)
Q Consensus 452 l~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~---- 524 (560)
+++++.+||+|||.++......... ....++..|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 246 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999998664322111 11223467999999998889999999999999999999 8999864321
Q ss_pred --------------cccccccccccccccCCCCCCChhHHHhh
Q 035761 525 --------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 525 --------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
....+...+..|...+|..||++.+++..
T Consensus 247 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 289 (314)
T cd05099 247 KLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEA 289 (314)
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 01234456677778899999998888764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=274.22 Aligned_cols=204 Identities=25% Similarity=0.344 Sum_probs=181.2
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchh-hhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLE-TELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLI 391 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 391 (560)
.++|+..+++|+|.||.|..++-+ +++.+|+|++++.. ....+...-..|-.++...+||.+..+--.++..+..|.|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 357888999999999999999754 68999999998765 2334455667899999999999999998889999999999
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 471 (560)
|||..||.|..++.+.+- +++....-+-..|+.||.|||++ +||.||+|.+|.|+|.||++||+|||+++.--.
T Consensus 247 MeyanGGeLf~HLsrer~---FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRERV---FSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEccCceEeeehhhhhc---ccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccc
Confidence 999999999988876543 89998888999999999999999 999999999999999999999999999986544
Q ss_pred CCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccc
Q 035761 472 DSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLS 523 (560)
Q Consensus 472 ~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~ 523 (560)
.+......+|||.|.|||++.+..|...+|+|-+||+||||++|+.||...+
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d 372 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD 372 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc
Confidence 5555667899999999999999999999999999999999999999997444
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=282.09 Aligned_cols=227 Identities=28% Similarity=0.431 Sum_probs=180.9
Q ss_pred ceeeccCCeeEEEEEeC----CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEe-CCEEEEEEecc
Q 035761 321 YCIGTGGYGSVYRARLP----SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLH-EKCMFLIYEYM 395 (560)
Q Consensus 321 ~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~ 395 (560)
+.||+|+||.||+|.+. ++..||+|.+.... .....+.+.+|+.+++.++|||++++++++.. ++..++|+||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 35899999999999753 23579999886432 22345678899999999999999999998764 55688999999
Q ss_pred CCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC-
Q 035761 396 EMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS- 474 (560)
Q Consensus 396 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~- 474 (560)
++|+|.+++..... .+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||+++.......
T Consensus 80 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 80 KHGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999999975432 267888899999999999999998 999999999999999999999999999986543211
Q ss_pred ---CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc------------------cccccccc
Q 035761 475 ---NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS------------------SSSSLDKN 532 (560)
Q Consensus 475 ---~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~------------------~~~~~~~~ 532 (560)
......++..|+|||.+.+..++.++||||||+++|||++ |.+||..... ....+.+.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 234 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEV 234 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHH
Confidence 1112345678999999988889999999999999999999 4566653221 11234455
Q ss_pred cccccccCCCCCCChhHHHhh
Q 035761 533 IKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 533 ~~~~~~~dp~~~p~~~~~~~~ 553 (560)
+..|...+|+.||++.+++..
T Consensus 235 i~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 235 MLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HHHHcCCChhhCCCHHHHHHH
Confidence 667778899999999998765
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=284.30 Aligned_cols=221 Identities=24% Similarity=0.316 Sum_probs=176.9
Q ss_pred eeeccCCeeEEEEEeCC-------------------------CcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcc
Q 035761 322 CIGTGGYGSVYRARLPS-------------------------GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIV 376 (560)
Q Consensus 322 ~ig~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 376 (560)
.||+|+||.||+|.+.. ...|++|.+..... .....+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR--DIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH--HHHHHHHHHHHHHhcCCCCCee
Confidence 58999999999997421 13588998865332 3345688899999999999999
Q ss_pred eeeeEEEeCCEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCC
Q 035761 377 KLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEF 456 (560)
Q Consensus 377 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~ 456 (560)
++++++.++...++||||+++|+|..++..... .+++..+..++.||++||+|||+. +|+||||||+||+++.++
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG--RVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLG 154 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccC
Confidence 999999999999999999999999999875332 388999999999999999999998 999999999999997653
Q ss_pred -------cEEEeeeccccccCCCCCCceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHH-hCCCCCCcccccc-
Q 035761 457 -------EAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVL-MGKHPGELLSSSS- 526 (560)
Q Consensus 457 -------~~kl~Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~-~g~~P~~~~~~~~- 526 (560)
.++++|||.+...... ....++..|+|||.+.+ ..++.++||||||+++||++ +|+.||.......
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred cccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 3799999988654221 12346788999998865 56889999999999999995 6999986432210
Q ss_pred ---------------cccccccccccccCCCCCCChhHHHhh
Q 035761 527 ---------------SSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 527 ---------------~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
..+.+.+..|...+|..||++++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 231 ERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 124455566777788888888888765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=280.78 Aligned_cols=231 Identities=27% Similarity=0.403 Sum_probs=192.0
Q ss_pred cCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
.+|++.+.||+|+||.||+|.+.+++.+|+|.+..... ....+.+|++++++++|||++++++++......++||||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM---SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC---CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 45788899999999999999887788999998875332 234688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
+++++|.+++..... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||.++.......
T Consensus 81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 81 MEHGCLSDYLRAQRG--KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred CCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 999999999875432 378999999999999999999998 999999999999999999999999999876532211
Q ss_pred C-ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------------ccccccccc
Q 035761 475 N-RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------------SSSLDKNIK 534 (560)
Q Consensus 475 ~-~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------------~~~~~~~~~ 534 (560)
. .....++.+|+|||.+.+..++.++||||||+++||+++ |+.||...... ...+.+.++
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQ 235 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Confidence 1 112235678999999998889999999999999999998 99998644311 112344556
Q ss_pred cccccCCCCCCChhHHHhh
Q 035761 535 LIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 535 ~~~~~dp~~~p~~~~~~~~ 553 (560)
.|...+|+.||++++++++
T Consensus 236 ~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 236 HCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHcccChhhCCCHHHHHHh
Confidence 6677899999999998875
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=281.75 Aligned_cols=233 Identities=30% Similarity=0.401 Sum_probs=188.8
Q ss_pred cCCcccceeeccCCeeEEEEEeCC-C---cEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPS-G---KVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFL 390 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 390 (560)
++|+..+.||+|+||.||+|..+. + ..+|+|.++.... ....+.+..|++++++++|||++++.+++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT-EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC-HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 467888999999999999998752 3 3799998865432 2334578899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccC
Q 035761 391 IYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN 470 (560)
Q Consensus 391 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 470 (560)
||||+++++|.+++.... ..+++.++..++.|++.|++|||+. +++||||||+||++++++.++++|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 999999999999997543 2389999999999999999999999 99999999999999999999999999998664
Q ss_pred CCCCCce---eeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------------ccc
Q 035761 471 YDSSNRT---LLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------------SSS 528 (560)
Q Consensus 471 ~~~~~~~---~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------------~~~ 528 (560)
....... ....+..|+|||++....++.++||||||+++||+++ |+.||...... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 238 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSA 238 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHH
Confidence 3221111 1123457999999998889999999999999999998 99998543210 112
Q ss_pred cccccccccccCCCCCCChhHHHhh
Q 035761 529 LDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 529 ~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
+.+.+..|...||..||+..++++.
T Consensus 239 ~~~li~~c~~~~p~~Rp~~~~i~~~ 263 (268)
T cd05063 239 VYQLMLQCWQQDRARRPRFVDIVNL 263 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHH
Confidence 3345566677788888888888764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=280.70 Aligned_cols=235 Identities=21% Similarity=0.356 Sum_probs=190.3
Q ss_pred HHHHHHHhcCCccccee--eccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEE
Q 035761 307 FQDMIEATEDFDIKYCI--GTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFC 382 (560)
Q Consensus 307 ~~~~~~~~~~~~~~~~i--g~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 382 (560)
..+.....++|++.+.+ |+|+||.||++..+ ++..+|+|.+...... . .|......+ +|||++++++++
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~--~-----~e~~~~~~~~~h~~iv~~~~~~ 78 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN--A-----IEPMVHQLMKDNPNFIKLYYSV 78 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc--h-----hhHHHHHHhhcCCCEEEEEEEE
Confidence 34555556677777776 99999999999764 5788999988643211 0 122222222 799999999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCC-cEEEe
Q 035761 383 LHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEF-EAFVA 461 (560)
Q Consensus 383 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~ 461 (560)
..++..++||||+++|+|.+++.... .+++.++..++.|+++|++|||+. +++||||||+||+++.++ .++|+
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~ 152 (267)
T PHA03390 79 TTLKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLC 152 (267)
T ss_pred ecCCeeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEe
Confidence 99999999999999999999997654 489999999999999999999999 999999999999999998 99999
Q ss_pred eeccccccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc----------------
Q 035761 462 DFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS---------------- 525 (560)
Q Consensus 462 Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~---------------- 525 (560)
|||.++..... ....++..|+|||++.+..++.++||||+|+++|||++|+.||......
T Consensus 153 dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 228 (267)
T PHA03390 153 DYGLCKIIGTP----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLP 228 (267)
T ss_pred cCccceecCCC----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCC
Confidence 99998765422 2235788999999999989999999999999999999999999743211
Q ss_pred -----ccccccccccccccCCCCCCC-hhHHHhhceeee
Q 035761 526 -----SSSLDKNIKLIDLLDPRLPPP-GDQMIRQGIILI 558 (560)
Q Consensus 526 -----~~~~~~~~~~~~~~dp~~~p~-~~~~~~~~~~~~ 558 (560)
+..+...+..|...+|..||+ ++++++|+|+.|
T Consensus 229 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 229 FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred cccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 112334456677889999996 699999999976
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=281.39 Aligned_cols=226 Identities=26% Similarity=0.382 Sum_probs=185.8
Q ss_pred cCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEe-CCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLH-EKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 393 (560)
++|++.+.||+|+||.||+|..+ |..||+|.++... ..+.+.+|+.++++++|+|++++++++.. +...++|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 46888999999999999999875 7889999886432 23568899999999999999999998654 456899999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++|+|.++++.... ..+++..+..++.|++.|++|||+. +++||||||+||++++++.+|++|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 81 YMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred CCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 9999999999876432 2388999999999999999999998 99999999999999999999999999987653221
Q ss_pred CCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------------ccccccccc
Q 035761 474 SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------------SSSLDKNIK 534 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------------~~~~~~~~~ 534 (560)
....++..|+|||++....++.++||||||+++|||++ |+.||...... ...+...+.
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 233 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMK 233 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 12234568999999998889999999999999999998 99998643321 112345556
Q ss_pred cccccCCCCCCChhHHHh
Q 035761 535 LIDLLDPRLPPPGDQMIR 552 (560)
Q Consensus 535 ~~~~~dp~~~p~~~~~~~ 552 (560)
.|...+|+.||++.++++
T Consensus 234 ~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 234 QCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHhcCChhhCcCHHHHHH
Confidence 667778888888888765
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=288.22 Aligned_cols=238 Identities=30% Similarity=0.395 Sum_probs=193.5
Q ss_pred HhcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCC-----
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEK----- 386 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 386 (560)
..++|++.+.||+|+||.||+|..+ +++.||+|.++...........+.+|++++++++|||++++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 4567899999999999999999875 5889999998754433333456778999999999999999999987654
Q ss_pred -----EEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEe
Q 035761 387 -----CMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVA 461 (560)
Q Consensus 387 -----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 461 (560)
..++|+||+++ ++..++.... ..+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGL--VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeC
Confidence 78999999986 7777776532 2489999999999999999999999 99999999999999999999999
Q ss_pred eeccccccCCCCC-CceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------
Q 035761 462 DFGIARLLNYDSS-NRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSS--------------- 524 (560)
Q Consensus 462 Dfg~~~~~~~~~~-~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~--------------- 524 (560)
|||.+........ ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.....
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 238 (302)
T cd07864 159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238 (302)
T ss_pred cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 9999987643322 1222346778999998764 4568899999999999999999999964221
Q ss_pred --------------------------------cccccccccccccccCCCCCCChhHHHhhcee
Q 035761 525 --------------------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 525 --------------------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
....+.+.+..|...||..||++++++.++|+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 01123445667788899999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=285.22 Aligned_cols=233 Identities=26% Similarity=0.412 Sum_probs=188.1
Q ss_pred cCCcccceeeccCCeeEEEEEeC------CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCM 388 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 388 (560)
.++...+.||+|+||.||++... ++..+|+|.+.... ....+.+.+|+++++.++|+||+++++++......
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC--HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 45777889999999999999642 35678999886533 23345789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCCc------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCC
Q 035761 389 FLIYEYMEMGSLFCILRTDEE------------AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEF 456 (560)
Q Consensus 389 ~lv~e~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~ 456 (560)
+++|||+++|+|.+++..... ...+++.++..++.|++.|++|||+. +++||||||+||++++++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGL 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCC
Confidence 999999999999999876432 12488999999999999999999998 999999999999999999
Q ss_pred cEEEeeeccccccCCCCC--CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc--------
Q 035761 457 EAFVADFGIARLLNYDSS--NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS-------- 525 (560)
Q Consensus 457 ~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~-------- 525 (560)
.++|+|||+++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||......
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence 999999999976532211 1122335678999999999999999999999999999998 99998543321
Q ss_pred ----------ccccccccccccccCCCCCCChhHHHh
Q 035761 526 ----------SSSLDKNIKLIDLLDPRLPPPGDQMIR 552 (560)
Q Consensus 526 ----------~~~~~~~~~~~~~~dp~~~p~~~~~~~ 552 (560)
...+.+.+..|...||..||++++++.
T Consensus 240 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 240 GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 122345556666777777777777764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=283.55 Aligned_cols=204 Identities=25% Similarity=0.330 Sum_probs=178.6
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhh-hhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETE-LASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
+.|..-++||+|+||.||-++.+ +|+-+|.|++.+.... .....-...|-.++.+++.+.||.+--+++..+..++|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 56778899999999999999754 6899999988654422 222334578999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
..|.||+|.-++...++ ..+++.+++-++.+|+.||++||.. +||.||+||+|||+|+.|+++|+|+|+|..+...
T Consensus 265 tlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 99999999988887664 4499999999999999999999999 9999999999999999999999999999988644
Q ss_pred CCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccc
Q 035761 473 SSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLS 523 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~ 523 (560)
... ...+||.+|||||++....|+...|+||+||++|||+.|+.||....
T Consensus 341 ~~~-~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K 390 (591)
T KOG0986|consen 341 KPI-RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK 390 (591)
T ss_pred Ccc-ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh
Confidence 333 34489999999999999999999999999999999999999996443
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=287.30 Aligned_cols=235 Identities=24% Similarity=0.349 Sum_probs=188.5
Q ss_pred cCCcccceeeccCCeeEEEEEeC-----------------CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcce
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-----------------SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVK 377 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 377 (560)
++|++.+.||+|+||.||++... ++..||+|.+..... ....+.+.+|+++++.++|+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN-KNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcce
Confidence 46889999999999999998542 234689999875432 234467889999999999999999
Q ss_pred eeeEEEeCCEEEEEEeccCCCCHHHHhhcCCc--------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCC
Q 035761 378 LYGFCLHEKCMFLIYEYMEMGSLFCILRTDEE--------AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNN 449 (560)
Q Consensus 378 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~N 449 (560)
+++++..++..++||||+++|+|.+++..... ...+++.++..++.|++.|++|||+. +++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence 99999999999999999999999999875321 12478889999999999999999999 99999999999
Q ss_pred eEeCCCCcEEEeeeccccccCCCCCC--ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh--CCCCCCccccc
Q 035761 450 ILLNSEFEAFVADFGIARLLNYDSSN--RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM--GKHPGELLSSS 525 (560)
Q Consensus 450 ill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~--g~~P~~~~~~~ 525 (560)
|+++.++.++|+|||+++.+...... .....++..|+|||...+..++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 99999999999999999865432211 112234678999999888889999999999999999998 77888543210
Q ss_pred -------------------------ccccccccccccccCCCCCCChhHHHhh
Q 035761 526 -------------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 526 -------------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
...+.+.+..|...||..||++.+++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 293 (296)
T cd05095 241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHAT 293 (296)
T ss_pred HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 1123355566677788888888887653
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=283.30 Aligned_cols=232 Identities=31% Similarity=0.450 Sum_probs=187.2
Q ss_pred CCcccceeeccCCeeEEEEEeCC-C---cEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEE
Q 035761 316 DFDIKYCIGTGGYGSVYRARLPS-G---KVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLI 391 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 391 (560)
+|++.+.||+|+||.||+|..+. + ..||||.+..... ....+.|..|+.+++.++||||+++++++..+...++|
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCC-HHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 47788999999999999998653 3 3699999875432 33456799999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 471 (560)
|||+++|+|.+++..... .+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 999999999999976432 389999999999999999999998 999999999999999999999999999876543
Q ss_pred CCCCc---eeec--cccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccccc------------------c
Q 035761 472 DSSNR---TLLA--GTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSS------------------S 527 (560)
Q Consensus 472 ~~~~~---~~~~--g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~~------------------~ 527 (560)
..... .... .+..|+|||.+.+..++.++||||||+++||+++ |..||......+ .
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 238 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPT 238 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCH
Confidence 22111 1111 2357999999999999999999999999999987 999986443211 1
Q ss_pred ccccccccccccCCCCCCChhHHHhh
Q 035761 528 SLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 528 ~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
.+.+.+..|...+|..||++++++..
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~i~~~ 264 (269)
T cd05065 239 ALHQLMLDCWQKDRNARPKFGQIVST 264 (269)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 23344455666688888888877653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=281.00 Aligned_cols=220 Identities=28% Similarity=0.408 Sum_probs=180.2
Q ss_pred ceeeccCCeeEEEEEeCCCc-----------EEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEE
Q 035761 321 YCIGTGGYGSVYRARLPSGK-----------VVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMF 389 (560)
Q Consensus 321 ~~ig~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 389 (560)
+.||+|+||.||+|...+.. .|++|.+...... ...+.+|+.+++.++||||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 35899999999999875433 5777876643321 4678899999999999999999999988 7789
Q ss_pred EEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCC-------cEEEee
Q 035761 390 LIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEF-------EAFVAD 462 (560)
Q Consensus 390 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-------~~kl~D 462 (560)
+||||+++|+|.+++..... .+++..+..++.||+.||+|||+. +++||||||+||+++.++ .++++|
T Consensus 77 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCC
Confidence 99999999999999986542 489999999999999999999998 999999999999999887 799999
Q ss_pred eccccccCCCCCCceeeccccCccCccccccC--ccCcchhHHHHHHHHHHHHh-CCCCCCccccc--------------
Q 035761 463 FGIARLLNYDSSNRTLLAGTYGSIAPELAYTM--VVTEKYDVYSFGVVALEVLM-GKHPGELLSSS-------------- 525 (560)
Q Consensus 463 fg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~--~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~-------------- 525 (560)
||++..... .....++..|+|||++... .++.++||||||+++|||++ |..||......
T Consensus 152 fg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 227 (259)
T cd05037 152 PGIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPM 227 (259)
T ss_pred CCccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCCCCC
Confidence 999987543 2223466789999998876 78889999999999999999 68888655211
Q ss_pred --ccccccccccccccCCCCCCChhHHHhh
Q 035761 526 --SSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 526 --~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
...+.+.+..|...+|..||++.++++.
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 257 (259)
T cd05037 228 PDCAELANLINQCWTYDPTKRPSFRAILRD 257 (259)
T ss_pred CCchHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 1233455666777788899988888764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=296.87 Aligned_cols=196 Identities=23% Similarity=0.377 Sum_probs=169.0
Q ss_pred CCcccceeeccCCeeEEEEE-eCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccC-C-----CCcceeeeEEEeCCEE
Q 035761 316 DFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIR-H-----RNIVKLYGFCLHEKCM 388 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~~~ 388 (560)
+|++.+.||+|.||.|.+|. .++++.||||+++... ...++-+.|+.++..++ | -|+|++++++......
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k---~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK---RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh---HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 78999999999999999996 4569999999998543 33455678999999986 4 3899999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCC--CcEEEeeeccc
Q 035761 389 FLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSE--FEAFVADFGIA 466 (560)
Q Consensus 389 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~--~~~kl~Dfg~~ 466 (560)
|||+|.++. +|.++++.+.. ..++...++.|+.||+.||.+||+. +|||+||||+|||+.+- -.+||+|||.|
T Consensus 264 ciVfELL~~-NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 264 CIVFELLST-NLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeeehhhhh-hHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccc
Confidence 999999966 99999998654 4499999999999999999999999 99999999999999654 36999999999
Q ss_pred cccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcc
Q 035761 467 RLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELL 522 (560)
Q Consensus 467 ~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~ 522 (560)
++...... ...-+..|.|||++.+..|+.+.||||||||++||++|.+-|...
T Consensus 339 c~~~q~vy---tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 339 CFESQRVY---TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred cccCCcce---eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 98543222 345667899999999999999999999999999999997666533
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=289.61 Aligned_cols=237 Identities=25% Similarity=0.367 Sum_probs=190.2
Q ss_pred CCcccceeeccCCeeEEEEEeC---CCcEEEEEEccchh-hhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC--CEEE
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP---SGKVVALKKLHRLE-TELASLESFQNEARLLSQIRHRNIVKLYGFCLHE--KCMF 389 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 389 (560)
+|++.+.||+|+||.||+|..+ +++.||+|.+.... ......+.+.+|+++++.++||||+++++++... +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3777889999999999999875 47899999987633 1122234677899999999999999999999988 7899
Q ss_pred EEEeccCCCCHHHHhhcCCc--ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCC----CCcEEEeee
Q 035761 390 LIYEYMEMGSLFCILRTDEE--AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNS----EFEAFVADF 463 (560)
Q Consensus 390 lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~----~~~~kl~Df 463 (560)
+||||+++ ++.+++..... ...+++..+..++.||+.|++|||+. +++||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 67766643321 22488999999999999999999999 9999999999999999 899999999
Q ss_pred ccccccCCCCC---CceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCcccccc-------------
Q 035761 464 GIARLLNYDSS---NRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSSSS------------- 526 (560)
Q Consensus 464 g~~~~~~~~~~---~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~------------- 526 (560)
|++........ ......++..|+|||++.+ ..++.++||||||+++|||++|+.||.......
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987643222 1223457889999998765 457889999999999999999999996433211
Q ss_pred --------------------------------------------------cccccccccccccCCCCCCChhHHHhhcee
Q 035761 527 --------------------------------------------------SSLDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 527 --------------------------------------------------~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
..+.+.+..|...||+.||++.+++.|+|+
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 112234455778899999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=280.97 Aligned_cols=232 Identities=29% Similarity=0.454 Sum_probs=191.6
Q ss_pred hcCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
.++|.+.+.||+|+||.||+|..++++.||||.+..... ..+.+.+|+.++++++|+|++++++++..+...++|||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM---SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc---CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 467888999999999999999988888999999875432 23568899999999999999999999998889999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++++|.+++.... ...+++.++..++.|++.|++|||++ +++||||+|+||++++++.++++|||.+.......
T Consensus 82 ~~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 82 YMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred ccCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 999999999997643 23489999999999999999999999 99999999999999999999999999998764321
Q ss_pred CC-ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------------cccccccc
Q 035761 474 SN-RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------------SSSLDKNI 533 (560)
Q Consensus 474 ~~-~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------------~~~~~~~~ 533 (560)
.. .....++..|+|||.+.+..++.++||||+|+++||+++ |+.||...... ...+.+.+
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 237 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLM 237 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 11 112234568999999998889999999999999999998 99998643321 11234444
Q ss_pred ccccccCCCCCCChhHHHh
Q 035761 534 KLIDLLDPRLPPPGDQMIR 552 (560)
Q Consensus 534 ~~~~~~dp~~~p~~~~~~~ 552 (560)
..|...+|+.||+++++..
T Consensus 238 ~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 238 LQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHcccCcccCCCHHHHHH
Confidence 5666778888888877764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=288.82 Aligned_cols=237 Identities=24% Similarity=0.352 Sum_probs=190.1
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCC------
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEK------ 386 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 386 (560)
.++|+..+.||+|+||.||+|... +++.||||.+............+.+|++++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 356889999999999999999865 5889999988654322223345668999999999999999999987653
Q ss_pred --EEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeec
Q 035761 387 --CMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFG 464 (560)
Q Consensus 387 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 464 (560)
..++||||+.+ ++.+++.... ..+++.++..++.||+.||+|||+. +++|+||||+||+++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCC
Confidence 45999999975 8888876543 2389999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCC----ceeeccccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCCCCCccccc--------------
Q 035761 465 IARLLNYDSSN----RTLLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKHPGELLSSS-------------- 525 (560)
Q Consensus 465 ~~~~~~~~~~~----~~~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~-------------- 525 (560)
++......... .....++..|+|||.+.+. .++.++||||||+++|||++|+.||......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99876432211 1234567889999987664 4688999999999999999999998543210
Q ss_pred -----------------------------------ccccccccccccccCCCCCCChhHHHhhcee
Q 035761 526 -----------------------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 526 -----------------------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
.....+.+..|...||..||+++++++|+|+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0111235667788899999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=281.56 Aligned_cols=227 Identities=26% Similarity=0.426 Sum_probs=181.3
Q ss_pred eeeccCCeeEEEEEeCC-Cc--EEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCEEEEEEeccCC
Q 035761 322 CIGTGGYGSVYRARLPS-GK--VVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKCMFLIYEYMEM 397 (560)
Q Consensus 322 ~ig~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (560)
.||+|+||.||+|..++ +. .+++|.++.... ....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCC-HHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 58999999999998754 33 468888764322 23345788999999999 899999999999999999999999999
Q ss_pred CCHHHHhhcCC-------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeec
Q 035761 398 GSLFCILRTDE-------------EAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFG 464 (560)
Q Consensus 398 g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 464 (560)
|+|.+++.... ....+++.++..++.|++.|++|||+. +++||||||+||++++++.+|++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 99999987532 112488999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc------------------c
Q 035761 465 IARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS------------------S 525 (560)
Q Consensus 465 ~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~------------------~ 525 (560)
++....... .......+..|+|||++....++.++||||||+++|||++ |..||...+. .
T Consensus 158 l~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 236 (270)
T cd05047 158 LSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNC 236 (270)
T ss_pred Cccccchhh-hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCcC
Confidence 986432111 1111223567999999988889999999999999999997 9999964321 0
Q ss_pred ccccccccccccccCCCCCCChhHHHhh
Q 035761 526 SSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 526 ~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
...+.+.+..|...+|..||++++++..
T Consensus 237 ~~~~~~li~~~l~~~p~~Rps~~~il~~ 264 (270)
T cd05047 237 DDEVYDLMRQCWREKPYERPSFAQILVS 264 (270)
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 1123445566677788888888888765
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=279.44 Aligned_cols=202 Identities=26% Similarity=0.368 Sum_probs=171.4
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchh---hhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC--CEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLE---TELASLESFQNEARLLSQIRHRNIVKLYGFCLHE--KCM 388 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 388 (560)
.+|++.+.||+|+||.||+|... +++.||+|.+.... ........+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888999999999999999764 58899999875321 1234456788999999999999999999998764 467
Q ss_pred EEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccc
Q 035761 389 FLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARL 468 (560)
Q Consensus 389 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 468 (560)
++|+||+++++|.+++..... +++.....++.|++.|++|||+. +++||||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~---l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGA---LTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999999875432 78999999999999999999999 999999999999999999999999999986
Q ss_pred cCCC---CCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcc
Q 035761 469 LNYD---SSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELL 522 (560)
Q Consensus 469 ~~~~---~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~ 522 (560)
.... ........++..|+|||.+.+..++.++|+||||+++||+++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 212 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence 5321 11122345788999999999888899999999999999999999999644
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=283.49 Aligned_cols=229 Identities=22% Similarity=0.252 Sum_probs=182.9
Q ss_pred eeeccCCeeEEEEEeC-CCcEEEEEEccchhhhh-hhHHHHHHHHHHHh---ccCCCCcceeeeEEEeCCEEEEEEeccC
Q 035761 322 CIGTGGYGSVYRARLP-SGKVVALKKLHRLETEL-ASLESFQNEARLLS---QIRHRNIVKLYGFCLHEKCMFLIYEYME 396 (560)
Q Consensus 322 ~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~---~l~h~niv~l~~~~~~~~~~~lv~e~~~ 396 (560)
.||+|+||.||++... +++.+|+|.+....... .....+.+|..+++ ..+|||++.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 3899999999999864 58899999886543211 11223344444333 3479999999999999999999999999
Q ss_pred CCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCc
Q 035761 397 MGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNR 476 (560)
Q Consensus 397 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 476 (560)
+|+|.+++..... +++..+..++.|++.||+|||+. +++||||||+||++++++.++++|||++....... .
T Consensus 81 ~~~L~~~i~~~~~---l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--~ 152 (279)
T cd05633 81 GGDLHYHLSQHGV---FSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--P 152 (279)
T ss_pred CCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--c
Confidence 9999999875443 89999999999999999999999 99999999999999999999999999987653222 2
Q ss_pred eeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCccccc--------------------cccccccccc
Q 035761 477 TLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------------SSSLDKNIKL 535 (560)
Q Consensus 477 ~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------------~~~~~~~~~~ 535 (560)
....|+..|+|||.+.. ..++.++||||+||++|||++|+.||...... ...+...++.
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 232 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEG 232 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHH
Confidence 23468999999998864 56788999999999999999999999643221 1123455567
Q ss_pred ccccCCCCCC-----ChhHHHhhceeee
Q 035761 536 IDLLDPRLPP-----PGDQMIRQGIILI 558 (560)
Q Consensus 536 ~~~~dp~~~p-----~~~~~~~~~~~~~ 558 (560)
|...||..|| +++++++|.|+..
T Consensus 233 ~l~~~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 233 LLQRDVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred HhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence 7888999998 5999999988753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=256.12 Aligned_cols=215 Identities=25% Similarity=0.361 Sum_probs=172.4
Q ss_pred HhcCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHH-hccCCCCcceeeeEEEeCCEEEE
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLL-SQIRHRNIVKLYGFCLHEKCMFL 390 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~~~~~~l 390 (560)
..++......||+|++|.|-+.++ .+|+..|||++.....+ +..+....|+.+. +...+|.+|.++|...+++..|+
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~-q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI 122 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNS-QEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI 122 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcCh-HHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence 344555667799999999999875 57999999999866544 3334555666664 45589999999999999999999
Q ss_pred EEeccCCCCHHHHhhcC-CcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccccc
Q 035761 391 IYEYMEMGSLFCILRTD-EEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL 469 (560)
Q Consensus 391 v~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 469 (560)
.||.|+. +|..+.+.- ......++.-+-+||..+.+||.|||++. .+||||+||+|||++.+|++|+||||.+-.+
T Consensus 123 cME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 123 CMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred eHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceee
Confidence 9999975 776554321 22344888899999999999999999875 8999999999999999999999999999876
Q ss_pred CCCCCCceeeccccCccCccccc----cCccCcchhHHHHHHHHHHHHhCCCCCCcccccccccccc
Q 035761 470 NYDSSNRTLLAGTYGSIAPELAY----TMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKN 532 (560)
Q Consensus 470 ~~~~~~~~~~~g~~~~~aPE~~~----~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~~~~~~~ 532 (560)
.+ .-..+...|...|||||.+. ...|+-|+||||+|+.+.||.+++.||+...+.-.++.+.
T Consensus 200 ~d-SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqv 265 (282)
T KOG0984|consen 200 VD-SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQV 265 (282)
T ss_pred hh-hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHH
Confidence 42 22334456889999999765 4468899999999999999999999999777665554443
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=277.65 Aligned_cols=227 Identities=26% Similarity=0.374 Sum_probs=187.0
Q ss_pred ceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEeccCCCCH
Q 035761 321 YCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSL 400 (560)
Q Consensus 321 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 400 (560)
+.||+|+||.||++...+++.||+|.+...... .....+.+|++++++++|+||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 358999999999998877999999988764432 3456789999999999999999999999999999999999999999
Q ss_pred HHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCc--ee
Q 035761 401 FCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNR--TL 478 (560)
Q Consensus 401 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~~ 478 (560)
.+++..... .+++..+..++.|++.|++|||++ +++||||+|+||+++.++.++|+|||.+.......... ..
T Consensus 80 ~~~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 80 LTFLRKKKN--RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 999975432 378999999999999999999999 99999999999999999999999999997653211111 11
Q ss_pred eccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------------cccccccccccccc
Q 035761 479 LAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------------SSSLDKNIKLIDLL 539 (560)
Q Consensus 479 ~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------------~~~~~~~~~~~~~~ 539 (560)
..++..|+|||.+.+..++.++|+||||+++|||++ |..||...... ...+.+.+..|...
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 234 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAY 234 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhcc
Confidence 223567999999988889999999999999999999 88998644310 12344555666777
Q ss_pred CCCCCCChhHHHhh
Q 035761 540 DPRLPPPGDQMIRQ 553 (560)
Q Consensus 540 dp~~~p~~~~~~~~ 553 (560)
+|+.||++.++++.
T Consensus 235 ~p~~Rp~~~ell~~ 248 (251)
T cd05041 235 DPENRPSFSEIYNE 248 (251)
T ss_pred ChhhCcCHHHHHHH
Confidence 88888888888764
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=291.67 Aligned_cols=234 Identities=24% Similarity=0.332 Sum_probs=189.5
Q ss_pred ceeecc--CCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEeccCC
Q 035761 321 YCIGTG--GYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEM 397 (560)
Q Consensus 321 ~~ig~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (560)
..||+| +||.||++... +|+.||+|.+..........+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 99999999864 689999999875543334557889999999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCc-
Q 035761 398 GSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNR- 476 (560)
Q Consensus 398 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~- 476 (560)
|++.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 999999876432 2489999999999999999999998 99999999999999999999999998654332111111
Q ss_pred ------eeeccccCccCccccccC--ccCcchhHHHHHHHHHHHHhCCCCCCccccc-----------------------
Q 035761 477 ------TLLAGTYGSIAPELAYTM--VVTEKYDVYSFGVVALEVLMGKHPGELLSSS----------------------- 525 (560)
Q Consensus 477 ------~~~~g~~~~~aPE~~~~~--~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~----------------------- 525 (560)
....++..|+|||++.+. .++.++||||||+++|||++|+.||......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence 112345679999998764 4688999999999999999999999643210
Q ss_pred -----------------------------------------ccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 526 -----------------------------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 526 -----------------------------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
+..+.+.++.|...||..||+++++++|.|+.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~ 313 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ 313 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence 112345566688889999999999999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=249.56 Aligned_cols=199 Identities=26% Similarity=0.381 Sum_probs=174.1
Q ss_pred CCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
+|...+.||+|.||+||+|+.+ +++.||+|+++-.++...-..+..+|+.+++.++|+|||+++++...++..-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 3555678999999999999854 578999999987665555556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
|.. +|..|...-.+ .++.+...+++.|+++|+.|+|+. .+.|||+||.|.+|+.+|+.|++|||+++.+.-+-.
T Consensus 83 cdq-dlkkyfdslng--~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNG--DLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hhH-HHHHHHHhcCC--cCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 976 88888776443 389999999999999999999999 999999999999999999999999999998876665
Q ss_pred CceeeccccCccCccccccCc-cCcchhHHHHHHHHHHHHh-CCCCCC
Q 035761 475 NRTLLAGTYGSIAPELAYTMV-VTEKYDVYSFGVVALEVLM-GKHPGE 520 (560)
Q Consensus 475 ~~~~~~g~~~~~aPE~~~~~~-~~~~~Dv~s~G~il~el~~-g~~P~~ 520 (560)
..+..+.|..|.+|.++.+.. |++..|+||-||++.|+.. |++-|.
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfp 204 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCC
Confidence 666777899999999988865 7888999999999999997 665554
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=293.00 Aligned_cols=237 Identities=24% Similarity=0.319 Sum_probs=195.3
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEe----CCEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLH----EKCM 388 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~ 388 (560)
.++|++.+.||+|+||.||+|..+ +|+.||+|++..........+.+.+|+.+++.++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 367888999999999999999764 58999999987644333445667889999999999999999998764 3468
Q ss_pred EEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccc
Q 035761 389 FLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARL 468 (560)
Q Consensus 389 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 468 (560)
++||||+. |+|.+++..... +++..+..++.||+.||+|||+. +++||||||+||++++++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQP---LTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhccCCC---CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999996 689998875433 89999999999999999999998 999999999999999999999999999976
Q ss_pred cCCCCCC----ceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCcccc-------------------
Q 035761 469 LNYDSSN----RTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSS------------------- 524 (560)
Q Consensus 469 ~~~~~~~----~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~------------------- 524 (560)
....... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 5332211 123467889999998765 4588899999999999999999999954321
Q ss_pred -----------------------------cccccccccccccccCCCCCCChhHHHhhceee
Q 035761 525 -----------------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 525 -----------------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
....+...++.|...||+.||++.+++.++|+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~ 298 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA 298 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhh
Confidence 112234566778888999999999999999984
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=306.05 Aligned_cols=241 Identities=19% Similarity=0.270 Sum_probs=183.2
Q ss_pred HhcCCcccceeeccCCeeEEEEEeCC--CcEEEEEE--------------ccc-hhhhhhhHHHHHHHHHHHhccCCCCc
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARLPS--GKVVALKK--------------LHR-LETELASLESFQNEARLLSQIRHRNI 375 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~--------------~~~-~~~~~~~~~~~~~e~~~l~~l~h~ni 375 (560)
..++|++.+.||+|+||.||++..+. +..+++|. +.+ ..........+.+|+.++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 35689999999999999999986532 22222221 111 01112234567899999999999999
Q ss_pred ceeeeEEEeCCEEEEEEeccCCCCHHHHhhcCCc--ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeC
Q 035761 376 VKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEE--AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLN 453 (560)
Q Consensus 376 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~ 453 (560)
+++++++...+..++|+|++. +++.+++..... .......+...++.||+.||+|||+. +||||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 999999999999999999985 577777654321 11234566788999999999999999 999999999999999
Q ss_pred CCCcEEEeeeccccccCCCCC-CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCC-CCccccc------
Q 035761 454 SEFEAFVADFGIARLLNYDSS-NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHP-GELLSSS------ 525 (560)
Q Consensus 454 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P-~~~~~~~------ 525 (560)
.++.+||+|||+++.+..... ......|+..|+|||++.+..++.++|||||||++|||++|..| |......
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 999999999999987653322 22235689999999999999999999999999999999998754 4321100
Q ss_pred ---------c------------------------------------cccccccccccccCCCCCCChhHHHhhceee
Q 035761 526 ---------S------------------------------------SSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 526 ---------~------------------------------------~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
. ..+...+..|...||..||++.+++.|+|+.
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~ 458 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFS 458 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhh
Confidence 0 0011113457889999999999999999975
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=281.39 Aligned_cols=230 Identities=26% Similarity=0.374 Sum_probs=194.8
Q ss_pred eeccCCeeEEEEEeCC-CcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEeccCCCCH
Q 035761 323 IGTGGYGSVYRARLPS-GKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSL 400 (560)
Q Consensus 323 ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 400 (560)
||+|+||.||++.... |+.+++|.+..... .....+.+.+|++++++++|||++++++.+..++..++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 5899999999998764 89999999875432 224456788999999999999999999999999999999999999999
Q ss_pred HHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC------
Q 035761 401 FCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS------ 474 (560)
Q Consensus 401 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~------ 474 (560)
.++++... .+++..+..++.|+++||+|||+. +++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99997644 389999999999999999999999 999999999999999999999999999876533211
Q ss_pred --CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc-------------------cccccccc
Q 035761 475 --NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS-------------------SSSLDKNI 533 (560)
Q Consensus 475 --~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~-------------------~~~~~~~~ 533 (560)
......++..|+|||.......+.++||||||+++||+++|+.||...... ...+...+
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 234 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLI 234 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHH
Confidence 223345788999999998888899999999999999999999998633210 23345666
Q ss_pred ccccccCCCCCCCh---hHHHhhceeee
Q 035761 534 KLIDLLDPRLPPPG---DQMIRQGIILI 558 (560)
Q Consensus 534 ~~~~~~dp~~~p~~---~~~~~~~~~~~ 558 (560)
+.|...+|+.||++ .+++.++|+..
T Consensus 235 ~~~l~~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 235 SKLLVPDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred HHHhcCCHhhcCCCccHHHHhcCccccC
Confidence 77788899999999 99999999863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=274.42 Aligned_cols=236 Identities=26% Similarity=0.301 Sum_probs=186.1
Q ss_pred CcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHH-hccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 317 FDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLL-SQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 317 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
.+....||.|+||+|+|-.++ .|+.+|||+++....+.+ .+++..|.+.. +.-+.||||+++|++..++..|+.||.
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~ke-q~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKE-QKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHH-HHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 344566999999999999764 699999999987766433 34566666654 445899999999999999999999999
Q ss_pred cCCCCHHHHhhcC--CcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 395 MEMGSLFCILRTD--EEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 395 ~~~g~L~~~l~~~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
|+- ++..+.+.- -....+++.-+-.|....++||+||-+.. .|||||+||+|||++..|.+|+||||.+-.+..
T Consensus 145 Md~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~- 220 (361)
T KOG1006|consen 145 MDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD- 220 (361)
T ss_pred Hhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH-
Confidence 965 664443221 11233788888888889999999998764 899999999999999999999999999977642
Q ss_pred CCCceeeccccCccCcccccc--CccCcchhHHHHHHHHHHHHhCCCCCCcccccc------------------------
Q 035761 473 SSNRTLLAGTYGSIAPELAYT--MVVTEKYDVYSFGVVALEVLMGKHPGELLSSSS------------------------ 526 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~--~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~------------------------ 526 (560)
....+.-+|...|||||-+.. ..|+-+|||||+|+.+||+.||+.|+..+++.-
T Consensus 221 SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s 300 (361)
T KOG1006|consen 221 SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYS 300 (361)
T ss_pred HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccC
Confidence 233444578889999998764 348889999999999999999999997666422
Q ss_pred cccccccccccccCCCCCCChhHHHhhceee
Q 035761 527 SSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 527 ~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
..+.+.+..|..-|-+.||..+++....|+.
T Consensus 301 ~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr 331 (361)
T KOG1006|consen 301 FSMVRFINTCLIKDRSDRPKYDDLKKFPFYR 331 (361)
T ss_pred HHHHHHHHHHhhcccccCcchhhhhcCchhh
Confidence 2244555677778999999999999887753
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=283.76 Aligned_cols=234 Identities=27% Similarity=0.367 Sum_probs=196.7
Q ss_pred CcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEecc
Q 035761 317 FDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYM 395 (560)
Q Consensus 317 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 395 (560)
|+..+.||+|++|.||+|... +++.+++|.+............+.+|+++++.++|+||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456788999999999999864 6889999998765443344567888999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCC
Q 035761 396 EMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSN 475 (560)
Q Consensus 396 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 475 (560)
++ ++.+++.... ..+++.++..++.|+++|++|||+. +++|+||+|+||++++++.++|+|||.+.........
T Consensus 81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP 154 (283)
T ss_pred CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc
Confidence 75 8888887643 2489999999999999999999999 9999999999999999999999999999877544322
Q ss_pred ceeeccccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCCCCCcccc------------------------------
Q 035761 476 RTLLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKHPGELLSS------------------------------ 524 (560)
Q Consensus 476 ~~~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~P~~~~~~------------------------------ 524 (560)
.....++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||...+.
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 2334577889999998776 788899999999999999999999854331
Q ss_pred -----------------cccccccccccccccCCCCCCChhHHHhhcee
Q 035761 525 -----------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 525 -----------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
.+..+.+.++.|...||..||++.+++.++|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 11234466778888899999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=290.47 Aligned_cols=235 Identities=23% Similarity=0.348 Sum_probs=191.4
Q ss_pred hcCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCC-----E
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEK-----C 387 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~ 387 (560)
.++|++.+.||+|+||.||+|.. .+|+.||+|++..... ......+.+|+.++++++||||+++++++.... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH-QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 46799999999999999999975 4689999999864322 233456788999999999999999999876543 4
Q ss_pred EEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccc
Q 035761 388 MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIAR 467 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~ 467 (560)
.++|+||+++ ++.+++... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++|+|||++.
T Consensus 83 ~~lv~e~~~~-~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 83 VYIVQELMET-DLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEEehhccc-CHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccccee
Confidence 7999999975 888877643 389999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCCC---ceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCcccc-------------------
Q 035761 468 LLNYDSSN---RTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSS------------------- 524 (560)
Q Consensus 468 ~~~~~~~~---~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~------------------- 524 (560)
........ .....|+..|+|||.+.+ ..++.++||||+|+++|||++|+.||...+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL 234 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 65432221 122457889999998654 5678899999999999999999999954221
Q ss_pred -----------------------------cccccccccccccccCCCCCCChhHHHhhceee
Q 035761 525 -----------------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 525 -----------------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
....+...++.|...||..||++.+++.++|+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~ 296 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLE 296 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccc
Confidence 112233456677888999999999999999985
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=290.89 Aligned_cols=232 Identities=26% Similarity=0.319 Sum_probs=190.1
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCC------
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEK------ 386 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 386 (560)
.++|...+.||+|+||.||+|... +|+.||||++............+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 468889999999999999999864 6899999998754332233456789999999999999999999987542
Q ss_pred EEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccc
Q 035761 387 CMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIA 466 (560)
Q Consensus 387 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~ 466 (560)
..++|+||+.. ++..+... .+++.++..++.|+++||+|||+. +++||||||+||+++.++.++|+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMGH-----PLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 46899999975 77766531 288999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCCceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------
Q 035761 467 RLLNYDSSNRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSS--------------------- 524 (560)
Q Consensus 467 ~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~--------------------- 524 (560)
+..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.
T Consensus 165 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07879 165 RHADAE---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK 241 (342)
T ss_pred cCCCCC---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 765321 223457888999998876 4688899999999999999999999974321
Q ss_pred ---------------------------cccccccccccccccCCCCCCChhHHHhhceee
Q 035761 525 ---------------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 525 ---------------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
....+.+.++.|...||..||++++++.|+|+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~ 301 (342)
T cd07879 242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFD 301 (342)
T ss_pred hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchh
Confidence 011233556667888999999999999999874
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=279.64 Aligned_cols=231 Identities=26% Similarity=0.401 Sum_probs=189.7
Q ss_pred hcCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
.++|++.+.||+|+||.||+|...++..+|+|.+.... ...+.+.+|++++++++|+|++++.+++.+ ...+++||
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 46788999999999999999998788889999887533 234578899999999999999999999887 67899999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++|+|.+++.... ...+++.++..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 81 FMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred eCCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 999999999997643 23478999999999999999999998 99999999999999999999999999997654322
Q ss_pred CC-ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------------cccccccc
Q 035761 474 SN-RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------------SSSLDKNI 533 (560)
Q Consensus 474 ~~-~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------------~~~~~~~~ 533 (560)
.. .....++..|+|||++....++.++|+||||+++||+++ |+.||...+.. ...+...+
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 236 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIM 236 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHH
Confidence 11 122335678999999998889999999999999999999 99999754321 11234455
Q ss_pred ccccccCCCCCCChhHHHh
Q 035761 534 KLIDLLDPRLPPPGDQMIR 552 (560)
Q Consensus 534 ~~~~~~dp~~~p~~~~~~~ 552 (560)
..|...+|+.||+++++..
T Consensus 237 ~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 237 MRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHcccCcccCcCHHHHHH
Confidence 6666778888888777654
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=279.48 Aligned_cols=234 Identities=25% Similarity=0.368 Sum_probs=190.5
Q ss_pred CCcccceeeccCCeeEEEEEeCC--CcEEEEEEccchh--------hhhhhHHHHHHHHHHHhc-cCCCCcceeeeEEEe
Q 035761 316 DFDIKYCIGTGGYGSVYRARLPS--GKVVALKKLHRLE--------TELASLESFQNEARLLSQ-IRHRNIVKLYGFCLH 384 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~~~~~~--------~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~ 384 (560)
+|++.+.||+|+||.||+|..+. ++.+|+|.+.... ........+.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36778889999999999998765 6889999875322 112234557788888875 799999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHhhcC-CcccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEeCCCCCCeEeCCCCcEEEee
Q 035761 385 EKCMFLIYEYMEMGSLFCILRTD-EEAVGLDWTKRVNIVKGMAHALSYLHH-HCTPPILHRDISSNNILLNSEFEAFVAD 462 (560)
Q Consensus 385 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~D 462 (560)
++..+++|||+++++|.+++... .....+++..+..++.|++.|+.|||+ . +++||||+|+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999887542 122348999999999999999999996 5 899999999999999999999999
Q ss_pred eccccccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc------------------
Q 035761 463 FGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS------------------ 524 (560)
Q Consensus 463 fg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~------------------ 524 (560)
||.+....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 158 fg~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd08528 158 FGLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEG 236 (269)
T ss_pred ccceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcc
Confidence 99998765433 33345688899999999988899999999999999999999999864321
Q ss_pred -cccccccccccccccCCCCCCChhHHHhh
Q 035761 525 -SSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 525 -~~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
....+.+.++.|...||+.||++.++...
T Consensus 237 ~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 237 MYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred cCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 11234455567788899999998887654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=283.45 Aligned_cols=234 Identities=30% Similarity=0.412 Sum_probs=192.6
Q ss_pred CcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC--CEEEEEEe
Q 035761 317 FDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHE--KCMFLIYE 393 (560)
Q Consensus 317 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 393 (560)
|++.+.||+|+||.||+|... +++.+|+|++..........+.+.+|+++++.++|||++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 566788999999999999876 488999999986543334445788999999999999999999999988 88999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++ +|.+++.... ..+++.++..++.||++|++|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9975 8888886542 2489999999999999999999998 99999999999999999999999999998765432
Q ss_pred C-CceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCccccc--------------------------
Q 035761 474 S-NRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSSS-------------------------- 525 (560)
Q Consensus 474 ~-~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~-------------------------- 525 (560)
. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||+.....
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence 1 1223356788999997765 45788999999999999999999998643310
Q ss_pred ----------------------ccccccccccccccCCCCCCChhHHHhhcee
Q 035761 526 ----------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 526 ----------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
...+.+.++.|...+|..||++.+++.+.|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 1122344566777899999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=281.50 Aligned_cols=231 Identities=23% Similarity=0.267 Sum_probs=186.4
Q ss_pred CcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccC-CCCcceeeeEEEeC--CEEEEEE
Q 035761 317 FDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIR-HRNIVKLYGFCLHE--KCMFLIY 392 (560)
Q Consensus 317 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~ 392 (560)
|++.+.||+|+||.||+|... +++.||+|+++........ ....+|+.++.++. |+|++++++++.++ +..++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 456788999999999999754 6889999998754322222 23457888888884 99999999999987 8899999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||++ |++.+++.... ..+++.++..++.|++.||+|||+. +++||||+|+||+++. +.+||+|||.++.....
T Consensus 80 e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 80 ELMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred ecCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 9997 58888876533 2389999999999999999999999 9999999999999999 99999999999876432
Q ss_pred CCCceeeccccCccCccccc-cCccCcchhHHHHHHHHHHHHhCCCCCCccccc--------------------------
Q 035761 473 SSNRTLLAGTYGSIAPELAY-TMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS-------------------------- 525 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~-~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~-------------------------- 525 (560)
.. .....++..|+|||.+. +..++.++||||+||++|||++|+.||...+..
T Consensus 153 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 153 PP-YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred CC-cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence 22 22345788999999764 455788999999999999999999999643210
Q ss_pred --------------------ccccccccccccccCCCCCCChhHHHhhcee
Q 035761 526 --------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 526 --------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
...+.+.++.|...+|..||+++++++++|+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1223344566788899999999999999985
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=283.29 Aligned_cols=230 Identities=27% Similarity=0.394 Sum_probs=192.8
Q ss_pred cceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEeccCCC
Q 035761 320 KYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMG 398 (560)
Q Consensus 320 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (560)
...||+|+||.||++..+ +++.||||++.... ......+.+|+.+++.++|+|++++++++...+..++||||++++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 356999999999999764 68899999875432 233456889999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCcee
Q 035761 399 SLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTL 478 (560)
Q Consensus 399 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 478 (560)
+|.+++... .+++.....++.|++.|++|||+. |++||||+|+||+++.++.++|+|||++............
T Consensus 103 ~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~ 175 (292)
T cd06657 103 ALTDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 175 (292)
T ss_pred cHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccccccc
Confidence 999987543 279999999999999999999999 9999999999999999999999999998766433323334
Q ss_pred eccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc--------------------ccccccccccccc
Q 035761 479 LAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------------SSSLDKNIKLIDL 538 (560)
Q Consensus 479 ~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------------~~~~~~~~~~~~~ 538 (560)
..+++.|+|||...+..++.++|+||+|+++|||++|+.||...... ...+...+..|..
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 255 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLV 255 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHh
Confidence 56889999999998888899999999999999999999998643211 1112334566677
Q ss_pred cCCCCCCChhHHHhhceeee
Q 035761 539 LDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 539 ~dp~~~p~~~~~~~~~~~~~ 558 (560)
.+|..||++.+++.|.|+..
T Consensus 256 ~~P~~R~~~~~ll~~~~~~~ 275 (292)
T cd06657 256 RDPAQRATAAELLKHPFLAK 275 (292)
T ss_pred CCcccCcCHHHHhcChHHhc
Confidence 89999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=282.29 Aligned_cols=234 Identities=26% Similarity=0.374 Sum_probs=190.8
Q ss_pred CcccceeeccCCeeEEEEEeCC-CcEEEEEEccchhhhhhhHHHHHHHHHHHhcc---CCCCcceeeeEEEeCCE-----
Q 035761 317 FDIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRLETELASLESFQNEARLLSQI---RHRNIVKLYGFCLHEKC----- 387 (560)
Q Consensus 317 ~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~----- 387 (560)
|++.+.||+|+||.||+|..+. ++.||+|.++...........+.+|+.+++++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5667889999999999998764 89999999875433222234566777777665 69999999999988776
Q ss_pred EEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccc
Q 035761 388 MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIAR 467 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~ 467 (560)
.+++|||+++ +|.+++..... ..+++.++..++.|+++||+|||+. +++|+|++|+||++++++.++|+|||.+.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999975 89888875432 2489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc----------------------
Q 035761 468 LLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS---------------------- 525 (560)
Q Consensus 468 ~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~---------------------- 525 (560)
.+..... .....++..|+|||.+.+..++.++|+||||+++|||++|+.||......
T Consensus 156 ~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 156 IYSFEMA-LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred eccCCcc-cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 7643322 22334788999999999999999999999999999999999998643210
Q ss_pred ----------------------ccccccccccccccCCCCCCChhHHHhhcee
Q 035761 526 ----------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 526 ----------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
...+.+.++.|...||+.||++++++.|+|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0112344567788899999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=289.91 Aligned_cols=235 Identities=25% Similarity=0.368 Sum_probs=190.4
Q ss_pred cCCcccceeeccCCeeEEEEEeC--------CCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeC
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP--------SGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLHE 385 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 385 (560)
.+|.+.+.||+|+||.||+|... .+..||+|.++... .....+.+.+|+++++++ +||||+++++++..+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 46888999999999999999642 12368999887432 223456788999999999 899999999999999
Q ss_pred CEEEEEEeccCCCCHHHHhhcCC-------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEe
Q 035761 386 KCMFLIYEYMEMGSLFCILRTDE-------------EAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILL 452 (560)
Q Consensus 386 ~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill 452 (560)
+..++++||+++|+|.+++.... ....+++.++..++.|++.||+|||+. +++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEE
Confidence 99999999999999999987532 123488999999999999999999998 99999999999999
Q ss_pred CCCCcEEEeeeccccccCCCCCCc--eeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc----
Q 035761 453 NSEFEAFVADFGIARLLNYDSSNR--TLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS---- 525 (560)
Q Consensus 453 ~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~---- 525 (560)
+.++.+||+|||+++......... ....++..|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 247 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 247 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 999999999999998654322111 11223567999999999999999999999999999998 88998644311
Q ss_pred --------------ccccccccccccccCCCCCCChhHHHhh
Q 035761 526 --------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 526 --------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
...+.+.++.|...+|..||++.+++.+
T Consensus 248 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 248 LLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 1123445666777899999999988875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=280.65 Aligned_cols=235 Identities=24% Similarity=0.372 Sum_probs=192.5
Q ss_pred cCCcccceeeccCCeeEEEEEeC------CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCM 388 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 388 (560)
++|+....||+|+||.||+|+.+ +.+.|++|.+..... ....+.+.+|++++++++|+||+++++++.+....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD-ENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc-hHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 56888899999999999999864 246799998865332 22456788999999999999999999999998999
Q ss_pred EEEEeccCCCCHHHHhhcCCcc------cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEee
Q 035761 389 FLIYEYMEMGSLFCILRTDEEA------VGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVAD 462 (560)
Q Consensus 389 ~lv~e~~~~g~L~~~l~~~~~~------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 462 (560)
++||||+++|+|.+++...... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcc
Confidence 9999999999999999765422 1489999999999999999999999 999999999999999999999999
Q ss_pred eccccccCCCCC-CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc----------------
Q 035761 463 FGIARLLNYDSS-NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS---------------- 524 (560)
Q Consensus 463 fg~~~~~~~~~~-~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~---------------- 524 (560)
||++........ ......++..|+|||.+.+..++.++||||||+++||+++ |..||.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 240 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV 240 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCC
Confidence 999875432211 1222346778999999988888999999999999999999 8889854321
Q ss_pred ---cccccccccccccccCCCCCCChhHHHhh
Q 035761 525 ---SSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 525 ---~~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
....+.+.+..|...+|..||++.+++..
T Consensus 241 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 241 PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 11234566677778899999999988764
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=289.21 Aligned_cols=240 Identities=24% Similarity=0.318 Sum_probs=196.0
Q ss_pred HHHHHHHhcCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC
Q 035761 307 FQDMIEATEDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHE 385 (560)
Q Consensus 307 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 385 (560)
..++...+++|+..+.||+|+||.||+|.. .+++.||+|++..........+.+.+|++++++++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 355667789999999999999999999975 5689999999876443333445678899999999999999999988643
Q ss_pred ------CEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEE
Q 035761 386 ------KCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAF 459 (560)
Q Consensus 386 ------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 459 (560)
...+++++++ +++|.+++... .+++..+..++.|+++|++|||+. +++||||||+||++++++.++
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEE
Confidence 3467888877 77998887643 289999999999999999999999 999999999999999999999
Q ss_pred EeeeccccccCCCCCCceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCccccc-------------
Q 035761 460 VADFGIARLLNYDSSNRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSSS------------- 525 (560)
Q Consensus 460 l~Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~------------- 525 (560)
|+|||+++.... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+..
T Consensus 161 l~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (345)
T cd07877 161 ILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 237 (345)
T ss_pred Eecccccccccc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999999876432 2223457889999998766 46788999999999999999999999633210
Q ss_pred -----------------------------------ccccccccccccccCCCCCCChhHHHhhceee
Q 035761 526 -----------------------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 526 -----------------------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
...+.+.+..|...||..||++.+++.|.|+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~ 304 (345)
T cd07877 238 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 304 (345)
T ss_pred CHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhh
Confidence 11123444567788999999999999999975
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=290.82 Aligned_cols=236 Identities=29% Similarity=0.400 Sum_probs=192.1
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeC--CEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLHE--KCMF 389 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--~~~~ 389 (560)
.++|++.+.||+|+||.||+|... +++.+|+|++............+.+|+.+++++ +||||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 467888899999999999999865 578999998864332223345677899999999 999999999998654 3689
Q ss_pred EEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccccc
Q 035761 390 LIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL 469 (560)
Q Consensus 390 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 469 (560)
+||||++ ++|.+++... .+++..+..++.||+.||+|||+. +++||||||+||+++.++.+||+|||.+...
T Consensus 86 lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 9999997 5999888754 388999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCC-----CceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCccccc------------------
Q 035761 470 NYDSS-----NRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSSS------------------ 525 (560)
Q Consensus 470 ~~~~~-----~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~------------------ 525 (560)
..... ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 43221 1223457889999998765 45788999999999999999999999643210
Q ss_pred ------------------------------ccccccccccccccCCCCCCChhHHHhhceee
Q 035761 526 ------------------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 526 ------------------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
...+.+.+..|...||..||++.+++++.|+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~ 299 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVA 299 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhh
Confidence 11223455667788999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=290.84 Aligned_cols=237 Identities=23% Similarity=0.303 Sum_probs=193.7
Q ss_pred hcCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC-----CE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHE-----KC 387 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 387 (560)
..+|.+.+.||+|+||.||+|.. .+++.||||.+............+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 35688899999999999999975 4689999999875432223345667899999999999999999988654 34
Q ss_pred EEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccc
Q 035761 388 MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIAR 467 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~ 467 (560)
.++|+||+. ++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 68988887543 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCcccc----------------------
Q 035761 468 LLNYDSSNRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------- 524 (560)
Q Consensus 468 ~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------- 524 (560)
.............++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 157 TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred ccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 76443333333457889999998765 4688899999999999999999999964310
Q ss_pred --------------------------cccccccccccccccCCCCCCChhHHHhhceee
Q 035761 525 --------------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 525 --------------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
....+.+.++.|...+|..||+++++++|.|+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~ 295 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLA 295 (337)
T ss_pred CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchh
Confidence 111223556677888999999999999999974
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=277.68 Aligned_cols=236 Identities=27% Similarity=0.362 Sum_probs=199.7
Q ss_pred CCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
+|++.+.||+|+||.||++... +++.+++|.+............+.+|+++++.++|+||+++.+++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778889999999999999754 678999999876543334456778899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCC-cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 395 MEMGSLFCILRTDE-EAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 395 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
+++++|.+++.... ....+++..+..++.|++.|++|||+. +++||||+|+||++++++.+|++|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999999986522 123489999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc------------------cccccccccc
Q 035761 474 SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS------------------SSSLDKNIKL 535 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~------------------~~~~~~~~~~ 535 (560)
......+++.|+|||...+..++.++|+||+|+++||+++|+.||...+.. ..++...+..
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 235 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRS 235 (256)
T ss_pred -CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHH
Confidence 222345788999999999998999999999999999999999999754421 1224455667
Q ss_pred ccccCCCCCCChhHHHhhcee
Q 035761 536 IDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 536 ~~~~dp~~~p~~~~~~~~~~~ 556 (560)
|...+|..||++.++++++++
T Consensus 236 ~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 236 MLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HcCCCcccCCCHHHHhcCCCC
Confidence 778899999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=280.56 Aligned_cols=231 Identities=25% Similarity=0.419 Sum_probs=186.2
Q ss_pred cCCcccceeeccCCeeEEEEEeCC-Cc----EEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPS-GK----VVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMF 389 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 389 (560)
.+|++.+.||+|+||.||+|.+++ |. .+|+|.+..... ......+.+|+..+++++|||++++++++.. ...+
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 567888999999999999998643 32 589998765432 2344678899999999999999999999987 7789
Q ss_pred EEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccccc
Q 035761 390 LIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL 469 (560)
Q Consensus 390 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 469 (560)
+||||+++|+|.+++..... .+++..+..++.||+.|++|||+. +++||||||+||+++.++.+||+|||.++..
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEEecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 99999999999999976433 389999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCCce--eeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccccc------------------cc
Q 035761 470 NYDSSNRT--LLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSS------------------SS 528 (560)
Q Consensus 470 ~~~~~~~~--~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~~------------------~~ 528 (560)
........ ...++..|+|||.+....++.++|+||||+++||+++ |+.||......+ ..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTID 239 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHH
Confidence 53222111 1223568999999988889999999999999999998 999997543211 11
Q ss_pred cccccccccccCCCCCCChhHHHh
Q 035761 529 LDKNIKLIDLLDPRLPPPGDQMIR 552 (560)
Q Consensus 529 ~~~~~~~~~~~dp~~~p~~~~~~~ 552 (560)
+......|...||..||++.+++.
T Consensus 240 ~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 240 VYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHHHHcCCChhhCCCHHHHHH
Confidence 223334556668888888877654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=285.28 Aligned_cols=232 Identities=23% Similarity=0.380 Sum_probs=185.5
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCc----EEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGK----VVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMF 389 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 389 (560)
++|+..+.||+|+||.||+|.+. +|. .||+|.+..... ......+.+|+.+++.++||||++++|++... ..+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG-PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 45777889999999999999763 343 478888765332 23344688999999999999999999998764 467
Q ss_pred EEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccccc
Q 035761 390 LIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL 469 (560)
Q Consensus 390 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 469 (560)
+++||+++|+|.+++..... .+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKD--NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeehhcCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccc
Confidence 99999999999999876432 388999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCC--ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------------ccc
Q 035761 470 NYDSSN--RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------------SSS 528 (560)
Q Consensus 470 ~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------------~~~ 528 (560)
...... .....++..|+|||.+.+..++.++||||||+++||+++ |..||...... ...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTID 239 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHH
Confidence 432221 122335678999999998999999999999999999998 99998643211 011
Q ss_pred cccccccccccCCCCCCChhHHHhh
Q 035761 529 LDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 529 ~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
+...+..|...+|..||+++++++.
T Consensus 240 ~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 240 VYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2334456666789999998887765
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=287.30 Aligned_cols=233 Identities=20% Similarity=0.274 Sum_probs=186.7
Q ss_pred ceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEeccCCCCH
Q 035761 321 YCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSL 400 (560)
Q Consensus 321 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 400 (560)
+.+|.|+++.||++.. +++.||||++..........+.+.+|+++++.++||||+++++++..++..+++|||+++|++
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3345555555555554 689999999876533344567899999999999999999999999999999999999999999
Q ss_pred HHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCC-----
Q 035761 401 FCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSN----- 475 (560)
Q Consensus 401 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~----- 475 (560)
.+++..... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++++|||.+.........
T Consensus 87 ~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 87 EDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 999976432 2388999999999999999999999 9999999999999999999999999988765322211
Q ss_pred --ceeeccccCccCccccccC--ccCcchhHHHHHHHHHHHHhCCCCCCcccccc-------------------------
Q 035761 476 --RTLLAGTYGSIAPELAYTM--VVTEKYDVYSFGVVALEVLMGKHPGELLSSSS------------------------- 526 (560)
Q Consensus 476 --~~~~~g~~~~~aPE~~~~~--~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~------------------------- 526 (560)
.....++..|+|||++... .++.++|||||||++|||++|+.||.......
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDS 242 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCC
Confidence 1223467789999998763 57889999999999999999999997433110
Q ss_pred --------------------------cccccccccccccCCCCCCChhHHHhhceeee
Q 035761 527 --------------------------SSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 527 --------------------------~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
..+...++.|...||+.||++++++.++|+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~ 300 (314)
T cd08216 243 MSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQ 300 (314)
T ss_pred cCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhh
Confidence 01223455577789999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=283.15 Aligned_cols=236 Identities=25% Similarity=0.357 Sum_probs=191.2
Q ss_pred cCCcccceeeccCCeeEEEEEeCC-CcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|++.+.||+|+||.||+|..++ ++.||||.++..... .....+..|+.++.+. +||||+++++++..+...++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 567889999999999999998865 899999998754322 2234556677766666 5999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHH-HCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 471 (560)
||+++ ++.++...... .+++..+..++.|+++|++|||+ . +++||||+|+||++++++.++|+|||++..+..
T Consensus 94 e~~~~-~l~~l~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 94 ELMST-CLDKLLKRIQG--PIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eccCc-CHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 99854 77776654322 48999999999999999999996 5 899999999999999999999999999977643
Q ss_pred CCCCceeeccccCccCccccccCc----cCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------cc
Q 035761 472 DSSNRTLLAGTYGSIAPELAYTMV----VTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------SS 526 (560)
Q Consensus 472 ~~~~~~~~~g~~~~~aPE~~~~~~----~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------~~ 526 (560)
... .....++..|+|||.+.+.. ++.++||||||+++|||++|+.||..... ..
T Consensus 168 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (296)
T cd06618 168 SKA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFS 246 (296)
T ss_pred CCc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCC
Confidence 222 22335778999999987654 78899999999999999999999964211 01
Q ss_pred cccccccccccccCCCCCCChhHHHhhceeee
Q 035761 527 SSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 527 ~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
..+.+.++.|...||..||++++++++.|+.+
T Consensus 247 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 278 (296)
T cd06618 247 PDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278 (296)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence 12445666778889999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=284.47 Aligned_cols=236 Identities=26% Similarity=0.305 Sum_probs=189.0
Q ss_pred CCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccC-CCCcceeeeEEEeCCEEEEEEe
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIR-HRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 393 (560)
+|+..+.||+|+||.||++... +++.||+|.+...... .....+.+|+.++.++. ||||+++++++..+...+++||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 4556678999999999999764 5899999998754332 34457889999999996 9999999999999999999999
Q ss_pred ccCCCCHHHHh---hcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccC
Q 035761 394 YMEMGSLFCIL---RTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN 470 (560)
Q Consensus 394 ~~~~g~L~~~l---~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 470 (560)
|++. ++.++. ... ....+++..+..++.|++.||+|||+.. +++||||||+||+++.++.++|+|||+++...
T Consensus 84 ~~~~-~l~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMDI-SLDKFYKYVYEV-LKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred cccC-CHHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9864 554433 221 1234899999999999999999999632 89999999999999999999999999997654
Q ss_pred CCCCCceeeccccCccCccccccC---ccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------------
Q 035761 471 YDSSNRTLLAGTYGSIAPELAYTM---VVTEKYDVYSFGVVALEVLMGKHPGELLSS----------------------- 524 (560)
Q Consensus 471 ~~~~~~~~~~g~~~~~aPE~~~~~---~~~~~~Dv~s~G~il~el~~g~~P~~~~~~----------------------- 524 (560)
... ......|+..|+|||++.+. .++.++||||||+++|||++|+.||.....
T Consensus 160 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd06616 160 DSI-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEERE 238 (288)
T ss_pred cCC-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCc
Confidence 322 12233578899999998876 688899999999999999999999864321
Q ss_pred cccccccccccccccCCCCCCChhHHHhhceee
Q 035761 525 SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 525 ~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
....+.+.++.|...||..||++++++.++|+.
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 271 (288)
T cd06616 239 FSPSFVNFINLCLIKDESKRPKYKELLEHPFIK 271 (288)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcChhhh
Confidence 011234556777788999999999999999974
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=282.57 Aligned_cols=234 Identities=27% Similarity=0.340 Sum_probs=195.8
Q ss_pred CcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEecc
Q 035761 317 FDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYM 395 (560)
Q Consensus 317 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 395 (560)
|+..+.||+|.+|.||+|... +++.+|+|.+..........+.+..|+++++.++|+|++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456678999999999999875 4899999998765433334456788999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCC
Q 035761 396 EMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSN 475 (560)
Q Consensus 396 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 475 (560)
+ ++|.+++.... ..+++.++..++.|+++|++|||+. +++||||+|+||++++++.++|+|||.+.........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence 8 58999998653 2389999999999999999999999 9999999999999999999999999999876543323
Q ss_pred ceeeccccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCCCCCcccc------------------------------
Q 035761 476 RTLLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKHPGELLSS------------------------------ 524 (560)
Q Consensus 476 ~~~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~P~~~~~~------------------------------ 524 (560)
.....++..|+|||.+.+. .++.++||||||+++||+++|+.||.....
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 3334457789999998776 788899999999999999999999854321
Q ss_pred ----------------cccccccccccccccCCCCCCChhHHHhhcee
Q 035761 525 ----------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 525 ----------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
....+.+.++.|...||+.||++.+++.++|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 01224455677788899999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=281.75 Aligned_cols=233 Identities=27% Similarity=0.384 Sum_probs=190.6
Q ss_pred cCCcccceeeccCCeeEEEEEeC-----CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEe--CCE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-----SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLH--EKC 387 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~ 387 (560)
++|+..+.||+|+||.||+|.+. ++..+|||.+...... ...+.+.+|+++++.++||||+++++++.. ...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 35777889999999999999853 3678999998765433 345679999999999999999999999987 557
Q ss_pred EEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccc
Q 035761 388 MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIAR 467 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~ 467 (560)
.++||||+++++|.+++..... .+++.++..++.|++.||+|||+. +++||||||+||+++.++.++|+|||.+.
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 8999999999999999976543 389999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCCc---eeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccccc------------------
Q 035761 468 LLNYDSSNR---TLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSS------------------ 526 (560)
Q Consensus 468 ~~~~~~~~~---~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~------------------ 526 (560)
......... ....++..|+|||...+..++.++||||||+++|||++|+.|+.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 765322211 11234567999999988889999999999999999999999976432111
Q ss_pred ---------------cccccccccccccCCCCCCChhHHHhh
Q 035761 527 ---------------SSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 527 ---------------~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
..+.+.+..|...+|..||++.+++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05038 238 LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILI 279 (284)
T ss_pred HHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 123355566677788888888888764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=280.68 Aligned_cols=222 Identities=24% Similarity=0.380 Sum_probs=180.3
Q ss_pred ceeeccCCeeEEEEEeCC--------CcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 321 YCIGTGGYGSVYRARLPS--------GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 321 ~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
+.||+|+||.||+|..+. ...|++|.+.... ....+.+.+|+.+++.++|||++++++++..++..++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 358999999999997532 2348888875432 234457888999999999999999999999989999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCc--------EEEeeec
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFE--------AFVADFG 464 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--------~kl~Dfg 464 (560)
||+++|+|.++++.... .+++..+..++.||+.|++|||+. +|+||||||+||+++.++. ++++|||
T Consensus 79 e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 79 EYVKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred ecCCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccc
Confidence 99999999999976543 489999999999999999999999 9999999999999987765 5899999
Q ss_pred cccccCCCCCCceeeccccCccCccccccC-ccCcchhHHHHHHHHHHHHhCC-CCCCccccc----------------c
Q 035761 465 IARLLNYDSSNRTLLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGK-HPGELLSSS----------------S 526 (560)
Q Consensus 465 ~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~-~P~~~~~~~----------------~ 526 (560)
.+..... .....++..|+|||++.+. .++.++||||||+++|||++|. .||...... .
T Consensus 154 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (258)
T cd05078 154 ISITVLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKW 229 (258)
T ss_pred cccccCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHccccCCCCCc
Confidence 8875432 2234578889999998874 5788999999999999999985 665433221 1
Q ss_pred cccccccccccccCCCCCCChhHHHhh
Q 035761 527 SSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 527 ~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
.++.+.+..|...||+.||+++++++.
T Consensus 230 ~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 230 TELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 224456677888899999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=279.08 Aligned_cols=228 Identities=22% Similarity=0.244 Sum_probs=181.9
Q ss_pred eeeccCCeeEEEEEeC-CCcEEEEEEccchhhh-hhhHHHHHHHH---HHHhccCCCCcceeeeEEEeCCEEEEEEeccC
Q 035761 322 CIGTGGYGSVYRARLP-SGKVVALKKLHRLETE-LASLESFQNEA---RLLSQIRHRNIVKLYGFCLHEKCMFLIYEYME 396 (560)
Q Consensus 322 ~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~---~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 396 (560)
.||+|+||.||+|... +++.||+|.+...... ......+..|. ..++..+||+|+++.+++..++..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 3799999999999764 5889999988654311 11111233343 34445689999999999999999999999999
Q ss_pred CCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCc
Q 035761 397 MGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNR 476 (560)
Q Consensus 397 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 476 (560)
+|+|.+++.... .+++.++..++.|+++|++|||+. +++||||||+||+++.++.++|+|||++...... ..
T Consensus 81 g~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--~~ 152 (278)
T cd05606 81 GGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KP 152 (278)
T ss_pred CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--CC
Confidence 999999887543 389999999999999999999998 9999999999999999999999999998765322 22
Q ss_pred eeeccccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCCCCCcccc--------------------ccccccccccc
Q 035761 477 TLLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKHPGELLSS--------------------SSSSLDKNIKL 535 (560)
Q Consensus 477 ~~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~P~~~~~~--------------------~~~~~~~~~~~ 535 (560)
....|+..|+|||.+.+. .++.++||||+|+++|||++|+.||..... .+..+...++.
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 232 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG 232 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHH
Confidence 234688999999998754 588999999999999999999999965421 11223345566
Q ss_pred ccccCCCCCC-----ChhHHHhhceee
Q 035761 536 IDLLDPRLPP-----PGDQMIRQGIIL 557 (560)
Q Consensus 536 ~~~~dp~~~p-----~~~~~~~~~~~~ 557 (560)
|...+|..|| ++++++++.|+.
T Consensus 233 ~l~~~p~~R~~~~~~~~~~ll~~~~~~ 259 (278)
T cd05606 233 LLQRDVNRRLGCLGRGAQEVKEHPFFR 259 (278)
T ss_pred HhhcCHHhccCCCCCCHHHHHhCcccc
Confidence 6777899999 888999998874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=289.21 Aligned_cols=236 Identities=26% Similarity=0.364 Sum_probs=198.1
Q ss_pred CCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCC-----EEE
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEK-----CMF 389 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 389 (560)
+|++.+.||+|++|.||+|... +++.||+|++..........+.+.+|+++++.++||||+++.+++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999875 4899999998765433444567889999999999999999999998775 789
Q ss_pred EEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccccc
Q 035761 390 LIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL 469 (560)
Q Consensus 390 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 469 (560)
+||||+++ +|.+++.... .+++..+..++.|+++||+|||+. |++||||||+||+++.++.++|+|||.+...
T Consensus 81 lv~e~~~~-~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchhh-hHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 99999984 8988887544 489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCC---CCceeeccccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------
Q 035761 470 NYDS---SNRTLLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKHPGELLSS--------------------- 524 (560)
Q Consensus 470 ~~~~---~~~~~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~P~~~~~~--------------------- 524 (560)
.... .......++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||...+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 5432 122334578899999999888 788999999999999999999999964331
Q ss_pred ---------------------------cccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 525 ---------------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 525 ---------------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
....+.+.++.|...+|..||++++++++.|+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 294 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ 294 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHh
Confidence 0112234667778889999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=276.77 Aligned_cols=226 Identities=25% Similarity=0.416 Sum_probs=184.6
Q ss_pred cCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
++|++.+.||+|+||.||+|.. .++.||+|.++... ..+.+.+|+.+++.++|||++++++++..+ ..++||||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence 4588899999999999999975 67889999986432 235788999999999999999999998765 47899999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
+++++|.+++..... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 80 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 80 MSKGNLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred CCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 999999999976432 3489999999999999999999998 9999999999999999999999999998764321
Q ss_pred CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------------cccccccccc
Q 035761 475 NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------------SSSLDKNIKL 535 (560)
Q Consensus 475 ~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------------~~~~~~~~~~ 535 (560)
......+..|+|||.+.+..++.++||||||+++|||++ |+.||...... ...+.+.++.
T Consensus 154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 232 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTS 232 (254)
T ss_pred -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHH
Confidence 111234567999999988889999999999999999998 99998644321 1123445566
Q ss_pred ccccCCCCCCChhHHHhh
Q 035761 536 IDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 536 ~~~~dp~~~p~~~~~~~~ 553 (560)
|...+|..||++++++..
T Consensus 233 ~l~~~p~~Rp~~~~l~~~ 250 (254)
T cd05083 233 CWETEPKKRPSFHKLREK 250 (254)
T ss_pred HcCCChhhCcCHHHHHHH
Confidence 667788888887777653
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=319.82 Aligned_cols=239 Identities=27% Similarity=0.402 Sum_probs=195.8
Q ss_pred CCcccceeeccCCeeEEEEE-eCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 316 DFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
++.....||.|.||.||.|. ..+|+..|||-++.............+|+.++..++|||+|+++|+-.+++..+|.|||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence 45556789999999999996 45689999998876654444556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
|++|+|.+.+...+. .++.....+..|++.|++|||+. |||||||||.||+++.+|.+|++|||.|..+.....
T Consensus 1316 C~~GsLa~ll~~gri---~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHGRI---EDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred hccCcHHHHHHhcch---hhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence 999999999986543 66777777899999999999999 999999999999999999999999999998754321
Q ss_pred ----CceeeccccCccCccccccCc---cCcchhHHHHHHHHHHHHhCCCCCCccccc-ccccccccccccccCCCCCCC
Q 035761 475 ----NRTLLAGTYGSIAPELAYTMV---VTEKYDVYSFGVVALEVLMGKHPGELLSSS-SSSLDKNIKLIDLLDPRLPPP 546 (560)
Q Consensus 475 ----~~~~~~g~~~~~aPE~~~~~~---~~~~~Dv~s~G~il~el~~g~~P~~~~~~~-~~~~~~~~~~~~~~dp~~~p~ 546 (560)
.....+||+.|||||++.+.. ...+.||||+|||+.||+||+.||...+.. ...+.--.--.++++.++.++
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~ 1469 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSE 1469 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHh
Confidence 123467999999999988654 345789999999999999999999866543 222222223335566668888
Q ss_pred hhHHHhhceeeecC
Q 035761 547 GDQMIRQGIILIST 560 (560)
Q Consensus 547 ~~~~~~~~~~~~~~ 560 (560)
..+++.||+..+|+
T Consensus 1470 g~dFle~Cl~~dP~ 1483 (1509)
T KOG4645|consen 1470 GRDFLEHCLEQDPK 1483 (1509)
T ss_pred HHHHHHHHHhcCch
Confidence 88888888887764
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=279.14 Aligned_cols=234 Identities=26% Similarity=0.371 Sum_probs=185.8
Q ss_pred CcccceeeccCCeeEEEEEeC----CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCC------
Q 035761 317 FDIKYCIGTGGYGSVYRARLP----SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEK------ 386 (560)
Q Consensus 317 ~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 386 (560)
|.+.+.||+|+||.||+|.+. +++.||||++..........+.+.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456778999999999999753 3688999998765433344567889999999999999999999886542
Q ss_pred EEEEEEeccCCCCHHHHhhcCC---cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeee
Q 035761 387 CMFLIYEYMEMGSLFCILRTDE---EAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADF 463 (560)
Q Consensus 387 ~~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 463 (560)
..++++||+++|+|.+++.... ....+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999988875321 223478999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCCC--ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc---------------
Q 035761 464 GIARLLNYDSSN--RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS--------------- 525 (560)
Q Consensus 464 g~~~~~~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~--------------- 525 (560)
|.++........ .....+++.|++||.+....++.++||||||+++|||++ |+.||......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 237 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQP 237 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCC
Confidence 999875432211 112235578999999998889999999999999999999 88998644321
Q ss_pred ---ccccccccccccccCCCCCCChhHHHhh
Q 035761 526 ---SSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 526 ---~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
...+.+.+..|...+|+.||++.++++.
T Consensus 238 ~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 238 PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1223445566677788888888888764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=275.99 Aligned_cols=229 Identities=23% Similarity=0.306 Sum_probs=186.2
Q ss_pred ceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHH-hccCCCCcceeeeEEEeCCEEEEEEeccCC
Q 035761 321 YCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLL-SQIRHRNIVKLYGFCLHEKCMFLIYEYMEM 397 (560)
Q Consensus 321 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (560)
+.||+|+||.||+|... +++.||+|.+..... .......+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 45899999999999764 588999999875432 122223344555444 455899999999999999999999999999
Q ss_pred CCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCce
Q 035761 398 GSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRT 477 (560)
Q Consensus 398 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 477 (560)
++|.+++.... .+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||++..... ..
T Consensus 82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~ 151 (260)
T cd05611 82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NK 151 (260)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc----cc
Confidence 99999997643 388999999999999999999998 999999999999999999999999999876432 22
Q ss_pred eeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------cccccccccccc
Q 035761 478 LLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------SSSSLDKNIKLI 536 (560)
Q Consensus 478 ~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------~~~~~~~~~~~~ 536 (560)
...++..|+|||.+.+..++.++||||+|+++|||++|..||..... ....+.+.++.|
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 231 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRL 231 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHH
Confidence 34578899999999888889999999999999999999999964321 112334556677
Q ss_pred cccCCCCCC---ChhHHHhhceeeec
Q 035761 537 DLLDPRLPP---PGDQMIRQGIILIS 559 (560)
Q Consensus 537 ~~~dp~~~p---~~~~~~~~~~~~~~ 559 (560)
...+|+.|| ++.+++.|+|+.+.
T Consensus 232 l~~~p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 232 LCMDPAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred ccCCHHHccCCCcHHHHHcChHhhcC
Confidence 788999999 44799999998653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=287.70 Aligned_cols=236 Identities=25% Similarity=0.313 Sum_probs=193.1
Q ss_pred HHHhcCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCC---
Q 035761 311 IEATEDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEK--- 386 (560)
Q Consensus 311 ~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--- 386 (560)
+...++|+..+.||+|+||.||+|.. .+++.||||++............+.+|+++++.++||||+++++++..+.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 33467899999999999999999975 46899999998654333333456789999999999999999999987653
Q ss_pred ---EEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeee
Q 035761 387 ---CMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADF 463 (560)
Q Consensus 387 ---~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 463 (560)
..++||||+ +++|.+++... .+++..+..++.|+++|++|||+. +|+||||||+||+++.++.++++||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeec
Confidence 358999999 67998888642 289999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCccccc-----------------
Q 035761 464 GIARLLNYDSSNRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSSS----------------- 525 (560)
Q Consensus 464 g~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~----------------- 525 (560)
|++...... .....+++.|+|||.+.+ ..++.++|+||+|+++|++++|+.||......
T Consensus 163 g~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07880 163 GLARQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF 239 (343)
T ss_pred ccccccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 999865422 223356889999998876 45788999999999999999999999643210
Q ss_pred -------------------------------ccccccccccccccCCCCCCChhHHHhhceee
Q 035761 526 -------------------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 526 -------------------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
...+...+..|...||+.||++.+++.++|+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~ 302 (343)
T cd07880 240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFE 302 (343)
T ss_pred HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHh
Confidence 11123444567788999999999999999975
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=282.54 Aligned_cols=232 Identities=28% Similarity=0.399 Sum_probs=191.5
Q ss_pred CcccceeeccCCeeEEEEEeC-CCcEEEEEEccchh-hhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 317 FDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLE-TELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 317 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
|+..+.||+|+||.||+|+.. +++.||+|.+.... ........+.+|+++++.++|||++++++++..+...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 667788999999999999864 68899999986432 2223345788899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
++ |++.+.+.... ..+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 107 ~~-g~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 107 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred CC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence 97 47877775433 2389999999999999999999999 9999999999999999999999999998764322
Q ss_pred CceeeccccCccCccccc---cCccCcchhHHHHHHHHHHHHhCCCCCCcccc-------------------cccccccc
Q 035761 475 NRTLLAGTYGSIAPELAY---TMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-------------------SSSSLDKN 532 (560)
Q Consensus 475 ~~~~~~g~~~~~aPE~~~---~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-------------------~~~~~~~~ 532 (560)
....+++.|+|||.+. ...++.++||||||+++|||++|+.||..... ....+...
T Consensus 179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 256 (317)
T cd06635 179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNF 256 (317)
T ss_pred --ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHH
Confidence 2335788999999874 45688899999999999999999999854321 11123455
Q ss_pred cccccccCCCCCCChhHHHhhceeee
Q 035761 533 IKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 533 ~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
+..|...+|..||++.+++++.|+..
T Consensus 257 i~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 257 VDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred HHHHccCCcccCcCHHHHHhChhhhc
Confidence 56688889999999999999988653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=275.00 Aligned_cols=232 Identities=29% Similarity=0.449 Sum_probs=191.4
Q ss_pred CcccceeeccCCeeEEEEEeCC-----CcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEE
Q 035761 317 FDIKYCIGTGGYGSVYRARLPS-----GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLI 391 (560)
Q Consensus 317 ~~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 391 (560)
+++.+.||+|+||.||++...+ +..||+|.+...... ...+.+..|+++++.++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE-QQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh-HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 3566789999999999998754 478999998654322 2456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 471 (560)
|||+++++|.+++..... ..+++.++..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.+.....
T Consensus 80 ~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred EeccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 999999999999976432 1289999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCCce-eeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc------------------ccccccc
Q 035761 472 DSSNRT-LLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS------------------SSSSLDK 531 (560)
Q Consensus 472 ~~~~~~-~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~------------------~~~~~~~ 531 (560)
...... ...+++.|+|||.+.+..++.++||||+|+++|||++ |+.||..... ....+.+
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYK 235 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHH
Confidence 322221 2236789999999988889999999999999999998 8899864331 1123445
Q ss_pred ccccccccCCCCCCChhHHHhh
Q 035761 532 NIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 532 ~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
.+..|...||+.||++.+++..
T Consensus 236 ~i~~~l~~~p~~Rpt~~~ll~~ 257 (258)
T smart00219 236 LMLQCWAEDPEDRPTFSELVEI 257 (258)
T ss_pred HHHHHCcCChhhCcCHHHHHhh
Confidence 6667778899999999988753
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=269.10 Aligned_cols=234 Identities=24% Similarity=0.297 Sum_probs=194.0
Q ss_pred hcCCccc-ceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEe----CC
Q 035761 314 TEDFDIK-YCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLH----EK 386 (560)
Q Consensus 314 ~~~~~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~ 386 (560)
+++|++. ++||-|-.|.|..+..+ +++.+|+|++.... ..++|++..-.. .|||||++++++.. .+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-------KARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-------HHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 4556553 56999999999999764 68899999986432 335777776555 79999999998864 46
Q ss_pred EEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCC---CCcEEEeee
Q 035761 387 CMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNS---EFEAFVADF 463 (560)
Q Consensus 387 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Df 463 (560)
++.+|||.|+||.|.+.++..+ ...+++.++.+|+.||+.|+.|||+. .|.||||||+|+|.+. |-.+||+||
T Consensus 133 cLLiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eeEeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccc
Confidence 7899999999999999998754 45599999999999999999999999 9999999999999964 456899999
Q ss_pred ccccccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccc--------------------
Q 035761 464 GIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLS-------------------- 523 (560)
Q Consensus 464 g~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~-------------------- 523 (560)
|+|+.-.. .......+-|+.|.|||++...+|+..+|+||+||+||-|++|.+||-...
T Consensus 209 GFAK~t~~-~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP 287 (400)
T KOG0604|consen 209 GFAKETQE-PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFP 287 (400)
T ss_pred ccccccCC-CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCC
Confidence 99987442 233344568999999999999999999999999999999999999984332
Q ss_pred -----ccccccccccccccccCCCCCCChhHHHhhceeeec
Q 035761 524 -----SSSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILIS 559 (560)
Q Consensus 524 -----~~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~~ 559 (560)
..++..+..++.+...+|..|-+..+++.|+||...
T Consensus 288 ~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 288 EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 133455677788889999999999999999999753
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=286.04 Aligned_cols=237 Identities=24% Similarity=0.324 Sum_probs=193.7
Q ss_pred HHHHhcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEe-CCE
Q 035761 310 MIEATEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLH-EKC 387 (560)
Q Consensus 310 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~ 387 (560)
+...+++|+..+.||+|+||.||+|... +++.||+|++..........+.+.+|+++++.++||||+++.+++.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3446778999999999999999999754 78999999886533222334567789999999999999999999876 457
Q ss_pred EEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccc
Q 035761 388 MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIAR 467 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~ 467 (560)
.++++||+ +++|.++++... +++..+..++.|+++||+|||+. +++||||+|+||++++++.++|+|||.+.
T Consensus 85 ~~lv~e~~-~~~L~~~~~~~~----~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTSRP----LEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEEeehh-ccCHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 89999998 568988886432 78888889999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCCCceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCcccc----------------------
Q 035761 468 LLNYDSSNRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------- 524 (560)
Q Consensus 468 ~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------- 524 (560)
.... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.....
T Consensus 157 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 157 IQDP---QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred ccCC---CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 6432 1223356788999998766 5688999999999999999999999854321
Q ss_pred --------------------------cccccccccccccccCCCCCCChhHHHhhceee
Q 035761 525 --------------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 525 --------------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
....+.+.++.|...+|+.||++++++.+.|+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~ 292 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLA 292 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccc
Confidence 112234555667788999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=280.68 Aligned_cols=236 Identities=26% Similarity=0.404 Sum_probs=199.6
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccC-CCCcceeeeEEEeCCEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQIR-HRNIVKLYGFCLHEKCMFLI 391 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 391 (560)
++|...+.||+|+||.||+|... +++.||+|++..... .....+.+.+|.+++++++ ||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36888899999999999999865 689999999875331 2233457888999999998 99999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 471 (560)
|||+++++|.+++...+ .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++++|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 99999999999998654 399999999999999999999999 999999999999999999999999999987643
Q ss_pred CCC--------------------CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-------
Q 035761 472 DSS--------------------NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS------- 524 (560)
Q Consensus 472 ~~~--------------------~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~------- 524 (560)
... ......++..|+|||...+..++.++|+||+|++++|+++|+.||.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 234 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI 234 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 221 12234578899999999888889999999999999999999999975432
Q ss_pred ----------cccccccccccccccCCCCCCCh----hHHHhhcee
Q 035761 525 ----------SSSSLDKNIKLIDLLDPRLPPPG----DQMIRQGII 556 (560)
Q Consensus 525 ----------~~~~~~~~~~~~~~~dp~~~p~~----~~~~~~~~~ 556 (560)
....+...++.|...+|..||++ .+++.|+|+
T Consensus 235 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 235 LKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 11234466677788899999999 999999885
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=279.23 Aligned_cols=228 Identities=29% Similarity=0.402 Sum_probs=183.6
Q ss_pred eeeccCCeeEEEEEeCC-------CcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 322 CIGTGGYGSVYRARLPS-------GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 322 ~ig~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
.||+|+||.||+|...+ ++.+|+|.+..... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccc-hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 58999999999998643 25789998765332 23345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCC----cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCC-----cEEEeeecc
Q 035761 395 MEMGSLFCILRTDE----EAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEF-----EAFVADFGI 465 (560)
Q Consensus 395 ~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-----~~kl~Dfg~ 465 (560)
+++|+|.+++.... ....+++.++..++.|++.|++|||+. +++|+||+|+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999997532 123478999999999999999999998 999999999999999887 899999999
Q ss_pred ccccCCCCCC--ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc------------------
Q 035761 466 ARLLNYDSSN--RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS------------------ 524 (560)
Q Consensus 466 ~~~~~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~------------------ 524 (560)
+......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPEN 237 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCccc
Confidence 9765322211 112235678999999999999999999999999999998 9999864321
Q ss_pred cccccccccccccccCCCCCCChhHHHhh
Q 035761 525 SSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 525 ~~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
....+.+.+..|...+|..||+++++...
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 266 (269)
T cd05044 238 CPDKIYQLMTNCWAQDPSERPTFDRIQEI 266 (269)
T ss_pred chHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 11224556667777788888888887653
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=277.09 Aligned_cols=232 Identities=28% Similarity=0.396 Sum_probs=186.6
Q ss_pred cCCcccceeeccCCeeEEEEEeCC----CcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPS----GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFL 390 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 390 (560)
++|.+.+.||+|+||.||+|...+ ...||||....... ....+.+.+|+.++++++||||+++++++.. ...++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS-PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 457788999999999999997643 24689998865432 2344678899999999999999999998875 45789
Q ss_pred EEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccC
Q 035761 391 IYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN 470 (560)
Q Consensus 391 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 470 (560)
||||+++|+|.+++..... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||+++...
T Consensus 84 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 84 VMELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEcCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecc
Confidence 9999999999999976432 389999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCCC-ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------------ccccc
Q 035761 471 YDSSN-RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------------SSSLD 530 (560)
Q Consensus 471 ~~~~~-~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------------~~~~~ 530 (560)
..... .....++..|+|||.+....++.++||||||+++||+++ |+.||...... ...+.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 238 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHH
Confidence 33211 112234568999999988889999999999999999996 99999644321 12334
Q ss_pred cccccccccCCCCCCChhHHHhh
Q 035761 531 KNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 531 ~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
+.+..|...+|..||++.+++..
T Consensus 239 ~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 239 SLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 44556667788888888877654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=279.32 Aligned_cols=237 Identities=26% Similarity=0.372 Sum_probs=190.0
Q ss_pred CCcccceeeccCCeeEEEEEe----CCCcEEEEEEccchhh--hhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCEE
Q 035761 316 DFDIKYCIGTGGYGSVYRARL----PSGKVVALKKLHRLET--ELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKCM 388 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 388 (560)
+|++.+.||+|+||.||.+.. .+|+.||+|++..... .....+.+.+|+.+++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 367788999999999999975 3688999999875432 122345678899999999 699999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccc
Q 035761 389 FLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARL 468 (560)
Q Consensus 389 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 468 (560)
++||||+++++|.+++.... .+++.++..++.|+++||+|||+. +++||||+|+||+++.++.++|+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 99999999999999997643 388999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCC-ceeeccccCccCccccccC--ccCcchhHHHHHHHHHHHHhCCCCCCccccc--------------------
Q 035761 469 LNYDSSN-RTLLAGTYGSIAPELAYTM--VVTEKYDVYSFGVVALEVLMGKHPGELLSSS-------------------- 525 (560)
Q Consensus 469 ~~~~~~~-~~~~~g~~~~~aPE~~~~~--~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~-------------------- 525 (560)
....... .....|+..|+|||.+... .++.++||||||+++|||++|+.||......
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 234 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCcc
Confidence 5432211 2234578899999998753 4678899999999999999999999632211
Q ss_pred -ccccccccccccccCCCCCC-----ChhHHHhhceeee
Q 035761 526 -SSSLDKNIKLIDLLDPRLPP-----PGDQMIRQGIILI 558 (560)
Q Consensus 526 -~~~~~~~~~~~~~~dp~~~p-----~~~~~~~~~~~~~ 558 (560)
...+...++.|...||..|| .+++++.++|+..
T Consensus 235 ~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 273 (290)
T cd05613 235 MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273 (290)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCccccc
Confidence 01123344555666788775 7788888877654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=285.18 Aligned_cols=237 Identities=25% Similarity=0.293 Sum_probs=190.3
Q ss_pred cCCc-ccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhh------------hHHHHHHHHHHHhccCCCCcceeee
Q 035761 315 EDFD-IKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELA------------SLESFQNEARLLSQIRHRNIVKLYG 380 (560)
Q Consensus 315 ~~~~-~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~------------~~~~~~~e~~~l~~l~h~niv~l~~ 380 (560)
++|. +.+.||.|+||.||+|..+ +++.||||.+........ ....+.+|+++++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4454 3567999999999999864 689999998865432110 0124678999999999999999999
Q ss_pred EEEeCCEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEE
Q 035761 381 FCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFV 460 (560)
Q Consensus 381 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 460 (560)
++..+...++||||++ |+|.+++..... +++.....++.|++.||+|||+. +++||||+|+||+++.++.++|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~---~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKIR---LTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEE
Confidence 9999999999999997 599998875433 89999999999999999999998 9999999999999999999999
Q ss_pred eeeccccccCCC--------------CCCceeeccccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCCCCCccccc
Q 035761 461 ADFGIARLLNYD--------------SSNRTLLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKHPGELLSSS 525 (560)
Q Consensus 461 ~Dfg~~~~~~~~--------------~~~~~~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~ 525 (560)
+|||.+...... ........++..|+|||.+.+. .++.++||||+|+++|||++|+.||...+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999765411 1111223467789999988764 4688999999999999999999998643210
Q ss_pred ---------------------------------------------ccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 526 ---------------------------------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 526 ---------------------------------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
...+.+.++.|...+|+.||++++++.++|+..
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~ 318 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKS 318 (335)
T ss_pred HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCC
Confidence 112334556677889999999999999999753
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=307.12 Aligned_cols=238 Identities=27% Similarity=0.409 Sum_probs=193.4
Q ss_pred HHHhcCCcccceeeccCCeeEEEEEeC----C----CcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeE
Q 035761 311 IEATEDFDIKYCIGTGGYGSVYRARLP----S----GKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGF 381 (560)
Q Consensus 311 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~ 381 (560)
+...++..+.+.+|+|+||.|++|... . ...||||.++..... .+.+.+..|+++|+.+ +|+||+.++|+
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 334455566679999999999999743 1 457999999877665 6678899999999998 69999999999
Q ss_pred EEeCCEEEEEEeccCCCCHHHHhhcCC-------c----c--cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 035761 382 CLHEKCMFLIYEYMEMGSLFCILRTDE-------E----A--VGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSN 448 (560)
Q Consensus 382 ~~~~~~~~lv~e~~~~g~L~~~l~~~~-------~----~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~ 448 (560)
|..++..++|+||++.|+|..|++..+ . . ..++..+.+.++.|||.||+||++. ++||||+.++
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaR 447 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAAR 447 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhh
Confidence 999999999999999999999998765 0 0 2389999999999999999999999 9999999999
Q ss_pred CeEeCCCCcEEEeeeccccccCCCCCCc-eeec--cccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc
Q 035761 449 NILLNSEFEAFVADFGIARLLNYDSSNR-TLLA--GTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS 524 (560)
Q Consensus 449 Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~--g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~ 524 (560)
|||++++..+||+|||+|+......... .... -+.+|||||.+....|+.|+|||||||++|||+| |..||.....
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 9999999999999999999765443332 1122 2457999999999999999999999999999999 9999986331
Q ss_pred c-------------------ccccccccccccccCCCCCCChhHHHh
Q 035761 525 S-------------------SSSLDKNIKLIDLLDPRLPPPGDQMIR 552 (560)
Q Consensus 525 ~-------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~ 552 (560)
. ..++..+++.|=..+|..||++.++..
T Consensus 528 ~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 528 TEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 0 111223345555668888888877654
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=284.44 Aligned_cols=237 Identities=26% Similarity=0.348 Sum_probs=189.6
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCC------
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEK------ 386 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 386 (560)
.++|++.+.||+|+||.||+|..+ +++.+|+|++............+.+|+++++.++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 467999999999999999999865 5889999988654332223345678999999999999999999875433
Q ss_pred --EEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeec
Q 035761 387 --CMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFG 464 (560)
Q Consensus 387 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 464 (560)
..++|+||+.+ ++...+.... ..+++.++..++.|+++||+|||+. +++||||||+||++++++.++|+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCc
Confidence 46999999975 6777765432 2489999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCC-----------ceeeccccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCCCCCccccc-------
Q 035761 465 IARLLNYDSSN-----------RTLLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKHPGELLSSS------- 525 (560)
Q Consensus 465 ~~~~~~~~~~~-----------~~~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~------- 525 (560)
+++........ .....+++.|+|||.+.+. .++.++||||||+++|||++|++||......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99865432211 1123467889999987654 5788999999999999999999998633210
Q ss_pred ----------------------------------------ccccccccccccccCCCCCCChhHHHhhcee
Q 035761 526 ----------------------------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 526 ----------------------------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
...+.+.++.|...||..||++.+++.|+|+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 0123356677778899999999999999985
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=275.04 Aligned_cols=196 Identities=22% Similarity=0.341 Sum_probs=157.4
Q ss_pred eeeccCCeeEEEEEeCCC---cEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEeccCCC
Q 035761 322 CIGTGGYGSVYRARLPSG---KVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMG 398 (560)
Q Consensus 322 ~ig~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (560)
.||+|+||.||+|...++ ..+++|.+..... ....+.+.+|+.+++.++||||+++++.+......++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS-SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC-hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 489999999999975443 3456666554322 234567899999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCc-ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC--CC
Q 035761 399 SLFCILRTDEE-AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS--SN 475 (560)
Q Consensus 399 ~L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~--~~ 475 (560)
+|.++++.... ....++..+..++.||++||+|||+. +++||||||+||+++.++.++|+|||++....... ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999975422 22366777889999999999999998 99999999999999999999999999986432111 11
Q ss_pred ceeeccccCccCcccccc-------CccCcchhHHHHHHHHHHHHh-CCCCCCc
Q 035761 476 RTLLAGTYGSIAPELAYT-------MVVTEKYDVYSFGVVALEVLM-GKHPGEL 521 (560)
Q Consensus 476 ~~~~~g~~~~~aPE~~~~-------~~~~~~~Dv~s~G~il~el~~-g~~P~~~ 521 (560)
.....++..|+|||+... ..++.++||||||+++|||++ |..||..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 211 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSH 211 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Confidence 223457889999998753 245778999999999999997 6778854
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=277.95 Aligned_cols=232 Identities=28% Similarity=0.384 Sum_probs=191.5
Q ss_pred CcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 317 FDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 317 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
|...+.||+|+||.||+|... +++.|++|++..... .....+.+.+|+++++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555677999999999999864 588999999864332 223345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
+. |++.+++.... ..+++.++..++.||+.|++|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 96 57877776433 2389999999999999999999999 999999999999999999999999999865322
Q ss_pred CceeeccccCccCccccc---cCccCcchhHHHHHHHHHHHHhCCCCCCcccc-------------------cccccccc
Q 035761 475 NRTLLAGTYGSIAPELAY---TMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-------------------SSSSLDKN 532 (560)
Q Consensus 475 ~~~~~~g~~~~~aPE~~~---~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-------------------~~~~~~~~ 532 (560)
.....|+..|+|||++. ...++.++||||||+++|||++|..||..... ....+...
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 252 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGF 252 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHH
Confidence 22346788999999974 45678899999999999999999999864331 11124455
Q ss_pred cccccccCCCCCCChhHHHhhceeee
Q 035761 533 IKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 533 ~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
+..|...+|..||++.++++++|+..
T Consensus 253 i~~~l~~~P~~Rp~~~~~l~~~~~~~ 278 (313)
T cd06633 253 VDYCLQKIPQERPASAELLRHDFVRR 278 (313)
T ss_pred HHHHccCChhhCcCHHHHhcCcccCC
Confidence 66788889999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=270.75 Aligned_cols=228 Identities=28% Similarity=0.369 Sum_probs=193.8
Q ss_pred eeccCCeeEEEEEeC-CCcEEEEEEccchhhh-hhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEeccCCCCH
Q 035761 323 IGTGGYGSVYRARLP-SGKVVALKKLHRLETE-LASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSL 400 (560)
Q Consensus 323 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 400 (560)
||+|+||.||++... +++.+|+|.+...... ......+..|+++++.++|||++++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999875 4889999998765422 23456788999999999999999999999999999999999999999
Q ss_pred HHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCceeec
Q 035761 401 FCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLA 480 (560)
Q Consensus 401 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 480 (560)
.+++.... .+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||.+..............
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (250)
T cd05123 81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC 154 (250)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCc
Confidence 99997654 389999999999999999999998 999999999999999999999999999987654333334456
Q ss_pred cccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------cccccccccccccccCCCC
Q 035761 481 GTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNIKLIDLLDPRL 543 (560)
Q Consensus 481 g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~~~~~~~dp~~ 543 (560)
++..|+|||...+...+.++|+||||+++||+++|+.||...+. ....+.+.++.|...||+.
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~ 234 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTK 234 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhh
Confidence 78899999999888889999999999999999999999964431 0123445557777889999
Q ss_pred CCCh---hHHHhhcee
Q 035761 544 PPPG---DQMIRQGII 556 (560)
Q Consensus 544 ~p~~---~~~~~~~~~ 556 (560)
||++ +++..|+|+
T Consensus 235 R~~~~~~~~l~~~~~f 250 (250)
T cd05123 235 RLGSGGAEEIKAHPFF 250 (250)
T ss_pred CCCcccHHHHHhCCCC
Confidence 9999 899888874
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=276.67 Aligned_cols=231 Identities=23% Similarity=0.289 Sum_probs=171.7
Q ss_pred cCCcccceeeccCCeeEEEEEeCCC----cEEEEEEccchhhhhh-h--------HHHHHHHHHHHhccCCCCcceeeeE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPSG----KVVALKKLHRLETELA-S--------LESFQNEARLLSQIRHRNIVKLYGF 381 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~-~--------~~~~~~e~~~l~~l~h~niv~l~~~ 381 (560)
++|.+.+.||+|+||.||+|.+.++ ..+|+|.......... + ......+...+..++|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5789999999999999999987543 4566665332211100 0 0112233344566789999999997
Q ss_pred EEeCC----EEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCc
Q 035761 382 CLHEK----CMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFE 457 (560)
Q Consensus 382 ~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~ 457 (560)
+.... ..++++|++.. ++.+.+.... ..++..+..++.|+++||+|||+. +|+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCc
Confidence 76543 34678887744 6666665422 257888899999999999999998 9999999999999999999
Q ss_pred EEEeeeccccccCCCCC-------CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccccc----
Q 035761 458 AFVADFGIARLLNYDSS-------NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSS---- 526 (560)
Q Consensus 458 ~kl~Dfg~~~~~~~~~~-------~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~---- 526 (560)
++|+|||+|+.+..... ......||+.|+|||+..+..++.++|||||||++|||++|+.||.......
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 99999999987643221 1123468999999999999999999999999999999999999997663211
Q ss_pred ---------------------cccccccccccccCCCCCCChhHHHh
Q 035761 527 ---------------------SSLDKNIKLIDLLDPRLPPPGDQMIR 552 (560)
Q Consensus 527 ---------------------~~~~~~~~~~~~~dp~~~p~~~~~~~ 552 (560)
..+.+..+.|..++|+.||+++++.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 245 AAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 11234455566778899998888765
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=287.59 Aligned_cols=235 Identities=25% Similarity=0.331 Sum_probs=193.9
Q ss_pred HhcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCE----
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKC---- 387 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---- 387 (560)
..++|+..+.||+|++|.||+|... +++.||+|++..........+.+.+|+.+++.++|||++++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3567899999999999999999875 57899999987543333334567789999999999999999998876554
Q ss_pred --EEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecc
Q 035761 388 --MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGI 465 (560)
Q Consensus 388 --~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 465 (560)
.++|+||+ +++|.+++... .+++.++..++.|+++|++|||+. +++||||+|+||++++++.++|+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQ----KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 56999988753 389999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCCceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCcccc--------------------
Q 035761 466 ARLLNYDSSNRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSS-------------------- 524 (560)
Q Consensus 466 ~~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-------------------- 524 (560)
+...... .....++..|+|||.+.+ ..++.++||||+|+++||+++|+.||.....
T Consensus 165 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (343)
T cd07851 165 ARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQ 241 (343)
T ss_pred ccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Confidence 9875432 223457888999998765 4678899999999999999999999953221
Q ss_pred ----------------------------cccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 525 ----------------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 525 ----------------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
.+..+.+.++.|...||..||++.++++|+|+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~ 303 (343)
T cd07851 242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE 303 (343)
T ss_pred hccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccc
Confidence 1122334556678889999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=264.92 Aligned_cols=205 Identities=28% Similarity=0.356 Sum_probs=172.6
Q ss_pred hcCCcccceeeccCCeeEEEEEeCC-----CcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEe-CCE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLPS-----GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLH-EKC 387 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~ 387 (560)
-..|+....||+|.||.||+|.-++ ...+|+|+++...+...-.....+|+.+++.++||||+.+..++.. ++.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 3568888999999999999995432 2379999998775544444567899999999999999999999877 889
Q ss_pred EEEEEeccCCCCHHHHhhcCC--cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCC----CcEEEe
Q 035761 388 MFLIYEYMEMGSLFCILRTDE--EAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSE----FEAFVA 461 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~----~~~kl~ 461 (560)
.++++||.+. +|.+.++-++ ....++...+.+|+.||+.|+.|||++ =|+|||+||.|||+..+ |.|||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEee
Confidence 9999999987 8888886543 234688899999999999999999999 69999999999999888 899999
Q ss_pred eeccccccCCCCCC---ceeeccccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCCCCCcc
Q 035761 462 DFGIARLLNYDSSN---RTLLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKHPGELL 522 (560)
Q Consensus 462 Dfg~~~~~~~~~~~---~~~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~P~~~~ 522 (560)
|||+++.+..+-.. ...++.|..|.|||++.+. .|+++.||||.|||+.||+|-.+-|...
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 99999988643322 2346789999999998876 5788899999999999999999888644
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=279.00 Aligned_cols=233 Identities=27% Similarity=0.396 Sum_probs=191.7
Q ss_pred CCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchh-hhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLE-TELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
.|+..+.||+|+||.||+|+.. +++.+|+|.+.... ......+.+.+|+++++.++|+|++++.+++..+...++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3666788999999999999864 57889999886432 222334567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+. |++.+++..... .+++.++..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~~--~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 96 YCL-GSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred ccC-CCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 996 588777754332 389999999999999999999998 9999999999999999999999999998765432
Q ss_pred CCceeeccccCccCccccc---cCccCcchhHHHHHHHHHHHHhCCCCCCcccc-------------------ccccccc
Q 035761 474 SNRTLLAGTYGSIAPELAY---TMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-------------------SSSSLDK 531 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~---~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-------------------~~~~~~~ 531 (560)
....++..|+|||.+. ...++.++|||||||++|||++|+.||..... ....+..
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (308)
T cd06634 169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN 245 (308)
T ss_pred ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHH
Confidence 2235788999999874 35578899999999999999999999854321 1112345
Q ss_pred ccccccccCCCCCCChhHHHhhceeee
Q 035761 532 NIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 532 ~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
.++.|...+|..||++++++.+.|+.+
T Consensus 246 li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 246 FVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred HHHHHhhCCcccCCCHHHHhhCccccc
Confidence 567788889999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=282.33 Aligned_cols=235 Identities=25% Similarity=0.336 Sum_probs=188.5
Q ss_pred CCcccceeeccCCeeEEEEEeC-C--CcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeC----CE
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-S--GKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLHE----KC 387 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----~~ 387 (560)
+|++.+.||+|+||.||+++.. . +..||+|++..........+.+.+|+++++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4777889999999999999864 3 67899999865332223345678899999999 599999999976432 35
Q ss_pred EEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccc
Q 035761 388 MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIAR 467 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~ 467 (560)
.++++||+. ++|.+++.... .+++.++..++.||+.||+|||+. +++||||||+||++++++.++|+|||.++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ---PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 788999986 58998886543 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC----CceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCcccc------------------
Q 035761 468 LLNYDSS----NRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSS------------------ 524 (560)
Q Consensus 468 ~~~~~~~----~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~------------------ 524 (560)
.+..... ......|+..|+|||...+ ..++.++|+||+|+++|++++|+.||...+.
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 6543211 1223468899999998765 4688899999999999999999999864321
Q ss_pred ------------------------------cccccccccccccccCCCCCCChhHHHhhceee
Q 035761 525 ------------------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 525 ------------------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
....+.+.+..|...||+.||++++++.++|+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~ 296 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLA 296 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhh
Confidence 011233455666778999999999999999974
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=303.22 Aligned_cols=240 Identities=26% Similarity=0.403 Sum_probs=187.4
Q ss_pred HHhcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC-----
Q 035761 312 EATEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHE----- 385 (560)
Q Consensus 312 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 385 (560)
+...+|+..+.+|+||||.||+++.+ ||+.+|||++.... +........+|+..+++++|||||+++..|.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 44567888999999999999999875 89999999998765 334455678899999999999999998544210
Q ss_pred --------------------------------------------------------------------------------
Q 035761 386 -------------------------------------------------------------------------------- 385 (560)
Q Consensus 386 -------------------------------------------------------------------------------- 385 (560)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHH
Q 035761 386 ----------------------------------KCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSY 431 (560)
Q Consensus 386 ----------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~ 431 (560)
..+|+-||||+...+.++++.+.... ......+++++|++||+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAY 712 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHH
Confidence 12467889998888888887654311 466778999999999999
Q ss_pred HHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccC------------------CCCCCceeeccccCccCcccccc
Q 035761 432 LHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN------------------YDSSNRTLLAGTYGSIAPELAYT 493 (560)
Q Consensus 432 LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~------------------~~~~~~~~~~g~~~~~aPE~~~~ 493 (560)
+|++ |+|||||||.||++|.+..|||+|||+|.... ......+..+||.-|+|||++.+
T Consensus 713 IH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 9999 99999999999999999999999999998721 01113345689999999999887
Q ss_pred Cc---cCcchhHHHHHHHHHHHHhC-----------------CCCCCcccc--cccccccccccccccCCCCCCChhHHH
Q 035761 494 MV---VTEKYDVYSFGVVALEVLMG-----------------KHPGELLSS--SSSSLDKNIKLIDLLDPRLPPPGDQMI 551 (560)
Q Consensus 494 ~~---~~~~~Dv~s~G~il~el~~g-----------------~~P~~~~~~--~~~~~~~~~~~~~~~dp~~~p~~~~~~ 551 (560)
.. |+.|+||||+|||++||+.- ..|++.... .-..-...++.+..-||.-||++.+++
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL 869 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLYPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELL 869 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHh
Confidence 65 99999999999999999862 222220000 001113455667777999999999999
Q ss_pred hhceee
Q 035761 552 RQGIIL 557 (560)
Q Consensus 552 ~~~~~~ 557 (560)
.+.|+.
T Consensus 870 ~s~llp 875 (1351)
T KOG1035|consen 870 NSELLP 875 (1351)
T ss_pred hccCCC
Confidence 998875
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=276.14 Aligned_cols=237 Identities=26% Similarity=0.367 Sum_probs=192.1
Q ss_pred CCcccceeeccCCeeEEEEEe----CCCcEEEEEEccchhh--hhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCEE
Q 035761 316 DFDIKYCIGTGGYGSVYRARL----PSGKVVALKKLHRLET--ELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKCM 388 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 388 (560)
+|++.+.||+|++|.||+++. .+++.||||.++.... .....+.+.+|++++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 367788999999999999874 3568899999875432 223345678999999999 699999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccc
Q 035761 389 FLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARL 468 (560)
Q Consensus 389 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 468 (560)
++||||+++|+|.+++.... .+++.++..++.|+++||+|||+. +++||||+|+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 99999999999999987543 388999999999999999999998 999999999999999999999999999887
Q ss_pred cCCCCCC-ceeeccccCccCccccccCc--cCcchhHHHHHHHHHHHHhCCCCCCccccc--------------------
Q 035761 469 LNYDSSN-RTLLAGTYGSIAPELAYTMV--VTEKYDVYSFGVVALEVLMGKHPGELLSSS-------------------- 525 (560)
Q Consensus 469 ~~~~~~~-~~~~~g~~~~~aPE~~~~~~--~~~~~Dv~s~G~il~el~~g~~P~~~~~~~-------------------- 525 (560)
....... .....|+..|+|||...+.. .+.++||||||+++|||++|+.||...+..
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKT 234 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcc
Confidence 5433222 22345788999999987665 678999999999999999999998532211
Q ss_pred -ccccccccccccccCCCCCCC---hhHHHhhceeee
Q 035761 526 -SSSLDKNIKLIDLLDPRLPPP---GDQMIRQGIILI 558 (560)
Q Consensus 526 -~~~~~~~~~~~~~~dp~~~p~---~~~~~~~~~~~~ 558 (560)
...+.+.++.|...||+.||+ +.+++.+.|+.+
T Consensus 235 ~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~ 271 (288)
T cd05583 235 MSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQG 271 (288)
T ss_pred cCHHHHHHHHHHhcCCHhhccCcchHHHHhcCccccc
Confidence 122344455677789999997 456688888765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=274.58 Aligned_cols=233 Identities=24% Similarity=0.364 Sum_probs=190.9
Q ss_pred CcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccC-CCCcceeeeEEEeCCEEEEEEec
Q 035761 317 FDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIR-HRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 317 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
|++.+.||+|++|.||+|... +++.|++|++....... ......+|+..+++++ |||++++++++..++..++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch-hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 566788999999999999875 47889999986543221 1223456899999998 99999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
+ +|++.+++.... ...+++.++..++.|++.+|.|||+. +++|+||+|+||++++++.++|+|||.+........
T Consensus 80 ~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 80 M-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred C-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 9 789999887654 23489999999999999999999998 999999999999999999999999999987643222
Q ss_pred CceeeccccCccCccccc-cCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------------------
Q 035761 475 NRTLLAGTYGSIAPELAY-TMVVTEKYDVYSFGVVALEVLMGKHPGELLSS----------------------------- 524 (560)
Q Consensus 475 ~~~~~~g~~~~~aPE~~~-~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~----------------------------- 524 (560)
.....++..|+|||.+. ...++.++|+||||+++|||++|+.||.....
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 22345788999999875 45578899999999999999999999853221
Q ss_pred ------------------cccccccccccccccCCCCCCChhHHHhhcee
Q 035761 525 ------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 525 ------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
....+...++.|...||+.||++++++.++|+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 01224466677888899999999999999884
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=273.27 Aligned_cols=237 Identities=26% Similarity=0.348 Sum_probs=190.4
Q ss_pred CCcccceeeccCCeeEEEEEeCC-CcEEEEEEccchh---hhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEE
Q 035761 316 DFDIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRLE---TELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLI 391 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 391 (560)
+|.+.+.||+|+||.||++.... +..+++|.++... ........+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47778899999999999997643 4445555554322 1122234566789999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCC-cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccC
Q 035761 392 YEYMEMGSLFCILRTDE-EAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN 470 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 470 (560)
|||+++++|.+++.... ....+++.++..++.|+++|++|||+. +++|+|++|+||++++ +.++|+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 99999999998886421 223489999999999999999999998 9999999999999975 569999999998764
Q ss_pred CCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc------------------cccccccc
Q 035761 471 YDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS------------------SSSSLDKN 532 (560)
Q Consensus 471 ~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~------------------~~~~~~~~ 532 (560)
..........|+..|+|||...+..++.++|+||||+++|+|++|..||..... ....+...
T Consensus 157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (260)
T cd08222 157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSI 236 (260)
T ss_pred CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHH
Confidence 433333345578899999999888889999999999999999999999863221 11233445
Q ss_pred cccccccCCCCCCChhHHHhhcee
Q 035761 533 IKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 533 ~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
++.|...+|+.||++.++++|+|+
T Consensus 237 i~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 237 MQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHhcCChhhCcCHHHHhhCCCC
Confidence 566777899999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=284.76 Aligned_cols=231 Identities=25% Similarity=0.323 Sum_probs=195.4
Q ss_pred hcCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKCMFLI 391 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 391 (560)
+++|+....+|.|+|+.|-.+.. .+++..+||++.+... .-.+|+.++... +|||++++.+.+.+....|+|
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v 394 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV 394 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc------ccccccchhhhhcCCCcceeecceecCCceeeee
Confidence 56788888899999999999865 4688999999986532 234677666665 799999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEe-CCCCcEEEeeeccccccC
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILL-NSEFEAFVADFGIARLLN 470 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill-~~~~~~kl~Dfg~~~~~~ 470 (560)
||++.++-+.+.+...+. +. .++..|+.+|+.++.|||++ |+||||+||+|||+ ++.++++|+|||.++...
T Consensus 395 ~e~l~g~ell~ri~~~~~---~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 395 MELLDGGELLRRIRSKPE---FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred ehhccccHHHHHHHhcch---hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 999999998888776543 33 77788999999999999999 99999999999999 588999999999998765
Q ss_pred CCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc----------------cccccccccc
Q 035761 471 YDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS----------------SSSSLDKNIK 534 (560)
Q Consensus 471 ~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~----------------~~~~~~~~~~ 534 (560)
.. ....+-|..|.|||++....|++.+|+||||+++|||++|+.||..... .++..+..+.
T Consensus 468 ~~---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s~~vS~~AKdLl~ 544 (612)
T KOG0603|consen 468 RS---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFSECVSDEAKDLLQ 544 (612)
T ss_pred hh---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccccccCHHHHHHHH
Confidence 43 2233567889999999999999999999999999999999999965443 3344567778
Q ss_pred cccccCCCCCCChhHHHhhcee-eecC
Q 035761 535 LIDLLDPRLPPPGDQMIRQGII-LIST 560 (560)
Q Consensus 535 ~~~~~dp~~~p~~~~~~~~~~~-~~~~ 560 (560)
.+.++||..|++++++..|+|+ .++|
T Consensus 545 ~LL~~dP~~Rl~~~~i~~h~w~~~~~t 571 (612)
T KOG0603|consen 545 QLLQVDPALRLGADEIGAHPWFLSHPT 571 (612)
T ss_pred HhccCChhhCcChhhhccCcchhcCCC
Confidence 8899999999999999999999 5544
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=281.87 Aligned_cols=233 Identities=22% Similarity=0.300 Sum_probs=187.8
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC--------
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHE-------- 385 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------- 385 (560)
.+|...+.||.|+||.||+|... +|+.||+|++..... ...+.+.+|+++++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 57888999999999999999764 588999998865432 3445688899999999999999999876543
Q ss_pred ------CEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCC-CCcE
Q 035761 386 ------KCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNS-EFEA 458 (560)
Q Consensus 386 ------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~ 458 (560)
...++||||++ ++|.+++... .+++..+..++.||+.||+|||+. +++||||||+||+++. ++.+
T Consensus 83 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 83 GSLTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred ccccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceE
Confidence 35789999997 5898888643 288999999999999999999999 9999999999999974 5678
Q ss_pred EEeeeccccccCCCCC---CceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCcccc----------
Q 035761 459 FVADFGIARLLNYDSS---NRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------- 524 (560)
Q Consensus 459 kl~Dfg~~~~~~~~~~---~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------- 524 (560)
+++|||.++....... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.....
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 9999999976532211 1122357888999997654 5678899999999999999999999963321
Q ss_pred -------------------------------------cccccccccccccccCCCCCCChhHHHhhceee
Q 035761 525 -------------------------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 525 -------------------------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
....+.+.++.|...||+.||++.+++.++|+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~ 304 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMS 304 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccc
Confidence 011123456677888999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=277.85 Aligned_cols=201 Identities=26% Similarity=0.407 Sum_probs=173.1
Q ss_pred cceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEeccCCC
Q 035761 320 KYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMG 398 (560)
Q Consensus 320 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (560)
.+++|.|.||+||-|++ ++|+.||||++.+..-.......+++|+.++..++||.||.+---|+..+..++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 47799999999999976 5799999999987664444456889999999999999999999999999999999999955
Q ss_pred CHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCC---CcEEEeeeccccccCCCCCC
Q 035761 399 SLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSE---FEAFVADFGIARLLNYDSSN 475 (560)
Q Consensus 399 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~~~~~~~~~~~ 475 (560)
+..+++-..... .+++.....++.||+.||.|||.+ +|||+|+||+|||+... -.+||||||+|+.+.+ ...
T Consensus 648 DMLEMILSsEkg-RL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE-ksF 722 (888)
T KOG4236|consen 648 DMLEMILSSEKG-RLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE-KSF 722 (888)
T ss_pred hHHHHHHHhhcc-cchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecch-hhh
Confidence 666665544332 388888888999999999999999 99999999999999654 4689999999999874 456
Q ss_pred ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccccc
Q 035761 476 RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSS 526 (560)
Q Consensus 476 ~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~ 526 (560)
+...+||+.|.|||++....|...-||||.|||+|--++|.+||....+..
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn 773 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN 773 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh
Confidence 667889999999999999999999999999999999999999997554433
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=297.00 Aligned_cols=147 Identities=29% Similarity=0.459 Sum_probs=131.2
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchh-hhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLE-TELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|.+.+.||+|+||.||+|... +++.||+|+++... ........+.+|+.+++.++||||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 56888999999999999999875 68899999987543 22233467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccc
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIAR 467 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~ 467 (560)
||+++++|.+++..... +++..+..++.||+.||+|||.. +||||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~~---l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYGY---FDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999976432 88999999999999999999998 99999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=261.34 Aligned_cols=215 Identities=21% Similarity=0.193 Sum_probs=176.0
Q ss_pred cCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEeccCCCCHHHHh
Q 035761 326 GGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCIL 404 (560)
Q Consensus 326 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l 404 (560)
|.+|.||++..+ +++.+|+|++.... .+.+|...+....|||++++++++......++||||+++|+|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 899999999764 68899999987543 1233444455567999999999999999999999999999999998
Q ss_pred hcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCceeeccccC
Q 035761 405 RTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYG 484 (560)
Q Consensus 405 ~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~ 484 (560)
..... +++..+..++.|+++||+|||+. +++||||||+||+++.++.++++|||.+...... .....++..
T Consensus 77 ~~~~~---l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~ 147 (237)
T cd05576 77 SKFLN---IPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVENM 147 (237)
T ss_pred HHhcC---CCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCcc
Confidence 76433 89999999999999999999998 9999999999999999999999999988765432 122345677
Q ss_pred ccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-------------cccccccccccccccCCCCCCCh----
Q 035761 485 SIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-------------SSSSLDKNIKLIDLLDPRLPPPG---- 547 (560)
Q Consensus 485 ~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-------------~~~~~~~~~~~~~~~dp~~~p~~---- 547 (560)
|+|||......++.++||||+|+++|||++|+.|+..... ....+...++.|...||+.|+++
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~ 227 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAG 227 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccc
Confidence 9999999888889999999999999999999988653321 11223456677778899999985
Q ss_pred -hHHHhhcee
Q 035761 548 -DQMIRQGII 556 (560)
Q Consensus 548 -~~~~~~~~~ 556 (560)
++++.|+|+
T Consensus 228 ~~~~~~h~~~ 237 (237)
T cd05576 228 VEDIKSHPFF 237 (237)
T ss_pred hHHHHcCCCC
Confidence 888888874
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=283.12 Aligned_cols=243 Identities=25% Similarity=0.419 Sum_probs=207.1
Q ss_pred HHHHHHhcCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEe-
Q 035761 308 QDMIEATEDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLH- 384 (560)
Q Consensus 308 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~- 384 (560)
+.+...++-|++.+.||+|.+|.||+++. ++++.+|+|+.....+.. ++...|.++++.. +|||++.++|++..
T Consensus 12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d---eEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE---EEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc---HHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 33344567799999999999999999975 468899999987655432 3455788888887 79999999999975
Q ss_pred ----CCEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEE
Q 035761 385 ----EKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFV 460 (560)
Q Consensus 385 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 460 (560)
++.+|||||||.+|+..++++.-. ...+.|.-+..|++.++.|+.+||.+ .++|||+|-.|||++.++.+|+
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEE
Confidence 468999999999999999998755 45599999999999999999999999 9999999999999999999999
Q ss_pred eeeccccccCCCCCCceeeccccCccCccccccC-----ccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------
Q 035761 461 ADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTM-----VVTEKYDVYSFGVVALEVLMGKHPGELLSS----------- 524 (560)
Q Consensus 461 ~Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-----~~~~~~Dv~s~G~il~el~~g~~P~~~~~~----------- 524 (560)
.|||.+..++.....+....||+.|||||++... .|+.++|+||+|++..||.-|.+|+-++.-
T Consensus 165 vDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNP 244 (953)
T KOG0587|consen 165 VDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 244 (953)
T ss_pred eeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCC
Confidence 9999999988777777788999999999997643 477799999999999999999999865542
Q ss_pred ---------cccccccccccccccCCCCCCChhHHHhhceee
Q 035761 525 ---------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 525 ---------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
+..++.+.+..|..-|-.-||...++++|+||.
T Consensus 245 PPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~ 286 (953)
T KOG0587|consen 245 PPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT 286 (953)
T ss_pred CccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence 334455666777777888999999999999986
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=264.11 Aligned_cols=204 Identities=25% Similarity=0.367 Sum_probs=178.0
Q ss_pred cCCcccceeeccCCeeEEEEEeCC-CcEEEEEEccchh-hhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRLE-TELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKCMFLI 391 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 391 (560)
.+|....+||+|+||.|-.|..++ .+.+|||++++.. .+....+.-+.|-.+++.- +-|.++++..+++.-+.+|.|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 468889999999999999997654 5679999998765 2333445566787787766 578999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 471 (560)
|||+.+|+|-.+++.-+. +.+..+.-+|..||-||-|||++ |||.||||..|||+|.+|++||+|||+++.--.
T Consensus 429 MEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred EEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccccc
Confidence 999999999888876554 78888999999999999999999 999999999999999999999999999986544
Q ss_pred CCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc
Q 035761 472 DSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS 524 (560)
Q Consensus 472 ~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~ 524 (560)
+.......+||+.|+|||++....|...+|+|||||++|||+.|.+||+..+.
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE 555 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE 555 (683)
T ss_pred CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 55566778999999999999999999999999999999999999999986653
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=266.54 Aligned_cols=238 Identities=27% Similarity=0.393 Sum_probs=190.7
Q ss_pred cCCcccceeeccCCeeEEEEE-eCCCcEEEEEEccchhhh-----hhhHHHHHHHHHHHhccCCCCcceeeeEEEe-CCE
Q 035761 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETE-----LASLESFQNEARLLSQIRHRNIVKLYGFCLH-EKC 387 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~ 387 (560)
++|-+...+|+|+|+.||+|. +...+.||||+-...... ....+..++|..+.+.++||.||++|+|+.- .+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 567777889999999999995 456788999975433222 2223457889999999999999999999865 457
Q ss_pred EEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCC---CCcEEEeeec
Q 035761 388 MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNS---EFEAFVADFG 464 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg 464 (560)
+|-|.|||+|.+|.-|++.+.- ++++++..|+.||+.||.||.+. +|+|||-||||.|||+-+ -|.+||+|||
T Consensus 543 FCTVLEYceGNDLDFYLKQhkl---mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHKL---MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ceeeeeecCCCchhHHHHhhhh---hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 8899999999999999987654 89999999999999999999986 889999999999999954 3789999999
Q ss_pred cccccCCCCCC-------ceeeccccCccCccccccC----ccCcchhHHHHHHHHHHHHhCCCCCCccccccccccc--
Q 035761 465 IARLLNYDSSN-------RTLLAGTYGSIAPELAYTM----VVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDK-- 531 (560)
Q Consensus 465 ~~~~~~~~~~~-------~~~~~g~~~~~aPE~~~~~----~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~~~~~~-- 531 (560)
+++.++.+... .+..+||++|++||.+.-. ..+.|+||||.|||+|+-+.|+.||...-+-.+-+.+
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT 698 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT 698 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence 99998765443 2346799999999987644 4677999999999999999999999865543333221
Q ss_pred cc---ccccccCCCCCCChhHHHhhcee
Q 035761 532 NI---KLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 532 ~~---~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
++ ......-|...+++..+|+.|+.
T Consensus 699 IlkAtEVqFP~KPvVsseAkaFIRRCLa 726 (775)
T KOG1151|consen 699 ILKATEVQFPPKPVVSSEAKAFIRRCLA 726 (775)
T ss_pred hhcceeccCCCCCccCHHHHHHHHHHHH
Confidence 11 22334467788999999998863
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=256.75 Aligned_cols=241 Identities=20% Similarity=0.280 Sum_probs=195.9
Q ss_pred HHHHHHhcCCcccceeeccCCeeEEEEEeCC------CcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeE
Q 035761 308 QDMIEATEDFDIKYCIGTGGYGSVYRARLPS------GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGF 381 (560)
Q Consensus 308 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 381 (560)
+++.....+++....+.+|.||.||.|.|.+ .+.|.||.++.... .-+...+..|..++..+.|||+.++.++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS-~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHAS-QIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhccc-HHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 3444445667777889999999999996653 45677887765443 3456678899999999999999999999
Q ss_pred EEeC-CEEEEEEeccCCCCHHHHhh-----cCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCC
Q 035761 382 CLHE-KCMFLIYEYMEMGSLFCILR-----TDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSE 455 (560)
Q Consensus 382 ~~~~-~~~~lv~e~~~~g~L~~~l~-----~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~ 455 (560)
+.++ ...+++|.++.-|+|..|+. .....+.++..+...++.|++.|++|||+. ++||.||.++|++||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence 9775 46788999999999999998 445566789999999999999999999999 99999999999999999
Q ss_pred CcEEEeeeccccccCCCCCCcee--eccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccccc------
Q 035761 456 FEAFVADFGIARLLNYDSSNRTL--LAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSS------ 526 (560)
Q Consensus 456 ~~~kl~Dfg~~~~~~~~~~~~~~--~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~~------ 526 (560)
..+||+|-.+++.+.+.+++.-. .-.+.+||+||.+....|+..+|||||||++|||+| |+.|+...+-.+
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk 512 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK 512 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh
Confidence 99999999999988665444311 224568999999999999999999999999999999 999987555311
Q ss_pred ------------cccccccccccccCCCCCCChhHHHh
Q 035761 527 ------------SSLDKNIKLIDLLDPRLPPPGDQMIR 552 (560)
Q Consensus 527 ------------~~~~~~~~~~~~~dp~~~p~~~~~~~ 552 (560)
+++...+.-|=.++|..||++.++..
T Consensus 513 dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 513 DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 22334444455779999999998764
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-33 Score=271.45 Aligned_cols=237 Identities=24% Similarity=0.348 Sum_probs=192.0
Q ss_pred cCCcccceeeccCCeeEEEEEeCCCc-EEEEEEccchh-hhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPSGK-VVALKKLHRLE-TELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~~~-~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
.+++....+|-|+||.|-.+..++.. .+|+|.+++.. ....+.+....|-.+|...+.|.||++|..|.++++.|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34555667999999999999875433 38888887654 22234456778999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
|-|-||.+.+.++..+. ++......++..+.+|++|||.. +||.|||||+|.++|.+|-+||.|||+|+.+. .
T Consensus 500 EaClGGElWTiLrdRg~---Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~-~ 572 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGS---FDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG-S 572 (732)
T ss_pred HhhcCchhhhhhhhcCC---cccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhc-c
Confidence 99999999999986554 89999999999999999999999 99999999999999999999999999999986 3
Q ss_pred CCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccc--CCCCCCChhHH
Q 035761 473 SSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLL--DPRLPPPGDQM 550 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~~~~~~~~~~~~~~--dp~~~p~~~~~ 550 (560)
+......+||+.|.|||++.....+..+|.||+|+++|||++|++||...+- -..+..+.+..+.+ +-.+.-++.++
T Consensus 573 g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp-mktYn~ILkGid~i~~Pr~I~k~a~~L 651 (732)
T KOG0614|consen 573 GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP-MKTYNLILKGIDKIEFPRRITKTATDL 651 (732)
T ss_pred CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch-HHHHHHHHhhhhhhhcccccchhHHHH
Confidence 4556678999999999999999999999999999999999999999985442 11222333333333 33455556666
Q ss_pred Hhhceeeec
Q 035761 551 IRQGIILIS 559 (560)
Q Consensus 551 ~~~~~~~~~ 559 (560)
+++.+=.+|
T Consensus 652 ik~LCr~~P 660 (732)
T KOG0614|consen 652 IKKLCRDNP 660 (732)
T ss_pred HHHHHhcCc
Confidence 666554444
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=272.02 Aligned_cols=242 Identities=18% Similarity=0.196 Sum_probs=173.8
Q ss_pred hcCCcccceeeccCCeeEEEEEe-----------------CCCcEEEEEEccchhhhh------------hhHHHHHHHH
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARL-----------------PSGKVVALKKLHRLETEL------------ASLESFQNEA 364 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~------------~~~~~~~~e~ 364 (560)
.++|++.+.||+|+||.||+|.. .+++.||||++....... ...+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 56899999999999999999964 235689999986432110 1122344577
Q ss_pred HHHhccCCCCc-----ceeeeEEEe--------CCEEEEEEeccCCCCHHHHhhcCCc---------------------c
Q 035761 365 RLLSQIRHRNI-----VKLYGFCLH--------EKCMFLIYEYMEMGSLFCILRTDEE---------------------A 410 (560)
Q Consensus 365 ~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~ 410 (560)
.++.+++|.++ ++++++|.. ++..++||||+++|+|.++++.... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77787866554 778888754 3568999999999999999874311 1
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCc-eeeccccCccCcc
Q 035761 411 VGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNR-TLLAGTYGSIAPE 489 (560)
Q Consensus 411 ~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~g~~~~~aPE 489 (560)
..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......... ....+++.|+|||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 2357888999999999999999998 99999999999999999999999999997653221111 1223478999999
Q ss_pred ccccCcc----------------------CcchhHHHHHHHHHHHHhCCC-CCCccccc---------------------
Q 035761 490 LAYTMVV----------------------TEKYDVYSFGVVALEVLMGKH-PGELLSSS--------------------- 525 (560)
Q Consensus 490 ~~~~~~~----------------------~~~~Dv~s~G~il~el~~g~~-P~~~~~~~--------------------- 525 (560)
.+..... ..+.||||+||++|||++|.. ||......
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~ 460 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK 460 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence 8754321 124799999999999999885 66422100
Q ss_pred ---------ccccccccccccccC---CCCCCChhHHHhhceeee
Q 035761 526 ---------SSSLDKNIKLIDLLD---PRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 526 ---------~~~~~~~~~~~~~~d---p~~~p~~~~~~~~~~~~~ 558 (560)
+......+..+...+ |..|+++++++.|+|+.+
T Consensus 461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 000111222223333 368999999999999865
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=263.39 Aligned_cols=202 Identities=23% Similarity=0.360 Sum_probs=170.0
Q ss_pred CCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 316 DFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
-|...+.||-|+||.|..++- .+...+|.|.+.+.+. ..........|-.++...+.+.||++|-.|.+++++|.|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 456677899999999999864 4456789999877552 23445567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccC--C
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN--Y 471 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~--~ 471 (560)
|++||++-.+|-+-+- |.+.-++.++..+++|+++.|.. |+|||||||.|||||.+|++||+|||++.-+. .
T Consensus 710 YIPGGDmMSLLIrmgI---FeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMGI---FEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred ccCCccHHHHHHHhcc---CHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecc
Confidence 9999999988865443 78888888899999999999999 99999999999999999999999999986321 0
Q ss_pred ------CC-----------------C-------------Cc----eeeccccCccCccccccCccCcchhHHHHHHHHHH
Q 035761 472 ------DS-----------------S-------------NR----TLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALE 511 (560)
Q Consensus 472 ------~~-----------------~-------------~~----~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~e 511 (560)
.+ . .+ ...+||+.|+|||++....|+.-+|+||.|||+||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 00 0 00 11469999999999999999999999999999999
Q ss_pred HHhCCCCCCccc
Q 035761 512 VLMGKHPGELLS 523 (560)
Q Consensus 512 l~~g~~P~~~~~ 523 (560)
|+.|+.||-...
T Consensus 864 m~~g~~pf~~~t 875 (1034)
T KOG0608|consen 864 MLVGQPPFLADT 875 (1034)
T ss_pred HhhCCCCccCCC
Confidence 999999996443
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=279.16 Aligned_cols=232 Identities=26% Similarity=0.366 Sum_probs=187.6
Q ss_pred CcccceeeccCCe-eEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCEEEEEEec
Q 035761 317 FDIKYCIGTGGYG-SVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 317 ~~~~~~ig~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
|...+++|.|+.| .||+|.+ +|+.||||++-..- ....++|+..++.- +|||||++++.-.+++..|+..|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~-----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF-----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh-----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence 3445678999997 7899998 58999999986422 23457899999988 699999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCC---C--CcEEEeeeccccc
Q 035761 395 MEMGSLFCILRTDEEAVG-LDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNS---E--FEAFVADFGIARL 468 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~-l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~--~~~kl~Dfg~~~~ 468 (560)
|.. +|.+++..+..... ......+.+..|+++|+++||+. +||||||||.||||+. + ..++|+|||+++.
T Consensus 585 C~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 585 CAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred hhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 965 99999987521111 11144577899999999999998 9999999999999975 3 4688999999999
Q ss_pred cCCCCCC---ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc----------------cc-
Q 035761 469 LNYDSSN---RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS----------------SS- 527 (560)
Q Consensus 469 ~~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~----------------~~- 527 (560)
+..+... .....||-+|+|||++....-+..+||||+||++|+.++ |..||++.-.. ..
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~~~~d 740 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLEPLPD 740 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeeccCch
Confidence 8654433 334679999999999999888889999999999999998 59999744321 11
Q ss_pred -ccccccccccccCCCCCCChhHHHhhceeee
Q 035761 528 -SLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 528 -~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
...+++..|...||..||++.+++.|+++-+
T Consensus 741 ~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 741 CEAKDLISRMLNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred HHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence 3456678888999999999999999998743
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=249.87 Aligned_cols=222 Identities=31% Similarity=0.461 Sum_probs=189.5
Q ss_pred CCeeEEEEEeCC-CcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEeccCCCCHHHHhh
Q 035761 327 GYGSVYRARLPS-GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILR 405 (560)
Q Consensus 327 ~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~ 405 (560)
+||.||+|...+ ++.+|+|++........ .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 589999998864 89999999876443211 5688999999999999999999999999999999999999999999987
Q ss_pred cCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCceeeccccCc
Q 035761 406 TDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGS 485 (560)
Q Consensus 406 ~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~~ 485 (560)
.... +++..+..++.++++++.|||+. +++|+||+|+||++++++.++++|||.+....... ......++..|
T Consensus 80 ~~~~---~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~ 152 (244)
T smart00220 80 KRGR---LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEY 152 (244)
T ss_pred hccC---CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCC
Confidence 6443 79999999999999999999998 99999999999999999999999999998765432 23344578899
Q ss_pred cCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------cccccccccccccccCCCCC
Q 035761 486 IAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------SSSSLDKNIKLIDLLDPRLP 544 (560)
Q Consensus 486 ~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------~~~~~~~~~~~~~~~dp~~~ 544 (560)
+|||.+....++.++||||+|+++|++++|..||..... ....+.+.+..|...+|+.|
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 232 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKR 232 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhc
Confidence 999999888889999999999999999999999975221 12234456677778899999
Q ss_pred CChhHHHhhcee
Q 035761 545 PPGDQMIRQGII 556 (560)
Q Consensus 545 p~~~~~~~~~~~ 556 (560)
|++.++++++|+
T Consensus 233 p~~~~~~~~~~~ 244 (244)
T smart00220 233 LTAEEALQHPFF 244 (244)
T ss_pred cCHHHHhhCCCC
Confidence 999999999885
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=245.12 Aligned_cols=203 Identities=24% Similarity=0.391 Sum_probs=179.6
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKCMFLI 391 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 391 (560)
++|.+.++||+|+|+.|..++++ +.+.+|+|++++.-- +.+..+=.+.|-.+..+. +||.+|-+..+++.+...+.|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 57899999999999999999875 578899999886542 223334456777777776 799999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 471 (560)
.||+++|+|--++++.++ ++++.+..+...|.-||.|||+. |||.||+|..|||+|.+|++|++|+|+++.--.
T Consensus 330 ieyv~ggdlmfhmqrqrk---lpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQRQRK---LPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEecCcceeeehhhhhc---CcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 999999999877776554 89999999999999999999999 999999999999999999999999999987666
Q ss_pred CCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccc
Q 035761 472 DSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLS 523 (560)
Q Consensus 472 ~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~ 523 (560)
+....+..+|||.|.|||++.+..|...+|+|++||+|+||+.|+.||+..+
T Consensus 404 ~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivg 455 (593)
T KOG0695|consen 404 PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVG 455 (593)
T ss_pred CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceec
Confidence 6777788899999999999999999999999999999999999999998555
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=276.90 Aligned_cols=237 Identities=19% Similarity=0.216 Sum_probs=167.0
Q ss_pred HhcCCcccceeeccCCeeEEEEEeCC-----CcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeE------
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARLPS-----GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGF------ 381 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~------ 381 (560)
..++|+..+.||+|+||.||+|.+.+ +..||||++...... +.+..| .+....+.++..+...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~----e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV----EIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh----HHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 34689999999999999999998754 689999987643211 111111 1112222222222221
Q ss_pred EEeCCEEEEEEeccCCCCHHHHhhcCCcc-----------------cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeC
Q 035761 382 CLHEKCMFLIYEYMEMGSLFCILRTDEEA-----------------VGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRD 444 (560)
Q Consensus 382 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~d 444 (560)
+..+...++||||+++++|.+++...... .......+..++.||+.||+|||+. +|+|||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRD 280 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRD 280 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCc
Confidence 23456789999999999999998753211 0112334567999999999999998 999999
Q ss_pred CCCCCeEeCC-CCcEEEeeeccccccCCCC-CCceeeccccCccCccccccC----------------------ccCcch
Q 035761 445 ISSNNILLNS-EFEAFVADFGIARLLNYDS-SNRTLLAGTYGSIAPELAYTM----------------------VVTEKY 500 (560)
Q Consensus 445 lk~~Nill~~-~~~~kl~Dfg~~~~~~~~~-~~~~~~~g~~~~~aPE~~~~~----------------------~~~~~~ 500 (560)
|||+|||++. ++.+||+|||+|+.+.... .......+++.|||||.+... .++.++
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 9999999986 5799999999998654322 222345688999999965322 234567
Q ss_pred hHHHHHHHHHHHHhCCCCCCcccc-----------------------cccc--------------cccccccccccCCCC
Q 035761 501 DVYSFGVVALEVLMGKHPGELLSS-----------------------SSSS--------------LDKNIKLIDLLDPRL 543 (560)
Q Consensus 501 Dv~s~G~il~el~~g~~P~~~~~~-----------------------~~~~--------------~~~~~~~~~~~dp~~ 543 (560)
||||+||++|||+++..|++.... .... ..+.++.|...||+.
T Consensus 361 DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 999999999999998777542100 0000 014667788899999
Q ss_pred CCChhHHHhhceeee
Q 035761 544 PPPGDQMIRQGIILI 558 (560)
Q Consensus 544 ~p~~~~~~~~~~~~~ 558 (560)
||+++++++|+|+..
T Consensus 441 R~ta~e~L~Hpff~~ 455 (566)
T PLN03225 441 RISAKAALAHPYFDR 455 (566)
T ss_pred CCCHHHHhCCcCcCC
Confidence 999999999999864
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-33 Score=243.66 Aligned_cols=229 Identities=24% Similarity=0.377 Sum_probs=182.0
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEe--------C
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLH--------E 385 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~ 385 (560)
..|+....||+|.||.||+|+.+ +|+.||+|+.--............+|+.++..++|+|++.++..|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 34666778999999999999865 57788998654322222333456789999999999999999998854 2
Q ss_pred CEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecc
Q 035761 386 KCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGI 465 (560)
Q Consensus 386 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 465 (560)
...++||++|+. +|.-.+... ...++..++.+++.++..||.|+|.. .|+|||+||.|+||+.++.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccc
Confidence 358999999987 888888643 23489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCC----CCceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccccccC
Q 035761 466 ARLLNYDS----SNRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLD 540 (560)
Q Consensus 466 ~~~~~~~~----~~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~~~~~~~~~~~~~~d 540 (560)
++.+.... ...+..+.|..|.+||.+.+ +.|+++.|||..||++.||+||.+-++ .++...++.-+...|-.+.
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimq-gnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQ-GNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCcccc-CChHHHHHHHHHHHhccCC
Confidence 97664221 12334567899999998765 678999999999999999999986665 4455555666666777777
Q ss_pred CCCCCChhHH
Q 035761 541 PRLPPPGDQM 550 (560)
Q Consensus 541 p~~~p~~~~~ 550 (560)
|+..|.++++
T Consensus 250 kevWP~~d~l 259 (376)
T KOG0669|consen 250 KEVWPNVDNL 259 (376)
T ss_pred cccCCCcccc
Confidence 7777777665
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=229.79 Aligned_cols=208 Identities=22% Similarity=0.347 Sum_probs=175.1
Q ss_pred HhcCCcccceeeccCCeeEEEEE-eCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccC-CCCcceeeeEEEeC--CEE
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIR-HRNIVKLYGFCLHE--KCM 388 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~ 388 (560)
..++|++.+.+|+|.|+.||.|. ..+.+.++||.++... .+...+|+.++..++ ||||+++++...++ +..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk-----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK-----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH-----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 34678999999999999999996 4568899999998544 346789999999996 99999999998775 457
Q ss_pred EEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCC-CcEEEeeecccc
Q 035761 389 FLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSE-FEAFVADFGIAR 467 (560)
Q Consensus 389 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~~~ 467 (560)
.|++||+.+.+......+ ++..++...+.++++||+|+|+. ||+|||+||+|++||.. ...+|+|+|+|.
T Consensus 111 aLiFE~v~n~Dfk~ly~t------l~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAE 181 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLYPT------LTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
T ss_pred hhHhhhhccccHHHHhhh------hchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHh
Confidence 899999999888777654 78888999999999999999999 99999999999999965 568999999999
Q ss_pred ccCCCCCCceeeccccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccc
Q 035761 468 LLNYDSSNRTLLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKL 535 (560)
Q Consensus 468 ~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~~~~~~~~~~ 535 (560)
++.+.. .....+.+..|.-||++.+- .|+..-|+|||||++.+|+..+.||....+..+++.++.+.
T Consensus 182 FYHp~~-eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakV 249 (338)
T KOG0668|consen 182 FYHPGK-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKV 249 (338)
T ss_pred hcCCCc-eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHH
Confidence 986543 33444566779999998865 46778899999999999999999998887776666555543
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-31 Score=245.76 Aligned_cols=234 Identities=19% Similarity=0.261 Sum_probs=191.6
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCC--C----CcceeeeEEEeCC
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRH--R----NIVKLYGFCLHEK 386 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~----niv~l~~~~~~~~ 386 (560)
+.+|.+...+|+|.||.|-++... .+..||||+++... ...+..+-|++++.++.+ | -+|.+.+|+...+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 578999999999999999999654 47899999987543 223455679999999832 3 3788999999999
Q ss_pred EEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCC------------
Q 035761 387 CMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNS------------ 454 (560)
Q Consensus 387 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~------------ 454 (560)
..++|+|.+ |-|+.+++..+.. .+++...+..|+.|++++++|||+. +++|.||||+|||+.+
T Consensus 165 hiCivfell-G~S~~dFlk~N~y-~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKENNY-IPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred ceEEEEecc-ChhHHHHhccCCc-cccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCc
Confidence 999999988 5599999987543 4589999999999999999999999 9999999999999832
Q ss_pred --------CCcEEEeeeccccccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccccc
Q 035761 455 --------EFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSS 526 (560)
Q Consensus 455 --------~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~ 526 (560)
+-.++++|||.|++-. ...+..+.|.-|.|||++.+..++.++||||+|||+.|+.+|..-|+.-++.+
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~---e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDH---EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred cceeccCCCcceEEEecCCcceec---cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 2358999999998743 33356778999999999999999999999999999999999998875433200
Q ss_pred ---------------------------------------------------------------cccccccccccccCCCC
Q 035761 527 ---------------------------------------------------------------SSLDKNIKLIDLLDPRL 543 (560)
Q Consensus 527 ---------------------------------------------------------------~~~~~~~~~~~~~dp~~ 543 (560)
.++.++++.+...||..
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 12334445667789999
Q ss_pred CCChhHHHhhceeee
Q 035761 544 PPPGDQMIRQGIILI 558 (560)
Q Consensus 544 ~p~~~~~~~~~~~~~ 558 (560)
|.++++++.|+|+.-
T Consensus 397 RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 397 RITLREALSHPFFAR 411 (415)
T ss_pred cccHHHHhcCHHhhc
Confidence 999999999998754
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-30 Score=253.27 Aligned_cols=199 Identities=25% Similarity=0.353 Sum_probs=171.1
Q ss_pred hcCCcccceeeccCCeeEEEEEeCC-CcEEEEEEccchhh---h-h--hhHHHHHHHHHHHhccC---CCCcceeeeEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRLET---E-L--ASLESFQNEARLLSQIR---HRNIVKLYGFCL 383 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~-~--~~~~~~~~e~~~l~~l~---h~niv~l~~~~~ 383 (560)
..+|.....+|.|+||.|+.|.++. ..+|+||.+.+... . . ......-.|+++|..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 3468888999999999999998765 56789998876541 1 0 11123456999999997 999999999999
Q ss_pred eCCEEEEEEecc-CCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEee
Q 035761 384 HEKCMFLIYEYM-EMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVAD 462 (560)
Q Consensus 384 ~~~~~~lv~e~~-~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 462 (560)
++++.||+||-. ++-+|.+++..++. +++.+...|++||+-|+++||++ ||||||||-+||.++.+|-+||+|
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp~---m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKPR---MDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccCc---cchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence 999999999986 55689999987665 99999999999999999999999 999999999999999999999999
Q ss_pred eccccccCCCCCCceeeccccCccCccccccCccCcc-hhHHHHHHHHHHHHhCCCCCC
Q 035761 463 FGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEK-YDVYSFGVVALEVLMGKHPGE 520 (560)
Q Consensus 463 fg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~-~Dv~s~G~il~el~~g~~P~~ 520 (560)
||.|... ........+||.+|.|||++.+..|--| -||||+|+++|.++....||.
T Consensus 714 fgsaa~~--ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYT--KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhh--cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999775 3345566789999999999999988664 799999999999999999985
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-31 Score=235.44 Aligned_cols=200 Identities=31% Similarity=0.372 Sum_probs=167.6
Q ss_pred CcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCC-----EEEE
Q 035761 317 FDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEK-----CMFL 390 (560)
Q Consensus 317 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~l 390 (560)
.+..+.||-|+||.||.+.. ++|+.||.|++...-.+....+.+.+|++++..++|.|++..++...-.. +.|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 44567799999999999865 57999999999766555566677889999999999999999998775442 4678
Q ss_pred EEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccC
Q 035761 391 IYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN 470 (560)
Q Consensus 391 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 470 (560)
+.|.|.. +|+..+-.. +.++.+.+.-+.+||++||.|||+. +|.||||||.|.|++.+-..||+|||+|+..+
T Consensus 135 ~TELmQS-DLHKIIVSP---Q~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIVSP---QALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHHh-hhhheeccC---CCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccc
Confidence 8898854 888777653 3488888999999999999999998 99999999999999999999999999999765
Q ss_pred CCC-CCceeeccccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCCCCCccc
Q 035761 471 YDS-SNRTLLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKHPGELLS 523 (560)
Q Consensus 471 ~~~-~~~~~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~P~~~~~ 523 (560)
.+. ...+..+-|..|.|||++.+. .|+...||||.||++.|++.++.-|+..+
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~ 262 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAG 262 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccC
Confidence 433 234445678999999998875 58889999999999999999998886443
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=230.73 Aligned_cols=199 Identities=36% Similarity=0.533 Sum_probs=171.6
Q ss_pred CcccceeeccCCeeEEEEEeCC-CcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEecc
Q 035761 317 FDIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYM 395 (560)
Q Consensus 317 ~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 395 (560)
|...+.||.|++|.||+|...+ ++.+++|.+...... ...+.+.+|++.++.++|+|++++++++......++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 4567889999999999998765 889999998764322 24567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC-C
Q 035761 396 EMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS-S 474 (560)
Q Consensus 396 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 474 (560)
++++|.+++...... +++..+..++.+++.++.|||+. +++|+|++|+||+++.++.++|+|||.+....... .
T Consensus 80 ~~~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 80 EGGDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 999999999764322 78999999999999999999999 99999999999999999999999999998765432 1
Q ss_pred CceeeccccCccCcccc-ccCccCcchhHHHHHHHHHHHHhCCCCCCc
Q 035761 475 NRTLLAGTYGSIAPELA-YTMVVTEKYDVYSFGVVALEVLMGKHPGEL 521 (560)
Q Consensus 475 ~~~~~~g~~~~~aPE~~-~~~~~~~~~Dv~s~G~il~el~~g~~P~~~ 521 (560)
......++..|++||.. ....++.++||||||++++||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22334577889999998 667778899999999999999999999975
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-29 Score=228.02 Aligned_cols=231 Identities=26% Similarity=0.314 Sum_probs=185.3
Q ss_pred CCcccceeeccCCeeEEEEE-eCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCC------EE
Q 035761 316 DFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEK------CM 388 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~ 388 (560)
+|.-...+|.|+- .|..+. .-.++.||+|++...-......+...+|...+..++|+|+++++.++.-.+ ..
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 4555666888887 555553 335889999988655433344456678999999999999999999986543 47
Q ss_pred EEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccc
Q 035761 389 FLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARL 468 (560)
Q Consensus 389 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 468 (560)
|+|||||.. +|.+.+.-. ++..++..|.+|++.|+.|||+. ||+||||||+||++..+..+||.|||+|+.
T Consensus 97 y~v~e~m~~-nl~~vi~~e-----lDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 97 YLVMELMDA-NLCQVILME-----LDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHhhhh-HHHHHHHHh-----cchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcc
Confidence 899999965 898888722 78899999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc------------------------
Q 035761 469 LNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS------------------------ 524 (560)
Q Consensus 469 ~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~------------------------ 524 (560)
-..+ -..+..+.+..|.|||++.+..+.+.+||||.||++.||++|+.-|...+.
T Consensus 168 e~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~ 246 (369)
T KOG0665|consen 168 EDTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP 246 (369)
T ss_pred cCcc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence 5433 345567788899999999999999999999999999999999977643221
Q ss_pred -----------------------------------cccccccccccccccCCCCCCChhHHHhhceee
Q 035761 525 -----------------------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 525 -----------------------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
...........|..++|+-|-+++++++|+.+.
T Consensus 247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 000123334566788999999999999998875
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=278.93 Aligned_cols=230 Identities=43% Similarity=0.662 Sum_probs=139.0
Q ss_pred CCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEE
Q 035761 3 RLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVL 82 (560)
Q Consensus 3 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 82 (560)
.+++|++|+|++|.+++..|..++++++|++|+|++|.+.+..|..+.++++|++|+|++|++.+..|..+.++++|++|
T Consensus 138 ~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 217 (968)
T PLN00113 138 SIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWI 217 (968)
T ss_pred ccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEE
Confidence 35566666666666666666666666666666666666666666666666666666666666665566666666666666
Q ss_pred EeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccc
Q 035761 83 DLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLS 162 (560)
Q Consensus 83 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 162 (560)
+|++|++++..|..+.++++|+.|+|++|.+++..|..+.++++|+.|+|++|.+.+..|..+.++++|+.|++++|.++
T Consensus 218 ~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~ 297 (968)
T PLN00113 218 YLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLS 297 (968)
T ss_pred ECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeec
Confidence 66666666566666666666666666666666556666666666666666666665555555555666666666666665
Q ss_pred cccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCccc---ccCCCCcCCCCCCCC
Q 035761 163 GSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFV---RKVPHLDVSGNQFGG 232 (560)
Q Consensus 163 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~~---~~l~~l~l~~n~~~~ 232 (560)
+..|..+..+++|+.|++++|.+.+..|..+..+++|+.|++++|.+++.+|..+ .+++.|++++|++.+
T Consensus 298 ~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~ 370 (968)
T PLN00113 298 GEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTG 370 (968)
T ss_pred cCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEe
Confidence 5555555555555555555555555555555555555555555555555444422 233444444444443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=220.49 Aligned_cols=211 Identities=36% Similarity=0.577 Sum_probs=181.9
Q ss_pred eeccCCeeEEEEEeCC-CcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEeccCCCCHH
Q 035761 323 IGTGGYGSVYRARLPS-GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLF 401 (560)
Q Consensus 323 ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 401 (560)
||+|.+|.||++...+ ++.+++|++....... ..+.+.+|++.++.++|++++++++++......++++||+++++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 6899999999998754 8999999987654321 3457889999999999999999999999999999999999999999
Q ss_pred HHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCC-CCcEEEeeeccccccCCCCCCceeec
Q 035761 402 CILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNS-EFEAFVADFGIARLLNYDSSNRTLLA 480 (560)
Q Consensus 402 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~ 480 (560)
+++.... ..+++..+..++.++++++++||+. +++|+||+|.||+++. ++.++|+|||.+..............
T Consensus 80 ~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (215)
T cd00180 80 DLLKENE--GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV 154 (215)
T ss_pred HHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhccc
Confidence 9987642 2389999999999999999999999 9999999999999999 89999999999987654332233345
Q ss_pred cccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccccccCCCCCCChhHHHhh
Q 035761 481 GTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 481 g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
+...|++||..... .++.++|+|++|++++++ ..+.+....|...+|..||++++++++
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 77889999998887 788899999999999999 455677778888999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.8e-30 Score=252.58 Aligned_cols=236 Identities=27% Similarity=0.398 Sum_probs=203.2
Q ss_pred hcCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
.++|+....+|.|.||.|||++. .+++..|||.++-... ......++|+-+++..+||||+.++|.+...+..|+.|
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~--dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG--DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCC--ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 46788899999999999999975 4688999999876442 23445678999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+.+|+|.+.-+.... +++.++..+++...+|++|||++ |-+|||||-.||++++.|.+|++|||.+..+...
T Consensus 92 EycgggslQdiy~~Tgp---lselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHVTGP---LSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred EecCCCcccceeeeccc---chhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhh
Confidence 99999999988876554 89999999999999999999999 8999999999999999999999999999888766
Q ss_pred CCCceeeccccCccCccccc---cCccCcchhHHHHHHHHHHHHhCCCCCC----------------------ccccccc
Q 035761 473 SSNRTLLAGTYGSIAPELAY---TMVVTEKYDVYSFGVVALEVLMGKHPGE----------------------LLSSSSS 527 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~---~~~~~~~~Dv~s~G~il~el~~g~~P~~----------------------~~~~~~~ 527 (560)
-..+....||+.|||||+.. .+.|..++|+|+.|+...|+---.+|-. +...+..
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~ 245 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSE 245 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchH
Confidence 66666778999999999743 5568889999999999999877666631 1223455
Q ss_pred ccccccccccccCCCCCCChhHHHhhceee
Q 035761 528 SLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 528 ~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
.+.+.++.+..-.|+-||+++.+++|+|+.
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~h~fvs 275 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVS 275 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhheeceeec
Confidence 677888888999999999999999999985
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-29 Score=244.37 Aligned_cols=206 Identities=25% Similarity=0.242 Sum_probs=136.6
Q ss_pred CCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEe
Q 035761 5 RNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDL 84 (560)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l 84 (560)
.++++|+|++|.|+.+-.+.|.++.+|.+|.|+.|+|+.+.+..|.++++|+.|+|.+|+|+-...-.|.+|++|+.|.|
T Consensus 173 ~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlkl 252 (873)
T KOG4194|consen 173 VNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKL 252 (873)
T ss_pred CCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhh
Confidence 46778888888887777777777778888888888887666677777778888888777777444566677777777777
Q ss_pred ecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccccc
Q 035761 85 SRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGS 164 (560)
Q Consensus 85 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 164 (560)
..|+|.....+.|..+.++++|+|+.|+++..-..++-+|+.|+.|+||+|.|..+.+++++.+++|++|+|++|+|+..
T Consensus 253 qrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l 332 (873)
T KOG4194|consen 253 QRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRL 332 (873)
T ss_pred hhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccC
Confidence 77777665556666666666666666666655555666666666666666666666666666666666666666666655
Q ss_pred cchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccc
Q 035761 165 IPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLS 210 (560)
Q Consensus 165 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~ 210 (560)
.+..|..+..|++|+|++|.++......|..+++|+.|||+.|.++
T Consensus 333 ~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls 378 (873)
T KOG4194|consen 333 DEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELS 378 (873)
T ss_pred ChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEE
Confidence 5555555555555555555555544455555555555555555554
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-29 Score=242.98 Aligned_cols=238 Identities=21% Similarity=0.206 Sum_probs=187.9
Q ss_pred CCCCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCC
Q 035761 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQ 80 (560)
Q Consensus 1 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~ 80 (560)
|++|.+|.+|.|++|+|+.+.+..|.++++|+.|+|..|+|.-..--.|+++++|+.|.|.+|.|.....+.|-++.+++
T Consensus 193 F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme 272 (873)
T KOG4194|consen 193 FDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKME 272 (873)
T ss_pred ccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccc
Confidence 56677888888888888877777888888888888888888755566788888888888888888877778888888888
Q ss_pred EEEeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcc
Q 035761 81 VLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNL 160 (560)
Q Consensus 81 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 160 (560)
+|+|+.|++...-.+++.+|+.|+.|+||.|.|..+.+++.+.+++|++|+|++|+|+...+.+|..+..|++|+|++|.
T Consensus 273 ~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Ns 352 (873)
T KOG4194|consen 273 HLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNS 352 (873)
T ss_pred eeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccc
Confidence 88888888887777778888888888888888887778888888888888888888887777788888888888888888
Q ss_pred cccccchhhccccccceeeccccccCCcCcc---ccCCCceeeEEEccCCccccccCcc---cccCCCCcCCCCCCCCcC
Q 035761 161 LSGSIPSQIGKLQELYYLDLSGNFINGKIPS---QLGEFSCIDTVDLSMNNLSGGIPVF---VRKVPHLDVSGNQFGGEI 234 (560)
Q Consensus 161 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~---~~~~~~~L~~l~l~~n~l~~~~~~~---~~~l~~l~l~~n~~~~~~ 234 (560)
++..-...|..+.+|+.|||++|.|++.+.+ .|..+++|+.|++.+|++....... +..+++|+|.+|.+....
T Consensus 353 i~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq 432 (873)
T KOG4194|consen 353 IDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQ 432 (873)
T ss_pred hHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeec
Confidence 8877777788888888888888888776654 4667788888888888887544443 356777888888877654
Q ss_pred Cccc
Q 035761 235 PTTL 238 (560)
Q Consensus 235 p~~~ 238 (560)
+...
T Consensus 433 ~nAF 436 (873)
T KOG4194|consen 433 PNAF 436 (873)
T ss_pred cccc
Confidence 4443
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-27 Score=225.80 Aligned_cols=132 Identities=25% Similarity=0.455 Sum_probs=111.3
Q ss_pred cCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccC-----C---CCcceeeeEEEeC
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIR-----H---RNIVKLYGFCLHE 385 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~~~ 385 (560)
.+|-+.++||-|.|++||.+.. ...+.||+|+.+... ...+....|++++++++ | .+||++++.|...
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq---hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ---HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh---HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 5788999999999999999964 567889999987543 44566788999999883 3 3699999999764
Q ss_pred ----CEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeC
Q 035761 386 ----KCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLN 453 (560)
Q Consensus 386 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~ 453 (560)
...+||+|++ |.+|..++....- +.++...+.+|++||+.||.|||..| ||||.||||+|||+.
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s~Y-rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYSNY-RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 4789999999 6689888876543 23899999999999999999999987 999999999999983
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.9e-28 Score=215.21 Aligned_cols=196 Identities=23% Similarity=0.397 Sum_probs=157.6
Q ss_pred cCCcccceeeccCCeeEEEEEeCC-CcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeE-EEeCCEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGF-CLHEKCMFLI 391 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~-~~~~~~~~lv 391 (560)
+.|.+.+.+|+|.||.+-.++++. .+.+++|.+++... ..++|.+|...--.+ .|.||+.-|++ ++..+..+.+
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t---t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT---TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh---hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 458888899999999999998764 67899998876543 356788888776666 58999988875 5567788899
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeC--CCCcEEEeeecccccc
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLN--SEFEAFVADFGIARLL 469 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfg~~~~~ 469 (560)
+||+|.|+|.+-+...+ +-+.....++.|++.|++|+|+. .+||||||.+||||- +...+|+||||..+..
T Consensus 101 qE~aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred eccCccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccccccc
Confidence 99999999998886533 67777889999999999999999 999999999999993 4468999999998865
Q ss_pred CCCCCCceeeccccCccCccccccC-----ccCcchhHHHHHHHHHHHHhCCCCCCccc
Q 035761 470 NYDSSNRTLLAGTYGSIAPELAYTM-----VVTEKYDVYSFGVVALEVLMGKHPGELLS 523 (560)
Q Consensus 470 ~~~~~~~~~~~g~~~~~aPE~~~~~-----~~~~~~Dv~s~G~il~el~~g~~P~~~~~ 523 (560)
...-.. .-.+..|.|||..... ...+.+|+|.||+++|..+||++||+...
T Consensus 174 g~tV~~---~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~ 229 (378)
T KOG1345|consen 174 GTTVKY---LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS 229 (378)
T ss_pred Cceehh---hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh
Confidence 322211 2234569999975533 35667999999999999999999999443
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-28 Score=233.74 Aligned_cols=209 Identities=23% Similarity=0.290 Sum_probs=173.4
Q ss_pred CCcCHHHHHHHhcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccC------CCCc
Q 035761 303 GRITFQDMIEATEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIR------HRNI 375 (560)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~ni 375 (560)
+.+.+.-.+....+|.+....|+|-|+.|.+|... -|+.||||++...+. -.+.=++|++++++++ --|+
T Consensus 420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~---M~KtGl~EleiLkKL~~AD~Edk~Hc 496 (752)
T KOG0670|consen 420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV---MHKTGLKELEILKKLNDADPEDKFHC 496 (752)
T ss_pred ceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH---HhhhhhHHHHHHHHhhccCchhhhHH
Confidence 34444444556678999999999999999999754 488999999975431 1223457999999995 3489
Q ss_pred ceeeeEEEeCCEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCC
Q 035761 376 VKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSE 455 (560)
Q Consensus 376 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~ 455 (560)
++++..|.....+|||||-+.. +|.+.++..+....|....+..++.|+.-||..|-.- +|+|.||||.|||+.+.
T Consensus 497 lrl~r~F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~ 572 (752)
T KOG0670|consen 497 LRLFRHFKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNES 572 (752)
T ss_pred HHHHHHhhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccC
Confidence 9999999999999999998854 9999999888888899999999999999999999887 99999999999999876
Q ss_pred Cc-EEEeeeccccccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCC
Q 035761 456 FE-AFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGE 520 (560)
Q Consensus 456 ~~-~kl~Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~ 520 (560)
.+ +||||||.|...... . -+.+..+..|.|||++.+..|+...|+||.||++||+.||+.-|.
T Consensus 573 k~iLKLCDfGSA~~~~en-e-itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFp 636 (752)
T KOG0670|consen 573 KNILKLCDFGSASFASEN-E-ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFP 636 (752)
T ss_pred cceeeeccCccccccccc-c-ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecC
Confidence 54 689999999876532 2 222334557999999999999999999999999999999997764
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-26 Score=254.54 Aligned_cols=183 Identities=16% Similarity=0.155 Sum_probs=137.5
Q ss_pred cCC-CCcceeeeEE-------EeCCEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 035761 370 IRH-RNIVKLYGFC-------LHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPIL 441 (560)
Q Consensus 370 l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iv 441 (560)
++| +||+++++++ .+....+.++||+ +++|.+++.... ..+++.++..++.||++||+|||++ ||+
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---gIv 102 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHSQ---GIV 102 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 445 5888888887 2334677888988 559999997532 3489999999999999999999999 999
Q ss_pred EeCCCCCCeEeCC-------------------CCcEEEeeeccccccCCCC----------------CCceeeccccCcc
Q 035761 442 HRDISSNNILLNS-------------------EFEAFVADFGIARLLNYDS----------------SNRTLLAGTYGSI 486 (560)
Q Consensus 442 H~dlk~~Nill~~-------------------~~~~kl~Dfg~~~~~~~~~----------------~~~~~~~g~~~~~ 486 (560)
||||||+|||++. ++.+|++|||+++...... ......+||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999954 4455666666665421100 0011235788899
Q ss_pred CccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccccc----------------cccccccccccccCCCCCCChhHH
Q 035761 487 APELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSS----------------SSLDKNIKLIDLLDPRLPPPGDQM 550 (560)
Q Consensus 487 aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~----------------~~~~~~~~~~~~~dp~~~p~~~~~ 550 (560)
|||++.+..++.++|||||||++|||++|..|+....... .........|...+|..||++.++
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~ei 262 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSEL 262 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHH
Confidence 9999999999999999999999999999999976332100 011122233567799999999999
Q ss_pred Hhhceeee
Q 035761 551 IRQGIILI 558 (560)
Q Consensus 551 ~~~~~~~~ 558 (560)
++|+|+..
T Consensus 263 l~h~~~~~ 270 (793)
T PLN00181 263 LQSEFINE 270 (793)
T ss_pred hhchhhhh
Confidence 99999864
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.2e-26 Score=216.01 Aligned_cols=202 Identities=28% Similarity=0.393 Sum_probs=167.3
Q ss_pred HHHHhcCCcccceeeccCCeeEEEEEeC----CCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEe
Q 035761 310 MIEATEDFDIKYCIGTGGYGSVYRARLP----SGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLH 384 (560)
Q Consensus 310 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 384 (560)
+....+.|...+.||.|.|++||++.+. ..+.||+|.+...+. .....+|++++..+ .+.||+++.+++..
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----p~ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----PSRILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----chHHHHHHHHHHHhccchhhhcchhhhcc
Confidence 3444567888999999999999999653 467899999876543 24578999999998 69999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCC-CcEEEeee
Q 035761 385 EKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSE-FEAFVADF 463 (560)
Q Consensus 385 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Df 463 (560)
++...+|+||++.....++... ++..++...++.+.+||+++|.+ |||||||||+|++.+.. +.-.|.||
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDF 177 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDF 177 (418)
T ss_pred CCeeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEec
Confidence 9999999999999999998865 77889999999999999999999 99999999999999854 56789999
Q ss_pred ccccccCC----------------C-----------------CCC-----------ceeeccccCccCcccccc-CccCc
Q 035761 464 GIARLLNY----------------D-----------------SSN-----------RTLLAGTYGSIAPELAYT-MVVTE 498 (560)
Q Consensus 464 g~~~~~~~----------------~-----------------~~~-----------~~~~~g~~~~~aPE~~~~-~~~~~ 498 (560)
|+|...+. . ... ....+||+||.|||++.. ...++
T Consensus 178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt 257 (418)
T KOG1167|consen 178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT 257 (418)
T ss_pred hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence 99872110 0 000 012469999999998765 45678
Q ss_pred chhHHHHHHHHHHHHhCCCCCCcccc
Q 035761 499 KYDVYSFGVVALEVLMGKHPGELLSS 524 (560)
Q Consensus 499 ~~Dv~s~G~il~el~~g~~P~~~~~~ 524 (560)
++||||.|||+.-+++++.||....+
T Consensus 258 aiDiws~GVI~Lslls~~~PFf~a~d 283 (418)
T KOG1167|consen 258 AIDIWSAGVILLSLLSRRYPFFKAKD 283 (418)
T ss_pred ccceeeccceeehhhccccccccCcc
Confidence 99999999999999999999865443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-24 Score=212.17 Aligned_cols=166 Identities=19% Similarity=0.160 Sum_probs=128.2
Q ss_pred HhcCCcccceeeccCCeeEEEEEeC--CCcEEEEEEccchhh---hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCE
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARLP--SGKVVALKKLHRLET---ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKC 387 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 387 (560)
..++|.+.+.||+|+||.||+|.++ +++.||||+...... .....+.+.+|++++++++|+|+++.+.. .+.
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~ 92 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGK 92 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCC
Confidence 4567999999999999999999764 577889998653211 12234568999999999999999853322 245
Q ss_pred EEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCC-CCCCeEeCCCCcEEEeeeccc
Q 035761 388 MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDI-SSNNILLNSEFEAFVADFGIA 466 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dl-k~~Nill~~~~~~kl~Dfg~~ 466 (560)
.++||||+++++|... .. .. ...++.|+++||+|||+. ||+|||| ||+|||++.++.+||+|||+|
T Consensus 93 ~~LVmE~~~G~~L~~~-~~------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 93 DGLVRGWTEGVPLHLA-RP------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred cEEEEEccCCCCHHHh-Cc------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 7999999999999632 11 11 146789999999999999 9999999 999999999999999999999
Q ss_pred cccCCCCCCc--------eeeccccCccCccccccC
Q 035761 467 RLLNYDSSNR--------TLLAGTYGSIAPELAYTM 494 (560)
Q Consensus 467 ~~~~~~~~~~--------~~~~g~~~~~aPE~~~~~ 494 (560)
+.+....... ....+++.|+|||.+...
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9765432111 234578889999987644
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-25 Score=199.26 Aligned_cols=224 Identities=22% Similarity=0.313 Sum_probs=177.8
Q ss_pred cccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEeccCC
Q 035761 318 DIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEM 397 (560)
Q Consensus 318 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (560)
.+...|.+...|..|+|+|+ |..+++|++...+......+.|..|.-.++-+.||||++++|.|.......++..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 34456888999999999997 45566677765554445556899999999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEe--eeccccccCCCCCC
Q 035761 398 GSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVA--DFGIARLLNYDSSN 475 (560)
Q Consensus 398 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~--Dfg~~~~~~~~~~~ 475 (560)
|+|...++... ....+..+..+++.+||+|++|||+. .|-|.---+.++.|++|++.+++|+ |--++..
T Consensus 272 gslynvlhe~t-~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfq------- 342 (448)
T KOG0195|consen 272 GSLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ------- 342 (448)
T ss_pred hHHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeee-------
Confidence 99999999754 34478889999999999999999986 4445555789999999999988864 2221111
Q ss_pred ceeeccccCccCccccccCccCc---chhHHHHHHHHHHHHhCCCCCCcccc-------------------ccccccccc
Q 035761 476 RTLLAGTYGSIAPELAYTMVVTE---KYDVYSFGVVALEVLMGKHPGELLSS-------------------SSSSLDKNI 533 (560)
Q Consensus 476 ~~~~~g~~~~~aPE~~~~~~~~~---~~Dv~s~G~il~el~~g~~P~~~~~~-------------------~~~~~~~~~ 533 (560)
.......+.||+||.++..+.+. .+|+|||++++||+.|+..||..... .+..+.+.+
T Consensus 343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm 422 (448)
T KOG0195|consen 343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLM 422 (448)
T ss_pred ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHH
Confidence 11123467899999998877554 68999999999999999999976553 223456667
Q ss_pred ccccccCCCCCCChhHHH
Q 035761 534 KLIDLLDPRLPPPGDQMI 551 (560)
Q Consensus 534 ~~~~~~dp~~~p~~~~~~ 551 (560)
..|..-||..||.++.++
T Consensus 423 ~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 423 NICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHhcCCCCcCCCcceeh
Confidence 788888999999998875
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-24 Score=194.89 Aligned_cols=143 Identities=22% Similarity=0.148 Sum_probs=119.8
Q ss_pred CCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCce
Q 035761 398 GSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRT 477 (560)
Q Consensus 398 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 477 (560)
|+|.++++..+ ..+++.++..|+.||++||+|||+. + ||+||+++.++.+++ ||+++......
T Consensus 1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc----
Confidence 68999997543 2399999999999999999999998 5 999999999999999 99998764322
Q ss_pred eeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccccc-------------------------c--ccc
Q 035761 478 LLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSS-------------------------S--SLD 530 (560)
Q Consensus 478 ~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~-------------------------~--~~~ 530 (560)
..|++.|||||++.+..++.++|||||||++|||++|+.||....... . .+.
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 142 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFA 142 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHH
Confidence 257899999999999999999999999999999999999996433210 0 245
Q ss_pred cccccccccCCCCCCChhHHHhhceeee
Q 035761 531 KNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 531 ~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
+.++.|...+|..||++.+++.+.++..
T Consensus 143 ~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 143 DFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 6667788889999999999999987653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.5e-23 Score=203.70 Aligned_cols=201 Identities=24% Similarity=0.310 Sum_probs=164.4
Q ss_pred CCcccceeeccCCeeEEEEEeCCC--cEEEEEEccchhhhhhhHHHHHHHHHHHhccCC----CCcceeeeEE-EeCCEE
Q 035761 316 DFDIKYCIGTGGYGSVYRARLPSG--KVVALKKLHRLETELASLESFQNEARLLSQIRH----RNIVKLYGFC-LHEKCM 388 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~l~~~~-~~~~~~ 388 (560)
+|.+.+.||+|+||.||.|...+. ..+|+|.-........ ..+..|..++..+.. +++..+++.. ..++..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 789999999999999999986553 4788887665332211 156778888888862 6888898888 577889
Q ss_pred EEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCC-----CcEEEeee
Q 035761 389 FLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSE-----FEAFVADF 463 (560)
Q Consensus 389 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-----~~~kl~Df 463 (560)
++||+.+ |.+|.++..... ...++..+...|+.|++.+|+++|+. |++||||||.|+++... ..+.+.||
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred EEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 9999987 779999886655 45599999999999999999999999 99999999999999765 45899999
Q ss_pred ccccccC--CCC-C----C---ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccc
Q 035761 464 GIARLLN--YDS-S----N---RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLS 523 (560)
Q Consensus 464 g~~~~~~--~~~-~----~---~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~ 523 (560)
|+++... ... . . .....||.+|+++.+..+...+.+.|+||++.++.|+..|..||....
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~ 241 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE 241 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence 9998322 111 1 1 223459999999999999999999999999999999999999997554
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-25 Score=221.92 Aligned_cols=233 Identities=27% Similarity=0.356 Sum_probs=165.3
Q ss_pred CCCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcce-ecCCccccCCCCCCeeeccccccccccccccCCCCCCC
Q 035761 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLV-GNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQ 80 (560)
Q Consensus 2 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~ 80 (560)
+.+.+|+.|.+++|++. .+-+.++.++.|+.+++.+|++. .-+|..+.++..|+.||||+|+++ ..|..+..-+++-
T Consensus 52 ~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~i 129 (1255)
T KOG0444|consen 52 SRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSI 129 (1255)
T ss_pred HHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcE
Confidence 34667788888888887 45566778888888888888776 335666777888888888888887 6777888888888
Q ss_pred EEEeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcc
Q 035761 81 VLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNL 160 (560)
Q Consensus 81 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 160 (560)
+|+||+|+|.++....|.+++.|-.||||+|++. .+|..+..+.+|++|.|++|.+....-..+..+++|+.|++++.+
T Consensus 130 VLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~Tq 208 (1255)
T KOG0444|consen 130 VLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQ 208 (1255)
T ss_pred EEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhccccc
Confidence 8888888888555556678888888888888888 666677788888888888887764333445555666666666654
Q ss_pred cc-cccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCcccccc--CcccccCCCCcCCCCCCCCcCCcc
Q 035761 161 LS-GSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGI--PVFVRKVPHLDVSGNQFGGEIPTT 237 (560)
Q Consensus 161 l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~--~~~~~~l~~l~l~~n~~~~~~p~~ 237 (560)
=+ ..+|.++..+.+|..+|||.|.+. ..|+.+-++++|+.|+||+|.|+..- ...+.+++.|+++.|++... |.+
T Consensus 209 RTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt~L-P~a 286 (1255)
T KOG0444|consen 209 RTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLTVL-PDA 286 (1255)
T ss_pred chhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhccc-hHH
Confidence 22 256667777777777777777776 67777777777777777777776322 22456667777777776643 444
Q ss_pred cC
Q 035761 238 LA 239 (560)
Q Consensus 238 ~~ 239 (560)
.+
T Consensus 287 vc 288 (1255)
T KOG0444|consen 287 VC 288 (1255)
T ss_pred Hh
Confidence 33
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.1e-25 Score=208.29 Aligned_cols=228 Identities=23% Similarity=0.235 Sum_probs=205.1
Q ss_pred CCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccc-cccccccccccCCCCCCCEEEe
Q 035761 6 NLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIAS-NRMNGSILLGIGSLKVLQVLDL 84 (560)
Q Consensus 6 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~-n~i~~~~~~~~~~l~~L~~L~l 84 (560)
..+.++|..|+|+.+.+++|+.+++|+.||||+|+|+.+-|++|.++.+|.+|-+.+ |+|+....+.|++|..|+.|.+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence 567899999999999999999999999999999999999999999999999888877 9999999999999999999999
Q ss_pred ecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcC-------------------------
Q 035761 85 SRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDG------------------------- 139 (560)
Q Consensus 85 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~------------------------- 139 (560)
.-|++.-+..+.|..+++|..|.+.+|.+..+...+|..+.+++.+.+..|.+..
T Consensus 148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~ 227 (498)
T KOG4237|consen 148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVS 227 (498)
T ss_pred ChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecc
Confidence 9999998888899999999999999999995555589999999999988887210
Q ss_pred ------------------------------------CC-CccCcCCCCCcEEEccCcccccccchhhccccccceeeccc
Q 035761 140 ------------------------------------PI-PPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSG 182 (560)
Q Consensus 140 ------------------------------------~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 182 (560)
.. ...|..+++|+.|+|++|+|+.+-+.+|.++.+++.|+|..
T Consensus 228 p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~ 307 (498)
T KOG4237|consen 228 PYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTR 307 (498)
T ss_pred hHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCc
Confidence 00 02367899999999999999999999999999999999999
Q ss_pred cccCCcCccccCCCceeeEEEccCCccccccCcccc---cCCCCcCCCCCCCCc
Q 035761 183 NFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVR---KVPHLDVSGNQFGGE 233 (560)
Q Consensus 183 n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~~~---~l~~l~l~~n~~~~~ 233 (560)
|+|.......|.+++.|+.|+|.+|+|++..|..+. .+..|++-+|++.|.
T Consensus 308 N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~Cn 361 (498)
T KOG4237|consen 308 NKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCN 361 (498)
T ss_pred chHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCc
Confidence 999988888999999999999999999999998774 567889999999875
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.7e-25 Score=217.71 Aligned_cols=203 Identities=28% Similarity=0.381 Sum_probs=95.9
Q ss_pred CCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEE
Q 035761 3 RLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVL 82 (560)
Q Consensus 3 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 82 (560)
+|..|+.||||+|+++ ..|..+...+++-+|+||+|+|..+.-+.|-++..|-.||||+|++. .+|..+..|..|++|
T Consensus 101 ~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL 178 (1255)
T KOG0444|consen 101 RLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTL 178 (1255)
T ss_pred ccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhh
Confidence 3455666666666665 45555555566666666666665444444555666666666666655 444455555555556
Q ss_pred EeecCccCccCCCCcCCCCCccEEEccCCCcc-CCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCccc
Q 035761 83 DLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLV-GPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLL 161 (560)
Q Consensus 83 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 161 (560)
+|++|.+....-..+..+++|++|.+++.+-+ .-+|.++..+.+|..++||.|.+. ..|+.+.++++|+.|+||+|+|
T Consensus 179 ~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~i 257 (1255)
T KOG0444|consen 179 KLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKI 257 (1255)
T ss_pred hcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCce
Confidence 66555543111111112222222222222111 113333444444444444444444 4444444444444444444444
Q ss_pred ccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccc
Q 035761 162 SGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLS 210 (560)
Q Consensus 162 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~ 210 (560)
+ .+........+|++|+||.|+++ .+|+.+++++.|+.|++.+|+++
T Consensus 258 t-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~ 304 (1255)
T KOG0444|consen 258 T-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLT 304 (1255)
T ss_pred e-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCccc
Confidence 4 22233334444444444444444 44444444444444444444443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.5e-23 Score=179.77 Aligned_cols=201 Identities=19% Similarity=0.283 Sum_probs=165.9
Q ss_pred hcCCcccceeeccCCeeEEEEE-eCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCC-CCcceeeeEEEeCCEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRH-RNIVKLYGFCLHEKCMFLI 391 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv 391 (560)
..+|.+.+.||.|+||.+|.|. ..+|++||+|.-...... ..+..|..+++.+++ ..|..+..+..+.....+|
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 3569999999999999999996 568999999986544322 356789999999964 6788888888888899999
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCC---CcEEEeeeccccc
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSE---FEAFVADFGIARL 468 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~~~~ 468 (560)
||.+ +-+|.+...--.. .++.++++-.|-|++.-++|+|.. ++|||||||.|+|..-+ ..+.++|||+|+.
T Consensus 90 MdLL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred eecc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhh
Confidence 9988 6688777654322 289999999999999999999999 99999999999999654 3478999999987
Q ss_pred cCCCCCC-------ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc
Q 035761 469 LNYDSSN-------RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS 524 (560)
Q Consensus 469 ~~~~~~~-------~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~ 524 (560)
+.+.... .....||.+|.+-....+.+.+.+.|+-|+|.++..+.-|..||+....
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 7432211 2235699999999888888889999999999999999999999987654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-22 Score=184.04 Aligned_cols=199 Identities=21% Similarity=0.295 Sum_probs=166.8
Q ss_pred cCCcccceeeccCCeeEEEEE-eCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 392 (560)
-.|.+.+.||+|+||+++.|. +-+++.||||.-...+.. .++..|...++.+ ..++|..++-+-.......||+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A----PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA----PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCCc----chHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 468999999999999999996 457999999976554332 3567788888888 5799999888888888889999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCC-----CcEEEeeecccc
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSE-----FEAFVADFGIAR 467 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-----~~~kl~Dfg~~~ 467 (560)
|.+ |-+|.++..-.+ +.|+.+++.-+|.|++.-++|+|+. ..|.|||||+|+||..- ..+.++|||+|+
T Consensus 104 dLL-GPSLEDLFD~Cg--R~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLCG--RRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hhh-CcCHHHHHHHhc--CcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 988 668887776433 2399999999999999999999999 99999999999999644 347899999999
Q ss_pred ccCCCCCC-------ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccc
Q 035761 468 LLNYDSSN-------RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLS 523 (560)
Q Consensus 468 ~~~~~~~~-------~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~ 523 (560)
.+.++... .....||.+||+-....+++.+.+.|+-|+|-++..++-|..||+...
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 87543322 123569999999999999999999999999999999999999998664
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-22 Score=181.88 Aligned_cols=142 Identities=19% Similarity=0.215 Sum_probs=109.3
Q ss_pred cceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhh------------------------HHHHHHHHHHHhccCCCCc
Q 035761 320 KYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELAS------------------------LESFQNEARLLSQIRHRNI 375 (560)
Q Consensus 320 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~------------------------~~~~~~e~~~l~~l~h~ni 375 (560)
...||+|+||.||+|..++|+.||||+++........ ......|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3579999999999999888999999998754221111 0122359999999988877
Q ss_pred ceeeeEEEeCCEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEEeCCCCCCeEeCC
Q 035761 376 VKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYL-HHHCTPPILHRDISSNNILLNS 454 (560)
Q Consensus 376 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~ivH~dlk~~Nill~~ 454 (560)
.....+... ..++||||++++++....... ..+++.+...++.|++.+|+|+ |+. ||+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-
Confidence 544433222 238999999998776543222 2388999999999999999999 687 999999999999998
Q ss_pred CCcEEEeeeccccccC
Q 035761 455 EFEAFVADFGIARLLN 470 (560)
Q Consensus 455 ~~~~kl~Dfg~~~~~~ 470 (560)
++.++|+|||+|....
T Consensus 153 ~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CCcEEEEEccccccCC
Confidence 4789999999997643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.5e-21 Score=191.93 Aligned_cols=202 Identities=35% Similarity=0.515 Sum_probs=171.2
Q ss_pred CcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhh-hHHHHHHHHHHHhccCCC-CcceeeeEEEeCCEEEEEEec
Q 035761 317 FDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELA-SLESFQNEARLLSQIRHR-NIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 317 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~ 394 (560)
|.....+|.|+||.||++... ..+++|.+........ ....+.+|+..++.+.|+ +++++.+.+......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566778999999999999876 7889999876554332 466789999999999988 799999999877778999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCC-cEEEeeeccccccCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEF-EAFVADFGIARLLNYDS 473 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~~~~~~~~~ 473 (560)
+.++++.+++........++......++.|++.+++|+|+. +++|||+||+||+++..+ .++++|||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997776543112388899999999999999999999 999999999999999988 79999999998654433
Q ss_pred C------CceeeccccCccCcccccc---CccCcchhHHHHHHHHHHHHhCCCCCCccc
Q 035761 474 S------NRTLLAGTYGSIAPELAYT---MVVTEKYDVYSFGVVALEVLMGKHPGELLS 523 (560)
Q Consensus 474 ~------~~~~~~g~~~~~aPE~~~~---~~~~~~~Dv~s~G~il~el~~g~~P~~~~~ 523 (560)
. ......|+..|+|||...+ ..+....|+||+|++++++++|..||....
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 2345679999999999987 578889999999999999999999977554
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.5e-23 Score=217.55 Aligned_cols=233 Identities=23% Similarity=0.311 Sum_probs=184.3
Q ss_pred cccceeeccCCeeEEEEEe-CCCcEEEEEEcc----chhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 318 DIKYCIGTGGYGSVYRARL-PSGKVVALKKLH----RLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 318 ~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~----~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
...+.+|.|++|.|+.+.. ...+..+.|.+. ...........+..|..+-..+.|||++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 3467799999998887753 334444444433 22333333334777888888999999988888887776666669
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++ +|..++..... ++..++..++.|+..|+.|+|+. |+.|||+|++|++++.++.+||+|||.+.....+
T Consensus 401 E~~~~-Dlf~~~~~~~~---~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGK---LTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhcccc---cchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 99999986533 88899999999999999999999 9999999999999999999999999999876544
Q ss_pred CCC----ceeeccccCccCccccccCccCcc-hhHHHHHHHHHHHHhCCCCCCcccccccc-------------------
Q 035761 473 SSN----RTLLAGTYGSIAPELAYTMVVTEK-YDVYSFGVVALEVLMGKHPGELLSSSSSS------------------- 528 (560)
Q Consensus 473 ~~~----~~~~~g~~~~~aPE~~~~~~~~~~-~Dv~s~G~il~el~~g~~P~~~~~~~~~~------------------- 528 (560)
.+. ....+|+..|+|||++.+.+|+++ .||||.|+++..|.+|+.||......+.+
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRL 553 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHH
Confidence 433 344678999999999999999986 79999999999999999999654432211
Q ss_pred -------cccccccccccCCCCCCChhHHHhhceee
Q 035761 529 -------LDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 529 -------~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
....+..+..+||..|-++++|++..|+.
T Consensus 554 ~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~ 589 (601)
T KOG0590|consen 554 LSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIR 589 (601)
T ss_pred HHhchhhHHHHHHHHccCChhheecHHHHhhChHhh
Confidence 12233455788999999999999999975
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.1e-25 Score=208.53 Aligned_cols=220 Identities=31% Similarity=0.500 Sum_probs=117.4
Q ss_pred CCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEE
Q 035761 3 RLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVL 82 (560)
Q Consensus 3 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 82 (560)
++..+++|++.+|+++ ..|.+++.+..++.|+.++|+++ .+|.....+.+|..|+.+.|.+. ..++.++.+..|+.|
T Consensus 66 nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl 142 (565)
T KOG0472|consen 66 NLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDL 142 (565)
T ss_pred cccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhh
Confidence 4555666666666665 44555555555555555555555 45555555555555555555554 334444444444444
Q ss_pred EeecCccCccCCCCcCC-----------------------CCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcC
Q 035761 83 DLSRNEIGGSIPSTLGH-----------------------LKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDG 139 (560)
Q Consensus 83 ~l~~n~l~~~~~~~~~~-----------------------l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 139 (560)
+..+|+++ ..|+.+.. ++.|++||..+|-++ .+|..++.+.+|..|+|.+|+|.
T Consensus 143 ~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~- 219 (565)
T KOG0472|consen 143 DATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR- 219 (565)
T ss_pred hccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-
Confidence 44444444 33333444 555555555555555 44555555666666666666665
Q ss_pred CCCccCcCCCCCcEEEccCcccccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCcccc-
Q 035761 140 PIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVR- 218 (560)
Q Consensus 140 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~~~- 218 (560)
.+| .|.+|..|++|+++.|+|.....+..+++++|.+|||.+|++. ..|+.+..+.+|..||+|+|.+++.++ .+.
T Consensus 220 ~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~-sLgn 296 (565)
T KOG0472|consen 220 FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPY-SLGN 296 (565)
T ss_pred cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccCCc-cccc
Confidence 334 5556666666666666665222223335666666666666665 455555556666666666666653333 222
Q ss_pred -cCCCCcCCCCCCC
Q 035761 219 -KVPHLDVSGNQFG 231 (560)
Q Consensus 219 -~l~~l~l~~n~~~ 231 (560)
.++.|.+.|||+.
T Consensus 297 lhL~~L~leGNPlr 310 (565)
T KOG0472|consen 297 LHLKFLALEGNPLR 310 (565)
T ss_pred ceeeehhhcCCchH
Confidence 3344555555543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-21 Score=177.34 Aligned_cols=190 Identities=13% Similarity=0.143 Sum_probs=141.4
Q ss_pred eeeecCCCCcCHHHHHH--HhcCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhh-hhhHHH------HHHHHHH
Q 035761 296 IAIWNYDGRITFQDMIE--ATEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETE-LASLES------FQNEARL 366 (560)
Q Consensus 296 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~------~~~e~~~ 366 (560)
..++..+....|.++.. ...+|...+.+|.|+||.||.+.. ++..+|+|.+...... ....+. +.+|+..
T Consensus 10 ~~~~~~~~~~~~~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~ 88 (232)
T PRK10359 10 YTVFYKDNDNKYKEIFDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQ 88 (232)
T ss_pred eEEEecCCcccHHHHHHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHH
Confidence 34444444444555543 357899999999999999999766 5778999999754322 122222 6789999
Q ss_pred HhccCCCCcceeeeEEEeC--------CEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 035761 367 LSQIRHRNIVKLYGFCLHE--------KCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTP 438 (560)
Q Consensus 367 l~~l~h~niv~l~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~ 438 (560)
+.+++||+|..+..++... +..++||||++|.+|.++.. ++. ....+++.++..+|..
T Consensus 89 l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~--- 154 (232)
T PRK10359 89 TDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQH--- 154 (232)
T ss_pred HHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHc---
Confidence 9999999999999886543 35789999999999987732 232 2456999999999999
Q ss_pred CeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHH
Q 035761 439 PILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVL 513 (560)
Q Consensus 439 ~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~ 513 (560)
|++|||++|+||++++++ ++++|||.......+.... .+.....+..++|+||||+.+..+.
T Consensus 155 gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~d------------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 155 GMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAKD------------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCccCCCChHHEEEeCCC-EEEEECCCcccccchhhHH------------HHHHHhHhcccccccceeEeehHHH
Confidence 999999999999999988 9999999887653221111 1334445667899999999876554
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.5e-21 Score=174.87 Aligned_cols=142 Identities=21% Similarity=0.275 Sum_probs=111.8
Q ss_pred cceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhh------------------------hHHHHHHHHHHHhccCCCCc
Q 035761 320 KYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELA------------------------SLESFQNEARLLSQIRHRNI 375 (560)
Q Consensus 320 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------------------------~~~~~~~e~~~l~~l~h~ni 375 (560)
.+.||+|++|.||+|...+|+.||||+++....... ....+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 467999999999999987899999999875421100 01224578999999999988
Q ss_pred ceeeeEEEeCCEEEEEEeccCCCCHHHH-hhcCCcccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEeCCCCCCeEeC
Q 035761 376 VKLYGFCLHEKCMFLIYEYMEMGSLFCI-LRTDEEAVGLDWTKRVNIVKGMAHALSYLHH-HCTPPILHRDISSNNILLN 453 (560)
Q Consensus 376 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~ 453 (560)
.....+.... .++||||++++++... +.. ..++..+...++.|++.++.++|+ . ||+||||||+||+++
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence 6555444333 4899999998865433 332 127788899999999999999999 8 999999999999998
Q ss_pred CCCcEEEeeeccccccCC
Q 035761 454 SEFEAFVADFGIARLLNY 471 (560)
Q Consensus 454 ~~~~~kl~Dfg~~~~~~~ 471 (560)
++.++|+|||++.....
T Consensus 153 -~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 -DGKPYIIDVSQAVELDH 169 (190)
T ss_pred -CCCEEEEEcccceecCC
Confidence 88999999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.3e-24 Score=178.32 Aligned_cols=154 Identities=33% Similarity=0.586 Sum_probs=84.8
Q ss_pred CCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEE
Q 035761 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLD 83 (560)
Q Consensus 4 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 83 (560)
+.+++.|.||+|.++ .+|..+..+.+|++|++++|+|. .+|..++.+++|+.|+++-|++. +.|..|+.++.|++||
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld 108 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence 344555555555555 44444555555555555555555 45555555555555555555554 5555555555555555
Q ss_pred eecCccCc-cCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccc
Q 035761 84 LSRNEIGG-SIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLS 162 (560)
Q Consensus 84 l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 162 (560)
|++|++.. .+|+.|..++.|+.|+|++|.++ .+|...+++++|+.|.+..|.+- .+|..++.+..|++|++.+|+++
T Consensus 109 ltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~ 186 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT 186 (264)
T ss_pred ccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee
Confidence 55555542 34555555555555555555555 45555555555555555555554 34555555555555555555555
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.2e-23 Score=204.64 Aligned_cols=219 Identities=26% Similarity=0.336 Sum_probs=177.0
Q ss_pred eeccCCeeEEEEE----eCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccC-CCCcceeeeEEEeCCEEEEEEeccCC
Q 035761 323 IGTGGYGSVYRAR----LPSGKVVALKKLHRLETELASLESFQNEARLLSQIR-HRNIVKLYGFCLHEKCMFLIYEYMEM 397 (560)
Q Consensus 323 ig~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (560)
+|+|+||.|+.++ ...|+.+|.|..++.............|..++..++ ||.+|++.-.++.+...+++.+|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 6899999999763 334777888887765432222235667888888886 99999999999999999999999999
Q ss_pred CCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCce
Q 035761 398 GSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRT 477 (560)
Q Consensus 398 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 477 (560)
|.+...+..... ++..........+|-+++++|+. +++|||+|++||+++.+|++++.|||+++..-.....
T Consensus 82 g~lft~l~~~~~---f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-- 153 (612)
T KOG0603|consen 82 GDLFTRLSKEVM---FDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-- 153 (612)
T ss_pred chhhhccccCCc---hHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence 999988876554 67777777888899999999999 9999999999999999999999999999876432222
Q ss_pred eeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccccccCCCCCCChhHHHhhceee
Q 035761 478 LLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 478 ~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
+||..|||||++. ......|.||||++++||+||..||.. +.+..+.+....+...+.+.++.+++..+..
T Consensus 154 --cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r 224 (612)
T KOG0603|consen 154 --CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILKAELEMPRELSAEARSLFRQLFKR 224 (612)
T ss_pred --ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhhhccCCchhhhHHHHHHHHHHHhh
Confidence 7999999999988 556789999999999999999999985 4445555656666666777777777665554
Q ss_pred e
Q 035761 558 I 558 (560)
Q Consensus 558 ~ 558 (560)
|
T Consensus 225 ~ 225 (612)
T KOG0603|consen 225 N 225 (612)
T ss_pred C
Confidence 4
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.1e-20 Score=167.09 Aligned_cols=185 Identities=14% Similarity=0.100 Sum_probs=138.6
Q ss_pred cccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhh--hHHHHHHHHHHHhccC-CCCcceeeeEEEeCCEEEEEEec
Q 035761 318 DIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELA--SLESFQNEARLLSQIR-HRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 318 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
.+...+++|+||+||.+.- .+.+++.+.+........ ....+.+|++++++++ |+++++++++ ...+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3467799999999998765 678888777764432111 1225789999999995 5889999886 346899999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCC-CCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDI-SSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dl-k~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
++|.+|.+.... ....++.|++++++++|+. ||+|||| ||+||+++.++.++|+|||+|.......
T Consensus 80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 999998654321 1135778999999999999 9999999 7999999999999999999998654333
Q ss_pred CC-----ce--------eeccccCccCccccccC-ccC-cchhHHHHHHHHHHHHhCCCCCC
Q 035761 474 SN-----RT--------LLAGTYGSIAPELAYTM-VVT-EKYDVYSFGVVALEVLMGKHPGE 520 (560)
Q Consensus 474 ~~-----~~--------~~~g~~~~~aPE~~~~~-~~~-~~~Dv~s~G~il~el~~g~~P~~ 520 (560)
.. .+ ....++.|++|+...-. ..+ .+.+.++-|.-+|.++||+.|+-
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 21 00 12257788888753322 222 46799999999999999998864
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.9e-22 Score=206.47 Aligned_cols=229 Identities=22% Similarity=0.274 Sum_probs=175.4
Q ss_pred CCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhh--hhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 316 DFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETE--LASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
++...+.+|.+.|=.|.+|+.++|. |+||++-+.... .....+..+|++ ...++|||++++.-+-..++..|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5667788999999999999998887 889998765432 222223334444 555699999999988888888899999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccccc--CC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL--NY 471 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~--~~ 471 (560)
|... +|++.+.+.+- +...+..-|+.|+++|+..+|.. ||+|||||.+|||++.-..+.|+||..-+.. .+
T Consensus 102 yvkh-nLyDRlSTRPF---L~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRPF---LVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred HHhh-hhhhhhccchH---HHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 9976 99999987654 77888889999999999999999 9999999999999999999999999765432 21
Q ss_pred CC-CCcee----eccccCccCccccccCc-----------cCcchhHHHHHHHHHHHHh-CCCCCCccc----------c
Q 035761 472 DS-SNRTL----LAGTYGSIAPELAYTMV-----------VTEKYDVYSFGVVALEVLM-GKHPGELLS----------S 524 (560)
Q Consensus 472 ~~-~~~~~----~~g~~~~~aPE~~~~~~-----------~~~~~Dv~s~G~il~el~~-g~~P~~~~~----------~ 524 (560)
++ ..... ......|.|||-+.... .+++.||||.||+++||++ |++||+... .
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~ 254 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADD 254 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccC
Confidence 11 11111 12345799999766421 4668999999999999998 899986321 0
Q ss_pred --------cccccccccccccccCCCCCCChhHHHhh
Q 035761 525 --------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 525 --------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
.+..+.+.+..|..+||+-|-++++.+++
T Consensus 255 ~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 255 PEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 11234455567788899999999999987
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.6e-22 Score=188.76 Aligned_cols=213 Identities=25% Similarity=0.268 Sum_probs=190.9
Q ss_pred CCCCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccC-CcceecCCccccCCCCCCeeeccccccccccccccCCCCCC
Q 035761 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSL-NSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVL 79 (560)
Q Consensus 1 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~-N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L 79 (560)
|+.+++|++||||+|+|+.+-|++|.++++|..|-+-+ |+|+.+..+.|.++..|+.|.+.-|++.-+..+.|..+++|
T Consensus 87 F~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l 166 (498)
T KOG4237|consen 87 FKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSL 166 (498)
T ss_pred ccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhc
Confidence 67899999999999999999999999999988877766 99998888999999999999999999998899999999999
Q ss_pred CEEEeecCccCccCCCCcCCCCCccEEEccCCCcc--------------------C------------------------
Q 035761 80 QVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLV--------------------G------------------------ 115 (560)
Q Consensus 80 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~--------------------~------------------------ 115 (560)
..|.+.+|.+..+-...|..+..++.+.+..|.+- |
T Consensus 167 ~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c 246 (498)
T KOG4237|consen 167 SLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLC 246 (498)
T ss_pred chhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhh
Confidence 99999999999555558888888888888877721 0
Q ss_pred -----------------C-CCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccccccchhhccccccce
Q 035761 116 -----------------P-IPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYY 177 (560)
Q Consensus 116 -----------------~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 177 (560)
+ ....|..|++|+.|+|++|+|+.+-+.+|..+..+++|.|..|+|..+....|.++..|+.
T Consensus 247 ~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~t 326 (498)
T KOG4237|consen 247 SLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKT 326 (498)
T ss_pred hHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhcccccee
Confidence 0 1124667899999999999999999999999999999999999999888889999999999
Q ss_pred eeccccccCCcCccccCCCceeeEEEccCCcccccc
Q 035761 178 LDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGI 213 (560)
Q Consensus 178 L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~ 213 (560)
|+|.+|+|+..-|..|..+..|.+|+|-.|++.+..
T Consensus 327 L~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC 362 (498)
T KOG4237|consen 327 LSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNC 362 (498)
T ss_pred eeecCCeeEEEecccccccceeeeeehccCcccCcc
Confidence 999999999999999999999999999999998644
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.1e-23 Score=196.34 Aligned_cols=224 Identities=29% Similarity=0.443 Sum_probs=173.2
Q ss_pred CCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEe
Q 035761 5 RNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDL 84 (560)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l 84 (560)
..++.|++++|.++ ...+.+.++..|.+|++++|++. ..|.+++.+..++.|+.++|++. ..|..+..+.+|..|+.
T Consensus 45 v~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~ 121 (565)
T KOG0472|consen 45 VDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDC 121 (565)
T ss_pred cchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhc
Confidence 35889999999998 56667899999999999999999 88999999999999999999998 78899999999999999
Q ss_pred ecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCC----------------------CC
Q 035761 85 SRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGP----------------------IP 142 (560)
Q Consensus 85 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~----------------------~~ 142 (560)
++|.+. ..++.++.+-.|..|+..+|+++ ..|..+..+.+|..|++.+|+++.. +|
T Consensus 122 s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~tlP 199 (565)
T KOG0472|consen 122 SSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIAMKRLKHLDCNSNLLETLP 199 (565)
T ss_pred ccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHHHHHHHhcccchhhhhcCC
Confidence 999999 67888999999999999999999 6777777787777777777777643 34
Q ss_pred ccCcCCCCCcEEEccCcccccccchhhccccccceeeccccccCCcCccc-cCCCceeeEEEccCCccccccCc--cccc
Q 035761 143 PELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQ-LGEFSCIDTVDLSMNNLSGGIPV--FVRK 219 (560)
Q Consensus 143 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~-~~~~~~L~~l~l~~n~l~~~~~~--~~~~ 219 (560)
+.++.+.+|..|+|.+|+|. ..| .|.++..|++|+++.|+|. .+|.. ...++++..|||.+|++...+.. .+++
T Consensus 200 ~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklke~Pde~clLrs 276 (565)
T KOG0472|consen 200 PELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLKEVPDEICLLRS 276 (565)
T ss_pred hhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccccCchHHHHhhh
Confidence 44444444444444444444 333 4455555555555555555 33333 34778889999999999865544 3478
Q ss_pred CCCCcCCCCCCCCcCCc
Q 035761 220 VPHLDVSGNQFGGEIPT 236 (560)
Q Consensus 220 l~~l~l~~n~~~~~~p~ 236 (560)
+.+||++.|.+++.+++
T Consensus 277 L~rLDlSNN~is~Lp~s 293 (565)
T KOG0472|consen 277 LERLDLSNNDISSLPYS 293 (565)
T ss_pred hhhhcccCCccccCCcc
Confidence 89999999999876443
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.3e-22 Score=167.04 Aligned_cols=164 Identities=30% Similarity=0.529 Sum_probs=111.7
Q ss_pred CCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEeecCccCccCCCCcCCCCCcc
Q 035761 25 LGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLR 104 (560)
Q Consensus 25 ~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 104 (560)
+.++.+++.|.||+|+++ ..|..++.+.+|+.|++.+|+|+ ..|..++.+++|+.|+++-|++. ..|..|+.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 334566667777777777 56666777777777777777776 56666777777777777777776 6677777777777
Q ss_pred EEEccCCCcc-CCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccccccchhhccccccceeecccc
Q 035761 105 SVDLSQNKLV-GPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGN 183 (560)
Q Consensus 105 ~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 183 (560)
.|||..|++. ..+|..|-.++.|+.|+|+.|.+. .+|..++++++|+.|.+.+|.+- .+|..++.+..|++|.+.+|
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgn 183 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGN 183 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccc
Confidence 7777777664 345666666677777777777766 66666777777777777777665 56666777777777777777
Q ss_pred ccCCcCccccC
Q 035761 184 FINGKIPSQLG 194 (560)
Q Consensus 184 ~l~~~~~~~~~ 194 (560)
+++ .+|..++
T Consensus 184 rl~-vlppel~ 193 (264)
T KOG0617|consen 184 RLT-VLPPELA 193 (264)
T ss_pred eee-ecChhhh
Confidence 776 4444443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.5e-19 Score=162.18 Aligned_cols=138 Identities=17% Similarity=0.239 Sum_probs=105.7
Q ss_pred cccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-----CCCCcceeeeEEEeCC---E-E
Q 035761 318 DIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQI-----RHRNIVKLYGFCLHEK---C-M 388 (560)
Q Consensus 318 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~-~ 388 (560)
.-.+.||+|+||.||. ++.....+||++..... ...+.+.+|+.+++.+ +||||++++|++.++. . .
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 3456799999999996 44333336888765321 2345789999999999 5799999999998874 4 3
Q ss_pred EEEEec--cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEEeCCCCCCeEeCC----CCcEEEe
Q 035761 389 FLIYEY--MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHAL-SYLHHHCTPPILHRDISSNNILLNS----EFEAFVA 461 (560)
Q Consensus 389 ~lv~e~--~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l-~~LH~~~~~~ivH~dlk~~Nill~~----~~~~kl~ 461 (560)
.+|+|| +++|+|.+++.... +++. ..++.|++.++ +|||++ +|+||||||+||+++. ++.++|+
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~~----~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQCR----YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred EEEecCCCCcchhHHHHHHccc----ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEE
Confidence 378999 66899999997532 5555 35678888887 999999 9999999999999974 3479999
Q ss_pred e-eccccc
Q 035761 462 D-FGIARL 468 (560)
Q Consensus 462 D-fg~~~~ 468 (560)
| ||....
T Consensus 152 Dg~G~~~~ 159 (210)
T PRK10345 152 DNIGESTF 159 (210)
T ss_pred ECCCCcce
Confidence 9 554443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.9e-19 Score=167.05 Aligned_cols=228 Identities=18% Similarity=0.232 Sum_probs=143.0
Q ss_pred CcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCC----------CCcceeeeEEE-
Q 035761 317 FDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQIRH----------RNIVKLYGFCL- 383 (560)
Q Consensus 317 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h----------~niv~l~~~~~- 383 (560)
+...+.||.|+++.||.+... +++++|||++..... .....+.+.+|.-....+.+ -.++-.++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 445678999999999999875 489999998865443 23345677777765555433 12222222221
Q ss_pred --------eC---C-----EEEEEEeccCCCCHHHHhhc---C-CcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEe
Q 035761 384 --------HE---K-----CMFLIYEYMEMGSLFCILRT---D-EEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHR 443 (560)
Q Consensus 384 --------~~---~-----~~~lv~e~~~~g~L~~~l~~---~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~ 443 (560)
.. . ..+++|+-+ .++|.+++.. . .....+....++.+..|+++.+++||.. |+||+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence 11 1 235677777 4588777542 1 1112245566677889999999999999 99999
Q ss_pred CCCCCCeEeCCCCcEEEeeeccccccCCCCCCceeeccccCccCccccccC--------ccCcchhHHHHHHHHHHHHhC
Q 035761 444 DISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTM--------VVTEKYDVYSFGVVALEVLMG 515 (560)
Q Consensus 444 dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~--------~~~~~~Dv~s~G~il~el~~g 515 (560)
||+|+|++++.+|.++|+||+....... .......+..|.+||..... .++.+.|.|++|+++|.|++|
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~---~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGT---RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTE---EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCc---eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 9999999999999999999998766432 11213345779999976543 578899999999999999999
Q ss_pred CCCCCcccccccccccccccccccCCCCCCChhHHHhhcee
Q 035761 516 KHPGELLSSSSSSLDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 516 ~~P~~~~~~~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
+.||+........-. ..+.|. .+|..++++|+..+-
T Consensus 247 ~lPf~~~~~~~~~~~-~f~~C~----~~Pe~v~~LI~~lL~ 282 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW-DFSRCR----DMPEPVQFLIRGLLQ 282 (288)
T ss_dssp S-STCCCGGGSTSGG-GGTTSS-------HHHHHHHHHHT-
T ss_pred cCCCCCCCccccccc-cchhcC----CcCHHHHHHHHHHcc
Confidence 999986543322211 222222 666777777766543
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=2e-19 Score=192.77 Aligned_cols=204 Identities=28% Similarity=0.429 Sum_probs=130.2
Q ss_pred CCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEee
Q 035761 6 NLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLS 85 (560)
Q Consensus 6 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~ 85 (560)
+|+.|+|++|+|+. +|..+. ++|++|+|++|+++ .+|..+. ++|+.|+|++|+++ .+|..+. .+|+.|+|+
T Consensus 200 ~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls 270 (754)
T PRK15370 200 QITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLF 270 (754)
T ss_pred CCcEEEecCCCCCc-CChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECc
Confidence 46667777777663 343332 46777777777766 3444433 35777777777766 3344332 467777777
Q ss_pred cCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCccccccc
Q 035761 86 RNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSI 165 (560)
Q Consensus 86 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 165 (560)
+|+|+ .+|..+. ++|+.|+|++|+|+. +|..+. ++|+.|++++|.++. +|..+. ++|+.|++++|.+++ +
T Consensus 271 ~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-L 340 (754)
T PRK15370 271 HNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTS-L 340 (754)
T ss_pred CCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-CCcccc--ccceeccccCCcccc-C
Confidence 77777 3455443 367777777777773 444332 467777777777763 344332 578888888888874 5
Q ss_pred chhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCcccccCCCCcCCCCCCCCc
Q 035761 166 PSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHLDVSGNQFGGE 233 (560)
Q Consensus 166 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~l~~n~~~~~ 233 (560)
|..+. ++|+.|++++|+|+ .+|..+. ++|+.|++++|+|+..++.....++.|++++|++.+.
T Consensus 341 P~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt~LP~~l~~sL~~LdLs~N~L~~L 403 (754)
T PRK15370 341 PASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALTNLPENLPAALQIMQASRNNLVRL 403 (754)
T ss_pred Chhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCCCCCHhHHHHHHHHhhccCCcccC
Confidence 55543 67888888888887 4555442 5788888888888854444445677788888887753
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.2e-21 Score=199.28 Aligned_cols=219 Identities=29% Similarity=0.422 Sum_probs=178.3
Q ss_pred CCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEe
Q 035761 5 RNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDL 84 (560)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l 84 (560)
.+|+++|+++|+++ .+|+++..+.+|+.|+..+|++. .+|..+...++|+.|.+..|.+. -+|....++++|++|+|
T Consensus 241 ~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL 317 (1081)
T KOG0618|consen 241 LNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDL 317 (1081)
T ss_pred ccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeee
Confidence 46888888888888 45588888888888888888886 77777777888888888888887 45666777889999999
Q ss_pred ecCccCccCCCCc-C-------------------------CCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCc
Q 035761 85 SRNEIGGSIPSTL-G-------------------------HLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLD 138 (560)
Q Consensus 85 ~~n~l~~~~~~~~-~-------------------------~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 138 (560)
..|+|.. .|+.+ . .+..|+.|.+.+|.++...-..+.+..+|+.|+|++|+|.
T Consensus 318 ~~N~L~~-lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~ 396 (1081)
T KOG0618|consen 318 QSNNLPS-LPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN 396 (1081)
T ss_pred hhccccc-cchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccc
Confidence 9998883 33321 1 1234777888888888766667888999999999999999
Q ss_pred CCCCccCcCCCCCcEEEccCcccccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCcccccc-Cccc
Q 035761 139 GPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGI-PVFV 217 (560)
Q Consensus 139 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~-~~~~ 217 (560)
......+.++..|++|+||+|+++ .+|..+..+..|++|...+|++. ..| .+.+++.|+.+|++-|+|+... |...
T Consensus 397 ~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~ 473 (1081)
T KOG0618|consen 397 SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEAL 473 (1081)
T ss_pred cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhC
Confidence 666667889999999999999999 78899999999999999999998 677 8899999999999999998543 3322
Q ss_pred --ccCCCCcCCCCCC
Q 035761 218 --RKVPHLDVSGNQF 230 (560)
Q Consensus 218 --~~l~~l~l~~n~~ 230 (560)
++|++||++||..
T Consensus 474 p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 474 PSPNLKYLDLSGNTR 488 (1081)
T ss_pred CCcccceeeccCCcc
Confidence 6899999999983
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.2e-18 Score=161.80 Aligned_cols=144 Identities=22% Similarity=0.215 Sum_probs=111.4
Q ss_pred CCcccceeeccCCeeEEEEE--eCCCcEEEEEEccchhhhh----------------------hhHHHHHHHHHHHhccC
Q 035761 316 DFDIKYCIGTGGYGSVYRAR--LPSGKVVALKKLHRLETEL----------------------ASLESFQNEARLLSQIR 371 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~~----------------------~~~~~~~~e~~~l~~l~ 371 (560)
-|++.+.||+|+||.||+|. ..+|+.||+|+++....+. .....+..|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46788899999999999998 5689999999987432100 01123568999999997
Q ss_pred CCC--cceeeeEEEeCCEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEEeCCCCC
Q 035761 372 HRN--IVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPP-ILHRDISSN 448 (560)
Q Consensus 372 h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~-ivH~dlk~~ 448 (560)
+.+ +.+++++ ...++||||++++++..+..... .++..+...++.|++.++++||+. + ++|||+||+
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~ 178 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV---EPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEY 178 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC---CcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChh
Confidence 533 3444442 23489999999988876543222 256667789999999999999999 9 999999999
Q ss_pred CeEeCCCCcEEEeeeccccccC
Q 035761 449 NILLNSEFEAFVADFGIARLLN 470 (560)
Q Consensus 449 Nill~~~~~~kl~Dfg~~~~~~ 470 (560)
||+++ ++.++++|||.+....
T Consensus 179 NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hEEEE-CCCEEEEEChhhhccC
Confidence 99999 8899999999987654
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.2e-18 Score=184.81 Aligned_cols=205 Identities=27% Similarity=0.397 Sum_probs=164.8
Q ss_pred CCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEe
Q 035761 5 RNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDL 84 (560)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l 84 (560)
.+.+.|+++++.++ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+++. +|..+. .+|+.|+|
T Consensus 178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lts-LP~~l~--~~L~~L~L 248 (754)
T PRK15370 178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLTS-IPATLP--DTIQEMEL 248 (754)
T ss_pred cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCcccc-CChhhh--ccccEEEC
Confidence 45789999999999 4666554 68999999999999 5565554 589999999999984 455443 57999999
Q ss_pred ecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccccc
Q 035761 85 SRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGS 164 (560)
Q Consensus 85 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 164 (560)
++|+++ .+|..+. .+|+.|+|++|+|+ .+|..+. ++|+.|++++|++++ +|..+. ++|+.|++++|.++.
T Consensus 249 s~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~- 318 (754)
T PRK15370 249 SINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA- 318 (754)
T ss_pred cCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-
Confidence 999999 5676654 57999999999999 5676664 589999999999995 555543 589999999999994
Q ss_pred cchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCcccccCCCCcCCCCCCCCc
Q 035761 165 IPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHLDVSGNQFGGE 233 (560)
Q Consensus 165 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~l~~n~~~~~ 233 (560)
+|..+. ++|+.|++++|.++. +|..+. ++|+.|++++|+|+..+.....+++.|++++|++...
T Consensus 319 LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~~LP~~lp~~L~~LdLs~N~Lt~L 382 (754)
T PRK15370 319 LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQITVLPETLPPTITTLDVSRNALTNL 382 (754)
T ss_pred CCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCCcCChhhcCCcCEEECCCCcCCCC
Confidence 555443 689999999999985 666553 6899999999999854333457899999999998854
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.6e-18 Score=183.10 Aligned_cols=205 Identities=25% Similarity=0.353 Sum_probs=117.5
Q ss_pred CCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccC-----------------CCCCCeeeccccccccc
Q 035761 6 NLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGH-----------------LTQLTTLAIASNRMNGS 68 (560)
Q Consensus 6 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~-----------------l~~L~~L~L~~n~i~~~ 68 (560)
+|+.|++++|+|+. +|. .+++|++|+|++|+|+. +|..+.+ ..+|+.|+|++|+++..
T Consensus 223 ~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lts-LP~lp~sL~~L~Ls~N~L~~Lp~lp~~L~~L~Ls~N~Lt~L 297 (788)
T PRK15387 223 HITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTS-LPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTSL 297 (788)
T ss_pred CCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccCc-ccCcccccceeeccCCchhhhhhchhhcCEEECcCCccccc
Confidence 46667777777663 343 24566677777766663 3322110 12233444444444321
Q ss_pred cccccCCCCCCCEEEeecCccCccCCCCcCC-----------------CCCccEEEccCCCccCCCCccCCCCCCCcEEE
Q 035761 69 ILLGIGSLKVLQVLDLSRNEIGGSIPSTLGH-----------------LKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLN 131 (560)
Q Consensus 69 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-----------------l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 131 (560)
|. .+++|+.|+|++|+|++ +|..... ..+|+.|+|++|+|++ +|.. ..+|+.|+
T Consensus 298 -P~---~p~~L~~LdLS~N~L~~-Lp~lp~~L~~L~Ls~N~L~~LP~lp~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~ 368 (788)
T PRK15387 298 -PV---LPPGLQELSVSDNQLAS-LPALPSELCKLWAYNNQLTSLPTLPSGLQELSVSDNQLAS-LPTL---PSELYKLW 368 (788)
T ss_pred -cc---cccccceeECCCCcccc-CCCCcccccccccccCccccccccccccceEecCCCccCC-CCCC---Ccccceeh
Confidence 21 12456666666666663 2221110 0245555555555552 3322 13455555
Q ss_pred CcCCcCcCCCCccCcCCCCCcEEEccCcccccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCcccc
Q 035761 132 MYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSG 211 (560)
Q Consensus 132 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~ 211 (560)
+++|+|+. +|.. ..+|+.|++++|+|++ +|.. .++|+.|++++|+|+. +|.. ..+|+.|++++|+|+
T Consensus 369 Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt- 435 (788)
T PRK15387 369 AYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT- 435 (788)
T ss_pred hhcccccc-Cccc---ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-
Confidence 55555552 3322 2468888888888884 4443 3578889999999984 5543 346788999999998
Q ss_pred ccCcc---cccCCCCcCCCCCCCCcCCcc
Q 035761 212 GIPVF---VRKVPHLDVSGNQFGGEIPTT 237 (560)
Q Consensus 212 ~~~~~---~~~l~~l~l~~n~~~~~~p~~ 237 (560)
.+|.. +.++..+++++|++++..+..
T Consensus 436 ~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~ 464 (788)
T PRK15387 436 RLPESLIHLSSETTVNLEGNPLSERTLQA 464 (788)
T ss_pred ccChHHhhccCCCeEECCCCCCCchHHHH
Confidence 45653 456777899999998775554
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=7.7e-18 Score=156.92 Aligned_cols=137 Identities=20% Similarity=0.341 Sum_probs=114.9
Q ss_pred ceeeccCCeeEEEEEeCCCcEEEEEEccchhh------hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 321 YCIGTGGYGSVYRARLPSGKVVALKKLHRLET------ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 321 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
+.||+|++|.||+|.+ .|..|++|+...... .......+.+|++++..++|+++.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4689999999999987 677899997653221 111234578899999999999998888888777888999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccccc
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL 469 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 469 (560)
+++++|.+++... .+ ++..++.+++.++.++|+. +++|||++|.||+++ ++.++++|||.+...
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 9999999998642 22 7889999999999999999 999999999999999 788999999998763
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.1e-18 Score=156.12 Aligned_cols=145 Identities=21% Similarity=0.230 Sum_probs=111.0
Q ss_pred HHHHhcCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhh--------------------hhHHHHHHHHHHHhc
Q 035761 310 MIEATEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETEL--------------------ASLESFQNEARLLSQ 369 (560)
Q Consensus 310 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------~~~~~~~~e~~~l~~ 369 (560)
+.....-|.+.+.||+|+||.||++..++|+.||||++....... .....+..|..++..
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 333333467788899999999999998889999999875432100 011236678888998
Q ss_pred cCCCC--cceeeeEEEeCCEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 035761 370 IRHRN--IVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISS 447 (560)
Q Consensus 370 l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~ 447 (560)
+.|++ +.+.++ ....++||||++++++...... .....++.+++.++.++|+. +++||||+|
T Consensus 90 l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p 153 (198)
T cd05144 90 LYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKH---GIIHGDLSE 153 (198)
T ss_pred HHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCc
Confidence 87774 444443 2345899999999998765431 23457889999999999998 999999999
Q ss_pred CCeEeCCCCcEEEeeeccccccC
Q 035761 448 NNILLNSEFEAFVADFGIARLLN 470 (560)
Q Consensus 448 ~Nill~~~~~~kl~Dfg~~~~~~ 470 (560)
+||++++++.++|+|||.+....
T Consensus 154 ~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred ccEEEcCCCcEEEEECCccccCC
Confidence 99999999999999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.1e-17 Score=178.53 Aligned_cols=197 Identities=26% Similarity=0.383 Sum_probs=108.2
Q ss_pred CCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEee
Q 035761 6 NLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLS 85 (560)
Q Consensus 6 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~ 85 (560)
.-..|+|++|.|+ .+|..+. ++|+.|++++|+|+. +|. ..++|++|+|++|+|+.+ |.. .++|+.|+|+
T Consensus 202 ~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~LtsL-P~l---p~sL~~L~Ls 270 (788)
T PRK15387 202 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTSL-PVL---PPGLLELSIF 270 (788)
T ss_pred CCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccCcc-cCc---ccccceeecc
Confidence 4568999999999 5677665 589999999999994 554 358999999999999854 432 3456666666
Q ss_pred cCccCccCCCCcC-----------------CCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCC
Q 035761 86 RNEIGGSIPSTLG-----------------HLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNC 148 (560)
Q Consensus 86 ~n~l~~~~~~~~~-----------------~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 148 (560)
+|.|+. +|..+. .+++|+.|+|++|+|++ +|... .+|+.|++++|.|++ +|. + .
T Consensus 271 ~N~L~~-Lp~lp~~L~~L~Ls~N~Lt~LP~~p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~~-LP~-l--p 341 (788)
T PRK15387 271 SNPLTH-LPALPSGLCKLWIFGNQLTSLPVLPPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLTS-LPT-L--P 341 (788)
T ss_pred CCchhh-hhhchhhcCEEECcCCccccccccccccceeECCCCcccc-CCCCc---ccccccccccCcccc-ccc-c--c
Confidence 666552 222111 12455566666665553 22211 123333333333332 121 0 1
Q ss_pred CCCcEEEccCcccccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCcccccCCCCcCCCC
Q 035761 149 SKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHLDVSGN 228 (560)
Q Consensus 149 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~l~~n 228 (560)
.+|+.|+|++|+|++ +|.. ..+|+.|++++|+|+. +|.. ..+|+.|++++|+|++ +|....++..|++++|
T Consensus 342 ~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l~s~L~~LdLS~N 412 (788)
T PRK15387 342 SGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVLPSELKELMVSGN 412 (788)
T ss_pred cccceEecCCCccCC-CCCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCcccC-CCCcccCCCEEEccCC
Confidence 356677777777663 3332 1344455555555542 3322 1234455555555442 2323334444444444
Q ss_pred CCC
Q 035761 229 QFG 231 (560)
Q Consensus 229 ~~~ 231 (560)
++.
T Consensus 413 ~Ls 415 (788)
T PRK15387 413 RLT 415 (788)
T ss_pred cCC
Confidence 444
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=5.3e-18 Score=181.90 Aligned_cols=197 Identities=24% Similarity=0.280 Sum_probs=156.9
Q ss_pred HHHhcCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccC---CCCcceeeeEEEeCCE
Q 035761 311 IEATEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIR---HRNIVKLYGFCLHEKC 387 (560)
Q Consensus 311 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~ 387 (560)
....+.|.+.+.+|+|+||.||+|...+|+.||+|+=+..... +|---.+++.+++ -+-|..+..++...+.
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W-----EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW-----EFYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce-----eeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 3345677888899999999999999888999999986544322 1111223344444 2345555555666777
Q ss_pred EEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCC-------CCcEEE
Q 035761 388 MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNS-------EFEAFV 460 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-------~~~~kl 460 (560)
.++|+||.+.|+|.+++...+ .++|.-.+.++.|+++-++.||.. +|||+||||.|++|.. ...++|
T Consensus 769 S~lv~ey~~~Gtlld~~N~~~---~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLINTNK---VMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred ceeeeeccccccHHHhhccCC---CCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEE
Confidence 899999999999999998543 389999999999999999999999 9999999999999942 345899
Q ss_pred eeeccccccC--CCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCC
Q 035761 461 ADFGIARLLN--YDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHP 518 (560)
Q Consensus 461 ~Dfg~~~~~~--~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P 518 (560)
+|||.+-.+. ++.......++|-.+--+|...++.++..+|-|-++-+++-|+.|+.-
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 9999987653 344455667788999999999999999999999999999999999853
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.9e-17 Score=152.74 Aligned_cols=133 Identities=22% Similarity=0.357 Sum_probs=108.6
Q ss_pred eeeccCCeeEEEEEeCCCcEEEEEEccchh------hhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEecc
Q 035761 322 CIGTGGYGSVYRARLPSGKVVALKKLHRLE------TELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYM 395 (560)
Q Consensus 322 ~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 395 (560)
.||+|+||.||+|.+ +|..|++|...... +.......+.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 379999999999986 57889999864321 11122356788999999999888766666666677778999999
Q ss_pred CCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccccc
Q 035761 396 EMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL 469 (560)
Q Consensus 396 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 469 (560)
++++|.+++.... . .++.|++.+++++|+. +++|||++|.||+++ ++.++++|||++...
T Consensus 80 ~g~~l~~~~~~~~----~------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGN----D------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcH----H------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999998875421 0 7899999999999999 999999999999999 789999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.5e-17 Score=176.18 Aligned_cols=140 Identities=19% Similarity=0.286 Sum_probs=112.5
Q ss_pred cCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchh-----hhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLE-----TELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMF 389 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 389 (560)
..|...+.||+|+||.||+|.+.+...++.++..+.. ......+.+.+|+++++.++|++++....++......+
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 4456678899999999999987654433322222211 11122356889999999999999998888888777789
Q ss_pred EEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccccc
Q 035761 390 LIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL 469 (560)
Q Consensus 390 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 469 (560)
+||||+++++|.+++. ....++.|+++++.|||+. +++|||+||+||++ +++.++|+|||+++..
T Consensus 413 lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 9999999999998875 3467899999999999999 99999999999999 6789999999999874
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.2e-17 Score=186.09 Aligned_cols=83 Identities=19% Similarity=0.266 Sum_probs=49.2
Q ss_pred CCCcEEEccCcccccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCcccccCCCCcCCCC
Q 035761 149 SKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHLDVSGN 228 (560)
Q Consensus 149 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~l~~n 228 (560)
++|+.|++++|.....+|..+.++++|+.|++++|...+.+|..+ .+++|+.|++++|......|....+++.|++++|
T Consensus 778 ~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~~~nL~~L~Ls~n 856 (1153)
T PLN03210 778 PSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDISTNISDLNLSRT 856 (1153)
T ss_pred ccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCccccccccccccCEeECCCC
Confidence 356666666665555566666677777777776664433455443 4566666666665544445554455666666666
Q ss_pred CCCC
Q 035761 229 QFGG 232 (560)
Q Consensus 229 ~~~~ 232 (560)
.+..
T Consensus 857 ~i~~ 860 (1153)
T PLN03210 857 GIEE 860 (1153)
T ss_pred CCcc
Confidence 6553
|
syringae 6; Provisional |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.1e-18 Score=181.23 Aligned_cols=199 Identities=26% Similarity=0.374 Sum_probs=143.3
Q ss_pred cCCcccceeeccCCeeEEEEEeCC-CcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
.+|+.++.|..|+||.||.++++. .+.+|.| +.+... ..++ ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l------ilRn---ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL------ILRN---ILTFAGNPFVV----------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccch------hhhc---cccccCCccee-----------------
Confidence 578889999999999999998864 5678873 332111 0111 22333344433
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC-
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD- 472 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~- 472 (560)
|+-...++..+. +... ++.+++|+|+. ||+|||+||.|.+|+.-|++|++|||+++..-..
T Consensus 136 ----gDc~tllk~~g~---lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ----GDCATLLKNIGP---LPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ----chhhhhcccCCC---Ccch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 455555544222 2222 27789999999 9999999999999999999999999998754210
Q ss_pred -C-------------CCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccccc---ccccccccc
Q 035761 473 -S-------------SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSS---SSLDKNIKL 535 (560)
Q Consensus 473 -~-------------~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~---~~~~~~~~~ 535 (560)
. -.....+||+.|.|||++....|...+|+|++|+|+||++-|+.||....-.+ ..+...+.+
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~w 277 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW 277 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccc
Confidence 0 01234579999999999999999999999999999999999999998542211 123455566
Q ss_pred ccccCCCCCCChhHHHhhceeeec
Q 035761 536 IDLLDPRLPPPGDQMIRQGIILIS 559 (560)
Q Consensus 536 ~~~~dp~~~p~~~~~~~~~~~~~~ 559 (560)
.+. |+.++|++++++.+.+-+|+
T Consensus 278 pE~-dea~p~Ea~dli~~LL~qnp 300 (1205)
T KOG0606|consen 278 PEE-DEALPPEAQDLIEQLLRQNP 300 (1205)
T ss_pred ccc-CcCCCHHHHHHHHHHHHhCh
Confidence 666 89999999999887665543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1e-17 Score=168.15 Aligned_cols=155 Identities=31% Similarity=0.524 Sum_probs=129.1
Q ss_pred HhccCCCCcceeeeEEEeCCEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCe-EEeCC
Q 035761 367 LSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPI-LHRDI 445 (560)
Q Consensus 367 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i-vH~dl 445 (560)
|+.+.|.|+.+++|.+..+...+.|.+|+..|+|.+.+... ..+++|.-...++++|++||+|+|+. +| .|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~--~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE--DIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc--ccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence 45689999999999999999999999999999999999863 34599999999999999999999987 55 99999
Q ss_pred CCCCeEeCCCCcEEEeeeccccccCCCC--CCceeeccccCccCccccccCc-------cCcchhHHHHHHHHHHHHhCC
Q 035761 446 SSNNILLNSEFEAFVADFGIARLLNYDS--SNRTLLAGTYGSIAPELAYTMV-------VTEKYDVYSFGVVALEVLMGK 516 (560)
Q Consensus 446 k~~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~g~~~~~aPE~~~~~~-------~~~~~Dv~s~G~il~el~~g~ 516 (560)
+++|+++|..+.+|++|||+........ ..........-|.|||.+.... .+.+.|+||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 9999999999999999999998764211 1111112345699999987642 355799999999999999999
Q ss_pred CCCCcccccc
Q 035761 517 HPGELLSSSS 526 (560)
Q Consensus 517 ~P~~~~~~~~ 526 (560)
.||.......
T Consensus 156 ~~~~~~~~~~ 165 (484)
T KOG1023|consen 156 GPFDLRNLVE 165 (484)
T ss_pred CccccccccC
Confidence 9998655433
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.9e-19 Score=179.25 Aligned_cols=231 Identities=26% Similarity=0.304 Sum_probs=166.2
Q ss_pred CCCCCCEEEccCCcCcc----cCCCCCCCcCCCCEEEccCCccee------cCCccccCCCCCCeeeccccccccccccc
Q 035761 3 RLRNLVHLDLSDNHFMG----HIPPTLGRLSELKILNLSLNSLVG------NIPSNVGHLTQLTTLAIASNRMNGSILLG 72 (560)
Q Consensus 3 ~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~N~i~~------~~~~~~~~l~~L~~L~L~~n~i~~~~~~~ 72 (560)
.+++|++|++++|.++. .++..+...++|++|++++|.+.+ .++..+..+++|+.|++++|.+....+..
T Consensus 21 ~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~ 100 (319)
T cd00116 21 KLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGV 100 (319)
T ss_pred HHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHH
Confidence 35678999999999853 245556677889999999987762 33456777889999999999887555555
Q ss_pred cCCCCC---CCEEEeecCccCc----cCCCCcCCC-CCccEEEccCCCccCC----CCccCCCCCCCcEEECcCCcCcCC
Q 035761 73 IGSLKV---LQVLDLSRNEIGG----SIPSTLGHL-KWLRSVDLSQNKLVGP----IPSSLGHLTQLTTLNMYNNKLDGP 140 (560)
Q Consensus 73 ~~~l~~---L~~L~l~~n~l~~----~~~~~~~~l-~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~ 140 (560)
+..+.+ |++|++++|.++. .+...+..+ ++|+.|++++|.+++. ++..+..+++|++|++++|.+++.
T Consensus 101 ~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ 180 (319)
T cd00116 101 LESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDA 180 (319)
T ss_pred HHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchH
Confidence 555544 9999999998873 223345566 8899999999998732 334566778899999999988742
Q ss_pred ----CCccCcCCCCCcEEEccCccccccc----chhhccccccceeeccccccCCcCccccC-----CCceeeEEEccCC
Q 035761 141 ----IPPELMNCSKLRILKLGNNLLSGSI----PSQIGKLQELYYLDLSGNFINGKIPSQLG-----EFSCIDTVDLSMN 207 (560)
Q Consensus 141 ----~~~~~~~l~~L~~L~l~~n~l~~~~----~~~~~~l~~L~~L~l~~n~l~~~~~~~~~-----~~~~L~~l~l~~n 207 (560)
++..+..+++|+.|++++|.+++.. +..+..+++|++|++++|++++.....+. ..+.|+.|++++|
T Consensus 181 ~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n 260 (319)
T cd00116 181 GIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCN 260 (319)
T ss_pred HHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCC
Confidence 2334556679999999999887543 34456778899999999988753333322 2378999999999
Q ss_pred ccccccC----c---ccccCCCCcCCCCCCCCc
Q 035761 208 NLSGGIP----V---FVRKVPHLDVSGNQFGGE 233 (560)
Q Consensus 208 ~l~~~~~----~---~~~~l~~l~l~~n~~~~~ 233 (560)
.++.... . .+.+++.+++++|.+...
T Consensus 261 ~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~ 293 (319)
T cd00116 261 DITDDGAKDLAEVLAEKESLLELDLRGNKFGEE 293 (319)
T ss_pred CCCcHHHHHHHHHHhcCCCccEEECCCCCCcHH
Confidence 8872111 1 235778889999988754
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.2e-16 Score=183.02 Aligned_cols=98 Identities=27% Similarity=0.350 Sum_probs=60.7
Q ss_pred CCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccccccchhhccccccceeeccccccCCcCccccCCCceeeEEEc
Q 035761 125 TQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDL 204 (560)
Q Consensus 125 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l 204 (560)
++|+.|+|++|.....+|..+.++++|+.|++++|...+.+|..+ ++++|+.|++++|.....+|.. ..+|+.|+|
T Consensus 778 ~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~L 853 (1153)
T PLN03210 778 PSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNL 853 (1153)
T ss_pred ccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeEC
Confidence 466777777776666677788888888888888775333566554 5677777777776544344432 245666666
Q ss_pred cCCccccccCc---ccccCCCCcCCC
Q 035761 205 SMNNLSGGIPV---FVRKVPHLDVSG 227 (560)
Q Consensus 205 ~~n~l~~~~~~---~~~~l~~l~l~~ 227 (560)
++|.++. +|. .++++..|++.+
T Consensus 854 s~n~i~~-iP~si~~l~~L~~L~L~~ 878 (1153)
T PLN03210 854 SRTGIEE-VPWWIEKFSNLSFLDMNG 878 (1153)
T ss_pred CCCCCcc-ChHHHhcCCCCCEEECCC
Confidence 6666653 333 234455555555
|
syringae 6; Provisional |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.1e-19 Score=178.94 Aligned_cols=223 Identities=25% Similarity=0.294 Sum_probs=129.2
Q ss_pred EEEccCCcCc-ccCCCCCCCcCCCCEEEccCCccee----cCCccccCCCCCCeeecccccccc------ccccccCCCC
Q 035761 9 HLDLSDNHFM-GHIPPTLGRLSELKILNLSLNSLVG----NIPSNVGHLTQLTTLAIASNRMNG------SILLGIGSLK 77 (560)
Q Consensus 9 ~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~i~~----~~~~~~~~l~~L~~L~L~~n~i~~------~~~~~~~~l~ 77 (560)
.|+|..+.++ ......|..+.+|++|++++|.++. .++..+...++|+.|+++++.+.. ..+..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 4666666665 2333445566667777777777642 234445566667777777766651 2234455566
Q ss_pred CCCEEEeecCccCccCCCCcCCCCC---ccEEEccCCCccC----CCCccCCCC-CCCcEEECcCCcCcCC----CCccC
Q 035761 78 VLQVLDLSRNEIGGSIPSTLGHLKW---LRSVDLSQNKLVG----PIPSSLGHL-TQLTTLNMYNNKLDGP----IPPEL 145 (560)
Q Consensus 78 ~L~~L~l~~n~l~~~~~~~~~~l~~---L~~L~l~~n~l~~----~~~~~~~~l-~~L~~L~l~~n~l~~~----~~~~~ 145 (560)
+|+.|++++|.+....+..+..+.+ |+.|++++|+++. .+...+..+ ++|+.|++++|.+++. ++..+
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~ 161 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL 161 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence 7777777777776444444433333 7777777777652 122234445 6777777777776632 22345
Q ss_pred cCCCCCcEEEccCcccccc----cchhhccccccceeeccccccCCcC----ccccCCCceeeEEEccCCccccccCc--
Q 035761 146 MNCSKLRILKLGNNLLSGS----IPSQIGKLQELYYLDLSGNFINGKI----PSQLGEFSCIDTVDLSMNNLSGGIPV-- 215 (560)
Q Consensus 146 ~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~~----~~~~~~~~~L~~l~l~~n~l~~~~~~-- 215 (560)
..+++|+.|++++|.+++. ++..+..+++|+.|++++|.+++.. ...+..+++|+.|++++|++++....
T Consensus 162 ~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l 241 (319)
T cd00116 162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAAL 241 (319)
T ss_pred HhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHH
Confidence 5556677777777776632 2233445557777777777765332 23345566677777777776642211
Q ss_pred --c----cccCCCCcCCCCCCC
Q 035761 216 --F----VRKVPHLDVSGNQFG 231 (560)
Q Consensus 216 --~----~~~l~~l~l~~n~~~ 231 (560)
. ...++.|++++|.+.
T Consensus 242 ~~~~~~~~~~L~~L~l~~n~i~ 263 (319)
T cd00116 242 ASALLSPNISLLTLSLSCNDIT 263 (319)
T ss_pred HHHHhccCCCceEEEccCCCCC
Confidence 1 246666777777665
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.8e-17 Score=153.08 Aligned_cols=175 Identities=26% Similarity=0.347 Sum_probs=126.8
Q ss_pred CCCCcceeeeEEEe---------------------------CCEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHH
Q 035761 371 RHRNIVKLYGFCLH---------------------------EKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVK 423 (560)
Q Consensus 371 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~ 423 (560)
+|||||+++++|.+ ...+|+||...+. +|++|+.... .+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----CchHHHHHHHH
Confidence 69999999998753 2458899998876 9999998754 56777788999
Q ss_pred HHHHHHHHHHhcCCCCeEEeCCCCCCeEe--CCCCc--EEEeeeccccccCC------CCCCceeeccccCccCcccccc
Q 035761 424 GMAHALSYLHHHCTPPILHRDISSNNILL--NSEFE--AFVADFGIARLLNY------DSSNRTLLAGTYGSIAPELAYT 493 (560)
Q Consensus 424 ~ia~~l~~LH~~~~~~ivH~dlk~~Nill--~~~~~--~kl~Dfg~~~~~~~------~~~~~~~~~g~~~~~aPE~~~~ 493 (560)
|+++|+.|||.+ ||.|||+|+.|||+ |+|+. ..++|||++---+. -.+..-..-|...-||||+...
T Consensus 349 QlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 999999999999 99999999999998 44443 57999998743111 0111222346778999998775
Q ss_pred Cc------cCcchhHHHHHHHHHHHHhCCCCCCcccccccccc-cccccccccCCCCCCChhHHHhh
Q 035761 494 MV------VTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLD-KNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 494 ~~------~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~~~~~-~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
.. ...|+|.|+.|-+.||+++...||...+....+.. ........+....+|.+++++..
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~ 492 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFD 492 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHH
Confidence 43 23589999999999999999999976443322221 22233445555566666666543
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=6.4e-19 Score=182.44 Aligned_cols=222 Identities=29% Similarity=0.377 Sum_probs=184.8
Q ss_pred CCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEe
Q 035761 5 RNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDL 84 (560)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l 84 (560)
++|+.|+.++|.++...+. .--.+|+++++++|+++ .+|+++..+.+|+.|+..+|++. ..|..+....+|+.|++
T Consensus 219 ~~l~~L~a~~n~l~~~~~~--p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~ 294 (1081)
T KOG0618|consen 219 PSLTALYADHNPLTTLDVH--PVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSA 294 (1081)
T ss_pred cchheeeeccCcceeeccc--cccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHh
Confidence 5678888888888743322 23368999999999999 66799999999999999999996 77888888999999999
Q ss_pred ecCccCccCCCCcCCCCCccEEEccCCCccCCCCccC-C-------------------------CCCCCcEEECcCCcCc
Q 035761 85 SRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSL-G-------------------------HLTQLTTLNMYNNKLD 138 (560)
Q Consensus 85 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-~-------------------------~l~~L~~L~l~~n~l~ 138 (560)
.+|.++ -+|....+++.|++|+|..|+|. ..|+.+ . .++.|+.|++.+|.++
T Consensus 295 ~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Lt 372 (1081)
T KOG0618|consen 295 AYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLT 372 (1081)
T ss_pred hhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCccc
Confidence 999999 57777888999999999999998 344322 1 1345788889999999
Q ss_pred CCCCccCcCCCCCcEEEccCcccccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCc-cc
Q 035761 139 GPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPV-FV 217 (560)
Q Consensus 139 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~-~~ 217 (560)
....+.+.++++|+.|+|++|+|.......+.+++.|+.|+||+|+++ .+|+.+..++.|++|...+|++...+-. .+
T Consensus 373 d~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~fPe~~~l 451 (1081)
T KOG0618|consen 373 DSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLSFPELAQL 451 (1081)
T ss_pred ccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceeechhhhhc
Confidence 877778899999999999999999666677889999999999999999 7889999999999999999999965522 44
Q ss_pred ccCCCCcCCCCCCCCc
Q 035761 218 RKVPHLDVSGNQFGGE 233 (560)
Q Consensus 218 ~~l~~l~l~~n~~~~~ 233 (560)
+.++.+|++.|.+...
T Consensus 452 ~qL~~lDlS~N~L~~~ 467 (1081)
T KOG0618|consen 452 PQLKVLDLSCNNLSEV 467 (1081)
T ss_pred CcceEEecccchhhhh
Confidence 6788899999987653
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.68 E-value=8.1e-18 Score=165.51 Aligned_cols=164 Identities=21% Similarity=0.310 Sum_probs=127.5
Q ss_pred EEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccc
Q 035761 387 CMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIA 466 (560)
Q Consensus 387 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~ 466 (560)
+.++.|+++..++|.+++.+.+.....++.....++.|++.|++| + +.+|||+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999877666778999999999999999999 5 8999999999999999999999999999
Q ss_pred cccCCCC------CCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc------cc---ccc-
Q 035761 467 RLLNYDS------SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS------SS---SSL- 529 (560)
Q Consensus 467 ~~~~~~~------~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~------~~---~~~- 529 (560)
....... ...+.-+||..||+||.+.+..|+.|+|+||+|++++|++. =.-+++.... .. ..+
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~d~r~g~ip~~~~~ 483 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATLTDIRDGIIPPEFLQ 483 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhhhhhcCCCChHHhh
Confidence 8765433 12234579999999999999999999999999999999998 2222221111 00 001
Q ss_pred -----ccccccccccCCCCCCChhHHHhhcee
Q 035761 530 -----DKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 530 -----~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
......+..+.|..||.+...-.+.|+
T Consensus 484 d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 484 DYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred cCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 122244567789999966665555543
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.8e-16 Score=142.47 Aligned_cols=138 Identities=21% Similarity=0.239 Sum_probs=98.8
Q ss_pred cceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHH----------------------HHHHHHHHhccCCCC--c
Q 035761 320 KYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLES----------------------FQNEARLLSQIRHRN--I 375 (560)
Q Consensus 320 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~----------------------~~~e~~~l~~l~h~n--i 375 (560)
.+.||+|+||.||+|...+++.||||++............ ...|...+..+++.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4569999999999999888999999988653321111111 135666666664433 4
Q ss_pred ceeeeEEEeCCEEEEEEeccCCCCHHHH-hhcCCcccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEeCCCCCCeEeC
Q 035761 376 VKLYGFCLHEKCMFLIYEYMEMGSLFCI-LRTDEEAVGLDWTKRVNIVKGMAHALSYLHH-HCTPPILHRDISSNNILLN 453 (560)
Q Consensus 376 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~ 453 (560)
.+.++. ...++||||++++.+... +.... .. .+...++.+++.++.++|. . +++|||+||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE
Confidence 444432 235899999999654321 11110 11 5567899999999999999 7 999999999999999
Q ss_pred CCCcEEEeeeccccccC
Q 035761 454 SEFEAFVADFGIARLLN 470 (560)
Q Consensus 454 ~~~~~kl~Dfg~~~~~~ 470 (560)
++.++++|||.+....
T Consensus 150 -~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 -DGKVYIIDVPQAVEID 165 (187)
T ss_pred -CCcEEEEECccccccc
Confidence 8999999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.4e-15 Score=133.58 Aligned_cols=135 Identities=19% Similarity=0.151 Sum_probs=113.1
Q ss_pred cceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCC--CCcceeeeEEEeCCEEEEEEeccCC
Q 035761 320 KYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRH--RNIVKLYGFCLHEKCMFLIYEYMEM 397 (560)
Q Consensus 320 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~ 397 (560)
.+.+|+|.++.||++...+ ..+++|....... ...+.+|...++.++| .++.+++++....+..+++|||+++
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 4679999999999999754 7899998865432 3468899999999976 5899999888887889999999998
Q ss_pred CCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccccc
Q 035761 398 GSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL 469 (560)
Q Consensus 398 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 469 (560)
+.+..+ +......++.+++++++++|.....+++|+|++|+||++++.+.+++.|||.++..
T Consensus 78 ~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 78 ETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred eecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 776543 45566788999999999999864447999999999999999899999999988753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.2e-15 Score=140.74 Aligned_cols=138 Identities=20% Similarity=0.274 Sum_probs=106.8
Q ss_pred cceee-ccCCeeEEEEEeCCCcEEEEEEccchh------h-----hhhhHHHHHHHHHHHhccCCCCc--ceeeeEEEeC
Q 035761 320 KYCIG-TGGYGSVYRARLPSGKVVALKKLHRLE------T-----ELASLESFQNEARLLSQIRHRNI--VKLYGFCLHE 385 (560)
Q Consensus 320 ~~~ig-~G~~g~Vy~~~~~~~~~vavK~~~~~~------~-----~~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~ 385 (560)
...+| .|+.|+||.+... +..++||.+.... . .......+.+|++++..++|+++ ++.+++...+
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35687 8999999999875 7789999885421 0 01223457889999999998875 6777765443
Q ss_pred CE----EEEEEeccCC-CCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEE
Q 035761 386 KC----MFLIYEYMEM-GSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFV 460 (560)
Q Consensus 386 ~~----~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 460 (560)
.. .++||||+++ .+|.+++.... ++.. .+.|++.++.+||+. ||+|||+||.|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~----l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEAP----LSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcCC----CCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence 22 3599999997 68988886432 4443 367899999999999 9999999999999999999999
Q ss_pred eeecccccc
Q 035761 461 ADFGIARLL 469 (560)
Q Consensus 461 ~Dfg~~~~~ 469 (560)
+|||.++..
T Consensus 184 IDfg~~~~~ 192 (239)
T PRK01723 184 IDFDRGELR 192 (239)
T ss_pred EECCCcccC
Confidence 999998764
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.8e-17 Score=161.92 Aligned_cols=193 Identities=32% Similarity=0.457 Sum_probs=132.4
Q ss_pred CCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEe
Q 035761 5 RNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDL 84 (560)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l 84 (560)
..-...||+.|++. .+|..+..+-.|+.|.|..|.|. .+|..+.++..|+.|||+.|++. ..|..++.|+ |+.|-+
T Consensus 75 tdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~ 150 (722)
T KOG0532|consen 75 TDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIV 150 (722)
T ss_pred cchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEE
Confidence 34456677777776 66666777777777777777777 66777777777777777777776 5666666665 777777
Q ss_pred ecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccccc
Q 035761 85 SRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGS 164 (560)
Q Consensus 85 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 164 (560)
++|+++ .+|..++.++.|..||.+.|.+. .+|..+.++.+|+.|++..|++. .+|..+. .-.|..||++.|+++ .
T Consensus 151 sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~-~LpLi~lDfScNkis-~ 225 (722)
T KOG0532|consen 151 SNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELC-SLPLIRLDFSCNKIS-Y 225 (722)
T ss_pred ecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHh-CCceeeeecccCcee-e
Confidence 777777 56666777777777777777776 56666777777777777777776 4555555 334777777777777 6
Q ss_pred cchhhccccccceeeccccccCCcCccccCCC---ceeeEEEccCC
Q 035761 165 IPSQIGKLQELYYLDLSGNFINGKIPSQLGEF---SCIDTVDLSMN 207 (560)
Q Consensus 165 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~---~~L~~l~l~~n 207 (560)
+|-.|.+|..|++|-|.+|+++ ..|..++.. .-.++|+..-+
T Consensus 226 iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~ 270 (722)
T KOG0532|consen 226 LPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQAC 270 (722)
T ss_pred cchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhc
Confidence 7777777777777777777776 555554322 23355655555
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.9e-16 Score=166.88 Aligned_cols=239 Identities=22% Similarity=0.280 Sum_probs=180.3
Q ss_pred cCCcccceeeccCCeeEEEEEeCC--CcEEEEEEccchhhhhhhHHHHHHHHHHHhccC-CCCcceeeeEEEeCCEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPS--GKVVALKKLHRLETELASLESFQNEARLLSQIR-HRNIVKLYGFCLHEKCMFLI 391 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 391 (560)
..|.+.+.||+|+|+.|-...... ...+|+|.+...............|..+-..+. |+|++.+++...+....+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 346677779999999998886533 345666666544322233344455777777775 99999999999999999999
Q ss_pred EeccCCCCHHHHh-hcCCcccCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEEeCCCCCCeEeCCCC-cEEEeeeccccc
Q 035761 392 YEYMEMGSLFCIL-RTDEEAVGLDWTKRVNIVKGMAHALSYLH-HHCTPPILHRDISSNNILLNSEF-EAFVADFGIARL 468 (560)
Q Consensus 392 ~e~~~~g~L~~~l-~~~~~~~~l~~~~~~~i~~~ia~~l~~LH-~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~~~~ 468 (560)
.+|..+|++.+-+ ..... ..+....-....|+..++.|+| +. ++.|||+||+|.+++..+ ..+++|||+|..
T Consensus 100 ~~~s~g~~~f~~i~~~~~~--~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDST--GTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred cCcccccccccccccCCcc--CCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 9999999998888 43321 2566667789999999999999 77 999999999999999999 999999999988
Q ss_pred cCC-CCCC--ceeecc-ccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCCCCCcccccccc---------------
Q 035761 469 LNY-DSSN--RTLLAG-TYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSS--------------- 528 (560)
Q Consensus 469 ~~~-~~~~--~~~~~g-~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~~~--------------- 528 (560)
+.. .+.. ....+| ++.|+|||...+. ...+..|+||.|+++.-+++|..||+........
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLP 254 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCc
Confidence 765 3322 233567 9999999998884 4566799999999999999999999755532221
Q ss_pred -------cccccccccccCCCCCCChhHHHhhceeee
Q 035761 529 -------LDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 529 -------~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
.....+-+...+|..|.+.+++-.+.|+..
T Consensus 255 ~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 255 WNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cccCChhhhhcccccccCCchhccccccccccccccc
Confidence 111112223357888888888888877653
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.57 E-value=6.7e-17 Score=159.25 Aligned_cols=198 Identities=27% Similarity=0.401 Sum_probs=172.7
Q ss_pred EEEccCCcCcccCCCCC-CCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEeecC
Q 035761 9 HLDLSDNHFMGHIPPTL-GRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRN 87 (560)
Q Consensus 9 ~L~L~~n~l~~~~~~~~-~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n 87 (560)
+|.|++-.+....-+.+ ..+..-...||+.|++. ++|..+..+-.|+.|.|+.|.+. .+|..+.++..|+.|||+.|
T Consensus 54 ~l~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~N 131 (722)
T KOG0532|consen 54 RLLLSGRRLKEFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSN 131 (722)
T ss_pred ccccccchhhcCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccc
Confidence 45666666663332223 34555678999999999 89999999999999999999999 78999999999999999999
Q ss_pred ccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccccccch
Q 035761 88 EIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPS 167 (560)
Q Consensus 88 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 167 (560)
+++ .+|..++.|+ |+.|.+++|+++ .+|..++.+..|..|+.+.|.+. .+|..++.+.+|+.|.+..|++. .+|.
T Consensus 132 qlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~ 206 (722)
T KOG0532|consen 132 QLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPE 206 (722)
T ss_pred hhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCH
Confidence 999 7888898887 999999999999 78888999999999999999999 67889999999999999999998 6777
Q ss_pred hhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCc
Q 035761 168 QIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPV 215 (560)
Q Consensus 168 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~ 215 (560)
.+..| .|..||++.|++. .+|-.|.+|..|++|-|.+|+|+..+..
T Consensus 207 El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqSPPAq 252 (722)
T KOG0532|consen 207 ELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQSPPAQ 252 (722)
T ss_pred HHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCCChHH
Confidence 77755 5889999999999 8999999999999999999999965443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.51 E-value=8.1e-14 Score=142.64 Aligned_cols=143 Identities=23% Similarity=0.242 Sum_probs=102.0
Q ss_pred cceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhh--------------------------------------hHHHHH
Q 035761 320 KYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELA--------------------------------------SLESFQ 361 (560)
Q Consensus 320 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~--------------------------------------~~~~~~ 361 (560)
.+.||.|++|.||+|++++|+.||||+.+......- ..-.|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 367999999999999999999999999754321100 001255
Q ss_pred HHHHHHhccC-----CCCcceeeeEE-EeCCEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHH-HHHHHHh
Q 035761 362 NEARLLSQIR-----HRNIVKLYGFC-LHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAH-ALSYLHH 434 (560)
Q Consensus 362 ~e~~~l~~l~-----h~niv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~-~l~~LH~ 434 (560)
+|+..+.+++ ++++ .+-.++ ...+..++||||++|+++.++....... . .+..++.++++ .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--L---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--C---CHHHHHHHHHHHHHHHHHh
Confidence 5666666552 3433 333333 2345579999999999998876532111 2 23456777766 4678898
Q ss_pred cCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC
Q 035761 435 HCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471 (560)
Q Consensus 435 ~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 471 (560)
. |++|+|++|.||++++++.++++|||++..+..
T Consensus 276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred C---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 8 999999999999999999999999999987753
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.9e-14 Score=147.40 Aligned_cols=198 Identities=34% Similarity=0.505 Sum_probs=122.6
Q ss_pred EEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCC-CCCeeeccccccccccccccCCCCCCCEEEeecC
Q 035761 9 HLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLT-QLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRN 87 (560)
Q Consensus 9 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~-~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n 87 (560)
.|+++.|.+. ........++.++.|++.+|.++ .++.....+. +|+.|++++|++. ..+..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 4566666653 12223444466777777777776 4444555553 6777777777776 34455666777777777777
Q ss_pred ccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccccccch
Q 035761 88 EIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPS 167 (560)
Q Consensus 88 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 167 (560)
+++ .+|.....+++|+.|++++|+++ .+|.....+..|++|.+++|++. ..+..+..+.++..|.+.+|++. ..+.
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~ 249 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPE 249 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccc
Confidence 777 44444446667777777777776 45554444555777777777543 34455666667777777777766 3355
Q ss_pred hhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCc
Q 035761 168 QIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPV 215 (560)
Q Consensus 168 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~ 215 (560)
.+..+++|+.|++++|+++.... +..+.+++.|++++|.+...++.
T Consensus 250 ~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 250 SIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred hhccccccceecccccccccccc--ccccCccCEEeccCccccccchh
Confidence 66666677777777777763333 66666777777777766655544
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.48 E-value=8.9e-14 Score=148.98 Aligned_cols=108 Identities=31% Similarity=0.500 Sum_probs=82.1
Q ss_pred CcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccC
Q 035761 127 LTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSM 206 (560)
Q Consensus 127 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~ 206 (560)
++.|+|++|.+++.+|..+..+++|+.|+|++|.+++.+|..+..+++|+.|+|++|++++.+|..+..+++|+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 66778888888877777788888888888888888777777788888888888888888877888788888888888888
Q ss_pred CccccccCccccc----CCCCcCCCCCCCCcC
Q 035761 207 NNLSGGIPVFVRK----VPHLDVSGNQFGGEI 234 (560)
Q Consensus 207 n~l~~~~~~~~~~----l~~l~l~~n~~~~~~ 234 (560)
|++++.+|..+.. +..+++.+|+..|..
T Consensus 500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~ 531 (623)
T PLN03150 500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGI 531 (623)
T ss_pred CcccccCChHHhhccccCceEEecCCccccCC
Confidence 8888777765532 345667777755543
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.9e-13 Score=126.67 Aligned_cols=193 Identities=23% Similarity=0.306 Sum_probs=142.4
Q ss_pred HHHhccCCCCcceeeeEEEeCCE-----EEEEEeccCCCCHHHHhhcCC-cccCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 035761 365 RLLSQIRHRNIVKLYGFCLHEKC-----MFLIYEYMEMGSLFCILRTDE-EAVGLDWTKRVNIVKGMAHALSYLHHHCTP 438 (560)
Q Consensus 365 ~~l~~l~h~niv~l~~~~~~~~~-----~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~ 438 (560)
.-+-.+.|-|||++..|+.+.++ ...+.|||+.|++.++|++.. ....+....-.+|+.||..||.|||+ +.|
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence 34445679999999999976543 678899999999999998643 23346777778999999999999998 588
Q ss_pred CeEEeCCCCCCeEeCCCCcEEEeeeccccccCC----CCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh
Q 035761 439 PILHRDISSNNILLNSEFEAFVADFGIARLLNY----DSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM 514 (560)
Q Consensus 439 ~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~----~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~ 514 (560)
+|+|+++.-+-|++..++-+|+.--.-...... .....+...+-++|.|||.-..-..+..+|||+||++..||.-
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 999999999999999998888743221111100 0011122335679999998777777778999999999999988
Q ss_pred CCCC-CCcccc-------------cccc-cccccccccccCCCCCCChhHHHhhceeee
Q 035761 515 GKHP-GELLSS-------------SSSS-LDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 515 g~~P-~~~~~~-------------~~~~-~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
|..- -..... .+.. -...+..|..-.|.-||+++.++.|..+++
T Consensus 278 lEiq~tnseS~~~~ee~ia~~i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIANVIIGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred heeccCCCcceeehhhhhhhheeeccCccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence 7654 221111 1111 245667788889999999999999988765
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.45 E-value=5e-14 Score=144.36 Aligned_cols=184 Identities=37% Similarity=0.546 Sum_probs=156.0
Q ss_pred CCCCCCEEEccCCcCcccCCCCCCCcC-CCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCE
Q 035761 3 RLRNLVHLDLSDNHFMGHIPPTLGRLS-ELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQV 81 (560)
Q Consensus 3 ~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~ 81 (560)
.++.++.|++.+|+++ .++.....+. +|+.|++++|++. .+|..+..+++|+.|++++|++. ..+.....++.|+.
T Consensus 114 ~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~ 190 (394)
T COG4886 114 ELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNN 190 (394)
T ss_pred cccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhh
Confidence 4567999999999999 4555666664 9999999999999 66678899999999999999998 45555558899999
Q ss_pred EEeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCccc
Q 035761 82 LDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLL 161 (560)
Q Consensus 82 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 161 (560)
|++++|+++ .+|.....+..|++|.+++|.+. ..+..+.++.++..|.+++|++. ..+..+..+++++.|++++|.+
T Consensus 191 L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i 267 (394)
T COG4886 191 LDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQI 267 (394)
T ss_pred eeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchhccccccceeccccccc
Confidence 999999999 56666666777999999999755 46678899999999999999998 3467888999999999999999
Q ss_pred ccccchhhccccccceeeccccccCCcCccccC
Q 035761 162 SGSIPSQIGKLQELYYLDLSGNFINGKIPSQLG 194 (560)
Q Consensus 162 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 194 (560)
+...+ +..+.+|+.|++++|.+....+....
T Consensus 268 ~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~~ 298 (394)
T COG4886 268 SSISS--LGSLTNLRELDLSGNSLSNALPLIAL 298 (394)
T ss_pred ccccc--ccccCccCEEeccCccccccchhhhc
Confidence 95443 89999999999999999977665543
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=4.1e-15 Score=138.79 Aligned_cols=229 Identities=20% Similarity=0.290 Sum_probs=174.3
Q ss_pred CCCCCCEEEccCCcCcc----cCCCCCCCcCCCCEEEccCC---cceecCCcc-------ccCCCCCCeeeccccccccc
Q 035761 3 RLRNLVHLDLSDNHFMG----HIPPTLGRLSELKILNLSLN---SLVGNIPSN-------VGHLTQLTTLAIASNRMNGS 68 (560)
Q Consensus 3 ~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~N---~i~~~~~~~-------~~~l~~L~~L~L~~n~i~~~ 68 (560)
.+..+++|+||+|.+.. .+...+.+.++|+..++|+= ++...+|++ +...++|+.|+||+|.+...
T Consensus 28 ~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~ 107 (382)
T KOG1909|consen 28 PMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPK 107 (382)
T ss_pred ccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCcc
Confidence 46689999999999973 34556777889999999863 233344443 45678999999999998643
Q ss_pred ccc----ccCCCCCCCEEEeecCccCccC-------------CCCcCCCCCccEEEccCCCccCC----CCccCCCCCCC
Q 035761 69 ILL----GIGSLKVLQVLDLSRNEIGGSI-------------PSTLGHLKWLRSVDLSQNKLVGP----IPSSLGHLTQL 127 (560)
Q Consensus 69 ~~~----~~~~l~~L~~L~l~~n~l~~~~-------------~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L 127 (560)
.+. -+..+..|+.|.|.+|.+...- ..-...-+.|+++...+|++... +...|..++.|
T Consensus 108 g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~l 187 (382)
T KOG1909|consen 108 GIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTL 187 (382)
T ss_pred chHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhcccc
Confidence 333 3456899999999999998321 12245568899999999999733 33467778999
Q ss_pred cEEECcCCcCcCC----CCccCcCCCCCcEEEccCccccc----ccchhhccccccceeeccccccCCcCcccc-----C
Q 035761 128 TTLNMYNNKLDGP----IPPELMNCSKLRILKLGNNLLSG----SIPSQIGKLQELYYLDLSGNFINGKIPSQL-----G 194 (560)
Q Consensus 128 ~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~----~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-----~ 194 (560)
+.+.++.|.|... +...|..+++|+.|||++|-++. .+...++.+++|+.|++++|.+.......| .
T Consensus 188 eevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~ 267 (382)
T KOG1909|consen 188 EEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKE 267 (382)
T ss_pred ceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhc
Confidence 9999999998732 23468899999999999999985 345667889999999999999976654433 3
Q ss_pred CCceeeEEEccCCccccccCc-------ccccCCCCcCCCCCCC
Q 035761 195 EFSCIDTVDLSMNNLSGGIPV-------FVRKVPHLDVSGNQFG 231 (560)
Q Consensus 195 ~~~~L~~l~l~~n~l~~~~~~-------~~~~l~~l~l~~n~~~ 231 (560)
..++|+.|.+.+|.++..... ..+.+..|++.+|.++
T Consensus 268 ~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 268 SAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred cCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 478999999999999843221 2367888999999985
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.40 E-value=3.5e-12 Score=129.73 Aligned_cols=167 Identities=18% Similarity=0.206 Sum_probs=126.7
Q ss_pred eCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEeccCCCCHHHHhhcCCcccCCCH
Q 035761 336 LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDW 415 (560)
Q Consensus 336 ~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~ 415 (560)
..++.+|.|...+.... ...+...+.++-++.+|||||++++..+..++..|+|+|-+. .|..+++. +..
T Consensus 34 k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~ 103 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGK 103 (690)
T ss_pred eccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHH
Confidence 44678888888765443 333456678899999999999999999999999999999884 56667765 344
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCceeeccccCccCccccccCc
Q 035761 416 TKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMV 495 (560)
Q Consensus 416 ~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~ 495 (560)
....-.+.||+.||.|||+.+ +++|++|+-.-|+++..|..||++|..+..............--..|..|+.+....
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc
Confidence 556677999999999999764 899999999999999999999999998876543222111111222456666433222
Q ss_pred cCcchhHHHHHHHHHHHHhCC
Q 035761 496 VTEKYDVYSFGVVALEVLMGK 516 (560)
Q Consensus 496 ~~~~~Dv~s~G~il~el~~g~ 516 (560)
-..|.|-||+++||++.|.
T Consensus 182 --~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred --cchhhhhHHHHHHHHhCcc
Confidence 2469999999999999993
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.2e-14 Score=137.56 Aligned_cols=206 Identities=22% Similarity=0.206 Sum_probs=93.7
Q ss_pred CCCCCCEEEccCCcCcccCC--CCCCCcCCCCEEEccCCcceec--CCccccCCCCCCeeeccccccccccccc-cCCCC
Q 035761 3 RLRNLVHLDLSDNHFMGHIP--PTLGRLSELKILNLSLNSLVGN--IPSNVGHLTQLTTLAIASNRMNGSILLG-IGSLK 77 (560)
Q Consensus 3 ~l~~L~~L~L~~n~l~~~~~--~~~~~l~~L~~L~L~~N~i~~~--~~~~~~~l~~L~~L~L~~n~i~~~~~~~-~~~l~ 77 (560)
++++|+...|.+..+. ..+ +....+++++.||||.|-+... +......+++|+.|+|+.|++....... -..++
T Consensus 119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 3455566666655554 222 2345556666666666655421 1222345556666666666554221111 11344
Q ss_pred CCCEEEeecCccCccC-CCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEc
Q 035761 78 VLQVLDLSRNEIGGSI-PSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKL 156 (560)
Q Consensus 78 ~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 156 (560)
+|+.|.|+.|+++... -..+...|+|+.|+|..|....+.......+..|+.|+|++|.+... +.
T Consensus 198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~-~~------------- 263 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDF-DQ------------- 263 (505)
T ss_pred hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccccc-cc-------------
Confidence 5555555555554211 11122334455555555532212222233344444455544444321 10
Q ss_pred cCcccccccchhhccccccceeeccccccCCc-Cccc-----cCCCceeeEEEccCCccccccCc----ccccCCCCcCC
Q 035761 157 GNNLLSGSIPSQIGKLQELYYLDLSGNFINGK-IPSQ-----LGEFSCIDTVDLSMNNLSGGIPV----FVRKVPHLDVS 226 (560)
Q Consensus 157 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~-----~~~~~~L~~l~l~~n~l~~~~~~----~~~~l~~l~l~ 226 (560)
-...+.++.|+.|+++.|.+... .|+. ...+++|+.|+++.|++...... .+.++.+|...
T Consensus 264 ---------~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~ 334 (505)
T KOG3207|consen 264 ---------GYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRIT 334 (505)
T ss_pred ---------ccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcc
Confidence 02233444555555555544432 1111 23456666666666666432221 34566777777
Q ss_pred CCCCCC
Q 035761 227 GNQFGG 232 (560)
Q Consensus 227 ~n~~~~ 232 (560)
+|.+..
T Consensus 335 ~n~ln~ 340 (505)
T KOG3207|consen 335 LNYLNK 340 (505)
T ss_pred cccccc
Confidence 777654
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.39 E-value=9.7e-13 Score=141.03 Aligned_cols=113 Identities=33% Similarity=0.605 Sum_probs=104.0
Q ss_pred CccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccccccchhhccccccceeecc
Q 035761 102 WLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLS 181 (560)
Q Consensus 102 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 181 (560)
.++.|+|++|.+++.+|..+.++++|+.|+|++|.+++.+|..+..+++|+.|+|++|++++.+|..+.++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 37899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCcCccccCCC-ceeeEEEccCCccccccC
Q 035761 182 GNFINGKIPSQLGEF-SCIDTVDLSMNNLSGGIP 214 (560)
Q Consensus 182 ~n~l~~~~~~~~~~~-~~L~~l~l~~n~l~~~~~ 214 (560)
+|++++.+|..+... .++..+++++|+..+..|
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCC
Confidence 999999999988763 467789999998766544
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.38 E-value=9.1e-13 Score=136.30 Aligned_cols=146 Identities=21% Similarity=0.204 Sum_probs=94.9
Q ss_pred cCCcccceeeccCCeeEEEEEeCC-CcEEEEEEccchhhhh--------------------------------hhHH---
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRLETEL--------------------------------ASLE--- 358 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~--------------------------------~~~~--- 358 (560)
.+|+. +.+|.|++|.||+|++++ |+.||||+.+...... +..+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45665 789999999999999987 9999999986432100 0011
Q ss_pred ---HHHHHHHHHhccC----CCCcceeeeEEEe-CCEEEEEEeccCCCCHHHHh--hcCCc-ccCCCHHHHHHHHHHHHH
Q 035761 359 ---SFQNEARLLSQIR----HRNIVKLYGFCLH-EKCMFLIYEYMEMGSLFCIL--RTDEE-AVGLDWTKRVNIVKGMAH 427 (560)
Q Consensus 359 ---~~~~e~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~~-~~~l~~~~~~~i~~~ia~ 427 (560)
.|.+|+..+.+++ +...+.+-.++.+ ....+|||||++|+.+.++- ...+. ...+.......++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 2444555544442 3333443344433 45678999999999997642 22110 0012222222333333
Q ss_pred HHHHHHhcCCCCeEEeCCCCCCeEeCCCC----cEEEeeeccccccCC
Q 035761 428 ALSYLHHHCTPPILHRDISSNNILLNSEF----EAFVADFGIARLLNY 471 (560)
Q Consensus 428 ~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg~~~~~~~ 471 (560)
+.. |++|+|++|.||+++.++ .+++.|||++..++.
T Consensus 277 -----f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 -----FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 345 999999999999999988 899999999987753
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.37 E-value=7.3e-14 Score=127.60 Aligned_cols=186 Identities=28% Similarity=0.325 Sum_probs=126.2
Q ss_pred CCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeecccccccc-----------------------ccccccCCCC
Q 035761 21 IPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNG-----------------------SILLGIGSLK 77 (560)
Q Consensus 21 ~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~-----------------------~~~~~~~~l~ 77 (560)
.|-.+.-+.+|+.+.+|.+.-..+ -+....-|.|+++...+..++. .....+....
T Consensus 206 l~f~l~~f~~l~~~~~s~~~~~~i-~~~~~~kptl~t~~v~~s~~~~~~~l~pe~~~~D~~~~E~~t~~G~~~~~~dTWq 284 (490)
T KOG1259|consen 206 LSFNLNAFRNLKTLKFSALSTENI-VDIELLKPTLQTICVHNTTIQDVPSLLPETILADPSGSEPSTSNGSALVSADTWQ 284 (490)
T ss_pred cccchHHhhhhheeeeeccchhhe-eceeecCchhheeeeecccccccccccchhhhcCccCCCCCccCCceEEecchHh
Confidence 344445567777777777643311 1112223566676666654431 1111222345
Q ss_pred CCCEEEeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEcc
Q 035761 78 VLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLG 157 (560)
Q Consensus 78 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 157 (560)
.|++|||++|.|+ .+..+..-+|.++.|++|+|.|... ..+..+++|+.|+||+|.++ .....-..+.+++.|.|+
T Consensus 285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La 360 (490)
T KOG1259|consen 285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLA 360 (490)
T ss_pred hhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehh
Confidence 7888888888888 5666777788888888888888743 33778888888888888888 344455567788888888
Q ss_pred CcccccccchhhccccccceeeccccccCCcC-ccccCCCceeeEEEccCCcccccc
Q 035761 158 NNLLSGSIPSQIGKLQELYYLDLSGNFINGKI-PSQLGEFSCIDTVDLSMNNLSGGI 213 (560)
Q Consensus 158 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~-~~~~~~~~~L~~l~l~~n~l~~~~ 213 (560)
+|.|.. -..+..+-+|..||+++|+|.... ...++++|.|+.+.|.+|++.+..
T Consensus 361 ~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 361 QNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred hhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 888863 245777888888888888886443 346788888888888888887544
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.36 E-value=7e-12 Score=112.57 Aligned_cols=138 Identities=18% Similarity=0.179 Sum_probs=98.5
Q ss_pred ceeeccCCeeEEEEEeCC-------CcEEEEEEccchhhh--------------------hhhHHHHH----HHHHHHhc
Q 035761 321 YCIGTGGYGSVYRARLPS-------GKVVALKKLHRLETE--------------------LASLESFQ----NEARLLSQ 369 (560)
Q Consensus 321 ~~ig~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~--------------------~~~~~~~~----~e~~~l~~ 369 (560)
..||.|.-+.||.|.-.+ +..+|||+++....+ ....+.+. +|...|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997543 479999986532110 01122233 78999988
Q ss_pred cCC--CCcceeeeEEEeCCEEEEEEeccCCCCHH-HHhhcCCcccCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEEeCC
Q 035761 370 IRH--RNIVKLYGFCLHEKCMFLIYEYMEMGSLF-CILRTDEEAVGLDWTKRVNIVKGMAHALSYL-HHHCTPPILHRDI 445 (560)
Q Consensus 370 l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~-~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~ivH~dl 445 (560)
+.. -++.+++++ ...++||||+.++.+. ..++.. .++..+...+..+++.+|..+ |.. ++||||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~----~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA----KLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc----ccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 853 456666654 3468999999765442 122221 255566677889999999999 787 9999999
Q ss_pred CCCCeEeCCCCcEEEeeeccccccC
Q 035761 446 SSNNILLNSEFEAFVADFGIARLLN 470 (560)
Q Consensus 446 k~~Nill~~~~~~kl~Dfg~~~~~~ 470 (560)
++.||+++ ++.+.++|||-+....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999997 4689999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.36 E-value=5.5e-13 Score=117.25 Aligned_cols=124 Identities=32% Similarity=0.377 Sum_probs=36.3
Q ss_pred CCCCCeeeccccccccccccccC-CCCCCCEEEeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccC-CCCCCCcE
Q 035761 52 LTQLTTLAIASNRMNGSILLGIG-SLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSL-GHLTQLTT 129 (560)
Q Consensus 52 l~~L~~L~L~~n~i~~~~~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-~~l~~L~~ 129 (560)
..++++|+|++|+|+.+ ..++ .+.+|+.|+|++|.|+.+ +.+..++.|++|++++|+|+.+ ...+ ..+++|+.
T Consensus 18 ~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i-~~~l~~~lp~L~~ 92 (175)
T PF14580_consen 18 PVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSI-SEGLDKNLPNLQE 92 (175)
T ss_dssp --------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT--E
T ss_pred ccccccccccccccccc--cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCcc-ccchHHhCCcCCE
Confidence 33455555555555532 1232 355666666666666632 2355566666666666666632 2223 24566666
Q ss_pred EECcCCcCcCCC-CccCcCCCCCcEEEccCccccccc---chhhccccccceeec
Q 035761 130 LNMYNNKLDGPI-PPELMNCSKLRILKLGNNLLSGSI---PSQIGKLQELYYLDL 180 (560)
Q Consensus 130 L~l~~n~l~~~~-~~~~~~l~~L~~L~l~~n~l~~~~---~~~~~~l~~L~~L~l 180 (560)
|+|++|+|.... -..+..+++|+.|+|.+|+++... ...+..+|+|+.||-
T Consensus 93 L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 93 LYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp EE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred EECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence 666666665321 134556666666666666665321 123445666666653
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.33 E-value=4.6e-12 Score=113.51 Aligned_cols=130 Identities=22% Similarity=0.217 Sum_probs=95.0
Q ss_pred ceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcc-eeeeEEEeCCEEEEEEeccCCCC
Q 035761 321 YCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIV-KLYGFCLHEKCMFLIYEYMEMGS 399 (560)
Q Consensus 321 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g~ 399 (560)
+.++.|.++.||+++.. +..+++|....... ....+.+|+.+++.+.+.+++ +++.+. .+..++||||+++.+
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~ 77 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE 77 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence 45788999999999875 77899998764321 122456889999988655544 444433 334579999999988
Q ss_pred HHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEEeCCCCCCeEeCCCCcEEEeeeccccc
Q 035761 400 LFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHC--TPPILHRDISSNNILLNSEFEAFVADFGIARL 468 (560)
Q Consensus 400 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 468 (560)
+.+. . .. ...++.+++++++.||... ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus 78 l~~~-~-------~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 78 LLTE-D-------FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc-c-------cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 7543 0 11 1245678999999999872 12369999999999999 66899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.4e-12 Score=114.63 Aligned_cols=105 Identities=33% Similarity=0.416 Sum_probs=22.0
Q ss_pred CCCCEEEeecCccCccCCCCcC-CCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccC-cCCCCCcEE
Q 035761 77 KVLQVLDLSRNEIGGSIPSTLG-HLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPEL-MNCSKLRIL 154 (560)
Q Consensus 77 ~~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-~~l~~L~~L 154 (560)
.++++|+|++|+|+. +. .++ .+.+|+.|+|++|.|+.+ ..+..+++|+.|++++|+|+.+ ...+ ..+++|++|
T Consensus 19 ~~~~~L~L~~n~I~~-Ie-~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i-~~~l~~~lp~L~~L 93 (175)
T PF14580_consen 19 VKLRELNLRGNQIST-IE-NLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSI-SEGLDKNLPNLQEL 93 (175)
T ss_dssp -------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT--EE
T ss_pred ccccccccccccccc-cc-chhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCcc-ccchHHhCCcCCEE
Confidence 344555555555552 21 232 344555555555555422 1344445555555555555432 1122 234455555
Q ss_pred EccCccccccc-chhhccccccceeeccccccC
Q 035761 155 KLGNNLLSGSI-PSQIGKLQELYYLDLSGNFIN 186 (560)
Q Consensus 155 ~l~~n~l~~~~-~~~~~~l~~L~~L~l~~n~l~ 186 (560)
++++|+|.... -..+..+++|++|+|.+|+++
T Consensus 94 ~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 94 YLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp E-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred ECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 55555444211 123334444444444444443
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.2e-12 Score=131.81 Aligned_cols=234 Identities=26% Similarity=0.250 Sum_probs=168.0
Q ss_pred CCcccceeec--cCCeeEEEEEe---CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCEEE
Q 035761 316 DFDIKYCIGT--GGYGSVYRARL---PSGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKCMF 389 (560)
Q Consensus 316 ~~~~~~~ig~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 389 (560)
.|.....+|. |.+|.||.+.. .++..+|+|+-+..-........-.+|....+++ .|++.++....+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3556677899 99999999976 3578899987433222222222334677777777 4999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEEeCCCCCCeEeCCC-CcEEEeeec
Q 035761 390 LIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAH----ALSYLHHHCTPPILHRDISSNNILLNSE-FEAFVADFG 464 (560)
Q Consensus 390 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~----~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg 464 (560)
+-.|++. .++.++.+..... ++.........+... |+.++|.. .++|-|+||.||+...+ ..++++|||
T Consensus 195 iqtE~~~-~sl~~~~~~~~~~--~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPCNF--LPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeecccc-chhHHhhhccccc--CCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcc
Confidence 9999885 6888888764332 555666667777777 99999999 99999999999999999 889999999
Q ss_pred cccccCCCCCCcee-----eccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcc--cccc-----------
Q 035761 465 IARLLNYDSSNRTL-----LAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELL--SSSS----------- 526 (560)
Q Consensus 465 ~~~~~~~~~~~~~~-----~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~--~~~~----------- 526 (560)
+...+....-.... ..|...|++||+..+. ++..+|+||+|.++.|..+|-.++... ..+.
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~ 347 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEF 347 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhh
Confidence 99887654422221 2467789999986654 677899999999999999887664322 1111
Q ss_pred -----cccccccccccccCCCCCCChhHHHhhcee
Q 035761 527 -----SSLDKNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 527 -----~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
..+......+...|+.+|+.++.+....+|
T Consensus 348 ~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i 382 (524)
T KOG0601|consen 348 CEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVI 382 (524)
T ss_pred hcCcchhhhhHHHHhcCcchhhhhHHHHHhccccc
Confidence 112223334445567777777666555443
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.8e-13 Score=123.83 Aligned_cols=179 Identities=26% Similarity=0.254 Sum_probs=138.5
Q ss_pred CCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcce---ecCCc--------------------cccCCCCCCeee
Q 035761 3 RLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLV---GNIPS--------------------NVGHLTQLTTLA 59 (560)
Q Consensus 3 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~---~~~~~--------------------~~~~l~~L~~L~ 59 (560)
-+++|..+.+|.+.-. .+.+....-|.|+++...+..++ ...|. .....+.|++||
T Consensus 212 ~f~~l~~~~~s~~~~~-~i~~~~~~kptl~t~~v~~s~~~~~~~l~pe~~~~D~~~~E~~t~~G~~~~~~dTWq~LtelD 290 (490)
T KOG1259|consen 212 AFRNLKTLKFSALSTE-NIVDIELLKPTLQTICVHNTTIQDVPSLLPETILADPSGSEPSTSNGSALVSADTWQELTELD 290 (490)
T ss_pred Hhhhhheeeeeccchh-heeceeecCchhheeeeecccccccccccchhhhcCccCCCCCccCCceEEecchHhhhhhcc
Confidence 3567888888877644 22233333466777777665443 11111 122346799999
Q ss_pred ccccccccccccccCCCCCCCEEEeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcC
Q 035761 60 IASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDG 139 (560)
Q Consensus 60 L~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 139 (560)
|++|.|+ .+..+..-++.++.|++++|.|+.. +.+..+++|+.||||+|.++ ....+-.++-+++.|.|++|.|..
T Consensus 291 LS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE~ 366 (490)
T KOG1259|consen 291 LSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIET 366 (490)
T ss_pred ccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhhHhh
Confidence 9999998 6677788889999999999999943 34899999999999999998 566777789999999999999985
Q ss_pred CCCccCcCCCCCcEEEccCcccccc-cchhhccccccceeeccccccCCc
Q 035761 140 PIPPELMNCSKLRILKLGNNLLSGS-IPSQIGKLQELYYLDLSGNFINGK 188 (560)
Q Consensus 140 ~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~l~~n~l~~~ 188 (560)
. ..+..+-+|..||+++|+|... ....++++|.|+.|.|.+|++.+.
T Consensus 367 L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 367 L--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred h--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 4 6788889999999999999743 235689999999999999999843
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.29 E-value=4e-13 Score=129.02 Aligned_cols=184 Identities=23% Similarity=0.207 Sum_probs=127.0
Q ss_pred cCCCCCCeeeccccccccccc-cccCCCCCCCEEEeecCccCccC--CCCcCCCCCccEEEccCCCccCCCCcc-CCCCC
Q 035761 50 GHLTQLTTLAIASNRMNGSIL-LGIGSLKVLQVLDLSRNEIGGSI--PSTLGHLKWLRSVDLSQNKLVGPIPSS-LGHLT 125 (560)
Q Consensus 50 ~~l~~L~~L~L~~n~i~~~~~-~~~~~l~~L~~L~l~~n~l~~~~--~~~~~~l~~L~~L~l~~n~l~~~~~~~-~~~l~ 125 (560)
+++.+|+...|.+..+..... .....+++++.|||++|-+.... ......+|+|+.|+|+.|++....... -..++
T Consensus 118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 446677777777776652211 34556777888888887776422 224457788888888888876221111 12467
Q ss_pred CCcEEECcCCcCcCCC-CccCcCCCCCcEEEccCcccccccchhhccccccceeeccccccCCcC-ccccCCCceeeEEE
Q 035761 126 QLTTLNMYNNKLDGPI-PPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKI-PSQLGEFSCIDTVD 203 (560)
Q Consensus 126 ~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~-~~~~~~~~~L~~l~ 203 (560)
.|+.|.|+.|.++... -..+..+|+|+.|+|+.|..-..-.....-+..|+.|||++|++.... -...+.++.|+.|+
T Consensus 198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Ln 277 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLN 277 (505)
T ss_pred hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhh
Confidence 8999999999988322 123557799999999999533344555667889999999999987432 24567899999999
Q ss_pred ccCCcccccc-C--------cccccCCCCcCCCCCCCCc
Q 035761 204 LSMNNLSGGI-P--------VFVRKVPHLDVSGNQFGGE 233 (560)
Q Consensus 204 l~~n~l~~~~-~--------~~~~~l~~l~l~~n~~~~~ 233 (560)
++.+.+...- | ..+.+++.|++..|++...
T Consensus 278 ls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w 316 (505)
T KOG3207|consen 278 LSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDW 316 (505)
T ss_pred ccccCcchhcCCCccchhhhcccccceeeecccCccccc
Confidence 9999887421 2 2457889999999998643
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=6.2e-11 Score=102.37 Aligned_cols=133 Identities=21% Similarity=0.330 Sum_probs=102.7
Q ss_pred eeeccCCeeEEEEEeCCCcEEEEEE-ccchh-----hhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEecc
Q 035761 322 CIGTGGYGSVYRARLPSGKVVALKK-LHRLE-----TELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYM 395 (560)
Q Consensus 322 ~ig~G~~g~Vy~~~~~~~~~vavK~-~~~~~-----~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 395 (560)
.+++|+-+.+|.+.+.+. .+++|. +++.- +..-....-.+|+.++.+++--.|....-+..+.+...++|||+
T Consensus 3 ~i~~GAEa~i~~~~~~g~-~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGL-PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeeccCc-ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 478999999999987543 455553 32221 22223345678999999998777777777777888889999999
Q ss_pred CCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccccc
Q 035761 396 EMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL 469 (560)
Q Consensus 396 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 469 (560)
++..|.+++... ...++..+-.-+.-||.. ||||+|+.++||.+..+. +.++|||++..-
T Consensus 82 ~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 82 EGELLKDALEEA----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred CChhHHHHHHhc----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 999999888754 245677777778889999 999999999999998764 999999999753
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.1e-12 Score=134.63 Aligned_cols=196 Identities=31% Similarity=0.365 Sum_probs=119.5
Q ss_pred CCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEE
Q 035761 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLD 83 (560)
Q Consensus 4 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 83 (560)
+..++.+++..|.|.. +-..+..+.+|+.|++.+|+|..+ ...+..+++|++|+|++|.|+.+ ..+..++.|+.|+
T Consensus 71 l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L~ 146 (414)
T KOG0531|consen 71 LTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKELN 146 (414)
T ss_pred hHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhc-ccchhhhhcchheeccccccccc--cchhhccchhhhe
Confidence 3455566666666663 334466667777777777777633 22266677777777777777643 2345556677777
Q ss_pred eecCccCccCCCCcCCCCCccEEEccCCCccCCCC-ccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccc
Q 035761 84 LSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIP-SSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLS 162 (560)
Q Consensus 84 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 162 (560)
+++|.|+.+ ..+..++.|+.+++++|++..+.+ . ...+.+|+.+++.+|.+... ..+..+..+..+++..|.++
T Consensus 147 l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i~ 221 (414)
T KOG0531|consen 147 LSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNKIS 221 (414)
T ss_pred eccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHhhcccccce
Confidence 777777732 245556777777777777764433 1 45667777777777776633 33444455555567777766
Q ss_pred cccchhhcccc--ccceeeccccccCCcCccccCCCceeeEEEccCCcccc
Q 035761 163 GSIPSQIGKLQ--ELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSG 211 (560)
Q Consensus 163 ~~~~~~~~~l~--~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~ 211 (560)
...+ +..+. .|+.+++++|++. ..+..+..+..+..+++.+|.+..
T Consensus 222 ~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~ 269 (414)
T KOG0531|consen 222 KLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISN 269 (414)
T ss_pred eccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhccccc
Confidence 3322 22222 2677777777776 333555666677777777777664
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.3e-12 Score=132.29 Aligned_cols=219 Identities=29% Similarity=0.325 Sum_probs=165.5
Q ss_pred CCCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCE
Q 035761 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQV 81 (560)
Q Consensus 2 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~ 81 (560)
..+++|+.|++.+|+|..+ ...+..+++|++|+|++|.|+.+ ..+..++.|+.|++++|.|..+ ..+..++.|+.
T Consensus 92 ~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~ 166 (414)
T KOG0531|consen 92 SKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKELNLSGNLISDI--SGLESLKSLKL 166 (414)
T ss_pred ccccceeeeeccccchhhc-ccchhhhhcchheeccccccccc--cchhhccchhhheeccCcchhc--cCCccchhhhc
Confidence 4678999999999999944 44478899999999999999977 5577888899999999999743 45566999999
Q ss_pred EEeecCccCccCC-CCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCC--CcEEEccC
Q 035761 82 LDLSRNEIGGSIP-STLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSK--LRILKLGN 158 (560)
Q Consensus 82 L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~--L~~L~l~~ 158 (560)
+++++|.++...+ . ...+.+|+.+++.+|.+... ..+..+..+..+++..|.++... .+..+.. |+.+++++
T Consensus 167 l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i~~~~--~l~~~~~~~L~~l~l~~ 241 (414)
T KOG0531|consen 167 LDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNKISKLE--GLNELVMLHLRELYLSG 241 (414)
T ss_pred ccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHhhcccccceecc--CcccchhHHHHHHhccc
Confidence 9999999995544 2 57889999999999999833 44556677777799999998542 2333344 89999999
Q ss_pred cccccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCcccccc-------CcccccCCCCcCCCCCCC
Q 035761 159 NLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGI-------PVFVRKVPHLDVSGNQFG 231 (560)
Q Consensus 159 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~-------~~~~~~l~~l~l~~n~~~ 231 (560)
|.+. ..+..+..+..+..|++++|++.... .+.....+..+.+..|++.... -.....+..+.+.+|+..
T Consensus 242 n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (414)
T KOG0531|consen 242 NRIS-RSPEGLENLKNLPVLDLSSNRISNLE--GLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIR 318 (414)
T ss_pred Cccc-cccccccccccccccchhhccccccc--cccccchHHHhccCcchhcchhhhhccccccccccccccccccCccc
Confidence 9998 44467788899999999999987432 2345556667777777766221 112245556667777665
Q ss_pred Cc
Q 035761 232 GE 233 (560)
Q Consensus 232 ~~ 233 (560)
..
T Consensus 319 ~~ 320 (414)
T KOG0531|consen 319 KI 320 (414)
T ss_pred cc
Confidence 43
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.3e-10 Score=108.96 Aligned_cols=143 Identities=20% Similarity=0.249 Sum_probs=109.3
Q ss_pred ceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCC--CcceeeeEEEeCC---EEEEEEecc
Q 035761 321 YCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHR--NIVKLYGFCLHEK---CMFLIYEYM 395 (560)
Q Consensus 321 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~~---~~~lv~e~~ 395 (560)
+.++.|.++.||++...+|+.+++|........ .....+..|.++++.+++. .+.+++.+..... ..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 458999999999998877789999987643321 1234678899999999753 4566777766542 568999999
Q ss_pred CCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 035761 396 EMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHC--------------------------------------- 436 (560)
Q Consensus 396 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--------------------------------------- 436 (560)
+++++.+.+.. ..++..++..++.++++++..||+..
T Consensus 83 ~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 83 DGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99888765532 12677788888899999999888521
Q ss_pred --------------CCCeEEeCCCCCCeEeCC--CCcEEEeeeccccc
Q 035761 437 --------------TPPILHRDISSNNILLNS--EFEAFVADFGIARL 468 (560)
Q Consensus 437 --------------~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~~~~ 468 (560)
...++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246799999999999998 56688999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.18 E-value=3.8e-10 Score=97.00 Aligned_cols=146 Identities=19% Similarity=0.276 Sum_probs=107.1
Q ss_pred ccceeeccCCeeEEEEEeCCCcEEEEE-Eccchh-----hhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 319 IKYCIGTGGYGSVYRARLPSGKVVALK-KLHRLE-----TELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 319 ~~~~ig~G~~g~Vy~~~~~~~~~vavK-~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
....+-+|+-+.|+++.+. |+...|| ++.+.- +..-..+...+|+..+.+++--.|....-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4567899999999999985 6666665 333221 22223456778999999987666665555666666678999
Q ss_pred eccCC-CCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCc---EEEeeeccccc
Q 035761 393 EYMEM-GSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFE---AFVADFGIARL 468 (560)
Q Consensus 393 e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg~~~~ 468 (560)
||+++ .++.+++...-.... +......++.+|-+.+.-||.+ ++||+||..+||++..++. +.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~-~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDES-EDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcc-cchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 477888766443322 2223367899999999999999 9999999999999976543 57999999865
Q ss_pred c
Q 035761 469 L 469 (560)
Q Consensus 469 ~ 469 (560)
-
T Consensus 166 s 166 (229)
T KOG3087|consen 166 S 166 (229)
T ss_pred c
Confidence 3
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.14 E-value=2e-11 Score=123.16 Aligned_cols=234 Identities=21% Similarity=0.198 Sum_probs=164.9
Q ss_pred HHHhcCCcccceeeccCCeeEEEEEe--CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCE
Q 035761 311 IEATEDFDIKYCIGTGGYGSVYRARL--PSGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKC 387 (560)
Q Consensus 311 ~~~~~~~~~~~~ig~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 387 (560)
.....+|.....||.|.|+.|++... .++..+++|..............-..|+.+...+ -|.+++..+..+.....
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 34456788899999999999999864 3577889987765442222222223455555555 58888888888877777
Q ss_pred EEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCC-CcEEEeeeccc
Q 035761 388 MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSE-FEAFVADFGIA 466 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~~ 466 (560)
.++--||+++++....... ...++...++++..|++.++.++|+. .++|+|+||+||++..+ +..+++|||.+
T Consensus 341 ~~ip~e~~~~~s~~l~~~~---~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVT---SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred ccCchhhhcCcchhhhhHH---HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccc
Confidence 8899999999998766633 23378888999999999999999998 99999999999999886 77889999998
Q ss_pred cccCCCCCCceeeccccCcc--CccccccCccCcchhHHHHHHHHHHHHhCCCC-CCcccc-------------cccccc
Q 035761 467 RLLNYDSSNRTLLAGTYGSI--APELAYTMVVTEKYDVYSFGVVALEVLMGKHP-GELLSS-------------SSSSLD 530 (560)
Q Consensus 467 ~~~~~~~~~~~~~~g~~~~~--aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P-~~~~~~-------------~~~~~~ 530 (560)
..+.-.. ....+.-+++ +|+......+..+.|+||||.-+.|.++|..- +....+ ...++.
T Consensus 415 t~~~~~~---~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i~~~~~p~~~~~~~~~q 491 (524)
T KOG0601|consen 415 TRLAFSS---GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTIRSGDTPNLPGLKLQLQ 491 (524)
T ss_pred cccceec---ccccccccccccchhhccccccccccccccccccccccccCcccCcccccceeeecccccCCCchHHhhh
Confidence 7532111 1111222344 56666677788899999999999999998733 221111 112333
Q ss_pred cccccccccCCCCCCChhHHHhh
Q 035761 531 KNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 531 ~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
...+.+...|+..+|-+.++..+
T Consensus 492 ~~~kv~~~~~~~~~~l~~~l~~~ 514 (524)
T KOG0601|consen 492 VLLKVMINPDRKRRPSAVELSLH 514 (524)
T ss_pred hhhhhhcCCccccchhhhhhccc
Confidence 44455555677777776665544
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=99.12 E-value=5.9e-11 Score=85.92 Aligned_cols=61 Identities=33% Similarity=0.481 Sum_probs=35.0
Q ss_pred CCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeecccccc
Q 035761 5 RNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRM 65 (560)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i 65 (560)
++|++|++++|+|+.+.++.|.++++|++|++++|.|+.+.|+.|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 3455566666655555555555566666666666665555555555555555555555543
|
... |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=2.5e-12 Score=120.41 Aligned_cols=209 Identities=23% Similarity=0.269 Sum_probs=150.6
Q ss_pred CCCCCCCEEEccCCcCc---ccCCC-------CCCCcCCCCEEEccCCcceecCCcc----ccCCCCCCeeecccccccc
Q 035761 2 GRLRNLVHLDLSDNHFM---GHIPP-------TLGRLSELKILNLSLNSLVGNIPSN----VGHLTQLTTLAIASNRMNG 67 (560)
Q Consensus 2 ~~l~~L~~L~L~~n~l~---~~~~~-------~~~~l~~L~~L~L~~N~i~~~~~~~----~~~l~~L~~L~L~~n~i~~ 67 (560)
++.++|+..++|+--.. ..+|+ ++...++|++||||+|-+...-+.. +.++..|++|.|.+|.+..
T Consensus 55 ~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~ 134 (382)
T KOG1909|consen 55 ASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGP 134 (382)
T ss_pred hhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCCh
Confidence 45567888888764321 22332 3445678999999999886433333 4667889999999998753
Q ss_pred ccc-------------cccCCCCCCCEEEeecCccCcc----CCCCcCCCCCccEEEccCCCccC----CCCccCCCCCC
Q 035761 68 SIL-------------LGIGSLKVLQVLDLSRNEIGGS----IPSTLGHLKWLRSVDLSQNKLVG----PIPSSLGHLTQ 126 (560)
Q Consensus 68 ~~~-------------~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~----~~~~~~~~l~~ 126 (560)
... .....-+.|+++..++|++... +...|...+.|+.+.++.|.|.. .+...|..+++
T Consensus 135 ~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~ 214 (382)
T KOG1909|consen 135 EAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPH 214 (382)
T ss_pred hHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCc
Confidence 221 2234557899999999998842 23356677899999999998862 23346788999
Q ss_pred CcEEECcCCcCcCC----CCccCcCCCCCcEEEccCcccccccchhh-----ccccccceeeccccccCCc----Ccccc
Q 035761 127 LTTLNMYNNKLDGP----IPPELMNCSKLRILKLGNNLLSGSIPSQI-----GKLQELYYLDLSGNFINGK----IPSQL 193 (560)
Q Consensus 127 L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-----~~l~~L~~L~l~~n~l~~~----~~~~~ 193 (560)
|+.|+|..|-++.. +...+..+++|++|++++|.++......| ...|+|++|.|.+|.|+.. +....
T Consensus 215 LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~ 294 (382)
T KOG1909|consen 215 LEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACM 294 (382)
T ss_pred ceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHH
Confidence 99999999988732 34567788899999999999986555443 2578999999999999643 23345
Q ss_pred CCCceeeEEEccCCccc
Q 035761 194 GEFSCIDTVDLSMNNLS 210 (560)
Q Consensus 194 ~~~~~L~~l~l~~n~l~ 210 (560)
...+.|..|+|++|.+.
T Consensus 295 ~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 295 AEKPDLEKLNLNGNRLG 311 (382)
T ss_pred hcchhhHHhcCCccccc
Confidence 56889999999999984
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=99.09 E-value=9.7e-11 Score=84.78 Aligned_cols=61 Identities=31% Similarity=0.408 Sum_probs=36.8
Q ss_pred CCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEeecCcc
Q 035761 29 SELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEI 89 (560)
Q Consensus 29 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~l 89 (560)
|+|++|++++|+|+.+.++.|.++++|++|++++|+++.+.+..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 3556666666666655555666666666666666666655555666666666666666553
|
... |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.98 E-value=5.5e-09 Score=93.63 Aligned_cols=128 Identities=26% Similarity=0.330 Sum_probs=83.3
Q ss_pred eEEEEEeCCCcEEEEEEccchhh------------------------hhhhHHHHHHHHHHHhccCCC--CcceeeeEEE
Q 035761 330 SVYRARLPSGKVVALKKLHRLET------------------------ELASLESFQNEARLLSQIRHR--NIVKLYGFCL 383 (560)
Q Consensus 330 ~Vy~~~~~~~~~vavK~~~~~~~------------------------~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~ 383 (560)
.||.|...+|..+|||..+.... .........+|.+.|.++... ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 38999988999999998643210 011123467899999999766 455665442
Q ss_pred eCCEEEEEEeccC--CCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHH-HHhcCCCCeEEeCCCCCCeEeCCCCcEEE
Q 035761 384 HEKCMFLIYEYME--MGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSY-LHHHCTPPILHRDISSNNILLNSEFEAFV 460 (560)
Q Consensus 384 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~-LH~~~~~~ivH~dlk~~Nill~~~~~~kl 460 (560)
...+||||++ +..+..+.... ++..+...++.+++..+.. +|.. |++|+|+.+.||+++++ .+.+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEE
Confidence 2469999998 55554433321 2234456678888886655 4677 99999999999999887 9999
Q ss_pred eeeccccccC
Q 035761 461 ADFGIARLLN 470 (560)
Q Consensus 461 ~Dfg~~~~~~ 470 (560)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999887643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.3e-08 Score=96.82 Aligned_cols=142 Identities=19% Similarity=0.107 Sum_probs=99.6
Q ss_pred eeeccCCeeEEEEEeCCCcEEEEEEccchhhhh---------hhHHHHHHHHHHHhccCCCC--cceeeeEEEe-----C
Q 035761 322 CIGTGGYGSVYRARLPSGKVVALKKLHRLETEL---------ASLESFQNEARLLSQIRHRN--IVKLYGFCLH-----E 385 (560)
Q Consensus 322 ~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~-----~ 385 (560)
.+-......|+++.+ +|+.+.||+........ .....+.+|...+.++...+ +.+++++... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 344444445777766 57889999774332110 01113678888888874333 3445556543 2
Q ss_pred CEEEEEEeccCCC-CHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCC-------CCc
Q 035761 386 KCMFLIYEYMEMG-SLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNS-------EFE 457 (560)
Q Consensus 386 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-------~~~ 457 (560)
...++|+|++++. +|.+++.... ....+......++.+++..+.-||.. ||+|+|++++|||++. ++.
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCce
Confidence 3478999999986 7888875321 11245667778999999999999999 9999999999999975 467
Q ss_pred EEEeeeccccc
Q 035761 458 AFVADFGIARL 468 (560)
Q Consensus 458 ~kl~Dfg~~~~ 468 (560)
+.++||+.++.
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 89999998864
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=2e-11 Score=124.24 Aligned_cols=181 Identities=27% Similarity=0.340 Sum_probs=99.3
Q ss_pred CCCCCCcCCCCEEEccCCcceecCCccccCC-CCCCeeecccc--ccccccc---cccCC---CCCCCEEEeecCccCcc
Q 035761 22 PPTLGRLSELKILNLSLNSLVGNIPSNVGHL-TQLTTLAIASN--RMNGSIL---LGIGS---LKVLQVLDLSRNEIGGS 92 (560)
Q Consensus 22 ~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l-~~L~~L~L~~n--~i~~~~~---~~~~~---l~~L~~L~l~~n~l~~~ 92 (560)
|-.+..+..|++|.|.++.|.. ...+..+ .+|+.|.-.+. .+..++. ..+.+ ...|.+.+.++|.+. .
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC~~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~-~ 178 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLICHNSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV-L 178 (1096)
T ss_pred CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhhhccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH-h
Confidence 3445566777777777777752 1112111 23444433221 0110111 11111 134566666777776 4
Q ss_pred CCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCc-cCcCCCCCcEEEccCcccccccchhhcc
Q 035761 93 IPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPP-ELMNCSKLRILKLGNNLLSGSIPSQIGK 171 (560)
Q Consensus 93 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 171 (560)
...++.-++.|+.|+|++|+++.. +.+..|+.|++|||+.|.++ .+|. ....+. |..|.+++|.++.. ..+.+
T Consensus 179 mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lrnN~l~tL--~gie~ 252 (1096)
T KOG1859|consen 179 MDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLRNNALTTL--RGIEN 252 (1096)
T ss_pred HHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhh-heeeeecccHHHhh--hhHHh
Confidence 555666667777777777777633 25666777777777777776 3332 233333 77777777777622 34566
Q ss_pred ccccceeeccccccCCcC-ccccCCCceeeEEEccCCcccc
Q 035761 172 LQELYYLDLSGNFINGKI-PSQLGEFSCIDTVDLSMNNLSG 211 (560)
Q Consensus 172 l~~L~~L~l~~n~l~~~~-~~~~~~~~~L~~l~l~~n~l~~ 211 (560)
+.+|+.||+++|-|.+-- -..+..+..|+.|+|.+|++.+
T Consensus 253 LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 253 LKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred hhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 667777777777665321 1234455666777777777764
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.87 E-value=4.6e-10 Score=119.42 Aligned_cols=205 Identities=21% Similarity=0.233 Sum_probs=142.7
Q ss_pred HhcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEE
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFL 390 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 390 (560)
..+.+...+.+.+|+++.++-+.-. .|...+.|....... .....+....+-.+.-..++|-+++..-.+.-....+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 3456666777889999999877532 233333332221110 01112222333333333456766665555445567899
Q ss_pred EEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccC
Q 035761 391 IYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN 470 (560)
Q Consensus 391 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 470 (560)
|++|..+++|...++..+. .+..-....+..+..+.+|||.. .+.|||++|.|.++..++..+++|||......
T Consensus 882 ~~~~~~~~~~~Skl~~~~~---~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGC---LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hhHHhccCCchhhhhcCCC---cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccc
Confidence 9999999999999987653 45555556677788999999997 69999999999999999999999998433211
Q ss_pred C------C---------------C----------CCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCC
Q 035761 471 Y------D---------------S----------SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPG 519 (560)
Q Consensus 471 ~------~---------------~----------~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~ 519 (560)
. . . .......||+.|.|||...+......+|+|+.|++++|.++|..||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 0 0 0 0011245899999999999999999999999999999999999999
Q ss_pred Cccc
Q 035761 520 ELLS 523 (560)
Q Consensus 520 ~~~~ 523 (560)
....
T Consensus 1036 na~t 1039 (1205)
T KOG0606|consen 1036 NAET 1039 (1205)
T ss_pred CCcc
Confidence 7443
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.1e-10 Score=105.67 Aligned_cols=229 Identities=17% Similarity=0.184 Sum_probs=163.8
Q ss_pred CCCCCEEEccCCcCccc----CCCCCCCcCCCCEEEccCCcce---ec-------CCccccCCCCCCeeecccccccccc
Q 035761 4 LRNLVHLDLSDNHFMGH----IPPTLGRLSELKILNLSLNSLV---GN-------IPSNVGHLTQLTTLAIASNRMNGSI 69 (560)
Q Consensus 4 l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~i~---~~-------~~~~~~~l~~L~~L~L~~n~i~~~~ 69 (560)
+..++.+|||+|.|... +...+.+-.+|+..++++--.. .. +-.++-.+++|+..+||+|.+....
T Consensus 29 ~d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDNAfg~~~ 108 (388)
T COG5238 29 MDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNAFGSEF 108 (388)
T ss_pred hcceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhhhcccHHHHHHHHHHHHHHHhcCCcceeeeccccccCccc
Confidence 56789999999999753 3445666788999999874221 22 2345677899999999999987655
Q ss_pred cc----ccCCCCCCCEEEeecCccCccCCCC-------------cCCCCCccEEEccCCCccCCC----CccCCCCCCCc
Q 035761 70 LL----GIGSLKVLQVLDLSRNEIGGSIPST-------------LGHLKWLRSVDLSQNKLVGPI----PSSLGHLTQLT 128 (560)
Q Consensus 70 ~~----~~~~l~~L~~L~l~~n~l~~~~~~~-------------~~~l~~L~~L~l~~n~l~~~~----~~~~~~l~~L~ 128 (560)
|. .++.-+.|+.|.|++|.+......- ..+-|.|+..+...|++..-. ...+..-.+|+
T Consensus 109 ~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nKKaa~kp~Le~vicgrNRlengs~~~~a~~l~sh~~lk 188 (388)
T COG5238 109 PEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAADKPKLEVVICGRNRLENGSKELSAALLESHENLK 188 (388)
T ss_pred chHHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHhhhccCCCceEEEeccchhccCcHHHHHHHHHhhcCce
Confidence 54 3456689999999999988332221 234578999999999997321 12334446899
Q ss_pred EEECcCCcCcCC-----CCccCcCCCCCcEEEccCcccccc----cchhhccccccceeeccccccCCcCcccc------
Q 035761 129 TLNMYNNKLDGP-----IPPELMNCSKLRILKLGNNLLSGS----IPSQIGKLQELYYLDLSGNFINGKIPSQL------ 193 (560)
Q Consensus 129 ~L~l~~n~l~~~-----~~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~~~~~~------ 193 (560)
.+.+..|.|.-. .-..+..+.+|+.|||++|-++.. +...+..++.|+.|.+.+|-++.....++
T Consensus 189 ~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~lrEL~lnDClls~~G~~~v~~~f~e 268 (388)
T COG5238 189 EVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLRELRLNDCLLSNEGVKSVLRRFNE 268 (388)
T ss_pred eEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchhhhccccchhhccccHHHHHHHhhh
Confidence 999999988721 112356778999999999999843 34556788999999999999976654432
Q ss_pred CCCceeeEEEccCCccccccCcc--c--------ccCCCCcCCCCCCCC
Q 035761 194 GEFSCIDTVDLSMNNLSGGIPVF--V--------RKVPHLDVSGNQFGG 232 (560)
Q Consensus 194 ~~~~~L~~l~l~~n~l~~~~~~~--~--------~~l~~l~l~~n~~~~ 232 (560)
...++|..|...+|...+.+-.. + +-+..+.+.||.+..
T Consensus 269 ~~~p~l~~L~~~Yne~~~~~i~~~~l~~~e~~~~p~L~~le~ngNr~~E 317 (388)
T COG5238 269 KFVPNLMPLPGDYNERRGGIILDISLNEFEQDAVPLLVDLERNGNRIKE 317 (388)
T ss_pred hcCCCccccccchhhhcCceeeeechhhhhhcccHHHHHHHHccCcchh
Confidence 24688999999999887655432 2 223345677887764
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.84 E-value=3.1e-11 Score=122.82 Aligned_cols=175 Identities=30% Similarity=0.264 Sum_probs=126.4
Q ss_pred CCCCCCCEEEccCCcCcccCCCCCCCc-CCCCEEEccCCcce----------ecCCccccCCCCCCeeeccccccccccc
Q 035761 2 GRLRNLVHLDLSDNHFMGHIPPTLGRL-SELKILNLSLNSLV----------GNIPSNVGHLTQLTTLAIASNRMNGSIL 70 (560)
Q Consensus 2 ~~l~~L~~L~L~~n~l~~~~~~~~~~l-~~L~~L~L~~N~i~----------~~~~~~~~~l~~L~~L~L~~n~i~~~~~ 70 (560)
..++.|+.|.|.++.|.. . ..+..+ ..|+.|--+ |.+. +.+.+++. ...|.+.+.+.|.+. ...
T Consensus 106 fpF~sLr~LElrg~~L~~-~-~GL~~lr~qLe~LIC~-~Sl~Al~~v~ascggd~~ns~~-Wn~L~~a~fsyN~L~-~mD 180 (1096)
T KOG1859|consen 106 FPFRSLRVLELRGCDLST-A-KGLQELRHQLEKLICH-NSLDALRHVFASCGGDISNSPV-WNKLATASFSYNRLV-LMD 180 (1096)
T ss_pred ccccceeeEEecCcchhh-h-hhhHHHHHhhhhhhhh-ccHHHHHHHHHHhccccccchh-hhhHhhhhcchhhHH-hHH
Confidence 457899999999999973 1 112222 335555333 3332 11111111 245888889999988 677
Q ss_pred cccCCCCCCCEEEeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCC
Q 035761 71 LGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSK 150 (560)
Q Consensus 71 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 150 (560)
..+.-++.|+.|+|++|+++.. +.+..++.|++|||+.|.+....--....+. |+.|.|++|.++.. ..+.++.+
T Consensus 181 ~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~tL--~gie~Lks 255 (1096)
T KOG1859|consen 181 ESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALTTL--RGIENLKS 255 (1096)
T ss_pred HHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-heeeeecccHHHhh--hhHHhhhh
Confidence 7788889999999999999843 3788999999999999999844333444554 99999999999854 56788999
Q ss_pred CcEEEccCcccccc-cchhhccccccceeeccccccC
Q 035761 151 LRILKLGNNLLSGS-IPSQIGKLQELYYLDLSGNFIN 186 (560)
Q Consensus 151 L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~l~~n~l~ 186 (560)
|+.||+++|-|.+. --..++.+..|+.|+|.||++-
T Consensus 256 L~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 256 LYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred hhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 99999999988753 2234677889999999999985
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.81 E-value=5.2e-08 Score=96.71 Aligned_cols=169 Identities=18% Similarity=0.276 Sum_probs=126.2
Q ss_pred CCeeEEEEE-eCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEe----CCEEEEEEeccCC-CCH
Q 035761 327 GYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLH----EKCMFLIYEYMEM-GSL 400 (560)
Q Consensus 327 ~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-g~L 400 (560)
...+.||+. ..+|..++.|+++..... ....-..-+++.+++.|+|+|++..++.. +...++||+|.|+ ++|
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~--~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQ--STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred ccceeEeeeeccCCceeeeeeecccccc--CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 346789986 457999999999543321 11122345788899999999999998863 4468999999987 567
Q ss_pred HHHhhcCC------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccc
Q 035761 401 FCILRTDE------------EAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARL 468 (560)
Q Consensus 401 ~~~l~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 468 (560)
.++.-... .....++..+..++.|++.||.++|+. |..-+-+.+++|+++.+.+++|+..|....
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dv 442 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDV 442 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceee
Confidence 66543221 123477889999999999999999999 999999999999999999999988887765
Q ss_pred cCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCC
Q 035761 469 LNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKH 517 (560)
Q Consensus 469 ~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~ 517 (560)
+..+.. |.+. .-.+-|.-.+|.++..|.||..
T Consensus 443 l~~d~~--------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 443 LQEDPT--------------EPLE---SQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred ecCCCC--------------cchh---HHhhhhHHHHHHHHHHHhhccc
Confidence 543320 1111 1135789999999999999964
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.78 E-value=6e-08 Score=89.25 Aligned_cols=138 Identities=25% Similarity=0.253 Sum_probs=96.6
Q ss_pred CcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhh--------------------hhhHHHHHHHHHHHhccCCC--C
Q 035761 317 FDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETE--------------------LASLESFQNEARLLSQIRHR--N 374 (560)
Q Consensus 317 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------~~~~~~~~~e~~~l~~l~h~--n 374 (560)
..+...||.|.-+.||.|..++|.++|||.=+...++ ........+|.+.|.++.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 3456789999999999999999999999942211110 11123467899999998654 6
Q ss_pred cceeeeEEEeCCEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCC
Q 035761 375 IVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNS 454 (560)
Q Consensus 375 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~ 454 (560)
|.+.+++- ...+||||+++-.|...- ++....-.++..|++-+.-.-.. |+||+|+.+-||++++
T Consensus 173 VP~P~~~n----RHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAWN----RHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCccccc----cceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence 77766543 357999999986654322 12233344555555555444455 9999999999999999
Q ss_pred CCcEEEeeecccccc
Q 035761 455 EFEAFVADFGIARLL 469 (560)
Q Consensus 455 ~~~~kl~Dfg~~~~~ 469 (560)
||.+.++||--+...
T Consensus 238 dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 238 DGDIVVIDWPQAVPI 252 (304)
T ss_pred CCCEEEEeCcccccC
Confidence 999999999765543
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.78 E-value=6.6e-10 Score=102.00 Aligned_cols=183 Identities=21% Similarity=0.200 Sum_probs=93.4
Q ss_pred cCCCCEEEccCCcce--ecCCccccCCCCCCeeecccccccccccccc-CCCCCCCEEEeecCccCc-cCCCCcCCCCCc
Q 035761 28 LSELKILNLSLNSLV--GNIPSNVGHLTQLTTLAIASNRMNGSILLGI-GSLKVLQVLDLSRNEIGG-SIPSTLGHLKWL 103 (560)
Q Consensus 28 l~~L~~L~L~~N~i~--~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~-~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L 103 (560)
.+.++.|||.+|.|+ +.+...+.++|.|++|+|+.|++...+ +.+ ..+.+|++|.|.+..+.- .....+..+|.+
T Consensus 70 ~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I-~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~v 148 (418)
T KOG2982|consen 70 VTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDI-KSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKV 148 (418)
T ss_pred hhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCcc-ccCcccccceEEEEEcCCCCChhhhhhhhhcchhh
Confidence 355666777777666 233334566667777777777665322 222 345566666666666552 122344566666
Q ss_pred cEEEccCCCccCC--CCccCCCC-CCCcEEECcCCcCcC--CCCccCcCCCCCcEEEccCcccccc-cchhhccccccce
Q 035761 104 RSVDLSQNKLVGP--IPSSLGHL-TQLTTLNMYNNKLDG--PIPPELMNCSKLRILKLGNNLLSGS-IPSQIGKLQELYY 177 (560)
Q Consensus 104 ~~L~l~~n~l~~~--~~~~~~~l-~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~ 177 (560)
++|.+|.|.+... ........ +.+.+|++-.|...- ....--.-+|++..+-+..|.+... ....+..+|.+-.
T Consensus 149 telHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~ 228 (418)
T KOG2982|consen 149 TELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIFPNVNSVFVCEGPLKTESSEKGSEPFPSLSC 228 (418)
T ss_pred hhhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhhcccchheeeecCcccchhhcccCCCCCcchh
Confidence 6666666643311 11111111 233333333332110 0000111235666666666666532 2233445566666
Q ss_pred eeccccccCC-cCccccCCCceeeEEEccCCcccc
Q 035761 178 LDLSGNFING-KIPSQLGEFSCIDTVDLSMNNLSG 211 (560)
Q Consensus 178 L~l~~n~l~~-~~~~~~~~~~~L~~l~l~~n~l~~ 211 (560)
|+|+.|+|.. .--+.+..++.|..|.+++|++..
T Consensus 229 LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d 263 (418)
T KOG2982|consen 229 LNLGANNIDSWASVDALNGFPQLVDLRVSENPLSD 263 (418)
T ss_pred hhhcccccccHHHHHHHcCCchhheeeccCCcccc
Confidence 7777777743 223456667777777777776654
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.77 E-value=3.4e-09 Score=116.37 Aligned_cols=104 Identities=31% Similarity=0.410 Sum_probs=50.9
Q ss_pred CCCEEEccCCc--CcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEE
Q 035761 6 NLVHLDLSDNH--FMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLD 83 (560)
Q Consensus 6 ~L~~L~L~~n~--l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 83 (560)
+|++|-+.+|. +..+..+.|..++.|++|||++|.=-+.+|..++.+-+|+.|+|++..++ .+|..+.+|..|.+|+
T Consensus 546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Ln 624 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLN 624 (889)
T ss_pred ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheec
Confidence 45555555553 33233333445555555555554333345555555555555555555554 4455555555555555
Q ss_pred eecCccCccCCCCcCCCCCccEEEccC
Q 035761 84 LSRNEIGGSIPSTLGHLKWLRSVDLSQ 110 (560)
Q Consensus 84 l~~n~l~~~~~~~~~~l~~L~~L~l~~ 110 (560)
+..+.-...+|.....|.+|++|.+..
T Consensus 625 l~~~~~l~~~~~i~~~L~~Lr~L~l~~ 651 (889)
T KOG4658|consen 625 LEVTGRLESIPGILLELQSLRVLRLPR 651 (889)
T ss_pred cccccccccccchhhhcccccEEEeec
Confidence 555443333344444455555555443
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.73 E-value=4.9e-09 Score=115.20 Aligned_cols=201 Identities=25% Similarity=0.300 Sum_probs=111.7
Q ss_pred CCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCc--ceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEE
Q 035761 5 RNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNS--LVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVL 82 (560)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~--i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 82 (560)
..++...+-+|.+. .++.... .++|++|-+..|. +..+..+.|..++.|++|||++|.=-+.+|..+++|-+|++|
T Consensus 523 ~~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL 600 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYL 600 (889)
T ss_pred hheeEEEEeccchh-hccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcc
Confidence 34566666666665 3333322 2367777777775 443444446667777777777765555677777777777777
Q ss_pred EeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcC--cCCCCccCcCCCCCcEEEccCcc
Q 035761 83 DLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKL--DGPIPPELMNCSKLRILKLGNNL 160 (560)
Q Consensus 83 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l--~~~~~~~~~~l~~L~~L~l~~n~ 160 (560)
+|++..++ .+|..+.++..|.+|++..+.-...+|.....+++|++|.+..-.. ....-..+..+.+|+.+......
T Consensus 601 ~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s 679 (889)
T KOG4658|consen 601 DLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISS 679 (889)
T ss_pred cccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecch
Confidence 77777777 5677777777777777776665445566666677777777654432 12222334445555555543333
Q ss_pred cccccchhhccccccc----eeeccccccCCcCccccCCCceeeEEEccCCcccc
Q 035761 161 LSGSIPSQIGKLQELY----YLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSG 211 (560)
Q Consensus 161 l~~~~~~~~~~l~~L~----~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~ 211 (560)
. .+-..+..+..|. .+.+.++... ..+..+..+.+|+.|.+.++....
T Consensus 680 ~--~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e 731 (889)
T KOG4658|consen 680 V--LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISE 731 (889)
T ss_pred h--HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCch
Confidence 2 1111222333333 2222222222 334455566666666666666553
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.6e-07 Score=91.03 Aligned_cols=195 Identities=15% Similarity=0.204 Sum_probs=128.2
Q ss_pred cccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEE------eC-CEEE
Q 035761 318 DIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCL------HE-KCMF 389 (560)
Q Consensus 318 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~------~~-~~~~ 389 (560)
...+.+|+|+.+.+|-.--- +.. +-|++...... .. .+..++|... .||-+-.-+.|-. ++ ....
T Consensus 14 ~~gr~LgqGgea~ly~l~e~-~d~-VAKIYh~Pppa--~~---aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG 86 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV-RDQ-VAKIYHAPPPA--AQ---AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG 86 (637)
T ss_pred CCCccccCCccceeeecchh-hch-hheeecCCCch--HH---HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence 44667999999999974211 122 34666543321 11 1223344444 6775433122211 11 2255
Q ss_pred EEEeccCCCC-HHHHhhcC---CcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecc
Q 035761 390 LIYEYMEMGS-LFCILRTD---EEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGI 465 (560)
Q Consensus 390 lv~e~~~~g~-L~~~l~~~---~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 465 (560)
+.|..+++.- ...+.... ..-...+|.-.++.++.+|.+.+-||+. |.+-+|+.++|+|+++++.+.+.|-..
T Consensus 87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccc
Confidence 6777776632 22333211 1112388999999999999999999999 999999999999999999999998654
Q ss_pred ccccCCCCCCceeeccccCccCcccc-----ccCccCcchhHHHHHHHHHHHHhC-CCCCCccc
Q 035761 466 ARLLNYDSSNRTLLAGTYGSIAPELA-----YTMVVTEKYDVYSFGVVALEVLMG-KHPGELLS 523 (560)
Q Consensus 466 ~~~~~~~~~~~~~~~g~~~~~aPE~~-----~~~~~~~~~Dv~s~G~il~el~~g-~~P~~~~~ 523 (560)
-... ..+......+|...|.+||.- .+..-+...|-|-+|+++++++.| +.||...-
T Consensus 164 fqi~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~ 226 (637)
T COG4248 164 FQIN-ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIP 226 (637)
T ss_pred eeec-cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccc
Confidence 3332 233334456788999999963 355567789999999999999875 99996544
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.73 E-value=8.2e-10 Score=101.40 Aligned_cols=185 Identities=18% Similarity=0.151 Sum_probs=127.7
Q ss_pred CCCCCEEEccCCcCcc--cCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccc-cccccCCCCCCC
Q 035761 4 LRNLVHLDLSDNHFMG--HIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGS-ILLGIGSLKVLQ 80 (560)
Q Consensus 4 l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~-~~~~~~~l~~L~ 80 (560)
.+.++.|||.+|.|+. .+...+.++|.|+.|+|+.|++...+...-..+.+|++|-|.+..+... ....+..++.++
T Consensus 70 ~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vt 149 (418)
T KOG2982|consen 70 VTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVT 149 (418)
T ss_pred hhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhh
Confidence 4578999999999983 4455578999999999999999844333225678999999999988743 445567889999
Q ss_pred EEEeecCccCccC--CCCcC-CCCCccEEEccCCCccC--CCCccCCCCCCCcEEECcCCcCcCCC-CccCcCCCCCcEE
Q 035761 81 VLDLSRNEIGGSI--PSTLG-HLKWLRSVDLSQNKLVG--PIPSSLGHLTQLTTLNMYNNKLDGPI-PPELMNCSKLRIL 154 (560)
Q Consensus 81 ~L~l~~n~l~~~~--~~~~~-~l~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L 154 (560)
.|+++.|++.... .+-.. --+.+++|.+..|.... .....-.-++++..+.+..|.++... .+.+..++.+..|
T Consensus 150 elHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~L 229 (418)
T KOG2982|consen 150 ELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIFPNVNSVFVCEGPLKTESSEKGSEPFPSLSCL 229 (418)
T ss_pred hhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhhcccchheeeecCcccchhhcccCCCCCcchhh
Confidence 9999999655211 11111 11234444444443220 00001112467788888899887443 3467778888999
Q ss_pred EccCcccccc-cchhhccccccceeeccccccCCc
Q 035761 155 KLGNNLLSGS-IPSQIGKLQELYYLDLSGNFINGK 188 (560)
Q Consensus 155 ~l~~n~l~~~-~~~~~~~l~~L~~L~l~~n~l~~~ 188 (560)
+|+.|+|..- .-+.+.+++.|..|.+++|++...
T Consensus 230 nL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~ 264 (418)
T KOG2982|consen 230 NLGANNIDSWASVDALNGFPQLVDLRVSENPLSDP 264 (418)
T ss_pred hhcccccccHHHHHHHcCCchhheeeccCCccccc
Confidence 9999999742 335678899999999999999743
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.69 E-value=4.4e-07 Score=81.77 Aligned_cols=140 Identities=16% Similarity=0.095 Sum_probs=101.9
Q ss_pred eeccCCeeEEEEEeCCCcEEEEEEccch-hhh---hhhHHHHHHHHHHHhccCCC--CcceeeeEEE-eC----CEEEEE
Q 035761 323 IGTGGYGSVYRARLPSGKVVALKKLHRL-ETE---LASLESFQNEARLLSQIRHR--NIVKLYGFCL-HE----KCMFLI 391 (560)
Q Consensus 323 ig~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~---~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~-~~----~~~~lv 391 (560)
-|+|+-+.|++..+. |+.+-+|+-... ..+ +.....|.+|...+..+..- .+.++. ++. .. -..+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 477888999998875 457888875411 111 23456799999999988532 344444 332 11 236799
Q ss_pred EeccCC-CCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCc--EEEeeeccccc
Q 035761 392 YEYMEM-GSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFE--AFVADFGIARL 468 (560)
Q Consensus 392 ~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfg~~~~ 468 (560)
+|-+++ -+|.+++..... ...+......+..+++..++-||.. |+.|+|+.++||+++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~-~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAV-SPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCc-CCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 998764 578888754321 2357777889999999999999999 9999999999999986667 89999987764
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.67 E-value=6.1e-10 Score=90.51 Aligned_cols=135 Identities=28% Similarity=0.270 Sum_probs=87.1
Q ss_pred CCEEEeecCccCccCCC---CcCCCCCccEEEccCCCccCCCCccCC-CCCCCcEEECcCCcCcCCCCccCcCCCCCcEE
Q 035761 79 LQVLDLSRNEIGGSIPS---TLGHLKWLRSVDLSQNKLVGPIPSSLG-HLTQLTTLNMYNNKLDGPIPPELMNCSKLRIL 154 (560)
Q Consensus 79 L~~L~l~~n~l~~~~~~---~~~~l~~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 154 (560)
+..++|+.|+|- -+++ .+.....|+..+|++|.+. ..|..|. ..+.++.|+|++|.|+ .+|..+..++.|+.|
T Consensus 29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL 105 (177)
T ss_pred hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence 455666666665 2333 3445566777788888887 3444443 4457788888888888 566668888888888
Q ss_pred EccCcccccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCcccc
Q 035761 155 KLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVR 218 (560)
Q Consensus 155 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~~~ 218 (560)
+++.|.+. ..|..+..+.+|-.|+..+|.+..+.-+ +---......++.++++.+..+..++
T Consensus 106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~eid~d-l~~s~~~al~~lgnepl~~~~~~klq 167 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARAEIDVD-LFYSSLPALIKLGNEPLGDETKKKLQ 167 (177)
T ss_pred ccccCccc-cchHHHHHHHhHHHhcCCCCccccCcHH-HhccccHHHHHhcCCcccccCccccc
Confidence 88888887 6777777788888888888877643333 22222233344566677666655443
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.66 E-value=2.4e-07 Score=85.36 Aligned_cols=105 Identities=24% Similarity=0.327 Sum_probs=83.5
Q ss_pred HHHHHHHHHhccC--CCCcceeeeEEEeCC----EEEEEEeccCCC-CHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHH
Q 035761 359 SFQNEARLLSQIR--HRNIVKLYGFCLHEK----CMFLIYEYMEMG-SLFCILRTDEEAVGLDWTKRVNIVKGMAHALSY 431 (560)
Q Consensus 359 ~~~~e~~~l~~l~--h~niv~l~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~ 431 (560)
...+|...+..+. .-.+.+.+++.+... ..++|+|++++. +|.+++..... .+......++.++++.++-
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIAK 133 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHHH
Confidence 4667888777774 344566777766532 458999999984 78888875332 5666778899999999999
Q ss_pred HHhcCCCCeEEeCCCCCCeEeCCCC---cEEEeeecccccc
Q 035761 432 LHHHCTPPILHRDISSNNILLNSEF---EAFVADFGIARLL 469 (560)
Q Consensus 432 LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfg~~~~~ 469 (560)
||.. ||+|+|++++|||++.+. .+.++||+.++..
T Consensus 134 lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 134 LHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999 999999999999999887 7899999988764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 560 | ||||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-43 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-43 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-30 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 4e-30 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 8e-09 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 4e-30 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 9e-09 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-29 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-27 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-27 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-27 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-27 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-27 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-27 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-27 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-27 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 8e-27 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-27 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-26 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-26 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-26 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-26 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-26 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-26 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-26 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-26 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-26 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-26 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-26 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-26 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-26 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-26 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-26 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-26 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-26 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-26 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-26 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-26 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-26 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-26 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-25 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-25 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-24 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-24 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-24 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-23 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 9e-23 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-21 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-20 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-20 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-20 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-20 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 7e-20 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 8e-20 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-19 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-19 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-19 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-19 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-19 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-19 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-19 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-18 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-18 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-18 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-18 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-18 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-18 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-17 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-17 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-17 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 9e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 9e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-16 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-16 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-16 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-16 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-16 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-16 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-16 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 8e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 8e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 9e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 9e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 9e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 9e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-15 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-15 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-15 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-15 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-15 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-15 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-15 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-15 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-15 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-15 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 8e-15 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 8e-15 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-15 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 8e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-15 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-15 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-15 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-15 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-14 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-14 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-14 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 8e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 8e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 8e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 8e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 9e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 9e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 9e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 9e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-12 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-12 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-12 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 6e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-12 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 8e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-11 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-11 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 8e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 8e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 8e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 8e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 8e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 8e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 9e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 9e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 9e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-10 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-10 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 8e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 9e-10 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 9e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 9e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-09 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-09 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 7e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 8e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 8e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 8e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 9e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 9e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 9e-09 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 9e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 9e-09 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 9e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-08 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-08 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-08 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-08 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 6e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 7e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 9e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 9e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-07 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-07 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-07 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 7e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 8e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 8e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 9e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 9e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-06 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-06 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-06 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-06 | ||
| 3rg1_A | 612 | Crystal Structure Of The Rp105MD-1 Complex Length = | 2e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 8e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-05 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 1e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-05 | ||
| 2z7x_B | 520 | Crystal Structure Of The Tlr1-Tlr2 Heterodimer Indu | 3e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-05 | ||
| 3j0a_A | 844 | Homology Model Of Human Toll-Like Receptor 5 Fitted | 5e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 6e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 6e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 6e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 7e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 7e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 7e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 7e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 8e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 8e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 9e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 9e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-04 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-04 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-04 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-04 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 1e-04 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-04 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-04 | ||
| 4g8a_A | 635 | Crystal Structure Of Human Tlr4 Polymorphic Variant | 4e-04 | ||
| 3fxi_A | 605 | Crystal Structure Of The Human Tlr4-Human Md-2-E.Co | 4e-04 |
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3RG1|A Chain A, Crystal Structure Of The Rp105MD-1 Complex Length = 612 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2Z7X|B Chain B, Crystal Structure Of The Tlr1-Tlr2 Heterodimer Induced By Binding Of A Tri-Acylated Lipopeptide Length = 520 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3J0A|A Chain A, Homology Model Of Human Toll-Like Receptor 5 Fitted Into An Electron Microscopy Single Particle Reconstruction Length = 844 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4G8A|A Chain A, Crystal Structure Of Human Tlr4 Polymorphic Variant D299g And T399i In Complex With Md-2 And Lps Length = 635 | Back alignment and structure |
|
| >pdb|3FXI|A Chain A, Crystal Structure Of The Human Tlr4-Human Md-2-E.Coli Lps Ra Complex Length = 605 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 264 bits (677), Expect = 2e-84
Identities = 98/263 (37%), Positives = 149/263 (56%), Gaps = 15/263 (5%)
Query: 304 RITFQDMIEATEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNE 363
R + +++ A+++F K +G GG+G VY+ RL G +VA+K+L T+ L+ FQ E
Sbjct: 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQ-FQTE 77
Query: 364 ARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSL-FCILRTDEEAVGLDWTKRVNIV 422
++S HRN+++L GFC+ L+Y YM GS+ C+ E LDW KR I
Sbjct: 78 VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 423 KGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSN-RTLLAG 481
G A L+YLH HC P I+HRD+ + NILL+ EFEA V DFG+A+L++Y ++ T + G
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 197
Query: 482 TYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSS----------LDK 531
T G IAPE T +EK DV+ +GV+ LE++ G+ +L ++ L K
Sbjct: 198 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257
Query: 532 NIKLIDLLDPRLP--PPGDQMIR 552
KL L+D L +++ +
Sbjct: 258 EKKLEALVDVDLQGNYKDEEVEQ 280
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 248 bits (635), Expect = 3e-78
Identities = 71/244 (29%), Positives = 116/244 (47%), Gaps = 9/244 (3%)
Query: 1 MGRLRNLVHLDLSDNHFMG--HIPPTLGRLSELKILNLS-LNSLVGNIPSNVGHLTQLTT 57
+ + +LDLS + IP +L L L L + +N+LVG IP + LTQL
Sbjct: 46 DTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHY 105
Query: 58 LAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPI 117
L I ++G+I + +K L LD S N + G++P ++ L L + N++ G I
Sbjct: 106 LYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAI 165
Query: 118 PSSLGHLTQLTT-LNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELY 176
P S G ++L T + + N+L G IPP N + L + L N+L G G +
Sbjct: 166 PDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQ 224
Query: 177 YLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVP---HLDVSGNQFGGE 233
+ L+ N + + +G ++ +DL N + G +P + ++ L+VS N GE
Sbjct: 225 KIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE 283
Query: 234 IPTT 237
IP
Sbjct: 284 IPQG 287
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 1e-73
Identities = 63/231 (27%), Positives = 112/231 (48%), Gaps = 6/231 (2%)
Query: 2 GRLRNLVHLDLSD-NHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAI 60
L L L + N+ +G IPP + +L++L L ++ ++ G IP + + L TL
Sbjct: 73 ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132
Query: 61 ASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWL-RSVDLSQNKLVGPIPS 119
+ N ++G++ I SL L + N I G+IP + G L S+ +S+N+L G IP
Sbjct: 133 SYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPP 192
Query: 120 SLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLD 179
+ +L L +++ N L+G + + + L N L+ + +G + L LD
Sbjct: 193 TFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLD 250
Query: 180 LSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVF--VRKVPHLDVSGN 228
L N I G +P L + + ++++S NNL G IP +++ + N
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANN 301
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 2e-71
Identities = 65/237 (27%), Positives = 106/237 (44%), Gaps = 7/237 (2%)
Query: 10 LDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVG--NIPSNVGHLTQLTTLAIAS-NRMN 66
D + ++G + T + + L+LS +L IPS++ +L L L I N +
Sbjct: 31 TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV 90
Query: 67 GSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQ 126
G I I L L L ++ + G+IP L +K L ++D S N L G +P S+ L
Sbjct: 91 GPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPN 150
Query: 127 LTTLNMYNNKLDGPIPPELMNCSKL-RILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFI 185
L + N++ G IP + SKL + + N L+G IP L L ++DLS N +
Sbjct: 151 LVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNML 209
Query: 186 NGKIPSQLGEFSCIDTVDLSMNNLSGGIP--VFVRKVPHLDVSGNQFGGEIPTTLAN 240
G G + L+ N+L+ + + + LD+ N+ G +P L
Sbjct: 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQ 266
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-35
Identities = 42/145 (28%), Positives = 67/145 (46%), Gaps = 6/145 (4%)
Query: 102 WLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDG--PIPPELMNCSKLRILKLGN- 158
WL + D +G + + ++ L++ L PIP L N L L +G
Sbjct: 27 WLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGI 86
Query: 159 NLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFV- 217
N L G IP I KL +L+YL ++ ++G IP L + + T+D S N LSG +P +
Sbjct: 87 NNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS 146
Query: 218 --RKVPHLDVSGNQFGGEIPTTLAN 240
+ + GN+ G IP + +
Sbjct: 147 SLPNLVGITFDGNRISGAIPDSYGS 171
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 7e-17
Identities = 33/151 (21%), Positives = 48/151 (31%), Gaps = 56/151 (37%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAI 60
G +N + L+ N +
Sbjct: 217 FGSDKNTQKIHLAKNSLAFDLGK------------------------------------- 239
Query: 61 ASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSS 120
+G K L LDL N I G++P L LK+L S+++S N L G IP
Sbjct: 240 ------------VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287
Query: 121 LGHLTQLTTLNMYNNKL--DGPIPPELMNCS 149
G+L + NNK P+P C+
Sbjct: 288 -GNLQRFDVSAYANNKCLCGSPLPA----CT 313
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 241 bits (617), Expect = 2e-75
Identities = 94/254 (37%), Positives = 128/254 (50%), Gaps = 22/254 (8%)
Query: 304 RITFQDMIEATEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNE 363
R+ D+ EAT +FD K+ IG G +G VY+ L G VALK+ E+ E F+ E
Sbjct: 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTP-ESSQGIEE-FETE 85
Query: 364 ARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSL-FCILRTDEEAVGLDWTKRVNIV 422
LS RH ++V L GFC M LIY+YME G+L + +D + + W +R+ I
Sbjct: 86 IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC 145
Query: 423 KGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNR--TLLA 480
G A L YLH T I+HRD+ S NILL+ F + DFGI++ T++
Sbjct: 146 IGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVK 202
Query: 481 GTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNI------- 533
GT G I PE +TEK DVYSFGVV EVL + + S N+
Sbjct: 203 GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA---IVQSLPREMVNLAEWAVES 259
Query: 534 ----KLIDLLDPRL 543
+L ++DP L
Sbjct: 260 HNNGQLEQIVDPNL 273
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 250 bits (640), Expect = 3e-74
Identities = 93/246 (37%), Positives = 129/246 (52%), Gaps = 7/246 (2%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPP-TLGRLSELKILNLSLNSLVGNIPSNVGHLT-QLTTLA 59
G L L LS N+F G +P TL ++ LK+L+LS N G +P ++ +L+ L TL
Sbjct: 315 GSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLD 374
Query: 60 IASNRMNGSILLGIG--SLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPI 117
++SN +G IL + LQ L L N G IP TL + L S+ LS N L G I
Sbjct: 375 LSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTI 434
Query: 118 PSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYY 177
PSSLG L++L L ++ N L+G IP ELM L L L N L+G IPS + L +
Sbjct: 435 PSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNW 494
Query: 178 LDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHL---DVSGNQFGGEI 234
+ LS N + G+IP +G + + LS N+ SG IP + L D++ N F G I
Sbjct: 495 ISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTI 554
Query: 235 PTTLAN 240
P +
Sbjct: 555 PAAMFK 560
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 5e-70
Identities = 83/266 (31%), Positives = 117/266 (43%), Gaps = 33/266 (12%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASN 63
L L L +N F G IPPTL SEL L+LS N L G IPS++G L++L L + N
Sbjct: 393 KNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLN 452
Query: 64 RMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGH 123
+ G I + +K L+ L L N++ G IPS L + L + LS N+L G IP +G
Sbjct: 453 MLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGR 512
Query: 124 LTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGN 183
L L L + NN G IP EL +C L L L NL +G+IP+ + K ++ N
Sbjct: 513 LENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS----GKIAAN 568
Query: 184 FINGKIPSQL--------------------------GEFSCIDTVDLSMNNLSGGIPVFV 217
FI GK + S + +++ G
Sbjct: 569 FIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTF 628
Query: 218 ---RKVPHLDVSGNQFGGEIPTTLAN 240
+ LD+S N G IP + +
Sbjct: 629 DNNGSMMFLDMSYNMLSGYIPKEIGS 654
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 8e-70
Identities = 82/248 (33%), Positives = 119/248 (47%), Gaps = 11/248 (4%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAI 60
+ R NL LD+S N+F IP LG S L+ L++S N L G+ + T+L L I
Sbjct: 196 VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNI 254
Query: 61 ASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTL-GHLKWLRSVDLSQNKLVGPIPS 119
+SN+ G I LK LQ L L+ N+ G IP L G L +DLS N G +P
Sbjct: 255 SSNQFVGPI--PPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPP 312
Query: 120 SLGHLTQLTTLNMYNNKLDGPIPPE-LMNCSKLRILKLGNNLLSGSIPSQIGKL-QELYY 177
G + L +L + +N G +P + L+ L++L L N SG +P + L L
Sbjct: 313 FFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLT 372
Query: 178 LDLSGNFINGKIPSQLGEF--SCIDTVDLSMNNLSGGIPVFVRKVP---HLDVSGNQFGG 232
LDLS N +G I L + + + + L N +G IP + L +S N G
Sbjct: 373 LDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSG 432
Query: 233 EIPTTLAN 240
IP++L +
Sbjct: 433 TIPSSLGS 440
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 237 bits (608), Expect = 1e-69
Identities = 78/252 (30%), Positives = 111/252 (44%), Gaps = 14/252 (5%)
Query: 3 RLRNLVHLDLSDNHFMGHIPPTL---GRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLA 59
+L +L LDLS N G ELK L +S N + G++ V L L
Sbjct: 149 KLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLD 206
Query: 60 IASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPS 119
++SN + I +G LQ LD+S N++ G + L+ +++S N+ VGPIP
Sbjct: 207 VSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP 265
Query: 120 SLGHLTQLTTLNMYNNKLDGPIPPELM-NCSKLRILKLGNNLLSGSIPSQIGKLQELYYL 178
L L L++ NK G IP L C L L L N G++P G L L
Sbjct: 266 LP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESL 323
Query: 179 DLSGNFINGKIP-SQLGEFSCIDTVDLSMNNLSGGIPVFVRKVP----HLDVSGNQFGGE 233
LS N +G++P L + + +DLS N SG +P + + LD+S N F G
Sbjct: 324 ALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGP 383
Query: 234 IPTTLANVPPPH 245
I L P
Sbjct: 384 ILPNLCQNPKNT 395
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 3e-68
Identities = 84/248 (33%), Positives = 126/248 (50%), Gaps = 13/248 (5%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAI 60
L HL +S N G + + R L+ L++S N+ IP +G + L L I
Sbjct: 174 SDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDI 230
Query: 61 ASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSS 120
+ N+++G I + L++L++S N+ G IP LK L+ + L++NK G IP
Sbjct: 231 SGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDF 288
Query: 121 L-GHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIP-SQIGKLQELYYL 178
L G LT L++ N G +PP +CS L L L +N SG +P + K++ L L
Sbjct: 289 LSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVL 348
Query: 179 DLSGNFINGKIPSQLGEFSC-IDTVDLSMNNLSGGIPVFVRKVP-----HLDVSGNQFGG 232
DLS N +G++P L S + T+DLS NN SG I + + P L + N F G
Sbjct: 349 DLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTG 408
Query: 233 EIPTTLAN 240
+IP TL+N
Sbjct: 409 KIPPTLSN 416
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 1e-65
Identities = 62/245 (25%), Positives = 108/245 (44%), Gaps = 9/245 (3%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAI 60
+ ++ L L L N G IP L + L ++LS N L G IP +G L L L +
Sbjct: 462 LMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKL 521
Query: 61 ASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSS 120
++N +G+I +G + L LDL+ N G+IP+ + S ++ N + G
Sbjct: 522 SNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ----SGKIAANFIAGKRYVY 577
Query: 121 LGHLTQLTTLNMYNN--KLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYL 178
+ + + N + G +L S + + + G + +L
Sbjct: 578 IKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFL 637
Query: 179 DLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPH---LDVSGNQFGGEIP 235
D+S N ++G IP ++G + ++L N++SG IP V + LD+S N+ G IP
Sbjct: 638 DMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIP 697
Query: 236 TTLAN 240
++
Sbjct: 698 QAMSA 702
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 7e-65
Identities = 75/245 (30%), Positives = 113/245 (46%), Gaps = 15/245 (6%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPP--TLGRLSELKILNLSLNSLVGNIP-SNVGHLTQLTTL 58
+L LDLS N G + +LG S LK LN+S N+L S L L L
Sbjct: 97 KCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVL 156
Query: 59 AIASNRMNGSI---LLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVG 115
+++N ++G+ + L+ L +S N+I G + + L +D+S N
Sbjct: 157 DLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFST 214
Query: 116 PIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQEL 175
IP LG + L L++ NKL G + C++L++L + +N G IP L+ L
Sbjct: 215 GIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSL 271
Query: 176 YYLDLSGNFINGKIPSQL-GEFSCIDTVDLSMNNLSGGIPVFVRKVP---HLDVSGNQFG 231
YL L+ N G+IP L G + +DLS N+ G +P F L +S N F
Sbjct: 272 QYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFS 331
Query: 232 GEIPT 236
GE+P
Sbjct: 332 GELPM 336
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 9e-64
Identities = 73/249 (29%), Positives = 111/249 (44%), Gaps = 16/249 (6%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNV--GHLTQLTTLA 59
L L L LS++H G + + L L+LS NSL G + + G + L L
Sbjct: 74 LSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLN 132
Query: 60 IASNRMNGSILLGIG-SLKVLQVLDLSRNEIGGSIPSTL---GHLKWLRSVDLSQNKLVG 115
++SN ++ + G L L+VLDLS N I G+ L+ + +S NK+ G
Sbjct: 133 VSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISG 192
Query: 116 PIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQEL 175
+ + L L++ +N I P L +CS L+ L + N LSG I EL
Sbjct: 193 DVD--VSRCVNLEFLDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDFSRAISTCTEL 249
Query: 176 YYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFV----RKVPHLDVSGNQFG 231
L++S N G IP + + L+ N +G IP F+ + LD+SGN F
Sbjct: 250 KLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFY 307
Query: 232 GEIPTTLAN 240
G +P +
Sbjct: 308 GAVPPFFGS 316
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 2e-62
Identities = 75/232 (32%), Positives = 111/232 (47%), Gaps = 17/232 (7%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAI 60
+GRL NL L LS+N F G+IP LG L L+L+ N G IP+ + + I
Sbjct: 510 IGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----I 565
Query: 61 ASNRMNGSILLGIGSLKVLQVLDLSRN--EIGGSIPSTLGHLKWLRSVDLSQNKLVGPIP 118
A+N + G + I + + + + N E G L L +++ G
Sbjct: 566 AANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTS 625
Query: 119 SSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYL 178
+ + + L+M N L G IP E+ + L IL LG+N +SGSIP ++G L+ L L
Sbjct: 626 PTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNIL 685
Query: 179 DLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHLDVSGNQF 230
DLS N ++G+IP + + + +DLS NNLSG IP QF
Sbjct: 686 DLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP-----------EMGQF 726
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 2e-58
Identities = 63/246 (25%), Positives = 112/246 (45%), Gaps = 14/246 (5%)
Query: 5 RNLVHLDLSDNHF---MGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIA 61
+ +DLS + +L L+ L+ L LS + + G++ LT+L ++
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLS 108
Query: 62 SNRMNGSI--LLGIGSLKVLQVLDLSRNEIGGSIP-STLGHLKWLRSVDLSQNKLVGPIP 118
N ++G + L +GS L+ L++S N + S L L +DLS N + G
Sbjct: 109 RNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANV 168
Query: 119 SSL---GHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQEL 175
+L L + NK+ G + + C L L + +N S IP +G L
Sbjct: 169 VGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSAL 225
Query: 176 YYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVF-VRKVPHLDVSGNQFGGEI 234
+LD+SGN ++G + + + +++S N G IP ++ + +L ++ N+F GEI
Sbjct: 226 QHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEI 285
Query: 235 PTTLAN 240
P L+
Sbjct: 286 PDFLSG 291
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 2e-44
Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 48 NVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVD 107
+T + + N ++ + SL L+ L LS + I GS+ L S+D
Sbjct: 48 RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLD 106
Query: 108 LSQNKLVGPIPS--SLGHLTQLTTLNMYNNKLDGPIP-PELMNCSKLRILKLGNNLLSGS 164
LS+N L GP+ + SLG + L LN+ +N LD P + + L +L L N +SG+
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166
Query: 165 IPSQI---GKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVR--K 219
EL +L +SGN I+G + + ++ +D+S NN S GIP
Sbjct: 167 NVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLGDCSA 224
Query: 220 VPHLDVSGNQFGGEIPTTLAN 240
+ HLD+SGN+ G+ ++
Sbjct: 225 LQHLDISGNKLSGDFSRAIST 245
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 3e-65
Identities = 78/257 (30%), Positives = 126/257 (49%), Gaps = 22/257 (8%)
Query: 304 RITFQDMIEATEDFDIKYC------IGTGGYGSVYRARLPSGKVVALKKLHRLETELAS- 356
+F ++ T +FD + +G GG+G VY+ + VA+KKL +
Sbjct: 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEE 72
Query: 357 -LESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDW 415
+ F E +++++ +H N+V+L GF + L+Y YM GSL L + L W
Sbjct: 73 LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132
Query: 416 TKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL--NYDS 473
R I +G A+ +++LH + +HRDI S NILL+ F A ++DFG+AR +
Sbjct: 133 HMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 474 SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGE-------LLSSSS 526
+ + GT +APE A +T K D+YSFGVV LE++ G + LL
Sbjct: 190 VMTSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKE 248
Query: 527 SSLDKNIKLIDLLDPRL 543
D+ + D +D ++
Sbjct: 249 EIEDEEKTIEDYIDKKM 265
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 1e-60
Identities = 67/204 (32%), Positives = 108/204 (52%), Gaps = 2/204 (0%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRN 374
D +IK IG G +G+V+RA G VA+K L + + F E ++ ++RH N
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 375 IVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHH 434
IV G + ++ EY+ GSL+ +L LD +R+++ +A ++YL H
Sbjct: 96 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYL-H 154
Query: 435 HCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTM 494
+ PPI+HR++ S N+L++ ++ V DFG++RL + AGT +APE+
Sbjct: 155 NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDE 214
Query: 495 VVTEKYDVYSFGVVALEVLMGKHP 518
EK DVYSFGV+ E+ + P
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQP 238
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 3e-58
Identities = 60/205 (29%), Positives = 104/205 (50%), Gaps = 11/205 (5%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRN 374
++ +++ +G G +G V +A+ K VA+K++ ++F E R LS++ H N
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER----KAFIVELRQLSRVNHPN 62
Query: 375 IVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHH 434
IVKLYG CL+ C+ + EY E GSL+ +L E ++ + ++YLH
Sbjct: 63 IVKLYGACLNPVCL--VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS 120
Query: 435 HCTPPILHRDISSNNILLNSEFEAF-VADFGIARLLNYDSSNRTLLAGTYGSIAPELAYT 493
++HRD+ N+LL + + DFG A + +N G+ +APE+
Sbjct: 121 MQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK---GSAAWMAPEVFEG 177
Query: 494 MVVTEKYDVYSFGVVALEVLMGKHP 518
+EK DV+S+G++ EV+ + P
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKP 202
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 5e-57
Identities = 67/217 (30%), Positives = 108/217 (49%), Gaps = 21/217 (9%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRLETE-----LASLESFQNEARLLS 368
+ + + IG GG+G V++ RL VVA+K L ++E + + FQ E ++S
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 369 QIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHA 428
+ H NIVKLYG + M + E++ G L+ L + W+ ++ ++ +A
Sbjct: 79 NLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIALG 134
Query: 429 LSYLHHHCTPPILHRDISSNNILLNSEFEAF-----VADFGIARLLNYDSSNRTLLAGTY 483
+ Y+ + PPI+HRD+ S NI L S E VADFG+++ + S G +
Sbjct: 135 IEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLL---GNF 190
Query: 484 GSIAPEL--AYTMVVTEKYDVYSFGVVALEVLMGKHP 518
+APE A TEK D YSF ++ +L G+ P
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 1e-56
Identities = 57/234 (24%), Positives = 101/234 (43%), Gaps = 26/234 (11%)
Query: 305 ITFQDMIEATEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEA 364
+ +++ + + G +G V++A+L + VA+K + S + + E
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFP--IQDKQSWQ-NEYEV 69
Query: 365 RLLSQIRHRNIVKLYGFCLH----EKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVN 420
L ++H NI++ G + ++LI + E GSL L+ + + W + +
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNELCH 125
Query: 421 IVKGMAHALSYLHHH-------CTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473
I + MA L+YLH P I HRDI S N+LL + A +ADFG+A
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 474 S--NRTLLAGTYGSIAPELA-----YTMVVTEKYDVYSFGVVALEVLMGKHPGE 520
S + GT +APE+ + + D+Y+ G+V E+ +
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 7e-56
Identities = 68/214 (31%), Positives = 108/214 (50%), Gaps = 17/214 (7%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELAS--LESFQNEARLLSQIRH 372
+ ++ IG GG+G VYRA G VA+K E S +E+ + EA+L + ++H
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYL 432
NI+ L G CL E + L+ E+ G L +L + VN +A ++YL
Sbjct: 66 PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR----IPPDILVNWAVQIARGMNYL 121
Query: 433 HHHCTPPILHRDISSNNILLNSEFEAF--------VADFGIARLLNYDSSNRTLLAGTYG 484
H PI+HRD+ S+NIL+ + E + DFG+AR + + AG Y
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--HRTTKMSAAGAYA 179
Query: 485 SIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHP 518
+APE+ + ++ DV+S+GV+ E+L G+ P
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 2e-52
Identities = 62/249 (24%), Positives = 115/249 (46%), Gaps = 26/249 (10%)
Query: 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHR 373
D +G G +G + +G+V+ +K+L R + E + +F E +++ + H
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEE--TQRTFLKEVKVMRCLEHP 67
Query: 374 NIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLH 433
N++K G +K + I EY++ G+L I+++ + W++RV+ K +A ++YLH
Sbjct: 68 NVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLH 125
Query: 434 HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSN--------------RTLL 479
I+HRD++S+N L+ VADFG+ARL+ + + R +
Sbjct: 126 SM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTV 182
Query: 480 AGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLL 539
G +APE+ EK DV+SFG+V E++ + + N++
Sbjct: 183 VGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR----G 238
Query: 540 DPRLPPPGD 548
P +
Sbjct: 239 FLDRYCPPN 247
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 2e-51
Identities = 40/209 (19%), Positives = 79/209 (37%), Gaps = 13/209 (6%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRN 374
+ + + G +++ R G + +K L + F E L H N
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 375 IVKLYGFCLHEKC--MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYL 432
++ + G C LI +M GSL+ +L V +D ++ V MA +++L
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV-VDQSQAVKFALDMARGMAFL 127
Query: 433 HHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPEL-- 490
H P I ++S +++++ + A ++ + S +APE
Sbjct: 128 -HTLEPLIPRHALNSRSVMIDEDMTARISMADVKF-----SFQSPGRMYAPAWVAPEALQ 181
Query: 491 -AYTMVVTEKYDVYSFGVVALEVLMGKHP 518
D++SF V+ E++ + P
Sbjct: 182 KKPEDTNRRSADMWSFAVLLWELVTREVP 210
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 9e-49
Identities = 57/265 (21%), Positives = 93/265 (35%), Gaps = 29/265 (10%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAI 60
+++ L L+ N G P G +L LNL+ N + IP+N G Q+ L+
Sbjct: 327 QKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSF 384
Query: 61 ASNRMNG-SILLGIGSLKVLQVLDLSRNEIGG-------SIPSTLGHLKWLRSVDLSQNK 112
A N++ + S+ V+ +D S NEIG + T + S++LS N+
Sbjct: 385 AHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQ 444
Query: 113 LVGPIPSSLGHLTQLTTLNMYNNKLDG-------PIPPELMNCSKLRILKLGNNLLSGSI 165
+ + L+++N+ N L N L + L N L+
Sbjct: 445 ISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLS 504
Query: 166 PS-QIGKLQELYYLDLSGNFINGKIPSQLG------EFSCIDTVDLSMNNLSGGIPVFVR 218
+ L L +DLS N + P+Q F + D N P +
Sbjct: 505 DDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGIT 563
Query: 219 KVP---HLDVSGNQFGGEIPTTLAN 240
P L + N N
Sbjct: 564 LCPSLTQLQIGSNDIRKVNEKITPN 588
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 1e-47
Identities = 45/284 (15%), Positives = 100/284 (35%), Gaps = 44/284 (15%)
Query: 1 MGRLRNLVHLDLSDNHFMGH-------------------IPPTLGRLSELKILNLSLNSL 41
+ RL L + ++ F+ L +L + +
Sbjct: 202 VMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPN 261
Query: 42 VGNIPSNVGHLTQLTTLAIASNRM--------NGSILLGIGSLKVLQVLDLSRNEI-GGS 92
+ +P+ + L ++ + +A NR + L + +Q++ + N +
Sbjct: 262 LTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFP 321
Query: 93 IPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELM-NCSKL 151
+ ++L +K L ++ N+L G +P+ G +L +LN+ N++ IP ++
Sbjct: 322 VETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITE-IPANFCGFTEQV 379
Query: 152 RILKLGNNLLSGSIPS--QIGKLQELYYLDLSGNFING-------KIPSQLGEFSCIDTV 202
L +N L IP+ + + +D S N I + + + ++
Sbjct: 380 ENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSI 438
Query: 203 DLSMNNLSGGIPVFVRKVPHL---DVSGNQFGGEIPTTLANVPP 243
+LS N +S L ++ GN +L +
Sbjct: 439 NLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENE 482
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-46
Identities = 39/273 (14%), Positives = 85/273 (31%), Gaps = 38/273 (13%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGN----IPSNVGHLTQLT 56
+ + L L G +P +G+L+EL++L L + N P +
Sbjct: 77 LNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDE 136
Query: 57 TLAIASNRMNGSILLGIGSLKV--LQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLV 114
+ + L ++ + SI + + N +
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT 196
Query: 115 GPIPSSLGHLTQLTTLNMYNNKLDGPIPPELM-------------------NCSKLRILK 155
+ ++ LT+L M N+ E N L ++
Sbjct: 197 F-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVE 255
Query: 156 LGNNLLSGSIPSQIGKLQELYYLDLSGNFI--------NGKIPSQLGEFSCIDTVDLSMN 207
+ N +P+ + L E+ ++++ N + + + I + + N
Sbjct: 256 VYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYN 315
Query: 208 NLSGG-IPVFVRKVP---HLDVSGNQFGGEIPT 236
NL + ++K+ L+ NQ G++P
Sbjct: 316 NLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA 348
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 5e-46
Identities = 46/267 (17%), Positives = 97/267 (36%), Gaps = 32/267 (11%)
Query: 2 GRLRNLVHLDLSDNHFM-GHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAI 60
+ + + N+ + +L ++ +L +L N L G +P+ G +L +L +
Sbjct: 302 PVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNL 360
Query: 61 ASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTL--GHLKWLRSVDLSQNKLVG--- 115
A N++ G + ++ L + N++ IP+ + + ++D S N++
Sbjct: 361 AYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDG 419
Query: 116 ----PIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSG-------S 164
P+ + ++++N+ NN++ S L + L N+L+
Sbjct: 420 KNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKD 479
Query: 165 IPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSC--IDTVDLSMNNLSGGIPVFVRKVPH 222
L +DL N + + + + +DLS N+ S P
Sbjct: 480 ENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFS-KFPTQPLNSST 537
Query: 223 L---------DVSGNQFGGEIPTTLAN 240
L D GN+ E P +
Sbjct: 538 LKGFGIRNQRDAQGNRTLREWPEGITL 564
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 8e-44
Identities = 37/247 (14%), Positives = 93/247 (37%), Gaps = 20/247 (8%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASN 63
+L+ ++ + I + + + N++ + V LT+L + ++
Sbjct: 158 FSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNS 216
Query: 64 RMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGH 123
+ + + + +LK L V++ + +P+ L
Sbjct: 217 PFVAENICEAWENENSEYAQQY-----KTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKA 271
Query: 124 LTQLTTLNMYNNKL--------DGPIPPELMNCSKLRILKL-GNNLLSGSIPSQIGKLQE 174
L ++ +N+ N+ D + K++I+ + NNL + + + + K+++
Sbjct: 272 LPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKK 331
Query: 175 LYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVP---HLDVSGNQFG 231
L L+ N + GK+P+ G + +++L+ N ++ F +L + N+
Sbjct: 332 LGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKL- 389
Query: 232 GEIPTTL 238
IP
Sbjct: 390 KYIPNIF 396
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-42
Identities = 36/236 (15%), Positives = 74/236 (31%), Gaps = 28/236 (11%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPPTL--GRLSELKILNLSLNSLVG-------NIPSNVGHL 52
G + +L + N +IP +S + ++ S N + +
Sbjct: 374 GFTEQVENLSFAHNKL-KYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKG 432
Query: 53 TQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRN-------EIGGSIPSTLGHLKWLRS 105
++++ +++N+++ + L ++L N + L S
Sbjct: 433 INVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTS 492
Query: 106 VDLSQNKLVG-PIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNL---- 160
+DL NKL L L +++ N P + +N S L+ + N
Sbjct: 493 IDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQG 551
Query: 161 --LSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIP 214
P I L L + N I + ++ I +D+ N
Sbjct: 552 NRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDL 604
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-40
Identities = 37/231 (16%), Positives = 75/231 (32%), Gaps = 25/231 (10%)
Query: 1 MGRLRNLVHLDLSDNHFMG-------HIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLT 53
+ + +D S N + PT + + +NLS N + +
Sbjct: 398 AKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGS 457
Query: 54 QLTTLAIASNRMNG-------SILLGIGSLKVLQVLDLSRNEIGGSIPS-TLGHLKWLRS 105
L+++ + N + + +L +DL N++ L +L
Sbjct: 458 PLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVG 517
Query: 106 VDLSQNKLVGPIPSSLGHLTQLTTLNMYN------NKLDGPIPPELMNCSKLRILKLGNN 159
+DLS N P+ + + L + N N+ P + C L L++G+N
Sbjct: 518 IDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSN 576
Query: 160 LLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLS 210
+ + +I + LD+ N S + + L +
Sbjct: 577 DIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 5e-37
Identities = 33/229 (14%), Positives = 75/229 (32%), Gaps = 15/229 (6%)
Query: 11 DLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNG--- 67
+ + + +L + L+L G +P +G LT+L LA+ S+
Sbjct: 63 NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER 122
Query: 68 -SILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKW--LRSVDLSQNKLVGPIPSSLGHL 124
GI + + R + + L ++ + I S
Sbjct: 123 LFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT 182
Query: 125 TQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNF 184
+ T + +N + + +M +KLR +GN+ + + + Y
Sbjct: 183 LKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKT- 240
Query: 185 INGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVP---HLDVSGNQF 230
+ + V++ +P F++ +P ++V+ N+
Sbjct: 241 ----EDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRG 285
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 18/167 (10%), Positives = 46/167 (27%), Gaps = 10/167 (5%)
Query: 83 DLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGP-- 140
+ + G +L + + L G +P ++G LT+L L + ++
Sbjct: 63 NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER 122
Query: 141 --IPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQ--ELYYLDLSGNFINGKIPSQLGEF 196
P + + + + +L ++ + I
Sbjct: 123 LFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT 182
Query: 197 SCIDTVDLSMNNLSGGIPVFVRKVP---HLDVSGNQFGGEIPTTLAN 240
+ NN++ + V ++ + + F E
Sbjct: 183 LKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWE 228
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 9e-49
Identities = 51/218 (23%), Positives = 93/218 (42%), Gaps = 22/218 (10%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRN 374
E +I IG G +G VY R G+V A++ + L++F+ E Q RH N
Sbjct: 33 EQLEIGELIGKGRFGQVYHGRW-HGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHEN 90
Query: 375 IVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHH 434
+V G C+ + +I + +L+ ++R + LD K I + + + YLH
Sbjct: 91 VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIV--LDVNKTRQIAQEIVKGMGYLH- 147
Query: 435 HCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNR-----TLLAGTYGSIAPE 489
ILH+D+ S N+ + + + DFG+ + + R + G +APE
Sbjct: 148 --AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPE 204
Query: 490 L---------AYTMVVTEKYDVYSFGVVALEVLMGKHP 518
+ + ++ DV++ G + E+ + P
Sbjct: 205 IIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 5e-48
Identities = 55/249 (22%), Positives = 88/249 (35%), Gaps = 10/249 (4%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASN 63
N+ L+L+ N R S+L L++ N++ P L L L + N
Sbjct: 24 PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83
Query: 64 RMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGH 123
++ L L L N I + K L ++DLS N L +
Sbjct: 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQ 143
Query: 124 LTQLTTLNMYNNKLDGPIPPEL--MNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLS 181
L L L + NNK+ EL S L+ L+L +N + P + L+ L L+
Sbjct: 144 LENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLN 203
Query: 182 GNFINGKIPSQLGEFSC---IDTVDLSMNNLSGGIPVFVRKVP-----HLDVSGNQFGGE 233
+ + +L I + LS + LS + LD+S N
Sbjct: 204 NVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVV 263
Query: 234 IPTTLANVP 242
+ A +P
Sbjct: 264 GNDSFAWLP 272
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-45
Identities = 58/249 (23%), Positives = 89/249 (35%), Gaps = 10/249 (4%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIA 61
R L LD+ N P +L LK+LNL N L T LT L +
Sbjct: 46 TRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLM 105
Query: 62 SNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSL 121
SN + K L LDLS N + + T L+ L+ + LS NK+ L
Sbjct: 106 SNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEEL 165
Query: 122 G--HLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIG---KLQELY 176
+ L L + +N++ P +L L L N L S+ ++ +
Sbjct: 166 DIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIR 225
Query: 177 YLDLSGNFINGKIPSQLGEFSC--IDTVDLSMNNLSGGIPVFVRKVPHL---DVSGNQFG 231
L LS + ++ + + +DLS NNL+ +P L + N
Sbjct: 226 NLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQ 285
Query: 232 GEIPTTLAN 240
+L
Sbjct: 286 HLFSHSLHG 294
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 6e-45
Identities = 54/249 (21%), Positives = 86/249 (34%), Gaps = 15/249 (6%)
Query: 3 RLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAIA 61
L L+L+ N L L++L+L LN + + L + + ++
Sbjct: 379 AHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLS 438
Query: 62 SNRMNGSILLGIGSLKVLQVLDLSRNEIGG--SIPSTLGHLKWLRSVDLSQNKLVGPIPS 119
N+ + LQ L L R + S PS L+ L +DLS N +
Sbjct: 439 YNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDD 498
Query: 120 SLGHLTQLTTLNMYNNKL--------DGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGK 171
L L +L L++ +N L G L S L IL L +N
Sbjct: 499 MLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKD 558
Query: 172 LQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKV----PHLDVSG 227
L EL +DL N +N S + +++L N ++ LD+
Sbjct: 559 LFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRF 618
Query: 228 NQFGGEIPT 236
N F +
Sbjct: 619 NPFDCTCES 627
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-42
Identities = 51/248 (20%), Positives = 88/248 (35%), Gaps = 11/248 (4%)
Query: 6 NLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRM 65
+ D S +P L + + +LNL+ N L +N +QLT+L + N +
Sbjct: 5 SHEVADCSHLKL-TQVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 66 NGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLT 125
+ L +L+VL+L NE+ T L + L N + +
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121
Query: 126 QLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPS--QIGKLQELYYLDLSGN 183
L TL++ +N L + L+ L L NN + I L L+LS N
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181
Query: 184 FINGKIPSQLGEFSCIDTVDLSMNNLSGGIP------VFVRKVPHLDVSGNQFGGEIPTT 237
I P + + L+ L + + + +L +S +Q TT
Sbjct: 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 241
Query: 238 LANVPPPH 245
+ +
Sbjct: 242 FLGLKWTN 249
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 2e-42
Identities = 51/253 (20%), Positives = 92/253 (36%), Gaps = 21/253 (8%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVG---HLTQLTTLAI 60
+L L+LS N P + L L L+ L ++ + T + L++
Sbjct: 170 NSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSL 229
Query: 61 ASNRMNGSILLGIGSLKV--LQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIP 118
++++++ + LK L +LDLS N + + L L L N +
Sbjct: 230 SNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFS 289
Query: 119 SSLGHLTQLTTLNMYNN---------KLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQI 169
SL L + LN+ + L L L + +N + G +
Sbjct: 290 HSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMF 349
Query: 170 GKLQELYYLDLSGNFINGKIPSQLG----EFSCIDTVDLSMNNLSGGIPVFVRKVPHL-- 223
L L YL LS +F + + + S + ++L+ N +S + HL
Sbjct: 350 TGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEV 409
Query: 224 -DVSGNQFGGEIP 235
D+ N+ G E+
Sbjct: 410 LDLGLNEIGQELT 422
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-42
Identities = 54/261 (20%), Positives = 88/261 (33%), Gaps = 18/261 (6%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLG----RLSELKILNLSLNSLVGNIPSNVGHLTQLT 56
L NL +L LS++ S L ILNL+ N + L L
Sbjct: 349 FTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLE 408
Query: 57 TLAIASNRMNGSILLG-IGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKL-- 113
L + N + + L+ + + LS N+ ++ + L+ + L + L
Sbjct: 409 VLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKN 468
Query: 114 VGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLS--------GSI 165
V PS L LT L++ NN + L KL IL L +N L+ G
Sbjct: 469 VDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGP 528
Query: 166 PSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVP---H 222
+ L L+ L+L N + + + +DL +NNL+
Sbjct: 529 IYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKS 588
Query: 223 LDVSGNQFGGEIPTTLANVPP 243
L++ N
Sbjct: 589 LNLQKNLITSVEKKVFGPAFR 609
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 4e-41
Identities = 50/261 (19%), Positives = 83/261 (31%), Gaps = 19/261 (7%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNL---------SLNSLVGNIPSNVGHL 52
L L + L N+ +L L ++ LNL SL SL + L
Sbjct: 269 AWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWL 328
Query: 53 TQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGS--IPSTLGHLKW--LRSVDL 108
L L + N + G L L+ L LS + T L L ++L
Sbjct: 329 KCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNL 388
Query: 109 SQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPP-ELMNCSKLRILKLGNNLLSGSIPS 167
++NK+ + L L L++ N++ + E + + L N +
Sbjct: 389 TKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRN 448
Query: 168 QIGKLQELYYLDLSGNFING--KIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVP---H 222
+ L L L + PS + +DLS NN++ + +
Sbjct: 449 SFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEI 508
Query: 223 LDVSGNQFGGEIPTTLANVPP 243
LD+ N P
Sbjct: 509 LDLQHNNLARLWKHANPGGPI 529
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-40
Identities = 51/259 (19%), Positives = 90/259 (34%), Gaps = 19/259 (7%)
Query: 3 RLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIAS 62
+ NL LDLS N+ + L +L+ L N++ ++ L + L +
Sbjct: 246 KWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKR 305
Query: 63 NRMNGSILLG---------IGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKL 113
+ SI L LK L+ L++ N+I G + L L+ + LS +
Sbjct: 306 SFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFT 365
Query: 114 --VGPIPSSLGHL--TQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQ- 168
+ L + L LN+ NK+ L +L LG N + + Q
Sbjct: 366 SLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQE 425
Query: 169 IGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSG--GIPVFVRKVPHL--- 223
L+ ++ + LS N + + + L L P + + +L
Sbjct: 426 WRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTIL 485
Query: 224 DVSGNQFGGEIPTTLANVP 242
D+S N L +
Sbjct: 486 DLSNNNIANINDDMLEGLE 504
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 5e-40
Identities = 58/257 (22%), Positives = 88/257 (34%), Gaps = 12/257 (4%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPP-TLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAI 60
L +L LDL N + L + + LS N + ++ + L L +
Sbjct: 402 SWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLML 461
Query: 61 ASNRMNG--SILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKL----- 113
+ S L+ L +LDLS N I L L+ L +DL N L
Sbjct: 462 RRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWK 521
Query: 114 ---VGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIG 170
G L L+ L LN+ +N D + +L+I+ LG N L+ S
Sbjct: 522 HANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFN 581
Query: 171 KLQELYYLDLSGNFINGKIPSQLGE-FSCIDTVDLSMNNLSGGIPVFVRKVPHLDVSGNQ 229
L L+L N I G F + +D+ N V ++ +
Sbjct: 582 NQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTN 641
Query: 230 FGGEIPTTLANVPPPHH 246
L N PP +H
Sbjct: 642 IPELSSHYLCNTPPHYH 658
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 38/187 (20%), Positives = 66/187 (35%), Gaps = 24/187 (12%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAI 60
+ L L LDL N+ + L ++ G + L+ L L +
Sbjct: 500 LEGLEKLEILDLQHNN----------------LARLWKHANPGGPIYFLKGLSHLHILNL 543
Query: 61 ASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSS 120
SN + + L L+++DL N + S + L+S++L +N +
Sbjct: 544 ESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKV 603
Query: 121 LGH-LTQLTTLNMYNNKLDGPIP-----PELMNCSKLRILKLGNNLLSGSIPSQIGKLQE 174
G LT L+M N D +N + I +L ++ L + P G
Sbjct: 604 FGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFP-- 661
Query: 175 LYYLDLS 181
+ D S
Sbjct: 662 VRLFDTS 668
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 5e-48
Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 13/209 (6%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRN 374
+ IG+G +G+VY+ + G V A+K L+ L++F+NE +L + RH N
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 375 IVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHH 434
I+ G+ + ++ ++ E SL+ L E + K ++I + A + YLH
Sbjct: 82 ILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHA 138
Query: 435 HCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN--YDSSNRTLLAGTYGSIAPEL-- 490
I+HRD+ SNNI L+ + + DFG+A + S L+G+ +APE+
Sbjct: 139 K---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 491 -AYTMVVTEKYDVYSFGVVALEVLMGKHP 518
+ + + DVY+FG+V E++ G+ P
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLP 224
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 7e-47
Identities = 56/240 (23%), Positives = 94/240 (39%), Gaps = 38/240 (15%)
Query: 305 ITFQDMIEATEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEA 364
+ ++ + IG G YG+VY+ L + VA+K A+ ++F NE
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSF-----ANRQNFINEK 56
Query: 365 R--LLSQIRHRNIVKLYGFCLH-----EKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTK 417
+ + H NI + L+ EY GSL L DW
Sbjct: 57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVS 112
Query: 418 RVNIVKGMAHALSYLH------HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471
+ + L+YLH H P I HRD++S N+L+ ++ ++DFG++ L
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 472 DSSNR--------TLLAGTYGSIAPELAYTMV-------VTEKYDVYSFGVVALEVLMGK 516
+ R GT +APE+ V ++ D+Y+ G++ E+ M
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-45
Identities = 60/228 (26%), Positives = 97/228 (42%), Gaps = 31/228 (13%)
Query: 314 TEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARL--LSQIR 371
D + C+G G YG V+R G+ VA+K + +S+ E L +R
Sbjct: 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD-----EKSWFRETELYNTVMLR 60
Query: 372 HRNIVKLYGFCLHEKC----MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAH 427
H NI+ + + ++LI Y EMGSL+ L+ LD + IV +A
Sbjct: 61 HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIAS 116
Query: 428 ALSYLH-----HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS----NRTL 478
L++LH P I HRD+ S NIL+ + +AD G+A + + ++
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 176
Query: 479 LAGTYGSIAPEL------AYTMVVTEKYDVYSFGVVALEVLMGKHPGE 520
GT +APE+ ++ D+++FG+V EV
Sbjct: 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG 224
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 3e-45
Identities = 57/227 (25%), Positives = 89/227 (39%), Gaps = 31/227 (13%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEAR--LLSQIRH 372
+ + IG G YG V+ + G+ VA+K E S+ E +RH
Sbjct: 37 KQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE-----EASWFRETEIYQTVLMRH 90
Query: 373 RNIVKLYGFCLHEKC----MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHA 428
NI+ + ++LI +Y E GSL+ L++ LD + +
Sbjct: 91 ENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSSVSG 146
Query: 429 LSYLH-----HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLL---- 479
L +LH P I HRD+ S NIL+ +AD G+A D++ +
Sbjct: 147 LCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR 206
Query: 480 AGTYGSIAPE-LAYTMVV-----TEKYDVYSFGVVALEVLMGKHPGE 520
GT + PE L ++ D+YSFG++ EV G
Sbjct: 207 VGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG 253
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 4e-43
Identities = 54/227 (23%), Positives = 89/227 (39%), Gaps = 31/227 (13%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEAR--LLSQIRH 372
++ IG G +G V+R + G+ VA+K E S+ EA +RH
Sbjct: 42 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRH 95
Query: 373 RNIVKLYGFCLHEK----CMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHA 428
NI+ + ++L+ +Y E GSLF L + + + A
Sbjct: 96 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASG 151
Query: 429 LSYLH-----HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLL---- 479
L++LH P I HRD+ S NIL+ +AD G+A + + +
Sbjct: 152 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR 211
Query: 480 AGTYGSIAPEL------AYTMVVTEKYDVYSFGVVALEVLMGKHPGE 520
GT +APE+ ++ D+Y+ G+V E+ G
Sbjct: 212 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-42
Identities = 44/213 (20%), Positives = 86/213 (40%), Gaps = 7/213 (3%)
Query: 5 RNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNR 64
+ +LDLS N + EL++L+LS + L+ L+TL + N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 65 MNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVG-PIPSSLGH 123
+ L L LQ L + +GHLK L+ ++++ N + +P +
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 124 LTQLTTLNMYNNKLDGPIPPELMNCSKLRI----LKLGNNLLSGSIPSQIGKLQELYYLD 179
LT L L++ +NK+ +L ++ + L L N ++ P +++ L+ L
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLT 206
Query: 180 LSGNFINGKIPSQ-LGEFSCIDTVDLSMNNLSG 211
L NF + + + + ++ L +
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN 239
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-41
Identities = 52/247 (21%), Positives = 84/247 (34%), Gaps = 13/247 (5%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASN 63
HL+L + F L L L+ S G + L L L ++ N
Sbjct: 303 NFGWQHLELVNCKFGQFPTLKLKSL-----KRLTFTSNKGGNAFSEVDLPSLEFLDLSRN 357
Query: 64 RMN--GSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSS- 120
++ G L+ LDLS N + + S L+ L +D + L S
Sbjct: 358 GLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSV 416
Query: 121 LGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQI-GKLQELYYLD 179
L L L++ + S L +LK+ N + I +L+ L +LD
Sbjct: 417 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 476
Query: 180 LSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHL---DVSGNQFGGEIPT 236
LS + P+ S + +++S NN + + L D S N
Sbjct: 477 LSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQ 536
Query: 237 TLANVPP 243
L + P
Sbjct: 537 ELQHFPS 543
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 4e-39
Identities = 49/244 (20%), Positives = 90/244 (36%), Gaps = 23/244 (9%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAI 60
+L +LDLS N + + L +L+ L+ ++L +V L L L I
Sbjct: 370 FGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDI 428
Query: 61 ASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSI-PSTLGHLKWLRSVDLSQNKLVGPIPS 119
+ + L L+VL ++ N + P L+ L +DLSQ +L P+
Sbjct: 429 SHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT 488
Query: 120 SLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQE-LYYL 178
+ L+ L LNM +N + L++L N + S ++ L +L
Sbjct: 489 AFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFL 548
Query: 179 DLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHLDVSGNQFGGEIPTTL 238
+L+ N +F+C + +++ L V + P+
Sbjct: 549 NLTQN-----------DFAC----TCEHQSFLQ----WIKDQRQLLVEVERMECATPSDK 589
Query: 239 ANVP 242
+P
Sbjct: 590 QGMP 593
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 9e-39
Identities = 51/252 (20%), Positives = 82/252 (32%), Gaps = 19/252 (7%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIA 61
L LDLS LS L L L+ N + L+ L L
Sbjct: 49 FSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108
Query: 62 SNRMNGSILLGIGSLKVLQVLDLSRNEI-GGSIPSTLGHLKWLRSVDLSQNKLVGPIPSS 120
+ IG LK L+ L+++ N I +P +L L +DLS NK+ +
Sbjct: 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168
Query: 121 LGHLTQLT----TLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQ-IGKLQEL 175
L L Q+ +L++ N ++ I P +L L L NN S ++ I L L
Sbjct: 169 LRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGL 227
Query: 176 YYLDLSGNFINGKIPSQLGEFSC--------IDTVDLSMNNLSGGIPVFV----RKVPHL 223
L + + + S I+ L+ + + + V
Sbjct: 228 EVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSF 287
Query: 224 DVSGNQFGGEIP 235
+
Sbjct: 288 SLVSVTIERVKD 299
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 6e-36
Identities = 46/212 (21%), Positives = 78/212 (36%), Gaps = 13/212 (6%)
Query: 34 LNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSI 93
+ L+ + N+P + L ++ N + S LQVLDLSR EI
Sbjct: 15 MELNFYKIPDNLPFS------TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIE 68
Query: 94 PSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRI 153
L L ++ L+ N + + L+ L L L + + L+
Sbjct: 69 DGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKE 128
Query: 154 LKL-GNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFS----CIDTVDLSMNN 208
L + N + S +P L L +LDLS N I + L ++DLS+N
Sbjct: 129 LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188
Query: 209 LSGGIPVFVRKVP--HLDVSGNQFGGEIPTTL 238
++ P +++ L + N + T
Sbjct: 189 MNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTC 220
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-32
Identities = 37/170 (21%), Positives = 65/170 (38%), Gaps = 8/170 (4%)
Query: 79 LQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLD 138
+ LDLS N + + L+ +DLS+ ++ + L+ L+TL + N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 139 GPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFING-KIPSQLGEFS 197
S L+ L L+ IG L+ L L+++ N I K+P +
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 198 CIDTVDLSMNNLSGGIPVFVRKVPH-------LDVSGNQFGGEIPTTLAN 240
++ +DLS N + +R + LD+S N P
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE 199
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 8e-30
Identities = 52/272 (19%), Positives = 93/272 (34%), Gaps = 40/272 (14%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKI----LNLSLNSLVGNIPSNVGHLTQLT 56
L NL HLDLS N L L ++ + L+LSLN + I +L
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLH 203
Query: 57 TLAIASNRMNGSIL-LGIGSLKVLQVLDLSRNEIGGSI---PSTLGHLKWLRSVDLSQNK 112
L + +N + +++ I L L+V L E L+ L ++ + + +
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263
Query: 113 L------VGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLS---- 162
L + I LT +++ ++ + ++ + L+L N
Sbjct: 264 LAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPT 321
Query: 163 ---------------GSIPSQIGKLQELYYLDLSGNFIN--GKIPSQLGEFSCIDTVDLS 205
G L L +LDLS N ++ G + + +DLS
Sbjct: 322 LKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381
Query: 206 MNNLSGGIPVFV--RKVPHLDVSGNQFGGEIP 235
N + F+ ++ HLD +
Sbjct: 382 FNGVITMSSNFLGLEQLEHLDFQHSNLKQMSE 413
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-28
Identities = 46/259 (17%), Positives = 82/259 (31%), Gaps = 22/259 (8%)
Query: 1 MGRLRNLVHLDLSDNHFMG-HIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLT--- 56
+G L+ L L+++ N +P L+ L+ L+LS N + +++ L Q+
Sbjct: 120 IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLN 179
Query: 57 -TLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGH-LKWLRSVDLS----- 109
+L ++ N MN ++ L L L N ++ T L L L
Sbjct: 180 LSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR 238
Query: 110 -QNKLVGPIPSSLGHLTQLTTLNMYNNKLD---GPIPPELMNCSKLRILKLGNNLLSGSI 165
+ L S+L L LT LD I + + L + +
Sbjct: 239 NEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVK 298
Query: 166 PSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHLDV 225
+L+L +L + N + + + LD+
Sbjct: 299 D--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEV--DLPSLEFLDL 354
Query: 226 SGNQ--FGGEIPTTLANVP 242
S N F G +
Sbjct: 355 SRNGLSFKGCCSQSDFGTT 373
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 7e-15
Identities = 18/138 (13%), Positives = 35/138 (25%), Gaps = 24/138 (17%)
Query: 105 SVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGS 164
+ + IP +L L++ N L + +L++L L +
Sbjct: 11 TYQCMELNFYK-IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTI 67
Query: 165 IPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHLD 224
L L L L+GN I +++L L
Sbjct: 68 EDGAYQSLSHLSTLILTGNPIQSLALGAFS----------GLSSLQ-----------KLV 106
Query: 225 VSGNQFGGEIPTTLANVP 242
+ ++
Sbjct: 107 AVETNLASLENFPIGHLK 124
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 21/88 (23%), Positives = 31/88 (35%), Gaps = 4/88 (4%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRL-SELKILNLSLNSLVGNIPSN--VGHLTQLTT 57
L +L LD S NH M L S L LNL+ N + +
Sbjct: 514 YKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQ 573
Query: 58 LAIASNRMNGSILLGIGSLKVLQVLDLS 85
L + RM + + VL L+++
Sbjct: 574 LLVEVERMECATPSDKQGMPVLS-LNIT 600
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 6e-42
Identities = 52/262 (19%), Positives = 90/262 (34%), Gaps = 31/262 (11%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVG-HLTQLTTLAI 60
++ L LD N G +L L L N + IP + Q+ L
Sbjct: 570 QKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGF 626
Query: 61 ASNRMNG-SILLGIGSLKVLQVLDLSRNEIGG---SIPSTLGHLKW--LRSVDLSQNKLV 114
+ N++ + S+ V+ +D S N+IG +I ++ K +V LS N++
Sbjct: 627 SHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ 686
Query: 115 GPIPSSLGHLTQLTTLNMYNNKLD-------GPIPPELMNCSKLRILKLGNNLLSGSIPS 167
+ ++T+ + NN + P N L + L N L+ S+
Sbjct: 687 KFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSD 745
Query: 168 QI--GKLQELYYLDLSGNFINGKIPSQLG------EFSCIDTVDLSMNNLSGGIPVFVRK 219
L L +D+S N + P+Q F D N + P +
Sbjct: 746 DFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITT 804
Query: 220 VPHL---DVSGNQFGGEIPTTL 238
P L + N ++ L
Sbjct: 805 CPSLIQLQIGSNDI-RKVDEKL 825
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-37
Identities = 48/264 (18%), Positives = 91/264 (34%), Gaps = 31/264 (11%)
Query: 1 MGRLRNLVHLDLSDNHFMGH------IPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQ 54
M ++ + L D I + RL++L+I+ + + + +
Sbjct: 414 MKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIA-----VD 468
Query: 55 LTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLV 114
+ + L +LK L ++L +P L L L+S++++ N+ +
Sbjct: 469 WEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGI 528
Query: 115 GP---------IPSSLGHLTQLTTLNMYNNKLDG-PIPPELMNCSKLRILKLGNNLLSGS 164
+ ++ M N L+ P L KL +L +N +
Sbjct: 529 SAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-H 587
Query: 165 IPSQIGKLQELYYLDLSGNFINGKIPSQLGEF-SCIDTVDLSMNNLSGGIP--VFVRKVP 221
+ + G +L L L N I IP F ++ + S N L IP + V
Sbjct: 588 LEA-FGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVY 644
Query: 222 HL---DVSGNQFGGEIPTTLANVP 242
+ D S N+ G E ++
Sbjct: 645 VMGSVDFSYNKIGSEGRNISCSMD 668
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 6e-36
Identities = 43/270 (15%), Positives = 84/270 (31%), Gaps = 43/270 (15%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAI 60
+ + L L+ G +P +G+L+ELK+L+ +S +
Sbjct: 319 LDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEE 378
Query: 61 ASNRMNGSI-LLGIGSLKVLQVLDLSRN------EIGGSIPSTLGHLKWLRSVDLSQNKL 113
+R+ + + + L + DL ++ E+ + LK + N++
Sbjct: 379 RKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDT-QIGNLTNRI 437
Query: 114 VGPIPSSLGHLTQLTTLNMYNNKLDGP-------------------IPPELMNCSKLRIL 154
I ++ LT+L + N+ N L +
Sbjct: 438 TF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDV 496
Query: 155 KLGNNLLSGSIPSQIGKLQELYYLDLSGNFING---------KIPSQLGEFSCIDTVDLS 205
+L N +P + L EL L+++ N ++ I +
Sbjct: 497 ELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMG 556
Query: 206 MNNLSGGIPVFV-----RKVPHLDVSGNQF 230
NNL P K+ LD N+
Sbjct: 557 YNNLE-EFPASASLQKMVKLGLLDCVHNKV 585
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-33
Identities = 44/257 (17%), Positives = 87/257 (33%), Gaps = 31/257 (12%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGN------IPSNVGHLTQL 55
+ L DL + + P + + + ++L + I + LT+L
Sbjct: 393 DYDQRLNLSDLLQDAINRN--PEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKL 450
Query: 56 TTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVG 115
+ A++ + + + + + +LK L V+L +
Sbjct: 451 QIIYFANSP-----FTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMT 505
Query: 116 PIPSSLGHLTQLTTLNMYNNKLDGP---------IPPELMNCSKLRILKLGNNLLSGSIP 166
+P L L +L +LN+ N+ + + K++I +G N L
Sbjct: 506 QLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPA 565
Query: 167 SQ-IGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFV----RKVP 221
S + K+ +L LD N + + + G + + L N + IP +V
Sbjct: 566 SASLQKMVKLGLLDCVHNKVR-HLEA-FGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVE 622
Query: 222 HLDVSGNQFGGEIPTTL 238
L S N+ IP
Sbjct: 623 GLGFSHNKL-KYIPNIF 638
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 6e-31
Identities = 35/231 (15%), Positives = 79/231 (34%), Gaps = 27/231 (11%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLG------RLSELKILNLSLNSLVGNIPSNVGHLTQ 54
+ + +D S N G + + + LS N + +
Sbjct: 640 AKSVYVMGSVDFSYNKI-GSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSP 698
Query: 55 LTTLAIASNR-------MNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTL--GHLKWLRS 105
++T+ +++N + +L +DL N++ S+ L +L +
Sbjct: 699 ISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKL-TSLSDDFRATTLPYLSN 757
Query: 106 VDLSQNKLVGPIPSSLGHLTQLTTLN------MYNNKLDGPIPPELMNCSKLRILKLGNN 159
+D+S N P+ + +QL N++ P + C L L++G+N
Sbjct: 758 MDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSN 816
Query: 160 LLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLS 210
+ + ++ +LY LD++ N + + + L +
Sbjct: 817 DIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-28
Identities = 34/244 (13%), Positives = 78/244 (31%), Gaps = 38/244 (15%)
Query: 24 TLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLD 83
L + L+L+ G +P +G LT+L L+ ++ S L + +
Sbjct: 318 DLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSE 377
Query: 84 LSRNEIGGSIPS-TLGHLKWLRSVDLSQNKL-----VGPIPSSLGHLTQLTTLNMYNNKL 137
++ I L + + L DL Q+ + + PI + T + N++
Sbjct: 378 ERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRI 437
Query: 138 DGPIPPELMNCSKLRILKLGNNLLSG-------------------SIPSQIGKLQELYYL 178
I + +KL+I+ N+ + + L++L +
Sbjct: 438 TF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDV 496
Query: 179 DLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVP------------HLDVS 226
+L ++P L + + +++++ N + +
Sbjct: 497 ELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMG 556
Query: 227 GNQF 230
N
Sbjct: 557 YNNL 560
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 2e-17
Identities = 20/165 (12%), Positives = 50/165 (30%), Gaps = 8/165 (4%)
Query: 82 LDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPI 141
+ + G L + + + L+ G +P ++G LT+L L+ +
Sbjct: 304 FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSG 363
Query: 142 PPELMNCSKLRILKLGNNLLSGSIPS-QIGKLQELYYLDLSGNFINGK---IPSQLGEFS 197
+ + + + + Q L DL + IN P +
Sbjct: 364 RLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRI 423
Query: 198 CIDTVDLS-MNNLSGGIPVFVRKVP---HLDVSGNQFGGEIPTTL 238
+ + + N I ++++ + + + F +
Sbjct: 424 SLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVD 468
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-40
Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 15/210 (7%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHR 373
E + IG G +G + G+ +K+++ E + E +L+ ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 374 NIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTD-----EEAVGLDWTKRVNIVKGMAHA 428
NIV+ ++++ +Y E G LF + +E LDW + + A
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQ------ICLA 137
Query: 429 LSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAP 488
L ++H ILHRDI S NI L + + DFGIAR+LN GT ++P
Sbjct: 138 LKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSP 194
Query: 489 ELAYTMVVTEKYDVYSFGVVALEVLMGKHP 518
E+ K D+++ G V E+ KH
Sbjct: 195 EICENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 6e-40
Identities = 53/248 (21%), Positives = 90/248 (36%), Gaps = 9/248 (3%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAIAS 62
L L L LS N F + L L++ N+ + + +L L L ++
Sbjct: 300 LSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSH 359
Query: 63 NRMNGSILLG--IGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVG-PIPS 119
+ + S + +L LQ L+LS NE L +DL+ +L S
Sbjct: 360 DDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQS 419
Query: 120 SLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELY--- 176
+L L LN+ ++ LD L+ L L N + LQ L
Sbjct: 420 PFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLE 479
Query: 177 YLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVP--HLDVSGNQFGGEI 234
L LS ++ ++ VDLS N L+ + + +L+++ N +
Sbjct: 480 ILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHISIIL 539
Query: 235 PTTLANVP 242
P+ L +
Sbjct: 540 PSLLPILS 547
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 8e-37
Identities = 46/245 (18%), Positives = 92/245 (37%), Gaps = 11/245 (4%)
Query: 6 NLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRM 65
++ ++L ++F T S L+ L+L+ L +PS + L+ L L +++N+
Sbjct: 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL-SELPSGLVGLSTLKKLVLSANKF 313
Query: 66 NGSILLGIGSLKVLQVLDLSRNEIGGSIPS-TLGHLKWLRSVDLSQNKL--VGPIPSSLG 122
+ + L L + N + + L +L+ LR +DLS + + L
Sbjct: 314 ENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLR 373
Query: 123 HLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIP-SQIGKLQELYYLDLS 181
+L+ L +LN+ N+ C +L +L L L S L L L+LS
Sbjct: 374 NLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLS 433
Query: 182 GNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVF------VRKVPHLDVSGNQFGGEIP 235
+ ++ + ++L N+ G + ++ L +S
Sbjct: 434 HSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQ 493
Query: 236 TTLAN 240
+
Sbjct: 494 HAFTS 498
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 9e-37
Identities = 48/237 (20%), Positives = 87/237 (36%), Gaps = 11/237 (4%)
Query: 4 LRNLVHLDLSDNHFMGHIPP-TLGRLSELKILNLSLNSL--VGNIPSNVGHLTQLTTLAI 60
+L HL + N + L L L+ L+LS + + + +L+ L +L +
Sbjct: 324 FPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNL 383
Query: 61 ASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIP-STLGHLKWLRSVDLSQNKLVGPIPS 119
+ N L++LDL+ + S +L L+ ++LS + L
Sbjct: 384 SYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQ 443
Query: 120 SLGHLTQLTTLNMYNNKLDGPI---PPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELY 176
L L LN+ N L +L IL L LS L+ +
Sbjct: 444 LFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMN 503
Query: 177 YLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHL---DVSGNQF 230
++DLS N + L I ++L+ N++S +P + + ++ N
Sbjct: 504 HVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPL 559
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 8e-36
Identities = 38/246 (15%), Positives = 70/246 (28%), Gaps = 10/246 (4%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASN 63
+ L+ S N T RL L L+L+ + +L TL + +N
Sbjct: 32 PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91
Query: 64 RMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGH 123
+ + K L+ L + I L + K L S+ L N +
Sbjct: 92 PLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFP 151
Query: 124 LTQLTTLNMYNNKLDGPIPPELMNCSKLRILKL--GNNLLSGSIPSQIGKLQELYYLDLS 181
+L L+ NN + ++ + + L L N ++ I L+
Sbjct: 152 TEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFDSAVFQSLNFG 210
Query: 182 GNFINGKIPSQLG--EFSCIDTVDLSMNNLSGGIPVFVRKVPH-----LDVSGNQFGGEI 234
G I L + + P + +++ + F
Sbjct: 211 GTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNIS 270
Query: 235 PTTLAN 240
T
Sbjct: 271 SNTFHC 276
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 9e-35
Identities = 56/214 (26%), Positives = 87/214 (40%), Gaps = 7/214 (3%)
Query: 4 LRNLVHLDLSDNH--FMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIA 61
L NL LDLS + L LS L+ LNLS N + QL L +A
Sbjct: 349 LENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLA 408
Query: 62 SNRMNGSILLGI-GSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPI--- 117
R+ +L +L+VL+LS + + S L L+ ++L N
Sbjct: 409 FTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQK 468
Query: 118 PSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYY 177
+SL L +L L + L + + + L +N L+ S + L+ + Y
Sbjct: 469 TNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-Y 527
Query: 178 LDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSG 211
L+L+ N I+ +PS L S T++L N L
Sbjct: 528 LNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-34
Identities = 53/274 (19%), Positives = 91/274 (33%), Gaps = 35/274 (12%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIA 61
RL NL LDL+ T L L L+ N L+ + + L L
Sbjct: 54 SRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFI 113
Query: 62 SNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSL 121
++ + + + K L+ L L N I + L+ +D N + +
Sbjct: 114 QTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDM 173
Query: 122 GHLTQLT--TLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIP-----SQIGKLQE 174
L Q T +LN+ N + G I P + + + L G I S I L
Sbjct: 174 SSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWL 232
Query: 175 LY-----------------------YLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSG 211
++L ++ + FS + +DL+ +LS
Sbjct: 233 GTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS- 291
Query: 212 GIPVFVRKVPH---LDVSGNQFGGEIPTTLANVP 242
+P + + L +S N+F + +N P
Sbjct: 292 ELPSGLVGLSTLKKLVLSANKFENLCQISASNFP 325
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 8e-33
Identities = 44/252 (17%), Positives = 82/252 (32%), Gaps = 14/252 (5%)
Query: 3 RLRNLVHLDLSDNHFMGHIPP-----TLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTT 57
L+ + I T+ L ++ + + + + + +
Sbjct: 200 DSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEM-SVES 258
Query: 58 LAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPI 117
+ + + LQ LDL+ + +PS L L L+ + LS NK
Sbjct: 259 INLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLC 317
Query: 118 PSSLGHLTQLTTLNMYNNKLDGPIPPE-LMNCSKLRILKLGNNLL--SGSIPSQIGKLQE 174
S + LT L++ N + L N LR L L ++ + S Q+ L
Sbjct: 318 QISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSH 377
Query: 175 LYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSG-GIPVFVRKVP---HLDVSGNQF 230
L L+LS N E ++ +DL+ L + + L++S +
Sbjct: 378 LQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLL 437
Query: 231 GGEIPTTLANVP 242
+P
Sbjct: 438 DISSEQLFDGLP 449
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-26
Identities = 43/167 (25%), Positives = 66/167 (39%), Gaps = 5/167 (2%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPPT-LGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAI 60
L LDL+ + L LK+LNLS + L + L L L +
Sbjct: 397 KECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNL 456
Query: 61 ASNRMNGSILLGIGSLKV---LQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPI 117
N + SL+ L++L LS ++ LK + VDLS N+L
Sbjct: 457 QGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSS 516
Query: 118 PSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGS 164
+L HL + LN+ +N + +P L S+ R + L N L +
Sbjct: 517 IEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-22
Identities = 28/166 (16%), Positives = 58/166 (34%), Gaps = 6/166 (3%)
Query: 80 QVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDG 139
+ + + IP TL ++ S N L ++ L LT L++ ++
Sbjct: 15 KTYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW 71
Query: 140 PIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCI 199
+ +L L L N L + + + L +L I+ L +
Sbjct: 72 IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTL 131
Query: 200 DTVDLSMNNLSG-GIPVFV--RKVPHLDVSGNQFGGEIPTTLANVP 242
+++ L N++S +P K+ LD N ++++
Sbjct: 132 ESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQ 177
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-39
Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 21/207 (10%)
Query: 322 CIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYG 380
IG G + +VY+ + VA +L + + + F+ EA +L ++H NIV+ Y
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 381 FCL----HEKCMFLIYEYMEMGSLFCILRT----DEEAVGLDWTKRVNIVKGMAHALSYL 432
+KC+ L+ E M G+L L+ + + W + I+KG L +L
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRS-WCR--QILKG----LQFL 145
Query: 433 HHHCTPPILHRDISSNNILLNSEF-EAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELA 491
H TPPI+HRD+ +NI + + D G+A L +S + GT +APE+
Sbjct: 146 HTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--ASFAKAVIGTPEFMAPEM- 201
Query: 492 YTMVVTEKYDVYSFGVVALEVLMGKHP 518
Y E DVY+FG+ LE+ ++P
Sbjct: 202 YEEKYDESVDVYAFGMCMLEMATSEYP 228
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-38
Identities = 57/233 (24%), Positives = 99/233 (42%), Gaps = 26/233 (11%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKK--LHRLETELASLESFQNEARLLSQIR 371
+F I+ IG G + VYRA L G VALKK + L + E LL Q+
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDA-KARADCIKEIDLLKQLN 90
Query: 372 HRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRT--------DEEAVGLDWTKRVNIVK 423
H N++K Y + + + ++ E + G L +++ E V + +
Sbjct: 91 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTV-WKYFVQ----- 144
Query: 424 GMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGT- 482
+ AL ++H ++HRDI N+ + + + D G+ R + ++ L GT
Sbjct: 145 -LCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTP 200
Query: 483 -YGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIK 534
Y ++PE + K D++S G + E+ + P + SL K I+
Sbjct: 201 YY--MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE 251
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-38
Identities = 49/220 (22%), Positives = 97/220 (44%), Gaps = 15/220 (6%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAI 60
RL +L H+ + M +P T+ + + L+ L L+ N L +P+++ L +L L+I
Sbjct: 100 AFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSI 157
Query: 61 ASNRM---------NGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQN 111
+ + L LQ L L I S+P+++ +L+ L+S+ + +
Sbjct: 158 RACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGI-RSLPASIANLQNLKSLKIRNS 216
Query: 112 KLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKL-GNNLLSGSIPSQIG 170
L + ++ HL +L L++ PP + L+ L L + L ++P I
Sbjct: 217 PLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIH 274
Query: 171 KLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLS 210
+L +L LDL G ++PS + + + + + +
Sbjct: 275 RLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-28
Identities = 34/252 (13%), Positives = 74/252 (29%), Gaps = 22/252 (8%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIA 61
+L + + L + + + +
Sbjct: 9 HHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQIETRT 64
Query: 62 SNRMNGSI-LLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSS 120
+ + LL + L+L + P L L+ + + L+ +P +
Sbjct: 65 GRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDT 122
Query: 121 LGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGK--------- 171
+ L TL + N L +P + + ++LR L + +P +
Sbjct: 123 MQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQG 181
Query: 172 LQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVP---HLDVSGN 228
L L L L I +P+ + + ++ + + LS + + +P LD+ G
Sbjct: 182 LVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGC 239
Query: 229 QFGGEIPTTLAN 240
P
Sbjct: 240 TALRNYPPIFGG 251
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 19/163 (11%), Positives = 44/163 (26%), Gaps = 24/163 (14%)
Query: 73 IGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPI--------------- 117
+ L + L + + D ++
Sbjct: 8 HHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRA 67
Query: 118 ----PSSLGHLTQ--LTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGK 171
L TQ L + + L P + S L+ + + L +P + +
Sbjct: 68 LKATADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQ 125
Query: 172 LQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIP 214
L L L+ N + +P+ + + + + + +P
Sbjct: 126 FAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELP 167
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 4e-10
Identities = 26/187 (13%), Positives = 58/187 (31%), Gaps = 27/187 (14%)
Query: 91 GSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMY----------------- 133
GS H ++ + + P L + +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE 61
Query: 134 --NNKLDGPIPPELMNCS--KLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKI 189
+ L + + L+L + L P Q +L L ++ + + ++
Sbjct: 62 TRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-EL 119
Query: 190 PSQLGEFSCIDTVDLSMNNLSGGIPVFV---RKVPHLDVSGNQFGGEIPTTLANVPPPHH 246
P + +F+ ++T+ L+ N L +P + ++ L + E+P LA+
Sbjct: 120 PDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGE 178
Query: 247 KTIATGL 253
L
Sbjct: 179 HQGLVNL 185
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 8e-38
Identities = 65/209 (31%), Positives = 98/209 (46%), Gaps = 15/209 (7%)
Query: 314 TEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRH 372
E F IG G +G V++ + KVVA+K + LE +E Q E +LSQ
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIEDIQQEITVLSQCDS 79
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRT---DEEAVGLDWTKRVNIVKGMAHAL 429
+ K YG L + +++I EY+ GS +L DE + I++ + L
Sbjct: 80 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT-------ILREILKGL 132
Query: 430 SYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPE 489
YLH +HRDI + N+LL+ E +ADFG+A L R GT +APE
Sbjct: 133 DYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 189
Query: 490 LAYTMVVTEKYDVYSFGVVALEVLMGKHP 518
+ K D++S G+ A+E+ G+ P
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-37
Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 16/211 (7%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGKV-VALKKLHRLETELASLESFQNEARLLSQIRHR 373
ED + IG G +G V+ RL + VA+K + F EAR+L Q H
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK-FLQEARILKQYSHP 172
Query: 374 NIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLH 433
NIV+L G C ++ ++++ E ++ G LRT+ + + + +V A + YL
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVK--TLLQMVGDAAAGMEYLE 230
Query: 434 HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI-----AP 488
+HRD+++ N L+ + ++DFG++R +G + AP
Sbjct: 231 SK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA---SGGLRQVPVKWTAP 284
Query: 489 ELAYTMVVTEKYDVYSFGVVALEVLM-GKHP 518
E + + DV+SFG++ E G P
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASP 315
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 52/229 (22%), Positives = 107/229 (46%), Gaps = 14/229 (6%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIA 61
L + L+L NH + + P L ++ L L ++ + + + + +LT L +L++
Sbjct: 129 ANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKD--VTPIANLTDLYSLSLN 185
Query: 62 SNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSL 121
N++ + SL L N+I P + ++ L S+ + NK+ P L
Sbjct: 186 YNQIEDIS--PLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--L 239
Query: 122 GHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLS 181
+L+QLT L + N++ + + +KL++L +G+N +S S + L +L L L+
Sbjct: 240 ANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLN 295
Query: 182 GNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPV-FVRKVPHLDVSGNQ 229
N + + +G + + T+ LS N+++ P+ + K+ D +
Sbjct: 296 NNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSADFANQV 344
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 129 bits (328), Expect = 1e-33
Identities = 52/231 (22%), Positives = 101/231 (43%), Gaps = 18/231 (7%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAI 60
+ L NL +L+L+ N P L L +L L + N + S + +LT L L +
Sbjct: 62 IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYL 117
Query: 61 ASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSS 120
+ ++ + + +L + L+L N S S L ++ L + ++++K+ P
Sbjct: 118 NEDNISD--ISPLANLTKMYSLNLGANHN-LSDLSPLSNMTGLNYLTVTESKVKDVTP-- 172
Query: 121 LGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDL 180
+ +LT L +L++ N+++ P L + + L N ++ P + + L L +
Sbjct: 173 IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKI 228
Query: 181 SGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVF--VRKVPHLDVSGNQ 229
N I P L S + +++ N +S I + K+ L+V NQ
Sbjct: 229 GNNKITDLSP--LANLSQLTWLEIGTNQIS-DINAVKDLTKLKMLNVGSNQ 276
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 51/209 (24%), Positives = 91/209 (43%), Gaps = 14/209 (6%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIA 61
+ L +L ++++ + P + L++L L+L+ N + S + LT L
Sbjct: 152 SNMTGLNYLTVTESKV-KDVTP-IANLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAY 207
Query: 62 SNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSL 121
N++ + ++ L L + N+I P L +L L +++ N++ +++
Sbjct: 208 VNQITDIT--PVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAV 261
Query: 122 GHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLS 181
LT+L LN+ +N++ L N S+L L L NN L IG L L L LS
Sbjct: 262 KDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLS 319
Query: 182 GNFINGKIPSQLGEFSCIDTVDLSMNNLS 210
N I P L S +D+ D + +
Sbjct: 320 QNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 51/229 (22%), Positives = 103/229 (44%), Gaps = 16/229 (6%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIA 61
L ++ L ++ I + L+ L+ LNL+ N + S + +L +LT L I
Sbjct: 41 EELESITKLVVAGEKV-ASIQG-IEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIG 96
Query: 62 SNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSL 121
+N++ + + + +L L+ L L+ + I P L +L + S++L N + S L
Sbjct: 97 TNKI--TDISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLS-DLSPL 151
Query: 122 GHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLS 181
++T L L + +K+ P + N + L L L N + P + L L+Y
Sbjct: 152 SNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAY 207
Query: 182 GNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPV-FVRKVPHLDVSGNQ 229
N I P + + ++++ + N ++ P+ + ++ L++ NQ
Sbjct: 208 VNQITDITP--VANMTRLNSLKIGNNKITDLSPLANLSQLTWLEIGTNQ 254
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 48/227 (21%), Positives = 91/227 (40%), Gaps = 16/227 (7%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASN 63
L + L T L + L ++ + + +LT L L + N
Sbjct: 21 LAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKV--ASIQGIEYLTNLEYLNLNGN 76
Query: 64 RMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGH 123
++ + + +L L L + N+I + S L +L LR + L+++ + P L +
Sbjct: 77 QITD--ISPLSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISDISP--LAN 130
Query: 124 LTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGN 183
LT++ +LN+ N L N + L L + + + P I L +LY L L+ N
Sbjct: 131 LTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYN 187
Query: 184 FINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVF-VRKVPHLDVSGNQ 229
I P L + + +N ++ PV + ++ L + N+
Sbjct: 188 QIEDISP--LASLTSLHYFTAYVNQITDITPVANMTRLNSLKIGNNK 232
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 50/224 (22%), Positives = 91/224 (40%), Gaps = 16/224 (7%)
Query: 7 LVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMN 66
L I P L+E L S+ L +T L +A ++
Sbjct: 2 AATLATLPAPI-NQIFP-DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKV- 56
Query: 67 GSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQ 126
+ + GI L L+ L+L+ N+I P L +L L ++ + NK+ S+L +LT
Sbjct: 57 -ASIQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTN 111
Query: 127 LTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFIN 186
L L + + + P L N +K+ L LG N S S + + L YL ++ + +
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVK 168
Query: 187 GKIPSQLGEFSCIDTVDLSMNNLSGGIPVF-VRKVPHLDVSGNQ 229
P + + + ++ L+ N + P+ + + + NQ
Sbjct: 169 DVTP--IANLTDLYSLSLNYNQIEDISPLASLTSLHYFTAYVNQ 210
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-36
Identities = 64/222 (28%), Positives = 99/222 (44%), Gaps = 20/222 (9%)
Query: 310 MIEATEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLS 368
M ED+++ Y IGTG YG + R GK++ K+L A + +E LL
Sbjct: 1 MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 369 QIRHRNIVKLYG-FCLHEKCMFLIY-EYMEMGSLFCILRT--------DEEAVGLDWTKR 418
+++H NIV+ Y I EY E G L ++ DEE V
Sbjct: 61 ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV------- 113
Query: 419 VNIVKGMAHALSYLH--HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNR 476
+ ++ + AL H +LHRD+ N+ L+ + + DFG+AR+LN+D+S
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA 173
Query: 477 TLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHP 518
GT ++PE M EK D++S G + E+ P
Sbjct: 174 KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 6e-36
Identities = 50/235 (21%), Positives = 74/235 (31%), Gaps = 12/235 (5%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGH---LTQLTTLAI 60
L L L L+ N G I L L L+LS N+L L L +
Sbjct: 327 LPFLKSLTLTMNK--GSISFKKVALPSLSYLDLSRNAL-SFSGCCSYSDLGTNSLRHLDL 383
Query: 61 ASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIP-STLGHLKWLRSVDLSQNKLVGPIPS 119
+ N + L+ LQ LD + + S L+ L +D+S
Sbjct: 384 SFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDG 442
Query: 120 SLGHLTQLTTLNMYNNKLDGPIPPE-LMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYL 178
LT L TL M N N + L L L L L L L
Sbjct: 443 IFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLL 502
Query: 179 DLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVP---HLDVSGNQF 230
++S N + S + + T+D S N + + +++ N
Sbjct: 503 NMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 3e-35
Identities = 47/211 (22%), Positives = 83/211 (39%), Gaps = 5/211 (2%)
Query: 4 LRNLVHLDLSDNH--FMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIA 61
L +L +LDLS N F G + + L+ L+LS N + + +N L +L L
Sbjct: 349 LPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQ 407
Query: 62 SNRMNGSILLG-IGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSS 120
+ + SL+ L LD+S L L ++ ++ N S+
Sbjct: 408 HSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSN 467
Query: 121 -LGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLD 179
+ T LT L++ +L+ +L++L + +N L S +L L LD
Sbjct: 468 VFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLD 527
Query: 180 LSGNFINGKIPSQLGEFSCIDTVDLSMNNLS 210
S N I + +L+ N+++
Sbjct: 528 CSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 9e-34
Identities = 40/255 (15%), Positives = 85/255 (33%), Gaps = 18/255 (7%)
Query: 5 RNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNR 64
+ ++DLS N + SEL+ L+LS + L L+ L + N
Sbjct: 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91
Query: 65 MNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVG-PIPSSLGH 123
+ L L+ L ++ +G L L+ ++++ N + +P+ +
Sbjct: 92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN 151
Query: 124 LTQLTTLNMYNNKLDGPIPPELMNCSKLRI----LKLGNNLLSGSIPSQIGKLQELYYLD 179
LT L +++ N + +L + L + N + I Q + +L+ L
Sbjct: 152 LTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELT 210
Query: 180 LSGNFINGKIPS-QLGEFSCIDTVDLSMNNLSGGIPVFVR-----------KVPHLDVSG 227
L GNF + I L + + L + + + + ++
Sbjct: 211 LRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTY 270
Query: 228 NQFGGEIPTTLANVP 242
+ +
Sbjct: 271 TNDFSDDIVKFHCLA 285
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-33
Identities = 46/246 (18%), Positives = 80/246 (32%), Gaps = 13/246 (5%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASN 63
L + P L LK L L++N +I L L+ L ++ N
Sbjct: 306 HFKWQSLSIIRCQL-KQFPT--LDLPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRN 360
Query: 64 RMN--GSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIP-SS 120
++ G L+ LDLS N + + L+ L+ +D + L S+
Sbjct: 361 ALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSA 419
Query: 121 LGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQI-GKLQELYYLD 179
L +L L++ + + L LK+ N + S + L +LD
Sbjct: 420 FLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLD 479
Query: 180 LSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVP---HLDVSGNQFGGEIPT 236
LS + + +++S NNL ++ LD S N+
Sbjct: 480 LSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGI 539
Query: 237 TLANVP 242
Sbjct: 540 LQHFPK 545
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-32
Identities = 45/212 (21%), Positives = 78/212 (36%), Gaps = 9/212 (4%)
Query: 8 VHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNG 67
+ D +P + S K ++LS N L + + ++L L ++ +
Sbjct: 14 ITYQCMDQKL-SKVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIET 70
Query: 68 SILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQL 127
L L L L+ N I P + L L ++ + KL +G L L
Sbjct: 71 IEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITL 130
Query: 128 TTLNMYNNKLDG-PIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQEL----YYLDLSG 182
LN+ +N + +P N + L + L N + + + L+E LD+S
Sbjct: 131 KKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSL 190
Query: 183 NFINGKIPSQLGEFSCIDTVDLSMNNLSGGIP 214
N I+ I Q + + + L N S I
Sbjct: 191 NPID-FIQDQAFQGIKLHELTLRGNFNSSNIM 221
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-31
Identities = 53/246 (21%), Positives = 86/246 (34%), Gaps = 18/246 (7%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIA 61
L LDLS L L L L+ N + P + LT L L
Sbjct: 53 SNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAV 112
Query: 62 SNRMNGSILLGIGSLKVLQVLDLSRNEIGG-SIPSTLGHLKWLRSVDLSQNKLVGPIPSS 120
++ IG L L+ L+++ N I +P+ +L L VDLS N + +
Sbjct: 113 ETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVND 172
Query: 121 LGHLTQLT----TLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPS-QIGKLQEL 175
L L + +L+M N +D I + KL L L N S +I + L L
Sbjct: 173 LQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGL 231
Query: 176 YYLDLSGNFINGKIPSQLGEFSCID--------TVDLSMNNLSGGIPVFVRKVPH---LD 224
+ L + ++ E S ++ L+ N V + + +
Sbjct: 232 HVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMS 291
Query: 225 VSGNQF 230
++G
Sbjct: 292 LAGVSI 297
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-27
Identities = 53/271 (19%), Positives = 88/271 (32%), Gaps = 39/271 (14%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKI----LNLSLNSLVGNIPSNVGHLTQLT 56
L NLVH+DLS N+ L L E L++SLN + I +L
Sbjct: 149 FSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPI-DFIQDQAFQGIKLH 207
Query: 57 TLAIASNRMNGSIL-LGIGSLKVLQVLDLSRNEIGGSI------PSTLGHLKWLR--SVD 107
L + N + +I+ + +L L V L E PS + L +
Sbjct: 208 ELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFR 267
Query: 108 LSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLS----- 162
L+ L ++ +++ + ++ K + L + L
Sbjct: 268 LTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQFPTL 325
Query: 163 --------------GSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSC--IDTVDLSM 206
GSI + L L YLDLS N ++ + + +DLS
Sbjct: 326 DLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSF 385
Query: 207 NNLSGGIPVF--VRKVPHLDVSGNQFGGEIP 235
N F + ++ HLD +
Sbjct: 386 NGAIIMSANFMGLEELQHLDFQHSTLKRVTE 416
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 5e-11
Identities = 26/112 (23%), Positives = 35/112 (31%), Gaps = 24/112 (21%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIA 61
NL LDLS L L++LN+S N+L+ S+ L
Sbjct: 470 ANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYS------- 522
Query: 62 SNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKL 113
L LD S N I S K L +L+ N +
Sbjct: 523 -----------------LSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-35
Identities = 52/254 (20%), Positives = 100/254 (39%), Gaps = 49/254 (19%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHR 373
DF IG+GG+G V++A+ GK +K++ + E A + E + L+++ H
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV-KYNNEKA-----EREVKALAKLDHV 64
Query: 374 NIVKLYGF----------------CLHEKCMFLIYEYMEMGSLFCILRT------DEEAV 411
NIV G KC+F+ E+ + G+L + D+
Sbjct: 65 NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124
Query: 412 GLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471
+ + + + + Y+H +++RD+ +NI L + + DFG+ L
Sbjct: 125 -------LELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN 174
Query: 472 DSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDK 531
D GT ++PE + ++ D+Y+ G++ E+L +
Sbjct: 175 DGKRTR-SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF---------ET 224
Query: 532 NIKLIDLLDPRLPP 545
+ DL D +
Sbjct: 225 SKFFTDLRDGIISD 238
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 2e-35
Identities = 47/236 (19%), Positives = 98/236 (41%), Gaps = 31/236 (13%)
Query: 304 RITFQDMIEA---TEDFDIKYCIGTG--GYGSVYRAR-LPSGKVVALKKLHRLETELASL 357
+ FQ M +++ IG G +V AR P+G+ V +++++ +
Sbjct: 11 NLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMV 70
Query: 358 ESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRT------DEEAV 411
Q E + H NIV + + ++++ +M GS ++ T +E A+
Sbjct: 71 TFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAI 130
Query: 412 GLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471
I++G+ AL Y+HH +HR + +++IL++ + + +++ +
Sbjct: 131 AY-------ILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180
Query: 472 DSSNR-TLLAGTYGSI------APELAYTMVV--TEKYDVYSFGVVALEVLMGKHP 518
+ + S+ +PE+ + K D+YS G+ A E+ G P
Sbjct: 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-35
Identities = 63/240 (26%), Positives = 106/240 (44%), Gaps = 17/240 (7%)
Query: 323 IGTGGYGSVYRARLPS-GKVVALKKLHRLETELAS----LESFQNEARLLSQIRHRNIVK 377
+G GG G VY A ++VALK + L+S Q EAR +++ ++V
Sbjct: 42 VGRGGMGDVYEAEDTVRERIVALKLMS---ETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 378 LYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCT 437
++ F + +++ + L +LR L + V IV+ + AL H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAA-- 153
Query: 438 PPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRT-LLAGTYGSIAPELAYTMVV 496
HRD+ NIL++++ A++ DFGIA + + GT +APE
Sbjct: 154 -GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHA 212
Query: 497 TEKYDVYSFGVVALEVLMGKHP--GELLSSSSSSLDKNIKLIDLLDPRLPPPGDQMIRQG 554
T + D+Y+ V E L G P G+ LS + +++ I + P +P D +I +G
Sbjct: 213 TYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIARG 272
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-35
Identities = 62/223 (27%), Positives = 94/223 (42%), Gaps = 38/223 (17%)
Query: 312 EATEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQI 370
E + +G G +G V+R + +G A+KK+ RLE E + +
Sbjct: 55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFR------VEELVACAGL 107
Query: 371 RHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRT----DEEAVGLDWTKRVNIVKGMA 426
IV LYG + + E +E GSL +++ E+ +
Sbjct: 108 SSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRAL-------YYLGQAL 160
Query: 427 HALSYLHHHCTPPILHRDISSNNILLNSE-FEAFVADFGIARLLNYDSSNRTLLAGTY-- 483
L YLH ILH D+ ++N+LL+S+ A + DFG A L D ++LL G Y
Sbjct: 161 EGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217
Query: 484 GSI---APELAYTMVVTE-----KYDVYSFGVVALEVLMGKHP 518
G+ APE VV K D++S + L +L G HP
Sbjct: 218 GTETHMAPE-----VVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 5e-35
Identities = 64/250 (25%), Positives = 114/250 (45%), Gaps = 41/250 (16%)
Query: 315 EDFDIKYCIGTGGYGSVYRARL--PSGKV---VALKKLHRLETELASLESFQNEARLLSQ 369
+F +G+G +G+VY+ KV VA+K+L R T + + +EA +++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMAS 73
Query: 370 IRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVG----LDWTKRVNIVKGM 425
+ + ++ +L G CL + LI + M G L +R ++ +G L+W V I KGM
Sbjct: 74 VDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGM 130
Query: 426 AHALSYL-HHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYG 484
YL +HRD+++ N+L+ + + DFG+A+LL + G
Sbjct: 131 N----YLEDRRL----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH---AEGG 179
Query: 485 SI-----APELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSSSSLDKNIKLIDL 538
+ A E + T + DV+S+GV E++ G P + + ++ +
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--------ASEISSI 231
Query: 539 LDP--RLPPP 546
L+ RLP P
Sbjct: 232 LEKGERLPQP 241
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-34
Identities = 60/221 (27%), Positives = 108/221 (48%), Gaps = 26/221 (11%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHR 373
+D++++ IG+G V A P + VA+K++ LE S++ E + +SQ H
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHHP 73
Query: 374 NIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRT-----DEEAVGLDWTKRVNIVKGMAHA 428
NIV Y + + ++L+ + + GS+ I++ + ++ LD + I++ +
Sbjct: 74 NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 429 LSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN-----YDSSNRTLLAGTY 483
L YLH + +HRD+ + NILL + +ADFG++ L + R GT
Sbjct: 134 LEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 484 GSIAPELAYTMVVTE------KYDVYSFGVVALEVLMGKHP 518
+APE V+ + K D++SFG+ A+E+ G P
Sbjct: 191 CWMAPE-----VMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 64/248 (25%), Positives = 104/248 (41%), Gaps = 35/248 (14%)
Query: 323 IGTGGYGSVYRARLP-----SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVK 377
+G G +G V R +G+ VA+K L + E+ + + E +L + H NIVK
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHENIVK 87
Query: 378 LYGFCLHEKC--MFLIYEYMEMGSLFCILRTDEEAVG----LDWTKRVNIVKGMAHALSY 431
G C + + LI E++ GSL L ++ + L + V I KGM Y
Sbjct: 88 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYA--VQICKGMD----Y 141
Query: 432 LH-HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI---A 487
L +HRD+++ N+L+ SE + + DFG+ + + D T+ + A
Sbjct: 142 LGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYA 197
Query: 488 PELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSSSSLD------KNIKLIDLLD 540
PE DV+SFGV E+L ++ + +L++ L
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK 257
Query: 541 P--RLPPP 546
RLP P
Sbjct: 258 EGKRLPCP 265
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-34
Identities = 58/238 (24%), Positives = 107/238 (44%), Gaps = 26/238 (10%)
Query: 319 IKYCIGTGGYGSVYRARL--PSGKV-VALKKLHRLETELASLESFQNEARLLSQIRHRNI 375
+G G +GSV + ++ VA+K L + TE A E EA+++ Q+ + I
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYI 72
Query: 376 VKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYL-HH 434
V+L G C E + L+ E G L L E + + ++ ++ + YL
Sbjct: 73 VRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYLEEK 129
Query: 435 HCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI---APELA 491
+ +HRD+++ N+LL + A ++DFG+++ L D S T + + APE
Sbjct: 130 NF----VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 185
Query: 492 YTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSSSSLDKNIKLIDLLDP--RLPPP 546
+ + DV+S+GV E L G+ P + + +++ ++ R+ P
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK--------GPEVMAFIEQGKRMECP 235
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-34
Identities = 54/239 (22%), Positives = 98/239 (41%), Gaps = 25/239 (10%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHR 373
+ + +G GG+ V L G ALK++ L E E Q EA + H
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRI--LCHEQQDREEAQREADMHRLFNHP 86
Query: 374 NIVKLYGFCLHEK----CMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRV-NIVKGMAHA 428
NI++L +CL E+ +L+ + + G+L+ + ++ ++ ++ G+
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 429 LSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRT------LLAGT 482
L +H HRD+ NILL E + + D G A
Sbjct: 147 LEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQ 203
Query: 483 YGSI---APEL----AYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIK 534
+I APEL ++ V+ E+ DV+S G V ++ G+ P +++ S+ ++
Sbjct: 204 RCTISYRAPELFSVQSHC-VIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ 261
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 5e-34
Identities = 65/242 (26%), Positives = 106/242 (43%), Gaps = 32/242 (13%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRN 374
+ IG+G +G V+ + VA+K + S E F EA ++ ++ H
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPK 64
Query: 375 IVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYL-H 433
+V+LYG CL + + L+ E+ME G L LRT + + + ++YL
Sbjct: 65 LVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAA--ETLLGMCLDVCEGMAYLEE 122
Query: 434 HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN---YDSSNRTLLAGTYGSI---A 487
+HRD+++ N L+ V+DFG+ R + Y SS T + +
Sbjct: 123 ACV----IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP-----VKWAS 173
Query: 488 PELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSSSSLDKNIKLIDLLDP--RLP 544
PE+ + K DV+SFGV+ EV GK P E S N ++++ + RL
Sbjct: 174 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--------NSEVVEDISTGFRLY 225
Query: 545 PP 546
P
Sbjct: 226 KP 227
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 6e-34
Identities = 60/211 (28%), Positives = 103/211 (48%), Gaps = 21/211 (9%)
Query: 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHR 373
+DF+ +G G G V++ PSG V+A K +H LE + A E ++L +
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH-LEIKPAIRNQIIRELQVLHECNSP 91
Query: 374 NIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRT----DEEAVGLDWTKRVNIVKGMAHAL 429
IV YG + + + E+M+ GSL +L+ E+ +G + + L
Sbjct: 92 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK-------VSIAVIKGL 144
Query: 430 SYLH--HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIA 487
+YL H I+HRD+ +NIL+NS E + DFG++ L DS + GT ++
Sbjct: 145 TYLREKHK----IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANS-FVGTRSYMS 198
Query: 488 PELAYTMVVTEKYDVYSFGVVALEVLMGKHP 518
PE + + D++S G+ +E+ +G++P
Sbjct: 199 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 6e-34
Identities = 52/207 (25%), Positives = 92/207 (44%), Gaps = 21/207 (10%)
Query: 322 CIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYG 380
+G G YG VY R L + +A+K++ ++ + E L ++H+NIV+ G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSR--YSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 381 FCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPI 440
+ + E + GSL +LR+ + + K + L YLH + I
Sbjct: 87 SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---I 143
Query: 441 LHRDISSNNILLNSEFEAFV--ADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVV-- 496
+HRDI +N+L+N+ + +DFG ++ L + GT +APE ++
Sbjct: 144 VHRDIKGDNVLINTY-SGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPE-----IIDK 197
Query: 497 -----TEKYDVYSFGVVALEVLMGKHP 518
+ D++S G +E+ GK P
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 9e-34
Identities = 55/216 (25%), Positives = 103/216 (47%), Gaps = 23/216 (10%)
Query: 314 TEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRH 372
E ++I +G G +G VY+A+ +G + A K + ++E LE + E +L+ H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI-ETKSE-EELEDYIVEIEILATCDH 75
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRT-----DEEAVGLDWTKRVNIVKGMAH 427
IVKL G H+ ++++ E+ G++ I+ E + + + + M
Sbjct: 76 PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-------VCRQMLE 128
Query: 428 ALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIA 487
AL++LH I+HRD+ + N+L+ E + +ADFG++ R GT +A
Sbjct: 129 ALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMA 185
Query: 488 PELAYTMVVTE-----KYDVYSFGVVALEVLMGKHP 518
PE+ + + K D++S G+ +E+ + P
Sbjct: 186 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-33
Identities = 56/234 (23%), Positives = 105/234 (44%), Gaps = 26/234 (11%)
Query: 323 IGTGGYGSVYRARLPSGKV---VALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLY 379
+G+G +G+V + KV VA+K L + A + EA ++ Q+ + IV++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 380 GFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYL-HHHCTP 438
G C E L+ E E+G L L+ + + + +V ++ + YL +
Sbjct: 85 GICEAES-WMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESNF-- 138
Query: 439 PILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI---APELAYTMV 495
+HRD+++ N+LL ++ A ++DFG+++ L D + + APE
Sbjct: 139 --VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 196
Query: 496 VTEKYDVYSFGVVALEVLM-GKHPGELLSSSSSSLDKNIKLIDLLDP--RLPPP 546
+ K DV+SFGV+ E G+ P + ++ +L+ R+ P
Sbjct: 197 FSSKSDVWSFGVLMWEAFSYGQKPYRGMK--------GSEVTAMLEKGERMGCP 242
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-33
Identities = 48/225 (21%), Positives = 93/225 (41%), Gaps = 29/225 (12%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHR 373
DF+ C+G GG+G V+ A+ A+K++ ELA E E + L+++ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA-REKVMREVKALAKLEHP 63
Query: 374 NIVKLYGFCLHEKCM------------FLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNI 421
IV+ + L + ++ + +L + + + ++I
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 422 VKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS-------- 473
+A A+ +LH ++HRD+ +NI + V DFG+ ++ D
Sbjct: 124 FLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 474 ----SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM 514
+ T GT ++PE + + K D++S G++ E+L
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-33
Identities = 73/249 (29%), Positives = 108/249 (43%), Gaps = 37/249 (14%)
Query: 323 IGTGGYGSVYRARLP-----SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVK 377
+G G +GSV R +G+VVA+KKL + L F+ E +L ++H NIVK
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 378 LYGFCLH--EKCMFLIYEYMEMGSLFCILRTDEEAVG----LDWTKRVNIVKGMAHALSY 431
G C + + LI EY+ GSL L+ +E + L +T I KGM Y
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT--SQICKGME----Y 129
Query: 432 LH-HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI---A 487
L +HRD+++ NIL+ +E + DFG+ ++L D + I A
Sbjct: 130 LGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA 185
Query: 488 PELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLD--------KNIKLIDLL 539
PE + DV+SFGVV E+ + + + LI+LL
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245
Query: 540 DP--RLPPP 546
RLP P
Sbjct: 246 KNNGRLPRP 254
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 68/250 (27%), Positives = 105/250 (42%), Gaps = 40/250 (16%)
Query: 323 IGTGGYGSVYRARLP-----SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVK 377
+G G +GSV R +G +VA+K+L + FQ E ++L + IVK
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD--QQRDFQREIQILKALHSDFIVK 88
Query: 378 LYGFCLH--EKCMFLIYEYMEMGSLFCILRTDEEAVG----LDWTKRVNIVKGMAHALSY 431
G + + L+ EY+ G L L+ + L ++ I KGM Y
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS--SQICKGME----Y 142
Query: 432 LH-HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI---- 486
L C +HRD+++ NIL+ SE +ADFG+A+LL D G
Sbjct: 143 LGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV--VREPGQSPIFW 196
Query: 487 -APELAYTMVVTEKYDVYSFGVVALEVLM-GKHP------GELLSSSSSSLDKNIKLIDL 538
APE + + + DV+SFGVV E+ + + +L++L
Sbjct: 197 YAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256
Query: 539 LDP--RLPPP 546
L+ RLP P
Sbjct: 257 LEEGQRLPAP 266
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 50/219 (22%), Positives = 102/219 (46%), Gaps = 23/219 (10%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRN 374
+ I IG+GG V++ ++ A+K ++ E + +L+S++NE L++++ +
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 375 --IVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYL 432
I++LY + + ++ ++++ E L L+ + +D +R + K M A+ +
Sbjct: 88 DKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTI 143
Query: 433 HHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSN--RTLLAGTYGSIAPEL 490
H H I+H D+ N L+ + + DFGIA + D+++ + GT + PE
Sbjct: 144 HQHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 199
Query: 491 -----------AYTMVVTEKYDVYSFGVVALEVLMGKHP 518
++ K DV+S G + + GK P
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-33
Identities = 63/239 (26%), Positives = 106/239 (44%), Gaps = 24/239 (10%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGKV-VALKKLHRLETELASLESFQNEARLLSQIRHR 373
D +K+ +G G YG VY + VA+K L E+ E F EA ++ +I+H
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHP 276
Query: 374 NIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLH 433
N+V+L G C E ++I E+M G+L LR + + + ++ A+ YL
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLE 335
Query: 434 HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN---YDSSNRTLLAGTYGSIAPEL 490
+HR++++ N L+ VADFG++RL+ Y + APE
Sbjct: 336 KKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPES 390
Query: 491 AYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSSSSLDKNIKLIDLLDP--RLPPP 546
+ K DV++FGV+ E+ G P + ++ +LL+ R+ P
Sbjct: 391 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--------LSQVYELLEKDYRMERP 441
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 59/214 (27%), Positives = 107/214 (50%), Gaps = 26/214 (12%)
Query: 314 TEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRH 372
+ + IG G G+VY A + +G+ VA+++++ L+ + E NE ++ + ++
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN-LQQQ-PKKELIINEILVMRENKN 76
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRT---DEEAVGLDWTKRVNIVKGMAHAL 429
NIV L ++++ EY+ GSL ++ DE + + + AL
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-------VCRECLQAL 129
Query: 430 SYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPE 489
+LH + ++HRDI S+NILL + + DFG + + S R+ + GT +APE
Sbjct: 130 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186
Query: 490 LAYTMVVTE-----KYDVYSFGVVALEVLMGKHP 518
VVT K D++S G++A+E++ G+ P
Sbjct: 187 -----VVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-33
Identities = 50/219 (22%), Positives = 101/219 (46%), Gaps = 23/219 (10%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRH-- 372
+ I IG+GG V++ ++ A+K ++ E + +L+S++NE L++++
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYL 432
I++LY + + ++ ++++ E L L+ + +D +R + K M A+ +
Sbjct: 69 DKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTI 124
Query: 433 HHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSN--RTLLAGTYGSIAPEL 490
H H I+H D+ N L+ + + DFGIA + D+++ + GT + PE
Sbjct: 125 HQHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180
Query: 491 -----------AYTMVVTEKYDVYSFGVVALEVLMGKHP 518
++ K DV+S G + + GK P
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-33
Identities = 62/242 (25%), Positives = 106/242 (43%), Gaps = 32/242 (13%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRN 374
+D +GTG +G V + VA+K + + F EA+++ + H
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEK 80
Query: 375 IVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYL-H 433
+V+LYG C ++ +F+I EYM G L LR + + + K + A+ YL
Sbjct: 81 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLES 138
Query: 434 HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL---NYDSSNRTLLAGTYGSI---A 487
LHRD+++ N L+N + V+DFG++R + Y SS + +
Sbjct: 139 KQF----LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP-----VRWSP 189
Query: 488 PELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSSSSLDKNIKLIDLLDP--RLP 544
PE+ + K D+++FGV+ E+ GK P E + N + + + RL
Sbjct: 190 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--------NSETAEHIAQGLRLY 241
Query: 545 PP 546
P
Sbjct: 242 RP 243
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 73/257 (28%), Positives = 108/257 (42%), Gaps = 37/257 (14%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLP-----SGKVVALKKLHRLETELASLESFQNEARLLSQ 369
+G G +GSV R +G+VVA+KKL + L F+ E +L
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKS 98
Query: 370 IRHRNIVKLYGFCLH--EKCMFLIYEYMEMGSLFCILRTDEEAVG----LDWTKRVNIVK 423
++H NIVK G C + + LI EY+ GSL L+ +E + L +T I K
Sbjct: 99 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT--SQICK 156
Query: 424 GMAHALSYLH-HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGT 482
GM YL +HRD+++ NIL+ +E + DFG+ ++L D +
Sbjct: 157 GME----YLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPG 208
Query: 483 YGSI---APELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLD--------K 531
I APE + DV+SFGVV E+ + + +
Sbjct: 209 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 268
Query: 532 NIKLIDLLDP--RLPPP 546
LI+LL RLP P
Sbjct: 269 VFHLIELLKNNGRLPRP 285
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 64/249 (25%), Positives = 115/249 (46%), Gaps = 39/249 (15%)
Query: 315 EDFDIKYCIGTGGYGSVYRARL--PSGKV---VALKKLHRLETELASLESFQNEARLLSQ 369
+F +G+G +G+VY+ KV VA+K+L R T + + +EA +++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMAS 73
Query: 370 IRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVG----LDWTKRVNIVKGM 425
+ + ++ +L G CL + LI + M G L +R ++ +G L+W V I KGM
Sbjct: 74 VDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGM 130
Query: 426 AHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGS 485
YL ++HRD+++ N+L+ + + DFG+A+LL + G
Sbjct: 131 N----YLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH---AEGGK 180
Query: 486 I-----APELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSSSSLDKNIKLIDLL 539
+ A E + T + DV+S+GV E++ G P + + ++ +L
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--------ASEISSIL 232
Query: 540 DP--RLPPP 546
+ RLP P
Sbjct: 233 EKGERLPQP 241
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-33
Identities = 77/238 (32%), Positives = 121/238 (50%), Gaps = 25/238 (10%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLES-FQNEARLLSQIRH 372
EDF+I +G G +G+VY AR S ++ALK L + + E A +E + E + S +RH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILR-----TDEEAVGLDWTKRVNIVKGMAH 427
NI++LYG+ ++LI EY +G+++ L+ ++ + +A+
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITELAN 120
Query: 428 ALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIA 487
ALSY H ++HRDI N+LL S E +ADFG + SS RT L GT +
Sbjct: 121 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA--PSSRRTDLCGTLDYLP 175
Query: 488 PELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRLPP 545
PE+ + EK D++S GV+ E L+GK P E +++ K I ++ P
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE--ANTYQETYKRISRVEF---TFPD 228
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-33
Identities = 59/242 (24%), Positives = 113/242 (46%), Gaps = 32/242 (13%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRN 374
E+ + +G+G +G V + VA+K + + F EA+ + ++ H
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPK 64
Query: 375 IVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYL-H 433
+VK YG C E ++++ EY+ G L LR+ + L+ ++ + + + +++L
Sbjct: 65 LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG--LEPSQLLEMCYDVCEGMAFLES 122
Query: 434 HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL---NYDSSNRTLLAGTYGSI---A 487
H +HRD+++ N L++ + V+DFG+ R + Y SS T + A
Sbjct: 123 HQF----IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFP-----VKWSA 173
Query: 488 PELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSSSSLDKNIKLIDLLDP--RLP 544
PE+ + + K DV++FG++ EV GK P +L + N +++ + RL
Sbjct: 174 PEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT--------NSEVVLKVSQGHRLY 225
Query: 545 PP 546
P
Sbjct: 226 RP 227
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-33
Identities = 66/211 (31%), Positives = 108/211 (51%), Gaps = 20/211 (9%)
Query: 314 TEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRH 372
E FD+ +G G YGSVY+A +G++VA+K++ +E++L + E ++ Q
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV-PVESDL---QEIIKEISIMQQCDS 83
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRT-----DEEAVGLDWTKRVNIVKGMAH 427
++VK YG ++++ EY GS+ I+R E+ + I++
Sbjct: 84 PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT-------ILQSTLK 136
Query: 428 ALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIA 487
L YLH +HRDI + NILLN+E A +ADFG+A L + R + GT +A
Sbjct: 137 GLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMA 193
Query: 488 PELAYTMVVTEKYDVYSFGVVALEVLMGKHP 518
PE+ + D++S G+ A+E+ GK P
Sbjct: 194 PEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-33
Identities = 63/241 (26%), Positives = 101/241 (41%), Gaps = 17/241 (7%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIA 61
L L LD+S N L +L+ L+ L + N + P +G LT L L++
Sbjct: 174 ANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLN 229
Query: 62 SNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSL 121
N++ + + SL L LDL+ N+I P L L L + L N++ P L
Sbjct: 230 GNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--L 283
Query: 122 GHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLS 181
LT LT L + N+L+ P + N L L L N +S P + L +L L
Sbjct: 284 AGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFY 339
Query: 182 GNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPV-FVRKVPHLDVSGNQFGGEIPTTLAN 240
N ++ S L + I+ + N +S P+ + ++ L ++ + AN
Sbjct: 340 NNKVSD--VSSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQAWTNAPVNYKAN 397
Query: 241 V 241
V
Sbjct: 398 V 398
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-32
Identities = 63/240 (26%), Positives = 105/240 (43%), Gaps = 17/240 (7%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIA 61
+L NL L ++N P LG L+ L L+L+ N L + LT LT L +A
Sbjct: 196 AKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 251
Query: 62 SNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSL 121
+N+++ + L L L L N+I P L L L +++L++N+L P +
Sbjct: 252 NNQISNLA--PLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--I 305
Query: 122 GHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLS 181
+L LT L +Y N + P + + +KL+ L NN +S S + L + +L
Sbjct: 306 SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAG 361
Query: 182 GNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHLDVSGNQFGGEI-PTTLAN 240
N I+ P L + I + L+ + + V + N G I P T+++
Sbjct: 362 HNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATISD 419
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 6e-31
Identities = 65/235 (27%), Positives = 102/235 (43%), Gaps = 18/235 (7%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIA 61
L NL L L +N L L+ L L LS N++ S + LT L L+
Sbjct: 109 ANLTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF- 163
Query: 62 SNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSL 121
N + L + +L L+ LD+S N++ S S L L L S+ + N++ P L
Sbjct: 164 GN--QVTDLKPLANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITP--L 217
Query: 122 GHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLS 181
G LT L L++ N+L L + + L L L NN +S P + L +L L L
Sbjct: 218 GILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLG 273
Query: 182 GNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPV-FVRKVPHLDVSGNQFGGEIP 235
N I+ P L + + ++L+ N L P+ ++ + +L + N P
Sbjct: 274 ANQISNISP--LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP 326
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 9e-31
Identities = 62/235 (26%), Positives = 104/235 (44%), Gaps = 18/235 (7%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIA 61
L NL ++ S+N P L L++L + ++ N + + + +LT LT L +
Sbjct: 65 EYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLF 120
Query: 62 SNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSL 121
+N++ + +L L L+LS N I S S L L L+ + N++ P L
Sbjct: 121 NNQITDID--PLKNLTNLNRLELSSNTI--SDISALSGLTSLQQLSFG-NQVTDLKP--L 173
Query: 122 GHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLS 181
+LT L L++ +NK+ L + L L NN +S P +G L L L L+
Sbjct: 174 ANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLN 229
Query: 182 GNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPV-FVRKVPHLDVSGNQFGGEIP 235
GN + L + + +DL+ N +S P+ + K+ L + NQ P
Sbjct: 230 GNQLKD--IGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISP 282
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-30
Identities = 60/236 (25%), Positives = 99/236 (41%), Gaps = 18/236 (7%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAI 60
+ L +L L + + P L L+ L+ L++S N + S + LT L +L
Sbjct: 152 LSGLTSLQQLSFGNQVT--DLKP-LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIA 206
Query: 61 ASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSS 120
+N+++ +G L L L L+ N++ TL L L +DL+ N++ P
Sbjct: 207 TNNQISDIT--PLGILTNLDELSLNGNQL--KDIGTLASLTNLTDLDLANNQISNLAP-- 260
Query: 121 LGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDL 180
L LT+LT L + N++ P L + L L+L N L P I L+ L YL L
Sbjct: 261 LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTL 316
Query: 181 SGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPV-FVRKVPHLDVSGNQFGGEIP 235
N I+ P + + + + N +S + + + L NQ P
Sbjct: 317 YFNNISDISP--VSSLTKLQRLFFYNNKVSDVSSLANLTNINWLSAGHNQISDLTP 370
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-29
Identities = 46/227 (20%), Positives = 93/227 (40%), Gaps = 18/227 (7%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASN 63
L + L + + L ++ L + V +L LT + ++N
Sbjct: 23 LAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNN 78
Query: 64 RMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGH 123
++ + + +L L + ++ N+I P L +L L + L N++ P L +
Sbjct: 79 QLTD--ITPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKN 132
Query: 124 LTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGN 183
LT L L + +N + L + L+ L GN + + L L LD+S N
Sbjct: 133 LTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD---LKPLANLTTLERLDISSN 187
Query: 184 FINGKIPSQLGEFSCIDTVDLSMNNLSGGIPV-FVRKVPHLDVSGNQ 229
++ S L + + ++++ + N +S P+ + + L ++GNQ
Sbjct: 188 KVSD--ISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQ 232
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-28
Identities = 50/213 (23%), Positives = 79/213 (37%), Gaps = 13/213 (6%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIA 61
L L L L N I P L L+ L L L+ N L S + +L LT L +
Sbjct: 262 SGLTKLTELKLGANQISN-ISP-LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLY 317
Query: 62 SNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSL 121
N ++ + + SL LQ L N++ S S+L +L + + N++ P L
Sbjct: 318 FNNISD--ISPVSSLTKLQRLFFYNNKV--SDVSSLANLTNINWLSAGHNQISDLTP--L 371
Query: 122 GHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLS 181
+LT++T L + + N S +K L P+ I D++
Sbjct: 372 ANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL--IAPATISDGGSYTEPDIT 429
Query: 182 GNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIP 214
N + FS T+ SG +
Sbjct: 430 WNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-25
Identities = 54/236 (22%), Positives = 91/236 (38%), Gaps = 22/236 (9%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIA 61
G L + D I L+E L ++ + L Q+TTL
Sbjct: 1 GPLGSA--TITQDTPI-NQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQAD 54
Query: 62 SNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSL 121
+ G+ L L ++ S N++ P L +L L + ++ N++ P L
Sbjct: 55 RL--GIKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--L 108
Query: 122 GHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLS 181
+LT LT L ++NN++ P L N + L L+L +N +S S + L L L
Sbjct: 109 ANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG 164
Query: 182 GNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFV--RKVPHLDVSGNQFGGEIP 235
+ L + ++ +D+S N +S I V + L + NQ P
Sbjct: 165 NQVTD---LKPLANLTTLERLDISSNKVS-DISVLAKLTNLESLIATNNQISDITP 216
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 7e-33
Identities = 75/242 (30%), Positives = 111/242 (45%), Gaps = 24/242 (9%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGK----VVALKKLHRLETELASLESFQNEARLLSQI 370
+ I +G G +G V RL VA+K L TE + F EA ++ Q
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQF 103
Query: 371 RHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALS 430
H NI++L G K + ++ EYME GSL LR + + V +++G+A +
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ--FTVIQLVGMLRGIASGMK 161
Query: 431 YLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI---A 487
YL +HRD+++ NIL+NS V+DFG+ R+L D G I +
Sbjct: 162 YLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 488 PELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSSSSLDKNIKLIDLLDP--RLP 544
PE T DV+S+G+V EV+ G+ P +S N +I +D RLP
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS--------NQDVIKAVDEGYRLP 270
Query: 545 PP 546
PP
Sbjct: 271 PP 272
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 7e-33
Identities = 74/242 (30%), Positives = 112/242 (46%), Gaps = 24/242 (9%)
Query: 315 EDFDIKYCIGTGGYGSVYRARL---PSGKV-VALKKLHRLETELASLESFQNEARLLSQI 370
I+ IG+G G V RL V VA+K L TE + F +EA ++ Q
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRD-FLSEASIMGQF 107
Query: 371 RHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALS 430
H NI++L G + ++ EYME GSL LRT + + V +++G+ +
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ--FTIMQLVGMLRGVGAGMR 165
Query: 431 YLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI---A 487
YL +HRD+++ N+L++S V+DFG++R+L D G I A
Sbjct: 166 YLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTA 222
Query: 488 PELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSSSSLDKNIKLIDLLDP--RLP 544
PE + DV+SFGVV EVL G+ P ++ N +I ++ RLP
Sbjct: 223 PEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT--------NRDVISSVEEGYRLP 274
Query: 545 PP 546
P
Sbjct: 275 AP 276
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 49/219 (22%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRH-- 372
+ I IG+GG V++ ++ A+K ++ E + +L+S++NE L++++
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYL 432
I++LY + + ++ ++++ E L L+ + +D +R + K M A+ +
Sbjct: 116 DKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTI 171
Query: 433 HHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTL--LAGTYGSIAPEL 490
H H I+H D+ N L+ + + DFGIA + D+++ G + PE
Sbjct: 172 HQHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEA 227
Query: 491 -----------AYTMVVTEKYDVYSFGVVALEVLMGKHP 518
++ K DV+S G + + GK P
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 61/248 (24%), Positives = 102/248 (41%), Gaps = 37/248 (14%)
Query: 323 IGTGGYGSVYRARL-----PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVK 377
+G G +G V +G++VA+K L + + ++ E +L + H +I+K
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 378 LYGFCLHEKC--MFLIYEYMEMGSLFCILRTDEEAVG--LDWTKRVNIVKGMAHALSYLH 433
G C + L+ EY+ +GSL L + L + I +GMA YLH
Sbjct: 98 YKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFA--QQICEGMA----YLH 151
Query: 434 -HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI-----A 487
H +HRD+++ N+LL+++ + DFG+A+ + G A
Sbjct: 152 AQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR--VREDGDSPVFWYA 205
Query: 488 PELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSSSSLD------KNIKLIDLLD 540
PE DV+SFGV E+L + + ++L +LL+
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265
Query: 541 P--RLPPP 546
RLP P
Sbjct: 266 RGERLPRP 273
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 57/209 (27%), Positives = 105/209 (50%), Gaps = 16/209 (7%)
Query: 314 TEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRH 372
D IG G G V AR SG+ VA+K + + + E NE ++ +H
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQH 101
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRT---DEEAVGLDWTKRVNIVKGMAHAL 429
N+V++Y L + ++++ E+++ G+L I+ +EE + + + + AL
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIAT-------VCEAVLQAL 154
Query: 430 SYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPE 489
+YLH ++HRDI S++ILL + ++DFG ++ D R L GT +APE
Sbjct: 155 AYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPE 211
Query: 490 LAYTMVVTEKYDVYSFGVVALEVLMGKHP 518
+ + + D++S G++ +E++ G+ P
Sbjct: 212 VISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 66/249 (26%), Positives = 112/249 (44%), Gaps = 39/249 (15%)
Query: 315 EDFDIKYCIGTGGYGSVYRARL----PSGKV-VALKKLHRLETELASLESFQNEARLLSQ 369
+ +G+G +G+V++ S K+ V +K + ++ S ++ + +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI-EDKSGRQSFQAVTDHMLAIGS 71
Query: 370 IRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVG----LDWTKRVNIVKGM 425
+ H +IV+L G C + L+ +Y+ +GSL +R A+G L+W V I KGM
Sbjct: 72 LDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWG--VQIAKGM 128
Query: 426 AHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGS 485
YL H ++HR++++ N+LL S + VADFG+A LL D +
Sbjct: 129 Y----YLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQL---LYSEAK 178
Query: 486 I-----APELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSSSSLDKNIKLIDLL 539
A E + T + DV+S+GV E++ G P L ++ DLL
Sbjct: 179 TPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR--------LAEVPDLL 230
Query: 540 DP--RLPPP 546
+ RL P
Sbjct: 231 EKGERLAQP 239
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 60/204 (29%), Positives = 94/204 (46%), Gaps = 19/204 (9%)
Query: 323 IGTGGYGSVYRA---RLPSGKVVALKKLHRLETELAS----LESFQNEARLLSQIRHRNI 375
+G GG +VY A L VA+K + L+ F+ E SQ+ H+NI
Sbjct: 19 LGGGGMSTVYLAEDTIL--NIKVAIKAIF---IPPREKEETLKRFEREVHNSSQLSHQNI 73
Query: 376 VKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHH 435
V + + C +L+ EY+E +L + + L +N + + + H
Sbjct: 74 VSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHDM 130
Query: 436 CTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRT-LLAGTYGSIAPELAYTM 494
I+HRDI NIL++S + DFGIA+ L+ S +T + GT +PE A
Sbjct: 131 ---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE 187
Query: 495 VVTEKYDVYSFGVVALEVLMGKHP 518
E D+YS G+V E+L+G+ P
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGEPP 211
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 63/248 (25%), Positives = 106/248 (42%), Gaps = 34/248 (13%)
Query: 315 EDFDIKYCIGTGGYGSVYRARL--PSGKV--VALKKLHR-LETELASLESFQNEARLLSQ 369
+D + +G G +G V R PSGK VA+K L + ++ +++ F E +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 370 IRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVG----LDWTKRVNIVKGM 425
+ HRN+++LYG L M ++ E +GSL LR + + V + +GM
Sbjct: 78 LDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA--VQVAEGM 134
Query: 426 AHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGS 485
YL +HRD+++ N+LL + + DFG+ R L + + +
Sbjct: 135 G----YLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 187
Query: 486 I---APELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSSSSLDKNIKLIDLLDP 541
APE T + D + FGV E+ G+ P L+ +++ +D
Sbjct: 188 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN--------GSQILHKIDK 239
Query: 542 ---RLPPP 546
RLP P
Sbjct: 240 EGERLPRP 247
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-32
Identities = 59/240 (24%), Positives = 112/240 (46%), Gaps = 32/240 (13%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRN 374
++ + IG G +G V G VA+K + A+ ++F EA +++Q+RH N
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIK----NDATAQAFLAEASVMTQLRHSN 75
Query: 375 IVKLYGFCLHEK-CMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYL- 432
+V+L G + EK ++++ EYM GSL LR+ +V L + + A+ YL
Sbjct: 76 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLE 134
Query: 433 HHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI---APE 489
++ +HRD+++ N+L++ + A V+DFG+ + + L + APE
Sbjct: 135 GNNF----VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------PVKWTAPE 184
Query: 490 LAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSSSSLDKNIKLIDLLDP--RLPPP 546
+ K DV+SFG++ E+ G+ P + ++ ++ ++ P
Sbjct: 185 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--------LKDVVPRVEKGYKMDAP 236
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 79/244 (32%), Positives = 119/244 (48%), Gaps = 27/244 (11%)
Query: 315 EDFDIKYCIGTGGYGSVYRARL--PSGKV---VALKKLHRLETELASLESFQNEARLLSQ 369
+ IG G +G VY+ L SGK VA+K L TE ++ F EA ++ Q
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD-FLGEAGIMGQ 102
Query: 370 IRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHAL 429
H NI++L G K M +I EYME G+L LR + + V +++G+A +
Sbjct: 103 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRGIAAGM 160
Query: 430 SYL-HHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI-- 486
YL + + +HRD+++ NIL+NS V+DFG++R+L D +G I
Sbjct: 161 KYLANMNY----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 216
Query: 487 -APELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSSSSLDKNIKLIDLLDP--R 542
APE T DV+SFG+V EV+ G+ P LS N +++ ++ R
Sbjct: 217 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--------NHEVMKAINDGFR 268
Query: 543 LPPP 546
LP P
Sbjct: 269 LPTP 272
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-32
Identities = 65/242 (26%), Positives = 107/242 (44%), Gaps = 30/242 (12%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGKV-VALKKLHRLETELASLESFQNEARLLSQIRHR 373
D +K+ +G G YG VY + VA+K L E+ E F EA ++ +I+H
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHP 69
Query: 374 NIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLH 433
N+V+L G C E ++I E+M G+L LR + + + ++ A+ YL
Sbjct: 70 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLE 128
Query: 434 HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN---YDSSNRTLLAGTYGSI---A 487
+HRD+++ N L+ VADFG++RL+ Y + I A
Sbjct: 129 KKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP-----IKWTA 180
Query: 488 PELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSSSSLDKNIKLIDLLDP--RLP 544
PE + K DV++FGV+ E+ G P + ++ +LL+ R+
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--------LSQVYELLEKDYRME 232
Query: 545 PP 546
P
Sbjct: 233 RP 234
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 130 bits (327), Expect = 4e-32
Identities = 58/234 (24%), Positives = 106/234 (45%), Gaps = 26/234 (11%)
Query: 323 IGTGGYGSVYRARLPSGKV---VALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLY 379
+G G +GSV + K VA+K L + TE A E EA+++ Q+ + IV+L
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 380 GFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYL-HHHCTP 438
G C E + L+ E G L L E + + ++ ++ + YL +
Sbjct: 403 GVCQAEA-LMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYLEEKNF-- 457
Query: 439 PILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI---APELAYTMV 495
+HR++++ N+LL + A ++DFG+++ L D S T + + APE
Sbjct: 458 --VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 496 VTEKYDVYSFGVVALEVLM-GKHPGELLSSSSSSLDKNIKLIDLLDP--RLPPP 546
+ + DV+S+GV E L G+ P + + +++ ++ R+ P
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKPYKKMK--------GPEVMAFIEQGKRMECP 561
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-32
Identities = 57/214 (26%), Positives = 90/214 (42%), Gaps = 17/214 (7%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEAR-LLSQIRH 372
ED IG G YGSV + PSG+++A+K++ R + + + ++
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLDVVMRSSDC 80
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRV--NIVKGMAHALS 430
IV+ YG E ++ E M S + + + + I AL+
Sbjct: 81 PYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139
Query: 431 YLH--HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAP 488
+L I+HRDI +NILL+ + DFGI+ L DS +T AG +AP
Sbjct: 140 HLKENLK----IIHRDIKPSNILLDRSGNIKLCDFGISGQLV-DSIAKTRDAGCRPYMAP 194
Query: 489 ELAYTMVVTEKY----DVYSFGVVALEVLMGKHP 518
E + Y DV+S G+ E+ G+ P
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-32
Identities = 40/210 (19%), Positives = 79/210 (37%), Gaps = 15/210 (7%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIA 61
L L+LS N + L LS L+ L+L+ N + + + TL A
Sbjct: 55 APFTKLELLNLSSNVL--YETLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAA 107
Query: 62 SNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVG-PIPSS 120
+N ++ + + + + L+ N+I G ++ +DL N++
Sbjct: 108 NNNISR---VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAEL 164
Query: 121 LGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDL 180
L LN+ N + + ++ +KL+ L L +N L+ + + + ++ L
Sbjct: 165 AASSDTLEHLNLQYNFIYD-VKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISL 221
Query: 181 SGNFINGKIPSQLGEFSCIDTVDLSMNNLS 210
N + I L ++ DL N
Sbjct: 222 RNNKLV-LIEKALRFSQNLEHFDLRGNGFH 250
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 48/248 (19%), Positives = 93/248 (37%), Gaps = 28/248 (11%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASN 63
++D+ + +K L+LS N L +++ T+L L ++SN
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 64 RMNGSILLGIGSLKVLQVLDLSRNEIGGSIPS-----------------TLGHLKWLRSV 106
+ L + SL L+ LDL+ N + + + + +++
Sbjct: 69 VL--YETLDLESLSTLRTLDLNNNYV-QELLVGPSIETLHAANNNISRVSCSRGQGKKNI 125
Query: 107 DLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDG-PIPPELMNCSKLRILKLGNNLLSGSI 165
L+ NK+ G +++ L++ N++D + L L L N + +
Sbjct: 126 YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DV 184
Query: 166 PSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVP---H 222
Q+ +L LDLS N + + + + + + L N L I +R H
Sbjct: 185 KGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEH 241
Query: 223 LDVSGNQF 230
D+ GN F
Sbjct: 242 FDLRGNGF 249
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 35/210 (16%), Positives = 69/210 (32%), Gaps = 11/210 (5%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVG-NIPSNVGHLTQLTTLAI 60
R + ++ L++N G S ++ L+L LN + N L L +
Sbjct: 117 SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176
Query: 61 ASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSS 120
N + + G L+ LDLS N++ + + + L NKLV I +
Sbjct: 177 QYNFI--YDVKGQVVFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLVL-IEKA 232
Query: 121 LGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDL 180
L L ++ N R+ + + + Q + + L
Sbjct: 233 LRFSQNLEHFDLRGNGFHC-GTLRDFFSKNQRVQTVAKQTVK-KLTGQNEEECTVPTLGH 290
Query: 181 SGNFINGKIPSQLGEFSCIDTVDLSMNNLS 210
G + +P+ + + L ++
Sbjct: 291 YGAYCCEDLPAPFAD----RLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 38/189 (20%), Positives = 67/189 (35%), Gaps = 14/189 (7%)
Query: 45 IPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLR 104
I + + + + + ++ S ++ LDLS N + + L L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 105 SVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGS 164
++LS N L L L+ L TL++ NN + EL+ + L NN +S
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-R 113
Query: 165 IPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSG-GIPVFVRKVP-- 221
+ Q + L+ N I G S + +DL +N +
Sbjct: 114 VSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 222 -HLDVSGNQ 229
HL++ N
Sbjct: 172 EHLNLQYNF 180
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 26/151 (17%), Positives = 56/151 (37%), Gaps = 7/151 (4%)
Query: 92 SIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKL 151
+I + + ++ + L + S + L++ N L +L +KL
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 152 RILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSG 211
+L L +N+L + L L LDL+ N++ +L I+T+ + NN+S
Sbjct: 61 ELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISR 113
Query: 212 GIPVFVRKVPHLDVSGNQFGGEIPTTLANVP 242
+ ++ ++ N+
Sbjct: 114 VSCSRGQGKKNIYLANNKITMLRDLDEGCRS 144
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-32
Identities = 59/239 (24%), Positives = 111/239 (46%), Gaps = 30/239 (12%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRN 374
++ + IG G +G V G VA+K + A+ ++F EA +++Q+RH N
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIK----NDATAQAFLAEASVMTQLRHSN 247
Query: 375 IVKLYGFCLHEK-CMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLH 433
+V+L G + EK ++++ EYM GSL LR+ +V L + + A+ YL
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLE 306
Query: 434 HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI---APEL 490
+ +HRD+++ N+L++ + A V+DFG+ + + L + APE
Sbjct: 307 GNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------PVKWTAPEA 357
Query: 491 AYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSSSSLDKNIKLIDLLDP--RLPPP 546
+ K DV+SFG++ E+ G+ P + ++ ++ ++ P
Sbjct: 358 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--------LKDVVPRVEKGYKMDAP 408
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 6e-32
Identities = 51/215 (23%), Positives = 89/215 (41%), Gaps = 22/215 (10%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEAR-LLSQIRH 372
D + +G+G G V++ R +G V+A+K++ R + + +L
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM-RRSGNKEENKRILMDLDVVLKSHDC 83
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRT----DEEAVGLDWTKRVNIVKGMAHA 428
IV+ +G + +F+ E M + R E +G + + A
Sbjct: 84 PYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG-------KMTVAIVKA 136
Query: 429 LSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAP 488
L YL ++HRD+ +NILL+ + + DFGI+ L D + AG +AP
Sbjct: 137 LYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLV-DDKAKDRSAGCAAYMAP 193
Query: 489 E-LAYTMVVTEKY----DVYSFGVVALEVLMGKHP 518
E + Y DV+S G+ +E+ G+ P
Sbjct: 194 ERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-32
Identities = 65/241 (26%), Positives = 112/241 (46%), Gaps = 30/241 (12%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRN 374
E + +G G +G V+ VA+K L + ++F EA L+ Q++H+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQR 69
Query: 375 IVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHH 434
+V+LY E +++I EYME GSL L+T L K +++ +A ++++
Sbjct: 70 LVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEE 127
Query: 435 HCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN---YDSSNRTLLAGTYGSI---AP 488
+HRD+ + NIL++ +ADFG+ARL+ Y + I AP
Sbjct: 128 RN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP-----IKWTAP 179
Query: 489 ELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSSSSLDKNIKLIDLLDP--RLPP 545
E T K DV+SFG++ E++ G+ P ++ N ++I L+ R+
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--------NPEVIQNLERGYRMVR 231
Query: 546 P 546
P
Sbjct: 232 P 232
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-32
Identities = 51/258 (19%), Positives = 99/258 (38%), Gaps = 51/258 (19%)
Query: 315 EDFDIKYCIGTGGYGSVYRARL--------PSGKVVALKKLHRLETELASLESFQNEARL 366
ED +G G + +++ V LK L + ESF A +
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD--KAHRNYSESFFEAASM 65
Query: 367 LSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMA 426
+S++ H+++V YG C+ L+ E+++ GSL L+ ++ + + W ++ + K +A
Sbjct: 66 MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLA 123
Query: 427 HALSYL-HHHCTPPILHRDISSNNILLNSEFEAF--------VADFGIARLLNYDSSNRT 477
A+ +L + +H ++ + NILL E + ++D GI+ +
Sbjct: 124 AAMHFLEENTL----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV-LPKD--- 175
Query: 478 LLAGTYGSI-----APE-LAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSSSSLD 530
PE + + D +SFG E+ G P L
Sbjct: 176 -----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD------- 223
Query: 531 KNIKLIDLLDP--RLPPP 546
+ + + + +LP P
Sbjct: 224 -SQRKLQFYEDRHQLPAP 240
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-31
Identities = 64/238 (26%), Positives = 110/238 (46%), Gaps = 24/238 (10%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRN 374
E ++ +G G +G V+ VA+K L E+F EA+++ ++RH
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEK 240
Query: 375 IVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHH 434
+V+LY E ++++ EYM GSL L+ + L + V++ +A ++Y+
Sbjct: 241 LVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVER 298
Query: 435 HCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN---YDSSNRTLLAGTYGSIAPELA 491
+HRD+ + NIL+ VADFG+ARL+ Y + APE A
Sbjct: 299 MN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEAA 353
Query: 492 YTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSSSSLDKNIKLIDLLDP--RLPPP 546
T K DV+SFG++ E+ G+ P + N +++D ++ R+P P
Sbjct: 354 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--------NREVLDQVERGYRMPCP 403
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-31
Identities = 64/238 (26%), Positives = 110/238 (46%), Gaps = 24/238 (10%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRN 374
E ++ +G G +G V+ VA+K L E+F EA+++ ++RH
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEK 323
Query: 375 IVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHH 434
+V+LY E ++++ EYM GSL L+ + L + V++ +A ++Y+
Sbjct: 324 LVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVER 381
Query: 435 HCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN---YDSSNRTLLAGTYGSIAPELA 491
+HRD+ + NIL+ VADFG+ARL+ Y + APE A
Sbjct: 382 MN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEAA 436
Query: 492 YTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSSSSLDKNIKLIDLLDP--RLPPP 546
T K DV+SFG++ E+ G+ P + N +++D ++ R+P P
Sbjct: 437 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--------NREVLDQVERGYRMPCP 486
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-31
Identities = 64/238 (26%), Positives = 116/238 (48%), Gaps = 24/238 (10%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRN 374
E ++ +G G +G V+ A VA+K + + E+F EA ++ ++H
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV---EAFLAEANVMKTLQHDK 244
Query: 375 IVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHH 434
+VKL+ E +++I E+M GSL L++DE + K ++ +A ++++
Sbjct: 245 LVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSK-QPLPKLIDFSAQIAEGMAFIEQ 302
Query: 435 HCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI---APELA 491
+HRD+ + NIL+++ +ADFG+AR++ + T G I APE
Sbjct: 303 RN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPEAI 357
Query: 492 YTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSSSSLDKNIKLIDLLDP--RLPPP 546
T K DV+SFG++ +E++ G+ P +S N ++I L+ R+P P
Sbjct: 358 NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS--------NPEVIRALERGYRMPRP 407
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 3e-31
Identities = 55/247 (22%), Positives = 107/247 (43%), Gaps = 33/247 (13%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEAR-LLSQIRH 372
+D + +G G YG V + R +PSG+++A+K++ R + + + +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDISMRTVDC 65
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLFCIL--------RTDEEAVGLDWTKRVNIVKG 424
V YG E +++ E M+ SL E+ +G I
Sbjct: 66 PFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILG-------KIAVS 117
Query: 425 MAHALSYLH--HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGT 482
+ AL +LH ++HRD+ +N+L+N+ + + DFGI+ L D + + AG
Sbjct: 118 IVKALEHLHSKLS----VIHRDVKPSNVLINALGQVKMCDFGISGYLV-DDVAKDIDAGC 172
Query: 483 YGSIAPELAYTMVVTEKY----DVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDL 538
+APE + + Y D++S G+ +E+ + + P S + + ++++
Sbjct: 173 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP---YDSWGTPFQQLKQVVEE 229
Query: 539 LDPRLPP 545
P+LP
Sbjct: 230 PSPQLPA 236
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 58/224 (25%), Positives = 100/224 (44%), Gaps = 32/224 (14%)
Query: 314 TEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQI-R 371
F++ +G G YG VY+ R + +G++ A+K + + E + E +L +
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLKKYSH 79
Query: 372 HRNIVKLYG------FCLHEKCMFLIYEYMEMGSLFCILRT------DEEAVGLDWTKRV 419
HRNI YG + ++L+ E+ GS+ +++ EE +
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY------ 133
Query: 420 NIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLL 479
I + + LS+LH H ++HRDI N+LL E + DFG++ L+ R
Sbjct: 134 -ICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF 189
Query: 480 AGTYGSIAPELAYTMVVTE-----KYDVYSFGVVALEVLMGKHP 518
GT +APE+ + K D++S G+ A+E+ G P
Sbjct: 190 IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 61/238 (25%), Positives = 98/238 (41%), Gaps = 30/238 (12%)
Query: 323 IGTGGYGSVYRARLPSGK----VVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKL 378
IG G +G VY L A+K L+R+ + F E ++ H N++ L
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-GEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 379 YGFCLH-EKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYL-HHHC 436
G CL E ++ YM+ G L +R + + +A + +L
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFLASKKF 213
Query: 437 TPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI-----APELA 491
+HRD+++ N +L+ +F VADFG+AR + YD ++ T + A E
Sbjct: 214 ----VHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEFDSVHNKTGAKLPVKWMALESL 268
Query: 492 YTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSSSSLDKNIKLIDLLDP--RLPPP 546
T T K DV+SFGV+ E++ G P ++ + L RL P
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN--------TFDITVYLLQGRRLLQP 318
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-31
Identities = 69/246 (28%), Positives = 109/246 (44%), Gaps = 35/246 (14%)
Query: 315 EDFDIKYCIGTGGYGSVYRARL--PSGKV--VALKKLHRLETELASLESFQNEARLLSQI 370
ED + +G G +G VY G+ VA+K + + L + E F +EA ++ +
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC-KKDCTLDNKEKFMSEAVIMKNL 70
Query: 371 RHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALS 430
H +IVKL G E ++I E G L L ++ ++ + V + A++
Sbjct: 71 DHPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAMA 127
Query: 431 YL-HHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL---NYDSSNRTLLAGTYGSI 486
YL +C +HRDI+ NIL+ S + DFG++R + +Y ++ T L I
Sbjct: 128 YLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-----I 178
Query: 487 ---APELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSSSSLDKNIKLIDLLDP- 541
+PE T DV+ F V E+L GK P L N +I +L+
Sbjct: 179 KWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE--------NKDVIGVLEKG 230
Query: 542 -RLPPP 546
RLP P
Sbjct: 231 DRLPKP 236
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 7e-31
Identities = 60/267 (22%), Positives = 108/267 (40%), Gaps = 54/267 (20%)
Query: 314 TEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRH 372
DF+ +G G +G V +AR + A+KK+ E +L + +E LL+ + H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL---STILSEVMLLASLNH 61
Query: 373 RNIVKLYGF-------------CLHEKCMFLIYEYMEMGSLFCILR-----TDEEAVGLD 414
+ +V+ Y + +F+ EY E G+L+ ++ +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY--- 118
Query: 415 WTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD-- 472
+ + + ALSY+H I+HRD+ NI ++ + DFG+A+ ++
Sbjct: 119 ----WRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 473 ------------SSNRTLLAGTYGSIAPE-LAYTMVVTEKYDVYSFGVVALEVLMGKHPG 519
S N T GT +A E L T EK D+YS G++ E++ G
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTG 231
Query: 520 ELLSSSSSSLDKNIKLIDLLDPRLPPP 546
++ K ++ + + PP
Sbjct: 232 M----ERVNILKKLRSVSI---EFPPD 251
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 8e-31
Identities = 51/208 (24%), Positives = 88/208 (42%), Gaps = 24/208 (11%)
Query: 319 IKYCIGTGGYGSVYRA---RLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNI 375
+K CI GG G +Y A + +G+ V LK L + + E + L+++ H +I
Sbjct: 84 VKGCIAHGGLGWIYLALDRNV-NGRPVVLKGL-VHSGDAEAQAMAMAERQFLAEVVHPSI 141
Query: 376 VKLYGFCLHE-----KCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALS 430
V+++ F H +++ EY+ SL + L + + + + ALS
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSL-----KRSKGQKLPVAEAIAYLLEILPALS 196
Query: 431 YLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPEL 490
YLH +++ D+ NI+L E + + D G +N L GT G APE+
Sbjct: 197 YLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY----LYGTPGFQAPEI 248
Query: 491 AYTMVVTEKYDVYSFGVVALEVLMGKHP 518
T T D+Y+ G + +
Sbjct: 249 VRTG-PTVATDIYTVGRTLAALTLDLPT 275
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 64/261 (24%), Positives = 105/261 (40%), Gaps = 39/261 (14%)
Query: 309 DMIEATEDFDIKY---------CIGTGGYGSVYRARLPSGK----VVALKKLHRLETELA 355
++++A + I IG G +G VY L A+K L+R+
Sbjct: 10 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-G 68
Query: 356 SLESFQNEARLLSQIRHRNIVKLYGFCLH-EKCMFLIYEYMEMGSLFCILRTDEEAVGLD 414
+ F E ++ H N++ L G CL E ++ YM+ G L +R +
Sbjct: 69 EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PT 126
Query: 415 WTKRVNIVKGMAHALSYLH-HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473
+ +A + YL +HRD+++ N +L+ +F VADFG+AR + YD
Sbjct: 127 VKDLIGFGLQVAKGMKYLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDM-YDK 181
Query: 474 SNRTLLAGTYGSI-----APELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSSS 527
++ T + A E T T K DV+SFGV+ E++ G P ++
Sbjct: 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN---- 237
Query: 528 SLDKNIKLIDLLDP--RLPPP 546
+ L RL P
Sbjct: 238 ----TFDITVYLLQGRRLLQP 254
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 67/246 (27%), Positives = 109/246 (44%), Gaps = 35/246 (14%)
Query: 315 EDFDIKYCIGTGGYGSVYRARL--PSGKV--VALKKLHRLETELASLESFQNEARLLSQI 370
E ++ CIG G +G V++ P VA+K + T + E F EA + Q
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEALTMRQF 73
Query: 371 RHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALS 430
H +IVKL G +++I E +G L L+ + ++ L + ++ AL+
Sbjct: 74 DHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALA 130
Query: 431 YL-HHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL---NYDSSNRTLLAGTYGSI 486
YL +HRDI++ N+L++S + DFG++R + Y +++ L I
Sbjct: 131 YLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-----PI 181
Query: 487 ---APELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSSSSLDKNIKLIDLLDP- 541
APE T DV+ FGV E+LM G P + + N +I ++
Sbjct: 182 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK--------NNDVIGRIENG 233
Query: 542 -RLPPP 546
RLP P
Sbjct: 234 ERLPMP 239
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-30
Identities = 49/217 (22%), Positives = 94/217 (43%), Gaps = 26/217 (11%)
Query: 316 DFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRN 374
F K +G G G++ + + VA+K++ E +LL + H N
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP-----ECFSFADREVQLLRESDEHPN 79
Query: 375 IVKLYGFCLHEKCMFLIYEYMEMGSLF-CILRTDEEAVGLDWTKRVNIVKGMAHALSYLH 433
+++ + + ++ E +L + + D +GL+ + +++ L++LH
Sbjct: 80 VIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQTTSGLAHLH 135
Query: 434 HHCTPPILHRDISSNNILL-----NSEFEAFVADFGIARLLNYDSSNRTLL---AGTYGS 485
I+HRD+ +NIL+ + + +A ++DFG+ + L + + GT G
Sbjct: 136 SLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 486 IAPEL---AYTMVVTEKYDVYSFGVVALEVL-MGKHP 518
IAPE+ T D++S G V V+ G HP
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHP 229
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 45/214 (21%), Positives = 74/214 (34%), Gaps = 26/214 (12%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQI-RH 372
+ F +G G YG V++ R G++ A+K+ E ++ +H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTD----EEAVGLDWTKRVNIVKGMAHA 428
V+L ++L E SL EA + + A
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLRD------TLLA 169
Query: 429 LSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAP 488
L++LH ++H D+ NI L + DFG+ L + G +AP
Sbjct: 170 LAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE-GDPRYMAP 225
Query: 489 ELAYTMVVTEKY----DVYSFGVVALEVLMGKHP 518
E ++ Y DV+S G+ LEV
Sbjct: 226 E-----LLQGSYGTAADVFSLGLTILEVACNMEL 254
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 323 IGTGGYGSVYRA---RLPSGKVVALKKLHRLETELAS----LESFQNEARLLSQIRHRNI 375
+G GG V+ A R + VA+K L +LA F+ EA+ + + H I
Sbjct: 20 LGFGGMSEVHLARDLRD--HRDVAVKVLR---ADLARDPSFYLRFRREAQNAAALNHPAI 74
Query: 376 VKLY--GF--CLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSY 431
V +Y G +++ EY++ +L I+ T+ + + + ++ AL++
Sbjct: 75 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNF 131
Query: 432 LHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGS---IAP 488
H + I+HRD+ NI++++ V DFGIAR + ++ T A G+ ++P
Sbjct: 132 SHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 489 ELAYTMVVTEKYDVYSFGVVALEVLMGKHP 518
E A V + DVYS G V EVL G+ P
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 3e-30
Identities = 52/233 (22%), Positives = 91/233 (39%), Gaps = 18/233 (7%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIA 61
N+ LDLS N L ++L++LNLS N L ++ L+ L TL +
Sbjct: 31 QSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLDLESLSTLRTLDLN 88
Query: 62 SNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSL 121
+N + + ++ L + N I S K + L+ NK+
Sbjct: 89 NNY-----VQELLVGPSIETLHAANNNISRVSCSRGQGKKNI---YLANNKITMLRDLDE 140
Query: 122 GHLTQLTTLNMYNNKLDG-PIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDL 180
G +++ L++ N++D + L L L N + + Q+ +L LDL
Sbjct: 141 GCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDL 198
Query: 181 SGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHL---DVSGNQF 230
S N + + + + + + L N L I +R +L D+ GN F
Sbjct: 199 SSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGF 249
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-26
Identities = 34/249 (13%), Positives = 70/249 (28%), Gaps = 13/249 (5%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVG-NIPSNVGHLTQLTTLAI 60
R + ++ L++N G S ++ L+L LN + N L L +
Sbjct: 117 SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176
Query: 61 ASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSS 120
N + + G L+ LDLS N++ + + + L NKLV I +
Sbjct: 177 QYNFI--YDVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKA 232
Query: 121 LGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDL 180
L L ++ N + + R+ + + +
Sbjct: 233 LRFSQNLEHFDLRGNGFHCGTLRDFFS-KNQRVQTVAKQTVKKLTGQNEEECTVPTLGHY 291
Query: 181 SGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVR-------KVPHLDVSGNQFGGE 233
+ + ++ + G + + +D Q+
Sbjct: 292 GAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTV 351
Query: 234 IPTTLANVP 242
I
Sbjct: 352 IDQVTLRKQ 360
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 5e-21
Identities = 33/216 (15%), Positives = 66/216 (30%), Gaps = 12/216 (5%)
Query: 1 MGRLRNLVHLDLSDNHFMG-HIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLA 59
G + +LDL N + L+ LNL N + ++ V +L TL
Sbjct: 140 EGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLD 197
Query: 60 IASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLV-GPIP 118
++SN++ + S + + L N++ I L + L DL N G +
Sbjct: 198 LSSNKLA-FMGPEFQSAAGVTWISLRNNKL-VLIEKALRFSQNLEHFDLRGNGFHCGTLR 255
Query: 119 SSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYL 178
++ T+ + C+ + G +L L
Sbjct: 256 DFFSKNQRVQTVA--KQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRK 313
Query: 179 DLSGNFING----KIPSQLGEFSCIDTVDLSMNNLS 210
+ + G ++ + + +D
Sbjct: 314 EHALLSGQGSETERLECERENQARQREIDALKEQYR 349
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 2e-18
Identities = 29/161 (18%), Positives = 63/161 (39%), Gaps = 13/161 (8%)
Query: 73 IGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNM 132
+ ++ ++ + + ++ S ++ +DLS N L + L T+L LN+
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 133 YNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQ 192
+N L +L + S LR L L NN + ++ + L + N I+ ++
Sbjct: 66 SSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSC- 116
Query: 193 LGEFSCIDTVDLSMNNLSGGIPVFVRKVP---HLDVSGNQF 230
+ L+ N ++ + +LD+ N+
Sbjct: 117 -SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEI 156
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 3e-16
Identities = 26/151 (17%), Positives = 56/151 (37%), Gaps = 7/151 (4%)
Query: 92 SIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKL 151
+I + + ++ + L + S + L++ N L +L +KL
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 152 RILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSG 211
+L L +N+L + L L LDL+ N++ +L I+T+ + NN+S
Sbjct: 61 ELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISR 113
Query: 212 GIPVFVRKVPHLDVSGNQFGGEIPTTLANVP 242
+ ++ ++ N+
Sbjct: 114 VSCSRGQGKKNIYLANNKITMLRDLDEGCRS 144
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 22/214 (10%), Positives = 53/214 (24%), Gaps = 29/214 (13%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTL-----------------------GRLSELKILNLS 37
+ +NL H DL N F + + +
Sbjct: 233 LRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYG 292
Query: 38 LNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKV----LQVLDLSRNEIGGSI 93
L L A GS + + + +D + + I
Sbjct: 293 AYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVI 352
Query: 94 PSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQL-TTLNMYNNKLDGPIPPELMNCSKLR 152
+ +++ + L + + +L TL +++ E + +L
Sbjct: 353 DQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQL- 411
Query: 153 ILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFIN 186
+ + + Q + + D+ +
Sbjct: 412 LRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKET 445
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 64/238 (26%), Positives = 100/238 (42%), Gaps = 30/238 (12%)
Query: 323 IGTGGYGSVYRARLPSGK----VVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKL 378
IG G +G VY A+K L R TE+ +E+F E L+ + H N++ L
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR-ITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 379 YGFCLHEKCM-FLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYL-HHHC 436
G L + + ++ YM G L +R+ + ++ +A + YL
Sbjct: 88 IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN--PTVKDLISFGLQVARGMEYLAEQKF 145
Query: 437 TPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI-----APELA 491
+HRD+++ N +L+ F VADFG+AR + D ++ + + A E
Sbjct: 146 ----VHRDLAARNCMLDESFTVKVADFGLARDI-LDREYYSVQQHRHARLPVKWTALESL 200
Query: 492 YTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSSSSLDKNIKLIDLLDP--RLPPP 546
T T K DV+SFGV+ E+L G P + L L RLP P
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID--------PFDLTHFLAQGRRLPQP 250
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-30
Identities = 66/253 (26%), Positives = 113/253 (44%), Gaps = 32/253 (12%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLES-FQNEARLLSQIRH 372
EDF + +G G + VYRA + +G VA+K + + A + QNE ++ Q++H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILR------TDEEAVGLDWTKRVNIVKGMA 426
+I++LY + ++L+ E G + L+ ++ EA + + +
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR--------HFMHQII 122
Query: 427 HALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI 486
+ YLH H ILHRD++ +N+LL +ADFG+A L L GT I
Sbjct: 123 TGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYI 179
Query: 487 APELAYTMVVTEKY-----DVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDP 541
+PE + T DV+S G + +L+G+ P + + + + + L D P
Sbjct: 180 SPE-----IATRSAHGLESDVWSLGCMFYTLLIGRPPFD--TDTVKNTLNKVVLADYEMP 232
Query: 542 R-LPPPGDQMIRQ 553
L +I Q
Sbjct: 233 SFLSIEAKDLIHQ 245
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 57/247 (23%), Positives = 105/247 (42%), Gaps = 21/247 (8%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLES-FQNEARLLSQIRH 372
+ +G GG+ + + +V A K + + E + + H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILR-----TDEEAVGLDWTKRVNIVKGMAH 427
+++V +GF +F++ E SL + + T+ EA R ++ +
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA-------R-YYLRQIVL 152
Query: 428 ALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIA 487
YLH + ++HRD+ N+ LN + E + DFG+A + YD + +L GT IA
Sbjct: 153 GCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 209
Query: 488 PELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPR-LPPP 546
PE+ + + DV+S G + +L+GK P E +S IK + P+ + P
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE--TSCLKETYLRIKKNEYSIPKHINPV 267
Query: 547 GDQMIRQ 553
+I++
Sbjct: 268 AASLIQK 274
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 36/312 (11%), Positives = 75/312 (24%), Gaps = 44/312 (14%)
Query: 274 RRRRDKEIEPTGTVEITKCADEIAIWNYDGRITFQDMI-EATEDFDIKYCIGTGGYGSVY 332
R + EP VE +W + T ++ + + + G V+
Sbjct: 24 YCREEALKEPAAMVEAVT----ATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVF 79
Query: 333 RAR-LPSGKVVALKKLH-RLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCM-- 388
R + + ALK E + LE +++ + +
Sbjct: 80 LVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA 139
Query: 389 ------------------------FLIYEYM--EMGSLFCILRTDEEAVG-LDWTKRVNI 421
L+ ++ LF L G +
Sbjct: 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHIL 199
Query: 422 VKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAG 481
+ + L ++H + +N+ + + + D + +
Sbjct: 200 TAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW---KVGTRGPASSV 253
Query: 482 TYGSIAPEL--AYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLL 539
E A T T + + G+ V P L++ K L
Sbjct: 254 PVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPG 313
Query: 540 DPRLPPPGDQMI 551
L +
Sbjct: 314 TDSLAFGSCTPL 325
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-30
Identities = 57/247 (23%), Positives = 105/247 (42%), Gaps = 21/247 (8%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLES-FQNEARLLSQIRH 372
+ +G GG+ + + +V A K + + E + + H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILR-----TDEEAVGLDWTKRVNIVKGMAH 427
+++V +GF +F++ E SL + + T+ EA R ++ +
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA-------R-YYLRQIVL 126
Query: 428 ALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIA 487
YLH + ++HRD+ N+ LN + E + DFG+A + YD + +L GT IA
Sbjct: 127 GCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 183
Query: 488 PELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPR-LPPP 546
PE+ + + DV+S G + +L+GK P E +S IK + P+ + P
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE--TSCLKETYLRIKKNEYSIPKHINPV 241
Query: 547 GDQMIRQ 553
+I++
Sbjct: 242 AASLIQK 248
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 27/216 (12%)
Query: 314 TEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELAS--LESFQNEARLLSQI 370
+ F IG G +G+VY AR + + +VVA+KK+ + ++ + E R L ++
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKM-SYSGKQSNEKWQDIIKEVRFLQKL 111
Query: 371 RHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRT-----DEEAVGLDWTKRVNIVKGM 425
RH N ++ G L E +L+ EY GS +L E + + G
Sbjct: 112 RHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA-------VTHGA 163
Query: 426 AHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGS 485
L+YLH H ++HRD+ + NILL+ + DFG A ++ + GT
Sbjct: 164 LQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANSFVGTPYW 216
Query: 486 IAPELAYTMVVTE---KYDVYSFGVVALEVLMGKHP 518
+APE+ M + K DV+S G+ +E+ K P
Sbjct: 217 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 35/274 (12%), Positives = 73/274 (26%), Gaps = 39/274 (14%)
Query: 314 TEDFDIKYCIGTGGYGSVYRAR------LPSGKVVALKKLHRLETELASLESFQNEARLL 367
++ + + +G G + VY A + + LK L
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK--PANPWEFYIGTQLMERL 121
Query: 368 SQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVG--LDWTKRVNIVKGM 425
+K Y L + L+ E G+L + + + ++ M
Sbjct: 122 KPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRM 181
Query: 426 AHALSYLHHHCTPPILHRDISSNNILLNSEFEAF-----------VADFGIARLLNYDSS 474
+ + +H I+H DI +N +L + F + D G + +
Sbjct: 182 LYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPK 238
Query: 475 NRTL--LAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKN 532
T G E+ + D + +L G + +
Sbjct: 239 GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGL 298
Query: 533 IK----------LIDLL---DPRLPPPGDQMIRQ 553
+ ++ P ++RQ
Sbjct: 299 FRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 1e-29
Identities = 67/242 (27%), Positives = 117/242 (48%), Gaps = 33/242 (13%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLES-FQNEARLLSQIRH 372
+DFDI +G G +G+VY AR + ++ALK L + + E +E + E + S +RH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILR-----TDEEAVGLDWTKRVNIVKGMAH 427
NI+++Y + K ++L+ E+ G L+ L+ ++ + ++ +A
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRS--------ATFMEELAD 125
Query: 428 ALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIA 487
AL Y H ++HRDI N+L+ + E +ADFG + S R + GT +
Sbjct: 126 ALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHA--PSLRRRTMCGTLDYLP 180
Query: 488 PELAYTMVVTEKY----DVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRL 543
PE M+ + + D++ GV+ E L+G P + S S + + I +DL +
Sbjct: 181 PE----MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD--SPSHTETHRRIVNVDL---KF 231
Query: 544 PP 545
PP
Sbjct: 232 PP 233
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-29
Identities = 65/245 (26%), Positives = 108/245 (44%), Gaps = 33/245 (13%)
Query: 315 EDFDIKYCIGTGGYGSVYRARL--PSGKV--VALKKLHRLETELASLESFQNEARLLSQI 370
E ++ CIG G +G V++ P VA+K + T + E F EA + Q
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFLQEALTMRQF 448
Query: 371 RHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALS 430
H +IVKL G +++I E +G L L+ + ++ L + ++ AL+
Sbjct: 449 DHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDL--ASLILYAYQLSTALA 505
Query: 431 YLH-HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI--- 486
YL +HRDI++ N+L++S + DFG++R + + + + G +
Sbjct: 506 YLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA----SKGKLPIK 557
Query: 487 --APELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSSSSLDKNIKLIDLLDP-- 541
APE T DV+ FGV E+LM G P + + N +I ++
Sbjct: 558 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK--------NNDVIGRIENGE 609
Query: 542 RLPPP 546
RLP P
Sbjct: 610 RLPMP 614
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 56/224 (25%), Positives = 91/224 (40%), Gaps = 27/224 (12%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGK----VVALKKLHRLETELASLESFQNEARLLSQI 370
+ F + +G G +GSV A+L VA+K L + +E F EA + +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 371 RHRNIVKLYGFCLHE------KCMFLIYEYMEMGSLFCILRT---DEEAVGLDWTKRVNI 421
H ++ KL G L +I +M+ G L L E L V
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 422 VKGMAHALSYL-HHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLA 480
+ +A + YL + +HRD+++ N +L + VADFG++R + R
Sbjct: 143 MVDIACGMEYLSSRNF----IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR---Q 195
Query: 481 GTYGSI-----APELAYTMVVTEKYDVYSFGVVALEVLM-GKHP 518
G + A E + T DV++FGV E++ G+ P
Sbjct: 196 GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-29
Identities = 43/212 (20%), Positives = 73/212 (34%), Gaps = 7/212 (3%)
Query: 3 RLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSL--VGNIPSNVGHLTQLTTLAI 60
+L++L L + N G + L L+ L+LS N L G + T L L +
Sbjct: 323 KLKSLKRLTFTSNK--GGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380
Query: 61 ASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIP-STLGHLKWLRSVDLSQNKLVGPIPS 119
+ N + ++ L+ L+ LD + + S L+ L +D+S
Sbjct: 381 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG 439
Query: 120 SLGHLTQLTTLNMYNNKLDGPIPPE-LMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYL 178
L+ L L M N P+ L L L L P+ L L L
Sbjct: 440 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 499
Query: 179 DLSGNFINGKIPSQLGEFSCIDTVDLSMNNLS 210
+++ N + + + + L N
Sbjct: 500 NMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-27
Identities = 46/214 (21%), Positives = 85/214 (39%), Gaps = 9/214 (4%)
Query: 5 RNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAIASN 63
+ +LDLS N + EL++L+LS + I L+ L+TL + N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI-QTIEDGAYQSLSHLSTLILTGN 86
Query: 64 RMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKL-VGPIPSSLG 122
+ L L LQ L + +GHLK L+ ++++ N + +P
Sbjct: 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 123 HLTQLTTLNMYNNKLDGPIPPELMNCSKLRI----LKLGNNLLSGSIPSQIGKLQELYYL 178
+LT L L++ +NK+ +L ++ + L L N ++ I K L+ L
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKL 205
Query: 179 DLSGNFINGKIPSQ-LGEFSCIDTVDLSMNNLSG 211
L NF + + + + ++ L +
Sbjct: 206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN 239
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-24
Identities = 49/219 (22%), Positives = 78/219 (35%), Gaps = 12/219 (5%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAI 60
L LDLS LS L L L+ N + ++ L+ L L
Sbjct: 49 FSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVA 107
Query: 61 ASNRMNGSILLGIGSLKVLQVLDLSRNEIG-GSIPSTLGHLKWLRSVDLSQNKLVGPIPS 119
+ IG LK L+ L+++ N I +P +L L +DLS NK+ +
Sbjct: 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT 167
Query: 120 SLGHLTQLT----TLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQ-IGKLQE 174
L L Q+ +L++ N ++ I P +L L L NN S ++ I L
Sbjct: 168 DLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAG 226
Query: 175 LYYLDLSGNFI--NGKIPS-QLGEFSCIDTVDLSMNNLS 210
L L G + + + + L+
Sbjct: 227 LEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-22
Identities = 40/168 (23%), Positives = 67/168 (39%), Gaps = 3/168 (1%)
Query: 3 RLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAIA 61
+L +LDLS N + + L +L+ L+ ++L +V L L L I+
Sbjct: 371 GTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 429
Query: 62 SNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPS-TLGHLKWLRSVDLSQNKLVGPIPSS 120
+ L L+VL ++ N + L+ L +DLSQ +L P++
Sbjct: 430 HTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 489
Query: 121 LGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQ 168
L+ L LNM +N+L + L+ + L N S P
Sbjct: 490 FNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 537
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-22
Identities = 48/212 (22%), Positives = 79/212 (37%), Gaps = 15/212 (7%)
Query: 35 NLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIP 94
L+ + N+P + L ++ N + S LQVLDLSR EI
Sbjct: 16 ELNFYKIPDNLPFS------TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69
Query: 95 STLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRIL 154
L L ++ L+ N + + L+ L L L + + L+ L
Sbjct: 70 GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129
Query: 155 KLGNNLL-SGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFS----CIDTVDLSMNNL 209
+ +NL+ S +P L L +LDLS N I + L ++DLS+N +
Sbjct: 130 NVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM 189
Query: 210 SGGIP--VFVR-KVPHLDVSGNQFGGEIPTTL 238
+ I F ++ L + N + T
Sbjct: 190 N-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTC 220
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 5e-22
Identities = 42/235 (17%), Positives = 86/235 (36%), Gaps = 20/235 (8%)
Query: 6 NLVHLDLS-DNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNR 64
+ L+ ++++ I L+ + +L ++ + + L + + +
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI--ERVKDFSYNFGWQHLELVNCK 315
Query: 65 MNGSILLGIGSLKVLQVLDLSRNEIGGSIP-STLGHLKWLRSVDLSQNKL--VGPIPSSL 121
LK L+ L + N+ G + L L++L DLS+N L G S
Sbjct: 316 FGQ---FPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFL---DLSRNGLSFKGCCSQSD 369
Query: 122 GHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQI--GKLQELYYLD 179
T L L++ N + + + +L L ++ L + L+ L YLD
Sbjct: 370 FGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLD 427
Query: 180 LSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIP--VF--VRKVPHLDVSGNQF 230
+S S ++ + ++ N+ +F +R + LD+S Q
Sbjct: 428 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 482
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 1e-17
Identities = 50/268 (18%), Positives = 93/268 (34%), Gaps = 42/268 (15%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKI----LNLSLNSLVGNIPSNVGHLTQLT 56
L NL HLDLS N L L ++ + L+LSLN + I +L
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKEIRLH 203
Query: 57 TLAIASNRMNGSILLG-IGSLKVLQVLDLSRNEIGGS---IPSTLGHLKWLRSVDLSQNK 112
L + +N + +++ I L L+V L E L+ L ++ + + +
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263
Query: 113 LVG------PIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIP 166
L I LT +++ ++ + ++ + + L+L N
Sbjct: 264 LAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFPT 321
Query: 167 SQIGKLQELY-------------------YLDLSGNFIN--GKIPSQLGEFSCIDTVDLS 205
++ L+ L +LDLS N ++ G + + +DLS
Sbjct: 322 LKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381
Query: 206 MNNLSGGIPVFVRKVP---HLDVSGNQF 230
N + + + HLD +
Sbjct: 382 FNGVI-TMSSNFLGLEQLEHLDFQHSNL 408
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 21/64 (32%), Positives = 31/64 (48%), Gaps = 2/64 (3%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAI 60
LRNL LDLS P LS L++LN++ N L ++P + LT L + +
Sbjct: 467 TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWL 525
Query: 61 ASNR 64
+N
Sbjct: 526 HTNP 529
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 37/230 (16%), Positives = 82/230 (35%), Gaps = 34/230 (14%)
Query: 314 TEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQI-R 371
T +F IG+G +GSV++ G + A+K+ + ++ E + + +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 372 HRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVG-LDWTKRVNIVKGMAHALS 430
H ++V+ + + M + EY GSL + + + + +++ + L
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 431 YLHHHCTPPILHRDISSNNILLNSEFEAFV-------------------ADFGIARLLNY 471
Y+H ++H DI +NI ++ D G +
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI-- 184
Query: 472 DSSNRTLLAGT--YGSIAPE-LAYTMVVTEKYDVYSFGVVALEVLMGKHP 518
S+ + G + +A E L K D+++ + + +
Sbjct: 185 --SSPQVEEGDSRF--LANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 52/223 (23%), Positives = 89/223 (39%), Gaps = 26/223 (11%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGK----VVALKKLHRLETELASLESFQNEARLLSQI 370
+ +G G +GSV L VA+K + + +E F +EA +
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 371 RHRNIVKLYGFCLHEK-----CMFLIYEYMEMGSLFCILRT---DEEAVGLDWTKRVNIV 422
H N+++L G C+ +I +M+ G L L + + + +
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 423 KGMAHALSYL-HHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAG 481
+A + YL + + LHRD+++ N +L + VADFG+++ + R G
Sbjct: 154 VDIALGMEYLSNRNF----LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR---QG 206
Query: 482 TYGSI-----APELAYTMVVTEKYDVYSFGVVALEVLM-GKHP 518
+ A E V T K DV++FGV E+ G P
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 53/219 (24%), Positives = 97/219 (44%), Gaps = 20/219 (9%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHR 373
+ + +G G +V+R R +G + A+K + + L ++ E +L ++ H+
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNN-ISFLRPVDVQMREFEVLKKLNHK 67
Query: 374 NIVKLYGF--CLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSY 431
NIVKL+ + LI E+ GSL+ +L A GL ++ + +++ + +++
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 432 LHHHCTPPILHRDISSNNILLNSEFEAF----VADFGIARLLNYDSSNRTLLAGTYGSIA 487
L + I+HR+I NI+ + + DFG AR L D +L GT +
Sbjct: 128 LRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY-GTEEYLH 183
Query: 488 PEL----AYTMVVTEKY----DVYSFGVVALEVLMGKHP 518
P++ +KY D++S GV G P
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 63/217 (29%), Positives = 96/217 (44%), Gaps = 30/217 (13%)
Query: 323 IGTGGYGSVYRARL------PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIV 376
+G G +G VY ++ PS VA+K L + +E L+ F EA ++S+ H+NIV
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 96
Query: 377 KLYGFCLHEKCMFLIYEYMEMGSLFCILR----TDEEAVGLDWTKRVNIVKGMAHALSYL 432
+ G L F++ E M G L LR + L +++ + +A YL
Sbjct: 97 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 433 -HHHCTPPILHRDISSNNILLNSEFEAFV---ADFGIARLLNYDSSNRTLLAGTYGSI-- 486
+H +HRDI++ N LL V DFG+AR + S R G +
Sbjct: 157 EENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR---KGGCAMLPV 209
Query: 487 ---APE-LAYTMVVTEKYDVYSFGVVALEVL-MGKHP 518
PE + T K D +SFGV+ E+ +G P
Sbjct: 210 KWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 119 bits (298), Expect = 2e-28
Identities = 59/213 (27%), Positives = 94/213 (44%), Gaps = 15/213 (7%)
Query: 316 DFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRN 374
+++K +GTGG+G V R +G+ VA+K+ + E + E + E +++ ++ H N
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQ-ELSPKNRERWCLEIQIMKKLNHPN 73
Query: 375 IVKLY------GFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHA 428
+V L EY E G L L E GL ++ ++ A
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 429 LSYLHHHCTPPILHRDISSNNILLNSEFEAF---VADFGIARLLNYDSSNRTLLAGTYGS 485
L YLH + I+HRD+ NI+L + + D G A+ L+ + GT
Sbjct: 134 LRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV-GTLQY 189
Query: 486 IAPELAYTMVVTEKYDVYSFGVVALEVLMGKHP 518
+APEL T D +SFG +A E + G P
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-28
Identities = 62/217 (28%), Positives = 95/217 (43%), Gaps = 30/217 (13%)
Query: 323 IGTGGYGSVYRARL------PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIV 376
+G G +G VY ++ PS VA+K L + +E L+ F EA ++S+ H+NIV
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 137
Query: 377 KLYGFCLHEKCMFLIYEYMEMGSLFCILR----TDEEAVGLDWTKRVNIVKGMAHALSYL 432
+ G L F++ E M G L LR + L +++ + +A YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 433 -HHHCTPPILHRDISSNNILLNSEFEAFV---ADFGIARLLNYDSSNRTLLAGTYGSI-- 486
+H +HRDI++ N LL V DFG+AR + R G +
Sbjct: 198 EENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR---KGGCAMLPV 250
Query: 487 ---APE-LAYTMVVTEKYDVYSFGVVALEVL-MGKHP 518
PE + T K D +SFGV+ E+ +G P
Sbjct: 251 KWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-27
Identities = 53/219 (24%), Positives = 97/219 (44%), Gaps = 20/219 (9%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHR 373
+ + +G G +V+R R +G + A+K + + L ++ E +L ++ H+
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNN-ISFLRPVDVQMREFEVLKKLNHK 67
Query: 374 NIVKLYGF--CLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSY 431
NIVKL+ + LI E+ GSL+ +L A GL ++ + +++ + +++
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 432 LHHHCTPPILHRDISSNNILLNSEFEAF----VADFGIARLLNYDSSNRTLLAGTYGSIA 487
L + I+HR+I NI+ + + DFG AR L D +L GT +
Sbjct: 128 LRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY-GTEEYLH 183
Query: 488 PEL----AYTMVVTEKY----DVYSFGVVALEVLMGKHP 518
P++ +KY D++S GV G P
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 53/278 (19%), Positives = 109/278 (39%), Gaps = 47/278 (16%)
Query: 308 QDMIEATEDFDIKYC----IGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNE 363
++ + +G G G+V G+ VA+K++ + E
Sbjct: 4 ANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI-----DFCDIALME 58
Query: 364 ARLLSQI-RHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCIL----RTDEEAVGLDWTKR 418
+LL++ H N+++ Y ++ +++ E +L ++ +DE
Sbjct: 59 IKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNP 117
Query: 419 VNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAF-------------VADFGI 465
+++++ +A +++LH I+HRD+ NIL+++ ++DFG+
Sbjct: 118 ISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174
Query: 466 ARLLNYDSSNRTL----LAGTYGSIAPEL---AYTMVVTEKY----DVYSFGVVALEVL- 513
+ L+ S+ +GT G APEL + + + D++S G V +L
Sbjct: 175 CKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234
Query: 514 MGKHPGELLSSSSSSLDKNIKLIDLLDPRLPPPGDQMI 551
GKHP S + NI + D+ +
Sbjct: 235 KGKHPF----GDKYSRESNIIRGIFSLDEMKCLHDRSL 268
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 57/246 (23%), Positives = 101/246 (41%), Gaps = 38/246 (15%)
Query: 323 IGTGGYGSVYRARL------PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIV 376
+G G +G VY VA+K ++ + +E F NEA ++ + ++V
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFNCHHVV 91
Query: 377 KLYGFCLHEKCMFLIYEYMEMGSLFCILR-------TDEEAVGLDWTKRVNIVKGMAHAL 429
+L G + +I E M G L LR + +K + + +A +
Sbjct: 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 430 SYLH-HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI-- 486
+YL+ + +HRD+++ N ++ +F + DFG+ R + R G G +
Sbjct: 152 AYLNANKF----VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR---KGGKGLLPV 204
Query: 487 ---APELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSSSSLDKNIKLIDLLDP- 541
+PE V T DV+SFGVV E+ + P + LS N +++ +
Sbjct: 205 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS--------NEQVLRFVMEG 256
Query: 542 -RLPPP 546
L P
Sbjct: 257 GLLDKP 262
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-27
Identities = 57/258 (22%), Positives = 94/258 (36%), Gaps = 51/258 (19%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHL----------- 52
L L++S N +P L EL I + L L +PS + L
Sbjct: 80 PPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLP-ALPSGLCKLWIFGNQLTSLP 137
Query: 53 ---TQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLS 109
L L+++ N++ S+ L L N++ S+P L+ L +S
Sbjct: 138 VLPPGLQELSVSDNQLA-SLPALPSE---LCKLWAYNNQL-TSLPMLPSGLQEL---SVS 189
Query: 110 QNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQI 169
N+L +P+ L +L NN+L +P S L+ L + N L+ S+P
Sbjct: 190 DNQLAS-LPTLPSELYKLWAY---NNRLT-SLPALP---SGLKELIVSGNRLT-SLPVLP 240
Query: 170 GKLQELY-----------------YLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGG 212
+L+EL L + N + ++P L S TV+L N LS
Sbjct: 241 SELKELMVSGNRLTSLPMLPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSER 299
Query: 213 IPVFVRKVPHLDVSGNQF 230
+R++
Sbjct: 300 TLQALREITSAPGYSGPI 317
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 7e-26
Identities = 53/254 (20%), Positives = 104/254 (40%), Gaps = 45/254 (17%)
Query: 3 RLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIAS 62
L++ ++ + +P L + + L + N+L ++P+ +L TL ++
Sbjct: 38 LNNGNAVLNVGESG-LTTLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSG 90
Query: 63 NRMNGSILLGIGSLKVLQVLDLSRNEIGG----------------SIPSTLGHLKWLRSV 106
N++ S+ + L L + + S+P L+ L
Sbjct: 91 NQLT-SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTSLPVLPPGLQEL--- 146
Query: 107 DLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIP 166
+S N+L +P+ L + L YNN+L +P S L+ L + +N L+ S+P
Sbjct: 147 SVSDNQLAS-LPALPSELCK---LWAYNNQLTS-LPMLP---SGLQELSVSDNQLA-SLP 197
Query: 167 SQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHLDVS 226
+ +L +L+ + + +PS L E +S N L+ +PV ++ L VS
Sbjct: 198 TLPSELYKLWAYNNRLTSLP-ALPSGLKEL------IVSGNRLT-SLPVLPSELKELMVS 249
Query: 227 GNQFGGEIPTTLAN 240
GN+ +P +
Sbjct: 250 GNRL-TSLPMLPSG 262
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 3e-22
Identities = 45/210 (21%), Positives = 74/210 (35%), Gaps = 27/210 (12%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPS----NVGH-------- 51
L L +SDN +P L +L N L SL +V
Sbjct: 140 PPGLQELSVSDNQL-ASLPALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLASLPT 198
Query: 52 -LTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQ 110
++L L +NR+ S+ L + L +S N + S+P LK L +S
Sbjct: 199 LPSELYKLWAYNNRLT-SLPALPSGL---KELIVSGNRLT-SLPVLPSELKEL---MVSG 250
Query: 111 NKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIG 170
N+L +P L +L++Y N+L +P L++ S + L N LS +
Sbjct: 251 NRLTS-LPMLPS---GLLSLSVYRNQLTR-LPESLIHLSSETTVNLEGNPLSERTLQALR 305
Query: 171 KLQELYYLDLSGNFINGKIPSQLGEFSCID 200
++ + S E +
Sbjct: 306 EITSAPGYSGPIIRFDMAGASAPRETRALH 335
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 6e-08
Identities = 25/157 (15%), Positives = 48/157 (30%), Gaps = 11/157 (7%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASN 63
L L +S N +P ELK L +S N L ++P + L +L++ N
Sbjct: 220 PSGLKELIVSGNRL-TSLPVLPS---ELKELMVSGNRLT-SLPML---PSGLLSLSVYRN 271
Query: 64 RMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGH 123
++ + + L ++L N + L + + S+
Sbjct: 272 QLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRE 330
Query: 124 LTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNL 160
L + L E + + +N
Sbjct: 331 TRALHLAA--ADWLVPAREGEPAPADRWHMFGQEDNA 365
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 46/207 (22%), Positives = 77/207 (37%), Gaps = 18/207 (8%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASN 63
+L +L LS N H+ + L N+S N L S + + L + N
Sbjct: 164 TTSLQNLQLSSNRL-THVDL--SLIPSLFHANVSYNLL-----STLAIPIAVEELDASHN 215
Query: 64 RMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGH 123
+N + L +L L N + + + L + L VDLS N+L +
Sbjct: 216 SINV---VRGPVNVELTILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVK 270
Query: 124 LTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGN 183
+ +L L + NN+L + L++L L +N L + + L L L N
Sbjct: 271 MQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHN 328
Query: 184 FINGKIPSQLGEFSCIDTVDLSMNNLS 210
I + L + + LS N+
Sbjct: 329 SIV-TLK--LSTHHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-25
Identities = 44/232 (18%), Positives = 89/232 (38%), Gaps = 20/232 (8%)
Query: 3 RLRNLVHLDLSDNHFMGHIPP-TLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAI 60
L N + ++ +P L ++++LNL+ + I + + + L +
Sbjct: 43 TLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYM 100
Query: 61 ASNRMNGSILLGI-GSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPS 119
N + + + ++ +L VL L RN++ + L ++ +S N L
Sbjct: 101 GFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDD 159
Query: 120 SLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLD 179
+ T L L + +N+L + L+ L + NLL S + + LD
Sbjct: 160 TFQATTSLQNLQLSSNRLTH-VDLSLI--PSLFHANVSYNLL-----STLAIPIAVEELD 211
Query: 180 LSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFV--RKVPHLDVSGNQ 229
S N IN + + + + L NNL+ + + +D+S N+
Sbjct: 212 ASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNE 259
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-24
Identities = 51/248 (20%), Positives = 94/248 (37%), Gaps = 25/248 (10%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPP-TLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLA 59
R + L+L+D I ++ L + N++ +P +V ++ LT L
Sbjct: 66 DSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLV 123
Query: 60 IASNRMNGSILLGI-GSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIP 118
+ N ++ S+ GI + L L +S N + T L+++ LS N+L +
Sbjct: 124 LERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VD 181
Query: 119 SSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYL 178
L + L N+ N L L + L +N ++ + + EL L
Sbjct: 182 --LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTIL 231
Query: 179 DLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFV----RKVPHLDVSGNQFGGEI 234
L N + + L + + VDLS N L I +++ L +S N+ +
Sbjct: 232 KLQHNNLTD--TAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRL-VAL 287
Query: 235 PTTLANVP 242
+P
Sbjct: 288 NLYGQPIP 295
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 40/227 (17%), Positives = 88/227 (38%), Gaps = 14/227 (6%)
Query: 7 LVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAIASNRM 65
+ + + L+ KI+ +++ +P+ + Q+ L + ++
Sbjct: 23 FYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQI 81
Query: 66 NGSILLGI-GSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHL 124
I +Q L + N I P ++ L + L +N L +
Sbjct: 82 E-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNT 140
Query: 125 TQLTTLNMYNNKLDGPIPPE-LMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGN 183
+LTTL+M NN L+ I + + L+ L+L +N L+ + + + L++ ++S N
Sbjct: 141 PKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYN 196
Query: 184 FINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHLDVSGNQF 230
+ S L ++ +D S N+++ ++ L + N
Sbjct: 197 LL-----STLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNL 238
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 4e-18
Identities = 35/189 (18%), Positives = 71/189 (37%), Gaps = 6/189 (3%)
Query: 45 IPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLR 104
I SN+ + + I + +L +++ + + + L + +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 105 SVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPE-LMNCSKLRILKLGNNLLSG 163
++L+ ++ + + + L M N + +PP N L +L L N LS
Sbjct: 73 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLS- 130
Query: 164 SIPSQI-GKLQELYYLDLSGNFINGKIPSQ-LGEFSCIDTVDLSMNNLSGGIPVFVRKVP 221
S+P I +L L +S N + +I + + + LS N L+ + +
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLF 189
Query: 222 HLDVSGNQF 230
H +VS N
Sbjct: 190 HANVSYNLL 198
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 23/146 (15%), Positives = 50/146 (34%), Gaps = 6/146 (4%)
Query: 68 SILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQL 127
I + V + + L + V + + + L Q+
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 128 TTLNMYNNKLDGPIPPE-LMNCSKLRILKLGNNLLSGSIPSQI-GKLQELYYLDLSGNFI 185
LN+ + +++ I ++ L +G N + +P + + L L L N +
Sbjct: 72 ELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 129
Query: 186 NGKIPSQL-GEFSCIDTVDLSMNNLS 210
+ +P + + T+ +S NNL
Sbjct: 130 S-SLPRGIFHNTPKLTTLSMSNNNLE 154
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 3e-27
Identities = 60/218 (27%), Positives = 99/218 (45%), Gaps = 30/218 (13%)
Query: 314 TEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRH 372
+E + +G+G YG V R + A+K + + +S E +L + H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLFC-ILR----TDEEAVGLDWTKRVNIVKGMAH 427
NI+KLY F ++ +L+ E + G LF I+ + +A I+K +
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDA--------AVIIKQVLS 147
Query: 428 ALSYLHHHCTPPILHRDISSNNILLNSEFEAF---VADFGIARLLNYDSSNRTLLAGTYG 484
++YLH H I+HRD+ N+LL S+ + + DFG++ + + GT
Sbjct: 148 GVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE-NQKKMKERLGTAY 203
Query: 485 SIAPELAYTMVVTEKY----DVYSFGVVALEVLMGKHP 518
IAPE V+ +KY DV+S GV+ +L G P
Sbjct: 204 YIAPE-----VLRKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 5e-27
Identities = 56/256 (21%), Positives = 96/256 (37%), Gaps = 52/256 (20%)
Query: 323 IGTGGYGSVYRARLPSGK------VVALKKLHRLETELASLESFQNEARLLSQIRHRNIV 376
+G +G VY+ L VA+K L E F++EA L ++++H N+V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREE-FRHEAMLRARLQHPNVV 75
Query: 377 KLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVN---------------- 420
L G ++ + +I+ Y G L L + T
Sbjct: 76 CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 421 -IVKGMAHALSYL-HHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTL 478
I GM YL HH +H+D+++ N+L+ + ++D G+ R + +
Sbjct: 136 QIAAGME----YLSSHHV----VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK-- 185
Query: 479 LAGTYGSI-----APELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSSSSLDKN 532
+ APE + D++S+GVV EV G P S N
Sbjct: 186 -LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS--------N 236
Query: 533 IKLIDLLDP--RLPPP 546
+++++ LP P
Sbjct: 237 QDVVEMIRNRQVLPCP 252
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 7e-27
Identities = 48/268 (17%), Positives = 91/268 (33%), Gaps = 47/268 (17%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKI-------------LNLSLNSLVGNIPS 47
+++ + + + + PP G E+ + L L+ L ++P
Sbjct: 30 AENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPE 88
Query: 48 NVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPS------------ 95
H L +L + N + + SLK L V + + + P
Sbjct: 89 LPPH---LESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLE 144
Query: 96 ---TLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLR 152
L + +L+ +D+ N L +P L + NN+L+ PEL N L
Sbjct: 145 KLPELQNSSFLKIIDVDNNSLKK-LPDLPP---SLEFIAAGNNQLE--ELPELQNLPFLT 198
Query: 153 ILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGG 212
+ NN L +P L+ + N + + +L + T+ N L
Sbjct: 199 AIYADNNSLK-KLPDLPLSLES---IVAGNNIL--EELPELQNLPFLTTIYADNNLLK-T 251
Query: 213 IPVFVRKVPHLDVSGNQFGGEIPTTLAN 240
+P + L+V N ++P +
Sbjct: 252 LPDLPPSLEALNVRDNYL-TDLPELPQS 278
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-25
Identities = 40/242 (16%), Positives = 70/242 (28%), Gaps = 39/242 (16%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASN 63
L ++ +P + + + N P G ++ +
Sbjct: 10 NTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC 68
Query: 64 RMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGH 123
L+L+ + S+P HL+ L S N L +P
Sbjct: 69 LDRQ-----------AHELELNNLGL-SSLPELPPHLESL---VASCNSLT-ELPELPQS 112
Query: 124 LTQLTTLNMYNNKLDGPIP---------------PELMNCSKLRILKLGNNLLSGSIPSQ 168
L L N L P PEL N S L+I+ + NN L +P
Sbjct: 113 LKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDL 171
Query: 169 IGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHLDVSGN 228
L+ + N + ++P L + + N+L +P + + N
Sbjct: 172 PPSLEF---IAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLK-KLPDLPLSLESIVAGNN 225
Query: 229 QF 230
Sbjct: 226 IL 227
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-25
Identities = 52/235 (22%), Positives = 90/235 (38%), Gaps = 28/235 (11%)
Query: 6 NLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRM 65
L +L +S+N +P L S LKI+++ NSL +P L +A +N++
Sbjct: 132 LLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLK-KLPDL---PPSLEFIAAGNNQL 185
Query: 66 NGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLT 125
L + +L L + N + +P L+ + N L L +L
Sbjct: 186 --EELPELQNLPFLTAIYADNNSLK-KLPDLPLSLESI---VAGNNILE--ELPELQNLP 237
Query: 126 QLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFI 185
LTT+ NN L +P L L + +N L+ +P L LD+S N
Sbjct: 238 FLTTIYADNNLLKT-LPDLP---PSLEALNVRDNYLT-DLPELPQSLTF---LDVSENIF 289
Query: 186 NGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHLDVSGNQFGGEIPTTLAN 240
+ + + ++ S N + + + L+VS N+ E+P
Sbjct: 290 S-GLSELPPN---LYYLNASSNEIR-SLCDLPPSLEELNVSNNKL-IELPALPPR 338
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-25
Identities = 49/237 (20%), Positives = 78/237 (32%), Gaps = 33/237 (13%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASN 63
+L + +N P L L L + N L +P L L N
Sbjct: 214 PLSLESIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVR---DN 267
Query: 64 RMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGH 123
+ + SL L V + + + +L +L + S N+ I S
Sbjct: 268 YLT-DLPELPQSLTFLDVSENIFS----GLSELPPNLYYL---NASSNE----IRSLCDL 315
Query: 124 LTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGN 183
L LN+ NNKL +P +L L N L+ +P L++L + N
Sbjct: 316 PPSLEELNVSNNKLIE-LPALP---PRLERLIASFNHLA-EVPELPQNLKQL---HVEYN 367
Query: 184 FINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHLDVSGNQFGGEIPTTLAN 240
+ + P DL MN+ +P + + L V N E P +
Sbjct: 368 PLR-EFPDIPESVE-----DLRMNSHLAEVPELPQNLKQLHVETNPL-REFPDIPES 417
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 7e-22
Identities = 43/230 (18%), Positives = 75/230 (32%), Gaps = 34/230 (14%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAI 60
+ L L + +N +P L L + + L L P LT L
Sbjct: 233 LQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNYLTDL----PELPQSLTFLDVSEN 287
Query: 61 ASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSS 120
+ ++ L L+ S NEI S+ L+ L ++S NKL+ +P+
Sbjct: 288 IFSGLSELP-------PNLYYLNASSNEI-RSLCDLPPSLEEL---NVSNNKLIE-LPAL 335
Query: 121 LGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDL 180
+L L N L +P L+ L + N L P +++L
Sbjct: 336 PP---RLERLIASFNHLAE-VPELP---QNLKQLHVEYNPLR-EFPDIPESVEDLR---- 383
Query: 181 SGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHLDVSGNQF 230
+N + + + + N L P V L ++ +
Sbjct: 384 ----MNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPESVEDLRMNSERV 428
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 4e-19
Identities = 36/223 (16%), Positives = 72/223 (32%), Gaps = 41/223 (18%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASN 63
+L L++ DN+ +P L+ L + + L P+ L L +SN
Sbjct: 256 PPSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPPN-------LYYLNASSN 307
Query: 64 RMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGH 123
+ L+ L++S N++ +P+ L+ L S N L +P +
Sbjct: 308 EIRSLC----DLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLAE-VPELPQN 358
Query: 124 LTQLTTLNMYNNKLDGPIPPELMN----------------CSKLRILKLGNNLLSGSIPS 167
L QL ++ N L P + L+ L + N L P
Sbjct: 359 LKQL---HVEYNPLRE-FPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPD 413
Query: 168 QIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLS 210
+++L ++ + ++ ++
Sbjct: 414 IPESVEDL---RMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 30/161 (18%), Positives = 54/161 (33%), Gaps = 21/161 (13%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIA 61
+L L++S+N + +P RL + L S N L +P +L QL +
Sbjct: 314 DLPPSLEELNVSNNKLI-ELPALPPRL---ERLIASFNHLA-EVPELPQNLKQLH---VE 365
Query: 62 SNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSL 121
N + S++ L++ +P +LK L + N L P
Sbjct: 366 YNPLR-EFPDIPESVEDLRMNSHL-----AEVPELPQNLKQL---HVETNPLRE-FPDIP 415
Query: 122 GHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLS 162
+ L M + ++ P KL ++
Sbjct: 416 E---SVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 67/252 (26%), Positives = 109/252 (43%), Gaps = 46/252 (18%)
Query: 323 IGTGGYGSVYRARLPSGK------VVALKKLHRLETELASLESFQNEARLLSQIRHRNIV 376
+G G +G V+ A + +VA+K L E ++ + FQ EA LL+ ++H++IV
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALK--EASESARQDFQREAELLTMLQHQHIV 106
Query: 377 KLYGFCLHEKCMFLIYEYMEMGSLFCILR------------TDEEAVGLDWTKRVNIVKG 424
+ +G C + + +++EYM G L LR D L + + +
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 425 MAHALSYL-HHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTY 483
+A + YL H +HRD+++ N L+ + DFG++R + R G
Sbjct: 167 VAAGMVYLAGLHF----VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR---VGGR 219
Query: 484 GSI-----APE-LAYTMVVTEKYDVYSFGVVALEVL-MGKHPGELLSSSSSSLDKNIKLI 536
+ PE + Y T + DV+SFGVV E+ GK P LS N + I
Sbjct: 220 TMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQPWYQLS--------NTEAI 270
Query: 537 DLLDP--RLPPP 546
D + L P
Sbjct: 271 DCITQGRELERP 282
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-26
Identities = 46/207 (22%), Positives = 77/207 (37%), Gaps = 18/207 (8%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASN 63
+L +L LS N H+ + L N+S N L S + + L + N
Sbjct: 170 TTSLQNLQLSSNRL-THVDL--SLIPSLFHANVSYNLL-----STLAIPIAVEELDASHN 221
Query: 64 RMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGH 123
+N + L +L L N + + + L + L VDLS N+L +
Sbjct: 222 SINV---VRGPVNVELTILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVK 276
Query: 124 LTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGN 183
+ +L L + NN+L + L++L L +N L + + L L L N
Sbjct: 277 MQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHN 334
Query: 184 FINGKIPSQLGEFSCIDTVDLSMNNLS 210
I + L + + LS N+
Sbjct: 335 SIV-TLK--LSTHHTLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-23
Identities = 44/233 (18%), Positives = 89/233 (38%), Gaps = 20/233 (8%)
Query: 3 RLRNLVHLDLSDNHFMGHIPP-TLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAI 60
L N + ++ +P L ++++LNL+ + I + + + L +
Sbjct: 49 TLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYM 106
Query: 61 ASNRMNGSILLGI-GSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPS 119
N + + + ++ +L VL L RN++ + L ++ +S N L
Sbjct: 107 GFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDD 165
Query: 120 SLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLD 179
+ T L L + +N+L + L+ L + NLL S + + LD
Sbjct: 166 TFQATTSLQNLQLSSNRLTH-VDLSLI--PSLFHANVSYNLL-----STLAIPIAVEELD 217
Query: 180 LSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFV--RKVPHLDVSGNQF 230
S N IN + + + + L NNL+ + + +D+S N+
Sbjct: 218 ASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNEL 266
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-23
Identities = 51/247 (20%), Positives = 95/247 (38%), Gaps = 23/247 (9%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPP-TLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLA 59
R + L+L+D I ++ L + N++ +P +V ++ LT L
Sbjct: 72 DSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLV 129
Query: 60 IASNRMNGSILLGI-GSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIP 118
+ N ++ S+ GI + L L +S N + T L+++ LS N+L +
Sbjct: 130 LERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VD 187
Query: 119 SSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYL 178
L + L N+ N L L + L +N ++ + + EL L
Sbjct: 188 --LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTIL 237
Query: 179 DLSGNFINGKIPSQLGEFSCIDTVDLSMNNLS---GGIPVFVRKVPHLDVSGNQFGGEIP 235
L N + + L + + VDLS N L V ++++ L +S N+ +
Sbjct: 238 KLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL-VALN 294
Query: 236 TTLANVP 242
+P
Sbjct: 295 LYGQPIP 301
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 97.7 bits (243), Expect = 1e-21
Identities = 40/227 (17%), Positives = 88/227 (38%), Gaps = 14/227 (6%)
Query: 7 LVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAIASNRM 65
+ + + L+ KI+ +++ +P+ + Q+ L + ++
Sbjct: 29 FYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQI 87
Query: 66 NGSILLGI-GSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHL 124
I +Q L + N I P ++ L + L +N L +
Sbjct: 88 E-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNT 146
Query: 125 TQLTTLNMYNNKLDGPIPPE-LMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGN 183
+LTTL+M NN L+ I + + L+ L+L +N L+ + + + L++ ++S N
Sbjct: 147 PKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYN 202
Query: 184 FINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHLDVSGNQF 230
+ S L ++ +D S N+++ ++ L + N
Sbjct: 203 LL-----STLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNL 244
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 84.6 bits (209), Expect = 2e-17
Identities = 34/188 (18%), Positives = 69/188 (36%), Gaps = 4/188 (2%)
Query: 45 IPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLR 104
I SN+ + + I + +L +++ + + + L + +
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 78
Query: 105 SVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPE-LMNCSKLRILKLGNNLLSG 163
++L+ ++ + + + L M N + +PP N L +L L N LS
Sbjct: 79 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLS- 136
Query: 164 SIPSQI-GKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPH 222
S+P I +L L +S N + + + + LS N L+ + + H
Sbjct: 137 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFH 196
Query: 223 LDVSGNQF 230
+VS N
Sbjct: 197 ANVSYNLL 204
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 23/146 (15%), Positives = 50/146 (34%), Gaps = 6/146 (4%)
Query: 68 SILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQL 127
I + V + + L + V + + + L Q+
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77
Query: 128 TTLNMYNNKLDGPIPPE-LMNCSKLRILKLGNNLLSGSIPSQI-GKLQELYYLDLSGNFI 185
LN+ + +++ I ++ L +G N + +P + + L L L N +
Sbjct: 78 ELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 135
Query: 186 NGKIPSQL-GEFSCIDTVDLSMNNLS 210
+ +P + + T+ +S NNL
Sbjct: 136 S-SLPRGIFHNTPKLTTLSMSNNNLE 160
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 59/224 (26%), Positives = 96/224 (42%), Gaps = 43/224 (19%)
Query: 323 IGTGGYGSVYRARLPSGKV---VALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKL 378
IG G +G V +AR+ + A+K++ ++ F E +L ++ H NI+ L
Sbjct: 33 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCKLGHHPNIINL 91
Query: 379 YGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVN-----------------I 421
G C H ++L EY G+L LR N +
Sbjct: 92 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 422 VKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAG 481
+GM + LS +HRD+++ NIL+ + A +ADFG++R +
Sbjct: 152 ARGMDY-LS--QKQF----IHRDLAARNILVGENYVAKIADFGLSRGQEV------YVKK 198
Query: 482 TYGSI-----APE-LAYTMVVTEKYDVYSFGVVALEVL-MGKHP 518
T G + A E L Y+ V T DV+S+GV+ E++ +G P
Sbjct: 199 TMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 54/195 (27%), Positives = 93/195 (47%), Gaps = 29/195 (14%)
Query: 309 DMIEATEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQN----E 363
D+ + ++ +G G + +VY+AR + ++VA+KK+ +L + + E
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKI-KLGHRSEAKDGINRTALRE 62
Query: 364 ARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVK 423
+LL ++ H NI+ L H+ + L++++ME L I++ + + K +
Sbjct: 63 IKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIK--AYML 119
Query: 424 GMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTY 483
L YLH H ILHRD+ NN+LL+ +ADFG+A+ ++
Sbjct: 120 MTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK--------------SF 162
Query: 484 GSIAPELAYT-MVVT 497
GS P AYT VVT
Sbjct: 163 GS--PNRAYTHQVVT 175
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 67/256 (26%), Positives = 106/256 (41%), Gaps = 53/256 (20%)
Query: 323 IGTGGYGSVYRARLPSGK------VVALKKLHRLETELASLESFQNEARLLSQIRHRNIV 376
+G G +G V+ A + +VA+K L + T A + FQ EA LL+ ++H +IV
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAARKD-FQREAELLTNLQHEHIV 80
Query: 377 KLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVN---------------- 420
K YG C + +++EYM+ G L LR + +
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 421 -IVKGMAHALSYL-HHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTL 478
I GM YL H +HRD+++ N L+ + + DFG++R + R
Sbjct: 141 QIASGMV----YLASQHF----VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR-- 190
Query: 479 LAGTYGSI-----APELAYTMVVTEKYDVYSFGVVALEVL-MGKHPGELLSSSSSSLDKN 532
G + + PE T + DV+SFGV+ E+ GK P LS N
Sbjct: 191 -VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS--------N 241
Query: 533 IKLIDLLDP--RLPPP 546
++I+ + L P
Sbjct: 242 TEVIECITQGRVLERP 257
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 41/225 (18%)
Query: 323 IGTGGYGSVYRARL------PSGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNI 375
+G G +G V A + VA+K L + E+ +E +++S + +H NI
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKML-KSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 376 VKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVN--------------- 420
V L G C H + +I EY G L LR + D +
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172
Query: 421 IVKGMAHALSYL-HHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLL 479
+ +GMA +L +C +HRD+++ N+LL + A + DFG+AR + DS+
Sbjct: 173 VAQGMA----FLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI--- 221
Query: 480 AGTYGSI-----APELAYTMVVTEKYDVYSFGVVALEVL-MGKHP 518
+ APE + V T + DV+S+G++ E+ +G +P
Sbjct: 222 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 7e-26
Identities = 55/218 (25%), Positives = 100/218 (45%), Gaps = 30/218 (13%)
Query: 314 TEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRH 372
E ++I +G G +G V + + + + A+K +++ + + E LL ++ H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLFC-ILR----TDEEAVGLDWTKRVNIVKGMAH 427
NI+KL+ +++ E G LF I++ ++ +A I+K +
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA--------ARIIKQVFS 132
Query: 428 ALSYLHHHCTPPILHRDISSNNILLNSEFEAF---VADFGIARLLNYDSSNRTLLAGTYG 484
++Y+H H I+HRD+ NILL S+ + + DFG++ ++ + GT
Sbjct: 133 GITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD-RIGTAY 188
Query: 485 SIAPELAYTMVVTEKY----DVYSFGVVALEVLMGKHP 518
IAPE V+ Y DV+S GV+ +L G P
Sbjct: 189 YIAPE-----VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 63/258 (24%), Positives = 100/258 (38%), Gaps = 52/258 (20%)
Query: 323 IGTGGYGSVYRARL------PSGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNI 375
+G G +G V A + VA+K L + L E+ +E ++LS + H NI
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 376 VKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVN--------------- 420
V L G C +I EY G L LR ++ T
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 421 ----IVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNR 476
+ KGMA L+ + +HRD+++ NILL + DFG+AR + DS+
Sbjct: 150 FSYQVAKGMAF-LASKN------CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 477 TLLAGTYGSI-----APELAYTMVVTEKYDVYSFGVVALEVL-MGKHPGELLSSSSSSLD 530
+ APE + V T + DV+S+G+ E+ +G P +
Sbjct: 203 ---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP-------YPGMP 252
Query: 531 KNIKLIDLLDP--RLPPP 546
+ K ++ R+ P
Sbjct: 253 VDSKFYKMIKEGFRMLSP 270
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 62/216 (28%), Positives = 105/216 (48%), Gaps = 33/216 (15%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQN----EARLLSQI 370
E + IG G YG VY+A+ G+ ALKK+ RLE E E + E +L ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKI-RLEKED---EGIPSTTIREISILKEL 57
Query: 371 RHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALS 430
+H NIVKLY +K + L++E+++ L +L E + K + + + + ++
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAK--SFLLQLLNGIA 114
Query: 431 YLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI---- 486
Y H +LHRD+ N+L+N E E +ADFG+AR + R T+ +
Sbjct: 115 YCHDRR---VLHRDLKPQNLLINREGELKIADFGLARA--FGIPVRKY---THEIVTLWY 166
Query: 487 -APEL-----AYTMVVTEKYDVYSFGVVALEVLMGK 516
AP++ Y+ + D++S G + E++ G
Sbjct: 167 RAPDVLMGSKKYSTTI----DIWSVGCIFAEMVNGT 198
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-25
Identities = 58/220 (26%), Positives = 102/220 (46%), Gaps = 33/220 (15%)
Query: 314 TEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKL--HRLETELASLESFQNEARLLSQI 370
++ + + +G G +G V + +G+ A+K + +++ + ES E +LL Q+
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQK-TDKESLLREVQLLKQL 83
Query: 371 RHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFC-ILR----TDEEAVGLDWTKRVNIVKGM 425
H NI+KLY F + +L+ E G LF I+ ++ +A I++ +
Sbjct: 84 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDA--------ARIIRQV 135
Query: 426 AHALSYLHHHCTPPILHRDISSNNILLNSEFEAF---VADFGIARLLNYDSSNRTLLAGT 482
++Y+H + I+HRD+ N+LL S+ + + DFG++ S GT
Sbjct: 136 LSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE-ASKKMKDKIGT 191
Query: 483 YGSIAPELAYTMVVTEKY----DVYSFGVVALEVLMGKHP 518
IAPE V+ Y DV+S GV+ +L G P
Sbjct: 192 AYYIAPE-----VLHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 59/257 (22%), Positives = 99/257 (38%), Gaps = 51/257 (19%)
Query: 323 IGTGGYGSVYRARL------PSGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNI 375
+G G +G V A + + VA+K L T + + +E ++L I H N+
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNV 93
Query: 376 VKLYGFCLHEKC-MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVN-------------- 420
V L G C + +I E+ + G+L LR+ +
Sbjct: 94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 421 ---IVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRT 477
+ KGM L+ +HRD+++ NILL+ + + DFG+AR + D
Sbjct: 154 SFQVAKGMEF-LASRK------CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV- 205
Query: 478 LLAGTYGSI-----APELAYTMVVTEKYDVYSFGVVALEVL-MGKHPGELLSSSSSSLDK 531
+ APE + V T + DV+SFGV+ E+ +G P +
Sbjct: 206 --RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-------YPGVKI 256
Query: 532 NIKLIDLLDP--RLPPP 546
+ + L R+ P
Sbjct: 257 DEEFCRRLKEGTRMRAP 273
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 48/220 (21%), Positives = 86/220 (39%), Gaps = 27/220 (12%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIR-HRNIVKLYG 380
+ GG+ VY A+ + SG+ ALK+L E + E + ++ H NIV+
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLS--NEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 381 FCL-------HEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLH 433
+ FL+ + G L L+ E L + I A+ ++H
Sbjct: 94 AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 434 HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRT---------LLAGTYG 484
PPI+HRD+ N+LL+++ + DFG A +++
Sbjct: 154 RQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 485 SI---APELAYTM---VVTEKYDVYSFGVVALEVLMGKHP 518
+ PE+ + EK D+++ G + + +HP
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-25
Identities = 57/239 (23%), Positives = 92/239 (38%), Gaps = 21/239 (8%)
Query: 4 LRNLVHLDLSDNHFMGHIPP-TLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAIA 61
L NL L L N IP LS L L++S N +V + + L L +L +
Sbjct: 79 LFNLRTLGLRSNRL-KLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVG 136
Query: 62 SNRMNGSILLGI-GSLKVLQVLDLSRNEIGGSIPS-TLGHLKWLRSVDLSQNKLVGPIPS 119
N + I L L+ L L + + SIP+ L HL L + L +
Sbjct: 137 DNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDY 194
Query: 120 SLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQ-IGKLQELYYL 178
S L +L L + + + P + L L + + L+ ++P + L L +L
Sbjct: 195 SFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFL 253
Query: 179 DLSGNFINGKIPSQLGEFSCID---TVDLSMNNLSGGIPVFV----RKVPHLDVSGNQF 230
+LS N I+ I + + L L+ + + + L+VSGNQ
Sbjct: 254 NLSYNPIS-TIEG--SMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQL 308
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 50/236 (21%), Positives = 89/236 (37%), Gaps = 17/236 (7%)
Query: 5 RNLVHLDLSDNHFMGHIPP-TLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAIAS 62
LDL N + L+ L L+ N + + +L L TL + S
Sbjct: 32 TETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIV-SAVEPGAFNNLFNLRTLGLRS 89
Query: 63 NR---MNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPS 119
NR + + G L L LD+S N+I + L L+S+++ N LV
Sbjct: 90 NRLKLIPLGVFTG---LSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHR 146
Query: 120 SLGHLTQLTTLNMYNNKLDGPIPPE-LMNCSKLRILKLGNNLLSGSIPSQI-GKLQELYY 177
+ L L L + L IP E L + L +L+L + ++ +I +L L
Sbjct: 147 AFSGLNSLEQLTLEKCNLTS-IPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKV 204
Query: 178 LDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSG---GIPVFVRKVPHLDVSGNQF 230
L++S + + ++ ++ NL+ + + L++S N
Sbjct: 205 LEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPI 260
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 40/210 (19%), Positives = 79/210 (37%), Gaps = 15/210 (7%)
Query: 35 NLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIP 94
++ IP+ L + NR+ S L+ L+L+ N + P
Sbjct: 20 RKRFVAVPEGIPTE------TRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEP 73
Query: 95 STLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPEL-MNCSKLRI 153
+L LR++ L N+L L+ LT L++ NK+ + + + L+
Sbjct: 74 GAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVI-LLDYMFQDLYNLKS 132
Query: 154 LKLGNNLLSGSIPSQI-GKLQELYYLDLSGNFINGKIPSQ-LGEFSCIDTVDLSMNNLS- 210
L++G+N L I + L L L L + IP++ L + + L N++
Sbjct: 133 LEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINA 190
Query: 211 --GGIPVFVRKVPHLDVSGNQFGGEIPTTL 238
+ ++ L++S + +
Sbjct: 191 IRDYSFKRLYRLKVLEISHWPYLDTMTPNC 220
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 6e-15
Identities = 35/161 (21%), Positives = 59/161 (36%), Gaps = 26/161 (16%)
Query: 3 RLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIAS 62
RL L L++S ++ + P L L+++ +L +P
Sbjct: 198 RLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLA------------- 243
Query: 63 NRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLG 122
+ L L+ L+LS N I S L L L+ + L +L P +
Sbjct: 244 ----------VRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFR 293
Query: 123 HLTQLTTLNMYNNKLDGPIPPELM-NCSKLRILKLGNNLLS 162
L L LN+ N+L + + + L L L +N L+
Sbjct: 294 GLNYLRVLNVSGNQLTT-LEESVFHSVGNLETLILDSNPLA 333
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-25
Identities = 46/230 (20%), Positives = 88/230 (38%), Gaps = 29/230 (12%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASN 63
+ L L+ + +P L ++ +L ++ N+L+ ++P L L N
Sbjct: 58 INQFSELQLNRLNLS-SLPDNLP--PQITVLEITQNALI-SLPEL---PASLEYLDACDN 110
Query: 64 RMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGH 123
R++ ++ S L+ LD+ N++ +P L+++ + N+L +P
Sbjct: 111 RLS-TLPELPAS---LKHLDVDNNQL-TMLPELPALLEYI---NADNNQLTM-LPEL--- 158
Query: 124 LTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQEL----YYLD 179
T L L++ NN+L +P + L L + NLL S+P+ + +
Sbjct: 159 PTSLEVLSVRNNQL-TFLPELPES---LEALDVSTNLLE-SLPAVPVRNHHSEETEIFFR 213
Query: 180 LSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHLDVSGNQ 229
N I IP + T+ L N LS I + +
Sbjct: 214 CRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGP 262
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 93.5 bits (232), Expect = 3e-20
Identities = 40/211 (18%), Positives = 78/211 (36%), Gaps = 26/211 (12%)
Query: 33 ILNLSLNSLVGNIPSNV-GHLTQLTTLAIASNRMNGSI-LLGIGSLKVLQVLDLSRNEIG 90
N N++ ++ + A+ N ++ LL + L L+R +
Sbjct: 14 SQNSFYNTIS-GTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNL- 71
Query: 91 GSIPSTLG-HLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCS 149
S+P L + L +++QN L+ +P L L+ +N+L +P +
Sbjct: 72 SSLPDNLPPQITVL---EITQNALI-SLPELPA---SLEYLDACDNRLST-LPELPAS-- 121
Query: 150 KLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNL 209
L+ L + NN L+ +P L+ ++ N + +P + + N L
Sbjct: 122 -LKHLDVDNNQLT-MLPELPALLEY---INADNNQLT-MLPELPTSLEVL---SVRNNQL 172
Query: 210 SGGIPVFVRKVPHLDVSGNQFGGEIPTTLAN 240
+ +P + LDVS N +P
Sbjct: 173 T-FLPELPESLEALDVSTNLL-ESLPAVPVR 201
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 91.6 bits (227), Expect = 1e-19
Identities = 38/236 (16%), Positives = 74/236 (31%), Gaps = 30/236 (12%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPS----NVGH-------- 51
+ L+++ N +P L L + L++L S +V +
Sbjct: 79 PPQITVLEITQNAL-ISLPELPASLEYLDACDNRLSTLPELPASLKHLDVDNNQLTMLPE 137
Query: 52 -LTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQ 110
L + +N++ + SL +VL + N++ +P L+ L D+S
Sbjct: 138 LPALLEYINADNNQLT-MLPELPTSL---EVLSVRNNQLT-FLPELPESLEAL---DVST 189
Query: 111 NKLVGPIPSSLGHLTQLTT----LNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIP 166
N L +P+ N++ IP +++ + L +N LS I
Sbjct: 190 NLLES-LPAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIR 247
Query: 167 SQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPH 222
+ + D G I + D V ++ H
Sbjct: 248 ESLSQQTAQ--PDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWH 301
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 49/215 (22%), Positives = 80/215 (37%), Gaps = 10/215 (4%)
Query: 3 RLRNLVHLDLSDNHF-MGHIPP-TLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAI 60
+L L L LS N + + LK L+LS N ++ + SN L QL L
Sbjct: 50 KLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDF 108
Query: 61 ASNRMNGSILLGI-GSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPS 119
+ + + SL+ L LD+S + L L + ++ N
Sbjct: 109 QHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP 168
Query: 120 -SLGHLTQLTTLNMYNNKLDGPIPPELMNC-SKLRILKLGNNLLSGSIPSQIGKLQELYY 177
L LT L++ +L+ + P N S L++L + +N L L
Sbjct: 169 DIFTELRNLTFLDLSQCQLEQ-LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQV 227
Query: 178 LDLSGNFINGKIPSQL--GEFSCIDTVDLSMNNLS 210
LD S N I Q S + ++L+ N+ +
Sbjct: 228 LDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 46/235 (19%), Positives = 81/235 (34%), Gaps = 13/235 (5%)
Query: 6 NLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSL-VGNIPSNV-GHLTQLTTLAIASN 63
+ L+L N +L++L L+LS N L S T L L ++ N
Sbjct: 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFN 88
Query: 64 RMNGSILLGIGSLKVLQVLDLSRNEIGGSIP--STLGHLKWLRSVDLSQNKLVGPIPSSL 121
+ ++ L+ L+ LD + + + S L+ L +D+S
Sbjct: 89 GVI-TMSSNFLGLEQLEHLDFQHSNL-KQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIF 146
Query: 122 GHLTQLTTLNMYNNKLDGPIPPE-LMNCSKLRILKLGNNLLSGSIPSQI-GKLQELYYLD 179
L+ L L M N P+ L L L L + L L L+
Sbjct: 147 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLN 205
Query: 180 LSGNFINGKIPSQLGEFSCIDTVDLSMNNLS----GGIPVFVRKVPHLDVSGNQF 230
+S N + + +D S+N++ + F + L+++ N F
Sbjct: 206 MSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 31/168 (18%), Positives = 63/168 (37%), Gaps = 16/168 (9%)
Query: 80 QVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLD- 138
+ + + S+P+ + ++L NKL LTQLT L++ +N L
Sbjct: 10 TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 139 -GPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFS 197
G + L+ L L N + ++ S L++L +LD + + ++ F
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEF-SVFL 123
Query: 198 CID---TVDLSMNNLSGGIPVFV----RKVPHLDVSGNQFGGEIPTTL 238
+ +D+S + + + L ++GN F +
Sbjct: 124 SLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 170
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 4e-25
Identities = 63/216 (29%), Positives = 107/216 (49%), Gaps = 33/216 (15%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQN----EARLLSQI 370
E + +G G YG VY+A+ G++VALK++ RL+ E E + E LL ++
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRI-RLDAED---EGIPSTAIREISLLKEL 76
Query: 371 RHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALS 430
H NIV L E+C+ L++E+ME L +L ++ + K + + ++
Sbjct: 77 HHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIK--IYLYQLLRGVA 133
Query: 431 YLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI---- 486
+ H H ILHRD+ N+L+NS+ +ADFG+AR + R+ T+ +
Sbjct: 134 HCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARA--FGIPVRSY---THEVVTLWY 185
Query: 487 -APEL-----AYTMVVTEKYDVYSFGVVALEVLMGK 516
AP++ Y+ V D++S G + E++ GK
Sbjct: 186 RAPDVLMGSKKYSTSV----DIWSIGCIFAEMITGK 217
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 45/230 (19%), Positives = 86/230 (37%), Gaps = 35/230 (15%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLE---------------TELASLES 359
D+ I + G + + K ALKK + + + +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 360 FQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILR-----TDEEAVGLD 414
F+NE ++++ I++ + G + +++IYEYME S+ +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 415 WTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474
I+K + ++ SY+H+ I HRD+ +NIL++ ++DFG + +
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYM--VDK 205
Query: 475 NRTLLAGTYGSIAPELAYTMVVTEKY------DVYSFGVVALEVLMGKHP 518
GTY + PE E D++S G+ + P
Sbjct: 206 KIKGSRGTYEFMPPE----FFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 60/263 (22%), Positives = 104/263 (39%), Gaps = 57/263 (21%)
Query: 323 IGTGGYGSVYRARL------PSGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNI 375
+G+G +G V A VA+K L + E+ +E ++++Q+ H NI
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS-SEREALMSELKMMTQLGSHENI 111
Query: 376 VKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVN--------------- 420
V L G C ++LI+EY G L LR+ E D + N
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 421 ---------IVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471
+ KGM L + +HRD+++ N+L+ + DFG+AR +
Sbjct: 172 EDLLCFAYQVAKGMEF-LEFKS------CVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 472 DSSNRTLLAGTYGSI-----APELAYTMVVTEKYDVYSFGVVALEVL-MGKHPGELLSSS 525
DS+ + APE + + T K DV+S+G++ E+ +G +P
Sbjct: 225 DSNYV---VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP------- 274
Query: 526 SSSLDKNIKLIDLLDP--RLPPP 546
+ + L+ ++ P
Sbjct: 275 YPGIPVDANFYKLIQNGFKMDQP 297
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 32/225 (14%)
Query: 304 RITFQDMIEATEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQN 362
+ FQ M E ++ +G G YG V + R +G++VA+KK + + +
Sbjct: 18 NLYFQSM----EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-LESDDD---KMVKK 69
Query: 363 ----EARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKR 418
E +LL Q+RH N+V L C +K +L++E+++ ++ L + GLD+
Sbjct: 70 IAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDL--ELFPNGLDYQVV 126
Query: 419 VNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTL 478
+ + + + + H H I+HRDI NIL++ + DFG AR L
Sbjct: 127 QKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD 183
Query: 479 LAGT--YGSIAPEL-----AYTMVVTEKYDVYSFGVVALEVLMGK 516
T Y APEL Y V DV++ G + E+ MG+
Sbjct: 184 EVATRWYR--APELLVGDVKYGKAV----DVWAIGCLVTEMFMGE 222
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 7e-25
Identities = 54/223 (24%), Positives = 100/223 (44%), Gaps = 39/223 (17%)
Query: 319 IKYCIGTGGYGSVYRAR---LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNI 375
+G G YG VY+A+ K ALK++ +++ E LL +++H N+
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR----EIALLRELKHPNV 80
Query: 376 VKLYGFCLH--EKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVN--IVKGMAH---- 427
+ L L ++ ++L+++Y E L+ I++ + ++ +VK + +
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 428 ALSYLHHHCTPPILHRDISSNNILLNSEFEAF----VADFGIARLLNYDSSNRTLLAGTY 483
+ YLH + +LHRD+ NIL+ E +AD G ARL ++S + L
Sbjct: 140 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL--FNSPLKPLADLDP 194
Query: 484 GSI-----APEL-----AYTMVVTEKYDVYSFGVVALEVLMGK 516
+ APEL YT + D+++ G + E+L +
Sbjct: 195 VVVTFWYRAPELLLGARHYTKAI----DIWAIGCIFAELLTSE 233
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 51/199 (25%), Positives = 89/199 (44%), Gaps = 40/199 (20%)
Query: 311 IEATEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQN----EAR 365
+ ++ F +G G Y +VY+ +G VALK++ +L++E E + E
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV-KLDSE----EGTPSTAIREIS 55
Query: 366 LLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEM--GSLFCILRTDEEAVGLDWTKRVNIVK 423
L+ +++H NIV+LY E + L++E+M+ GL+ +N+VK
Sbjct: 56 LMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLE----LNLVK 111
Query: 424 GMAH----ALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLL 479
L++ H + ILHRD+ N+L+N + + DFG+AR
Sbjct: 112 YFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLAR------------ 156
Query: 480 AGTYGSIAPELAYT-MVVT 497
+G P ++ VVT
Sbjct: 157 --AFGI--PVNTFSSEVVT 171
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-25
Identities = 34/271 (12%), Positives = 87/271 (32%), Gaps = 50/271 (18%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELAS-LESFQNEA---RLLSQIRHRNIVK 377
+G + A +G+ + + E ++ ++ + E RLL I+++ K
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 378 LYGFCLHEKCM------------------------FLIYEYME--MGSLFCILRTDEEAV 411
++ + + F +Y M+ + + +L +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 412 G-LDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN 470
L R+ + + L+ LHH+ ++H + +I+L+ F+ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 261
Query: 471 YDSSNRTLLAGTYGS---IAPELAY-----TMVVTEKYDVYSFGVVALEVLMGKHPGELL 522
+S + + + A + ++T +D ++ G+ + P
Sbjct: 262 -GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNT-- 318
Query: 523 SSSSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553
+ + I +P P ++
Sbjct: 319 ---DDAALGGSEWIFRSCKNIPQPVRALLEG 346
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 58/228 (25%), Positives = 93/228 (40%), Gaps = 43/228 (18%)
Query: 323 IGTGGYGSVYRARLP--------SGKVVALKKLHRLETELASLESFQNEARLLSQI-RHR 373
+G G +G V A VA+K L TE L +E ++ I +H+
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD-LSDLVSEMEMMKMIGKHK 101
Query: 374 NIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVN------------- 420
NI+ L G C + +++I EY G+L LR
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 421 ----IVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNR 476
+ +GM + L+ +HRD+++ N+L+ +ADFG+AR +N +
Sbjct: 162 CTYQLARGMEY-LASQK------CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 477 TLLAGTYGSI-----APELAYTMVVTEKYDVYSFGVVALEVL-MGKHP 518
T G + APE + V T + DV+SFGV+ E+ +G P
Sbjct: 215 ---KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 57/233 (24%), Positives = 101/233 (43%), Gaps = 48/233 (20%)
Query: 323 IGTGGYGSVYRARL------PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIV 376
+G G +G V +A VA+K L + + L +E +L Q+ H +++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASP-SELRDLLSEFNVLKQVNHPHVI 89
Query: 377 KLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVN---------------- 420
KLYG C + + LI EY + GSL LR + +
Sbjct: 90 KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 421 ---------IVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471
I +GM + L+ + ++HRD+++ NIL+ + ++DFG++R +
Sbjct: 150 GDLISFAWQISQGMQY-LAEMK------LVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 472 DSSNRTLLAGTYGSI-----APELAYTMVVTEKYDVYSFGVVALEVL-MGKHP 518
+ S + G I A E + + T + DV+SFGV+ E++ +G +P
Sbjct: 203 EDSYV---KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 66/245 (26%), Positives = 111/245 (45%), Gaps = 32/245 (13%)
Query: 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLE-TELASLESFQNEARLLSQIRH 372
+ F+I IG G +G V + + K+ A+K +++ + E + + E +++ + H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 373 RNIVKL-YGFCLHEKCMFLIYEYMEMGSLFCILRT----DEEAVGLDWTKRVNIVKGMAH 427
+V L Y F E MF++ + + G L L+ EE V L + +
Sbjct: 75 PFLVNLWYSFQDEED-MFMVVDLLLGGDLRYHLQQNVHFKEETVKL-FICEL------VM 126
Query: 428 ALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIA 487
AL YL + I+HRD+ +NILL+ + DF IA +L ++ T +AGT +A
Sbjct: 127 ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT-MAGTKPYMA 182
Query: 488 PEL-------AYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLD 540
PE+ Y+ V D +S GV A E+L G+ P SS+S + + +
Sbjct: 183 PEMFSSRKGAGYSFAV----DWWSLGVTAYELLRGRRPYH--IRSSTSSKEIVHTFETTV 236
Query: 541 PRLPP 545
P
Sbjct: 237 VTYPS 241
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 102 bits (258), Expect = 1e-24
Identities = 62/193 (32%), Positives = 92/193 (47%), Gaps = 39/193 (20%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQN----EARLLSQ 369
E+F IG G YG VY+AR +G+VVALKK+ RL+TE E + E LL +
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTET---EGVPSTAIREISLLKE 58
Query: 370 IRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAH-- 427
+ H NIVKL E ++L++E++ L + G+ + ++K
Sbjct: 59 LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMD-ASALTGIP----LPLIKSYLFQL 112
Query: 428 --ALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGS 485
L++ H H +LHRD+ N+L+N+E +ADFG+AR +G
Sbjct: 113 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR--------------AFGV 155
Query: 486 IAPELAYT-MVVT 497
P YT VVT
Sbjct: 156 --PVRTYTHEVVT 166
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 52/207 (25%), Positives = 96/207 (46%), Gaps = 39/207 (18%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQN----EARLLSQ 369
+ ++ IG G YG+V++A+ + ++VALK++ RL+ + E + E LL +
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDD---EGVPSSALREICLLKE 57
Query: 370 IRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHAL 429
++H+NIV+L+ +K + L++E+ + L + + + K + + + L
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVK--SFLFQLLKGL 114
Query: 430 SYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPE 489
+ H +LHRD+ N+L+N E +A+FG+AR +G P
Sbjct: 115 GFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLAR--------------AFGI--PV 155
Query: 490 LAYT-MVVTEKYDVYSFGVVALEVLMG 515
Y+ VVT Y +VL G
Sbjct: 156 RCYSAEVVTLWYR-------PPDVLFG 175
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 30/208 (14%)
Query: 314 TEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRH 372
E ++I +G G +G V + + + + A+K +++ + + E LL ++ H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLF-CILR----TDEEAVGLDWTKRVNIVKGMAH 427
NI+KL+ +++ E G LF I++ ++ +A I+K +
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA--------ARIIKQVFS 132
Query: 428 ALSYLHHHCTPPILHRDISSNNILLNSEFEAF---VADFGIARLLNYDSSNRTLLAGTYG 484
++Y+H H I+HRD+ NILL S+ + + DFG++ ++ + GT
Sbjct: 133 GITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD-RIGTAY 188
Query: 485 SIAPELAYTMVVTEKY----DVYSFGVV 508
IAPE V+ Y DV+S GV+
Sbjct: 189 YIAPE-----VLRGTYDEKCDVWSAGVI 211
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 48/158 (30%), Positives = 77/158 (48%), Gaps = 16/158 (10%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQN----EARLLSQ 369
E + +G G Y +VY+ + + +VALK++ RLE E E E LL
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI-RLEHE----EGAPCTAIREVSLLKD 56
Query: 370 IRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHAL 429
++H NIV L+ EK + L++EY++ L L D+ ++ + + L
Sbjct: 57 LKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYL--DDCGNIINMHNVKLFLFQLLRGL 113
Query: 430 SYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIAR 467
+Y H +LHRD+ N+L+N E +ADFG+AR
Sbjct: 114 AYCHRQK---VLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 63/235 (26%), Positives = 96/235 (40%), Gaps = 52/235 (22%)
Query: 323 IGTGGYGSVYRARLPSGK------VVALKKLHRLETELASLESFQNEARLLSQIRHRNIV 376
IG G +G V++AR P +VA+K L + + FQ EA L+++ + NIV
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD-FQREAALMAEFDNPNIV 113
Query: 377 KLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVN---------------- 420
KL G C K M L++EYM G L LR+ +
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 421 ---------IVKGMAHALSYLH-HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN 470
+ GMA YL +HRD+++ N L+ +ADFG++R +
Sbjct: 174 AEQLCIARQVAAGMA----YLSERKF----VHRDLATRNCLVGENMVVKIADFGLSRNIY 225
Query: 471 YDSSNRTLLAGTYGSI-----APE-LAYTMVVTEKYDVYSFGVVALEVL-MGKHP 518
+ A +I PE + Y T + DV+++GVV E+ G P
Sbjct: 226 SADYYK---ADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 60/229 (26%), Positives = 93/229 (40%), Gaps = 45/229 (19%)
Query: 323 IGTGGYGSVYRARL--------PSGKVVALKKLHRLETELASLESFQNEARLLSQI-RHR 373
+G G +G V A VA+K L TE L +E ++ I +H+
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD-LSDLVSEMEMMKMIGKHK 147
Query: 374 NIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVN------------- 420
NI+ L G C + +++I EY G+L LR
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 421 ----IVKGMAHALSYL-HHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSN 475
+ +GM YL C +HRD+++ N+L+ +ADFG+AR +N
Sbjct: 208 CTYQLARGME----YLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 259
Query: 476 RTLLAGTYGSI-----APELAYTMVVTEKYDVYSFGVVALEVL-MGKHP 518
+ T G + APE + V T + DV+SFGV+ E+ +G P
Sbjct: 260 K---KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 44/158 (27%), Positives = 76/158 (48%), Gaps = 9/158 (5%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQ-NEARLLSQIRH 372
E ++ IG G YG V++ R +G++VA+KK + ++ E R+L Q++H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQLKH 61
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYL 432
N+V L ++ + L++EY + ++ L D G+ +I A+++
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 433 HHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN 470
H H +HRD+ NIL+ + DFG ARLL
Sbjct: 119 HKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLT 153
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 57/229 (24%), Positives = 96/229 (41%), Gaps = 45/229 (19%)
Query: 323 IGTGGYGSVYRARLP--------SGKVVALKKLHRLETELASLESFQNEARLLSQI-RHR 373
+G G +G V A VA+K L TE L +E ++ I +H+
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEMMKMIGKHK 135
Query: 374 NIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVN------------- 420
NI+ L G C + +++I EY G+L L+ +
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195
Query: 421 ----IVKGMAHALSYL-HHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSN 475
+ +GM YL C +HRD+++ N+L+ + +ADFG+AR +++
Sbjct: 196 CAYQVARGME----YLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 247
Query: 476 RTLLAGTYGSI-----APELAYTMVVTEKYDVYSFGVVALEVL-MGKHP 518
+ T G + APE + + T + DV+SFGV+ E+ +G P
Sbjct: 248 K---KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-24
Identities = 65/229 (28%), Positives = 98/229 (42%), Gaps = 41/229 (17%)
Query: 314 TEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHR-----------LETELASLESFQ 361
E + +G+G YG V + A+K + + + E
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 362 NEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFC-ILR----TDEEAVGLDWT 416
NE LL + H NI+KL+ +K +L+ E+ E G LF I+ + +A
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDA------ 148
Query: 417 KRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAF---VADFGIARLLNYDS 473
NI+K + + YLH H I+HRDI NILL ++ + DFG++ + D
Sbjct: 149 --ANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY 203
Query: 474 SNRTLLAGTYGSIAPELAYTMVVTEKY----DVYSFGVVALEVLMGKHP 518
R GT IAPE V+ +KY DV+S GV+ +L G P
Sbjct: 204 KLRD-RLGTAYYIAPE-----VLKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 54/232 (23%), Positives = 98/232 (42%), Gaps = 52/232 (22%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESF----QNEARLLSQ 369
++ IG G +G V++AR +G+ VALKK+ +E E E F E ++L
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV-LMENEK---EGFPITALREIKILQL 72
Query: 370 IRHRNIVKLYG--------FCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNI 421
++H N+V L + + ++L++++ E L +L L K +
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIK--RV 129
Query: 422 VKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAG 481
++ + + L Y+H + ILHRD+ + N+L+ + +ADFG+AR + + +
Sbjct: 130 MQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARA--FSLAKNS---- 180
Query: 482 TYGSIAPELAYT-MVVT------------EKY----DVYSFGVVALEVLMGK 516
YT VVT Y D++ G + E+
Sbjct: 181 ------QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 57/238 (23%), Positives = 103/238 (43%), Gaps = 17/238 (7%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASN 63
L + L I + L+ L L L N + ++ + + +LT++T L ++ N
Sbjct: 40 LDGITTLSAFGTGV-TTIEG-VQYLNNLIGLELKDNQIT-DL-APLKNLTKITELELSGN 95
Query: 64 RMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGH 123
+ + I L+ ++ LDL+ +I + + L L L+ + L N++ S L
Sbjct: 96 PL--KNVSAIAGLQSIKTLDLTSTQI--TDVTPLAGLSNLQVLYLDLNQITN--ISPLAG 149
Query: 124 LTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGN 183
LT L L++ N ++ + P L N SKL LK +N +S I + L L + L N
Sbjct: 150 LTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNN 205
Query: 184 FINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHLDVSGNQFGGEI-PTTLAN 240
I+ P L S + V L+ ++ + + +V G I P T+++
Sbjct: 206 QISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPATISD 261
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 3e-22
Identities = 46/207 (22%), Positives = 86/207 (41%), Gaps = 16/207 (7%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASN 63
L N + + ++ T L + L+ + I V +L L L + N
Sbjct: 18 LANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKDN 73
Query: 64 RMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGH 123
++ + L + +L + L+LS N + S + L+ ++++DL+ ++ P L
Sbjct: 74 QI--TDLAPLKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVTP--LAG 127
Query: 124 LTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGN 183
L+ L L + N++ I P L + L+ L +GN +S + + L +L L N
Sbjct: 128 LSNLQVLYLDLNQITN-ISP-LAGLTNLQYLSIGNAQVS-DLTP-LANLSKLTTLKADDN 183
Query: 184 FINGKIPSQLGEFSCIDTVDLSMNNLS 210
I+ I L + V L N +S
Sbjct: 184 KIS-DISP-LASLPNLIEVHLKNNQIS 208
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 8e-17
Identities = 50/208 (24%), Positives = 85/208 (40%), Gaps = 13/208 (6%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASN 63
L+++ LDL+ + + P L LS L++L L LN + NI S + LT L L+I +
Sbjct: 106 LQSIKTLDLTSTQ-ITDVTP-LAGLSNLQVLYLDLNQIT-NI-SPLAGLTNLQYLSIGNA 161
Query: 64 RMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGH 123
++ S L + +L L L N+I I L L L V L N++ S L +
Sbjct: 162 QV--SDLTPLANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISDV--SPLAN 215
Query: 124 LTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGN 183
+ L + + N + P N + + + + P+ I +L+ N
Sbjct: 216 TSNLFIVTLTNQTITN--QPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWN 273
Query: 184 FINGKIPSQLGEFSCIDTVDLSMNNLSG 211
+ I + F+ T + SG
Sbjct: 274 LTSF-INNVSYTFNQSVTFKNTTVPFSG 300
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 30/164 (18%), Positives = 66/164 (40%), Gaps = 13/164 (7%)
Query: 68 SILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQL 127
+++ +L + ++ + T L + ++ + + +L L
Sbjct: 10 NVIFPDPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTTI--EGVQYLNNL 65
Query: 128 TTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFING 187
L + +N++ + P L N +K+ L+L N L ++ + I LQ + LDL+ I
Sbjct: 66 IGLELKDNQITD-LAP-LKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITD 121
Query: 188 KIPSQLGEFSCIDTVDLSMNNLSGGIPVF--VRKVPHLDVSGNQ 229
P L S + + L +N ++ I + + +L + Q
Sbjct: 122 VTP--LAGLSNLQVLYLDLNQIT-NISPLAGLTNLQYLSIGNAQ 162
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 6e-24
Identities = 48/187 (25%), Positives = 80/187 (42%), Gaps = 11/187 (5%)
Query: 3 RLRNLVHLDLSDNHFMGHIPP-TLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAI 60
RNL L L N I L+ L+ L+LS N+ + ++ L +L TL +
Sbjct: 54 ACRNLTILWLHSNVL-ARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112
Query: 61 ASNRMNGSILLGI-GSLKVLQVLDLSRNEIGGSIPS-TLGHLKWLRSVDLSQNKLVGPIP 118
+ + G+ L LQ L L N + ++P T L L + L N++
Sbjct: 113 DRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPE 170
Query: 119 SSLGHLTQLTTLNMYNNKLDGPIPPE-LMNCSKLRILKLGNNLLSGSIPSQI-GKLQELY 176
+ L L L ++ N++ + P + +L L L N LS ++P++ L+ L
Sbjct: 171 RAFRGLHSLDRLLLHQNRVAH-VHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQ 228
Query: 177 YLDLSGN 183
YL L+ N
Sbjct: 229 YLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-21
Identities = 45/212 (21%), Positives = 71/212 (33%), Gaps = 13/212 (6%)
Query: 5 RNLVHLDLSDNHFMGHIPP-TLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAIAS 62
+ L N H+P + L IL L N L I + L L L ++
Sbjct: 32 AASQRIFLHGNRI-SHVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLALLEQLDLSD 89
Query: 63 NRMNGSILLGI-GSLKVLQVLDLSRNEIGGSIPS-TLGHLKWLRSVDLSQNKLVGPIPS- 119
N S+ L L L L R + + L L+ + L N L +P
Sbjct: 90 NAQLRSVDPATFHGLGRLHTLHLDRCGL-QELGPGLFRGLAALQYLYLQDNALQA-LPDD 147
Query: 120 SLGHLTQLTTLNMYNNKLDGPIPPE-LMNCSKLRILKLGNNLLSGSIPSQI-GKLQELYY 177
+ L LT L ++ N++ +P L L L N ++ + L L
Sbjct: 148 TFRDLGNLTHLFLHGNRISS-VPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMT 205
Query: 178 LDLSGNFINGKIPSQLGEFSCIDTVDLSMNNL 209
L L N ++ L + + L+ N
Sbjct: 206 LYLFANNLSALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 7e-13
Identities = 32/160 (20%), Positives = 55/160 (34%), Gaps = 14/160 (8%)
Query: 79 LQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLD 138
Q + L N I ++ + L + L N L ++ L L L++ +N
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 139 GPIPPE-LMNCSKLRILKLGNNLLSGSIPSQI-GKLQELYYLDLSGNFINGKIPSQLGEF 196
+ P +L L L L + + L L YL L N + +P F
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDT--F 149
Query: 197 SC---IDTVDLSMNNLSGGIP--VFV--RKVPHLDVSGNQ 229
+ + L N +S +P F + L + N+
Sbjct: 150 RDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNR 188
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 43/163 (26%), Positives = 76/163 (46%), Gaps = 21/163 (12%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQN----EARLLSQ 369
+ + +G G YG VY+A + + VA+K++ RLE E E E LL +
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI-RLEHEE---EGVPGTAIREVSLLKE 89
Query: 370 IRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHAL 429
++HRNI++L H + LI+EY E L + ++ + + + + + +
Sbjct: 90 LQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM---DKNPDVSMRVIKSFLYQLINGV 145
Query: 430 SYLHHHCTPPILHRDISSNNILLNSEFEAF-----VADFGIAR 467
++ H LHRD+ N+LL+ + + DFG+AR
Sbjct: 146 NFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 59/243 (24%), Positives = 100/243 (41%), Gaps = 41/243 (16%)
Query: 294 DEIAI-WNYDGRITFQDMIEA-----TEDFDIKYCI----GTGGYGSVYRAR-LPSGKVV 342
EIA+ + + F D+ + +Y + G+G G V A + K V
Sbjct: 104 SEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKV 163
Query: 343 ALKKLHR------LETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYME 396
A++ + + E + + E +L ++ H I+K+ F + +++ E ME
Sbjct: 164 AIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELME 222
Query: 397 MGSLF-CILR----TDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNIL 451
G LF ++ + M A+ YLH + I+HRD+ N+L
Sbjct: 223 GGELFDKVVGNKRLKEATC--------KLYFYQMLLAVQYLHENG---IIHRDLKPENVL 271
Query: 452 LNSEFEAF---VADFGIARLLNYDSSNRTLLAGTYGSIAPE-LAYTMVV--TEKYDVYSF 505
L+S+ E + DFG +++L S RT L GT +APE L D +S
Sbjct: 272 LSSQEEDCLIKITDFGHSKILGETSLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSL 330
Query: 506 GVV 508
GV+
Sbjct: 331 GVI 333
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-23
Identities = 48/209 (22%), Positives = 99/209 (47%), Gaps = 30/209 (14%)
Query: 314 TEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRH 372
TE++ + +G G + V R + +G+ A ++ + + + EAR+ ++H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLF-CILR----TDEEAVGLDWTKRVNIVKGMAH 427
NIV+L+ E +LI++ + G LF I+ ++ +A + ++ +
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADA--------SHCIQQILE 121
Query: 428 ALSYLHHHCTPPILHRDISSNNILLNSEFEAF---VADFGIARLLNYDSSNRTLLAGTYG 484
A+ + H ++HR++ N+LL S+ + +ADFG+A + + AGT G
Sbjct: 122 AVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPG 178
Query: 485 SIAPELAYTMVVTEK-Y----DVYSFGVV 508
++PE V+ + Y D+++ GV+
Sbjct: 179 YLSPE-----VLRKDPYGKPVDLWACGVI 202
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 44/203 (21%), Positives = 88/203 (43%), Gaps = 11/203 (5%)
Query: 314 TEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALK---KLHRLETELASLESFQNEARLLSQ 369
+ +++ IG G + V R +G+ A+K + S E + EA +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 370 IRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLF-CILRTDEEAVGLDWTKRVNIVKGMAHA 428
++H +IV+L + +++++E+M+ L I++ + + ++ + A
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 429 LSYLHHHCTPPILHRDISSNNILLNSEFEAF---VADFGIARLLNYDSSNRTLLAGTYGS 485
L Y H + I+HRD+ + +LL S+ + + FG+A L GT
Sbjct: 143 LRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHF 199
Query: 486 IAPELAYTMVVTEKYDVYSFGVV 508
+APE+ + DV+ GV+
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVI 222
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 4e-23
Identities = 48/212 (22%), Positives = 86/212 (40%), Gaps = 36/212 (16%)
Query: 314 TEDFDIKYCI----GTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLS 368
D + Y + G G +G V A + A KK+ + + ++ F+ E ++
Sbjct: 4 KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK--YFVEDVDRFKQEIEIMK 61
Query: 369 QIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLF-CILR----TDEEAVGLDWTKRVNIVK 423
+ H NI++LY ++L+ E G LF ++ + +A I+K
Sbjct: 62 SLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDA--------ARIMK 113
Query: 424 GMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAF---VADFGIARLLNYDSSNRTLLA 480
+ A++Y H + HRD+ N L ++ + DFG+A RT
Sbjct: 114 DVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT-KV 169
Query: 481 GTYGSIAPELAYTMVVTEKY----DVYSFGVV 508
GT ++P+ V+ Y D +S GV+
Sbjct: 170 GTPYYVSPQ-----VLEGLYGPECDEWSAGVM 196
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-23
Identities = 46/232 (19%), Positives = 84/232 (36%), Gaps = 31/232 (13%)
Query: 3 RLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVG-HLTQLTTLAIA 61
+ L + + + L ++K + + + + +P + HL L L ++
Sbjct: 284 ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKV-FLVPCSFSQHLKSLEFLDLS 342
Query: 62 SNRMNGSIL---LGIGSLKVLQVLDLSRNEIG--GSIPSTLGHLKWLRSVDLSQNKLVGP 116
N M L G+ LQ L LS+N + L LK L S+D+S+N P
Sbjct: 343 ENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTF-HP 401
Query: 117 IPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELY 176
+P S ++ LN+ + + + + L +L + NN L S + +LQELY
Sbjct: 402 MPDSCQWPEKMRFLNLSSTGIRV-VKTCIP--QTLEVLDVSNNNLD-SFSLFLPRLQELY 457
Query: 177 -------------------YLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNL 209
+ +S N + + + + L N
Sbjct: 458 ISRNKLKTLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-23
Identities = 50/240 (20%), Positives = 96/240 (40%), Gaps = 19/240 (7%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLV---GNIPSNVGHLTQLTTLAI 60
R V D S N + + + LSE++ + +LN L + V L ++ T+ I
Sbjct: 230 FRGSVLTDESFNELL-KLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTI 288
Query: 61 ASNRMNGSILLGI-----GSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKL-- 113
+ L L+ ++ + + +++ S HLK L +DLS+N +
Sbjct: 289 RRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVE 348
Query: 114 -VGPIPSSLGHLTQLTTLNMYNNKLD--GPIPPELMNCSKLRILKLGNNLLSGSIPSQIG 170
+ G L TL + N L L+ L L + N +P
Sbjct: 349 EYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQ 407
Query: 171 KLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHLDVSGNQF 230
+++ +L+LS I + + + ++ +D+S NNL +F+ ++ L +S N+
Sbjct: 408 WPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLDS-FSLFLPRLQELYISRNKL 463
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 5e-22
Identities = 40/277 (14%), Positives = 82/277 (29%), Gaps = 51/277 (18%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASN 63
L +L L++ + +L + ++ L L L+ + L+ + L +
Sbjct: 147 LTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDT 206
Query: 64 RMNG----------------------------------SILLGIGSLKVLQVLDLSRNEI 89
+ +L I L ++ D + N +
Sbjct: 207 NLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGL 266
Query: 90 GGSIPSTLGHLKW--------LRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPI 141
G PS + +R + + Q L + + L ++ + + N+K+
Sbjct: 267 GDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVP 326
Query: 142 PPELMNCSKLRILKLGNNLLSGSIPSQ---IGKLQELYYLDLSGNFINGKIPSQLGEFSC 198
+ L L L NL+ G L L LS N + +
Sbjct: 327 CSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLT 385
Query: 199 ---IDTVDLSMNNLSGGIPVFV--RKVPHLDVSGNQF 230
+ ++D+S N K+ L++S
Sbjct: 386 LKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGI 422
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 9e-22
Identities = 38/212 (17%), Positives = 71/212 (33%), Gaps = 6/212 (2%)
Query: 3 RLRNLVHLDLSDNHFMGHIPP-TLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAI 60
NL L L + I L L+ L+LS N L ++ S+ G L+ L L +
Sbjct: 48 ACANLQVLILKSSRI-NTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNL 105
Query: 61 ASNRMNGSILLG-IGSLKVLQVLDLSRNEIGGSIP-STLGHLKWLRSVDLSQNKLVGPIP 118
N + +L LQ L + E I L L +++ L
Sbjct: 106 MGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQS 165
Query: 119 SSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYL 178
SL + + L ++ ++ + S +R L+L + L+ S + + +
Sbjct: 166 QSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPM 225
Query: 179 DLSGNFINGKIPSQLGEFSCIDTVDLSMNNLS 210
+ E + L ++ +
Sbjct: 226 KKLAFRGSVLTDESFNELLKLLRYILELSEVE 257
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-21
Identities = 42/211 (19%), Positives = 75/211 (35%), Gaps = 28/211 (13%)
Query: 4 LRNLVHLDLSDNHFMGHIPPT-LGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIAS 62
+ LDLS N +I L + L++L L + + I +
Sbjct: 25 TAAMKSLDLSFNKI-TYIGHGDLRACANLQVLILKSSRI-NTIEGDA------------- 69
Query: 63 NRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVG-PIPSSL 121
SL L+ LDLS N + S G L L+ ++L N + S
Sbjct: 70 ----------FYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLF 119
Query: 122 GHLTQLTTLNMYNNKLDGPIPPE-LMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDL 180
+LT L TL + N + I + L L++ L + ++++++L L
Sbjct: 120 PNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTL 179
Query: 181 SGNFINGKIPSQLGEFSCIDTVDLSMNNLSG 211
+ + S + ++L NL+
Sbjct: 180 HLSESAFLLEIFADILSSVRYLELRDTNLAR 210
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-20
Identities = 45/225 (20%), Positives = 71/225 (31%), Gaps = 32/225 (14%)
Query: 10 LDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSI 69
D F IP L + +K L+LS N + I
Sbjct: 10 CDGRSRSFT-SIPSGL--TAAMKSLDLSFNKIT-YIGHGD-------------------- 45
Query: 70 LLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTT 129
+ + LQVL L + I L L +DLS N L S G L+ L
Sbjct: 46 ---LRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKY 102
Query: 130 LNMYNNKLDG-PIPPELMNCSKLRILKLGNNLLSGSIPSQ-IGKLQELYYLDLSGNFING 187
LN+ N + N + L+ L++GN I L L L++ +
Sbjct: 103 LNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRN 162
Query: 188 KIPSQLGEFSCIDTVDLSMNNLSG---GIPVFVRKVPHLDVSGNQ 229
L I + L ++ + + V +L++
Sbjct: 163 YQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTN 207
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 3e-20
Identities = 38/160 (23%), Positives = 66/160 (41%), Gaps = 12/160 (7%)
Query: 2 GRLRNLVHLDLSDNHF--MGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLA 59
G +L L LS NH M L L L L++S N+ +P + ++ L
Sbjct: 358 GAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTF-HPMPDSCQWPEKMRFLN 416
Query: 60 IASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPS 119
++S + ++ + L+VLD+S N + S L L+ L +S+NKL +P
Sbjct: 417 LSSTGIR---VVKTCIPQTLEVLDVSNNNLD-SFSLFLPRLQEL---YISRNKLKT-LPD 468
Query: 120 SLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNN 159
+ L + + N+L + L+ + L N
Sbjct: 469 A-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 5e-18
Identities = 34/254 (13%), Positives = 78/254 (30%), Gaps = 25/254 (9%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPP-TLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAI 60
L NL L + + I L+ L L + SL ++ + + L +
Sbjct: 120 PNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTL 179
Query: 61 ASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLV------ 114
+ + + L ++ L+L + S L + + +
Sbjct: 180 HLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDES 239
Query: 115 -GPIPSSLGHLTQLTTLNMYNNKLDG--PIPPEL---------MNCSKLRILKLGNNLLS 162
+ L ++ +L+ + + L+G P + +R L + L
Sbjct: 240 FNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLF 299
Query: 163 GSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGI---PVFVRK 219
+ + L+++ + + + + S ++ +DLS N +
Sbjct: 300 YDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGA 359
Query: 220 VP---HLDVSGNQF 230
P L +S N
Sbjct: 360 WPSLQTLVLSQNHL 373
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 4e-23
Identities = 32/160 (20%), Positives = 67/160 (41%), Gaps = 7/160 (4%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASN 63
+ +L ++ L++ + + + +K L ++ N + + L+ L L I
Sbjct: 43 MNSLTYITLANINV-TDLTG-IEYAHNIKDLTINNIHA-TNY-NPISGLSNLERLRIMGK 98
Query: 64 RMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGH 123
+ + + L L +LD+S + SI + + L + S+DLS N + I L
Sbjct: 99 DVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKT 157
Query: 124 LTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSG 163
L +L +LN+ + + + + KL L + + G
Sbjct: 158 LPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 9e-18
Identities = 26/191 (13%), Positives = 68/191 (35%), Gaps = 11/191 (5%)
Query: 44 NIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWL 103
NIP + + + + + L + L+ + + + + + +
Sbjct: 16 NIP-----DSTFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT-DL-TGIEYAHNI 68
Query: 104 RSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSG 163
+ + ++ + + L+ L L + + P L + L +L + ++
Sbjct: 69 KDLTINNIHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDD 126
Query: 164 SIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPV-FVRKVPH 222
SI ++I L ++ +DLS N I L + ++++ + + + K+
Sbjct: 127 SILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRGIEDFPKLNQ 185
Query: 223 LDVSGNQFGGE 233
L GG+
Sbjct: 186 LYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 9e-06
Identities = 22/141 (15%), Positives = 43/141 (30%), Gaps = 28/141 (19%)
Query: 100 LKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNN 159
K + L Q+ I + + LT + + N + + + ++ L + N
Sbjct: 22 FKAYLNGLLGQSS-TANI--TEAQMNSLTYITLANINVTD-LTG-IEYAHNIKDLTINNI 76
Query: 160 LLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRK 219
+ P I L L L + G + L + +L+
Sbjct: 77 HATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLS----------GLTSLT--------- 115
Query: 220 VPHLDVSGNQFGGEIPTTLAN 240
LD+S + I T +
Sbjct: 116 --LLDISHSAHDDSILTKINT 134
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 52/215 (24%), Positives = 94/215 (43%), Gaps = 25/215 (11%)
Query: 314 TEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRH 372
+ +DI +G+G +G V+R +G+V K ++ + +NE +++Q+ H
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT--PYPLDKYTVKNEISIMNQLHH 107
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLF--CILR----TDEEAVGLDWTKRVNIVKGMA 426
++ L+ + M LI E++ G LF ++ E +N ++
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEV--------INYMRQAC 159
Query: 427 HALSYLHHHCTPPILHRDISSNNILLNSEFEAFV--ADFGIARLLNYDSSNRTLLAGTYG 484
L ++H H I+H DI NI+ ++ + V DFG+A LN D + T
Sbjct: 160 EGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV-TTATAE 215
Query: 485 SIAPE-LAYTMVVTEKYDVYSFGVVALEVLMGKHP 518
APE + V D+++ GV+ +L G P
Sbjct: 216 FAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSP 249
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-23
Identities = 42/213 (19%), Positives = 82/213 (38%), Gaps = 12/213 (5%)
Query: 8 VHLDLSDNHFMG--HIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRM 65
++ F +P L+ + L LS N + S+ L QL L + S
Sbjct: 4 FDGRIAFYRFCNLTQVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYT 60
Query: 66 NGSILLGI-GSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPI--PSSLG 122
+I +L L++LDL ++I P L L + L L +
Sbjct: 61 PLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFR 120
Query: 123 HLTQLTTLNMYNNKLDG-PIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQ--ELYYLD 179
+L LT L++ N++ + P + L+ + +N + ++ LQ L +
Sbjct: 121 NLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFS 180
Query: 180 LSGNFINGKIPSQLGE-FSCIDTVDLSMNNLSG 211
L+ N + ++ G+ + + L + ++SG
Sbjct: 181 LAANSLYSRVSVDWGKCMNPFRNMVLEILDVSG 213
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 6e-23
Identities = 53/259 (20%), Positives = 85/259 (32%), Gaps = 35/259 (13%)
Query: 4 LRNLVHLDLSDNHFMGHIPP-TLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAIA 61
L L LS N+ + + L +L++L L I +L L L +
Sbjct: 23 LNTTERLLLSFNYIR-TVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLG 81
Query: 62 SNRMNGSILLGI-GSLKVLQVLDLSRNEIGGSI--PSTLGHLKWLRSVDLSQNKLVG-PI 117
S+++ + L L L L + ++ +LK L +DLS+N++ +
Sbjct: 82 SSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYL 140
Query: 118 PSSLGHLTQLTTLNMYNNKLDGPIPPELMNCS--KLRILKLGNNLLSGSIPSQIGKLQE- 174
S G L L +++ +N++ EL L L N L + GK
Sbjct: 141 HPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNP 200
Query: 175 -----LYYLDLSGNFINGKIPS------------QLGEFSCIDTVDLSMNNLSGGIPVFV 217
L LD+SGN I L I +N+
Sbjct: 201 FRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK-DPDQNT 259
Query: 218 ------RKVPHLDVSGNQF 230
V HLD+S
Sbjct: 260 FAGLARSSVRHLDLSHGFV 278
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-22
Identities = 46/248 (18%), Positives = 86/248 (34%), Gaps = 26/248 (10%)
Query: 3 RLRNLVHLDLSDNHFMGHIPPTLGRLSE------LKILNLSLNSLVGNIPSNV-GHLTQL 55
+ + L L+ N + G+ L+IL++S N +I N +++
Sbjct: 172 QGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKS 231
Query: 56 TTLAIASNRMNGSILLGIGSLKV-------------LQVLDLSRNEIGGSIPSTLGHLKW 102
++ G ++K ++ LDLS + LK
Sbjct: 232 QAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKD 291
Query: 103 LRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLS 162
L+ ++L+ NK+ + L L LN+ N L K+ + L N ++
Sbjct: 292 LKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA 351
Query: 163 GSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPH 222
L++L LDL N + + + I + LS N L +P
Sbjct: 352 IIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLV-TLPKINLTANL 405
Query: 223 LDVSGNQF 230
+ +S N+
Sbjct: 406 IHLSENRL 413
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 99.9 bits (249), Expect = 4e-22
Identities = 50/259 (19%), Positives = 93/259 (35%), Gaps = 33/259 (12%)
Query: 3 RLRNLVHLDLSDNHFMGHIPP-TLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAI 60
L L L+L + I L L+IL+L + + + + L L L +
Sbjct: 46 FLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRL 104
Query: 61 ASNRMNGSILLG--IGSLKVLQVLDLSRNEIGG-SIPSTLGHLKWLRSVDLSQNKLVGPI 117
++ ++L +LK L LDLS+N+I + + G L L+S+D S N++
Sbjct: 105 YFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVC 164
Query: 118 PSSLGHLTQ--LTTLNMYNNKLDGPIPPELMNCSK------LRILKLGNN---------- 159
L L L+ ++ N L + + C L IL + N
Sbjct: 165 EHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNF 224
Query: 160 --LLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLG--EFSCIDTVDLSMNNLSGGIPV 215
+S S + + + I + S + +DLS + +
Sbjct: 225 SNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF-SLNS 283
Query: 216 FV----RKVPHLDVSGNQF 230
V + + L+++ N+
Sbjct: 284 RVFETLKDLKVLNLAYNKI 302
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 4e-20
Identities = 55/251 (21%), Positives = 86/251 (34%), Gaps = 24/251 (9%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLS--ELKILNLSLNSLVGNIP------SNVGHLT 53
G+L +L +D S N L L L +L+ NSL + N
Sbjct: 145 GKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNM 204
Query: 54 QLTTLAIASNRMN------------GSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLK 101
L L ++ N S + + + I +T L
Sbjct: 205 VLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLA 264
Query: 102 W--LRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNN 159
+R +DLS + L L LN+ NK++ L++L L N
Sbjct: 265 RSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYN 324
Query: 160 LLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRK 219
LL S L ++ Y+DL N I + T+DL N L+ I F+
Sbjct: 325 LLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-TIH-FIPS 382
Query: 220 VPHLDVSGNQF 230
+P + +SGN+
Sbjct: 383 IPDIFLSGNKL 393
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 5e-20
Identities = 51/225 (22%), Positives = 82/225 (36%), Gaps = 21/225 (9%)
Query: 32 KILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGI-GSLKVLQVLDLSRNEIG 90
+I +L +P L L ++ N + ++ L+ LQ+L+L
Sbjct: 7 RIAFYRFCNLT-QVPQV---LNTTERLLLSFNYIR-TVTASSFPFLEQLQLLELGSQYTP 61
Query: 91 GSI-PSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPE--LMN 147
+I +L LR +DL +K+ P + L L L +Y L + + N
Sbjct: 62 LTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRN 121
Query: 148 CSKLRILKLGNNLLSG-SIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCID--TVDL 204
L L L N + + GKL L +D S N I +L L
Sbjct: 122 LKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSL 181
Query: 205 SMNNLSGGIPVFVRKVPH---------LDVSGNQFGGEIPTTLAN 240
+ N+L + V K + LDVSGN + +I +N
Sbjct: 182 AANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSN 226
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 1e-15
Identities = 54/301 (17%), Positives = 91/301 (30%), Gaps = 38/301 (12%)
Query: 4 LRNLVHLDLSDNHFMG-HIPPTLGRLS--------------ELKILNLSLNSLVG-NIPS 47
L L LDL DN H P++ + +++LS N L +I
Sbjct: 361 LEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILY 420
Query: 48 NVGHLTQLTTLAIASNRMNGSILLGI-GSLKVLQVLDLSRNEIGGSI-----PSTLGHLK 101
+ + L L + NR + L+ L L N + + L
Sbjct: 421 FLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLS 480
Query: 102 WLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLL 161
L+ + L+ N L P HLT L L++ +N+L + + L IL + N L
Sbjct: 481 HLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTV-LSHN-DLPANLEILDISRNQL 538
Query: 162 SGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEF-----SCIDTVDLSMNNLSGGIPVF 216
+ + L LD++ N + +L F T+ ++ P
Sbjct: 539 L-APNPDV--FVSLSVLDITHNKFICEC--ELSTFINWLNHTNVTIAGPPADIYCVYPDS 593
Query: 217 VRKVPHLDVSGNQFGGEIPTTLANVPPPHHKTIATGLVAIILAMVAFLALIFGILIIRRR 276
V +S E I + + M F
Sbjct: 594 FSGVSLFSLSTEGCDEEEVLKSL----KFSLFIVCTVTLTLFLMTILTVTKFRGFCFICY 649
Query: 277 R 277
+
Sbjct: 650 K 650
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 2e-15
Identities = 37/178 (20%), Positives = 60/178 (33%), Gaps = 25/178 (14%)
Query: 76 LKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPI-PSSLGHLTQLTTLNMYN 134
L + L LS N I S+ L+ L+ ++L I + +L L L++ +
Sbjct: 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82
Query: 135 NKLDGPIPPE-LMNCSKLRILKLGNNLLSGSI--PSQIGKLQELYYLDLSGNFINGKIPS 191
+K+ + P+ L L+L LS ++ L+ L LDLS N I
Sbjct: 83 SKIYF-LHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLH 141
Query: 192 QLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHLDVSGNQFGGEIPTTLANVPPPHHKTI 249
F +N+L +D S NQ L +
Sbjct: 142 --PSFG-------KLNSLK-----------SIDFSSNQIFLVCEHELEPLQGKTLSFF 179
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 32/118 (27%), Positives = 52/118 (44%), Gaps = 10/118 (8%)
Query: 2 GRLRNLVHLDLSDNHF----MGHIPP-TLGRLSELKILNLSLNSLVGNIPSNVGHLTQLT 56
+L L L +N + LS L++L L+ N L P HLT L
Sbjct: 448 SENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALR 507
Query: 57 TLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLV 114
L++ SNR+ ++L L++LD+SRN++ P L +D++ NK +
Sbjct: 508 GLSLNSNRL--TVLSHNDLPANLEILDISRNQLLAPNPDVFVSLS---VLDITHNKFI 560
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 102 bits (254), Expect = 5e-23
Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 14/206 (6%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASN 63
L ++ + +++ + + L + L L+ N L +I + +L L L + N
Sbjct: 42 LNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDEN 97
Query: 64 RMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGH 123
++ L + LK L+ L L N I S + L HL L S+ L NK+ + L
Sbjct: 98 KI--KDLSSLKDLKKLKSLSLEHNGI--SDINGLVHLPQLESLYLGNNKIT--DITVLSR 151
Query: 124 LTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGN 183
LT+L TL++ +N++ I P L +KL+ L L N +S + + L+ L L+L
Sbjct: 152 LTKLDTLSLEDNQISD-IVP-LAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQ 207
Query: 184 FINGKIPSQLGEFSCIDTVDLSMNNL 209
K + +TV + +L
Sbjct: 208 ECLNKPINHQSNLVVPNTVKNTDGSL 233
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 49/208 (23%), Positives = 86/208 (41%), Gaps = 16/208 (7%)
Query: 3 RLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIAS 62
+ +L T L+ + + + + + ++ + +L +T L +
Sbjct: 19 AFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNG 74
Query: 63 NRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLG 122
N++ + + + +LK L L L N+I S+L LK L+S+ L N + + L
Sbjct: 75 NKL--TDIKPLTNLKNLGWLFLDENKI--KDLSSLKDLKKLKSLSLEHNGIS--DINGLV 128
Query: 123 HLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSG 182
HL QL +L + NNK+ L +KL L L +N +S I + L +L L LS
Sbjct: 129 HLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSK 184
Query: 183 NFINGKIPSQLGEFSCIDTVDLSMNNLS 210
N I L +D ++L
Sbjct: 185 NHI--SDLRALAGLKNLDVLELFSQECL 210
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 92.5 bits (229), Expect = 6e-20
Identities = 49/204 (24%), Positives = 88/204 (43%), Gaps = 16/204 (7%)
Query: 7 LVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMN 66
+ + I P +E NL S+ L + + ++ +
Sbjct: 1 MGETITVSTP-IKQIFP-DDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDI- 55
Query: 67 GSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQ 126
+ GI L + L L+ N++ I L +LK L + L +NK+ + SSL L +
Sbjct: 56 -KSVQGIQYLPNVTKLFLNGNKL-TDI-KPLTNLKNLGWLFLDENKIKD-L-SSLKDLKK 110
Query: 127 LTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFIN 186
L +L++ +N + I L++ +L L LGNN ++ I + +L +L L L N I+
Sbjct: 111 LKSLSLEHNGISD-ING-LVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS 166
Query: 187 GKIPSQLGEFSCIDTVDLSMNNLS 210
I L + + + LS N++S
Sbjct: 167 -DIVP-LAGLTKLQNLYLSKNHIS 188
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 79.4 bits (195), Expect = 1e-15
Identities = 42/205 (20%), Positives = 75/205 (36%), Gaps = 10/205 (4%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASN 63
L+ L L L N I L L +L+ L L N + + + LT+L TL++ N
Sbjct: 108 LKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDN 163
Query: 64 RMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGH 123
++ S ++ + L LQ L LS+N I S L LK L ++L + + + +
Sbjct: 164 QI--SDIVPLAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSN 219
Query: 124 LTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGN 183
L T+ + L P + + + +L + Q +
Sbjct: 220 LVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKAR 277
Query: 184 FINGKIPSQLGEFSCIDTVDLSMNN 208
F ++ VD ++
Sbjct: 278 FHGRVTQPLKEVYTVSYDVDGTVIK 302
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 72.4 bits (177), Expect = 2e-13
Identities = 34/162 (20%), Positives = 63/162 (38%), Gaps = 13/162 (8%)
Query: 70 LLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTT 129
+ + +L + + + T L + + + + + + +L +T
Sbjct: 14 IFPDDAFAETIKDNLKKKSV--TDAVTQNELNSIDQIIANNSDIK--SVQGIQYLPNVTK 69
Query: 130 LNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKI 189
L + NKL I P L N L L L N + + S + L++L L L N I+ I
Sbjct: 70 LFLNGNKLTD-IKP-LTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGIS-DI 124
Query: 190 PSQLGEFSCIDTVDLSMNNLSGGIPVFV--RKVPHLDVSGNQ 229
L ++++ L N ++ I V K+ L + NQ
Sbjct: 125 NG-LVHLPQLESLYLGNNKIT-DITVLSRLTKLDTLSLEDNQ 164
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 6e-23
Identities = 51/204 (25%), Positives = 96/204 (47%), Gaps = 24/204 (11%)
Query: 314 TEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRH 372
+ F +G+G + V+ + +GK+ ALK + + + S +NE +L +I+H
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKK--SPAFRDSSLENEIAVLKKIKH 65
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLF-CILR----TDEEAVGLDWTKRVNIVKGMAH 427
NIV L +L+ + + G LF IL T+++A +++ +
Sbjct: 66 ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDA--------SLVIQQVLS 117
Query: 428 ALSYLHHHCTPPILHRDISSNNILLNSEFEAF---VADFGIARLLNYDSSNRTLLAGTYG 484
A+ YLH + I+HRD+ N+L + E + DFG++++ + + GT G
Sbjct: 118 AVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGIMSTACGTPG 172
Query: 485 SIAPELAYTMVVTEKYDVYSFGVV 508
+APE+ ++ D +S GV+
Sbjct: 173 YVAPEVLAQKPYSKAVDCWSIGVI 196
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 9e-23
Identities = 49/204 (24%), Positives = 89/204 (43%), Gaps = 25/204 (12%)
Query: 316 DFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRN 374
+G G +G V++ +G +A K + + E +NE +++Q+ H N
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT--RGMKDKEEVKNEISVMNQLDHAN 147
Query: 375 IVKLYGFCLHEKCMFLIYEYMEMGSLF--CILR----TDEEAVGLDWTKRVNIVKGMAHA 428
+++LY + + L+ EY++ G LF I T+ + + +K +
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDT--------ILFMKQICEG 199
Query: 429 LSYLHHHCTPPILHRDISSNNILLNSEFEAFV--ADFGIARLLNYDSSNRTLLAGTYGSI 486
+ ++H ILH D+ NIL + + DFG+AR + GT +
Sbjct: 200 IRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF-GTPEFL 255
Query: 487 APE-LAYTMVVTEKYDVYSFGVVA 509
APE + Y V+ D++S GV+A
Sbjct: 256 APEVVNYD-FVSFPTDMWSVGVIA 278
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-22
Identities = 54/215 (25%), Positives = 90/215 (41%), Gaps = 19/215 (8%)
Query: 303 GRITFQDMIEATEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQ 361
GR + F K +G+G +G V+ SG +K +++ ++ +E +
Sbjct: 10 GRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIE 68
Query: 362 NEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLF-CILRTDEEAVGLDWTKRVN 420
E +L + H NI+K++ M+++ E E G L I+ L
Sbjct: 69 AEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAE 128
Query: 421 IVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAF---VADFGIARLLNYDSSNRT 477
++K M +AL+Y H ++H+D+ NIL + DFG+A L D +
Sbjct: 129 LMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN 185
Query: 478 LLAGTYGSIAPELAYTMVVTEKY----DVYSFGVV 508
AGT +APE V D++S GVV
Sbjct: 186 -AAGTALYMAPE-----VFKRDVTFKCDIWSAGVV 214
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 55/241 (22%), Positives = 88/241 (36%), Gaps = 24/241 (9%)
Query: 3 RLRNLVHLDLSDNHFMGHIPP-TLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIA 61
L+NL L L +N I P L +L+ L LS N L +P + L L +
Sbjct: 74 NLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVH 129
Query: 62 SNRMNGSILLGI-GSLKVLQVLDLSRNEIGGSI--PSTLGHLKWLRSVDLSQNKLVGPIP 118
N + + + L + V++L N + S +K L + ++ + IP
Sbjct: 130 ENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IP 187
Query: 119 SSLGHLTQLTTLNMYNNKLDGPIPPE-LMNCSKLRILKLGNNLLSGSIPSQIGKLQELYY 177
L LT L++ NK+ + L + L L L N +S + L
Sbjct: 188 QGL--PPSLTELHLDGNKITK-VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRE 244
Query: 178 LDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLS---------GGIPVFVRKVPHLDVSGN 228
L L+ N + K+P L + I V L NN+S G + + N
Sbjct: 245 LHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSN 303
Query: 229 Q 229
Sbjct: 304 P 304
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 42/193 (21%), Positives = 77/193 (39%), Gaps = 18/193 (9%)
Query: 4 LRNLVHLDLSDNHFMGHIPP-TLGRLSELKILNLSLNSL-VGNIPSNV-GHLTQLTTLAI 60
+ L L + +N + L+++ ++ L N L I + + +L+ + I
Sbjct: 120 PKTLQELRVHENEI-TKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRI 178
Query: 61 ASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPS-TLGHLKWLRSVDLSQNKLVGPIPS 119
A + + G L L L N+I + + +L L L + LS N +
Sbjct: 179 ADTNITT---IPQGLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNG 234
Query: 120 SLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQ-------IGKL 172
SL + L L++ NNKL +P L + ++++ L NN +S +I S K
Sbjct: 235 SLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKK 292
Query: 173 QELYYLDLSGNFI 185
+ L N +
Sbjct: 293 ASYSGVSLFSNPV 305
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 50/235 (21%), Positives = 84/235 (35%), Gaps = 20/235 (8%)
Query: 5 RNLVHLDLSDNHFMGHIPP-TLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAIAS 62
+ LDL +N I L L L L N + I L +L L ++
Sbjct: 52 PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSK 109
Query: 63 NRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPS-TLGHLKWLRSVDLSQNKL-VGPIPS- 119
N++ L K LQ L + NEI + L + V+L N L I +
Sbjct: 110 NQLK---ELPEKMPKTLQELRVHENEI-TKVRKSVFNGLNQMIVVELGTNPLKSSGIENG 165
Query: 120 SLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQI-GKLQELYYL 178
+ + +L+ + + + + IP L L L L N ++ + + L L L
Sbjct: 166 AFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKIT-KVDAASLKGLNNLAKL 221
Query: 179 DLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHL---DVSGNQF 230
LS N I+ L + + L+ N L +P + ++ + N
Sbjct: 222 GLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNI 275
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 6e-20
Identities = 36/191 (18%), Positives = 67/191 (35%), Gaps = 16/191 (8%)
Query: 4 LRNLVHLDLSDNHF-MGHIPP-TLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIA 61
L ++ ++L N I + +L + ++ ++ IP + LT L +
Sbjct: 144 LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLD 200
Query: 62 SNRMNGSILLGI-GSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSS 120
N++ + L L L LS N I +L + LR + L+ NKLV +P
Sbjct: 201 GNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGG 258
Query: 121 LGHLTQLTTLNMYNNKL------DGPIPPELMNCSKLRILKL-GNNLLSGSIPSQI-GKL 172
L + + ++NN + D P + + L N + I +
Sbjct: 259 LADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCV 318
Query: 173 QELYYLDLSGN 183
+ L
Sbjct: 319 YVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 4e-13
Identities = 31/144 (21%), Positives = 52/144 (36%), Gaps = 15/144 (10%)
Query: 4 LRNLVHLDLSDNHFMGHIPP-TLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAIA 61
+L L L N + +L L+ L L LS NS+ + + + L L +
Sbjct: 191 PPSLTELHLDGNKI-TKVDAASLKGLNNLAKLGLSFNSI-SAVDNGSLANTPHLRELHLN 248
Query: 62 SNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPST-------LGHLKWLRSVDLSQNKL- 113
+N++ + G+ K +QV+ L N I +I S V L N +
Sbjct: 249 NNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 306
Query: 114 VGPIPSSL-GHLTQLTTLNMYNNK 136
I S + + + N K
Sbjct: 307 YWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 39/158 (24%), Positives = 61/158 (38%), Gaps = 15/158 (9%)
Query: 79 LQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLD 138
L+V+ S + +P L +DL NK+ +L L TL + NNK+
Sbjct: 33 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 89
Query: 139 GPIPPE-LMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQ-LGEF 196
I P KL L L N L +P + L L + N I K+
Sbjct: 90 K-ISPGAFAPLVKLERLYLSKNQLK-ELPE--KMPKTLQELRVHENEIT-KVRKSVFNGL 144
Query: 197 SCIDTVDLSMNNL-SGGIP--VFV--RKVPHLDVSGNQ 229
+ + V+L N L S GI F +K+ ++ ++
Sbjct: 145 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN 182
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 60/227 (26%), Positives = 88/227 (38%), Gaps = 60/227 (26%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEA-------RLLSQIRHRN 374
IG G YG+VY+AR SG VALK + R+ R L H N
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSV-RVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 375 IVKLY-----GFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAH-- 427
+V+L E + L++E+++ L L GL +K +
Sbjct: 76 VVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLD-KAPPPGLP----AETIKDLMRQF 129
Query: 428 --ALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGS 485
L +LH +C I+HRD+ NIL+ S +ADFG+AR Y
Sbjct: 130 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR--------------IYSY 172
Query: 486 IAPELAYT-MVVT-----------EKY----DVYSFGVVALEVLMGK 516
++A T +VVT Y D++S G + E+ K
Sbjct: 173 ---QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-22
Identities = 49/212 (23%), Positives = 100/212 (47%), Gaps = 33/212 (15%)
Query: 314 TEDFDIKYCI----GTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLS 368
+ F Y + G G + V R +G A K ++ + + + EAR+
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 369 QIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLF-CILR----TDEEAVGLDWTKRVNIVK 423
+++H NIV+L+ E +L+++ + G LF I+ ++ +A + ++
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADA--------SHCIQ 112
Query: 424 GMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAF---VADFGIARLLNYDSSNRTLLA 480
+ +++Y H + I+HR++ N+LL S+ + +ADFG+A +N + A
Sbjct: 113 QILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG-FA 168
Query: 481 GTYGSIAPEL----AYTMVVTEKYDVYSFGVV 508
GT G ++PE+ Y ++ D+++ GV+
Sbjct: 169 GTPGYLSPEVLKKDPY----SKPVDIWACGVI 196
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 3e-22
Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 11/208 (5%)
Query: 314 TEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRH 372
+ +DI +GTG +G V+R +G A K + + E+ + E + +S +RH
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRH 213
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYL 432
+V L+ + M +IYE+M G LF + +E + + V ++ + L ++
Sbjct: 214 PTLVNLHDAFEDDNEMVMIYEFMSGGELFE--KVADEHNKMSEDEAVEYMRQVCKGLCHM 271
Query: 433 HHHCTPPILHRDISSNNILLNSEFEAFV--ADFGIARLLNYDSSNRTLLAGTYGSIAPEL 490
H + +H D+ NI+ ++ + DFG+ L+ S + GT APE+
Sbjct: 272 HEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT-GTAEFAAPEV 327
Query: 491 AYTMVVTEKYDVYSFGVVALEVLMGKHP 518
A V D++S GV++ +L G P
Sbjct: 328 AEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 51/216 (23%), Positives = 103/216 (47%), Gaps = 33/216 (15%)
Query: 310 MIEATEDFDIKY----CIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEA 364
M+ A+ F Y +G G + V R +G A K ++ + + + EA
Sbjct: 20 MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79
Query: 365 RLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLF-CILR----TDEEAVGLDWTKRV 419
R+ +++H NIV+L+ E +L+++ + G LF I+ ++ +A
Sbjct: 80 RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADA--------S 131
Query: 420 NIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAF---VADFGIARLLNYDSSNR 476
+ ++ + +++Y H + I+HR++ N+LL S+ + +ADFG+A +N +
Sbjct: 132 HCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH 188
Query: 477 TLLAGTYGSIAPEL----AYTMVVTEKYDVYSFGVV 508
AGT G ++PE+ Y ++ D+++ GV+
Sbjct: 189 G-FAGTPGYLSPEVLKKDPY----SKPVDIWACGVI 219
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-22
Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 31/213 (14%)
Query: 314 TEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHR------LETELASLESFQNEARL 366
+++ + +G+G G V A + K VA+K + + E + + E +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 367 LSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLF-CILR----TDEEAVGLDWTKRVNI 421
L ++ H I+K+ F + +++ E ME G LF ++ +
Sbjct: 69 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATC--------KLY 119
Query: 422 VKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAF---VADFGIARLLNYDSSNRTL 478
M A+ YLH + I+HRD+ N+LL+S+ E + DFG +++L S RT
Sbjct: 120 FYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT- 175
Query: 479 LAGTYGSIAPE-LAYTMVV--TEKYDVYSFGVV 508
L GT +APE L D +S GV+
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 208
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 4e-22
Identities = 49/222 (22%), Positives = 72/222 (32%), Gaps = 19/222 (8%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGR-----LSELKILNLSLNSLVGNIPSNVGHL-TQLTT 57
+ L L L + G PP L L+ L + N+S + + L L
Sbjct: 94 ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKV 153
Query: 58 LAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSI-------PSTLGHLKWLRSVDLSQ 110
L+IA + L LDLS N G P L+ L +
Sbjct: 154 LSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM 213
Query: 111 NKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELM-NCSKLRILKLGNNLLSGSIPSQI 169
G + QL L++ +N L S+L L L L +P +
Sbjct: 214 ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL 272
Query: 170 GKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSG 211
+L LDLS N ++ PS E + + L N
Sbjct: 273 --PAKLSVLDLSYNRLDR-NPS-PDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 92.7 bits (230), Expect = 8e-21
Identities = 42/238 (17%), Positives = 83/238 (34%), Gaps = 14/238 (5%)
Query: 7 LVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMN 66
L +D + L L + + S + V ++ L L + + +
Sbjct: 49 LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108
Query: 67 GSILLGIGSLKV--LQVLDLSRNEIGGSIPSTLGHLKW----LRSVDLSQNKLVGPIPSS 120
G+ + L +L+L +W L+ + ++Q +
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQ 168
Query: 121 LGHLTQLTTLNMYNNKLDGPIPPELMNC----SKLRILKLGNNL---LSGSIPSQIGKLQ 173
+ L+TL++ +N G C L++L L N SG +
Sbjct: 169 VRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARV 228
Query: 174 ELYYLDLSGNFINGKIPSQLGEF-SCIDTVDLSMNNLSGGIPVFVRKVPHLDVSGNQF 230
+L LDLS N + + ++ S +++++LS L K+ LD+S N+
Sbjct: 229 QLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLSVLDLSYNRL 286
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 1e-17
Identities = 35/148 (23%), Positives = 53/148 (35%), Gaps = 13/148 (8%)
Query: 1 MGRLRNLVHLDLSDNHFMGHI-------PPTLGRLSELKILNLSLNSLVGNIPSNVGHLT 53
+ L LDLSDN +G P L L + N + + G +
Sbjct: 169 VRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARV 228
Query: 54 QLTTLAIASNRMNGSILLGIGS-LKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNK 112
QL L ++ N + + L L+LS + +P L L +DLS N+
Sbjct: 229 QLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGL-KQVPKGLPAK--LSVLDLSYNR 285
Query: 113 LVGPIPSSLGHLTQLTTLNMYNNKLDGP 140
L PS L Q+ L++ N
Sbjct: 286 LDR-NPSPD-ELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 6e-06
Identities = 33/177 (18%), Positives = 58/177 (32%), Gaps = 18/177 (10%)
Query: 78 VLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKL 137
L + E+ G S LK VD + + L+ L L + ++
Sbjct: 27 AFNCLGAADVELYGGGRSLEYLLK---RVDTEADLG--QFTDIIKSLS-LKRLTVRAARI 80
Query: 138 DGPIPP---ELMNCSKLRILKLGNNLLSGSIPSQIGKLQ--ELYYLDLSGNFINGKIPSQ 192
I ++ S L+ L L N ++G+ P + + +L L+L +
Sbjct: 81 PSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWL 140
Query: 193 LGEFSCIDT----VDLSMNNLSGGIPVFVRKVP---HLDVSGNQFGGEIPTTLANVP 242
+ + ++ + VR P LD+S N GE A P
Sbjct: 141 AELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCP 197
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 6e-22
Identities = 51/211 (24%), Positives = 90/211 (42%), Gaps = 28/211 (13%)
Query: 314 TEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALK----KLHRLETELASLESFQNEARLLS 368
+ +DI +G+G + V + R +G A K + R E + E +L
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 369 QIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLF--CILR---TDEEAVGLDWTKRVNIVK 423
Q+ H NI+ L+ + + LI E + G LF + ++EEA + +K
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA--------TSFIK 122
Query: 424 GMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAF----VADFGIARLLNYDSSNRTLL 479
+ ++YLH I H D+ NI+L + + DFG+A + + +
Sbjct: 123 QILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN-I 178
Query: 480 AGTYGSIAPE-LAYTMVVTEKYDVYSFGVVA 509
GT +APE + Y + + D++S GV+
Sbjct: 179 FGTPEFVAPEIVNYEP-LGLEADMWSIGVIT 208
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 6e-22
Identities = 52/185 (28%), Positives = 78/185 (42%), Gaps = 11/185 (5%)
Query: 4 LRNLVHLDLSDNHFMGHIPP-TLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAIA 61
L +L L+L DN + IP LS+L+ L L N + +IPS + L L +
Sbjct: 122 LASLNTLELFDNW-LTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLG 179
Query: 62 SNRMNGSILLGI-GSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSS 120
+ I G L L+ L+L I +P L L L +++S N P S
Sbjct: 180 ELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGS 237
Query: 121 LGHLTQLTTLNMYNNKLDGPIPPE-LMNCSKLRILKLGNNLLSGSIPSQI-GKLQELYYL 178
L+ L L + N+++ I + L L L +N LS S+P + L+ L L
Sbjct: 238 FHGLSSLKKLWVMNSQVSL-IERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVEL 295
Query: 179 DLSGN 183
L N
Sbjct: 296 HLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 2e-20
Identities = 58/238 (24%), Positives = 89/238 (37%), Gaps = 22/238 (9%)
Query: 5 RNLVHLDLSDNHFMGHIPP-TLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAIAS 62
N +L+L +N+ I T L L++L L NS+ I L L TL +
Sbjct: 75 SNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSI-RQIEVGAFNGLASLNTLELFD 132
Query: 63 NRMNGSILLGI-GSLKVLQVLDLSRNEIGGSIPS-TLGHLKWLRSVDLSQ-NKLVGPIPS 119
N + I G L L+ L L N I SIPS + L +DL + KL
Sbjct: 133 NWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEG 190
Query: 120 SLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQ-IGKLQELYYL 178
+ L L LN+ + P L L L++ N I L L L
Sbjct: 191 AFEGLFNLKYLNLGMCNIKDM--PNLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKL 247
Query: 179 DLSGNFINGKIPSQLGEFSC---IDTVDLSMNNLS---GGIPVFVRKVPHLDVSGNQF 230
+ + ++ I F + ++L+ NNLS + +R + L + N +
Sbjct: 248 WVMNSQVS-LIER--NAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 27/88 (30%), Positives = 39/88 (44%), Gaps = 6/88 (6%)
Query: 3 RLRNLVHLDLSDNHFMGHIPP-TLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAI 60
L L L++S NHF I P + LS LK L + + + I N L L L +
Sbjct: 216 PLVGLEELEMSGNHF-PEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNL 273
Query: 61 ASNRMNGSILLGI-GSLKVLQVLDLSRN 87
A N ++ S+ + L+ L L L N
Sbjct: 274 AHNNLS-SLPHDLFTPLRYLVELHLHHN 300
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 8e-22
Identities = 52/211 (24%), Positives = 92/211 (43%), Gaps = 28/211 (13%)
Query: 314 TEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALK----KLHRLETELASLESFQNEARLLS 368
+ +++ +G+G + V + R +GK A K + S E + E +L
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 369 QIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLF--CILR---TDEEAVGLDWTKRVNIVK 423
+IRH NI+ L+ ++ + LI E + G LF + T++EA +K
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEA--------TQFLK 115
Query: 424 GMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAF----VADFGIARLLNYDSSNRTLL 479
+ + YLH I H D+ NI+L + + DFGIA + + + +
Sbjct: 116 QILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN-I 171
Query: 480 AGTYGSIAPE-LAYTMVVTEKYDVYSFGVVA 509
GT +APE + Y + + D++S GV+
Sbjct: 172 FGTPEFVAPEIVNYEP-LGLEADMWSIGVIT 201
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 9e-22
Identities = 27/231 (11%), Positives = 63/231 (27%), Gaps = 45/231 (19%)
Query: 322 CIGTGGYGSVYRA---RLPSGKVVALKKLH-RLETELASLESFQNEARLLSQIRHRNIVK 377
G ++A L + VAL + + L+ + LS+I + +
Sbjct: 38 FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 378 LYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCT 437
+ ++ E++ GSL + T + ++ +A A H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADT-----SPSPVGAIRAMQSLAAAADAAHRA-- 148
Query: 438 PPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVT 497
+ + + ++ + + +A D++ +
Sbjct: 149 -GVALSIDHPSRVRVSIDGDVVLAYPATMP----DANPQD-------------------- 183
Query: 498 EKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRLPPPGD 548
D+ G +L+ + P S + P D
Sbjct: 184 ---DIRGIGASLYALLVNRWPLPEAGVRSGLAP----AERDTAGQPIEPAD 227
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 9e-22
Identities = 66/265 (24%), Positives = 101/265 (38%), Gaps = 56/265 (21%)
Query: 305 ITFQDMIEATEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALK---KLHRLETELASLESF 360
++E + + +K IG G YG V A + + A+K K + +E
Sbjct: 16 FQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERI 75
Query: 361 QNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLF------------------- 401
+ E RL+ ++ H NI +LY E+ + L+ E G L
Sbjct: 76 KTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVV 135
Query: 402 ------CILRTDEEAVGLDWTKRV------------NIVKGMAHALSYLHHHCTPPILHR 443
C +E G R NI++ + AL YLH+ I HR
Sbjct: 136 KTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHR 192
Query: 444 DISSNNILLNSEFEAFV--ADFGIARLL----NYDSSNRTLLAGTYGSIAPELAYTMVVT 497
DI N L ++ + DFG+++ N + T AGT +APE+ T
Sbjct: 193 DIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT--N 250
Query: 498 EKY----DVYSFGVVALEVLMGKHP 518
E Y D +S GV+ +LMG P
Sbjct: 251 ESYGPKCDAWSAGVLLHLLLMGAVP 275
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 52/215 (24%), Positives = 88/215 (40%), Gaps = 26/215 (12%)
Query: 314 TEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRH 372
E + I +G G +G V+R S K K + + + E +L+ RH
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNIARH 60
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLF--CILR----TDEEAVGLDWTKRVNIVKGMA 426
RNI+ L+ + + +I+E++ +F + E V+ V +
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREI--------VSYVHQVC 112
Query: 427 HALSYLHHHCTPPILHRDISSNNILLNSEFEAFV--ADFGIARLLNYDSSNRTLLAGTYG 484
AL +LH H I H DI NI+ + + + +FG AR L + R L
Sbjct: 113 EALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-LFTAPE 168
Query: 485 SIAPE-LAYTMVVTEKYDVYSFGVVALEVLMGKHP 518
APE + + V+ D++S G + +L G +P
Sbjct: 169 YYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINP 202
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 59/236 (25%), Positives = 95/236 (40%), Gaps = 64/236 (27%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR--LPSGKVVALKKLHRLETELASLESFQNEA-------R 365
+ ++ IG G YG V++AR G+ VALK++ R++T E R
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGE---EGMPLSTIREVAVLR 66
Query: 366 LLSQIRHRNIVKLY-----GFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVN 420
L H N+V+L+ E + L++E+++ L L G+
Sbjct: 67 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLD-KVPEPGVP----TE 120
Query: 421 IVKGMAH----ALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNR 476
+K M L +LH H ++HRD+ NIL+ S + +ADFG+AR
Sbjct: 121 TIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR--------- 168
Query: 477 TLLAGTYGSIAPELAYT-MVVT-----------EKY----DVYSFGVVALEVLMGK 516
Y ++A T +VVT Y D++S G + E+ K
Sbjct: 169 -----IYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 18/214 (8%)
Query: 3 RLRNLVHLDLSDNHFMGHIPP-TLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIA 61
L++L L L +N I L +L+ L +S N LV IP N+ + L L I
Sbjct: 76 GLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIH 131
Query: 62 SNRMNGSILLGI-GSLKVLQVLDLSRNEIGGSI--PSTLGHLKWLRSVDLSQNKLVGPIP 118
NR+ + G+ L+ + +++ N + S P LK L + +S+ KL G IP
Sbjct: 132 DNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLK-LNYLRISEAKLTG-IP 188
Query: 119 SSLGHLTQLTTLNMYNNKLDGPIPPE-LMNCSKLRILKLGNNLLSGSIPSQI-GKLQELY 176
L L L++ +NK+ I E L+ SKL L LG+N + I + L L
Sbjct: 189 KDL--PETLNELHLDHNKIQA-IELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLR 244
Query: 177 YLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLS 210
L L N ++ ++P+ L + + V L NN++
Sbjct: 245 ELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT 277
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 50/235 (21%), Positives = 81/235 (34%), Gaps = 23/235 (9%)
Query: 6 NLVHLDLSDNHFMGHIPP-TLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAIASN 63
+ LDL +N + L L L L N + I L +L L I+ N
Sbjct: 55 DTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKN 112
Query: 64 RMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKL-VGPIPSSLG 122
+ + L L + N I L+ + +++ N L
Sbjct: 113 HLV---EIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAF 169
Query: 123 HLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQI-GKLQELYYLDLS 181
+L L + KL G IP +L L L L +N + +I + + +LY L L
Sbjct: 170 DGLKLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLG 225
Query: 182 GNFINGKIPSQLGEFSCID---TVDLSMNNLSGGIPVFVRKVP---HLDVSGNQF 230
N I I + G S + + L N LS +P + + + + N
Sbjct: 226 HNQIR-MIEN--GSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNI 276
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 5e-16
Identities = 35/165 (21%), Positives = 63/165 (38%), Gaps = 18/165 (10%)
Query: 6 NLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAIASNR 64
L +L +S+ IP L L L+L N + I ++L L + N+
Sbjct: 173 KLNYLRISEAKL-TGIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQ 228
Query: 65 MNGSILLGI-GSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSS--- 120
+ I G L L+ L L N++ +P+ L LK L+ V L N + + +
Sbjct: 229 IR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITK-VGVNDFC 285
Query: 121 ----LGHLTQLTTLNMYNNKLD-GPIPPELMNC-SKLRILKLGNN 159
++++NN + + P C + ++ GN
Sbjct: 286 PVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 31/157 (19%), Positives = 55/157 (35%), Gaps = 12/157 (7%)
Query: 79 LQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLD 138
L+V+ S + ++P + +DL N + L L L + NNK+
Sbjct: 35 LRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS 91
Query: 139 GPIPPE-LMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFS 197
I + KL+ L + N L IP L L + N I
Sbjct: 92 K-IHEKAFSPLRKLQKLYISKNHLV-EIPP--NLPSSLVELRIHDNRIRKVPKGVFSGLR 147
Query: 198 CIDTVDLSMNNL-SGGIPVFV---RKVPHLDVSGNQF 230
++ +++ N L + G K+ +L +S +
Sbjct: 148 NMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKL 184
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 51/211 (24%), Positives = 91/211 (43%), Gaps = 28/211 (13%)
Query: 314 TEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALK----KLHRLETELASLESFQNEARLLS 368
+ +DI +G+G + V + R +G A K + R S E + E +L
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 369 QIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLF--CILR---TDEEAVGLDWTKRVNIVK 423
Q+ H N++ L+ + + LI E + G LF + ++EEA + +K
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA--------TSFIK 122
Query: 424 GMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAF----VADFGIARLLNYDSSNRTLL 479
+ ++YLH I H D+ NI+L + + DFG+A + + +
Sbjct: 123 QILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN-I 178
Query: 480 AGTYGSIAPE-LAYTMVVTEKYDVYSFGVVA 509
GT +APE + Y + + D++S GV+
Sbjct: 179 FGTPEFVAPEIVNYEP-LGLEADMWSIGVIT 208
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 1e-21
Identities = 58/217 (26%), Positives = 99/217 (45%), Gaps = 21/217 (9%)
Query: 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLE-TELASLESFQNEARLLSQIRH 372
+DF+I IG G + V ++ +G+V A+K +++ + + + F+ E +L
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 373 RNIVKLYGFCLH-EKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTK--RVNIVKGMAHAL 429
R I +L+ F E ++L+ EY G L +L E + + + IV A+
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVM----AI 175
Query: 430 SYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLA-GTYGSIAP 488
+H +HRDI +NILL+ +ADFG L D + R+L+A GT ++P
Sbjct: 176 DSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSP 232
Query: 489 ELAYTMVVTEKYDVY-------SFGVVALEVLMGKHP 518
E+ + Y + GV A E+ G+ P
Sbjct: 233 EILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 95.5 bits (237), Expect = 2e-21
Identities = 35/242 (14%), Positives = 78/242 (32%), Gaps = 56/242 (23%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELAS-LESFQNEA---RLLSQIR------ 371
+G + A +G+ + + E ++ ++ + E RLL I+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 372 ----------------HRNIVKLYGFCLHEKCM--FLIYEYMEM------GSLFCILRTD 407
+ ++++ + F +Y M+ L T
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 408 EEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIAR 467
+ L R+ + + L+ LHH+ ++H + +I+L+ F+ F
Sbjct: 201 KS---LVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV 254
Query: 468 LLNYDSSNRTLLAGTYGSIAPEL-----------AYTMVVTEKYDVYSFGVVALEVLMGK 516
R + + + G PEL ++T +D ++ G+V +
Sbjct: 255 RDG----ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 517 HP 518
P
Sbjct: 311 LP 312
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 51/204 (25%), Positives = 98/204 (48%), Gaps = 25/204 (12%)
Query: 314 TEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRH 372
++ F+++ +G G VYR + + K ALK L + + + + E +L ++ H
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK----KIVRTEIGVLLRLSH 107
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLF-CILR----TDEEAVGLDWTKRVNIVKGMAH 427
NI+KL + L+ E + G LF I+ ++ +A + VK +
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDA--------ADAVKQILE 159
Query: 428 ALSYLHHHCTPPILHRDISSNNILLNSEFEAF---VADFGIARLLNYDSSNRTLLAGTYG 484
A++YLH + I+HRD+ N+L + +ADFG+++++ + +T + GT G
Sbjct: 160 AVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT-VCGTPG 215
Query: 485 SIAPELAYTMVVTEKYDVYSFGVV 508
APE+ + D++S G++
Sbjct: 216 YCAPEILRGCAYGPEVDMWSVGII 239
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 2e-21
Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 17/214 (7%)
Query: 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLET-ELASLESFQNEARLLSQIRH 372
EDF+I IG G +G V +L + KV A+K L++ E + A F+ E +L
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTK--RVNIVKGMAHALS 430
+ I L+ + ++L+ +Y G L +L E+ + + + +V A+
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVI----AID 189
Query: 431 YLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLA-GTYGSIAPE 489
+H +HRDI +NIL++ +ADFG L D + ++ +A GT I+PE
Sbjct: 190 SVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 246
Query: 490 -LAYTMVVTEKY----DVYSFGVVALEVLMGKHP 518
L +Y D +S GV E+L G+ P
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 2e-21
Identities = 54/185 (29%), Positives = 76/185 (41%), Gaps = 11/185 (5%)
Query: 4 LRNLVHLDLSDNHFMGHIPP-TLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAIA 61
L NL L+L DN + IP LS+LK L L N + +IPS + L L +
Sbjct: 111 LANLNTLELFDNR-LTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLG 168
Query: 62 SNRMNGSILLGI-GSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSS 120
+ I G L L+ L+L+ + IP L L L +DLS N L P S
Sbjct: 169 ELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGS 226
Query: 121 LGHLTQLTTLNMYNNKLDGPIPPE-LMNCSKLRILKLGNNLLSGSIPSQI-GKLQELYYL 178
L L L M +++ I N L + L +N L+ +P + L L +
Sbjct: 227 FQGLMHLQKLWMIQSQIQV-IERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERI 284
Query: 179 DLSGN 183
L N
Sbjct: 285 HLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 1e-20
Identities = 52/213 (24%), Positives = 83/213 (38%), Gaps = 13/213 (6%)
Query: 3 RLRNLVHLDLSDNHFMGHIPP-TLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAI 60
LR+L L LS NH + I L+ L L L N L IP+ +L++L L +
Sbjct: 86 HLRHLEILQLSRNH-IRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWL 143
Query: 61 ASNRMNGSILLGI-GSLKVLQVLDLSR-NEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIP 118
+N + SI + L+ LDL + L LR ++L+ L IP
Sbjct: 144 RNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IP 201
Query: 119 SSLGHLTQLTTLNMYNNKLDGPIPPE-LMNCSKLRILKLGNNLLSGSIPSQ-IGKLQELY 176
+L L +L L++ N L I P L+ L + + + I LQ L
Sbjct: 202 -NLTPLIKLDELDLSGNHLSA-IRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLV 258
Query: 177 YLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNL 209
++L+ N + ++ + L N
Sbjct: 259 EINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 48/159 (30%), Positives = 74/159 (46%), Gaps = 12/159 (7%)
Query: 79 LQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLD 138
++L+L N+I ++ HL+ L + LS+N + + L L TL +++N+L
Sbjct: 66 TRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT 125
Query: 139 GPIPPE-LMNCSKLRILKLGNNLLSGSIPSQI-GKLQELYYLDLSGNFINGKIPSQLGEF 196
IP + SKL+ L L NN + SIPS ++ L LDL I G F
Sbjct: 126 T-IPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISE--GAF 181
Query: 197 SC---IDTVDLSMNNLSGGIPVFVR--KVPHLDVSGNQF 230
+ ++L+M NL IP K+ LD+SGN
Sbjct: 182 EGLSNLRYLNLAMCNLR-EIPNLTPLIKLDELDLSGNHL 219
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 52/202 (25%), Positives = 85/202 (42%), Gaps = 18/202 (8%)
Query: 35 NLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGI-GSLKVLQVLDLSRNEIGGSI 93
+L + I +N L + N++ I + L+ L++L LSRN I
Sbjct: 52 RKNLREVPDGISTN------TRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIRTIE 104
Query: 94 PSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPEL-MNCSKLR 152
L L +++L N+L + +L++L L + NN ++ IP LR
Sbjct: 105 IGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIES-IPSYAFNRIPSLR 163
Query: 153 ILKLG-NNLLSGSIPSQI-GKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLS 210
L LG LS I L L YL+L+ + +IP+ L +D +DLS N+LS
Sbjct: 164 RLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLS 220
Query: 211 ---GGIPVFVRKVPHLDVSGNQ 229
G + + L + +Q
Sbjct: 221 AIRPGSFQGLMHLQKLWMIQSQ 242
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 49/214 (22%), Positives = 92/214 (42%), Gaps = 31/214 (14%)
Query: 314 TEDFDIKYCI-----GTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLL 367
E+F+ Y + G G + V + +G+ A K L + +E +L
Sbjct: 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVL 82
Query: 368 SQIRHR-NIVKLYGFCLHEKCMFLIYEYMEMGSLF--CILRTDE-----EAVGLDWTKRV 419
+ ++ L+ + + LI EY G +F C+ E + +
Sbjct: 83 ELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDV--------I 134
Query: 420 NIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAF---VADFGIARLLNYDSSNR 476
++K + + YLH + I+H D+ NILL+S + + DFG++R + + R
Sbjct: 135 RLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELR 191
Query: 477 TLLAGTYGSIAPE-LAYTMVVTEKYDVYSFGVVA 509
++ GT +APE L Y +T D+++ G++A
Sbjct: 192 EIM-GTPEYLAPEILNYDP-ITTATDMWNIGIIA 223
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 3e-21
Identities = 42/211 (19%), Positives = 83/211 (39%), Gaps = 10/211 (4%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAIAS 62
L+ L + + F S + I N +++ + ++ L ++
Sbjct: 275 LKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGT-RMVHMLCPSKISPFLHLDFSN 333
Query: 63 NRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLG---HLKWLRSVDLSQNKL-VGPIP 118
N + ++ G L L+ L L N++ + +K L+ +D+SQN +
Sbjct: 334 NLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKK 392
Query: 119 SSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYL 178
L +LNM +N L I L ++++L L +N + SIP Q+ KL+ L L
Sbjct: 393 GDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQEL 449
Query: 179 DLSGNFINGKIPSQLGEFSCIDTVDLSMNNL 209
+++ N + + + + L N
Sbjct: 450 NVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 1e-18
Identities = 42/162 (25%), Positives = 71/162 (43%), Gaps = 8/162 (4%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSL--VGNIPSNVGHLTQLTTLA 59
++ +HLD S+N + G L+EL+ L L +N L + I + L L
Sbjct: 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLD 380
Query: 60 IASNRMNGSILLGI-GSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIP 118
I+ N ++ G K L L++S N + +I L ++ +DL NK+ IP
Sbjct: 381 ISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPR--IKVLDLHSNKIKS-IP 437
Query: 119 SSLGHLTQLTTLNMYNNKLDGPIPPE-LMNCSKLRILKLGNN 159
+ L L LN+ +N+L +P + L+ + L N
Sbjct: 438 KQVVKLEALQELNVASNQLKS-VPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 6e-15
Identities = 44/255 (17%), Positives = 92/255 (36%), Gaps = 25/255 (9%)
Query: 5 RNLVHLDLSDNHFMGHIPPT-LGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAIAS 62
+ L++S N+ + + + LS+L+IL +S N + + +V +L L ++
Sbjct: 21 QKTTILNISQNYIS-ELWTSDILSLSKLRILIISHNRI-QYLDISVFKFNQELEYLDLSH 78
Query: 63 NRMNGSILLGIGSLKVLQVLDLSRNEIGGSIP--STLGHLKWLRSVDLSQNKLVGPIPSS 120
N++ + L+ LDLS N ++P G++ L+ + LS L
Sbjct: 79 NKLVK---ISCHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLP 134
Query: 121 LGHLTQLTTLNMYNNKLDGPIPPELMNC---SKLRILKLGNNLLSGSIPSQIGKLQELYY 177
+ HL L + PE + L I+ N + + + L
Sbjct: 135 IAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLEL 194
Query: 178 LDLSGNFINGKIPSQLGEFSCI----DTVDLSMNNLS------GGIPVFVRKVP--HLDV 225
++ + K L + + +L++NN+ I V + +
Sbjct: 195 SNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSI 254
Query: 226 SGNQFGGEIPTTLAN 240
S + G++ +
Sbjct: 255 SNVKLQGQLDFRDFD 269
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 1e-14
Identities = 34/141 (24%), Positives = 62/141 (43%), Gaps = 8/141 (5%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPPTLG---RLSELKILNLSLNSLVGNIPSNV-GHLTQLTT 57
G L L L L N + ++ L+ L++S NS+ + L +
Sbjct: 345 GHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLS 403
Query: 58 LAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPI 117
L ++SN + +I + ++VLDL N+I SIP + L+ L+ ++++ N+L
Sbjct: 404 LNMSSNILTDTIFRCLPPR--IKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVP 460
Query: 118 PSSLGHLTQLTTLNMYNNKLD 138
LT L + ++ N D
Sbjct: 461 DGIFDRLTSLQKIWLHTNPWD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 50/222 (22%), Positives = 75/222 (33%), Gaps = 33/222 (14%)
Query: 10 LDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSI 69
+D S N + H+P + ILN+S N + S++ L++L
Sbjct: 5 VDRSKNGLI-HVPK--DLSQKTTILNISQNYISELWTSDILSLSKLR------------- 48
Query: 70 LLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTT 129
+L +S N I S + L +DLS NKLV I L
Sbjct: 49 -----------ILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVK-ISC--HPTVNLKH 94
Query: 130 LNMYNNKLDG-PIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGK 188
L++ N D PI E N S+L+ L L L S I L L + G
Sbjct: 95 LDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGE--TYG 152
Query: 189 IPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHLDVSGNQF 230
+T L + + F+ V V+ +
Sbjct: 153 EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLEL 194
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 4e-12
Identities = 37/238 (15%), Positives = 77/238 (32%), Gaps = 20/238 (8%)
Query: 3 RLRNLVHLDLSDNHFMGHIPP-TLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIA 61
L L L +S N ++ EL+ L+LS N L I + L L ++
Sbjct: 43 SLSKLRILIISHNRI-QYLDISVFKFNQELEYLDLSHNKL-VKISCH--PTVNLKHLDLS 98
Query: 62 SNRMNGSILLGI-GSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSS 120
N + + G++ L+ L LS + S + HL + + +
Sbjct: 99 FNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKE--D 156
Query: 121 LGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSG-----------SIPSQI 169
L T +++ +++ S + L + + SI +++
Sbjct: 157 PEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKL 216
Query: 170 GKLQELYYLDLSGNFINGKIPSQLGEF-SCIDTVDLSMNNLSGGIPVFVRKVPHLDVS 226
+L L L+ ++ + S++N+ + R + S
Sbjct: 217 QTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTS 274
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 5e-12
Identities = 38/257 (14%), Positives = 85/257 (33%), Gaps = 22/257 (8%)
Query: 3 RLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVG------NIPSNVGHLTQLT 56
+L + ++ F + ++ ++ L++ N+ +I + + +L+
Sbjct: 164 NTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLS 223
Query: 57 TLAIASNRMNGSILLGIGSL---KVLQVLDLSRNEIGGSIPSTLGH-----LKWLRSVDL 108
L + + + + I L + +S ++ G + LK L +
Sbjct: 224 NLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQV 283
Query: 109 SQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQ 168
+ P + + N + S L NNLL+ ++
Sbjct: 284 VSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFEN 343
Query: 169 IGKLQELYYLDLSGNFINGKIPSQLGEFSC---IDTVDLSMNNLSGGIPVFV----RKVP 221
G L EL L L N + ++ + + +D+S N++S + +
Sbjct: 344 CGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLL 402
Query: 222 HLDVSGNQFGGEIPTTL 238
L++S N I L
Sbjct: 403 SLNMSSNILTDTIFRCL 419
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 7e-10
Identities = 48/221 (21%), Positives = 87/221 (39%), Gaps = 16/221 (7%)
Query: 3 RLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSL-VGNIPSNVGHLTQLTTLAIA 61
+ L +LDLS N + I LK L+LS N+ I G+++QL L ++
Sbjct: 67 FNQELEYLDLSHNK-LVKIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLS 123
Query: 62 SNRMNGSILLGIGSLKVLQV-LDLSRNEIGGSIPSTLGHL--KWLRSVDLSQNKLVGPIP 118
+ + S +L I L + +V L L P L + L V + + +
Sbjct: 124 TTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILD 183
Query: 119 SSLGHLTQLTTLNMYNNKLDG------PIPPELMNCSKLRILKLGNNLLSGSIPSQIGKL 172
S+ + L N+ D I +L KL L L N + + +I +L
Sbjct: 184 VSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQL 243
Query: 173 Q---ELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLS 210
++Y +S + G++ + ++S LS++ +
Sbjct: 244 VWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVV 284
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 7e-10
Identities = 38/251 (15%), Positives = 76/251 (30%), Gaps = 24/251 (9%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIA 61
G + L L LS H + L+ K+L + + L T ++
Sbjct: 112 GNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDP--EGLQDFNTESLH 169
Query: 62 SNRMNGSILLGIGSLKVLQVLDLSRNEIGG-----------SIPSTLGHLKWLRSVDLSQ 110
I + V V +L + I SI + L L ++ L+
Sbjct: 170 IVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNN 229
Query: 111 NKLVGPIPSSLGHL---TQLTTLNMYNNKLDGPIPPELMNCS-----KLRILKLGNNLLS 162
+ + L T + ++ N KL G + + S L I ++ +++
Sbjct: 230 IETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFG 289
Query: 163 GSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLS---GGIPVFVRK 219
+ + + + + S +D S N L+ + +
Sbjct: 290 FPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTE 349
Query: 220 VPHLDVSGNQF 230
+ L + NQ
Sbjct: 350 LETLILQMNQL 360
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 9e-10
Identities = 42/253 (16%), Positives = 77/253 (30%), Gaps = 27/253 (10%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPPT--LGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLA 59
NL HLDLS N F +P G +S+LK L LS L + + HL L
Sbjct: 87 HPTVNLKHLDLSFNAF-DALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLL 145
Query: 60 IASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVG---- 115
+ L+ L + + +L + +
Sbjct: 146 VLGE--TYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLED 203
Query: 116 -------PIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNC---SKLRILKLGNNLLSGSI 165
I + L +L+ L + N + ++ + + + N L G +
Sbjct: 204 NKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQL 263
Query: 166 PSQIG-----KLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNL-SGGIPVFVRK 219
+ L+ L + + FS ++ + +++ + +
Sbjct: 264 DFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKI 323
Query: 220 VP--HLDVSGNQF 230
P HLD S N
Sbjct: 324 SPFLHLDFSNNLL 336
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 6e-08
Identities = 42/181 (23%), Positives = 67/181 (37%), Gaps = 10/181 (5%)
Query: 105 SVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGS 164
VD S+N L+ +P L + T LN+ N + ++++ SKLRIL + +N +
Sbjct: 4 LVDRSKNGLIH-VPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYL 60
Query: 165 IPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLS--GGIPVF--VRKV 220
S QEL YLDLS N + KI + +DLS N F + ++
Sbjct: 61 DISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQL 117
Query: 221 PHLDVSGNQFGGEIPTTLANVPPPHHKTIATGLVAIILAMVAFLALIFGILIIRRRRDKE 280
L +S +A++ + L I +KE
Sbjct: 118 KFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKE 177
Query: 281 I 281
Sbjct: 178 F 178
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 3e-21
Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 18/213 (8%)
Query: 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLE-TELASLESFQNEARLLSQIRH 372
ED+++ IG G +G V R + KV A+K L + E + + F E +++
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTK--RVNIVKGMAHALS 430
+V+L+ ++ ++++ EYM G L ++ V W + +V AL
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS--NYDVPEKWARFYTAEVVL----ALD 182
Query: 431 YLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRT-LLAGTYGSIAPE 489
+H +HRD+ +N+LL+ +ADFG +N + R GT I+PE
Sbjct: 183 AIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE 239
Query: 490 LAYTMVVTEKY----DVYSFGVVALEVLMGKHP 518
+ + Y D +S GV E+L+G P
Sbjct: 240 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 4e-21
Identities = 48/242 (19%), Positives = 86/242 (35%), Gaps = 24/242 (9%)
Query: 6 NLVHLDLSDNHFMGHIPP-TLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAIASN 63
+ LDLS+N +I L R L+ L L+ N + I + L L L ++ N
Sbjct: 53 AVKSLDLSNNRI-TYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYN 110
Query: 64 RMNGSILLGI-GSLKVLQVLDLSRNEIGGSIP--STLGHLKWLRSVDLSQNKLVGPIPS- 119
+ ++ L L L+L N ++ S HL L+ + + I
Sbjct: 111 YL-SNLSSSWFKPLSSLTFLNLLGNPY-KTLGETSLFSHLTKLQILRVGNMDTFTKIQRK 168
Query: 120 SLGHLTQLTTLNMYNNKLDGPIPPE-LMNCSKLRILKLGNNLLSGSIPSQI-GKLQELYY 177
LT L L + + L P+ L + + L L + +
Sbjct: 169 DFAGLTFLEELEIDASDLQS-YEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVEC 226
Query: 178 LDLSGNFINGKIPSQL--GEFS------CIDTVDLSMNNLSGGIPVF--VRKVPHLDVSG 227
L+L ++ S+L GE + V ++ +L + + + + L+ S
Sbjct: 227 LELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSR 286
Query: 228 NQ 229
NQ
Sbjct: 287 NQ 288
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 9e-20
Identities = 41/218 (18%), Positives = 84/218 (38%), Gaps = 13/218 (5%)
Query: 3 RLRNLVHLDLSDNHFMGHIPP-TLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAI 60
L +L HLDLS N+ + ++ LS L LNL N +++ HLT+L L +
Sbjct: 98 SLGSLEHLDLSYNY-LSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRV 156
Query: 61 ASNRMNGSILLGI-GSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPS 119
+ I L L+ L++ +++ P +L ++ + + L + + +
Sbjct: 157 GNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEI 216
Query: 120 SLGHLTQLTTLNMYNNKLDGPIPPEL--------MNCSKLRILKLGNNLLSGSIPSQIGK 171
+ + + L + + LD EL + R +K+ + L + + +
Sbjct: 217 FVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQ 275
Query: 172 LQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNL 209
+ L L+ S N + + + + L N
Sbjct: 276 ISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 47/243 (19%), Positives = 95/243 (39%), Gaps = 22/243 (9%)
Query: 3 RLRNLVHLDLSDNHFMGHIPP-TLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAI 60
R NL L L+ N + I + L L+ L+LS N L N+ S+ L+ LT L +
Sbjct: 74 RCVNLQALVLTSNG-INTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNL 131
Query: 61 ASNRMNGSILLGI-GSLKVLQVLDLSRNEIGGSIPS-TLGHLKWLRSVDLSQNKLVGPIP 118
N + L LQ+L + + I L +L +++ + L P
Sbjct: 132 LGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEP 191
Query: 119 SSLGHLTQLTTLNMYNNKLDGPIPPELMNC-SKLRILKLGNNLLSGSIPSQI-------- 169
SL + ++ L ++ + + ++ S + L+L + L S++
Sbjct: 192 KSLKSIQNVSHLILHMKQHIL-LLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSL 250
Query: 170 GKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIP--VF--VRKVPHLDV 225
K + ++ + ++ L + S + ++ S N L +P +F + + + +
Sbjct: 251 IKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWL 308
Query: 226 SGN 228
N
Sbjct: 309 HTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 18/145 (12%), Positives = 49/145 (33%), Gaps = 11/145 (7%)
Query: 3 RLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAIA 61
L L L++ + + P +L + + L L + + + + + L +
Sbjct: 172 GLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELR 230
Query: 62 SNRMNGSILLGIGS--------LKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKL 113
++ + + + + ++ + + L + L ++ S+N+L
Sbjct: 231 DTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQL 289
Query: 114 VGPIPSSLGHLTQLTTLNMYNNKLD 138
LT L + ++ N D
Sbjct: 290 KSVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 6e-13
Identities = 43/181 (23%), Positives = 72/181 (39%), Gaps = 14/181 (7%)
Query: 35 NLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGI-GSLKVLQVLDLSRNEIGGSI 93
+ SLNS+ + + +L +++NR+ I LQ L L+ N I +I
Sbjct: 40 SGSLNSIPSGLTEA------VKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN-TI 91
Query: 94 PS-TLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELM--NCSK 150
+ L L +DLS N L S L+ LT LN+ N + + + +K
Sbjct: 92 EEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKT-LGETSLFSHLTK 150
Query: 151 LRILKLGNNLLSGSIPSQI-GKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNL 209
L+IL++GN I + L L L++ + + P L + + L M
Sbjct: 151 LQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQH 210
Query: 210 S 210
Sbjct: 211 I 211
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 52/215 (24%), Positives = 93/215 (43%), Gaps = 32/215 (14%)
Query: 314 TEDFDIKYCI----GTGGYGSVYRAR-LPSGKVVALK----KLHRLETELASLESFQNEA 364
E+ D Y G+G + V + R +G A K + + S E + E
Sbjct: 6 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 365 RLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLF--CILR---TDEEAVGLDWTKRV 419
+L +I+H N++ L+ ++ + LI E + G LF + T+EEA
Sbjct: 66 SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEA--------T 117
Query: 420 NIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAF----VADFGIARLLNYDSSN 475
+K + + + YLH I H D+ NI+L + DFG+A +++ +
Sbjct: 118 EFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 476 RTLLAGTYGSIAPE-LAYTMVVTEKYDVYSFGVVA 509
+ + GT +APE + Y + + D++S GV+
Sbjct: 175 KN-IFGTPEFVAPEIVNYEP-LGLEADMWSIGVIT 207
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 5e-21
Identities = 44/182 (24%), Positives = 82/182 (45%), Gaps = 15/182 (8%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASN 63
L N V +L + LS ++ N +++ ++ + + T L L ++ N
Sbjct: 18 LANAVKQNLGKQSV-TDLVS-QKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLSHN 73
Query: 64 RMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGH 123
++ S L + L L+ L ++RN + + + L + L N+L SL H
Sbjct: 74 QI--SDLSPLKDLTKLEELSVNRNRL--KNLNGIPSAC-LSRLFLDNNELRD--TDSLIH 126
Query: 124 LTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGN 183
L L L++ NNKL I L SKL +L L N ++ + + +L+++ ++DL+G
Sbjct: 127 LKNLEILSIRNNKLKS-IVM-LGFLSKLEVLDLHGNEIT-NT-GGLTRLKKVNWIDLTGQ 182
Query: 184 FI 185
Sbjct: 183 KC 184
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 6e-17
Identities = 46/186 (24%), Positives = 76/186 (40%), Gaps = 15/186 (8%)
Query: 25 LGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDL 84
L+ NL S+ + L+ + ++ + L G+ L+ L L
Sbjct: 15 DPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNI--QSLAGMQFFTNLKELHL 70
Query: 85 SRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPE 144
S N+I S S L L L + +++N+L + + L+ L + NN+L
Sbjct: 71 SHNQI--SDLSPLKDLTKLEELSVNRNRLK--NLNGIPSAC-LSRLFLDNNELRDTDS-- 123
Query: 145 LMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDL 204
L++ L IL + NN L SI +G L +L LDL GN I L ++ +DL
Sbjct: 124 LIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDL 179
Query: 205 SMNNLS 210
+
Sbjct: 180 TGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 36/141 (25%), Positives = 57/141 (40%), Gaps = 15/141 (10%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGN---IPSNVGHLTQLTTLAI 60
L L L ++ N L L+ + LS L N ++ HL L L+I
Sbjct: 84 LTKLEELSVNRNR--------LKNLNGIPSACLSRLFLDNNELRDTDSLIHLKNLEILSI 135
Query: 61 ASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSS 120
+N++ ++ +G L L+VLDL NEI + L LK + +DL+ K V
Sbjct: 136 RNNKL--KSIVMLGFLSKLEVLDLHGNEI--TNTGGLTRLKKVNWIDLTGQKCVNEPVKY 191
Query: 121 LGHLTQLTTLNMYNNKLDGPI 141
L T+ + + P
Sbjct: 192 QPELYITNTVKDPDGRWISPY 212
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 21/141 (14%), Positives = 51/141 (36%), Gaps = 11/141 (7%)
Query: 70 LLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTT 129
+ L +L + + + + L +++ + + + + + T L
Sbjct: 12 VFPDPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQ--SLAGMQFFTNLKE 67
Query: 130 LNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKI 189
L++ +N++ + P L + +KL L + N L L L+ L N + +
Sbjct: 68 LHLSHNQISD-LSP-LKDLTKLEELSVNRNRLKNLNGIPSACLSRLF---LDNNEL--RD 120
Query: 190 PSQLGEFSCIDTVDLSMNNLS 210
L ++ + + N L
Sbjct: 121 TDSLIHLKNLEILSIRNNKLK 141
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 6e-21
Identities = 51/229 (22%), Positives = 92/229 (40%), Gaps = 23/229 (10%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIA 61
+L L L + N+ + L + + L L N L N+ V LT+LT L
Sbjct: 61 EKLTGLTKLICTSNNI-TTLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCD 114
Query: 62 SNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSL 121
+N++ L + +L L+ +RN + I + H L +D NK + + +
Sbjct: 115 TNKLTK---LDVSQNPLLTYLNCARNTL-TEID--VSHNTQLTELDCHLNKKITKLD--V 166
Query: 122 GHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLS 181
TQLTTL+ NK+ ++ L L N ++ + + + +L +LD S
Sbjct: 167 TPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCS 220
Query: 182 GNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHLDVSGNQF 230
N + +I + + + D S+N L+ + K+ L
Sbjct: 221 SNKLT-EID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDL 266
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 51/239 (21%), Positives = 100/239 (41%), Gaps = 24/239 (10%)
Query: 3 RLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIAS 62
+L L LD ++ + + +L+ L L + N++ + + T LT LA S
Sbjct: 40 QLATLTSLDCHNSSI-TDMTG-IEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDS 94
Query: 63 NRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLG 122
N++ L + L L L+ N++ + + L ++ ++N L +
Sbjct: 95 NKLTN---LDVTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLTEI---DVS 145
Query: 123 HLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSG 182
H TQLT L+ + NK ++ ++L L N ++ + + + + L L+
Sbjct: 146 HNTQLTELDCHLNKKITK--LDVTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDT 200
Query: 183 NFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVF-VRKVPHLDVSGNQFGGEIPTTLAN 240
N I K+ L + + +D S N L+ I V + ++ + D S N +TL+
Sbjct: 201 NNIT-KLD--LNQNIQLTFLDCSSNKLT-EIDVTPLTQLTYFDCSVNPLTELDVSTLSK 255
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 42/227 (18%), Positives = 85/227 (37%), Gaps = 24/227 (10%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASN 63
+ V + +L+ L L+ +S+ ++ + LT LT L SN
Sbjct: 20 FASEVAAAFEMQAT---DTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSN 74
Query: 64 RMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGH 123
+ L + L L N++ ++ + L L ++ NKL +
Sbjct: 75 NITT---LDLSQNTNLTYLACDSNKL-TNLD--VTPLTKLTYLNCDTNKL---TKLDVSQ 125
Query: 124 LTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGN 183
LT LN N L ++ + ++L L N + + +L LD S N
Sbjct: 126 NPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFN 180
Query: 184 FINGKIPSQLGEFSCIDTVDLSMNNLSGGIPV-FVRKVPHLDVSGNQ 229
I ++ + + ++ ++ NN++ + + ++ LD S N+
Sbjct: 181 KIT-ELD--VSQNKLLNRLNCDTNNIT-KLDLNQNIQLTFLDCSSNK 223
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 5e-17
Identities = 47/215 (21%), Positives = 78/215 (36%), Gaps = 25/215 (11%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAI 60
+ L L +L+ N + + + L LN + N+L I V H TQLT L
Sbjct: 102 VTPLTKLTYLNCDTNKL-TKLD--VSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDC 155
Query: 61 ASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSS 120
N L + L LD S N+I + + K L ++ N +
Sbjct: 156 HLN--KKITKLDVTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNITKL---D 207
Query: 121 LGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDL 180
L QLT L+ +NKL I + ++L N L+ + + L +L L
Sbjct: 208 LNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHC 261
Query: 181 SGNFINGKIP----SQLGEFSCIDTVDLSMNNLSG 211
+ +I +QL F + +++
Sbjct: 262 IQTDLL-EIDLTHNTQLIYFQAEGCRKIKELDVTH 295
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 42/214 (19%), Positives = 69/214 (32%), Gaps = 25/214 (11%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASN 63
L L + D S N + + LS+L L+ L+ ++ H TQL
Sbjct: 232 LTQLTYFDCSVNPL-TELD--VSTLSKLTTLHCIQTDLLEI---DLTHNTQLIYFQAEGC 285
Query: 64 RMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGH 123
L + L +LD I + L L + L+ +L + + H
Sbjct: 286 --RKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELTE-LD--VSH 337
Query: 124 LTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYY------ 177
T+L +L+ N + + L ++P + L
Sbjct: 338 NTKLKSLSCVNAHIQD-FSS-VGKIPALNNNFEAEGQTI-TMPKETLTNNSLTIAVSPDL 394
Query: 178 LDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSG 211
LD GN +N I G T ++ NLS
Sbjct: 395 LDQFGNPMN--IEPGDGGVYDQATNTITWENLST 426
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 35/177 (19%), Positives = 67/177 (37%), Gaps = 15/177 (8%)
Query: 55 LTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLV 114
+ A+ M + + L L LD + I + + L L + + N +
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSI-TDMTG-IEKLTGLTKLICTSNNIT 77
Query: 115 GPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQE 174
+ L T LT L +NKL + + +KL L N L+ + + +
Sbjct: 78 T-LD--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCDTNKLT-KLD--VSQNPL 128
Query: 175 LYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVF-VRKVPHLDVSGNQF 230
L YL+ + N + +I + + + +D +N + V ++ LD S N+
Sbjct: 129 LTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKI 182
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 7e-21
Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 14/206 (6%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASN 63
L ++ + +++ + + L + L L+ N L +I + +L L L + N
Sbjct: 45 LNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLT-DI-KPLANLKNLGWLFLDEN 100
Query: 64 RMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGH 123
++ L + LK L+ L L N I S + L HL L S+ L NK+ + L
Sbjct: 101 KV--KDLSSLKDLKKLKSLSLEHNGI--SDINGLVHLPQLESLYLGNNKIT--DITVLSR 154
Query: 124 LTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGN 183
LT+L TL++ +N++ I P L +KL+ L L N +S + + L+ L L+L
Sbjct: 155 LTKLDTLSLEDNQISD-IVP-LAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQ 210
Query: 184 FINGKIPSQLGEFSCIDTVDLSMNNL 209
K + +TV + +L
Sbjct: 211 ECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 48/208 (23%), Positives = 88/208 (42%), Gaps = 16/208 (7%)
Query: 3 RLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIAS 62
+ +L T L+ + + + + + ++ + +L +T L +
Sbjct: 22 AFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNG 77
Query: 63 NRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLG 122
N++ + + + +LK L L L N++ S+L LK L+S+ L N + + L
Sbjct: 78 NKL--TDIKPLANLKNLGWLFLDENKV--KDLSSLKDLKKLKSLSLEHNGIS--DINGLV 131
Query: 123 HLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSG 182
HL QL +L + NNK+ L +KL L L +N +S I + L +L L LS
Sbjct: 132 HLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSK 187
Query: 183 NFINGKIPSQLGEFSCIDTVDLSMNNLS 210
N I+ + L +D ++L
Sbjct: 188 NHIS-DL-RALAGLKNLDVLELFSQECL 213
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 47/186 (25%), Positives = 83/186 (44%), Gaps = 14/186 (7%)
Query: 25 LGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDL 84
+E NL S+ L + + ++ + + GI L + L L
Sbjct: 20 DDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDI--KSVQGIQYLPNVTKLFL 75
Query: 85 SRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPE 144
+ N++ I L +LK L + L +NK+ SSL L +L +L++ +N + I
Sbjct: 76 NGNKL-TDI-KPLANLKNLGWLFLDENKVK--DLSSLKDLKKLKSLSLEHNGISD-ING- 129
Query: 145 LMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDL 204
L++ +L L LGNN ++ I + +L +L L L N I+ I L + + + L
Sbjct: 130 LVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYL 185
Query: 205 SMNNLS 210
S N++S
Sbjct: 186 SKNHIS 191
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 42/185 (22%), Positives = 77/185 (41%), Gaps = 12/185 (6%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASN 63
L+NL L L +N + + L L +LK L+L N + +I + + HL QL +L + +N
Sbjct: 89 LKNLGWLFLDENK-VKDLSS-LKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNN 144
Query: 64 RMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGH 123
++ + + + L L L L N+I S L L L+++ LS+N + +L
Sbjct: 145 KI--TDITVLSRLTKLDTLSLEDNQI--SDIVPLAGLTKLQNLYLSKNHISDL--RALAG 198
Query: 124 LTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGN 183
L L L +++ + N +K + L P I + ++ +
Sbjct: 199 LKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWH 256
Query: 184 FINGK 188
Sbjct: 257 LPEFT 261
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 35/164 (21%), Positives = 66/164 (40%), Gaps = 12/164 (7%)
Query: 47 SNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSV 106
+ + + + + L + + + ++I S+ + +L + +
Sbjct: 18 FSDDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDI-KSV-QGIQYLPNVTKL 73
Query: 107 DLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIP 166
L+ NKL I L +L L L + NK+ + L + KL+ L L +N +S I
Sbjct: 74 FLNGNKLTD-I-KPLANLKNLGWLFLDENKVKD-LSS-LKDLKKLKSLSLEHNGIS-DIN 128
Query: 167 SQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLS 210
+ L +L L L N I + L + +DT+ L N +S
Sbjct: 129 G-LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS 169
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 34/160 (21%), Positives = 62/160 (38%), Gaps = 13/160 (8%)
Query: 72 GIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLN 131
+ +L + + + T L + + + + + + +L +T L
Sbjct: 19 SDDAFAETIKDNLKKKSV--TDAVTQNELNSIDQIIANNSDIK--SVQGIQYLPNVTKLF 74
Query: 132 MYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPS 191
+ NKL I P L N L L L N + + S + L++L L L N I+ I
Sbjct: 75 LNGNKLTD-IKP-LANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DING 129
Query: 192 QLGEFSCIDTVDLSMNNLSGGIPVFV--RKVPHLDVSGNQ 229
L ++++ L N ++ I V K+ L + NQ
Sbjct: 130 -LVHLPQLESLYLGNNKIT-DITVLSRLTKLDTLSLEDNQ 167
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 74/303 (24%), Positives = 129/303 (42%), Gaps = 70/303 (23%)
Query: 274 RRRRDKEIEPTGTVEITKCADEIAI-----WNYDGRITFQDMIEATEDFDIKYC----IG 324
R R E V+ + + + + ++ Y IG
Sbjct: 4 RPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIG 63
Query: 325 TGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQN-EARLLSQIRHRNIVKLYGF- 381
G +G VY+A+L SG++VA+KK+ + F+N E +++ ++ H NIV+L F
Sbjct: 64 NGSFGVVYQAKLCDSGELVAIKKV-LQDKR------FKNRELQIMRKLDHCNIVRLRYFF 116
Query: 382 -----CLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNI--VKG----MAHALS 430
E + L+ +Y+ +++ + R A + + + VK + +L+
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRA-----KQTLPVIYVKLYMYQLFRSLA 170
Query: 431 YLHHHCTPPILHRDISSNNILLNSEFEAF-VADFGIARLLNYDSSNRTLLAGTYGSI--- 486
Y+H I HRDI N+LL+ + + DFG A+ L N +Y I
Sbjct: 171 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-----SY--ICSR 220
Query: 487 ---APEL-----AYTMVVTEKYDVYSFGVVALEVLMGKH--PGELLSSSSSSLDKNIKLI 536
APEL YT + DV+S G V E+L+G+ PG+ S +D+ +++I
Sbjct: 221 YYRAPELIFGATDYTSSI----DVWSAGCVLAELLLGQPIFPGD------SGVDQLVEII 270
Query: 537 DLL 539
+L
Sbjct: 271 KVL 273
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 49/209 (23%), Positives = 86/209 (41%), Gaps = 34/209 (16%)
Query: 314 TEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRH 372
T+ +++K IG G Y R + A+K + + + + + LL +H
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK-----SKRDPTEEIEILLRYGQH 75
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLF-CILR----TDEEAVGLDWTKRVNIVKGMAH 427
NI+ L K ++++ E M+ G L ILR ++ EA ++ +
Sbjct: 76 PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREA--------SAVLFTITK 127
Query: 428 ALSYLHHHCTPPILHRDISSNNILLNSEFEAF----VADFGIARLLNYDSSNRTLLAGTY 483
+ YLH ++HRD+ +NIL E + DFG A+ L ++ T
Sbjct: 128 TVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTA 184
Query: 484 GSIAPEL----AYTMVVTEKYDVYSFGVV 508
+APE+ Y D++S GV+
Sbjct: 185 NFVAPEVLERQGYDAAC----DIWSLGVL 209
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 48/201 (23%), Positives = 82/201 (40%), Gaps = 36/201 (17%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIR-HRNIVKLYG 380
+G G + + S + A+K + + + Q E L H NIVKL+
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISK-----RMEANTQKEITALKLCEGHPNIVKLHE 73
Query: 381 FCLHEKCMFLIYEYMEMGSLF-CILR----TDEEAVGLDWTKRVNIVKGMAHALSYLHHH 435
+ FL+ E + G LF I + ++ EA I++ + A+S++H
Sbjct: 74 VFHDQLHTFLVMELLNGGELFERIKKKKHFSETEA--------SYIMRKLVSAVSHMHDV 125
Query: 436 CTPPILHRDISSNNILLNSEFEAF---VADFGIARLLNYDSSNRTLLAGTYGSIAPELAY 492
++HRD+ N+L E + + DFG ARL D+ T APE
Sbjct: 126 G---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE--- 179
Query: 493 TMVVTEKY-----DVYSFGVV 508
++ + D++S GV+
Sbjct: 180 --LLNQNGYDESCDLWSLGVI 198
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 3e-20
Identities = 48/301 (15%), Positives = 95/301 (31%), Gaps = 81/301 (26%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVA------------LKKLHRLETELASLE--- 358
DF+ C+G GG+G V+ A+ A +K+ R LA LE
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 359 -----------------------------------------SFQNEARLLSQIRHRNIVK 377
+ + R + +N V
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 378 LYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCT 437
+ +++ + +L + + ++I +A A+ +LH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG- 184
Query: 438 PPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS------------NRTLLAGTYGS 485
++HRD+ +NI + V DFG+ ++ D T GT
Sbjct: 185 --LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 486 IAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRLPP 545
++PE + + K D++S G++ E+L ++ + D+ + + P
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM---------ERVRIITDVRNLKFPL 293
Query: 546 P 546
Sbjct: 294 L 294
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 4e-20
Identities = 53/221 (23%), Positives = 89/221 (40%), Gaps = 36/221 (16%)
Query: 312 EATEDFDIKY----CIGTGGYGSVYRAR-LPSGKVVALK-------KLHRLETELASLES 359
+T F Y +G G V R P+ K A+K E E+
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 360 FQNEARLLSQI-RHRNIVKLYGFCLHEKCMFLIYEYMEMGSLF-CILR----TDEEAVGL 413
E +L ++ H NI++L FL+++ M+ G LF + +++E
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKET--- 126
Query: 414 DWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473
I++ + + LH I+HRD+ NILL+ + + DFG + L+
Sbjct: 127 -----RKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE 178
Query: 474 SNRTLLAGTYGSIAPE-LAYTMVVTEK-Y----DVYSFGVV 508
R + GT +APE + +M Y D++S GV+
Sbjct: 179 KLRE-VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 218
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 5e-20
Identities = 47/218 (21%), Positives = 87/218 (39%), Gaps = 36/218 (16%)
Query: 314 TEDFDI-KYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIR 371
+ + + + +G G + V L + + A+K + + E +L Q +
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEK--QPGHIRSRVFREVEMLYQCQ 68
Query: 372 -HRNIVKLYGFCLHEKCMFLIYEYMEMGSLF-CILR----TDEEAVGLDWTKRVNIVKGM 425
HRN+++L F E +L++E M GS+ I + + EA +V+ +
Sbjct: 69 GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEA--------SVVVQDV 120
Query: 426 AHALSYLHHHCTPPILHRDISSNNILLNSEFEAF---VADFGIARLLNYDSSNRTL---- 478
A AL +LH+ I HRD+ NIL + + DF + + + +
Sbjct: 121 ASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177
Query: 479 ---LAGTYGSIAPE-LAYTMVVTEKY----DVYSFGVV 508
G+ +APE + Y D++S GV+
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 52/194 (26%), Positives = 79/194 (40%), Gaps = 22/194 (11%)
Query: 3 RLRNLVHLDLSDNHFMGHIPP-TLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAI 60
L LDLS + I LS L L L+ N + ++ L+ L L
Sbjct: 50 SFPELQVLDLSRCE-IQTIEDGAYQSLSHLSTLILTGNPI-QSLALGAFSGLSSLQKLVA 107
Query: 61 ASNRMNGSILLGI-GSLKVLQVLDLSRNEIGGSIP-----STLGHLKWLRSVDLSQNKLV 114
+ S+ G LK L+ L+++ N I S S L +L+ L DLS NK+
Sbjct: 108 VETNLA-SLENFPIGHLKTLKELNVAHNLI-QSFKLPEYFSNLTNLEHL---DLSSNKIQ 162
Query: 115 GPIPSSLGHLTQLT----TLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQI- 169
+ L L Q+ +L++ N ++ I P +L+ L L N L S+P I
Sbjct: 163 SIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLKELALDTNQLK-SVPDGIF 220
Query: 170 GKLQELYYLDLSGN 183
+L L + L N
Sbjct: 221 DRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 50/213 (23%), Positives = 79/213 (37%), Gaps = 35/213 (16%)
Query: 35 NLSLNSLVGNIPSNVGHLT----QLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIG 90
L+ + N+P + +L L L + S S LQVLDLSR EI
Sbjct: 16 ELNFYKIPDNLPFSTKNLDLSFNPLRHLG------SYSF----FSFPELQVLDLSRCEI- 64
Query: 91 GSIPS-TLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPEL-MNC 148
+I L L ++ L+ N + + L+ L L L + +
Sbjct: 65 QTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHL 123
Query: 149 SKLRILKLGNNLLSGSIPSQ--IGKLQELYYLDLSGNFINGKIPSQLGEFS-------CI 199
L+ L + +NL+ S L L +LDLS N I I +
Sbjct: 124 KTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYC--TDLRVLHQMPLLN 179
Query: 200 DTVDLSMNNLSGGIP--VFVR-KVPHLDVSGNQ 229
++DLS+N ++ I F ++ L + NQ
Sbjct: 180 LSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQ 211
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 52/220 (23%), Positives = 87/220 (39%), Gaps = 34/220 (15%)
Query: 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLE-TELASLESFQNEARLLSQIRH 372
EDF +G G + +V AR + + A+K L + + + E ++S++ H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKG------MA 426
VKLY ++ ++ Y + G L +R + +
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK---------IGSFDETCTRFYTAEIV 140
Query: 427 HALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIA-RLLNYDSSNRTL-LAGT-- 482
AL YLH I+HRD+ NILLN + + DFG A L R GT
Sbjct: 141 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 197
Query: 483 YGSIAPEL----AYTMVVTEKYDVYSFGVVALEVLMGKHP 518
Y ++PEL + D+++ G + +++ G P
Sbjct: 198 Y--VSPELLTEKSACKSS----DLWALGCIIYQLVAGLPP 231
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 52/226 (23%), Positives = 91/226 (40%), Gaps = 34/226 (15%)
Query: 312 EATEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQN--------- 362
+ ++ I +G YG+V G VA+K++ ++ ++ +
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78
Query: 363 EARLLSQIRHRNIVKLYGFCLHEKC-----MFLIYEYMEMGSLFCILRTDEEAVGLDWTK 417
E RLL+ H NI+ L +H + ++L+ E M L ++ + +
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQ 137
Query: 418 RVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRT 477
+ + L LH ++HRD+ NILL + + DF +AR D +N+T
Sbjct: 138 --YFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTAD-ANKT 191
Query: 478 LLAGT--YGSIAPEL-----AYTMVVTEKYDVYSFGVVALEVLMGK 516
Y APEL +T +V D++S G V E+ K
Sbjct: 192 HYVTHRWYR--APELVMQFKGFTKLV----DMWSAGCVMAEMFNRK 231
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 4e-19
Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 35/219 (15%)
Query: 313 ATEDFDIKY----CIGTGGYGSVYRAR-LPSGKVVALK-----KLHRLETELASL-ESFQ 361
A ++F KY IG G V R +G A+K +L + E+ +
Sbjct: 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATR 147
Query: 362 NEARLLSQIR-HRNIVKLYGFCLHEKCMFLIYEYMEMGSLF-CILR----TDEEAVGLDW 415
E +L Q+ H +I+ L MFL+++ M G LF + +++E
Sbjct: 148 RETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKET----- 202
Query: 416 TKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSN 475
+I++ + A+S+LH + I+HRD+ NILL+ + ++DFG + L
Sbjct: 203 ---RSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL 256
Query: 476 RTLLAGTYGSIAPE-LAYTMVVTEK-Y----DVYSFGVV 508
R L GT G +APE L +M T Y D+++ GV+
Sbjct: 257 RE-LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVI 294
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 35/211 (16%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGF 381
IG G + V AR + +G+ VA+K + + + SL+ E R++ + H NIVKL+
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 382 CLHEKCMFLIYEYMEMGSLFCILR-----TDEEAVGLDWTKRVNIVKGMAHALSYLHHHC 436
EK ++LI EY G +F L ++EA + + + A+ Y H
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEA--------RSKFRQIVSAVQYCHQKR 134
Query: 437 TPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGS---IAPELAYT 493
I+HRD+ + N+LL+++ +ADFG + L G+ APE
Sbjct: 135 ---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG----KLDAFCGAPPYAAPE---- 183
Query: 494 MVVTEKY-----DVYSFGVVALEVLM-GKHP 518
+ +KY DV+S GV+ L L+ G P
Sbjct: 184 LFQGKKYDGPEVDVWSLGVI-LYTLVSGSLP 213
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 6e-19
Identities = 64/255 (25%), Positives = 111/255 (43%), Gaps = 68/255 (26%)
Query: 318 DIKYC----IGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQN-EARLLSQIRH 372
+I Y IG G +G V++A+L VA+KK+ + F+N E +++ ++H
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKV-LQDKR------FKNRELQIMRIVKH 91
Query: 373 RNIVKLYGF------CLHEKCMFLIYEYMEMGSLFCILRT-DEEAVGLDWTKRVNIVKG- 424
N+V L F E + L+ EY+ +++ R + + + ++K
Sbjct: 92 PNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMP----MLLIKLY 146
Query: 425 ---MAHALSYLHHHCTPPILHRDISSNNILLNSEFEAF-VADFGIARLLNYDSSN----- 475
+ +L+Y+H I HRDI N+LL+ + DFG A++L N
Sbjct: 147 MYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC 203
Query: 476 ----RTLLAGTYGSIAPEL-----AYTMVVTEKYDVYSFGVVALEVLMGK--HPGELLSS 524
R APEL YT + D++S G V E++ G+ PGE
Sbjct: 204 SRYYR----------APELIFGATNYTTNI----DIWSTGCVMAELMQGQPLFPGE---- 245
Query: 525 SSSSLDKNIKLIDLL 539
S +D+ +++I +L
Sbjct: 246 --SGIDQLVEIIKVL 258
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 7e-19
Identities = 54/257 (21%), Positives = 106/257 (41%), Gaps = 57/257 (22%)
Query: 312 EATEDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQI 370
+ + F ++ G G +G+V + +G VA+KK+ + + E Q + L+ +
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-IQDPRFRNRE-LQ-IMQDLAVL 76
Query: 371 RHRNIVKLYGF-------CLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVK 423
H NIV+L + + + ++ EY+ +L R ++K
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRR---QVAPPPILIK 132
Query: 424 G----MAHALSYLHHHCTPPILHRDISSNNILLN-SEFEAFVADFGIARLLNYDSSN--- 475
+ ++ LH + + HRDI +N+L+N ++ + DFG A+ L+ N
Sbjct: 133 VFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAY 191
Query: 476 ------RTLLAGTYGSIAPEL-----AYTMVVTEKYDVYSFGVVALEVLMGKH--PGELL 522
R APEL YT V D++S G + E+++G+ G+
Sbjct: 192 ICSRYYR----------APELIFGNQHYTTAV----DIWSVGCIFAEMMLGEPIFRGD-- 235
Query: 523 SSSSSSLDKNIKLIDLL 539
+S + +++ +L
Sbjct: 236 ----NSAGQLHEIVRVL 248
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 8e-19
Identities = 50/262 (19%), Positives = 89/262 (33%), Gaps = 36/262 (13%)
Query: 3 RLRNLVHLDLSDNHFMGHIPP-TLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAI 60
RL++L L + I T LS L IL L N + + + L L L +
Sbjct: 52 RLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTL 110
Query: 61 ASNRMNGSILLG--IGSLKVLQVLDLSRNEIGGSIPSTL-GHLKWLRSVDLSQNKLVGPI 117
++G++L G L L++L L N I P++ +++ +DL+ NK+
Sbjct: 111 TQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSIC 170
Query: 118 PSSLGHLT--QLTTLNMYNNKL--------DGPIPPELMNCSKLRILKLGNNLLSGSIPS 167
L + T L + + L + + L L N S+
Sbjct: 171 EEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAK 230
Query: 168 QIGKL---QELYYLDLSGNFINGKIPSQLGEFSCID-------------TVDLSMNNLS- 210
+ ++ L LS ++ G F D T DLS + +
Sbjct: 231 RFFDAIAGTKIQSLILSNSYNMGSSFGH-TNFKDPDNFTFKGLEASGVKTCDLSKSKIFA 289
Query: 211 --GGIPVFVRKVPHLDVSGNQF 230
+ + L ++ N+
Sbjct: 290 LLKSVFSHFTDLEQLTLAQNEI 311
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 2e-18
Identities = 50/251 (19%), Positives = 92/251 (36%), Gaps = 22/251 (8%)
Query: 6 NLVHLDLSDNHFMGHIPPT-LGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAIASN 63
++ ++DLS N + T RL +L+ L + + I +N L+ L L + N
Sbjct: 31 HVNYVDLSLNSI-AELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 64 RMNGSILLGI-GSLKVLQVLDLSRNEIGGSI--PSTLGHLKWLRSVDLSQNKLVGPIPSS 120
+ + G L L+VL L++ + G++ + L L + L N + P+S
Sbjct: 90 QF-LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148
Query: 121 L-GHLTQLTTLNMYNNKLDGPIPPEL---MNCSKLRILKLGNNLLSGSIPSQIG------ 170
++ + L++ NK+ I E +L+L + L +G
Sbjct: 149 FFLNMRRFHVLDLTFNKVKS-ICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGN 207
Query: 171 --KLQELYYLDLSGNFINGKIPSQL-GEFSCIDTVDLSMNNLSGGIPVFVRKVPHLDVSG 227
K + LDLSGN + + + L ++N F D
Sbjct: 208 PFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFK-DPDN 266
Query: 228 NQFGGEIPTTL 238
F G + +
Sbjct: 267 FTFKGLEASGV 277
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 38/201 (18%), Positives = 75/201 (37%), Gaps = 21/201 (10%)
Query: 3 RLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIAS 62
RL ++ D+++ + + + L+LS N ++ T +
Sbjct: 186 RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLI 245
Query: 63 NRMNGSILLGIGSLKV---------------LQVLDLSRNEIGGSIPSTL-GHLKWLRSV 106
+ ++ G ++ DLS+++I ++ ++ H L +
Sbjct: 246 LSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQL 304
Query: 107 DLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPEL-MNCSKLRILKLGNNLLSGSI 165
L+QN++ ++ LT L LN+ N L I + N KL +L L N + ++
Sbjct: 305 TLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGS-IDSRMFENLDKLEVLDLSYNHIR-AL 362
Query: 166 PSQI-GKLQELYYLDLSGNFI 185
Q L L L L N +
Sbjct: 363 GDQSFLGLPNLKELALDTNQL 383
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 46/264 (17%), Positives = 93/264 (35%), Gaps = 41/264 (15%)
Query: 3 RLRNLVHLDLSDNHFMGHIPP--TLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLA 59
L NL L L+ + G + L+ L++L L N++ P++ ++ + L
Sbjct: 101 GLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLD 160
Query: 60 IASNRMN----------GSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLS 109
+ N++ + L + + D++ +G + ++DLS
Sbjct: 161 LTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLS 220
Query: 110 QNKLVGPIPS---SLGHLTQLTTLNMYNNKLDGPIPPEL------------MNCSKLRIL 154
N + T++ +L + N+ G + S ++
Sbjct: 221 GNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTC 280
Query: 155 KLGNNLLSGSIPSQI-GKLQELYYLDLSGNFINGKIPSQLGEFSC---IDTVDLSMNNLS 210
L + + ++ + +L L L+ N IN KI F + ++LS N L
Sbjct: 281 DLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDD--NAFWGLTHLLKLNLSQNFLG 336
Query: 211 GGIPVFV----RKVPHLDVSGNQF 230
I + K+ LD+S N
Sbjct: 337 -SIDSRMFENLDKLEVLDLSYNHI 359
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 36/137 (26%), Positives = 61/137 (44%), Gaps = 8/137 (5%)
Query: 6 NLVHLDLSDNHFMGHIPPTL-GRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAIASN 63
+ DLS + + ++ ++L+ L L+ N + I N LT L L ++ N
Sbjct: 276 GVKTCDLSKSKI-FALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQN 333
Query: 64 RMNGSILLGI-GSLKVLQVLDLSRNEIGGSIPS-TLGHLKWLRSVDLSQNKLVGPIPSSL 121
+ GSI + +L L+VLDLS N I ++ + L L+ + L N+L
Sbjct: 334 FL-GSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKSVPDGIF 391
Query: 122 GHLTQLTTLNMYNNKLD 138
LT L + ++ N D
Sbjct: 392 DRLTSLQKIWLHTNPWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 42/153 (27%), Positives = 63/153 (41%), Gaps = 14/153 (9%)
Query: 11 DLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAIASNRMNGSI 69
D + F G S +K +LS + + + +V H T L L +A N +N I
Sbjct: 263 DPDNFTFKGL------EASGVKTCDLSKSKI-FALLKSVFSHFTDLEQLTLAQNEIN-KI 314
Query: 70 LLGI-GSLKVLQVLDLSRNEIGGSIPS-TLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQL 127
L L L+LS+N + GSI S +L L +DLS N + S L L
Sbjct: 315 DDNAFWGLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNL 373
Query: 128 TTLNMYNNKLDGPIPPE-LMNCSKLRILKLGNN 159
L + N+L +P + L+ + L N
Sbjct: 374 KELALDTNQLKS-VPDGIFDRLTSLQKIWLHTN 405
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-18
Identities = 54/180 (30%), Positives = 78/180 (43%), Gaps = 8/180 (4%)
Query: 6 NLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRM 65
+ L LS+N TL + L LNL L + + G L L TL ++ N++
Sbjct: 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL-TKLQVD-GTLPVLGTLDLSHNQL 89
Query: 66 NGSILLGIGSLKVLQVLDLSRNEIGGSIPS-TLGHLKWLRSVDLSQNKLVGPIPSSLGHL 124
S+ L +L L VLD+S N + S+P L L L+ + L N+L P L
Sbjct: 90 Q-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPT 147
Query: 125 TQLTTLNMYNNKLDGPIPPELM-NCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGN 183
+L L++ NN L +P L+ L L L N L +IP L + L GN
Sbjct: 148 PKLEKLSLANNNLTE-LPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 7e-18
Identities = 52/180 (28%), Positives = 83/180 (46%), Gaps = 10/180 (5%)
Query: 6 NLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRM 65
+ + ++ + +PP + IL+LS N L + + T+LT L + +
Sbjct: 11 SHLEVNCDKRNL-TALPP--DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67
Query: 66 NGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLT 125
+ L G+L VL LDLS N++ S+P L L +D+S N+L +L L
Sbjct: 68 --TKLQVDGTLPVLGTLDLSHNQL-QSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLG 124
Query: 126 QLTTLNMYNNKLDGPIPPEL-MNCSKLRILKLGNNLLSGSIPSQI-GKLQELYYLDLSGN 183
+L L + N+L +PP L KL L L NN L+ +P+ + L+ L L L N
Sbjct: 125 ELQELYLKGNELKT-LPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQEN 182
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 46/159 (28%), Positives = 60/159 (37%), Gaps = 8/159 (5%)
Query: 3 RLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIAS 62
L L+L G L L L+LS N L ++P L LT L ++
Sbjct: 53 PYTRLTQLNLDRAEL--TKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSF 109
Query: 63 NRMNGSILLGI-GSLKVLQVLDLSRNEIGGSIPS-TLGHLKWLRSVDLSQNKLVGPIPSS 120
NR+ S+ LG L LQ L L NE+ ++P L L + L+ N L
Sbjct: 110 NRLT-SLPLGALRGLGELQELYLKGNEL-KTLPPGLLTPTPKLEKLSLANNNLTELPAGL 167
Query: 121 LGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNN 159
L L L TL + N L IP L L N
Sbjct: 168 LNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 38/159 (23%), Positives = 63/159 (39%), Gaps = 19/159 (11%)
Query: 79 LQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLD 138
++ + + ++P L K + LS+N L ++L T+LT LN+ +L
Sbjct: 12 HLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT 68
Query: 139 GPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPS----QLG 194
L L L +N L S+P L L LD+S N + +P LG
Sbjct: 69 --KLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLG 124
Query: 195 EFSCIDTVDLSMNNLSGGIP--VFVR--KVPHLDVSGNQ 229
E + + L N L +P + K+ L ++ N
Sbjct: 125 E---LQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNN 159
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-18
Identities = 36/191 (18%), Positives = 71/191 (37%), Gaps = 12/191 (6%)
Query: 4 LRNLVHLDLSDNHFMGHIPP-TLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAIA 61
+ L L + H IP L + + +S++ + + S+ +L+++T + I
Sbjct: 30 PPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIR 88
Query: 62 SNRMNGSILLGI-GSLKVLQVLDLSRNEIGGSIP--STLGHLKWLRSVDLSQNKLVGPIP 118
+ R I L +L+ L + + P + + ++++ N + IP
Sbjct: 89 NTRNLTYIDPDALKELPLLKFLGIFNTGL-KMFPDLTKVYSTDIFFILEITDNPYMTSIP 147
Query: 119 S-SLGHLT-QLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQI--GKLQE 174
+ L + TL +YNN + N +KL + L N I G
Sbjct: 148 VNAFQGLCNETLTLKLYNNGFTS-VQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSG 206
Query: 175 LYYLDLSGNFI 185
LD+S +
Sbjct: 207 PSLLDVSQTSV 217
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-16
Identities = 32/186 (17%), Positives = 70/186 (37%), Gaps = 12/186 (6%)
Query: 4 LRNLVHLDLSDNHFMGHIPP-TLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAIA 61
L N+ + +S + + + + LS++ + + + I + L L L I
Sbjct: 54 LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIF 113
Query: 62 SNRMNGSI--LLGIGSLKVLQVLDLSRNEIGGSIPSTL--GHLKWLRSVDLSQNKLVGPI 117
+ + L + S + +L+++ N SIP G ++ L N +
Sbjct: 114 NTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS-V 171
Query: 118 PSSLGHLTQLTTLNMYNNKLDGPIPPELMN--CSKLRILKLGNNLLSGSIPSQI-GKLQE 174
+ T+L + + NK I + S +L + ++ ++PS+ L+E
Sbjct: 172 QGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKE 230
Query: 175 LYYLDL 180
L +
Sbjct: 231 LIARNT 236
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 57/213 (26%), Positives = 93/213 (43%), Gaps = 25/213 (11%)
Query: 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLE-TELASLESFQNEARLLSQIRH 372
+ FD +GTG +G V + SG A+K L + + +L +E NE R+L +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTK--RVNIVKGMAHALS 430
+VKL ++++ EY+ G +F LR + IV
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVL----TFE 155
Query: 431 YLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTL-LAGTYGSIAPE 489
YLH +++RD+ N+L++ + V DFG A+ + RT L GT ++APE
Sbjct: 156 YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWTLCGTPEALAPE 208
Query: 490 L----AYTMVVTEKYDVYSFGVVALEVLMGKHP 518
+ Y V D ++ GV+ E+ G P
Sbjct: 209 IILSKGYNKAV----DWWALGVLIYEMAAGYPP 237
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 5e-18
Identities = 55/187 (29%), Positives = 87/187 (46%), Gaps = 18/187 (9%)
Query: 6 NLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAIASNR 64
+ LDL N RL++L++L L+ N L +P+ + L L TL + N+
Sbjct: 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNK 96
Query: 65 MNGSILLGI-GSLKVLQVLDLSRNEIGGSIPST----LGHLKWLRSVDLSQNKLVGPIPS 119
+ ++ +G+ L L L L RN++ S+P L L +L L N+L +P
Sbjct: 97 LQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYL---SLGYNELQS-LPK 150
Query: 120 SL-GHLTQLTTLNMYNNKLDGPIPPELM-NCSKLRILKLGNNLLSGSIPSQI-GKLQELY 176
+ LT L L +YNN+L +P ++L+ LKL NN L +P L++L
Sbjct: 151 GVFDKLTSLKELRLYNNQLKR-VPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLK 208
Query: 177 YLDLSGN 183
L L N
Sbjct: 209 MLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 49/164 (29%), Positives = 73/164 (44%), Gaps = 14/164 (8%)
Query: 3 RLRNLVHLDLSDNHFMGHIPPTL-GRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAI 60
RL L L L+DN + +P + L L+ L ++ N L +P V L L L +
Sbjct: 59 RLTKLRLLYLNDNK-LQTLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRL 116
Query: 61 ASNRMNGSILLGI-GSLKVLQVLDLSRNEIGGSIPST----LGHLKWLRSVDLSQNKLVG 115
N++ S+ + SL L L L NE+ S+P L LK L L N+L
Sbjct: 117 DRNQLK-SLPPRVFDSLTKLTYLSLGYNEL-QSLPKGVFDKLTSLKEL---RLYNNQLKR 171
Query: 116 PIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNN 159
+ LT+L TL + NN+L + KL++L+L N
Sbjct: 172 VPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 41/143 (28%), Positives = 62/143 (43%), Gaps = 14/143 (9%)
Query: 3 RLRNLVHLDLSDNHFMGHIPP-TLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAI 60
L+NL L ++DN +P +L L L L N L ++P V LT+LT L++
Sbjct: 83 ELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSL 140
Query: 61 ASNRMNGSILLGI-GSLKVLQVLDLSRNEIGGSIPST----LGHLKWLRSVDLSQNKLVG 115
N + S+ G+ L L+ L L N++ +P L LK L L N+L
Sbjct: 141 GYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTL---KLDNNQLKR 195
Query: 116 PIPSSLGHLTQLTTLNMYNNKLD 138
+ L +L L + N D
Sbjct: 196 VPEGAFDSLEKLKMLQLQENPWD 218
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 7e-07
Identities = 37/146 (25%), Positives = 59/146 (40%), Gaps = 21/146 (14%)
Query: 93 IPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNC-SKL 151
IP+ L DL NKL + LT+L L + +NKL +P + L
Sbjct: 35 IPADTKKL------DLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNL 87
Query: 152 RILKLGNNLLSGSIPSQI-GKLQELYYLDLSGNFINGKIPSQLGEF---SCIDTVDLSMN 207
L + +N L ++P + +L L L L N + +P F + + + L N
Sbjct: 88 ETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPP--RVFDSLTKLTYLSLGYN 143
Query: 208 NLSGGIP--VFVR--KVPHLDVSGNQ 229
L +P VF + + L + NQ
Sbjct: 144 ELQ-SLPKGVFDKLTSLKELRLYNNQ 168
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 6e-18
Identities = 44/186 (23%), Positives = 78/186 (41%), Gaps = 8/186 (4%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASN 63
L++L+ + + F+ +E+ I LS++ + T L N
Sbjct: 304 LKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQN 363
Query: 64 RMNGSILLGIGSLKVLQVLDLSRNEIGGSIPST---LGHLKWLRSVDLSQNKL-VGPIPS 119
S+ G +LK LQ L L RN + + ++ L ++D+S N L
Sbjct: 364 VFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDR 422
Query: 120 SLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLD 179
+ + LN+ +N L G + L K+++L L NN + SIP + LQ L L+
Sbjct: 423 TCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELN 479
Query: 180 LSGNFI 185
++ N +
Sbjct: 480 VASNQL 485
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 2e-17
Identities = 38/164 (23%), Positives = 66/164 (40%), Gaps = 12/164 (7%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIA 61
+ L+ + N F + L L+ L L N L N +++L
Sbjct: 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETL 408
Query: 62 SNRMN----GSILLGIGSLKVLQVLDLSRNEIGGSIPSTL-GHLKWLRSVDLSQNKLVGP 116
+N + + + VL+LS N + GS+ L +K L DL N+++
Sbjct: 409 DVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVL---DLHNNRIMS- 464
Query: 117 IPSSLGHLTQLTTLNMYNNKLDGPIPPE-LMNCSKLRILKLGNN 159
IP + HL L LN+ +N+L +P + L+ + L +N
Sbjct: 465 IPKDVTHLQALQELNVASNQLKS-VPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 6e-12
Identities = 47/246 (19%), Positives = 91/246 (36%), Gaps = 23/246 (9%)
Query: 10 LDLSDNHFMGHIPPT-LGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAIASNRMNG 67
L LS N + + LSEL++L LS N + ++ +V L L ++ NR+
Sbjct: 57 LSLSQNSIS-ELRMPDISFLSELRVLRLSHNRI-RSLDFHVFLFNQDLEYLDVSHNRLQN 114
Query: 68 SILLGIGSLKVLQVLDLSRNEIGGSIP--STLGHLKWLRSVDLSQNKLVGPIPSSLGHLT 125
+ + L+ LDLS N+ +P G+L L + LS K + HL
Sbjct: 115 ---ISCCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLH 170
Query: 126 QLT-TLNMYNNKLDGPIPPELM--NCSKLRILKLGNNLLSGSIPSQIGKLQ--ELYYLDL 180
L++ + + G L N + L ++ N+L S + + L +L + L
Sbjct: 171 LSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKL 230
Query: 181 SGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVR--------KVPHLDVSGNQFGG 232
+ + +++++ ++ V+ V +L++
Sbjct: 231 NDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITE 290
Query: 233 EIPTTL 238
I
Sbjct: 291 RIDREE 296
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 8e-11
Identities = 42/220 (19%), Positives = 83/220 (37%), Gaps = 16/220 (7%)
Query: 3 RLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNV--GHLTQLTTLAI 60
++L +LD+S N +I ++ L+ L+LS N +P G+LT+LT L +
Sbjct: 98 FNQDLEYLDVSHNRL-QNISC--CPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGL 153
Query: 61 ASNRMNGSILLGIGSLKVLQV-LDLSRNEIGGSIPSTLGHLK--WLRSVDLSQNKLVGPI 117
++ + LL + L + + LDL I G +L L V + +
Sbjct: 154 SAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQV 213
Query: 118 PSSLGHLTQLTTLNMYNNKLDGPIPPELMNC----SKLRILKLGNNLLSGSIPSQIGKLQ 173
S+ L L N+ N + ++ L + L + + ++ +
Sbjct: 214 NMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFF 273
Query: 174 ELY---YLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLS 210
YL++ I +I + +S L + ++
Sbjct: 274 WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVK 313
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 32/141 (22%), Positives = 55/141 (39%), Gaps = 8/141 (5%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLV----GNIPSNVGHLTQLTT 57
L+ L L L N + + L SL +
Sbjct: 374 STLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILV 432
Query: 58 LAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPI 117
L ++SN + GS+ + ++VLDL N I SIP + HL+ L+ ++++ N+L
Sbjct: 433 LNLSSNMLTGSVFRCLPPK--VKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVP 489
Query: 118 PSSLGHLTQLTTLNMYNNKLD 138
LT L + +++N D
Sbjct: 490 DGVFDRLTSLQYIWLHDNPWD 510
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 29/231 (12%), Positives = 68/231 (29%), Gaps = 20/231 (8%)
Query: 6 NLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRM 65
L ++ L+D + + +LN++L + +V + +
Sbjct: 224 QLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNI 283
Query: 66 NGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLT 125
+ + + + LK L + + +
Sbjct: 284 YNLTITERIDREEFTYSETA--------------LKSLMIEHVKNQVFLFSKEALYSVFA 329
Query: 126 QLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFI 185
++ + + + S L N+ + S+ L+ L L L N +
Sbjct: 330 EMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGL 389
Query: 186 N--GKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVP----HLDVSGNQF 230
K+ S ++T+D+S+N+L+ L++S N
Sbjct: 390 KNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNML 440
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 8e-09
Identities = 28/109 (25%), Positives = 43/109 (39%), Gaps = 6/109 (5%)
Query: 79 LQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLD 138
+ L LS+N I + L LR + LS N++ L L++ +N+L
Sbjct: 54 TKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ 113
Query: 139 GPIPPELMNCSKLRILKLGNNLLSGSIP--SQIGKLQELYYLDLSGNFI 185
I + LR L L N +P + G L +L +L LS
Sbjct: 114 N-ISCC--PMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKF 158
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 38/222 (17%), Positives = 77/222 (34%), Gaps = 18/222 (8%)
Query: 3 RLRNLVHLDLSDNHFMGHIPP-TLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIA 61
L L L LS N + + +L+ L++S N L NI + L L ++
Sbjct: 74 FLSELRVLRLSHNR-IRSLDFHVFLFNQDLEYLDVSHNRLQ-NISC--CPMASLRHLDLS 129
Query: 62 SNRMNGSILLGI-GSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKL-VGPIPS 119
N + + G+L L L LS + + L + L + +
Sbjct: 130 FNDFDVLPVCKEFGNLTKLTFLGLSAAKF-RQLDLLPVAHLHLSCILLDLVSYHIKGGET 188
Query: 120 SLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSG-------SIPSQIGKL 172
+ T L++ + M+ + L L+L N L+ + S++ +
Sbjct: 189 ESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRG 248
Query: 173 QELYYLDLSGNFINGKIPSQLGEF---SCIDTVDLSMNNLSG 211
L + L K +L +F ++ +++ ++
Sbjct: 249 PTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITE 290
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 41/253 (16%), Positives = 84/253 (33%), Gaps = 29/253 (11%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPPT--LGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLA 59
+ +L HLDLS N F +P G L++L L LS ++ + L
Sbjct: 118 CPMASLRHLDLSFNDF-DVLPVCKEFGNLTKLTFLGLSAAKFRQ---LDLLPVAHLHLSC 173
Query: 60 IASNRMNGSI------LLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWL--RSVDLSQN 111
I + ++ I L I + VL ++ + + ++ L L ++ L+
Sbjct: 174 ILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDE 233
Query: 112 KLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPP-----ELMNCSKLRILKLGNNLLSGSIP 166
+ T LN+ ++ + + L + N ++ I
Sbjct: 234 NCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERID 293
Query: 167 SQIG-----KLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVP 221
+ L+ L + + F+ ++ LS+++ I + P
Sbjct: 294 REEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTP-FIHMVCPPSP 352
Query: 222 ----HLDVSGNQF 230
L+ + N F
Sbjct: 353 SSFTFLNFTQNVF 365
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 6e-07
Identities = 38/247 (15%), Positives = 78/247 (31%), Gaps = 18/247 (7%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKI-LNLSLNSLVGNIPSNVGHL-TQLTTLA 59
G L L L LS F + L I L+L + G ++ T + L
Sbjct: 143 GNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLV 202
Query: 60 IASNRMNGSIL-LGIGSLKVLQV--LDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGP 116
N + + + + +L LQ+ + L+ + + ++++ +
Sbjct: 203 FHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETT 262
Query: 117 IPSSLGHL-----TQLTTLNMYNNKLDGPIPPELMNCSK-----LRILKLGNNLLSGSIP 166
S+ + LN+YN + I E S+ L I + N + S
Sbjct: 263 WKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKE 322
Query: 167 SQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLS---GGIPVFVRKVPHL 223
+ E+ LS + S ++ + N + ++++ L
Sbjct: 323 ALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTL 382
Query: 224 DVSGNQF 230
+ N
Sbjct: 383 ILQRNGL 389
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 6e-18
Identities = 52/206 (25%), Positives = 83/206 (40%), Gaps = 43/206 (20%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYG 380
+G G G V + + + ALK L + E L + + +IV++
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQDCP-------KARREVELHWRASQCPHIVRIVD 122
Query: 381 FC----LHEKCMFLIYEYMEMGSLF-CILR------TDEEAVGLDWTKRVNIVKGMAHAL 429
KC+ ++ E ++ G LF I T+ EA I+K + A+
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS--------EIMKSIGEAI 174
Query: 430 SYLHHHCTPPILHRDISSNNILLNSEFEAF---VADFGIARLLNYDSSNRTLLAGTYGSI 486
YLH I HRD+ N+L S+ + DFG A+ +S T T +
Sbjct: 175 QYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT-PCYTPYYV 230
Query: 487 APELAYTMVVTEKY----DVYSFGVV 508
APE+ + EKY D++S GV+
Sbjct: 231 APEV----LGPEKYDKSCDMWSLGVI 252
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 8e-18
Identities = 59/243 (24%), Positives = 101/243 (41%), Gaps = 28/243 (11%)
Query: 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKL------HRLETELASLESFQNEARLL 367
+ F +G GG+G V+ ++ +GK+ A KKL R + A E ++L
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA-----MVEKKIL 239
Query: 368 SQIRHRNIVKL-YGFCLHEKCMFLIYEYMEMGSLFC-ILRTDEEAVGLDWTKRVNIVKGM 425
+++ R IV L Y F + L+ M G + I DE+ G + + +
Sbjct: 240 AKVHSRFIVSLAYAFETKTD-LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI 298
Query: 426 AHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGS 485
L +LH I++RD+ N+LL+ + ++D G+A L + AGT G
Sbjct: 299 VSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGF 355
Query: 486 IAPEL----AYTMVVTEKYDVYSFGVVALEVLMGKHP--GELLSSSSSSLDKNIKLIDLL 539
+APEL Y V D ++ GV E++ + P + L + + +
Sbjct: 356 MAPELLLGEEYDFSV----DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVT 411
Query: 540 DPR 542
P
Sbjct: 412 YPD 414
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 55/221 (24%), Positives = 95/221 (42%), Gaps = 35/221 (15%)
Query: 312 EATEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQN-------- 362
+ + IG+G G V A + VA+KKL R FQN
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR---------PFQNQTHAKRAY 72
Query: 363 -EARLLSQIRHRNIVKLYGFCLHEKCM------FLIYEYMEMGSLFCILRTDEEAVGLDW 415
E L+ + H+NI+ L +K + +++ E M+ +L +++ + LD
Sbjct: 73 RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME-----LDH 126
Query: 416 TKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSN 475
+ ++ M + +LH + I+HRD+ +NI++ S+ + DFG+AR S
Sbjct: 127 ERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFM 182
Query: 476 RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGK 516
T T APE+ M E D++S G + E++ G
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 52/216 (24%), Positives = 91/216 (42%), Gaps = 27/216 (12%)
Query: 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKL------HRLETELASLESFQNEARLL 367
F +G GG+G V ++ +GK+ A KKL R +A NE ++L
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA-----LNEKQIL 238
Query: 368 SQIRHRNIVKL-YGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMA 426
++ R +V L Y + + + L+ M G L + +A + + +
Sbjct: 239 EKVNSRFVVSLAYAYETKDA-LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-IC 296
Query: 427 HALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI 486
L LH I++RD+ NILL+ ++D G+A + + + GT G +
Sbjct: 297 CGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG-RVGTVGYM 352
Query: 487 APEL----AYTMVVTEKYDVYSFGVVALEVLMGKHP 518
APE+ YT D ++ G + E++ G+ P
Sbjct: 353 APEVVKNERYTFSP----DWWALGCLLYEMIAGQSP 384
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 3e-17
Identities = 55/220 (25%), Positives = 88/220 (40%), Gaps = 41/220 (18%)
Query: 316 DFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHR------LETELASLESFQNEARLLS 368
+ +G+G +G V+ A K V +K + + E L E +LS
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 369 QIRHRNIVKLYGFCLHEKCMFLIYEYMEMGS-LFCIL----RTDE-EAVGLDWTKRVNIV 422
++ H NI+K+ ++ L+ E G LF + R DE A I
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLAS--------YIF 136
Query: 423 KGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGT 482
+ + A+ YL I+HRDI NI++ +F + DFG A L L
Sbjct: 137 RQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK----LFYTF 189
Query: 483 YGSI---APELAYTMVVTEKY-----DVYSFGVVALEVLM 514
G+I APE +++ Y +++S GV L L+
Sbjct: 190 CGTIEYCAPE----VLMGNPYRGPELEMWSLGVT-LYTLV 224
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 81.9 bits (202), Expect = 5e-17
Identities = 56/278 (20%), Positives = 93/278 (33%), Gaps = 78/278 (28%)
Query: 315 EDFDIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRLETELASLESFQNEARLLS 368
+ + +G G +G V A + + VA+K L + + +E ++L
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE-GATHSEHRALMSELKILI 80
Query: 369 QI-RHRNIVKLYGFCLHEKC-MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGM- 425
I H N+V L G C + +I E+ + G+L LR+ TK +G
Sbjct: 81 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKD 140
Query: 426 -----------------------------AHALSYLHHHCTPPILHRDISSN-------- 448
+LS + P L++D +
Sbjct: 141 YVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSF 200
Query: 449 ----------------------NILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI 486
NILL+ + + DFG+AR + D +
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV---RKGDARL 257
Query: 487 -----APELAYTMVVTEKYDVYSFGVVALEVL-MGKHP 518
APE + V T + DV+SFGV+ E+ +G P
Sbjct: 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 5e-17
Identities = 60/244 (24%), Positives = 98/244 (40%), Gaps = 47/244 (19%)
Query: 314 TEDFDI-KYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQI- 370
T+D+ + K +G G G V +G+ ALK L+ + E Q
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQAS 79
Query: 371 RHRNIVKLYGFC----LHEKCMFLIYEYMEMGSLFC-ILR------TDEEAVGLDWTKRV 419
+IV + ++C+ +I E ME G LF I T+ EA
Sbjct: 80 GGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAA-------- 131
Query: 420 NIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAF---VADFGIARLLNYDSSNR 476
I++ + A+ +LH H I HRD+ N+L S+ + + DFG A+ +
Sbjct: 132 EIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNAL 186
Query: 477 TLLAGTYGSIAPELAYTMVVTEKY----DVYSFGVVALEVLMGKHP--GELLSSSSSSLD 530
T +APE ++ EKY D++S GV+ +L G P + S +
Sbjct: 187 QTPCYTPYYVAPE----VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK 242
Query: 531 KNIK 534
+ I+
Sbjct: 243 RRIR 246
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 7e-17
Identities = 56/234 (23%), Positives = 108/234 (46%), Gaps = 38/234 (16%)
Query: 304 RITFQDMIEATEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQN 362
RI + + DF +K +G G YG V A P+G++VA+KK+ + L +L + +
Sbjct: 4 RIVY----NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR- 58
Query: 363 EARLLSQIRHRNIVKLYGFCLHEKC-----MFLIYEYMEMGSLFCILRTDEEAVGLDWTK 417
E ++L +H NI+ ++ + +++I E M+ L ++ T L
Sbjct: 59 EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQM----LSDDH 113
Query: 418 RVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRT 477
+ A+ LH ++HRD+ +N+L+NS + V DFG+AR+++ +++ +
Sbjct: 114 IQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS 170
Query: 478 LLAGTYGSI----------APEL-----AYTMVVTEKYDVYSFGVVALEVLMGK 516
G + APE+ Y+ + DV+S G + E+ + +
Sbjct: 171 EPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAM----DVWSCGCILAELFLRR 220
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 8e-17
Identities = 53/219 (24%), Positives = 99/219 (45%), Gaps = 27/219 (12%)
Query: 312 EATEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQI 370
+ + IG G YG V A + VA+KK+ E + + + E ++L +
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRF 82
Query: 371 RHRNIVKLYGFCLHEKC-----MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGM 425
RH NI+ + ++++ + ME L+ +L+T L + +
Sbjct: 83 RHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH----LSNDHICYFLYQI 137
Query: 426 AHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGS 485
L Y+H + +LHRD+ +N+LLN+ + + DFG+AR+ + D + L Y +
Sbjct: 138 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE-YVA 193
Query: 486 I----APELAYTMVVTEKY----DVYSFGVVALEVLMGK 516
APE+ M+ ++ Y D++S G + E+L +
Sbjct: 194 TRWYRAPEI---MLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 8e-17
Identities = 67/224 (29%), Positives = 104/224 (46%), Gaps = 47/224 (20%)
Query: 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLE-TELASLESFQNEARLLSQIRH 372
+DF I +GTG +G V+ R +G+ A+K L + L +E +E +LS + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILR-----TDEEA------VGLDWTKRVNI 421
I++++G + +F+I +Y+E G LF +LR + A V L
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL-------- 117
Query: 422 VKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTL-LA 480
AL YLH I++RD+ NILL+ + DFG A+ + + T L
Sbjct: 118 ------ALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLC 164
Query: 481 GT--YGSIAPEL----AYTMVVTEKYDVYSFGVVALEVLMGKHP 518
GT Y IAPE+ Y + D +SFG++ E+L G P
Sbjct: 165 GTPDY--IAPEVVSTKPYNKSI----DWWSFGILIYEMLAGYTP 202
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 9e-17
Identities = 50/230 (21%), Positives = 96/230 (41%), Gaps = 44/230 (19%)
Query: 312 EATEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQN-------- 362
+ + ++I++ IGTG YG V A +VVA+KK+ R F++
Sbjct: 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR---------VFEDLIDCKRIL 100
Query: 363 -EARLLSQIRHRNIVKLYGFCLHEKC-----MFLIYEYMEMGSLFCILRTDEEAVGL-DW 415
E +L+++ H ++VK+ + + ++++ E + + RT L +
Sbjct: 101 REIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVY---LTEL 156
Query: 416 TKRV---NIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472
+ N++ G + Y+H ILHRD+ N L+N + V DFG+AR ++Y
Sbjct: 157 HIKTLLYNLLVG----VKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209
Query: 473 SSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVV-----ALEVLMGKH 517
+ + L + L + VV A E+++ +
Sbjct: 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQE 259
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 1e-16
Identities = 57/223 (25%), Positives = 96/223 (43%), Gaps = 39/223 (17%)
Query: 312 EATEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQN-------- 362
+ + IG+G G V A + VA+KKL R FQN
Sbjct: 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR---------PFQNQTHAKRAY 109
Query: 363 -EARLLSQIRHRNIVKLYGFCLHEKCM------FLIYEYMEMGSLFCILRTDEEAVGLDW 415
E L+ + H+NI+ L +K + +L+ E M+ +L +++ + LD
Sbjct: 110 RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQME-----LDH 163
Query: 416 TKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSN 475
+ ++ M + +LH + I+HRD+ +NI++ S+ + DFG+AR S
Sbjct: 164 ERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFM 219
Query: 476 RTLLAGT--YGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGK 516
T T Y APE+ M E D++S G + E++ K
Sbjct: 220 MTPYVVTRYYR--APEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 53/219 (24%), Positives = 87/219 (39%), Gaps = 44/219 (20%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHR----LETELASLESFQNEARLLSQIRHR--NI 375
+G+GG+GSVY + VA+K + + EL + E LL ++ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 376 VKLYGFCLHEKCMFLIYEYME-MGSLF--CILR---TDEEAVGLDWTKRVNIVKGMAHAL 429
++L + LI E E + LF R +E A R + + A+
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA-------R-SFFWQVLEAV 162
Query: 430 SYLHHHCTPPILHRDISSNNILLNSE-FEAFVADFGIARLLNYDSSNRTLLAGTYGSI-- 486
+ H+ +LHRDI NIL++ E + DFG LL T+ G+
Sbjct: 163 RHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTDFDGTRVY 214
Query: 487 -APELAYTMVVTEKY-----DVYSFGVVALEVLM-GKHP 518
PE + +Y V+S G++ L ++ G P
Sbjct: 215 SPPE----WIRYHRYHGRSAAVWSLGIL-LYDMVCGDIP 248
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 57/229 (24%), Positives = 99/229 (43%), Gaps = 51/229 (22%)
Query: 312 EATEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQN-------- 362
E + +G+G YG+V A +G VA+KKL+R FQ+
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP---------FQSELFAKRAY 72
Query: 363 -EARLLSQIRHRNIVKLYGFCLHEKCM------FLIYEYMEMGSLFCILRTDEEAVGLDW 415
E RLL +RH N++ L ++ + +L+ +M L +++ ++ L
Sbjct: 73 RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEK----LGE 127
Query: 416 TKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSN 475
+ +V M L Y+H I+HRD+ N+ +N + E + DFG+AR + + +
Sbjct: 128 DRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG 184
Query: 476 -------RTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGK 516
R APE+ M T+ D++S G + E++ GK
Sbjct: 185 YVVTRWYR----------APEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 51/238 (21%), Positives = 95/238 (39%), Gaps = 56/238 (23%)
Query: 312 EATEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQN-------- 362
+ + +G GG G V+ A K VA+KK+ +
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI-----------VLTDPQSVKHAL 56
Query: 363 -EARLLSQIRHRNIVKLY--------------GFCLHEKCMFLIYEYMEMGSLFCILRTD 407
E +++ ++ H NIVK++ G ++++ EYME L +L
Sbjct: 57 REIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQG 115
Query: 408 EEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEF-EAFVADFGIA 466
L + + L Y+H + +LHRD+ N+ +N+E + DFG+A
Sbjct: 116 P----LLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLA 168
Query: 467 RLLNYDSSNRTLLAGTYGSI----APELAYTMVVTEKY----DVYSFGVVALEVLMGK 516
R+++ S++ L+ +P L ++ Y D+++ G + E+L GK
Sbjct: 169 RIMDPHYSHKGHLSE-GLVTKWYRSPRL---LLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 81.0 bits (199), Expect = 3e-16
Identities = 41/237 (17%), Positives = 76/237 (32%), Gaps = 31/237 (13%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIA 61
L +LS + + L+ S L P N L + L A
Sbjct: 346 ATDEQLFRCELSVE-----------KSTVLQSELESCKELQELEPENKWCLLTIILLMRA 394
Query: 62 SNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWL--------RSVDLSQNKL 113
+ + + L+ +D R + S + R + L+ L
Sbjct: 395 LDPLLYEKE-TLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL 453
Query: 114 VGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQ 173
+ L L +T L++ +N+L +PP L L +L+ +N L ++ + L
Sbjct: 454 T--VLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-NVDG-VANLP 508
Query: 174 ELYYLDLSGNFING-KIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKV----PHLDV 225
L L L N + L + ++L N+L ++ P +
Sbjct: 509 RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEMLPSVSS 564
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 65.2 bits (158), Expect = 3e-11
Identities = 31/111 (27%), Positives = 52/111 (46%), Gaps = 7/111 (6%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAI 60
+ +L + HLDLS N +PP L L L++L S N+L N+ V +L +L L +
Sbjct: 459 LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLL 515
Query: 61 ASNRMNG-SILLGIGSLKVLQVLDLSRNEIG---GSIPSTLGHLKWLRSVD 107
+NR+ + + + S L +L+L N + G L + S+
Sbjct: 516 CNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 566
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 5e-16
Identities = 55/259 (21%), Positives = 103/259 (39%), Gaps = 60/259 (23%)
Query: 312 EATEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQN-------- 362
+++ IK+ IG G YG VY A + K VA+KK++R+ F++
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM---------FEDLIDCKRIL 73
Query: 363 -EARLLSQIRHRNIVKLYGFCLHEKC-----MFLIYEYMEMGSLFCILRTDEEAVGLDWT 416
E +L++++ I++LY + + ++++ E + L + +T L
Sbjct: 74 REITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIF---LTEE 129
Query: 417 KRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNR 476
I+ + +++H I+HRD+ N LLN + V DFG+AR +N +
Sbjct: 130 HIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTN 186
Query: 477 TLLAGTYGSI----------------------APELAYTMVVTEKY----DVYSFGVVAL 510
+ APEL +++ E Y D++S G +
Sbjct: 187 IVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPEL---ILLQENYTKSIDIWSTGCIFA 243
Query: 511 EVLMGKHPGELLSSSSSSL 529
E+L ++ L
Sbjct: 244 ELLNMLQSHINDPTNRFPL 262
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 5e-16
Identities = 57/229 (24%), Positives = 95/229 (41%), Gaps = 52/229 (22%)
Query: 312 EATEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQN-------- 362
E + + +G+G YGSV A SG+ VA+KKL R FQ+
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR---------PFQSEIFAKRAY 71
Query: 363 -EARLLSQIRHRNIVKLYGFCLHEKCM------FLIYEYMEMGSLFCILRTDEEAVGLDW 415
E LL ++H N++ L + +L+ +M+ L I+
Sbjct: 72 RELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLK-----FSE 125
Query: 416 TKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSN 475
K +V M L Y+H + ++HRD+ N+ +N + E + DFG+AR + + +
Sbjct: 126 EKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG 182
Query: 476 -------RTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGK 516
R APE+ + M + D++S G + E+L GK
Sbjct: 183 YVVTRWYR----------APEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 6e-16
Identities = 58/223 (26%), Positives = 93/223 (41%), Gaps = 40/223 (17%)
Query: 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLH------RLETELASLESFQNEARLL 367
DF + IG GG+G VY R +GK+ A+K L + LA NE +L
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA-----LNERIML 243
Query: 368 SQI---RHRNIVKL-YGFCLHEKCMFLIYEYMEMGSLFCILRTD---EEAVGLDWTKRVN 420
S + IV + Y F +K + I + M G L L EA + +
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDK-LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 302
Query: 421 IVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLA 480
+ L ++H+ +++RD+ NILL+ ++D G+A + +
Sbjct: 303 L------GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA--SV 351
Query: 481 GTYGSIAPEL-----AYTMVVTEKYDVYSFGVVALEVLMGKHP 518
GT+G +APE+ AY D +S G + ++L G P
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSA----DWFSLGCMLFKLLRGHSP 390
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 7e-16
Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 35/207 (16%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLE-TELASLESFQNEARLLSQIRHRNIVKLYG 380
+G G +G V +G VA+K L+R + L + + E + L RH +I+KLY
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 381 FCLHEKCMFLIYEYMEMGSLFCIL----RTDE-EAVGLDWTKRVNIVKGMAHALSYLHHH 435
F++ EY+ G LF + R +E EA + + + A+ Y H H
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEA--------RRLFQQILSAVDYCHRH 130
Query: 436 CTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGS---IAPELAY 492
++HRD+ N+LL++ A +ADFG++ +++ L + GS APE
Sbjct: 131 M---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE----FLRTSCGSPNYAAPE--- 180
Query: 493 TMVVTEKY-----DVYSFGVVALEVLM 514
++ Y D++S GV+ L L+
Sbjct: 181 -VISGRLYAGPEVDIWSCGVI-LYALL 205
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 9e-16
Identities = 45/228 (19%), Positives = 86/228 (37%), Gaps = 46/228 (20%)
Query: 316 DFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHR----LETELASLESFQNEARLLSQI 370
++ + +G GG+G+V+ L VA+K + R + L+ + E LL ++
Sbjct: 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 371 R----HRNIVKLYGFCLHEKCMFLIYEYMEMGS-LF--CILR---TDEEAVGLDWTKRVN 420
H +++L + ++ L+ E LF + + + R
Sbjct: 92 GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPS-------R-C 143
Query: 421 IVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAF-VADFGIARLLNYDSSNRTLL 479
+ A+ + H ++HRDI NIL++ + DFG LL +
Sbjct: 144 FFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALL-----HDEPY 195
Query: 480 AGTYGSI---APELAYTMVVTEKY-----DVYSFGVVALEVLM-GKHP 518
G+ PE + +Y V+S G++ L ++ G P
Sbjct: 196 TDFDGTRVYSPPE----WISRHQYHALPATVWSLGIL-LYDMVCGDIP 238
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-15
Identities = 56/222 (25%), Positives = 95/222 (42%), Gaps = 23/222 (10%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGF 381
+G G YG V A + + VA+K + + + E+ + E + + H N+VK YG
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 382 CLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPIL 441
+L EY G LF + E +G+ + + YLH I
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHGIG---IT 127
Query: 442 HRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGS---IAPELAYTMVVTE 498
HRDI N+LL+ ++DFG+A + ++ LL G+ +APE ++
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMCGTLPYVAPE----LLKRR 182
Query: 499 KY-----DVYSFGVVALEVLM-GKHPGELLSSSSSSLDKNIK 534
++ DV+S G+V L ++ G+ P + S S +
Sbjct: 183 EFHAEPVDVWSCGIV-LTAMLAGELPWDQPSDSCQEYSDWKE 223
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 62/252 (24%), Positives = 110/252 (43%), Gaps = 62/252 (24%)
Query: 303 GRITFQDMIEATEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQ 361
GR+ +++ +G G YG V+++ +G+VVA+KK+ FQ
Sbjct: 1 GRVDR----HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA---------FQ 47
Query: 362 N---------EARLLSQIR-HRNIVKLYGFCLHE--KCMFLIYEYMEMGSLFCILRTDEE 409
N E +L+++ H NIV L + + ++L+++YME L ++R +
Sbjct: 48 NSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANI- 105
Query: 410 AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL 469
L+ + +V + + YLH + +LHRD+ +NILLN+E VADFG++R
Sbjct: 106 ---LEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSF 159
Query: 470 NYDSSNRTLLAGTYGSI---------------------APELAYTMVVTEKY----DVYS 504
+ + APE+ ++ + KY D++S
Sbjct: 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEI---LLGSTKYTKGIDMWS 216
Query: 505 FGVVALEVLMGK 516
G + E+L GK
Sbjct: 217 LGCILGEILCGK 228
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 38/210 (18%), Positives = 76/210 (36%), Gaps = 16/210 (7%)
Query: 4 LRNLVHLDLSDNHFMGHIPP-TLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAIA 61
+L +++S N + I L +L + + + + I +L L L I+
Sbjct: 53 FGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLIS 112
Query: 62 SNRMNGSI--LLGIGSLKVLQVLDLSRNEIGGSIPSTL--GHLKWLRSVDLSQNKLVGPI 117
+ + + + I SL+ +LD+ N +I G + L++N +
Sbjct: 113 NTGIK-HLPDVHKIHSLQ-KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIH 170
Query: 118 PSSLGHLTQLTTLNMYNNKLDGPIPPE-LMNCSKLRILKLGNNLLSGSIPSQI-GKLQEL 175
S+ NN L+ +P + S IL + + S+PS L++L
Sbjct: 171 NSAFNGTQLDELNLSDNNNLEE-LPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKL 228
Query: 176 YYLDLSGNFINGKIPSQLGEFSCIDTVDLS 205
K+P+ L + + L+
Sbjct: 229 RARSTYNLK---KLPT-LEKLVALMEASLT 254
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 28/160 (17%), Positives = 54/160 (33%), Gaps = 10/160 (6%)
Query: 4 LRNLVHLDLSDNHFMGHIPP-TLGRLSELKILNLSLNSLVGNIPSNV--GHLTQLTTLAI 60
L NL +L +S+ H+P + +L++ N + I N G + L +
Sbjct: 103 LPNLQYLLISNTGI-KHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWL 161
Query: 61 ASNRMNGSILLGI-GSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPS 119
N + I ++ ++ N + +D+S+ ++
Sbjct: 162 NKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSY 220
Query: 120 SLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNN 159
L +L +L + YN K +P L L L
Sbjct: 221 GLENLKKLRARSTYNLKK---LPT-LEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 7e-11
Identities = 38/206 (18%), Positives = 80/206 (38%), Gaps = 19/206 (9%)
Query: 35 NLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGI-GSLKVLQVLDLSRNEIGGSI 93
+ + ++P N L ++ I G L+ +++S+N++ I
Sbjct: 18 ESKVTEIPSDLPRN------AIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVI 70
Query: 94 PS-TLGHLKWLRSVDLSQ-NKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPEL-MNCSK 150
+ +L L + + + N L+ P + +L L L + N + +P ++ +
Sbjct: 71 EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH-LPDVHKIHSLQ 129
Query: 151 LRILKLGNNLLSGSIPSQI--GKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNN 208
+L + +N+ +I G E L L+ N I +I + + +D ++LS NN
Sbjct: 130 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNN 188
Query: 209 ----LSGGIPVFVRKVPHLDVSGNQF 230
L + LD+S +
Sbjct: 189 NLEELPNDVFHGASGPVILDISRTRI 214
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 4e-07
Identities = 31/164 (18%), Positives = 53/164 (32%), Gaps = 22/164 (13%)
Query: 80 QVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDG 139
+V +++ IPS L + + KL + L + + N +
Sbjct: 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68
Query: 140 PIPPE-LMNCSKLRILKLGN-NLLSGSIPSQI-GKLQELYYLDLSGNFINGKIPSQLGEF 196
I + N KL +++ N L I + L L YL +S I L +
Sbjct: 69 VIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGI-----KHLPDV 122
Query: 197 SCID-----TVDLSMNNLSGGIP--VFV---RKVPHLDVSGNQF 230
I +D+ N I FV + L ++ N
Sbjct: 123 HKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI 166
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 56/222 (25%), Positives = 95/222 (42%), Gaps = 23/222 (10%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGF 381
+G G YG V A + + VA+K + + + E+ + E + + H N+VK YG
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 382 CLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPIL 441
+L EY G LF + E +G+ + + YLH I
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHGIG---IT 127
Query: 442 HRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGS---IAPELAYTMVVTE 498
HRDI N+LL+ ++DFG+A + ++ LL G+ +APE ++
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMCGTLPYVAPE----LLKRR 182
Query: 499 KY-----DVYSFGVVALEVLM-GKHPGELLSSSSSSLDKNIK 534
++ DV+S G+V L ++ G+ P + S S +
Sbjct: 183 EFHAEPVDVWSCGIV-LTAMLAGELPWDQPSDSCQEYSDWKE 223
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 49/230 (21%), Positives = 81/230 (35%), Gaps = 58/230 (25%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYG 380
+G G G V + + + ALK L + E L + + +IV++
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQDCP-------KARREVELHWRASQCPHIVRIVD 78
Query: 381 FC----LHEKCMFLIYEYMEMGSLF-CILR------TDEEAVGLDWTKRVNIVKGMAHAL 429
KC+ ++ E ++ G LF I T+ EA I+K + A+
Sbjct: 79 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS--------EIMKSIGEAI 130
Query: 430 SYLHHHCTPPILHRDISSNNILLNSEFEAF---VADFGIARLLNYDSSNRTLLAGTYGSI 486
YLH I HRD+ N+L S+ + DFG A + Y
Sbjct: 131 QYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA---------KETTGEKYD-- 176
Query: 487 APELAYTMVVTEKYDVYSFGVVALEVLMGKHP--GELLSSSSSSLDKNIK 534
+ D++S GV+ +L G P + S + I+
Sbjct: 177 -----------KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 215
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 3e-15
Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 35/207 (16%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLE-TELASLESFQNEARLLSQIRHRNIVKLYG 380
+G G +G V + +G VA+K L+R + L + + E + L RH +I+KLY
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 381 FCLHEKCMFLIYEYMEMGSLFCIL----RTDE-EAVGLDWTKRVNIVKGMAHALSYLHHH 435
+F++ EY+ G LF + R DE E+ + + + + Y H H
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKES--------RRLFQQILSGVDYCHRH 135
Query: 436 CTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGS---IAPELAY 492
++HRD+ N+LL++ A +ADFG++ +++ L + GS APE
Sbjct: 136 M---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE----FLRTSCGSPNYAAPE--- 185
Query: 493 TMVVTEKY-----DVYSFGVVALEVLM 514
++ Y D++S GV+ L L+
Sbjct: 186 -VISGRLYAGPEVDIWSSGVI-LYALL 210
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 4e-15
Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 33/219 (15%)
Query: 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVA---LKKLHRLETELASLESFQNEARLLSQI 370
+F+ +G G +G V + +G+ A LKK + + + E R+L
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKD--EVAHTLTENRVLQNS 205
Query: 371 RHRNIVKL-YGFCLHEKCMFLIYEYMEMGSLFCILRT----DEEAVGLDWTKRVNIVKG- 424
RH + L Y F H++ + + EY G LF L E+ R
Sbjct: 206 RHPFLTALKYSFQTHDR-LCFVMEYANGGELFFHLSRERVFSED--------RARFYGAE 256
Query: 425 MAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARL-LNYDSSNRTLLAGTY 483
+ AL YLH +++RD+ N++L+ + + DFG+ + + ++ +T GT
Sbjct: 257 IVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTP 313
Query: 484 GSIAPEL----AYTMVVTEKYDVYSFGVVALEVLMGKHP 518
+APE+ Y V D + GVV E++ G+ P
Sbjct: 314 EYLAPEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLP 348
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 9e-15
Identities = 50/236 (21%), Positives = 92/236 (38%), Gaps = 57/236 (24%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHR------------------------LETELASL 357
IG G YG V A A+K L + +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 358 ESFQNEARLLSQIRHRNIVKLYG--FCLHEKCMFLIYEYMEMGSLFCILR----TDEEAV 411
E E +L ++ H N+VKL +E +++++E + G + + ++++A
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140
Query: 412 GLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471
+ + + YLH+ I+HRDI +N+L+ + +ADFG++
Sbjct: 141 --------FYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEF-- 187
Query: 472 DSSNRTLLAGTYGS---IAPELAYTMVVTEKY-----DVYSFGVVALEVLM-GKHP 518
+ LL+ T G+ +APE + + DV++ GV L + G+ P
Sbjct: 188 -KGSDALLSNTVGTPAFMAPES--LSETRKIFSGKALDVWAMGVT-LYCFVFGQCP 239
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 9e-15
Identities = 44/184 (23%), Positives = 68/184 (36%), Gaps = 22/184 (11%)
Query: 35 NLSLNSLVGNIPSNVGHL----TQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIG 90
L ++ ++PS L L+ L L L L LS N +
Sbjct: 27 KQQLPNVPQSLPSYTALLDLSHNNLSRL------RAEWTPTR---LTNLHSLLLSHNHLN 77
Query: 91 GSIPS-TLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPE-LMNC 148
I S + LR +DLS N L L L L +YNN + + +
Sbjct: 78 -FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVV-VDRNAFEDM 135
Query: 149 SKLRILKLGNNLLSGSIPSQI----GKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDL 204
++L+ L L N +S P ++ KL +L LDLS N + + L + L
Sbjct: 136 AQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGL 194
Query: 205 SMNN 208
++N
Sbjct: 195 YLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 41/165 (24%), Positives = 68/165 (41%), Gaps = 14/165 (8%)
Query: 29 SELKILNLSLNSLVGNIPSNV--GHLTQLTTLAIASNRMNGSILLGI-GSLKVLQVLDLS 85
S +L+LS N+L + + LT L +L ++ N +N I + L+ LDLS
Sbjct: 39 SYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLS 96
Query: 86 RNEIGGSIPS-TLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPE 144
N + ++ L+ L + L N +V ++ + QL L + N++ P E
Sbjct: 97 SNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR-FPVE 154
Query: 145 ----LMNCSKLRILKLGNNLLSGSIPSQIGKLQELY--YLDLSGN 183
KL +L L +N L + + KL L L N
Sbjct: 155 LIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 34/140 (24%), Positives = 56/140 (40%), Gaps = 12/140 (8%)
Query: 79 LQVLDLSRNEIGGSIPS--TLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNK 136
+LDLS N + + + T L L S+ LS N L + + L L++ +N
Sbjct: 41 TALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNH 99
Query: 137 LDGPIPPE-LMNCSKLRILKLGNNLLSGSIPSQI-GKLQELYYLDLSGNFINGKIP---- 190
L + + L +L L NN + + + +L L LS N I+ + P
Sbjct: 100 LHT-LDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELI 156
Query: 191 SQLGEFSCIDTVDLSMNNLS 210
+ + +DLS N L
Sbjct: 157 KDGNKLPKLMLLDLSSNKLK 176
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 6e-13
Identities = 42/145 (28%), Positives = 60/145 (41%), Gaps = 13/145 (8%)
Query: 3 RLRNLVHLDLSDNHFMGHIPP-TLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAI 60
RL NL L LS NH + I + L+ L+LS N L + + L L L +
Sbjct: 62 RLTNLHSLLLSHNH-LNFISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLL 119
Query: 61 ASNRMNGSILLGI-GSLKVLQVLDLSRNEIGGSIP----STLGHLKWLRSVDLSQNKLVG 115
+N + + + LQ L LS+N+I P L L +DLS NKL
Sbjct: 120 YNNHIV-VVDRNAFEDMAQLQKLYLSQNQI-SRFPVELIKDGNKLPKLMLLDLSSNKLKK 177
Query: 116 PIPSSLGHLTQLT--TLNMYNNKLD 138
+ L L L ++NN L+
Sbjct: 178 LPLTDLQKLPAWVKNGLYLHNNPLE 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 31/135 (22%), Positives = 56/135 (41%), Gaps = 17/135 (12%)
Query: 104 RSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPE--LMNCSKLRILKLGNNLL 161
+ S+ +L +P SL T L++ +N L + E + L L L +N L
Sbjct: 21 NILSCSKQQLPN-VPQSLPSYTA--LLDLSHNNLSR-LRAEWTPTRLTNLHSLLLSHNHL 76
Query: 162 SGSIPSQI-GKLQELYYLDLSGNFINGKIPSQ-LGEFSCIDTVDLSMNNLSGGIP--VFV 217
+ I S+ + L YLDLS N ++ + + ++ + L N++ + F
Sbjct: 77 N-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAF- 132
Query: 218 RKVP---HLDVSGNQ 229
+ L +S NQ
Sbjct: 133 EDMAQLQKLYLSQNQ 147
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 50/225 (22%), Positives = 90/225 (40%), Gaps = 54/225 (24%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHR--LETELASLESFQNEARLLSQIRHRNIVKLY 379
+G G YG V + A+K L + L + + E +LL ++RH+N+++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 380 GFCLHE--KCMFLIYEYMEMGS--LFCILRTDEEAVGLDWTKRVNIVKG-----MAH--- 427
+E + M+++ EY G + D + + AH
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEML------------DS-----VPEKRFPVCQAHGYF 115
Query: 428 -----ALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGT 482
L YLH I+H+DI N+LL + ++ G+A L+ +++ +
Sbjct: 116 CQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD-DTCRTS 171
Query: 483 YGS---IAPELAYTMVVTEKY-----DVYSFGVVALEVLM-GKHP 518
GS PE+A + + D++S GV L + G +P
Sbjct: 172 QGSPAFQPPEIANG---LDTFSGFKVDIWSAGVT-LYNITTGLYP 212
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 57/222 (25%), Positives = 95/222 (42%), Gaps = 37/222 (16%)
Query: 312 EATEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQN-------- 362
E E + +G+G YGSV A +G VA+KKL R FQ+
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR---------PFQSIIHAKRTY 76
Query: 363 -EARLLSQIRHRNIVKLYGFCLHEKCM------FLIYEYMEMGSLFCILRTDEEAVGLDW 415
E RLL ++H N++ L + + +L+ M L I++ + L
Sbjct: 77 RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQK----LTD 131
Query: 416 TKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSN 475
++ + L Y+H + I+HRD+ +N+ +N + E + DFG+AR +
Sbjct: 132 DHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT---ADE 185
Query: 476 RTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGK 516
T T APE+ M + D++S G + E+L G+
Sbjct: 186 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 3e-14
Identities = 59/221 (26%), Positives = 98/221 (44%), Gaps = 34/221 (15%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLP----SGKVVALKKL--HRLETELASLESFQNEARLLS 368
E F++ +G GGYG V++ R +GK+ A+K L + + E +L
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 369 QIRHRNIVKL-YGFCLHEKCMFLIYEYMEMGSLFCILRT----DEEAVGLDWTKRVNIVK 423
+++H IV L Y F K ++LI EY+ G LF L E+
Sbjct: 77 EVKHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQLEREGIFMED--------TACFYL 127
Query: 424 G-MAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARL-LNYDSSNRTLLAG 481
++ AL +LH I++RD+ NI+LN + + DFG+ + ++ + T G
Sbjct: 128 AEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC-G 183
Query: 482 TYGSIAPEL----AYTMVVTEKYDVYSFGVVALEVLMGKHP 518
T +APE+ + V D +S G + ++L G P
Sbjct: 184 TIEYMAPEILMRSGHNRAV----DWWSLGALMYDMLTGAPP 220
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 45/233 (19%), Positives = 99/233 (42%), Gaps = 38/233 (16%)
Query: 299 WNYD-GRITFQDMIEATEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELAS 356
W+Y+ + + +D+ + +G G Y V+ A + + + V +K L ++ +
Sbjct: 23 WDYESHVVEW----GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI- 77
Query: 357 LESFQNEARLLSQIR-HRNIVKLYGFCLHEKCMF---LIYEYMEMGSLFCILRTDEEAVG 412
+ E ++L +R NI+ L + + L++E++ + +T
Sbjct: 78 ----KREIKILENLRGGPNIITLAD-IVKDPVSRTPALVFEHVNNTDFKQLYQTLT---- 128
Query: 413 LDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEF-EAFVADFGIARLLNY 471
D+ R + + AL Y H I+HRD+ +N++++ E + + D+G+A +
Sbjct: 129 -DYDIR-FYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183
Query: 472 DSSNRTLLAGT--YGSIAPELAYTMVVTEKY----DVYSFGVVALEVLMGKHP 518
+ + + PEL +V + Y D++S G + ++ K P
Sbjct: 184 GQE-YNVRVASRYFK--GPEL---LVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 59/283 (20%), Positives = 101/283 (35%), Gaps = 91/283 (32%)
Query: 318 DIKYC----IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQN-EARLLSQIR 371
KY +GTG +G V + SGK ALKK+ + ++N E ++ +
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-------RYKNRELDIMKVLD 58
Query: 372 HRNIVKLYGF---CLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKR----VNIV-- 422
H NI+KL + E+ + + +N++
Sbjct: 59 HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118
Query: 423 -------KGMAH----------------------ALSYLHHHCTPPILHRDISSNNILLN 453
K + A+ ++H I HRDI N+L+N
Sbjct: 119 YVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVN 175
Query: 454 SEFEAF-VADFGIARLLNYDSSN---------RTLLAGTYGSIAPEL-----AYTMVVTE 498
S+ + DFG A+ L + R APEL YT +
Sbjct: 176 SKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYR----------APELMLGATEYTPSI-- 223
Query: 499 KYDVYSFGVVALEVLMGKH--PGELLSSSSSSLDKNIKLIDLL 539
D++S G V E+++GK GE +S+D+ +++I ++
Sbjct: 224 --DLWSIGCVFGELILGKPLFSGE------TSIDQLVRIIQIM 258
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 36/207 (17%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLE-TELASLESFQNEARLLSQIRHRNIVKLYG 380
+G G +G V A + + VALK + R + + E L +RH +I+KLY
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 381 FCLHEKCMFLIYEYMEMGSLFCIL----RTDE-EAVGLDWTKRVNIVKGMAHALSYLHHH 435
+ ++ EY G LF + R E E + + A+ Y H H
Sbjct: 77 VITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEGR--------RFFQQIICAIEYCHRH 127
Query: 436 CTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGS---IAPELAY 492
I+HRD+ N+LL+ +ADFG++ ++ + L + GS APE
Sbjct: 128 K---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN----FLKTSCGSPNYAAPE--- 177
Query: 493 TMVVTEKY-----DVYSFGVVALEVLM 514
++ + Y DV+S G+V L V++
Sbjct: 178 -VINGKLYAGPEVDVWSCGIV-LYVML 202
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 6e-14
Identities = 66/224 (29%), Positives = 101/224 (45%), Gaps = 36/224 (16%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLP----SGKVVALKKLH--RLETELASLESFQNEARLLS 368
E+F++ +GTG YG V+ R +GK+ A+K L + + + E + E ++L
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 369 QIRHRN-IVKL-YGFCLHEKCMFLIYEYMEMGSLFCILRT----DEEAVGLDWTKRVNIV 422
IR +V L Y F K + LI +Y+ G LF L E V I
Sbjct: 114 HIRQSPFLVTLHYAFQTETK-LHLILDYINGGELFTHLSQRERFTEH--------EVQIY 164
Query: 423 KG-MAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTL-LA 480
G + AL +LH I++RDI NILL+S + DFG+++ D + R
Sbjct: 165 VGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC 221
Query: 481 GTYGSIAPEL------AYTMVVTEKYDVYSFGVVALEVLMGKHP 518
GT +AP++ + V D +S GV+ E+L G P
Sbjct: 222 GTIEYMAPDIVRGGDSGHDKAV----DWWSLGVLMYELLTGASP 261
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 43/285 (15%), Positives = 95/285 (33%), Gaps = 58/285 (20%)
Query: 5 RNLVHLDLSDNHF----MGHIPPTLGRLSELKILNLS---LNSLVGNIPSNVGHL----- 52
++ + LS N + + +L+I S + IP + L
Sbjct: 32 DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALL 91
Query: 53 --TQLTTLAIASNRM--NGSILLG--IGSLKVLQVLDLSRNEIG-------------GSI 93
+L T+ ++ N L + L+ L L N +G ++
Sbjct: 92 KCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAV 151
Query: 94 PSTLGHLKWLRSVDLSQNKL----VGPIPSSLGHLTQLTTLNMYNNKL-----DGPIPPE 144
+ LRS+ +N+L + + L T+ M N + + +
Sbjct: 152 NKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEG 211
Query: 145 LMNCSKLRILKLGNNLLSG----SIPSQIGKLQELYYLDLSGNFINGKIPSQLGE----- 195
L C +L++L L +N + ++ + L L L+ ++ + + + +
Sbjct: 212 LAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKL 271
Query: 196 -FSCIDTVDLSMNNLSG-GIPVFVRKVPH-------LDVSGNQFG 231
+ T+ L N + + + L+++GN+F
Sbjct: 272 ENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 32/226 (14%), Positives = 67/226 (29%), Gaps = 47/226 (20%)
Query: 55 LTTLAIASNRMNG----SILLGIGSLKVLQVLDLSRNEIGG----SIPSTLGHLKWLRSV 106
+ ++ + + S+ + ++ + LS N IG + + K L
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 107 DLSQNKL----------VGPIPSSLGHLTQLTTLNMYNNKL--DG--PIPPELMNCSKLR 152
+ S + + +L +L T+ + +N P+ L + L
Sbjct: 66 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125
Query: 153 ILKLGNN-------------LLSGSIPSQIGKLQELYYLDLSGNFINGK----IPSQLGE 195
L L NN L ++ + L + N +
Sbjct: 126 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 185
Query: 196 FSCIDTVDLSMNNLSG-GIPVFV-------RKVPHLDVSGNQFGGE 233
+ TV + N + GI + +++ LD+ N F
Sbjct: 186 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHL 231
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 71.0 bits (175), Expect = 1e-13
Identities = 60/227 (26%), Positives = 101/227 (44%), Gaps = 48/227 (21%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLP----SGKVVALKKLH--------RLETELASLESFQN 362
F++ +G G +G V+ + + ++ A+K L R+ T +
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT--------KM 75
Query: 363 EARLLSQIRHRNIVKL-YGFCLHEKCMFLIYEYMEMGSLFCILRT----DEEAVGLDWTK 417
E +L ++ H IVKL Y F K ++LI +++ G LF L EE
Sbjct: 76 ERDILVEVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEE-------- 126
Query: 418 RVNIVKG-MAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARL-LNYDSSN 475
V +A AL +LH I++RD+ NILL+ E + DFG+++ ++++
Sbjct: 127 DVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 183
Query: 476 RTLLAGTYGSIAPEL----AYTMVVTEKYDVYSFGVVALEVLMGKHP 518
+ GT +APE+ +T D +SFGV+ E+L G P
Sbjct: 184 YSFC-GTVEYMAPEVVNRRGHTQSA----DWWSFGVLMFEMLTGTLP 225
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 55/219 (25%), Positives = 91/219 (41%), Gaps = 34/219 (15%)
Query: 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVA---LKKLHRLETELASLESFQNEARLLSQI 370
DFD +G G +G V R +G+ A L+K + + + E+R+L
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD--EVAHTVTESRVLQNT 62
Query: 371 RHRNIVKLYGFCLH-EKCMFLIYEYMEMGSLFCILRT----DEEAVGLDWTKRVNIVKG- 424
RH + L + + + EY G LF L EE R
Sbjct: 63 RHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE--------RARFYGAE 113
Query: 425 MAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARL-LNYDSSNRTLLAGTY 483
+ AL YLH +++RDI N++L+ + + DFG+ + ++ ++ +T GT
Sbjct: 114 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTP 169
Query: 484 GSIAPEL----AYTMVVTEKYDVYSFGVVALEVLMGKHP 518
+APE+ Y V D + GVV E++ G+ P
Sbjct: 170 EYLAPEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLP 204
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 4e-13
Identities = 49/161 (30%), Positives = 71/161 (44%), Gaps = 22/161 (13%)
Query: 10 LDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAIASNRMNGS 68
LDL T L++L LNL N L + + V LT+L TL +A+N++ S
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA-S 97
Query: 69 ILLGI-GSLKVLQVLDLSRNEIGGSIPS----TLGHLKWLRSVDLSQNKLVGPIPSSLGH 123
+ LG+ L L L L N++ S+PS L LK L L+ N+L S+
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQL-KSLPSGVFDRLTKLKEL---RLNTNQL-----QSIPA 148
Query: 124 -----LTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNN 159
LT L TL++ N+L KL+ + L N
Sbjct: 149 GAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 5e-10
Identities = 43/159 (27%), Positives = 68/159 (42%), Gaps = 14/159 (8%)
Query: 32 KILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGI-GSLKVLQVLDLSRNEIG 90
+ L+L L + LT+LT L + N++ ++ G+ L L L L+ N++
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQL- 95
Query: 91 GSIPS----TLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELM 146
S+P L L L L N+L LT+L L + N+L IP
Sbjct: 96 ASLPLGVFDHLTQLDKL---YLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQS-IPAGAF 151
Query: 147 NC-SKLRILKLGNNLLSGSIPSQI-GKLQELYYLDLSGN 183
+ + L+ L L N L S+P +L +L + L GN
Sbjct: 152 DKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 42/146 (28%), Positives = 66/146 (45%), Gaps = 21/146 (14%)
Query: 93 IPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNC-SKL 151
IP+ L DL L ++ LT+LT LN+ N+L + + + ++L
Sbjct: 33 IPADTEKL------DLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTEL 85
Query: 152 RILKLGNNLLSGSIPSQI-GKLQELYYLDLSGNFINGKIPSQLGEF---SCIDTVDLSMN 207
L L NN L+ S+P + L +L L L GN + +PS G F + + + L+ N
Sbjct: 86 GTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPS--GVFDRLTKLKELRLNTN 141
Query: 208 NLSGGIP--VF--VRKVPHLDVSGNQ 229
L IP F + + L +S NQ
Sbjct: 142 QLQ-SIPAGAFDKLTNLQTLSLSTNQ 166
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 6e-13
Identities = 29/133 (21%), Positives = 53/133 (39%), Gaps = 8/133 (6%)
Query: 10 LDLSDNHFMGHIPPT-LGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAIASNRMNG 67
+ L N IPP +L+ ++LS N + + + L L +L + N++
Sbjct: 37 IRLEQNTI-KVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT- 93
Query: 68 SILLGI-GSLKVLQVLDLSRNEIGGSIPS-TLGHLKWLRSVDLSQNKLVGPIPSSLGHLT 125
+ + L LQ+L L+ N+I + L L + L NKL + L
Sbjct: 94 ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLR 152
Query: 126 QLTTLNMYNNKLD 138
+ T+++ N
Sbjct: 153 AIQTMHLAQNPFI 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-11
Identities = 29/108 (26%), Positives = 45/108 (41%), Gaps = 4/108 (3%)
Query: 80 QVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDG 139
+ L +N I P K LR +DLS N++ P + L L +L +Y NK+
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITE 94
Query: 140 PIPPELM-NCSKLRILKLGNNLLSGSIPSQI-GKLQELYYLDLSGNFI 185
+P L L++L L N ++ + L L L L N +
Sbjct: 95 -LPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKL 140
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-10
Identities = 28/112 (25%), Positives = 48/112 (42%), Gaps = 6/112 (5%)
Query: 75 SLKVLQVLDLSRNEIGGSIPS-TLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMY 133
K L+ +DLS N+I + L+ L S+ L NK+ S L L L +
Sbjct: 54 PYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLN 112
Query: 134 NNKLDGPIPPELM-NCSKLRILKLGNNLLSGSIPSQI-GKLQELYYLDLSGN 183
NK++ + + + L +L L +N L +I L+ + + L+ N
Sbjct: 113 ANKINC-LRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 1e-06
Identities = 21/96 (21%), Positives = 39/96 (40%), Gaps = 16/96 (16%)
Query: 93 IPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPP----ELMNC 148
+P T+ + L QN + P + +L +++ NN++ + P L +
Sbjct: 30 LPETITEI------RLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLRS- 81
Query: 149 SKLRILKLGNNLLSGSIPSQI-GKLQELYYLDLSGN 183
L L L N ++ +P + L L L L+ N
Sbjct: 82 --LNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNAN 114
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 7e-06
Identities = 22/88 (25%), Positives = 41/88 (46%), Gaps = 6/88 (6%)
Query: 3 RLRNLVHLDLSDNHFMGHIPP-TLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAI 60
LR+L L L N + +P L L++L L+ N + + + L L L++
Sbjct: 78 GLRSLNSLVLYGNK-ITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSL 135
Query: 61 ASNRMNGSILLGI-GSLKVLQVLDLSRN 87
N++ +I G L+ +Q + L++N
Sbjct: 136 YDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 70.1 bits (171), Expect = 8e-13
Identities = 53/218 (24%), Positives = 99/218 (45%), Gaps = 31/218 (14%)
Query: 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVA---LKKLHRLETELASLESFQNEARLLSQI 370
DF+ +G G +G V + + ++ A LKK ++ + +E E R+L+
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDD--DVECTMVEKRVLALP 398
Query: 371 -RHRNIVKL-YGFCLHEKCMFLIYEYMEMGSLFC-ILRTD--EEAVGLDWTKRVNIVKGM 425
+ + +L F ++ + + EY+ G L I + +E + + + I
Sbjct: 399 GKPPFLTQLHSCFQTMDRL-YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI---- 453
Query: 426 AHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARL-LNYDSSNRTLLAGTYG 484
L +L I++RD+ +N++L+SE +ADFG+ + + + +T GT
Sbjct: 454 --GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPD 507
Query: 485 SIAPEL----AYTMVVTEKYDVYSFGVVALEVLMGKHP 518
IAPE+ Y V D ++FGV+ E+L G+ P
Sbjct: 508 YIAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAP 541
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 58/213 (27%), Positives = 90/213 (42%), Gaps = 40/213 (18%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGF 381
IG+G +G R + ++VA+K + R A E+ Q E +RH NIV+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIER---GAAIDENVQREIINHRSLRHPNIVRFKEV 84
Query: 382 CLHEKCMFLIYEYMEMGSLFCIL----RTDE-EAVGLDWTKRVNIVKGMAHALSYLHHHC 436
L + +I EY G L+ + R E EA ++ +SY H
Sbjct: 85 ILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQ----QLL----SGVSYCHSMQ 136
Query: 437 TPPILHRDISSNNILLNSEFEAF--VADFGIARLLNYDSSNRTLLAGTYGS---IAPELA 491
I HRD+ N LL+ + DFG ++ S T G+ IAPE
Sbjct: 137 ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPE-- 187
Query: 492 YTMVVTEKY-----DVYSFGVVALEVLM-GKHP 518
+++ ++Y DV+S GV L V++ G +P
Sbjct: 188 --VLLRQEYDGKIADVWSCGVT-LYVMLVGAYP 217
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 64/251 (25%), Positives = 109/251 (43%), Gaps = 39/251 (15%)
Query: 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVA---LKKLHRLETELASLESFQNEARLLSQI 370
+DFD+ IG G Y V RL + ++ A +KK + E ++ Q E + Q
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDE--DIDWVQTEKHVFEQA 66
Query: 371 -RHRNIVKL-YGFCLHEKCMFLIYEYMEMGSLFCILRT----DEEAVGLDWTKRVNIVKG 424
H +V L F + +F + EY+ G L ++ EE
Sbjct: 67 SNHPFLVGLHSCFQTESR-LFFVIEYVNGGDLMFHMQRQRKLPEE--------HARFYSA 117
Query: 425 -MAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARL-LNYDSSNRTLLAGT 482
++ AL+YLH I++RD+ +N+LL+SE + D+G+ + L + T GT
Sbjct: 118 EISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGT 173
Query: 483 YGSIAPEL----AYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNI----K 534
IAPE+ Y V D ++ GV+ E++ G+ P +++ SS + +
Sbjct: 174 PNYIAPEILRGEDYGFSV----DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ 229
Query: 535 LIDLLDPRLPP 545
+I R+P
Sbjct: 230 VILEKQIRIPR 240
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 52/276 (18%), Positives = 90/276 (32%), Gaps = 49/276 (17%)
Query: 4 LRNLVHLDLSDNHF----MGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHL------- 52
L+ + L D I L L LNL N L V +
Sbjct: 27 LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELG---DVGVHCVLQGLQTP 83
Query: 53 -TQLTTLAIASNRMN----GSILLGIGSLKVLQVLDLSRNEIGGS----IPSTLGHLKW- 102
++ L++ + + G + + +L LQ L LS N +G + + L +
Sbjct: 84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCR 143
Query: 103 LRSVDLSQNKL----VGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELM-----NCSKLRI 153
L + L L P+ S L L + NN ++ L + +L
Sbjct: 144 LEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEA 203
Query: 154 LKLGNNLLS----GSIPSQIGKLQELYYLDLSGNFINGK-----IPSQLGEFSCIDTVDL 204
LKL + ++ + + L L L N + P L S + T+ +
Sbjct: 204 LKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWI 263
Query: 205 SMNNLSG-GIPVFVRKVP------HLDVSGNQFGGE 233
++ G R + L ++GN+ G E
Sbjct: 264 WECGITAKGCGDLCRVLRAKESLKELSLAGNELGDE 299
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 44/260 (16%), Positives = 81/260 (31%), Gaps = 51/260 (19%)
Query: 5 RNLVHLDLSDNHFM-GHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASN 63
++ LD+ L L + +++ L L T+ I+S
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGL-----------TEARCKDISS- 50
Query: 64 RMNGSILLGIGSLKVLQVLDLSRNEIGGS----IPSTLGHLKW-LRSVDLSQNKL----V 114
+ L L+L NE+G + L ++ + L L
Sbjct: 51 --------ALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGC 102
Query: 115 GPIPSSLGHLTQLTTLNMYNNKLDGP-----IPPELMNCSKLRILKLGNNLLSGSIPSQI 169
G + S+L L L L++ +N L L +L L+L LS + +
Sbjct: 103 GVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 162
Query: 170 GKL----QELYYLDLSGNFINGK----IPSQLGEFSC-IDTVDLSMNNLSG-GIPVFVRK 219
+ + L +S N IN + L + C ++ + L ++
Sbjct: 163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGI 222
Query: 220 VP------HLDVSGNQFGGE 233
V L + N+ G
Sbjct: 223 VASKASLRELALGSNKLGDV 242
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 7e-11
Identities = 51/267 (19%), Positives = 88/267 (32%), Gaps = 47/267 (17%)
Query: 6 NLVHLDLSDNHF----MGHIPPTLGRLSELKILNLSLNSL----VGNIPSNVGH-LTQLT 56
L L L + + + L+ L L N L + + + H ++L
Sbjct: 200 QLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLR 259
Query: 57 TLAIASNRMN----GSILLGIGSLKVLQVLDLSRNEIGGS----IPSTLGHLKW-LRSVD 107
TL I + G + + + + L+ L L+ NE+G + TL L S+
Sbjct: 260 TLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLW 319
Query: 108 LSQNKL----VGPIPSSLGHLTQLTTLNMYNNKLDGPIPPEL-----MNCSKLRILKLGN 158
+ S L L L + NN+L+ EL S LR+L L +
Sbjct: 320 VKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLAD 379
Query: 159 NLLS----GSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIP 214
+S S+ + + L LDLS N + D + L +
Sbjct: 380 CDVSDSSCSSLAATLLANHSLRELDLSNNCLG----------------DAGILQLVESVR 423
Query: 215 VFVRKVPHLDVSGNQFGGEIPTTLANV 241
+ L + + E+ L +
Sbjct: 424 QPGCLLEQLVLYDIYWSEEMEDRLQAL 450
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 40/177 (22%), Positives = 67/177 (37%), Gaps = 27/177 (15%)
Query: 5 RNLVHLDLSDNHF----MGHIPPTLGR-LSELKILNLSLNSL----VGNIPSNVGHLTQL 55
+L L L+ N + TL +L+ L + S + S + L
Sbjct: 284 ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFL 343
Query: 56 TTLAIASNRM--NGSILLGIG---SLKVLQVLDLSRNEIG----GSIPSTLGHLKWLRSV 106
L I++NR+ G L G VL+VL L+ ++ S+ +TL LR +
Sbjct: 344 LELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLREL 403
Query: 107 DLSQNKL----VGPIPSSLGHL-TQLTTLNMYNNKLDGPIPPELM----NCSKLRIL 154
DLS N L + + S+ L L +Y+ + L + LR++
Sbjct: 404 DLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 460
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 61/220 (27%), Positives = 96/220 (43%), Gaps = 35/220 (15%)
Query: 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVA---LKKLHRLETELASLESFQNEARLLSQ- 369
EDF + +G G +G V+ A + + A LKK L + +E E R+LS
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD--DVECTMVEKRVLSLA 74
Query: 370 IRHRNIVKL-YGFCLHEKCMFLIYEYMEMGSLFCIL----RTDEEAVGLDWTKRVNIVKG 424
H + + F E +F + EY+ G L + + D R
Sbjct: 75 WEHPFLTHMFCTFQTKEN-LFFVMEYLNGGDLMYHIQSCHKFDLS--------RATFYAA 125
Query: 425 -MAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARL-LNYDSSNRTLLAGT 482
+ L +LH I++RD+ +NILL+ + +ADFG+ + + D+ T GT
Sbjct: 126 EIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGT 181
Query: 483 YGSIAPEL----AYTMVVTEKYDVYSFGVVALEVLMGKHP 518
IAPE+ Y V D +SFGV+ E+L+G+ P
Sbjct: 182 PDYIAPEILLGQKYNHSV----DWWSFGVLLYEMLIGQSP 217
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 66.4 bits (161), Expect = 4e-12
Identities = 33/241 (13%), Positives = 64/241 (26%), Gaps = 53/241 (21%)
Query: 305 ITFQDMIEATEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEA 364
+ F + TE IG G +G V++ VA+K + +L + +
Sbjct: 11 VPFSHCL-PTEKLQRCEKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTFE 68
Query: 365 RLLSQI---------------RHRNIVKLYGFCLH------------------------- 384
+L +I R + L
Sbjct: 69 EILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDR 128
Query: 385 -----EKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPP 439
+ +F++ E+ G +RT +I+ + +L+
Sbjct: 129 PDFFKDDQLFIVLEFEFGGIDLEQMRTKL----SSLATAKSILHQLTASLAVAEASL--R 182
Query: 440 ILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEK 499
HRD+ N+LL + + S + Y E +V +
Sbjct: 183 FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDV 242
Query: 500 Y 500
Sbjct: 243 S 243
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 64/251 (25%), Positives = 109/251 (43%), Gaps = 39/251 (15%)
Query: 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVA---LKKLHRLETELASLESFQNEARLLSQI 370
+DFD+ IG G Y V RL + ++ A +KK + E ++ Q E + Q
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDE--DIDWVQTEKHVFEQA 109
Query: 371 -RHRNIVKL-YGFCLHEKCMFLIYEYMEMGSLFCILRT----DEEAVGLDWTKRVNIVKG 424
H +V L F + +F + EY+ G L ++ EE
Sbjct: 110 SNHPFLVGLHSCFQTESR-LFFVIEYVNGGDLMFHMQRQRKLPEE--------HARFYSA 160
Query: 425 -MAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARL-LNYDSSNRTLLAGT 482
++ AL+YLH I++RD+ +N+LL+SE + D+G+ + L + T GT
Sbjct: 161 EISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGT 216
Query: 483 YGSIAPEL----AYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNI----K 534
IAPE+ Y V D ++ GV+ E++ G+ P +++ SS + +
Sbjct: 217 PNYIAPEILRGEDYGFSV----DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ 272
Query: 535 LIDLLDPRLPP 545
+I R+P
Sbjct: 273 VILEKQIRIPR 283
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 6e-12
Identities = 31/134 (23%), Positives = 61/134 (45%), Gaps = 9/134 (6%)
Query: 10 LDLSDNHFMGHIPPT--LGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAIASNRMN 66
L L++N F + T +L +L+ +N S N + +I + + + + SNR+
Sbjct: 37 LRLNNNEF-TVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLE 94
Query: 67 GSILLGI-GSLKVLQVLDLSRNEIGGSIPS-TLGHLKWLRSVDLSQNKLVGPIPSSLGHL 124
++ + L+ L+ L L N I + + + L +R + L N++ P + L
Sbjct: 95 -NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTL 152
Query: 125 TQLTTLNMYNNKLD 138
L+TLN+ N +
Sbjct: 153 HSLSTLNLLANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 4e-11
Identities = 22/110 (20%), Positives = 46/110 (41%), Gaps = 7/110 (6%)
Query: 80 QVLDLSRNEIGGSIPST--LGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKL 137
L L+ NE + +T L LR ++ S NK+ + + + + + +N+L
Sbjct: 35 AELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRL 93
Query: 138 DGPIPPELM-NCSKLRILKLGNNLLSGSIPSQI-GKLQELYYLDLSGNFI 185
+ + ++ L+ L L +N ++ + + L + L L N I
Sbjct: 94 EN-VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQI 141
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 4e-05
Identities = 17/88 (19%), Positives = 37/88 (42%), Gaps = 6/88 (6%)
Query: 3 RLRNLVHLDLSDNHFMGHIPP-TLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAI 60
+ + L+ N + ++ L LK L L N + + ++ L+ + L++
Sbjct: 79 GASGVNEILLTSNR-LENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSL 136
Query: 61 ASNRMNGSILLGI-GSLKVLQVLDLSRN 87
N++ ++ G +L L L+L N
Sbjct: 137 YDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 7e-12
Identities = 60/220 (27%), Positives = 96/220 (43%), Gaps = 35/220 (15%)
Query: 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVA---LKKLHRLETELASLESFQNEARLLSQ- 369
DF IG G +G V AR A L+K L+ + + +E +L +
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKK--EEKHIMSERNVLLKN 95
Query: 370 IRHRNIVKL-YGFCLHEKCMFLIYEYMEMGSLFCILRT----DEEAVGLDWTKRVNI-VK 423
++H +V L + F +K ++ + +Y+ G LF L+ E R
Sbjct: 96 VKHPFLVGLHFSFQTADK-LYFVLDYINGGELFYHLQRERCFLEP--------RARFYAA 146
Query: 424 GMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARL-LNYDSSNRTLLAGT 482
+A AL YLH I++RD+ NILL+S+ + DFG+ + + ++S+ T GT
Sbjct: 147 EIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST-FCGT 202
Query: 483 YGSIAPEL----AYTMVVTEKYDVYSFGVVALEVLMGKHP 518
+APE+ Y V D + G V E+L G P
Sbjct: 203 PEYLAPEVLHKQPYDRTV----DWWCLGAVLYEMLYGLPP 238
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 2e-11
Identities = 53/220 (24%), Positives = 97/220 (44%), Gaps = 35/220 (15%)
Query: 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVA---LKKLHRLETELASLESFQNEARLLSQI 370
DF+ +G G +G V + + ++ A LKK ++ + +E E R+L+
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDD--DVECTMVEKRVLALP 77
Query: 371 -RHRNIVKL-YGFCLHEKCMFLIYEYMEMGSLFCIL----RTDEEAVGLDWTKRVNIVKG 424
+ + +L F ++ ++ + EY+ G L + R E
Sbjct: 78 GKPPFLTQLHSCFQTMDR-LYFVMEYVNGGDLMYHIQQVGRFKEP--------HAVFYAA 128
Query: 425 -MAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARL-LNYDSSNRTLLAGT 482
+A L +L I++RD+ +N++L+SE +ADFG+ + + + +T GT
Sbjct: 129 EIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGT 184
Query: 483 YGSIAPEL----AYTMVVTEKYDVYSFGVVALEVLMGKHP 518
IAPE+ Y V D ++FGV+ E+L G+ P
Sbjct: 185 PDYIAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAP 220
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 2e-11
Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 35/220 (15%)
Query: 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVA---LKKLHRLETELASLESFQNEARLLSQI 370
++F+ +G G +G V AR+ +G + A LKK L+ + +E E R+LS
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDD--DVECTMTEKRILSLA 80
Query: 371 -RHRNIVKL-YGFCLHEKCMFLIYEYMEMGSLFCIL----RTDEEAVGLDWTKRVNIVKG 424
H + +L F ++ +F + E++ G L + R DE R
Sbjct: 81 RNHPFLTQLFCCFQTPDR-LFFVMEFVNGGDLMFHIQKSRRFDEA--------RARFYAA 131
Query: 425 -MAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARL-LNYDSSNRTLLAGT 482
+ AL +LH I++RD+ +N+LL+ E +ADFG+ + + + T GT
Sbjct: 132 EIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-FCGT 187
Query: 483 YGSIAPEL----AYTMVVTEKYDVYSFGVVALEVLMGKHP 518
IAPE+ Y V D ++ GV+ E+L G P
Sbjct: 188 PDYIAPEILQEMLYGPAV----DWWAMGVLLYEMLCGHAP 223
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 8e-11
Identities = 35/164 (21%), Positives = 62/164 (37%), Gaps = 17/164 (10%)
Query: 28 LSELKILNLSLN-SLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSR 86
+E + + L + + + + L LA+++N + + + ++ L++L L R
Sbjct: 22 ATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNI--EKISSLSGMENLRILSLGR 79
Query: 87 NEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPE-L 145
N I I + L + +S N++ S + L L L M NNK+ + L
Sbjct: 80 NLI-KKIENLDAVADTLEELWISYNQIA--SLSGIEKLVNLRVLYMSNNKITNWGEIDKL 136
Query: 146 MNCSKLRILKLGNNLLSGSIPSQ----------IGKLQELYYLD 179
KL L L N L + +L L LD
Sbjct: 137 AALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-10
Identities = 39/141 (27%), Positives = 58/141 (41%), Gaps = 18/141 (12%)
Query: 3 RLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIAS 62
L+ HL LS N+ I L + L+IL+L N + I + L L I+
Sbjct: 46 TLKACKHLALSTNNI-EKISS-LSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISY 102
Query: 63 NRMNGSILLGIGSLKVLQVLDLSRNEIG--GSIPSTLGHLKWLRSVDLSQNKLVGPIPSS 120
N++ + L GI L L+VL +S N+I G I L L L + L+ N L +
Sbjct: 103 NQI--ASLSGIEKLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGNPLYNDYKEN 159
Query: 121 ----------LGHLTQLTTLN 131
+ L L L+
Sbjct: 160 NATSEYRIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 5e-10
Identities = 35/134 (26%), Positives = 58/134 (43%), Gaps = 11/134 (8%)
Query: 7 LVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMN 66
V L + TL L K L LS N++ I S++ + L L++ N +
Sbjct: 27 KVELHGMIPPI-EKMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLI- 82
Query: 67 GSILLGIGSL-KVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKL--VGPIPSSLGH 123
+ + ++ L+ L +S N+I + S + L LR + +S NK+ G I L
Sbjct: 83 -KKIENLDAVADTLEELWISYNQI--ASLSGIEKLVNLRVLYMSNNKITNWGEI-DKLAA 138
Query: 124 LTQLTTLNMYNNKL 137
L +L L + N L
Sbjct: 139 LDKLEDLLLAGNPL 152
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 8e-10
Identities = 36/146 (24%), Positives = 59/146 (40%), Gaps = 14/146 (9%)
Query: 69 ILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLT 128
+ + +LK + L LS N I I S+L ++ LR + L +N + I + L
Sbjct: 40 MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIKK-IENLDAVADTLE 96
Query: 129 TLNMYNN---KLDGPIPPELMNCSKLRILKLGNNLLS--GSIPSQIGKLQELYYLDLSGN 183
L + N L G + LR+L + NN ++ G I ++ L +L L L+GN
Sbjct: 97 ELWISYNQIASLSG-----IEKLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGN 150
Query: 184 FINGKIPSQLGEFSCIDTVDLSMNNL 209
+ V + NL
Sbjct: 151 PLYNDYKENNATSEYRIEVVKRLPNL 176
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-09
Identities = 33/129 (25%), Positives = 51/129 (39%), Gaps = 11/129 (8%)
Query: 82 LDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIP--SSLGHLTQLTTLNMYNNKLDG 139
L I + +TL LK + + LS N I SSL + L L++ N +
Sbjct: 30 LHGMIPPIEK-MDATLSTLKACKHLALSTNN----IEKISSLSGMENLRILSLGRNLIKK 84
Query: 140 PIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFING-KIPSQLGEFSC 198
I L L + N ++ S+ S I KL L L +S N I +L
Sbjct: 85 -IENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDK 141
Query: 199 IDTVDLSMN 207
++ + L+ N
Sbjct: 142 LEDLLLAGN 150
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 4e-10
Identities = 53/263 (20%), Positives = 107/263 (40%), Gaps = 52/263 (19%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALK--KLHRLETELASLESFQNEARLLSQIR-------- 371
+G G + +V+ A+ + + VA+K + ++ TE A ++E +LL ++
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAA-----EDEIKLLQRVNDADNTKED 81
Query: 372 ---HRNIVKLYGFCLHEKC----MFLIYEYMEMGSLFCIL-RTDEEAVGLDWTKRVNIVK 423
+I+KL H+ + +++E + +L ++ + + + L + K+ I K
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQ--ISK 138
Query: 424 GMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAF------VADFGIARLLNYDSSNRT 477
+ L Y+H C I+H DI N+L+ +AD G A + + T
Sbjct: 139 QLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC---WYDEHYT 193
Query: 478 LLAGTYGSIAPE----LAYTMVVTEKYDVYSFGVVALEVLMGKH--PGELLSSSSSSLDK 531
T +PE + D++S + E++ G + S + D
Sbjct: 194 NSIQTREYRSPEVLLGAPWGCGA----DIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249
Query: 532 NIKLIDLLDPRLPPPGDQMIRQG 554
++I+LL P ++R G
Sbjct: 250 IAQIIELLGE--LPS--YLLRNG 268
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 5e-10
Identities = 26/111 (23%), Positives = 44/111 (39%), Gaps = 4/111 (3%)
Query: 27 RLSELKILNLSLNSL-VGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLS 85
+ ++ L L G I L L++ + + + + L L+ L+LS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL--ISVSNLPKLPKLKKLELS 79
Query: 86 RNEIGGSIPSTLGHLKWLRSVDLSQNKLVGP-IPSSLGHLTQLTTLNMYNN 135
N I G + L L ++LS NKL L L L +L+++N
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-09
Identities = 27/104 (25%), Positives = 39/104 (37%), Gaps = 4/104 (3%)
Query: 81 VLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGP 140
VLD ++ G I L + L L+ S+L L +L L + N++ G
Sbjct: 30 VLDNCKSNDG-KIEGLTAEFVNLEFLSLINVGLI--SVSNLPKLPKLKKLELSENRIFGG 86
Query: 141 IPPELMNCSKLRILKLGNNLLSG-SIPSQIGKLQELYYLDLSGN 183
+ L L L N L S + KL+ L LDL
Sbjct: 87 LDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-08
Identities = 40/143 (27%), Positives = 62/143 (43%), Gaps = 20/143 (13%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSL--VGNIPSNVGHLTQLTTLAIA 61
+R LV LD ++ G I L+ L+L L V N+P L +L L ++
Sbjct: 26 VRELV-LDNCKSN-DGKIEGLTAEFVNLEFLSLINVGLISVSNLP----KLPKLKKLELS 79
Query: 62 SNRMNGSILLGIGSLKVLQVLDLSRNEIGG-SIPSTLGHLKWLRSVDLSQNKLVGPI--- 117
NR+ G + + L L L+LS N++ S L L+ L+S+DL +
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC----EVTNL 135
Query: 118 ----PSSLGHLTQLTTLNMYNNK 136
S L QLT L+ Y+ +
Sbjct: 136 NDYRESVFKLLPQLTYLDGYDRE 158
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 5e-07
Identities = 26/89 (29%), Positives = 41/89 (46%), Gaps = 3/89 (3%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIA 61
NL L L + + + L +L +LK L LS N + G + L LT L ++
Sbjct: 46 AEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLS 103
Query: 62 SNRMNG-SILLGIGSLKVLQVLDLSRNEI 89
N++ S L + L+ L+ LDL E+
Sbjct: 104 GNKLKDISTLEPLKKLECLKSLDLFNCEV 132
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-06
Identities = 28/107 (26%), Positives = 44/107 (41%), Gaps = 4/107 (3%)
Query: 103 LRSVDLSQNKL-VGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLL 161
+R + L K G I L L++ N L + L KL+ L+L N +
Sbjct: 26 VRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-VSN-LPKLPKLKKLELSENRI 83
Query: 162 SGSIPSQIGKLQELYYLDLSGNFING-KIPSQLGEFSCIDTVDLSMN 207
G + KL L +L+LSGN + L + C+ ++DL
Sbjct: 84 FGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 6e-04
Identities = 25/88 (28%), Positives = 37/88 (42%), Gaps = 3/88 (3%)
Query: 124 LTQLTTLNMYNNKLD-GPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSG 182
+ L + N K + G I L L L N L S+ S + KL +L L+LS
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSE 80
Query: 183 NFINGKIPSQLGEFSCIDTVDLSMNNLS 210
N I G + + + ++LS N L
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 6e-10
Identities = 24/111 (21%), Positives = 46/111 (41%), Gaps = 4/111 (3%)
Query: 27 RLSELKILNLSLNSL-VGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLS 85
S++K L L + G + +L L+ + + + + + L L+ L+LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL--TSIANLPKLNKLKKLELS 72
Query: 86 RNEIGGSIPSTLGHLKWLRSVDLSQNKLVGP-IPSSLGHLTQLTTLNMYNN 135
N + G + L ++LS NK+ L L L +L+++N
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-08
Identities = 26/104 (25%), Positives = 41/104 (39%), Gaps = 4/104 (3%)
Query: 81 VLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGP 140
VLD SR+ G + + L + L ++L L +L L + +N++ G
Sbjct: 23 VLDNSRSNEG-KLEGLTDEFEELEFLSTINVGLT--SIANLPKLNKLKKLELSDNRVSGG 79
Query: 141 IPPELMNCSKLRILKLGNNLLSG-SIPSQIGKLQELYYLDLSGN 183
+ C L L L N + S + KL+ L LDL
Sbjct: 80 LEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-08
Identities = 28/110 (25%), Positives = 49/110 (44%), Gaps = 8/110 (7%)
Query: 6 NLVHLDLSDNHF-MGHIPPTLGRLSELKILNLSLNSL--VGNIPSNVGHLTQLTTLAIAS 62
++ L L ++ G + EL+ L+ L + N+P L +L L ++
Sbjct: 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLP----KLNKLKKLELSD 73
Query: 63 NRMNGSILLGIGSLKVLQVLDLSRNEIGG-SIPSTLGHLKWLRSVDLSQN 111
NR++G + + L L+LS N+I S L L+ L+S+DL
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-07
Identities = 29/124 (23%), Positives = 50/124 (40%), Gaps = 14/124 (11%)
Query: 88 EIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNN---KLDGPIPPE 144
E+ PS + L +D S++ G + +L L+ N +
Sbjct: 10 ELRNRTPSDVKEL----VLDNSRSNE-GKLEGLTDEFEELEFLSTINVGLTSIAN----- 59
Query: 145 LMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFING-KIPSQLGEFSCIDTVD 203
L +KL+ L+L +N +SG + K L +L+LSGN I L + + ++D
Sbjct: 60 LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLD 119
Query: 204 LSMN 207
L
Sbjct: 120 LFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-06
Identities = 23/88 (26%), Positives = 39/88 (44%), Gaps = 3/88 (3%)
Query: 3 RLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIAS 62
L L + + I L +L++LK L LS N + G + LT L ++
Sbjct: 40 EFEELEFLSTINVG-LTSIAN-LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSG 97
Query: 63 NRMNG-SILLGIGSLKVLQVLDLSRNEI 89
N++ S + + L+ L+ LDL E+
Sbjct: 98 NKIKDLSTIEPLKKLENLKSLDLFNCEV 125
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 5e-04
Identities = 20/89 (22%), Positives = 41/89 (46%), Gaps = 3/89 (3%)
Query: 123 HLTQLTTLNMYNNKLD-GPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLS 181
+ + L + N++ + G + +L L N L+ SI + + KL +L L+LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72
Query: 182 GNFINGKIPSQLGEFSCIDTVDLSMNNLS 210
N ++G + + + ++LS N +
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 38.9 bits (91), Expect = 9e-04
Identities = 23/88 (26%), Positives = 42/88 (47%), Gaps = 6/88 (6%)
Query: 147 NCSKLRILKL-GNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLS 205
S ++ L L + G + + +EL +L + I + L + + + ++LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72
Query: 206 MNNLSGGIPVFVRKVP---HLDVSGNQF 230
N +SGG+ V K P HL++SGN+
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKI 100
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 4e-09
Identities = 36/128 (28%), Positives = 55/128 (42%), Gaps = 5/128 (3%)
Query: 10 LDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAIASNRMNGS 68
L L DN P L LK L L N L +P V LTQLT L + +N++
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT-V 102
Query: 69 ILLGI-GSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQL 127
+ + L L+ L + N++ +P + L L + L QN+L + L+ L
Sbjct: 103 LPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSL 161
Query: 128 TTLNMYNN 135
T ++ N
Sbjct: 162 THAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 41/159 (25%), Positives = 56/159 (35%), Gaps = 39/159 (24%)
Query: 32 KILNLSLNSLVGNIPSNVGH-LTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIG 90
+IL L N + + V L L L + SN+ L L +G
Sbjct: 43 QILYLHDNQIT-KLEPGVFDSLINLKELYLGSNQ--------------LGAL-----PVG 82
Query: 91 GSIPSTLGHLKWLRSVDLSQNKLVGPIPSSL-----GHLTQLTTLNMYNNKLDGPIPPEL 145
+ +L L L L N+L + L L L L M NKL +P +
Sbjct: 83 --VFDSLTQLTVLD---LGTNQL-----TVLPSAVFDRLVHLKELFMCCNKLTE-LPRGI 131
Query: 146 MNCSKLRILKLGNNLLSGSIPSQI-GKLQELYYLDLSGN 183
+ L L L N L SIP +L L + L GN
Sbjct: 132 ERLTHLTHLALDQNQLK-SIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 7e-05
Identities = 25/96 (26%), Positives = 38/96 (39%), Gaps = 16/96 (16%)
Query: 93 IPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKL----DGPIPPELMNC 148
IP+ L L N++ P L L L + +N+L G + L
Sbjct: 38 IPTNAQIL------YLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVG-VFDSLTQ- 89
Query: 149 SKLRILKLGNNLLSGSIPSQI-GKLQELYYLDLSGN 183
L +L LG N L+ +PS + +L L L + N
Sbjct: 90 --LTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCN 122
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 6e-09
Identities = 45/191 (23%), Positives = 85/191 (44%), Gaps = 24/191 (12%)
Query: 3 RLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVG---HLTQLTTLA 59
L ++ + +++ + L ++ L L N L ++ LT LT L
Sbjct: 39 ELNSIDQIIANNSDIKS--VQGIQYLPNVRYLALGGNKL-----HDISALKELTNLTYLI 91
Query: 60 IASNRMNGSILLGI-GSLKVLQVLDLSRNEIGGSIPSTL-GHLKWLRSVDLSQNKLVGPI 117
+ N++ S+ G+ L L+ L L N++ S+P + L L ++L+ N+L
Sbjct: 92 LTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQSLP 149
Query: 118 PSSLGHLTQLTTLNMYNNKLDGPIPPELMN-CSKLRILKLGNNLLSGSIPS----QIGKL 172
LT LT L++ N+L +P + + ++L+ L+L N L S+P ++ L
Sbjct: 150 KGVFDKLTNLTELDLSYNQLQS-LPEGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSL 207
Query: 173 QELYYLDLSGN 183
Q ++ L N
Sbjct: 208 QYIW---LHDN 215
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 56.7 bits (136), Expect = 6e-09
Identities = 18/99 (18%), Positives = 38/99 (38%), Gaps = 2/99 (2%)
Query: 62 SNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPS-TLGHLKWLRSVDLSQNKLVGPIPSS 120
+ L + + L L + + + L L LR++ + ++ L P +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 121 LGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNN 159
+L+ LN+ N L+ + + + L+ L L N
Sbjct: 76 FHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.9 bits (121), Expect = 6e-07
Identities = 19/96 (19%), Positives = 37/96 (38%), Gaps = 2/96 (2%)
Query: 44 NIPSNVGHLTQLTTLAIASNRMNGSILLG-IGSLKVLQVLDLSRNEIGGSIPSTLGHLKW 102
+ ++ LT L I + + + L + L L+ L + ++ + P
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 103 LRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLD 138
L ++LS N L ++ L+ L L + N L
Sbjct: 82 LSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.5 bits (107), Expect = 3e-05
Identities = 20/88 (22%), Positives = 36/88 (40%), Gaps = 4/88 (4%)
Query: 4 LRNLVHLDLSDNHFMGHIPP-TLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAIA 61
NL L + + + H+ L L EL+ L + + L + + +L+ L ++
Sbjct: 30 AENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLS 88
Query: 62 SNRMNGSILLGIGSLKVLQVLDLSRNEI 89
N + S+ LQ L LS N +
Sbjct: 89 FNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 57.9 bits (139), Expect = 7e-09
Identities = 96/585 (16%), Positives = 174/585 (29%), Gaps = 201/585 (34%)
Query: 28 LSELK-ILNLSLNSLVGNIPSNVGHLTQLTTLAIAS-------NRMNGSIL-LGIGS--- 75
L EL+ N+ ++ ++G G T +A+ +M+ I L + +
Sbjct: 144 LLELRPAKNVLIDGVLG-----SGK----TWVALDVCLSYKVQCKMDFKIFWLNLKNCNS 194
Query: 76 ----LKVLQVL-------DLSRNEIGGSIPSTLGHLK-WLRSVDLSQNKLVGPIPSSLGH 123
L++LQ L SR++ +I + ++ LR L ++K P + L
Sbjct: 195 PETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELR--RLLKSK---PYENCL-- 247
Query: 124 LTQLTTLNMYN----NKLDGPIPPELMNCSKLRIL-----KLGNNLLSGSIPSQI----- 169
L LN+ N N + +C +IL K + LS + + I
Sbjct: 248 ---LVLLNVQNAKAWNAFNL-------SC---KILLTTRFKQVTDFLSAATTTHISLDHH 294
Query: 170 -GKLQELYYLDLSGNFINGKIPSQLGEFSC-IDTVDLSMNNLSGGIPVFVRKVPH----- 222
L L +++ + P L + LS+ I +R
Sbjct: 295 SMTLTPDEVKSLLLKYLDCR-PQDLPREVLTTNPRRLSI------IAESIRDGLATWDNW 347
Query: 223 LDVSGNQFGGEIPTTLANVPPPHHKTIATGLVAIILAMVAFLAL-IFGILIIRRRRDKEI 281
V+ ++ I ++L + P ++ + F L +F I
Sbjct: 348 KHVNCDKLTTIIESSLNVLEPAEYRKM-------------FDRLSVF-------PPSAHI 387
Query: 282 EPTGTVEITKCADEIAIWNYDGRITFQDMIEATEDFDIKYCIGTGGYGSVYRARLPSGKV 341
PT + + IW + D++ + S
Sbjct: 388 -PTILLSL--------IWFD---VIKSDVMVVVNKLHKYSLVEKQPKESTIS-------- 427
Query: 342 VALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLY----GFCLHEKCMFLIYEYMEM 397
+ + EL +NE L HR+IV Y F + + +Y
Sbjct: 428 -----IPSIYLEL--KVKLENEYAL-----HRSIVDHYNIPKTFDSDDLIPPYLDQY--- 472
Query: 398 GSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFE 457
F S++ HH + + + F
Sbjct: 473 ---FY---------------------------SHIGHHLK--------NIEHPERMTLFR 494
Query: 458 AFVADFG-IARLLNYDSSNRTLLAGTYGSIAPELA----YTMVVTEKYDVYSFGVVALEV 512
DF + + + +DS+ GSI L Y + + Y V A+
Sbjct: 495 MVFLDFRFLEQKIRHDSTAW----NASGSILNTLQQLKFYKPYICDNDPKYERLVNAILD 550
Query: 513 LMGKHPGELLSSSSSSLDKNIKLIDLLDPRLPPPGDQMI----RQ 553
+ K L+ S K DLL L + + +Q
Sbjct: 551 FLPKIEENLICS---------KYTDLLRIALMAEDEAIFEEAHKQ 586
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.9 bits (100), Expect = 3e-04
Identities = 54/377 (14%), Positives = 106/377 (28%), Gaps = 125/377 (33%)
Query: 213 IPVFVRK-VPHLDVSGNQFGGEIPTTLANVPPPHHKTIATGLVAIILAM---VAFLALIF 268
+ VF V + D ++ ++ ++ + I+ V+ +F
Sbjct: 22 LSVFEDAFVDNFDCK------DVQDMPKSI-------LSKEEIDHIIMSKDAVSGTLRLF 68
Query: 269 GILIIRRRRDKEIEPTGTVEITKCADEIAIWNYDGRITFQDMIEATEDFDIKYCIGTGGY 328
L K V+ K +E+ NY F ++ + + + T Y
Sbjct: 69 WTL-----LSK---QEEMVQ--KFVEEVLRINYK----F--LMSPIKTEQRQPSMMTRMY 112
Query: 329 GSVYRARLPSGKVVALKKLH--RLETELASLESFQNEARLLSQIRHRNIVKLYGF----- 381
R RL + V K + RL+ L + L ++R V + G
Sbjct: 113 IE-QRDRLYNDNQV-FAKYNVSRLQ-PYLKLR------QALLELRPAKNVLIDGVLGSGK 163
Query: 382 -CL---------HEKCM-FLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALS 430
+ + M F I+ ++ + + C + E + + I S
Sbjct: 164 TWVALDVCLSYKVQCKMDFKIF-WLNLKN--C--NSPETVLEMLQKLLYQIDPNWT---S 215
Query: 431 YLHHHCTPP------------------------ILHRDISSNNILLNSEFEAFVADFGIA 466
H +L ++ + AF +
Sbjct: 216 RSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVL-LNVQNAKAW-----NAF--NLSC- 266
Query: 467 RLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALE-VLMGKHPGELLSSS 525
+ LL + VT+ + ++L+ M P E+ S
Sbjct: 267 ---------KILLTTRFKQ----------VTDFLSAATTTHISLDHHSMTLTPDEVKSLL 307
Query: 526 SSSLDKNIKLIDLLDPR 542
L + + DL PR
Sbjct: 308 LKYL--DCRPQDL--PR 320
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 7e-09
Identities = 26/113 (23%), Positives = 42/113 (37%), Gaps = 4/113 (3%)
Query: 72 GIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLN 131
+ + LDL +I I + L ++D S N++ + L +L TL
Sbjct: 14 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLL 70
Query: 132 MYNNKLDGPIPPELMNCSKLRILKLGNNLLSG-SIPSQIGKLQELYYLDLSGN 183
+ NN++ L L L NN L + L+ L YL + N
Sbjct: 71 VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-06
Identities = 27/132 (20%), Positives = 50/132 (37%), Gaps = 14/132 (10%)
Query: 81 VLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGH-LTQLTTLNMYNN---K 136
++ L+ I + + + R +DL K+ P+ +LG L Q ++ +N K
Sbjct: 1 MVKLTAELIEQA--AQYTNAVRDRELDLRGYKI--PVIENLGATLDQFDAIDFSDNEIRK 56
Query: 137 LDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFING-KIPSQLGE 195
LDG +L+ L + NN + L +L L L+ N + L
Sbjct: 57 LDG-----FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLAS 111
Query: 196 FSCIDTVDLSMN 207
+ + + N
Sbjct: 112 LKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 4e-06
Identities = 27/115 (23%), Positives = 42/115 (36%), Gaps = 10/115 (8%)
Query: 4 LRNLVHLDLSDNHFMGHIPP--TLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIA 61
L +D SDN I L LK L ++ N + L LT L +
Sbjct: 41 LDQFDAIDFSDNE----IRKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILT 96
Query: 62 SNRMNG-SILLGIGSLKVLQVLDLSRNEI---GGSIPSTLGHLKWLRSVDLSQNK 112
+N + L + SLK L L + RN + + + +R +D + K
Sbjct: 97 NNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVK 151
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 2e-04
Identities = 12/92 (13%), Positives = 30/92 (32%), Gaps = 3/92 (3%)
Query: 119 SSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYL 178
+ + + L++ K+ I + + +N + + L+ L L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTL 69
Query: 179 DLSGNFINGKIPSQLGEFSCIDTVDLSMNNLS 210
++ N I + + L+ N+L
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 56.5 bits (135), Expect = 9e-09
Identities = 22/144 (15%), Positives = 40/144 (27%), Gaps = 24/144 (16%)
Query: 3 RLRNLVHLDLSDNHFMGHIPPTLG--RLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAI 60
NL L++ + + L L+ L L + + G +
Sbjct: 191 PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGV------EDYGFDGDMNVFRP 244
Query: 61 ASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGH---LKWLRSVDLSQNKL---- 113
L L+ L + E + L L ++D+S L
Sbjct: 245 ---------LFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEG 295
Query: 114 VGPIPSSLGHLTQLTTLNMYNNKL 137
+ + + L +NM N L
Sbjct: 296 ARLLLDHVDKIKHLKFINMKYNYL 319
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 51.9 bits (123), Expect = 3e-07
Identities = 28/202 (13%), Positives = 68/202 (33%), Gaps = 28/202 (13%)
Query: 16 HFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGS 75
+ P L + L L + + N+ L +L I S + S++ I
Sbjct: 159 IEQVDLSPVLDAMPLLNNLKIKGTN---NLSIGKKPRPNLKSLEIISGGLPDSVVEDILG 215
Query: 76 --LKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMY 133
L L+ L L + + L S L L +
Sbjct: 216 SDLPNLEKLVLYVGVEDYGFDGDMNVFRPL---------------FSKDRFPNLKWLGIV 260
Query: 134 NNKLDGPIPPELMNC---SKLRILKLGNNLLSGS----IPSQIGKLQELYYLDLSGNFIN 186
+ + + + +L + + +L+ + + K++ L ++++ N+++
Sbjct: 261 DAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
Query: 187 GKIPSQLGEFSCIDTVDLSMNN 208
++ +L + S +D+S +
Sbjct: 321 DEMKKELQK-SLPMKIDVSDSQ 341
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 3e-04
Identities = 21/174 (12%), Positives = 51/174 (29%), Gaps = 24/174 (13%)
Query: 91 GSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELM--NC 148
+ L + L ++ + + L +L + + L + +++ +
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGT---NNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDL 218
Query: 149 SKLRILKL---GNNLLSGSIPSQI------GKLQELYYLDLSGNFINGKIPSQLGEFSCI 199
L L L + + + L +L + + E +
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278
Query: 200 D---TVDLSMNNLSG-GIPVFVRKVP------HLDVSGNQFGGEIPTTLANVPP 243
T+D+S L+ G + + V +++ N E+ L P
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLP 332
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 45/216 (20%), Positives = 84/216 (38%), Gaps = 34/216 (15%)
Query: 317 FDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHR-- 373
+++ IG G +G V +A + VALK + + E R+L +R +
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK---RFHRQAAEEIRILEHLRKQDK 155
Query: 374 ----NIVKLYGFCLHEKCMFLIYEYMEMGSLFCILR-TDEEAVGLDWTKRVNIVKGMAHA 428
N++ + + + +E + M +L+ +++ + L ++ +
Sbjct: 156 DNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRK--FAHSILQC 212
Query: 429 LSYLHHHCTPPILHRDISSNNILLNSEFEAF--VADFGIARLLNYDSSNRTLLAGTYGSI 486
L LH + I+H D+ NILL + + V DFG + + TY I
Sbjct: 213 LDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY-------TY--I 260
Query: 487 ------APELAYTMVVTEKYDVYSFGVVALEVLMGK 516
APE+ D++S G + E+L G
Sbjct: 261 QSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 49/289 (16%), Positives = 91/289 (31%), Gaps = 55/289 (19%)
Query: 5 RNLVHLDLSDNHF----MGHIPPTLGRLSE-LKILNLSLNSL----VGNIPSNVGHL-TQ 54
+ LDLS N+ + + LNLS NSL + + +
Sbjct: 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81
Query: 55 LTTLAIASNRMNGSILLGIGSL-----KVLQVLDLSRNEIGGS----IPSTLGHLKW-LR 104
+T+L ++ N ++ + + VLDL N+ +L +
Sbjct: 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASIT 141
Query: 105 SVDLSQNKL----VGPIPSSLGHL-TQLTTLNMYNNKLDGPIPPELM-----NCSKLRIL 154
S++L N L + L + + +LN+ N L EL + + L
Sbjct: 142 SLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSL 201
Query: 155 KLGNN--------LLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEF----SCIDTV 202
L N L+ S + L+L N ++G L + TV
Sbjct: 202 DLSANLLGLKSYAELAYIFSSIPNHVVS---LNLCLNCLHGPSLENLKLLKDSLKHLQTV 258
Query: 203 DLSMNNLSG----GIPVFVRKVPH------LDVSGNQFGGEIPTTLANV 241
L + + P+ +D +G + ++N+
Sbjct: 259 YLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNL 307
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 33/224 (14%), Positives = 72/224 (32%), Gaps = 54/224 (24%)
Query: 5 RNLVHLDLSDNHF----MGHIPPTLGRL-SELKILNLSLNSLVGNIPSNVGHL------- 52
++ L+L N + L + + + LNL N+L N L
Sbjct: 138 ASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA---SKNCAELAKFLASI 194
Query: 53 -TQLTTLAIASNRMN--GSILLGIGSLKV---LQVLDLSRNEIGGS----IPSTLGHLKW 102
+T+L +++N + L + + L+L N + G + LK
Sbjct: 195 PASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKH 254
Query: 103 LRSVDLSQNKL-------VGPIPSSLGHLTQLTTLNMYNNKLD----------------G 139
L++V L + + + ++ ++ ++ ++ ++
Sbjct: 255 LQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGK 314
Query: 140 PIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGN 183
P L+N + K N+ +IP EL +
Sbjct: 315 ADVPSLLNQCLIFAQKHQTNIEDLNIPD------ELRESIQTCK 352
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 5e-08
Identities = 38/116 (32%), Positives = 53/116 (45%), Gaps = 20/116 (17%)
Query: 32 KILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGI-GSLKVLQVLDLSRNEIG 90
L+L NSL LT LT L + N++ S+ G+ L L L+LS N++
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQL- 88
Query: 91 GSIPS----TLGHLKWLRSVDLSQNKLVGPIPSSLGH-----LTQLTTLNMYNNKL 137
S+P+ L LK L L+ N+L SL LTQL L +Y N+L
Sbjct: 89 QSLPNGVFDKLTQLKEL---ALNTNQL-----QSLPDGVFDKLTQLKDLRLYQNQL 136
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 6e-07
Identities = 40/133 (30%), Positives = 62/133 (46%), Gaps = 14/133 (10%)
Query: 10 LDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAIASNRMNGS 68
LDL N L+ L L L N L ++P+ V LT LT L +++N++ S
Sbjct: 33 LDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ-S 90
Query: 69 ILLGI-GSLKVLQVLDLSRNEIGGSIPS----TLGHLKWLRSVDLSQNKLVGPIPS-SLG 122
+ G+ L L+ L L+ N++ S+P L LK L L QN+L +P
Sbjct: 91 LPNGVFDKLTQLKELALNTNQL-QSLPDGVFDKLTQLKDL---RLYQNQLKS-VPDGVFD 145
Query: 123 HLTQLTTLNMYNN 135
LT L + +++N
Sbjct: 146 RLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 41/153 (26%), Positives = 64/153 (41%), Gaps = 18/153 (11%)
Query: 37 SLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPS- 95
S+ IP Q T L + +N + L L L L N++ S+P+
Sbjct: 18 GRTSVPTGIP------AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNG 70
Query: 96 ---TLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMN-CSKL 151
L L +L LS N+L LTQL L + N+L +P + + ++L
Sbjct: 71 VFNKLTSLTYLN---LSTNQLQSLPNGVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQL 126
Query: 152 RILKLGNNLLSGSIPSQI-GKLQELYYLDLSGN 183
+ L+L N L S+P + +L L Y+ L N
Sbjct: 127 KDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 63/256 (24%), Positives = 111/256 (43%), Gaps = 44/256 (17%)
Query: 317 FDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHR-- 373
++I IG G +G V +A + VA+K + + A L Q E RLL +
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK---AFLNQAQIEVRLLELMNKHDT 112
Query: 374 ----NIVKLYGFCLHEKCMFLIYEYMEMGSLFCILR-TDEEAVGLDWTKRVNIVKGMAHA 428
IV L + + L++E + +L+ +LR T+ V L+ T++ + M A
Sbjct: 113 EMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRK--FAQQMCTA 169
Query: 429 LSYLHHHCTPPILHRDISSNNILLNSEFEAF--VADFGIARLLNYDSSNRTLLAGTYGSI 486
L +L I+H D+ NILL + + + DFG + L Y
Sbjct: 170 LLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY-------QYIQS 221
Query: 487 ----APE----LAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDL 538
+PE + Y + + D++S G + +E+ H GE L S ++ +D+ K++++
Sbjct: 222 RFYRSPEVLLGMPYDLAI----DMWSLGCILVEM----HTGEPLFSGANEVDQMNKIVEV 273
Query: 539 LDPRLPPPGDQMIRQG 554
L PP ++ Q
Sbjct: 274 LGI--PP--AHILDQA 285
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 34/165 (20%), Positives = 64/165 (38%), Gaps = 31/165 (18%)
Query: 317 FDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRH-RN 374
F + IG G +G + + L + + VA+K LE + E R Q+
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIK----LEPMKSRAPQLHLEYRFYKQLGSGDG 66
Query: 375 IVKLYGFCLHEKCMFLIYEYMEM-G-SL-----FCILRTDEEAVGLDWTKRVNIVKGMAH 427
I ++Y F K ++ +E+ G SL C + V + I +
Sbjct: 67 IPQVYYFGPCGKYNAMV---LELLGPSLEDLFDLCDRTFSLKTV-------LMIAIQLIS 116
Query: 428 ALSYLHHHCTPPILHRDISSNNILL-----NSEFEAFVADFGIAR 467
+ Y+H +++RD+ N L+ ++ + DF +A+
Sbjct: 117 RMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 31/157 (19%), Positives = 61/157 (38%), Gaps = 29/157 (18%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRH-RNIVKLYG 380
IG+G +G +Y + +G+ VA+K E E+++ ++ I +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL----ECVKTKHPQLHIESKIYKMMQGGVGIPTIRW 72
Query: 381 FCLHEKCMFLIYEYMEM--GSL-----FCILRTDEEAVGLDWTKRVNIVKGMAHALSYLH 433
++ ME+ SL FC + + V + + M + Y+H
Sbjct: 73 CGAEGDYNVMV---MELLGPSLEDLFNFCSRKFSLKTV-------LLLADQMISRIEYIH 122
Query: 434 HHCTPPILHRDISSNNILL---NSEFEAFVADFGIAR 467
+HRD+ +N L+ ++ DFG+A+
Sbjct: 123 SKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 46/217 (21%), Positives = 87/217 (40%), Gaps = 40/217 (18%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIR-HRNIVKLYG 380
IG+G +G +Y + + + VA+K E E+++ ++ I +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLLYESKIYRILQGGTGIPNVRW 70
Query: 381 FCLHEKCMFLIYEYMEM--GSL-----FCILRTDEEAVGLDWTKRVNIVKGMAHALSYLH 433
F + L+ M++ SL FC + + V + + M + + ++H
Sbjct: 71 FGVEGDYNVLV---MDLLGPSLEDLFNFCSRKLSLKTV-------LMLADQMINRVEFVH 120
Query: 434 HHCTPPILHRDISSNNILL---NSEFEAFVADFGIARLLNYDSSNRTL-------LAGT- 482
LHRDI +N L+ + ++ DFG+A+ S+++ + L GT
Sbjct: 121 SKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTA 177
Query: 483 -YGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHP 518
Y S+ L + + D+ S G V + L G P
Sbjct: 178 RYASVNTHLGIEQ--SRRDDLESLGYVLMYFLRGSLP 212
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 62/311 (19%), Positives = 112/311 (36%), Gaps = 88/311 (28%)
Query: 315 EDFDIKYCI----GTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQ 369
+ F+ +Y + G G + +V+ + + K VA+K + E E+ +E RLL
Sbjct: 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT---ETALDEIRLLKS 89
Query: 370 IR--------HRNIVKLYG-FCL------HEKCMFLIYEYMEMGSLFCILRTDEEAVGLD 414
+R +V+L F + H CM ++E + L I++++ + + L
Sbjct: 90 VRNSDPNDPNREMVVQLLDDFKISGVNGTHI-CM--VFEVLGHHLLKWIIKSNYQGLPLP 146
Query: 415 WTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSE------------------- 455
K+ I++ + L YLH C I+H DI NILL+
Sbjct: 147 CVKK--IIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGA 202
Query: 456 ------------------------------FEAFVADFGIARLLNYDSSNRTLLAGTYGS 485
+ +AD G A + + T T
Sbjct: 203 PPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNAC---WVHKHFTEDIQTRQY 259
Query: 486 IAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNI--KLIDLLDPRL 543
+ E+ D++S +A E+ G + E S + D++ +I+LL
Sbjct: 260 RSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGK-- 317
Query: 544 PPPGDQMIRQG 554
P ++I G
Sbjct: 318 VPR--KLIVAG 326
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 41/171 (23%), Positives = 67/171 (39%), Gaps = 37/171 (21%)
Query: 323 IGTGGYGSVYRARLPSGKVVALK-----KLHR-----LETELASLESFQNEARLLSQIRH 372
IG GG+G +Y A + S + V K+ L TEL + ++ IR
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 373 RN-----IVKLYGFCLHEKCMFLIYEYMEMGSL---------FCILRTDEEAVGLDWTKR 418
R + K +G LH+K Y +M M R + V
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKS-YRFMIMDRFGSDLQKIYEANAKRFSRKTV------- 154
Query: 419 VNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFE--AFVADFGIAR 467
+ + + L Y+H H +H DI ++N+LLN + ++ D+G+A
Sbjct: 155 LQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 2e-06
Identities = 31/131 (23%), Positives = 51/131 (38%), Gaps = 29/131 (22%)
Query: 10 LDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAIASNRMNGS 68
L L N F +P L L +++LS N + + + ++TQL TL ++ NR+
Sbjct: 36 LYLDGNQFTL-VPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR-C 92
Query: 69 ILLGI-GSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQL 127
I LK L++L L N+I +P + L+ L
Sbjct: 93 IPPRTFDGLKSLRLLSLHGNDIS-VVPE-----------------------GAFNDLSAL 128
Query: 128 TTLNMYNNKLD 138
+ L + N L
Sbjct: 129 SHLAIGANPLY 139
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 4e-06
Identities = 25/93 (26%), Positives = 40/93 (43%), Gaps = 11/93 (11%)
Query: 93 IPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELM-NCSKL 151
IP + L L N+ +P L + LT +++ NN++ + + N ++L
Sbjct: 29 IPRDVTEL------YLDGNQFTL-VPKELSNYKHLTLIDLSNNRI-STLSNQSFSNMTQL 80
Query: 152 RILKLGNNLLSGSIPSQI-GKLQELYYLDLSGN 183
L L N L IP + L+ L L L GN
Sbjct: 81 LTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGN 112
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 5e-06
Identities = 31/124 (25%), Positives = 53/124 (42%), Gaps = 9/124 (7%)
Query: 37 SLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPST 96
L L IP +V T L + N+ + + + K L ++DLS N I +
Sbjct: 21 GLKVLPKGIPRDV------TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQS 73
Query: 97 LGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELM-NCSKLRILK 155
++ L ++ LS N+L P + L L L+++ N + +P + S L L
Sbjct: 74 FSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISV-VPEGAFNDLSALSHLA 132
Query: 156 LGNN 159
+G N
Sbjct: 133 IGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 6e-04
Identities = 22/88 (25%), Positives = 38/88 (43%), Gaps = 6/88 (6%)
Query: 3 RLRNLVHLDLSDNHFMGHIPP-TLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAI 60
++L +DLS+N + + + +++L L LS N L IP L L L++
Sbjct: 52 NYKHLTLIDLSNNR-ISTLSNQSFSNMTQLLTLILSYNRL-RCIPPRTFDGLKSLRLLSL 109
Query: 61 ASNRMNGSILLGI-GSLKVLQVLDLSRN 87
N ++ + G L L L + N
Sbjct: 110 HGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 30/188 (15%), Positives = 57/188 (30%), Gaps = 30/188 (15%)
Query: 3 RLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIAS 62
+ L +L L I TL + S L LNL S ++ + S
Sbjct: 116 QCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNL----------SGCSGFSEFALQTLLS 165
Query: 63 NRMNGSILLGIGSLKVLQVLDLSR------NEIGGSIPSTLGHLKWLRSVDLSQNKLVGP 116
+ L L+LS + ++ + L +N
Sbjct: 166 S------------CSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSD 213
Query: 117 IPSSLGHLTQLTTLNM-YNNKLDGPIPPELMNCSKLRILKL-GNNLLSGSIPSQIGKLQE 174
+ + + L L++ + L E + L+ L L + ++G++
Sbjct: 214 LSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPT 273
Query: 175 LYYLDLSG 182
L L + G
Sbjct: 274 LKTLQVFG 281
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 8e-06
Identities = 41/217 (18%), Positives = 87/217 (40%), Gaps = 13/217 (5%)
Query: 23 PTLGRLSELKILNLSLNSLV---GNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVL 79
P S ++ ++ L++ V + + ++L L++ R++ I+ + L
Sbjct: 85 PLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNL 144
Query: 80 QVLDLSRNEI--GGSIPSTLGHLKWLRSVDLSQNKLVG--PIPSSLGHLT-QLTTLNM-- 132
L+LS ++ + L L ++LS + ++ H++ +T LN+
Sbjct: 145 VRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG 204
Query: 133 YNNKL-DGPIPPELMNCSKLRILKL-GNNLLSGSIPSQIGKLQELYYLDLSG-NFINGKI 189
Y L + + C L L L + +L + +L L +L LS I +
Sbjct: 205 YRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPET 264
Query: 190 PSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHLDVS 226
+LGE + T+ + G + + +PHL ++
Sbjct: 265 LLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQIN 301
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 8e-06
Identities = 38/165 (23%), Positives = 61/165 (36%), Gaps = 16/165 (9%)
Query: 2 GRLRNLVHLDLSD-----NHFMGHIPPTLGRLSELKILNLSLNSLVGN--IPSNVGHLT- 53
+ NLV L+LS + + L S L LNLS + V H++
Sbjct: 139 AKNSNLVRLNLSGCSGFSEFALQTL---LSSCSRLDELNLSWCFDFTEKHVQVAVAHVSE 195
Query: 54 QLTTLAIASNRMN---GSILLGIGSLKVLQVLDLSR-NEIGGSIPSTLGHLKWLRSVDLS 109
+T L ++ R N + + L LDLS + L +L+ + LS
Sbjct: 196 TITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLS 255
Query: 110 QNKLVGPI-PSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRI 153
+ + P LG + L TL ++ DG + L+I
Sbjct: 256 RCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQI 300
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 3e-06
Identities = 34/133 (25%), Positives = 49/133 (36%), Gaps = 31/133 (23%)
Query: 10 LDLSDNHFMGHIPPT--LGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAIASNRMN 66
L L+DN G I GRL L L L N L I N + + L + N++
Sbjct: 34 LLLNDNEL-GRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK 91
Query: 67 GSILLGI-GSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLT 125
I + L L+ L+L N+I + P S HL
Sbjct: 92 -EISNKMFLGLHQLKTLNLYDNQIS-CVM-----------------------PGSFEHLN 126
Query: 126 QLTTLNMYNNKLD 138
LT+LN+ +N +
Sbjct: 127 SLTSLNLASNPFN 139
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 3e-06
Identities = 33/136 (24%), Positives = 56/136 (41%), Gaps = 27/136 (19%)
Query: 35 NLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGI-GSLKVLQVLDLSRNEIGGSI 93
L + +IP + T L + N + G+ G L L L+L RN++ I
Sbjct: 17 GRGLKEIPRDIPLHT------TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GI 69
Query: 94 PS----TLGHLKWLRSVDLSQNKLVGPIPSSLGH-----LTQLTTLNMYNNKLDGPIPPE 144
H++ L L +NK+ + + L QL TLN+Y+N++ + P
Sbjct: 70 EPNAFEGASHIQEL---QLGENKI-----KEISNKMFLGLHQLKTLNLYDNQISC-VMPG 120
Query: 145 LM-NCSKLRILKLGNN 159
+ + L L L +N
Sbjct: 121 SFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 4e-04
Identities = 27/88 (30%), Positives = 42/88 (47%), Gaps = 6/88 (6%)
Query: 3 RLRNLVHLDLSDNHFMGHIPP-TLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAI 60
RL +LV L+L N G I P S ++ L L N + I + + L QL TL +
Sbjct: 52 RLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLGENKI-KEISNKMFLGLHQLKTLNL 109
Query: 61 ASNRMNGSILLGI-GSLKVLQVLDLSRN 87
N+++ ++ G L L L+L+ N
Sbjct: 110 YDNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 31/159 (19%), Positives = 58/159 (36%), Gaps = 31/159 (19%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRH-RNIVKLYG 380
IG G +G ++ L + + VA+K E + ++E R + I +Y
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKF----EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYY 73
Query: 381 FCLHEKCMFLIYEYMEM--GSL-----FCILRTDEEAVGLDWTKRVNIVKGMAHALSYLH 433
F L+ +++ SL C + + V K M + +H
Sbjct: 74 FGQEGLHNVLV---IDLLGPSLEDLLDLCGRKFSVKTV-------AMAAKQMLARVQSIH 123
Query: 434 HHCTPPILHRDISSNNILLNSEFEA-----FVADFGIAR 467
+++RDI +N L+ +V DFG+ +
Sbjct: 124 EKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 1e-05
Identities = 30/106 (28%), Positives = 47/106 (44%), Gaps = 4/106 (3%)
Query: 80 QVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDG 139
L+L N++ L L + LSQN++ LT+LT L ++ NKL
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQS 90
Query: 140 PIPPELM-NCSKLRILKLGNNLLSGSIPSQI-GKLQELYYLDLSGN 183
+P + ++L+ L L N L S+P I +L L + L N
Sbjct: 91 -LPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 39.9 bits (94), Expect = 6e-04
Identities = 32/131 (24%), Positives = 49/131 (37%), Gaps = 34/131 (25%)
Query: 10 LDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAIASNRMNGS 68
L+L N +L++L L+LS N + ++P V LT+LT L + N+
Sbjct: 33 LELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENK---- 87
Query: 69 ILLGIGSLKVLQVLDLSRNEIGGSIPS----TLGHLKWLRSVDLSQNKLVGPIPSSLGHL 124
LQ S+P+ L LK L L N+L L
Sbjct: 88 ----------LQ-----------SLPNGVFDKLTQLKEL---ALDTNQLKSVPDGIFDRL 123
Query: 125 TQLTTLNMYNN 135
T L + ++ N
Sbjct: 124 TSLQKIWLHTN 134
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 35/201 (17%), Positives = 69/201 (34%), Gaps = 50/201 (24%)
Query: 323 IGTGGYGSVYRAR---------LPSGKVVALK---KLHRLETELASLESFQNEARL---- 366
G +Y A P + +LK K RL E + ++
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 367 -LSQIRHRNIVKLYGFCLHE-KCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKR------ 418
L I GF +H+ K FL+ + L ++ LD + +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLV---LPS------LGRSLQSA-LDVSPKHVLSER 159
Query: 419 --VNIVKGMAHALSYLHHHCTPPILHRDISSNNILL--NSEFEAFVADFGIARL------ 468
+ + + AL +LH + +H ++++ NI + + + +A +G A
Sbjct: 160 SVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGK 216
Query: 469 -LNYDSSNRTLLAGT--YGSI 486
+ Y +R+ G + S+
Sbjct: 217 HVAYVEGSRSPHEGDLEFISM 237
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 40/198 (20%), Positives = 70/198 (35%), Gaps = 47/198 (23%)
Query: 323 IGTGGYGSVYRA-RLPSGKVVALK-------KLHRLETELASLESFQ-----NEARLLSQ 369
IG+GG+G +Y A + A + L +EL + + Q
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 370 IRHRNIVKLYGFCLHEKCM----FLIYEYMEM-----GSLFCILRT-DEEAVGLDWTKRV 419
+ + I YG L E F++ ME + T + V +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMV---MERLGIDLQKISGQNGTFKKSTV-------L 154
Query: 420 NIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFE--AFVADFGIARL-------LN 470
+ M L Y+H + +H DI + N+LL + ++AD+G++
Sbjct: 155 QLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQ 211
Query: 471 YDSSNRTLLAGT--YGSI 486
Y + R GT + S+
Sbjct: 212 YQENPRKGHNGTIEFTSL 229
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 30/203 (14%), Positives = 64/203 (31%), Gaps = 22/203 (10%)
Query: 3 RLRNLVHLDLS----DNHFMGHIPPTLGRLSELKILNLSLNSLVGN--IPSNVGHLTQLT 56
L + L + + I K+L LS + + L
Sbjct: 103 SYTWLEEIRLKRMVVTDDCLELI---AKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLK 159
Query: 57 TLAIASNRMNGSILLGIGSL----KVLQVLDLS--RNEIG-GSIPSTLGHLKWLRSVDLS 109
L + + ++ + L L++S +E+ ++ + L+S+ L+
Sbjct: 160 ELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLN 219
Query: 110 QNKLVGPIPSSLGHLTQLTTLNMY------NNKLDGPIPPELMNCSKLRILKLGNNLLSG 163
+ + + + L QL L + + L C +LR L + +
Sbjct: 220 RAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPA 279
Query: 164 SIPSQIGKLQELYYLDLSGNFIN 186
+P+ L L+LS +
Sbjct: 280 YLPAVYSVCSRLTTLNLSYATVQ 302
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 35/204 (17%), Positives = 63/204 (30%), Gaps = 45/204 (22%)
Query: 4 LRNLVHLDLSDNHF----MGHIPPTLGRLSE-LKILNLSLNSLVGNIPSNVGHLTQLTTL 58
L +L L+L+ + LG L +NL+ L G
Sbjct: 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQL-----DPAG------LR 119
Query: 59 AIASNRMNGSILLGIGSLKVLQVLDLSRNEIG----GSIPSTLGHLKW-LRSVDLSQNKL 113
+ + L L N +G + L H + + ++ LS N L
Sbjct: 120 TLLP------------VFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPL 167
Query: 114 ----VGPIPSSLGHLTQLTTLNMYNNKLDGP----IPPELMNCSKLRILKLGNNLLSGS- 164
V + L T +T L++ + L + +L +L+ L + N +
Sbjct: 168 TAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTA 227
Query: 165 ---IPSQIGKLQELYYLDLSGNFI 185
+ + L L L N +
Sbjct: 228 ALALARAAREHPSLELLHLYFNEL 251
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 560 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.98 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.98 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.97 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.97 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.97 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.97 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.97 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.97 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.97 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.96 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.96 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.96 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.96 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.96 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.96 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.96 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.96 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.96 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.95 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.95 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.95 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.95 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.95 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.95 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.95 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.95 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.95 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.95 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.95 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.95 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.95 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.94 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.94 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.94 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.94 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.94 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.94 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.94 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.94 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.94 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.94 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.94 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.93 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.93 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.93 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.93 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.93 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.93 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.93 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.93 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.93 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.92 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.92 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.92 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.92 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.92 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.91 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.9 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.9 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.89 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.89 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.89 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.88 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.88 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.88 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.88 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.88 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.88 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.87 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.87 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.87 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.87 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.87 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.87 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.87 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.87 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.86 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.86 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.86 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.85 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.85 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.84 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.84 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.84 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.83 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.82 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.82 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.82 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.82 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.81 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.8 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.79 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.78 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.78 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.77 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.77 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.75 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.75 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.75 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.74 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.74 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.72 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.72 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.71 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.71 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.69 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.67 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.66 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.66 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.66 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.65 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.63 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.61 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.61 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.59 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.57 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.57 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.55 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.51 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.51 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.48 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.48 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.4 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.4 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.31 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.22 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.2 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 99.15 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.1 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.08 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 99.07 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.06 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.06 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.02 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.89 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.8 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.72 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.71 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.68 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.56 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.56 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.54 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.45 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.37 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.3 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 98.18 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 98.17 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.12 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.01 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.85 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.83 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.82 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.72 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.61 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.4 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.38 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.36 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.35 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.28 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.24 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.18 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.08 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.0 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.79 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.66 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.55 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.4 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.75 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.38 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 93.57 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.3 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 90.32 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 90.29 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 89.89 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 88.26 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 88.26 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 87.57 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 86.94 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-54 Score=424.71 Aligned_cols=240 Identities=25% Similarity=0.351 Sum_probs=204.1
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
++|++.+.||+|+||.||+|+.+ +|+.||||++..........+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 57999999999999999999864 68999999997655444556789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
||++|+|.+++...+. ..+++.++..|+.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.+....
T Consensus 104 y~~gg~L~~~i~~~~~-~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKG-VLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 9999999999976432 3378999999999999999999999 99999999999999999999999999998765332
Q ss_pred CCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc------------------ccccccccccc
Q 035761 474 SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS------------------SSSSLDKNIKL 535 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~------------------~~~~~~~~~~~ 535 (560)
......+||+.|||||++.+..|+.++||||+||++|||++|+.||...+. .+.++.++++.
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ 259 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQ 259 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHH
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHHH
Confidence 333446799999999999999999999999999999999999999975432 12235566778
Q ss_pred ccccCCCCCCChhHHHhhceeee
Q 035761 536 IDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 536 ~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
|...||..||+++++++|+|+..
T Consensus 260 ~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 260 LFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp HTCSSGGGSCCHHHHHTSHHHHT
T ss_pred HccCChhHCcCHHHHhcCHHhhc
Confidence 88999999999999999999853
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-53 Score=418.86 Aligned_cols=236 Identities=26% Similarity=0.391 Sum_probs=208.8
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
+.|+..+.||+|+||.||+|+.+ +|+.||||++..... ...+.+.+|+++|+.++|||||++++++.+++..|+|||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 56888999999999999999875 689999999975432 233467899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
||++|+|.+++... .+++.++..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.+....
T Consensus 152 y~~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 152 FLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp CCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred CCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence 99999999999753 289999999999999999999999 99999999999999999999999999999876655
Q ss_pred CCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc--------------------ccccccccc
Q 035761 474 SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS--------------------SSSSLDKNI 533 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~--------------------~~~~~~~~~ 533 (560)
......+||+.|||||++.+..|+.++||||+||++|||++|+.||...+. .+..+.+.+
T Consensus 225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli 304 (346)
T 4fih_A 225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFL 304 (346)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHH
T ss_pred CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHH
Confidence 556667899999999999999999999999999999999999999965431 122345566
Q ss_pred ccccccCCCCCCChhHHHhhceeeec
Q 035761 534 KLIDLLDPRLPPPGDQMIRQGIILIS 559 (560)
Q Consensus 534 ~~~~~~dp~~~p~~~~~~~~~~~~~~ 559 (560)
+.|...||..||+++++++|+|+..+
T Consensus 305 ~~~L~~dP~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 305 DRLLVRDPAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp HHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHcCCChhHCcCHHHHhcCHhhcCC
Confidence 77889999999999999999999754
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-53 Score=406.27 Aligned_cols=236 Identities=25% Similarity=0.363 Sum_probs=198.1
Q ss_pred cccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEe----CCEEEEEE
Q 035761 318 DIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLH----EKCMFLIY 392 (560)
Q Consensus 318 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 392 (560)
++.+.||+|+||.||+|.+. ++..||+|++..........+.|.+|++++++++|||||++++++.+ ++..++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 56678999999999999865 58899999997655444556789999999999999999999999875 34689999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCC-CCcEEEeeeccccccCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNS-EFEAFVADFGIARLLNY 471 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~~~~~~~ 471 (560)
|||++|+|.++++... .+++.++..++.||+.||+|||++ .++||||||||+|||++. ++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~- 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR- 183 (290)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC-
T ss_pred eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCC-
Confidence 9999999999998644 389999999999999999999998 123999999999999984 7999999999998643
Q ss_pred CCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc--------------------cccccc
Q 035761 472 DSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------------SSSLDK 531 (560)
Q Consensus 472 ~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------------~~~~~~ 531 (560)
.......+||+.|||||++.+ .|+.++|||||||++|||+||+.||...... ..++.+
T Consensus 184 -~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 261 (290)
T 3fpq_A 184 -ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 261 (290)
T ss_dssp -TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred -CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHH
Confidence 234455689999999998875 5999999999999999999999999643321 112445
Q ss_pred ccccccccCCCCCCChhHHHhhceeeecC
Q 035761 532 NIKLIDLLDPRLPPPGDQMIRQGIILIST 560 (560)
Q Consensus 532 ~~~~~~~~dp~~~p~~~~~~~~~~~~~~~ 560 (560)
.+..|...||..||+++++++|+|+.--|
T Consensus 262 li~~~L~~dP~~R~s~~e~l~Hp~~~~~T 290 (290)
T 3fpq_A 262 IIEGCIRQNKDERYSIKDLLNHAFFQEET 290 (290)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTSGGGC---
T ss_pred HHHHHccCChhHCcCHHHHhcCccccCCC
Confidence 66778889999999999999999997654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=407.03 Aligned_cols=237 Identities=24% Similarity=0.347 Sum_probs=205.9
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchh-hhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLE-TELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|++.+.||+|+||.||+|+.+ +|+.||||++.+.. ......+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 56999999999999999999864 68999999997654 23345677899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++|+|.+++...+. +++.++..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~~~~---l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 99999999999986443 99999999999999999999999 9999999999999999999999999999987543
Q ss_pred CC--CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------ccccccccc
Q 035761 473 SS--NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNI 533 (560)
Q Consensus 473 ~~--~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~ 533 (560)
.. .....+||+.|||||++.+..|+.++||||+||++|||++|+.||...+. .+.++...+
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli 265 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLV 265 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHH
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHH
Confidence 32 33456899999999999999999999999999999999999999975432 122345567
Q ss_pred ccccccCCCCCCChhHH------Hhhceee
Q 035761 534 KLIDLLDPRLPPPGDQM------IRQGIIL 557 (560)
Q Consensus 534 ~~~~~~dp~~~p~~~~~------~~~~~~~ 557 (560)
+.|...||..||+++++ .+|+|+.
T Consensus 266 ~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~ 295 (311)
T 4aw0_A 266 EKLLVLDATKRLGCEEMEGYGPLKAHPFFE 295 (311)
T ss_dssp HHHSCSSGGGSTTSGGGTCHHHHHTSGGGT
T ss_pred HHHccCCHhHCcChHHHcCCHHHHCCCCcC
Confidence 78889999999999985 6667764
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=420.89 Aligned_cols=236 Identities=26% Similarity=0.393 Sum_probs=209.6
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
+.|+..+.||+|+||.||+|+.+ +|+.||||++..... ...+.+.+|+.+|+.++|||||++++++.+++..|+|||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE 228 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 228 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC--SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence 56999999999999999999875 689999999975432 233468899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
||++|+|.++++..+ +++.++..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.+....
T Consensus 229 y~~gG~L~~~i~~~~----l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 229 FLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp CCTTEEHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred CCCCCcHHHHHhccC----CCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 999999999997532 89999999999999999999999 99999999999999999999999999999886655
Q ss_pred CCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc--------------------ccccccccc
Q 035761 474 SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS--------------------SSSSLDKNI 533 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~--------------------~~~~~~~~~ 533 (560)
......+||+.|||||++.+..|+.++||||+||++|||++|+.||..... .+..+..++
T Consensus 302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli 381 (423)
T 4fie_A 302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFL 381 (423)
T ss_dssp CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHH
T ss_pred ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHH
Confidence 566677899999999999999999999999999999999999999964431 122345667
Q ss_pred ccccccCCCCCCChhHHHhhceeeec
Q 035761 534 KLIDLLDPRLPPPGDQMIRQGIILIS 559 (560)
Q Consensus 534 ~~~~~~dp~~~p~~~~~~~~~~~~~~ 559 (560)
+.|...||..||+++++++|+|+..+
T Consensus 382 ~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 382 DRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp HHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 78889999999999999999999764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=405.83 Aligned_cols=232 Identities=25% Similarity=0.417 Sum_probs=191.5
Q ss_pred hcCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
.+++.+.+.||+|+||.||+|++++ .||||+++......+..+.|.+|++++++++|||||+++|++.+ +..++|||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 3568889999999999999999753 69999997655555667789999999999999999999998865 56899999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
||++|+|.++++.... .++|.++..|+.|||+||+|||++ +||||||||+|||+++++.+||+|||+|+......
T Consensus 112 y~~gGsL~~~l~~~~~--~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 112 WCEGSSLYKHLHVQET--KFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp CCSSCBHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred cCCCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 9999999999976433 399999999999999999999999 99999999999999999999999999998764322
Q ss_pred C--CceeeccccCccCcccccc---CccCcchhHHHHHHHHHHHHhCCCCCCccccc-----------------------
Q 035761 474 S--NRTLLAGTYGSIAPELAYT---MVVTEKYDVYSFGVVALEVLMGKHPGELLSSS----------------------- 525 (560)
Q Consensus 474 ~--~~~~~~g~~~~~aPE~~~~---~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~----------------------- 525 (560)
. .....+||+.|||||++.+ ..|+.++|||||||++|||+||+.||......
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 266 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNC 266 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTS
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccc
Confidence 2 2344679999999999864 35899999999999999999999999754321
Q ss_pred ccccccccccccccCCCCCCChhHHHhh
Q 035761 526 SSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 526 ~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
...+.+++..|...||..||++++++++
T Consensus 267 ~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 267 PKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp CHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1123445566778899999999988654
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-53 Score=409.50 Aligned_cols=238 Identities=24% Similarity=0.328 Sum_probs=199.1
Q ss_pred cCCcccceeeccCCeeEEEEEeC----CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP----SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFL 390 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 390 (560)
++|++.+.||+|+||.||+|+.. +++.||||++++..........+.+|++++++++|||||++++++.+++..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 56999999999999999999752 47899999997654322333467889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccC
Q 035761 391 IYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN 470 (560)
Q Consensus 391 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 470 (560)
||||+++|+|.+++...+. +++.++..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~~~~---l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVM---FTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 9999999999999986543 99999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------ccccccccc
Q 035761 471 YDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNI 533 (560)
Q Consensus 471 ~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~ 533 (560)
.........+||+.|||||++.+..|+.++||||+||++|||+||+.||...+. .+.++...+
T Consensus 178 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 257 (304)
T 3ubd_A 178 DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLL 257 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence 444445557899999999999999999999999999999999999999975432 223455677
Q ss_pred ccccccCCCCCCCh-----hHHHhhceeee
Q 035761 534 KLIDLLDPRLPPPG-----DQMIRQGIILI 558 (560)
Q Consensus 534 ~~~~~~dp~~~p~~-----~~~~~~~~~~~ 558 (560)
+.|...||..||++ +++++|+|+..
T Consensus 258 ~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 258 RMLFKRNPANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp HHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred HHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence 78888999999984 79999999853
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-52 Score=406.94 Aligned_cols=235 Identities=23% Similarity=0.296 Sum_probs=195.8
Q ss_pred cCCcccceeeccCCeeEEEEEeC------CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCM 388 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 388 (560)
+++++.+.||+|+||.||+|.+. +++.||||+++.... ....+.|.+|+.++++++|||||+++|+|.+++..
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~-~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~ 104 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE-GPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 104 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC-C-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC-hHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence 34667889999999999999863 467899999975432 23456899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCCc-------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCC
Q 035761 389 FLIYEYMEMGSLFCILRTDEE-------------AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSE 455 (560)
Q Consensus 389 ~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~ 455 (560)
++|||||++|+|.+++..... ...++|.++++|+.|||+||+|||+. +||||||||+|||++++
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDK 181 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCC
Confidence 999999999999999965321 23599999999999999999999999 99999999999999999
Q ss_pred CcEEEeeeccccccCCCCC--CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc-------
Q 035761 456 FEAFVADFGIARLLNYDSS--NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------- 525 (560)
Q Consensus 456 ~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------- 525 (560)
+.+||+|||+|+....... ......||++|||||++.+..|+.++|||||||++|||+| |+.||......
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~ 261 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR 261 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHH
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 9999999999987643322 2334579999999999999999999999999999999999 89999754421
Q ss_pred -----------ccccccccccccccCCCCCCChhHHHhh
Q 035761 526 -----------SSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 526 -----------~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
...+.+++..|...||..||++++++++
T Consensus 262 ~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 262 NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 1123455566677788888888888765
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-52 Score=396.23 Aligned_cols=236 Identities=23% Similarity=0.364 Sum_probs=190.9
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchh-hhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLE-TELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|++.+.||+|+||.||+|... +|+.||||++++.. ......+.+.+|++++++++|||||++++++.+++..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999864 68999999997544 22334567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+ +|+|.+++...+. +++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~~~~---l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRDK---MSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHHSCS---CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 6799999976543 99999999999999999999999 9999999999999999999999999999876532
Q ss_pred CCCceeeccccCccCccccccCcc-CcchhHHHHHHHHHHHHhCCCCCCcccc-----------------cccccccccc
Q 035761 473 SSNRTLLAGTYGSIAPELAYTMVV-TEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNIK 534 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~~~~-~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~~ 534 (560)
......+||+.|||||++.+..+ +.++||||+||++|||++|+.||...+. .+..+.+.++
T Consensus 166 -~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 244 (275)
T 3hyh_A 166 -NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIK 244 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHH
T ss_pred -CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 23344679999999999998876 5799999999999999999999975431 1223456667
Q ss_pred cccccCCCCCCChhHHHhhceeee
Q 035761 535 LIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 535 ~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
.|...||..||+++++++|+|++.
T Consensus 245 ~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 245 RMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp HHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred HHccCChhHCcCHHHHHcCccccc
Confidence 888999999999999999999863
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-52 Score=407.91 Aligned_cols=234 Identities=25% Similarity=0.407 Sum_probs=191.5
Q ss_pred cCCcccceeeccCCeeEEEEEeC------CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCM 388 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 388 (560)
++|.+.+.||+|+||.||+|+++ +++.||||+++... ....+.|.+|+++|++++|||||+++|+|.+++..
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 45777889999999999999864 47889999997543 34456899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCCc------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCC
Q 035761 389 FLIYEYMEMGSLFCILRTDEE------------AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEF 456 (560)
Q Consensus 389 ~lv~e~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~ 456 (560)
++|||||++|+|.++++.... ...++|.+++.|+.|||+||+|||+. +||||||||+|||+++++
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTT
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCC
Confidence 999999999999999976432 23599999999999999999999998 999999999999999999
Q ss_pred cEEEeeeccccccCCCCCC--ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc---------
Q 035761 457 EAFVADFGIARLLNYDSSN--RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS--------- 524 (560)
Q Consensus 457 ~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~--------- 524 (560)
.+||+|||+|+........ .....||+.|||||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~ 275 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 275 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHH
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 9999999999876433222 234579999999999999999999999999999999999 9999975442
Q ss_pred ---------cccccccccccccccCCCCCCChhHHHhh
Q 035761 525 ---------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 525 ---------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
....+.+++..|...||..||++++++++
T Consensus 276 g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 276 GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 11234455666777888888888888764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-52 Score=405.35 Aligned_cols=233 Identities=26% Similarity=0.407 Sum_probs=194.4
Q ss_pred cCCcccceeeccCCeeEEEEEeC------CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCM 388 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 388 (560)
++|.+.+.||+|+||.||+|++. +++.||||+++... ....+.|.+|+++|++++|||||+++|+|.+++..
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC--hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 46788899999999999999864 47789999997643 33456899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCC----------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcE
Q 035761 389 FLIYEYMEMGSLFCILRTDE----------EAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEA 458 (560)
Q Consensus 389 ~lv~e~~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 458 (560)
++|||||++|+|.++++..+ ....++|.++..|+.|||+||+|||++ +||||||||+|||+++++.+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcE
Confidence 99999999999999997643 234599999999999999999999999 99999999999999999999
Q ss_pred EEeeeccccccCCCCCCc--eeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc-----------
Q 035761 459 FVADFGIARLLNYDSSNR--TLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS----------- 524 (560)
Q Consensus 459 kl~Dfg~~~~~~~~~~~~--~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~----------- 524 (560)
||+|||+|+......... ....||++|||||++.+..|+.++|||||||++|||+| |+.||.....
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~ 247 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 247 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTC
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999998764332222 22468999999999999999999999999999999999 9999975542
Q ss_pred -------cccccccccccccccCCCCCCChhHHHh
Q 035761 525 -------SSSSLDKNIKLIDLLDPRLPPPGDQMIR 552 (560)
Q Consensus 525 -------~~~~~~~~~~~~~~~dp~~~p~~~~~~~ 552 (560)
....+.+++..|...||+.||+++++.+
T Consensus 248 ~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~ 282 (299)
T 4asz_A 248 VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHT 282 (299)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1123445556666778888888777743
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-51 Score=399.34 Aligned_cols=225 Identities=25% Similarity=0.286 Sum_probs=190.3
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
+.|+..+.||+|+||.||+|+.+ +|+.||||+++.... ..+|+.+++.++|||||++++++.+++..++|||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE 130 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 45778889999999999999864 689999999975331 2469999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCC-cEEEeeeccccccCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEF-EAFVADFGIARLLNYD 472 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~~~~~~~~ 472 (560)
||++|+|.++++..+. +++.++..++.||+.||+|||++ +||||||||+|||++.++ .+||+|||+|+.+...
T Consensus 131 y~~gg~L~~~l~~~~~---l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 131 LLEGGSLGQLIKQMGC---LPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp CCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred ccCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 9999999999986443 99999999999999999999999 999999999999999987 5999999999987543
Q ss_pred CCC-----ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc--------------------cc
Q 035761 473 SSN-----RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------------SS 527 (560)
Q Consensus 473 ~~~-----~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------------~~ 527 (560)
... ....+||+.|||||++.+..|+.++||||+||++|||++|+.||...... ..
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~ 284 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAP 284 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCH
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCH
Confidence 222 12357999999999999999999999999999999999999999754321 11
Q ss_pred ccccccccccccCCCCCCChhHHHh
Q 035761 528 SLDKNIKLIDLLDPRLPPPGDQMIR 552 (560)
Q Consensus 528 ~~~~~~~~~~~~dp~~~p~~~~~~~ 552 (560)
.+.+.++.|...||..||++.++++
T Consensus 285 ~~~~li~~~L~~dP~~R~sa~el~~ 309 (336)
T 4g3f_A 285 LTAQAIQEGLRKEPVHRASAMELRR 309 (336)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHH
Confidence 2344556677789999999998854
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-50 Score=389.56 Aligned_cols=237 Identities=21% Similarity=0.326 Sum_probs=190.4
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCC-------
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEK------- 386 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------- 386 (560)
++|++.+.||+|+||.||+|+.+ +|+.||||+++.... ....+.+.+|+++|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR-ELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 45899999999999999999864 689999999875443 234467899999999999999999999987644
Q ss_pred -----EEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEe
Q 035761 387 -----CMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVA 461 (560)
Q Consensus 387 -----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 461 (560)
..++||||+++|+|.+++.........++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence 3689999999999999998765544567788899999999999999999 99999999999999999999999
Q ss_pred eeccccccCCCCCC------------ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc----
Q 035761 462 DFGIARLLNYDSSN------------RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS---- 525 (560)
Q Consensus 462 Dfg~~~~~~~~~~~------------~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~---- 525 (560)
|||+|+.+...... ....+||+.|||||++.+..|+.++||||+||++|||++ ||......
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~ 237 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTL 237 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHH
Confidence 99999877543221 123579999999999999999999999999999999996 77533210
Q ss_pred ---------------ccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 526 ---------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 526 ---------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
.......++.|...||..||++.++++|+|+..
T Consensus 238 ~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~ 285 (299)
T 4g31_A 238 TDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285 (299)
T ss_dssp HHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred HHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence 011234567788899999999999999999864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=399.99 Aligned_cols=242 Identities=24% Similarity=0.337 Sum_probs=200.6
Q ss_pred HHHHHHhcCCcccceeeccCCeeEEEEEeCC------CcEEEEEEccchhhhhhhHHHHHHHHHHHhccCC-CCcceeee
Q 035761 308 QDMIEATEDFDIKYCIGTGGYGSVYRARLPS------GKVVALKKLHRLETELASLESFQNEARLLSQIRH-RNIVKLYG 380 (560)
Q Consensus 308 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~ 380 (560)
.+++...++|++.+.||+|+||.||+|.+.. ++.||||+++..... ...+.|.+|+++|++++| ||||+++|
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~-~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccCh-HHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 4455566889999999999999999998643 368999999765432 345679999999999965 99999999
Q ss_pred EEEeC-CEEEEEEeccCCCCHHHHhhcCCc-------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCC
Q 035761 381 FCLHE-KCMFLIYEYMEMGSLFCILRTDEE-------------AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDIS 446 (560)
Q Consensus 381 ~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk 446 (560)
+|.++ +..++|||||++|+|.++++.... ...++|.+++.++.|||+||+|||++ +|||||||
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK 212 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA 212 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccC
Confidence 99775 568999999999999999976432 23489999999999999999999999 99999999
Q ss_pred CCCeEeCCCCcEEEeeeccccccCCCCCCc--eeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccc
Q 035761 447 SNNILLNSEFEAFVADFGIARLLNYDSSNR--TLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLS 523 (560)
Q Consensus 447 ~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~ 523 (560)
|+|||+++++.+||+|||+|+.+....... ....||+.|||||++.+..|+.++|||||||++|||+| |+.||....
T Consensus 213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999999775443322 23568999999999999999999999999999999998 999997544
Q ss_pred cc-------------------ccccccccccccccCCCCCCChhHHHhh
Q 035761 524 SS-------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 524 ~~-------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
.. ..++.+.+..|...||..||++.+++++
T Consensus 293 ~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 293 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp CSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 21 1123445566677788888888888876
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=387.00 Aligned_cols=198 Identities=26% Similarity=0.369 Sum_probs=163.3
Q ss_pred cCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCC----EEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEK----CMFL 390 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~l 390 (560)
++|.+.+.||+|+||.||+|++ +|+.||||+++..... ...+.+|+..+.+++|||||+++|+|.+++ ..+|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~---~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH---HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh---hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 4577889999999999999998 5899999999754321 112334566667889999999999998754 5799
Q ss_pred EEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEEeCCCCCCeEeCCCCcEEEeeecc
Q 035761 391 IYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHH-----CTPPILHRDISSNNILLNSEFEAFVADFGI 465 (560)
Q Consensus 391 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-----~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 465 (560)
|||||++|+|.++++... ++|.++.+++.|+|+||+|||++ ..++||||||||+|||++.++++||+|||+
T Consensus 79 V~Ey~~~gsL~~~l~~~~----l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEECCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EecCCCCCcHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 999999999999998643 89999999999999999999975 245899999999999999999999999999
Q ss_pred ccccCCCCCC----ceeeccccCccCccccccC------ccCcchhHHHHHHHHHHHHhCCCCCC
Q 035761 466 ARLLNYDSSN----RTLLAGTYGSIAPELAYTM------VVTEKYDVYSFGVVALEVLMGKHPGE 520 (560)
Q Consensus 466 ~~~~~~~~~~----~~~~~g~~~~~aPE~~~~~------~~~~~~Dv~s~G~il~el~~g~~P~~ 520 (560)
|+........ ....+||+.|||||++.+. .++.++|||||||++|||+||+.||.
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~ 219 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCC
Confidence 9876543221 2235799999999998764 47789999999999999999987764
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=391.93 Aligned_cols=236 Identities=23% Similarity=0.349 Sum_probs=199.8
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEe------CCE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLH------EKC 387 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~ 387 (560)
++|++.+.||+|+||.||+|+.+ +|+.||||+++.........+.+.+|+++|+.++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999864 69999999997655444555678899999999999999999998764 357
Q ss_pred EEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccc
Q 035761 388 MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIAR 467 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~ 467 (560)
.|+|||||+ |+|.+++...+. +++.++..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~~---l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQP---LTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSSC---CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceee
Confidence 899999996 689999976543 99999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCC----CCCceeeccccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCCCCCcccc------------------
Q 035761 468 LLNYD----SSNRTLLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKHPGELLSS------------------ 524 (560)
Q Consensus 468 ~~~~~----~~~~~~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~P~~~~~~------------------ 524 (560)
.+... .......+||+.|||||++.+. .++.++||||+||++|||++|+.||...+.
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV 286 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 76432 1223446899999999998875 568899999999999999999999964431
Q ss_pred ------------------------------cccccccccccccccCCCCCCChhHHHhhceee
Q 035761 525 ------------------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 525 ------------------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
.+.+....++.|...||..||+++++++|+|+.
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~ 349 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLA 349 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGT
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhC
Confidence 011223456778899999999999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=382.57 Aligned_cols=233 Identities=24% Similarity=0.284 Sum_probs=194.9
Q ss_pred HhcCCcccceeeccCCeeEEEEEeC----CCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCE
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARLP----SGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKC 387 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 387 (560)
..++|++.+.||+|+||.||+|+.+ .++.||||++..... ...+.+|+++++.+ +||||+++++++.+++.
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH----PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC----HHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 3568999999999999999999753 467899999865432 34577899999988 69999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCC-CcEEEeeeccc
Q 035761 388 MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSE-FEAFVADFGIA 466 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~~ 466 (560)
.++||||+++|+|.+++.. +++.++..++.||+.||+|||++ |||||||||+|||++.+ +.+||+|||+|
T Consensus 95 ~~lvmE~~~g~~L~~~~~~------l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILNS------LSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp EEEEEECCCCCCHHHHHTT------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEeCCCcccHHHHHcC------CCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 9999999999999999852 89999999999999999999999 99999999999999877 79999999999
Q ss_pred cccCCCCC----------------------------CceeeccccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCC
Q 035761 467 RLLNYDSS----------------------------NRTLLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKH 517 (560)
Q Consensus 467 ~~~~~~~~----------------------------~~~~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~ 517 (560)
+....... .....+||+.|||||++.+. .|+.++||||+||++|||++|+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 86532211 11234799999999998875 58899999999999999999999
Q ss_pred CCCccccc------------------------------------------------------------------------
Q 035761 518 PGELLSSS------------------------------------------------------------------------ 525 (560)
Q Consensus 518 P~~~~~~~------------------------------------------------------------------------ 525 (560)
||....+.
T Consensus 246 Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~i 325 (361)
T 4f9c_A 246 PFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEV 325 (361)
T ss_dssp SSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTC
T ss_pred CCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccC
Confidence 99533211
Q ss_pred ccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 526 SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 526 ~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
+.+..+.++.|...||+.|++++++++|+|+.+
T Consensus 326 s~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 326 PDEAYDLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred CHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 111234556778899999999999999999864
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=392.45 Aligned_cols=235 Identities=21% Similarity=0.249 Sum_probs=197.5
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhh-hhhHHH---HHHHHHHHhccCCCCcceeeeEEEeCCEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETE-LASLES---FQNEARLLSQIRHRNIVKLYGFCLHEKCMF 389 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~---~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 389 (560)
++|++.+.||+|+||.||+|+.+ +|+.||||++.+.... ...... ...++.+++.++|||||++++++.+++..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 57999999999999999999865 6899999999764421 122222 334467777889999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccccc
Q 035761 390 LIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL 469 (560)
Q Consensus 390 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 469 (560)
+||||++||+|.+++...+. +++.++..++.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+.+
T Consensus 269 lVmEy~~GGdL~~~l~~~~~---l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHGV---FSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEECCCCSCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeec
Confidence 99999999999999986543 99999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCcccc--------------------cccc
Q 035761 470 NYDSSNRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSS--------------------SSSS 528 (560)
Q Consensus 470 ~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~--------------------~~~~ 528 (560)
... .....+||+.|||||++.. ..|+.++||||+||++|||++|+.||..... .+..
T Consensus 343 ~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~ 420 (689)
T 3v5w_A 343 SKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 420 (689)
T ss_dssp SSC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred CCC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHH
Confidence 532 2334689999999999964 5799999999999999999999999964332 1223
Q ss_pred cccccccccccCCCCCCC-----hhHHHhhceee
Q 035761 529 LDKNIKLIDLLDPRLPPP-----GDQMIRQGIIL 557 (560)
Q Consensus 529 ~~~~~~~~~~~dp~~~p~-----~~~~~~~~~~~ 557 (560)
...+++.|...||..|+. ++++..|+|+.
T Consensus 421 a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~ 454 (689)
T 3v5w_A 421 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 454 (689)
T ss_dssp HHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGT
T ss_pred HHHHHHHHccCCHhHCCCCCCCCHHHHhcCcccc
Confidence 455666778889999987 68999999975
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=391.46 Aligned_cols=236 Identities=25% Similarity=0.340 Sum_probs=204.5
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
++|++.+.||+|+||.||+|..+ +|+.||+|++..... ...+.+.+|+++|+.++|||||++++++.+++..++|||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~--~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE--SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch--hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 57999999999999999999864 689999999875432 234578899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCC--CcEEEeeeccccccCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSE--FEAFVADFGIARLLNY 471 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~--~~~kl~Dfg~~~~~~~ 471 (560)
||++|+|.+++..... .+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.+..
T Consensus 235 ~~~gg~L~~~i~~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 235 FMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCCCCBHHHHHTCTTS--CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred ecCCCcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 9999999999965432 389999999999999999999999 99999999999999854 8899999999998753
Q ss_pred CCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------cccccc
Q 035761 472 DSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------SSSSLD 530 (560)
Q Consensus 472 ~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------~~~~~~ 530 (560)
. ......+||+.|||||++.+..|+.++||||+||++|||++|+.||...+. .+....
T Consensus 310 ~-~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 388 (573)
T 3uto_A 310 K-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 388 (573)
T ss_dssp T-SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHH
T ss_pred C-CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 3 334456899999999999999999999999999999999999999964432 112234
Q ss_pred cccccccccCCCCCCChhHHHhhceeee
Q 035761 531 KNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 531 ~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
.+++.|...||..||+++++++|+|+..
T Consensus 389 dli~~~L~~dp~~R~t~~e~l~Hpw~~~ 416 (573)
T 3uto_A 389 DFIRKLLLADPNTRMTIHQALEHPWLTP 416 (573)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSTTTSC
T ss_pred HHHHHHccCChhHCcCHHHHhcCcCcCC
Confidence 4556778889999999999999999863
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=355.82 Aligned_cols=238 Identities=26% Similarity=0.407 Sum_probs=207.8
Q ss_pred hcCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
.++|++.+.||+|+||.||+|.. .+|+.||||++..........+.+.+|+++++.++||||+++++++..++..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 35799999999999999999987 57999999999765544455667889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++|+|.+++...+. +++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 94 e~~~~~~L~~~l~~~~~---l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHGR---MKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 99999999999976443 89999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCCceeeccccCccCccccccCccC-cchhHHHHHHHHHHHHhCCCCCCcccc-----------------cccccccccc
Q 035761 473 SSNRTLLAGTYGSIAPELAYTMVVT-EKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNIK 534 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~~~~~-~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~~ 534 (560)
......+||+.|+|||++.+..++ .++||||+||++|||++|+.||...+. ....+...++
T Consensus 168 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 246 (328)
T 3fe3_A 168 -GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK 246 (328)
T ss_dssp -CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred -CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 233445799999999999988875 789999999999999999999975432 1233456677
Q ss_pred cccccCCCCCCChhHHHhhceeee
Q 035761 535 LIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 535 ~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
.|...||..||+++++++|+|+..
T Consensus 247 ~~L~~dP~~R~t~~eil~h~~~~~ 270 (328)
T 3fe3_A 247 RFLVLNPIKRGTLEQIMKDRWINA 270 (328)
T ss_dssp HHCCSSTTTSCCHHHHTTCTTTTT
T ss_pred HHCCCChhHCcCHHHHhcCHhhcC
Confidence 888999999999999999999853
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=347.79 Aligned_cols=237 Identities=24% Similarity=0.372 Sum_probs=208.9
Q ss_pred hcCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
.++|+..+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc--cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 36799999999999999999985 5689999999875432 23457889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++|+|.+++.... +++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 97 e~~~~~~L~~~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 97 EYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp ECCTTCBHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred ECCCCCCHHHHHhhcC----CCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 9999999999997642 89999999999999999999999 9999999999999999999999999999887655
Q ss_pred CCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc--------------------cccccccc
Q 035761 473 SSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS--------------------SSSSLDKN 532 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~--------------------~~~~~~~~ 532 (560)
........||+.|+|||++.+..++.++||||+|+++|||++|+.||..... ....+.+.
T Consensus 170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 249 (297)
T 3fxz_A 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249 (297)
T ss_dssp TCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHH
T ss_pred ccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHH
Confidence 5555566799999999999999999999999999999999999999965432 12224566
Q ss_pred cccccccCCCCCCChhHHHhhceeeec
Q 035761 533 IKLIDLLDPRLPPPGDQMIRQGIILIS 559 (560)
Q Consensus 533 ~~~~~~~dp~~~p~~~~~~~~~~~~~~ 559 (560)
++.|...||..||+++++++|+|+..+
T Consensus 250 i~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 250 LNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHccCChhHCcCHHHHhhChhhccc
Confidence 778889999999999999999998754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=346.99 Aligned_cols=248 Identities=26% Similarity=0.392 Sum_probs=213.0
Q ss_pred CCCcCHHHHHHHhcC----------CcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc
Q 035761 302 DGRITFQDMIEATED----------FDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQI 370 (560)
Q Consensus 302 ~~~~~~~~~~~~~~~----------~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l 370 (560)
.+.++++++..+++. |+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+++.+
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l 99 (321)
T 2c30_A 22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDY 99 (321)
T ss_dssp ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCSHHHHHHHHHHHTTC
T ss_pred CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc--hhHHHHHHHHHHHHHhC
Confidence 356788888877754 666778999999999999876 69999999987543 23456788999999999
Q ss_pred CCCCcceeeeEEEeCCEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCe
Q 035761 371 RHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNI 450 (560)
Q Consensus 371 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Ni 450 (560)
+||||+++++++...+..++||||+++|+|.+++... .+++.++..++.|++.||+|||+. +|+||||||+||
T Consensus 100 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NI 172 (321)
T 2c30_A 100 QHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSI 172 (321)
T ss_dssp CCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred CCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHE
Confidence 9999999999999999999999999999999998753 389999999999999999999999 999999999999
Q ss_pred EeCCCCcEEEeeeccccccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc------
Q 035761 451 LLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS------ 524 (560)
Q Consensus 451 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~------ 524 (560)
+++.++.+||+|||++..............||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 173 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~ 252 (321)
T 2c30_A 173 LLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR 252 (321)
T ss_dssp EECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred EECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99999999999999998776544444556799999999999999999999999999999999999999964331
Q ss_pred --------------cccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 525 --------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 525 --------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
....+.+.+..|...||..||+++++++|+|+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 300 (321)
T 2c30_A 253 LRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQ 300 (321)
T ss_dssp HHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGG
T ss_pred HhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcc
Confidence 1122456667788899999999999999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=348.78 Aligned_cols=239 Identities=25% Similarity=0.356 Sum_probs=201.2
Q ss_pred hcCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
.++|++.+.||+|+||.||+|+..+|+.||+|++..........+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 36799999999999999999999889999999997654444445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++ ++.+++..... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 100 ~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 100 FMEK-DLKKVLDENKT--GLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp CCSE-EHHHHHHTCTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred CCCC-CHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 9985 88888875432 389999999999999999999999 99999999999999999999999999998875444
Q ss_pred CCceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCcccccc--------------------------
Q 035761 474 SNRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSSSS-------------------------- 526 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~-------------------------- 526 (560)
.......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.......
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 253 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW 253 (311)
T ss_dssp C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchh
Confidence 44455678999999999876 568999999999999999999999996443211
Q ss_pred ---------------------cccccccccccccCCCCCCChhHHHhhceeee
Q 035761 527 ---------------------SSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 527 ---------------------~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
.++.+.++.|...||..||+++++++|+|+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 306 (311)
T 3niz_A 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306 (311)
T ss_dssp HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccccc
Confidence 11234667788899999999999999999864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=348.65 Aligned_cols=237 Identities=23% Similarity=0.308 Sum_probs=206.8
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|++.+.||+|+||.||+|+.+ +|+.||+|++++... .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 57899999999999999999875 689999999976432 2344567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++|+|.+++...+ .+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 85 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 85 EYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 9999999999997643 389999999999999999999999 9999999999999999999999999999875444
Q ss_pred CCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------ccccccccccc
Q 035761 473 SSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNIKL 535 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~~~ 535 (560)
.......+||+.|+|||++.+..++.++||||+||++|||++|+.||...+. ....+...++.
T Consensus 159 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 238 (337)
T 1o6l_A 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 4445556799999999999999999999999999999999999999965432 12234566677
Q ss_pred ccccCCCCCC-----ChhHHHhhceee
Q 035761 536 IDLLDPRLPP-----PGDQMIRQGIIL 557 (560)
Q Consensus 536 ~~~~dp~~~p-----~~~~~~~~~~~~ 557 (560)
|...||..|| +++++++|+|+.
T Consensus 239 lL~~dP~~R~g~~~~~~~ei~~h~~f~ 265 (337)
T 1o6l_A 239 LLKKDPKQRLGGGPSDAKEVMEHRFFL 265 (337)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred HhhcCHHHhcCCCCCCHHHHHcCCCcC
Confidence 8889999998 899999999975
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=352.51 Aligned_cols=238 Identities=24% Similarity=0.373 Sum_probs=201.9
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchh-hhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLE-TELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKCMFL 390 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 390 (560)
.++|++.+.||+|+||.||+|+.+ +++.||||+++... ......+.+.+|..+++.+ +||||+++++++.+++..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 468999999999999999999875 58999999997643 2334556788999999988 79999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccC
Q 035761 391 IYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN 470 (560)
Q Consensus 391 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 470 (560)
||||+++|+|.+++..... +++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 102 v~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSRR---FDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 9999999999999976443 89999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------ccccccccc
Q 035761 471 YDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNI 533 (560)
Q Consensus 471 ~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~ 533 (560)
.........+||+.|+|||++.+..++.++||||+||++|||++|+.||...+. ....+...+
T Consensus 176 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 255 (353)
T 3txo_A 176 CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGIL 255 (353)
T ss_dssp C---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 444445556799999999999999999999999999999999999999975442 122345666
Q ss_pred ccccccCCCCCCCh------hHHHhhceee
Q 035761 534 KLIDLLDPRLPPPG------DQMIRQGIIL 557 (560)
Q Consensus 534 ~~~~~~dp~~~p~~------~~~~~~~~~~ 557 (560)
+.|...||..||++ +++++|+|+.
T Consensus 256 ~~lL~~dP~~R~~~~~~~~~~~il~hp~f~ 285 (353)
T 3txo_A 256 KSFMTKNPTMRLGSLTQGGEHAILRHPFFK 285 (353)
T ss_dssp HHHTCSSGGGSTTSGGGTCTHHHHTSGGGT
T ss_pred HHHhhhCHHHccCCcccCCHHHHhhCCccc
Confidence 77888899999998 8999999975
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=359.07 Aligned_cols=240 Identities=21% Similarity=0.282 Sum_probs=207.7
Q ss_pred HhcCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEE
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLI 391 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 391 (560)
..++|++.+.||+|+||.||+|.. .+|+.+|+|++..........+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 356799999999999999999976 4689999999876554444566789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeC---CCCcEEEeeeccccc
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLN---SEFEAFVADFGIARL 468 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg~~~~ 468 (560)
|||+++|+|.+++..... +++.++..++.||+.||+|||+. +|+||||||+||+++ .++.+||+|||++..
T Consensus 89 ~E~~~gg~L~~~i~~~~~---~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREY---YSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp ECCCBCCBHHHHHHHCSC---CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEeCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 999999999999976543 89999999999999999999999 999999999999998 467899999999988
Q ss_pred cCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------ccc
Q 035761 469 LNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------SSS 527 (560)
Q Consensus 469 ~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------~~~ 527 (560)
............||+.|+|||++.+..++.++||||+||++|||++|+.||...+. ...
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 242 (444)
T 3soa_A 163 VEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTP 242 (444)
T ss_dssp CCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred ecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCH
Confidence 76554444556799999999999999999999999999999999999999954331 223
Q ss_pred ccccccccccccCCCCCCChhHHHhhceeee
Q 035761 528 SLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 528 ~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
.+.+.++.|...||..||++.++++|+|+..
T Consensus 243 ~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 243 EAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred HHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 4556778888999999999999999999853
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=343.25 Aligned_cols=238 Identities=26% Similarity=0.354 Sum_probs=198.8
Q ss_pred cCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
++|++.+.||+|+||.||+|+..+|+.||+|++..........+.+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 46889999999999999999988899999999976544334446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
+++ +|.+++..... .+++.++..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp CSE-EHHHHHHTSTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 986 99998876432 389999999999999999999999 999999999999999999999999999987654333
Q ss_pred CceeeccccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCCCCCccccc----------------------------
Q 035761 475 NRTLLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKHPGELLSSS---------------------------- 525 (560)
Q Consensus 475 ~~~~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~---------------------------- 525 (560)
......||+.|+|||++.+. .++.++||||+||++|||++|+.||......
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence 34445789999999998764 5899999999999999999999999653311
Q ss_pred ------------------ccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 526 ------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 526 ------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
...+.+.++.|...||..||+++++++|+|+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 011124566788889999999999999999864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=348.20 Aligned_cols=238 Identities=24% Similarity=0.315 Sum_probs=205.9
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhh----hhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETEL----ASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCM 388 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 388 (560)
.+.|++.+.||+|+||.||+|..+ +|+.||+|.++...... ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 457899999999999999999875 58999999997644221 1346788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCC----cEEEeeec
Q 035761 389 FLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEF----EAFVADFG 464 (560)
Q Consensus 389 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg 464 (560)
++||||+++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 99999999999999997643 389999999999999999999999 999999999999998877 79999999
Q ss_pred cccccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc--------------------
Q 035761 465 IARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-------------------- 524 (560)
Q Consensus 465 ~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-------------------- 524 (560)
++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.....
T Consensus 165 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (361)
T 2yab_A 165 LAHEIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFS 243 (361)
T ss_dssp SCEECCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred CceEcCCC-CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhcc
Confidence 99876543 233445799999999999999999999999999999999999999964331
Q ss_pred -cccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 525 -SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 525 -~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
....+...++.|...||..||+++++++|+|+..
T Consensus 244 ~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 244 QTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred CCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 1223456778888999999999999999999863
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=353.25 Aligned_cols=238 Identities=24% Similarity=0.346 Sum_probs=202.6
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKCMFL 390 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 390 (560)
.++|++.+.||+|+||.||+|+.+ +++.||+|++++... .....+.+.+|..++.++ +||||+++++++.+++..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 357999999999999999999875 578899999976542 222334578899999887 89999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccC
Q 035761 391 IYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN 470 (560)
Q Consensus 391 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 470 (560)
||||+++|+|.+++...+. +++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 9999999999999976443 99999999999999999999999 99999999999999999999999999998754
Q ss_pred CCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc--------------------------
Q 035761 471 YDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-------------------------- 524 (560)
Q Consensus 471 ~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-------------------------- 524 (560)
.........+||+.|+|||++.+..++.++||||+||++|||++|+.||.....
T Consensus 205 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~ 284 (396)
T 4dc2_A 205 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 284 (396)
T ss_dssp CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTT
T ss_pred cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCc
Confidence 444455567899999999999999999999999999999999999999963321
Q ss_pred cccccccccccccccCCCCCCCh------hHHHhhceee
Q 035761 525 SSSSLDKNIKLIDLLDPRLPPPG------DQMIRQGIIL 557 (560)
Q Consensus 525 ~~~~~~~~~~~~~~~dp~~~p~~------~~~~~~~~~~ 557 (560)
.+..+...++.|...||..||.+ +++++|+|+.
T Consensus 285 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~ 323 (396)
T 4dc2_A 285 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 323 (396)
T ss_dssp SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTT
T ss_pred CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCcccc
Confidence 11223456677788899999985 7999999975
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=343.82 Aligned_cols=236 Identities=29% Similarity=0.435 Sum_probs=195.0
Q ss_pred HhcCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
..++|++.+.||+|+||.||+|+. .|+.||||++..........+.+.+|++++++++||||+++++++...+..++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 356789999999999999999987 5889999998765544455678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEEeCCCCCCeEeCCCCcEEEeeeccccccC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPP--ILHRDISSNNILLNSEFEAFVADFGIARLLN 470 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 470 (560)
||+++|+|.+++........+++.++..++.||+.||+|||+. + |+||||||+||+++.++.+||+|||+++...
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 9999999999998765444589999999999999999999998 8 9999999999999999999999999998654
Q ss_pred CCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-------------------ccccccc
Q 035761 471 YDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-------------------SSSSLDK 531 (560)
Q Consensus 471 ~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-------------------~~~~~~~ 531 (560)
..........||+.|+|||++.+..++.++||||||+++|||++|+.||..... ....+.+
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 270 (309)
T 3p86_A 191 STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAA 270 (309)
T ss_dssp -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHH
T ss_pred ccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHH
Confidence 433334456799999999999999999999999999999999999999975432 1223456
Q ss_pred ccccccccCCCCCCChhHHHh
Q 035761 532 NIKLIDLLDPRLPPPGDQMIR 552 (560)
Q Consensus 532 ~~~~~~~~dp~~~p~~~~~~~ 552 (560)
.++.|...||..||+++++++
T Consensus 271 li~~~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 271 IIEGCWTNEPWKRPSFATIMD 291 (309)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHH
Confidence 667788889999999999887
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=345.33 Aligned_cols=238 Identities=24% Similarity=0.341 Sum_probs=204.3
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKCMFLI 391 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 391 (560)
++|++.+.||+|+||.||+|+.+ +++.||+|++..... .....+.+.+|..+++++ +||||+++++++.+++..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 56899999999999999999875 588999999976542 234456788999999988 899999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 471 (560)
|||+++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 99999999999997643 389999999999999999999999 999999999999999999999999999987544
Q ss_pred CCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc--------------------------c
Q 035761 472 DSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS--------------------------S 525 (560)
Q Consensus 472 ~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~--------------------------~ 525 (560)
........+||+.|+|||++.+..++.++||||+||++|||++|+.||...+. .
T Consensus 163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~ 242 (345)
T 3a8x_A 163 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 242 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTS
T ss_pred CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCC
Confidence 44445556899999999999999999999999999999999999999964221 1
Q ss_pred ccccccccccccccCCCCCCCh------hHHHhhceeee
Q 035761 526 SSSLDKNIKLIDLLDPRLPPPG------DQMIRQGIILI 558 (560)
Q Consensus 526 ~~~~~~~~~~~~~~dp~~~p~~------~~~~~~~~~~~ 558 (560)
...+...++.|...||..||++ ++++.|+|+.+
T Consensus 243 s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 243 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp CHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred CHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 1223455677788899999996 79999999753
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=346.94 Aligned_cols=239 Identities=22% Similarity=0.353 Sum_probs=206.0
Q ss_pred HhcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCEEE
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKCMF 389 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 389 (560)
..++|++.+.||+|+||.||+|+.+ +|+.||+|+++.... .....+.+..|..++..+ +||||+++++++.+++..+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 4578999999999999999999875 588999999976432 223456678899999877 9999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccccc
Q 035761 390 LIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL 469 (560)
Q Consensus 390 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 469 (560)
+||||+++|+|.+++..... +++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 95 lv~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 99999999999999976433 89999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------cccccccc
Q 035761 470 NYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKN 532 (560)
Q Consensus 470 ~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~ 532 (560)
..........+||+.|+|||++.+..++.++||||+||++|||++|+.||...+. .+..+...
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 248 (345)
T 1xjd_A 169 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDL 248 (345)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred ccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHH
Confidence 4444445556799999999999999999999999999999999999999975432 12334566
Q ss_pred cccccccCCCCCCChh-HHHhhceee
Q 035761 533 IKLIDLLDPRLPPPGD-QMIRQGIIL 557 (560)
Q Consensus 533 ~~~~~~~dp~~~p~~~-~~~~~~~~~ 557 (560)
++.|...||..||++. ++.+|+|+.
T Consensus 249 i~~lL~~dp~~R~~~~~~i~~hp~f~ 274 (345)
T 1xjd_A 249 LVKLFVREPEKRLGVRGDIRQHPLFR 274 (345)
T ss_dssp HHHHSCSSGGGSBTTBSCGGGSGGGT
T ss_pred HHHHhcCCHhHcCCChHHHHcCcccc
Confidence 6778888999999998 999999875
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=342.26 Aligned_cols=236 Identities=24% Similarity=0.276 Sum_probs=205.0
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
.++|++.+.||+|+||.||+|... +++.||+|.+.... .....+.+|+++++.++||||+++++++.+.+..++||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc---ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 367899999999999999999875 57899999987543 22356889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCC--CCcEEEeeeccccccC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNS--EFEAFVADFGIARLLN 470 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~~~~~~ 470 (560)
||+++|+|.+++.... ..+++.++..++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||+++...
T Consensus 81 e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 81 EFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred EeCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 9999999999997543 2389999999999999999999999 9999999999999987 7899999999998875
Q ss_pred CCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------ccccc
Q 035761 471 YDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------SSSSL 529 (560)
Q Consensus 471 ~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------~~~~~ 529 (560)
.. .......||+.|+|||++.+..++.++||||+|+++|||++|+.||..... ....+
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 234 (321)
T 1tki_A 156 PG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234 (321)
T ss_dssp TT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred CC-CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHH
Confidence 32 334456799999999999998899999999999999999999999965432 12334
Q ss_pred ccccccccccCCCCCCChhHHHhhceeee
Q 035761 530 DKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 530 ~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
.+.++.|...||..||++.++++|+|+..
T Consensus 235 ~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 263 (321)
T 1tki_A 235 MDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred HHHHHHHcCCChhHCcCHHHHhcChhhcc
Confidence 56678888999999999999999999864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=344.97 Aligned_cols=236 Identities=24% Similarity=0.350 Sum_probs=202.1
Q ss_pred cCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|.+.+.||+|+||.||+|.. .+++.||||++..... .......+.+|+.+++.++||||+++++++..++..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5789999999999999999986 5789999999875432 2233457889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+ +|+|.+++..... +++.++..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 89 E~~-~g~l~~~l~~~~~---l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKKR---MTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp CCC-CEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred ECC-CCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 999 6899998875433 89999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCCceeeccccCccCccccccCcc-CcchhHHHHHHHHHHHHhCCCCCCcccc-----------------cccccccccc
Q 035761 473 SSNRTLLAGTYGSIAPELAYTMVV-TEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNIK 534 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~~~~-~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~~ 534 (560)
......+||+.|+|||++.+..+ ++++||||+||++|||++|+.||..... ....+.+.++
T Consensus 162 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 240 (336)
T 3h4j_B 162 -NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIR 240 (336)
T ss_dssp -BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHH
T ss_pred -cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence 23344579999999999988876 6799999999999999999999975432 1123445667
Q ss_pred cccccCCCCCCChhHHHhhceeee
Q 035761 535 LIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 535 ~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
.|...||..||+++++++|+|+..
T Consensus 241 ~~L~~dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 241 RMIVADPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp TTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred HHcCCChhHCcCHHHHHhChhhcc
Confidence 788899999999999999999753
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=339.86 Aligned_cols=235 Identities=27% Similarity=0.388 Sum_probs=204.7
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|++.+.||+|+||.||+|+.+ +|+.||+|+++.... .....+.+.+|..+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 56899999999999999999875 689999999976432 2344567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++|+|.+++..... +++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~- 158 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQR---FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD- 158 (318)
T ss_dssp CCCCSCBHHHHHHHTSS---CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred eCCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC-
Confidence 99999999999986543 89999999999999999999999 999999999999999999999999999987543
Q ss_pred CCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------ccccccccccc
Q 035761 473 SSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNIKL 535 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~~~ 535 (560)
.....+||+.|+|||++.+..++.++||||+||++|||++|+.||...+. ....+...++.
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 236 (318)
T 1fot_A 159 --VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSR 236 (318)
T ss_dssp --CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred --ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 22345799999999999999999999999999999999999999964432 12234556677
Q ss_pred ccccCCCCCC-----ChhHHHhhceeee
Q 035761 536 IDLLDPRLPP-----PGDQMIRQGIILI 558 (560)
Q Consensus 536 ~~~~dp~~~p-----~~~~~~~~~~~~~ 558 (560)
|...||..|| ++++++.|+|+..
T Consensus 237 lL~~dp~~R~~~~~~~~~~i~~hp~f~~ 264 (318)
T 1fot_A 237 LITRDLSQRLGNLQNGTEDVKNHPWFKE 264 (318)
T ss_dssp HTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred HhccCHHHcCCCcCCCHHHHhcCccccC
Confidence 8888999999 8999999999853
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=347.98 Aligned_cols=239 Identities=23% Similarity=0.350 Sum_probs=206.1
Q ss_pred HhcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEE
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLI 391 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 391 (560)
..++|++.+.||+|+||.||+|..+ +|+.||+|++..........+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3467999999999999999999865 589999999976544444556789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCC---cEEEeeeccccc
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEF---EAFVADFGIARL 468 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfg~~~~ 468 (560)
|||+++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++ .+||+|||++..
T Consensus 107 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 99999999999987643 389999999999999999999999 999999999999998654 599999999987
Q ss_pred cCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------ccc
Q 035761 469 LNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------SSS 527 (560)
Q Consensus 469 ~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------~~~ 527 (560)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...+. ...
T Consensus 181 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 259 (362)
T 2bdw_A 181 VNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP 259 (362)
T ss_dssp CTTC-CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCH
T ss_pred ecCC-cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 6532 233445799999999999999999999999999999999999999964331 122
Q ss_pred ccccccccccccCCCCCCChhHHHhhceeee
Q 035761 528 SLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 528 ~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
.+.+.+..|...||..||++.++++|+|+..
T Consensus 260 ~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 260 EAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 3456677888899999999999999999853
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=338.67 Aligned_cols=238 Identities=21% Similarity=0.288 Sum_probs=201.0
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
++|++.+.||+|+||.||+|... +++.||||++..........+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46889999999999999999875 58999999997655444455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++ ++.+++.... ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 9986 5655555432 2389999999999999999999999 99999999999999999999999999998876544
Q ss_pred CCceeeccccCccCccccccCc-cCcchhHHHHHHHHHHHHhCCCCCCccccc---------------------------
Q 035761 474 SNRTLLAGTYGSIAPELAYTMV-VTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------------------- 525 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~~~-~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------------------- 525 (560)
.......||+.|+|||++.+.. ++.++||||+||++|||++|..||....+.
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence 4455567899999999988766 799999999999999999988885322210
Q ss_pred --------------------ccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 526 --------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 526 --------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
...+.+.++.|...||..||+++++++|+|+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 288 (292)
T 3o0g_A 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccccc
Confidence 112235667788899999999999999999864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=346.53 Aligned_cols=242 Identities=21% Similarity=0.272 Sum_probs=205.4
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhh---hhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETE---LASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMF 389 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 389 (560)
.++|++.+.||+|+||.||+|..+ +++.||||++...... ....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 356899999999999999999864 6899999998654321 123567899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCC-cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCc---EEEeeecc
Q 035761 390 LIYEYMEMGSLFCILRTDE-EAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFE---AFVADFGI 465 (560)
Q Consensus 390 lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg~ 465 (560)
+||||+++|+|.+++.... ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999988876432 223489999999999999999999999 9999999999999987655 99999999
Q ss_pred ccccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc--------------------c
Q 035761 466 ARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS--------------------S 525 (560)
Q Consensus 466 ~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~--------------------~ 525 (560)
++.............||+.|+|||++.+..++.++||||+||++|||++|+.||..... .
T Consensus 180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (351)
T 3c0i_A 180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHI 259 (351)
T ss_dssp CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHHTCCCCCHHHHTTS
T ss_pred eeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHcCCCCCCccccccC
Confidence 98876544434456799999999999999999999999999999999999999964321 1
Q ss_pred ccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 526 SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 526 ~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
...+.+.++.|...||..||++.++++|+|+..
T Consensus 260 s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 260 SESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 233456677888999999999999999999853
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=340.15 Aligned_cols=238 Identities=26% Similarity=0.308 Sum_probs=199.3
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
++|++.+.||+|+||.||+|... +|+.||||++..........+.+.+|++++++++||||+++++++..++..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57889999999999999999875 58999999987655444556678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++++|.+++..... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~~~l~~~~~~~~~---~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDRYQRG---VPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHHTSSC---CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHhhhcC---CCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 9999999998875443 89999999999999999999999 99999999999999999999999999998876544
Q ss_pred CCceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCccccc---------------------------
Q 035761 474 SNRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------------------- 525 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------------------- 525 (560)
.......||+.|+|||++.+ ..++.++||||+|+++|||++|+.||......
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence 44455678999999999876 66899999999999999999999999654321
Q ss_pred ---------------------ccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 526 ---------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 526 ---------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
...+.+.++.|...||..||+++++++|+|+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 290 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFEN 290 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTT
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHh
Confidence 111334677788999999999999999999875
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=356.64 Aligned_cols=245 Identities=25% Similarity=0.300 Sum_probs=202.5
Q ss_pred HHHHHHhcCCcccceeeccCCeeEEEEEeCC-CcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC
Q 035761 308 QDMIEATEDFDIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHE 385 (560)
Q Consensus 308 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 385 (560)
.++....++|++.+.||+|+||.||+|+.+. ++.||+|++++... .....+.+.+|..++..++||||+++++++.++
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 146 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD 146 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 3444456789999999999999999998764 78999999976432 122233488999999999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecc
Q 035761 386 KCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGI 465 (560)
Q Consensus 386 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 465 (560)
+..++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+. +||||||||+|||++.++.+||+|||+
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~~--~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGl 221 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGS 221 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEecCCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhh
Confidence 99999999999999999998632 2389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCC-ceeeccccCccCccccc-----cCccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------
Q 035761 466 ARLLNYDSSN-RTLLAGTYGSIAPELAY-----TMVVTEKYDVYSFGVVALEVLMGKHPGELLSS--------------- 524 (560)
Q Consensus 466 ~~~~~~~~~~-~~~~~g~~~~~aPE~~~-----~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~--------------- 524 (560)
++........ ....+||+.|+|||++. ...++.++|||||||++|||++|+.||...+.
T Consensus 222 a~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~ 301 (437)
T 4aw2_A 222 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ 301 (437)
T ss_dssp CEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC
T ss_pred hhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccccc
Confidence 9876543332 23357999999999987 56789999999999999999999999964431
Q ss_pred -------cccccccccccccccCCCC--CCChhHHHhhceee
Q 035761 525 -------SSSSLDKNIKLIDLLDPRL--PPPGDQMIRQGIIL 557 (560)
Q Consensus 525 -------~~~~~~~~~~~~~~~dp~~--~p~~~~~~~~~~~~ 557 (560)
.+......++.+...+|+. ||+++++++|+|+.
T Consensus 302 ~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~ 343 (437)
T 4aw2_A 302 FPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFS 343 (437)
T ss_dssp CCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGT
T ss_pred CCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccC
Confidence 1122333444555556776 99999999999985
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=343.87 Aligned_cols=237 Identities=27% Similarity=0.374 Sum_probs=200.5
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
++|++.+.||+|+||.||+|... +++.||||++..... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 57999999999999999999875 789999999865432 1233568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++|+|.+++..... +++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.+....
T Consensus 86 ~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSBTTTB---CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 9999999999976433 89999999999999999999999 99999999999999999999999999998764322
Q ss_pred --CCceeeccccCccCccccccCcc-CcchhHHHHHHHHHHHHhCCCCCCccccc--------------------ccccc
Q 035761 474 --SNRTLLAGTYGSIAPELAYTMVV-TEKYDVYSFGVVALEVLMGKHPGELLSSS--------------------SSSLD 530 (560)
Q Consensus 474 --~~~~~~~g~~~~~aPE~~~~~~~-~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------------~~~~~ 530 (560)
.......||+.|+|||++.+..+ +.++||||+|+++|||++|+.||...... ...+.
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHH
Confidence 22234578999999999988775 67899999999999999999999754431 12234
Q ss_pred cccccccccCCCCCCChhHHHhhceeee
Q 035761 531 KNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 531 ~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
+.++.|...||..||+++++++|+|+..
T Consensus 240 ~li~~~L~~dP~~R~t~~eil~h~~~~~ 267 (323)
T 3tki_A 240 ALLHKILVENPSARITIPDIKKDRWYNK 267 (323)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred HHHHHHccCChhhCcCHHHHhhChhhcc
Confidence 5567788899999999999999999864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=355.32 Aligned_cols=242 Identities=22% Similarity=0.274 Sum_probs=202.4
Q ss_pred HHHHhcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCE
Q 035761 310 MIEATEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKC 387 (560)
Q Consensus 310 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 387 (560)
+....++|++.+.||+|+||.||+|+.+ +++.||+|++++... .....+.+.+|..+++.++||||+++++++.+++.
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 3344578999999999999999999875 588999999976432 22233457899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccc
Q 035761 388 MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIAR 467 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~ 467 (560)
.++||||+++|+|.++++.. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 144 ~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp EEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeE
Confidence 99999999999999999753 289999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC-CceeeccccCccCccccccCc----cCcchhHHHHHHHHHHHHhCCCCCCcccc------------------
Q 035761 468 LLNYDSS-NRTLLAGTYGSIAPELAYTMV----VTEKYDVYSFGVVALEVLMGKHPGELLSS------------------ 524 (560)
Q Consensus 468 ~~~~~~~-~~~~~~g~~~~~aPE~~~~~~----~~~~~Dv~s~G~il~el~~g~~P~~~~~~------------------ 524 (560)
....... .....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.
T Consensus 217 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 296 (410)
T 3v8s_A 217 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD 296 (410)
T ss_dssp ECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCT
T ss_pred eeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCC
Confidence 7653322 123457999999999988765 78899999999999999999999964431
Q ss_pred ---cccccccccccccccCCCC--CCChhHHHhhceeee
Q 035761 525 ---SSSSLDKNIKLIDLLDPRL--PPPGDQMIRQGIILI 558 (560)
Q Consensus 525 ---~~~~~~~~~~~~~~~dp~~--~p~~~~~~~~~~~~~ 558 (560)
.+..+...++.|...+|.. ||+++++++|+|+.+
T Consensus 297 ~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~ 335 (410)
T 3v8s_A 297 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 335 (410)
T ss_dssp TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence 1122344555666667777 999999999999864
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=346.32 Aligned_cols=252 Identities=38% Similarity=0.663 Sum_probs=212.4
Q ss_pred CCCcCHHHHHHHhcCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeE
Q 035761 302 DGRITFQDMIEATEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGF 381 (560)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 381 (560)
...+++.++....++|+..+.||+|+||.||+|+.++++.||||++...... .....+.+|+++++.++||||++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEE
Confidence 3467889999999999999999999999999999888999999999764432 222368899999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCCHHHHhhcCCc-ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEE
Q 035761 382 CLHEKCMFLIYEYMEMGSLFCILRTDEE-AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFV 460 (560)
Q Consensus 382 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 460 (560)
+..++..++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+...++|+||||||+||+++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 9999999999999999999999986532 334899999999999999999999987779999999999999999999999
Q ss_pred eeeccccccCCCCCC-ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc--------------
Q 035761 461 ADFGIARLLNYDSSN-RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS-------------- 525 (560)
Q Consensus 461 ~Dfg~~~~~~~~~~~-~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~-------------- 525 (560)
+|||+++........ .....||+.|+|||++.+..++.++||||||+++|||++|+.||+.....
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred ccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 999999876543332 23345899999999999999999999999999999999999999521100
Q ss_pred ----------------------ccccccccccccccCCCCCCChhHHHhhc
Q 035761 526 ----------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQG 554 (560)
Q Consensus 526 ----------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~ 554 (560)
...+.+.+..|...||..||++++++++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 306 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306 (326)
T ss_dssp TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHh
Confidence 01234555677888999999999999873
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=343.84 Aligned_cols=238 Identities=22% Similarity=0.287 Sum_probs=205.7
Q ss_pred hcCCcccceeeccCCeeEEEEEeCC-CcEEEEEEccchhh-hhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRLET-ELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKCMFL 390 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 390 (560)
.++|++.+.||+|+||.||+|+.+. ++.||+|+++.... .....+.+.+|..++..+ +||||+++++++.+.+..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 4679999999999999999998764 78999999976542 234456788999999988 89999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccC
Q 035761 391 IYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN 470 (560)
Q Consensus 391 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 470 (560)
||||+++|+|.+++...+. +++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 99 v~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVGR---FKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEeCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 9999999999999976433 89999999999999999999999 99999999999999999999999999998754
Q ss_pred CCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------ccccccccc
Q 035761 471 YDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNI 533 (560)
Q Consensus 471 ~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~ 533 (560)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+. ....+...+
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 252 (353)
T 2i0e_A 173 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAIC 252 (353)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred cCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 444445556799999999999999999999999999999999999999975432 122345666
Q ss_pred ccccccCCCCCCC-----hhHHHhhceee
Q 035761 534 KLIDLLDPRLPPP-----GDQMIRQGIIL 557 (560)
Q Consensus 534 ~~~~~~dp~~~p~-----~~~~~~~~~~~ 557 (560)
+.|...||..||. +++++.|+|+.
T Consensus 253 ~~lL~~dP~~R~~~~~~~~~~i~~h~~f~ 281 (353)
T 2i0e_A 253 KGLMTKHPGKRLGCGPEGERDIKEHAFFR 281 (353)
T ss_dssp HHHTCSCTTSCTTCSTTHHHHHHTSGGGT
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhcCcccc
Confidence 7788889999995 58999999874
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=340.03 Aligned_cols=238 Identities=24% Similarity=0.333 Sum_probs=204.8
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhh----hhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETEL----ASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCM 388 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 388 (560)
.+.|++.+.||+|+||.||+|... +|+.||+|.+....... ...+.+.+|+.+++.++||||+++++++..++..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356889999999999999999875 58999999987543211 1356788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCC----cEEEeeec
Q 035761 389 FLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEF----EAFVADFG 464 (560)
Q Consensus 389 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg 464 (560)
++||||+++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSS---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 99999999999999997643 389999999999999999999999 999999999999999887 79999999
Q ss_pred cccccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc--------------------
Q 035761 465 IARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-------------------- 524 (560)
Q Consensus 465 ~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-------------------- 524 (560)
+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.....
T Consensus 164 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (326)
T 2y0a_A 164 LAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242 (326)
T ss_dssp TCEECCTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred CCeECCCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccc
Confidence 998765332 23345699999999999999999999999999999999999999964331
Q ss_pred -cccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 525 -SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 525 -~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
....+.+.++.|...||..||++.++++|+|+..
T Consensus 243 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 277 (326)
T 2y0a_A 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277 (326)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence 1223445667888999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=338.43 Aligned_cols=237 Identities=21% Similarity=0.231 Sum_probs=195.5
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|+..+.||+|+||.||+|... +|+.||||++............+..|+..+..+ +||||+++++++.+++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57999999999999999999876 689999999865443333334455566555555 9999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+ +++|.+++.... ..+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 137 e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp ECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred ecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 999 679988887643 2499999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc----------------cccccccccccc
Q 035761 473 SSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS----------------SSSSLDKNIKLI 536 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~----------------~~~~~~~~~~~~ 536 (560)
.......||+.|+|||++.+ .++.++|||||||++|||++|..|+..... ....+.+.++.|
T Consensus 211 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 288 (311)
T 3p1a_A 211 -GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMM 288 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTTTCCCHHHHTTSCHHHHHHHHHH
T ss_pred -CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhccCCCcccccCCCHHHHHHHHHH
Confidence 22334568999999998876 689999999999999999999766542221 233456777888
Q ss_pred cccCCCCCCChhHHHhhceeeec
Q 035761 537 DLLDPRLPPPGDQMIRQGIILIS 559 (560)
Q Consensus 537 ~~~dp~~~p~~~~~~~~~~~~~~ 559 (560)
...||..||+++++++++|+..|
T Consensus 289 L~~dP~~Rpt~~ell~hp~~~~p 311 (311)
T 3p1a_A 289 LEPDPKLRATAEALLALPVLRQP 311 (311)
T ss_dssp SCSSTTTSCCHHHHHTSGGGSCC
T ss_pred cCCChhhCcCHHHHHhCccccCC
Confidence 99999999999999999999765
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=341.65 Aligned_cols=228 Identities=25% Similarity=0.294 Sum_probs=178.9
Q ss_pred cceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccC-CCCcceeeeEEEeCCEEEEEEeccCC
Q 035761 320 KYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIR-HRNIVKLYGFCLHEKCMFLIYEYMEM 397 (560)
Q Consensus 320 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (560)
.+.||+|+||.||+|..+ +++.||||++.... ...+.+|+.+++.++ ||||+++++++.++...++||||+++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~ 90 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM-----EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG 90 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG-----HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChhh-----hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence 377999999999999875 58999999986532 346778999999996 99999999999999999999999999
Q ss_pred CCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCC---cEEEeeeccccccCCCCC
Q 035761 398 GSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEF---EAFVADFGIARLLNYDSS 474 (560)
Q Consensus 398 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfg~~~~~~~~~~ 474 (560)
|+|.+++..... +++.++..++.||+.||+|||+. +|+||||||+||+++.++ .+||+|||+++.......
T Consensus 91 ~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 164 (325)
T 3kn6_A 91 GELFERIKKKKH---FSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164 (325)
T ss_dssp CBHHHHHHHCSC---CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred CcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence 999999987543 89999999999999999999999 999999999999997765 799999999987655444
Q ss_pred CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc----------------------------cc
Q 035761 475 NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS----------------------------SS 526 (560)
Q Consensus 475 ~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~----------------------------~~ 526 (560)
......||+.|+|||++.+..++.++||||+|+++|||++|+.||...+. ..
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s 244 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVS 244 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSC
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCC
Confidence 44556789999999999999999999999999999999999999975332 12
Q ss_pred cccccccccccccCCCCCCChhHHHhhceeee
Q 035761 527 SSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 527 ~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
..+.+.++.|...||..||+++++++|+|+..
T Consensus 245 ~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~ 276 (325)
T 3kn6_A 245 QEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQD 276 (325)
T ss_dssp HHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCT
T ss_pred HHHHHHHHHHCCCChhHCCCHHHHhcChhhcc
Confidence 33455677888899999999999999999975
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=341.58 Aligned_cols=234 Identities=24% Similarity=0.318 Sum_probs=205.0
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|++.+.||+|+||.||+|+.+ +|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57899999999999999999875 689999999976542 2345567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++|+|.+++..... +++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC
Confidence 99999999999986433 89999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------ccccccccccc
Q 035761 473 SSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNIKL 535 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~~~ 535 (560)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+...++.
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 271 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHH
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 2345799999999999999999999999999999999999999964431 12334566677
Q ss_pred ccccCCCCCCC-----hhHHHhhceee
Q 035761 536 IDLLDPRLPPP-----GDQMIRQGIIL 557 (560)
Q Consensus 536 ~~~~dp~~~p~-----~~~~~~~~~~~ 557 (560)
|...||..||+ ++++++|+|+.
T Consensus 272 lL~~dp~~R~~~~~~~~~ei~~h~~f~ 298 (350)
T 1rdq_E 272 LLQVDLTKRFGNLKNGVNDIKNHKWFA 298 (350)
T ss_dssp HSCSCTTTCTTSSTTTTHHHHTSGGGT
T ss_pred HhhcCHHhccCCccCCHHHHHhCcCcC
Confidence 88899999998 99999999975
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=343.56 Aligned_cols=241 Identities=20% Similarity=0.313 Sum_probs=202.3
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCC------
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEK------ 386 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 386 (560)
.++|++.+.||+|+||.||+|+.+ +|+.||||++..... ....+.+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR-ELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCST-TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCc-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 457899999999999999999876 789999999875432 234567899999999999999999999986543
Q ss_pred ---------------------------------------------------EEEEEEeccCCCCHHHHhhcCCcccCCCH
Q 035761 387 ---------------------------------------------------CMFLIYEYMEMGSLFCILRTDEEAVGLDW 415 (560)
Q Consensus 387 ---------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~ 415 (560)
..++||||+++|+|.+++.........++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 37999999999999999988766556788
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC------------Cceeecccc
Q 035761 416 TKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS------------NRTLLAGTY 483 (560)
Q Consensus 416 ~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~------------~~~~~~g~~ 483 (560)
..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....... ......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 88999999999999999999 999999999999999999999999999987754321 122346899
Q ss_pred CccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc----------------cccccccccccccccCCCCCCCh
Q 035761 484 GSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS----------------SSSSLDKNIKLIDLLDPRLPPPG 547 (560)
Q Consensus 484 ~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~----------------~~~~~~~~~~~~~~~dp~~~p~~ 547 (560)
.|+|||++.+..++.++||||+|+++|||++|..|+..... ....+...++.|...||..||++
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 320 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEA 320 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCH
Confidence 99999999999999999999999999999999888642211 11234556788899999999999
Q ss_pred hHHHhhceeee
Q 035761 548 DQMIRQGIILI 558 (560)
Q Consensus 548 ~~~~~~~~~~~ 558 (560)
+++++|+|+.+
T Consensus 321 ~~~l~~~~f~~ 331 (332)
T 3qd2_B 321 TDIIENAIFEN 331 (332)
T ss_dssp HHHHHSTTCCC
T ss_pred HHHhhchhhhc
Confidence 99999999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=337.65 Aligned_cols=236 Identities=22% Similarity=0.294 Sum_probs=196.2
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhh------------------------hhhHHHHHHHHHHHhc
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETE------------------------LASLESFQNEARLLSQ 369 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------------------------~~~~~~~~~e~~~l~~ 369 (560)
++|++.+.||+|+||.||+|... +++.||||++...... ....+.+.+|+++++.
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 57899999999999999999864 6889999998654311 1123468899999999
Q ss_pred cCCCCcceeeeEEEe--CCEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 035761 370 IRHRNIVKLYGFCLH--EKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISS 447 (560)
Q Consensus 370 l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~ 447 (560)
++||||+++++++.+ .+..++||||+++|+|.+++... .+++.++..++.||+.||+|||+. +|+||||||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp 165 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK----PLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKP 165 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCG
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCH
Confidence 999999999999987 56899999999999998876432 389999999999999999999999 999999999
Q ss_pred CCeEeCCCCcEEEeeeccccccCCCCCCceeeccccCccCccccccCc---cCcchhHHHHHHHHHHHHhCCCCCCcccc
Q 035761 448 NNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMV---VTEKYDVYSFGVVALEVLMGKHPGELLSS 524 (560)
Q Consensus 448 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~---~~~~~Dv~s~G~il~el~~g~~P~~~~~~ 524 (560)
+||+++.++.+||+|||+++.............||+.|+|||++.+.. ++.++||||||+++|||++|+.||.....
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 999999999999999999987754444344567999999999988765 47789999999999999999999964321
Q ss_pred -------------------cccccccccccccccCCCCCCChhHHHhhceee
Q 035761 525 -------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 525 -------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
....+.+.++.|...||..||+++++++|+|+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 246 MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 123355677888899999999999999999974
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=342.32 Aligned_cols=238 Identities=23% Similarity=0.329 Sum_probs=194.2
Q ss_pred cCCcccceeeccCCeeEEEEEe----CCCcEEEEEEccchhh--hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL----PSGKVVALKKLHRLET--ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCM 388 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 388 (560)
++|++.+.||+|+||.||+|+. .+++.||+|+++.... .......+.+|+.+++.++||||+++++++..++..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 5799999999999999999986 4789999999976431 223345678899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccc
Q 035761 389 FLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARL 468 (560)
Q Consensus 389 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 468 (560)
++||||+++|+|.+++..... +++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 97 YLILEYLSGGELFMQLEREGI---FMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEECCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEeCCCCCcHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 999999999999999976433 89999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------ccccccc
Q 035761 469 LNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDK 531 (560)
Q Consensus 469 ~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~ 531 (560)
............||+.|+|||++.+..++.++||||||+++|||++|+.||..... ....+.+
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 250 (327)
T 3a62_A 171 SIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARD 250 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHHH
T ss_pred cccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 54333334445799999999999999999999999999999999999999975432 1223456
Q ss_pred ccccccccCCCCCC-----ChhHHHhhceeee
Q 035761 532 NIKLIDLLDPRLPP-----PGDQMIRQGIILI 558 (560)
Q Consensus 532 ~~~~~~~~dp~~~p-----~~~~~~~~~~~~~ 558 (560)
.++.|...||..|| +++++++|+|+..
T Consensus 251 li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~ 282 (327)
T 3a62_A 251 LLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282 (327)
T ss_dssp HHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred HHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence 66778888999998 7889999999854
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=343.85 Aligned_cols=236 Identities=25% Similarity=0.354 Sum_probs=203.0
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchh-hhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLE-TELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 56899999999999999999865 58899999997644 23345567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++|+|.+++..... +++.++..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+++.....
T Consensus 95 e~~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNVH---FKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHHTTCC---CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 99999999999986443 89999999999999999999999 9999999999999999999999999999876532
Q ss_pred CCCceeeccccCccCcccccc---CccCcchhHHHHHHHHHHHHhCCCCCCcccc--------------------ccccc
Q 035761 473 SSNRTLLAGTYGSIAPELAYT---MVVTEKYDVYSFGVVALEVLMGKHPGELLSS--------------------SSSSL 529 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~---~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~--------------------~~~~~ 529 (560)
......+||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ....+
T Consensus 169 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~ 247 (384)
T 4fr4_A 169 -TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEM 247 (384)
T ss_dssp -CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred -CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHHH
Confidence 33445679999999999874 4588899999999999999999999974332 12234
Q ss_pred ccccccccccCCCCCCC-hhHHHhhceee
Q 035761 530 DKNIKLIDLLDPRLPPP-GDQMIRQGIIL 557 (560)
Q Consensus 530 ~~~~~~~~~~dp~~~p~-~~~~~~~~~~~ 557 (560)
...++.|...||..||+ ++++..|+|+.
T Consensus 248 ~~li~~lL~~dP~~R~s~~~~l~~hp~f~ 276 (384)
T 4fr4_A 248 VSLLKKLLEPNPDQRFSQLSDVQNFPYMN 276 (384)
T ss_dssp HHHHHHHSCSSGGGSCCSHHHHHTSGGGT
T ss_pred HHHHHHHhcCCHhHhcccHHHHHcChhhh
Confidence 45667788889999998 88999988875
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=347.46 Aligned_cols=241 Identities=18% Similarity=0.283 Sum_probs=205.6
Q ss_pred hcCCcccceeecc--CCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEE
Q 035761 314 TEDFDIKYCIGTG--GYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFL 390 (560)
Q Consensus 314 ~~~~~~~~~ig~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 390 (560)
.++|++.+.||+| +||.||+|+.. +++.||||++..........+.+.+|+.+++.++||||+++++++..++..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4679999999999 99999999876 68999999998765444556778899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccC
Q 035761 391 IYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN 470 (560)
Q Consensus 391 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 470 (560)
||||+++|+|.+++..... ..+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||.+....
T Consensus 104 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFM-DGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 9999999999999976532 2389999999999999999999999 99999999999999999999999999986543
Q ss_pred CCC-------CCceeeccccCccCcccccc--CccCcchhHHHHHHHHHHHHhCCCCCCcccccc---------------
Q 035761 471 YDS-------SNRTLLAGTYGSIAPELAYT--MVVTEKYDVYSFGVVALEVLMGKHPGELLSSSS--------------- 526 (560)
Q Consensus 471 ~~~-------~~~~~~~g~~~~~aPE~~~~--~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~--------------- 526 (560)
... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.......
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence 211 11122468899999999987 678999999999999999999999997543211
Q ss_pred ------------------------------------------------cccccccccccccCCCCCCChhHHHhhceeee
Q 035761 527 ------------------------------------------------SSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 527 ------------------------------------------------~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
..+.+.++.|...||..||+++++++|+|+..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~ 339 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 339 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGG
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHH
Confidence 11334667788999999999999999999863
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=339.64 Aligned_cols=240 Identities=23% Similarity=0.333 Sum_probs=188.7
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
.++|++.+.||+|+||.||+|..+ +|+.||+|+++.... ....+.+.+|+++++.++||||+++++++..++..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 457889999999999999999865 589999999875432 223356789999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCC---cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccccc
Q 035761 393 EYMEMGSLFCILRTDE---EAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL 469 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 469 (560)
||++ |+|.+++.... ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9998 59999886532 123489999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCCceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCccccc-----------------------
Q 035761 470 NYDSSNRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSSS----------------------- 525 (560)
Q Consensus 470 ~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~----------------------- 525 (560)
...........||+.|+|||++.+ ..++.++||||+||++|||++|+.||......
T Consensus 159 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 159 GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp TSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred CCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 544444445578999999999876 46899999999999999999999999643310
Q ss_pred ----------------------------ccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 526 ----------------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 526 ----------------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
...+.+.++.|...||..||+++++++|+|+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 299 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAE 299 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGG
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhc
Confidence 112334556788889999999999999999863
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=343.46 Aligned_cols=237 Identities=23% Similarity=0.308 Sum_probs=204.5
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
.++|++.+.||+|+||.||+|... +|+.||+|.+..... .....+.+|+++++.++||||+++++++.+.+..++||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP--LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch--hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence 357999999999999999999865 688999999875432 23357889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCC--CCcEEEeeeccccccC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNS--EFEAFVADFGIARLLN 470 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~~~~~~ 470 (560)
||+++|+|.+++.... ..+++.++..++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||+++...
T Consensus 128 E~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 128 EFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp ECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EcCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 9999999999997543 2389999999999999999999999 9999999999999974 4779999999998865
Q ss_pred CCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------ccccc
Q 035761 471 YDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------SSSSL 529 (560)
Q Consensus 471 ~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------~~~~~ 529 (560)
.. .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ....+
T Consensus 203 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 281 (387)
T 1kob_A 203 PD-EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA 281 (387)
T ss_dssp TT-SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHH
T ss_pred CC-cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHH
Confidence 33 233445799999999999999999999999999999999999999975431 12234
Q ss_pred ccccccccccCCCCCCChhHHHhhceeee
Q 035761 530 DKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 530 ~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
.+.++.|...||..||+++++++|+|+..
T Consensus 282 ~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (387)
T 1kob_A 282 KDFIKNLLQKEPRKRLTVHDALEHPWLKG 310 (387)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred HHHHHHHcCCChhHCcCHHHHhhCccccC
Confidence 56677888999999999999999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=330.34 Aligned_cols=239 Identities=25% Similarity=0.411 Sum_probs=184.4
Q ss_pred cCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|++.+.||+|+||.||+|.. .+|+.||||.+..... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 5688999999999999999986 4789999999975432 2233567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++++|.+++.... ..+++.++..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 91 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp ECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred ecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 9999999999998643 2389999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc-----------------cccccccccc
Q 035761 473 SSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS-----------------SSSLDKNIKL 535 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~-----------------~~~~~~~~~~ 535 (560)
........|++.|+|||.+.+..++.++||||+|+++|||++|+.||...... ...+.+.++.
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 245 (278)
T 3cok_A 166 HEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQ 245 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHHH
T ss_pred CCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHHH
Confidence 33334457899999999999989999999999999999999999999754321 1223456677
Q ss_pred ccccCCCCCCChhHHHhhceeee
Q 035761 536 IDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 536 ~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
|...||..||+++++++|+|+..
T Consensus 246 ~l~~dp~~Rps~~~~l~h~~~~~ 268 (278)
T 3cok_A 246 LLRRNPADRLSLSSVLDHPFMSR 268 (278)
T ss_dssp HSCSSGGGSCCHHHHTTSTTTC-
T ss_pred HcccCHhhCCCHHHHhcCccccC
Confidence 88899999999999999999865
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=332.40 Aligned_cols=231 Identities=27% Similarity=0.445 Sum_probs=195.2
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
++|...+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD--EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence 56888999999999999999875 58999999886533 3445678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++|+|.+++..... .+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 88 ~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 88 YIKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp CCTTCBHHHHHHHCCT--TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred ecCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 9999999999986432 389999999999999999999999 99999999999999999999999999998764322
Q ss_pred CCc--------------eeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc--------------
Q 035761 474 SNR--------------TLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS-------------- 525 (560)
Q Consensus 474 ~~~--------------~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~-------------- 525 (560)
... ....||+.|+|||++.+..++.++||||||+++|||++|..||......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR 242 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc
Confidence 111 1346899999999999999999999999999999999999998653321
Q ss_pred ------ccccccccccccccCCCCCCChhHHHh
Q 035761 526 ------SSSLDKNIKLIDLLDPRLPPPGDQMIR 552 (560)
Q Consensus 526 ------~~~~~~~~~~~~~~dp~~~p~~~~~~~ 552 (560)
...+.+.+..|...||..||+++++++
T Consensus 243 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 243 YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 123445666777778888888887765
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=349.64 Aligned_cols=244 Identities=23% Similarity=0.313 Sum_probs=201.1
Q ss_pred HHHHHHhcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC
Q 035761 308 QDMIEATEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHE 385 (560)
Q Consensus 308 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 385 (560)
++.....++|++.+.||+|+||.||+|+.+ +|+.||||++++... .....+.+.+|..++..++||||+++++++.++
T Consensus 54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 133 (412)
T 2vd5_A 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE 133 (412)
T ss_dssp HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence 333444678999999999999999999875 689999999975432 223344688999999999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecc
Q 035761 386 KCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGI 465 (560)
Q Consensus 386 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 465 (560)
+..++||||+++|+|.+++...+ ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++++||+|||+
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGl 208 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGS 208 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechh
Confidence 99999999999999999997643 2389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCC-ceeeccccCccCccccc-------cCccCcchhHHHHHHHHHHHHhCCCCCCccccc------------
Q 035761 466 ARLLNYDSSN-RTLLAGTYGSIAPELAY-------TMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS------------ 525 (560)
Q Consensus 466 ~~~~~~~~~~-~~~~~g~~~~~aPE~~~-------~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~------------ 525 (560)
++........ ....+||+.|+|||++. ...++.++|||||||++|||++|+.||...+..
T Consensus 209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~ 288 (412)
T 2vd5_A 209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH 288 (412)
T ss_dssp CEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred heeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Confidence 9876543322 22357999999999987 456899999999999999999999999654321
Q ss_pred ----------ccccccccccccccCCCCC---CChhHHHhhceee
Q 035761 526 ----------SSSLDKNIKLIDLLDPRLP---PPGDQMIRQGIIL 557 (560)
Q Consensus 526 ----------~~~~~~~~~~~~~~dp~~~---p~~~~~~~~~~~~ 557 (560)
...+...++.|.. +|..| |+++++++|+|+.
T Consensus 289 ~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~ 332 (412)
T 2vd5_A 289 LSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFF 332 (412)
T ss_dssp CCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGT
T ss_pred cCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcC
Confidence 1122344455555 77766 6899999999874
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=356.49 Aligned_cols=238 Identities=20% Similarity=0.280 Sum_probs=196.1
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|++.+.||+|+||.||+|... +|+.||||++..... .......+.+|+.+++.++||||+++++++...+..++||
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 227 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence 57899999999999999999864 689999999975432 2334456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHH-HCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 471 (560)
||+++|+|.+++.... .+++.++..++.||+.||+|||+ . +|+||||||+|||++.++.+||+|||+++....
T Consensus 228 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 228 EYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp CCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred eeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 9999999999997644 38999999999999999999998 7 999999999999999999999999999987544
Q ss_pred CCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------cccccccccc
Q 035761 472 DSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNIK 534 (560)
Q Consensus 472 ~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~~ 534 (560)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+. ....+...+.
T Consensus 302 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 381 (446)
T 4ejn_A 302 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLS 381 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHH
Confidence 44444556799999999999999999999999999999999999999965432 1223456678
Q ss_pred cccccCCCCCC-----ChhHHHhhceeee
Q 035761 535 LIDLLDPRLPP-----PGDQMIRQGIILI 558 (560)
Q Consensus 535 ~~~~~dp~~~p-----~~~~~~~~~~~~~ 558 (560)
.|...||..|| +++++++|+|+..
T Consensus 382 ~~L~~dP~~R~~~~~~t~~ell~hp~f~~ 410 (446)
T 4ejn_A 382 GLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410 (446)
T ss_dssp HHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence 88899999999 9999999999864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=351.87 Aligned_cols=236 Identities=24% Similarity=0.379 Sum_probs=205.1
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|.+.+.||+|+||.||+|... +|+.||||++..... .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56889999999999999999875 689999999976442 2234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++|+|.+++..... +++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 96 E~~~gg~L~~~l~~~~~---l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 96 EYVSGGELFDYICKNGR---LDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp ECCSSEEHHHHTTSSSS---CCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred eCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 99999999999976443 89999999999999999999999 9999999999999999999999999999876532
Q ss_pred CCCceeeccccCccCccccccCcc-CcchhHHHHHHHHHHHHhCCCCCCcccc-----------------cccccccccc
Q 035761 473 SSNRTLLAGTYGSIAPELAYTMVV-TEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNIK 534 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~~~~-~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~~ 534 (560)
......+||+.|+|||++.+..+ +.++||||+||++|||++|+.||..... ....+...++
T Consensus 170 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~ 248 (476)
T 2y94_A 170 -EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLK 248 (476)
T ss_dssp -CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHHH
T ss_pred -ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHHHH
Confidence 33344579999999999988765 6799999999999999999999975432 1223456677
Q ss_pred cccccCCCCCCChhHHHhhceee
Q 035761 535 LIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 535 ~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
.|...||..||+++++++|+|+.
T Consensus 249 ~~L~~dP~~Rpt~~eil~hp~~~ 271 (476)
T 2y94_A 249 HMLQVDPMKRATIKDIREHEWFK 271 (476)
T ss_dssp HHTCSSTTTSCCHHHHHTCHHHH
T ss_pred HHcCCCchhCcCHHHHHhCHHhh
Confidence 88899999999999999999975
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=329.73 Aligned_cols=238 Identities=23% Similarity=0.356 Sum_probs=205.9
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
.++|++.+.||+|+||.||+|... +++.||+|++..........+.+.+|+.++++++||||+++++++..++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467999999999999999999865 5899999999765544455567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCc---EEEeeecccccc
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFE---AFVADFGIARLL 469 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg~~~~~ 469 (560)
||+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 9999999998887643 389999999999999999999999 9999999999999987655 999999999876
Q ss_pred CCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------cccc
Q 035761 470 NYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------SSSS 528 (560)
Q Consensus 470 ~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------~~~~ 528 (560)
... .......|++.|+|||++.+..++.++||||+|+++|||++|+.||..... ....
T Consensus 159 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T 3kk8_A 159 NDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE 237 (284)
T ss_dssp CSS-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred ccC-ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHH
Confidence 532 223345689999999999999999999999999999999999999954431 1233
Q ss_pred cccccccccccCCCCCCChhHHHhhceeee
Q 035761 529 LDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 529 ~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
+.+.++.|...||..||+++++++|+|+.+
T Consensus 238 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (284)
T 3kk8_A 238 AKSLIDSMLTVNPKKRITADQALKVPWICN 267 (284)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTSHHHHS
T ss_pred HHHHHHHHcccChhhCCCHHHHhcCccccC
Confidence 556677788999999999999999999865
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=341.54 Aligned_cols=238 Identities=21% Similarity=0.266 Sum_probs=192.5
Q ss_pred hcCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
.++|++.+.||+|+||.||+|.. .+++.||||+++.........+.+.+|+++++.++||||+++++++.+++..++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 46799999999999999999975 46889999999765544444567789999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEe-----CCCCcEEEeeecccc
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILL-----NSEFEAFVADFGIAR 467 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill-----~~~~~~kl~Dfg~~~ 467 (560)
||+++ +|.+++..... +++.++..++.||+.||+|||+. +|+||||||+||++ +.++.+||+|||+++
T Consensus 113 e~~~~-~L~~~~~~~~~---~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 113 EYAEN-DLKKYMDKNPD---VSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp ECCSE-EHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred ecCCC-CHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 99985 99999986543 89999999999999999999999 99999999999999 455569999999998
Q ss_pred ccCCCCCCceeeccccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCCCCCcccc----------------------
Q 035761 468 LLNYDSSNRTLLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------- 524 (560)
Q Consensus 468 ~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------- 524 (560)
.............||+.|+|||++.+. .++.++||||+||++|||++|+.||.....
T Consensus 186 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (329)
T 3gbz_A 186 AFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV 265 (329)
T ss_dssp HHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred ccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhh
Confidence 775444444556789999999998875 489999999999999999999999964432
Q ss_pred -------------------------cccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 525 -------------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 525 -------------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
....+.+.++.|...||..||+++++++|+|+.+
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 324 (329)
T 3gbz_A 266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSH 324 (329)
T ss_dssp GGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred hhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCC
Confidence 1122335667788999999999999999999875
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=340.10 Aligned_cols=238 Identities=26% Similarity=0.352 Sum_probs=199.7
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
++|++.+.||+|+||.||+|... +|+.||||++..........+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 57899999999999999999875 48999999987655444455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|++++++.++...... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 105 ~~~~~~l~~~~~~~~~---~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 105 FVDHTILDDLELFPNG---LDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp CCSEEHHHHHHHSTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred cCCcchHHHHHhhccC---CCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 9999999888765433 89999999999999999999999 99999999999999999999999999998765544
Q ss_pred CCceeeccccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCCCCCcccc----------------------------
Q 035761 474 SNRTLLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------------- 524 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------------- 524 (560)
.......|++.|+|||++.+. .++.++||||+|+++|||++|+.||.....
T Consensus 179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 444556789999999998875 688999999999999999999999975432
Q ss_pred --------------------cccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 525 --------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 525 --------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
....+.+.++.|...||..||++.++++|+|+..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 1223456677888999999999999999999864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=340.66 Aligned_cols=234 Identities=24% Similarity=0.343 Sum_probs=187.8
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
.++|++.+.||+|+||.||+|+.. +++.||||+++... ..+.+.+|++++++++||||+++++++...+..++||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 467899999999999999999876 57899999997543 2346788999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCC---CCcEEEeeecccccc
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNS---EFEAFVADFGIARLL 469 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~~~~~ 469 (560)
||+++|+|.+++..... +++.++..++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||+++..
T Consensus 128 e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 128 ELVTGGELFDRIVEKGY---YSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp CCCCSCBHHHHHTTCSS---CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred EeCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 99999999999976443 89999999999999999999999 9999999999999975 889999999999876
Q ss_pred CCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc----------------------cc
Q 035761 470 NYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS----------------------SS 527 (560)
Q Consensus 470 ~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~----------------------~~ 527 (560)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..
T Consensus 202 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 280 (349)
T 2w4o_A 202 EHQ-VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL 280 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred Ccc-cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCH
Confidence 432 2233456899999999999999999999999999999999999999644321 12
Q ss_pred ccccccccccccCCCCCCChhHHHhhceeee
Q 035761 528 SLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 528 ~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
.+.+.++.|...||..||++.++++|+|+..
T Consensus 281 ~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 311 (349)
T 2w4o_A 281 NAKDLVRKLIVLDPKKRLTTFQALQHPWVTG 311 (349)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSTTTTS
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence 3445667788899999999999999999864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=355.64 Aligned_cols=240 Identities=22% Similarity=0.270 Sum_probs=206.3
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLI 391 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 391 (560)
.++|+..+.||+|+||.||+|+.+ +|+.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 356889999999999999999875 689999999976442 233456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 471 (560)
|||+++|+|.+++.... ...+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999999997643 23489999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------cccccc
Q 035761 472 DSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------SSSSLD 530 (560)
Q Consensus 472 ~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------~~~~~~ 530 (560)
. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||..... .+..+.
T Consensus 339 ~-~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~ 417 (576)
T 2acx_A 339 G-QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQAR 417 (576)
T ss_dssp T-CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred C-ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHHH
Confidence 2 233445799999999999999999999999999999999999999976432 112334
Q ss_pred cccccccccCCCCCC-----ChhHHHhhceeee
Q 035761 531 KNIKLIDLLDPRLPP-----PGDQMIRQGIILI 558 (560)
Q Consensus 531 ~~~~~~~~~dp~~~p-----~~~~~~~~~~~~~ 558 (560)
..++.|...||..|| +++++++|+|+..
T Consensus 418 dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 418 SLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp HHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred HHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 566777888999999 7899999999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=340.88 Aligned_cols=239 Identities=22% Similarity=0.312 Sum_probs=204.7
Q ss_pred HhcCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhh------hhHHHHHHHHHHHhccCCCCcceeeeEEEeC
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETEL------ASLESFQNEARLLSQIRHRNIVKLYGFCLHE 385 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 385 (560)
..++|++.+.||+|+||.||+|.. .+++.||||++....... ...+.+.+|+++++.++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 356799999999999999999985 468899999987643111 1233567899999999999999999999999
Q ss_pred CEEEEEEeccCCC-CHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeec
Q 035761 386 KCMFLIYEYMEMG-SLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFG 464 (560)
Q Consensus 386 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 464 (560)
+..++||||+.+| +|.+++..... +++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~---l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPR---LDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCC---CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 99999986543 89999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCceeeccccCccCccccccCcc-CcchhHHHHHHHHHHHHhCCCCCCcccc-----------cccccccc
Q 035761 465 IARLLNYDSSNRTLLAGTYGSIAPELAYTMVV-TEKYDVYSFGVVALEVLMGKHPGELLSS-----------SSSSLDKN 532 (560)
Q Consensus 465 ~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~-~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------~~~~~~~~ 532 (560)
+++...... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||..... ....+...
T Consensus 176 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~l~~l 254 (335)
T 3dls_A 176 SAAYLERGK-LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELMSL 254 (335)
T ss_dssp TCEECCTTC-CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTTTCCCCSSCCCHHHHHH
T ss_pred cceECCCCC-ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHhhccCCCcccCHHHHHH
Confidence 998765432 3344579999999999988876 7899999999999999999999975443 12345566
Q ss_pred cccccccCCCCCCChhHHHhhceeee
Q 035761 533 IKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 533 ~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
++.|...||..||+++++++|+|+..
T Consensus 255 i~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 255 VSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp HHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred HHHHccCChhhCcCHHHHhcCccccC
Confidence 77888999999999999999999864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=345.17 Aligned_cols=237 Identities=25% Similarity=0.383 Sum_probs=190.6
Q ss_pred HhcCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccC-CCCcceeeeEEEeCC--EE
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIR-HRNIVKLYGFCLHEK--CM 388 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~~ 388 (560)
..++|++.+.||+|+||.||+|.. .+|+.||||++..........+.+.+|+.+++.+. ||||+++++++..++ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 457899999999999999999976 46899999998755444445567789999999997 999999999997654 68
Q ss_pred EEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccc
Q 035761 389 FLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARL 468 (560)
Q Consensus 389 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 468 (560)
++||||++ |+|.+++... .+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+|+.
T Consensus 87 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99999998 5899998753 389999999999999999999999 999999999999999999999999999986
Q ss_pred cCCC---------------------CCCceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCcccc--
Q 035761 469 LNYD---------------------SSNRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSS-- 524 (560)
Q Consensus 469 ~~~~---------------------~~~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-- 524 (560)
+... .......+||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 5321 111233579999999999876 6789999999999999999999999964431
Q ss_pred --------------------------------------------------------------cccccccccccccccCCC
Q 035761 525 --------------------------------------------------------------SSSSLDKNIKLIDLLDPR 542 (560)
Q Consensus 525 --------------------------------------------------------------~~~~~~~~~~~~~~~dp~ 542 (560)
....+.+.++.|...||.
T Consensus 239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~ 318 (388)
T 3oz6_A 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN 318 (388)
T ss_dssp HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence 122345667788899999
Q ss_pred CCCChhHHHhhceee
Q 035761 543 LPPPGDQMIRQGIIL 557 (560)
Q Consensus 543 ~~p~~~~~~~~~~~~ 557 (560)
.||+++++++|+|+.
T Consensus 319 ~R~t~~e~l~Hp~~~ 333 (388)
T 3oz6_A 319 KRISANDALKHPFVS 333 (388)
T ss_dssp GSCCHHHHTTSTTTT
T ss_pred cCCCHHHHhCCHHHH
Confidence 999999999999974
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=353.23 Aligned_cols=241 Identities=22% Similarity=0.290 Sum_probs=206.4
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|+..+.||+|+||.||+|+.+ +|+.||+|++..... .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 57888899999999999999875 689999999976542 2234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCc-ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC
Q 035761 393 EYMEMGSLFCILRTDEE-AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 471 (560)
||+++|+|.+++..... ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.+..
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 99999999999876432 23499999999999999999999999 999999999999999999999999999988754
Q ss_pred CCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------cccccc
Q 035761 472 DSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------SSSSLD 530 (560)
Q Consensus 472 ~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------~~~~~~ 530 (560)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+.
T Consensus 342 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 421 (543)
T 3c4z_A 342 GQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASK 421 (543)
T ss_dssp TCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred CCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCHHHH
Confidence 44444455899999999999999999999999999999999999999975421 112344
Q ss_pred cccccccccCCCCCCC-----hhHHHhhceeee
Q 035761 531 KNIKLIDLLDPRLPPP-----GDQMIRQGIILI 558 (560)
Q Consensus 531 ~~~~~~~~~dp~~~p~-----~~~~~~~~~~~~ 558 (560)
..++.|...||..||+ +++++.|+|+..
T Consensus 422 ~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 422 DFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp HHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred HHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 5667778889999996 478999998753
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=338.08 Aligned_cols=243 Identities=36% Similarity=0.534 Sum_probs=203.4
Q ss_pred CHHHHHHHhcCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC
Q 035761 306 TFQDMIEATEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHE 385 (560)
Q Consensus 306 ~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 385 (560)
++.++...+++|+..+.||+|+||.||+|.+++++.||||++.... ....+.+.+|+++++.++||||+++++++..+
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 3344445678899999999999999999998889999999987543 23456789999999999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHhhcCCc-ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeec
Q 035761 386 KCMFLIYEYMEMGSLFCILRTDEE-AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFG 464 (560)
Q Consensus 386 ~~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 464 (560)
+..++||||+++|+|.+++..... ...+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecc
Confidence 999999999999999999976432 23589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCC--CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccccc---------------
Q 035761 465 IARLLNYDSS--NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSS--------------- 527 (560)
Q Consensus 465 ~~~~~~~~~~--~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~~--------------- 527 (560)
+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 9987543221 22334689999999999999999999999999999999999999964322110
Q ss_pred -------------------ccccccccccccCCCCCCChhHHHhh
Q 035761 528 -------------------SLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 528 -------------------~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
.+.+.+..|...||..||++++++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 01223346778899999999999876
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=340.43 Aligned_cols=236 Identities=23% Similarity=0.380 Sum_probs=197.8
Q ss_pred cCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCC--CCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRH--RNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~ 392 (560)
++|++.+.||+|+||.||+|...+++.||||++..........+.+.+|+.+++.++| |||+++++++..+...++||
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 88 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence 5688999999999999999998889999999997655444556788999999999976 99999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
| +.+|+|.+++..... +++.++..++.||+.||+|||+. +|+||||||+|||++ ++.+||+|||+++.....
T Consensus 89 e-~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 89 E-CGNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp C-CCSEEHHHHHHHSCC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred e-CCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 9 567899999987543 89999999999999999999999 999999999999997 678999999999876533
Q ss_pred CCC--ceeeccccCccCcccccc-----------CccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------
Q 035761 473 SSN--RTLLAGTYGSIAPELAYT-----------MVVTEKYDVYSFGVVALEVLMGKHPGELLSS--------------- 524 (560)
Q Consensus 473 ~~~--~~~~~g~~~~~aPE~~~~-----------~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~--------------- 524 (560)
... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 240 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 240 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCccc
Confidence 221 234579999999999865 6788899999999999999999999975321
Q ss_pred -----cccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 525 -----SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 525 -----~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
....+.+.++.|...||..||++.++++|+|+..
T Consensus 241 ~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 279 (343)
T 3dbq_A 241 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279 (343)
T ss_dssp CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence 1123556677888999999999999999999863
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=333.89 Aligned_cols=235 Identities=24% Similarity=0.330 Sum_probs=198.8
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCC--EEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEK--CMFLI 391 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv 391 (560)
++|.+.+.||+|+||.||+|... +++.||||++..... ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 56889999999999999999875 489999999975442 234567889999999999999999999998765 78999
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEe----CCCCcEEEeeecccc
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILL----NSEFEAFVADFGIAR 467 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfg~~~ 467 (560)
|||+++|+|.+++........+++.++..++.||+.||+|||+. +|+||||||+||++ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999998765555599999999999999999999999 99999999999999 788889999999998
Q ss_pred ccCCCCCCceeeccccCccCccccc--------cCccCcchhHHHHHHHHHHHHhCCCCCCcccccc-------------
Q 035761 468 LLNYDSSNRTLLAGTYGSIAPELAY--------TMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSS------------- 526 (560)
Q Consensus 468 ~~~~~~~~~~~~~g~~~~~aPE~~~--------~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~------------- 526 (560)
...... ......||+.|+|||++. +..++.++|||||||++|||++|+.||.......
T Consensus 165 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (319)
T 4euu_A 165 ELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (319)
T ss_dssp ECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred ecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence 775433 233456899999999886 5778899999999999999999999996322110
Q ss_pred ---------------------------------cccccccccccccCCCCCCChhHHHhhc
Q 035761 527 ---------------------------------SSLDKNIKLIDLLDPRLPPPGDQMIRQG 554 (560)
Q Consensus 527 ---------------------------------~~~~~~~~~~~~~dp~~~p~~~~~~~~~ 554 (560)
..+...++.|...||..||+++++++|.
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 1233455778888999999999999874
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=341.93 Aligned_cols=234 Identities=26% Similarity=0.302 Sum_probs=191.4
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ..+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 95 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM 95 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT---SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc---ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence 357999999999999999999875 689999999975432 2246789999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCc--EEEeeeccccccC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFE--AFVADFGIARLLN 470 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfg~~~~~~ 470 (560)
||+++|+|.+++..... +++.++..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+++...
T Consensus 96 e~~~~~~L~~~l~~~~~---~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 96 EYASGGELYERICNAGR---FSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp ECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred EeCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 99999999999976433 89999999999999999999999 9999999999999987765 9999999997543
Q ss_pred CCCCCceeeccccCccCccccccCccCcc-hhHHHHHHHHHHHHhCCCCCCccccc-----------------------c
Q 035761 471 YDSSNRTLLAGTYGSIAPELAYTMVVTEK-YDVYSFGVVALEVLMGKHPGELLSSS-----------------------S 526 (560)
Q Consensus 471 ~~~~~~~~~~g~~~~~aPE~~~~~~~~~~-~Dv~s~G~il~el~~g~~P~~~~~~~-----------------------~ 526 (560)
.. .......||+.|+|||++.+..++.+ +||||+||++|||++|+.||...... .
T Consensus 170 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 248 (361)
T 3uc3_A 170 LH-SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRIS 248 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCC
T ss_pred cc-CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCC
Confidence 22 22334569999999999988887766 89999999999999999999754321 2
Q ss_pred cccccccccccccCCCCCCChhHHHhhceee
Q 035761 527 SSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 527 ~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
..+...++.|...||..||++.++++|+|+.
T Consensus 249 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 279 (361)
T 3uc3_A 249 PECCHLISRIFVADPATRISIPEIKTHSWFL 279 (361)
T ss_dssp HHHHHHHHHHSCSCTTTSCCHHHHHTSHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHhCcchh
Confidence 2344566778899999999999999999984
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=340.17 Aligned_cols=237 Identities=22% Similarity=0.305 Sum_probs=192.7
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
++|.+.+.||+|+||.||+|... +++.||||++...... .....+.+|+++++.++||||+++++++..++..++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 46889999999999999999875 6899999998754321 111235579999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|++ |+|.+++..... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 81 YLD-KDLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CCS-EEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred ccc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 998 599998876533 389999999999999999999999 99999999999999999999999999998765444
Q ss_pred CCceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCccccc---------------------------
Q 035761 474 SNRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------------------- 525 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------------------- 525 (560)
.......||+.|+|||++.+ ..++.++||||+|+++|||++|+.||......
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence 44455678999999999876 56899999999999999999999999654311
Q ss_pred --------------------ccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 526 --------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 526 --------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
...+.+.++.|...||..||+++++++|+|+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 287 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLS 287 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGG
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhh
Confidence 112346677888999999999999999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=332.92 Aligned_cols=238 Identities=24% Similarity=0.319 Sum_probs=205.5
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhh----hhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETEL----ASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCM 388 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 388 (560)
.++|++.+.||+|+||.||+|... +|+.||||.+....... ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 356899999999999999999875 58999999987644221 1356789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCC----cEEEeeec
Q 035761 389 FLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEF----EAFVADFG 464 (560)
Q Consensus 389 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg 464 (560)
++||||+++++|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 99999999999999997643 389999999999999999999999 999999999999999887 79999999
Q ss_pred cccccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc--------------------
Q 035761 465 IARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-------------------- 524 (560)
Q Consensus 465 ~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-------------------- 524 (560)
++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 165 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (321)
T 2a2a_A 165 LAHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS 243 (321)
T ss_dssp TCEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred cceecCccc-cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhc
Confidence 998765432 23345689999999999999999999999999999999999999964331
Q ss_pred -cccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 525 -SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 525 -~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
....+.+.++.|...||..||+++++++|+|+..
T Consensus 244 ~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~ 278 (321)
T 2a2a_A 244 HTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (321)
T ss_dssp TCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred ccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence 1223456678888999999999999999999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=339.26 Aligned_cols=234 Identities=22% Similarity=0.306 Sum_probs=200.0
Q ss_pred HhcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCEEEE
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKCMFL 390 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 390 (560)
..++|++.+.||+|+||.||+|..+ +++.||||++..... ...+|++++.++ +||||+++++++.+++..++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 3567999999999999999999875 588999999975432 234688888887 79999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCC----CcEEEeeeccc
Q 035761 391 IYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSE----FEAFVADFGIA 466 (560)
Q Consensus 391 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg~~ 466 (560)
||||+++|+|.+++..... +++.++..++.||+.||+|||+. ||+||||||+||++.++ +.+||+|||++
T Consensus 94 v~E~~~gg~L~~~i~~~~~---~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a 167 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQKF---FSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFA 167 (342)
T ss_dssp EECCCCSCBHHHHHHTCTT---CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred EEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence 9999999999999976543 89999999999999999999999 99999999999998543 35999999999
Q ss_pred cccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc----------------------
Q 035761 467 RLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------- 524 (560)
Q Consensus 467 ~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------- 524 (560)
+............+||+.|+|||++.+..++.++||||+||++|||++|+.||.....
T Consensus 168 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 247 (342)
T 2qr7_A 168 KQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYW 247 (342)
T ss_dssp EECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTT
T ss_pred ccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccc
Confidence 8775544444556789999999999988899999999999999999999999974211
Q ss_pred --cccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 525 --SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 525 --~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
.+..+.+.++.|...||+.||++.++++|+|+.+
T Consensus 248 ~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 1233456678888999999999999999999853
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=341.11 Aligned_cols=236 Identities=26% Similarity=0.382 Sum_probs=197.7
Q ss_pred hcCCcccceeeccCCeeEEEEEeC--------CCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEe
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP--------SGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLH 384 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 384 (560)
.++|++.+.||+|+||.||+|.+. ++..||||+++.... ....+.+.+|+++++.+ +||||+++++++..
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCB-HHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcC-HHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 367889999999999999999752 356799999976432 34456789999999999 89999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHhhcCCc-------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeE
Q 035761 385 EKCMFLIYEYMEMGSLFCILRTDEE-------------AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNIL 451 (560)
Q Consensus 385 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nil 451 (560)
++..++||||+++|+|.+++..... ...+++.++..++.||++||+|||+. +|+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEE
Confidence 9999999999999999999986432 13489999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeeeccccccCCCCCC--ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc---
Q 035761 452 LNSEFEAFVADFGIARLLNYDSSN--RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS--- 525 (560)
Q Consensus 452 l~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~--- 525 (560)
++.++.+||+|||+++........ .....+++.|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~ 315 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 999999999999999876433221 223456789999999999999999999999999999999 99999754321
Q ss_pred ---------------ccccccccccccccCCCCCCChhHHHhh
Q 035761 526 ---------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 526 ---------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
...+.+.++.|...||..||++.+++++
T Consensus 316 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 316 KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1134455667778899999999888875
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=342.72 Aligned_cols=241 Identities=23% Similarity=0.301 Sum_probs=203.3
Q ss_pred CHHHHHHHhcCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccC-----CCCcceee
Q 035761 306 TFQDMIEATEDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIR-----HRNIVKLY 379 (560)
Q Consensus 306 ~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~l~ 379 (560)
++.+.....++|++.+.||+|+||.||+|+. .+++.||||+++... ...+.+..|+++++.++ ||||++++
T Consensus 26 ~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK---KYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp CCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH---HHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch---hhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 3333344467899999999999999999987 468899999997433 23346678999999886 99999999
Q ss_pred eEEEeCCEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCC-----
Q 035761 380 GFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNS----- 454 (560)
Q Consensus 380 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~----- 454 (560)
+++...+..++||||+ +++|.+++..... ..+++.++..++.||+.||+|||+. +|+||||||+|||++.
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCE
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccc
Confidence 9999999999999999 8999999986542 2389999999999999999999999 9999999999999975
Q ss_pred --------------------CCcEEEeeeccccccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh
Q 035761 455 --------------------EFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM 514 (560)
Q Consensus 455 --------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~ 514 (560)
++.+||+|||+++.... ......||+.|+|||++.+..++.++||||+||++|||++
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 254 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD---YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS---CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCC---CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHH
Confidence 78899999999987543 2234568999999999999999999999999999999999
Q ss_pred CCCCCCcccccc---------------------------------------------------------------ccccc
Q 035761 515 GKHPGELLSSSS---------------------------------------------------------------SSLDK 531 (560)
Q Consensus 515 g~~P~~~~~~~~---------------------------------------------------------------~~~~~ 531 (560)
|+.||....... ..+.+
T Consensus 255 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 334 (360)
T 3llt_A 255 GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCD 334 (360)
T ss_dssp SSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHH
T ss_pred CCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHH
Confidence 999996433100 12236
Q ss_pred ccccccccCCCCCCChhHHHhhceee
Q 035761 532 NIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 532 ~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
.++.|...||..||+++++++|+|++
T Consensus 335 li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 335 FLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHHHhcCChhhCCCHHHHhcCcccC
Confidence 67788899999999999999999974
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=327.36 Aligned_cols=237 Identities=32% Similarity=0.480 Sum_probs=201.7
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLI 391 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 391 (560)
.++|++.+.||+|+||.||+|... +++.||||++..... .......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 357899999999999999999765 577999999875442 223356788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 471 (560)
|||+++|+|.+++..... +++.++..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 999999999999976433 89999999999999999999998 999999999999999999999999999866432
Q ss_pred CCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------cccccccccc
Q 035761 472 DSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNIK 534 (560)
Q Consensus 472 ~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~~ 534 (560)
.......|++.|+|||.+.+..++.++||||+|+++|||++|+.||..... ....+.+.++
T Consensus 162 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 239 (279)
T 3fdn_A 162 --SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 239 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHH
T ss_pred --ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHH
Confidence 223345689999999999999999999999999999999999999975432 1223456778
Q ss_pred cccccCCCCCCChhHHHhhceeee
Q 035761 535 LIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 535 ~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
.|...||..||+++++++|+|+..
T Consensus 240 ~~l~~~p~~Rps~~e~l~h~~~~~ 263 (279)
T 3fdn_A 240 RLLKHNPSQRPMLREVLEHPWITA 263 (279)
T ss_dssp HHCCSSGGGSCCHHHHHHCHHHHH
T ss_pred HHhccChhhCCCHHHHhhCccccC
Confidence 888999999999999999999864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=349.96 Aligned_cols=234 Identities=24% Similarity=0.277 Sum_probs=194.2
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC------C
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHE------K 386 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 386 (560)
.++|++.+.||+|+||.||+|... +++.||||++..........+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 367999999999999999999754 688999999976544445566788999999999999999999999654 4
Q ss_pred EEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccc
Q 035761 387 CMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIA 466 (560)
Q Consensus 387 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~ 466 (560)
..++||||+++ ++.+.+.. .+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEee
Confidence 57999999986 46666643 289999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc---------------------
Q 035761 467 RLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------------- 525 (560)
Q Consensus 467 ~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------------- 525 (560)
+..... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||...+..
T Consensus 212 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 212 RTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp -----C-CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred eecCCC-cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence 876532 2334567999999999999999999999999999999999999999754310
Q ss_pred --------------------------------------ccccccccccccccCCCCCCChhHHHhhceee
Q 035761 526 --------------------------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 526 --------------------------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
...+.+.++.|...||..||+++++++|+|+.
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~ 360 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 360 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTG
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhh
Confidence 11234566778899999999999999999985
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=327.41 Aligned_cols=238 Identities=22% Similarity=0.367 Sum_probs=207.0
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchh-hhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLE-TELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 57889999999999999999875 57899999987543 22344567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++++|.+++.... .+++.++..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 95 e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 95 ELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp ECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred ecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 9999999999987543 389999999999999999999999 9999999999999999999999999999887544
Q ss_pred CCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------ccccccccccc
Q 035761 473 SSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNIKL 535 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~~~ 535 (560)
........|++.|+|||++.+..++.++||||+|+++|||++|+.||..... ....+.+.++.
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 248 (294)
T 2rku_A 169 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 248 (294)
T ss_dssp TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHH
Confidence 4445556789999999999999999999999999999999999999975431 12234566778
Q ss_pred ccccCCCCCCChhHHHhhceeee
Q 035761 536 IDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 536 ~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
|...||..||+++++++|.|+..
T Consensus 249 ~l~~~p~~Rps~~~ll~~~~~~~ 271 (294)
T 2rku_A 249 MLQTDPTARPTINELLNDEFFTS 271 (294)
T ss_dssp HTCSSGGGSCCGGGGGGSHHHHT
T ss_pred HcccChhhCcCHHHHhhChheec
Confidence 88899999999999999998753
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=340.22 Aligned_cols=233 Identities=22% Similarity=0.302 Sum_probs=194.7
Q ss_pred cccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEeccC
Q 035761 318 DIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYME 396 (560)
Q Consensus 318 ~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 396 (560)
...+.||+|+||.||+|.. .+|+.||+|+++.... ...+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 169 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM--KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVD 169 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence 3356799999999999986 4689999999876432 334678999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEe--CCCCcEEEeeeccccccCCCCC
Q 035761 397 MGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILL--NSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 397 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill--~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
+|+|.+++.... ..+++.++..++.||++||+|||+. +|+||||||+|||+ +.++.+||+|||+++......
T Consensus 170 ~~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~- 243 (373)
T 2x4f_A 170 GGELFDRIIDES--YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE- 243 (373)
T ss_dssp TCEEHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-
T ss_pred CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-
Confidence 999999887543 2389999999999999999999999 99999999999999 667899999999998765332
Q ss_pred CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------ccccccccc
Q 035761 475 NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------SSSSLDKNI 533 (560)
Q Consensus 475 ~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------~~~~~~~~~ 533 (560)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+.+.+
T Consensus 244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 323 (373)
T 2x4f_A 244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFI 323 (373)
T ss_dssp BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHH
T ss_pred ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHH
Confidence 23345699999999999999999999999999999999999999964432 122345667
Q ss_pred ccccccCCCCCCChhHHHhhceeee
Q 035761 534 KLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 534 ~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
+.|...||..||+++++++|+|+..
T Consensus 324 ~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 324 SKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp HTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred HHHcCCChhhCCCHHHHhcCcCcCC
Confidence 7888999999999999999999854
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=328.73 Aligned_cols=233 Identities=28% Similarity=0.367 Sum_probs=190.3
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchh-hhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLE-TELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 57899999999999999999864 68999999985433 22344567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 91 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 91 EYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp ECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 9999999999997644 389999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCC-ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc----------------------cccc
Q 035761 473 SSN-RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS----------------------SSSL 529 (560)
Q Consensus 473 ~~~-~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~----------------------~~~~ 529 (560)
... .....||+.|+|||++.+..++.++||||+|+++|||++|+.||...... ...+
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 244 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSL 244 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHH
T ss_pred cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHH
Confidence 222 23356899999999999999999999999999999999999999754421 1223
Q ss_pred ccccccccccCCCCCCChhHHHhh
Q 035761 530 DKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 530 ~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
.+.+..|...||..||+..+.+.+
T Consensus 245 ~~li~~~l~~dp~~R~~~~~~l~~ 268 (294)
T 4eqm_A 245 SNVILRATEKDKANRYKTIQEMKD 268 (294)
T ss_dssp HHHHHHHSCSSGGGSCSSHHHHHH
T ss_pred HHHHHHHhcCCHhHccccHHHHHH
Confidence 445566667788888755444444
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=334.24 Aligned_cols=239 Identities=22% Similarity=0.365 Sum_probs=207.8
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchh-hhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLE-TELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLI 391 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 391 (560)
.++|.+.+.||+|+||.||++... +++.||+|++.... ......+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 367889999999999999999875 47899999987543 2234456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 471 (560)
|||+++++|.+++.... .+++.++..++.||++||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 120 ~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 99999999999987543 389999999999999999999999 999999999999999999999999999988754
Q ss_pred CCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------cccccccccc
Q 035761 472 DSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNIK 534 (560)
Q Consensus 472 ~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~~ 534 (560)
.........|++.|+|||++.+..++.++||||||+++|||++|+.||..... ....+.+.++
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 273 (335)
T 2owb_A 194 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ 273 (335)
T ss_dssp TTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHH
T ss_pred CcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHH
Confidence 44445556799999999999999999999999999999999999999975431 1223456677
Q ss_pred cccccCCCCCCChhHHHhhceeee
Q 035761 535 LIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 535 ~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
.|...||..||+++++++|.|+..
T Consensus 274 ~~l~~dp~~Rps~~ell~~~~~~~ 297 (335)
T 2owb_A 274 KMLQTDPTARPTINELLNDEFFTS 297 (335)
T ss_dssp HHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred HHccCChhHCcCHHHHhcCccccC
Confidence 888999999999999999999864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=330.99 Aligned_cols=239 Identities=26% Similarity=0.335 Sum_probs=195.9
Q ss_pred hcCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhh---hhhhHHHHHHHHHHHhcc---CCCCcceeeeEEEeCC
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLET---ELASLESFQNEARLLSQI---RHRNIVKLYGFCLHEK 386 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~ 386 (560)
.++|++.+.||+|+||.||+|+. .+++.||||++..... .......+.+|+++++.+ +||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 56899999999999999999986 4689999999874331 111123556777777766 4999999999998765
Q ss_pred -----EEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEe
Q 035761 387 -----CMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVA 461 (560)
Q Consensus 387 -----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 461 (560)
..++||||+. |+|.+++..... ..+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 88 TDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp SSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEe
Confidence 5799999997 599999986543 3389999999999999999999999 99999999999999999999999
Q ss_pred eeccccccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc----------------
Q 035761 462 DFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS---------------- 525 (560)
Q Consensus 462 Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~---------------- 525 (560)
|||+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||......
T Consensus 163 Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (308)
T 3g33_A 163 DFGLARIYSYQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241 (308)
T ss_dssp SCSCTTTSTTC-CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eCccccccCCC-cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 99999876432 2334457899999999999999999999999999999999999999643321
Q ss_pred ----------------------------ccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 526 ----------------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 526 ----------------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
...+.+.++.|...||..||++.++++|+|+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~ 302 (308)
T 3g33_A 242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 302 (308)
T ss_dssp TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC--
T ss_pred hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccC
Confidence 112234667788999999999999999999875
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=327.39 Aligned_cols=239 Identities=26% Similarity=0.363 Sum_probs=197.8
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
++|.+.+.||+|+||.||+|... ++..||+|++..... ....+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 56899999999999999999864 588999999876442 2345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCC-cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEe---CCCCcEEEeeecccccc
Q 035761 394 YMEMGSLFCILRTDE-EAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILL---NSEFEAFVADFGIARLL 469 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~~~~~ 469 (560)
|+++|+|.+++.... ....+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 999999999886431 123489999999999999999999999 99999999999999 45678999999999876
Q ss_pred CCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc--------------------ccccc
Q 035761 470 NYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS--------------------SSSSL 529 (560)
Q Consensus 470 ~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~--------------------~~~~~ 529 (560)
... .......|++.|+|||++. ..++.++||||+|+++|||++|+.||..... ....+
T Consensus 178 ~~~-~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (285)
T 3is5_A 178 KSD-EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQA 255 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHH
T ss_pred CCc-ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHH
Confidence 432 2234456899999999876 5688999999999999999999999975431 12234
Q ss_pred ccccccccccCCCCCCChhHHHhhceeeec
Q 035761 530 DKNIKLIDLLDPRLPPPGDQMIRQGIILIS 559 (560)
Q Consensus 530 ~~~~~~~~~~dp~~~p~~~~~~~~~~~~~~ 559 (560)
.+.++.|...||+.||+++++++|+|+..|
T Consensus 256 ~~li~~~L~~dP~~Rps~~e~l~hp~f~~a 285 (285)
T 3is5_A 256 VDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285 (285)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHHTSGGGGC-
T ss_pred HHHHHHHccCChhhCcCHHHHhcCHHhhcC
Confidence 466778889999999999999999999865
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=342.72 Aligned_cols=236 Identities=23% Similarity=0.371 Sum_probs=198.0
Q ss_pred cCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccC--CCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIR--HRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|++.+.||+|+||.||+|...+++.||||++..........+.+.+|+.+++.++ ||||+++++++..++..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 458999999999999999999888999999999765544455678999999999996 599999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
| +.+++|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||++ ++.+||+|||+++.+...
T Consensus 136 E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp E-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred e-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9 56889999998654 389999999999999999999999 999999999999996 589999999999876533
Q ss_pred CC--CceeeccccCccCcccccc-----------CccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------
Q 035761 473 SS--NRTLLAGTYGSIAPELAYT-----------MVVTEKYDVYSFGVVALEVLMGKHPGELLSS--------------- 524 (560)
Q Consensus 473 ~~--~~~~~~g~~~~~aPE~~~~-----------~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~--------------- 524 (560)
.. .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~ 287 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 287 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCC
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccC
Confidence 22 1234579999999999875 3688899999999999999999999975321
Q ss_pred -----cccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 525 -----SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 525 -----~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
....+.+.++.|...||..||++.++++|+|+..
T Consensus 288 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 326 (390)
T 2zmd_A 288 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 326 (390)
T ss_dssp CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred CCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccc
Confidence 1123456677788999999999999999999853
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=323.94 Aligned_cols=235 Identities=21% Similarity=0.302 Sum_probs=202.7
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
.++|++.+.||+|+||.||+|... ++..||+|++..... ...+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 456899999999999999999875 467899999875432 33567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEe---CCCCcEEEeeecccccc
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILL---NSEFEAFVADFGIARLL 469 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~~~~~ 469 (560)
||+++++|.+++..... +++.++..++.|++.||+|||+. +++||||||+||++ +.++.++|+|||++...
T Consensus 86 e~~~~~~L~~~~~~~~~---~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 86 ELCTGGELFERVVHKRV---FRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp ECCCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred eccCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 99999999999876433 89999999999999999999999 99999999999999 78899999999999876
Q ss_pred CCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------cccc
Q 035761 470 NYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------SSSS 528 (560)
Q Consensus 470 ~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------~~~~ 528 (560)
... .......||+.|+|||++.+. ++.++||||+|+++|||++|+.||..... ....
T Consensus 160 ~~~-~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (277)
T 3f3z_A 160 KPG-KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQ 237 (277)
T ss_dssp CTT-SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHH
T ss_pred cCc-cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHH
Confidence 533 233445689999999988765 89999999999999999999999975432 1234
Q ss_pred cccccccccccCCCCCCChhHHHhhceeee
Q 035761 529 LDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 529 ~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
+...++.|...||..||++.++++|+|+..
T Consensus 238 ~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 238 AESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 556778888999999999999999999864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=337.15 Aligned_cols=246 Identities=26% Similarity=0.302 Sum_probs=201.6
Q ss_pred HHHHhcCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhh---hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC
Q 035761 310 MIEATEDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLET---ELASLESFQNEARLLSQIRHRNIVKLYGFCLHE 385 (560)
Q Consensus 310 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 385 (560)
+....++|++.+.||+|+||.||+|.. .+++.||+|++..... .....+.+.+|+++++.++||||+++++++.++
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 345567899999999999999999986 4678999999875432 234456789999999999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHhhcCC-------------------------------------cccCCCHHHHHHHHHHHHHH
Q 035761 386 KCMFLIYEYMEMGSLFCILRTDE-------------------------------------EAVGLDWTKRVNIVKGMAHA 428 (560)
Q Consensus 386 ~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~ia~~ 428 (560)
+..++||||+++|+|.+++.... ....+++..+..++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999985210 01124677888999999999
Q ss_pred HHHHHhcCCCCeEEeCCCCCCeEeCCCC--cEEEeeeccccccCCCCC----CceeeccccCccCcccccc--CccCcch
Q 035761 429 LSYLHHHCTPPILHRDISSNNILLNSEF--EAFVADFGIARLLNYDSS----NRTLLAGTYGSIAPELAYT--MVVTEKY 500 (560)
Q Consensus 429 l~~LH~~~~~~ivH~dlk~~Nill~~~~--~~kl~Dfg~~~~~~~~~~----~~~~~~g~~~~~aPE~~~~--~~~~~~~ 500 (560)
|+|||+. +|+||||||+||+++.++ .+||+|||+++.+..... ......||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 9999999 999999999999998776 899999999987643221 1234568999999999875 6788999
Q ss_pred hHHHHHHHHHHHHhCCCCCCcccc---------------------cccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 501 DVYSFGVVALEVLMGKHPGELLSS---------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 501 Dv~s~G~il~el~~g~~P~~~~~~---------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
||||||+++|||++|+.||..... ....+.+.++.|...||..||++.++++|+|+..
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~ 336 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQ 336 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHT
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhcc
Confidence 999999999999999999964332 1234566778888999999999999999999854
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=341.56 Aligned_cols=232 Identities=22% Similarity=0.306 Sum_probs=188.6
Q ss_pred cCCccc-ceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhc-cCCCCcceeeeEEEe----CCE
Q 035761 315 EDFDIK-YCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQ-IRHRNIVKLYGFCLH----EKC 387 (560)
Q Consensus 315 ~~~~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~----~~~ 387 (560)
++|.+. +.||+|+||.||+|..+ +++.||||++... ..+.+|++++.+ .+||||+++++++.. .+.
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 456665 68999999999999865 6889999998642 245678888744 589999999999876 567
Q ss_pred EEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCC---CCcEEEeeec
Q 035761 388 MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNS---EFEAFVADFG 464 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg 464 (560)
.++||||+++|+|.+++.... ...+++.++..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecc
Confidence 899999999999999998643 23489999999999999999999999 9999999999999997 7899999999
Q ss_pred cccccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc--------------------
Q 035761 465 IARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-------------------- 524 (560)
Q Consensus 465 ~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-------------------- 524 (560)
+++..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 210 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~ 288 (400)
T 1nxk_A 210 FAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 288 (400)
T ss_dssp TCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT
T ss_pred cccccCCC-CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC
Confidence 99876432 223445789999999999999999999999999999999999999964332
Q ss_pred -----cccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 525 -----SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 525 -----~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
....+.+.++.|...||..||+++++++|+|+..
T Consensus 289 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 327 (400)
T 1nxk_A 289 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 327 (400)
T ss_dssp TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence 1223455677888899999999999999999864
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=324.63 Aligned_cols=237 Identities=23% Similarity=0.330 Sum_probs=199.4
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEe----CCEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLH----EKCMF 389 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~ 389 (560)
..|.+.+.||+|+||.||+|... ++..||+|.+..........+.+.+|+.+++.++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 34777889999999999999864 57899999987655444556788999999999999999999999876 35689
Q ss_pred EEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEEeCCCCCCeEeC-CCCcEEEeeeccc
Q 035761 390 LIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPP--ILHRDISSNNILLN-SEFEAFVADFGIA 466 (560)
Q Consensus 390 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~dlk~~Nill~-~~~~~kl~Dfg~~ 466 (560)
+||||+++|+|.+++.... .+++..+..++.||+.||+|||+. + ++||||||+||+++ .++.+||+|||++
T Consensus 106 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 9999999999999997643 389999999999999999999998 7 99999999999998 7899999999999
Q ss_pred cccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc--------------------cc
Q 035761 467 RLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS--------------------SS 526 (560)
Q Consensus 467 ~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~--------------------~~ 526 (560)
..... .......|++.|+|||++.+ .++.++||||+|+++|||++|+.||..... ..
T Consensus 180 ~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (290)
T 1t4h_A 180 TLKRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 256 (290)
T ss_dssp GGCCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred ccccc--cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCC
Confidence 76432 33445578999999998764 589999999999999999999999975332 11
Q ss_pred cccccccccccccCCCCCCChhHHHhhceeeecC
Q 035761 527 SSLDKNIKLIDLLDPRLPPPGDQMIRQGIILIST 560 (560)
Q Consensus 527 ~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~~~ 560 (560)
..+.+.++.|...||..||+++++++|+|+...|
T Consensus 257 ~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~~ 290 (290)
T 1t4h_A 257 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEET 290 (290)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC---
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhhCcccccCC
Confidence 2345667788899999999999999999998754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=336.32 Aligned_cols=234 Identities=27% Similarity=0.391 Sum_probs=199.9
Q ss_pred cCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchh-hhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLE-TELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
+.|+..+.||+|+||.||+|+. .+++.||||++.... ......+.+.+|++++++++||||+++++++..++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588899999999999999986 578999999987543 22344567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||++ |++.+++.... ..+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp ECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 9997 68888876432 2389999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCCceeeccccCccCccccc---cCccCcchhHHHHHHHHHHHHhCCCCCCcccc-------------------cccccc
Q 035761 473 SSNRTLLAGTYGSIAPELAY---TMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-------------------SSSSLD 530 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~---~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-------------------~~~~~~ 530 (560)
....||+.|+|||++. ...++.++|||||||++|||++|+.||..... ....+.
T Consensus 208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 283 (348)
T 1u5q_A 208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFR 283 (348)
T ss_dssp ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHH
T ss_pred ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 2346899999999884 56789999999999999999999999864331 122345
Q ss_pred cccccccccCCCCCCChhHHHhhceeee
Q 035761 531 KNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 531 ~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
+.+..|...||..||+++++++|+|+..
T Consensus 284 ~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 284 NFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp HHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred HHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 6677888999999999999999999864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=340.05 Aligned_cols=237 Identities=23% Similarity=0.291 Sum_probs=193.3
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHH-HhccCCCCcceeeeEEEeCCEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARL-LSQIRHRNIVKLYGFCLHEKCMFLI 391 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv 391 (560)
++|++.+.||+|+||.||+|+.+ +++.||+|++++... .......+.+|..+ ++.++||||+++++++.+.+..++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 56899999999999999999875 578999999976542 22233456667776 5678999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 471 (560)
|||+++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 118 ~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 118 LDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 99999999999997643 389999999999999999999999 999999999999999999999999999987544
Q ss_pred CCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------cccccccccc
Q 035761 472 DSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNIK 534 (560)
Q Consensus 472 ~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~~ 534 (560)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+. ....+...++
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~ 271 (373)
T 2r5t_A 192 HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLE 271 (373)
T ss_dssp CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHHH
T ss_pred CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Confidence 44445556899999999999999999999999999999999999999965432 1223445567
Q ss_pred cccccCCCCCCCh----hHHHhhceee
Q 035761 535 LIDLLDPRLPPPG----DQMIRQGIIL 557 (560)
Q Consensus 535 ~~~~~dp~~~p~~----~~~~~~~~~~ 557 (560)
.|...||..||.+ .++..|.|+.
T Consensus 272 ~lL~~dp~~R~~~~~~~~~i~~h~~f~ 298 (373)
T 2r5t_A 272 GLLQKDRTKRLGAKDDFMEIKSHVFFS 298 (373)
T ss_dssp HHTCSSGGGSTTTTTTHHHHHTSGGGT
T ss_pred HHcccCHHhCCCCCCCHHHHhCCcccc
Confidence 7778899999886 5888888864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=323.03 Aligned_cols=239 Identities=27% Similarity=0.382 Sum_probs=204.1
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
.++|++.+.||+|+||.||+|... +++.||||++..... ....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 467899999999999999999875 689999999875432 234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++++|.+++.... .+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||.+......
T Consensus 85 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 85 EYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp ECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EecCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 9999999999997543 389999999999999999999999 9999999999999999999999999999865432
Q ss_pred C--CCceeeccccCccCccccccCcc-CcchhHHHHHHHHHHHHhCCCCCCccccc--------------------cccc
Q 035761 473 S--SNRTLLAGTYGSIAPELAYTMVV-TEKYDVYSFGVVALEVLMGKHPGELLSSS--------------------SSSL 529 (560)
Q Consensus 473 ~--~~~~~~~g~~~~~aPE~~~~~~~-~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------------~~~~ 529 (560)
. .......|++.|+|||++.+..+ +.++||||||+++|||++|+.||...... ...+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHH
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHH
Confidence 2 12234568999999999987765 67899999999999999999999754321 1223
Q ss_pred ccccccccccCCCCCCChhHHHhhceeeec
Q 035761 530 DKNIKLIDLLDPRLPPPGDQMIRQGIILIS 559 (560)
Q Consensus 530 ~~~~~~~~~~dp~~~p~~~~~~~~~~~~~~ 559 (560)
.+.++.|...||..||+++++++|+|+..+
T Consensus 239 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 239 LALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 456677888999999999999999998764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=326.40 Aligned_cols=246 Identities=30% Similarity=0.489 Sum_probs=207.4
Q ss_pred CCcCHHHHHHHhcCCccc------ceeeccCCeeEEEEEeCCCcEEEEEEccchh--hhhhhHHHHHHHHHHHhccCCCC
Q 035761 303 GRITFQDMIEATEDFDIK------YCIGTGGYGSVYRARLPSGKVVALKKLHRLE--TELASLESFQNEARLLSQIRHRN 374 (560)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~------~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~n 374 (560)
..+++.++..++++|... +.||+|+||.||+|.. +++.||||++.... ......+.+.+|+.+++.++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 356889999999998877 8899999999999987 58899999987543 22334567899999999999999
Q ss_pred cceeeeEEEeCCEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCC
Q 035761 375 IVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNS 454 (560)
Q Consensus 375 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~ 454 (560)
|+++++++.+.+..++||||+++|+|.+++........+++..+..++.|++.||+|||+. +++||||||+||+++.
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcC
Confidence 9999999999999999999999999999997654445599999999999999999999999 9999999999999999
Q ss_pred CCcEEEeeeccccccCCCCCC--ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccccc------
Q 035761 455 EFEAFVADFGIARLLNYDSSN--RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSS------ 526 (560)
Q Consensus 455 ~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~------ 526 (560)
++.+||+|||+++........ .....|++.|+|||.+.+ .++.++||||||+++|||++|+.||.......
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 247 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 247 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHH
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHH
Confidence 999999999999876432222 223468999999998765 57899999999999999999999997543221
Q ss_pred --------------------------cccccccccccccCCCCCCChhHHHhh
Q 035761 527 --------------------------SSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 527 --------------------------~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
..+.+.+..|...||..||++++++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 248 EEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp HHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 112345667788899999999998875
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=332.00 Aligned_cols=233 Identities=30% Similarity=0.399 Sum_probs=194.8
Q ss_pred cCCcccceeeccCCeeEEEEEeC----CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP----SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFL 390 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 390 (560)
++|++.+.||+|+||.||+|.+. .+..||||+++.... ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT-ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 56888999999999999999874 345699999975432 2345678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccC
Q 035761 391 IYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN 470 (560)
Q Consensus 391 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 470 (560)
||||+++|+|.++++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 128 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999975432 389999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCc---eeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc------------------cccc
Q 035761 471 YDSSNR---TLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS------------------SSSS 528 (560)
Q Consensus 471 ~~~~~~---~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~------------------~~~~ 528 (560)
...... ....+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... ....
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHA 282 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHH
Confidence 432222 22345778999999999999999999999999999999 9999964432 1223
Q ss_pred cccccccccccCCCCCCChhHHHhh
Q 035761 529 LDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 529 ~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
+.+.+..|...||..||++.++++.
T Consensus 283 l~~li~~~l~~dp~~Rps~~eil~~ 307 (325)
T 3kul_A 283 LHQLMLDCWHKDRAQRPRFSQIVSV 307 (325)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHHH
Confidence 4566777888899999999988764
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=332.83 Aligned_cols=250 Identities=20% Similarity=0.283 Sum_probs=207.9
Q ss_pred CcCHHHHHHHhcCCccc-ceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeee
Q 035761 304 RITFQDMIEATEDFDIK-YCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYG 380 (560)
Q Consensus 304 ~~~~~~~~~~~~~~~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~ 380 (560)
.+.++......++|.+. +.||+|+||.||+|... +++.||+|++............+.+|+.+++.+ +||||+++++
T Consensus 17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~ 96 (327)
T 3lm5_A 17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96 (327)
T ss_dssp CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 34455556667778877 88999999999999865 589999999986554444566888999999999 5699999999
Q ss_pred EEEeCCEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCC---CCc
Q 035761 381 FCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNS---EFE 457 (560)
Q Consensus 381 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~ 457 (560)
++...+..++||||+++|+|.+++.... ...+++.++..++.|++.||+|||+. +|+||||||+||+++. ++.
T Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~ 172 (327)
T 3lm5_A 97 VYENTSEIILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGD 172 (327)
T ss_dssp EEECSSEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCC
T ss_pred EEEeCCeEEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCc
Confidence 9999999999999999999999986532 23489999999999999999999999 9999999999999998 789
Q ss_pred EEEeeeccccccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-------------
Q 035761 458 AFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS------------- 524 (560)
Q Consensus 458 ~kl~Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~------------- 524 (560)
+||+|||+++...... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||.....
T Consensus 173 ~kL~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 251 (327)
T 3lm5_A 173 IKIVDFGMSRKIGHAC-ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVD 251 (327)
T ss_dssp EEECCGGGCEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred EEEeeCccccccCCcc-ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccc
Confidence 9999999998765332 23345699999999999999999999999999999999999999964432
Q ss_pred --------cccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 525 --------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 525 --------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
....+.+.++.|...||..||+++++++|+|+..
T Consensus 252 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~ 293 (327)
T 3lm5_A 252 YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQ 293 (327)
T ss_dssp CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCC
T ss_pred cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcc
Confidence 1122455667788899999999999999999864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=349.11 Aligned_cols=237 Identities=26% Similarity=0.346 Sum_probs=185.8
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC-----CEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHE-----KCM 388 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~ 388 (560)
++|++.+.||+|+||.||+|... +++.||||++..........+.+.+|+++++.++||||+++++++... ...
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 67999999999999999999764 689999999876544445567789999999999999999999998543 568
Q ss_pred EEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccc
Q 035761 389 FLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARL 468 (560)
Q Consensus 389 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 468 (560)
++||||+. |+|.+++.... .+++..+..++.||+.||+|||+. +||||||||+|||++.++.+||+|||+++.
T Consensus 133 ~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 133 YVVLEIAD-SDFKKLFRTPV---YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEECCCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEeccc-cchhhhcccCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchh
Confidence 99999985 69999987643 399999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC---------------------------CceeeccccCccCcccc-ccCccCcchhHHHHHHHHHHHHh------
Q 035761 469 LNYDSS---------------------------NRTLLAGTYGSIAPELA-YTMVVTEKYDVYSFGVVALEVLM------ 514 (560)
Q Consensus 469 ~~~~~~---------------------------~~~~~~g~~~~~aPE~~-~~~~~~~~~Dv~s~G~il~el~~------ 514 (560)
...... .....+||+.|+|||++ ....++.++|||||||++|||++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 643211 12335689999999976 56679999999999999999999
Q ss_pred -----CCCCCCcccc-----------------------------------------------------------------
Q 035761 515 -----GKHPGELLSS----------------------------------------------------------------- 524 (560)
Q Consensus 515 -----g~~P~~~~~~----------------------------------------------------------------- 524 (560)
|++||...+.
T Consensus 286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (458)
T 3rp9_A 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER 365 (458)
T ss_dssp SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence 6666643220
Q ss_pred ---cccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 525 ---SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 525 ---~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
....+..+++.|...||..||+++++++|+|+..
T Consensus 366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~ 402 (458)
T 3rp9_A 366 FPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKE 402 (458)
T ss_dssp STTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred CCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhh
Confidence 0223345677888999999999999999999853
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=322.75 Aligned_cols=232 Identities=25% Similarity=0.411 Sum_probs=199.5
Q ss_pred hcCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
.++|++.+.||+|+||.||+|+.+++..||||+++.... ..+.+.+|++++++++||||+++++++..+...++|||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM---SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC---cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 357889999999999999999998888999999976442 23568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++|+|.+++.... ..+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 84 YISNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp CCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred ccCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 999999999997643 2389999999999999999999999 99999999999999999999999999998764332
Q ss_pred CC-ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc------------------ccccccccc
Q 035761 474 SN-RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS------------------SSSSLDKNI 533 (560)
Q Consensus 474 ~~-~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~------------------~~~~~~~~~ 533 (560)
.. .....+++.|+|||++.+..++.++||||+|+++|||++ |+.||..... ....+.+.+
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (268)
T 3sxs_A 159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIM 238 (268)
T ss_dssp EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHHH
Confidence 21 122345678999999999999999999999999999999 9999974432 122355677
Q ss_pred ccccccCCCCCCChhHHHhh
Q 035761 534 KLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 534 ~~~~~~dp~~~p~~~~~~~~ 553 (560)
+.|...||..||++++++++
T Consensus 239 ~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 239 YSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHTTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCChhhCcCHHHHHHH
Confidence 78888999999999999876
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=325.86 Aligned_cols=239 Identities=17% Similarity=0.265 Sum_probs=199.7
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKCMFLI 391 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 391 (560)
.++|++.+.||+|+||.||+|... +++.||+|++............+.+|+..+..+ +||||+++++++.+++..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467999999999999999999875 789999999876544334456788999999999 999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCc-ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCC---------------
Q 035761 392 YEYMEMGSLFCILRTDEE-AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSE--------------- 455 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~--------------- 455 (560)
|||+++|+|.+++..... ...+++.++..++.||+.||+|||+. +|+||||||+||+++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999976422 13489999999999999999999999 99999999999999844
Q ss_pred ----CcEEEeeeccccccCCCCCCceeeccccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCCCCCccc-------
Q 035761 456 ----FEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKHPGELLS------- 523 (560)
Q Consensus 456 ----~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~P~~~~~------- 523 (560)
..+||+|||.+....... ...|++.|+|||++.+. .++.++||||||+++|||++|.+|+....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~ 242 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQ 242 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHHHHT
T ss_pred cCCceEEEEcccccccccCCcc----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHHHHc
Confidence 479999999998765322 23589999999998876 56679999999999999999998764322
Q ss_pred --------ccccccccccccccccCCCCCCChhHHHhhceeeec
Q 035761 524 --------SSSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILIS 559 (560)
Q Consensus 524 --------~~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~~ 559 (560)
.....+.+.++.|...||..||++.++++|+|+..+
T Consensus 243 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 243 GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 123345667788889999999999999999999865
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=333.27 Aligned_cols=244 Identities=26% Similarity=0.373 Sum_probs=206.2
Q ss_pred HHHHHHHhcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh------hhhhHHHHHHHHHHHhcc-CCCCccee
Q 035761 307 FQDMIEATEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET------ELASLESFQNEARLLSQI-RHRNIVKL 378 (560)
Q Consensus 307 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l-~h~niv~l 378 (560)
+.......++|++.+.||+|+||.||+|... +|+.||||++..... .....+.+.+|+.+++.+ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3444556678999999999999999999875 699999999865331 122345688999999999 89999999
Q ss_pred eeEEEeCCEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcE
Q 035761 379 YGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEA 458 (560)
Q Consensus 379 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 458 (560)
++++...+..++||||+++|+|.+++.... .+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence 999999999999999999999999997543 389999999999999999999999 99999999999999999999
Q ss_pred EEeeeccccccCCCCCCceeeccccCccCcccccc------CccCcchhHHHHHHHHHHHHhCCCCCCcccc--------
Q 035761 459 FVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYT------MVVTEKYDVYSFGVVALEVLMGKHPGELLSS-------- 524 (560)
Q Consensus 459 kl~Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~------~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-------- 524 (560)
||+|||++..+... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 240 kl~DfG~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~ 318 (365)
T 2y7j_A 240 RLSDFGFSCHLEPG-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIM 318 (365)
T ss_dssp EECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred EEEecCcccccCCC-cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 99999999876533 23344579999999998863 3578899999999999999999999964321
Q ss_pred -------------cccccccccccccccCCCCCCChhHHHhhceee
Q 035761 525 -------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 525 -------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
....+...++.|...||..||+++++++|+|+.
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 319 EGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp HTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred hCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 112255667788899999999999999999974
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=341.31 Aligned_cols=239 Identities=24% Similarity=0.340 Sum_probs=191.5
Q ss_pred HHhcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh------hhhhHHHHHHHHHHHhccCCCCcceeeeEEEe
Q 035761 312 EATEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET------ELASLESFQNEARLLSQIRHRNIVKLYGFCLH 384 (560)
Q Consensus 312 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 384 (560)
...++|.+.+.||+|+||.||+|... +++.||||++..... .......+.+|++++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 34578999999999999999999764 579999999875431 1112235789999999999999999999975
Q ss_pred CCEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCC---CcEEEe
Q 035761 385 EKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSE---FEAFVA 461 (560)
Q Consensus 385 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~ 461 (560)
.+..++||||+++|+|.+++..... +++.++..++.|++.||+|||+. +|+||||||+|||++.+ ..+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGNKR---LKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSSCC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEe
Confidence 4568999999999999999876543 89999999999999999999999 99999999999999754 459999
Q ss_pred eeccccccCCCCCCceeeccccCccCcccccc---CccCcchhHHHHHHHHHHHHhCCCCCCccccc-------------
Q 035761 462 DFGIARLLNYDSSNRTLLAGTYGSIAPELAYT---MVVTEKYDVYSFGVVALEVLMGKHPGELLSSS------------- 525 (560)
Q Consensus 462 Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~---~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~------------- 525 (560)
|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 285 DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~ 363 (419)
T 3i6u_A 285 DFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 363 (419)
T ss_dssp CSSTTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCC
T ss_pred ecccceecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCC
Confidence 99999876532 23344579999999999863 56788999999999999999999999754321
Q ss_pred ---------ccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 526 ---------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 526 ---------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
...+.+.++.|...||..||+++++++|+|+..
T Consensus 364 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 364 FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 223445667788889999999999999999875
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=334.98 Aligned_cols=237 Identities=26% Similarity=0.357 Sum_probs=194.8
Q ss_pred cCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchh-hhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCC----EE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLE-TELASLESFQNEARLLSQIRHRNIVKLYGFCLHEK----CM 388 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~ 388 (560)
++|++.+.||+|+||.||+|+. .+++.||||+++... ........+.+|+.++++++||||+++++++.... ..
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 5799999999999999999986 568999999997643 22344567899999999999999999999987654 34
Q ss_pred EEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccc
Q 035761 389 FLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARL 468 (560)
Q Consensus 389 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 468 (560)
++||||+++|+|.++++... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 92 ~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred EEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 99999999999999997643 389999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCC---ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------
Q 035761 469 LNYDSSN---RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS--------------------- 524 (560)
Q Consensus 469 ~~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~--------------------- 524 (560)
....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 245 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTT
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCC
Confidence 6433221 2234689999999999999999999999999999999999999975442
Q ss_pred cccccccccccccccCCCCCCChhHHHhhceee
Q 035761 525 SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 525 ~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
....+...+..|...||..||+..+++++.|+.
T Consensus 246 ~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 246 LSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 122345667778889999999999999998764
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=349.62 Aligned_cols=237 Identities=24% Similarity=0.384 Sum_probs=202.5
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
.++|++.+.||+|+||.||+|... +++.||||++............+.+|++++++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 457999999999999999999875 6899999999765543445677899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeC---CCCcEEEeeecccccc
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLN---SEFEAFVADFGIARLL 469 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg~~~~~ 469 (560)
||+++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++ .++.+||+|||+++..
T Consensus 101 e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp CCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 9999999999887643 389999999999999999999999 999999999999995 4567999999999876
Q ss_pred CCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------cccc
Q 035761 470 NYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------SSSS 528 (560)
Q Consensus 470 ~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------~~~~ 528 (560)
... .......||+.|+|||++.+ .++.++||||+||++|||++|+.||..... .+..
T Consensus 175 ~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 252 (486)
T 3mwu_A 175 QQN-TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD 252 (486)
T ss_dssp CCC-----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHH
T ss_pred CCC-CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHH
Confidence 533 22344579999999999876 589999999999999999999999964432 1223
Q ss_pred cccccccccccCCCCCCChhHHHhhceeee
Q 035761 529 LDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 529 ~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
+...++.|...||..||++.++++|+|+..
T Consensus 253 ~~~li~~~L~~dp~~R~t~~~~l~hp~~~~ 282 (486)
T 3mwu_A 253 AKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (486)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHCHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCHhhcc
Confidence 456677888999999999999999999863
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=335.52 Aligned_cols=238 Identities=22% Similarity=0.327 Sum_probs=199.1
Q ss_pred cCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC--------
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHE-------- 385 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------- 385 (560)
++|++.+.||+|+||.||+|+. .+|+.||||++............+.+|+++++.++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5799999999999999999987 5689999999876554334445678999999999999999999999873
Q ss_pred CEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecc
Q 035761 386 KCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGI 465 (560)
Q Consensus 386 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 465 (560)
+..++||||+++ ++.+.+..... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCC-CHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 468999999985 77777765432 389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCC----CCceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCccccc---------------
Q 035761 466 ARLLNYDS----SNRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------- 525 (560)
Q Consensus 466 ~~~~~~~~----~~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------- 525 (560)
++.+.... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 98764221 22234568999999998876 45799999999999999999999999754311
Q ss_pred ----------------------------------ccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 526 ----------------------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 526 ----------------------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
+..+.+.++.|...||..||+++++++|+|+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 317 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 317 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGS
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCC
Confidence 112345667788999999999999999999864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=334.61 Aligned_cols=240 Identities=25% Similarity=0.313 Sum_probs=196.3
Q ss_pred HhcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhh---hhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEE
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETEL---ASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCM 388 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 388 (560)
..++|++.+.||+|+||.||+|... +|+.||||++....... ...+.+.+|+++++.++||||+++++++.+.+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3567999999999999999999875 58999999987543211 1124678999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccc
Q 035761 389 FLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARL 468 (560)
Q Consensus 389 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 468 (560)
++||||+++ +|.+++.... ..+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred EEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 999999986 8888887543 3488999999999999999999999 999999999999999999999999999988
Q ss_pred cCCCCCCceeeccccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCCCCCccccc----------------------
Q 035761 469 LNYDSSNRTLLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKHPGELLSSS---------------------- 525 (560)
Q Consensus 469 ~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~---------------------- 525 (560)
............||+.|+|||++.+. .++.++|||||||++|||++|..||......
T Consensus 162 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 241 (346)
T 1ua2_A 162 FGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 241 (346)
T ss_dssp TTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred ccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhc
Confidence 75544444556789999999998764 4788999999999999999999998643310
Q ss_pred -----------------------ccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 526 -----------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 526 -----------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
...+.+.++.|...||..||+++++++|+|+.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~ 297 (346)
T 1ua2_A 242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297 (346)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhc
Confidence 122344667788899999999999999999864
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=323.14 Aligned_cols=236 Identities=27% Similarity=0.427 Sum_probs=204.1
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+.+|+++++.++||||+++++++.+++..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 56889999999999999999875 578899999875432 2233467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++|+|.+++.... .+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~- 166 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS- 166 (284)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS-
T ss_pred EeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc-
Confidence 9999999999997643 389999999999999999999999 999999999999999999999999999976542
Q ss_pred CCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------ccccccccccc
Q 035761 473 SSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNIKL 535 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~~~ 535 (560)
.......|++.|+|||++.+..++.++||||||+++|||++|+.||..... ....+.+.++.
T Consensus 167 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 245 (284)
T 2vgo_A 167 -LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISK 245 (284)
T ss_dssp -SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred -cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHHHH
Confidence 223345689999999999999999999999999999999999999975432 12334566777
Q ss_pred ccccCCCCCCChhHHHhhceeee
Q 035761 536 IDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 536 ~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
|...||..||+++++++|+|+..
T Consensus 246 ~l~~~p~~Rps~~~ll~h~~~~~ 268 (284)
T 2vgo_A 246 LLRYHPPQRLPLKGVMEHPWVKA 268 (284)
T ss_dssp HSCSSGGGSCCHHHHHTCHHHHH
T ss_pred HhhcCHhhCCCHHHHhhCHHHHh
Confidence 88899999999999999999864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=341.62 Aligned_cols=234 Identities=26% Similarity=0.387 Sum_probs=195.9
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
.++|.+.+.||+|+||.||+|.+. +++.||||.++.... ....+.+.+|++++++++||||+++++++..++..++||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP-PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSC-HHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 457888999999999999999886 689999999875432 233456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++|+|.++++... ..+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 192 e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp ECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred EcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 9999999999997543 2389999999999999999999999 9999999999999999999999999999865322
Q ss_pred CCC--ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------------cccccc
Q 035761 473 SSN--RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------------SSSLDK 531 (560)
Q Consensus 473 ~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------------~~~~~~ 531 (560)
... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||...... ...+.+
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 346 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFR 346 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 111 111235778999999999999999999999999999998 99999754321 123445
Q ss_pred ccccccccCCCCCCChhHHHhh
Q 035761 532 NIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 532 ~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
.++.|...||..||+++++++.
T Consensus 347 li~~cl~~dP~~Rps~~~i~~~ 368 (377)
T 3cbl_A 347 LMEQCWAYEPGQRPSFSTIYQE 368 (377)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCchhCcCHHHHHHH
Confidence 6677778889999998888764
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=335.87 Aligned_cols=234 Identities=25% Similarity=0.308 Sum_probs=193.1
Q ss_pred hcCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCC------
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEK------ 386 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 386 (560)
.++|+..+.||+|+||.||+|.. .+|+.||||++..........+.+.+|+++++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 35789999999999999999986 46899999999765444445567889999999999999999999997653
Q ss_pred EEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccc
Q 035761 387 CMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIA 466 (560)
Q Consensus 387 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~ 466 (560)
..++||||+ +++|.+++... .+++.++..++.||++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 459999999 78999999753 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCccccc--------------------
Q 035761 467 RLLNYDSSNRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSSS-------------------- 525 (560)
Q Consensus 467 ~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~-------------------- 525 (560)
+.... ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...+..
T Consensus 176 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 252 (367)
T 1cm8_A 176 RQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 252 (367)
T ss_dssp EECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred ccccc---ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 87543 2334568999999999887 67899999999999999999999999754320
Q ss_pred ----------------------------ccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 526 ----------------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 526 ----------------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
...+...++.|...||..||+++++++|+|+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~ 313 (367)
T 1cm8_A 253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 313 (367)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHh
Confidence 112334556778889999999999999999853
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=323.76 Aligned_cols=231 Identities=28% Similarity=0.398 Sum_probs=198.2
Q ss_pred cCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
++|++.+.||+|+||.||+|...+++.||+|++..... ..+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc---CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 56888999999999999999998899999999975432 235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC-
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS- 473 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~- 473 (560)
+++|+|.+++..... .+++.++..++.|+++||+|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 87 ~~~~~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 87 MEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp CTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCCCcHHHHHHhcCc--ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccc
Confidence 999999999976433 389999999999999999999999 99999999999999999999999999998654321
Q ss_pred CCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc------------------cccccccccc
Q 035761 474 SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS------------------SSSSLDKNIK 534 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~------------------~~~~~~~~~~ 534 (560)
.......+++.|+|||++.+..++.++||||+|+++|||++ |+.||..... ....+.+.++
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 241 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN 241 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHH
Confidence 11222346778999999999999999999999999999999 9999975432 1223445667
Q ss_pred cccccCCCCCCChhHHHhh
Q 035761 535 LIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 535 ~~~~~dp~~~p~~~~~~~~ 553 (560)
.|...||..||++.+++++
T Consensus 242 ~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 242 HCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHccCCcccCcCHHHHHHH
Confidence 7888899999999999876
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=322.33 Aligned_cols=237 Identities=25% Similarity=0.343 Sum_probs=201.0
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhh----hhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETE----LASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMF 389 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 389 (560)
++|++.+.||+|+||.||+|... +++.||+|.++..... ....+.+.+|+.++++++||||+++++++......+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56889999999999999999876 6899999998754321 113567899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCC----cEEEeeecc
Q 035761 390 LIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEF----EAFVADFGI 465 (560)
Q Consensus 390 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg~ 465 (560)
+||||+++++|.+++.... .+++.++..++.||+.||+|||+. +++||||||+||+++.++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 9999999999999997543 389999999999999999999999 999999999999998877 799999999
Q ss_pred ccccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------
Q 035761 466 ARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS--------------------- 524 (560)
Q Consensus 466 ~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~--------------------- 524 (560)
+....... ......|++.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 159 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T 3bhy_A 159 AHKIEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSN 237 (283)
T ss_dssp CEECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred ceeccCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhccc
Confidence 98764322 22344689999999999999999999999999999999999999975432
Q ss_pred cccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 525 SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 525 ~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
....+.+.++.|...||..||++.++++|+|+..
T Consensus 238 ~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 238 TSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp CCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 1223456677888899999999999999999753
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=328.74 Aligned_cols=236 Identities=21% Similarity=0.307 Sum_probs=194.1
Q ss_pred cCCccc-ceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCEEEEE
Q 035761 315 EDFDIK-YCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKCMFLI 391 (560)
Q Consensus 315 ~~~~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 391 (560)
+.|++. +.||+|+||.||+|... +++.||||++.... ....+.+.+|++++.++ +||||+++++++.+++..++|
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 457774 77999999999999854 68999999997543 23345788999999985 799999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCc---EEEeeeccccc
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFE---AFVADFGIARL 468 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg~~~~ 468 (560)
|||+++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++. +||+|||++..
T Consensus 90 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 99999999999997643 389999999999999999999999 9999999999999998776 99999999986
Q ss_pred cCCCCC-------CceeeccccCccCcccccc-----CccCcchhHHHHHHHHHHHHhCCCCCCcccc------------
Q 035761 469 LNYDSS-------NRTLLAGTYGSIAPELAYT-----MVVTEKYDVYSFGVVALEVLMGKHPGELLSS------------ 524 (560)
Q Consensus 469 ~~~~~~-------~~~~~~g~~~~~aPE~~~~-----~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~------------ 524 (560)
...... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 542211 1123458999999999875 5688999999999999999999999975421
Q ss_pred ------------------------cccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 525 ------------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 525 ------------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
....+.+.++.|...||..||+++++++|+|+..
T Consensus 244 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 301 (316)
T 2ac3_A 244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQG 301 (316)
T ss_dssp HHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-
T ss_pred hHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcC
Confidence 1123456667788899999999999999999874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=331.07 Aligned_cols=232 Identities=25% Similarity=0.339 Sum_probs=190.8
Q ss_pred hcCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCC----EEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEK----CMF 389 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~ 389 (560)
.++|++.+.||+|+||.||+|++. ++.||||++..... ....+.+|+.++++++||||+++++++.... ..+
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK---QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch---HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 367999999999999999999885 78999999975432 2234556889999999999999999998754 479
Q ss_pred EEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcC-------CCCeEEeCCCCCCeEeCCCCcEEEee
Q 035761 390 LIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHC-------TPPILHRDISSNNILLNSEFEAFVAD 462 (560)
Q Consensus 390 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-------~~~ivH~dlk~~Nill~~~~~~kl~D 462 (560)
+||||+++|+|.++++... +++.++..++.|++.||+|||+.. .++|+||||||+||+++.++.+||+|
T Consensus 99 lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKANV----VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EEEECCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred EEEecCCCCCHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 9999999999999997643 899999999999999999999751 33899999999999999999999999
Q ss_pred eccccccCCCCCC--ceeeccccCccCcccccc-----CccCcchhHHHHHHHHHHHHhCCCCCCcccccc---------
Q 035761 463 FGIARLLNYDSSN--RTLLAGTYGSIAPELAYT-----MVVTEKYDVYSFGVVALEVLMGKHPGELLSSSS--------- 526 (560)
Q Consensus 463 fg~~~~~~~~~~~--~~~~~g~~~~~aPE~~~~-----~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~--------- 526 (560)
||+++........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 9999876543322 223568999999999886 456678999999999999999999996432110
Q ss_pred -------------------------------cccccccccccccCCCCCCChhHHHhh
Q 035761 527 -------------------------------SSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 527 -------------------------------~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
..+.+.++.|...||..||+++++++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 312 (322)
T 3soc_A 255 QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312 (322)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 014455677888899999999988865
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=326.49 Aligned_cols=243 Identities=28% Similarity=0.444 Sum_probs=204.0
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEe--CCEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLH--EKCMFL 390 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l 390 (560)
.++|++.+.||+|+||.||+|... +++.||+|.+..........+.+.+|++++++++||||+++++++.. ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 357899999999999999999875 68999999997655444556789999999999999999999998854 568999
Q ss_pred EEeccCCCCHHHHhhcCCc-ccCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----eEEeCCCCCCeEeCCCCcEEEeeec
Q 035761 391 IYEYMEMGSLFCILRTDEE-AVGLDWTKRVNIVKGMAHALSYLHHHCTPP-----ILHRDISSNNILLNSEFEAFVADFG 464 (560)
Q Consensus 391 v~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~-----ivH~dlk~~Nill~~~~~~kl~Dfg 464 (560)
||||+++|+|.+++..... ...+++.++..++.|++.||+|||+. + ++||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 9999999999999975322 23489999999999999999999998 7 9999999999999999999999999
Q ss_pred cccccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc------------------cc
Q 035761 465 IARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS------------------SS 526 (560)
Q Consensus 465 ~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~------------------~~ 526 (560)
+++.............|++.|+|||++.+..++.++||||||+++|||++|+.||..... ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (279)
T 2w5a_A 162 LARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYS 241 (279)
T ss_dssp HHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTTSC
T ss_pred hheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcccC
Confidence 998765433323345689999999999998999999999999999999999999975432 12
Q ss_pred cccccccccccccCCCCCCChhHHHhhceeeec
Q 035761 527 SSLDKNIKLIDLLDPRLPPPGDQMIRQGIILIS 559 (560)
Q Consensus 527 ~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~~ 559 (560)
..+.+.++.|...||..||++++++++.|..-+
T Consensus 242 ~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 242 DELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 345667788889999999999999999987643
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=325.49 Aligned_cols=236 Identities=31% Similarity=0.454 Sum_probs=206.0
Q ss_pred cCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
+.|+..+.||+|+||.||+|.. .+++.||||++..... ....+.+.+|+.+++.++||||+++++++..+...++|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 5688899999999999999976 4689999999875432 2345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++++|.+++... .+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 99999999999753 389999999999999999999999 99999999999999999999999999998775544
Q ss_pred CCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc------------------ccccccccccc
Q 035761 474 SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS------------------SSSSLDKNIKL 535 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~------------------~~~~~~~~~~~ 535 (560)
.......|++.|+|||++.+..++.++||||||+++|||++|+.||..... ....+...++.
T Consensus 174 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 253 (303)
T 3a7i_A 174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA 253 (303)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHH
T ss_pred cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHH
Confidence 444556789999999999999999999999999999999999999975432 12234566678
Q ss_pred ccccCCCCCCChhHHHhhceeee
Q 035761 536 IDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 536 ~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
|...||..||++++++++.|+..
T Consensus 254 ~l~~dp~~Rps~~~ll~~~~~~~ 276 (303)
T 3a7i_A 254 CLNKEPSFRPTAKELLKHKFILR 276 (303)
T ss_dssp HCCSSGGGSCCHHHHTTCHHHHH
T ss_pred HcCCChhhCcCHHHHhhChhhhc
Confidence 88999999999999999999854
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=358.52 Aligned_cols=239 Identities=22% Similarity=0.285 Sum_probs=206.9
Q ss_pred HhcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchh-hhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCEEE
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLE-TELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKCMF 389 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 389 (560)
..++|++.+.||+|+||.||+|+.+ +++.||||+++... ......+.+..|..++..+ +||+|+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3467999999999999999999865 57899999997643 2234456778899999988 7999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccccc
Q 035761 390 LIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL 469 (560)
Q Consensus 390 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 469 (560)
+||||+++|+|.+++...+. +++.++..++.||+.||+|||+. +||||||||+|||++.++.+||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVGR---FKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 99999999999999986543 99999999999999999999999 9999999999999999999999999999875
Q ss_pred CCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------cccccccc
Q 035761 470 NYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKN 532 (560)
Q Consensus 470 ~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~ 532 (560)
..........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+. ....+..+
T Consensus 493 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 572 (674)
T 3pfq_A 493 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAI 572 (674)
T ss_dssp CCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHH
T ss_pred ccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHH
Confidence 4444455567899999999999999999999999999999999999999975432 12334566
Q ss_pred cccccccCCCCCCCh-----hHHHhhceee
Q 035761 533 IKLIDLLDPRLPPPG-----DQMIRQGIIL 557 (560)
Q Consensus 533 ~~~~~~~dp~~~p~~-----~~~~~~~~~~ 557 (560)
++.+...||..|+.+ +++++|+|+.
T Consensus 573 i~~lL~~dP~~R~~~~~~~~~ei~~h~ff~ 602 (674)
T 3pfq_A 573 CKGLMTKHPGKRLGCGPEGERDIKEHAFFR 602 (674)
T ss_dssp HHHHSCSSSTTCTTCSTTHHHHHHSSGGGS
T ss_pred HHHHccCCHHHCCCCCCCcHHHHhcCcccc
Confidence 677888899999998 8999999975
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=348.33 Aligned_cols=236 Identities=27% Similarity=0.373 Sum_probs=197.2
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
.++|++.+.||+|+||.||+|+.+ ++..||+|++............+.+|+.+++.++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 356899999999999999999875 6889999999865543344567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCC---CcEEEeeecccccc
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSE---FEAFVADFGIARLL 469 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~~~~~ 469 (560)
||+++|+|.+++..... +++.++..++.||+.||+|||+. +|+||||||+||+++.. +.+||+|||+++..
T Consensus 116 e~~~~g~L~~~~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIHRMK---FNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 99999999998875433 89999999999999999999999 99999999999999764 55999999999876
Q ss_pred CCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------cccc
Q 035761 470 NYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------SSSS 528 (560)
Q Consensus 470 ~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------~~~~ 528 (560)
... .......||+.|+|||++. ..++.++||||+||++|||++|+.||..... .+..
T Consensus 190 ~~~-~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 267 (494)
T 3lij_A 190 ENQ-KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEG 267 (494)
T ss_dssp BTT-BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHH
T ss_pred CCC-ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHH
Confidence 533 2334457999999999876 4689999999999999999999999964432 1223
Q ss_pred cccccccccccCCCCCCChhHHHhhceee
Q 035761 529 LDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 529 ~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
+...++.|...||..||++.++++|+|+.
T Consensus 268 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~ 296 (494)
T 3lij_A 268 AKDLIKQMLQFDSQRRISAQQALEHPWIK 296 (494)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTCHHHH
T ss_pred HHHHHHHHCCCChhhCccHHHHhcCcccc
Confidence 45667788899999999999999999985
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=337.52 Aligned_cols=233 Identities=29% Similarity=0.409 Sum_probs=186.2
Q ss_pred cCCcccceeeccCCeeEEEEEeC----CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP----SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFL 390 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 390 (560)
++|++.+.||+|+||.||+|+.+ ++..||||+++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT-EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 57889999999999999999865 577899999975432 2345679999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccC
Q 035761 391 IYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN 470 (560)
Q Consensus 391 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 470 (560)
||||+++|+|.++++... ..+++.++..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 124 v~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 999999999999998643 2389999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCC---ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc------------------cccc
Q 035761 471 YDSSN---RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS------------------SSSS 528 (560)
Q Consensus 471 ~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~------------------~~~~ 528 (560)
..... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||..... ....
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 278 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAA 278 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHH
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHH
Confidence 43221 112235678999999999999999999999999999998 9999964432 1123
Q ss_pred cccccccccccCCCCCCChhHHHhh
Q 035761 529 LDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 529 ~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
+.+.+..|...||..||+++++++.
T Consensus 279 l~~li~~cl~~dp~~RPs~~~i~~~ 303 (373)
T 2qol_A 279 LYQLMLDCWQKDRNNRPKFEQIVSI 303 (373)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhCcChhhCcCHHHHHHH
Confidence 4566677888899999999998764
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=322.89 Aligned_cols=239 Identities=24% Similarity=0.321 Sum_probs=199.0
Q ss_pred CCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 316 DFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
+|.....||+|+||.||+|.. .+++.||||.+.... ....+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence 355566899999999999986 468899999987543 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCC-CCcEEEeeeccccccCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNS-EFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~~~~~~~~~ 473 (560)
+++++|.+++........+++..+..++.|++.||+|||+. +++||||||+||+++. ++.+||+|||++.......
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 99999999998765445578999999999999999999999 9999999999999987 8999999999998765433
Q ss_pred CCceeeccccCccCccccccCc--cCcchhHHHHHHHHHHHHhCCCCCCcccc--------------------ccccccc
Q 035761 474 SNRTLLAGTYGSIAPELAYTMV--VTEKYDVYSFGVVALEVLMGKHPGELLSS--------------------SSSSLDK 531 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~~~--~~~~~Dv~s~G~il~el~~g~~P~~~~~~--------------------~~~~~~~ 531 (560)
.......|++.|+|||++.+.. ++.++||||||+++|||++|+.||..... ....+.+
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKA 257 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHH
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHH
Confidence 3344457899999999987653 78899999999999999999999964332 1223445
Q ss_pred ccccccccCCCCCCChhHHHhhceeeec
Q 035761 532 NIKLIDLLDPRLPPPGDQMIRQGIILIS 559 (560)
Q Consensus 532 ~~~~~~~~dp~~~p~~~~~~~~~~~~~~ 559 (560)
.++.|...||..||+++++++|+|+...
T Consensus 258 li~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 258 FILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp HHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred HHHHHccCChhhCCCHHHHhcChhhhhc
Confidence 6677888999999999999999998754
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=330.47 Aligned_cols=243 Identities=23% Similarity=0.365 Sum_probs=183.4
Q ss_pred HhcCCcccceeeccCCeeEEEEEeCCCc----EEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEE
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARLPSGK----VVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCM 388 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 388 (560)
..++|++.+.||+|+||.||+|...... .||||+++.........+.+.+|++++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 3467999999999999999999875432 799999976543444567899999999999999999999999887655
Q ss_pred ------EEEEeccCCCCHHHHhhcCC---cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEE
Q 035761 389 ------FLIYEYMEMGSLFCILRTDE---EAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAF 459 (560)
Q Consensus 389 ------~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 459 (560)
++||||+++|+|.+++.... ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEE
Confidence 99999999999999986532 122489999999999999999999999 999999999999999999999
Q ss_pred EeeeccccccCCCCCC--ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc------------
Q 035761 460 VADFGIARLLNYDSSN--RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS------------ 524 (560)
Q Consensus 460 l~Dfg~~~~~~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~------------ 524 (560)
|+|||+++........ .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~ 257 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR 257 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC
Confidence 9999999876433222 123346788999999999999999999999999999999 9999975432
Q ss_pred ------cccccccccccccccCCCCCCC-------hhHHHhhceeee
Q 035761 525 ------SSSSLDKNIKLIDLLDPRLPPP-------GDQMIRQGIILI 558 (560)
Q Consensus 525 ------~~~~~~~~~~~~~~~dp~~~p~-------~~~~~~~~~~~~ 558 (560)
....+.+.++.|...||..||+ +++++.+.|+..
T Consensus 258 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~ 304 (323)
T 3qup_A 258 LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLS 304 (323)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----
T ss_pred CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcC
Confidence 1123456677888999999999 777777777754
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=340.55 Aligned_cols=238 Identities=26% Similarity=0.329 Sum_probs=195.7
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC-----CE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHE-----KC 387 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 387 (560)
.++|++.+.||+|+||.||+|... +++.||||++..........+.+.+|+++++.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 367999999999999999999864 578999999976544445567889999999999999999999999776 56
Q ss_pred EEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccc
Q 035761 388 MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIAR 467 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~ 467 (560)
.++||||++ |+|.+++.... .+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI---FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999997 59999997643 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC----------------------CceeeccccCccCcccc-ccCccCcchhHHHHHHHHHHHHhCCCCCC----
Q 035761 468 LLNYDSS----------------------NRTLLAGTYGSIAPELA-YTMVVTEKYDVYSFGVVALEVLMGKHPGE---- 520 (560)
Q Consensus 468 ~~~~~~~----------------------~~~~~~g~~~~~aPE~~-~~~~~~~~~Dv~s~G~il~el~~g~~P~~---- 520 (560)
....... .....+||+.|+|||++ ....++.++||||+||++|||++|..||.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~ 257 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGG
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccc
Confidence 7643221 12446789999999985 56679999999999999999998544432
Q ss_pred -------ccc-----------------------------------------------------------------ccccc
Q 035761 521 -------LLS-----------------------------------------------------------------SSSSS 528 (560)
Q Consensus 521 -------~~~-----------------------------------------------------------------~~~~~ 528 (560)
..+ .....
T Consensus 258 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 337 (432)
T 3n9x_A 258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDD 337 (432)
T ss_dssp GCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHH
T ss_pred cccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHH
Confidence 211 01223
Q ss_pred cccccccccccCCCCCCChhHHHhhceeee
Q 035761 529 LDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 529 ~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
+...++.|...||..||+++++++|+|+..
T Consensus 338 ~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 367 (432)
T 3n9x_A 338 GINLLESMLKFNPNKRITIDQALDHPYLKD 367 (432)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHTCGGGTT
T ss_pred HHHHHHHHhcCCcccCCCHHHHhcChhhhh
Confidence 345667888999999999999999999853
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=326.96 Aligned_cols=238 Identities=29% Similarity=0.435 Sum_probs=201.2
Q ss_pred HhcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEE
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLI 391 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 391 (560)
..++|++.+.||+|+||.||+|... +|+.||+|.+.... ..+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 3567999999999999999999875 58999999987543 235688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 471 (560)
|||+++|+|.+++.... ..+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 103 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 103 MEYCGAGSVSDIIRLRN--KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp EECCTTEEHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred eecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 99999999999987422 2389999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc--------------------ccccccc
Q 035761 472 DSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS--------------------SSSSLDK 531 (560)
Q Consensus 472 ~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~--------------------~~~~~~~ 531 (560)
.........|++.|+|||++.+..++.++||||||+++|||++|+.||..... ....+.+
T Consensus 178 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 257 (314)
T 3com_A 178 TMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTD 257 (314)
T ss_dssp TBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred hccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHH
Confidence 43344455789999999999999999999999999999999999999975432 1223456
Q ss_pred ccccccccCCCCCCChhHHHhhceeeec
Q 035761 532 NIKLIDLLDPRLPPPGDQMIRQGIILIS 559 (560)
Q Consensus 532 ~~~~~~~~dp~~~p~~~~~~~~~~~~~~ 559 (560)
.++.|...||..||++.++++|+|+..+
T Consensus 258 li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 258 FVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp HHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred HHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 6778889999999999999999998653
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=320.64 Aligned_cols=237 Identities=23% Similarity=0.365 Sum_probs=196.5
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|.+.+.||+|+||.||+|... +|+.||||.+..... .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 57889999999999999999875 689999999876432 2344567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++++|.+++..... +++.++..++.||+.||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 91 e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 91 EYVSGGELFDYICKHGR---VEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp ECCCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred eccCCCcHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 99999999999976433 89999999999999999999999 9999999999999999999999999999876532
Q ss_pred CCCceeeccccCccCccccccCcc-CcchhHHHHHHHHHHHHhCCCCCCcccc-----------------cccccccccc
Q 035761 473 SSNRTLLAGTYGSIAPELAYTMVV-TEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNIK 534 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~~~~-~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~~ 534 (560)
.......|++.|+|||.+.+..+ +.++||||+|+++|||++|+.||..... ....+...++
T Consensus 165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 243 (276)
T 2h6d_A 165 -EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLM 243 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred -cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHHHH
Confidence 22334568999999999988765 5799999999999999999999975431 1233456677
Q ss_pred cccccCCCCCCChhHHHhhceeee
Q 035761 535 LIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 535 ~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
.|...||..||+++++++|+|+..
T Consensus 244 ~~l~~~p~~Rps~~~~l~h~~~~~ 267 (276)
T 2h6d_A 244 HMLQVDPLKRATIKDIREHEWFKQ 267 (276)
T ss_dssp HHTCSSGGGSCCHHHHHHSHHHHT
T ss_pred HHccCChhhCCCHHHHHhChhhcc
Confidence 888899999999999999999853
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=336.64 Aligned_cols=235 Identities=24% Similarity=0.314 Sum_probs=202.0
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
++|++.+.||+|+||.||+|... +++.||+|++..... ....+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCC-HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccC-HHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 57899999999999999999875 689999999876432 2345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHH-HCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
|+++|+|.+++..... +++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~~~---~~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHhC---CEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999999976433 8999999999999999999998 5 7999999999999999999999999999765322
Q ss_pred CCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc----------------------------
Q 035761 473 SSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------------- 524 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------------- 524 (560)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...+.
T Consensus 186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3eqc_A 186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263 (360)
T ss_dssp --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence 22334689999999999999999999999999999999999999964331
Q ss_pred ---------------------------------cccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 525 ---------------------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 525 ---------------------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
....+.+.++.|...||..||+++++++|+|+..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 330 (360)
T 3eqc_A 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 330 (360)
T ss_dssp ----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHH
T ss_pred ccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhc
Confidence 1223446677888999999999999999999864
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=343.01 Aligned_cols=236 Identities=14% Similarity=0.120 Sum_probs=190.8
Q ss_pred hcCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchh-hhhhhHHHHHHHHH---HHhccCCCCcceee-------eE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLE-TELASLESFQNEAR---LLSQIRHRNIVKLY-------GF 381 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~~---~l~~l~h~niv~l~-------~~ 381 (560)
.++|++.+.||+|+||.||+|.. .+|+.||||++.... ......+.+.+|++ .++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788899999999999999986 468999999987542 22334567889994 55556899999999 66
Q ss_pred EEeCC-----------------EEEEEEeccCCCCHHHHhhcCCc----ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 035761 382 CLHEK-----------------CMFLIYEYMEMGSLFCILRTDEE----AVGLDWTKRVNIVKGMAHALSYLHHHCTPPI 440 (560)
Q Consensus 382 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i 440 (560)
+..++ ..++||||+ +|+|.+++..... ...+++..+..|+.||+.||+|||+. +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 65543 278999999 6899999975422 11244688889999999999999999 99
Q ss_pred EEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCceeeccccCccCccccccC-----------ccCcchhHHHHHHHH
Q 035761 441 LHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTM-----------VVTEKYDVYSFGVVA 509 (560)
Q Consensus 441 vH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-----------~~~~~~Dv~s~G~il 509 (560)
+||||||+|||++.++.+||+|||+++... .......| +.|+|||++.+. .++.++|||||||++
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~---~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il 303 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG---ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT---CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecC---CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence 999999999999999999999999998633 23344567 999999999988 899999999999999
Q ss_pred HHHHhCCCCCCcccc-------------cccccccccccccccCCCCCCChhHHHhhceee
Q 035761 510 LEVLMGKHPGELLSS-------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 510 ~el~~g~~P~~~~~~-------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
|||++|+.||..... ....+.+.+..|...||..||++.++++|+|+.
T Consensus 304 ~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~ 364 (377)
T 3byv_A 304 YWIWCADLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYE 364 (377)
T ss_dssp HHHHHSSCCC------CCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHH
T ss_pred HHHHHCCCCCcccccccchhhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHH
Confidence 999999999965432 123445667788899999999999999999975
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=335.62 Aligned_cols=233 Identities=24% Similarity=0.280 Sum_probs=190.6
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCC------E
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEK------C 387 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~ 387 (560)
++|++.+.||+|+||.||+|... +++.||||++..........+.+.+|+.+++.++||||+++++++...+ .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 57899999999999999999764 6889999999765444445567889999999999999999999997664 7
Q ss_pred EEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccc
Q 035761 388 MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIAR 467 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~ 467 (560)
.++||||+++ +|.+++.. .+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 105 ~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 105 VYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred eEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 8999999975 78888853 289999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc----------------------
Q 035761 468 LLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS---------------------- 525 (560)
Q Consensus 468 ~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~---------------------- 525 (560)
..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...+..
T Consensus 176 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 176 TAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred ccccc-cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 76432 2233457899999999999999999999999999999999999999654320
Q ss_pred -------------------------------------ccccccccccccccCCCCCCChhHHHhhceee
Q 035761 526 -------------------------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 526 -------------------------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
...+.+.++.|...||..||+++++++|+|+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 323 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 323 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchh
Confidence 11234567788899999999999999999975
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=349.54 Aligned_cols=237 Identities=25% Similarity=0.384 Sum_probs=204.2
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLI 391 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 391 (560)
.++|++.+.||+|+||.||+|... +|+.||||++..... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 457899999999999999999875 689999999865432 233456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEe---CCCCcEEEeeeccccc
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILL---NSEFEAFVADFGIARL 468 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~~~~ 468 (560)
|||+++|+|.+++..... +++.++..++.||+.||+|||+. +|+||||||+||++ +.++.+||+|||+++.
T Consensus 105 ~e~~~~~~L~~~~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRKR---FSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHTCSC---CBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 999999999999976543 89999999999999999999999 99999999999999 5678999999999987
Q ss_pred cCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------ccc
Q 035761 469 LNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------SSS 527 (560)
Q Consensus 469 ~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------~~~ 527 (560)
+... .......||+.|+|||++.+ .++.++||||+||++|||++|+.||..... .+.
T Consensus 179 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 256 (484)
T 3nyv_A 179 FEAS-KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSE 256 (484)
T ss_dssp BCCC-CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCH
T ss_pred cccc-cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCH
Confidence 6533 23344579999999999876 689999999999999999999999965432 122
Q ss_pred ccccccccccccCCCCCCChhHHHhhceeee
Q 035761 528 SLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 528 ~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
.+...++.|...||..||+++++++|+|+..
T Consensus 257 ~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~ 287 (484)
T 3nyv_A 257 SAKDLIRKMLTYVPSMRISARDALDHEWIQT 287 (484)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSHHHHH
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhhChhhcc
Confidence 3456678888999999999999999999864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=337.11 Aligned_cols=243 Identities=23% Similarity=0.348 Sum_probs=201.6
Q ss_pred HHHHHHHhcCCcccceeeccCCeeEEEEEe------CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceee
Q 035761 307 FQDMIEATEDFDIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLY 379 (560)
Q Consensus 307 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~ 379 (560)
..++....++|++.+.||+|+||.||+|++ .+++.||||+++.... ....+.+.+|+++++++ +||||++++
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCC-HHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 445555668899999999999999999973 2467899999975432 23456789999999999 799999999
Q ss_pred eEEEeCCE-EEEEEeccCCCCHHHHhhcCCc-------------------------------------------------
Q 035761 380 GFCLHEKC-MFLIYEYMEMGSLFCILRTDEE------------------------------------------------- 409 (560)
Q Consensus 380 ~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------- 409 (560)
+++.+.+. .++||||+++|+|.++++....
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 99987654 8999999999999999976532
Q ss_pred --------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCC
Q 035761 410 --------------AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSN 475 (560)
Q Consensus 410 --------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 475 (560)
...+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence 11289999999999999999999999 9999999999999999999999999999876433322
Q ss_pred --ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc-------------------ccccccccc
Q 035761 476 --RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS-------------------SSSSLDKNI 533 (560)
Q Consensus 476 --~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~-------------------~~~~~~~~~ 533 (560)
.....||+.|+|||++.+..++.++||||||+++|||++ |+.||..... ....+.+.+
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 329 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTM 329 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHH
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 233568889999999999999999999999999999998 9999975432 112345666
Q ss_pred ccccccCCCCCCChhHHHhh
Q 035761 534 KLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 534 ~~~~~~dp~~~p~~~~~~~~ 553 (560)
..|...||..||++.+++++
T Consensus 330 ~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 330 LDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHccCChhhCCCHHHHHHH
Confidence 77888899999999999876
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=329.09 Aligned_cols=228 Identities=18% Similarity=0.238 Sum_probs=194.2
Q ss_pred cCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|++.+.||+|+||.||+|.. .+++.||||++..... .+.+.+|+++++.+ +||||+++++++...+..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 5789999999999999999986 5789999999865432 23578899999999 9999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCc-----EEEeeecccc
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFE-----AFVADFGIAR 467 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-----~kl~Dfg~~~ 467 (560)
||+ +++|.+++.... ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+++
T Consensus 85 e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 85 ELL-GPSLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp ECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred EeC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 999 999999998642 2499999999999999999999999 9999999999999999887 9999999998
Q ss_pred ccCCCCCC-------ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccccc--------------
Q 035761 468 LLNYDSSN-------RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSS-------------- 526 (560)
Q Consensus 468 ~~~~~~~~-------~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~-------------- 526 (560)
.+...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~ 238 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA 238 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence 76433221 234579999999999999999999999999999999999999998643211
Q ss_pred ----------cccccccccccccCCCCCCChhHHHh
Q 035761 527 ----------SSLDKNIKLIDLLDPRLPPPGDQMIR 552 (560)
Q Consensus 527 ----------~~~~~~~~~~~~~dp~~~p~~~~~~~ 552 (560)
..+.+.++.|...||..||+++++.+
T Consensus 239 ~~~~~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 239 TPIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp SCHHHHTTTCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CCHHHHhccChHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 13445566677889999999988876
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=323.87 Aligned_cols=227 Identities=29% Similarity=0.430 Sum_probs=186.5
Q ss_pred hcCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhc--cCCCCcceeeeEEEeC----CE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQ--IRHRNIVKLYGFCLHE----KC 387 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~----~~ 387 (560)
.++|++.+.||+|+||.||+|++ +++.||||++.... ...+.+|.+++.. ++||||+++++++... ..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD-----EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG-----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc-----chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 46799999999999999999988 68999999987532 2345667777766 7999999999997653 45
Q ss_pred EEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEEeCCCCCCeEeCCCCcEE
Q 035761 388 MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLH--------HHCTPPILHRDISSNNILLNSEFEAF 459 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH--------~~~~~~ivH~dlk~~Nill~~~~~~k 459 (560)
.++||||+++|+|.++++.. .+++.++..++.|++.||+||| +. +|+||||||+||+++.++.+|
T Consensus 81 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp EEEEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEE
T ss_pred eEEehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEE
Confidence 89999999999999999643 3899999999999999999999 77 999999999999999999999
Q ss_pred EeeeccccccCCCCCC----ceeeccccCccCccccccC------ccCcchhHHHHHHHHHHHHhC----------CCCC
Q 035761 460 VADFGIARLLNYDSSN----RTLLAGTYGSIAPELAYTM------VVTEKYDVYSFGVVALEVLMG----------KHPG 519 (560)
Q Consensus 460 l~Dfg~~~~~~~~~~~----~~~~~g~~~~~aPE~~~~~------~~~~~~Dv~s~G~il~el~~g----------~~P~ 519 (560)
|+|||+++........ .....||+.|+|||++.+. .++.++||||||+++|||++| +.||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 9999999876433222 1224689999999998877 556799999999999999999 8888
Q ss_pred Ccccccc-----------------------------cccccccccccccCCCCCCChhHHHhh
Q 035761 520 ELLSSSS-----------------------------SSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 520 ~~~~~~~-----------------------------~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
....... ..+.+.++.|...||..||+++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~ 296 (301)
T 3q4u_A 234 YDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296 (301)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 5432111 124456677788899999999988764
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=332.47 Aligned_cols=232 Identities=16% Similarity=0.180 Sum_probs=188.8
Q ss_pred hcCCcccceeeccCCeeEEEEE------eCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccC---CCCcceeeeEEEe
Q 035761 314 TEDFDIKYCIGTGGYGSVYRAR------LPSGKVVALKKLHRLETELASLESFQNEARLLSQIR---HRNIVKLYGFCLH 384 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~ 384 (560)
.++|.+.+.||+|+||.||+|. ..+++.||||++.... ...+.+|.++++.++ |+||+++++++..
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 4678899999999999999994 4568899999987543 336777888888876 9999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHhhcCC--cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCC--------
Q 035761 385 EKCMFLIYEYMEMGSLFCILRTDE--EAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNS-------- 454 (560)
Q Consensus 385 ~~~~~lv~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-------- 454 (560)
++..++||||+++|+|.+++.... ....+++.++..|+.||++||+|||+. +||||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccc
Confidence 999999999999999999997421 223499999999999999999999998 9999999999999998
Q ss_pred ---CCcEEEeeeccccccCCC--CCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccccc--
Q 035761 455 ---EFEAFVADFGIARLLNYD--SSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSS-- 527 (560)
Q Consensus 455 ---~~~~kl~Dfg~~~~~~~~--~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~~-- 527 (560)
++.+||+|||+|+.+... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 295 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKP 295 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEEE
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCceee
Confidence 899999999999765422 2223345799999999999999999999999999999999999999864433211
Q ss_pred -----------ccccccccccccCCCCCCChhHHHhh
Q 035761 528 -----------SLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 528 -----------~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
.+.+....+...+|..|++..+.+++
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 296 EGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp CSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred chhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 22334445667788877665554443
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=334.17 Aligned_cols=245 Identities=22% Similarity=0.276 Sum_probs=198.1
Q ss_pred HHHHHHHhcCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhh---------hhhHHHHHHHHHHHhccCCCCcce
Q 035761 307 FQDMIEATEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETE---------LASLESFQNEARLLSQIRHRNIVK 377 (560)
Q Consensus 307 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------~~~~~~~~~e~~~l~~l~h~niv~ 377 (560)
..++....++|++.+.||+|+||.||+|...+|+.||||++...... ....+.+.+|++++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 45667778999999999999999999999888999999998653321 122467899999999999999999
Q ss_pred eeeEEEe-----CCEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEe
Q 035761 378 LYGFCLH-----EKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILL 452 (560)
Q Consensus 378 l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill 452 (560)
+++++.. ....++||||++ |+|.+++.... ..+++.++..++.||+.||+|||+. +|+||||||+||++
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILL 167 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEE
Confidence 9999854 236899999998 58888887543 2489999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeeeccccccCCCCCCceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCcccc-------
Q 035761 453 NSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSS------- 524 (560)
Q Consensus 453 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~------- 524 (560)
+.++.+||+|||+++..... .......|++.|+|||++.+ ..++.++||||+||++|||++|+.||.....
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i 246 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKI 246 (362)
T ss_dssp CTTCCEEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cCCCCEEEEecCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99999999999999865432 22334568999999999877 6789999999999999999999999975431
Q ss_pred ------------------------------------------cccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 525 ------------------------------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 525 ------------------------------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
....+.+.++.|...||..||++.++++|+|+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 322 (362)
T 3pg1_A 247 VEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFES 322 (362)
T ss_dssp HHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhh
Confidence 0122456677888999999999999999999863
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=345.15 Aligned_cols=237 Identities=29% Similarity=0.385 Sum_probs=200.2
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhh-----------hhHHHHHHHHHHHhccCCCCcceeeeE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETEL-----------ASLESFQNEARLLSQIRHRNIVKLYGF 381 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~niv~l~~~ 381 (560)
.++|.+.+.||+|+||.||+|..+ +++.||||++....... ...+.+.+|+.+++.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 467999999999999999999875 57899999987543211 234678899999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCC---cE
Q 035761 382 CLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEF---EA 458 (560)
Q Consensus 382 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~ 458 (560)
+.+++..++||||+++|+|.+++..... +++.++..++.||+.||+|||+. +|+||||||+||+++.++ .+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRHK---FDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccE
Confidence 9999999999999999999999876433 89999999999999999999999 999999999999998775 69
Q ss_pred EEeeeccccccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc--------------
Q 035761 459 FVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-------------- 524 (560)
Q Consensus 459 kl~Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-------------- 524 (560)
||+|||+++..... .......||+.|+|||++. ..++.++||||+||++|||++|+.||.....
T Consensus 189 kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 266 (504)
T 3q5i_A 189 KIVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYF 266 (504)
T ss_dssp EECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred EEEECCCCEEcCCC-CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 99999999876533 2334457999999999987 4689999999999999999999999975432
Q ss_pred -------cccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 525 -------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 525 -------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
.+..+.+.++.|...||..||+++++++|+|+..
T Consensus 267 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 307 (504)
T 3q5i_A 267 DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK 307 (504)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhh
Confidence 2234566778888999999999999999999853
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=326.39 Aligned_cols=229 Identities=18% Similarity=0.274 Sum_probs=197.3
Q ss_pred cCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccC-CCCcceeeeEEEe--CCEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIR-HRNIVKLYGFCLH--EKCMFL 390 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~l 390 (560)
++|++.+.||+|+||.||+|.. .+++.||||+++... .+.+.+|+++++.++ ||||+++++++.. ....++
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 6789999999999999999975 568999999987433 346889999999997 9999999999988 567899
Q ss_pred EEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCC-cEEEeeecccccc
Q 035761 391 IYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEF-EAFVADFGIARLL 469 (560)
Q Consensus 391 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~~~~~ 469 (560)
||||+++++|.+++.. +++.++..++.||+.||+|||+. +|+||||||+||+++.++ .+||+|||+++..
T Consensus 111 v~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EEECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEeccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 9999999999999853 88999999999999999999999 999999999999999776 8999999999876
Q ss_pred CCCCCCceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCcccc------------------------
Q 035761 470 NYDSSNRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSS------------------------ 524 (560)
Q Consensus 470 ~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~------------------------ 524 (560)
.... ......|+..|+|||++.+ ..++.++||||+||++|||++|+.||.....
T Consensus 182 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 260 (330)
T 3nsz_A 182 HPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 260 (330)
T ss_dssp CTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCCC-ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHh
Confidence 5332 2334568999999999887 6689999999999999999999999943211
Q ss_pred -------------------------------cccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 525 -------------------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 525 -------------------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
....+.+.++.|...||..||+++++++|+|+..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~ 325 (330)
T 3nsz_A 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 325 (330)
T ss_dssp TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTT
T ss_pred ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhh
Confidence 1233456778888999999999999999999864
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=323.56 Aligned_cols=235 Identities=23% Similarity=0.338 Sum_probs=200.4
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
.++|.+.+.||+|+||.||+|+.. +|+.||+|.+..... ...+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 457899999999999999999875 689999999975432 22356889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEe---CCCCcEEEeeecccccc
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILL---NSEFEAFVADFGIARLL 469 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~~~~~ 469 (560)
||+++|+|.+++.... .+++.++..++.|++.||+|||+. +++||||||+||++ +.++.+||+|||++...
T Consensus 86 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 86 QLVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred EcCCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 9999999999987543 389999999999999999999999 99999999999999 78899999999999764
Q ss_pred CCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------cccc
Q 035761 470 NYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------SSSS 528 (560)
Q Consensus 470 ~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------~~~~ 528 (560)
.. .......|++.|+|||++.+..++.++||||+|+++|||++|+.||..... ....
T Consensus 160 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 237 (304)
T 2jam_A 160 QN--GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISES 237 (304)
T ss_dssp CC--BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHH
T ss_pred CC--CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHH
Confidence 32 223345689999999999999999999999999999999999999964321 1233
Q ss_pred cccccccccccCCCCCCChhHHHhhceeee
Q 035761 529 LDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 529 ~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
+.+.+..|...||..||+++++++|+|+..
T Consensus 238 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (304)
T 2jam_A 238 AKDFICHLLEKDPNERYTCEKALSHPWIDG 267 (304)
T ss_dssp HHHHHHHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcCccccC
Confidence 456667788899999999999999999854
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=322.60 Aligned_cols=232 Identities=25% Similarity=0.396 Sum_probs=196.0
Q ss_pred hcCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
.++|++.+.||+|+||.||+|.+.++..||+|+++.... ..+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC---CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 467899999999999999999999888999999975432 23568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++|+|.+++..... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 100 ~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 100 YMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp CCTTCBHHHHHHCGGG--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred ccCCCcHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 9999999999976332 389999999999999999999999 99999999999999999999999999998654321
Q ss_pred -CCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc------------------ccccccccc
Q 035761 474 -SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS------------------SSSSLDKNI 533 (560)
Q Consensus 474 -~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~------------------~~~~~~~~~ 533 (560)
.......+++.|+|||++.+..++.++||||+|+++|||++ |+.||..... ....+.+.+
T Consensus 175 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 254 (283)
T 3gen_A 175 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIM 254 (283)
T ss_dssp HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHHH
Confidence 11122346778999999999999999999999999999998 9999975432 122345666
Q ss_pred ccccccCCCCCCChhHHHhh
Q 035761 534 KLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 534 ~~~~~~dp~~~p~~~~~~~~ 553 (560)
+.|...||..||++++++++
T Consensus 255 ~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 255 YSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHTTCSSGGGSCCHHHHHHH
T ss_pred HHHccCChhHCcCHHHHHHH
Confidence 77888899999999999876
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=332.65 Aligned_cols=237 Identities=25% Similarity=0.397 Sum_probs=197.0
Q ss_pred HhcCCcccceeeccCCeeEEEEEe------CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeC
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLHE 385 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 385 (560)
..++|++.+.||+|+||.||+|.. .+++.||||.+..... ....+.+.+|+.+++++ +||||+++++++...
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 457899999999999999999985 2456899999975432 23346788999999999 899999999999999
Q ss_pred CEEEEEEeccCCCCHHHHhhcCCcc--------------------cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCC
Q 035761 386 KCMFLIYEYMEMGSLFCILRTDEEA--------------------VGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDI 445 (560)
Q Consensus 386 ~~~~lv~e~~~~g~L~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dl 445 (560)
+..++||||+++|+|.+++...... ..+++.++..++.||+.||+|||+. +|+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCC
Confidence 9999999999999999999765321 2379999999999999999999999 9999999
Q ss_pred CCCCeEeCCCCcEEEeeeccccccCCCCCC--ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcc
Q 035761 446 SSNNILLNSEFEAFVADFGIARLLNYDSSN--RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELL 522 (560)
Q Consensus 446 k~~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~ 522 (560)
||+||+++.++.+||+|||++......... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 999999999999999999999876543332 123457889999999999999999999999999999998 99999754
Q ss_pred ccc-------------------ccccccccccccccCCCCCCChhHHHhh
Q 035761 523 SSS-------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 523 ~~~-------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
... ...+...++.|...||..||++.+++++
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 279 PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp CCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 421 1234456677888899999999998876
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=336.52 Aligned_cols=235 Identities=11% Similarity=0.048 Sum_probs=181.6
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhcc--CCCCcceee-------eEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQI--RHRNIVKLY-------GFCL 383 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l--~h~niv~l~-------~~~~ 383 (560)
.+|...+.||+|+||.||+|.+. +|+.||||++..... .....+.+.+|+.+++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45888999999999999999865 689999999987543 334455677885544444 699977754 4444
Q ss_pred eC-----------------CEEEEEEeccCCCCHHHHhhcCCcccCCCHHHH------HHHHHHHHHHHHHHHhcCCCCe
Q 035761 384 HE-----------------KCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKR------VNIVKGMAHALSYLHHHCTPPI 440 (560)
Q Consensus 384 ~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~------~~i~~~ia~~l~~LH~~~~~~i 440 (560)
.+ ...++||||++ |+|.+++..... .+++..+ ..++.||+.||+|||+. +|
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~i 215 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSK---GL 215 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CC
Confidence 33 33799999999 899999986432 2566666 78889999999999999 99
Q ss_pred EEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCceeeccccCccCcccccc--CccCcchhHHHHHHHHHHHHhCCCC
Q 035761 441 LHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYT--MVVTEKYDVYSFGVVALEVLMGKHP 518 (560)
Q Consensus 441 vH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~--~~~~~~~Dv~s~G~il~el~~g~~P 518 (560)
+||||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGT---RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTC---EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCC---CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999987532 2224457799999999987 7799999999999999999999999
Q ss_pred CCcccc--------------------------cccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 519 GELLSS--------------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 519 ~~~~~~--------------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
|..... ....+.+.++.|...||..||++.++++|+|+..
T Consensus 293 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 293 FGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp TTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred CCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 976521 1223445667788899999999999999999753
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=336.52 Aligned_cols=233 Identities=19% Similarity=0.239 Sum_probs=196.7
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc------CCCCcceeeeEEEeCCE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQI------RHRNIVKLYGFCLHEKC 387 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~~~~ 387 (560)
.+|++.+.||+|+||.||+|... +++.||||++.... ...+.+.+|+.+++.+ +|+||+++++++.....
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK---RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc---chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 56899999999999999999765 58899999997543 2234567788887776 57799999999999999
Q ss_pred EEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCc--EEEeeecc
Q 035761 388 MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFE--AFVADFGI 465 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfg~ 465 (560)
.++||||+. ++|.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|||+
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 999999996 699999876542 3389999999999999999999999 9999999999999999887 99999999
Q ss_pred ccccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc--------------------
Q 035761 466 ARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS-------------------- 525 (560)
Q Consensus 466 ~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~-------------------- 525 (560)
++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..
T Consensus 249 a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~ 325 (429)
T 3kvw_A 249 SCYEHQ---RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA 325 (429)
T ss_dssp CEETTC---CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred ceecCC---cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHh
Confidence 976432 223356899999999999999999999999999999999999999644310
Q ss_pred --------------------------------------------------------ccccccccccccccCCCCCCChhH
Q 035761 526 --------------------------------------------------------SSSLDKNIKLIDLLDPRLPPPGDQ 549 (560)
Q Consensus 526 --------------------------------------------------------~~~~~~~~~~~~~~dp~~~p~~~~ 549 (560)
...+.+.++.|...||..||++++
T Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e 405 (429)
T 3kvw_A 326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQ 405 (429)
T ss_dssp BTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred hhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHH
Confidence 111335667788999999999999
Q ss_pred HHhhceeee
Q 035761 550 MIRQGIILI 558 (560)
Q Consensus 550 ~~~~~~~~~ 558 (560)
+++|+|+..
T Consensus 406 ~L~Hpw~~~ 414 (429)
T 3kvw_A 406 ALRHPWLRR 414 (429)
T ss_dssp HHTSTTTC-
T ss_pred HhCChhhcc
Confidence 999999874
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=333.20 Aligned_cols=236 Identities=25% Similarity=0.356 Sum_probs=199.7
Q ss_pred hcCCcccceeeccCCeeEEEEEeC--------CCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEe
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP--------SGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLH 384 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 384 (560)
.++|.+.+.||+|+||.||+|+.. .+..||||+++.... ....+.+.+|+++++.+ +||||+++++++..
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccC-HHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 367889999999999999999852 246799999976432 34456788999999999 99999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHhhcCCc-------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeE
Q 035761 385 EKCMFLIYEYMEMGSLFCILRTDEE-------------AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNIL 451 (560)
Q Consensus 385 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nil 451 (560)
++..++||||+++|+|.+++..... ...+++.++..++.||+.||+|||+. +|+||||||+||+
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEE
Confidence 9999999999999999999976432 23489999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeeeccccccCCCCC--CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc----
Q 035761 452 LNSEFEAFVADFGIARLLNYDSS--NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS---- 524 (560)
Q Consensus 452 l~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~---- 524 (560)
++.++.+||+|||+++....... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~ 303 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 303 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999987653322 2223457889999999999999999999999999999999 9999975431
Q ss_pred --------------cccccccccccccccCCCCCCChhHHHhh
Q 035761 525 --------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 525 --------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
....+.+.++.|...||..||++++++++
T Consensus 304 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 304 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 12234566777888899999999999876
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=334.44 Aligned_cols=238 Identities=27% Similarity=0.373 Sum_probs=198.3
Q ss_pred cCCcccceeeccCCeeEEEEEe----CCCcEEEEEEccchhh--hhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL----PSGKVVALKKLHRLET--ELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKC 387 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 387 (560)
++|++.+.||+|+||.||+|+. .+++.||||+++.... .....+.+.+|+++++.+ +||||+++++++..++.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5799999999999999999987 3689999999875331 112234567899999999 69999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccc
Q 035761 388 MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIAR 467 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~ 467 (560)
.++||||+++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 999999999999999997643 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC-CceeeccccCccCcccccc--CccCcchhHHHHHHHHHHHHhCCCCCCccccc-------------------
Q 035761 468 LLNYDSS-NRTLLAGTYGSIAPELAYT--MVVTEKYDVYSFGVVALEVLMGKHPGELLSSS------------------- 525 (560)
Q Consensus 468 ~~~~~~~-~~~~~~g~~~~~aPE~~~~--~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~------------------- 525 (560)
....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 287 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCc
Confidence 7543222 2233569999999999885 34788999999999999999999999643321
Q ss_pred --ccccccccccccccCCCCCC-----ChhHHHhhceeee
Q 035761 526 --SSSLDKNIKLIDLLDPRLPP-----PGDQMIRQGIILI 558 (560)
Q Consensus 526 --~~~~~~~~~~~~~~dp~~~p-----~~~~~~~~~~~~~ 558 (560)
...+.+.++.|...||..|| +++++++|+|+..
T Consensus 288 ~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 288 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 11234566778888999999 9999999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=334.95 Aligned_cols=237 Identities=25% Similarity=0.341 Sum_probs=198.0
Q ss_pred cCCcccceeeccCCeeEEEEEeC------CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCM 388 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 388 (560)
++|++.+.||+|+||.||+|.+. +++.||||+++.... ......+.+|+.++++++||||+++++++......
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS-EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccC-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 57889999999999999999853 467899999975432 23345688999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCC----cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCC---cEEEe
Q 035761 389 FLIYEYMEMGSLFCILRTDE----EAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEF---EAFVA 461 (560)
Q Consensus 389 ~lv~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~ 461 (560)
++||||+++|+|.+++.... ....+++.++..++.||++||+|||+. +|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999997643 123489999999999999999999999 999999999999999554 59999
Q ss_pred eeccccccCCCC--CCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc--------------
Q 035761 462 DFGIARLLNYDS--SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS-------------- 524 (560)
Q Consensus 462 Dfg~~~~~~~~~--~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~-------------- 524 (560)
|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~ 306 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD 306 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 999998653222 22233467899999999999999999999999999999998 9999975432
Q ss_pred ----cccccccccccccccCCCCCCChhHHHhhce
Q 035761 525 ----SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGI 555 (560)
Q Consensus 525 ----~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~ 555 (560)
....+.++++.|...||..||++++++++.+
T Consensus 307 ~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~ 341 (367)
T 3l9p_A 307 PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 341 (367)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 1123456778888999999999999998743
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=325.54 Aligned_cols=239 Identities=26% Similarity=0.383 Sum_probs=197.7
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 467999999999999999999875 58899999987543 234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++++|.+++.... ..+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 96 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp ECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred EeCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999999987532 2389999999999999999999999 9999999999999999999999999987643222
Q ss_pred CCCceeeccccCccCcccc-----ccCccCcchhHHHHHHHHHHHHhCCCCCCcccc--------------------ccc
Q 035761 473 SSNRTLLAGTYGSIAPELA-----YTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS--------------------SSS 527 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~-----~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~--------------------~~~ 527 (560)
........|++.|+|||++ .+..++.++||||||+++|||++|+.||..... ...
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (302)
T 2j7t_A 171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSV 250 (302)
T ss_dssp HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCH
T ss_pred ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCH
Confidence 1222334689999999988 366788899999999999999999999975432 112
Q ss_pred ccccccccccccCCCCCCChhHHHhhceeeec
Q 035761 528 SLDKNIKLIDLLDPRLPPPGDQMIRQGIILIS 559 (560)
Q Consensus 528 ~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~~ 559 (560)
.+...++.|...||..||++.++++|+|+...
T Consensus 251 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 251 EFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp HHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred HHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence 34566677888999999999999999998653
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=317.47 Aligned_cols=232 Identities=31% Similarity=0.488 Sum_probs=185.3
Q ss_pred cCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhh--hhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETE--LASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|++.+.||+|+||.||+|.+. ++.||||+++..... ....+.+.+|+++++.++||||+++++++..++..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 57888999999999999999975 889999998754322 233567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCC--------CCcEEEeeec
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNS--------EFEAFVADFG 464 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~--------~~~~kl~Dfg 464 (560)
||+++++|.+++... .+++.++..++.|++.||+|||+....+|+||||||+||+++. ++.+||+|||
T Consensus 86 e~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 86 EFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp ECCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EcCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 999999999999643 3899999999999999999999981112999999999999986 6789999999
Q ss_pred cccccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-------------------c
Q 035761 465 IARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-------------------S 525 (560)
Q Consensus 465 ~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-------------------~ 525 (560)
++....... .....|++.|+|||.+.+..++.++||||+|+++|||++|+.||..... .
T Consensus 162 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (271)
T 3dtc_A 162 LAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTC 239 (271)
T ss_dssp C---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTC
T ss_pred ccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCccc
Confidence 998764322 2234689999999999999999999999999999999999999975432 1
Q ss_pred ccccccccccccccCCCCCCChhHHHhh
Q 035761 526 SSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 526 ~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
...+.+.++.|...||..||++++++++
T Consensus 240 ~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 240 PEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 2235566777888899999999998875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=326.87 Aligned_cols=232 Identities=23% Similarity=0.405 Sum_probs=188.5
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCc----EEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGK----VVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMF 389 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 389 (560)
++|+..+.||+|+||.||+|.+. +++ +||+|.+.... .....+.+.+|+.++++++||||+++++++..+. .+
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 56889999999999999999864 344 36888876433 2344567899999999999999999999998765 78
Q ss_pred EEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccccc
Q 035761 390 LIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL 469 (560)
Q Consensus 390 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 469 (560)
+|+||+++|+|.+++..... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTT--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 99999999999999986433 389999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCC--ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------------ccc
Q 035761 470 NYDSSN--RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------------SSS 528 (560)
Q Consensus 470 ~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------------~~~ 528 (560)
...... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... ...
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 247 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHH
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence 543322 223456789999999999999999999999999999999 99999754321 112
Q ss_pred cccccccccccCCCCCCChhHHHhh
Q 035761 529 LDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 529 ~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
+...+..|...||..||++.+++++
T Consensus 248 ~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 248 VYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCCCHHHHHHH
Confidence 4455677888899999999999865
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=329.63 Aligned_cols=237 Identities=28% Similarity=0.399 Sum_probs=198.1
Q ss_pred HhcCCcccceeeccCCeeEEEEEeC------CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCC
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEK 386 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 386 (560)
..++|++.+.||+|+||.||+|+.. +++.||||.++.... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 3578999999999999999999874 347899999975432 234567899999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHhhcCCc---------------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCC
Q 035761 387 CMFLIYEYMEMGSLFCILRTDEE---------------------AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDI 445 (560)
Q Consensus 387 ~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dl 445 (560)
..++||||+++|+|.+++..... ...+++.++..++.||++||+|||+. +|+||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 99999999999999999976421 14589999999999999999999999 9999999
Q ss_pred CCCCeEeCCCCcEEEeeeccccccCCCCC--CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcc
Q 035761 446 SSNNILLNSEFEAFVADFGIARLLNYDSS--NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELL 522 (560)
Q Consensus 446 k~~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~ 522 (560)
||+||+++.++.+||+|||+++....... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 99999999999999999999987643221 2233467889999999999999999999999999999999 99999754
Q ss_pred cc------------------cccccccccccccccCCCCCCChhHHHhh
Q 035761 523 SS------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 523 ~~------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
.. ....+.+.++.|...||..||++.++++.
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 281 AHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 32 11234556677788899999998888764
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=338.76 Aligned_cols=228 Identities=27% Similarity=0.393 Sum_probs=190.7
Q ss_pred hcCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCC-EEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEK-CMFLIY 392 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~ 392 (560)
.++|++.+.||+|+||.||+|.+. |+.||||+++... ..+.|.+|+.++++++||||+++++++...+ ..++||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 467888999999999999999985 7899999997543 3457899999999999999999999988765 789999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++|+|.++++.... ..+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 267 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp ECCTTCBHHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 99999999999986432 2379999999999999999999999 9999999999999999999999999999864322
Q ss_pred CCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------------cccccccc
Q 035761 473 SSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------------SSSLDKNI 533 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------------~~~~~~~~ 533 (560)
.....+++.|+|||++.+..++.++||||||+++|||++ |+.||...... ...+.+.+
T Consensus 343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li 419 (450)
T 1k9a_A 343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVM 419 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence 222357889999999999999999999999999999998 99999754321 12234455
Q ss_pred ccccccCCCCCCChhHHHhh
Q 035761 534 KLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 534 ~~~~~~dp~~~p~~~~~~~~ 553 (560)
+.|...||..||++.+++..
T Consensus 420 ~~cl~~dp~~Rpt~~~l~~~ 439 (450)
T 1k9a_A 420 KNCWHLDAATRPTFLQLREQ 439 (450)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCChhHCcCHHHHHHH
Confidence 66677788888888877653
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=323.21 Aligned_cols=232 Identities=26% Similarity=0.381 Sum_probs=190.9
Q ss_pred cCCcccceeeccCCeeEEEEEe-----CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC--CE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-----PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHE--KC 387 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~ 387 (560)
++|++.+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|++++++++||||+++++++... ..
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 5788999999999999999984 368899999987543 23456789999999999999999999998654 45
Q ss_pred EEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccc
Q 035761 388 MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIAR 467 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~ 467 (560)
.++||||+++|+|.+++..... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHCGG--GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred eEEEEEeCCCCCHHHHHHhccc--ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 8999999999999999986543 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCC---ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc--------------------
Q 035761 468 LLNYDSSN---RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-------------------- 524 (560)
Q Consensus 468 ~~~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-------------------- 524 (560)
........ .....++..|+|||++.+..++.++||||||+++|||++|..||.....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence 76433221 2223467789999999999999999999999999999999998864321
Q ss_pred --------------cccccccccccccccCCCCCCChhHHHhh
Q 035761 525 --------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 525 --------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
....+.+.++.|...||..||++.++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~ 285 (295)
T 3ugc_A 243 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285 (295)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 12235566677888899999999888764
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=332.45 Aligned_cols=233 Identities=24% Similarity=0.320 Sum_probs=181.1
Q ss_pred hcCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC------C
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHE------K 386 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 386 (560)
.++|++.+.||+|+||.||+|.. .+|+.||||++..........+.+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 36799999999999999999975 4689999999976544444556788999999999999999999999754 4
Q ss_pred EEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccc
Q 035761 387 CMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIA 466 (560)
Q Consensus 387 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~ 466 (560)
..++|+||+ +++|.+++... .+++..+..++.||++||+|||+. ||+||||||+||+++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC-----C----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccc
Confidence 579999999 67999888752 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCccccc--------------------
Q 035761 467 RLLNYDSSNRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSSS-------------------- 525 (560)
Q Consensus 467 ~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~-------------------- 525 (560)
+.... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+..
T Consensus 180 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 256 (367)
T 2fst_X 180 RHTAD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred ccccc---cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 87542 2334578999999999887 67899999999999999999999999754321
Q ss_pred ----------------------------ccccccccccccccCCCCCCChhHHHhhceee
Q 035761 526 ----------------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 526 ----------------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
...+...++.|...||..||+++++++|+|+.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~ 316 (367)
T 2fst_X 257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 316 (367)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhh
Confidence 11234456678889999999999999999975
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=330.07 Aligned_cols=237 Identities=22% Similarity=0.330 Sum_probs=202.1
Q ss_pred cCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhh---------------HHHHHHHHHHHhccCCCCcceee
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELAS---------------LESFQNEARLLSQIRHRNIVKLY 379 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---------------~~~~~~e~~~l~~l~h~niv~l~ 379 (560)
++|++.+.||+|+||.||+|.. +++.||||++......... .+.+.+|+++++.++||||++++
T Consensus 31 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp TTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred CceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 5799999999999999999998 8999999998754422111 16789999999999999999999
Q ss_pred eEEEeCCEEEEEEeccCCCCHHHH------hhcCCcccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEeCCCCCCeEe
Q 035761 380 GFCLHEKCMFLIYEYMEMGSLFCI------LRTDEEAVGLDWTKRVNIVKGMAHALSYLHH-HCTPPILHRDISSNNILL 452 (560)
Q Consensus 380 ~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill 452 (560)
+++.+.+..++||||+++|+|.++ +.... ...+++.++..++.|++.||+|||+ . +++||||||+||++
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILM 185 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEE
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEE
Confidence 999999999999999999999998 55421 3449999999999999999999998 8 99999999999999
Q ss_pred CCCCcEEEeeeccccccCCCCCCceeeccccCccCccccccC-ccCc-chhHHHHHHHHHHHHhCCCCCCcccc------
Q 035761 453 NSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTM-VVTE-KYDVYSFGVVALEVLMGKHPGELLSS------ 524 (560)
Q Consensus 453 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~-~~Dv~s~G~il~el~~g~~P~~~~~~------ 524 (560)
+.++.+||+|||.+...... ......|++.|+|||++.+. .++. ++||||||+++|||++|+.||.....
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 263 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN 263 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHH
T ss_pred cCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence 99999999999999876432 33345689999999999887 6666 99999999999999999999975432
Q ss_pred -------------------------------cccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 525 -------------------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 525 -------------------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
....+.+.++.|...||..||++.++++|+|+..
T Consensus 264 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 328 (348)
T 2pml_X 264 NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD 328 (348)
T ss_dssp HHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence 1122345667788889999999999999999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=318.09 Aligned_cols=238 Identities=22% Similarity=0.320 Sum_probs=202.8
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchh-------hhhhhHHHHHHHHHHHhccC-CCCcceeeeEEEe
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLE-------TELASLESFQNEARLLSQIR-HRNIVKLYGFCLH 384 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~ 384 (560)
.++|++.+.||+|+||.||+|..+ +|+.||||++.... ......+.+.+|++++++++ ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 467999999999999999999875 58899999986432 11233457889999999995 9999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeec
Q 035761 385 EKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFG 464 (560)
Q Consensus 385 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 464 (560)
++..++||||+++++|.+++.... .+++.++..++.||+.||+|||+. +++||||||+||+++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEeccc
Confidence 999999999999999999997643 389999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCceeeccccCccCccccc------cCccCcchhHHHHHHHHHHHHhCCCCCCcccc--------------
Q 035761 465 IARLLNYDSSNRTLLAGTYGSIAPELAY------TMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-------------- 524 (560)
Q Consensus 465 ~~~~~~~~~~~~~~~~g~~~~~aPE~~~------~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-------------- 524 (560)
++...... .......|++.|+|||++. ...++.++||||||+++|||++|+.||.....
T Consensus 170 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (298)
T 1phk_A 170 FSCQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 248 (298)
T ss_dssp TCEECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred chhhcCCC-cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCccc
Confidence 99876533 2333456899999999875 45678899999999999999999999864331
Q ss_pred -------cccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 525 -------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 525 -------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
....+.+.++.|...||..||+++++++|+|+..
T Consensus 249 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (298)
T 1phk_A 249 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289 (298)
T ss_dssp CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred CcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhh
Confidence 1223556677888999999999999999999865
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=328.22 Aligned_cols=236 Identities=24% Similarity=0.324 Sum_probs=198.8
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC-----CE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHE-----KC 387 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 387 (560)
.++|++.+.||+|+||.||+|... +++.||||++..... ....+.+.+|++++++++||||+++++++... ..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTC-HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccC-cHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 357999999999999999999864 688999999875432 23446788999999999999999999999765 36
Q ss_pred EEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccc
Q 035761 388 MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIAR 467 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~ 467 (560)
.++||||++ |+|.+++.... +++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 105 ~~iv~e~~~-~~L~~~l~~~~----~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKTQH----LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEEECCS-EEHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEcccC-cCHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceE
Confidence 899999997 59999987532 89999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCC---ceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCcccc-------------------
Q 035761 468 LLNYDSSN---RTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSS------------------- 524 (560)
Q Consensus 468 ~~~~~~~~---~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~------------------- 524 (560)
........ .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.....
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 256 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 76533221 234578999999998654 4589999999999999999999999965431
Q ss_pred -----------------------------cccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 525 -----------------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 525 -----------------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
....+.+.++.|...||..||++.++++|+|+..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 319 (364)
T 3qyz_A 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319 (364)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhh
Confidence 1223456777888999999999999999999863
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=324.20 Aligned_cols=236 Identities=25% Similarity=0.391 Sum_probs=198.5
Q ss_pred hcCCcccceeeccCCeeEEEEEe------CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKC 387 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 387 (560)
.++|.+.+.||+|+||.||+|.. .+++.||||++..... ....+.+.+|+++++.++||||+++++++..++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS-PSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCC-HHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 46788999999999999999975 2457899999975432 3445678999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhcCCc---------------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCC
Q 035761 388 MFLIYEYMEMGSLFCILRTDEE---------------------AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDIS 446 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk 446 (560)
.++||||+++|+|.+++..... ...+++.++..++.||++||+|||+. +|+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccc
Confidence 9999999999999999976432 13389999999999999999999999 99999999
Q ss_pred CCCeEeCCCCcEEEeeeccccccCCCCCC--ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccc
Q 035761 447 SNNILLNSEFEAFVADFGIARLLNYDSSN--RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLS 523 (560)
Q Consensus 447 ~~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~ 523 (560)
|+||+++.++.+||+|||+++........ .....+++.|+|||++.+..++.++||||+|+++|||++ |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999876433222 223456788999999999999999999999999999999 999997543
Q ss_pred c------------------cccccccccccccccCCCCCCChhHHHhh
Q 035761 524 S------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 524 ~------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
. ....+.+.++.|...||..||++.+++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 258 PERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp GGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2 12234566677788899999999988765
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=330.55 Aligned_cols=232 Identities=25% Similarity=0.321 Sum_probs=196.0
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEE----
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCM---- 388 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~---- 388 (560)
.++|...+.||+|+||.||+|... +|+.||||++..........+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 357889999999999999999864 689999999986554444567788999999999999999999999876654
Q ss_pred --EEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccc
Q 035761 389 --FLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIA 466 (560)
Q Consensus 389 --~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~ 466 (560)
++||||++ ++|.+++.. .+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999998 588888743 289999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------
Q 035761 467 RLLNYDSSNRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSS--------------------- 524 (560)
Q Consensus 467 ~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~--------------------- 524 (560)
+.... ......||+.|+|||++.+ ..++.++||||+|+++|||++|+.||...+.
T Consensus 192 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 268 (371)
T 4exu_A 192 RHADA---EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 268 (371)
T ss_dssp -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred ccccc---CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHH
Confidence 86542 2334568999999999887 7789999999999999999999999975431
Q ss_pred ---------------------------cccccccccccccccCCCCCCChhHHHhhceee
Q 035761 525 ---------------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 525 ---------------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
....+.+.++.|...||..||+++++++|+|+.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 328 (371)
T 4exu_A 269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 328 (371)
T ss_dssp CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccc
Confidence 123445677888999999999999999999985
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=328.84 Aligned_cols=241 Identities=26% Similarity=0.420 Sum_probs=196.4
Q ss_pred HHHhcCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEe----
Q 035761 311 IEATEDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLH---- 384 (560)
Q Consensus 311 ~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~---- 384 (560)
....++|++.+.||+|+||.||+|.. .+++.||||++..... ..+.+.+|+.+++++ +||||+++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc---cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 33467899999999999999999987 4689999999875432 235688999999999 89999999999987
Q ss_pred --CCEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEee
Q 035761 385 --EKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVAD 462 (560)
Q Consensus 385 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 462 (560)
.+..++||||+++|+|.+++.... ...+++..+..++.||+.||+|||+. +++||||||+||+++.++.+||+|
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECC
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEee
Confidence 467899999999999999998653 23489999999999999999999999 999999999999999999999999
Q ss_pred eccccccCCCCCCceeeccccCccCccccc-----cCccCcchhHHHHHHHHHHHHhCCCCCCcccc-------------
Q 035761 463 FGIARLLNYDSSNRTLLAGTYGSIAPELAY-----TMVVTEKYDVYSFGVVALEVLMGKHPGELLSS------------- 524 (560)
Q Consensus 463 fg~~~~~~~~~~~~~~~~g~~~~~aPE~~~-----~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~------------- 524 (560)
||++..............|++.|+|||++. +..++.++||||||+++|||++|+.||.....
T Consensus 173 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 252 (326)
T 2x7f_A 173 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP 252 (326)
T ss_dssp CTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC
T ss_pred CcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc
Confidence 999987654333344457899999999987 56788999999999999999999999965431
Q ss_pred ------cccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 525 ------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 525 ------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
....+...++.|...||..||+++++++|+|+..
T Consensus 253 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~ 292 (326)
T 2x7f_A 253 RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292 (326)
T ss_dssp CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHC
T ss_pred cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhh
Confidence 1233556777888899999999999999999864
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=342.69 Aligned_cols=233 Identities=25% Similarity=0.395 Sum_probs=196.4
Q ss_pred HhcCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
..++|++.+.||+|+||.||+|.++++..||||+++... ...+.|.+|+.+++.++||||+++++++. .+..++||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 346788999999999999999999889999999997543 23568999999999999999999999986 56689999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++|+|.++++... ...+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 262 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp CCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred eecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 9999999999997542 22489999999999999999999999 9999999999999999999999999999876432
Q ss_pred CC-CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc------------------cccccccc
Q 035761 473 SS-NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS------------------SSSSLDKN 532 (560)
Q Consensus 473 ~~-~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~------------------~~~~~~~~ 532 (560)
.. ......+++.|+|||++....++.++|||||||++|||++ |+.||..... ....+.++
T Consensus 338 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 417 (454)
T 1qcf_A 338 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNI 417 (454)
T ss_dssp HHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHHH
T ss_pred ceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 11 1122346788999999999999999999999999999999 9999975432 11234556
Q ss_pred cccccccCCCCCCChhHHHhh
Q 035761 533 IKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 533 ~~~~~~~dp~~~p~~~~~~~~ 553 (560)
+..|...||..||++++++..
T Consensus 418 i~~cl~~dp~~RPt~~~i~~~ 438 (454)
T 1qcf_A 418 MMRCWKNRPEERPTFEYIQSV 438 (454)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCChhHCcCHHHHHHH
Confidence 677788899999999888753
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=316.32 Aligned_cols=229 Identities=20% Similarity=0.283 Sum_probs=194.9
Q ss_pred cCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC--CEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHE--KCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 392 (560)
++|++.+.||+|+||.||+|++. ++.||||+++.........+.+.+|+.++++++||||+++++++... +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 56889999999999999999985 88999999987654445567899999999999999999999999887 6789999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEEeCCCCCCeEeCCCCcEEEeeeccccccC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPP--ILHRDISSNNILLNSEFEAFVADFGIARLLN 470 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 470 (560)
||+++|+|.+++..... ..+++.++..++.|++.||+|||+. + ++||||||+||+++.++.++++|||++....
T Consensus 89 e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp ECCTTCBHHHHHHSCSS-CCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred cccCCCcHHHHHhhccc-CCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 99999999999986432 3489999999999999999999998 7 9999999999999999999999999876533
Q ss_pred CCCCCceeeccccCccCccccccCccCc---chhHHHHHHHHHHHHhCCCCCCcccc-------------------cccc
Q 035761 471 YDSSNRTLLAGTYGSIAPELAYTMVVTE---KYDVYSFGVVALEVLMGKHPGELLSS-------------------SSSS 528 (560)
Q Consensus 471 ~~~~~~~~~~g~~~~~aPE~~~~~~~~~---~~Dv~s~G~il~el~~g~~P~~~~~~-------------------~~~~ 528 (560)
.. ...||+.|+|||++.+..++. ++||||||+++|||++|+.||..... ....
T Consensus 165 ~~-----~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (271)
T 3kmu_A 165 SP-----GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPH 239 (271)
T ss_dssp CT-----TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHH
T ss_pred cc-----CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHH
Confidence 22 235789999999998766555 79999999999999999999975432 1223
Q ss_pred cccccccccccCCCCCCChhHHHhh
Q 035761 529 LDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 529 ~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
+.+.++.|...||..||+++++++.
T Consensus 240 ~~~li~~~l~~~p~~Rps~~~il~~ 264 (271)
T 3kmu_A 240 VSKLMKICMNEDPAKRPKFDMIVPI 264 (271)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4556677788899999999888764
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=317.42 Aligned_cols=229 Identities=19% Similarity=0.238 Sum_probs=195.7
Q ss_pred cCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|++.+.||+|+||.||+|.. .+++.||||++..... .+.+.+|+.+++.+ +|+|++++++++......++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 5789999999999999999985 5789999999865432 23577899999999 8999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCc-----EEEeeecccc
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFE-----AFVADFGIAR 467 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-----~kl~Dfg~~~ 467 (560)
||+ +++|.+++..... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++. +||+|||+++
T Consensus 86 e~~-~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 86 DLL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp ECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred Eec-CCCHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 999 9999999986432 389999999999999999999999 9999999999999987776 9999999998
Q ss_pred ccCCCCC-------CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc----------------
Q 035761 468 LLNYDSS-------NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------- 524 (560)
Q Consensus 468 ~~~~~~~-------~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------- 524 (560)
....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence 7654322 12345689999999999999999999999999999999999999986432
Q ss_pred ---------cccccccccccccccCCCCCCChhHHHhh
Q 035761 525 ---------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 525 ---------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
....+.+.+..|...||..||+++++++.
T Consensus 240 ~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 240 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 12245566677888899999999988764
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=324.10 Aligned_cols=237 Identities=26% Similarity=0.356 Sum_probs=194.7
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh------hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCC
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET------ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEK 386 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 386 (560)
.++|++.+.||+|+||.||+|... +++.||||.+..... .......+.+|+++++.++||||+++++++..+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 467999999999999999999865 578999999875431 1122345789999999999999999999987665
Q ss_pred EEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCc---EEEeee
Q 035761 387 CMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFE---AFVADF 463 (560)
Q Consensus 387 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Df 463 (560)
.++||||+++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++. +||+||
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred -eEEEEecCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccC
Confidence 899999999999999987643 389999999999999999999999 9999999999999987654 999999
Q ss_pred ccccccCCCCCCceeeccccCccCccccc---cCccCcchhHHHHHHHHHHHHhCCCCCCccccc---------------
Q 035761 464 GIARLLNYDSSNRTLLAGTYGSIAPELAY---TMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------- 525 (560)
Q Consensus 464 g~~~~~~~~~~~~~~~~g~~~~~aPE~~~---~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------- 525 (560)
|+++..... .......|++.|+|||++. ...++.++||||||+++|||++|+.||......
T Consensus 162 g~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (322)
T 2ycf_A 162 GHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 240 (322)
T ss_dssp TTCEECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCC
T ss_pred ccceecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccC
Confidence 999876422 1223346899999999874 566888999999999999999999999644321
Q ss_pred -------ccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 526 -------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 526 -------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
...+.+.++.|...||..||+++++++|+|+..
T Consensus 241 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 241 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 122445667788899999999999999999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=334.60 Aligned_cols=233 Identities=21% Similarity=0.243 Sum_probs=190.8
Q ss_pred cCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCC------EE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEK------CM 388 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~ 388 (560)
.+|+..+.||+|+||.||+|+...+..||+|++..... ...+|+++++.++||||+++++++...+ ..
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 46889999999999999999988777899998864332 1236999999999999999999996543 37
Q ss_pred EEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeC-CCCcEEEeeecccc
Q 035761 389 FLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLN-SEFEAFVADFGIAR 467 (560)
Q Consensus 389 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~~~ 467 (560)
++||||++++.+............+++..+..++.||++||+|||+. +|+||||||+||+++ .++.+||+|||+++
T Consensus 114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 89999998754443332222233489999999999999999999999 999999999999999 78999999999998
Q ss_pred ccCCCCCCceeeccccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCCCCCcccc----------------------
Q 035761 468 LLNYDSSNRTLLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------- 524 (560)
Q Consensus 468 ~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------- 524 (560)
...... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||...+.
T Consensus 191 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 191 ILIAGE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp ECCTTC-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cccCCC-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 764332 23345689999999998765 589999999999999999999999975431
Q ss_pred ------------------------cccccccccccccccCCCCCCChhHHHhhceee
Q 035761 525 ------------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 525 ------------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
....+.+.++.|...||..||++.++++|+|+.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 326 (394)
T 4e7w_A 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFD 326 (394)
T ss_dssp CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGS
T ss_pred ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhh
Confidence 112344666778889999999999999999985
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=330.70 Aligned_cols=234 Identities=19% Similarity=0.284 Sum_probs=189.5
Q ss_pred hcCCcccceeeccCCeeEEEEEeCC------CcEEEEEEccchhhhhh---------hHHHHHHHHHHHhccCCCCccee
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLPS------GKVVALKKLHRLETELA---------SLESFQNEARLLSQIRHRNIVKL 378 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~---------~~~~~~~e~~~l~~l~h~niv~l 378 (560)
.++|++.+.||+|+||.||+|.+.. ++.||||++........ ....+..|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 3579999999999999999998764 47899999865432110 11234456667788899999999
Q ss_pred eeEEEeC----CEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeC-
Q 035761 379 YGFCLHE----KCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLN- 453 (560)
Q Consensus 379 ~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~- 453 (560)
++++... ...++||||+ +++|.+++.... ..+++.++..++.||+.||+|||+. +|+||||||+|||++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEES
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEec
Confidence 9999775 4589999999 999999998643 2399999999999999999999999 999999999999999
Q ss_pred -CCCcEEEeeeccccccCCCCCC-------ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-
Q 035761 454 -SEFEAFVADFGIARLLNYDSSN-------RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS- 524 (560)
Q Consensus 454 -~~~~~kl~Dfg~~~~~~~~~~~-------~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~- 524 (560)
.++.+||+|||+++.+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 8899999999999876432211 1334599999999999999999999999999999999999999985321
Q ss_pred ---------------------------cccccccccccccccCCCCCCChhHHHhh
Q 035761 525 ---------------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 525 ---------------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
....+...++.|...||..||+++++++.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~ 323 (364)
T 3op5_A 268 PKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDI 323 (364)
T ss_dssp HHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHH
Confidence 12234566677888899999999888753
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=329.49 Aligned_cols=238 Identities=25% Similarity=0.377 Sum_probs=198.4
Q ss_pred HHhcCCcccceeeccCCeeEEEEEeCC------CcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEe
Q 035761 312 EATEDFDIKYCIGTGGYGSVYRARLPS------GKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLH 384 (560)
Q Consensus 312 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 384 (560)
...++|++.+.||+|+||.||+|.... ...||+|.+..... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH-ADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccC-hHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 345789999999999999999998642 24799999976432 23456789999999999 89999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHhhcCCc-----------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeC
Q 035761 385 EKCMFLIYEYMEMGSLFCILRTDEE-----------AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLN 453 (560)
Q Consensus 385 ~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~ 453 (560)
++..++||||+++|+|.+++..... ...+++.++..++.||+.||+|||+. +|+||||||+||+++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLT 198 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEE
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEEC
Confidence 9999999999999999999875321 23479999999999999999999999 999999999999999
Q ss_pred CCCcEEEeeeccccccCCCCCC--ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc-----
Q 035761 454 SEFEAFVADFGIARLLNYDSSN--RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS----- 525 (560)
Q Consensus 454 ~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~----- 525 (560)
.++.+||+|||+++........ .....+++.|+|||++.+..++.++||||||+++|||++ |+.||......
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 278 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK 278 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHH
Confidence 9999999999999876433322 122456789999999999999999999999999999998 99999754321
Q ss_pred --------------ccccccccccccccCCCCCCChhHHHhh
Q 035761 526 --------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 526 --------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
...+...++.|...||..||++.++++.
T Consensus 279 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 279 LVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 1234566677888899999999998764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=315.56 Aligned_cols=229 Identities=31% Similarity=0.492 Sum_probs=190.1
Q ss_pred cCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhh-----hHHHHHHHHHHHhccCCCCcceeeeEEEeCCEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELA-----SLESFQNEARLLSQIRHRNIVKLYGFCLHEKCM 388 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 388 (560)
++|++.+.||+|+||.||+|+. .+++.||+|++........ ..+.+.+|++++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 5788999999999999999987 4689999999865432211 1267899999999999999999999997665
Q ss_pred EEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEEeCCCCCCeEeCCCCc-----EEEe
Q 035761 389 FLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPP--ILHRDISSNNILLNSEFE-----AFVA 461 (560)
Q Consensus 389 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~dlk~~Nill~~~~~-----~kl~ 461 (560)
++||||+++|+|.+++..... .+++..+..++.|++.||+|||+. + |+||||||+||+++.++. +||+
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred eEEEEecCCCCHHHHHhcccC--CccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 699999999999998875432 489999999999999999999998 8 999999999999988776 9999
Q ss_pred eeccccccCCCCCCceeeccccCccCcccc--ccCccCcchhHHHHHHHHHHHHhCCCCCCccccc--------------
Q 035761 462 DFGIARLLNYDSSNRTLLAGTYGSIAPELA--YTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS-------------- 525 (560)
Q Consensus 462 Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~--~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~-------------- 525 (560)
|||+++.... ......|++.|+|||++ ....++.++||||+|+++|||++|+.||......
T Consensus 172 Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 248 (287)
T 4f0f_A 172 DFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR 248 (287)
T ss_dssp CCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCC
T ss_pred CCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCC
Confidence 9999975432 33445789999999998 4556788999999999999999999999754321
Q ss_pred -------ccccccccccccccCCCCCCChhHHHhh
Q 035761 526 -------SSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 526 -------~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
...+.+.++.|...||..||+++++++.
T Consensus 249 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 283 (287)
T 4f0f_A 249 PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283 (287)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 1124556677778899999998888764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=321.21 Aligned_cols=229 Identities=28% Similarity=0.443 Sum_probs=186.9
Q ss_pred cCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
++|++.+.||+|+||.||+|++. ++.||||++.... ..+.+.+|++++++++||||+++++++.+ ..++||||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~ 80 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESES----ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY 80 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTT----HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChh----HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence 56888999999999999999985 7899999986432 34578899999999999999999998874 36899999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCc-EEEeeeccccccCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFE-AFVADFGIARLLNYDS 473 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-~kl~Dfg~~~~~~~~~ 473 (560)
+++|+|.+++........+++.++..++.|+++||+|||+....+|+||||||+||+++.++. +||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~- 159 (307)
T 2eva_A 81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH- 159 (307)
T ss_dssp CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence 999999999987655445889999999999999999999932129999999999999998886 799999999765422
Q ss_pred CCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc--------------------cccccccc
Q 035761 474 SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------------SSSLDKNI 533 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------------~~~~~~~~ 533 (560)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...... ...+.+.+
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 237 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLM 237 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHHH
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHHH
Confidence 22345899999999999999999999999999999999999999754321 12344566
Q ss_pred ccccccCCCCCCChhHHHhh
Q 035761 534 KLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 534 ~~~~~~dp~~~p~~~~~~~~ 553 (560)
..|...||..||+++++++.
T Consensus 238 ~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 238 TRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCChhhCcCHHHHHHH
Confidence 77888899999999998874
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=324.00 Aligned_cols=240 Identities=25% Similarity=0.337 Sum_probs=197.4
Q ss_pred HhcCCcccceeeccCCeeEEEEEe--CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc---CCCCcceeeeEEE----
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARL--PSGKVVALKKLHRLETELASLESFQNEARLLSQI---RHRNIVKLYGFCL---- 383 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~---- 383 (560)
..++|++.+.||+|+||.||+|.. .+|+.||+|++............+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 346899999999999999999987 4678999999875443222223456777777766 8999999999987
Q ss_pred -eCCEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEee
Q 035761 384 -HEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVAD 462 (560)
Q Consensus 384 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 462 (560)
.....++||||++ |+|.+++..... ..+++.++..++.||+.||+|||+. ||+||||||+||+++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEec
Confidence 4567899999998 699999976432 2389999999999999999999999 999999999999999999999999
Q ss_pred eccccccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc-----------------
Q 035761 463 FGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS----------------- 525 (560)
Q Consensus 463 fg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~----------------- 525 (560)
||+++...... ......|++.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 164 fg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 164 FGLARIYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp CCSCCCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred CcccccccCCC-CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence 99998764322 233456899999999999999999999999999999999999999743311
Q ss_pred ---------------------------ccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 526 ---------------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 526 ---------------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
...+.+.++.|...||..||++.++++|+|+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 302 (326)
T 1blx_A 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 302 (326)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccc
Confidence 111234556788889999999999999999853
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=324.27 Aligned_cols=232 Identities=24% Similarity=0.358 Sum_probs=190.8
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcE----EEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKV----VALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMF 389 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 389 (560)
++|+..+.||+|+||.||+|.+. +++. ||+|.+..... ....+.+.+|+.+++.++||||+++++++. ++..+
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 56888999999999999999864 3443 78887754332 222345778999999999999999999986 45688
Q ss_pred EEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccccc
Q 035761 390 LIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL 469 (560)
Q Consensus 390 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 469 (560)
+||||+++|+|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 91 ~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHRG--ALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEECCTTCBSHHHHHSSGG--GSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEEeCCCCCHHHHHHHccc--cCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccccc
Confidence 99999999999999976532 389999999999999999999999 9999999999999999999999999999887
Q ss_pred CCCCC--CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc------------------cccc
Q 035761 470 NYDSS--NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS------------------SSSS 528 (560)
Q Consensus 470 ~~~~~--~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~------------------~~~~ 528 (560)
..... ......++..|+|||++.+..++.++||||||+++|||++ |+.||..... ....
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTID 245 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTT
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHH
Confidence 54332 2234567889999999999999999999999999999999 9999975432 1223
Q ss_pred cccccccccccCCCCCCChhHHHhh
Q 035761 529 LDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 529 ~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
+...++.|...||..||++.+++++
T Consensus 246 ~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 246 VYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp TTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4556677888899999999999876
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=332.81 Aligned_cols=234 Identities=24% Similarity=0.332 Sum_probs=195.6
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCC--EEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEK--CMFLI 391 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv 391 (560)
++|.+.+.||+|+||.||+|... +|+.||||++..... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 56889999999999999999875 489999999975432 234567889999999999999999999998765 78999
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEe----CCCCcEEEeeecccc
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILL----NSEFEAFVADFGIAR 467 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfg~~~ 467 (560)
|||+++|+|.+++........+++.++..++.||+.||+|||+. +|+||||||+||++ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999998765555599999999999999999999999 99999999999999 778889999999998
Q ss_pred ccCCCCCCceeeccccCccCcccccc--------CccCcchhHHHHHHHHHHHHhCCCCCCcccccc-------------
Q 035761 468 LLNYDSSNRTLLAGTYGSIAPELAYT--------MVVTEKYDVYSFGVVALEVLMGKHPGELLSSSS------------- 526 (560)
Q Consensus 468 ~~~~~~~~~~~~~g~~~~~aPE~~~~--------~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~------------- 526 (560)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......
T Consensus 165 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 243 (396)
T 4eut_A 165 ELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (396)
T ss_dssp ECCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSC
T ss_pred EccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCC
Confidence 765332 2233568999999999875 567889999999999999999999996432110
Q ss_pred ---------------------------------cccccccccccccCCCCCCChhHHHhh
Q 035761 527 ---------------------------------SSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 527 ---------------------------------~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
..+...++.|...||..||++++++.+
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 112345567788899999999998654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=323.49 Aligned_cols=241 Identities=27% Similarity=0.412 Sum_probs=183.0
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
.++|++.+.||+|+||.||+|... +++.||||++..... ....+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 468999999999999999999864 688999999865432 233457889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcC-----CcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccc
Q 035761 393 EYMEMGSLFCILRTD-----EEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIAR 467 (560)
Q Consensus 393 e~~~~g~L~~~l~~~-----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~ 467 (560)
||+++|+|.+++... .....+++.++..++.||+.||+|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999998641 1123489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC-----CceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCccccc----------------
Q 035761 468 LLNYDSS-----NRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSSS---------------- 525 (560)
Q Consensus 468 ~~~~~~~-----~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~---------------- 525 (560)
....... ......|++.|+|||++.+ ..++.++||||||+++|||++|+.||......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 249 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcccc
Confidence 7643221 1233568999999999876 56889999999999999999999999753321
Q ss_pred -----------ccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 526 -----------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 526 -----------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
...+.+.++.|...||..||++.++++|+|+..
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 293 (303)
T 2vwi_A 250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293 (303)
T ss_dssp -----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC--
T ss_pred ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhc
Confidence 112334567788899999999999999999875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=318.10 Aligned_cols=232 Identities=26% Similarity=0.427 Sum_probs=184.9
Q ss_pred hcCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
.++|++.+.||+|+||.||+|+.. ..||||+++.........+.+.+|+++++.++||||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 467999999999999999999864 3699999976655555667899999999999999999999965 4556899999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++++|.+++.... ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 100 ~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 100 WCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp CCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred ecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccccc
Confidence 999999999997543 2389999999999999999999999 99999999999999999999999999998654321
Q ss_pred --CCceeeccccCccCccccc---cCccCcchhHHHHHHHHHHHHhCCCCCCccccc-----------------------
Q 035761 474 --SNRTLLAGTYGSIAPELAY---TMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS----------------------- 525 (560)
Q Consensus 474 --~~~~~~~g~~~~~aPE~~~---~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~----------------------- 525 (560)
.......||+.|+|||++. +..++.++||||||+++|||++|+.||......
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNC 254 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTS
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccC
Confidence 2223456899999999986 566888999999999999999999999754321
Q ss_pred ccccccccccccccCCCCCCChhHHHhh
Q 035761 526 SSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 526 ~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
...+.+.++.|...||..||+++++++.
T Consensus 255 ~~~l~~li~~~l~~~p~~Rps~~ell~~ 282 (289)
T 3og7_A 255 PKRMKRLMAECLKKKRDERPSFPRILAE 282 (289)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 1224556677788899999999988764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=343.78 Aligned_cols=233 Identities=26% Similarity=0.398 Sum_probs=197.3
Q ss_pred hcCCcccceeeccCCeeEEEEEeCC-CcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
.++|++.+.||+|+||.||+|.++. +..||||.++... ...+.|.+|+.++++++||||+++++++...+..++||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc---cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 4568889999999999999998865 8899999997543 23567999999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++|+|.++++.... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 296 E~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 296 EFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp ECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred EccCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 99999999999986432 3489999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCC-ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------------ccccccc
Q 035761 473 SSN-RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------------SSSLDKN 532 (560)
Q Consensus 473 ~~~-~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------------~~~~~~~ 532 (560)
... .....+++.|+|||++....++.++|||||||++|||++ |+.||...... ...+.++
T Consensus 372 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 451 (495)
T 1opk_A 372 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL 451 (495)
T ss_dssp CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 211 122345678999999999999999999999999999999 99999754321 1234456
Q ss_pred cccccccCCCCCCChhHHHhh
Q 035761 533 IKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 533 ~~~~~~~dp~~~p~~~~~~~~ 553 (560)
++.|...||..||++.++++.
T Consensus 452 i~~cl~~dP~~RPs~~el~~~ 472 (495)
T 1opk_A 452 MRACWQWNPSDRPSFAEIHQA 472 (495)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCcChhHCcCHHHHHHH
Confidence 677788899999999888764
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=336.31 Aligned_cols=236 Identities=25% Similarity=0.369 Sum_probs=180.9
Q ss_pred cCCcc-cceeeccCCeeEEEEEeC---CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEe--CCEE
Q 035761 315 EDFDI-KYCIGTGGYGSVYRARLP---SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLH--EKCM 388 (560)
Q Consensus 315 ~~~~~-~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 388 (560)
+.|++ .+.||+|+||.||+|+++ +++.||||++..... ...+.+|+++++.++||||+++++++.. ....
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 34555 457999999999999865 578999999975432 2357789999999999999999999965 6789
Q ss_pred EEEEeccCCCCHHHHhhcCC------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEe----CCCCcE
Q 035761 389 FLIYEYMEMGSLFCILRTDE------EAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILL----NSEFEA 458 (560)
Q Consensus 389 ~lv~e~~~~g~L~~~l~~~~------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~ 458 (560)
++||||+++ +|.+++.... ....+++.++..++.||+.||+|||+. +|+||||||+|||+ +.++.+
T Consensus 96 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 96 WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp EEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCE
T ss_pred EEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcE
Confidence 999999975 8887775322 122489999999999999999999999 99999999999999 677899
Q ss_pred EEeeeccccccCCCC---CCceeeccccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCCCCCccccc---------
Q 035761 459 FVADFGIARLLNYDS---SNRTLLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKHPGELLSSS--------- 525 (560)
Q Consensus 459 kl~Dfg~~~~~~~~~---~~~~~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------- 525 (560)
||+|||+++...... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||......
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 251 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence 999999998764322 122345789999999998874 5899999999999999999999999643220
Q ss_pred -------------------------------------------------------ccccccccccccccCCCCCCChhHH
Q 035761 526 -------------------------------------------------------SSSLDKNIKLIDLLDPRLPPPGDQM 550 (560)
Q Consensus 526 -------------------------------------------------------~~~~~~~~~~~~~~dp~~~p~~~~~ 550 (560)
...+.+.++.|...||..||+++++
T Consensus 252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~ 331 (405)
T 3rgf_A 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 331 (405)
T ss_dssp HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 1223345677889999999999999
Q ss_pred Hhhceeee
Q 035761 551 IRQGIILI 558 (560)
Q Consensus 551 ~~~~~~~~ 558 (560)
++|+|+..
T Consensus 332 L~hp~f~~ 339 (405)
T 3rgf_A 332 MQDPYFLE 339 (405)
T ss_dssp HTSGGGTS
T ss_pred hcChhhcc
Confidence 99999864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=326.59 Aligned_cols=236 Identities=22% Similarity=0.358 Sum_probs=196.2
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC-----CE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHE-----KC 387 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 387 (560)
.++|++.+.||+|+||.||+|... +|+.||||++..... ......+.+|+++++.++||||+++++++..+ ..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK-PLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccccc-chHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 367899999999999999999875 688999999864332 23445788999999999999999999998764 67
Q ss_pred EEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccc
Q 035761 388 MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIAR 467 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~ 467 (560)
.++||||++ |+|.+++... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 89 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 899999997 5999998753 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCC----------ceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCcccc------------
Q 035761 468 LLNYDSSN----------RTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSS------------ 524 (560)
Q Consensus 468 ~~~~~~~~----------~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~------------ 524 (560)
........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 240 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence 76432211 122468999999998764 6788999999999999999999999975431
Q ss_pred -------------------------------------cccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 525 -------------------------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 525 -------------------------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
....+.+.++.|...||+.||+++++++|+|+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 311 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT 311 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 1112335667788899999999999999999864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=321.75 Aligned_cols=236 Identities=27% Similarity=0.396 Sum_probs=199.6
Q ss_pred hcCCcccceeeccCCeeEEEEEe------CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCC
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEK 386 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 386 (560)
.++|++.+.||+|+||.||+|.+ .+++.||||+++.... ....+.+.+|+.+++++ +||||+++++++..++
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh-HHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 46789999999999999999975 3467899999975432 23456789999999999 9999999999999999
Q ss_pred EEEEEEeccCCCCHHHHhhcCCc---------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeE
Q 035761 387 CMFLIYEYMEMGSLFCILRTDEE---------------AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNIL 451 (560)
Q Consensus 387 ~~~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nil 451 (560)
..++||||+++|+|.+++..... ...+++.++..++.||+.||+|||+. +++||||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEE
Confidence 99999999999999999986532 12489999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeeeccccccCCCCCC--ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc----
Q 035761 452 LNSEFEAFVADFGIARLLNYDSSN--RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS---- 524 (560)
Q Consensus 452 l~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~---- 524 (560)
++.++.+||+|||+++........ .....+++.|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 257 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence 999999999999999877543332 122456789999999999999999999999999999999 9999975432
Q ss_pred ---------------cccccccccccccccCCCCCCChhHHHhh
Q 035761 525 ---------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 525 ---------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
....+.+.++.|...||..||+++++++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 258 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 11234566677888899999999998875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=316.72 Aligned_cols=233 Identities=27% Similarity=0.375 Sum_probs=182.9
Q ss_pred hcCCcccceeeccCCeeEEEEEeCC----CcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLPS----GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMF 389 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 389 (560)
.++|++.+.||+|+||.||+|.... +..||+|.+..... ....+.+.+|+.++++++||||+++++++. ++..+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-DSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 3678899999999999999998643 45799999875432 234567899999999999999999999984 45688
Q ss_pred EEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccccc
Q 035761 390 LIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL 469 (560)
Q Consensus 390 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 469 (560)
+||||+++|+|.+++.... ..+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 92 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccccc
Confidence 9999999999999997643 2389999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCC-ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------------cccc
Q 035761 470 NYDSSN-RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------------SSSL 529 (560)
Q Consensus 470 ~~~~~~-~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------------~~~~ 529 (560)
...... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||...... ...+
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l 246 (281)
T 1mp8_A 167 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 246 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred CcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 533221 223446788999999998999999999999999999997 99999754321 1223
Q ss_pred ccccccccccCCCCCCChhHHHhh
Q 035761 530 DKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 530 ~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
.+.++.|...||..||++.+++++
T Consensus 247 ~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 247 YSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHHHH
Confidence 455667777888888888888764
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=315.68 Aligned_cols=238 Identities=25% Similarity=0.379 Sum_probs=202.7
Q ss_pred HhcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEE
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLI 391 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 391 (560)
..++|++.+.||+|+||.||+|... +++.||+|++..........+.+.+|++++++++||||+++++++...+..++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 4568999999999999999999875 689999999976554444567889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCC---CcEEEeeeccccc
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSE---FEAFVADFGIARL 468 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~~~~ 468 (560)
|||+++++|.+++.... .+++.++..++.||+.||+|||+. +++||||||+||+++.+ +.+||+|||++..
T Consensus 100 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 100 GELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 99999999999887543 389999999999999999999999 99999999999999754 4699999999987
Q ss_pred cCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------ccc
Q 035761 469 LNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------SSS 527 (560)
Q Consensus 469 ~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------~~~ 527 (560)
..... ......|++.|+|||.+.+. ++.++||||||+++|||++|+.||..... ...
T Consensus 174 ~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (287)
T 2wei_A 174 FQQNT-KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD 251 (287)
T ss_dssp BCCCS-SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCH
T ss_pred ecCCC-ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCH
Confidence 64332 22334689999999988764 88999999999999999999999964331 122
Q ss_pred ccccccccccccCCCCCCChhHHHhhceeee
Q 035761 528 SLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 528 ~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
.+.+.++.|...||..||+++++++++|+..
T Consensus 252 ~~~~li~~~l~~dp~~Rps~~ell~hp~~~~ 282 (287)
T 2wei_A 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (287)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred HHHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence 3456677788899999999999999999753
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=323.07 Aligned_cols=236 Identities=26% Similarity=0.385 Sum_probs=197.4
Q ss_pred hcCCcccceeeccCCeeEEEEEeC--------CCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEe
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP--------SGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLH 384 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 384 (560)
.++|++.+.||+|+||.||+|... +++.||||++..... ....+.+.+|+++++++ +||||+++++++..
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCc-HHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 467899999999999999999863 467899999975432 34456788999999999 89999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHhhcCCc-------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeE
Q 035761 385 EKCMFLIYEYMEMGSLFCILRTDEE-------------AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNIL 451 (560)
Q Consensus 385 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nil 451 (560)
++..++||||+++|+|.+++..... ...+++.++..++.||+.||+|||+. +|+||||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEE
Confidence 9999999999999999999986532 12489999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeeeccccccCCCCCC--ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc----
Q 035761 452 LNSEFEAFVADFGIARLLNYDSSN--RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS---- 524 (560)
Q Consensus 452 l~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~---- 524 (560)
++.++.+||+|||+++........ .....+++.|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 269 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence 999999999999999876533221 222346788999999999999999999999999999999 9999975432
Q ss_pred --------------cccccccccccccccCCCCCCChhHHHhh
Q 035761 525 --------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 525 --------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
....+.+.++.|...||..||++++++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 270 KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 11234556677888899999999998875
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=329.76 Aligned_cols=235 Identities=24% Similarity=0.277 Sum_probs=191.7
Q ss_pred HHhcCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC-----
Q 035761 312 EATEDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHE----- 385 (560)
Q Consensus 312 ~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 385 (560)
...++|++.+.||+|+||.||+|.. .+|+.||||++..... ...+|+++++.++||||+++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 3457899999999999999999976 5789999999865432 234799999999999999999998543
Q ss_pred ---------------------------------CEEEEEEeccCCCCHHHHhhcC-CcccCCCHHHHHHHHHHHHHHHHH
Q 035761 386 ---------------------------------KCMFLIYEYMEMGSLFCILRTD-EEAVGLDWTKRVNIVKGMAHALSY 431 (560)
Q Consensus 386 ---------------------------------~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~ 431 (560)
...++||||+++ +|.+.+... .....+++..+..++.||++||+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 348899999984 877766531 112348999999999999999999
Q ss_pred HHhcCCCCeEEeCCCCCCeEeC-CCCcEEEeeeccccccCCCCCCceeeccccCccCccccccC-ccCcchhHHHHHHHH
Q 035761 432 LHHHCTPPILHRDISSNNILLN-SEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVA 509 (560)
Q Consensus 432 LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il 509 (560)
||+. ||+||||||+||+++ .++.+||+|||+++...... ......||+.|+|||++.+. .++.++||||+||++
T Consensus 157 LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 157 IHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 9999 999999999999997 68899999999998764332 23345689999999998765 489999999999999
Q ss_pred HHHHhCCCCCCccccc----------------------------------------------ccccccccccccccCCCC
Q 035761 510 LEVLMGKHPGELLSSS----------------------------------------------SSSLDKNIKLIDLLDPRL 543 (560)
Q Consensus 510 ~el~~g~~P~~~~~~~----------------------------------------------~~~~~~~~~~~~~~dp~~ 543 (560)
|||++|+.||...... ...+.+.++.|...||..
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 9999999999754321 112446677888999999
Q ss_pred CCChhHHHhhceee
Q 035761 544 PPPGDQMIRQGIIL 557 (560)
Q Consensus 544 ~p~~~~~~~~~~~~ 557 (560)
||++.++++|+|+.
T Consensus 313 R~t~~e~l~hp~f~ 326 (383)
T 3eb0_A 313 RINPYEAMAHPFFD 326 (383)
T ss_dssp SCCHHHHHTSGGGH
T ss_pred CCCHHHHhcCHHHH
Confidence 99999999999975
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=318.41 Aligned_cols=241 Identities=21% Similarity=0.310 Sum_probs=187.8
Q ss_pred hcCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
.++|++.+.||+|+||.||+|.. .+|+.||||++..........+.+.++...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 36789999999999999999986 46899999999765444444455666666788899999999999999999999999
Q ss_pred eccCCCCHHHHhhcC-CcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC
Q 035761 393 EYMEMGSLFCILRTD-EEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471 (560)
Q Consensus 393 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 471 (560)
||+++ +|.+++... .....+++.++..++.|++.||+|||+.. +++||||||+||+++.++.+||+|||+++....
T Consensus 86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 99974 887777541 11234999999999999999999999842 899999999999999999999999999987643
Q ss_pred CCCCceeeccccCccCcccc----ccCccCcchhHHHHHHHHHHHHhCCCCCCcccc--------------------ccc
Q 035761 472 DSSNRTLLAGTYGSIAPELA----YTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS--------------------SSS 527 (560)
Q Consensus 472 ~~~~~~~~~g~~~~~aPE~~----~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~--------------------~~~ 527 (560)
. .......||+.|+|||++ .+..++.++||||+|+++|||++|+.||..... ...
T Consensus 163 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (290)
T 3fme_A 163 D-VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSA 241 (290)
T ss_dssp --------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCH
T ss_pred c-ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCH
Confidence 2 223334689999999995 566788999999999999999999999974321 122
Q ss_pred ccccccccccccCCCCCCChhHHHhhceeee
Q 035761 528 SLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 528 ~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
.+.+.+..|...||..||+++++++|+|+..
T Consensus 242 ~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 242 EFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 3455677888999999999999999999853
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=321.41 Aligned_cols=239 Identities=23% Similarity=0.368 Sum_probs=197.9
Q ss_pred HhcCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccC--CCCcceeeeEEEeCCEEEE
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIR--HRNIVKLYGFCLHEKCMFL 390 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~l 390 (560)
..++|++.+.||+|+||.||+|...+++.||||++..........+.+.+|++++++++ ||||+++++++..++..++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 34679999999999999999999888999999999765444455678899999999997 5999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccC
Q 035761 391 IYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN 470 (560)
Q Consensus 391 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 470 (560)
||| +.+++|.+++.... .+++.++..++.|+++||+|||+. +|+||||||+||++++ +.+||+|||+++...
T Consensus 106 v~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 106 VME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQ 177 (313)
T ss_dssp EEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred EEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecccccccc
Confidence 999 56889999998654 389999999999999999999999 9999999999999964 899999999998764
Q ss_pred CCCCC--ceeeccccCccCcccccc-----------CccCcchhHHHHHHHHHHHHhCCCCCCcccc-------------
Q 035761 471 YDSSN--RTLLAGTYGSIAPELAYT-----------MVVTEKYDVYSFGVVALEVLMGKHPGELLSS------------- 524 (560)
Q Consensus 471 ~~~~~--~~~~~g~~~~~aPE~~~~-----------~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~------------- 524 (560)
..... .....|++.|+|||++.+ ..++.++||||||+++|||++|+.||.....
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 257 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 257 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccc
Confidence 33221 233468999999999875 4678899999999999999999999975421
Q ss_pred -------cccccccccccccccCCCCCCChhHHHhhceeeec
Q 035761 525 -------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILIS 559 (560)
Q Consensus 525 -------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~~ 559 (560)
....+.+.++.|...||..||+++++++++|+...
T Consensus 258 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 258 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 11235566778889999999999999999998653
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=316.98 Aligned_cols=236 Identities=22% Similarity=0.308 Sum_probs=186.6
Q ss_pred cCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchh-hhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLE-TELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|++.+.||+|+||.||+|.. .+|+.||||++.... ......+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 5689999999999999999986 478999999987532 22344567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCC-cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC
Q 035761 393 EYMEMGSLFCILRTDE-EAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 471 (560)
||+++|+|.+++.... ....+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 9999999999986421 123489999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------cccccc
Q 035761 472 DSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------SSSSLD 530 (560)
Q Consensus 472 ~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------~~~~~~ 530 (560)
.........|++.|+|||++.+..++.++||||||+++|||++|+.||..... ....+.
T Consensus 189 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 268 (310)
T 2wqm_A 189 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR 268 (310)
T ss_dssp ----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHH
T ss_pred CCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHH
Confidence 43334445689999999999999999999999999999999999999964321 122345
Q ss_pred cccccccccCCCCCCChhHHHhh
Q 035761 531 KNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 531 ~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
+.++.|...||..||+++++++.
T Consensus 269 ~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 269 QLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCChhhCCCHHHHHHH
Confidence 66677888899999999998865
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=326.18 Aligned_cols=241 Identities=23% Similarity=0.352 Sum_probs=200.9
Q ss_pred HHHHHhcCCcccceeeccCCeeEEEEEeC------CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEE
Q 035761 309 DMIEATEDFDIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFC 382 (560)
Q Consensus 309 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 382 (560)
++....++|++.+.||+|+||.||+|.+. +++.||||.+..... ......+.+|+.+++.++||||+++++++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC-HHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccC-HHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 34445678999999999999999999764 367899999975432 23445788999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHhhcCCc-------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCC
Q 035761 383 LHEKCMFLIYEYMEMGSLFCILRTDEE-------AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSE 455 (560)
Q Consensus 383 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~ 455 (560)
.+.+..++||||+++|+|.+++..... ...+++.++..++.||+.||+|||+. +|+||||||+||+++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 174 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCC
Confidence 999999999999999999999875321 13479999999999999999999999 99999999999999999
Q ss_pred CcEEEeeeccccccCCCCCC--ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc--------
Q 035761 456 FEAFVADFGIARLLNYDSSN--RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS-------- 524 (560)
Q Consensus 456 ~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~-------- 524 (560)
+.+||+|||+++........ .....+++.|+|||++.+..++.++||||+|+++|||++ |+.||.....
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 254 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence 99999999999876433221 122346889999999999999999999999999999999 8999975432
Q ss_pred ----------cccccccccccccccCCCCCCChhHHHhh
Q 035761 525 ----------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 525 ----------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
....+.+.++.|...||..||++.+++++
T Consensus 255 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 255 EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 11234566777888899999999999876
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=319.35 Aligned_cols=238 Identities=24% Similarity=0.337 Sum_probs=187.1
Q ss_pred HhcCCcccceeeccCCeeEEEEEeC----CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCE-
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARLP----SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKC- 387 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~- 387 (560)
..++|.+.+.||+|+||.||+|... .++.||+|.++.........+.+.+|+.++++++||||+++++++...+.
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 4567889999999999999999754 34589999997654444556778999999999999999999999987653
Q ss_pred ----EEEEEeccCCCCHHHHhhcC---CcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEE
Q 035761 388 ----MFLIYEYMEMGSLFCILRTD---EEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFV 460 (560)
Q Consensus 388 ----~~lv~e~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 460 (560)
.++||||+++|+|.+++... .....+++.++..++.||++||+|||+. +|+||||||+||+++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEE
Confidence 49999999999999998532 1234589999999999999999999999 9999999999999999999999
Q ss_pred eeeccccccCCCCCC--ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------
Q 035761 461 ADFGIARLLNYDSSN--RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------ 525 (560)
Q Consensus 461 ~Dfg~~~~~~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------ 525 (560)
+|||+++........ .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 268 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRL 268 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCC
Confidence 999999876433221 223456789999999999999999999999999999999 99998754321
Q ss_pred ------ccccccccccccccCCCCCCChhHHHhh
Q 035761 526 ------SSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 526 ------~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
...+.+.+..|...||..||++.+++++
T Consensus 269 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 269 KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1234556677788899999999988765
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=319.24 Aligned_cols=233 Identities=22% Similarity=0.331 Sum_probs=192.9
Q ss_pred cCCcccceeeccCCeeEEEEEe-----CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC--CE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-----PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHE--KC 387 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~ 387 (560)
+.|+..+.||+|+||.||+|++ .+++.||||++..... ....+.+.+|+++++.++||||+++++++..+ ..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 4588899999999999999984 4688999999975442 34456789999999999999999999999876 56
Q ss_pred EEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccc
Q 035761 388 MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIAR 467 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~ 467 (560)
.++||||+++|+|.+++..... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKN--KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccc
Confidence 8999999999999999965432 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCC---ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccc---------------------
Q 035761 468 LLNYDSSN---RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLS--------------------- 523 (560)
Q Consensus 468 ~~~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~--------------------- 523 (560)
........ .....||..|+|||++.+..++.++||||+|+++|||++|+.|+....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 77543321 223457888999999999999999999999999999999998863221
Q ss_pred ------------ccccccccccccccccCCCCCCChhHHHhh
Q 035761 524 ------------SSSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 524 ------------~~~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
.....+.+.++.|...||..||+++++++.
T Consensus 255 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 296 (302)
T 4e5w_A 255 TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEG 296 (302)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence 112335567778888899999999988764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=314.39 Aligned_cols=231 Identities=28% Similarity=0.388 Sum_probs=197.5
Q ss_pred cCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
++|++.+.||+|+||.||+|...+++.||+|++..... ..+.+.+|+++++.++||||+++++++.+++..++||||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 56888999999999999999998889999999976442 235788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC-
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS- 473 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~- 473 (560)
+++++|.+++..... .+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 159 (267)
T 3t9t_A 85 MEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 159 (267)
T ss_dssp CTTCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCCCcHHHHHhhCcc--cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccc
Confidence 999999999976532 389999999999999999999999 99999999999999999999999999998753211
Q ss_pred CCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc------------------cccccccccc
Q 035761 474 SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS------------------SSSSLDKNIK 534 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~------------------~~~~~~~~~~ 534 (560)
.......++..|+|||++.+..++.++||||+|+++|||++ |+.||..... ....+.+.++
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 239 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN 239 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHH
Confidence 11122346778999999998899999999999999999999 9999975432 1223455667
Q ss_pred cccccCCCCCCChhHHHhh
Q 035761 535 LIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 535 ~~~~~dp~~~p~~~~~~~~ 553 (560)
.|...||..||++.+++++
T Consensus 240 ~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 240 HCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHccCChhhCcCHHHHHHH
Confidence 7888899999999998875
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=338.56 Aligned_cols=232 Identities=27% Similarity=0.403 Sum_probs=190.9
Q ss_pred hcCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
.++|++.+.||+|+||.||+|.++++..||||+++.... ..+.|.+|++++++++||||+++++++.+ +..++|||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 467888999999999999999998888999999975432 24578999999999999999999999876 66899999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++|+|.+++.... ...+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 259 ~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 259 YMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp CCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred hhcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 999999999997532 23489999999999999999999999 99999999999999999999999999998764322
Q ss_pred CC-ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc------------------ccccccccc
Q 035761 474 SN-RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS------------------SSSSLDKNI 533 (560)
Q Consensus 474 ~~-~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~------------------~~~~~~~~~ 533 (560)
.. .....+++.|+|||++.+..++.++||||||+++|||++ |+.||..... ....+.+.+
T Consensus 335 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li 414 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM 414 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 21 223446789999999999999999999999999999999 9999975432 112245566
Q ss_pred ccccccCCCCCCChhHHHhh
Q 035761 534 KLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 534 ~~~~~~dp~~~p~~~~~~~~ 553 (560)
..|...||..||+++++++.
T Consensus 415 ~~cl~~dP~~Rpt~~~l~~~ 434 (452)
T 1fmk_A 415 CQCWRKEPEERPTFEYLQAF 434 (452)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHccCChhhCcCHHHHHHH
Confidence 77788899999999888764
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=315.46 Aligned_cols=240 Identities=21% Similarity=0.261 Sum_probs=197.8
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhh--hhhHHHHHHHHHHHhccCCCCcceeeeEEE--eCCEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETE--LASLESFQNEARLLSQIRHRNIVKLYGFCL--HEKCM 388 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~ 388 (560)
.++|++.+.||+|+||.||+|... +++.||+|++...... ....+.+.+|+++++.++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 367999999999999999999874 6889999999765422 234567899999999999999999999985 34578
Q ss_pred EEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccc
Q 035761 389 FLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARL 468 (560)
Q Consensus 389 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 468 (560)
++||||++++ +.+++.... ...+++.++..++.||+.||+|||+. +++||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999886 777776533 23489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC--CceeeccccCccCccccccCc--cCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------ccc
Q 035761 469 LNYDSS--NRTLLAGTYGSIAPELAYTMV--VTEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSS 527 (560)
Q Consensus 469 ~~~~~~--~~~~~~g~~~~~aPE~~~~~~--~~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~ 527 (560)
...... ......|++.|+|||++.+.. ++.++||||||+++|||++|+.||..... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 238 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGP 238 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCH
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCH
Confidence 643222 223356899999999987644 47799999999999999999999975431 122
Q ss_pred ccccccccccccCCCCCCChhHHHhhceeee
Q 035761 528 SLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 528 ~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
.+.+.++.|...||..||+++++++|+|+..
T Consensus 239 ~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 269 (305)
T 2wtk_C 239 PLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK 269 (305)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHSHHHHS
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcCccccc
Confidence 3566778888999999999999999999864
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=324.97 Aligned_cols=231 Identities=26% Similarity=0.321 Sum_probs=193.9
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCE------
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKC------ 387 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------ 387 (560)
++|...+.||+|+||.||+|... +|+.||||++..........+.+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 56888999999999999999864 68999999997654444455678899999999999999999999987653
Q ss_pred EEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccc
Q 035761 388 MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIAR 467 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~ 467 (560)
.++||||++ |+|.+++.. .+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 104 ~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred EEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccccc
Confidence 499999997 588887753 289999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCcccc----------------------
Q 035761 468 LLNYDSSNRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------- 524 (560)
Q Consensus 468 ~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------- 524 (560)
..... .....||+.|+|||++.+ ..++.++||||+|+++|||++|+.||...+.
T Consensus 175 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 251 (353)
T 3coi_A 175 HADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL 251 (353)
T ss_dssp C-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTC
T ss_pred CCCCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHH
Confidence 75422 334568999999999877 6788999999999999999999999975431
Q ss_pred --------------------------cccccccccccccccCCCCCCChhHHHhhceee
Q 035761 525 --------------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 525 --------------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
....+...++.|...||..||+++++++|+|+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~ 310 (353)
T 3coi_A 252 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 310 (353)
T ss_dssp SCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred hhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchh
Confidence 122344566778889999999999999999985
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=316.20 Aligned_cols=233 Identities=24% Similarity=0.294 Sum_probs=183.8
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLI 391 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 391 (560)
.++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 467999999999999999999865 688999999976542 233456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 471 (560)
|||+++++|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 113 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 99999999999997643 389999999999999999999999 999999999999999999999999999987643
Q ss_pred CCC-CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc--------------------ccccc
Q 035761 472 DSS-NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------------SSSLD 530 (560)
Q Consensus 472 ~~~-~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------------~~~~~ 530 (560)
... ......|++.|+|||++.+..++.++||||||+++|||++|+.||...... ...+.
T Consensus 187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 266 (309)
T 2h34_A 187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFD 266 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHH
T ss_pred cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHH
Confidence 321 223456899999999999999999999999999999999999999754321 12234
Q ss_pred cccccccccCCCCCC-ChhHHHh
Q 035761 531 KNIKLIDLLDPRLPP-PGDQMIR 552 (560)
Q Consensus 531 ~~~~~~~~~dp~~~p-~~~~~~~ 552 (560)
+.++.|...||..|| ++++++.
T Consensus 267 ~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 267 AVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHhccCCHHHHHHhHHHHHH
Confidence 455666666777777 5555543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=315.05 Aligned_cols=233 Identities=24% Similarity=0.356 Sum_probs=192.8
Q ss_pred hcCCcccc-eeeccCCeeEEEEEe---CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEE
Q 035761 314 TEDFDIKY-CIGTGGYGSVYRARL---PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMF 389 (560)
Q Consensus 314 ~~~~~~~~-~ig~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 389 (560)
.++|.+.+ .||+|+||.||+|.+ .+++.||||+++.........+.+.+|+.+++.++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 35677777 899999999999954 2468899999986554444567899999999999999999999999 566789
Q ss_pred EEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccccc
Q 035761 390 LIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL 469 (560)
Q Consensus 390 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 469 (560)
+||||+++++|.+++..... +++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 94 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEECCTTEEHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHhCcC---CCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 99999999999999986543 89999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCc---eeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc------------------ccc
Q 035761 470 NYDSSNR---TLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS------------------SSS 527 (560)
Q Consensus 470 ~~~~~~~---~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~------------------~~~ 527 (560)
....... ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ...
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPR 247 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 5433221 12345688999999998889999999999999999999 9999975432 123
Q ss_pred ccccccccccccCCCCCCChhHHHhh
Q 035761 528 SLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 528 ~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
.+.+.++.|...||..||++.++++.
T Consensus 248 ~l~~li~~~l~~dp~~Rps~~~l~~~ 273 (291)
T 1xbb_A 248 EMYDLMNLCWTYDVENRPGFAAVELR 273 (291)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 45667777888899999999988764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=328.28 Aligned_cols=232 Identities=25% Similarity=0.403 Sum_probs=182.1
Q ss_pred CCcccceeeccCCeeEEEEEeC--CC--cEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEe-CCEEEE
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP--SG--KVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLH-EKCMFL 390 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~l 390 (560)
.|.+.+.||+|+||.||+|.+. ++ ..||||.++.... ....+.+.+|+.++++++||||+++++++.. ++..++
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSC-SHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 4667789999999999999863 22 3689999875432 3445689999999999999999999999765 457899
Q ss_pred EEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccC
Q 035761 391 IYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN 470 (560)
Q Consensus 391 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 470 (560)
||||+++|+|.++++.... .+++.++..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 169 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999999976433 388999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCC----ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------------cc
Q 035761 471 YDSSN----RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------------SS 527 (560)
Q Consensus 471 ~~~~~----~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------------~~ 527 (560)
..... .....+++.|+|||++.+..++.++||||||+++|||++ |.+||...... ..
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~ 323 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 323 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCH
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 32211 223456789999999999999999999999999999999 77888654321 12
Q ss_pred ccccccccccccCCCCCCChhHHHhh
Q 035761 528 SLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 528 ~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
.+.+.+..|...||..||++++++++
T Consensus 324 ~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 324 PLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 24455677778899999999988765
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=318.73 Aligned_cols=234 Identities=26% Similarity=0.400 Sum_probs=199.2
Q ss_pred HhcCCcccceeeccCCeeEEEEEeCC-CcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEE
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLI 391 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 391 (560)
..++|++.+.||+|+||.||+|.... +..||+|.+.... ...+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 45678999999999999999998764 7889999987543 2346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 471 (560)
|||+++|+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++.....
T Consensus 88 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp EECCTTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EEcCCCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 999999999999976432 3489999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCC-ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------------cccccc
Q 035761 472 DSSN-RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------------SSSLDK 531 (560)
Q Consensus 472 ~~~~-~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------------~~~~~~ 531 (560)
.... .....+++.|+|||++.+..++.++||||+|+++|||++ |+.||...... ...+.+
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 243 (288)
T 3kfa_A 164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 243 (288)
T ss_dssp SSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred CccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHHH
Confidence 3322 222456788999999999999999999999999999999 99999754321 123456
Q ss_pred ccccccccCCCCCCChhHHHhh
Q 035761 532 NIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 532 ~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
.++.|...||..||+++++++.
T Consensus 244 li~~~l~~dp~~Rps~~~~~~~ 265 (288)
T 3kfa_A 244 LMRACWQWNPSDRPSFAEIHQA 265 (288)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhCCChhhCcCHHHHHHH
Confidence 6677888899999999998764
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=321.17 Aligned_cols=233 Identities=19% Similarity=0.299 Sum_probs=198.0
Q ss_pred cCCcccceeeccCCeeEEEEEe--CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCC------CcceeeeEEEeCC
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL--PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHR------NIVKLYGFCLHEK 386 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~l~~~~~~~~ 386 (560)
++|++.+.||+|+||.||+|.. .+++.||||+++... ...+.+.+|+++++.++|+ +++++++++...+
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD---RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH---HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC---chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 5799999999999999999986 368899999997543 2345678899999888665 4999999999999
Q ss_pred EEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCC------------
Q 035761 387 CMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNS------------ 454 (560)
Q Consensus 387 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~------------ 454 (560)
..++||||+ +++|.+++..... ..+++.++..++.||+.||+|||+. +|+||||||+||+++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----
T ss_pred cEEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccc
Confidence 999999999 8899999976542 3489999999999999999999999 9999999999999987
Q ss_pred -------CCcEEEeeeccccccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccccc-
Q 035761 455 -------EFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSS- 526 (560)
Q Consensus 455 -------~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~- 526 (560)
++.+||+|||+++.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+...
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDE---HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTS---CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred cccccccCCCceEeeCcccccCcc---ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 66899999999987542 2234568999999999999999999999999999999999999997543210
Q ss_pred ------------------------------------------------------------cccccccccccccCCCCCCC
Q 035761 527 ------------------------------------------------------------SSLDKNIKLIDLLDPRLPPP 546 (560)
Q Consensus 527 ------------------------------------------------------------~~~~~~~~~~~~~dp~~~p~ 546 (560)
..+.+.++.|...||..||+
T Consensus 243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 12336677888999999999
Q ss_pred hhHHHhhceeee
Q 035761 547 GDQMIRQGIILI 558 (560)
Q Consensus 547 ~~~~~~~~~~~~ 558 (560)
++++++|+|+..
T Consensus 323 ~~ell~hp~f~~ 334 (339)
T 1z57_A 323 LREALKHPFFDL 334 (339)
T ss_dssp HHHHTTSGGGGG
T ss_pred HHHHhcCHHHHH
Confidence 999999999864
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=326.88 Aligned_cols=243 Identities=19% Similarity=0.201 Sum_probs=186.4
Q ss_pred HHHHHHhcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCC
Q 035761 308 QDMIEATEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEK 386 (560)
Q Consensus 308 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 386 (560)
.......++|++.+.||+|+||.||+|... +|+.||||++..... ....+.+|++.++.++||||+++++++...+
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~ 92 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR---FRNRELQIMQDLAVLHHPNIVQLQSYFYTLG 92 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT---CCCHHHHHHHHHHHHCCTTBCCEEEEEEEEC
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc---ccHHHHHHHHHHHhcCCCCcccHHHhhhccc
Confidence 445566789999999999999999999874 689999998865332 1234567888888899999999999997643
Q ss_pred E-------EEEEEeccCCCCHHHHhhc-CCcccCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeEEeCCCCCCeEeCC-C
Q 035761 387 C-------MFLIYEYMEMGSLFCILRT-DEEAVGLDWTKRVNIVKGMAHALSYLH--HHCTPPILHRDISSNNILLNS-E 455 (560)
Q Consensus 387 ~-------~~lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~ia~~l~~LH--~~~~~~ivH~dlk~~Nill~~-~ 455 (560)
. .++||||+++ ++.+.+.. ......+++..+..++.|++.|++||| +. +|+||||||+||+++. +
T Consensus 93 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~ 168 (360)
T 3e3p_A 93 ERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEAD 168 (360)
T ss_dssp SSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTT
T ss_pred cccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCC
Confidence 3 7899999987 44433321 122334899999999999999999999 77 9999999999999996 8
Q ss_pred CcEEEeeeccccccCCCCCCceeeccccCccCccccccCc-cCcchhHHHHHHHHHHHHhCCCCCCccccc---------
Q 035761 456 FEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMV-VTEKYDVYSFGVVALEVLMGKHPGELLSSS--------- 525 (560)
Q Consensus 456 ~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~-~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------- 525 (560)
+.+||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||......
T Consensus 169 ~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~ 247 (360)
T 3e3p_A 169 GTLKLCDFGSAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV 247 (360)
T ss_dssp TEEEECCCTTCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred CcEEEeeCCCceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHH
Confidence 999999999998765332 233456899999999986654 899999999999999999999999754321
Q ss_pred ----------------------------------------ccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 526 ----------------------------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 526 ----------------------------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
...+.+.++.|...||..||++.++++|+|+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 320 (360)
T 3e3p_A 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDE 320 (360)
T ss_dssp HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGG
T ss_pred cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccc
Confidence 123456778888999999999999999999864
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=317.45 Aligned_cols=229 Identities=22% Similarity=0.322 Sum_probs=194.0
Q ss_pred CcccceeeccCCeeEEEEEeC-----CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC--CEEE
Q 035761 317 FDIKYCIGTGGYGSVYRARLP-----SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHE--KCMF 389 (560)
Q Consensus 317 ~~~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 389 (560)
|++.+.||+|+||.||++.+. +++.||||+++.... ....+.+.+|++++++++||||+++++++.+. ...+
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG-PQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccC-hHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 488999999999999998653 578999999976432 34456789999999999999999999999884 6789
Q ss_pred EEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccccc
Q 035761 390 LIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL 469 (560)
Q Consensus 390 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 469 (560)
+||||+++|+|.+++.... +++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 112 lv~e~~~~~~L~~~l~~~~----~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EEECCCTTCBHHHHGGGSC----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEecccCCcHHHHHhhCC----CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence 9999999999999997643 89999999999999999999999 9999999999999999999999999999887
Q ss_pred CCCCCC---ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc----------------------
Q 035761 470 NYDSSN---RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------- 524 (560)
Q Consensus 470 ~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------- 524 (560)
...... .....++..|+|||++.+..++.++||||+|+++|||++|+.||.....
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence 543321 2234578889999999999999999999999999999999999864321
Q ss_pred -----------cccccccccccccccCCCCCCChhHHHhh
Q 035761 525 -----------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 525 -----------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
....+.+.++.|...||..||+++++++.
T Consensus 265 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 304 (318)
T 3lxp_A 265 ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPI 304 (318)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 12235567778888899999999998864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=315.01 Aligned_cols=228 Identities=25% Similarity=0.396 Sum_probs=192.6
Q ss_pred cCCcccceeeccCCeeEEEEEeCC-C-------cEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCC
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPS-G-------KVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEK 386 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 386 (560)
++|.+.+.||+|+||.||+|.... + ..||+|.+.... ....+.+.+|+++++.++||||+++++++..++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 578899999999999999997643 3 479999986543 344567899999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCc--------E
Q 035761 387 CMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFE--------A 458 (560)
Q Consensus 387 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--------~ 458 (560)
..++||||+++|+|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++. +
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKNKN--CINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGG--GCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CCEEEEECCCCCCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccccccccee
Confidence 99999999999999999986533 389999999999999999999999 9999999999999998887 9
Q ss_pred EEeeeccccccCCCCCCceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhC-CCCCCcccc------------
Q 035761 459 FVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMG-KHPGELLSS------------ 524 (560)
Q Consensus 459 kl~Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g-~~P~~~~~~------------ 524 (560)
||+|||++..... .....|++.|+|||++.+ ..++.++||||||+++|||++| ..||.....
T Consensus 161 kl~Dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~ 236 (289)
T 4fvq_A 161 KLSDPGISITVLP----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQ 236 (289)
T ss_dssp EECCCCSCTTTSC----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC
T ss_pred eeccCcccccccC----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCC
Confidence 9999999876432 233458899999999987 7789999999999999999995 455543221
Q ss_pred ----cccccccccccccccCCCCCCChhHHHhh
Q 035761 525 ----SSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 525 ----~~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
....+.+.++.|...||..||++++++++
T Consensus 237 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 237 LPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 22345667788888899999999999876
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=332.79 Aligned_cols=232 Identities=24% Similarity=0.289 Sum_probs=188.2
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC------CE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHE------KC 387 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~ 387 (560)
.+|+..+.||+|+||.||+|++. +|+.||||++..... ...+|+++++.++||||+++++++... ..
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 46888999999999999999875 589999999865331 234799999999999999999998642 23
Q ss_pred EEEEEeccCCCCHHHHhhcC-CcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCC-CcEEEeeecc
Q 035761 388 MFLIYEYMEMGSLFCILRTD-EEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSE-FEAFVADFGI 465 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~ 465 (560)
.++||||+++ ++.+.+... .....+++..+..++.||++||+|||+. +|+||||||+|||++.+ +.+||+|||+
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchh
Confidence 6799999986 565555421 1223489999999999999999999999 99999999999999965 5689999999
Q ss_pred ccccCCCCCCceeeccccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCCCCCccccc-------------------
Q 035761 466 ARLLNYDSSNRTLLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKHPGELLSSS------------------- 525 (560)
Q Consensus 466 ~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~------------------- 525 (560)
++.+.... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......
T Consensus 204 a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 204 AKQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp CEECCTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred hhhcccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 98764332 23345689999999998765 7899999999999999999999999754310
Q ss_pred ---------------------------ccccccccccccccCCCCCCChhHHHhhceee
Q 035761 526 ---------------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 526 ---------------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
...+.++++.|...||..||++.+++.|+|+.
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~ 341 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 341 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhc
Confidence 12234556778888999999999999999974
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=312.98 Aligned_cols=232 Identities=24% Similarity=0.343 Sum_probs=193.0
Q ss_pred cCCcccc-eeeccCCeeEEEEEeC---CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEE
Q 035761 315 EDFDIKY-CIGTGGYGSVYRARLP---SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFL 390 (560)
Q Consensus 315 ~~~~~~~-~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 390 (560)
++|.+.+ .||+|+||.||+|.+. ++..||||+++... .....+.+.+|+++++.++||||+++++++ ..+..++
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 4566665 8999999999999753 57889999997643 234456789999999999999999999999 4556899
Q ss_pred EEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccC
Q 035761 391 IYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN 470 (560)
Q Consensus 391 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 470 (560)
||||+++++|.+++.... ..+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 87 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCCHHHHHHhCC--ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 999999999999997543 2389999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCC---ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc------------------cccc
Q 035761 471 YDSSN---RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS------------------SSSS 528 (560)
Q Consensus 471 ~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~------------------~~~~ 528 (560)
..... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... ....
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 241 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPE 241 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHH
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHH
Confidence 33221 122346789999999998899999999999999999998 9999975432 1123
Q ss_pred cccccccccccCCCCCCChhHHHhh
Q 035761 529 LDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 529 ~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
+.+.++.|...||..||++.+++++
T Consensus 242 l~~li~~~l~~~p~~Rps~~~l~~~ 266 (287)
T 1u59_A 242 LYALMSDCWIYKWEDRPDFLTVEQR 266 (287)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4456677788899999999988876
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=316.81 Aligned_cols=234 Identities=26% Similarity=0.375 Sum_probs=188.5
Q ss_pred HHHHhcCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc--CCCCcceeeeEEEeC--
Q 035761 310 MIEATEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQI--RHRNIVKLYGFCLHE-- 385 (560)
Q Consensus 310 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~-- 385 (560)
.....++|++.+.||+|+||.||+|+.. ++.||||++..... ..+.+|.+++... +||||+++++++...
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~-----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE-----ASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc-----chhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 3344578999999999999999999985 89999999864332 2445566666654 999999999999887
Q ss_pred --CEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEEeCCCCCCeEeCCCCcE
Q 035761 386 --KCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHC-----TPPILHRDISSNNILLNSEFEA 458 (560)
Q Consensus 386 --~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----~~~ivH~dlk~~Nill~~~~~~ 458 (560)
...++||||+++|+|.++++.. .+++.++..++.|++.||+|||+.. +++|+||||||+||+++.++.+
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 181 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC 181 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred CCCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCE
Confidence 7899999999999999999754 2899999999999999999999751 3489999999999999999999
Q ss_pred EEeeeccccccCCCCCCc----eeeccccCccCccccccCccCcc------hhHHHHHHHHHHHHhC----------CCC
Q 035761 459 FVADFGIARLLNYDSSNR----TLLAGTYGSIAPELAYTMVVTEK------YDVYSFGVVALEVLMG----------KHP 518 (560)
Q Consensus 459 kl~Dfg~~~~~~~~~~~~----~~~~g~~~~~aPE~~~~~~~~~~------~Dv~s~G~il~el~~g----------~~P 518 (560)
||+|||+++.+....... ....||+.|+|||++.+...+.+ +|||||||++|||++| +.|
T Consensus 182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 999999998764332221 23468999999999988776665 9999999999999999 677
Q ss_pred CCcccccc-----------------------------cccccccccccccCCCCCCChhHHHhh
Q 035761 519 GELLSSSS-----------------------------SSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 519 ~~~~~~~~-----------------------------~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
|....... ..+.+.++.|...||..||++++++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 262 YHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 65432110 113456677888899999999999876
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=320.58 Aligned_cols=232 Identities=27% Similarity=0.369 Sum_probs=196.3
Q ss_pred cCCcccceeeccCCeeEEEEEe-----CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEE--eCCE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-----PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCL--HEKC 387 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~ 387 (560)
++|++.+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|++++++++||||+++++++. ....
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 5789999999999999999984 468899999987543 234467899999999999999999999987 4567
Q ss_pred EEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccc
Q 035761 388 MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIAR 467 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~ 467 (560)
.++||||+++|+|.+++..... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEEEeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccce
Confidence 8999999999999999976432 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCC---ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc--------------------
Q 035761 468 LLNYDSSN---RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-------------------- 524 (560)
Q Consensus 468 ~~~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-------------------- 524 (560)
........ .....+++.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE 255 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence 76533321 2234578889999999999999999999999999999999999853321
Q ss_pred -------------cccccccccccccccCCCCCCChhHHHhh
Q 035761 525 -------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 525 -------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
....+.+.++.|...||..||++++++++
T Consensus 256 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 256 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 12335667778888999999999999765
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=319.01 Aligned_cols=234 Identities=23% Similarity=0.303 Sum_probs=189.9
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEE----------
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCL---------- 383 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~---------- 383 (560)
++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC--hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 57889999999999999999876 48999999987543 344567889999999999999999999874
Q ss_pred ----eCCEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeC-CCCcE
Q 035761 384 ----HEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLN-SEFEA 458 (560)
Q Consensus 384 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~ 458 (560)
+....++||||++ |+|.+++... .+++.++..++.|++.||+|||+. +|+||||||+||+++ +++.+
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQG----PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEE
T ss_pred ccccccCceeEEeeccC-CCHHHHhhcC----CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeE
Confidence 3467899999998 6999999643 389999999999999999999999 999999999999997 56799
Q ss_pred EEeeeccccccCCCCC---CceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCcccc----------
Q 035761 459 FVADFGIARLLNYDSS---NRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------- 524 (560)
Q Consensus 459 kl~Dfg~~~~~~~~~~---~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------- 524 (560)
||+|||+++....... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.....
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 240 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 9999999987643211 1233457889999998765 6788999999999999999999999975432
Q ss_pred -------------------------------------cccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 525 -------------------------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 525 -------------------------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
....+.+.++.|...||..||+++++++|+|+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 311 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSI 311 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHT
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccc
Confidence 1233456677888999999999999999999853
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=313.40 Aligned_cols=232 Identities=28% Similarity=0.433 Sum_probs=195.7
Q ss_pred hcCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
.++|++.+.||+|+||.||+|...+++.||||.+..... ..+.+.+|+++++.++||||+++++++.. +..++|||
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 87 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc---cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEe
Confidence 467899999999999999999998888999999875432 34578899999999999999999999864 45889999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++++|.+++.... ...+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|||++.......
T Consensus 88 ~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 88 YMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp CCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred cCCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 999999999997532 22489999999999999999999999 99999999999999999999999999998765322
Q ss_pred CC-ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc------------------ccccccccc
Q 035761 474 SN-RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS------------------SSSSLDKNI 533 (560)
Q Consensus 474 ~~-~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~------------------~~~~~~~~~ 533 (560)
.. .....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ....+.+.+
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 243 (279)
T 1qpc_A 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLM 243 (279)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHHHH
Confidence 11 122346778999999998899999999999999999999 9999965432 122345667
Q ss_pred ccccccCCCCCCChhHHHhh
Q 035761 534 KLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 534 ~~~~~~dp~~~p~~~~~~~~ 553 (560)
+.|...||..||+++++++.
T Consensus 244 ~~~l~~~p~~Rps~~~l~~~ 263 (279)
T 1qpc_A 244 RLCWKERPEDRPTFDYLRSV 263 (279)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhccChhhCCCHHHHHHH
Confidence 77888899999999988763
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=312.76 Aligned_cols=234 Identities=26% Similarity=0.459 Sum_probs=190.5
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEe--------
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLH-------- 384 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------- 384 (560)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ...+.+.+|+++++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE---EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH---HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 467999999999999999999864 78999999996532 334678899999999999999999999865
Q ss_pred -----CCEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEE
Q 035761 385 -----EKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAF 459 (560)
Q Consensus 385 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 459 (560)
.+..++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+. +++||||||+||+++.++.+|
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEE
Confidence 356899999999999999998643 2378899999999999999999999 999999999999999999999
Q ss_pred EeeeccccccCCCC--------------CCceeeccccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCCCCCcccc
Q 035761 460 VADFGIARLLNYDS--------------SNRTLLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKHPGELLSS 524 (560)
Q Consensus 460 l~Dfg~~~~~~~~~--------------~~~~~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~P~~~~~~ 524 (560)
|+|||++....... .......|++.|+|||++.+. .++.++||||+|+++|||++ ||.....
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~ 233 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME 233 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence 99999998764221 112334689999999998764 68899999999999999998 4431110
Q ss_pred ----------------------cccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 525 ----------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 525 ----------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
....+.+.++.|...||..||+++++++|+|+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 234 RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred HHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 1112456778888999999999999999999864
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=323.64 Aligned_cols=232 Identities=20% Similarity=0.226 Sum_probs=188.0
Q ss_pred cCCcccceeeccCCeeEEEEEeC----CCcEEEEEEccchhhhh---------hhHHHHHHHHHHHhccCCCCcceeeeE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP----SGKVVALKKLHRLETEL---------ASLESFQNEARLLSQIRHRNIVKLYGF 381 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~---------~~~~~~~~e~~~l~~l~h~niv~l~~~ 381 (560)
++|++.+.||+|+||.||+|... ++..||||++....... .....+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 57899999999999999999875 57889999987543211 112346788899999999999999999
Q ss_pred EEe----CCEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCC-
Q 035761 382 CLH----EKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEF- 456 (560)
Q Consensus 382 ~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~- 456 (560)
+.. ....++||||+ +++|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSST
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCC
Confidence 988 67899999999 999999998654 499999999999999999999999 999999999999998887
Q ss_pred -cEEEeeeccccccCCCCC-------CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc----
Q 035761 457 -EAFVADFGIARLLNYDSS-------NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS---- 524 (560)
Q Consensus 457 -~~kl~Dfg~~~~~~~~~~-------~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---- 524 (560)
.+||+|||+++.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 999999999987643221 11335689999999999999999999999999999999999999954211
Q ss_pred ------------------------cccccccccccccccCCCCCCChhHHHhh
Q 035761 525 ------------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 525 ------------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
....+.+.+..|...||..||+++++++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 270 VQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 11245566778888999999999998865
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=318.68 Aligned_cols=233 Identities=30% Similarity=0.395 Sum_probs=189.2
Q ss_pred cCCcccceeeccCCeeEEEEEeCC-----CcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPS-----GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMF 389 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 389 (560)
++|...+.||+|+||.||+|.... +..||||.++.... ......+.+|+.+++.++||||+++++++...+..+
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT-EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 467778999999999999997643 23599999875432 234457889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccccc
Q 035761 390 LIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL 469 (560)
Q Consensus 390 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 469 (560)
+||||+++|+|.+++.... ..+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 123 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 9999999999999997643 2389999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCC---ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc------------------ccc
Q 035761 470 NYDSSN---RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS------------------SSS 527 (560)
Q Consensus 470 ~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~------------------~~~ 527 (560)
...... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||..... ...
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS 277 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBH
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCH
Confidence 533221 122345778999999999999999999999999999999 9999964331 112
Q ss_pred ccccccccccccCCCCCCChhHHHhh
Q 035761 528 SLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 528 ~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
.+.+.++.|...||..||++.++++.
T Consensus 278 ~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 278 AIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 34566677888899999999998765
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=311.90 Aligned_cols=231 Identities=17% Similarity=0.268 Sum_probs=190.2
Q ss_pred HhcCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEE-EeCCEEEE
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFC-LHEKCMFL 390 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~l 390 (560)
..++|++.+.||+|+||.||+|.. .+++.||||++...... +.+.+|+++++.++|++++..++++ ...+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 457899999999999999999986 57889999987643322 2477899999999988877777766 55678899
Q ss_pred EEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEe---CCCCcEEEeeecccc
Q 035761 391 IYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILL---NSEFEAFVADFGIAR 467 (560)
Q Consensus 391 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~~~ 467 (560)
||||+ +++|.+++..... .+++.++..++.||+.||+|||+. +|+||||||+||++ +.++.+||+|||+++
T Consensus 83 v~e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EEECC-CCBHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEEcc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 99999 9999999975332 389999999999999999999999 99999999999999 788999999999998
Q ss_pred ccCCCCC-------CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc---------------
Q 035761 468 LLNYDSS-------NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------- 525 (560)
Q Consensus 468 ~~~~~~~-------~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------- 525 (560)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 236 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc
Confidence 7654322 123456899999999999999999999999999999999999999754321
Q ss_pred ----------ccccccccccccccCCCCCCChhHHHhh
Q 035761 526 ----------SSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 526 ----------~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
...+.+.++.|...||..||+++++++.
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 274 (296)
T 4hgt_A 237 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 274 (296)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred chhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHH
Confidence 2345566677888899999999988764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=318.93 Aligned_cols=232 Identities=22% Similarity=0.409 Sum_probs=187.2
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCc----EEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGK----VVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMF 389 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 389 (560)
++|++.+.||+|+||.||+|.+. +++ +||+|.+.... .....+.+.+|+.+++.++||||+++++++..+. .+
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 57899999999999999999864 344 35777775433 2344567899999999999999999999998765 78
Q ss_pred EEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccccc
Q 035761 390 LIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL 469 (560)
Q Consensus 390 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 469 (560)
+|+||+++|+|.+++..... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 99999999999999986533 389999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCC--ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc------------------cccc
Q 035761 470 NYDSSN--RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS------------------SSSS 528 (560)
Q Consensus 470 ~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~------------------~~~~ 528 (560)
...... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... ....
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 247 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHH
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence 433222 223446788999999999999999999999999999999 9999975432 1123
Q ss_pred cccccccccccCCCCCCChhHHHhh
Q 035761 529 LDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 529 ~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
+...++.|...||..||+++++++.
T Consensus 248 l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 248 VYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4556677888899999999998874
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=318.74 Aligned_cols=242 Identities=24% Similarity=0.345 Sum_probs=199.9
Q ss_pred HHHHHHhcCCcccceeeccCCeeEEEEEe------CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeee
Q 035761 308 QDMIEATEDFDIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYG 380 (560)
Q Consensus 308 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~ 380 (560)
..+....++|++.+.||+|+||.||+|.+ .+++.||||+++.... ....+.+.+|+.+++++ +||||+++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCC-cHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 34444567899999999999999999974 3468899999976432 23446788999999999 7999999999
Q ss_pred EEEeCC-EEEEEEeccCCCCHHHHhhcCCc-------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCC
Q 035761 381 FCLHEK-CMFLIYEYMEMGSLFCILRTDEE-------------AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDIS 446 (560)
Q Consensus 381 ~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk 446 (560)
++...+ ..++||||+++|+|.+++..... ...+++.++..++.|++.||+|||+. +|+|||||
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dik 175 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA 175 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCc
Confidence 998755 48999999999999999986543 12278999999999999999999999 99999999
Q ss_pred CCCeEeCCCCcEEEeeeccccccCCCCCCc--eeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccc
Q 035761 447 SNNILLNSEFEAFVADFGIARLLNYDSSNR--TLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLS 523 (560)
Q Consensus 447 ~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~ 523 (560)
|+||+++.++.+||+|||+++......... ....+|+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 176 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 999999999999999999998765433222 23457889999999999999999999999999999998 999996543
Q ss_pred c-------------------cccccccccccccccCCCCCCChhHHHhh
Q 035761 524 S-------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 524 ~-------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
. ....+.+.+..|...||..||++.+++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 256 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp CSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2 11234556667778899999999998876
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=344.88 Aligned_cols=226 Identities=25% Similarity=0.366 Sum_probs=188.4
Q ss_pred ceeeccCCeeEEEEEeC---CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEeccCC
Q 035761 321 YCIGTGGYGSVYRARLP---SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEM 397 (560)
Q Consensus 321 ~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (560)
+.||+|+||.||+|.+. .++.||||+++.........+.+.+|++++++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999653 46789999998765545556789999999999999999999999965 457899999999
Q ss_pred CCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCC--
Q 035761 398 GSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSN-- 475 (560)
Q Consensus 398 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-- 475 (560)
|+|.+++..... +++.++..|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 454 g~L~~~l~~~~~---l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhhCCC---CCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 999999976443 89999999999999999999999 9999999999999999999999999999876543221
Q ss_pred -ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------------cccccccccc
Q 035761 476 -RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------------SSSLDKNIKL 535 (560)
Q Consensus 476 -~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------------~~~~~~~~~~ 535 (560)
.....+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... ...+.++++.
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 607 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNL 607 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 222346788999999999999999999999999999998 99999754421 1234556677
Q ss_pred ccccCCCCCCChhHHHhh
Q 035761 536 IDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 536 ~~~~dp~~~p~~~~~~~~ 553 (560)
|...||..||+++++++.
T Consensus 608 cl~~dP~~RPs~~~l~~~ 625 (635)
T 4fl3_A 608 CWTYDVENRPGFAAVELR 625 (635)
T ss_dssp HTCSSTTTSCCHHHHHHH
T ss_pred HcCCCHhHCcCHHHHHHH
Confidence 888899999999988764
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=326.69 Aligned_cols=234 Identities=22% Similarity=0.258 Sum_probs=194.5
Q ss_pred hcCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccC--------CCCcceeeeEEE-
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIR--------HRNIVKLYGFCL- 383 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~- 383 (560)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ...+.+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE---HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC---cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 36799999999999999999975 468899999997543 23456789999999885 788999999987
Q ss_pred ---eCCEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCC----
Q 035761 384 ---HEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEF---- 456 (560)
Q Consensus 384 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---- 456 (560)
.....++||||+ ++++.+++.... ...+++.++..++.||+.||+|||+++ +|+||||||+|||++.++
T Consensus 113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 113 SGVNGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp EETTEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHH
T ss_pred cCCCCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhh
Confidence 455789999999 567766665432 234899999999999999999999853 799999999999999775
Q ss_pred ---------------------------------------------cEEEeeeccccccCCCCCCceeeccccCccCcccc
Q 035761 457 ---------------------------------------------EAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELA 491 (560)
Q Consensus 457 ---------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~ 491 (560)
.+||+|||+++..... .....||+.|+|||++
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChhh
Confidence 7999999999876432 2334689999999999
Q ss_pred ccCccCcchhHHHHHHHHHHHHhCCCCCCcccccc---------------------------------------------
Q 035761 492 YTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSS--------------------------------------------- 526 (560)
Q Consensus 492 ~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~--------------------------------------------- 526 (560)
.+..++.++|||||||++|||++|+.||.......
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 99999999999999999999999999997433211
Q ss_pred --------------------cccccccccccccCCCCCCChhHHHhhceee
Q 035761 527 --------------------SSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 527 --------------------~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
..+.+.++.|...||..||+++++++|+|+.
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 1133667788999999999999999999985
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=310.81 Aligned_cols=232 Identities=24% Similarity=0.392 Sum_probs=196.8
Q ss_pred HhcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEe-------
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLH------- 384 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------- 384 (560)
...+|++.+.||+|+||.||+|... +++.||+|++.... +.+.+|+++++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 3467999999999999999999875 78999999987543 245689999999999999999998864
Q ss_pred ---------CCEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCC
Q 035761 385 ---------EKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSE 455 (560)
Q Consensus 385 ---------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~ 455 (560)
....++||||+++|+|.+++.... ...+++..+..++.||+.||+|||+. +|+||||||+||+++.+
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDT 158 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEET
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCC
Confidence 345899999999999999997543 23489999999999999999999999 99999999999999999
Q ss_pred CcEEEeeeccccccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------
Q 035761 456 FEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS----------- 524 (560)
Q Consensus 456 ~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~----------- 524 (560)
+.+||+|||++....... ......|++.|+|||++.+..++.++||||||+++|||++|..||.....
T Consensus 159 ~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIIS 237 (284)
T ss_dssp TEEEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHHHHHTTCCC
T ss_pred CCEEECcchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHHHHhhccccc
Confidence 999999999998765432 23345689999999999999999999999999999999999998743211
Q ss_pred --cccccccccccccccCCCCCCChhHHHhhce
Q 035761 525 --SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGI 555 (560)
Q Consensus 525 --~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~ 555 (560)
....+...++.|...||..||++.+++++.+
T Consensus 238 ~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~ 270 (284)
T 2a19_B 238 DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLT 270 (284)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 1223456678888999999999999998754
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=310.98 Aligned_cols=233 Identities=27% Similarity=0.324 Sum_probs=191.4
Q ss_pred hcCCcccceeeccCCeeEEEEEeCC----CcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLPS----GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMF 389 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 389 (560)
.++|.+.+.||+|+||.||+|.+.. +..||+|.+..... ....+.+.+|+.+++.++||||+++++++.++ ..+
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~ 88 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT-LDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW 88 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSC-HHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccC-chHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence 3678899999999999999997543 34699999876432 23456789999999999999999999998654 568
Q ss_pred EEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccccc
Q 035761 390 LIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL 469 (560)
Q Consensus 390 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 469 (560)
+||||+++++|.+++.... ..+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 89 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 9999999999999997643 2389999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCC-ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------------cccc
Q 035761 470 NYDSSN-RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------------SSSL 529 (560)
Q Consensus 470 ~~~~~~-~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------------~~~~ 529 (560)
...... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||...... ...+
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVL 243 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHHH
T ss_pred ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHHH
Confidence 533221 233456789999999998999999999999999999998 99999643321 1234
Q ss_pred ccccccccccCCCCCCChhHHHhh
Q 035761 530 DKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 530 ~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
.+.++.|...||..||++.+++.+
T Consensus 244 ~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 244 YTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHccCCchhCcCHHHHHHH
Confidence 566677888899999999998865
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=309.91 Aligned_cols=230 Identities=17% Similarity=0.262 Sum_probs=192.4
Q ss_pred hcCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEE-EeCCEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFC-LHEKCMFLI 391 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv 391 (560)
.++|++.+.||+|+||.||+|+. .+++.||||++..... .+.+.+|+.+++.++|++++..++++ ...+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence 46799999999999999999986 5789999999865432 23578999999999998877777666 556788999
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEe---CCCCcEEEeeeccccc
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILL---NSEFEAFVADFGIARL 468 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~~~~ 468 (560)
|||+ +++|.+++..... .+++.++..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++.
T Consensus 84 ~e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 84 MELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEec-CCCHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 9999 8999999975432 389999999999999999999999 99999999999999 4888999999999987
Q ss_pred cCCCCCC-------ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------
Q 035761 469 LNYDSSN-------RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS----------------- 524 (560)
Q Consensus 469 ~~~~~~~-------~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~----------------- 524 (560)
....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence 6543321 2345689999999999999999999999999999999999999975432
Q ss_pred --------cccccccccccccccCCCCCCChhHHHhh
Q 035761 525 --------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 525 --------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
....+.+.++.|...||..||+++++++.
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 274 (296)
T 3uzp_A 238 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 274 (296)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHH
Confidence 12234566677888899999999888764
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=312.46 Aligned_cols=233 Identities=25% Similarity=0.390 Sum_probs=190.4
Q ss_pred cCCcccceeeccCCeeEEEEEeCC----CcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEe-CCEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPS----GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLH-EKCMF 389 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~ 389 (560)
..|++.+.||+|+||.||+|...+ ...||+|.+..... ....+.+.+|+.++++++||||+++++++.. ++..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCC-HHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 467888999999999999998643 23589999875432 3445678999999999999999999999754 55789
Q ss_pred EEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccccc
Q 035761 390 LIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL 469 (560)
Q Consensus 390 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 469 (560)
+||||+++|+|.+++.... ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 104 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccc
Confidence 9999999999999997643 3389999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCC----CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------------c
Q 035761 470 NYDSS----NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------------S 526 (560)
Q Consensus 470 ~~~~~----~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------------~ 526 (560)
..... ......+|+.|+|||.+.+..++.++||||+|+++|||++ |.+||...... .
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP 258 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCC
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCC
Confidence 43221 1233457789999999999999999999999999999999 66666543321 2
Q ss_pred cccccccccccccCCCCCCChhHHHhh
Q 035761 527 SSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 527 ~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
..+.+.++.|...||..||+++++++.
T Consensus 259 ~~l~~li~~~l~~~p~~Rps~~ell~~ 285 (298)
T 3f66_A 259 DPLYEVMLKCWHPKAEMRPSFSELVSR 285 (298)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 234566677888899999999988865
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=342.34 Aligned_cols=231 Identities=23% Similarity=0.318 Sum_probs=187.3
Q ss_pred CCcccc-eeeccCCeeEEEEEeC---CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEE
Q 035761 316 DFDIKY-CIGTGGYGSVYRARLP---SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLI 391 (560)
Q Consensus 316 ~~~~~~-~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 391 (560)
++.+.+ .||+|+||.||+|.++ ++..||||+++.... ....+.+.+|++++++++||||+++++++.. +..++|
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS-STTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 344444 7999999999999764 466799999976432 2345789999999999999999999999976 568999
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 471 (560)
|||+++|+|.+++.... ..+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 414 ~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp EECCTTCBHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EEeCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 99999999999997543 3489999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCCc---eeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------------cccc
Q 035761 472 DSSNR---TLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------------SSSL 529 (560)
Q Consensus 472 ~~~~~---~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------------~~~~ 529 (560)
..... ....+++.|+|||++.+..++.++|||||||++|||++ |+.||...... ...+
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l 568 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL 568 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHH
Confidence 32211 22335689999999999999999999999999999998 99999754421 1234
Q ss_pred ccccccccccCCCCCCChhHHHhh
Q 035761 530 DKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 530 ~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
.+++..|...||..||+++++++.
T Consensus 569 ~~li~~cl~~dP~~RPs~~~l~~~ 592 (613)
T 2ozo_A 569 YALMSDCWIYKWEDRPDFLTVEQR 592 (613)
T ss_dssp HHHHHHTTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHHH
Confidence 555667778889999998887653
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=322.73 Aligned_cols=227 Identities=22% Similarity=0.263 Sum_probs=191.8
Q ss_pred cCCcccceeeccCCeeEEEEEeCC---------CcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcce--------
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPS---------GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVK-------- 377 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-------- 377 (560)
++|++.+.||+|+||.||+|.... ++.||||.+... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 578999999999999999998763 789999998743 25778999999999999988
Q ss_pred -------eeeEEEe-CCEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCC
Q 035761 378 -------LYGFCLH-EKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNN 449 (560)
Q Consensus 378 -------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~N 449 (560)
+++++.. ++..++||||+ +++|.+++.... ...+++.++..++.||+.||+|||+. +|+||||||+|
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~N 189 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAEN 189 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGG
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHH
Confidence 6777776 67899999999 999999998652 23499999999999999999999999 99999999999
Q ss_pred eEeCCCC--cEEEeeeccccccCCCCC-------CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCC
Q 035761 450 ILLNSEF--EAFVADFGIARLLNYDSS-------NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGE 520 (560)
Q Consensus 450 ill~~~~--~~kl~Dfg~~~~~~~~~~-------~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~ 520 (560)
|+++.++ .+||+|||+++.+..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 899999999987643221 1233468999999999999999999999999999999999999998
Q ss_pred cccc----------------------------cccccccccccccccCCCCCCChhHHHhh
Q 035761 521 LLSS----------------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 521 ~~~~----------------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
.... ....+.+.++.|...||..||+++++++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 270 NCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp GGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred cCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence 6531 12345566777888999999999998764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=317.05 Aligned_cols=234 Identities=26% Similarity=0.425 Sum_probs=192.2
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcE--EEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKV--VALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKCMFL 390 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~--vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 390 (560)
++|++.+.||+|+||.||+|... ++.. ||+|.+..... ....+.+.+|+++++++ +||||+++++++.+++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccc-hHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 56899999999999999999864 4554 49998875332 23445788999999999 89999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCC-------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCc
Q 035761 391 IYEYMEMGSLFCILRTDE-------------EAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFE 457 (560)
Q Consensus 391 v~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~ 457 (560)
||||+++|+|.+++.... ....+++.++..++.||+.||+|||+. +|+||||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCe
Confidence 999999999999997643 123589999999999999999999999 9999999999999999999
Q ss_pred EEEeeeccccccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc------------
Q 035761 458 AFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS------------ 524 (560)
Q Consensus 458 ~kl~Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~------------ 524 (560)
+||+|||+++..... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 181 ~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~ 259 (327)
T 1fvr_A 181 AKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 259 (327)
T ss_dssp EEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred EEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCC
Confidence 999999999754322 12223356789999999998889999999999999999998 9999965431
Q ss_pred ------cccccccccccccccCCCCCCChhHHHhh
Q 035761 525 ------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 525 ------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
....+.+.++.|...||..||++++++++
T Consensus 260 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 260 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 12234566677888899999999998875
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=318.29 Aligned_cols=233 Identities=24% Similarity=0.317 Sum_probs=173.1
Q ss_pred hcCCccc-ceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEe----CCE
Q 035761 314 TEDFDIK-YCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLH----EKC 387 (560)
Q Consensus 314 ~~~~~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~ 387 (560)
.++|.+. +.||+|+||.||+|..+ +++.||||++..... ...+....++.++||||+++++++.. +..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK------ARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH------HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH------HHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 4578885 46999999999999876 689999999865321 12223334566799999999999976 455
Q ss_pred EEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCC---CCcEEEeeec
Q 035761 388 MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNS---EFEAFVADFG 464 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg 464 (560)
.++||||+++|+|.+++..... ..+++.++..++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 8999999999999999986532 3489999999999999999999999 9999999999999986 4559999999
Q ss_pred cccccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc--------------------
Q 035761 465 IARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-------------------- 524 (560)
Q Consensus 465 ~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-------------------- 524 (560)
+++.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 177 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (336)
T 3fhr_A 177 FAKETTQ--NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPN 254 (336)
T ss_dssp TCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCT
T ss_pred cceeccc--cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCc
Confidence 9987542 223345689999999999999999999999999999999999999954332
Q ss_pred -----cccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 525 -----SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 525 -----~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
....+.+.++.|...||..||+++++++|+|+..
T Consensus 255 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 255 PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 1223455667788899999999999999999864
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=319.67 Aligned_cols=229 Identities=25% Similarity=0.370 Sum_probs=182.1
Q ss_pred cCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHH--HhccCCCCcceeeeEEEe-----CCE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARL--LSQIRHRNIVKLYGFCLH-----EKC 387 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~-----~~~ 387 (560)
++|++.+.||+|+||.||+|+. +++.||||++..... +.+..|.++ +..++||||+++++++.. ...
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~-----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR-----QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch-----hhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 6789999999999999999987 689999999875332 234445555 445899999999986643 235
Q ss_pred EEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeEEeCCCCCCeEeCCCCcEEEe
Q 035761 388 MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHC------TPPILHRDISSNNILLNSEFEAFVA 461 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------~~~ivH~dlk~~Nill~~~~~~kl~ 461 (560)
.++||||+++|+|.+++.... .++.++..++.||++||+|||+.. .++|+||||||+|||++.++.+||+
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred EEEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence 789999999999999997643 589999999999999999999762 3489999999999999999999999
Q ss_pred eeccccccCCCCC--------CceeeccccCccCcccccc-------CccCcchhHHHHHHHHHHHHhCCCCCCcccccc
Q 035761 462 DFGIARLLNYDSS--------NRTLLAGTYGSIAPELAYT-------MVVTEKYDVYSFGVVALEVLMGKHPGELLSSSS 526 (560)
Q Consensus 462 Dfg~~~~~~~~~~--------~~~~~~g~~~~~aPE~~~~-------~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~ 526 (560)
|||+++.+..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 9999987643221 1123468999999999887 456779999999999999999977764322110
Q ss_pred -------------------------------------------cccccccccccccCCCCCCChhHHHhh
Q 035761 527 -------------------------------------------SSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 527 -------------------------------------------~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
..+.+.+..|...||..||+++++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~ 312 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEER 312 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHH
Confidence 024566778888899999999999543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=321.54 Aligned_cols=200 Identities=25% Similarity=0.330 Sum_probs=169.2
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccC-CC-----CcceeeeEEEeCC
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIR-HR-----NIVKLYGFCLHEK 386 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~~~~ 386 (560)
.++|++.+.||+|+||.||+|... +++.||||+++... .....+..|+.+++.++ |+ +++++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK---AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH---HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH---HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 468999999999999999999865 57899999997533 22446677888888774 55 4999999999999
Q ss_pred EEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeC--CCCcEEEeeec
Q 035761 387 CMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLN--SEFEAFVADFG 464 (560)
Q Consensus 387 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfg 464 (560)
..++||||++ |+|.+++..... ..+++..+..++.|++.||+|||.. ..+|+||||||+|||++ .++.+||+|||
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred ceEEEEecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 9999999996 599999986532 2389999999999999999999952 22999999999999995 47889999999
Q ss_pred cccccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcc
Q 035761 465 IARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELL 522 (560)
Q Consensus 465 ~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~ 522 (560)
+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 207 ~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 207 SSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp TCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred Cceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99876432 23356899999999999999999999999999999999999999743
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=316.21 Aligned_cols=238 Identities=26% Similarity=0.290 Sum_probs=175.1
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHH-HHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEAR-LLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|+..+.||+|+||.||+|... +|+.||||++........ ...+..|.. +++.++||||+++++++..++..++||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE-QKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHH-HHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchH-HHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 57888999999999999999875 689999999976543322 334445555 777889999999999999999999999
Q ss_pred eccCCCCHHHHhhcC--CcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccC
Q 035761 393 EYMEMGSLFCILRTD--EEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN 470 (560)
Q Consensus 393 e~~~~g~L~~~l~~~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 470 (560)
||+++ +|.+++... .....+++..+..++.|++.||+|||+.. +++||||||+||+++.++.+||+|||+++...
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 99985 887777531 11234899999999999999999999842 89999999999999999999999999998764
Q ss_pred CCCCCceeeccccCccCcccc----ccCccCcchhHHHHHHHHHHHHhCCCCCCccccc---------------------
Q 035761 471 YDSSNRTLLAGTYGSIAPELA----YTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------------- 525 (560)
Q Consensus 471 ~~~~~~~~~~g~~~~~aPE~~----~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------------- 525 (560)
... ......|++.|+|||++ .+..++.++||||||+++|||++|+.||......
T Consensus 178 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3aln_A 178 DSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEER 256 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSC
T ss_pred ccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccc
Confidence 322 22334689999999998 4667889999999999999999999999754321
Q ss_pred --ccccccccccccccCCCCCCChhHHHhhceee
Q 035761 526 --SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 526 --~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
...+.+.++.|...||..||+++++++++|+.
T Consensus 257 ~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~ 290 (327)
T 3aln_A 257 EFSPSFINFVNLCLTKDESKRPKYKELLKHPFIL 290 (327)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred cCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHH
Confidence 11234566777888999999999999999975
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=317.47 Aligned_cols=241 Identities=20% Similarity=0.257 Sum_probs=193.6
Q ss_pred HHHhcCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhh----hhHHHHHHHHHHHhcc----CCCCcceeeeE
Q 035761 311 IEATEDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETEL----ASLESFQNEARLLSQI----RHRNIVKLYGF 381 (560)
Q Consensus 311 ~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l----~h~niv~l~~~ 381 (560)
....++|++.+.||+|+||.||+|.. .+++.||||++....... .....+.+|+.+++++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34457899999999999999999986 468899999997543211 1223456789999888 89999999999
Q ss_pred EEeCCEEEEEEec-cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeC-CCCcEE
Q 035761 382 CLHEKCMFLIYEY-MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLN-SEFEAF 459 (560)
Q Consensus 382 ~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~k 459 (560)
+...+..++|+|| +++++|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++ .++.+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEE
Confidence 9999999999999 78999999997643 389999999999999999999999 999999999999999 889999
Q ss_pred EeeeccccccCCCCCCceeeccccCccCccccccCccC-cchhHHHHHHHHHHHHhCCCCCCcccc-----------ccc
Q 035761 460 VADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVT-EKYDVYSFGVVALEVLMGKHPGELLSS-----------SSS 527 (560)
Q Consensus 460 l~Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~-~~~Dv~s~G~il~el~~g~~P~~~~~~-----------~~~ 527 (560)
|+|||+++..... ......|+..|+|||++.+..+. .++||||+|+++|||++|+.||..... ...
T Consensus 181 l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 258 (312)
T 2iwi_A 181 LIDFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVSP 258 (312)
T ss_dssp ECCCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHTCCCCCTTSCH
T ss_pred EEEcchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHhhhccCCcccCCH
Confidence 9999999876532 23345689999999998877665 489999999999999999999964321 233
Q ss_pred ccccccccccccCCCCCCChhHHHhhceeeec
Q 035761 528 SLDKNIKLIDLLDPRLPPPGDQMIRQGIILIS 559 (560)
Q Consensus 528 ~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~~ 559 (560)
.+.+.++.|...||..||+++++++|+|+...
T Consensus 259 ~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 259 DCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 45677788899999999999999999998753
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=317.81 Aligned_cols=238 Identities=26% Similarity=0.346 Sum_probs=194.8
Q ss_pred hcCCcccceeeccCCeeEEEEEe------CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKC 387 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 387 (560)
.++|++.+.||+|+||.||+|.+ .+++.||||.+..... ......+.+|+.++++++||||+++++++...+.
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS-EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccc-hhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 36799999999999999999984 3467899999964432 2344578899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhcCCc----ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCC---CCcEEE
Q 035761 388 MFLIYEYMEMGSLFCILRTDEE----AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNS---EFEAFV 460 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl 460 (560)
.++||||+++|+|.+++..... ...+++.++..++.||+.||+|||+. +|+||||||+||+++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999986532 13489999999999999999999999 9999999999999984 456999
Q ss_pred eeeccccccCCCCCC--ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc-------------
Q 035761 461 ADFGIARLLNYDSSN--RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS------------- 524 (560)
Q Consensus 461 ~Dfg~~~~~~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~------------- 524 (560)
+|||+++........ .....+++.|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~ 264 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 264 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCC
Confidence 999999865332221 223457889999999999999999999999999999998 9999975432
Q ss_pred -----cccccccccccccccCCCCCCChhHHHhhce
Q 035761 525 -----SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGI 555 (560)
Q Consensus 525 -----~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~ 555 (560)
....+.+.++.|...||..||++++++++.+
T Consensus 265 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 300 (327)
T 2yfx_A 265 DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300 (327)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 1123456677788899999999999998754
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=313.56 Aligned_cols=235 Identities=24% Similarity=0.348 Sum_probs=191.7
Q ss_pred hcCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEe----CCEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLH----EKCM 388 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~ 388 (560)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+++++.++||||+++++++.. ....
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE--QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS--HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC--HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 36799999999999999999986 578999999986533 2345678899999999999999999999973 3478
Q ss_pred EEEEeccCCCCHHHHhhcCC-cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccc
Q 035761 389 FLIYEYMEMGSLFCILRTDE-EAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIAR 467 (560)
Q Consensus 389 ~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~ 467 (560)
++||||+++|+|.+++.... ....+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 99999999999999987521 123489999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCC---------ceeeccccCccCccccccCc---cCcchhHHHHHHHHHHHHhCCCCCCcccc-----------
Q 035761 468 LLNYDSSN---------RTLLAGTYGSIAPELAYTMV---VTEKYDVYSFGVVALEVLMGKHPGELLSS----------- 524 (560)
Q Consensus 468 ~~~~~~~~---------~~~~~g~~~~~aPE~~~~~~---~~~~~Dv~s~G~il~el~~g~~P~~~~~~----------- 524 (560)
........ .....|++.|+|||++.+.. ++.++||||||+++|||++|+.||.....
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 262 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN 262 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc
Confidence 65321111 11234689999999987554 68899999999999999999999954211
Q ss_pred ---------cccccccccccccccCCCCCCChhHHHhh
Q 035761 525 ---------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 525 ---------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
....+.+.++.|...||..||++++++++
T Consensus 263 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 263 QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 12235567778888899999999999876
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=340.93 Aligned_cols=233 Identities=27% Similarity=0.401 Sum_probs=195.6
Q ss_pred HhcCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
..++|++.+.||+|+||.||+|.++++..||||+++.... ..+.|.+|+++|++++||||+++++++.+ +..++||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~ 340 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 340 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEee
Confidence 3467888999999999999999998888999999975432 24578999999999999999999999876 6689999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++|+|.++++... ...+++.++..|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 341 e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp CCCTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred ehhcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 9999999999997532 23389999999999999999999999 9999999999999999999999999999876422
Q ss_pred CC-CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc------------------cccccccc
Q 035761 473 SS-NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS------------------SSSSLDKN 532 (560)
Q Consensus 473 ~~-~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~------------------~~~~~~~~ 532 (560)
.. ......++..|+|||++....++.++|||||||++|||++ |+.||..... ....+.++
T Consensus 417 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 496 (535)
T 2h8h_A 417 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL 496 (535)
T ss_dssp HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 11 1122346788999999999999999999999999999999 9999975432 11234566
Q ss_pred cccccccCCCCCCChhHHHhh
Q 035761 533 IKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 533 ~~~~~~~dp~~~p~~~~~~~~ 553 (560)
++.|...||..||++++++..
T Consensus 497 i~~cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 497 MCQCWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCChhHCcCHHHHHHH
Confidence 677788899999999888764
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=310.16 Aligned_cols=232 Identities=25% Similarity=0.372 Sum_probs=189.7
Q ss_pred CCcccceeeccCCeeEEEEEeCC-C---cEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEE-EE
Q 035761 316 DFDIKYCIGTGGYGSVYRARLPS-G---KVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCM-FL 390 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~l 390 (560)
.|...+.||+|+||.||+|.+.+ + ..||+|.+..... ....+.+.+|+.+++.++||||+++++++.+.+.. ++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE-MQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccccc-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 35556889999999999997532 2 3799999875432 34456789999999999999999999999876655 89
Q ss_pred EEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccC
Q 035761 391 IYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN 470 (560)
Q Consensus 391 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 470 (560)
||||+.+|+|.+++.... ..+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 101 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp EECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EEecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 999999999999997643 3389999999999999999999999 99999999999999999999999999998654
Q ss_pred CCC----CCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCC-CCcccc------------------ccc
Q 035761 471 YDS----SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHP-GELLSS------------------SSS 527 (560)
Q Consensus 471 ~~~----~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P-~~~~~~------------------~~~ 527 (560)
... .......+++.|+|||.+.+..++.++||||||+++|||++|..| |..... ...
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPD 255 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchH
Confidence 321 122334578899999999999999999999999999999995555 432221 122
Q ss_pred ccccccccccccCCCCCCChhHHHhh
Q 035761 528 SLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 528 ~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
.+.+.++.|...||..||++++++..
T Consensus 256 ~l~~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 256 SLYQVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHH
Confidence 34566777888899999999988764
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=313.68 Aligned_cols=236 Identities=23% Similarity=0.312 Sum_probs=180.3
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
++|+..+.||+|+||.||+|... +|+.||||++..........+.+.++..+++.++||||+++++++..++..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 56888999999999999999875 68999999997654433444455666677888899999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHH-HCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
|+ ++.+..+..... ..+++..+..++.|+++||+|||+ . +++||||||+||+++.++.+||+|||++......
T Consensus 105 ~~-~~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 105 LM-GTCAEKLKKRMQ--GPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp CC-SEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred cc-CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 99 445555554322 238999999999999999999998 6 8999999999999999999999999999776432
Q ss_pred CCCceeeccccCccCccccc-----cCccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------cc
Q 035761 473 SSNRTLLAGTYGSIAPELAY-----TMVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------SS 526 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~-----~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------~~ 526 (560)
.......|++.|+|||++. ...++.++||||||+++|||++|+.||..... ..
T Consensus 179 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (318)
T 2dyl_A 179 -KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFS 257 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCC
T ss_pred -ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCC
Confidence 2233456899999999984 55688899999999999999999999975321 12
Q ss_pred cccccccccccccCCCCCCChhHHHhhceee
Q 035761 527 SSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 527 ~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
..+...++.|...||..||+++++++|+|+.
T Consensus 258 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~ 288 (318)
T 2dyl_A 258 GDFQSFVKDCLTKDHRKRPKYNKLLEHSFIK 288 (318)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHTTSHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhhCHHHH
Confidence 2355667788889999999999999999875
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=314.22 Aligned_cols=235 Identities=24% Similarity=0.323 Sum_probs=193.5
Q ss_pred CHHHHHHHhcCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhc--cCCCCcceeeeEEE
Q 035761 306 TFQDMIEATEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQ--IRHRNIVKLYGFCL 383 (560)
Q Consensus 306 ~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~ 383 (560)
++.......++|++.+.||+|+||.||+|+. +++.||||++.... .+.+.+|.+++.. ++||||+++++++.
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~ 106 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADN 106 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG-----HHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh-----HHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence 3444445567899999999999999999998 58999999986432 3467788888887 79999999999998
Q ss_pred eCC----EEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEEeCCCCCCeE
Q 035761 384 HEK----CMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLH--------HHCTPPILHRDISSNNIL 451 (560)
Q Consensus 384 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH--------~~~~~~ivH~dlk~~Nil 451 (560)
... ..++||||+++|+|.+++... .+++.++..++.|++.||+||| +. +|+||||||+||+
T Consensus 107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIl 179 (342)
T 1b6c_B 107 KDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNIL 179 (342)
T ss_dssp CCCSSCCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEE
T ss_pred ccCCccceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEE
Confidence 876 789999999999999999754 2899999999999999999999 77 9999999999999
Q ss_pred eCCCCcEEEeeeccccccCCCCCC----ceeeccccCccCccccccC------ccCcchhHHHHHHHHHHHHhC------
Q 035761 452 LNSEFEAFVADFGIARLLNYDSSN----RTLLAGTYGSIAPELAYTM------VVTEKYDVYSFGVVALEVLMG------ 515 (560)
Q Consensus 452 l~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~g~~~~~aPE~~~~~------~~~~~~Dv~s~G~il~el~~g------ 515 (560)
++.++.+||+|||++......... .....||+.|+|||++.+. .++.++||||||+++|||++|
T Consensus 180 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 259 (342)
T 1b6c_B 180 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259 (342)
T ss_dssp ECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred ECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence 999999999999999876543321 2334689999999998876 344689999999999999999
Q ss_pred ----CCCCCcccccc-----------------------------cccccccccccccCCCCCCChhHHHhh
Q 035761 516 ----KHPGELLSSSS-----------------------------SSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 516 ----~~P~~~~~~~~-----------------------------~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
+.||....... ..+.+.++.|...||..||++.+++++
T Consensus 260 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 260 HEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred ccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 78886532110 023345666777899999999998876
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=318.67 Aligned_cols=238 Identities=23% Similarity=0.277 Sum_probs=200.7
Q ss_pred HhcCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhh----hhHHHHHHHHHHHhccC--CCCcceeeeEEEeC
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETEL----ASLESFQNEARLLSQIR--HRNIVKLYGFCLHE 385 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~ 385 (560)
..++|++.+.||+|+||.||+|.. .+++.||||++....... ...+.+.+|+.++++++ ||||+++++++..+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 346799999999999999999975 468899999987643211 12235668999999996 59999999999999
Q ss_pred CEEEEEEeccCC-CCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeC-CCCcEEEeee
Q 035761 386 KCMFLIYEYMEM-GSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLN-SEFEAFVADF 463 (560)
Q Consensus 386 ~~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Df 463 (560)
+..++||||+.+ ++|.+++.... .+++..+..++.||++||+|||+. +|+||||||+||+++ +++.+||+||
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCC
T ss_pred CcEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 999999999986 89999997643 389999999999999999999999 999999999999999 7899999999
Q ss_pred ccccccCCCCCCceeeccccCccCccccccCcc-CcchhHHHHHHHHHHHHhCCCCCCcccc-----------ccccccc
Q 035761 464 GIARLLNYDSSNRTLLAGTYGSIAPELAYTMVV-TEKYDVYSFGVVALEVLMGKHPGELLSS-----------SSSSLDK 531 (560)
Q Consensus 464 g~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~-~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------~~~~~~~ 531 (560)
|+++..... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||..... ....+.+
T Consensus 195 g~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 272 (320)
T 3a99_A 195 GSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQH 272 (320)
T ss_dssp TTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCCCCCSSCCCHHHHH
T ss_pred ccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhhcccccccccCCHHHHH
Confidence 999876532 2334568999999999887766 6789999999999999999999974432 2234567
Q ss_pred ccccccccCCCCCCChhHHHhhceeee
Q 035761 532 NIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 532 ~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
.++.|...||..||+++++++++|+..
T Consensus 273 li~~~l~~dp~~Rps~~~ll~hp~~~~ 299 (320)
T 3a99_A 273 LIRWCLALRPSDRPTFEEIQNHPWMQD 299 (320)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred HHHHHccCChhhCcCHHHHhcCHhhcC
Confidence 778889999999999999999999865
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=315.45 Aligned_cols=234 Identities=22% Similarity=0.297 Sum_probs=179.1
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccC-CCCcceeeeEEE--------e
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIR-HRNIVKLYGFCL--------H 384 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~--------~ 384 (560)
.+|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++++. ||||+++++++. .
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS--HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc--hHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 57899999999999999999864 68999999986543 234457889999999995 999999999994 3
Q ss_pred CCEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEEeCCCCCCeEeCCCCcEEEee
Q 035761 385 EKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPP--ILHRDISSNNILLNSEFEAFVAD 462 (560)
Q Consensus 385 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~dlk~~Nill~~~~~~kl~D 462 (560)
....++||||+. |+|.+++........+++.++..++.||+.||+|||+. + |+||||||+||+++.++.+||+|
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEec
Confidence 345899999996 69999887533334599999999999999999999998 7 99999999999999999999999
Q ss_pred eccccccCCCCCC------------ceeeccccCccCcccc---ccCccCcchhHHHHHHHHHHHHhCCCCCCcccc---
Q 035761 463 FGIARLLNYDSSN------------RTLLAGTYGSIAPELA---YTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS--- 524 (560)
Q Consensus 463 fg~~~~~~~~~~~------------~~~~~g~~~~~aPE~~---~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~--- 524 (560)
||+++........ .....||+.|+|||++ .+..++.++||||||+++|||++|+.||.....
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~ 261 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI 261 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh
Confidence 9999876532221 1134589999999998 566788999999999999999999999964332
Q ss_pred ------------cccccccccccccccCCCCCCChhHHHhhc
Q 035761 525 ------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQG 554 (560)
Q Consensus 525 ------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~ 554 (560)
....+..+++.|...||..||++++++++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 262 VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp ----CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 112355667888899999999999998863
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=308.99 Aligned_cols=228 Identities=26% Similarity=0.395 Sum_probs=185.4
Q ss_pred hcCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC-CEEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHE-KCMFLIY 392 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~ 392 (560)
.++|++.+.||+|+||.||+|... |+.||||.++... ..+.+.+|+++++.++||||+++++++.+. +..++||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 367899999999999999999874 8899999987533 345788999999999999999999997655 4689999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++|+|.+++..... ..+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp CCCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred ecCCCCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 99999999999975432 2378999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------------cccccccc
Q 035761 473 SSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------------SSSLDKNI 533 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------------~~~~~~~~ 533 (560)
.....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... ...+.+.+
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 247 (278)
T 1byg_A 171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVM 247 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHH
T ss_pred ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHHH
Confidence 223357889999999999999999999999999999998 99999754321 12344566
Q ss_pred ccccccCCCCCCChhHHHhh
Q 035761 534 KLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 534 ~~~~~~dp~~~p~~~~~~~~ 553 (560)
+.|...||..||++.++++.
T Consensus 248 ~~~l~~~p~~Rps~~~l~~~ 267 (278)
T 1byg_A 248 KNCWHLDAAMRPSFLQLREQ 267 (278)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCChhhCCCHHHHHHH
Confidence 77778889999998888764
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=316.18 Aligned_cols=234 Identities=21% Similarity=0.272 Sum_probs=196.1
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CC-cEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCC------cceeeeEEEeC
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SG-KVVALKKLHRLETELASLESFQNEARLLSQIRHRN------IVKLYGFCLHE 385 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~ 385 (560)
.++|++.+.||+|+||.||+|... ++ +.||+|+++... ...+.+.+|+.+++.++|++ ++.+++++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG---KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc---cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 367999999999999999999864 34 689999997533 23456788999999887665 89999999999
Q ss_pred CEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEe-------------
Q 035761 386 KCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILL------------- 452 (560)
Q Consensus 386 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill------------- 452 (560)
+..++||||+ ++++.+++..... ..+++.++..++.||+.||+|||+. +|+||||||+||++
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKENNF-QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred CeEEEEEecc-CCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccc
Confidence 9999999999 6677777765432 3489999999999999999999999 99999999999999
Q ss_pred ------CCCCcEEEeeeccccccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccccc
Q 035761 453 ------NSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSS 526 (560)
Q Consensus 453 ------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~ 526 (560)
+.++.+||+|||+++.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHE---HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTS---CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccccCCCcEEEeecCccccccc---cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 5678999999999987432 2234568999999999999999999999999999999999999997543210
Q ss_pred -------------------------------------------------------------cccccccccccccCCCCCC
Q 035761 527 -------------------------------------------------------------SSLDKNIKLIDLLDPRLPP 545 (560)
Q Consensus 527 -------------------------------------------------------------~~~~~~~~~~~~~dp~~~p 545 (560)
..+.+.++.|...||..||
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 1233667788899999999
Q ss_pred ChhHHHhhceeee
Q 035761 546 PGDQMIRQGIILI 558 (560)
Q Consensus 546 ~~~~~~~~~~~~~ 558 (560)
+++++++|+|+..
T Consensus 327 t~~e~l~hp~f~~ 339 (355)
T 2eu9_A 327 TLAEALLHPFFAG 339 (355)
T ss_dssp CHHHHTTSGGGGG
T ss_pred CHHHHhcChhhcC
Confidence 9999999999864
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=314.35 Aligned_cols=232 Identities=26% Similarity=0.377 Sum_probs=191.9
Q ss_pred cCCcccceeeccCCeeEEEEEe-----CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCC--E
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-----PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEK--C 387 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~ 387 (560)
++|++.+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|+++++.++||||+++++++...+ .
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC--SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 5688899999999999999984 368899999987543 234567899999999999999999999987654 6
Q ss_pred EEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccc
Q 035761 388 MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIAR 467 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~ 467 (560)
.++||||+++|+|.+++..... .+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHSTT--SSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eEEEEECCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 7999999999999999986532 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCC---ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccc---------------------
Q 035761 468 LLNYDSSN---RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLS--------------------- 523 (560)
Q Consensus 468 ~~~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~--------------------- 523 (560)
........ .....++..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence 77543321 122346778999999999889999999999999999999999876321
Q ss_pred -------------ccccccccccccccccCCCCCCChhHHHhh
Q 035761 524 -------------SSSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 524 -------------~~~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
.....+.+.++.|...||..||++.++++.
T Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~ 316 (326)
T 2w1i_A 274 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 316 (326)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 011234456667777888888888888754
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=327.17 Aligned_cols=233 Identities=23% Similarity=0.314 Sum_probs=183.0
Q ss_pred CCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCEEEEEEec
Q 035761 316 DFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
.|...+.||+|+||.||.+...+|+.||||++.... .+.+.+|+++++++ +||||+++++++.+++..++||||
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 345567899999999987766789999999986432 23567899999876 899999999999999999999999
Q ss_pred cCCCCHHHHhhcCCccc----CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCC-------------Cc
Q 035761 395 MEMGSLFCILRTDEEAV----GLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSE-------------FE 457 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~----~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-------------~~ 457 (560)
+. |+|.+++....... ..++.++..++.||+.||+|||+. +|+||||||+|||++.+ +.
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceE
Confidence 96 69999998653211 113335678999999999999999 99999999999999654 48
Q ss_pred EEEeeeccccccCCCCCC----ceeeccccCccCcccccc-------CccCcchhHHHHHHHHHHHHh-CCCCCCccccc
Q 035761 458 AFVADFGIARLLNYDSSN----RTLLAGTYGSIAPELAYT-------MVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS 525 (560)
Q Consensus 458 ~kl~Dfg~~~~~~~~~~~----~~~~~g~~~~~aPE~~~~-------~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~ 525 (560)
+||+|||+++........ .....||+.|+|||++.+ ..++.++|||||||++|||++ |+.||......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 999999999887543221 223579999999999876 668899999999999999999 99999643211
Q ss_pred ----------------------ccccccccccccccCCCCCCChhHHHhhceee
Q 035761 526 ----------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 526 ----------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
...+.+.++.|...||..||++.++++|+|+.
T Consensus 247 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~ 300 (434)
T 2rio_A 247 ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFW 300 (434)
T ss_dssp HHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred HHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccC
Confidence 02345666778889999999999999999985
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=320.37 Aligned_cols=234 Identities=21% Similarity=0.299 Sum_probs=194.0
Q ss_pred cCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccC-----------CCCcceeeeEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIR-----------HRNIVKLYGFC 382 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~ 382 (560)
++|++.+.||+|+||.||+|.. .+++.||||++.... ...+.+.+|+.++++++ ||||+++++++
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc---cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 5799999999999999999986 468999999997533 23456778999988876 89999999999
Q ss_pred EeCC----EEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeC-----
Q 035761 383 LHEK----CMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLN----- 453 (560)
Q Consensus 383 ~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~----- 453 (560)
...+ ..++||||+ +++|.+++..... ..+++.++..++.||+.||+|||+.. +|+||||||+||+++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETT
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCC
Confidence 8654 789999999 8899999976432 23899999999999999999999842 899999999999994
Q ss_pred -CCCcEEEeeeccccccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc-------
Q 035761 454 -SEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS------- 525 (560)
Q Consensus 454 -~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~------- 525 (560)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 248 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred cCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence 4457999999999876432 23346899999999999999999999999999999999999999744310
Q ss_pred ----------------------------------------------------------ccccccccccccccCCCCCCCh
Q 035761 526 ----------------------------------------------------------SSSLDKNIKLIDLLDPRLPPPG 547 (560)
Q Consensus 526 ----------------------------------------------------------~~~~~~~~~~~~~~dp~~~p~~ 547 (560)
...+.+.++.|...||..||++
T Consensus 249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 328 (373)
T 1q8y_A 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 328 (373)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence 1123466788899999999999
Q ss_pred hHHHhhceeee
Q 035761 548 DQMIRQGIILI 558 (560)
Q Consensus 548 ~~~~~~~~~~~ 558 (560)
+++++|+|+..
T Consensus 329 ~ell~hp~f~~ 339 (373)
T 1q8y_A 329 GGLVNHPWLKD 339 (373)
T ss_dssp HHHHTCGGGTT
T ss_pred HHHhhChhhhc
Confidence 99999999875
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=308.61 Aligned_cols=233 Identities=24% Similarity=0.355 Sum_probs=184.7
Q ss_pred cCCcccceeeccCCeeEEEEEeC--CCc--EEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP--SGK--VVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMF 389 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 389 (560)
++|++.+.||+|+||.||+|.+. +++ .||||+++.... .....+.+.+|+++++.++||||+++++++..+. .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 57899999999999999999853 333 689998875432 2344567899999999999999999999998765 78
Q ss_pred EEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccccc
Q 035761 390 LIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL 469 (560)
Q Consensus 390 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 469 (560)
+||||+++|+|.+++.... ..+++.++..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 97 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccc
Confidence 9999999999999997643 2389999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCC---ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc-------------------cc
Q 035761 470 NYDSSN---RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS-------------------SS 526 (560)
Q Consensus 470 ~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~-------------------~~ 526 (560)
...... .....++..|+|||++.+..++.++||||||+++|||++ |+.||..... ..
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 251 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcC
Confidence 543322 123456778999999999889999999999999999999 9999965432 11
Q ss_pred cccccccccccccCCCCCCChhHHHhh
Q 035761 527 SSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 527 ~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
..+.+.++.|...||..||++.++++.
T Consensus 252 ~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 252 QDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 234566677788899999999998764
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=325.08 Aligned_cols=233 Identities=22% Similarity=0.324 Sum_probs=185.2
Q ss_pred cCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 393 (560)
.+|+..+.||+|+||.||.....+++.||||++...... .+.+|+++++.+ +||||+++++++.+....++|||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~-----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE-----ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH-----HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 468888999999999966555567999999998653321 345799999999 89999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCC-----CCcEEEeeeccccc
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNS-----EFEAFVADFGIARL 468 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Dfg~~~~ 468 (560)
|++ |+|.+++..... .+++.++..++.||++||+|||+. +|+||||||+||+++. ...+||+|||+++.
T Consensus 99 ~~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 99 LCA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp CCS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred CCC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 996 599999986543 245556778999999999999999 9999999999999953 34588999999987
Q ss_pred cCCCC---CCceeeccccCccCccccc---cCccCcchhHHHHHHHHHHHHh-CCCCCCccccc----------------
Q 035761 469 LNYDS---SNRTLLAGTYGSIAPELAY---TMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS---------------- 525 (560)
Q Consensus 469 ~~~~~---~~~~~~~g~~~~~aPE~~~---~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~---------------- 525 (560)
..... .......||+.|+|||++. ...++.++||||+||++|||++ |+.||......
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 252 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHP 252 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCT
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCc
Confidence 65332 1233457999999999987 4567779999999999999999 99999643211
Q ss_pred ----ccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 526 ----SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 526 ----~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
...+.+.++.|...||..||+++++++|+|+..
T Consensus 253 ~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 253 EKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred cccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 011345677888899999999999999999853
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=321.36 Aligned_cols=228 Identities=19% Similarity=0.286 Sum_probs=191.0
Q ss_pred cCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCC-CCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRH-RNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 392 (560)
++|++.+.||+|+||.||+|.. .+++.||||++...... ..+.+|+++++.++| +++..+..++...+..++||
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 5789999999999999999986 56899999987654322 247789999999976 55666666667788899999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEe---CCCCcEEEeeecccccc
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILL---NSEFEAFVADFGIARLL 469 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~~~~~ 469 (560)
||+ +++|.+++..... .+++.++..|+.||+.||+|||+. +||||||||+|||+ +.++.+||+|||+++.+
T Consensus 83 e~~-g~sL~~ll~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp ECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ECC-CCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 999 9999999975332 399999999999999999999999 99999999999999 58899999999999876
Q ss_pred CCCCCC-------ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc------------------
Q 035761 470 NYDSSN-------RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS------------------ 524 (560)
Q Consensus 470 ~~~~~~-------~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~------------------ 524 (560)
...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence 543221 1245799999999999999999999999999999999999999976432
Q ss_pred -------cccccccccccccccCCCCCCChhHHHh
Q 035761 525 -------SSSSLDKNIKLIDLLDPRLPPPGDQMIR 552 (560)
Q Consensus 525 -------~~~~~~~~~~~~~~~dp~~~p~~~~~~~ 552 (560)
....+.+++..|...||..||+++++++
T Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1223566677788899999999988765
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=313.26 Aligned_cols=233 Identities=21% Similarity=0.390 Sum_probs=190.3
Q ss_pred HhcCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
..++|++.+.||+|+||.||+|..++ .||+|+++.........+.+.+|+.++++++||||+++++++..++..++||
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 34678999999999999999998754 4999998765433333456778999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++++|.+++.... ..+++.++..++.||+.||+|||+. +++||||||+||+++ ++.+||+|||+++.....
T Consensus 109 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp BCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred ecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 9999999999997643 3489999999999999999999999 999999999999998 679999999998765321
Q ss_pred -----CCCceeeccccCccCcccccc---------CccCcchhHHHHHHHHHHHHhCCCCCCcccc--------------
Q 035761 473 -----SSNRTLLAGTYGSIAPELAYT---------MVVTEKYDVYSFGVVALEVLMGKHPGELLSS-------------- 524 (560)
Q Consensus 473 -----~~~~~~~~g~~~~~aPE~~~~---------~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-------------- 524 (560)
........|++.|+|||++.+ ..++.++||||||+++|||++|+.||.....
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 262 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN 262 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC
Confidence 122233458999999999874 4478899999999999999999999975431
Q ss_pred -----cccccccccccccccCCCCCCChhHHHhh
Q 035761 525 -----SSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 525 -----~~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
....+.+.+..|...||..||+++++++.
T Consensus 263 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 263 LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 12345566677788899999999988865
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=334.96 Aligned_cols=238 Identities=26% Similarity=0.338 Sum_probs=195.9
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEe------CCE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLH------EKC 387 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~ 387 (560)
++|++.+.||+|+||.||+|... +|+.||||++.... .....+.+.+|++++++++||||+++++++.. .+.
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL-SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC-CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 67999999999999999999864 68999999987543 23445678999999999999999999998765 567
Q ss_pred EEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCc---EEEeeec
Q 035761 388 MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFE---AFVADFG 464 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg 464 (560)
.++||||+++|+|.+++........+++.++..++.|++.||+|||+. ||+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 899999999999999998765545589999999999999999999999 9999999999999997765 8999999
Q ss_pred cccccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc--------------------
Q 035761 465 IARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-------------------- 524 (560)
Q Consensus 465 ~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-------------------- 524 (560)
++....... ......|++.|+|||++.+..++.++||||+|+++|||++|+.||.....
T Consensus 170 ~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~ 248 (676)
T 3qa8_A 170 YAKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248 (676)
T ss_dssp CCCBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCC
T ss_pred ccccccccc-ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhh
Confidence 998765332 33445789999999999999999999999999999999999999953200
Q ss_pred ---------------------cccccccccccccccCCCCCCChhHHHhhceee
Q 035761 525 ---------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 525 ---------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
....+.+.++.|...||..||++.+++.|+|+.
T Consensus 249 ~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~ 302 (676)
T 3qa8_A 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQ 302 (676)
T ss_dssp CCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHH
T ss_pred hhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHH
Confidence 011234556677888999999999999998853
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=333.26 Aligned_cols=235 Identities=27% Similarity=0.370 Sum_probs=191.4
Q ss_pred HHhcCCcccceeeccCCeeEEEEEeCC----CcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCE
Q 035761 312 EATEDFDIKYCIGTGGYGSVYRARLPS----GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKC 387 (560)
Q Consensus 312 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 387 (560)
...++|++.+.||+|+||.||+|.+.. +..||||.++.... ....+.+.+|+.++++++||||+++++++. ++.
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 464 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS-DSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 464 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence 345678889999999999999998742 46799999875432 234467899999999999999999999985 456
Q ss_pred EEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccc
Q 035761 388 MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIAR 467 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~ 467 (560)
.++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred eEEEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCe
Confidence 899999999999999998643 2389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCC-ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc------------------ccc
Q 035761 468 LLNYDSSN-RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS------------------SSS 527 (560)
Q Consensus 468 ~~~~~~~~-~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~------------------~~~ 527 (560)
........ .....+++.|+|||++.+..++.++||||||+++|||++ |+.||..... ...
T Consensus 540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 619 (656)
T 2j0j_A 540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 619 (656)
T ss_dssp SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCH
T ss_pred ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccH
Confidence 76433222 223456789999999999999999999999999999997 9999975432 112
Q ss_pred ccccccccccccCCCCCCChhHHHhh
Q 035761 528 SLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 528 ~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
.+...+..|...||..||+++++++.
T Consensus 620 ~l~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 620 TLYSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 34556667778888888888888764
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=295.77 Aligned_cols=212 Identities=23% Similarity=0.343 Sum_probs=177.5
Q ss_pred cCCccc-ceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHH-hccCCCCcceeeeEEEe----CCE
Q 035761 315 EDFDIK-YCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLL-SQIRHRNIVKLYGFCLH----EKC 387 (560)
Q Consensus 315 ~~~~~~-~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~ 387 (560)
++|.+. +.||+|+||.||+|.. .+++.||+|++... ..+.+|++++ +..+||||+++++++.. ...
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 456666 7799999999999986 46899999998642 2456788887 55699999999999987 667
Q ss_pred EEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCC---CCcEEEeeec
Q 035761 388 MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNS---EFEAFVADFG 464 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg 464 (560)
.++||||+++|+|.+++..... ..+++.++..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 8999999999999999987532 3489999999999999999999999 9999999999999998 7889999999
Q ss_pred cccccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc--------------------
Q 035761 465 IARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-------------------- 524 (560)
Q Consensus 465 ~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-------------------- 524 (560)
++.... +..++.++||||+|+++|||++|+.||.....
T Consensus 166 ~a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (299)
T 3m2w_A 166 FAKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 223 (299)
T ss_dssp TCEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCH
T ss_pred cccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCc
Confidence 986542 23467789999999999999999999964321
Q ss_pred -----cccccccccccccccCCCCCCChhHHHhhceeeec
Q 035761 525 -----SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILIS 559 (560)
Q Consensus 525 -----~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~~ 559 (560)
....+...++.|...||..||+++++++|+|+..+
T Consensus 224 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 224 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred hhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 12234556777889999999999999999998654
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=312.40 Aligned_cols=225 Identities=16% Similarity=0.182 Sum_probs=177.2
Q ss_pred hcCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhh------hhhhHHHHHHHHHHHhccC---------CCCccee
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLET------ELASLESFQNEARLLSQIR---------HRNIVKL 378 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~---------h~niv~l 378 (560)
.++|++.+.||+|+||.||+|+. +|+.||||++..... .....+.+.+|+.+++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35688899999999999999988 689999999976431 1223467888999988886 6666665
Q ss_pred eeEE-----------------Ee-------------CCEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHH
Q 035761 379 YGFC-----------------LH-------------EKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHA 428 (560)
Q Consensus 379 ~~~~-----------------~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~ 428 (560)
.+++ .+ ++..++||||+++|++.+.+.. ..+++.++..++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 5543 32 6789999999999987776643 238999999999999999
Q ss_pred HHHHH-hcCCCCeEEeCCCCCCeEeCCCC--------------------cEEEeeeccccccCCCCCCceeeccccCccC
Q 035761 429 LSYLH-HHCTPPILHRDISSNNILLNSEF--------------------EAFVADFGIARLLNYDSSNRTLLAGTYGSIA 487 (560)
Q Consensus 429 l~~LH-~~~~~~ivH~dlk~~Nill~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~g~~~~~a 487 (560)
|+||| +. +|+||||||+|||++.++ .+||+|||+|+..... ...||+.|+|
T Consensus 174 L~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~a 245 (336)
T 2vuw_A 174 LAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMD 245 (336)
T ss_dssp HHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTC
T ss_pred HHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccC
Confidence 99999 88 999999999999999887 8999999999876432 3479999999
Q ss_pred ccccccCccCcchhHHHHHHH-HHHHHhCCCCCCcccc-------------------------cccccccccccccccCC
Q 035761 488 PELAYTMVVTEKYDVYSFGVV-ALEVLMGKHPGELLSS-------------------------SSSSLDKNIKLIDLLDP 541 (560)
Q Consensus 488 PE~~~~~~~~~~~Dv~s~G~i-l~el~~g~~P~~~~~~-------------------------~~~~~~~~~~~~~~~dp 541 (560)
||++.+.. +.++||||+|++ .+++++|..||....+ .+..+.+.++.|...|
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d- 323 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS- 323 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-
Confidence 99998776 889999998777 7888999999864210 1122344445555544
Q ss_pred CCCCChhHHH-hhceee
Q 035761 542 RLPPPGDQMI-RQGIIL 557 (560)
Q Consensus 542 ~~~p~~~~~~-~~~~~~ 557 (560)
++++++ +|+|+.
T Consensus 324 ----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 324 ----SATDLLCQHSLFK 336 (336)
T ss_dssp ----SHHHHHHHCGGGC
T ss_pred ----CHHHHHhcCCCcC
Confidence 788888 788763
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=330.37 Aligned_cols=227 Identities=24% Similarity=0.313 Sum_probs=189.3
Q ss_pred cCCcccceeeccCCeeEEEEEeC--CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCE-----
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP--SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKC----- 387 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 387 (560)
++|++.+.||+|+||.||+|... +|+.||||++..... ....+.+.+|++++++++||||+++++++...+.
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD-AEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCC-HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCC-HHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 67999999999999999999875 589999999875332 2445678899999999999999999999987655
Q ss_pred EEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccc
Q 035761 388 MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIAR 467 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~ 467 (560)
.++||||+++++|.+++.. .+++.++..++.||+.||+|||+. +|+||||||+||+++.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccch
Confidence 7999999999999988754 389999999999999999999999 99999999999999986 89999999998
Q ss_pred ccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc-----------ccccccccccc
Q 035761 468 LLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS-----------SSSLDKNIKLI 536 (560)
Q Consensus 468 ~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~-----------~~~~~~~~~~~ 536 (560)
..... ....||+.|+|||++.+.. +.++|||||||++|||++|..||...... ...+..++..|
T Consensus 230 ~~~~~----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 304 (681)
T 2pzi_A 230 RINSF----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLLRRA 304 (681)
T ss_dssp ETTCC----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCCTTCHHHHHCHHHHHHHHHH
T ss_pred hcccC----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccccccccccccCHHHHHHHhhh
Confidence 76432 3456999999999987654 88999999999999999999987643211 12345677788
Q ss_pred cccCCCCCCChhHHHhhcee
Q 035761 537 DLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 537 ~~~dp~~~p~~~~~~~~~~~ 556 (560)
...||..||+..+.+.+.|.
T Consensus 305 l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 305 IDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp TCSSGGGSCSSHHHHHHHHH
T ss_pred ccCChhhCCCHHHHHHHHHH
Confidence 88999999998888877653
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=310.00 Aligned_cols=235 Identities=14% Similarity=0.115 Sum_probs=179.9
Q ss_pred cCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchh-hhhhhHHHHHHHHHHHhccCC-CCcceee---------eE-
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLE-TELASLESFQNEARLLSQIRH-RNIVKLY---------GF- 381 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h-~niv~l~---------~~- 381 (560)
..|...+.||+|+||.||+|.+ .+|+.||||++.... ......+.+.+|+.+++.++| +|..... ..
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 4577788999999999999985 468999999987433 222345678999999999987 3221111 11
Q ss_pred -----------EEe-----CCEEEEEEeccCCCCHHHHhhc----CCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 035761 382 -----------CLH-----EKCMFLIYEYMEMGSLFCILRT----DEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPIL 441 (560)
Q Consensus 382 -----------~~~-----~~~~~lv~e~~~~g~L~~~l~~----~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iv 441 (560)
... ....+++|+++ +++|.++++. ......+++..+..++.||++||+|||+. +|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 111 12356777765 6799988842 11123488999999999999999999999 999
Q ss_pred EeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCceeeccccCccCcccc----------ccCccCcchhHHHHHHHHHH
Q 035761 442 HRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELA----------YTMVVTEKYDVYSFGVVALE 511 (560)
Q Consensus 442 H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~----------~~~~~~~~~Dv~s~G~il~e 511 (560)
||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||++||
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence 9999999999999999999999999875432 333467 999999998 66668889999999999999
Q ss_pred HHhCCCCCCcccc-------------cccccccccccccccCCCCCCChhHHHhhceee
Q 035761 512 VLMGKHPGELLSS-------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 512 l~~g~~P~~~~~~-------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
|++|+.||..... ....+.+.++.|...||..||++.++++++|+.
T Consensus 310 lltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~ 368 (413)
T 3dzo_A 310 IWCADLPNTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYE 368 (413)
T ss_dssp HHHSSCCCCTTGGGSCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred HHHCCCCCCCcchhhhHHHHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHH
Confidence 9999999975432 122345566778888999999999999998864
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=286.82 Aligned_cols=175 Identities=13% Similarity=0.098 Sum_probs=153.2
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|++.+.||+|+||.||+|... +++.||||++..... .....+.+.+|+..++.++||||+++++++..++..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 56999999999999999999875 489999999976542 2344567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++++|.++++.. ....++.+++.|++.||+|||+. ||+||||||+||+++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc--------
Confidence 999999999999642 45667889999999999999999 99999999999999999999998543
Q ss_pred CCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc
Q 035761 473 SSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS 524 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~ 524 (560)
|++| ++.++|||||||++|||++|+.||.....
T Consensus 175 ------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~ 207 (286)
T 3uqc_A 175 ------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGV 207 (286)
T ss_dssp ------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSB
T ss_pred ------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 3443 67899999999999999999999986543
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=278.76 Aligned_cols=229 Identities=31% Similarity=0.490 Sum_probs=130.2
Q ss_pred CCCCEEEccCCcCcc--cCCCCCCCcCCCCEEEccC-CcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCE
Q 035761 5 RNLVHLDLSDNHFMG--HIPPTLGRLSELKILNLSL-NSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQV 81 (560)
Q Consensus 5 ~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~-N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~ 81 (560)
.+++.|+|++|.+++ .+|..|.++++|++|+|++ |.+.+.+|..|.++++|++|+|++|++++..|..|.++++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 345566666666655 5555566666666666663 5555555666666666666666666665555555666666666
Q ss_pred EEeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCC-CCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcc
Q 035761 82 LDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLT-QLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNL 160 (560)
Q Consensus 82 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 160 (560)
|+|++|.+++..|..+..+++|++|+|++|++++.+|..+..++ +|+.|++++|++++..|..+..++ |+.|++++|.
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~ 208 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNM 208 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSE
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCc
Confidence 66666666655555566666666666666666555555555555 566666666665555555555554 5555555555
Q ss_pred cccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCccc---ccCCCCcCCCCCCCCcCC
Q 035761 161 LSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFV---RKVPHLDVSGNQFGGEIP 235 (560)
Q Consensus 161 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~~---~~l~~l~l~~n~~~~~~p 235 (560)
+++..|..|..+++|+.|+|++|++++.+|. +..+++|+.|++++|.+++.+|..+ .+++.|++++|++.+.+|
T Consensus 209 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip 285 (313)
T 1ogq_A 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285 (313)
T ss_dssp EEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECC
T ss_pred ccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCC
Confidence 5555555555555555555555555543333 4455555555555555555555433 334445555555554433
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.98 E-value=9e-33 Score=272.47 Aligned_cols=230 Identities=27% Similarity=0.468 Sum_probs=216.2
Q ss_pred CCCCCCCCEEEccC-CcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCC
Q 035761 1 MGRLRNLVHLDLSD-NHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVL 79 (560)
Q Consensus 1 ~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L 79 (560)
|+++++|++|+|++ |.+++.+|..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|
T Consensus 72 l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 151 (313)
T 1ogq_A 72 LANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNL 151 (313)
T ss_dssp GGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTC
T ss_pred HhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCC
Confidence 45789999999995 99999999999999999999999999999999999999999999999999998999999999999
Q ss_pred CEEEeecCccCccCCCCcCCCC-CccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccC
Q 035761 80 QVLDLSRNEIGGSIPSTLGHLK-WLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGN 158 (560)
Q Consensus 80 ~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 158 (560)
++|+|++|.+++..|..+..++ +|+.|+|++|++++..|..+..++ |+.|++++|.+++..|..+..+++|+.|++++
T Consensus 152 ~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 230 (313)
T 1ogq_A 152 VGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAK 230 (313)
T ss_dssp CEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCS
T ss_pred CeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCC
Confidence 9999999999988999999998 999999999999999999999987 99999999999999999999999999999999
Q ss_pred cccccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCc--ccccCCCCcCCCCCCCC
Q 035761 159 NLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPV--FVRKVPHLDVSGNQFGG 232 (560)
Q Consensus 159 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~--~~~~l~~l~l~~n~~~~ 232 (560)
|.+++..|. +..+++|++|++++|++++.+|..+..+++|+.|++++|++++.+|. .+++++.+++.+|+.-|
T Consensus 231 N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc 305 (313)
T 1ogq_A 231 NSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLC 305 (313)
T ss_dssp SEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEE
T ss_pred CceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCcc
Confidence 999966665 88999999999999999999999999999999999999999998887 46788899999999433
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=302.53 Aligned_cols=234 Identities=37% Similarity=0.598 Sum_probs=155.8
Q ss_pred CCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEE
Q 035761 3 RLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVL 82 (560)
Q Consensus 3 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 82 (560)
++++|++|+|++|.+++..|..|..+++|++|+|++|.+++..|..+..+++|++|+|++|++++..|..+.++++|++|
T Consensus 416 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 495 (768)
T 3rgz_A 416 NCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWI 495 (768)
T ss_dssp GCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEE
T ss_pred cCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEE
Confidence 45556666666666665666666666666666666666666666666666666666666666666666666666666666
Q ss_pred EeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCcc------------------
Q 035761 83 DLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPE------------------ 144 (560)
Q Consensus 83 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~------------------ 144 (560)
+|++|++++.+|..+..+++|+.|+|++|++++.+|..+.++++|+.|++++|.+++.+|..
T Consensus 496 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~ 575 (768)
T 3rgz_A 496 SLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRY 575 (768)
T ss_dssp ECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEE
T ss_pred EccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccc
Confidence 66666666666666666666666666666666666666666666666666666666544432
Q ss_pred ----------------------------------------------------CcCCCCCcEEEccCcccccccchhhccc
Q 035761 145 ----------------------------------------------------LMNCSKLRILKLGNNLLSGSIPSQIGKL 172 (560)
Q Consensus 145 ----------------------------------------------------~~~l~~L~~L~l~~n~l~~~~~~~~~~l 172 (560)
+..+++|+.|+|++|++++.+|..++.+
T Consensus 576 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l 655 (768)
T 3rgz_A 576 VYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSM 655 (768)
T ss_dssp EEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGC
T ss_pred cccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhcc
Confidence 2234566677777777777777777777
Q ss_pred cccceeeccccccCCcCccccCCCceeeEEEccCCccccccCccc---ccCCCCcCCCCCCCCcCCc
Q 035761 173 QELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFV---RKVPHLDVSGNQFGGEIPT 236 (560)
Q Consensus 173 ~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~~---~~l~~l~l~~n~~~~~~p~ 236 (560)
++|+.|+|++|++++.+|..++.+++|+.|||++|++++.+|..+ ..++.|++++|++.|.+|.
T Consensus 656 ~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~ 722 (768)
T 3rgz_A 656 PYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPE 722 (768)
T ss_dssp TTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCS
T ss_pred ccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCC
Confidence 777777777777777777777777777777777777777777654 3455667777777766554
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-31 Score=257.20 Aligned_cols=231 Identities=19% Similarity=0.151 Sum_probs=142.4
Q ss_pred CCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccc-cccccccccCCCCCCCEEE
Q 035761 5 RNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNR-MNGSILLGIGSLKVLQVLD 83 (560)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~-i~~~~~~~~~~l~~L~~L~ 83 (560)
++|++|+|++|.++++.+..|..+++|++|+|++|.++++.|..|.++++|++|+|++|+ ++...+..|.++++|++|+
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~ 111 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence 456666666666666555666666666666666666666656666666666666666665 5555566666666666666
Q ss_pred eecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCccccc
Q 035761 84 LSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSG 163 (560)
Q Consensus 84 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 163 (560)
+++|++++..+..|.++++|++|++++|.+++..+..|.++++|+.|+|++|++++..+..|..+++|+.|++++|.+++
T Consensus 112 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 191 (285)
T 1ozn_A 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191 (285)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred CCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccc
Confidence 66666665556666666666666666666665555556666666666666666665555556666666666666666666
Q ss_pred ccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCc--ccccCCCCcCCCCCCCCcCC
Q 035761 164 SIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPV--FVRKVPHLDVSGNQFGGEIP 235 (560)
Q Consensus 164 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~--~~~~l~~l~l~~n~~~~~~p 235 (560)
..|..|..+++|+.|++++|++++..+..+..+++|+.|++++|++.+..+. .+..++.+....+.+.|..|
T Consensus 192 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~~~~l~~~~~~~~~~~c~~p 265 (285)
T 1ozn_A 192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLP 265 (285)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEES
T ss_pred cCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcHHHHHHHHhcccccCccccCCc
Confidence 5566666666666666666666655555566666666666666666654443 11223333444455444433
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-31 Score=293.83 Aligned_cols=231 Identities=38% Similarity=0.562 Sum_probs=216.1
Q ss_pred CCCCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCC
Q 035761 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQ 80 (560)
Q Consensus 1 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~ 80 (560)
|+++++|++|+|++|.+++.+|..|..+++|++|+|++|++++..|..|.++++|++|+|++|++++..|..+.++++|+
T Consensus 438 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 517 (768)
T 3rgz_A 438 LGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLA 517 (768)
T ss_dssp GGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCC
T ss_pred HhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCC
Confidence 35688999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEeecCccCccCCCCcCCCCCccEEEccCCCccCCCCcc----------------------------------------
Q 035761 81 VLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSS---------------------------------------- 120 (560)
Q Consensus 81 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~---------------------------------------- 120 (560)
+|+|++|++++.+|..+.++++|+.|+|++|.+++.+|..
T Consensus 518 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (768)
T 3rgz_A 518 ILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQ 597 (768)
T ss_dssp EEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECT
T ss_pred EEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccc
Confidence 9999999999999999999999999999999998766643
Q ss_pred ------------------------------CCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccccccchhhc
Q 035761 121 ------------------------------LGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIG 170 (560)
Q Consensus 121 ------------------------------~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 170 (560)
+..+++|+.|+|++|++++.+|..++.+++|+.|+|++|++++.+|..|+
T Consensus 598 ~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~ 677 (768)
T 3rgz_A 598 GIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVG 677 (768)
T ss_dssp TCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGG
T ss_pred cccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHh
Confidence 34467899999999999999999999999999999999999999999999
Q ss_pred cccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCc--ccccCCCCcCCCCCCC
Q 035761 171 KLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPV--FVRKVPHLDVSGNQFG 231 (560)
Q Consensus 171 ~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~--~~~~l~~l~l~~n~~~ 231 (560)
.+++|+.|+|++|++++.+|..+..+++|+.|++++|+++|.+|. .+..+....+.||+.-
T Consensus 678 ~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~L 740 (768)
T 3rgz_A 678 DLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGL 740 (768)
T ss_dssp GCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEE
T ss_pred CCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchh
Confidence 999999999999999999999999999999999999999999997 4677788888888743
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.5e-31 Score=273.68 Aligned_cols=235 Identities=21% Similarity=0.265 Sum_probs=146.3
Q ss_pred CCCCCCCCEEEccCCcCcc-cCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccc--cCCCC
Q 035761 1 MGRLRNLVHLDLSDNHFMG-HIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLG--IGSLK 77 (560)
Q Consensus 1 ~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~--~~~l~ 77 (560)
|+++++|++|+|++|.+.+ +.+..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..+.. |.+++
T Consensus 50 ~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~ 129 (455)
T 3v47_A 50 FSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLT 129 (455)
T ss_dssp TSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCT
T ss_pred hccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcc
Confidence 4566777777777777753 34556777777777777777777666777777777777777777776543333 67777
Q ss_pred CCCEEEeecCccCccCCCC-cCCCCCccEEEccCCCccCCCCccCCCC--------------------------------
Q 035761 78 VLQVLDLSRNEIGGSIPST-LGHLKWLRSVDLSQNKLVGPIPSSLGHL-------------------------------- 124 (560)
Q Consensus 78 ~L~~L~l~~n~l~~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~l-------------------------------- 124 (560)
+|++|+|++|.+++..|.. +.++++|++|++++|.+++..+..+..+
T Consensus 130 ~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~ 209 (455)
T 3v47_A 130 SLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPF 209 (455)
T ss_dssp TCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTT
T ss_pred cCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhcccccccccc
Confidence 7777777777777665554 6667777777777776665544333221
Q ss_pred -----------------------------------------------------------------CCCcEEECcCCcCcC
Q 035761 125 -----------------------------------------------------------------TQLTTLNMYNNKLDG 139 (560)
Q Consensus 125 -----------------------------------------------------------------~~L~~L~l~~n~l~~ 139 (560)
++|+.|++++|.+++
T Consensus 210 ~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~ 289 (455)
T 3v47_A 210 KNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFA 289 (455)
T ss_dssp TTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCE
T ss_pred ccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccc
Confidence 234444444444444
Q ss_pred CCCccCcCCCCCcEEEccCcccccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCccc--
Q 035761 140 PIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFV-- 217 (560)
Q Consensus 140 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~~-- 217 (560)
..|..+..+++|+.|++++|.+++..|..|..+++|++|+|++|++++..|..+..+++|+.|++++|.+++..|..+
T Consensus 290 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 369 (455)
T 3v47_A 290 LLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLG 369 (455)
T ss_dssp ECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTT
T ss_pred cchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccc
Confidence 455556666666666666666665555566666666666666666665555666666666666666666665555433
Q ss_pred -ccCCCCcCCCCCCCCcCC
Q 035761 218 -RKVPHLDVSGNQFGGEIP 235 (560)
Q Consensus 218 -~~l~~l~l~~n~~~~~~p 235 (560)
++++.|++++|++.+.++
T Consensus 370 l~~L~~L~L~~N~l~~~~~ 388 (455)
T 3v47_A 370 LPNLKELALDTNQLKSVPD 388 (455)
T ss_dssp CTTCCEEECCSSCCSCCCT
T ss_pred cccccEEECCCCccccCCH
Confidence 345555666666655433
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=270.37 Aligned_cols=227 Identities=21% Similarity=0.184 Sum_probs=210.5
Q ss_pred CCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEe
Q 035761 5 RNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDL 84 (560)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l 84 (560)
++|++|+|++|+|+++.+..|.++++|++|+|++|+|+++.+..|.++++|++|+|++|+++...+..|.++++|++|+|
T Consensus 75 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 154 (452)
T 3zyi_A 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWL 154 (452)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEEC
T ss_pred CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEEC
Confidence 47999999999999999999999999999999999999999999999999999999999999888888999999999999
Q ss_pred ecCccCccCCCCcCCCCCccEEEccC-CCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCccccc
Q 035761 85 SRNEIGGSIPSTLGHLKWLRSVDLSQ-NKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSG 163 (560)
Q Consensus 85 ~~n~l~~~~~~~~~~l~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 163 (560)
++|+|+...+..|.++++|+.|+|++ |.+..+.+..|.++++|+.|+|++|.+++. | .+..+++|+.|+|++|.+++
T Consensus 155 ~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~ 232 (452)
T 3zyi_A 155 RNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPE 232 (452)
T ss_dssp CSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSE
T ss_pred CCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c-cccccccccEEECcCCcCcc
Confidence 99999988888999999999999999 566656666899999999999999999965 3 68899999999999999999
Q ss_pred ccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCcc---cccCCCCcCCCCCCCCc
Q 035761 164 SIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVF---VRKVPHLDVSGNQFGGE 233 (560)
Q Consensus 164 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~---~~~l~~l~l~~n~~~~~ 233 (560)
..|..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|++++..+.. +.+++.|++.+|++.|.
T Consensus 233 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~Cd 305 (452)
T 3zyi_A 233 IRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCD 305 (452)
T ss_dssp ECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECS
T ss_pred cCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCC
Confidence 99999999999999999999999999999999999999999999999777664 46778899999999876
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-30 Score=267.51 Aligned_cols=227 Identities=23% Similarity=0.207 Sum_probs=209.8
Q ss_pred CCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEe
Q 035761 5 RNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDL 84 (560)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l 84 (560)
++++.|+|++|+|+++.+..|.++++|++|+|++|+|+.+.+..|.++++|++|+|++|+++...+..|.++++|++|+|
T Consensus 64 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 143 (440)
T 3zyj_A 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWL 143 (440)
T ss_dssp TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEEC
T ss_pred CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeC
Confidence 57999999999999998999999999999999999999888899999999999999999999888889999999999999
Q ss_pred ecCccCccCCCCcCCCCCccEEEccC-CCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCccccc
Q 035761 85 SRNEIGGSIPSTLGHLKWLRSVDLSQ-NKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSG 163 (560)
Q Consensus 85 ~~n~l~~~~~~~~~~l~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 163 (560)
++|.|+...+..|.++++|+.|+|++ |.+..+.+..|.++++|+.|+|++|.++.. | .+..+++|+.|+|++|.+++
T Consensus 144 ~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~ 221 (440)
T 3zyj_A 144 RNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI-P-NLTPLIKLDELDLSGNHLSA 221 (440)
T ss_dssp CSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSC-C-CCTTCSSCCEEECTTSCCCE
T ss_pred CCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCccc-c-ccCCCcccCEEECCCCccCc
Confidence 99999988888999999999999999 556656666899999999999999999954 4 58899999999999999999
Q ss_pred ccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCccc---ccCCCCcCCCCCCCCc
Q 035761 164 SIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFV---RKVPHLDVSGNQFGGE 233 (560)
Q Consensus 164 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~~---~~l~~l~l~~n~~~~~ 233 (560)
..|..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..+..+ .+++.|++.+|++.|.
T Consensus 222 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~Cd 294 (440)
T 3zyj_A 222 IRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCN 294 (440)
T ss_dssp ECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECS
T ss_pred cChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCC
Confidence 889999999999999999999999999999999999999999999998777644 6678899999999875
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.8e-30 Score=266.00 Aligned_cols=137 Identities=20% Similarity=0.222 Sum_probs=70.3
Q ss_pred CCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcce-ecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEe
Q 035761 6 NLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLV-GNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDL 84 (560)
Q Consensus 6 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l 84 (560)
+|++|+|++|.++++.|..|.++++|++|+|++|.+. .+.+..|.++++|++|+|++|++++..|..|.++++|++|+|
T Consensus 31 ~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 110 (455)
T 3v47_A 31 HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTL 110 (455)
T ss_dssp TCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEEC
T ss_pred ccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEeC
Confidence 4555555555555555555555555555555555553 233444555555555555555555444555555555555555
Q ss_pred ecCccCccCCC--CcCCCCCccEEEccCCCccCCCCcc-CCCCCCCcEEECcCCcCcCCCC
Q 035761 85 SRNEIGGSIPS--TLGHLKWLRSVDLSQNKLVGPIPSS-LGHLTQLTTLNMYNNKLDGPIP 142 (560)
Q Consensus 85 ~~n~l~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~-~~~l~~L~~L~l~~n~l~~~~~ 142 (560)
++|++++..+. .|.++++|++|+|++|.+++..|.. +.++++|++|++++|.+++..+
T Consensus 111 ~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 171 (455)
T 3v47_A 111 TQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICE 171 (455)
T ss_dssp TTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCT
T ss_pred CCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccCh
Confidence 55555542222 2555555555555555555444433 4555555555555555554433
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-30 Score=254.36 Aligned_cols=228 Identities=20% Similarity=0.220 Sum_probs=206.7
Q ss_pred CCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceec--CCccccCCCCCCeeeccccccccccccccCCCCCCCEE
Q 035761 5 RNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGN--IPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVL 82 (560)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~--~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 82 (560)
++|++|+|++|+++.+.+..|.++++|++|+|++|.++.. .+..+..+++|++|+|++|.++ ..+..+.++++|++|
T Consensus 28 ~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L 106 (306)
T 2z66_A 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHL 106 (306)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEE
T ss_pred CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEE
Confidence 5899999999999977667789999999999999999843 3677888999999999999998 456678999999999
Q ss_pred EeecCccCccCC-CCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcC-CCCccCcCCCCCcEEEccCcc
Q 035761 83 DLSRNEIGGSIP-STLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDG-PIPPELMNCSKLRILKLGNNL 160 (560)
Q Consensus 83 ~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~ 160 (560)
++++|++++..+ ..+..+++|++|++++|.+++..+..+.++++|++|++++|.+++ ..|..+..+++|+.|++++|.
T Consensus 107 ~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~ 186 (306)
T 2z66_A 107 DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 186 (306)
T ss_dssp ECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSC
T ss_pred ECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCC
Confidence 999999997655 689999999999999999998889999999999999999999986 578899999999999999999
Q ss_pred cccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCccc----ccCCCCcCCCCCCCCc
Q 035761 161 LSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFV----RKVPHLDVSGNQFGGE 233 (560)
Q Consensus 161 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~~----~~l~~l~l~~n~~~~~ 233 (560)
+++..|..|..+++|++|++++|++++..+..+..+++|+.|++++|++++..|..+ .+++.|++++|++.|.
T Consensus 187 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~ 263 (306)
T 2z66_A 187 LEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 263 (306)
T ss_dssp CCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECS
T ss_pred cCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecc
Confidence 998889999999999999999999998888889999999999999999999888654 3677899999999875
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-32 Score=288.17 Aligned_cols=217 Identities=24% Similarity=0.251 Sum_probs=189.9
Q ss_pred CCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEE
Q 035761 3 RLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVL 82 (560)
Q Consensus 3 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 82 (560)
.+++|++|+|++|.+++..|..|..+++|++|+|++|.+++..| |..+++|++|+|++|.|++..+ .++|++|
T Consensus 32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L 104 (487)
T 3oja_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETL 104 (487)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEE
T ss_pred cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEE
Confidence 34589999999999998888999999999999999999997765 9999999999999999986543 2899999
Q ss_pred EeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCc-CCCCCcEEEccCccc
Q 035761 83 DLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELM-NCSKLRILKLGNNLL 161 (560)
Q Consensus 83 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~l~~n~l 161 (560)
++++|.|++..+. .+++|+.|+|++|.+++..|..+.++++|+.|+|++|.+++..|..+. .+++|+.|+|++|.+
T Consensus 105 ~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l 181 (487)
T 3oja_A 105 HAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181 (487)
T ss_dssp ECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCC
T ss_pred ECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcc
Confidence 9999999976654 357899999999999988888999999999999999999988888876 799999999999999
Q ss_pred ccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCc--ccccCCCCcCCCCCCCC
Q 035761 162 SGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPV--FVRKVPHLDVSGNQFGG 232 (560)
Q Consensus 162 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~--~~~~l~~l~l~~n~~~~ 232 (560)
++..+ +..+++|+.|+|++|.+++..| .+..+++|+.|++++|.+++.++. .++++..|++++|++.|
T Consensus 182 ~~~~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~l~~N~l~c 251 (487)
T 3oja_A 182 YDVKG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHC 251 (487)
T ss_dssp CEEEC--CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCBCH
T ss_pred ccccc--cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcccchhhccCCCCCEEEcCCCCCcC
Confidence 96632 4469999999999999996555 588999999999999999964332 33678889999999874
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-30 Score=255.15 Aligned_cols=224 Identities=22% Similarity=0.300 Sum_probs=204.8
Q ss_pred CCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEE
Q 035761 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLD 83 (560)
Q Consensus 4 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 83 (560)
.++++.|+|++|.++ .+|..+..+++|++|+|++|.++ .+|..+.++++|++|+|++|+++ .+|..+.++++|++|+
T Consensus 80 ~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~ 156 (328)
T 4fcg_A 80 QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS 156 (328)
T ss_dssp STTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred ccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence 478999999999999 67888999999999999999999 88999999999999999999999 6788899999999999
Q ss_pred eecCccCccCCCCcCC---------CCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEE
Q 035761 84 LSRNEIGGSIPSTLGH---------LKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRIL 154 (560)
Q Consensus 84 l~~n~l~~~~~~~~~~---------l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 154 (560)
|++|++.+.+|..+.. +++|++|+|++|+++ .+|..+.++++|++|+|++|.+++ +|..+..+++|+.|
T Consensus 157 L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L 234 (328)
T 4fcg_A 157 IRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEEL 234 (328)
T ss_dssp EEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEE
T ss_pred CCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEE
Confidence 9999888888887764 999999999999999 788899999999999999999995 66789999999999
Q ss_pred EccCcccccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCcccccCC---CCcCCCCCCC
Q 035761 155 KLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVP---HLDVSGNQFG 231 (560)
Q Consensus 155 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~---~l~l~~n~~~ 231 (560)
++++|.+.+.+|..|..+++|++|+|++|++.+.+|..+..+++|+.|++++|++.+.+|..+.+++ .+++..|.+.
T Consensus 235 ~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp ECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred ECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 9999999999999999999999999999999999999999999999999999999999999776555 4556655544
Q ss_pred C
Q 035761 232 G 232 (560)
Q Consensus 232 ~ 232 (560)
.
T Consensus 315 ~ 315 (328)
T 4fcg_A 315 Q 315 (328)
T ss_dssp C
T ss_pred H
Confidence 3
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=284.10 Aligned_cols=186 Identities=18% Similarity=0.096 Sum_probs=132.1
Q ss_pred eeccCCeeEEEEE-eCCCcEEEEEEccchh--------hhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCEEEEEE
Q 035761 323 IGTGGYGSVYRAR-LPSGKVVALKKLHRLE--------TELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 323 ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~--------~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 392 (560)
.+.|+.|.+..++ .-.|+.++||.+.... ......++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4455555555543 2348889999986531 1223446799999999999 7999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||++|++|.+++...+. ++.. +|+.||+.||+|+|++ |||||||||+|||+++++.+||+|||+|+....+
T Consensus 322 Eyv~G~~L~d~i~~~~~---l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGEE---IDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp ECCCSEEHHHHHHTTCC---CCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred ecCCCCcHHHHHHhCCC---CCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 99999999999986543 6654 5899999999999999 9999999999999999999999999999987655
Q ss_pred CCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCC
Q 035761 473 SSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHP 518 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P 518 (560)
.......+||+.|||||++.+. +..++|+||+|++++++.+|..|
T Consensus 393 ~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 CSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 5555567899999999998764 56789999999998877665544
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-29 Score=244.72 Aligned_cols=224 Identities=21% Similarity=0.183 Sum_probs=205.2
Q ss_pred CCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEeec
Q 035761 7 LVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSR 86 (560)
Q Consensus 7 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~ 86 (560)
-++++.+++.++ .+|..+ .++|++|+|++|.++++.+..|..+++|++|+|++|++++..+..|.++++|++|+|++
T Consensus 13 ~~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 89 (285)
T 1ozn_A 13 KVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89 (285)
T ss_dssp SCEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CeEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence 368999999998 456544 47999999999999988888999999999999999999988899999999999999999
Q ss_pred Cc-cCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCccccccc
Q 035761 87 NE-IGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSI 165 (560)
Q Consensus 87 n~-l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 165 (560)
|. ++...+..|..+++|++|++++|.+++..+..|.++++|++|++++|.+++..+..|..+++|+.|++++|.+++..
T Consensus 90 n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 169 (285)
T 1ozn_A 90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP 169 (285)
T ss_dssp CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred CCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccC
Confidence 97 88777889999999999999999999888899999999999999999999877778999999999999999999777
Q ss_pred chhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCcc---cccCCCCcCCCCCCCCc
Q 035761 166 PSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVF---VRKVPHLDVSGNQFGGE 233 (560)
Q Consensus 166 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~---~~~l~~l~l~~n~~~~~ 233 (560)
+..|..+++|++|++++|++++..|..+..+++|+.|++++|.+++..+.. +.+++.|++++|++.|.
T Consensus 170 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 240 (285)
T 1ozn_A 170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240 (285)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred HHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCC
Confidence 778999999999999999999888999999999999999999999877654 46778899999999875
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-29 Score=265.60 Aligned_cols=235 Identities=22% Similarity=0.196 Sum_probs=126.6
Q ss_pred CCCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCE
Q 035761 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQV 81 (560)
Q Consensus 2 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~ 81 (560)
.++++|++|+|++|.++++.|..|.++++|++|+|++|+++.+.+..|.++++|++|+|++|+++...+..|.++++|++
T Consensus 53 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 132 (477)
T 2id5_A 53 ASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKS 132 (477)
T ss_dssp TTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred cCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCE
Confidence 34455555555555555555555555555555555555555444444555555555555555555444555555555555
Q ss_pred EEeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCC----------
Q 035761 82 LDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKL---------- 151 (560)
Q Consensus 82 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L---------- 151 (560)
|+|++|.+++..+..|.++++|+.|+|++|++++..+..|.++++|+.|+|++|.+.+..+..|..+++|
T Consensus 133 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~ 212 (477)
T 2id5_A 133 LEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPY 212 (477)
T ss_dssp EEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTT
T ss_pred EECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCcc
Confidence 5555555555445555555555555555555554433444445555555555554444333344443333
Q ss_pred --------------cEEEccCcccccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCccc
Q 035761 152 --------------RILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFV 217 (560)
Q Consensus 152 --------------~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~~ 217 (560)
+.|++++|.++...+..|..+++|+.|+|++|++++..+..|..+++|+.|++++|.+++..|..+
T Consensus 213 ~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 292 (477)
T 2id5_A 213 LDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAF 292 (477)
T ss_dssp CCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTB
T ss_pred ccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHh
Confidence 333333344443333455666666666666666666556666666666666666666666555433
Q ss_pred ---ccCCCCcCCCCCCCCcCCc
Q 035761 218 ---RKVPHLDVSGNQFGGEIPT 236 (560)
Q Consensus 218 ---~~l~~l~l~~n~~~~~~p~ 236 (560)
.+++.|++++|++.+..+.
T Consensus 293 ~~l~~L~~L~L~~N~l~~~~~~ 314 (477)
T 2id5_A 293 RGLNYLRVLNVSGNQLTTLEES 314 (477)
T ss_dssp TTCTTCCEEECCSSCCSCCCGG
T ss_pred cCcccCCEEECCCCcCceeCHh
Confidence 4455666666666654433
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-30 Score=252.72 Aligned_cols=239 Identities=22% Similarity=0.250 Sum_probs=212.3
Q ss_pred CCCCCCCCEEEccCCcCccc--CCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccc-cccCCCC
Q 035761 1 MGRLRNLVHLDLSDNHFMGH--IPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSIL-LGIGSLK 77 (560)
Q Consensus 1 ~~~l~~L~~L~L~~n~l~~~--~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~-~~~~~l~ 77 (560)
|+++++|++|+|++|.++.. .+..+..+++|++|+|++|.++ .+|..+..+++|++|+|++|++++..+ ..+..++
T Consensus 48 ~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~ 126 (306)
T 2z66_A 48 FDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 126 (306)
T ss_dssp TTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCT
T ss_pred hhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhcc
Confidence 46889999999999999843 3566778999999999999999 567779999999999999999997655 6899999
Q ss_pred CCCEEEeecCccCccCCCCcCCCCCccEEEccCCCccC-CCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEc
Q 035761 78 VLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVG-PIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKL 156 (560)
Q Consensus 78 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 156 (560)
+|++|++++|.+++..+..+..+++|++|+|++|.+++ ..|..+..+++|++|+|++|.+++..|..+..+++|+.|++
T Consensus 127 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 206 (306)
T 2z66_A 127 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNM 206 (306)
T ss_dssp TCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEEC
Confidence 99999999999998888999999999999999999986 57889999999999999999999888999999999999999
Q ss_pred cCcccccccchhhccccccceeeccccccCCcCccccCCCc-eeeEEEccCCccccccC-----cccccCCCCcCCCCCC
Q 035761 157 GNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFS-CIDTVDLSMNNLSGGIP-----VFVRKVPHLDVSGNQF 230 (560)
Q Consensus 157 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~-~L~~l~l~~n~l~~~~~-----~~~~~l~~l~l~~n~~ 230 (560)
++|.+++..+..+..+++|++|++++|++++..|..+..++ +|+.|++++|++++..+ .+++..+.+.+..+.+
T Consensus 207 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~ 286 (306)
T 2z66_A 207 SHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERM 286 (306)
T ss_dssp TTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGC
T ss_pred CCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhcccccc
Confidence 99999988888899999999999999999999999999985 99999999999997654 3556667777777777
Q ss_pred CCcCCcccCC
Q 035761 231 GGEIPTTLAN 240 (560)
Q Consensus 231 ~~~~p~~~~~ 240 (560)
.|..|....+
T Consensus 287 ~C~~p~~~~g 296 (306)
T 2z66_A 287 ECATPSDKQG 296 (306)
T ss_dssp BEEESGGGTT
T ss_pred ccCCchhhCC
Confidence 7765555433
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=266.26 Aligned_cols=233 Identities=21% Similarity=0.184 Sum_probs=198.9
Q ss_pred CCCCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCC
Q 035761 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQ 80 (560)
Q Consensus 1 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~ 80 (560)
|+++++|++|+|++|.++++.+..|.++++|++|+|++|.+++..|..|.++++|+.|+|++|+++...+..|.++++|+
T Consensus 76 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 155 (477)
T 2id5_A 76 FNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLE 155 (477)
T ss_dssp TTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCC
T ss_pred hhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCC
Confidence 56788999999999999977777889999999999999999988888899999999999999999888888888899999
Q ss_pred EEEeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcE------------------------EECcCCc
Q 035761 81 VLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTT------------------------LNMYNNK 136 (560)
Q Consensus 81 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~------------------------L~l~~n~ 136 (560)
+|+|++|++++..+..|.++++|+.|+|++|.+++..+..|..+++|+. |+|++|.
T Consensus 156 ~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~ 235 (477)
T 2id5_A 156 QLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCN 235 (477)
T ss_dssp EEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSC
T ss_pred EEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCc
Confidence 9999999888766667788888888888888887666666666655554 5555566
Q ss_pred CcCCCCccCcCCCCCcEEEccCcccccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCcc
Q 035761 137 LDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVF 216 (560)
Q Consensus 137 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~ 216 (560)
+++..+..+..+++|+.|+|++|.+++..+..|..+++|+.|+|++|++++..|..|..+++|+.|++++|.+++..+..
T Consensus 236 l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 315 (477)
T 2id5_A 236 LTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESV 315 (477)
T ss_dssp CCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGG
T ss_pred ccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhH
Confidence 66444457889999999999999999888888999999999999999999999999999999999999999999877765
Q ss_pred c---ccCCCCcCCCCCCCCc
Q 035761 217 V---RKVPHLDVSGNQFGGE 233 (560)
Q Consensus 217 ~---~~l~~l~l~~n~~~~~ 233 (560)
+ .+++.|++.+|++.|.
T Consensus 316 ~~~l~~L~~L~l~~N~l~c~ 335 (477)
T 2id5_A 316 FHSVGNLETLILDSNPLACD 335 (477)
T ss_dssp BSCGGGCCEEECCSSCEECS
T ss_pred cCCCcccCEEEccCCCccCc
Confidence 4 6788999999999875
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.3e-30 Score=260.15 Aligned_cols=228 Identities=21% Similarity=0.167 Sum_probs=180.1
Q ss_pred CCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEE
Q 035761 3 RLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVL 82 (560)
Q Consensus 3 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 82 (560)
++++|++|+|++|.++++.+..|..+++|++|+|++|.+++..|..|.++++|++|+|++|+++...+..|.++++|++|
T Consensus 67 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L 146 (390)
T 3o6n_A 67 SFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTL 146 (390)
T ss_dssp HCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred ccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEE
Confidence 46788888888888887777788888888888888888887777778888888888888888886666667788888888
Q ss_pred EeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCC-------------------------------------C
Q 035761 83 DLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHL-------------------------------------T 125 (560)
Q Consensus 83 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l-------------------------------------~ 125 (560)
++++|.+++..+..|.++++|++|++++|.+++.....+..+ +
T Consensus 147 ~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~L~~L~l~~n~l~~~~~~~~~ 226 (390)
T 3o6n_A 147 SMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNV 226 (390)
T ss_dssp ECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSSCCSEEECCSSCSEEECCSSCCCEEECCCCS
T ss_pred ECCCCccCccChhhccCCCCCCEEECCCCcCCccccccccccceeecccccccccCCCCcceEEECCCCeeeeccccccc
Confidence 888888887777778888888888888888775432222222 2
Q ss_pred CCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccccccchhhccccccceeeccccccCCcCccccCCCceeeEEEcc
Q 035761 126 QLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLS 205 (560)
Q Consensus 126 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~ 205 (560)
+|+.|++++|.+++. ..+..+++|+.|++++|.+++..|..|..+++|++|+|++|++++ +|..+..+++|+.|+++
T Consensus 227 ~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~ 303 (390)
T 3o6n_A 227 ELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLS 303 (390)
T ss_dssp SCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECC
T ss_pred cccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECC
Confidence 455556666666543 567888999999999999998889999999999999999999985 56677889999999999
Q ss_pred CCccccccCc--ccccCCCCcCCCCCCCCc
Q 035761 206 MNNLSGGIPV--FVRKVPHLDVSGNQFGGE 233 (560)
Q Consensus 206 ~n~l~~~~~~--~~~~l~~l~l~~n~~~~~ 233 (560)
+|++++.++. .+++++.|++++|++...
T Consensus 304 ~n~l~~~~~~~~~l~~L~~L~L~~N~i~~~ 333 (390)
T 3o6n_A 304 HNHLLHVERNQPQFDRLENLYLDHNSIVTL 333 (390)
T ss_dssp SSCCCCCGGGHHHHTTCSEEECCSSCCCCC
T ss_pred CCcceecCccccccCcCCEEECCCCcccee
Confidence 9999865443 457889999999998765
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=245.42 Aligned_cols=224 Identities=21% Similarity=0.225 Sum_probs=145.7
Q ss_pred CCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEe
Q 035761 5 RNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDL 84 (560)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l 84 (560)
++|++|+|++|+++++.+..|.++++|++|+|++|.++++.|..|.++++|++|+|++|+++.. |..+. ++|++|++
T Consensus 52 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~l-~~~~~--~~L~~L~l 128 (330)
T 1xku_A 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKEL-PEKMP--KTLQELRV 128 (330)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBC-CSSCC--TTCCEEEC
T ss_pred CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCCcc-Chhhc--ccccEEEC
Confidence 4678888888888877777788888888888888888877778888888888888888887733 33332 56777777
Q ss_pred ecCccCccCCCCcCCCCCccEEEccCCCccC--CCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccc
Q 035761 85 SRNEIGGSIPSTLGHLKWLRSVDLSQNKLVG--PIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLS 162 (560)
Q Consensus 85 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 162 (560)
++|.+++..+..|.++++|+.|++++|.++. ..+..+.++++|+.|++++|.++. +|..+. ++|+.|++++|.++
T Consensus 129 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~ 205 (330)
T 1xku_A 129 HENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKIT 205 (330)
T ss_dssp CSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTSCCC
T ss_pred CCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc-CCcccc--ccCCEEECCCCcCC
Confidence 7777776555566666777777777776642 455566666666666666666663 333332 56666666666666
Q ss_pred cccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCcc---cccCCCCcCCCCCCCCcCC
Q 035761 163 GSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVF---VRKVPHLDVSGNQFGGEIP 235 (560)
Q Consensus 163 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~---~~~l~~l~l~~n~~~~~~p 235 (560)
+..|..|..+++|++|++++|++++..+..+..+++|+.|++++|+++ .+|.. +++++.|++++|++.+..+
T Consensus 206 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~ 280 (330)
T 1xku_A 206 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGS 280 (330)
T ss_dssp EECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCT
T ss_pred ccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccCh
Confidence 555566666666666666666666555555666666666666666666 33332 2445556666666655433
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6e-30 Score=257.10 Aligned_cols=229 Identities=18% Similarity=0.132 Sum_probs=199.4
Q ss_pred CCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEe
Q 035761 5 RNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDL 84 (560)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l 84 (560)
++|++|+|++|+++++.+..|.++++|++|+|++|+++++.|..|.++++|++|+|++|++++..+..|.++++|++|+|
T Consensus 52 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 131 (353)
T 2z80_A 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNL 131 (353)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEEC
T ss_pred ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEEC
Confidence 47999999999999888879999999999999999999888999999999999999999999777777999999999999
Q ss_pred ecCccCccCC-CCcCCCCCccEEEccCC-CccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccc
Q 035761 85 SRNEIGGSIP-STLGHLKWLRSVDLSQN-KLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLS 162 (560)
Q Consensus 85 ~~n~l~~~~~-~~~~~l~~L~~L~l~~n-~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 162 (560)
++|++++..+ ..+.++++|++|++++| .++...+..|.++++|++|++++|.+++..|..+..+++|+.|++++|.++
T Consensus 132 ~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~ 211 (353)
T 2z80_A 132 LGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI 211 (353)
T ss_dssp TTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST
T ss_pred CCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc
Confidence 9999996544 47899999999999999 577777889999999999999999999888999999999999999999998
Q ss_pred cccchhhccccccceeeccccccCCcC-------------------------------ccccCCCceeeEEEccCCcccc
Q 035761 163 GSIPSQIGKLQELYYLDLSGNFINGKI-------------------------------PSQLGEFSCIDTVDLSMNNLSG 211 (560)
Q Consensus 163 ~~~~~~~~~l~~L~~L~l~~n~l~~~~-------------------------------~~~~~~~~~L~~l~l~~n~l~~ 211 (560)
...+..+..+++|+.|++++|.+++.. |..+..+++|+.|++++|+++.
T Consensus 212 ~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~ 291 (353)
T 2z80_A 212 LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKS 291 (353)
T ss_dssp THHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCC
T ss_pred cchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCc
Confidence 555455567899999999999998743 3345677889999999999985
Q ss_pred ccCcc---cccCCCCcCCCCCCCCc
Q 035761 212 GIPVF---VRKVPHLDVSGNQFGGE 233 (560)
Q Consensus 212 ~~~~~---~~~l~~l~l~~n~~~~~ 233 (560)
..+.. +++++.|++++|++.|.
T Consensus 292 i~~~~~~~l~~L~~L~L~~N~~~~~ 316 (353)
T 2z80_A 292 VPDGIFDRLTSLQKIWLHTNPWDCS 316 (353)
T ss_dssp CCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred cCHHHHhcCCCCCEEEeeCCCccCc
Confidence 44432 45677889999998875
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=272.33 Aligned_cols=228 Identities=21% Similarity=0.167 Sum_probs=182.5
Q ss_pred CCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEE
Q 035761 3 RLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVL 82 (560)
Q Consensus 3 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 82 (560)
++++|++|+|++|.|+++.|..|..+++|++|+|++|.|++..|..|.++++|++|+|++|.++...+..|.++++|++|
T Consensus 73 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L 152 (597)
T 3oja_B 73 SFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTL 152 (597)
T ss_dssp HCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEE
Confidence 46788889999888888888888888899999999998888888888888899999999998887777777888889999
Q ss_pred EeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCC-------------------------------------C
Q 035761 83 DLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHL-------------------------------------T 125 (560)
Q Consensus 83 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l-------------------------------------~ 125 (560)
+|++|.+++..|..|.++++|+.|+|++|.+++.....+.++ +
T Consensus 153 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n~l~~l~~~~~L~~L~ls~n~l~~~~~~~~~ 232 (597)
T 3oja_B 153 SMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNV 232 (597)
T ss_dssp ECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSSCCSEEECCTTCSEEECCSSCCCEEECSCCS
T ss_pred EeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccCccccccCCchhheeeccCCcccccccccCC
Confidence 999998888888888888888888888888875533333222 2
Q ss_pred CCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccccccchhhccccccceeeccccccCCcCccccCCCceeeEEEcc
Q 035761 126 QLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLS 205 (560)
Q Consensus 126 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~ 205 (560)
+|+.|+|++|.+++ +..+..+++|+.|+|++|.+++..|..|..+++|+.|+|++|.+++ +|..+..+++|+.|+|+
T Consensus 233 ~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls 309 (597)
T 3oja_B 233 ELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLS 309 (597)
T ss_dssp CCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECC
T ss_pred CCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECC
Confidence 35555555555553 3567888899999999999998888889999999999999999985 56677788899999999
Q ss_pred CCccccccCc--ccccCCCCcCCCCCCCCc
Q 035761 206 MNNLSGGIPV--FVRKVPHLDVSGNQFGGE 233 (560)
Q Consensus 206 ~n~l~~~~~~--~~~~l~~l~l~~n~~~~~ 233 (560)
+|++++.++. .++++..|++++|++.+.
T Consensus 310 ~N~l~~i~~~~~~l~~L~~L~L~~N~l~~~ 339 (597)
T 3oja_B 310 HNHLLHVERNQPQFDRLENLYLDHNSIVTL 339 (597)
T ss_dssp SSCCCCCGGGHHHHTTCSEEECCSSCCCCC
T ss_pred CCCCCccCcccccCCCCCEEECCCCCCCCc
Confidence 9998854332 346788888888888765
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=255.30 Aligned_cols=213 Identities=21% Similarity=0.221 Sum_probs=197.8
Q ss_pred CCCCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCC
Q 035761 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQ 80 (560)
Q Consensus 1 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~ 80 (560)
|+++++|++|+|++|.|+++.+..|.++++|++|+|++|+|+.+.+..|..+++|++|+|++|+++...+..|.++++|+
T Consensus 84 ~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~ 163 (440)
T 3zyj_A 84 FKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLR 163 (440)
T ss_dssp TSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCC
T ss_pred hhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccC
Confidence 56889999999999999988889999999999999999999988788899999999999999999988888999999999
Q ss_pred EEEeec-CccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCc
Q 035761 81 VLDLSR-NEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNN 159 (560)
Q Consensus 81 ~L~l~~-n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 159 (560)
+|+|++ |.++...+..|.++++|+.|+|++|+++ .+| .+..+++|+.|+|++|.+++..|..|..+++|+.|++++|
T Consensus 164 ~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n 241 (440)
T 3zyj_A 164 RLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQS 241 (440)
T ss_dssp EEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTC
T ss_pred EeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCC
Confidence 999999 5666566668999999999999999999 455 4889999999999999999988999999999999999999
Q ss_pred ccccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCc
Q 035761 160 LLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPV 215 (560)
Q Consensus 160 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~ 215 (560)
++++..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++.+....
T Consensus 242 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~l 297 (440)
T 3zyj_A 242 QIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCDI 297 (440)
T ss_dssp CCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSSTT
T ss_pred ceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCCCc
Confidence 99999999999999999999999999988888899999999999999999876543
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-28 Score=255.38 Aligned_cols=213 Identities=20% Similarity=0.168 Sum_probs=198.2
Q ss_pred CCCCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCC
Q 035761 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQ 80 (560)
Q Consensus 1 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~ 80 (560)
|+++++|++|+|++|.|+++.+..|.++++|++|+|++|+|+.+.+..|.++++|++|+|++|+++.+.+..|.++++|+
T Consensus 95 ~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 174 (452)
T 3zyi_A 95 FRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLM 174 (452)
T ss_dssp TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCC
T ss_pred cCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCccc
Confidence 56899999999999999999999999999999999999999988888899999999999999999988888999999999
Q ss_pred EEEeec-CccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCc
Q 035761 81 VLDLSR-NEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNN 159 (560)
Q Consensus 81 ~L~l~~-n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 159 (560)
+|+|++ |.++...+..|.++++|+.|+|++|++++. | .+..+++|+.|+|++|.+++..|..|..+++|+.|++++|
T Consensus 175 ~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n 252 (452)
T 3zyi_A 175 RLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNS 252 (452)
T ss_dssp EEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTS
T ss_pred EEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCC
Confidence 999999 567766666899999999999999999954 4 5889999999999999999988999999999999999999
Q ss_pred ccccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCc
Q 035761 160 LLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPV 215 (560)
Q Consensus 160 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~ 215 (560)
++++..+..|..+++|+.|+|++|++++..+..+..+++|+.|++++|++.+....
T Consensus 253 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~~ 308 (452)
T 3zyi_A 253 QVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCDI 308 (452)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTTT
T ss_pred cCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCCc
Confidence 99999999999999999999999999988888899999999999999999876653
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-28 Score=242.73 Aligned_cols=225 Identities=23% Similarity=0.259 Sum_probs=159.9
Q ss_pred CCCCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCC
Q 035761 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQ 80 (560)
Q Consensus 1 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~ 80 (560)
|+++++|++|+|++|.++++.|..|..+++|++|+|++|+++ .+|..+. ++|++|++++|++++..+..|.++++|+
T Consensus 72 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 148 (330)
T 1xku_A 72 FKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMI 148 (330)
T ss_dssp TTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCC
T ss_pred hccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCcccc
Confidence 356677777777777777766777777777777777777777 4444443 6777777777777766666777777777
Q ss_pred EEEeecCccCc--cCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccC
Q 035761 81 VLDLSRNEIGG--SIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGN 158 (560)
Q Consensus 81 ~L~l~~n~l~~--~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 158 (560)
+|++++|.++. ..+..+.++++|+.|++++|.++. +|..+. ++|++|++++|.+++..+..+..+++|+.|++++
T Consensus 149 ~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~ 225 (330)
T 1xku_A 149 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSF 225 (330)
T ss_dssp EEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCS
T ss_pred EEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCC
Confidence 77777777753 556677777777777777777773 444443 6777777777777766677777777777777777
Q ss_pred cccccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCccc---------ccCCCCcCCCCC
Q 035761 159 NLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFV---------RKVPHLDVSGNQ 229 (560)
Q Consensus 159 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~~---------~~l~~l~l~~n~ 229 (560)
|.+++..+..|..+++|++|++++|+++ .+|..+..+++|+.|++++|++++..+..+ ..+..+++.+|+
T Consensus 226 n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~ 304 (330)
T 1xku_A 226 NSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNP 304 (330)
T ss_dssp SCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSS
T ss_pred CcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCc
Confidence 7777666667777777777777777777 566667777777777777777776555433 344566777777
Q ss_pred CCC
Q 035761 230 FGG 232 (560)
Q Consensus 230 ~~~ 232 (560)
+..
T Consensus 305 ~~~ 307 (330)
T 1xku_A 305 VQY 307 (330)
T ss_dssp SCG
T ss_pred ccc
Confidence 653
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-28 Score=242.58 Aligned_cols=224 Identities=22% Similarity=0.244 Sum_probs=157.2
Q ss_pred CCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEe
Q 035761 5 RNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDL 84 (560)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l 84 (560)
++|++|+|++|.++++.+..|.++++|++|+|++|+++++.|..|.++++|++|+|++|+++.. |..+. ++|++|++
T Consensus 54 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l-~~~~~--~~L~~L~l 130 (332)
T 2ft3_A 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVEI-PPNLP--SSLVELRI 130 (332)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCCSC-CSSCC--TTCCEEEC
T ss_pred CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCCcc-Ccccc--ccCCEEEC
Confidence 4688888888888877777888888888888888888877788888888888888888888743 33333 78888888
Q ss_pred ecCccCccCCCCcCCCCCccEEEccCCCcc--CCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccc
Q 035761 85 SRNEIGGSIPSTLGHLKWLRSVDLSQNKLV--GPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLS 162 (560)
Q Consensus 85 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~--~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 162 (560)
++|+++...+..|.++++|+.|++++|.++ +..+..+..+ +|+.|++++|.+++ +|..+. ++|+.|++++|.++
T Consensus 131 ~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~ 206 (332)
T 2ft3_A 131 HDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQ 206 (332)
T ss_dssp CSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCC
T ss_pred CCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCC
Confidence 888888666667888888888888888885 3566666666 66666666666663 333332 56666666666666
Q ss_pred cccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCcc---cccCCCCcCCCCCCCCcCCc
Q 035761 163 GSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVF---VRKVPHLDVSGNQFGGEIPT 236 (560)
Q Consensus 163 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~---~~~l~~l~l~~n~~~~~~p~ 236 (560)
+..+..|..+++|++|++++|++++..+..+..+++|+.|++++|+++ .+|.. +++++.|++++|++.+..+.
T Consensus 207 ~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~ 282 (332)
T 2ft3_A 207 AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVN 282 (332)
T ss_dssp CCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTT
T ss_pred ccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChh
Confidence 655566666666666666666666655556666666666666666666 33332 24555666666666655443
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.4e-28 Score=232.21 Aligned_cols=206 Identities=23% Similarity=0.232 Sum_probs=184.1
Q ss_pred CCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEee
Q 035761 6 NLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLS 85 (560)
Q Consensus 6 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~ 85 (560)
+++++++++++++ .+|..+. ++|++|+|++|+++++.+..|.++++|++|+|++|+++.+.+..|.++++|++|+|+
T Consensus 17 ~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~ 93 (270)
T 2o6q_A 17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT 93 (270)
T ss_dssp TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence 5789999999998 4666554 689999999999998877889999999999999999997777888999999999999
Q ss_pred cCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCccccccc
Q 035761 86 RNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSI 165 (560)
Q Consensus 86 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 165 (560)
+|.+++..+..|..+++|++|+|++|.+++..+..|..+++|++|+|++|.+++..+..|..+++|+.|++++|.+++..
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 173 (270)
T 2o6q_A 94 DNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVP 173 (270)
T ss_dssp SSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeC
Confidence 99999877788899999999999999999888888999999999999999999777777899999999999999999877
Q ss_pred chhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccC
Q 035761 166 PSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIP 214 (560)
Q Consensus 166 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~ 214 (560)
+..|..+++|++|+|++|++++..+..+..+++|+.|++++|++.+...
T Consensus 174 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 174 EGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred hhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 7789999999999999999997777788889999999999999887654
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-28 Score=237.98 Aligned_cols=222 Identities=21% Similarity=0.205 Sum_probs=174.8
Q ss_pred CEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEeecC
Q 035761 8 VHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRN 87 (560)
Q Consensus 8 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n 87 (560)
.+++.++.+++ .+|..+. ++|++|+|++|+++++.+..|.++++|++|+|++|+++...+..|.++++|++|+|++|
T Consensus 10 ~~~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n 86 (276)
T 2z62_A 10 ITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86 (276)
T ss_dssp TEEECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred ceEEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCC
Confidence 35667777776 4565554 57888888888888777778888888888888888888777778888888888888888
Q ss_pred ccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCC-CCccCcCCCCCcEEEccCcccccccc
Q 035761 88 EIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGP-IPPELMNCSKLRILKLGNNLLSGSIP 166 (560)
Q Consensus 88 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~l~~n~l~~~~~ 166 (560)
.+++..+..|.++++|++|++++|.+++..+..+.++++|++|++++|.+++. +|..+..+++|+.|++++|++++..+
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~ 166 (276)
T 2z62_A 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 166 (276)
T ss_dssp CCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECG
T ss_pred ccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCH
Confidence 88877777888888888888888888877666788888888888888888764 47788888888888888888887777
Q ss_pred hhhccccccc----eeeccccccCCcCccccCCCceeeEEEccCCccccccCcc---cccCCCCcCCCCCCCCc
Q 035761 167 SQIGKLQELY----YLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVF---VRKVPHLDVSGNQFGGE 233 (560)
Q Consensus 167 ~~~~~l~~L~----~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~---~~~l~~l~l~~n~~~~~ 233 (560)
..|..+++|+ .|++++|++++..+..+. ..+|+.|++++|.+++..+.. +.+++.|++++|++.|.
T Consensus 167 ~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 239 (276)
T 2z62_A 167 TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 239 (276)
T ss_dssp GGGHHHHTCTTCCEEEECCSSCCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCC
T ss_pred HHhhhhhhccccceeeecCCCcccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCccccc
Confidence 7777777777 788888888865555544 347888888888888766654 35667788888888775
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-28 Score=263.90 Aligned_cols=236 Identities=22% Similarity=0.199 Sum_probs=168.9
Q ss_pred CCCCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCC-ccccCCCCCCeeecccccccccc--ccccCCCC
Q 035761 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIP-SNVGHLTQLTTLAIASNRMNGSI--LLGIGSLK 77 (560)
Q Consensus 1 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~n~i~~~~--~~~~~~l~ 77 (560)
+.++++|++|++++|.+++..|..+..+++|++|++++|.+.+..| ..+..+++|++|++++|++++.. +..+.+++
T Consensus 297 l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~ 376 (606)
T 3t6q_A 297 LVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLS 376 (606)
T ss_dssp CCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCT
T ss_pred hcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCC
Confidence 3567788888888888887777777778888888888887764443 34777777888888887777655 66677777
Q ss_pred CCCEEEeecCccCccCCCCcCCCCCccEEEccCCCccCCCCc-cCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEc
Q 035761 78 VLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPS-SLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKL 156 (560)
Q Consensus 78 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 156 (560)
+|++|++++|++++..+..|..+++|+.|++++|.+++..+. .+.++++|+.|++++|.+++..|..+..+++|+.|++
T Consensus 377 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 456 (606)
T 3t6q_A 377 HLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNL 456 (606)
T ss_dssp TCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEEC
Confidence 777777777777777777777777777777777777755443 3777777777777777777766777777777777777
Q ss_pred cCcccccc---cchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCcccccCC--CCcCCCCCCC
Q 035761 157 GNNLLSGS---IPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVP--HLDVSGNQFG 231 (560)
Q Consensus 157 ~~n~l~~~---~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~--~l~l~~n~~~ 231 (560)
++|.+++. .+..+..+++|++|++++|++++..|..|..+++|+.|++++|++++..|..+.+++ .|++++|++.
T Consensus 457 ~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~L~L~~N~l~ 536 (606)
T 3t6q_A 457 QGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHIS 536 (606)
T ss_dssp TTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSCEEECCSSCCC
T ss_pred CCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCcccccEEECcCCccc
Confidence 77777652 224567777777777777777766677777777777777777777776666554333 4566777776
Q ss_pred CcCCc
Q 035761 232 GEIPT 236 (560)
Q Consensus 232 ~~~p~ 236 (560)
+.+|.
T Consensus 537 ~~~~~ 541 (606)
T 3t6q_A 537 IILPS 541 (606)
T ss_dssp CCCGG
T ss_pred ccCHh
Confidence 65443
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-28 Score=244.93 Aligned_cols=205 Identities=24% Similarity=0.346 Sum_probs=192.4
Q ss_pred CCCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCC------
Q 035761 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGS------ 75 (560)
Q Consensus 2 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~------ 75 (560)
.++++|++|+|++|.++ .+|..|..+++|++|+|++|.++ .+|..|.++++|++|+|++|++.+..|..+..
T Consensus 101 ~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~ 178 (328)
T 4fcg_A 101 FRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGE 178 (328)
T ss_dssp GGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCC
T ss_pred hhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhh
Confidence 45789999999999999 88999999999999999999999 78999999999999999999888788877654
Q ss_pred ---CCCCCEEEeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCc
Q 035761 76 ---LKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLR 152 (560)
Q Consensus 76 ---l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 152 (560)
+++|++|+|++|+++ .+|..+.++++|++|+|++|.+++ +|..+..+++|++|+|++|.+.+.+|..+..+++|+
T Consensus 179 ~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~ 256 (328)
T 4fcg_A 179 HQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLK 256 (328)
T ss_dssp EEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCC
T ss_pred hccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCC
Confidence 999999999999999 788889999999999999999994 666899999999999999999999999999999999
Q ss_pred EEEccCcccccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccc
Q 035761 153 ILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLS 210 (560)
Q Consensus 153 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~ 210 (560)
.|++++|.+.+.+|..+..+++|++|+|++|++.+.+|..+..+++|+.+++..|.+.
T Consensus 257 ~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 257 RLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp EEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred EEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 9999999999999999999999999999999999999999999999999999988765
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-28 Score=248.26 Aligned_cols=229 Identities=18% Similarity=0.140 Sum_probs=199.4
Q ss_pred CCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEE
Q 035761 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLD 83 (560)
Q Consensus 4 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 83 (560)
++++++|++++|.++.+.+..|..+++|++|+|++|.++++.+..|..+++|++|+|++|++++..+..|.++++|++|+
T Consensus 44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 123 (390)
T 3o6n_A 44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123 (390)
T ss_dssp GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence 57899999999999977666789999999999999999988888999999999999999999988899999999999999
Q ss_pred eecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCC---------------
Q 035761 84 LSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNC--------------- 148 (560)
Q Consensus 84 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l--------------- 148 (560)
|++|+++...+..|.++++|++|++++|.+++..+..|.++++|+.|++++|.+++.....+..+
T Consensus 124 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n~l~~~~~ 203 (390)
T 3o6n_A 124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAI 203 (390)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSSCCSEEEC
T ss_pred CCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccccccccccceeecccccccccCC
Confidence 99999996666668999999999999999998888899999999999999999986533333222
Q ss_pred ----------------------CCCcEEEccCcccccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccC
Q 035761 149 ----------------------SKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSM 206 (560)
Q Consensus 149 ----------------------~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~ 206 (560)
++|+.|++++|.+++. ..+..+++|++|++++|.+++..|..+..+++|+.|++++
T Consensus 204 ~~~L~~L~l~~n~l~~~~~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~ 281 (390)
T 3o6n_A 204 PIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISN 281 (390)
T ss_dssp CSSCSEEECCSSCCCEEECCCCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCS
T ss_pred CCcceEEECCCCeeeeccccccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCC
Confidence 2466666677776643 5688999999999999999988899999999999999999
Q ss_pred CccccccCc--ccccCCCCcCCCCCCCCcC
Q 035761 207 NNLSGGIPV--FVRKVPHLDVSGNQFGGEI 234 (560)
Q Consensus 207 n~l~~~~~~--~~~~l~~l~l~~n~~~~~~ 234 (560)
|++++.... .+++++.|++++|++.+.+
T Consensus 282 n~l~~~~~~~~~l~~L~~L~L~~n~l~~~~ 311 (390)
T 3o6n_A 282 NRLVALNLYGQPIPTLKVLDLSHNHLLHVE 311 (390)
T ss_dssp SCCCEEECSSSCCTTCCEEECCSSCCCCCG
T ss_pred CcCcccCcccCCCCCCCEEECCCCcceecC
Confidence 999975443 4578999999999998653
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.9e-28 Score=271.21 Aligned_cols=228 Identities=25% Similarity=0.278 Sum_probs=162.2
Q ss_pred CCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEe
Q 035761 5 RNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDL 84 (560)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l 84 (560)
++|++|+|++|.+++..+..|..+++|++|+|++|+++++.|..|.++++|+.|+|++|++++..+..|.++++|++|+|
T Consensus 266 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 345 (844)
T 3j0a_A 266 SSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDL 345 (844)
T ss_dssp SCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEEC
T ss_pred CCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEEC
Confidence 56777777777777666777777777777777777777666777777777777777777777666677777777777777
Q ss_pred ecCccCccCCCCcCCCCCccEEEccCCCccCCC------------------Cc----------------------cCCCC
Q 035761 85 SRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPI------------------PS----------------------SLGHL 124 (560)
Q Consensus 85 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~------------------~~----------------------~~~~l 124 (560)
++|.++...+..|.++++|+.|+|++|.+++.. |. .+.++
T Consensus 346 ~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l 425 (844)
T 3j0a_A 346 QKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRV 425 (844)
T ss_dssp CSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTC
T ss_pred CCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCccccCchhhhhhcC
Confidence 777777666666666777777777766665321 00 02245
Q ss_pred CCCcEEECcCCcCcCC------------------------------CCccCcCCCCCcEEEccCcccccccchhhccccc
Q 035761 125 TQLTTLNMYNNKLDGP------------------------------IPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQE 174 (560)
Q Consensus 125 ~~L~~L~l~~n~l~~~------------------------------~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 174 (560)
++|+.|+|++|++++. .+..|..+++|+.|+|++|.+++..|..|..+++
T Consensus 426 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 505 (844)
T 3j0a_A 426 PHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTA 505 (844)
T ss_dssp TTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCS
T ss_pred CccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhh
Confidence 5666666666655532 2234666777888888888888777777888888
Q ss_pred cceeeccccccCCcCccccCCCceeeEEEccCCccccccCcccccCCCCcCCCCCCCCcC
Q 035761 175 LYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHLDVSGNQFGGEI 234 (560)
Q Consensus 175 L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~l~~n~~~~~~ 234 (560)
|+.|+|++|++++..+..+. ++|+.|++++|++++..|..+.++..+++.+|++.|.+
T Consensus 506 L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~c 563 (844)
T 3j0a_A 506 LRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICEC 563 (844)
T ss_dssp CSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCSS
T ss_pred hheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhCCcCEEEecCCCccccc
Confidence 88888888888876666655 77888888888888888888888999999999998843
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7e-28 Score=260.08 Aligned_cols=241 Identities=26% Similarity=0.289 Sum_probs=210.2
Q ss_pred CCCCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeecccccccccc-ccccCCCCCC
Q 035761 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSI-LLGIGSLKVL 79 (560)
Q Consensus 1 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~-~~~~~~l~~L 79 (560)
|+++++|++|++++|.++ .+|..+..+++|++|++++|.+++..|..+.++++|+.|++++|.+.+.. +..+.++++|
T Consensus 274 ~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L 352 (606)
T 3t6q_A 274 FHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENL 352 (606)
T ss_dssp TTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTC
T ss_pred hccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcC
Confidence 467889999999999998 67888999999999999999999888889999999999999999988544 4558999999
Q ss_pred CEEEeecCccCccC--CCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCc-cCcCCCCCcEEEc
Q 035761 80 QVLDLSRNEIGGSI--PSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPP-ELMNCSKLRILKL 156 (560)
Q Consensus 80 ~~L~l~~n~l~~~~--~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~l 156 (560)
++|++++|.+++.. +..+..+++|++|++++|.+++..|..|..+++|+.|++++|.+++..+. .+..+++|+.|++
T Consensus 353 ~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l 432 (606)
T 3t6q_A 353 RELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNL 432 (606)
T ss_dssp CEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEEC
T ss_pred CEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEEC
Confidence 99999999999765 77899999999999999999988889999999999999999999877655 4889999999999
Q ss_pred cCcccccccchhhccccccceeeccccccCCc---CccccCCCceeeEEEccCCccccccCccc---ccCCCCcCCCCCC
Q 035761 157 GNNLLSGSIPSQIGKLQELYYLDLSGNFINGK---IPSQLGEFSCIDTVDLSMNNLSGGIPVFV---RKVPHLDVSGNQF 230 (560)
Q Consensus 157 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~~~~~~~L~~l~l~~n~l~~~~~~~~---~~l~~l~l~~n~~ 230 (560)
++|.+++..|..+..+++|++|++++|++++. .+..+..+++|+.|++++|.+++..|..+ ++++.|++++|++
T Consensus 433 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 512 (606)
T 3t6q_A 433 SHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRL 512 (606)
T ss_dssp TTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCcc
Confidence 99999988889999999999999999999863 33568889999999999999998877654 5677889999999
Q ss_pred CCcCCcccCCCC
Q 035761 231 GGEIPTTLANVP 242 (560)
Q Consensus 231 ~~~~p~~~~~~~ 242 (560)
.+..+......+
T Consensus 513 ~~~~~~~l~~l~ 524 (606)
T 3t6q_A 513 TSSSIEALSHLK 524 (606)
T ss_dssp CGGGGGGGTTCC
T ss_pred CcCChhHhCccc
Confidence 987766655443
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-27 Score=230.36 Aligned_cols=209 Identities=22% Similarity=0.233 Sum_probs=191.2
Q ss_pred CCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEe
Q 035761 5 RNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDL 84 (560)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l 84 (560)
++|++|+|++|+++++.+..|.++++|++|+|++|+++++.+..|.++++|++|+|++|++++..+..|.++++|++|++
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 36999999999999888889999999999999999999888889999999999999999999888899999999999999
Q ss_pred ecCccCccCCCCcCCCCCccEEEccCCCccCC-CCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCc----EEEccCc
Q 035761 85 SRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGP-IPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLR----ILKLGNN 159 (560)
Q Consensus 85 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~----~L~l~~n 159 (560)
++|.+++..+..+..+++|++|++++|.+++. +|..+.++++|+.|+|++|++++..+..+..+++|+ .|++++|
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n 187 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSS
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCC
Confidence 99999987777899999999999999999864 589999999999999999999988777887777777 8999999
Q ss_pred ccccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccC
Q 035761 160 LLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIP 214 (560)
Q Consensus 160 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~ 214 (560)
.+++..+..+. ..+|+.|++++|++++..+..+..+++|+.|++++|++++..+
T Consensus 188 ~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 188 PMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp CCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred cccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence 99966665554 4589999999999998777788999999999999999998876
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=232.29 Aligned_cols=205 Identities=26% Similarity=0.267 Sum_probs=184.0
Q ss_pred CCCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCE
Q 035761 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQV 81 (560)
Q Consensus 2 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~ 81 (560)
++++++++|++++|+++ .+|..+. +++++|+|++|.|++..+..|.++++|+.|+|++|+|+...+. ..+++|++
T Consensus 7 ~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~~ 81 (290)
T 1p9a_G 7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLGT 81 (290)
T ss_dssp ECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCCE
T ss_pred cccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCCE
Confidence 57889999999999999 4555554 7899999999999988899999999999999999999865443 78999999
Q ss_pred EEeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCccc
Q 035761 82 LDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLL 161 (560)
Q Consensus 82 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 161 (560)
|+|++|+|+ .+|..+..+++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|+.|+|++|++
T Consensus 82 L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 160 (290)
T 1p9a_G 82 LDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL 160 (290)
T ss_dssp EECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred EECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcC
Confidence 999999999 6788899999999999999999988888999999999999999999988788889999999999999999
Q ss_pred ccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCcccccc
Q 035761 162 SGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGI 213 (560)
Q Consensus 162 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~ 213 (560)
+...+..|..+++|+.|+|++|+++ .+|..+..+.+|+.+++++|++.+..
T Consensus 161 ~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 161 TELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp SCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred CccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcC
Confidence 9777777899999999999999999 67777778889999999999998654
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=261.45 Aligned_cols=231 Identities=23% Similarity=0.230 Sum_probs=197.6
Q ss_pred CCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCC-ccccCCCCCCeeeccccccccccccccCCCCCCCEEE
Q 035761 5 RNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIP-SNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLD 83 (560)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 83 (560)
++|+.|++++|+++++.|..|..+++|++|+|++|.+.+.+| ..|.++++|++|+|++|++....+..|..+++|++|+
T Consensus 381 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~ 460 (680)
T 1ziw_A 381 SPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLM 460 (680)
T ss_dssp SCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEE
T ss_pred CcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccch
Confidence 367777777788887788888889999999999998886555 6788889999999999998888888888899999999
Q ss_pred eecCccC--ccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCC--------ccCcCCCCCcE
Q 035761 84 LSRNEIG--GSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIP--------PELMNCSKLRI 153 (560)
Q Consensus 84 l~~n~l~--~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~--------~~~~~l~~L~~ 153 (560)
+++|.++ +..|..|.++++|+.|+|++|+++++.+..|.++++|++|+|++|++++..+ ..|..+++|+.
T Consensus 461 l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~ 540 (680)
T 1ziw_A 461 LRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHI 540 (680)
T ss_dssp CTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCE
T ss_pred hccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCE
Confidence 9999886 4678889999999999999999998888889999999999999999985422 23788999999
Q ss_pred EEccCcccccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCc----ccccCCCCcCCCCC
Q 035761 154 LKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPV----FVRKVPHLDVSGNQ 229 (560)
Q Consensus 154 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~----~~~~l~~l~l~~n~ 229 (560)
|++++|+++.+.+..|.++++|+.|+|++|++++..+..|..+++|+.|++++|++++..+. .+++++.+++.+|+
T Consensus 541 L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~ 620 (680)
T 1ziw_A 541 LNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNP 620 (680)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCC
T ss_pred EECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCC
Confidence 99999999966666799999999999999999987778889999999999999999987776 35788899999999
Q ss_pred CCCcCC
Q 035761 230 FGGEIP 235 (560)
Q Consensus 230 ~~~~~p 235 (560)
+.|.++
T Consensus 621 ~~c~c~ 626 (680)
T 1ziw_A 621 FDCTCE 626 (680)
T ss_dssp CCBCCC
T ss_pred cccCCc
Confidence 988643
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-27 Score=237.21 Aligned_cols=223 Identities=25% Similarity=0.312 Sum_probs=200.0
Q ss_pred CCCCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCC
Q 035761 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQ 80 (560)
Q Consensus 1 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~ 80 (560)
|+++++|++|+|++|.++++.|..|.++++|++|+|++|+++ .+|..+. ++|++|++++|+++...+..|.++++|+
T Consensus 74 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~ 150 (332)
T 2ft3_A 74 FKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMN 150 (332)
T ss_dssp TTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCC
T ss_pred hhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCC
Confidence 568899999999999999888999999999999999999999 5555554 8999999999999988888899999999
Q ss_pred EEEeecCccCc--cCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccC
Q 035761 81 VLDLSRNEIGG--SIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGN 158 (560)
Q Consensus 81 ~L~l~~n~l~~--~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 158 (560)
+|++++|.++. ..+..+..+ +|+.|++++|++++ +|..+. ++|++|++++|.+++..+..+..+++|+.|++++
T Consensus 151 ~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~ 226 (332)
T 2ft3_A 151 CIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGH 226 (332)
T ss_dssp EEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCS
T ss_pred EEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCC
Confidence 99999999963 678888888 99999999999995 555554 7999999999999988888999999999999999
Q ss_pred cccccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCccc---------ccCCCCcCCCCC
Q 035761 159 NLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFV---------RKVPHLDVSGNQ 229 (560)
Q Consensus 159 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~~---------~~l~~l~l~~n~ 229 (560)
|.+++..+..|..+++|++|++++|+++ .+|..+..+++|+.|++++|++++..+..+ ..+..+++.+|+
T Consensus 227 N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~ 305 (332)
T 2ft3_A 227 NQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNP 305 (332)
T ss_dssp SCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSS
T ss_pred CcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCc
Confidence 9999888889999999999999999999 788889999999999999999997766543 346778999999
Q ss_pred CC
Q 035761 230 FG 231 (560)
Q Consensus 230 ~~ 231 (560)
+.
T Consensus 306 ~~ 307 (332)
T 2ft3_A 306 VP 307 (332)
T ss_dssp SC
T ss_pred cc
Confidence 87
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.4e-28 Score=258.31 Aligned_cols=229 Identities=18% Similarity=0.138 Sum_probs=201.1
Q ss_pred CCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEE
Q 035761 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLD 83 (560)
Q Consensus 4 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 83 (560)
+++++.|++++|.++.+.+..|..+++|++|+|++|.|+++.|..|..+++|+.|+|++|.+++..+..|.++++|++|+
T Consensus 50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 129 (597)
T 3oja_B 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129 (597)
T ss_dssp GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence 57899999999999987777789999999999999999999889999999999999999999998899999999999999
Q ss_pred eecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCC---------------
Q 035761 84 LSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNC--------------- 148 (560)
Q Consensus 84 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l--------------- 148 (560)
|++|.|++..+..|.++++|++|+|++|.+++..|..|.++++|+.|+|++|.+++.....+.++
T Consensus 130 L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n~l~~l~~ 209 (597)
T 3oja_B 130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAI 209 (597)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSSCCSEEEC
T ss_pred eeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccCccccccC
Confidence 99999997777778999999999999999998889999999999999999999986543333222
Q ss_pred ----------------------CCCcEEEccCcccccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccC
Q 035761 149 ----------------------SKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSM 206 (560)
Q Consensus 149 ----------------------~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~ 206 (560)
++|+.|+|++|.+++ +..+..+++|+.|+|++|.+++..|..|..+++|+.|+|++
T Consensus 210 ~~~L~~L~ls~n~l~~~~~~~~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 287 (597)
T 3oja_B 210 PIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISN 287 (597)
T ss_dssp CTTCSEEECCSSCCCEEECSCCSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTT
T ss_pred CchhheeeccCCcccccccccCCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCC
Confidence 246666666666664 36788999999999999999999999999999999999999
Q ss_pred CccccccCc--ccccCCCCcCCCCCCCCcC
Q 035761 207 NNLSGGIPV--FVRKVPHLDVSGNQFGGEI 234 (560)
Q Consensus 207 n~l~~~~~~--~~~~l~~l~l~~n~~~~~~ 234 (560)
|.+++..+. .++++..|++++|++.+.+
T Consensus 288 N~l~~l~~~~~~l~~L~~L~Ls~N~l~~i~ 317 (597)
T 3oja_B 288 NRLVALNLYGQPIPTLKVLDLSHNHLLHVE 317 (597)
T ss_dssp SCCCEEECSSSCCTTCCEEECCSSCCCCCG
T ss_pred CCCCCCCcccccCCCCcEEECCCCCCCccC
Confidence 999975443 3578999999999998643
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.8e-29 Score=268.93 Aligned_cols=207 Identities=21% Similarity=0.334 Sum_probs=108.1
Q ss_pred CCCCCCCcCCCCEEEccCCcceec-----------------CCcccc--CCCCCCeeeccccccccccccccCCCCCCCE
Q 035761 21 IPPTLGRLSELKILNLSLNSLVGN-----------------IPSNVG--HLTQLTTLAIASNRMNGSILLGIGSLKVLQV 81 (560)
Q Consensus 21 ~~~~~~~l~~L~~L~L~~N~i~~~-----------------~~~~~~--~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~ 81 (560)
+|..|+++++|++|+|++|.+++. +|..+. ++++|++|+|++|++.+..|..|.++++|++
T Consensus 198 ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~ 277 (636)
T 4eco_A 198 VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQL 277 (636)
T ss_dssp ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCE
T ss_pred CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCE
Confidence 344455555555555555555543 555555 5555555555555555555555555555555
Q ss_pred EEeecCc-cCc-cCCCCcCCC------CCccEEEccCCCccCCCCc--cCCCCCCCcEEECcCCcCcCCCCccCcCCCCC
Q 035761 82 LDLSRNE-IGG-SIPSTLGHL------KWLRSVDLSQNKLVGPIPS--SLGHLTQLTTLNMYNNKLDGPIPPELMNCSKL 151 (560)
Q Consensus 82 L~l~~n~-l~~-~~~~~~~~l------~~L~~L~l~~n~l~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 151 (560)
|+|++|+ +++ .+|..++.+ ++|++|+|++|+++ .+|. .+.++++|+.|++++|.+++.+| .+..+++|
T Consensus 278 L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L 355 (636)
T 4eco_A 278 INVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKL 355 (636)
T ss_dssp EECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEE
T ss_pred EECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCC
Confidence 5555555 554 444444443 55555555555555 4444 55555555555555555554444 55555555
Q ss_pred cEEEccCcccccccchhhccccc-cceeeccccccCCcCccccCCCc--eeeEEEccCCccccccCcccc----------
Q 035761 152 RILKLGNNLLSGSIPSQIGKLQE-LYYLDLSGNFINGKIPSQLGEFS--CIDTVDLSMNNLSGGIPVFVR---------- 218 (560)
Q Consensus 152 ~~L~l~~n~l~~~~~~~~~~l~~-L~~L~l~~n~l~~~~~~~~~~~~--~L~~l~l~~n~l~~~~~~~~~---------- 218 (560)
+.|++++|.++ .+|..+..+++ |++|++++|+++ .+|..+..++ +|+.|++++|.+++..|..+.
T Consensus 356 ~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~ 433 (636)
T 4eco_A 356 ASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGI 433 (636)
T ss_dssp SEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCC
T ss_pred CEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCC
Confidence 55555555555 44445555555 555555555555 4444444332 555555555555554444332
Q ss_pred cCCCCcCCCCCCC
Q 035761 219 KVPHLDVSGNQFG 231 (560)
Q Consensus 219 ~l~~l~l~~n~~~ 231 (560)
+++.|++++|++.
T Consensus 434 ~L~~L~Ls~N~l~ 446 (636)
T 4eco_A 434 NVSSINLSNNQIS 446 (636)
T ss_dssp CEEEEECCSSCCC
T ss_pred CCCEEECcCCccC
Confidence 3444555555544
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-28 Score=264.34 Aligned_cols=229 Identities=20% Similarity=0.315 Sum_probs=208.2
Q ss_pred CCCCCCCCEEEccCCcCccc-----------------CCCCCC--CcCCCCEEEccCCcceecCCccccCCCCCCeeecc
Q 035761 1 MGRLRNLVHLDLSDNHFMGH-----------------IPPTLG--RLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIA 61 (560)
Q Consensus 1 ~~~l~~L~~L~L~~n~l~~~-----------------~~~~~~--~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~ 61 (560)
|+++++|++|+|++|.+++. +|..+. ++++|++|+|++|++.+.+|..|.++++|++|+|+
T Consensus 202 l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls 281 (636)
T 4eco_A 202 VMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVA 281 (636)
T ss_dssp GGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECT
T ss_pred HhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECc
Confidence 45789999999999999985 899999 99999999999999999999999999999999999
Q ss_pred ccc-ccc-ccccccCCC------CCCCEEEeecCccCccCCC--CcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEE
Q 035761 62 SNR-MNG-SILLGIGSL------KVLQVLDLSRNEIGGSIPS--TLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLN 131 (560)
Q Consensus 62 ~n~-i~~-~~~~~~~~l------~~L~~L~l~~n~l~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 131 (560)
+|+ +++ ..|..+..+ ++|++|+|++|+++ .+|. .+.++++|+.|+|++|++++.+| .|..+++|+.|+
T Consensus 282 ~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~ 359 (636)
T 4eco_A 282 CNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLN 359 (636)
T ss_dssp TCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEE
T ss_pred CCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEE
Confidence 998 987 788888776 99999999999999 7888 89999999999999999998888 899999999999
Q ss_pred CcCCcCcCCCCccCcCCCC-CcEEEccCcccccccchhhcccc--ccceeeccccccCCcCccccC-------CCceeeE
Q 035761 132 MYNNKLDGPIPPELMNCSK-LRILKLGNNLLSGSIPSQIGKLQ--ELYYLDLSGNFINGKIPSQLG-------EFSCIDT 201 (560)
Q Consensus 132 l~~n~l~~~~~~~~~~l~~-L~~L~l~~n~l~~~~~~~~~~l~--~L~~L~l~~n~l~~~~~~~~~-------~~~~L~~ 201 (560)
|++|.++ .+|..+..+++ |+.|++++|.++ .+|..+..+. +|++|++++|++++..|..+. .+++|+.
T Consensus 360 L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~ 437 (636)
T 4eco_A 360 LAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSS 437 (636)
T ss_dssp CCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEE
T ss_pred CCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCE
Confidence 9999999 77888999999 999999999999 7788777655 899999999999999998888 7889999
Q ss_pred EEccCCccccccCcc---cccCCCCcCCCCCCCCc
Q 035761 202 VDLSMNNLSGGIPVF---VRKVPHLDVSGNQFGGE 233 (560)
Q Consensus 202 l~l~~n~l~~~~~~~---~~~l~~l~l~~n~~~~~ 233 (560)
|++++|.++..++.. +++++.|++++|++...
T Consensus 438 L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i 472 (636)
T 4eco_A 438 INLSNNQISKFPKELFSTGSPLSSINLMGNMLTEI 472 (636)
T ss_dssp EECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBC
T ss_pred EECcCCccCcCCHHHHccCCCCCEEECCCCCCCCc
Confidence 999999999544433 46788999999999843
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-28 Score=246.60 Aligned_cols=214 Identities=19% Similarity=0.173 Sum_probs=189.8
Q ss_pred CCCCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccc-cccCCCCCC
Q 035761 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSIL-LGIGSLKVL 79 (560)
Q Consensus 1 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~-~~~~~l~~L 79 (560)
|+++++|++|+|++|+++++.+..|.++++|++|+|++|+++++.+..|.++++|++|+|++|+++.... ..|.++++|
T Consensus 72 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L 151 (353)
T 2z80_A 72 LQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKL 151 (353)
T ss_dssp TTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTC
T ss_pred hccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCC
Confidence 4678999999999999999889999999999999999999997666669999999999999999996655 589999999
Q ss_pred CEEEeecC-ccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccC
Q 035761 80 QVLDLSRN-EIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGN 158 (560)
Q Consensus 80 ~~L~l~~n-~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 158 (560)
++|++++| .++...+..|.++++|++|++++|.+++..|..+..+++|++|++++|.++......+..+++|+.|++++
T Consensus 152 ~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~ 231 (353)
T 2z80_A 152 QILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRD 231 (353)
T ss_dssp CEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEES
T ss_pred cEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCC
Confidence 99999999 58877788999999999999999999988899999999999999999999754333455689999999999
Q ss_pred cccccc-------------------------------cchhhccccccceeeccccccCCcCccccCCCceeeEEEccCC
Q 035761 159 NLLSGS-------------------------------IPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMN 207 (560)
Q Consensus 159 n~l~~~-------------------------------~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n 207 (560)
|.+++. +|..+..+++|+.|++++|+++...+..|..+++|+.|++++|
T Consensus 232 n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 311 (353)
T 2z80_A 232 TDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTN 311 (353)
T ss_dssp CBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCC
Confidence 999863 3456788999999999999999554445689999999999999
Q ss_pred ccccccC
Q 035761 208 NLSGGIP 214 (560)
Q Consensus 208 ~l~~~~~ 214 (560)
++.+..|
T Consensus 312 ~~~~~~~ 318 (353)
T 2z80_A 312 PWDCSCP 318 (353)
T ss_dssp CBCCCHH
T ss_pred CccCcCC
Confidence 9999887
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-27 Score=256.92 Aligned_cols=132 Identities=25% Similarity=0.307 Sum_probs=89.3
Q ss_pred CCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEee
Q 035761 6 NLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLS 85 (560)
Q Consensus 6 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~ 85 (560)
++++|||++|+|+++.+.+|.++++|++|+|++|+|+++.|++|.++++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus 53 ~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls 132 (635)
T 4g8a_A 53 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 132 (635)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECT
T ss_pred CCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECC
Confidence 56777777777776666677777777777777777776666677777777777777777776666667777777777777
Q ss_pred cCccCccCCCCcCCCCCccEEEccCCCccCC-CCccCCCCCCCcEEECcCCcC
Q 035761 86 RNEIGGSIPSTLGHLKWLRSVDLSQNKLVGP-IPSSLGHLTQLTTLNMYNNKL 137 (560)
Q Consensus 86 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~l~~n~l 137 (560)
+|+|+++.+..|+++++|++|+|++|.+++. .|..+..+++|++|+|++|++
T Consensus 133 ~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l 185 (635)
T 4g8a_A 133 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 185 (635)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCC
T ss_pred CCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccc
Confidence 7777765555666677777777777766532 345555666666666655544
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-27 Score=227.97 Aligned_cols=207 Identities=22% Similarity=0.210 Sum_probs=123.9
Q ss_pred CCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEE
Q 035761 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLD 83 (560)
Q Consensus 4 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 83 (560)
+++|+.|++++|.++.. ..+..+++|++|+|++|.+++. ..+..+++|++|+|++|++++..+..|.++++|++|+
T Consensus 40 l~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 115 (272)
T 3rfs_A 40 LNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELV 115 (272)
T ss_dssp HTTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred ccceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEE
Confidence 45566666666666532 2355666666666666666542 3556666666666666666655555566666666666
Q ss_pred eecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCccccc
Q 035761 84 LSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSG 163 (560)
Q Consensus 84 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 163 (560)
|++|++++..+..|..+++|++|+|++|.+++..+..|.++++|+.|++++|++++..+..+..+++|+.|++++|++++
T Consensus 116 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 195 (272)
T 3rfs_A 116 LVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKS 195 (272)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred CCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCc
Confidence 66666665555556666666666666666665555555666666666666666665555555666666666666666665
Q ss_pred ccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCcccccCC
Q 035761 164 SIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVP 221 (560)
Q Consensus 164 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~ 221 (560)
..+..|..+++|+.|++++|++.+ .+++|+.+++..|.++|.+|..+..+.
T Consensus 196 ~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~l~~~~n~~~g~ip~~~~~~~ 246 (272)
T 3rfs_A 196 VPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVA 246 (272)
T ss_dssp CCTTTTTTCTTCCEEECCSSCBCC-------CTTTTHHHHHHHHHTGGGBBCTTSCBC
T ss_pred cCHHHHhCCcCCCEEEccCCCccc-------cCcHHHHHHHHHHhCCCcccCcccccC
Confidence 555556666666666666666553 233455556666666666665554443
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-27 Score=255.72 Aligned_cols=209 Identities=21% Similarity=0.173 Sum_probs=164.9
Q ss_pred CCCCcCCCCEEEccCCcceec--CCccccCCCCCCeeeccccccccccccccCCCCCCCEEEeecCccCccCC-CCcCCC
Q 035761 24 TLGRLSELKILNLSLNSLVGN--IPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIP-STLGHL 100 (560)
Q Consensus 24 ~~~~l~~L~~L~L~~N~i~~~--~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l 100 (560)
.+..+++|++|++++|.+++. .|..+..+++|+.|+|++|.+++ .+..|.++++|++|++++|++++..+ ..+.++
T Consensus 345 ~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l 423 (606)
T 3vq2_A 345 KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSL 423 (606)
T ss_dssp CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTC
T ss_pred hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhcc
Confidence 455677777777777777755 37777888888888888888774 45778888888888888888887666 577888
Q ss_pred CCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcC-CCCccCcCCCCCcEEEccCcccccccchhhccccccceee
Q 035761 101 KWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDG-PIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLD 179 (560)
Q Consensus 101 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 179 (560)
++|++|++++|.+++..|..+.++++|++|++++|.+++ ..|..+..+++|+.|++++|++++..|..|..+++|++|+
T Consensus 424 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 503 (606)
T 3vq2_A 424 EKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLN 503 (606)
T ss_dssp TTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred ccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEE
Confidence 888888888888887788888888888888888888886 4677888888888888888888877788888888888888
Q ss_pred ccccccCCcCccccCCCceeeEEEccCCccccccCc--ccc-cCCCCcCCCCCCCCc
Q 035761 180 LSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPV--FVR-KVPHLDVSGNQFGGE 233 (560)
Q Consensus 180 l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~--~~~-~l~~l~l~~n~~~~~ 233 (560)
+++|++++..|..+..+++|+.|++++|+++..++. .+. +++.+++.+|++.|.
T Consensus 504 Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~ 560 (606)
T 3vq2_A 504 MSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACI 560 (606)
T ss_dssp CCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCS
T ss_pred CCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccC
Confidence 888888887788888888888888888888843332 122 477788888888765
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.95 E-value=4.6e-28 Score=233.89 Aligned_cols=227 Identities=19% Similarity=0.203 Sum_probs=199.5
Q ss_pred CCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEee
Q 035761 6 NLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLS 85 (560)
Q Consensus 6 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~ 85 (560)
++..+++.++.+.+. ..+..+++|+.|++++|.++.. ..+..+++|++|+|++|++++. ..+..+++|++|+|+
T Consensus 20 ~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~ 93 (272)
T 3rfs_A 20 ETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILT 93 (272)
T ss_dssp HHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECT
T ss_pred HHHHHHhcCcccccc--cccccccceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECC
Confidence 344566777777654 3367889999999999999843 4588999999999999999863 478999999999999
Q ss_pred cCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCccccccc
Q 035761 86 RNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSI 165 (560)
Q Consensus 86 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 165 (560)
+|.+++..+..|.++++|++|+|++|++++..+..|..+++|++|++++|.+++..+..+..+++|+.|++++|++++..
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 173 (272)
T 3rfs_A 94 GNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLP 173 (272)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccC
Confidence 99999888888999999999999999999888888999999999999999999888888899999999999999999888
Q ss_pred chhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCcccccCCCCcCCCCCCCCcCCcccCCCC
Q 035761 166 PSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHLDVSGNQFGGEIPTTLANVP 242 (560)
Q Consensus 166 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~l~~n~~~~~~p~~~~~~~ 242 (560)
+..|..+++|++|++++|++++..+..+..+++|+.|++++|++.+.+| ++..+++..|.+.|.+|......+
T Consensus 174 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~----~l~~l~~~~n~~~g~ip~~~~~~~ 246 (272)
T 3rfs_A 174 EGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP----GIRYLSEWINKHSGVVRNSAGSVA 246 (272)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT----TTHHHHHHHHHTGGGBBCTTSCBC
T ss_pred HHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc----HHHHHHHHHHhCCCcccCcccccC
Confidence 8888999999999999999998888889999999999999999998765 567788888998888777655443
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4e-27 Score=249.31 Aligned_cols=88 Identities=25% Similarity=0.312 Sum_probs=45.8
Q ss_pred cCCCCCcEEEccCcccccccchhhccccccceeeccccccCC--cCccccCCCceeeEEEccCCccccccCc----cccc
Q 035761 146 MNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFING--KIPSQLGEFSCIDTVDLSMNNLSGGIPV----FVRK 219 (560)
Q Consensus 146 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~--~~~~~~~~~~~L~~l~l~~n~l~~~~~~----~~~~ 219 (560)
..+++|+.|++++|.+++..|..+..+++|++|++++|++++ .+|..+..+++|+.|++++|.+++.+|. .+.+
T Consensus 321 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~ 400 (520)
T 2z7x_B 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKS 400 (520)
T ss_dssp SSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTT
T ss_pred hhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCcc
Confidence 344555555555555555555555555555555555555554 2334455555555555555555543332 1234
Q ss_pred CCCCcCCCCCCCCc
Q 035761 220 VPHLDVSGNQFGGE 233 (560)
Q Consensus 220 l~~l~l~~n~~~~~ 233 (560)
++.|++++|++.+.
T Consensus 401 L~~L~Ls~N~l~~~ 414 (520)
T 2z7x_B 401 LLSLNMSSNILTDT 414 (520)
T ss_dssp CCEEECCSSCCCGG
T ss_pred CCEEECcCCCCCcc
Confidence 45555555555443
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-26 Score=252.67 Aligned_cols=231 Identities=24% Similarity=0.242 Sum_probs=117.6
Q ss_pred CCCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcce--ecCCccccCC--CCCCeeeccccccccccccccCCCC
Q 035761 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLV--GNIPSNVGHL--TQLTTLAIASNRMNGSILLGIGSLK 77 (560)
Q Consensus 2 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~--~~~~~~~~~l--~~L~~L~L~~n~i~~~~~~~~~~l~ 77 (560)
+.+++|++|++++|.++++.+..|.++++|++|++++|.+. .+.+..|..+ ++|+.|+|++|++++..+..|.+++
T Consensus 326 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~ 405 (680)
T 1ziw_A 326 QWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLG 405 (680)
T ss_dssp TTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCT
T ss_pred ccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCC
Confidence 45778888888888888877777888877777777766422 1222222221 3445555555555544455555555
Q ss_pred CCCEEEeecCccCccCC-CCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCc--CCCCccCcCCCCCcEE
Q 035761 78 VLQVLDLSRNEIGGSIP-STLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLD--GPIPPELMNCSKLRIL 154 (560)
Q Consensus 78 ~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~--~~~~~~~~~l~~L~~L 154 (560)
+|++|+|++|.+++.++ ..|.++++|++|++++|++.+..+..|..+++|+.|++++|.++ +..|..|..+++|+.|
T Consensus 406 ~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L 485 (680)
T 1ziw_A 406 HLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTIL 485 (680)
T ss_dssp TCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEE
T ss_pred CCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEE
Confidence 55555555555543333 34555555555555555555444444444455555555544443 2334444444445555
Q ss_pred EccCcccccccchhhccccccceeeccccccCCcCc--------cccCCCceeeEEEccCCccccccCcc---cccCCCC
Q 035761 155 KLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIP--------SQLGEFSCIDTVDLSMNNLSGGIPVF---VRKVPHL 223 (560)
Q Consensus 155 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~--------~~~~~~~~L~~l~l~~n~l~~~~~~~---~~~l~~l 223 (560)
++++|++++..+..|..+++|++|++++|++++..+ ..+..+++|+.|++++|.++...+.. +.+++.|
T Consensus 486 ~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L 565 (680)
T 1ziw_A 486 DLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKII 565 (680)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred ECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCccee
Confidence 555554444444444444444444444444443211 12344444444444444444322221 2333444
Q ss_pred cCCCCCCCC
Q 035761 224 DVSGNQFGG 232 (560)
Q Consensus 224 ~l~~n~~~~ 232 (560)
++++|++.+
T Consensus 566 ~Ls~N~l~~ 574 (680)
T 1ziw_A 566 DLGLNNLNT 574 (680)
T ss_dssp ECCSSCCCC
T ss_pred ECCCCCCCc
Confidence 444444443
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.1e-28 Score=237.44 Aligned_cols=221 Identities=23% Similarity=0.259 Sum_probs=142.6
Q ss_pred CCEEEccCCcCc-ccCCCCCC-------CcCCCCEEEccCCcceecCCccc--cCCCCCCeeeccccccccccccccCCC
Q 035761 7 LVHLDLSDNHFM-GHIPPTLG-------RLSELKILNLSLNSLVGNIPSNV--GHLTQLTTLAIASNRMNGSILLGIGSL 76 (560)
Q Consensus 7 L~~L~L~~n~l~-~~~~~~~~-------~l~~L~~L~L~~N~i~~~~~~~~--~~l~~L~~L~L~~n~i~~~~~~~~~~l 76 (560)
|++|+|++|.++ ..+|..+. ++++|++|+|++|++++..|..+ ..+++|++|+|++|++++. |..+..+
T Consensus 65 L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l 143 (312)
T 1wwl_A 65 IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAEL 143 (312)
T ss_dssp HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHH
T ss_pred HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHH
Confidence 566677777774 23444333 56777777777777776666665 6777777777777777755 5555555
Q ss_pred -----CCCCEEEeecCccCccCCCCcCCCCCccEEEccCCCccCC--CCccC--CCCCCCcEEECcCCcCcCC---CCcc
Q 035761 77 -----KVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGP--IPSSL--GHLTQLTTLNMYNNKLDGP---IPPE 144 (560)
Q Consensus 77 -----~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~--~~l~~L~~L~l~~n~l~~~---~~~~ 144 (560)
++|++|+|++|++++..+..|.++++|++|+|++|++.+. .+..+ ..+++|++|+|++|++++. ....
T Consensus 144 ~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 223 (312)
T 1wwl_A 144 QQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSAL 223 (312)
T ss_dssp HTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHH
T ss_pred HHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHH
Confidence 6777777777777766667777777777777777776543 12222 6677777777777777621 1123
Q ss_pred CcCCCCCcEEEccCcccccccc-hhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCc--ccccCC
Q 035761 145 LMNCSKLRILKLGNNLLSGSIP-SQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPV--FVRKVP 221 (560)
Q Consensus 145 ~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~--~~~~l~ 221 (560)
+..+++|+.|++++|++++..| ..+..+++|++|+|++|+|+ .+|..+. ++|+.|++++|++++. |. .+++++
T Consensus 224 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~~~~l~~L~ 299 (312)
T 1wwl_A 224 AAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PSPDELPQVG 299 (312)
T ss_dssp HHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CCTTTSCEEE
T ss_pred HhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hhHhhCCCCC
Confidence 3456777777777777776553 34555677777777777776 5555554 6777777777777755 32 234556
Q ss_pred CCcCCCCCCCC
Q 035761 222 HLDVSGNQFGG 232 (560)
Q Consensus 222 ~l~l~~n~~~~ 232 (560)
.|++++|++.+
T Consensus 300 ~L~L~~N~l~~ 310 (312)
T 1wwl_A 300 NLSLKGNPFLD 310 (312)
T ss_dssp EEECTTCTTTC
T ss_pred EEeccCCCCCC
Confidence 66777777664
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.1e-27 Score=249.18 Aligned_cols=104 Identities=29% Similarity=0.280 Sum_probs=47.9
Q ss_pred CCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEee
Q 035761 6 NLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLS 85 (560)
Q Consensus 6 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~ 85 (560)
+|++|+|++|.|+++.+..|.++++|++|+|++|+|+++.|+.|.++++|++|+|++|+++. +|.. .+++|++|+|+
T Consensus 53 ~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~--~l~~L~~L~Ls 129 (562)
T 3a79_B 53 RTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQN-ISCC--PMASLRHLDLS 129 (562)
T ss_dssp TCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCE-ECSC--CCTTCSEEECC
T ss_pred CcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCc-cCcc--ccccCCEEECC
Confidence 44555555555554444445555555555555555554444455555555555555554442 2222 34444444444
Q ss_pred cCccCcc-CCCCcCCCCCccEEEccCCC
Q 035761 86 RNEIGGS-IPSTLGHLKWLRSVDLSQNK 112 (560)
Q Consensus 86 ~n~l~~~-~~~~~~~l~~L~~L~l~~n~ 112 (560)
+|++++. .|..|.++++|++|+|++|.
T Consensus 130 ~N~l~~l~~p~~~~~l~~L~~L~L~~n~ 157 (562)
T 3a79_B 130 FNDFDVLPVCKEFGNLTKLTFLGLSAAK 157 (562)
T ss_dssp SSCCSBCCCCGGGGGCTTCCEEEEECSB
T ss_pred CCCccccCchHhhcccCcccEEecCCCc
Confidence 4444432 12344444444444444443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=6e-28 Score=238.53 Aligned_cols=217 Identities=24% Similarity=0.244 Sum_probs=186.2
Q ss_pred CCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEE
Q 035761 3 RLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVL 82 (560)
Q Consensus 3 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 82 (560)
.+++|++|+|++|.+++..|..|..+++|++|+|++|.+++..+ |..+++|++|+|++|++++.. ..++|++|
T Consensus 32 ~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~-----~~~~L~~L 104 (317)
T 3o53_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIETL 104 (317)
T ss_dssp TGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEE-----ECTTCCEE
T ss_pred cCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccccc-----CCCCcCEE
Confidence 46789999999999998888899999999999999999997654 999999999999999998544 23899999
Q ss_pred EeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccC-cCCCCCcEEEccCccc
Q 035761 83 DLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPEL-MNCSKLRILKLGNNLL 161 (560)
Q Consensus 83 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-~~l~~L~~L~l~~n~l 161 (560)
++++|++++..+.. +++|++|++++|++++..+..+..+++|++|+|++|.+++..+..+ ..+++|+.|++++|.+
T Consensus 105 ~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l 181 (317)
T 3o53_A 105 HAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181 (317)
T ss_dssp ECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCC
T ss_pred ECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcC
Confidence 99999999765544 5789999999999998878899999999999999999998777766 4789999999999999
Q ss_pred ccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCc--ccccCCCCcCCCCCCCC
Q 035761 162 SGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPV--FVRKVPHLDVSGNQFGG 232 (560)
Q Consensus 162 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~--~~~~l~~l~l~~n~~~~ 232 (560)
++. +. ...+++|++|+|++|++++. |..+..+++|+.|++++|++++.++. .+.+++.|++++|++.|
T Consensus 182 ~~~-~~-~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~~l~~~~~~l~~L~~L~l~~N~~~~ 251 (317)
T 3o53_A 182 YDV-KG-QVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHC 251 (317)
T ss_dssp CEE-EC-CCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCCBH
T ss_pred ccc-cc-ccccccCCEEECCCCcCCcc-hhhhcccCcccEEECcCCcccchhhHhhcCCCCCEEEccCCCccC
Confidence 855 32 34589999999999999954 44588999999999999999954322 34678889999999874
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.7e-28 Score=255.96 Aligned_cols=186 Identities=16% Similarity=0.223 Sum_probs=147.2
Q ss_pred cccceeeccCCeeEEEEEeCCCcEEEEEEccchh------hhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEE
Q 035761 318 DIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLE------TELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLI 391 (560)
Q Consensus 318 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 391 (560)
...+.||+|+||.||+|.. .++.+++|+..... ......+.+.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3456899999999999965 47788888754322 1122245689999999999999999777777777788999
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 471 (560)
|||+++|+|.+++.. +..++.|+++||+|||+. +|+||||||+|||++. .+||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999975 458999999999999999 9999999999999998 999999999998753
Q ss_pred CCCC-------ceeeccccCccCcccccc--CccCcchhHHHHHHHHHHHHhCCCCCC
Q 035761 472 DSSN-------RTLLAGTYGSIAPELAYT--MVVTEKYDVYSFGVVALEVLMGKHPGE 520 (560)
Q Consensus 472 ~~~~-------~~~~~g~~~~~aPE~~~~--~~~~~~~Dv~s~G~il~el~~g~~P~~ 520 (560)
.... .....||+.|||||++.. ..|+..+|+||..+-..+-+.++.+|.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 2211 134579999999999987 567888999999999999888887764
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.94 E-value=7e-28 Score=265.23 Aligned_cols=227 Identities=24% Similarity=0.336 Sum_probs=196.6
Q ss_pred CCCCEEEccCCcCcccCCCCCCCcCCCCEEEc-cCCcceec---------------------------------------
Q 035761 5 RNLVHLDLSDNHFMGHIPPTLGRLSELKILNL-SLNSLVGN--------------------------------------- 44 (560)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L-~~N~i~~~--------------------------------------- 44 (560)
.+++.|+|++|++++.+|+.|+++++|++|+| ++|.+.+.
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 46899999999999999999999999999999 77754333
Q ss_pred -------------------------------------CCccccCCCCCCeeecccccccc-----------------ccc
Q 035761 45 -------------------------------------IPSNVGHLTQLTTLAIASNRMNG-----------------SIL 70 (560)
Q Consensus 45 -------------------------------------~~~~~~~l~~L~~L~L~~n~i~~-----------------~~~ 70 (560)
+|..|.++++|+.|+|++|++++ .+|
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP 482 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYEN 482 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTT
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCC
Confidence 78889999999999999999997 378
Q ss_pred cccC--CCCCCCEEEeecCccCccCCCCcCCCCCccEEEccCCC-ccC-CCCccCCCCC-------CCcEEECcCCcCcC
Q 035761 71 LGIG--SLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNK-LVG-PIPSSLGHLT-------QLTTLNMYNNKLDG 139 (560)
Q Consensus 71 ~~~~--~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~-l~~-~~~~~~~~l~-------~L~~L~l~~n~l~~ 139 (560)
..++ ++++|++|+|++|++.+.+|..|.++++|+.|+|++|+ +++ .+|..+.+++ +|+.|+|++|.++
T Consensus 483 ~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~- 561 (876)
T 4ecn_A 483 EELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE- 561 (876)
T ss_dssp SCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-
T ss_pred hhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-
Confidence 8877 99999999999999998999999999999999999998 887 6776555544 9999999999999
Q ss_pred CCCc--cCcCCCCCcEEEccCcccccccchhhccccccceeeccccccCCcCccccCCCce-eeEEEccCCccccccCcc
Q 035761 140 PIPP--ELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSC-IDTVDLSMNNLSGGIPVF 216 (560)
Q Consensus 140 ~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~-L~~l~l~~n~l~~~~~~~ 216 (560)
.+|. .+.++++|+.|+|++|.++ .+| .|..+++|+.|+|++|+++ .+|..+..+++ |+.|++++|+++ .+|..
T Consensus 562 ~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~ 637 (876)
T 4ecn_A 562 EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNI 637 (876)
T ss_dssp BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSC
T ss_pred ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchh
Confidence 7777 8999999999999999998 777 8999999999999999999 78888999998 999999999998 66664
Q ss_pred cc-----cCCCCcCCCCCCCCcCCc
Q 035761 217 VR-----KVPHLDVSGNQFGGEIPT 236 (560)
Q Consensus 217 ~~-----~l~~l~l~~n~~~~~~p~ 236 (560)
+. +++.|++++|++.+.+|.
T Consensus 638 ~~~~~~~~L~~L~Ls~N~l~g~ip~ 662 (876)
T 4ecn_A 638 FNAKSVYVMGSVDFSYNKIGSEGRN 662 (876)
T ss_dssp CCTTCSSCEEEEECCSSCTTTTSSS
T ss_pred hhccccCCCCEEECcCCcCCCcccc
Confidence 43 377889999999886553
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-28 Score=241.46 Aligned_cols=223 Identities=20% Similarity=0.210 Sum_probs=118.3
Q ss_pred CCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcce-ecCCcccc-------CCCCCCeeecccccccccccccc--C
Q 035761 5 RNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLV-GNIPSNVG-------HLTQLTTLAIASNRMNGSILLGI--G 74 (560)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~~-------~l~~L~~L~L~~n~i~~~~~~~~--~ 74 (560)
++|++|++++|.+ .+|..+... |++|+|++|.++ ...|..+. ++++|++|+|++|++++..|..+ .
T Consensus 43 ~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~ 118 (312)
T 1wwl_A 43 RSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEA 118 (312)
T ss_dssp EECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSC
T ss_pred CCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHh
Confidence 3455566666665 344433322 555666666653 23333333 45566666666666655555544 5
Q ss_pred CCCCCCEEEeecCccCccCCCCcCCC-----CCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCC--CCccC--
Q 035761 75 SLKVLQVLDLSRNEIGGSIPSTLGHL-----KWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGP--IPPEL-- 145 (560)
Q Consensus 75 ~l~~L~~L~l~~n~l~~~~~~~~~~l-----~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~-- 145 (560)
.+++|++|+|++|++++. |..+..+ ++|++|+|++|++++..+..|.++++|++|+|++|++.+. .+..+
T Consensus 119 ~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~ 197 (312)
T 1wwl_A 119 TGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCP 197 (312)
T ss_dssp CSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCT
T ss_pred cCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHh
Confidence 566666666666666644 5545444 5566666666666555555566666666666666655432 12222
Q ss_pred cCCCCCcEEEccCccccc---ccchhhccccccceeeccccccCCcCc-cccCCCceeeEEEccCCccccccCccc-ccC
Q 035761 146 MNCSKLRILKLGNNLLSG---SIPSQIGKLQELYYLDLSGNFINGKIP-SQLGEFSCIDTVDLSMNNLSGGIPVFV-RKV 220 (560)
Q Consensus 146 ~~l~~L~~L~l~~n~l~~---~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~~~~L~~l~l~~n~l~~~~~~~~-~~l 220 (560)
..+++|+.|++++|.+++ .....+..+++|++|++++|++++..| ..+..+++|+.|++++|.++ .+|..+ .++
T Consensus 198 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~~~L 276 (312)
T 1wwl_A 198 LKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPAKL 276 (312)
T ss_dssp TSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCCSEE
T ss_pred ccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhccCCc
Confidence 555666666666666552 111223455566666666666655443 33444556666666666665 333322 355
Q ss_pred CCCcCCCCCCCCc
Q 035761 221 PHLDVSGNQFGGE 233 (560)
Q Consensus 221 ~~l~l~~n~~~~~ 233 (560)
+.|++++|++.+.
T Consensus 277 ~~L~Ls~N~l~~~ 289 (312)
T 1wwl_A 277 SVLDLSYNRLDRN 289 (312)
T ss_dssp EEEECCSSCCCSC
T ss_pred eEEECCCCCCCCC
Confidence 5566666665544
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.8e-26 Score=219.52 Aligned_cols=202 Identities=23% Similarity=0.248 Sum_probs=183.9
Q ss_pred CCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEeecCccCccCCCCcCCCCCccEEEc
Q 035761 29 SELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDL 108 (560)
Q Consensus 29 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 108 (560)
.+++.+++++|.++ .+|..+. ++|+.|+|++|+++...+..|.++++|++|+|++|.++...+..|.++++|++|+|
T Consensus 16 ~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l 92 (270)
T 2o6q_A 16 NNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWV 92 (270)
T ss_dssp TTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEEC
T ss_pred CCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEEC
Confidence 46889999999999 5666554 68999999999999888889999999999999999999777778899999999999
Q ss_pred cCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccccccchhhccccccceeeccccccCCc
Q 035761 109 SQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGK 188 (560)
Q Consensus 109 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 188 (560)
++|++++..+..|.++++|++|+|++|.+++..+..|..+++|+.|++++|.+++..+..|..+++|++|++++|++++.
T Consensus 93 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 172 (270)
T 2o6q_A 93 TDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRV 172 (270)
T ss_dssp CSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEe
Confidence 99999988888899999999999999999988888899999999999999999987777799999999999999999988
Q ss_pred CccccCCCceeeEEEccCCccccccCccc---ccCCCCcCCCCCCCCc
Q 035761 189 IPSQLGEFSCIDTVDLSMNNLSGGIPVFV---RKVPHLDVSGNQFGGE 233 (560)
Q Consensus 189 ~~~~~~~~~~L~~l~l~~n~l~~~~~~~~---~~l~~l~l~~n~~~~~ 233 (560)
.+..|..+++|+.|++++|++++..+..+ .+++.|++.+|++.|.
T Consensus 173 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 220 (270)
T 2o6q_A 173 PEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCT 220 (270)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCS
T ss_pred ChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCC
Confidence 88889999999999999999997776544 5778899999999875
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.2e-27 Score=248.45 Aligned_cols=225 Identities=23% Similarity=0.263 Sum_probs=155.1
Q ss_pred CCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEe
Q 035761 5 RNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDL 84 (560)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l 84 (560)
++|++|+|++|.++++.|..|.++++|++|+|++|++++..|..|.++++|++|+|++|+|+. +|.. .+++|++|+|
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~--~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVK-ISCH--PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCE-EECC--CCCCCSEEEC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceee-cCcc--ccCCccEEec
Confidence 467778888888776666777777888888888888777777777778888888888887774 3333 6777777777
Q ss_pred ecCccCcc-CCCCcCCCCCccEEEccCCCccCCCCccCCCCCCC--cEEECcCCcC--cCCCCccCcCCC----------
Q 035761 85 SRNEIGGS-IPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQL--TTLNMYNNKL--DGPIPPELMNCS---------- 149 (560)
Q Consensus 85 ~~n~l~~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L--~~L~l~~n~l--~~~~~~~~~~l~---------- 149 (560)
++|.+++. .|..|+++++|++|++++|.+++ ..+..+++| +.|++++|.+ .+..|..+..+.
T Consensus 98 ~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~ 174 (520)
T 2z7x_B 98 SFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPT 174 (520)
T ss_dssp CSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCS
T ss_pred cCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEecc
Confidence 77777753 56677777777777777777653 234444444 5555555555 333333333321
Q ss_pred -------------------------------------------------------------------------CCcEEEc
Q 035761 150 -------------------------------------------------------------------------KLRILKL 156 (560)
Q Consensus 150 -------------------------------------------------------------------------~L~~L~l 156 (560)
+|+.|++
T Consensus 175 n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l 254 (520)
T 2z7x_B 175 NKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSI 254 (520)
T ss_dssp SSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEE
T ss_pred CcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEe
Confidence 4555555
Q ss_pred cCcccccccchhh-----------------------------------------------------ccccccceeecccc
Q 035761 157 GNNLLSGSIPSQI-----------------------------------------------------GKLQELYYLDLSGN 183 (560)
Q Consensus 157 ~~n~l~~~~~~~~-----------------------------------------------------~~l~~L~~L~l~~n 183 (560)
++|.+++.+|..+ ..+++|++|++++|
T Consensus 255 ~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~Ls~n 334 (520)
T 2z7x_B 255 SNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNN 334 (520)
T ss_dssp EEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSS
T ss_pred ecccccCccccchhhcccccCceeEeccccccceecchhhhhcccccCceeEEEcCCCccccccchhhCCcccEEEeECC
Confidence 5555554333332 56788888999999
Q ss_pred ccCCcCccccCCCceeeEEEccCCcccc--ccCc---ccccCCCCcCCCCCCCCcCC
Q 035761 184 FINGKIPSQLGEFSCIDTVDLSMNNLSG--GIPV---FVRKVPHLDVSGNQFGGEIP 235 (560)
Q Consensus 184 ~l~~~~~~~~~~~~~L~~l~l~~n~l~~--~~~~---~~~~l~~l~l~~n~~~~~~p 235 (560)
++++..|..+..+++|+.|++++|++++ .+|. .+.+++.|++++|++.+..|
T Consensus 335 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~ 391 (520)
T 2z7x_B 335 LLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEK 391 (520)
T ss_dssp CCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGG
T ss_pred ccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccc
Confidence 9888788888888999999999998886 3343 44677888899998887434
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.8e-27 Score=252.34 Aligned_cols=213 Identities=22% Similarity=0.173 Sum_probs=197.2
Q ss_pred CCCCCCCCEEEccCCcCccc--CCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccc-cccCCCC
Q 035761 1 MGRLRNLVHLDLSDNHFMGH--IPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSIL-LGIGSLK 77 (560)
Q Consensus 1 ~~~l~~L~~L~L~~n~l~~~--~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~-~~~~~l~ 77 (560)
+..+++|++|++++|.+++. .+..+..+++|++|++++|.+++ .|..|.++++|+.|++++|++.+..+ ..|.+++
T Consensus 346 ~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~ 424 (606)
T 3vq2_A 346 KVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLE 424 (606)
T ss_dssp CCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCT
T ss_pred hccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccc
Confidence 35789999999999999866 47889999999999999999994 66899999999999999999998777 7899999
Q ss_pred CCCEEEeecCccCccCCCCcCCCCCccEEEccCCCccC-CCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEc
Q 035761 78 VLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVG-PIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKL 156 (560)
Q Consensus 78 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 156 (560)
+|++|++++|.+++..|..+.++++|++|++++|.+++ ..|..+..+++|+.|+|++|++++..|..+..+++|+.|++
T Consensus 425 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 504 (606)
T 3vq2_A 425 KLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNM 504 (606)
T ss_dssp TCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEEC
Confidence 99999999999999899999999999999999999997 47889999999999999999999988999999999999999
Q ss_pred cCcccccccchhhccccccceeeccccccCCcCccccCCCc-eeeEEEccCCccccccCc
Q 035761 157 GNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFS-CIDTVDLSMNNLSGGIPV 215 (560)
Q Consensus 157 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~-~L~~l~l~~n~l~~~~~~ 215 (560)
++|++++..|..|..+++|++|++++|+++ .+|..+..++ +|+.|++++|++.+..+.
T Consensus 505 s~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 505 SHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEH 563 (606)
T ss_dssp CSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred CCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence 999999988999999999999999999999 6677788887 599999999999987764
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=259.39 Aligned_cols=232 Identities=22% Similarity=0.239 Sum_probs=152.3
Q ss_pred CCCCCCCCEEEccCCcCcc-cCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccc--cCCCC
Q 035761 1 MGRLRNLVHLDLSDNHFMG-HIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLG--IGSLK 77 (560)
Q Consensus 1 ~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~--~~~l~ 77 (560)
|+++++|++|+|++|.+.+ +.|..|.++++|++|+|++|.|++..|+.|.++++|++|+|++|.+++..+.. |.+++
T Consensus 44 ~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~ 123 (844)
T 3j0a_A 44 FPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLK 123 (844)
T ss_dssp CSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCS
T ss_pred CcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccC
Confidence 4677788888888885443 34777888888888888888888777888888888888888888887644443 77888
Q ss_pred CCCEEEeecCccCccCC-CCcCCCCCccEEEccCCCccCCCCccCCCC--------------------------------
Q 035761 78 VLQVLDLSRNEIGGSIP-STLGHLKWLRSVDLSQNKLVGPIPSSLGHL-------------------------------- 124 (560)
Q Consensus 78 ~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l-------------------------------- 124 (560)
+|++|+|++|.+++..+ ..|.++++|++|+|++|.+++..+..+..+
T Consensus 124 ~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~ 203 (844)
T 3j0a_A 124 ALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRN 203 (844)
T ss_dssp SCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTT
T ss_pred CCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCcccc
Confidence 88888888888876544 467778888888888777765444333221
Q ss_pred --------------------------------------------------------------CCCcEEECcCCcCcCCCC
Q 035761 125 --------------------------------------------------------------TQLTTLNMYNNKLDGPIP 142 (560)
Q Consensus 125 --------------------------------------------------------------~~L~~L~l~~n~l~~~~~ 142 (560)
++|+.|+|++|.+.+..+
T Consensus 204 ~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~ 283 (844)
T 3j0a_A 204 MVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNS 283 (844)
T ss_dssp CCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECS
T ss_pred CceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccCh
Confidence 234444444444444444
Q ss_pred ccCcCCCCCcEEEccCcccccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCcc---ccc
Q 035761 143 PELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVF---VRK 219 (560)
Q Consensus 143 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~---~~~ 219 (560)
..|..+++|+.|+|++|.+++..|..|..+++|++|+|++|++++..|..|..+++|+.|++++|++++..+.. +.+
T Consensus 284 ~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~ 363 (844)
T 3j0a_A 284 RVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEK 363 (844)
T ss_dssp CCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCC
T ss_pred hhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCC
Confidence 45555666666666666666555666666666666666666666555666666666666666666665554433 345
Q ss_pred CCCCcCCCCCCCC
Q 035761 220 VPHLDVSGNQFGG 232 (560)
Q Consensus 220 l~~l~l~~n~~~~ 232 (560)
++.|++++|.+.+
T Consensus 364 L~~L~Ls~N~l~~ 376 (844)
T 3j0a_A 364 LQTLDLRDNALTT 376 (844)
T ss_dssp CCEEEEETCCSCC
T ss_pred CCEEECCCCCCCc
Confidence 5556666666654
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=247.74 Aligned_cols=107 Identities=22% Similarity=0.193 Sum_probs=76.4
Q ss_pred CCCCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccc-cccccCCCCCC
Q 035761 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGS-ILLGIGSLKVL 79 (560)
Q Consensus 1 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~-~~~~~~~l~~L 79 (560)
|+++++|++|+|++|+|+++.|+.|.++++|++|+|++|+|+. +|.. .+++|++|+|++|++++. .|..|.++++|
T Consensus 72 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L 148 (562)
T 3a79_B 72 ISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQN-ISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKL 148 (562)
T ss_dssp TTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCE-ECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTC
T ss_pred hccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCc-cCcc--ccccCCEEECCCCCccccCchHhhcccCcc
Confidence 4567788888888888887777888888888888888888874 4444 678888888888888764 35678888888
Q ss_pred CEEEeecCccCccCCCCcCCCCCc--cEEEccCCCc
Q 035761 80 QVLDLSRNEIGGSIPSTLGHLKWL--RSVDLSQNKL 113 (560)
Q Consensus 80 ~~L~l~~n~l~~~~~~~~~~l~~L--~~L~l~~n~l 113 (560)
++|+|++|+++.. .+..+++| +.|++++|.+
T Consensus 149 ~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l 181 (562)
T 3a79_B 149 TFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSY 181 (562)
T ss_dssp CEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSC
T ss_pred cEEecCCCccccC---chhhhhhceeeEEEeecccc
Confidence 8888888877642 23333333 6666665555
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.6e-27 Score=257.51 Aligned_cols=228 Identities=21% Similarity=0.236 Sum_probs=199.6
Q ss_pred CCCCCCCCEEEccCCcCcc-----------------cCCCCCC--CcCCCCEEEccCCcceecCCccccCCCCCCeeecc
Q 035761 1 MGRLRNLVHLDLSDNHFMG-----------------HIPPTLG--RLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIA 61 (560)
Q Consensus 1 ~~~l~~L~~L~L~~n~l~~-----------------~~~~~~~--~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~ 61 (560)
|+++++|++|+|++|.+++ .+|..++ ++++|++|+|++|++.+.+|..|.++++|+.|+|+
T Consensus 444 l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls 523 (876)
T 4ecn_A 444 IQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIA 523 (876)
T ss_dssp GGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECT
T ss_pred HhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECc
Confidence 4578999999999999998 3888877 99999999999999999999999999999999999
Q ss_pred ccc-ccc-ccccccC-------CCCCCCEEEeecCccCccCCC--CcCCCCCccEEEccCCCccCCCCccCCCCCCCcEE
Q 035761 62 SNR-MNG-SILLGIG-------SLKVLQVLDLSRNEIGGSIPS--TLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTL 130 (560)
Q Consensus 62 ~n~-i~~-~~~~~~~-------~l~~L~~L~l~~n~l~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 130 (560)
+|+ +++ ..|..+. .+++|++|+|++|+++ .+|. .+.++++|+.|+|++|+++ .+| .|.++++|+.|
T Consensus 524 ~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L 600 (876)
T 4ecn_A 524 CNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDL 600 (876)
T ss_dssp TCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEE
T ss_pred CCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEE
Confidence 998 887 6676554 4559999999999999 7888 8999999999999999999 777 89999999999
Q ss_pred ECcCCcCcCCCCccCcCCCC-CcEEEccCcccccccchhhccccc--cceeeccccccCCcCcccc---C--CCceeeEE
Q 035761 131 NMYNNKLDGPIPPELMNCSK-LRILKLGNNLLSGSIPSQIGKLQE--LYYLDLSGNFINGKIPSQL---G--EFSCIDTV 202 (560)
Q Consensus 131 ~l~~n~l~~~~~~~~~~l~~-L~~L~l~~n~l~~~~~~~~~~l~~--L~~L~l~~n~l~~~~~~~~---~--~~~~L~~l 202 (560)
+|++|.++ .+|..+..+++ |+.|+|++|.++ .+|..+..++. |+.|+|++|++.+.+|... . .+++|+.|
T Consensus 601 ~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L 678 (876)
T 4ecn_A 601 KLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTV 678 (876)
T ss_dssp ECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEE
T ss_pred ECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEE
Confidence 99999999 78888999999 999999999999 77888877654 9999999999998766432 2 34589999
Q ss_pred EccCCccccccCc---ccccCCCCcCCCCCCCCc
Q 035761 203 DLSMNNLSGGIPV---FVRKVPHLDVSGNQFGGE 233 (560)
Q Consensus 203 ~l~~n~l~~~~~~---~~~~l~~l~l~~n~~~~~ 233 (560)
++++|.++..++. .+++++.|++++|++...
T Consensus 679 ~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~i 712 (876)
T 4ecn_A 679 TLSYNEIQKFPTELFATGSPISTIILSNNLMTSI 712 (876)
T ss_dssp ECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCC
T ss_pred EccCCcCCccCHHHHccCCCCCEEECCCCcCCcc
Confidence 9999999944333 246889999999999843
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.94 E-value=4.7e-26 Score=221.54 Aligned_cols=203 Identities=24% Similarity=0.241 Sum_probs=182.1
Q ss_pred CCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEeecCccCccCCCCcCCCCCcc
Q 035761 25 LGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLR 104 (560)
Q Consensus 25 ~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 104 (560)
+.++++++++++++|.++ .+|..+. ++|+.|+|++|++++..+..|.++++|++|+|++|.|++..+. ..+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence 678899999999999999 5565554 7899999999999988899999999999999999999965443 7899999
Q ss_pred EEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccccccchhhccccccceeeccccc
Q 035761 105 SVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNF 184 (560)
Q Consensus 105 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 184 (560)
+|+|++|+++ .+|..+..+++|++|+|++|++++..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|+
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 159 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence 9999999999 678889999999999999999998888899999999999999999998888889999999999999999
Q ss_pred cCCcCccccCCCceeeEEEccCCccccccCccc--ccCCCCcCCCCCCCCc
Q 035761 185 INGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFV--RKVPHLDVSGNQFGGE 233 (560)
Q Consensus 185 l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~~--~~l~~l~l~~n~~~~~ 233 (560)
++...+..|..+++|+.|++++|+++..++..+ .+++.+++.+|++.|.
T Consensus 160 l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~ 210 (290)
T 1p9a_G 160 LTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCN 210 (290)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred CCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCc
Confidence 997777788999999999999999995444433 4688899999999875
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.3e-26 Score=243.96 Aligned_cols=231 Identities=22% Similarity=0.207 Sum_probs=147.9
Q ss_pred CCCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccc-cccccCCCCCCC
Q 035761 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGS-ILLGIGSLKVLQ 80 (560)
Q Consensus 2 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~-~~~~~~~l~~L~ 80 (560)
+++++|++|+|++|++++..|+.|.++++|++|+|++|++++..|..|.++++|++|+|++|++++. .+..|.++++|+
T Consensus 47 ~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~ 126 (549)
T 2z81_A 47 RACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQ 126 (549)
T ss_dssp SSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCC
T ss_pred hcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCcc
Confidence 4556666666666666666666666666666666666666655555566666666666666666542 345566666666
Q ss_pred EEEeecCc-cCccCCCCcCCCCCccEEEccCCCccCCCCccCCC------------------------CCCCcEEECcCC
Q 035761 81 VLDLSRNE-IGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGH------------------------LTQLTTLNMYNN 135 (560)
Q Consensus 81 ~L~l~~n~-l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~------------------------l~~L~~L~l~~n 135 (560)
+|++++|. ++...+..|.++++|++|++++|.+++..|..+.. +++|++|++++|
T Consensus 127 ~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n 206 (549)
T 2z81_A 127 TLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDT 206 (549)
T ss_dssp EEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESC
T ss_pred EEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCC
Confidence 66666665 33333345666666667777666666555555443 445555666666
Q ss_pred cCcCC---------------------------------------------------------------------------
Q 035761 136 KLDGP--------------------------------------------------------------------------- 140 (560)
Q Consensus 136 ~l~~~--------------------------------------------------------------------------- 140 (560)
++++.
T Consensus 207 ~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L 286 (549)
T 2z81_A 207 NLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETV 286 (549)
T ss_dssp BCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEE
T ss_pred ccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccc
Confidence 55542
Q ss_pred --------------------------------------CCccC-cCCCCCcEEEccCcccccccch---hhcccccccee
Q 035761 141 --------------------------------------IPPEL-MNCSKLRILKLGNNLLSGSIPS---QIGKLQELYYL 178 (560)
Q Consensus 141 --------------------------------------~~~~~-~~l~~L~~L~l~~n~l~~~~~~---~~~~l~~L~~L 178 (560)
+|..+ ..+++|+.|++++|++++..|. .+..+++|++|
T Consensus 287 ~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L 366 (549)
T 2z81_A 287 TIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTL 366 (549)
T ss_dssp EEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCCCCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEE
T ss_pred cccccccchhhhcccchhhhhhcccceEEEeccCccccCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEE
Confidence 11111 3477888899999988876543 36778888888
Q ss_pred eccccccCCcCc--cccCCCceeeEEEccCCccccccCc---ccccCCCCcCCCCCCCCc
Q 035761 179 DLSGNFINGKIP--SQLGEFSCIDTVDLSMNNLSGGIPV---FVRKVPHLDVSGNQFGGE 233 (560)
Q Consensus 179 ~l~~n~l~~~~~--~~~~~~~~L~~l~l~~n~l~~~~~~---~~~~l~~l~l~~n~~~~~ 233 (560)
++++|++++..+ ..+..+++|+.|++++|+++. +|. .+.+++.|++++|.+...
T Consensus 367 ~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~~~~~~~L~~L~Ls~N~l~~l 425 (549)
T 2z81_A 367 VLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHP-MPDSCQWPEKMRFLNLSSTGIRVV 425 (549)
T ss_dssp ECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCCC-CCSCCCCCTTCCEEECTTSCCSCC
T ss_pred EccCCcccccccchhhhhcCCCCCEEECCCCCCcc-CChhhcccccccEEECCCCCcccc
Confidence 888888875533 457778888888888888874 443 235677777888877643
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.9e-26 Score=216.02 Aligned_cols=205 Identities=15% Similarity=0.122 Sum_probs=156.4
Q ss_pred CcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccc-cccccccccCCCCCCCEEEeec-CccCccCC
Q 035761 17 FMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNR-MNGSILLGIGSLKVLQVLDLSR-NEIGGSIP 94 (560)
Q Consensus 17 l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~-i~~~~~~~~~~l~~L~~L~l~~-n~l~~~~~ 94 (560)
++ .+|. +. ++|++|+|++|+++++.+..|.++++|++|+|++|+ ++.+.+..|.++++|++|++++ |++++..+
T Consensus 23 l~-~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~ 98 (239)
T 2xwt_C 23 IQ-RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDP 98 (239)
T ss_dssp CS-SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECT
T ss_pred cc-ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCH
Confidence 55 4455 43 478888888888887777778888888888888886 7766677788888888888887 88887666
Q ss_pred CCcCCCCCccEEEccCCCccCCCCccCCCCCCCc---EEECcCC-cCcCCCCccCcCCCCCc-EEEccCcccccccchhh
Q 035761 95 STLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLT---TLNMYNN-KLDGPIPPELMNCSKLR-ILKLGNNLLSGSIPSQI 169 (560)
Q Consensus 95 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~---~L~l~~n-~l~~~~~~~~~~l~~L~-~L~l~~n~l~~~~~~~~ 169 (560)
..|.++++|++|++++|.+++ +|. |..+++|+ .|++++| .+++..+..|..+++|+ .|++++|.++...+..|
T Consensus 99 ~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~ 176 (239)
T 2xwt_C 99 DALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAF 176 (239)
T ss_dssp TSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTT
T ss_pred HHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhc
Confidence 778888888888888888875 554 77777777 8888888 88766666788888888 88888888874444445
Q ss_pred ccccccceeeccccc-cCCcCccccCCC-ceeeEEEccCCccccccCcccccCCCCcCCCC
Q 035761 170 GKLQELYYLDLSGNF-INGKIPSQLGEF-SCIDTVDLSMNNLSGGIPVFVRKVPHLDVSGN 228 (560)
Q Consensus 170 ~~l~~L~~L~l~~n~-l~~~~~~~~~~~-~~L~~l~l~~n~l~~~~~~~~~~l~~l~l~~n 228 (560)
.. ++|+.|++++|+ +++..+..|..+ ++|+.|++++|++++..+..+.+++.|++.++
T Consensus 177 ~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 177 NG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIARNT 236 (239)
T ss_dssp TT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCTTCTTCSEEECTTC
T ss_pred CC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChhHhccCceeeccCc
Confidence 44 788888888884 876667777888 88888888888888766666777887777765
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.4e-26 Score=216.42 Aligned_cols=198 Identities=16% Similarity=0.164 Sum_probs=175.8
Q ss_pred CCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCc-ceecCCccccCCCCCCeeeccc-cccccccccccCCCCCCCEE
Q 035761 5 RNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNS-LVGNIPSNVGHLTQLTTLAIAS-NRMNGSILLGIGSLKVLQVL 82 (560)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~-i~~~~~~~~~~l~~L~~L~L~~-n~i~~~~~~~~~~l~~L~~L 82 (560)
++|++|+|++|+++++.+..|.++++|++|++++|+ ++.+.+..|.++++|++|+|++ |+++...+..|.++++|++|
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 479999999999998888899999999999999997 9888888999999999999999 99998888899999999999
Q ss_pred EeecCccCccCCCCcCCCCCcc---EEEccCC-CccCCCCccCCCCCCCc-EEECcCCcCcCCCCccCcCCCCCcEEEcc
Q 035761 83 DLSRNEIGGSIPSTLGHLKWLR---SVDLSQN-KLVGPIPSSLGHLTQLT-TLNMYNNKLDGPIPPELMNCSKLRILKLG 157 (560)
Q Consensus 83 ~l~~n~l~~~~~~~~~~l~~L~---~L~l~~n-~l~~~~~~~~~~l~~L~-~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 157 (560)
++++|++++ +|. |..+++|+ .|++++| .++++.+..|.++++|+ .|++++|+++.+.+..+.. ++|+.|+++
T Consensus 111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~ 187 (239)
T 2xwt_C 111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLN 187 (239)
T ss_dssp EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECT
T ss_pred eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcC
Confidence 999999996 665 88888888 9999999 99988888899999999 9999999999554445555 899999999
Q ss_pred Ccc-cccccchhhccc-cccceeeccccccCCcCccccCCCceeeEEEccCCc
Q 035761 158 NNL-LSGSIPSQIGKL-QELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNN 208 (560)
Q Consensus 158 ~n~-l~~~~~~~~~~l-~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~ 208 (560)
+|+ +++..+..|..+ ++|+.|++++|++++..+. .+++|+.|+++++.
T Consensus 188 ~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~~ 237 (239)
T 2xwt_C 188 KNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNTW 237 (239)
T ss_dssp TCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC-
T ss_pred CCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCcc
Confidence 995 997778889999 9999999999999954443 67788899988763
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.8e-26 Score=245.74 Aligned_cols=229 Identities=18% Similarity=0.190 Sum_probs=186.2
Q ss_pred CCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCcc-c-------------------cCCCCCCeeeccc
Q 035761 3 RLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSN-V-------------------GHLTQLTTLAIAS 62 (560)
Q Consensus 3 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~-~-------------------~~l~~L~~L~L~~ 62 (560)
.+++|++|++++|.++ .+|..+..+ +|++|++++|.+. .+|.. + ..+++|+.|++++
T Consensus 280 ~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~~~l~~L~~L~l~~n~~~~~~~~~~~~~L~~L~l~~ 356 (570)
T 2z63_A 280 CLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSR 356 (570)
T ss_dssp GGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCBCBCSSCCEEEEESCBSCCBCCCCBCTTCCEEECCS
T ss_pred CcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCcccccccCEEeCcCCccccccccccCCCCCEEeCcC
Confidence 4567778888877777 456666666 6666666666665 22221 1 5678888888888
Q ss_pred ccccccc--ccccCCCCCCCEEEeecCccCccCCCCcCCCCCccEEEccCCCccCCCC-ccCCCCCCCcEEECcCCcCcC
Q 035761 63 NRMNGSI--LLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIP-SSLGHLTQLTTLNMYNNKLDG 139 (560)
Q Consensus 63 n~i~~~~--~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~ 139 (560)
|+++... +..+.++++|++|++++|.+++..+. +..+++|+.|++++|.+++..+ ..+.++++|++|++++|.+.+
T Consensus 357 n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~ 435 (570)
T 2z63_A 357 NGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV 435 (570)
T ss_dssp SCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEE
T ss_pred CccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccc
Confidence 8887554 67788889999999999998865444 8899999999999999987655 578899999999999999998
Q ss_pred CCCccCcCCCCCcEEEccCcccc-cccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCccc-
Q 035761 140 PIPPELMNCSKLRILKLGNNLLS-GSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFV- 217 (560)
Q Consensus 140 ~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~~- 217 (560)
..|..+..+++|+.|++++|.++ +.+|..+..+++|++|++++|++++..|..+..+++|+.|++++|++++.++..+
T Consensus 436 ~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 515 (570)
T 2z63_A 436 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFD 515 (570)
T ss_dssp CCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTT
T ss_pred cchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhh
Confidence 88889999999999999999997 5688889999999999999999998889999999999999999999998877644
Q ss_pred --ccCCCCcCCCCCCCCcCC
Q 035761 218 --RKVPHLDVSGNQFGGEIP 235 (560)
Q Consensus 218 --~~l~~l~l~~n~~~~~~p 235 (560)
.+++.|++++|++.|.++
T Consensus 516 ~l~~L~~L~l~~N~~~~~~~ 535 (570)
T 2z63_A 516 RLTSLQKIWLHTNPWDCSCP 535 (570)
T ss_dssp TCTTCCEEECCSSCBCCCTT
T ss_pred cccCCcEEEecCCcccCCCc
Confidence 567788999999987643
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.93 E-value=8.6e-26 Score=226.27 Aligned_cols=220 Identities=27% Similarity=0.363 Sum_probs=151.3
Q ss_pred CCCCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCC
Q 035761 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQ 80 (560)
Q Consensus 1 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~ 80 (560)
|.++++|++|++++|.+++..+ +..+++|++|++++|..... +..+..+++|+.|++++|.+....+ +..+++|+
T Consensus 106 ~~~l~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~-~~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~ 180 (347)
T 4fmz_A 106 LQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSD-LSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLY 180 (347)
T ss_dssp GTTCTTCSEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCC-CGGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCS
T ss_pred HcCCCcCCEEECcCCcccCchh--hccCCceeEEECCCCCCccc-ccchhhCCCCcEEEecCCCcCCchh--hccCCCCC
Confidence 4578899999999999885433 88888888888888865533 3447888888888888888875444 77788888
Q ss_pred EEEeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcc
Q 035761 81 VLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNL 160 (560)
Q Consensus 81 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 160 (560)
+|++++|.+++..+ +..+++|+.|++++|.+++..+ +..+++|+.|++++|.+++..+ +..+++|+.|++++|.
T Consensus 181 ~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~ 254 (347)
T 4fmz_A 181 SLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQ 254 (347)
T ss_dssp EEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred EEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCc
Confidence 88888888874332 6667777777777777764332 6667777777777777764422 6666777777777777
Q ss_pred cccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCcc---cccCCCCcCCCCCCCCcCC
Q 035761 161 LSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVF---VRKVPHLDVSGNQFGGEIP 235 (560)
Q Consensus 161 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~---~~~l~~l~l~~n~~~~~~p 235 (560)
+++. ..+..+++|++|++++|++++. ..+..+++|+.|++++|++++..+.. +++++.|++++|++.+..|
T Consensus 255 l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~ 328 (347)
T 4fmz_A 255 ISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328 (347)
T ss_dssp CCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG
T ss_pred cCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC
Confidence 7643 3466677777777777776643 34566667777777777776655543 3455666777777665533
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.6e-25 Score=211.89 Aligned_cols=177 Identities=21% Similarity=0.252 Sum_probs=96.9
Q ss_pred CCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEeec
Q 035761 7 LVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSR 86 (560)
Q Consensus 7 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~ 86 (560)
.++++++++.++ .+|..+. ++|++|+|++|.+++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++
T Consensus 16 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 92 (251)
T 3m19_A 16 KKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLAN 92 (251)
T ss_dssp GTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred CeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCC
Confidence 455666666665 3444333 4566666666666655555566666666666666666555555555555555555555
Q ss_pred CccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccccccc
Q 035761 87 NEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIP 166 (560)
Q Consensus 87 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 166 (560)
|++++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..+
T Consensus 93 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 172 (251)
T 3m19_A 93 NQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPH 172 (251)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred CcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCH
Confidence 55555444555555555555555555554444445555555555555555554444445555555555555555554444
Q ss_pred hhhccccccceeeccccccC
Q 035761 167 SQIGKLQELYYLDLSGNFIN 186 (560)
Q Consensus 167 ~~~~~l~~L~~L~l~~n~l~ 186 (560)
..|..+++|+.|+|++|++.
T Consensus 173 ~~~~~l~~L~~L~l~~N~~~ 192 (251)
T 3m19_A 173 GAFDRLGKLQTITLFGNQFD 192 (251)
T ss_dssp TTTTTCTTCCEEECCSCCBC
T ss_pred HHHhCCCCCCEEEeeCCcee
Confidence 44444555555555555444
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.2e-26 Score=244.08 Aligned_cols=183 Identities=19% Similarity=0.143 Sum_probs=160.9
Q ss_pred CCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEe
Q 035761 5 RNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDL 84 (560)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l 84 (560)
++|++|+|++|+++++.|..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..+..|.++++|++|+|
T Consensus 26 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 105 (549)
T 2z81_A 26 AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNL 105 (549)
T ss_dssp TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEEC
T ss_pred CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEEC
Confidence 58999999999999988999999999999999999999999999999999999999999999888888999999999999
Q ss_pred ecCccCcc-CCCCcCCCCCccEEEccCCC-ccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccc
Q 035761 85 SRNEIGGS-IPSTLGHLKWLRSVDLSQNK-LVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLS 162 (560)
Q Consensus 85 ~~n~l~~~-~~~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 162 (560)
++|.+++. .|..+.++++|++|++++|. +....+..|.++++|++|++++|.+++..|..+..+++|+.|++++|.+.
T Consensus 106 s~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~ 185 (549)
T 2z81_A 106 MGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA 185 (549)
T ss_dssp TTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBST
T ss_pred CCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCccc
Confidence 99999963 46789999999999999998 55445578999999999999999999888999988888888888888876
Q ss_pred cccchhhccccccceeeccccccCC
Q 035761 163 GSIPSQIGKLQELYYLDLSGNFING 187 (560)
Q Consensus 163 ~~~~~~~~~l~~L~~L~l~~n~l~~ 187 (560)
......+..+++|++|++++|++++
T Consensus 186 ~~~~~~~~~l~~L~~L~L~~n~l~~ 210 (549)
T 2z81_A 186 FLLEIFADILSSVRYLELRDTNLAR 210 (549)
T ss_dssp THHHHHHHSTTTBSEEEEESCBCTT
T ss_pred ccchhhHhhcccccEEEccCCcccc
Confidence 3333333567778888888877765
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=241.14 Aligned_cols=165 Identities=23% Similarity=0.255 Sum_probs=143.5
Q ss_pred CCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEe
Q 035761 5 RNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDL 84 (560)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l 84 (560)
+++++|+|++|.++++.+..|.++++|++|+|++|+++++.|..|.++++|++|+|++|+++...+..|.++++|++|++
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 46899999999999888889999999999999999999888889999999999999999999888889999999999999
Q ss_pred ecCccCccCCCCcCCCCCccEEEccCCCccCC-CCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCC----cEEEccCc
Q 035761 85 SRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGP-IPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKL----RILKLGNN 159 (560)
Q Consensus 85 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L----~~L~l~~n 159 (560)
++|++++..+..++++++|++|++++|.+++. +|..|.++++|++|++++|.+++..+..+..+++| +.|++++|
T Consensus 108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n 187 (570)
T 2z63_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (570)
T ss_dssp TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred cccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCC
Confidence 99999976666799999999999999999863 68889999999999999999987777777777777 77888888
Q ss_pred ccccccchhh
Q 035761 160 LLSGSIPSQI 169 (560)
Q Consensus 160 ~l~~~~~~~~ 169 (560)
.+++..|..|
T Consensus 188 ~l~~~~~~~~ 197 (570)
T 2z63_A 188 PMNFIQPGAF 197 (570)
T ss_dssp CCCEECTTTT
T ss_pred CceecCHHHh
Confidence 7765554444
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.93 E-value=5.3e-25 Score=209.78 Aligned_cols=182 Identities=23% Similarity=0.232 Sum_probs=169.1
Q ss_pred CCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEeecCccCccCCCCcCCCCCccEEEc
Q 035761 29 SELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDL 108 (560)
Q Consensus 29 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 108 (560)
.+.++++++++.++ .+|..+. ++|+.|+|++|++++..+..|.++++|++|+|++|.|++..+..|.++++|++|+|
T Consensus 14 ~~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 90 (251)
T 3m19_A 14 EGKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL 90 (251)
T ss_dssp GGGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEEC
Confidence 46789999999999 6666665 68999999999999988999999999999999999999888888999999999999
Q ss_pred cCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccccccchhhccccccceeeccccccCCc
Q 035761 109 SQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGK 188 (560)
Q Consensus 109 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 188 (560)
++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|++++..+..|..+++|++|+|++|++++.
T Consensus 91 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 170 (251)
T 3m19_A 91 ANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSV 170 (251)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCcc
Confidence 99999988888999999999999999999988777889999999999999999988777899999999999999999988
Q ss_pred CccccCCCceeeEEEccCCcccccc
Q 035761 189 IPSQLGEFSCIDTVDLSMNNLSGGI 213 (560)
Q Consensus 189 ~~~~~~~~~~L~~l~l~~n~l~~~~ 213 (560)
.+..+..+++|+.|++++|++++..
T Consensus 171 ~~~~~~~l~~L~~L~l~~N~~~c~~ 195 (251)
T 3m19_A 171 PHGAFDRLGKLQTITLFGNQFDCSR 195 (251)
T ss_dssp CTTTTTTCTTCCEEECCSCCBCTTS
T ss_pred CHHHHhCCCCCCEEEeeCCceeCCc
Confidence 8889999999999999999999873
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.4e-26 Score=240.16 Aligned_cols=205 Identities=22% Similarity=0.196 Sum_probs=179.5
Q ss_pred CCCCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCC
Q 035761 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQ 80 (560)
Q Consensus 1 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~ 80 (560)
|+++++|++|+|++|.+++..| |..+++|++|+|++|.|+++.+ .++|+.|+|++|.+++..+. .+++|+
T Consensus 54 ~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L~~N~l~~~~~~---~l~~L~ 123 (487)
T 3oja_A 54 LAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHAANNNISRVSCS---RGQGKK 123 (487)
T ss_dssp GTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEECCSSCCCCEEEC---CCSSCE
T ss_pred HhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEECcCCcCCCCCcc---ccCCCC
Confidence 4678999999999999997766 9999999999999999996543 38999999999999977665 458899
Q ss_pred EEEeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCC-CCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCc
Q 035761 81 VLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLG-HLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNN 159 (560)
Q Consensus 81 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 159 (560)
+|+|++|.+++..|..+..+++|+.|+|++|.+++..|..+. .+++|+.|+|++|.+++. ..+..+++|+.|+|++|
T Consensus 124 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~--~~~~~l~~L~~L~Ls~N 201 (487)
T 3oja_A 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV--KGQVVFAKLKTLDLSSN 201 (487)
T ss_dssp EEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE--ECCCCCTTCCEEECCSS
T ss_pred EEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc--cccccCCCCCEEECCCC
Confidence 999999999998888999999999999999999988888876 799999999999999976 33456899999999999
Q ss_pred ccccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccc-cccCccccc
Q 035761 160 LLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLS-GGIPVFVRK 219 (560)
Q Consensus 160 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~-~~~~~~~~~ 219 (560)
.+++..| .+..+++|+.|+|++|++++ +|..+..+++|+.|++++|++. +.+|.++..
T Consensus 202 ~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~ 260 (487)
T 3oja_A 202 KLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSK 260 (487)
T ss_dssp CCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTT
T ss_pred CCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHh
Confidence 9996544 59999999999999999995 7778999999999999999998 444544443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.2e-26 Score=227.30 Aligned_cols=212 Identities=21% Similarity=0.189 Sum_probs=181.3
Q ss_pred CCCCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCC
Q 035761 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQ 80 (560)
Q Consensus 1 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~ 80 (560)
|+++++|++|+|++|.+++..+ |..+++|++|+|++|+++++. ..++|++|++++|++++..+.. +++|+
T Consensus 54 ~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~ 123 (317)
T 3o53_A 54 LAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKK 123 (317)
T ss_dssp HTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCE
T ss_pred hhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccccc-----CCCCcCEEECCCCccCCcCccc---cCCCC
Confidence 3678999999999999997655 999999999999999998543 3389999999999999766554 67899
Q ss_pred EEEeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccC-CCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCc
Q 035761 81 VLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSL-GHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNN 159 (560)
Q Consensus 81 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 159 (560)
+|++++|++++..+..+..+++|++|+|++|.+++..+..+ ..+++|++|+|++|.+++. .....+++|+.|++++|
T Consensus 124 ~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~~~l~~L~~L~Ls~N 201 (317)
T 3o53_A 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV--KGQVVFAKLKTLDLSSN 201 (317)
T ss_dssp EEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE--ECCCCCTTCCEEECCSS
T ss_pred EEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc--ccccccccCCEEECCCC
Confidence 99999999998888899999999999999999997777766 4789999999999999965 33445899999999999
Q ss_pred ccccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccc-cccCcccc---cCCCCcCC
Q 035761 160 LLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLS-GGIPVFVR---KVPHLDVS 226 (560)
Q Consensus 160 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~-~~~~~~~~---~l~~l~l~ 226 (560)
++++. |..+..+++|+.|++++|+++ .+|..+..+++|+.|++++|+++ +.+|.++. +++.+++.
T Consensus 202 ~l~~l-~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~ 270 (317)
T 3o53_A 202 KLAFM-GPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (317)
T ss_dssp CCCEE-CGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHH
T ss_pred cCCcc-hhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECC
Confidence 99954 555999999999999999999 57888999999999999999999 55555443 34445555
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.93 E-value=4.1e-25 Score=230.35 Aligned_cols=217 Identities=28% Similarity=0.390 Sum_probs=178.6
Q ss_pred CCCCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCC
Q 035761 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQ 80 (560)
Q Consensus 1 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~ 80 (560)
++++++|++|++++|.+++. ..+..+++|++|++++|.+++..| +..+++|+.|++++|+++.. ..+..+++|+
T Consensus 173 ~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~ 246 (466)
T 1o6v_A 173 LANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLT 246 (466)
T ss_dssp GTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCS
T ss_pred hccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCC
Confidence 35678889999999988754 347888899999999998886544 77788999999999988754 4577889999
Q ss_pred EEEeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcc
Q 035761 81 VLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNL 160 (560)
Q Consensus 81 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 160 (560)
+|++++|.+++..+ +..+++|+.|++++|.+++..+ +..+++|+.|++++|++++..+ +..+++|+.|++++|+
T Consensus 247 ~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~ 320 (466)
T 1o6v_A 247 DLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNN 320 (466)
T ss_dssp EEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSC
T ss_pred EEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCc
Confidence 99999999986544 8888999999999999985543 7888999999999999986543 7888999999999999
Q ss_pred cccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCc-ccccCCCCcCCCCCCCCc
Q 035761 161 LSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPV-FVRKVPHLDVSGNQFGGE 233 (560)
Q Consensus 161 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~-~~~~l~~l~l~~n~~~~~ 233 (560)
+++..| +..+++|+.|++++|++++. ..+..+++|+.|++++|++++..|. .+++++.|++++|++.+.
T Consensus 321 l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~~~~~ 390 (466)
T 1o6v_A 321 ISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQAWTNA 390 (466)
T ss_dssp CSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGGGTTCTTCCEEECCCEEEECC
T ss_pred CCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccchhhcCCCCCEEeccCCcccCC
Confidence 987655 78899999999999999865 4688899999999999999887773 446778889999998875
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.93 E-value=9.1e-25 Score=226.18 Aligned_cols=211 Identities=21% Similarity=0.196 Sum_probs=178.9
Q ss_pred CCCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCE
Q 035761 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQV 81 (560)
Q Consensus 2 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~ 81 (560)
+++++|++|++++|.+++. | .|..+++|++|+|++|+++++ | +..+++|++|+|++|++++. + +.++++|++
T Consensus 39 ~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~ 110 (457)
T 3bz5_A 39 EQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTY 110 (457)
T ss_dssp HHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCE
T ss_pred hHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCE
Confidence 3578999999999999965 4 689999999999999999964 4 88999999999999999865 2 889999999
Q ss_pred EEeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCccc
Q 035761 82 LDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLL 161 (560)
Q Consensus 82 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 161 (560)
|++++|++++. + +..+++|++|++++|++++. + +..+++|++|++++|...+.+ .+..+++|+.|++++|++
T Consensus 111 L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l 182 (457)
T 3bz5_A 111 LNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKI 182 (457)
T ss_dssp EECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCC
T ss_pred EECCCCcCCee-c--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCcc
Confidence 99999999964 3 88999999999999999964 3 788999999999999555444 578889999999999999
Q ss_pred ccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCcccccCCCCcCCCCCCCCcC
Q 035761 162 SGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHLDVSGNQFGGEI 234 (560)
Q Consensus 162 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~l~~n~~~~~~ 234 (560)
++ +| +..+++|+.|++++|++++. .+..+++|+.|++++|++++.....+++++.|++++|++.+.+
T Consensus 183 ~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~ip~~~l~~L~~L~l~~N~l~~~~ 249 (457)
T 3bz5_A 183 TE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEIDVTPLTQLTYFDCSVNPLTELD 249 (457)
T ss_dssp CC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSCCCCTTCTTCSEEECCSSCCSCCC
T ss_pred ce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccccCccccCCCCEEEeeCCcCCCcC
Confidence 86 44 78889999999999999865 3788899999999999999854345677888899999988753
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.93 E-value=5.4e-25 Score=220.44 Aligned_cols=226 Identities=23% Similarity=0.374 Sum_probs=188.1
Q ss_pred CCCCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCC
Q 035761 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQ 80 (560)
Q Consensus 1 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~ 80 (560)
|.++++|++|++++|.+++. +.|..+++|++|++++|.+++..+ +..+++|+.|++++|..... ...+..+++|+
T Consensus 84 ~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~-~~~~~~l~~L~ 158 (347)
T 4fmz_A 84 LSNLVKLTNLYIGTNKITDI--SALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSD-LSPLSNMTGLN 158 (347)
T ss_dssp GTTCTTCCEEECCSSCCCCC--GGGTTCTTCSEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCC-CGGGTTCTTCC
T ss_pred hhcCCcCCEEEccCCcccCc--hHHcCCCcCCEEECcCCcccCchh--hccCCceeEEECCCCCCccc-ccchhhCCCCc
Confidence 46789999999999999854 469999999999999999985533 88999999999999966533 34489999999
Q ss_pred EEEeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcc
Q 035761 81 VLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNL 160 (560)
Q Consensus 81 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 160 (560)
+|++++|.++...+ +..+++|+.|++++|.+++..+ +..+++|+.|++++|.+.+..+ +..+++|+.|++++|.
T Consensus 159 ~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~ 232 (347)
T 4fmz_A 159 YLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNK 232 (347)
T ss_dssp EEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSC
T ss_pred EEEecCCCcCCchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCc
Confidence 99999999985443 8899999999999999985433 8889999999999999986543 8899999999999999
Q ss_pred cccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccC-cccccCCCCcCCCCCCCCcCCcccC
Q 035761 161 LSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIP-VFVRKVPHLDVSGNQFGGEIPTTLA 239 (560)
Q Consensus 161 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~-~~~~~l~~l~l~~n~~~~~~p~~~~ 239 (560)
+++..+ +..+++|++|++++|.+++. +.+..+++|+.|++++|.+++... ..+++++.|++++|++.+..+....
T Consensus 233 l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~ 308 (347)
T 4fmz_A 233 ITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDISVLNNLSQLNSLFLNNNQLGNEDMEVIG 308 (347)
T ss_dssp CCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCGGGHHHHH
T ss_pred cCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCChhhcCCCCCCEEECcCCcCCCcChhHhh
Confidence 986544 88999999999999999864 468899999999999999987532 2457888999999999876655444
Q ss_pred CC
Q 035761 240 NV 241 (560)
Q Consensus 240 ~~ 241 (560)
..
T Consensus 309 ~l 310 (347)
T 4fmz_A 309 GL 310 (347)
T ss_dssp TC
T ss_pred cc
Confidence 33
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=6.4e-26 Score=223.29 Aligned_cols=223 Identities=20% Similarity=0.186 Sum_probs=181.3
Q ss_pred CCCEEEccCCcCcccCC---CCCCCcCCCCEEEccCCcceecCCccc--cCCCCCCeeeccccccccccc----cccCCC
Q 035761 6 NLVHLDLSDNHFMGHIP---PTLGRLSELKILNLSLNSLVGNIPSNV--GHLTQLTTLAIASNRMNGSIL----LGIGSL 76 (560)
Q Consensus 6 ~L~~L~L~~n~l~~~~~---~~~~~l~~L~~L~L~~N~i~~~~~~~~--~~l~~L~~L~L~~n~i~~~~~----~~~~~l 76 (560)
.++.|.+.++.++...- ..+..+++|++|+|++|.+++..|..+ ..+++|++|+|++|++++..+ ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 47888888888763210 012245679999999999998888888 899999999999999986433 455678
Q ss_pred CCCCEEEeecCccCccCCCCcCCCCCccEEEccCCCccCC----CCccCCCCCCCcEEECcCCcCcCCCCc----cCcCC
Q 035761 77 KVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGP----IPSSLGHLTQLTTLNMYNNKLDGPIPP----ELMNC 148 (560)
Q Consensus 77 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~~~~----~~~~l 148 (560)
++|++|+|++|++++..+..|..+++|++|+|++|++.+. .+..+..+++|++|+|++|+++. ++. .+..+
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l 223 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAG 223 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHT
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcC
Confidence 9999999999999988888999999999999999997642 23345788999999999999973 333 25788
Q ss_pred CCCcEEEccCcccccccchhhccc---cccceeeccccccCCcCccccCCCceeeEEEccCCcccc-ccCcccccCCCCc
Q 035761 149 SKLRILKLGNNLLSGSIPSQIGKL---QELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSG-GIPVFVRKVPHLD 224 (560)
Q Consensus 149 ~~L~~L~l~~n~l~~~~~~~~~~l---~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~-~~~~~~~~l~~l~ 224 (560)
++|+.|+|++|++++..|..+..+ ++|++|+|++|+++ .+|..+. ++|+.|++++|++++ ..+..+++++.|+
T Consensus 224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~~~~~~l~~L~~L~ 300 (310)
T 4glp_A 224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRAPQPDELPEVDNLT 300 (310)
T ss_dssp CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSCCCTTSCCCCSCEE
T ss_pred CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCCchhhhCCCccEEE
Confidence 999999999999998878777776 69999999999999 5676664 799999999999997 4556778899999
Q ss_pred CCCCCCCC
Q 035761 225 VSGNQFGG 232 (560)
Q Consensus 225 l~~n~~~~ 232 (560)
+++|++..
T Consensus 301 L~~N~l~~ 308 (310)
T 4glp_A 301 LDGNPFLV 308 (310)
T ss_dssp CSSTTTSC
T ss_pred CcCCCCCC
Confidence 99999874
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.92 E-value=3.1e-25 Score=217.93 Aligned_cols=196 Identities=27% Similarity=0.344 Sum_probs=164.7
Q ss_pred CCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEE
Q 035761 3 RLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVL 82 (560)
Q Consensus 3 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 82 (560)
++++|++|++++|.++. ++ .+..+++|++|+|++|.+++..+ +..+++|++|+|++|++++. ..+..+++|++|
T Consensus 39 ~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L 112 (308)
T 1h6u_A 39 DLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTL 112 (308)
T ss_dssp HHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEE
T ss_pred HcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEE
Confidence 36789999999999985 34 58889999999999999986544 89999999999999999854 368889999999
Q ss_pred EeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccc
Q 035761 83 DLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLS 162 (560)
Q Consensus 83 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 162 (560)
+|++|++++. + .+..+++|+.|++++|.+++..+ +..+++|+.|++++|.+++..+ +..+++|+.|++++|.++
T Consensus 113 ~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~ 186 (308)
T 1h6u_A 113 DLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKIS 186 (308)
T ss_dssp ECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred ECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccC
Confidence 9999999854 3 38899999999999999985533 8889999999999999986433 888999999999999998
Q ss_pred cccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccC
Q 035761 163 GSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIP 214 (560)
Q Consensus 163 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~ 214 (560)
+..+ +..+++|++|++++|++++..+ +..+++|+.|++++|++++...
T Consensus 187 ~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~~~~ 234 (308)
T 1h6u_A 187 DISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPV 234 (308)
T ss_dssp CCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEECCCE
T ss_pred cChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeecCCe
Confidence 6543 8899999999999999986553 7889999999999999986443
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-24 Score=226.43 Aligned_cols=218 Identities=28% Similarity=0.381 Sum_probs=140.0
Q ss_pred CCCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCE
Q 035761 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQV 81 (560)
Q Consensus 2 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~ 81 (560)
..+++|++|+|++|.+++..+ +.++++|++|++++|.+++..+ +.++++|++|+|++|++++..+ +.++++|++
T Consensus 65 ~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~ 138 (466)
T 1o6v_A 65 EYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNR 138 (466)
T ss_dssp GGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSE
T ss_pred hhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCChH--HcCCCCCCE
Confidence 456778888888888875544 7788888888888888875544 7778888888888887775433 677777777
Q ss_pred EEeecCccCccCC-------------------CCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCC
Q 035761 82 LDLSRNEIGGSIP-------------------STLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIP 142 (560)
Q Consensus 82 L~l~~n~l~~~~~-------------------~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 142 (560)
|++++|.+++... ..+.++++|+.|++++|.+++. ..+..+++|++|++++|.+++..+
T Consensus 139 L~l~~n~l~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~ 216 (466)
T 1o6v_A 139 LELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP 216 (466)
T ss_dssp EEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG
T ss_pred EECCCCccCCChhhccCCcccEeecCCcccCchhhccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc
Confidence 7777777664210 1255667777777777777643 346677777777777777765433
Q ss_pred ccCcCCCCCcEEEccCcccccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCc-ccccCC
Q 035761 143 PELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPV-FVRKVP 221 (560)
Q Consensus 143 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~-~~~~l~ 221 (560)
+..+++|+.|++++|.+++. ..+..+++|+.|++++|++++..+ +..+++|+.|++++|.+++..+. .+.+++
T Consensus 217 --~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~ 290 (466)
T 1o6v_A 217 --LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALT 290 (466)
T ss_dssp --GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCS
T ss_pred --ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCccccccCCCccC
Confidence 55566666666666666532 245566666666666666654433 55556666666666665544331 234455
Q ss_pred CCcCCCCCCCCc
Q 035761 222 HLDVSGNQFGGE 233 (560)
Q Consensus 222 ~l~l~~n~~~~~ 233 (560)
.|++++|++.+.
T Consensus 291 ~L~L~~n~l~~~ 302 (466)
T 1o6v_A 291 NLELNENQLEDI 302 (466)
T ss_dssp EEECCSSCCSCC
T ss_pred eEEcCCCcccCc
Confidence 555555555543
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.4e-24 Score=221.91 Aligned_cols=207 Identities=23% Similarity=0.246 Sum_probs=176.9
Q ss_pred CCCCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCC
Q 035761 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQ 80 (560)
Q Consensus 1 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~ 80 (560)
|+.+++|++|+|++|+++++ | +..+++|++|+|++|++++. + +.++++|++|+|++|++++. + +..+++|+
T Consensus 60 l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~l-~--~~~l~~L~ 130 (457)
T 3bz5_A 60 IEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTKL-D--VSQNPLLT 130 (457)
T ss_dssp GGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSCC-C--CTTCTTCC
T ss_pred hcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCee-c--CCCCCcCC
Confidence 35688999999999999975 3 89999999999999999965 3 89999999999999999864 3 88999999
Q ss_pred EEEeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcc
Q 035761 81 VLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNL 160 (560)
Q Consensus 81 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 160 (560)
+|++++|++++. .+..+++|++|++++|...+.+ .+..+++|+.|++++|++++. | +..+++|+.|++++|.
T Consensus 131 ~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~l-~--l~~l~~L~~L~l~~N~ 202 (457)
T 3bz5_A 131 YLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITEL-D--VSQNKLLNRLNCDTNN 202 (457)
T ss_dssp EEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCCC-C--CTTCTTCCEEECCSSC
T ss_pred EEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCcccee-c--cccCCCCCEEECcCCc
Confidence 999999999964 3889999999999999655454 488899999999999999964 4 8889999999999999
Q ss_pred cccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCcccccCCCCcCCCCCC
Q 035761 161 LSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHLDVSGNQF 230 (560)
Q Consensus 161 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~l~~n~~ 230 (560)
+++. .+..+++|++|++++|++++ +| +..+++|+.|++++|++++..+..+++++.|++.+|.+
T Consensus 203 l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n~L 266 (457)
T 3bz5_A 203 ITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDL 266 (457)
T ss_dssp CSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECTTCCC
T ss_pred CCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEeccCCCC
Confidence 9965 38899999999999999997 45 88899999999999999987776666665544444443
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-25 Score=220.74 Aligned_cols=201 Identities=23% Similarity=0.237 Sum_probs=127.4
Q ss_pred CCCCEEEccCCcCcccCCCCC--CCcCCCCEEEccCCcceecCC----ccccCCCCCCeeeccccccccccccccCCCCC
Q 035761 5 RNLVHLDLSDNHFMGHIPPTL--GRLSELKILNLSLNSLVGNIP----SNVGHLTQLTTLAIASNRMNGSILLGIGSLKV 78 (560)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~--~~l~~L~~L~L~~N~i~~~~~----~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~ 78 (560)
++|++|+|++|.+++..|..+ ..+++|++|+|++|.+++..+ ..+..+++|++|+|++|++++..+..|.++++
T Consensus 91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~ 170 (310)
T 4glp_A 91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA 170 (310)
T ss_dssp SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence 456777777777776666666 667777777777777665333 23345667777777777776666666777777
Q ss_pred CCEEEeecCccCc---cC-CCCcCCCCCccEEEccCCCccCCCCc----cCCCCCCCcEEECcCCcCcCCCCccCcCC--
Q 035761 79 LQVLDLSRNEIGG---SI-PSTLGHLKWLRSVDLSQNKLVGPIPS----SLGHLTQLTTLNMYNNKLDGPIPPELMNC-- 148 (560)
Q Consensus 79 L~~L~l~~n~l~~---~~-~~~~~~l~~L~~L~l~~n~l~~~~~~----~~~~l~~L~~L~l~~n~l~~~~~~~~~~l-- 148 (560)
|++|+|++|++.+ .. +..+..+++|++|+|++|+++ .++. .+.++++|++|+|++|++++..|..+..+
T Consensus 171 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ 249 (310)
T 4glp_A 171 LTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMW 249 (310)
T ss_dssp CCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCC
T ss_pred CCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccC
Confidence 7777777776653 11 223356667777777777765 2222 24556677777777777776656555555
Q ss_pred -CCCcEEEccCcccccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCcccc
Q 035761 149 -SKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSG 211 (560)
Q Consensus 149 -~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~ 211 (560)
++|+.|++++|+++ .+|..+. ++|++|+|++|++++. |. +..+++|+.|++++|+++.
T Consensus 250 ~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 250 SSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp CTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred cCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence 47777777777776 4455443 5677777777777643 22 4566677777777777653
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.91 E-value=3.5e-24 Score=210.38 Aligned_cols=208 Identities=21% Similarity=0.309 Sum_probs=177.9
Q ss_pred EEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEeecCcc
Q 035761 10 LDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEI 89 (560)
Q Consensus 10 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~l 89 (560)
+.+..+.+++.. .+..+++|++|++++|.++. +| .+..+++|+.|+|++|+++...+ +.++++|++|+|++|.+
T Consensus 24 ~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l 97 (308)
T 1h6u_A 24 IAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPL 97 (308)
T ss_dssp HHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCC
T ss_pred HHhCCCCcCcee--cHHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcC
Confidence 345566666433 35678999999999999985 44 68999999999999999996655 99999999999999999
Q ss_pred CccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccccccchhh
Q 035761 90 GGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQI 169 (560)
Q Consensus 90 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 169 (560)
++. ..+..+++|+.|+|++|++++. + .+..+++|+.|++++|.+++..+ +..+++|+.|++++|.+++..+ +
T Consensus 98 ~~~--~~~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l 169 (308)
T 1h6u_A 98 KNV--SAIAGLQSIKTLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--L 169 (308)
T ss_dssp SCC--GGGTTCTTCCEEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--G
T ss_pred CCc--hhhcCCCCCCEEECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--h
Confidence 953 3689999999999999999964 3 38999999999999999996533 8999999999999999996544 8
Q ss_pred ccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCc-ccccCCCCcCCCCCCCCc
Q 035761 170 GKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPV-FVRKVPHLDVSGNQFGGE 233 (560)
Q Consensus 170 ~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~-~~~~l~~l~l~~n~~~~~ 233 (560)
..+++|+.|++++|++++..+ +..+++|+.|++++|++++..+. .+++++.|++++|++.+.
T Consensus 170 ~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~l~~l~~L~~L~l~~N~i~~~ 232 (308)
T 1h6u_A 170 ANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQTITNQ 232 (308)
T ss_dssp TTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGGGTTCTTCCEEEEEEEEEECC
T ss_pred cCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCccccccCCCCCCEEEccCCeeecC
Confidence 999999999999999996554 88999999999999999977653 456788899999999764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3e-24 Score=207.44 Aligned_cols=155 Identities=16% Similarity=0.191 Sum_probs=122.5
Q ss_pred HHHHHHhcCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhh----------------hhHHHHHHHHHHHhccC
Q 035761 308 QDMIEATEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETEL----------------ASLESFQNEARLLSQIR 371 (560)
Q Consensus 308 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------~~~~~~~~e~~~l~~l~ 371 (560)
..+......|++.+.||+|+||.||+|...+|+.||+|.++...... .....+.+|++++++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 34444456677789999999999999998779999999986433211 13456889999999999
Q ss_pred CCCcceeeeEEEeCCEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeE
Q 035761 372 HRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNIL 451 (560)
Q Consensus 372 h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nil 451 (560)
| +++.+++.. +..++||||+++|+|.+ +.. .+...++.|++.||+|||+. ||+||||||+|||
T Consensus 163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NIL 225 (282)
T 1zar_A 163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVL 225 (282)
T ss_dssp --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEE
T ss_pred --C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEE
Confidence 5 677776544 44699999999999988 432 12347999999999999999 9999999999999
Q ss_pred eCCCCcEEEeeeccccccCCCCCCceeeccccCccCcccccc
Q 035761 452 LNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYT 493 (560)
Q Consensus 452 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~ 493 (560)
++ ++.+||+|||+|+.. ..++|||++.+
T Consensus 226 l~-~~~vkl~DFG~a~~~-------------~~~~a~e~l~r 253 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVEV-------------GEEGWREILER 253 (282)
T ss_dssp EE-TTEEEECCCTTCEET-------------TSTTHHHHHHH
T ss_pred EE-CCcEEEEECCCCeEC-------------CCCCHHHHHHH
Confidence 99 999999999999743 34788887653
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-23 Score=192.32 Aligned_cols=180 Identities=22% Similarity=0.241 Sum_probs=144.6
Q ss_pred CEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEeecC
Q 035761 8 VHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRN 87 (560)
Q Consensus 8 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n 87 (560)
+.++++++.++. +|..+ .++|++|+|++|+++++.+..|.++++|++|+|++|+++...+..|.++++|++|+|++|
T Consensus 10 ~~v~c~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRTS-VPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCccC-CCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 578888888874 45443 358889999999888777777888888999999998888777777888888888888888
Q ss_pred ccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccccccch
Q 035761 88 EIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPS 167 (560)
Q Consensus 88 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 167 (560)
++++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|.+++..+..+..+++|+.|++++|.+.+
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~---- 162 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC---- 162 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC----
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec----
Confidence 8887666678888888888888888887777778888888888888888887666668888888888888887763
Q ss_pred hhccccccceeeccccccCCcCccccCCCc
Q 035761 168 QIGKLQELYYLDLSGNFINGKIPSQLGEFS 197 (560)
Q Consensus 168 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~ 197 (560)
.+++|+.|+++.|++++.+|..++.++
T Consensus 163 ---~~~~l~~L~~~~n~~~g~ip~~~~~l~ 189 (208)
T 2o6s_A 163 ---TCPGIRYLSEWINKHSGVVRNSAGSVA 189 (208)
T ss_dssp ---CTTTTHHHHHHHHHCTTTBBCTTSSBC
T ss_pred ---CCCCHHHHHHHHHhCCceeeccCcccc
Confidence 345788888888888888887776554
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2e-26 Score=234.36 Aligned_cols=231 Identities=20% Similarity=0.293 Sum_probs=189.9
Q ss_pred CCCCCCEEEccCCcCccc----CCCCCCCcCCCCEEEccCCc---ceecCCccc-------cCCCCCCeeecccccccc-
Q 035761 3 RLRNLVHLDLSDNHFMGH----IPPTLGRLSELKILNLSLNS---LVGNIPSNV-------GHLTQLTTLAIASNRMNG- 67 (560)
Q Consensus 3 ~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~---i~~~~~~~~-------~~l~~L~~L~L~~n~i~~- 67 (560)
.+++|++|+|++|.++.. ++..|..+++|++|+|++|. +++..|..+ ..+++|++|+|++|+++.
T Consensus 30 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~ 109 (386)
T 2ca6_A 30 EDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPT 109 (386)
T ss_dssp HCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTT
T ss_pred cCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHH
Confidence 468899999999999865 34558899999999999964 444455554 789999999999999987
Q ss_pred ---ccccccCCCCCCCEEEeecCccCccCCCC----cCCC---------CCccEEEccCCCcc-CCCC---ccCCCCCCC
Q 035761 68 ---SILLGIGSLKVLQVLDLSRNEIGGSIPST----LGHL---------KWLRSVDLSQNKLV-GPIP---SSLGHLTQL 127 (560)
Q Consensus 68 ---~~~~~~~~l~~L~~L~l~~n~l~~~~~~~----~~~l---------~~L~~L~l~~n~l~-~~~~---~~~~~l~~L 127 (560)
.++..+..+++|++|+|++|.++...+.. +..+ ++|++|+|++|+++ ...+ ..+..+++|
T Consensus 110 ~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L 189 (386)
T 2ca6_A 110 AQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLL 189 (386)
T ss_dssp THHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTC
T ss_pred HHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCc
Confidence 46778889999999999999997543333 3334 89999999999997 3344 467788999
Q ss_pred cEEECcCCcCcC-----CCCccCcCCCCCcEEEccCcccc----cccchhhccccccceeeccccccCCc----Ccccc-
Q 035761 128 TTLNMYNNKLDG-----PIPPELMNCSKLRILKLGNNLLS----GSIPSQIGKLQELYYLDLSGNFINGK----IPSQL- 193 (560)
Q Consensus 128 ~~L~l~~n~l~~-----~~~~~~~~l~~L~~L~l~~n~l~----~~~~~~~~~l~~L~~L~l~~n~l~~~----~~~~~- 193 (560)
++|+|++|+++. ..+..+..+++|+.|+|++|.++ ..+|..+..+++|++|+|++|++++. ++..+
T Consensus 190 ~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~ 269 (386)
T 2ca6_A 190 HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFS 269 (386)
T ss_dssp CEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHH
T ss_pred CEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHh
Confidence 999999999982 33447889999999999999996 56788899999999999999999866 45666
Q ss_pred -CCCceeeEEEccCCcccc----ccCcc----cccCCCCcCCCCCCCCc
Q 035761 194 -GEFSCIDTVDLSMNNLSG----GIPVF----VRKVPHLDVSGNQFGGE 233 (560)
Q Consensus 194 -~~~~~L~~l~l~~n~l~~----~~~~~----~~~l~~l~l~~n~~~~~ 233 (560)
..+++|+.|+|++|.+++ .+|.. +++++.|++++|++.+.
T Consensus 270 ~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~ 318 (386)
T 2ca6_A 270 KLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 318 (386)
T ss_dssp TCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTT
T ss_pred hccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcc
Confidence 348999999999999998 46653 47889999999998764
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.9e-25 Score=221.41 Aligned_cols=233 Identities=17% Similarity=0.253 Sum_probs=194.3
Q ss_pred CCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceec-CCccccCCCCCCeeeccccccccccccccCCCCCCCEEE
Q 035761 5 RNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGN-IPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLD 83 (560)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~-~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 83 (560)
++++.|++++|.+++..+. +..+++|++|+|++|.+++. .+..+..+++|++|+|++|+++...+..+..+++|++|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 6899999999999977665 55799999999999999865 788899999999999999999988888999999999999
Q ss_pred eecC-ccCcc-CCCCcCCCCCccEEEccCC-CccCC-CCccCCCCC-CCcEEECcCCc--Cc-CCCCccCcCCCCCcEEE
Q 035761 84 LSRN-EIGGS-IPSTLGHLKWLRSVDLSQN-KLVGP-IPSSLGHLT-QLTTLNMYNNK--LD-GPIPPELMNCSKLRILK 155 (560)
Q Consensus 84 l~~n-~l~~~-~~~~~~~l~~L~~L~l~~n-~l~~~-~~~~~~~l~-~L~~L~l~~n~--l~-~~~~~~~~~l~~L~~L~ 155 (560)
|++| .+++. ++..+.++++|++|++++| .+++. ++..+..++ +|++|++++|. ++ +.++..+..+++|+.|+
T Consensus 149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~ 228 (336)
T 2ast_B 149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 228 (336)
T ss_dssp CTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEE
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEe
Confidence 9999 67752 5666788999999999999 88753 466788899 99999999994 54 34566778899999999
Q ss_pred ccCcc-cccccchhhccccccceeeccccc-cCCcCccccCCCceeeEEEccCCccccccCccc-ccCCCCcCCCCCCCC
Q 035761 156 LGNNL-LSGSIPSQIGKLQELYYLDLSGNF-INGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFV-RKVPHLDVSGNQFGG 232 (560)
Q Consensus 156 l~~n~-l~~~~~~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~~-~~l~~l~l~~n~~~~ 232 (560)
+++|. +++..+..+..+++|++|++++|. +.......+..+++|+.|++++| ++......+ ..++.|++.+|++.+
T Consensus 229 l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~~~~~~~l~~~l~~L~l~~n~l~~ 307 (336)
T 2ast_B 229 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDGTLQLLKEALPHLQINCSHFTT 307 (336)
T ss_dssp CTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTTCHHHHHHHSTTSEESCCCSCC
T ss_pred CCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cCHHHHHHHHhhCcceEEecccCcc
Confidence 99999 777788899999999999999995 33222336788999999999999 554333334 469999999999998
Q ss_pred cCCcccC
Q 035761 233 EIPTTLA 239 (560)
Q Consensus 233 ~~p~~~~ 239 (560)
..|+...
T Consensus 308 ~~~~~~~ 314 (336)
T 2ast_B 308 IARPTIG 314 (336)
T ss_dssp TTCSSCS
T ss_pred ccCCccc
Confidence 7666543
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.89 E-value=9.8e-23 Score=188.21 Aligned_cols=182 Identities=21% Similarity=0.183 Sum_probs=158.7
Q ss_pred CCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEeecCccCccCCCCcCCCCCccEEEccC
Q 035761 31 LKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQ 110 (560)
Q Consensus 31 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 110 (560)
-+.++.+++.++ .+|..+ .++|++|+|++|+++...+..|.++++|++|+|++|++++..+..|..+++|++|+|++
T Consensus 9 ~~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~ 85 (208)
T 2o6s_A 9 GTTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLST 85 (208)
T ss_dssp TTEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCC
Confidence 367889999888 455444 36899999999999988888899999999999999999977777889999999999999
Q ss_pred CCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccccccchhhccccccceeeccccccCCcCc
Q 035761 111 NKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIP 190 (560)
Q Consensus 111 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 190 (560)
|++++..+..|.++++|++|+|++|++++..+..|..+++|+.|++++|.+++..+..|..+++|++|++++|++.+
T Consensus 86 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~--- 162 (208)
T 2o6s_A 86 NQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC--- 162 (208)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC---
T ss_pred CcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec---
Confidence 99997777778999999999999999998777778999999999999999997777778999999999999998874
Q ss_pred cccCCCceeeEEEccCCccccccCcccccCCC
Q 035761 191 SQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPH 222 (560)
Q Consensus 191 ~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~ 222 (560)
.+++|+.|+++.|.+++.+|..+..++.
T Consensus 163 ----~~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 163 ----TCPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp ----CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred ----CCCCHHHHHHHHHhCCceeeccCccccC
Confidence 4567889999999999999987776654
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.1e-22 Score=220.65 Aligned_cols=227 Identities=20% Similarity=0.224 Sum_probs=139.9
Q ss_pred CCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcce--ecCCccccCCCCCCeeeccccccccccccccCCCCCCCE
Q 035761 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLV--GNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQV 81 (560)
Q Consensus 4 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~--~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~ 81 (560)
++.|+.+++++|.+... ..+..+++|+.|++++|.+. +..+..+..+.+|+.|++..|.+. ..+..+..+++|+.
T Consensus 348 l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~~ 424 (635)
T 4g8a_A 348 LKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVI-TMSSNFLGLEQLEH 424 (635)
T ss_dssp CTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEE-EECSCCTTCTTCCE
T ss_pred chhhhhcccccccCCCC--cccccccccccchhhccccccccccccchhhhhhhhhhhccccccc-cccccccccccccc
Confidence 45667777777766533 23445677777777777664 234455556666666666666665 33445566666666
Q ss_pred EEeecCccCccCC-CCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcC-cCCCCccCcCCCCCcEEEccCc
Q 035761 82 LDLSRNEIGGSIP-STLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKL-DGPIPPELMNCSKLRILKLGNN 159 (560)
Q Consensus 82 L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l-~~~~~~~~~~l~~L~~L~l~~n 159 (560)
++++.|+.....+ ..|..+++++.++++.|.+.+..+..+..+++|+.|+|++|.+ .+..|..|..+++|+.|+|++|
T Consensus 425 l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N 504 (635)
T 4g8a_A 425 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 504 (635)
T ss_dssp EECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTS
T ss_pred hhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCC
Confidence 6666665553332 3455666666666666666666666666666666666666653 2345556666666666666666
Q ss_pred ccccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCccc----ccCCCCcCCCCCCCCc
Q 035761 160 LLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFV----RKVPHLDVSGNQFGGE 233 (560)
Q Consensus 160 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~~----~~l~~l~l~~n~~~~~ 233 (560)
++++..|..|.++++|++|+|++|+|++..+..|..+++|+.|++++|+|++..|..+ .+++.|++++|++.|.
T Consensus 505 ~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~ 582 (635)
T 4g8a_A 505 QLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 582 (635)
T ss_dssp CCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCS
T ss_pred ccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCccc
Confidence 6666666666666666666666666666666666666666666666666666666543 3455566666666664
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.4e-22 Score=202.86 Aligned_cols=218 Identities=16% Similarity=0.036 Sum_probs=177.0
Q ss_pred CEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccc-cccccCCCCCCCE-EEee
Q 035761 8 VHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGS-ILLGIGSLKVLQV-LDLS 85 (560)
Q Consensus 8 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~-~~~~~~~l~~L~~-L~l~ 85 (560)
++++.++++++ .+|..+. +++++|+|++|+|+.+.+++|.++++|++|+|++|++.+. .+..|.++++|++ +.++
T Consensus 12 ~~v~C~~~~Lt-~iP~~l~--~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCC-SCCTTCC--TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCC-ccCcCcC--CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 67889999998 5666553 6899999999999977778899999999999999998654 4567889988775 6677
Q ss_pred cCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcC-CcCcCCCCccCcCCC-CCcEEEccCccccc
Q 035761 86 RNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYN-NKLDGPIPPELMNCS-KLRILKLGNNLLSG 163 (560)
Q Consensus 86 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~-n~l~~~~~~~~~~l~-~L~~L~l~~n~l~~ 163 (560)
+|+|+.+.|+.|..+++|++|++++|+++...+..+....++..|++.+ |.+..+.+..|..+. .++.|++++|+|+.
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~ 168 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 168 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccC
Confidence 7999988888999999999999999999977777777788888998865 577766666777765 68899999999985
Q ss_pred ccchhhccccccceeeccc-cccCCcCccccCCCceeeEEEccCCccccccCcccccCCCCcCCCCC
Q 035761 164 SIPSQIGKLQELYYLDLSG-NFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHLDVSGNQ 229 (560)
Q Consensus 164 ~~~~~~~~l~~L~~L~l~~-n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~l~~n~ 229 (560)
+.+. .....+|+.|++++ |.++...++.|..+++|+.|++++|+|+..++..+.+++.|.+.++.
T Consensus 169 i~~~-~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~~ 234 (350)
T 4ay9_X 169 IHNS-AFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 234 (350)
T ss_dssp ECTT-SSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTCT
T ss_pred CChh-hccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccCC
Confidence 4444 44567899999975 66775556678999999999999999998777778888888766554
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=8.6e-23 Score=204.38 Aligned_cols=219 Identities=16% Similarity=0.080 Sum_probs=174.5
Q ss_pred CCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCccee-cCCccccCCCCCCe-eeccccccccccccccCCCCCCCEE
Q 035761 5 RNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVG-NIPSNVGHLTQLTT-LAIASNRMNGSILLGIGSLKVLQVL 82 (560)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~-~~~~~~~~l~~L~~-L~L~~n~i~~~~~~~~~~l~~L~~L 82 (560)
+++++|+|++|+|+.+.+++|.++++|++|+|++|++.+ +.+.+|.++++|+. +.++.|+++.+.+..|.++++|++|
T Consensus 30 ~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L 109 (350)
T 4ay9_X 30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 109 (350)
T ss_dssp TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEE
T ss_pred CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccc
Confidence 579999999999998878899999999999999999865 44567899999876 6677899998889999999999999
Q ss_pred EeecCccCccCCCCcCCCCCccEEEccC-CCccCCCCccCCCCC-CCcEEECcCCcCcCCCCccCcCCCCCcEEEccC-c
Q 035761 83 DLSRNEIGGSIPSTLGHLKWLRSVDLSQ-NKLVGPIPSSLGHLT-QLTTLNMYNNKLDGPIPPELMNCSKLRILKLGN-N 159 (560)
Q Consensus 83 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~-n~l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~-n 159 (560)
++++|+|+...+..+....++..|++.+ |++..+.+..|..+. .++.|+|++|+|+.+.+ ......+|+.|++++ |
T Consensus 110 ~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i~~-~~f~~~~L~~l~l~~~n 188 (350)
T 4ay9_X 110 LISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHN-SAFNGTQLDELNLSDNN 188 (350)
T ss_dssp EEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECT-TSSTTEEEEEEECTTCT
T ss_pred cccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccCCCh-hhccccchhHHhhccCC
Confidence 9999999977777788888899999976 678867777788775 68999999999995544 444567899999975 7
Q ss_pred ccccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCc--ccccCCCCcCCC
Q 035761 160 LLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPV--FVRKVPHLDVSG 227 (560)
Q Consensus 160 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~--~~~~l~~l~l~~ 227 (560)
.++.+.+..|..+++|++|+|++|+|+...+..+.++.+|+.+++ +.++ .+|. .+.++..+++..
T Consensus 189 ~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~--~~l~-~lP~l~~l~~L~~l~l~~ 255 (350)
T 4ay9_X 189 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLPTLEKLVALMEASLTY 255 (350)
T ss_dssp TCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTC--TTCC-CCCCTTTCCSCCEEECSC
T ss_pred cccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccC--CCcC-cCCCchhCcChhhCcCCC
Confidence 788666678999999999999999999666655655555544433 3333 3442 345555556543
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=3.6e-25 Score=222.87 Aligned_cols=230 Identities=20% Similarity=0.228 Sum_probs=175.7
Q ss_pred CCCCCEEEccCCcCcccCC----CCCCCcC-CCCEEEccCCcceecCCccccCC-----CCCCeeeccccccccccccc-
Q 035761 4 LRNLVHLDLSDNHFMGHIP----PTLGRLS-ELKILNLSLNSLVGNIPSNVGHL-----TQLTTLAIASNRMNGSILLG- 72 (560)
Q Consensus 4 l~~L~~L~L~~n~l~~~~~----~~~~~l~-~L~~L~L~~N~i~~~~~~~~~~l-----~~L~~L~L~~n~i~~~~~~~- 72 (560)
.++|++|+|++|.+++..+ ..|..++ +|++|+|++|.|++..+..+..+ ++|++|+|++|+++...+..
T Consensus 21 ~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l 100 (362)
T 3goz_A 21 PHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDEL 100 (362)
T ss_dssp CTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHH
T ss_pred CCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHH
Confidence 4569999999999997766 7788888 89999999999987767777664 89999999999998766554
Q ss_pred ---cCCC-CCCCEEEeecCccCccCCCCc----CC-CCCccEEEccCCCccCCCC----ccCCCCC-CCcEEECcCCcCc
Q 035761 73 ---IGSL-KVLQVLDLSRNEIGGSIPSTL----GH-LKWLRSVDLSQNKLVGPIP----SSLGHLT-QLTTLNMYNNKLD 138 (560)
Q Consensus 73 ---~~~l-~~L~~L~l~~n~l~~~~~~~~----~~-l~~L~~L~l~~n~l~~~~~----~~~~~l~-~L~~L~l~~n~l~ 138 (560)
+..+ ++|++|+|++|+++...+..+ .. .++|++|+|++|.++...+ ..+..++ +|++|+|++|+++
T Consensus 101 ~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~ 180 (362)
T 3goz_A 101 VKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA 180 (362)
T ss_dssp HHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGG
T ss_pred HHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCc
Confidence 4444 899999999999986655443 33 3689999999999985433 3344555 8999999999998
Q ss_pred CCCCcc----CcCC-CCCcEEEccCcccccc----cchhhccc-cccceeeccccccCCcCc----cccCCCceeeEEEc
Q 035761 139 GPIPPE----LMNC-SKLRILKLGNNLLSGS----IPSQIGKL-QELYYLDLSGNFINGKIP----SQLGEFSCIDTVDL 204 (560)
Q Consensus 139 ~~~~~~----~~~l-~~L~~L~l~~n~l~~~----~~~~~~~l-~~L~~L~l~~n~l~~~~~----~~~~~~~~L~~l~l 204 (560)
+..+.. +..+ ++|+.|+|++|.+++. ++..+..+ ++|++|+|++|++++..+ ..+..+++|+.|++
T Consensus 181 ~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L 260 (362)
T 3goz_A 181 SKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYL 260 (362)
T ss_dssp GSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEE
T ss_pred hhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEe
Confidence 766544 3445 5999999999999863 44555554 589999999999987654 34567889999999
Q ss_pred cCCccccccCc----------ccccCCCCcCCCCCCCCc
Q 035761 205 SMNNLSGGIPV----------FVRKVPHLDVSGNQFGGE 233 (560)
Q Consensus 205 ~~n~l~~~~~~----------~~~~l~~l~l~~n~~~~~ 233 (560)
++|.+.+..+. .+.++..|++++|++.+.
T Consensus 261 ~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~ 299 (362)
T 3goz_A 261 DYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS 299 (362)
T ss_dssp EHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred ccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence 99985543322 234567789999997653
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.7e-22 Score=212.72 Aligned_cols=187 Identities=25% Similarity=0.376 Sum_probs=159.0
Q ss_pred CCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEee
Q 035761 6 NLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLS 85 (560)
Q Consensus 6 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~ 85 (560)
+|+.|+|++|+|++ +|..+. ++|++|+|++|+|+ .+| ..+++|+.|+|++|+|++ +|. +.+ +|++|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 89999999999997 566553 88999999999999 566 457999999999999997 555 665 99999999
Q ss_pred cCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCccccccc
Q 035761 86 RNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSI 165 (560)
Q Consensus 86 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 165 (560)
+|+|++ +|. .+++|+.|+|++|.|++ +|. .+++|+.|+|++|.|++ +|. |. ++|+.|+|++|.|+ .+
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~l 195 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SL 195 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SC
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-ch
Confidence 999996 555 68999999999999996 555 57899999999999996 566 66 99999999999999 56
Q ss_pred chhhcccccc-------ceeeccccccCCcCccccCCCceeeEEEccCCccccccCcccccC
Q 035761 166 PSQIGKLQEL-------YYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKV 220 (560)
Q Consensus 166 ~~~~~~l~~L-------~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l 220 (560)
|. |.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|++++.+|..+..+
T Consensus 196 p~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l 253 (571)
T 3cvr_A 196 PA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQ 253 (571)
T ss_dssp CC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHH
T ss_pred hh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHh
Confidence 66 654 77 99999999999 578777789999999999999999888766543
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.88 E-value=2e-22 Score=202.47 Aligned_cols=176 Identities=24% Similarity=0.205 Sum_probs=135.5
Q ss_pred CEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCcccc-CCCCCCeeeccccccccccccccCCCCCCCEEEeec
Q 035761 8 VHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVG-HLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSR 86 (560)
Q Consensus 8 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~-~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~ 86 (560)
+.+++++|+++ .+|..+. +.+++|+|++|+|+++.+..|. ++++|+.|+|++|+|+.+.+..|.++++|++|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 57888888887 4555443 4578888888888877777777 888888888888888877777788888888888888
Q ss_pred CccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccC---cCCCCCcEEEccCccccc
Q 035761 87 NEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPEL---MNCSKLRILKLGNNLLSG 163 (560)
Q Consensus 87 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~---~~l~~L~~L~l~~n~l~~ 163 (560)
|+|+...+..|.++++|+.|+|++|+|+++.+..|.++++|+.|+|++|+|++..+..| ..+++|+.|+|++|+|+.
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 88887777778888888888888888887777788888888888888888886544444 567888888888888886
Q ss_pred ccchhhcccccc--ceeeccccccC
Q 035761 164 SIPSQIGKLQEL--YYLDLSGNFIN 186 (560)
Q Consensus 164 ~~~~~~~~l~~L--~~L~l~~n~l~ 186 (560)
..+..|..++.+ +.|+|++|++.
T Consensus 178 l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 178 LPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp CCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred cCHHHhhhccHhhcceEEecCCCcc
Confidence 666677777763 77788887775
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.88 E-value=2.2e-21 Score=200.63 Aligned_cols=140 Identities=28% Similarity=0.354 Sum_probs=93.6
Q ss_pred CCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEe
Q 035761 5 RNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDL 84 (560)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l 84 (560)
++|++|++++|++++ +| .|.++++|++|++++|++++ +|..+ .+|++|++++|++++ .| .+.++++|++|++
T Consensus 131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l 202 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYA 202 (454)
T ss_dssp TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEEC
Confidence 578889999988886 55 58888888888888888884 45433 478888888888875 34 5777888888888
Q ss_pred ecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccc
Q 035761 85 SRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLS 162 (560)
Q Consensus 85 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 162 (560)
++|++++ +|... ++|++|++++|.++ .+| .+..+++|++|++++|++++ +|.. +++|+.|++++|+++
T Consensus 203 ~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~ 270 (454)
T 1jl5_A 203 DNNSLKK-LPDLP---LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLT 270 (454)
T ss_dssp CSSCCSS-CCCCC---TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCS
T ss_pred CCCcCCc-CCCCc---CcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCccc
Confidence 8887774 33322 46666777777666 444 36666666666666666664 2221 134444444444444
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-24 Score=221.22 Aligned_cols=214 Identities=22% Similarity=0.239 Sum_probs=177.2
Q ss_pred CCCCCCCCEEEccCCcC---cccCCCCC-------CCcCCCCEEEccCCccee----cCCccccCCCCCCeeeccccccc
Q 035761 1 MGRLRNLVHLDLSDNHF---MGHIPPTL-------GRLSELKILNLSLNSLVG----NIPSNVGHLTQLTTLAIASNRMN 66 (560)
Q Consensus 1 ~~~l~~L~~L~L~~n~l---~~~~~~~~-------~~l~~L~~L~L~~N~i~~----~~~~~~~~l~~L~~L~L~~n~i~ 66 (560)
|.++++|++|+|++|.+ ++.+|..+ ..+++|++|+|++|.++. .+|..+..+++|++|+|++|.++
T Consensus 56 l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~ 135 (386)
T 2ca6_A 56 IASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLG 135 (386)
T ss_dssp TTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCH
T ss_pred HHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCC
Confidence 45789999999999754 44445444 788999999999999996 47778899999999999999997
Q ss_pred ccccccc----CCC---------CCCCEEEeecCccC-ccCC---CCcCCCCCccEEEccCCCccC-----CCCccCCCC
Q 035761 67 GSILLGI----GSL---------KVLQVLDLSRNEIG-GSIP---STLGHLKWLRSVDLSQNKLVG-----PIPSSLGHL 124 (560)
Q Consensus 67 ~~~~~~~----~~l---------~~L~~L~l~~n~l~-~~~~---~~~~~l~~L~~L~l~~n~l~~-----~~~~~~~~l 124 (560)
...+..+ ..+ ++|++|+|++|+++ ...+ ..+..+++|+.|+|++|+++. ..+..+..+
T Consensus 136 ~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~ 215 (386)
T 2ca6_A 136 PQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYC 215 (386)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGC
T ss_pred HHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcC
Confidence 5444433 334 89999999999998 3333 466788999999999999972 344478899
Q ss_pred CCCcEEECcCCcCc----CCCCccCcCCCCCcEEEccCcccccc----cchhhcc--ccccceeeccccccCC----cCc
Q 035761 125 TQLTTLNMYNNKLD----GPIPPELMNCSKLRILKLGNNLLSGS----IPSQIGK--LQELYYLDLSGNFING----KIP 190 (560)
Q Consensus 125 ~~L~~L~l~~n~l~----~~~~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~--l~~L~~L~l~~n~l~~----~~~ 190 (560)
++|+.|+|++|.++ ..+|..+..+++|+.|+|++|.+++. ++..+.. +++|++|+|++|++++ .+|
T Consensus 216 ~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~ 295 (386)
T 2ca6_A 216 QELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLK 295 (386)
T ss_dssp TTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHH
T ss_pred CCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHH
Confidence 99999999999996 46777899999999999999999865 4566643 8999999999999997 477
Q ss_pred ccc-CCCceeeEEEccCCccccccC
Q 035761 191 SQL-GEFSCIDTVDLSMNNLSGGIP 214 (560)
Q Consensus 191 ~~~-~~~~~L~~l~l~~n~l~~~~~ 214 (560)
..+ .++++|+.|++++|++++..+
T Consensus 296 ~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 296 TVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp HHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred HHHHhcCCCceEEEccCCcCCcchh
Confidence 776 668999999999999998775
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.9e-21 Score=201.01 Aligned_cols=181 Identities=24% Similarity=0.346 Sum_probs=134.7
Q ss_pred CCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEe
Q 035761 5 RNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDL 84 (560)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l 84 (560)
++|++|++++|+++++ +.. .++|++|++++|++++ +| .|.++++|++|++++|++++ .|.. ..+|++|++
T Consensus 111 ~~L~~L~l~~n~l~~l-~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~---~~~L~~L~L 180 (454)
T 1jl5_A 111 QSLKSLLVDNNNLKAL-SDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDL---PPSLEFIAA 180 (454)
T ss_dssp TTCCEEECCSSCCSCC-CSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCC---CTTCCEEEC
T ss_pred CCCcEEECCCCccCcc-cCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCC---cccccEEEC
Confidence 4566666666666642 221 1689999999999985 66 59999999999999999985 4433 358999999
Q ss_pred ecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccccc
Q 035761 85 SRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGS 164 (560)
Q Consensus 85 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 164 (560)
++|++++ +| .+.++++|+.|++++|.+++ +|... ++|++|++++|.++ .+| .+..+++|+.|++++|++++
T Consensus 181 ~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~- 251 (454)
T 1jl5_A 181 GNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT- 251 (454)
T ss_dssp CSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-
T ss_pred cCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-
Confidence 9999996 55 58999999999999999985 44432 58999999999998 556 48899999999999999985
Q ss_pred cchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCcccc
Q 035761 165 IPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSG 211 (560)
Q Consensus 165 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~ 211 (560)
+|.. +++|+.|++++|++++ +|.. .++|+.|++++|.+++
T Consensus 252 l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~ 291 (454)
T 1jl5_A 252 LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSG 291 (454)
T ss_dssp CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSE
T ss_pred cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCc
Confidence 4432 3677777777777774 3332 2445555555555554
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.3e-21 Score=208.63 Aligned_cols=204 Identities=27% Similarity=0.322 Sum_probs=105.3
Q ss_pred CCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEee
Q 035761 6 NLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLS 85 (560)
Q Consensus 6 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~ 85 (560)
+|++|+|++|+|+. +|. .+++|++|+|++|+|++ +|. .+++|++|+|++|++++... .+++|+.|+++
T Consensus 62 ~L~~L~L~~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~l~~----~l~~L~~L~L~ 129 (622)
T 3g06_A 62 HITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTS-LPV---LPPGLLELSIFSNPLTHLPA----LPSGLCKLWIF 129 (622)
T ss_dssp TCSEEEECSCCCSC-CCC---CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEECSCCCCCCCC----CCTTCCEEECC
T ss_pred CCcEEEecCCCCCC-CCC---cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEECcCCcCCCCCC----CCCCcCEEECC
Confidence 45555555555552 232 34555555555555552 332 44555555555555553222 33445555555
Q ss_pred cCccCccCCCCcCCCCCccEEEccCCCccCCCCccCC-----------------CCCCCcEEECcCCcCcCCCCccCcCC
Q 035761 86 RNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLG-----------------HLTQLTTLNMYNNKLDGPIPPELMNC 148 (560)
Q Consensus 86 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~-----------------~l~~L~~L~l~~n~l~~~~~~~~~~l 148 (560)
+|+|+. +|.. +++|++|+|++|.+++ +|..+. .+++|+.|++++|.+++ +|.. +
T Consensus 130 ~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~~~~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~l~~-l~~~---~ 200 (622)
T 3g06_A 130 GNQLTS-LPVL---PPGLQELSVSDNQLAS-LPALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLAS-LPTL---P 200 (622)
T ss_dssp SSCCSC-CCCC---CTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSC-CCCC---C
T ss_pred CCCCCc-CCCC---CCCCCEEECcCCcCCC-cCCccCCCCEEECCCCCCCCCcccCCCCcEEECCCCCCCC-CCCc---c
Confidence 555552 2222 2455555555555553 222111 12455555555555553 2221 2
Q ss_pred CCCcEEEccCcccccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCcccccCCCCcCCCC
Q 035761 149 SKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHLDVSGN 228 (560)
Q Consensus 149 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~l~~n 228 (560)
++|+.|++++|.++ .+|. .+++|+.|++++|+|++ +| ..+++|+.|++++|.|+. +|..+.++..|++++|
T Consensus 201 ~~L~~L~L~~N~l~-~l~~---~~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~~~~~L~~L~Ls~N 271 (622)
T 3g06_A 201 SELYKLWAYNNRLT-SLPA---LPSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPMLPSGLLSLSVYRN 271 (622)
T ss_dssp TTCCEEECCSSCCS-SCCC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSS
T ss_pred chhhEEECcCCccc-ccCC---CCCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCcccccCcEEeCCCC
Confidence 34444444444444 2222 23667777777777774 44 345677777777777774 3446667777777777
Q ss_pred CCCCcCCcccCC
Q 035761 229 QFGGEIPTTLAN 240 (560)
Q Consensus 229 ~~~~~~p~~~~~ 240 (560)
++.. +|.....
T Consensus 272 ~L~~-lp~~l~~ 282 (622)
T 3g06_A 272 QLTR-LPESLIH 282 (622)
T ss_dssp CCCS-CCGGGGG
T ss_pred CCCc-CCHHHhh
Confidence 7773 3443333
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.88 E-value=6.2e-23 Score=199.66 Aligned_cols=191 Identities=25% Similarity=0.302 Sum_probs=149.3
Q ss_pred EEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEeecCc
Q 035761 9 HLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNE 88 (560)
Q Consensus 9 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~ 88 (560)
.+.+..+.+++.. .+..+++|++|++++|.++.. + .+..+++|++|+|++|++++..+ +.++++|++|+|++|.
T Consensus 28 ~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~ 101 (291)
T 1h6t_A 28 KDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENK 101 (291)
T ss_dssp HHHTTCSCTTSEE--CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred HHHhcCCCccccc--chhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCc
Confidence 3455566665432 245778888888888888754 3 47888888888888888886554 8888888999998888
Q ss_pred cCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccccccchh
Q 035761 89 IGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQ 168 (560)
Q Consensus 89 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 168 (560)
+++ ++ .+..+++|+.|+|++|++++. ..+..+++|+.|++++|++++. ..+..+++|+.|++++|.+++..+
T Consensus 102 l~~-~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~-- 173 (291)
T 1h6t_A 102 VKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-- 173 (291)
T ss_dssp CCC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--
T ss_pred CCC-Ch-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--
Confidence 885 33 488888899999999988853 4678888899999999988865 678888899999999998886554
Q ss_pred hccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCc
Q 035761 169 IGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPV 215 (560)
Q Consensus 169 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~ 215 (560)
+..+++|+.|++++|++++. + .+..+++|+.|++++|+++.....
T Consensus 174 l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~~~~~ 218 (291)
T 1h6t_A 174 LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLNKPIN 218 (291)
T ss_dssp GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEECCCEE
T ss_pred hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccCCccc
Confidence 88888999999999988853 3 378888899999999988864443
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.87 E-value=3.6e-22 Score=185.85 Aligned_cols=152 Identities=20% Similarity=0.223 Sum_probs=102.0
Q ss_pred CEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEeecC
Q 035761 8 VHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRN 87 (560)
Q Consensus 8 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n 87 (560)
+.+++++|.++ .+|..+. ++|++|+|++|+|+++.+..|.++++|+.|+|++|+|++..+..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 45677777776 3444443 56777777777777666666777777777777777777666667777777777777777
Q ss_pred ccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccc
Q 035761 88 EIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLS 162 (560)
Q Consensus 88 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 162 (560)
+|+.+.+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|.|++..+..|..+++|+.|++++|.+.
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 777555555666677777777777776666666666666777777777666655556666666666666666665
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.87 E-value=3.1e-22 Score=194.69 Aligned_cols=173 Identities=27% Similarity=0.325 Sum_probs=153.3
Q ss_pred CCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEE
Q 035761 3 RLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVL 82 (560)
Q Consensus 3 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 82 (560)
++++|++|++++|.++.. + .+..+++|++|+|++|++++..+ +.++++|+.|+|++|+++.. ..+..+++|++|
T Consensus 44 ~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L 117 (291)
T 1h6t_A 44 ELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDL--SSLKDLKKLKSL 117 (291)
T ss_dssp HHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCG--GGGTTCTTCCEE
T ss_pred hcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCC--hhhccCCCCCEE
Confidence 467899999999999855 3 48999999999999999996654 99999999999999999863 348999999999
Q ss_pred EeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccc
Q 035761 83 DLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLS 162 (560)
Q Consensus 83 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 162 (560)
+|++|++++. ..+..+++|+.|++++|++++. ..+..+++|+.|++++|++++..+ +..+++|+.|++++|.++
T Consensus 118 ~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~ 191 (291)
T 1h6t_A 118 SLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS 191 (291)
T ss_dssp ECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred ECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCC
Confidence 9999999964 5688999999999999999965 679999999999999999997644 899999999999999999
Q ss_pred cccchhhccccccceeeccccccCCcC
Q 035761 163 GSIPSQIGKLQELYYLDLSGNFINGKI 189 (560)
Q Consensus 163 ~~~~~~~~~l~~L~~L~l~~n~l~~~~ 189 (560)
+. + .+..+++|+.|++++|++....
T Consensus 192 ~l-~-~l~~l~~L~~L~l~~n~i~~~~ 216 (291)
T 1h6t_A 192 DL-R-ALAGLKNLDVLELFSQECLNKP 216 (291)
T ss_dssp BC-G-GGTTCTTCSEEEEEEEEEECCC
T ss_pred CC-h-hhccCCCCCEEECcCCcccCCc
Confidence 54 4 4899999999999999998543
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1.5e-21 Score=181.62 Aligned_cols=154 Identities=23% Similarity=0.242 Sum_probs=143.2
Q ss_pred CCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEeecCccCccCCCCcCCCCCccEEEccC
Q 035761 31 LKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQ 110 (560)
Q Consensus 31 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 110 (560)
-+.+++++|.++ .+|..+. ++|+.|+|++|+|+.+.+..|.++++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 13 ~~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~ 89 (220)
T 2v9t_B 13 NNIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYG 89 (220)
T ss_dssp TTEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCS
T ss_pred CCEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCC
Confidence 368999999999 5666554 7899999999999988888999999999999999999988899999999999999999
Q ss_pred CCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccccccchhhccccccceeeccccccCC
Q 035761 111 NKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFING 187 (560)
Q Consensus 111 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 187 (560)
|+|+.+.+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|.+++..+..|..+++|+.|+|++|++..
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 90 NKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 99997777788999999999999999999889999999999999999999998888889999999999999999964
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.87 E-value=2.2e-22 Score=202.23 Aligned_cols=181 Identities=25% Similarity=0.214 Sum_probs=158.3
Q ss_pred CCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccC-CCCCCCEEEeecCccCccCCCCcCCCCCccEEEcc
Q 035761 31 LKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIG-SLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLS 109 (560)
Q Consensus 31 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 109 (560)
-+++++++|.++ .+|..+. +.++.|+|++|+|+...+..|. ++++|++|+|++|+|+++.+..|.++++|++|+|+
T Consensus 20 ~~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 96 (361)
T 2xot_A 20 SNILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS 96 (361)
T ss_dssp TTEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECC
Confidence 478999999998 5666554 4689999999999988888888 99999999999999998888899999999999999
Q ss_pred CCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccccccchhh---ccccccceeeccccccC
Q 035761 110 QNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQI---GKLQELYYLDLSGNFIN 186 (560)
Q Consensus 110 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~---~~l~~L~~L~l~~n~l~ 186 (560)
+|+|+...+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..+..| ..+++|+.|+|++|+|+
T Consensus 97 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~ 176 (361)
T 2xot_A 97 SNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK 176 (361)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred CCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence 999998888889999999999999999998888999999999999999999997666556 57999999999999999
Q ss_pred CcCccccCCCce--eeEEEccCCccccccC
Q 035761 187 GKIPSQLGEFSC--IDTVDLSMNNLSGGIP 214 (560)
Q Consensus 187 ~~~~~~~~~~~~--L~~l~l~~n~l~~~~~ 214 (560)
...+..+..++. ++.|+|++|++.+...
T Consensus 177 ~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~ 206 (361)
T 2xot_A 177 KLPLTDLQKLPAWVKNGLYLHNNPLECDCK 206 (361)
T ss_dssp CCCHHHHHHSCHHHHTTEECCSSCEECCHH
T ss_pred ccCHHHhhhccHhhcceEEecCCCccCCcC
Confidence 777777777776 4789999999986543
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.87 E-value=4.1e-24 Score=215.10 Aligned_cols=225 Identities=17% Similarity=0.170 Sum_probs=182.1
Q ss_pred EEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCC----ccccCCC-CCCeeeccccccccccccccCCC-----CC
Q 035761 9 HLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIP----SNVGHLT-QLTTLAIASNRMNGSILLGIGSL-----KV 78 (560)
Q Consensus 9 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~----~~~~~l~-~L~~L~L~~n~i~~~~~~~~~~l-----~~ 78 (560)
.++|++|++++.+|..+...++|++|+|++|.+++..+ +.|.+++ +|++|+|++|+++...+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 57899999999888877777889999999999997666 7888998 99999999999998777777664 99
Q ss_pred CCEEEeecCccCccCCCC----cCCC-CCccEEEccCCCccCCCCccC----CC-CCCCcEEECcCCcCcCCCCc----c
Q 035761 79 LQVLDLSRNEIGGSIPST----LGHL-KWLRSVDLSQNKLVGPIPSSL----GH-LTQLTTLNMYNNKLDGPIPP----E 144 (560)
Q Consensus 79 L~~L~l~~n~l~~~~~~~----~~~l-~~L~~L~l~~n~l~~~~~~~~----~~-l~~L~~L~l~~n~l~~~~~~----~ 144 (560)
|++|+|++|.+++..+.. +..+ ++|++|+|++|.+++..+..+ .. .++|++|+|++|.+++..+. .
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 999999999999766654 3444 899999999999987665443 33 36999999999999964433 3
Q ss_pred CcCCC-CCcEEEccCcccccccchhhc----cc-cccceeeccccccCCc----CccccCC-CceeeEEEccCCcccccc
Q 035761 145 LMNCS-KLRILKLGNNLLSGSIPSQIG----KL-QELYYLDLSGNFINGK----IPSQLGE-FSCIDTVDLSMNNLSGGI 213 (560)
Q Consensus 145 ~~~l~-~L~~L~l~~n~l~~~~~~~~~----~l-~~L~~L~l~~n~l~~~----~~~~~~~-~~~L~~l~l~~n~l~~~~ 213 (560)
+..++ +|+.|+|++|++++..+..+. .+ ++|++|+|++|++++. ++..+.. .++|+.|+|++|++++..
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~ 241 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence 45555 999999999999987776554 44 5999999999999864 3444544 458999999999999766
Q ss_pred C-------cccccCCCCcCCCCCCCCc
Q 035761 214 P-------VFVRKVPHLDVSGNQFGGE 233 (560)
Q Consensus 214 ~-------~~~~~l~~l~l~~n~~~~~ 233 (560)
+ ..+.+++.|++++|.+.+.
T Consensus 242 ~~~l~~~~~~l~~L~~L~L~~n~l~~i 268 (362)
T 3goz_A 242 LENLKLLKDSLKHLQTVYLDYDIVKNM 268 (362)
T ss_dssp HHHHHHTTTTTTTCSEEEEEHHHHTTC
T ss_pred HHHHHHHHhcCCCccEEEeccCCcccc
Confidence 5 2446788999999986543
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.87 E-value=3.7e-21 Score=205.06 Aligned_cols=201 Identities=23% Similarity=0.306 Sum_probs=151.4
Q ss_pred CCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEee
Q 035761 6 NLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLS 85 (560)
Q Consensus 6 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~ 85 (560)
++++|++++|.++ .+|..+. ++|++|+|++|+|+ .+|. .+++|++|+|++|+|+++ |. .+++|++|+|+
T Consensus 41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~l-p~---~l~~L~~L~Ls 109 (622)
T 3g06_A 41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTSL-PV---LPPGLLELSIF 109 (622)
T ss_dssp CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSCC-CC---CCTTCCEEEEC
T ss_pred CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCcC-CC---CCCCCCEEECc
Confidence 5899999999999 6676665 89999999999999 4554 578999999999999854 43 77999999999
Q ss_pred cCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCc---CC--------------
Q 035761 86 RNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELM---NC-------------- 148 (560)
Q Consensus 86 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~---~l-------------- 148 (560)
+|+|++ +|. .+++|+.|++++|+++. +|.. +++|++|+|++|.+++. |..+. .+
T Consensus 110 ~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~l-~~~~~~L~~L~L~~N~l~~l~~~~ 180 (622)
T 3g06_A 110 SNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLASL-PALPSELCKLWAYNNQLTSLPMLP 180 (622)
T ss_dssp SCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSCC-CCCCTTCCEEECCSSCCSCCCCCC
T ss_pred CCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCCc-CCccCCCCEEECCCCCCCCCcccC
Confidence 999995 444 57889999999999995 5543 48999999999999853 33221 11
Q ss_pred CCCcEEEccCcccccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCcccccCCCCcCCCC
Q 035761 149 SKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHLDVSGN 228 (560)
Q Consensus 149 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~l~~n 228 (560)
++|+.|++++|.+++ +|. .+++|+.|++++|.++. +|. .+++|+.|++++|.+++ +|..+.+++.|++++|
T Consensus 181 ~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~-l~~---~~~~L~~L~Ls~N~L~~-lp~~l~~L~~L~Ls~N 251 (622)
T 3g06_A 181 SGLQELSVSDNQLAS-LPT---LPSELYKLWAYNNRLTS-LPA---LPSGLKELIVSGNRLTS-LPVLPSELKELMVSGN 251 (622)
T ss_dssp TTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSS-CCC---CCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSS
T ss_pred CCCcEEECCCCCCCC-CCC---ccchhhEEECcCCcccc-cCC---CCCCCCEEEccCCccCc-CCCCCCcCcEEECCCC
Confidence 455555555555553 222 23455556666665552 332 23779999999999996 5577789999999999
Q ss_pred CCCCcCC
Q 035761 229 QFGGEIP 235 (560)
Q Consensus 229 ~~~~~~p 235 (560)
.+...++
T Consensus 252 ~L~~lp~ 258 (622)
T 3g06_A 252 RLTSLPM 258 (622)
T ss_dssp CCSCCCC
T ss_pred CCCcCCc
Confidence 9986533
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=2.1e-21 Score=180.59 Aligned_cols=153 Identities=18% Similarity=0.188 Sum_probs=98.3
Q ss_pred CEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCC-ccccCCCCCCeeeccccccccccccccCCCCCCCEEEeec
Q 035761 8 VHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIP-SNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSR 86 (560)
Q Consensus 8 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~ 86 (560)
+++++++|.++. +|..+. +.+++|+|++|+|++..+ ..|..+++|+.|+|++|+|+++.+..|.++++|++|+|++
T Consensus 14 ~~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 14 TTVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp TEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 467777777763 444443 345677777777765543 3466666777777777776666666666666666666666
Q ss_pred CccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCccccc
Q 035761 87 NEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSG 163 (560)
Q Consensus 87 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 163 (560)
|.|++..+..|.++++|++|+|++|+|++..|..|.++++|+.|+|++|++++..|..|..+++|+.|++++|.+..
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 167 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNC 167 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEEC
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcC
Confidence 66665555566666666666666666666666666666666666666666666556666666666666666666653
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.87 E-value=2.3e-22 Score=214.06 Aligned_cols=196 Identities=24% Similarity=0.290 Sum_probs=151.3
Q ss_pred CCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEeec
Q 035761 7 LVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSR 86 (560)
Q Consensus 7 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~ 86 (560)
+..+.++.+.+++..+ +..+++|+.|+|++|.|..+ + .+..+++|+.|+|++|++++..+ +..+++|+.|+|++
T Consensus 23 l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~ 96 (605)
T 1m9s_A 23 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDE 96 (605)
T ss_dssp HHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCS
T ss_pred HHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcC
Confidence 4455666777765433 56778888888888888743 3 57888888888888888886555 78888888888888
Q ss_pred CccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccccccc
Q 035761 87 NEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIP 166 (560)
Q Consensus 87 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 166 (560)
|.|++ ++ .+..+++|+.|+|++|.+++. ..+..+++|+.|+|++|.+++. ..+..+++|+.|+|++|.+++..|
T Consensus 97 N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~ 170 (605)
T 1m9s_A 97 NKIKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP 170 (605)
T ss_dssp SCCCC-CT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG
T ss_pred CCCCC-Ch-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh
Confidence 88884 33 678888888888888888853 4578888888888888888865 678888888888888888886655
Q ss_pred hhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCcccc
Q 035761 167 SQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVR 218 (560)
Q Consensus 167 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~~~ 218 (560)
+..+++|+.|+|++|+|++. ..+..+++|+.|+|++|++++.+...+.
T Consensus 171 --l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~~~~~ 218 (605)
T 1m9s_A 171 --LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQS 218 (605)
T ss_dssp --GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCCCCCS
T ss_pred --hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCcccccc
Confidence 88888888888888888854 3578888888888888888865544333
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=6.2e-22 Score=184.23 Aligned_cols=155 Identities=20% Similarity=0.209 Sum_probs=119.9
Q ss_pred CCEEEccCCcceecCCccccCCCCCCeeeccccccccccc-cccCCCCCCCEEEeecCccCccCCCCcCCCCCccEEEcc
Q 035761 31 LKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSIL-LGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLS 109 (560)
Q Consensus 31 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 109 (560)
-+++++++|.++ .+|..+. +.++.|+|++|+|++..+ ..|.++++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus 13 ~~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 89 (220)
T 2v70_A 13 GTTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLT 89 (220)
T ss_dssp TTEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECC
Confidence 357888888887 4565543 456788888888886643 457788888888888888887777778888888888888
Q ss_pred CCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccccccchhhccccccceeeccccccCCc
Q 035761 110 QNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGK 188 (560)
Q Consensus 110 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 188 (560)
+|.+++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|++...
T Consensus 90 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 90 SNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp SSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred CCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence 8888877777788888888888888888877777788888888888888888877777777778888888888777643
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.86 E-value=2.7e-23 Score=207.11 Aligned_cols=219 Identities=16% Similarity=0.169 Sum_probs=185.7
Q ss_pred CCCEEEccCCcCcccCCCCCCCc--CCCCEEEccCCcceecCCccccCCCCCCeeeccccccccc-cccccCCCCCCCEE
Q 035761 6 NLVHLDLSDNHFMGHIPPTLGRL--SELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGS-ILLGIGSLKVLQVL 82 (560)
Q Consensus 6 ~L~~L~L~~n~l~~~~~~~~~~l--~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~-~~~~~~~l~~L~~L 82 (560)
.++.|++++|.+. +..+..+ ++++.|++++|.+.+..+. +..+++|++|+|++|.++.. .+..+..+++|++|
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L 123 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 123 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence 4889999999887 4556777 8999999999999976665 56799999999999999865 78889999999999
Q ss_pred EeecCccCccCCCCcCCCCCccEEEccCC-CccCC-CCccCCCCCCCcEEECcCC-cCcCC-CCccCcCCC-CCcEEEcc
Q 035761 83 DLSRNEIGGSIPSTLGHLKWLRSVDLSQN-KLVGP-IPSSLGHLTQLTTLNMYNN-KLDGP-IPPELMNCS-KLRILKLG 157 (560)
Q Consensus 83 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n-~l~~~-~~~~~~~l~~L~~L~l~~n-~l~~~-~~~~~~~l~-~L~~L~l~ 157 (560)
+|++|.+++..+..+..+++|++|+|++| .+++. ++..+.++++|++|++++| .+++. ++..+..++ +|+.|+++
T Consensus 124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~ 203 (336)
T 2ast_B 124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS 203 (336)
T ss_dssp ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECC
T ss_pred eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeC
Confidence 99999999878888999999999999999 67742 5666888999999999999 88853 466688899 99999999
Q ss_pred Cc--ccc-cccchhhccccccceeeccccc-cCCcCccccCCCceeeEEEccCCc-cccccC---cccccCCCCcCCCC
Q 035761 158 NN--LLS-GSIPSQIGKLQELYYLDLSGNF-INGKIPSQLGEFSCIDTVDLSMNN-LSGGIP---VFVRKVPHLDVSGN 228 (560)
Q Consensus 158 ~n--~l~-~~~~~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~~~~L~~l~l~~n~-l~~~~~---~~~~~l~~l~l~~n 228 (560)
+| .++ +.++..+..+++|++|++++|. +++..+..+..+++|+.|++++|. +..... ..+++++.|++++|
T Consensus 204 ~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~ 282 (336)
T 2ast_B 204 GYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 282 (336)
T ss_dssp SCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc
Confidence 99 455 3567788899999999999999 777788889999999999999995 333211 23567888999988
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.86 E-value=1.6e-21 Score=207.70 Aligned_cols=184 Identities=25% Similarity=0.305 Sum_probs=160.0
Q ss_pred CCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEE
Q 035761 3 RLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVL 82 (560)
Q Consensus 3 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 82 (560)
.|++|+.|++++|.|+.+ + .|..+++|+.|+|++|+|+++.| +..+++|+.|+|++|+++.. ..+..+++|+.|
T Consensus 41 ~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L 114 (605)
T 1m9s_A 41 ELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDL--SSLKDLKKLKSL 114 (605)
T ss_dssp HHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCC--TTSTTCTTCCEE
T ss_pred cCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCCC--hhhccCCCCCEE
Confidence 467899999999999854 3 58999999999999999996655 99999999999999999853 378999999999
Q ss_pred EeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccc
Q 035761 83 DLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLS 162 (560)
Q Consensus 83 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 162 (560)
+|++|.|++. ..+..+++|+.|+|++|.+++. ..+..+++|+.|+|++|.|++..| +..+++|+.|+|++|+|+
T Consensus 115 ~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~ 188 (605)
T 1m9s_A 115 SLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS 188 (605)
T ss_dssp ECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred EecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCC
Confidence 9999999953 4689999999999999999965 679999999999999999997655 899999999999999999
Q ss_pred cccchhhccccccceeeccccccCCcCccccCCCceee
Q 035761 163 GSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCID 200 (560)
Q Consensus 163 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~ 200 (560)
+. ..+..+++|+.|+|++|++.+.....+..+..+.
T Consensus 189 ~l--~~l~~l~~L~~L~L~~N~l~~~p~~~~~~l~~~~ 224 (605)
T 1m9s_A 189 DL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPN 224 (605)
T ss_dssp BC--GGGTTCTTCSEEECCSEEEECCCCCCCSSCEEEC
T ss_pred CC--hHHccCCCCCEEEccCCcCcCCcccccccEEecc
Confidence 64 4689999999999999999866555544444443
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.1e-20 Score=177.02 Aligned_cols=151 Identities=25% Similarity=0.276 Sum_probs=84.3
Q ss_pred CEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEeecC
Q 035761 8 VHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRN 87 (560)
Q Consensus 8 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n 87 (560)
+.++.+++.++ .+|..+. ++|++|+|++|+|+++.|..|.++++|+.|+|++|+|+.+.+..|.++++|++|+|++|
T Consensus 22 ~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N 98 (229)
T 3e6j_A 22 TTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTN 98 (229)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCC
Confidence 45566666655 3333332 55666666666666555555666666666666666665444455555555666666666
Q ss_pred ccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccc
Q 035761 88 EIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLS 162 (560)
Q Consensus 88 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 162 (560)
+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..|..+++|+.|++++|.+.
T Consensus 99 ~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 172 (229)
T 3e6j_A 99 QLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWD 172 (229)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBC
T ss_pred cCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCcc
Confidence 555444445555555555555555555 44555555555555555555555444444555555555555555554
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.4e-20 Score=176.24 Aligned_cols=152 Identities=23% Similarity=0.234 Sum_probs=74.8
Q ss_pred CCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEeecCccCccCCCCcCCCCCccEEEccC
Q 035761 31 LKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQ 110 (560)
Q Consensus 31 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 110 (560)
.+.++.+++.++ .+|..+. ++|+.|+|++|+|++..+..|.++++|++|+|++|+|+...+..|..+++|+.|+|++
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence 445666666655 3333332 4555555555555554455555555555555555555544444445555555555555
Q ss_pred CCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccccccchhhccccccceeeccccccC
Q 035761 111 NKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFIN 186 (560)
Q Consensus 111 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 186 (560)
|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|++++..+..|..+++|+.|+|++|++.
T Consensus 98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 172 (229)
T 3e6j_A 98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWD 172 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBC
T ss_pred CcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCcc
Confidence 5555444444444555555555555554 33444444444444444444444333333444444444444444443
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.84 E-value=1.2e-23 Score=219.08 Aligned_cols=228 Identities=19% Similarity=0.170 Sum_probs=170.5
Q ss_pred CCCEEEccCCcCcc----cCCCCCCCcCCCCEEEccCCcceecCCccc-----cCCCCCCeeecccccccccc----ccc
Q 035761 6 NLVHLDLSDNHFMG----HIPPTLGRLSELKILNLSLNSLVGNIPSNV-----GHLTQLTTLAIASNRMNGSI----LLG 72 (560)
Q Consensus 6 ~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~-----~~l~~L~~L~L~~n~i~~~~----~~~ 72 (560)
+|++|+|++|.++. .++..+..+++|++|+|++|.++...+..+ ...++|++|+|++|+++... +..
T Consensus 86 ~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 165 (461)
T 1z7x_W 86 KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASV 165 (461)
T ss_dssp CCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred ceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHH
Confidence 79999999999984 457889999999999999999875444333 33568999999999988643 556
Q ss_pred cCCCCCCCEEEeecCccCccCCCCcC-----CCCCccEEEccCCCccCC----CCccCCCCCCCcEEECcCCcCcCCC--
Q 035761 73 IGSLKVLQVLDLSRNEIGGSIPSTLG-----HLKWLRSVDLSQNKLVGP----IPSSLGHLTQLTTLNMYNNKLDGPI-- 141 (560)
Q Consensus 73 ~~~l~~L~~L~l~~n~l~~~~~~~~~-----~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~~-- 141 (560)
+..+++|++|++++|.++...+..+. .+++|+.|+|++|.++.. ++..+..+++|++|++++|.+++..
T Consensus 166 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~ 245 (461)
T 1z7x_W 166 LRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMA 245 (461)
T ss_dssp HHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHH
T ss_pred HhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHH
Confidence 67788999999999998754333332 356899999999988853 4666777889999999999887432
Q ss_pred ---CccCcCCCCCcEEEccCcccccc----cchhhccccccceeeccccccCCcCccccCC-----CceeeEEEccCCcc
Q 035761 142 ---PPELMNCSKLRILKLGNNLLSGS----IPSQIGKLQELYYLDLSGNFINGKIPSQLGE-----FSCIDTVDLSMNNL 209 (560)
Q Consensus 142 ---~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-----~~~L~~l~l~~n~l 209 (560)
+..+..+++|+.|++++|.+++. ++..+..+++|++|++++|++.+..+..+.. .++|+.|++++|.+
T Consensus 246 ~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l 325 (461)
T 1z7x_W 246 ELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSF 325 (461)
T ss_dssp HHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred HHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCC
Confidence 22233578899999999988854 5667777888999999999886554443332 36888888888888
Q ss_pred cccc----Ccc---cccCCCCcCCCCCCCCc
Q 035761 210 SGGI----PVF---VRKVPHLDVSGNQFGGE 233 (560)
Q Consensus 210 ~~~~----~~~---~~~l~~l~l~~n~~~~~ 233 (560)
++.. +.. +++++.|++++|++.+.
T Consensus 326 ~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~ 356 (461)
T 1z7x_W 326 TAACCSHFSSVLAQNRFLLELQISNNRLEDA 356 (461)
T ss_dssp BGGGHHHHHHHHHHCSSCCEEECCSSBCHHH
T ss_pred chHHHHHHHHHHhhCCCccEEEccCCccccc
Confidence 8653 222 26778888888887654
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.84 E-value=1.6e-23 Score=218.14 Aligned_cols=232 Identities=20% Similarity=0.147 Sum_probs=163.7
Q ss_pred CCCCCCCCEEEccCCcCcccCCCC-----CCCcCCCCEEEccCCcceec----CCccccCCCCCCeeecccccccccccc
Q 035761 1 MGRLRNLVHLDLSDNHFMGHIPPT-----LGRLSELKILNLSLNSLVGN----IPSNVGHLTQLTTLAIASNRMNGSILL 71 (560)
Q Consensus 1 ~~~l~~L~~L~L~~n~l~~~~~~~-----~~~l~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~L~~n~i~~~~~~ 71 (560)
|.++++|++|+|++|.+++..+.. +...++|++|+|++|.++.. ++..+..+++|++|+|++|+++...+.
T Consensus 109 l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~ 188 (461)
T 1z7x_W 109 LRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVR 188 (461)
T ss_dssp TTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHH
T ss_pred HccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHH
Confidence 467889999999999987543332 22356799999999988853 355667788899999999988754444
Q ss_pred ccC-----CCCCCCEEEeecCccCcc----CCCCcCCCCCccEEEccCCCccCCC-----CccCCCCCCCcEEECcCCcC
Q 035761 72 GIG-----SLKVLQVLDLSRNEIGGS----IPSTLGHLKWLRSVDLSQNKLVGPI-----PSSLGHLTQLTTLNMYNNKL 137 (560)
Q Consensus 72 ~~~-----~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~~-----~~~~~~l~~L~~L~l~~n~l 137 (560)
.+. ..++|++|+|++|.++.. ++..+..+++|++|+|++|.++... +..+..+++|++|++++|.+
T Consensus 189 ~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l 268 (461)
T 1z7x_W 189 VLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGI 268 (461)
T ss_dssp HHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred HHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCC
Confidence 433 356888888888888853 3556677788888888888876432 23334578888888888888
Q ss_pred cCC----CCccCcCCCCCcEEEccCcccccccchhhccc-----cccceeeccccccCCc----CccccCCCceeeEEEc
Q 035761 138 DGP----IPPELMNCSKLRILKLGNNLLSGSIPSQIGKL-----QELYYLDLSGNFINGK----IPSQLGEFSCIDTVDL 204 (560)
Q Consensus 138 ~~~----~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l-----~~L~~L~l~~n~l~~~----~~~~~~~~~~L~~l~l 204 (560)
+.. ++..+..+++|+.|++++|.+++..+..+... ++|++|++++|.+++. ++..+..+++|+.|++
T Consensus 269 ~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L 348 (461)
T 1z7x_W 269 TAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQI 348 (461)
T ss_dssp CHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEEC
T ss_pred CHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEc
Confidence 743 45566678888888888888876555444433 5788888888887754 3455566678888888
Q ss_pred cCCccccccCcc--------cccCCCCcCCCCCCCC
Q 035761 205 SMNNLSGGIPVF--------VRKVPHLDVSGNQFGG 232 (560)
Q Consensus 205 ~~n~l~~~~~~~--------~~~l~~l~l~~n~~~~ 232 (560)
++|.+++..+.. ..+++.|++++|++.+
T Consensus 349 s~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~ 384 (461)
T 1z7x_W 349 SNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSD 384 (461)
T ss_dssp CSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCH
T ss_pred cCCccccccHHHHHHHHcCCCCceEEEECCCCCCCh
Confidence 888777554432 2367778888887764
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.84 E-value=2.1e-21 Score=185.77 Aligned_cols=165 Identities=24% Similarity=0.335 Sum_probs=76.4
Q ss_pred CCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEeec
Q 035761 7 LVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSR 86 (560)
Q Consensus 7 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~ 86 (560)
+..+++++|.+++.. .+..+++|++|++++|.|+. ++ .+..+++|+.|+|++|+|++..+ +.++++|++|+|++
T Consensus 21 l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~ 94 (263)
T 1xeu_A 21 AVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNR 94 (263)
T ss_dssp HHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCS
T ss_pred HHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCC
Confidence 344455555555332 34455555555555555552 22 44555555555555555553333 45555555555555
Q ss_pred CccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccccccc
Q 035761 87 NEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIP 166 (560)
Q Consensus 87 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 166 (560)
|++++ ++. +.. ++|+.|+|++|++++. ..+..+++|+.|+|++|++++. ..+..+++|+.|++++|++++.
T Consensus 95 N~l~~-l~~-~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~--~~l~~l~~L~~L~L~~N~i~~~-- 165 (263)
T 1xeu_A 95 NRLKN-LNG-IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLHGNEITNT-- 165 (263)
T ss_dssp SCCSC-CTT-CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC--GGGGGCTTCCEEECTTSCCCBC--
T ss_pred CccCC-cCc-ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC--hHHccCCCCCEEECCCCcCcch--
Confidence 55553 222 111 4455555555554432 1344444444454444444432 1344444444444444444433
Q ss_pred hhhccccccceeeccccccC
Q 035761 167 SQIGKLQELYYLDLSGNFIN 186 (560)
Q Consensus 167 ~~~~~l~~L~~L~l~~n~l~ 186 (560)
..+..+++|+.|++++|++.
T Consensus 166 ~~l~~l~~L~~L~l~~N~~~ 185 (263)
T 1xeu_A 166 GGLTRLKKVNWIDLTGQKCV 185 (263)
T ss_dssp TTSTTCCCCCEEEEEEEEEE
T ss_pred HHhccCCCCCEEeCCCCccc
Confidence 33444444444444444444
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.83 E-value=4.3e-20 Score=194.50 Aligned_cols=186 Identities=25% Similarity=0.343 Sum_probs=153.0
Q ss_pred CCCCcC-----CCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEeecCccCccCCCCcC
Q 035761 24 TLGRLS-----ELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLG 98 (560)
Q Consensus 24 ~~~~l~-----~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 98 (560)
.+..++ +|+.|+|++|+|++ +|..+ +++|+.|+|++|+|+ .+| ..+++|++|+|++|+|++ +|. +.
T Consensus 49 ~~~~l~~C~~~~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~ 119 (571)
T 3cvr_A 49 AVSLLKECLINQFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LP 119 (571)
T ss_dssp HHHHHHHHHHTTCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CC
T ss_pred hhhhccccccCCccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hh
Confidence 355555 89999999999996 66655 378999999999999 455 457999999999999996 666 66
Q ss_pred CCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccccccchhhcccccccee
Q 035761 99 HLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYL 178 (560)
Q Consensus 99 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 178 (560)
+ +|+.|+|++|.|++ +|. .+++|+.|+|++|.|++ +|. .+++|+.|+|++|+|++ +|. |. ++|+.|
T Consensus 120 ~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L 185 (571)
T 3cvr_A 120 A--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEAL 185 (571)
T ss_dssp T--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEE
T ss_pred c--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEE
Confidence 5 99999999999996 555 68999999999999996 554 57899999999999996 666 66 899999
Q ss_pred eccccccCCcCccccCCCcee-------eEEEccCCccccccCcc---cccCCCCcCCCCCCCCcCCcc
Q 035761 179 DLSGNFINGKIPSQLGEFSCI-------DTVDLSMNNLSGGIPVF---VRKVPHLDVSGNQFGGEIPTT 237 (560)
Q Consensus 179 ~l~~n~l~~~~~~~~~~~~~L-------~~l~l~~n~l~~~~~~~---~~~l~~l~l~~n~~~~~~p~~ 237 (560)
+|++|+|+ .+|. +.. +| +.|+|++|+|+. +|.. ++++..|++++|++.+..|..
T Consensus 186 ~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~L~~N~l~~~~p~~ 249 (571)
T 3cvr_A 186 DVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRES 249 (571)
T ss_dssp ECCSSCCS-SCCC-CC----------CCEEEECCSSCCCC-CCGGGGGSCTTEEEECCSSSCCHHHHHH
T ss_pred ECcCCCCC-chhh-HHH--hhhcccccceEEecCCCccee-cCHHHhcCCCCCEEEeeCCcCCCcCHHH
Confidence 99999999 5666 554 77 999999999995 4543 467778999999998865544
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.82 E-value=5.7e-21 Score=182.81 Aligned_cols=175 Identities=24% Similarity=0.307 Sum_probs=152.2
Q ss_pred CcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEeecCccCccCCCCcCCCCCccEE
Q 035761 27 RLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSV 106 (560)
Q Consensus 27 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 106 (560)
.+.++..+++++|.++++. .+..+++|+.|++++|+++.. + .+..+++|++|+|++|+|++..+ +..+++|+.|
T Consensus 17 ~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQSL-A-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcccc-h-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence 5677889999999998553 688999999999999999854 4 78899999999999999996544 9999999999
Q ss_pred EccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccccccchhhccccccceeeccccccC
Q 035761 107 DLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFIN 186 (560)
Q Consensus 107 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 186 (560)
+|++|++++. +. +.. ++|+.|+|++|++++. ..+..+++|+.|++++|++++. + .+..+++|+.|++++|+++
T Consensus 91 ~L~~N~l~~l-~~-~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~ 163 (263)
T 1xeu_A 91 SVNRNRLKNL-NG-IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEIT 163 (263)
T ss_dssp ECCSSCCSCC-TT-CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCC
T ss_pred ECCCCccCCc-Cc-ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCc
Confidence 9999999964 43 333 9999999999999964 4699999999999999999965 3 6899999999999999999
Q ss_pred CcCccccCCCceeeEEEccCCccccccCcc
Q 035761 187 GKIPSQLGEFSCIDTVDLSMNNLSGGIPVF 216 (560)
Q Consensus 187 ~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~ 216 (560)
+. ..+..+++|+.|++++|++++.....
T Consensus 164 ~~--~~l~~l~~L~~L~l~~N~~~~~~~~~ 191 (263)
T 1xeu_A 164 NT--GGLTRLKKVNWIDLTGQKCVNEPVKY 191 (263)
T ss_dssp BC--TTSTTCCCCCEEEEEEEEEECCCEEC
T ss_pred ch--HHhccCCCCCEEeCCCCcccCCcccc
Confidence 76 77899999999999999999775443
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.82 E-value=2.2e-20 Score=170.72 Aligned_cols=156 Identities=17% Similarity=0.226 Sum_probs=131.3
Q ss_pred CCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEeecCccCccCCCCcCCCCCc
Q 035761 24 TLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWL 103 (560)
Q Consensus 24 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 103 (560)
....+++|++|++++|.++ .+| .+..+++|++|++++|.++. +..+..+++|++|++++|++++..+..+..+++|
T Consensus 39 ~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L 114 (197)
T 4ezg_A 39 TEAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSL 114 (197)
T ss_dssp BHHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTC
T ss_pred ChhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCC
Confidence 3467889999999999998 455 68889999999999997763 3478889999999999999997778889999999
Q ss_pred cEEEccCCCccCCCCccCCCCCCCcEEECcCCc-CcCCCCccCcCCCCCcEEEccCcccccccchhhccccccceeeccc
Q 035761 104 RSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNK-LDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSG 182 (560)
Q Consensus 104 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 182 (560)
++|+|++|.+++..+..+..+++|++|++++|. ++. ++ .+..+++|+.|++++|.+++. + .+..+++|++|++++
T Consensus 115 ~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~-~~-~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~L~l~~ 190 (197)
T 4ezg_A 115 TLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD-IM-PLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQLYAFS 190 (197)
T ss_dssp CEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCC-CG-GGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCEEEECB
T ss_pred CEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccc-cH-hhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCEEEeeC
Confidence 999999999987778889999999999999998 664 44 688999999999999999853 3 788999999999999
Q ss_pred cccCC
Q 035761 183 NFING 187 (560)
Q Consensus 183 n~l~~ 187 (560)
|++.+
T Consensus 191 N~i~~ 195 (197)
T 4ezg_A 191 QTIGG 195 (197)
T ss_dssp C----
T ss_pred cccCC
Confidence 99864
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.82 E-value=2.8e-20 Score=170.02 Aligned_cols=156 Identities=17% Similarity=0.237 Sum_probs=132.4
Q ss_pred cccCCCCCCeeeccccccccccccccCCCCCCCEEEeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCC
Q 035761 48 NVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQL 127 (560)
Q Consensus 48 ~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 127 (560)
....+++|+.|++++|.++. .+ .+..+++|++|++++|.++. +..+..+++|++|++++|.+++..+..+..+++|
T Consensus 39 ~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L 114 (197)
T 4ezg_A 39 TEAQMNSLTYITLANINVTD-LT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSL 114 (197)
T ss_dssp BHHHHHTCCEEEEESSCCSC-CT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTC
T ss_pred ChhhcCCccEEeccCCCccC-hH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCC
Confidence 34667899999999999984 44 68889999999999998773 3478899999999999999997778889999999
Q ss_pred cEEECcCCcCcCCCCccCcCCCCCcEEEccCcc-cccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccC
Q 035761 128 TTLNMYNNKLDGPIPPELMNCSKLRILKLGNNL-LSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSM 206 (560)
Q Consensus 128 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~ 206 (560)
++|++++|.+++..+..+..+++|+.|++++|. ++ .+| .+..+++|++|++++|++++. + .+..+++|+.|++++
T Consensus 115 ~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~L~l~~ 190 (197)
T 4ezg_A 115 TLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQLYAFS 190 (197)
T ss_dssp CEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCEEEECB
T ss_pred CEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCEEEeeC
Confidence 999999999998778889999999999999998 66 445 689999999999999999853 3 788899999999999
Q ss_pred Ccccc
Q 035761 207 NNLSG 211 (560)
Q Consensus 207 n~l~~ 211 (560)
|++.+
T Consensus 191 N~i~~ 195 (197)
T 4ezg_A 191 QTIGG 195 (197)
T ss_dssp C----
T ss_pred cccCC
Confidence 99864
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.2e-22 Score=215.17 Aligned_cols=107 Identities=23% Similarity=0.313 Sum_probs=62.2
Q ss_pred ccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccccccchhhccccccceeeccc
Q 035761 103 LRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSG 182 (560)
Q Consensus 103 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 182 (560)
|+.|+|++|.|++ +|. |.++++|+.|+|++|.|+ .+|..+..+++|+.|+|++|.|++ +| .+..+++|++|+|++
T Consensus 443 L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~ 517 (567)
T 1dce_A 443 VRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCN 517 (567)
T ss_dssp CSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCS
T ss_pred ceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCC
Confidence 5556666666653 343 555666666666666665 445556666666666666666653 34 555666666666666
Q ss_pred cccCCcC-ccccCCCceeeEEEccCCccccccC
Q 035761 183 NFINGKI-PSQLGEFSCIDTVDLSMNNLSGGIP 214 (560)
Q Consensus 183 n~l~~~~-~~~~~~~~~L~~l~l~~n~l~~~~~ 214 (560)
|+|++.. |..+..+++|+.|+|++|++++.+|
T Consensus 518 N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 518 NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp SCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred CCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 6665544 5556666666666666666655544
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=4e-20 Score=176.38 Aligned_cols=139 Identities=22% Similarity=0.257 Sum_probs=106.4
Q ss_pred CcccceeeccCCeeEEEEEe-CCCcE--EEEEEccchhhhh----------------------hhHHHHHHHHHHHhccC
Q 035761 317 FDIKYCIGTGGYGSVYRARL-PSGKV--VALKKLHRLETEL----------------------ASLESFQNEARLLSQIR 371 (560)
Q Consensus 317 ~~~~~~ig~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~~----------------------~~~~~~~~e~~~l~~l~ 371 (560)
|++.+.||+|+||.||+|.. .+|+. ||||+++...... .....+.+|+.++..++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999987 67888 9999875432110 11235788999999998
Q ss_pred CCCc--ceeeeEEEeCCEEEEEEeccCC-C----CHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEEe
Q 035761 372 HRNI--VKLYGFCLHEKCMFLIYEYMEM-G----SLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLH-HHCTPPILHR 443 (560)
Q Consensus 372 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH-~~~~~~ivH~ 443 (560)
|+++ ..++++ +..++||||+.+ | +|.++... .++.++..++.|++.||+||| +. ||+||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~---givHr 195 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEA---ELVHA 195 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTS---CEECS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHC---CEEeC
Confidence 8764 333332 245899999942 4 66665432 234556789999999999999 88 99999
Q ss_pred CCCCCCeEeCCCCcEEEeeeccccccC
Q 035761 444 DISSNNILLNSEFEAFVADFGIARLLN 470 (560)
Q Consensus 444 dlk~~Nill~~~~~~kl~Dfg~~~~~~ 470 (560)
||||+|||+++ .++|+|||+|....
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEETT
T ss_pred CCCHHHEEEcC--cEEEEECcccccCC
Confidence 99999999998 99999999997653
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.80 E-value=9.7e-20 Score=165.56 Aligned_cols=130 Identities=24% Similarity=0.339 Sum_probs=89.0
Q ss_pred CEEEccCCcceecCCccccCCCCCCeeecccccccccccc-ccCCCCCCCEEEeecCccCccCCCCcCCCCCccEEEccC
Q 035761 32 KILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILL-GIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQ 110 (560)
Q Consensus 32 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 110 (560)
++|++++|.++ .+|..+.. +|++|+|++|+|++..+. .|..+++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 67777777776 45554432 677777777777755543 366777777777777777766667777777777777777
Q ss_pred CCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccccc
Q 035761 111 NKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGS 164 (560)
Q Consensus 111 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 164 (560)
|+|++..+..|.++++|++|+|++|++++..|..|..+++|+.|++++|.+++.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 141 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCc
Confidence 777766666666777777777777777766666666666777777766666643
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1e-21 Score=207.99 Aligned_cols=197 Identities=20% Similarity=0.218 Sum_probs=157.1
Q ss_pred CCCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCc-------------ceecCCccccCCCCCCeee-cccccccc
Q 035761 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNS-------------LVGNIPSNVGHLTQLTTLA-IASNRMNG 67 (560)
Q Consensus 2 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~-------------i~~~~~~~~~~l~~L~~L~-L~~n~i~~ 67 (560)
...++|+.|+|++|+|+ .+|..++++++|+.|++++|. +.+..|..+.++++|+.|+ ++.|.+..
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~~ 424 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDD 424 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHHH
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccch
Confidence 45678899999999997 678889999999999997775 4456677788888888888 56654432
Q ss_pred cccc-----ccCC--CCCCCEEEeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCC
Q 035761 68 SILL-----GIGS--LKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGP 140 (560)
Q Consensus 68 ~~~~-----~~~~--l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 140 (560)
.... .+.. ...|+.|+|++|+|++ +|. +..+++|+.|+|++|.|+ .+|..|.++++|+.|+|++|.|++
T Consensus 425 L~~l~l~~n~i~~l~~~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~- 500 (567)
T 1dce_A 425 LRSKFLLENSVLKMEYADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN- 500 (567)
T ss_dssp HHHHHHHHHHHHHHHHTTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-
T ss_pred hhhhhhhcccccccCccCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-
Confidence 1100 0111 1258999999999995 566 999999999999999999 778899999999999999999996
Q ss_pred CCccCcCCCCCcEEEccCccccccc-chhhccccccceeeccccccCCcCccc---cCCCceeeEEEc
Q 035761 141 IPPELMNCSKLRILKLGNNLLSGSI-PSQIGKLQELYYLDLSGNFINGKIPSQ---LGEFSCIDTVDL 204 (560)
Q Consensus 141 ~~~~~~~l~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~---~~~~~~L~~l~l 204 (560)
+| .+..+++|+.|+|++|+|++.. |..|..+++|+.|+|++|++++.+|.. +..+++|+.|++
T Consensus 501 lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 501 VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 55 8999999999999999999776 899999999999999999998665532 233677888764
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.78 E-value=7.4e-19 Score=159.72 Aligned_cols=173 Identities=23% Similarity=0.294 Sum_probs=82.8
Q ss_pred CeeeccccccccccccccCCCCCCCEEEeecCccCccCCC-CcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcC
Q 035761 56 TTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPS-TLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYN 134 (560)
Q Consensus 56 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 134 (560)
+.|++++|+++ .+|..+. .+|++|+|++|+|++..+. .|..+++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 44555555554 2222222 1455555555555543332 244555555555555555544455555555555555555
Q ss_pred CcCcCCCCccCcCCCCCcEEEccCcccccccchhhccccccceeeccccccCCcCcc-ccCCCceeeEEEccCCcccccc
Q 035761 135 NKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPS-QLGEFSCIDTVDLSMNNLSGGI 213 (560)
Q Consensus 135 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~-~~~~~~~L~~l~l~~n~l~~~~ 213 (560)
|+|++..+..|..+++|+.|+|++|++++..|..|..+++|++|+|++|++.+..+- ++. ..++...+..+...+..
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~--~~l~~~~~~~~~~~C~~ 165 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFA--EWLRKKSLNGGAARCGA 165 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHH--HHHHHHCCSGGGCBBCS
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHH--HHHHHcCCCCCCCCCCC
Confidence 555544444455555555555555555544455555555555555555555433221 000 01111123334445555
Q ss_pred CcccccCCCCcCCCCCCCCc
Q 035761 214 PVFVRKVPHLDVSGNQFGGE 233 (560)
Q Consensus 214 ~~~~~~l~~l~l~~n~~~~~ 233 (560)
|..++.....++..+.+.|.
T Consensus 166 P~~l~~~~l~~l~~~~~~C~ 185 (192)
T 1w8a_A 166 PSKVRDVQIKDLPHSEFKCS 185 (192)
T ss_dssp STTTTTSBGGGSCTTTCCCC
T ss_pred ChHHcCCChhhCcHhhcCcC
Confidence 65555555566666666554
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.78 E-value=8.2e-20 Score=199.37 Aligned_cols=191 Identities=20% Similarity=0.207 Sum_probs=123.6
Q ss_pred CCCCEEEccCCcCcccCCCCCCCcCCCC-----EEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCC
Q 035761 5 RNLVHLDLSDNHFMGHIPPTLGRLSELK-----ILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVL 79 (560)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~-----~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L 79 (560)
+.++.|+|.+|.+... +..+.....|. .++++.|.+. ..++.|..+++|+.|+|++|.+. .++..+.++++|
T Consensus 173 ~~~~~l~L~~n~~~~~-~~~~l~~l~Ls~~~i~~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L 249 (727)
T 4b8c_D 173 PLTPKIELFANGKDEA-NQALLQHKKLSQYSIDEDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFL 249 (727)
T ss_dssp ---------------------------------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSC
T ss_pred CccceEEeeCCCCCcc-hhhHhhcCccCcccccCcccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCC
Confidence 4588999999999853 43332222222 2334444454 66888999999999999999998 556666699999
Q ss_pred CEEEeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCc
Q 035761 80 QVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNN 159 (560)
Q Consensus 80 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 159 (560)
++|+|++|.|+ .+|..|.++++|++|+|++|+|+ .+|..|.+|++|++|+|++|.|+ .+|..|..+++|+.|+|++|
T Consensus 250 ~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N 326 (727)
T 4b8c_D 250 TRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGN 326 (727)
T ss_dssp SCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTS
T ss_pred CEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCC
Confidence 99999999999 78889999999999999999999 77999999999999999999998 67888999999999999999
Q ss_pred ccccccchhhccccc-cceeeccccccCCcCccccCCCceeeEEEccCC
Q 035761 160 LLSGSIPSQIGKLQE-LYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMN 207 (560)
Q Consensus 160 ~l~~~~~~~~~~l~~-L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n 207 (560)
.|++.+|..+..+.. +..|+|++|.+++.+|.. |+.|+++.|
T Consensus 327 ~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n 369 (727)
T 4b8c_D 327 PLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTD 369 (727)
T ss_dssp CCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC---------------
T ss_pred ccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeecc
Confidence 999988988866533 345899999999888765 445566666
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.77 E-value=7e-19 Score=174.38 Aligned_cols=210 Identities=11% Similarity=0.020 Sum_probs=128.1
Q ss_pred CCCCCEEEccCCcCc--ccCCCCCCCcCCCCEEEccCCcceecCCccccC--------CCCCCeeecccccccccccccc
Q 035761 4 LRNLVHLDLSDNHFM--GHIPPTLGRLSELKILNLSLNSLVGNIPSNVGH--------LTQLTTLAIASNRMNGSILLGI 73 (560)
Q Consensus 4 l~~L~~L~L~~n~l~--~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~--------l~~L~~L~L~~n~i~~~~~~~~ 73 (560)
+++|++|||++|+|. ......+. .++.+.+..|. +.+.+|.+ +++|+.|+|.+ .++.+...+|
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~~~~---~~~~~~~~~~~---I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF 120 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAGTYP---NGKFYIYMANF---VPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAF 120 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSSSSG---GGCCEEECTTE---ECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTT
T ss_pred hccCeEEecCcceeEEecCcccccc---ccccccccccc---cCHHHhcccccccccccCCCcEEECCc-cccchhHHHh
Confidence 678999999999998 22222222 23344444442 23344555 55555555555 5555555555
Q ss_pred CCCCCCCEEEeecCccCccCCCCcCCCCCccEEEccCCCc----cCCCCccC----------------------------
Q 035761 74 GSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKL----VGPIPSSL---------------------------- 121 (560)
Q Consensus 74 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l----~~~~~~~~---------------------------- 121 (560)
.++++|+.|++++|.++.+.+..|.++.++..+.+..+.. .......|
T Consensus 121 ~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~ 200 (329)
T 3sb4_A 121 KGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQ 200 (329)
T ss_dssp TTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCC
T ss_pred hcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhcccC
Confidence 5555566666655555555555555555555444433111 00000000
Q ss_pred ----------------------CCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccccccchhhccccccc-ee
Q 035761 122 ----------------------GHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELY-YL 178 (560)
Q Consensus 122 ----------------------~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~-~L 178 (560)
..+++|+.|+|++|+++.+.+.+|.++++|+.|++.+| ++.+.+.+|.++.+|+ .+
T Consensus 201 ~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l 279 (329)
T 3sb4_A 201 PRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTL 279 (329)
T ss_dssp GGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEE
T ss_pred ccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEE
Confidence 02677888888887777666667888888888888777 6666777778888887 88
Q ss_pred eccccccCCcCccccCCCceeeEEEccCCccccccCcccccCCC
Q 035761 179 DLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPH 222 (560)
Q Consensus 179 ~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~ 222 (560)
++.+ .++.+.+..|..+++|+.+++++|.++...+..+.+++.
T Consensus 280 ~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~ 322 (329)
T 3sb4_A 280 ELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVP 322 (329)
T ss_dssp EECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCC
T ss_pred EEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcc
Confidence 8877 666666777888888888888777777666665554443
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.77 E-value=6e-20 Score=200.46 Aligned_cols=167 Identities=26% Similarity=0.285 Sum_probs=124.0
Q ss_pred CCEEEccCCcCcc---------cCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCC
Q 035761 7 LVHLDLSDNHFMG---------HIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLK 77 (560)
Q Consensus 7 L~~L~L~~n~l~~---------~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~ 77 (560)
++.++|+.|.|++ ..++.|..+++|++|+|++|.+. .+|..+.++++|++|+|++|.|+ .+|..|.+++
T Consensus 193 l~~l~Ls~~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~ 270 (727)
T 4b8c_D 193 LQHKKLSQYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLS 270 (727)
T ss_dssp -----------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGT
T ss_pred hhcCccCcccccCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCC
Confidence 4555555555543 45888999999999999999999 67777779999999999999999 7788899999
Q ss_pred CCCEEEeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCC-CcEEEc
Q 035761 78 VLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSK-LRILKL 156 (560)
Q Consensus 78 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~-L~~L~l 156 (560)
+|++|+|++|.|+ .+|..|.++++|++|+|++|.|+ .+|..|.++++|+.|+|++|.|++.+|..+..+.. +..|+|
T Consensus 271 ~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l 348 (727)
T 4b8c_D 271 NLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYL 348 (727)
T ss_dssp TCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHH
T ss_pred CCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhh
Confidence 9999999999999 67999999999999999999998 67888999999999999999999888877765432 235889
Q ss_pred cCcccccccchhhccccccceeecccc
Q 035761 157 GNNLLSGSIPSQIGKLQELYYLDLSGN 183 (560)
Q Consensus 157 ~~n~l~~~~~~~~~~l~~L~~L~l~~n 183 (560)
++|.+++.+|. .|+.|+++.|
T Consensus 349 ~~N~l~~~~p~------~l~~l~l~~n 369 (727)
T 4b8c_D 349 RDNRPEIPLPH------ERRFIEINTD 369 (727)
T ss_dssp HHCCCCCCCCC------C---------
T ss_pred ccCcccCcCcc------ccceeEeecc
Confidence 99999988776 4566777777
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.75 E-value=2.1e-18 Score=153.22 Aligned_cols=132 Identities=21% Similarity=0.200 Sum_probs=91.5
Q ss_pred CCCCEEEccCCcce-ecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEeecCccCccCCCCcCCCCCccEEE
Q 035761 29 SELKILNLSLNSLV-GNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVD 107 (560)
Q Consensus 29 ~~L~~L~L~~N~i~-~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 107 (560)
++|++|+|++|.++ +.+|..+..+++|+.|+|++|.++.. ..+..+++|++|+|++|++++.+|..+..+++|+.|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 56777777777776 45566666777777777777777654 5666777777777777777755666666677777777
Q ss_pred ccCCCccCCCC-ccCCCCCCCcEEECcCCcCcCCCC---ccCcCCCCCcEEEccCcccc
Q 035761 108 LSQNKLVGPIP-SSLGHLTQLTTLNMYNNKLDGPIP---PELMNCSKLRILKLGNNLLS 162 (560)
Q Consensus 108 l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~---~~~~~l~~L~~L~l~~n~l~ 162 (560)
|++|.+++... ..+..+++|+.|++++|.+++..+ ..+..+++|+.|++++|.+.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 77777774322 567777777777777777775444 36777777777777777776
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.75 E-value=5e-18 Score=150.77 Aligned_cols=132 Identities=26% Similarity=0.241 Sum_probs=90.3
Q ss_pred CCCCeeeccccccc-cccccccCCCCCCCEEEeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEE
Q 035761 53 TQLTTLAIASNRMN-GSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLN 131 (560)
Q Consensus 53 ~~L~~L~L~~n~i~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 131 (560)
++|+.|+|++|+++ +.+|..+..+++|++|+|++|.+++. ..+..+++|++|+|++|++++.+|..+.++++|+.|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 66777777777776 45566667777777777777777754 5667777777777777777755666666677777777
Q ss_pred CcCCcCcCCCC-ccCcCCCCCcEEEccCcccccccc---hhhccccccceeeccccccC
Q 035761 132 MYNNKLDGPIP-PELMNCSKLRILKLGNNLLSGSIP---SQIGKLQELYYLDLSGNFIN 186 (560)
Q Consensus 132 l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~---~~~~~l~~L~~L~l~~n~l~ 186 (560)
|++|.+++... ..+..+++|+.|++++|.+++..+ ..+..+++|++|++++|.+.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 77777764322 566677777777777777765444 36666777777777777665
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.75 E-value=1.2e-17 Score=151.60 Aligned_cols=128 Identities=23% Similarity=0.283 Sum_probs=87.9
Q ss_pred CEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEeecCccCccCCCCcCCCCCccEEEccCC
Q 035761 32 KILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQN 111 (560)
Q Consensus 32 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 111 (560)
+++++++|.++ .+|..+. ++|++|+|++|+|+ .+|..|.++++|++|+|++|.|++..+..|.++++|++|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 45666666666 3444332 46666666666666 44466666777777777777777666666777777777777777
Q ss_pred CccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCccccc
Q 035761 112 KLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSG 163 (560)
Q Consensus 112 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 163 (560)
+|+++.+..|.++++|+.|+|++|.|+...+..|..+++|+.|++++|.+..
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 7776666677777777777777777776655667777778888888887763
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.5e-18 Score=172.00 Aligned_cols=228 Identities=11% Similarity=0.062 Sum_probs=160.7
Q ss_pred CCCCEEEccCCcCcccCCCCCCC-cCCCCEEEccCCcce--ecCCccccCCCCCCeeeccccccccccccccCC------
Q 035761 5 RNLVHLDLSDNHFMGHIPPTLGR-LSELKILNLSLNSLV--GNIPSNVGHLTQLTTLAIASNRMNGSILLGIGS------ 75 (560)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~L~~N~i~--~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~------ 75 (560)
.+|+.|.++++ +.......+.. +++|++|||++|+|. ...+..+ +.+..+.+..|. +....|.+
T Consensus 25 ~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~~---I~~~aF~~~~~~~~ 97 (329)
T 3sb4_A 25 NSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMANF---VPAYAFSNVVNGVT 97 (329)
T ss_dssp HHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTTE---ECTTTTEEEETTEE
T ss_pred CceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccccc---cccccccccccc---cCHHHhcccccccc
Confidence 45677777764 22111112222 677888888888776 3333222 224555555553 44667777
Q ss_pred --CCCCCEEEeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcC----cCCCCccC----
Q 035761 76 --LKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKL----DGPIPPEL---- 145 (560)
Q Consensus 76 --l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l----~~~~~~~~---- 145 (560)
+++|+.|+|.+ +++.+.+.+|.++++|+.|++++|.+..+.+.+|.++.++..+.+..+.. .......|
T Consensus 98 ~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~ 176 (329)
T 3sb4_A 98 KGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGE 176 (329)
T ss_dssp EECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESC
T ss_pred cccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccc
Confidence 99999999998 88878888899999999999999998878888999888888877766321 11111111
Q ss_pred ----------------------------------------------cCCCCCcEEEccCcccccccchhhccccccceee
Q 035761 146 ----------------------------------------------MNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLD 179 (560)
Q Consensus 146 ----------------------------------------------~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 179 (560)
..+++|+.|++++|+++.+.+..|.++.+|+.|+
T Consensus 177 ~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~ 256 (329)
T 3sb4_A 177 PLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIK 256 (329)
T ss_dssp CCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEE
T ss_pred ccceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEE
Confidence 0278999999999999977888899999999999
Q ss_pred ccccccCCcCccccCCCceee-EEEccCCccccccCccc---ccCCCCcCCCCCCCCcCCcccCCCC
Q 035761 180 LSGNFINGKIPSQLGEFSCID-TVDLSMNNLSGGIPVFV---RKVPHLDVSGNQFGGEIPTTLANVP 242 (560)
Q Consensus 180 l~~n~l~~~~~~~~~~~~~L~-~l~l~~n~l~~~~~~~~---~~l~~l~l~~n~~~~~~p~~~~~~~ 242 (560)
|.+| +..+.+..|..+.+|+ .+++.+ .++...+..+ .+|+.+++.+|.+....+....+.+
T Consensus 257 l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~ 321 (329)
T 3sb4_A 257 LPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGV 321 (329)
T ss_dssp CCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTC
T ss_pred CCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCc
Confidence 9988 7777788899999998 999988 6665555554 4567778888888776555555443
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.7e-17 Score=150.72 Aligned_cols=130 Identities=22% Similarity=0.303 Sum_probs=79.3
Q ss_pred CEEEeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCc
Q 035761 80 QVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNN 159 (560)
Q Consensus 80 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 159 (560)
+++++++|+++ .+|..+. ++|+.|+|++|.|+ .+|..|.++++|+.|+|++|.|++..+..|.++++|+.|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 34555555555 3343332 35666666666665 44556666666666666666666555556666666666666666
Q ss_pred ccccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCcccccc
Q 035761 160 LLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGI 213 (560)
Q Consensus 160 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~ 213 (560)
.|++..+..|..+++|++|+|++|+|+...+..|..+++|+.|++++|++.+..
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c 142 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDC 142 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCC
Confidence 666555556666666666666666666555555666666677777777666543
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.72 E-value=3.8e-18 Score=148.30 Aligned_cols=127 Identities=20% Similarity=0.234 Sum_probs=73.6
Q ss_pred CCCCEEEccCCcce-ecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEeecCccCccCCCCcCCCCCccEEE
Q 035761 29 SELKILNLSLNSLV-GNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVD 107 (560)
Q Consensus 29 ~~L~~L~L~~N~i~-~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 107 (560)
++|++|++++|.++ +.+|..+..+++|+.|+|++|++++. ..+.++++|++|+|++|.+++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 45555555555555 44455555555555555555555543 4555566666666666666644555555566666666
Q ss_pred ccCCCccCC-CCccCCCCCCCcEEECcCCcCcCCCC---ccCcCCCCCcEEEcc
Q 035761 108 LSQNKLVGP-IPSSLGHLTQLTTLNMYNNKLDGPIP---PELMNCSKLRILKLG 157 (560)
Q Consensus 108 l~~n~l~~~-~~~~~~~l~~L~~L~l~~n~l~~~~~---~~~~~l~~L~~L~l~ 157 (560)
+++|.+++. .+..+..+++|++|++++|.+++..+ ..+..+++|+.|+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 666666532 22556666666666666666665444 356666666666654
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.72 E-value=6.9e-17 Score=144.69 Aligned_cols=132 Identities=23% Similarity=0.213 Sum_probs=90.4
Q ss_pred CCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEeecCccCccCCCCcCCCCCccEEEccC
Q 035761 31 LKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQ 110 (560)
Q Consensus 31 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 110 (560)
.+.+++++|+++ .+|..+. ++|+.|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++
T Consensus 9 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 355666666665 3333222 4666666666666655555666777777777777777765556667777777777777
Q ss_pred CCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCccccccc
Q 035761 111 NKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSI 165 (560)
Q Consensus 111 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 165 (560)
|++++..+..|..+++|+.|++++|.+++..+..+..+++|+.|++++|.+++..
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 140 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 140 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccC
Confidence 7777666666777778888888888777665556677788888888888877543
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.71 E-value=1e-17 Score=145.55 Aligned_cols=127 Identities=23% Similarity=0.263 Sum_probs=73.6
Q ss_pred CCCCeeeccccccc-cccccccCCCCCCCEEEeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEE
Q 035761 53 TQLTTLAIASNRMN-GSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLN 131 (560)
Q Consensus 53 ~~L~~L~L~~n~i~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 131 (560)
++|+.|++++|.++ +..|..+..+++|++|++++|.+++. ..+..+++|++|+|++|.+++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 55666666666665 44555556666666666666666643 4555666666666666666644555555566666666
Q ss_pred CcCCcCcCC-CCccCcCCCCCcEEEccCcccccccc---hhhccccccceeecc
Q 035761 132 MYNNKLDGP-IPPELMNCSKLRILKLGNNLLSGSIP---SQIGKLQELYYLDLS 181 (560)
Q Consensus 132 l~~n~l~~~-~~~~~~~l~~L~~L~l~~n~l~~~~~---~~~~~l~~L~~L~l~ 181 (560)
+++|.+++. .+..+..+++|+.|++++|.+++..+ ..+..+++|+.|+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 666666542 22455556666666666666654433 345555566655554
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.71 E-value=8.8e-17 Score=144.02 Aligned_cols=129 Identities=23% Similarity=0.224 Sum_probs=62.1
Q ss_pred CeeeccccccccccccccCCCCCCCEEEeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCC
Q 035761 56 TTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNN 135 (560)
Q Consensus 56 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 135 (560)
+.+++++|+++.. |..+ .++|++|++++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|
T Consensus 10 ~~l~~~~~~l~~~-p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 10 TEIRCNSKGLTSV-PTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp TEEECCSSCCSSC-CTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCCccC-CCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 4445555554422 2211 134555555555555444444455555555555555555444444455555555555555
Q ss_pred cCcCCCCccCcCCCCCcEEEccCcccccccchhhccccccceeeccccccCC
Q 035761 136 KLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFING 187 (560)
Q Consensus 136 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 187 (560)
.+++..+..+..+++|+.|++++|.+++..+..|..+++|++|++++|++.+
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 138 (177)
T 2o6r_A 87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 138 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeec
Confidence 5554444444455555555555555554433334445555555555555543
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.69 E-value=7.6e-17 Score=159.40 Aligned_cols=142 Identities=13% Similarity=0.135 Sum_probs=101.9
Q ss_pred cCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhh------------hhhHH--------HHHHHHHHHhccCCCC
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETE------------LASLE--------SFQNEARLLSQIRHRN 374 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------~~~~~--------~~~~e~~~l~~l~h~n 374 (560)
.=|++...||+|+||.||+|...+|+.||||+++..... ..... ...+|...+.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 348889999999999999999989999999987532110 00001 1234666677765544
Q ss_pred cceeeeEEEeCCEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCC
Q 035761 375 IVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNS 454 (560)
Q Consensus 375 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~ 454 (560)
+....-+.... .+|||||+++++|..+... .+...++.|++.+|.|||+. |||||||||.|||+++
T Consensus 175 v~vp~p~~~~~--~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 175 FPVPEPIAQSR--HTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIRE 240 (397)
T ss_dssp CSCCCEEEEET--TEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEE
T ss_pred CCCCeeeeccC--ceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeC
Confidence 43222222222 3699999999888655432 12356889999999999998 9999999999999988
Q ss_pred CC----------cEEEeeeccccccC
Q 035761 455 EF----------EAFVADFGIARLLN 470 (560)
Q Consensus 455 ~~----------~~kl~Dfg~~~~~~ 470 (560)
++ .+.|+||+-+....
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CCCcccccccccceEEEEeCCcccCC
Confidence 76 38999999776543
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.67 E-value=1.8e-18 Score=185.97 Aligned_cols=229 Identities=15% Similarity=0.096 Sum_probs=159.6
Q ss_pred CCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCC-ccccCCCCCCeeecccccccc-ccccccCCCCCCC
Q 035761 3 RLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIP-SNVGHLTQLTTLAIASNRMNG-SILLGIGSLKVLQ 80 (560)
Q Consensus 3 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~n~i~~-~~~~~~~~l~~L~ 80 (560)
.+++|+.|+++++... .+|..+..+++|++|+|++|.++.... ..+.++++|+.|+++ |.+.. ..+..+..+++|+
T Consensus 268 ~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~ 345 (592)
T 3ogk_B 268 FPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLK 345 (592)
T ss_dssp CCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCC
T ss_pred ccccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCC
Confidence 4455566666554332 455666777888888888888664332 335778888888888 44432 3344445678888
Q ss_pred EEEee-----------cCccCccC-CCCcCCCCCccEEEccCCCccCCCCccCCC-CCCCcEEECc----CCcCcCC---
Q 035761 81 VLDLS-----------RNEIGGSI-PSTLGHLKWLRSVDLSQNKLVGPIPSSLGH-LTQLTTLNMY----NNKLDGP--- 140 (560)
Q Consensus 81 ~L~l~-----------~n~l~~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-l~~L~~L~l~----~n~l~~~--- 140 (560)
+|+|+ .|.++... +..+..+++|+.|+++.|.+++..+..+.. +++|+.|+++ .|.+++.
T Consensus 346 ~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~ 425 (592)
T 3ogk_B 346 RLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLD 425 (592)
T ss_dssp EEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCH
T ss_pred EEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHH
Confidence 88888 35665321 222345788999999888887655555554 8899999996 6677753
Q ss_pred --CCccCcCCCCCcEEEccCcc--cccccchhhc-cccccceeeccccccCCc-CccccCCCceeeEEEccCCccccccC
Q 035761 141 --IPPELMNCSKLRILKLGNNL--LSGSIPSQIG-KLQELYYLDLSGNFINGK-IPSQLGEFSCIDTVDLSMNNLSGGIP 214 (560)
Q Consensus 141 --~~~~~~~l~~L~~L~l~~n~--l~~~~~~~~~-~l~~L~~L~l~~n~l~~~-~~~~~~~~~~L~~l~l~~n~l~~~~~ 214 (560)
++..+..+++|+.|++++|. +++..+..+. .+++|++|++++|++++. .+..+..+++|+.|++++|++++...
T Consensus 426 ~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~ 505 (592)
T 3ogk_B 426 NGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAI 505 (592)
T ss_dssp HHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHH
T ss_pred HHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHH
Confidence 22236678999999998543 6665555554 488999999999999863 45566788999999999999875433
Q ss_pred c----ccccCCCCcCCCCCCCCc
Q 035761 215 V----FVRKVPHLDVSGNQFGGE 233 (560)
Q Consensus 215 ~----~~~~l~~l~l~~n~~~~~ 233 (560)
. .+++++.|++++|+++..
T Consensus 506 ~~~~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 506 AAAVTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp HHHHHHCSSCCEEEEESCBCCTT
T ss_pred HHHHHhcCccCeeECcCCcCCHH
Confidence 2 357889999999997754
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.66 E-value=5.9e-17 Score=144.97 Aligned_cols=105 Identities=22% Similarity=0.218 Sum_probs=54.1
Q ss_pred CCCEEEeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCc--cCcCCCCCcEEE
Q 035761 78 VLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPP--ELMNCSKLRILK 155 (560)
Q Consensus 78 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~--~~~~l~~L~~L~ 155 (560)
+|++|+|++|.|++. ..+..+++|++|+|++|.+++..+..|..+++|++|+|++|.++ .+|. .+..+++|+.|+
T Consensus 43 ~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~ 119 (176)
T 1a9n_A 43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLC 119 (176)
T ss_dssp CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEE
T ss_pred CCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEE
Confidence 444444444444432 34444555555555555555333333355555555555555554 2232 455555666666
Q ss_pred ccCcccccccch----hhccccccceeeccccccC
Q 035761 156 LGNNLLSGSIPS----QIGKLQELYYLDLSGNFIN 186 (560)
Q Consensus 156 l~~n~l~~~~~~----~~~~l~~L~~L~l~~n~l~ 186 (560)
+++|.++ ..|. .+..+++|+.|++++|.+.
T Consensus 120 l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 120 ILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred ecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 6666665 2333 2566666666666666554
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.66 E-value=1.1e-16 Score=143.23 Aligned_cols=133 Identities=20% Similarity=0.190 Sum_probs=74.1
Q ss_pred CCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEeecCccCccCCCCcCCCCCcc
Q 035761 25 LGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLR 104 (560)
Q Consensus 25 ~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 104 (560)
+.++++|++|++++|+++. +|......++|+.|+|++|++++. ..|.++++|++|+|++|+|++..+..|..+++|+
T Consensus 15 ~~~~~~L~~L~l~~n~l~~-i~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 91 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 91 (176)
T ss_dssp EECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred cCCcCCceEEEeeCCCCch-hHHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCC
Confidence 4455566666666666653 233222223666666666666543 4555666666666666666644334445566666
Q ss_pred EEEccCCCccCCCCc--cCCCCCCCcEEECcCCcCcCCCCc----cCcCCCCCcEEEccCcccc
Q 035761 105 SVDLSQNKLVGPIPS--SLGHLTQLTTLNMYNNKLDGPIPP----ELMNCSKLRILKLGNNLLS 162 (560)
Q Consensus 105 ~L~l~~n~l~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~----~~~~l~~L~~L~l~~n~l~ 162 (560)
+|+|++|.++ .+|. .+..+++|+.|++++|.++. .|. .+..+++|+.|++++|.+.
T Consensus 92 ~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 92 ELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp EEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHH
T ss_pred EEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHH
Confidence 6666666665 3333 55556666666666666653 233 2555666666666666554
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.66 E-value=1.7e-15 Score=153.23 Aligned_cols=222 Identities=9% Similarity=0.036 Sum_probs=174.3
Q ss_pred CCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEee
Q 035761 6 NLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLS 85 (560)
Q Consensus 6 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~ 85 (560)
+|+.++|..| ++.+...+|.+. +|+.+.|.. .++.+.+.+|.++++|+.++|.+|+++.+....|. ..+|+.+.|.
T Consensus 136 ~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp 211 (401)
T 4fdw_A 136 QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLP 211 (401)
T ss_dssp CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECC
T ss_pred CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeC
Confidence 6899998776 777888888884 799999986 67778888999999999999999999877777777 5889999998
Q ss_pred cCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccc---
Q 035761 86 RNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLS--- 162 (560)
Q Consensus 86 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~--- 162 (560)
.+ ++.+...+|.++++|+.+++.+| ++.+...+|.+ .+|+.+.|. |.++.+...+|.+|++|+.+++.+|.+.
T Consensus 212 ~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~ 287 (401)
T 4fdw_A 212 VT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-NGVTNIASRAFYYCPELAEVTTYGSTFNDDP 287 (401)
T ss_dssp TT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-TTCCEECTTTTTTCTTCCEEEEESSCCCCCT
T ss_pred Cc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeC-CCccEEChhHhhCCCCCCEEEeCCccccCCc
Confidence 44 77677888999999999999875 55577778887 789999984 5566566778999999999999888765
Q ss_pred --cccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCcccc--cCCCCcCCCCCCCCcCCcc
Q 035761 163 --GSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVR--KVPHLDVSGNQFGGEIPTT 237 (560)
Q Consensus 163 --~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~~~--~l~~l~l~~n~~~~~~p~~ 237 (560)
.+.+..|.++++|+.++|. +.++......|..+.+|+.+++..| ++......+. +++.+++.+|......+..
T Consensus 288 ~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~~L~~l~l~~n~~~~l~~~~ 364 (401)
T 4fdw_A 288 EAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNTGIKEVKVEGTTPPQVFEKV 364 (401)
T ss_dssp TCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSSCCCEEEECCSSCCBCCCSS
T ss_pred ccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCCCCCEEEEcCCCCccccccc
Confidence 4667788899999999998 4577677788888899999998555 5543333332 6777888888765443333
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.65 E-value=2.1e-15 Score=152.63 Aligned_cols=205 Identities=11% Similarity=0.079 Sum_probs=175.6
Q ss_pred CCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEe
Q 035761 5 RNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDL 84 (560)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l 84 (560)
.+|+.+.|.+ .++.+...+|.++++|+.++|++|+++.+...+|. ..+|+.+.|.++ ++.+...+|.++++|+.+++
T Consensus 157 ~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l 233 (401)
T 4fdw_A 157 STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEI 233 (401)
T ss_dssp CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEEC
T ss_pred CCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEec
Confidence 3699999986 78878889999999999999999999988788887 689999999855 88788999999999999999
Q ss_pred ecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCc-----CCCCccCcCCCCCcEEEccCc
Q 035761 85 SRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLD-----GPIPPELMNCSKLRILKLGNN 159 (560)
Q Consensus 85 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-----~~~~~~~~~l~~L~~L~l~~n 159 (560)
..| ++.+...+|.+ .+|+.+.|. |.++.+...+|.+|++|+.+.+.+|.+. .+.+.+|.+|++|+.+++.+
T Consensus 234 ~~~-l~~I~~~aF~~-~~L~~i~lp-~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~- 309 (401)
T 4fdw_A 234 PEN-VSTIGQEAFRE-SGITTVKLP-NGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE- 309 (401)
T ss_dssp CTT-CCEECTTTTTT-CCCSEEEEE-TTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-
T ss_pred CCC-ccCcccccccc-CCccEEEeC-CCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-
Confidence 875 67677778888 789999994 5566678899999999999999998775 45677899999999999994
Q ss_pred ccccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCcccc
Q 035761 160 LLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVR 218 (560)
Q Consensus 160 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~~~ 218 (560)
.++.+....|.++.+|+.++|..| ++......|..+ +|+.+++++|.+....+..+.
T Consensus 310 ~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~ 366 (401)
T 4fdw_A 310 SIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWY 366 (401)
T ss_dssp TCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCC
T ss_pred ceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCccccccccc
Confidence 587788889999999999999655 776778899999 999999999988765555443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.63 E-value=1.3e-18 Score=159.12 Aligned_cols=152 Identities=25% Similarity=0.300 Sum_probs=82.7
Q ss_pred cCCCCEEEccCCcceecCCc------cccCCCCCCeeeccccccccccccccCCCCCCCEEEeecCccCccCCCCcCCCC
Q 035761 28 LSELKILNLSLNSLVGNIPS------NVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLK 101 (560)
Q Consensus 28 l~~L~~L~L~~N~i~~~~~~------~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 101 (560)
..+++.++++.|.+.+..|. .|..+++|++|+|++|++++ +| .+.++++|++|++++|.++ .+|..+..++
T Consensus 17 ~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~ 93 (198)
T 1ds9_A 17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVAD 93 (198)
T ss_dssp TTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHH
T ss_pred cccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCC
Confidence 34455555555555544443 55556666666666666654 33 5555566666666666665 3454555555
Q ss_pred CccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCC-ccCcCCCCCcEEEccCcccccccch----------hhc
Q 035761 102 WLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIP-PELMNCSKLRILKLGNNLLSGSIPS----------QIG 170 (560)
Q Consensus 102 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~----------~~~ 170 (560)
+|+.|+|++|++++ +| .+..+++|+.|++++|.+++..+ ..+..+++|+.|++++|.+++..|. .+.
T Consensus 94 ~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~ 171 (198)
T 1ds9_A 94 TLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVK 171 (198)
T ss_dssp HCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHH
T ss_pred cCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHH
Confidence 66666666666653 22 35555666666666666653221 2455566666666666666544332 245
Q ss_pred cccccceeeccccccC
Q 035761 171 KLQELYYLDLSGNFIN 186 (560)
Q Consensus 171 ~l~~L~~L~l~~n~l~ 186 (560)
.+++|+.|+ +|+++
T Consensus 172 ~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 172 RLPNLKKLD--GMPVD 185 (198)
T ss_dssp HCSSCSEEC--CGGGT
T ss_pred hCCCcEEEC--CcccC
Confidence 555555554 44443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.61 E-value=2.2e-18 Score=157.48 Aligned_cols=137 Identities=22% Similarity=0.251 Sum_probs=81.7
Q ss_pred ccCCCCCCeeecccccccccccc------ccCCCCCCCEEEeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCC
Q 035761 49 VGHLTQLTTLAIASNRMNGSILL------GIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLG 122 (560)
Q Consensus 49 ~~~l~~L~~L~L~~n~i~~~~~~------~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 122 (560)
+....+++.++++.|.+.+..+. .|..+++|++|+|++|.+++ +| .+..+++|+.|++++|.++ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 44456677777777777655554 56666666666666666664 44 5666666666666666666 4455555
Q ss_pred CCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccccccc-hhhccccccceeeccccccCCcCc
Q 035761 123 HLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIP-SQIGKLQELYYLDLSGNFINGKIP 190 (560)
Q Consensus 123 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~ 190 (560)
.+++|+.|++++|++++. | .+..+++|+.|++++|++++..+ ..+..+++|++|++++|++.+..|
T Consensus 91 ~~~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~ 157 (198)
T 1ds9_A 91 VADTLEELWISYNQIASL-S-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp HHHHCSEEEEEEEECCCH-H-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHH
T ss_pred cCCcCCEEECcCCcCCcC-C-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccc
Confidence 556666666666666642 2 45555666666666666653222 345556666666666666554433
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.61 E-value=2.5e-17 Score=177.00 Aligned_cols=221 Identities=10% Similarity=0.104 Sum_probs=123.5
Q ss_pred CCCCCEEEccCCcCccc----CCCCCCCcCCCCEEEccCCcce----ecCCccccCCCCCCeeeccccccccccccccCC
Q 035761 4 LRNLVHLDLSDNHFMGH----IPPTLGRLSELKILNLSLNSLV----GNIPSNVGHLTQLTTLAIASNRMNGSILLGIGS 75 (560)
Q Consensus 4 l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~i~----~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~ 75 (560)
+++|++|+|++|.+++. ++..+..+++|++|+|++|.++ ..++..+.++++|++|+|++|.+.+ .+..+.+
T Consensus 163 ~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~ 241 (592)
T 3ogk_B 163 CRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKA 241 (592)
T ss_dssp CTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHH
T ss_pred CCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhh
Confidence 45566666666655433 1122334555666666666554 2233334455666666666665553 3455555
Q ss_pred CCCCCEEEeecCccC---ccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCC-ccCcCCCCC
Q 035761 76 LKVLQVLDLSRNEIG---GSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIP-PELMNCSKL 151 (560)
Q Consensus 76 l~~L~~L~l~~n~l~---~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L 151 (560)
+++|++|+++.+... ...+..+..+++|+.|+++++... .+|..+..+++|++|+|++|.+++... ..+..+++|
T Consensus 242 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L 320 (592)
T 3ogk_B 242 AANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNL 320 (592)
T ss_dssp CTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTC
T ss_pred hhHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCC
Confidence 566666666543222 122334556666777776665433 456666677777777777777653222 234667777
Q ss_pred cEEEccCcccccccchhhccccccceeeccc-----------cccCCcCc-cccCCCceeeEEEccCCccccccCcc---
Q 035761 152 RILKLGNNLLSGSIPSQIGKLQELYYLDLSG-----------NFINGKIP-SQLGEFSCIDTVDLSMNNLSGGIPVF--- 216 (560)
Q Consensus 152 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~-----------n~l~~~~~-~~~~~~~~L~~l~l~~n~l~~~~~~~--- 216 (560)
+.|+++++......+..+..+++|++|++++ |.+++... .....+++|+.|+++.|.+++..+..
T Consensus 321 ~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~ 400 (592)
T 3ogk_B 321 EVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGT 400 (592)
T ss_dssp CEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHH
T ss_pred CEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHh
Confidence 7777773322223334445677777777773 45543322 22334677777777777777654432
Q ss_pred -cccCCCCcCC
Q 035761 217 -VRKVPHLDVS 226 (560)
Q Consensus 217 -~~~l~~l~l~ 226 (560)
+++++.|+++
T Consensus 401 ~~~~L~~L~l~ 411 (592)
T 3ogk_B 401 YLKNLCDFRLV 411 (592)
T ss_dssp HCCSCCEEEEE
T ss_pred hCCCCcEEEEe
Confidence 4557777775
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.59 E-value=6.8e-15 Score=130.51 Aligned_cols=106 Identities=23% Similarity=0.245 Sum_probs=68.8
Q ss_pred CCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEeecCccCccCCCCcCCCCCccEEEccC
Q 035761 31 LKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQ 110 (560)
Q Consensus 31 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 110 (560)
.++|++++|.++ .+|..+. ++|+.|+|++|+|++..+..|.++++|++|+|++|+|+++.+..|.++++|++|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 455666666665 3444332 5666666666666666666666666677777777777665555666777777777777
Q ss_pred CCccCCCCccCCCCCCCcEEECcCCcCcC
Q 035761 111 NKLVGPIPSSLGHLTQLTTLNMYNNKLDG 139 (560)
Q Consensus 111 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 139 (560)
|+|++..+..|.++++|+.|+|++|.++.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 116 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDC 116 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence 77775555567777777777777777663
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.57 E-value=1.2e-14 Score=129.47 Aligned_cols=104 Identities=23% Similarity=0.291 Sum_probs=72.7
Q ss_pred CEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEeecCccCccCCCCcCCCCCccEEEccCC
Q 035761 32 KILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQN 111 (560)
Q Consensus 32 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 111 (560)
+.+++++|.++ .+|..+. ++|+.|+|++|+|++..+..|.++++|++|+|++|+|+++.+..|.++++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 56677777665 4454443 66777777777777666667777777777777777777655556677777777777777
Q ss_pred CccCCCCccCCCCCCCcEEECcCCcCc
Q 035761 112 KLVGPIPSSLGHLTQLTTLNMYNNKLD 138 (560)
Q Consensus 112 ~l~~~~~~~~~~l~~L~~L~l~~n~l~ 138 (560)
+|++..+..|..+++|+.|+|++|.+.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc
Confidence 777655556777777777777777776
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.57 E-value=8.7e-15 Score=129.83 Aligned_cols=104 Identities=23% Similarity=0.256 Sum_probs=50.3
Q ss_pred CEEEeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCc
Q 035761 80 QVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNN 159 (560)
Q Consensus 80 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 159 (560)
+.|++++|+++. +|..+. ++|+.|+|++|+|++..|..|.++++|++|+|++|+|+++.+..|..+++|+.|+|++|
T Consensus 12 ~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 455555555552 333331 44555555555555444445555555555555555555444444444555555555555
Q ss_pred ccccccchhhccccccceeeccccccC
Q 035761 160 LLSGSIPSQIGKLQELYYLDLSGNFIN 186 (560)
Q Consensus 160 ~l~~~~~~~~~~l~~L~~L~l~~n~l~ 186 (560)
+|++..+..|..+++|++|+|++|++.
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~ 115 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWD 115 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence 554433334444444444444444443
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.55 E-value=2.4e-14 Score=127.37 Aligned_cols=106 Identities=28% Similarity=0.264 Sum_probs=85.6
Q ss_pred CCeeeccccccccccccccCCCCCCCEEEeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcC
Q 035761 55 LTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYN 134 (560)
Q Consensus 55 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 134 (560)
-+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|+.|+|++|+|+++.+..|.++++|+.|+|++
T Consensus 14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 367888888887 4454443 7888888888888877788888888888888888888876666778888888888888
Q ss_pred CcCcCCCCccCcCCCCCcEEEccCccccc
Q 035761 135 NKLDGPIPPELMNCSKLRILKLGNNLLSG 163 (560)
Q Consensus 135 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 163 (560)
|+|++..+..|..+++|+.|+|++|.+..
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c 119 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDC 119 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred CccceeCHHHhccccCCCEEEeCCCCccc
Confidence 88887666668888888888888888873
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.51 E-value=1.5e-16 Score=170.99 Aligned_cols=204 Identities=14% Similarity=0.092 Sum_probs=142.0
Q ss_pred CCCcCCCCEEEccCCcceecC-CccccCCCCCCeeeccccccccc-cccccCCCCCCCEEEeec---------CccCccC
Q 035761 25 LGRLSELKILNLSLNSLVGNI-PSNVGHLTQLTTLAIASNRMNGS-ILLGIGSLKVLQVLDLSR---------NEIGGSI 93 (560)
Q Consensus 25 ~~~l~~L~~L~L~~N~i~~~~-~~~~~~l~~L~~L~L~~n~i~~~-~~~~~~~l~~L~~L~l~~---------n~l~~~~ 93 (560)
+..+++|++|+|++|.++... +..+.++++|+.|++++| +... .+.....+++|++|++++ |.++...
T Consensus 285 ~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~ 363 (594)
T 2p1m_B 285 YSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQG 363 (594)
T ss_dssp HHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHH
T ss_pred HHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHH
Confidence 346788999999999876432 233567889999999988 4422 222333578899998843 4454322
Q ss_pred CCCc-CCCCCccEEEccCCCccCCCCccCC-CCCCCcEEECc--C----CcCcCCCC-----ccCcCCCCCcEEEccCcc
Q 035761 94 PSTL-GHLKWLRSVDLSQNKLVGPIPSSLG-HLTQLTTLNMY--N----NKLDGPIP-----PELMNCSKLRILKLGNNL 160 (560)
Q Consensus 94 ~~~~-~~l~~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~l~--~----n~l~~~~~-----~~~~~l~~L~~L~l~~n~ 160 (560)
...+ ..+++|+.|+++.|.+++.....+. .+++|+.|+++ + |.+++... ..+..+++|+.|++++ .
T Consensus 364 l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~ 442 (594)
T 2p1m_B 364 LVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-L 442 (594)
T ss_dssp HHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-S
T ss_pred HHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-c
Confidence 2222 2478899998888888754444444 57899999998 4 55553211 1256788999999977 6
Q ss_pred cccccchhhcc-ccccceeeccccccCCcCcccc-CCCceeeEEEccCCccccccCc----ccccCCCCcCCCCCC
Q 035761 161 LSGSIPSQIGK-LQELYYLDLSGNFINGKIPSQL-GEFSCIDTVDLSMNNLSGGIPV----FVRKVPHLDVSGNQF 230 (560)
Q Consensus 161 l~~~~~~~~~~-l~~L~~L~l~~n~l~~~~~~~~-~~~~~L~~l~l~~n~l~~~~~~----~~~~l~~l~l~~n~~ 230 (560)
+++..+..+.. +++|+.|+|++|.+++..+..+ ..+++|+.|++++|++++.... .+++++.|++++|++
T Consensus 443 l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~ 518 (594)
T 2p1m_B 443 LTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV 518 (594)
T ss_dssp CCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCC
T ss_pred ccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCC
Confidence 76665666655 8889999999999876655554 5688999999999998654332 357888899998875
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.51 E-value=1.2e-16 Score=171.76 Aligned_cols=220 Identities=14% Similarity=0.088 Sum_probs=158.7
Q ss_pred CCCCCCEEEccCCcCcccC-CCCCCCcCCCCEEEccCCcceec-CCccccCCCCCCeeecc---------cccccccccc
Q 035761 3 RLRNLVHLDLSDNHFMGHI-PPTLGRLSELKILNLSLNSLVGN-IPSNVGHLTQLTTLAIA---------SNRMNGSILL 71 (560)
Q Consensus 3 ~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~N~i~~~-~~~~~~~l~~L~~L~L~---------~n~i~~~~~~ 71 (560)
.+++|++|+|++|.+++.. ...+..+++|++|++++| +... .+.....+++|++|+|+ .|.++.....
T Consensus 287 ~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~ 365 (594)
T 2p1m_B 287 VCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLV 365 (594)
T ss_dssp HHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHH
T ss_pred hhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHH
Confidence 3579999999999987432 223568899999999998 5422 22333468999999993 4566543333
Q ss_pred ccC-CCCCCCEEEeecCccCccCCCCcC-CCCCccEEEcc--C----CCccCCCC-----ccCCCCCCCcEEECcCCcCc
Q 035761 72 GIG-SLKVLQVLDLSRNEIGGSIPSTLG-HLKWLRSVDLS--Q----NKLVGPIP-----SSLGHLTQLTTLNMYNNKLD 138 (560)
Q Consensus 72 ~~~-~l~~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~l~--~----n~l~~~~~-----~~~~~l~~L~~L~l~~n~l~ 138 (560)
.+. ++++|++|.++.|.++......+. .+++|+.|+|+ + |.++.... ..+..+++|+.|+|++ .++
T Consensus 366 ~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~ 444 (594)
T 2p1m_B 366 SVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLT 444 (594)
T ss_dssp HHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCC
T ss_pred HHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-ccc
Confidence 333 489999999999999865444454 58999999999 4 56652211 2256789999999987 565
Q ss_pred CCCCccCcC-CCCCcEEEccCcccccccchhh-ccccccceeeccccccCCcCcc-ccCCCceeeEEEccCCccccccCc
Q 035761 139 GPIPPELMN-CSKLRILKLGNNLLSGSIPSQI-GKLQELYYLDLSGNFINGKIPS-QLGEFSCIDTVDLSMNNLSGGIPV 215 (560)
Q Consensus 139 ~~~~~~~~~-l~~L~~L~l~~n~l~~~~~~~~-~~l~~L~~L~l~~n~l~~~~~~-~~~~~~~L~~l~l~~n~l~~~~~~ 215 (560)
+..+..+.. +++|+.|++++|.+++..+..+ ..+++|++|+|++|++++.... ....+++|+.|++++|+++.....
T Consensus 445 ~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~ 524 (594)
T 2p1m_B 445 DKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACK 524 (594)
T ss_dssp HHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHH
T ss_pred HHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHH
Confidence 444444554 8999999999999987666555 6799999999999999655444 445689999999999999654433
Q ss_pred cc-ccCCCCc
Q 035761 216 FV-RKVPHLD 224 (560)
Q Consensus 216 ~~-~~l~~l~ 224 (560)
.+ ..++.+.
T Consensus 525 ~l~~~lp~l~ 534 (594)
T 2p1m_B 525 LLGQKMPKLN 534 (594)
T ss_dssp HHHHHCTTEE
T ss_pred HHHHhCCCCE
Confidence 33 3445443
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.48 E-value=2.1e-16 Score=158.37 Aligned_cols=184 Identities=20% Similarity=0.162 Sum_probs=115.8
Q ss_pred cCCCCEEEccCCcceecCCccccC-----CCCCCeeecccccccccccccc-CCCCCCCEEEeecCccCccCCCCc----
Q 035761 28 LSELKILNLSLNSLVGNIPSNVGH-----LTQLTTLAIASNRMNGSILLGI-GSLKVLQVLDLSRNEIGGSIPSTL---- 97 (560)
Q Consensus 28 l~~L~~L~L~~N~i~~~~~~~~~~-----l~~L~~L~L~~n~i~~~~~~~~-~~l~~L~~L~l~~n~l~~~~~~~~---- 97 (560)
+++|++|+|++|.|+......+.. .++|++|+|++|.++......+ ..+++|++|+|++|.|+......+
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L 150 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL 150 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence 356777777777776433333322 2577777777777764333222 235577888888887764332222
Q ss_pred -CCCCCccEEEccCCCccCC----CCccCCCCCCCcEEECcCCcCcCC----CCccCcCCCCCcEEEccCccccccc---
Q 035761 98 -GHLKWLRSVDLSQNKLVGP----IPSSLGHLTQLTTLNMYNNKLDGP----IPPELMNCSKLRILKLGNNLLSGSI--- 165 (560)
Q Consensus 98 -~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~~--- 165 (560)
...++|++|+|++|.|+.. ++..+..+++|++|+|++|.|+.. ++..+...++|+.|+|++|.|++..
T Consensus 151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~ 230 (372)
T 3un9_A 151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALA 230 (372)
T ss_dssp HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHH
T ss_pred HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHH
Confidence 3456788888888887632 334446678888888888887742 2445667788899999999887533
Q ss_pred -chhhccccccceeeccccccCCcCccccCCC---c--eeeEEE--ccCCcccc
Q 035761 166 -PSQIGKLQELYYLDLSGNFINGKIPSQLGEF---S--CIDTVD--LSMNNLSG 211 (560)
Q Consensus 166 -~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~---~--~L~~l~--l~~n~l~~ 211 (560)
+..+...++|++|+|++|+|+......+..+ . .|+.+. +..|.++.
T Consensus 231 l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~~~~~~~ 284 (372)
T 3un9_A 231 LARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSE 284 (372)
T ss_dssp HHHHHHHCSSCCEEECTTSSCCHHHHHHHHHCC------CEEECCCC----CHH
T ss_pred HHHHHHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhcCCccCH
Confidence 3445567889999999998876554444332 2 167777 67777664
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.48 E-value=2.3e-16 Score=158.10 Aligned_cols=166 Identities=22% Similarity=0.204 Sum_probs=126.5
Q ss_pred CCCCCeeecccccccccccccc----C-CCCCCCEEEeecCccCccCCCCc-CCCCCccEEEccCCCccCCCCccC----
Q 035761 52 LTQLTTLAIASNRMNGSILLGI----G-SLKVLQVLDLSRNEIGGSIPSTL-GHLKWLRSVDLSQNKLVGPIPSSL---- 121 (560)
Q Consensus 52 l~~L~~L~L~~n~i~~~~~~~~----~-~l~~L~~L~l~~n~l~~~~~~~~-~~l~~L~~L~l~~n~l~~~~~~~~---- 121 (560)
+++|+.|+|++|.++......+ . ..++|++|+|++|.|+......+ ..+++|+.|+|++|.++......+
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L 150 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL 150 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence 4689999999999986443333 2 23799999999999975333333 346789999999999974433333
Q ss_pred -CCCCCCcEEECcCCcCcCC----CCccCcCCCCCcEEEccCccccccc----chhhccccccceeeccccccCCcCc--
Q 035761 122 -GHLTQLTTLNMYNNKLDGP----IPPELMNCSKLRILKLGNNLLSGSI----PSQIGKLQELYYLDLSGNFINGKIP-- 190 (560)
Q Consensus 122 -~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~~----~~~~~~l~~L~~L~l~~n~l~~~~~-- 190 (560)
...++|+.|+|++|.|+.. ++..+..+++|++|+|++|.|++.. +..+...++|++|+|++|.|+....
T Consensus 151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~ 230 (372)
T 3un9_A 151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALA 230 (372)
T ss_dssp HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHH
T ss_pred HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHH
Confidence 3568999999999999742 3345577899999999999998643 5667788899999999999986433
Q ss_pred --cccCCCceeeEEEccCCccccccCccc
Q 035761 191 --SQLGEFSCIDTVDLSMNNLSGGIPVFV 217 (560)
Q Consensus 191 --~~~~~~~~L~~l~l~~n~l~~~~~~~~ 217 (560)
..+...++|+.|+|++|+|+......+
T Consensus 231 l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L 259 (372)
T 3un9_A 231 LARAAREHPSLELLHLYFNELSSEGRQVL 259 (372)
T ss_dssp HHHHHHHCSSCCEEECTTSSCCHHHHHHH
T ss_pred HHHHHHhCCCCCEEeccCCCCCHHHHHHH
Confidence 344567899999999999987655544
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.40 E-value=6e-13 Score=132.63 Aligned_cols=103 Identities=23% Similarity=0.202 Sum_probs=66.4
Q ss_pred EEEeecC-ccCccCCCCcCCCCCccEEEccC-CCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccC
Q 035761 81 VLDLSRN-EIGGSIPSTLGHLKWLRSVDLSQ-NKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGN 158 (560)
Q Consensus 81 ~L~l~~n-~l~~~~~~~~~~l~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 158 (560)
.++++++ +|+ .+|. +..+++|+.|+|++ |.|+++.+..|.++++|+.|+|++|+|+++.|..|.++++|+.|+|++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 4566666 666 3555 66666677777764 666665556666677777777777776666666666666666666666
Q ss_pred cccccccchhhccccccceeeccccccC
Q 035761 159 NLLSGSIPSQIGKLQELYYLDLSGNFIN 186 (560)
Q Consensus 159 n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 186 (560)
|+|++..+..|..++ |+.|+|++|++.
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 666655555555444 666666666665
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.40 E-value=7.7e-13 Score=131.86 Aligned_cols=102 Identities=21% Similarity=0.216 Sum_probs=57.8
Q ss_pred EEccCC-cceecCCccccCCCCCCeeeccc-cccccccccccCCCCCCCEEEeecCccCccCCCCcCCCCCccEEEccCC
Q 035761 34 LNLSLN-SLVGNIPSNVGHLTQLTTLAIAS-NRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQN 111 (560)
Q Consensus 34 L~L~~N-~i~~~~~~~~~~l~~L~~L~L~~-n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 111 (560)
++++++ +++ .+|. +..+++|+.|+|++ |+|+++.+..|.++++|++|+|++|+|+++.|..|.++++|+.|+|++|
T Consensus 13 v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 13 LRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp EECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 455554 555 3444 55555555555553 5555555555555666666666666666555555566666666666666
Q ss_pred CccCCCCccCCCCCCCcEEECcCCcCc
Q 035761 112 KLVGPIPSSLGHLTQLTTLNMYNNKLD 138 (560)
Q Consensus 112 ~l~~~~~~~~~~l~~L~~L~l~~n~l~ 138 (560)
+|+++.+..|..++ |+.|+|++|.+.
T Consensus 91 ~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 91 ALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp CCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred ccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 66644444444444 666666666655
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=1e-11 Score=118.43 Aligned_cols=146 Identities=13% Similarity=0.057 Sum_probs=112.8
Q ss_pred HHhcCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccC-CCCcceeeeEEEeCCEEEE
Q 035761 312 EATEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIR-HRNIVKLYGFCLHEKCMFL 390 (560)
Q Consensus 312 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 390 (560)
..-+.|......+.|+.+.||++... ++.+++|....... .....+.+|+++++.+. +..+.++++++...+..++
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 34456877888888888999999864 68899999864321 11235778999999884 6778899999999899999
Q ss_pred EEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------
Q 035761 391 IYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHH----------------------------------- 435 (560)
Q Consensus 391 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~----------------------------------- 435 (560)
||||++|.++.+.+.. ..+...++.+++++++.||+.
T Consensus 88 v~e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 88 LMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred EEEecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 9999999999776421 122347889999999999981
Q ss_pred ---------------------CCCCeEEeCCCCCCeEeCCCCcEEEeeeccccc
Q 035761 436 ---------------------CTPPILHRDISSNNILLNSEFEAFVADFGIARL 468 (560)
Q Consensus 436 ---------------------~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 468 (560)
..+.++|+|++|.||+++++..+.|+||+.+..
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 013589999999999998765567999997754
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.22 E-value=1.5e-10 Score=117.34 Aligned_cols=106 Identities=11% Similarity=0.192 Sum_probs=59.0
Q ss_pred ccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccccccchhhccccccceeeccccccCCcCccccCCCce
Q 035761 119 SSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSC 198 (560)
Q Consensus 119 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~ 198 (560)
.+|.++..|+.+.+..+..+ +...+|.++++|+.+.+. +.++.+....|.++.+|+.++|..+ ++.+....|..+.+
T Consensus 259 ~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~ 335 (394)
T 4gt6_A 259 HAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQ 335 (394)
T ss_dssp TTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTT
T ss_pred ceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCC
Confidence 35666677777777655433 444566666666666664 3344455556666666666666543 44445556666666
Q ss_pred eeEEEccCCccccccCccc---ccCCCCcCCCC
Q 035761 199 IDTVDLSMNNLSGGIPVFV---RKVPHLDVSGN 228 (560)
Q Consensus 199 L~~l~l~~n~l~~~~~~~~---~~l~~l~l~~n 228 (560)
|+.+.+..+ ++......+ .+|+.+++.++
T Consensus 336 L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~ 367 (394)
T 4gt6_A 336 LERIAIPSS-VTKIPESAFSNCTALNNIEYSGS 367 (394)
T ss_dssp CCEEEECTT-CCBCCGGGGTTCTTCCEEEESSC
T ss_pred CCEEEECcc-cCEEhHhHhhCCCCCCEEEECCc
Confidence 666666433 333222233 34555555554
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.20 E-value=3.4e-11 Score=114.62 Aligned_cols=137 Identities=19% Similarity=0.127 Sum_probs=100.3
Q ss_pred CCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCC--cceeeeEEEeCCEEEEEEe
Q 035761 316 DFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRN--IVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e 393 (560)
.+.+....+.|..+.||++...+|+.+++|...... ...+.+|+++++.+.+.+ +.+++++...++..++|||
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 344433334566699999988778889999876431 134678999999885444 5568888888778899999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHC------------------------------------- 436 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------------------------------------- 436 (560)
|++|.++. ... .+ ...++.++++.++.||+..
T Consensus 96 ~i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 96 EVPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp CCSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred ecCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 99998883 221 12 2357788888888888641
Q ss_pred ------------------CCCeEEeCCCCCCeEeCCCCcEEEeeeccccc
Q 035761 437 ------------------TPPILHRDISSNNILLNSEFEAFVADFGIARL 468 (560)
Q Consensus 437 ------------------~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 468 (560)
.+.++|+|++|.||+++++..+.|+|||.+..
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11399999999999998776667999998754
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=99.15 E-value=4.1e-12 Score=126.16 Aligned_cols=152 Identities=16% Similarity=0.229 Sum_probs=78.3
Q ss_pred CCCCCCCEEEeecCc-cCccCCCCcCCCCCccEEEccCCCccCCCCccCC--CCCCCcEEECcC--CcCcCC-----CCc
Q 035761 74 GSLKVLQVLDLSRNE-IGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLG--HLTQLTTLNMYN--NKLDGP-----IPP 143 (560)
Q Consensus 74 ~~l~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~--~l~~L~~L~l~~--n~l~~~-----~~~ 143 (560)
..+++|+.|+|++|. +. ++. + .+++|+.|+|..|.+.......+. .+++|+.|+|+. |...+. +..
T Consensus 169 ~~~P~L~~L~L~g~~~l~--l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~ 244 (362)
T 2ra8_A 169 DAMPLLNNLKIKGTNNLS--IGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRP 244 (362)
T ss_dssp HTCTTCCEEEEECCBTCB--CCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGG
T ss_pred hcCCCCcEEEEeCCCCce--ecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHH
Confidence 444555555555552 21 121 2 255566666655555422111221 455666665532 111100 001
Q ss_pred cC--cCCCCCcEEEccCcccccccchhhc---cccccceeeccccccCCcC----ccccCCCceeeEEEccCCccccccC
Q 035761 144 EL--MNCSKLRILKLGNNLLSGSIPSQIG---KLQELYYLDLSGNFINGKI----PSQLGEFSCIDTVDLSMNNLSGGIP 214 (560)
Q Consensus 144 ~~--~~l~~L~~L~l~~n~l~~~~~~~~~---~l~~L~~L~l~~n~l~~~~----~~~~~~~~~L~~l~l~~n~l~~~~~ 214 (560)
.+ ..+++|+.|+|++|.+.+..+..+. .+++|++|+|+.|.+.+.. +..+..+++|+.|++++|.++...-
T Consensus 245 ~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~ 324 (362)
T 2ra8_A 245 LFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMK 324 (362)
T ss_dssp GSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHH
T ss_pred HHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHH
Confidence 12 2467777777777777643333332 4677778888777776532 2233445777888888777775544
Q ss_pred ccccc-C-CCCcCCCCC
Q 035761 215 VFVRK-V-PHLDVSGNQ 229 (560)
Q Consensus 215 ~~~~~-l-~~l~l~~n~ 229 (560)
..+.. + ..++++.++
T Consensus 325 ~~l~~alg~~~~~~~~~ 341 (362)
T 2ra8_A 325 KELQKSLPMKIDVSDSQ 341 (362)
T ss_dssp HHHHHHCCSEEECCSBC
T ss_pred HHHHHHcCCEEEecCCc
Confidence 43432 2 345666655
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.10 E-value=1.9e-09 Score=109.13 Aligned_cols=196 Identities=13% Similarity=0.026 Sum_probs=102.0
Q ss_pred CCCCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCC
Q 035761 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQ 80 (560)
Q Consensus 1 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~ 80 (560)
|.++++|+.+.+.++. +.+...+|.++.+|+.+++..| ++.+...+|.++..|+.+.+..+... + ...+....+|+
T Consensus 158 F~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~-i-~~~~~~~~~l~ 233 (394)
T 4fs7_A 158 FATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY-L-GDFALSKTGVK 233 (394)
T ss_dssp TTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE-E-CTTTTTTCCCC
T ss_pred hcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceE-e-ehhhcccCCCc
Confidence 3445566666665443 3355556666666666666555 44455556666666666665554322 1 12222234455
Q ss_pred EEEeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcc
Q 035761 81 VLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNL 160 (560)
Q Consensus 81 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 160 (560)
.+.+..+ ++.+....|.++..|+.+.+..+..+ +....|..+..++.+.+..+.+. ...|..+.+|+.+.+.++
T Consensus 234 ~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~- 307 (394)
T 4fs7_A 234 NIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS- 307 (394)
T ss_dssp EEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-
T ss_pred eEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeec---cccccccccccccccccc-
Confidence 5554332 22234445566666666666655443 44455555555555555444322 234555556666665543
Q ss_pred cccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCC
Q 035761 161 LSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMN 207 (560)
Q Consensus 161 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n 207 (560)
++.+...+|.++.+|+.++|..+ ++.....+|.++.+|+.+++..|
T Consensus 308 i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~ 353 (394)
T 4fs7_A 308 VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS 353 (394)
T ss_dssp CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT
T ss_pred cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc
Confidence 44344555556666666666432 44444555566666666655444
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.08 E-value=3.1e-09 Score=107.59 Aligned_cols=220 Identities=10% Similarity=0.094 Sum_probs=133.4
Q ss_pred CCCC-CCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCc---ceecCCccccCCCCCCeeeccccccccccccccCCCC
Q 035761 2 GRLR-NLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNS---LVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLK 77 (560)
Q Consensus 2 ~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~---i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~ 77 (560)
.+.+ .|+.+.+-. .++.+-..+|.++.+|+.+.+..|. ++.+-..+|.++.+|+.+.+..+ ++.+....|.++.
T Consensus 60 ~~~~~~L~sI~iP~-svt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~ 137 (394)
T 4gt6_A 60 CNYKYVLTSVQIPD-TVTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHCE 137 (394)
T ss_dssp TTCCSCCCEEEECT-TCCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTCT
T ss_pred cCCCCcCEEEEECC-CeeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhhhc
Confidence 3443 478888865 4666777888888888888887663 66666677777777777777654 4445566666777
Q ss_pred CCCEEEeecCccCccCCCCcCCCCCccEEEccCCCcc---------------------CCCCccCCCCCCCcEEECcCCc
Q 035761 78 VLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLV---------------------GPIPSSLGHLTQLTTLNMYNNK 136 (560)
Q Consensus 78 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~---------------------~~~~~~~~~l~~L~~L~l~~n~ 136 (560)
+|+.+.+..+ +..+....|..+..|+.+.+.++--. .+...+|.++.+|.......+.
T Consensus 138 ~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~~~~I~~~aF~~~~l~~i~ip~~~~~i~~~af~~c~~l~~~~~~~~~ 216 (394)
T 4gt6_A 138 ELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDSVTAIEERAFTGTALTQIHIPAKVTRIGTNAFSECFALSTITSDSES 216 (394)
T ss_dssp TCCEEECCTT-CCEECTTTTTTCTTCCEEECCTTCCEECTTTTTTCCCSEEEECTTCCEECTTTTTTCTTCCEEEECCSS
T ss_pred ccccccccce-eeeecccceecccccccccccceeeEeccccccccceeEEEECCcccccccchhhhccccceecccccc
Confidence 7777776543 23244445555555555555443111 0222333444444433322111
Q ss_pred ------------------------------------CcCCCCccCcCCCCCcEEEccCcccccccchhhccccccceeec
Q 035761 137 ------------------------------------LDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDL 180 (560)
Q Consensus 137 ------------------------------------l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 180 (560)
++.+...+|.++.+|+.+.+.++..+ +....|.++++|+.+.+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l 295 (394)
T 4gt6_A 217 YPAIDNVLYEKSANGDYALIRYPSQREDPAFKIPNGVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEF 295 (394)
T ss_dssp SCBSSSCEEEECTTSCEEEEECCTTCCCSEEECCTTEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEEC
T ss_pred cccccceeecccccccccccccccccccceEEcCCcceEcccceeeecccccEEecccccce-ecCcccccccccccccC
Confidence 11122345777888888888776554 66777888888888888
Q ss_pred cccccCCcCccccCCCceeeEEEccCCccccccCccc---ccCCCCcCCC
Q 035761 181 SGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFV---RKVPHLDVSG 227 (560)
Q Consensus 181 ~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~~---~~l~~l~l~~ 227 (560)
. +.++......|..+.+|+.+++..+ ++......+ .+|+.+.+..
T Consensus 296 ~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~ 343 (394)
T 4gt6_A 296 S-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPS 343 (394)
T ss_dssp C-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECT
T ss_pred C-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECc
Confidence 5 4566566678888888888888654 443333333 4556666643
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=99.07 E-value=2.7e-11 Score=120.28 Aligned_cols=181 Identities=11% Similarity=0.146 Sum_probs=117.5
Q ss_pred CCCCCCcCCCCEEEccCCcce---------ecCCccccCCCCCCeeeccccc-cccccccccCCCCCCCEEEeecCccCc
Q 035761 22 PPTLGRLSELKILNLSLNSLV---------GNIPSNVGHLTQLTTLAIASNR-MNGSILLGIGSLKVLQVLDLSRNEIGG 91 (560)
Q Consensus 22 ~~~~~~l~~L~~L~L~~N~i~---------~~~~~~~~~l~~L~~L~L~~n~-i~~~~~~~~~~l~~L~~L~l~~n~l~~ 91 (560)
..+...+++|+.|.+..+... +.++..+..+++|+.|+|++|. +. . +. +. +++|+.|+|..|.++.
T Consensus 132 ~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~-l-~~-~~-~~~L~~L~L~~~~l~~ 207 (362)
T 2ra8_A 132 VENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLS-I-GK-KP-RPNLKSLEIISGGLPD 207 (362)
T ss_dssp HTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCB-C-CS-CB-CTTCSEEEEECSBCCH
T ss_pred HHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCce-e-cc-cc-CCCCcEEEEecCCCCh
Confidence 344567788888888665321 1233456778899999998873 32 2 22 33 7889999998888774
Q ss_pred cCCCCcC--CCCCccEEEccC--CCccCC-----CCccC--CCCCCCcEEECcCCcCcCCCCccC---cCCCCCcEEEcc
Q 035761 92 SIPSTLG--HLKWLRSVDLSQ--NKLVGP-----IPSSL--GHLTQLTTLNMYNNKLDGPIPPEL---MNCSKLRILKLG 157 (560)
Q Consensus 92 ~~~~~~~--~l~~L~~L~l~~--n~l~~~-----~~~~~--~~l~~L~~L~l~~n~l~~~~~~~~---~~l~~L~~L~l~ 157 (560)
.....+. .+++|+.|+|+. |...+. +...+ ..+++|+.|+|++|.+.+..+..+ ..+++|+.|+|+
T Consensus 208 ~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs 287 (362)
T 2ra8_A 208 SVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDIS 287 (362)
T ss_dssp HHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECC
T ss_pred HHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECC
Confidence 3323333 678899998863 221111 11122 247899999999998874322222 247899999999
Q ss_pred Cccccccc----chhhccccccceeeccccccCCcCccccCC-CceeeEEEccCCc
Q 035761 158 NNLLSGSI----PSQIGKLQELYYLDLSGNFINGKIPSQLGE-FSCIDTVDLSMNN 208 (560)
Q Consensus 158 ~n~l~~~~----~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-~~~L~~l~l~~n~ 208 (560)
.|.+++.. +..+..+++|+.|+|++|.|+...-..+.. + ...+++++|+
T Consensus 288 ~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 288 AGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp SSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHHC--CSEEECCSBC
T ss_pred CCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHHc--CCEEEecCCc
Confidence 99998643 334456789999999999887554444433 2 2457888876
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.06 E-value=3.9e-10 Score=112.74 Aligned_cols=142 Identities=18% Similarity=0.310 Sum_probs=105.3
Q ss_pred cceeeccCCeeEEEEEeCCCcEEEEEEcc--chhhhhhhHHHHHHHHHHHhccC--CCCcceeeeEEEeC---CEEEEEE
Q 035761 320 KYCIGTGGYGSVYRARLPSGKVVALKKLH--RLETELASLESFQNEARLLSQIR--HRNIVKLYGFCLHE---KCMFLIY 392 (560)
Q Consensus 320 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~ 392 (560)
.+.++.|.++.||+....+ ..+++|+.. .... ......+.+|..+++.+. +..+.++++++.+. +..++||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 4568899999999998754 678888775 3221 112345778999999986 45678888888776 4578999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHC------------------------------------ 436 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------------------------------------ 436 (560)
||+++..+.+... ..++..++..++.++++.|+.||+..
T Consensus 121 e~v~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQSL-----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTTC-----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCcc-----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 9999987743211 12778888999999999999999730
Q ss_pred -------------------CCCeEEeCCCCCCeEeCCCCc--EEEeeeccccc
Q 035761 437 -------------------TPPILHRDISSNNILLNSEFE--AFVADFGIARL 468 (560)
Q Consensus 437 -------------------~~~ivH~dlk~~Nill~~~~~--~kl~Dfg~~~~ 468 (560)
.+.++|||+++.||+++.++. +.|.||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999997753 58999998875
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.06 E-value=1.5e-09 Score=109.86 Aligned_cols=152 Identities=10% Similarity=0.036 Sum_probs=85.1
Q ss_pred CCCCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCC
Q 035761 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQ 80 (560)
Q Consensus 1 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~ 80 (560)
|.++++|+++.|.. .++.+...+|.++++|+.++|.++ ++.+...+|.++.+|+.+.+..+ +..+...+|.+...++
T Consensus 67 F~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~~~~ 143 (394)
T 4fs7_A 67 FQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCDFKE 143 (394)
T ss_dssp TTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCCCSE
T ss_pred hhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeecccccc
Confidence 45667778888864 466666777888888888888654 55566677777777777766544 2223334444433222
Q ss_pred EEEeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCc
Q 035761 81 VLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNN 159 (560)
Q Consensus 81 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 159 (560)
.... +.+......+|.++++|+.+.+.++..+ +....|.++++|+.+.+..| ++.+....|.++..|+.+.+..+
T Consensus 144 ~~~~--~~~~~i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~ 218 (394)
T 4fs7_A 144 ITIP--EGVTVIGDEAFATCESLEYVSLPDSMET-LHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNS 218 (394)
T ss_dssp EECC--TTCCEECTTTTTTCTTCCEEECCTTCCE-ECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTT
T ss_pred cccC--ccccccchhhhcccCCCcEEecCCccce-eccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCC
Confidence 1111 1122233445666666666666554332 44555666666666666554 33333445555555555555444
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.02 E-value=1.3e-10 Score=113.36 Aligned_cols=186 Identities=20% Similarity=0.191 Sum_probs=121.7
Q ss_pred cceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccC-CCC--cceeeeEEEeCC---EEEEEEe
Q 035761 320 KYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIR-HRN--IVKLYGFCLHEK---CMFLIYE 393 (560)
Q Consensus 320 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e 393 (560)
.+.++.|.+..||+.. ..+++|..... .....+.+|.++++.+. +.. +.++++...... ..|+|||
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT 96 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence 3458999999999863 46888886532 22356788999998873 333 334444332222 3488999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHH-------------------------------------- 435 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-------------------------------------- 435 (560)
+++|.++.+.... .++..++..++.++++.++.||+.
T Consensus 97 ~i~G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 97 KIKGVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp CCCCEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred ccCCeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 9999887643321 267788888899999999888861
Q ss_pred -----------------CCCCeEEeCCCCCCeEeCC--CCcEEEeeeccccccCCCCC----------Cc----eeeccc
Q 035761 436 -----------------CTPPILHRDISSNNILLNS--EFEAFVADFGIARLLNYDSS----------NR----TLLAGT 482 (560)
Q Consensus 436 -----------------~~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~~~~~~~~~~----------~~----~~~~g~ 482 (560)
..+.++|+|++|.||++++ ...+.++||+.+....+... .. ......
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence 1245899999999999998 45578999998865422100 00 000011
Q ss_pred cCccC-ccccccCccCcchhHHHHHHHHHHHHhCCCCCC
Q 035761 483 YGSIA-PELAYTMVVTEKYDVYSFGVVALEVLMGKHPGE 520 (560)
Q Consensus 483 ~~~~a-PE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~ 520 (560)
++... |+..... ....+.|++|.++|++.+|+.||.
T Consensus 252 Y~~~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 252 YKHKDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HTCSCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred cCCCCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHHH
Confidence 11222 2221111 223689999999999999998875
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.89 E-value=4.3e-08 Score=98.55 Aligned_cols=127 Identities=12% Similarity=0.086 Sum_probs=85.8
Q ss_pred cCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccccccchhhccccccc
Q 035761 97 LGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELY 176 (560)
Q Consensus 97 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 176 (560)
+....+|+.+.+..+ ++.+....|.++..|+.+.+..+ ++.+...+|.++.+|+.+.+..+ ++......|.++.+|+
T Consensus 213 f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~ 289 (379)
T 4h09_A 213 FSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLT 289 (379)
T ss_dssp TTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCC
T ss_pred cccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccc
Confidence 344455555555544 23345567778888888888766 55466677888888888888654 5546667788888888
Q ss_pred eeeccccccCCcCccccCCCceeeEEEccCCccccccCccc---ccCCCCcCCC
Q 035761 177 YLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFV---RKVPHLDVSG 227 (560)
Q Consensus 177 ~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~~---~~l~~l~l~~ 227 (560)
.+.+.++.++......|.++.+|+.+.+..+ ++......+ .+|+.+.+..
T Consensus 290 ~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~ 342 (379)
T 4h09_A 290 KVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPK 342 (379)
T ss_dssp EEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCT
T ss_pred cccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECC
Confidence 8888888887677778888888888888654 443333333 3455555543
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.72 E-value=9.1e-10 Score=98.65 Aligned_cols=116 Identities=17% Similarity=0.143 Sum_probs=82.9
Q ss_pred CCCCCcCCCCEEEccCC-ccee----cCCccccCCCCCCeeeccccccccc----cccccCCCCCCCEEEeecCccCcc-
Q 035761 23 PTLGRLSELKILNLSLN-SLVG----NIPSNVGHLTQLTTLAIASNRMNGS----ILLGIGSLKVLQVLDLSRNEIGGS- 92 (560)
Q Consensus 23 ~~~~~l~~L~~L~L~~N-~i~~----~~~~~~~~l~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~l~~n~l~~~- 92 (560)
..+...++|++|+|++| .|.. .+...+...++|++|+|++|+|... +...+...++|++|+|++|.|+..
T Consensus 30 ~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g 109 (185)
T 1io0_A 30 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSG 109 (185)
T ss_dssp HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHH
T ss_pred HHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHH
Confidence 34566788888888888 7763 2345566678888888888888642 334455567888888888888842
Q ss_pred ---CCCCcCCCCCccEEEc--cCCCccCC----CCccCCCCCCCcEEECcCCcCc
Q 035761 93 ---IPSTLGHLKWLRSVDL--SQNKLVGP----IPSSLGHLTQLTTLNMYNNKLD 138 (560)
Q Consensus 93 ---~~~~~~~l~~L~~L~l--~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~ 138 (560)
+...+...++|++|+| ++|.|... +...+...++|++|+|++|.+.
T Consensus 110 ~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 110 ILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 3456677788888888 77888633 3345556688999999988875
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.71 E-value=2e-07 Score=93.64 Aligned_cols=190 Identities=14% Similarity=0.079 Sum_probs=132.5
Q ss_pred CCCCCCCEEEccCCcCcc------------cCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeecccccccccc
Q 035761 2 GRLRNLVHLDLSDNHFMG------------HIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSI 69 (560)
Q Consensus 2 ~~l~~L~~L~L~~n~l~~------------~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~ 69 (560)
.+..+++.+.+..+.... .....+.....+..+.+..+... .....+....+|+.+.+..+ ++.+.
T Consensus 155 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~ 232 (379)
T 4h09_A 155 YKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLG 232 (379)
T ss_dssp TTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEEC
T ss_pred cccccccccccccccceeecccceecccccceeccccccccccccccccceeE-Eeecccccccccceeeeccc-eeEEc
Confidence 445666776666554321 12223445556666666554333 56677777888888888665 44466
Q ss_pred ccccCCCCCCCEEEeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCC
Q 035761 70 LLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCS 149 (560)
Q Consensus 70 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 149 (560)
...|.++..|+.+.+..+ ++.+....|.++.+|+.+.+..+ ++.+....|.++++|+.+.+.++.++.+...+|.++.
T Consensus 233 ~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~ 310 (379)
T 4h09_A 233 DGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCV 310 (379)
T ss_dssp TTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCT
T ss_pred cccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCC
Confidence 777888888888888765 66566777888888888888654 4446667788888888888888888766677888888
Q ss_pred CCcEEEccCcccccccchhhccccccceeeccccccCCcCccccCCCc
Q 035761 150 KLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFS 197 (560)
Q Consensus 150 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~ 197 (560)
+|+.+.|..+ ++.+...+|.++.+|+.+.+..+ ++.+...+|.+++
T Consensus 311 ~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c~ 356 (379)
T 4h09_A 311 KLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGSS 356 (379)
T ss_dssp TCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTSS
T ss_pred CCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCCC
Confidence 8888888755 66566778888888888888654 5555566676654
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.68 E-value=1.6e-09 Score=97.04 Aligned_cols=121 Identities=12% Similarity=0.103 Sum_probs=95.2
Q ss_pred ecCCccccCCCCCCeeecccc-ccccc----cccccCCCCCCCEEEeecCccCcc----CCCCcCCCCCccEEEccCCCc
Q 035761 43 GNIPSNVGHLTQLTTLAIASN-RMNGS----ILLGIGSLKVLQVLDLSRNEIGGS----IPSTLGHLKWLRSVDLSQNKL 113 (560)
Q Consensus 43 ~~~~~~~~~l~~L~~L~L~~n-~i~~~----~~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l 113 (560)
..+...+...++|++|+|++| .|... +...+...++|++|+|++|.|+.. +...+...++|++|+|++|.|
T Consensus 26 ~~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i 105 (185)
T 1io0_A 26 ETLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFI 105 (185)
T ss_dssp HHHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCC
T ss_pred HHHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcC
Confidence 344566788899999999999 88742 455677789999999999999842 234456668899999999999
Q ss_pred cCC----CCccCCCCCCCcEEEC--cCCcCcCC----CCccCcCCCCCcEEEccCccccc
Q 035761 114 VGP----IPSSLGHLTQLTTLNM--YNNKLDGP----IPPELMNCSKLRILKLGNNLLSG 163 (560)
Q Consensus 114 ~~~----~~~~~~~l~~L~~L~l--~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~ 163 (560)
... +...+...++|++|+| ++|.|... +...+...++|+.|+|++|.+..
T Consensus 106 ~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~~ 165 (185)
T 1io0_A 106 SGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQGP 165 (185)
T ss_dssp CHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHHH
T ss_pred CHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCCh
Confidence 743 4566778899999999 88999843 33456677899999999999863
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.56 E-value=5.1e-09 Score=98.50 Aligned_cols=80 Identities=29% Similarity=0.331 Sum_probs=51.1
Q ss_pred CCCCCccEEEccCCCccCC--CCccCCCCCCCcEEECcCCcCcCCCCccCcCCC--CCcEEEccCcccccccc-------
Q 035761 98 GHLKWLRSVDLSQNKLVGP--IPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCS--KLRILKLGNNLLSGSIP------- 166 (560)
Q Consensus 98 ~~l~~L~~L~l~~n~l~~~--~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~--~L~~L~l~~n~l~~~~~------- 166 (560)
.++++|+.|+|++|+|+++ ++..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|.+.+..|
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 3456677777777776652 234455677777777777777654 2333333 77888888888775444
Q ss_pred hhhccccccceee
Q 035761 167 SQIGKLQELYYLD 179 (560)
Q Consensus 167 ~~~~~l~~L~~L~ 179 (560)
..+..+|+|+.||
T Consensus 245 ~il~~~P~L~~LD 257 (267)
T 3rw6_A 245 AIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHCTTCCEES
T ss_pred HHHHHCcccCeEC
Confidence 3466788888776
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.56 E-value=4.8e-07 Score=86.24 Aligned_cols=135 Identities=19% Similarity=0.159 Sum_probs=96.6
Q ss_pred eeeccCCe-eEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccC-CCCcceeeeEEEeCCEEEEEEeccCCC
Q 035761 322 CIGTGGYG-SVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIR-HRNIVKLYGFCLHEKCMFLIYEYMEMG 398 (560)
Q Consensus 322 ~ig~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g 398 (560)
.+..|..| .||+.... ++..+++|+-.... ...+.+|...++.+. +--+.++++++.+.+..++|||++++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~-----~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSV-----ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETHH-----HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCCC-----HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 35556665 68988764 45678889865432 345778999988874 444778889999999999999999998
Q ss_pred CHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 035761 399 SLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHC------------------------------------------ 436 (560)
Q Consensus 399 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------------------------------------------ 436 (560)
++.+..... ..+...++.++++.++-||...
T Consensus 106 ~~~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 106 TAFQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp EHHHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred cccccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 877655432 1223345666666666666421
Q ss_pred -------------CCCeEEeCCCCCCeEeCCCCcEEEeeeccccc
Q 035761 437 -------------TPPILHRDISSNNILLNSEFEAFVADFGIARL 468 (560)
Q Consensus 437 -------------~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 468 (560)
.+.++|+|+.+.||++++++.+-|+||+.+..
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12379999999999999877677999998864
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.54 E-value=4.8e-09 Score=98.66 Aligned_cols=105 Identities=21% Similarity=0.211 Sum_probs=71.3
Q ss_pred ccCCCCCCe--eeccccccc---cccccccCCCCCCCEEEeecCccCcc--CCCCcCCCCCccEEEccCCCccCCCCccC
Q 035761 49 VGHLTQLTT--LAIASNRMN---GSILLGIGSLKVLQVLDLSRNEIGGS--IPSTLGHLKWLRSVDLSQNKLVGPIPSSL 121 (560)
Q Consensus 49 ~~~l~~L~~--L~L~~n~i~---~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 121 (560)
|...+.|.. ++++.|+.. ........++++|+.|+|++|+|+++ ++..+..+++|+.|+|++|+|++. ..+
T Consensus 137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l 214 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--REL 214 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGG
T ss_pred cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhh
Confidence 444455555 667777443 22222335678888888888888863 345566788888888888888854 234
Q ss_pred CCCC--CCcEEECcCCcCcCCCCc-------cCcCCCCCcEEE
Q 035761 122 GHLT--QLTTLNMYNNKLDGPIPP-------ELMNCSKLRILK 155 (560)
Q Consensus 122 ~~l~--~L~~L~l~~n~l~~~~~~-------~~~~l~~L~~L~ 155 (560)
..+. +|++|+|++|.+.+..|. .+..+|+|+.||
T Consensus 215 ~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 215 DKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp GGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred hhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 4444 888999999988865542 366788888886
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=1.6e-06 Score=84.18 Aligned_cols=137 Identities=18% Similarity=0.119 Sum_probs=94.0
Q ss_pred cceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCC---CcceeeeEEE-eCCEEEEEEecc
Q 035761 320 KYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHR---NIVKLYGFCL-HEKCMFLIYEYM 395 (560)
Q Consensus 320 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~ 395 (560)
.+.++.|....||+. |..+++|+.... .....+.+|.++++.+.+. .+.+.+.+.. ..+..++||||+
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~~----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i 95 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKSQ----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV 95 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESSH----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCCc----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence 355788988999988 566788875321 2235688999999998642 3556666664 345678999999
Q ss_pred CCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhc----------------------------------------
Q 035761 396 EMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHH---------------------------------------- 435 (560)
Q Consensus 396 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~---------------------------------------- 435 (560)
+|..+.+..-. .++..+...++.++++.|+.||+.
T Consensus 96 ~G~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 96 QGQILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp CSEECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred CCeECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 99887653211 134445555555555555555532
Q ss_pred -----------------CCCCeEEeCCCCCCeEeCC---CCcE-EEeeecccccc
Q 035761 436 -----------------CTPPILHRDISSNNILLNS---EFEA-FVADFGIARLL 469 (560)
Q Consensus 436 -----------------~~~~ivH~dlk~~Nill~~---~~~~-kl~Dfg~~~~~ 469 (560)
..+.++|+|++|.||+++. ++.+ .|+||+.+..-
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2335799999999999987 4554 79999988754
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=98.18 E-value=3.7e-07 Score=79.57 Aligned_cols=34 Identities=15% Similarity=0.084 Sum_probs=14.4
Q ss_pred CCcEEEccCcc-cccccchhhccccccceeecccc
Q 035761 150 KLRILKLGNNL-LSGSIPSQIGKLQELYYLDLSGN 183 (560)
Q Consensus 150 ~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~l~~n 183 (560)
+|+.|+|++|. +++..-..+..+++|++|++++|
T Consensus 115 ~L~~L~Ls~C~~ITD~Gl~~L~~~~~L~~L~L~~c 149 (176)
T 3e4g_A 115 SMLEMEIISCGNVTDKGIIALHHFRNLKYLFLSDL 149 (176)
T ss_dssp HCCEEEEESCTTCCHHHHHHGGGCTTCCEEEEESC
T ss_pred CCCEEEcCCCCcCCHHHHHHHhcCCCCCEEECCCC
Confidence 34444444442 44333333444444444444444
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=98.17 E-value=4.7e-07 Score=78.86 Aligned_cols=86 Identities=8% Similarity=0.061 Sum_probs=66.9
Q ss_pred CCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcc-cccccchhhccc----cccceeeccccc-cCCcCccccCCCce
Q 035761 125 TQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNL-LSGSIPSQIGKL----QELYYLDLSGNF-INGKIPSQLGEFSC 198 (560)
Q Consensus 125 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~l----~~L~~L~l~~n~-l~~~~~~~~~~~~~ 198 (560)
..|+.|++++|.|+..--..+..+++|+.|+|++|. +++..-..+..+ ++|++|+|++|. +++..-..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 467777777777765444567788899999999985 776665666664 479999999985 88766667888999
Q ss_pred eeEEEccCCc-cc
Q 035761 199 IDTVDLSMNN-LS 210 (560)
Q Consensus 199 L~~l~l~~n~-l~ 210 (560)
|+.|++++++ ++
T Consensus 141 L~~L~L~~c~~It 153 (176)
T 3e4g_A 141 LKYLFLSDLPGVK 153 (176)
T ss_dssp CCEEEEESCTTCC
T ss_pred CCEEECCCCCCCC
Confidence 9999999986 44
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.12 E-value=5.1e-06 Score=82.56 Aligned_cols=81 Identities=7% Similarity=0.001 Sum_probs=53.9
Q ss_pred cee-eccCCeeEEEEEeC-------CCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccC-C--CCcceeeeEEEeC---
Q 035761 321 YCI-GTGGYGSVYRARLP-------SGKVVALKKLHRLET-ELASLESFQNEARLLSQIR-H--RNIVKLYGFCLHE--- 385 (560)
Q Consensus 321 ~~i-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~--- 385 (560)
+.+ +.|....+|+.... +++.+++|....... .......+.+|..+++.+. + ..+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 457 78888999998764 266788887654320 0001124667888888774 2 3567788877654
Q ss_pred CEEEEEEeccCCCCHH
Q 035761 386 KCMFLIYEYMEMGSLF 401 (560)
Q Consensus 386 ~~~~lv~e~~~~g~L~ 401 (560)
+..++||||++|..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3468999999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.01 E-value=3.5e-05 Score=75.87 Aligned_cols=141 Identities=19% Similarity=0.290 Sum_probs=79.0
Q ss_pred ceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-----CCCCcceee-e--EEEeCCEEEEEE
Q 035761 321 YCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQI-----RHRNIVKLY-G--FCLHEKCMFLIY 392 (560)
Q Consensus 321 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~-~--~~~~~~~~~lv~ 392 (560)
+.++.|..+.||+....+| .+++|+..... .....|..+++.+ ..|.++... | +....+..+++|
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~------~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~ 110 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRPE------KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY 110 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSCH------HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCCH------HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence 3456677889999987655 58899887522 1222344444443 234433311 1 223467789999
Q ss_pred eccCCCCHH--------------HHhhcCCc----c-------cCCCHHHH-----------------------------
Q 035761 393 EYMEMGSLF--------------CILRTDEE----A-------VGLDWTKR----------------------------- 418 (560)
Q Consensus 393 e~~~~g~L~--------------~~l~~~~~----~-------~~l~~~~~----------------------------- 418 (560)
+|++|..+. ..+|.... . ..-.|...
T Consensus 111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 190 (346)
T 2q83_A 111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ 190 (346)
T ss_dssp ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence 999986531 11111000 0 00123221
Q ss_pred --HHHHHHHHHHHHHHHh----------cCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccc
Q 035761 419 --VNIVKGMAHALSYLHH----------HCTPPILHRDISSNNILLNSEFEAFVADFGIARL 468 (560)
Q Consensus 419 --~~i~~~ia~~l~~LH~----------~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 468 (560)
..+..++.+++++|++ ...+.++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 1112234446667763 1245899999999999998888899999998754
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.85 E-value=9.1e-05 Score=71.54 Aligned_cols=138 Identities=20% Similarity=0.209 Sum_probs=91.8
Q ss_pred cceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccC---CCCcceeeeEEEeCCEEEEEEeccC
Q 035761 320 KYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIR---HRNIVKLYGFCLHEKCMFLIYEYME 396 (560)
Q Consensus 320 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~ 396 (560)
.+.++.|.+..+|+... ++..+++|+.... ....+..|.+.++.+. ...+.++++++...+..++||||++
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 45689999999999986 4678888987532 2346788988888873 3668889998888888999999999
Q ss_pred CCCHH-----------HHhhcCCc--cc-----------------CCCHHHHH---HHHHH----------------HHH
Q 035761 397 MGSLF-----------CILRTDEE--AV-----------------GLDWTKRV---NIVKG----------------MAH 427 (560)
Q Consensus 397 ~g~L~-----------~~l~~~~~--~~-----------------~l~~~~~~---~i~~~----------------ia~ 427 (560)
+..+. ..++.... .. .-+|.+.. ++..+ +..
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 87641 11222111 00 12455432 11111 111
Q ss_pred H-HHHHHh-cCCCCeEEeCCCCCCeEeCCCCcEEEeeec
Q 035761 428 A-LSYLHH-HCTPPILHRDISSNNILLNSEFEAFVADFG 464 (560)
Q Consensus 428 ~-l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 464 (560)
. .+.|.. ...|.+||+|+.+.|++++.++ +.|.|++
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1 123321 2356899999999999999887 8899984
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.83 E-value=2.1e-06 Score=76.24 Aligned_cols=113 Identities=10% Similarity=0.099 Sum_probs=69.6
Q ss_pred CCcCCCCEEEccCC-ccee----cCCccccCCCCCCeeecccccccccc----ccccCCCCCCCEEEeecCccCcc----
Q 035761 26 GRLSELKILNLSLN-SLVG----NIPSNVGHLTQLTTLAIASNRMNGSI----LLGIGSLKVLQVLDLSRNEIGGS---- 92 (560)
Q Consensus 26 ~~l~~L~~L~L~~N-~i~~----~~~~~~~~l~~L~~L~L~~n~i~~~~----~~~~~~l~~L~~L~l~~n~l~~~---- 92 (560)
.+-+.|++|+|++| +|.. .+.+++.....|+.|+|++|+|.... ...+..-+.|++|+|+.|.|+..
T Consensus 38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~a 117 (197)
T 1pgv_A 38 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 117 (197)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHH
Confidence 34566777777774 6652 23445566677777777777776432 33344557788888888877732
Q ss_pred CCCCcCCCCCccEEEccCCCc---cC----CCCccCCCCCCCcEEECcCCcCc
Q 035761 93 IPSTLGHLKWLRSVDLSQNKL---VG----PIPSSLGHLTQLTTLNMYNNKLD 138 (560)
Q Consensus 93 ~~~~~~~l~~L~~L~l~~n~l---~~----~~~~~~~~l~~L~~L~l~~n~l~ 138 (560)
+...+..-+.|++|+|++|.. .. .+...+..-+.|+.|+++.|.+.
T Consensus 118 la~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 118 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 233455566788888876533 21 12334555677888888776543
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.82 E-value=4.2e-05 Score=77.07 Aligned_cols=77 Identities=12% Similarity=0.131 Sum_probs=48.3
Q ss_pred cceeeccCCeeEEEEEeC-CCcEEEEEEccchhh---h--hhhHHHHHHHHHHHhccCC--CCc-ceeeeEEEeCCEEEE
Q 035761 320 KYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET---E--LASLESFQNEARLLSQIRH--RNI-VKLYGFCLHEKCMFL 390 (560)
Q Consensus 320 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~--~~~~~~~~~e~~~l~~l~h--~ni-v~l~~~~~~~~~~~l 390 (560)
.+.+|.|.++.||++... +++.++||....... . ....+.+..|.++++.+.. +.. .+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 456899999999999754 468899997643211 0 0122356778888887732 333 345543 3444689
Q ss_pred EEeccCCC
Q 035761 391 IYEYMEMG 398 (560)
Q Consensus 391 v~e~~~~g 398 (560)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.72 E-value=3.9e-06 Score=74.52 Aligned_cols=118 Identities=14% Similarity=0.106 Sum_probs=87.6
Q ss_pred CCccccCCCCCCeeecccc-cccc----ccccccCCCCCCCEEEeecCccCccC----CCCcCCCCCccEEEccCCCccC
Q 035761 45 IPSNVGHLTQLTTLAIASN-RMNG----SILLGIGSLKVLQVLDLSRNEIGGSI----PSTLGHLKWLRSVDLSQNKLVG 115 (560)
Q Consensus 45 ~~~~~~~l~~L~~L~L~~n-~i~~----~~~~~~~~l~~L~~L~l~~n~l~~~~----~~~~~~l~~L~~L~l~~n~l~~ 115 (560)
+...+.+-+.|+.|+|++| +|.. .+...+..-+.|+.|+|++|+|.... ...+..-+.|+.|+|++|.|..
T Consensus 33 l~~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~ 112 (197)
T 1pgv_A 33 INRLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP 112 (197)
T ss_dssp HHHHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH
T ss_pred HHHHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCH
Confidence 3344567789999999986 8763 34566777889999999999998533 3344566899999999999973
Q ss_pred C----CCccCCCCCCCcEEECcCCcC---cC----CCCccCcCCCCCcEEEccCcccc
Q 035761 116 P----IPSSLGHLTQLTTLNMYNNKL---DG----PIPPELMNCSKLRILKLGNNLLS 162 (560)
Q Consensus 116 ~----~~~~~~~l~~L~~L~l~~n~l---~~----~~~~~~~~l~~L~~L~l~~n~l~ 162 (560)
. +...+..-+.|++|+|++|.. .. .+...+..-+.|+.|+++.|.+.
T Consensus 113 ~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 113 ELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 2 344566778899999987643 31 12345667789999999988765
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00027 Score=67.58 Aligned_cols=79 Identities=19% Similarity=0.192 Sum_probs=54.9
Q ss_pred CCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCC---CcceeeeEEEeCCEEEEEE
Q 035761 316 DFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHR---NIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~~~~~~~lv~ 392 (560)
+..-.+.+|.|..+.||+.+..+|+.|++|+...... .....|..|...|+.+... -+.+++++ .. .++||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~lv~ 89 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAP--ALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTLAM 89 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCC--CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEEEE
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCc--chhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceEEE
Confidence 3444667899999999999999999999998654321 1223577899998887422 23444443 22 36899
Q ss_pred eccCCCCH
Q 035761 393 EYMEMGSL 400 (560)
Q Consensus 393 e~~~~g~L 400 (560)
||++++..
T Consensus 90 e~l~~~~~ 97 (288)
T 3f7w_A 90 EWVDERPP 97 (288)
T ss_dssp ECCCCCCC
T ss_pred EeecccCC
Confidence 99987653
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00057 Score=69.28 Aligned_cols=78 Identities=10% Similarity=0.028 Sum_probs=45.7
Q ss_pred CCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCceeecc--ccCccCccccccC---ccCcchhHHHHHHHHHH
Q 035761 437 TPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAG--TYGSIAPELAYTM---VVTEKYDVYSFGVVALE 511 (560)
Q Consensus 437 ~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g--~~~~~aPE~~~~~---~~~~~~Dv~s~G~il~e 511 (560)
.+.++|+|++|.||+++.++ ++++||+.+..-.+.-. ...... ...|++|+..... ......++.+....+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D-la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD-IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH-HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH-HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 34899999999999998876 99999998875321100 000000 1235555543311 11123455566777777
Q ss_pred HHhCC
Q 035761 512 VLMGK 516 (560)
Q Consensus 512 l~~g~ 516 (560)
.++++
T Consensus 309 ~y~~~ 313 (420)
T 2pyw_A 309 LFNKR 313 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 76653
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00026 Score=58.62 Aligned_cols=55 Identities=20% Similarity=0.245 Sum_probs=31.8
Q ss_pred EEEccCCcCc-ccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeecccccc
Q 035761 9 HLDLSDNHFM-GHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRM 65 (560)
Q Consensus 9 ~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i 65 (560)
.++.++++++ ..+|..+. ++|++|+|++|+|+.+.+..|..+++|+.|+|++|.+
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 5666666665 23343322 3566666666666655555566666666666666654
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00071 Score=66.18 Aligned_cols=141 Identities=20% Similarity=0.172 Sum_probs=72.5
Q ss_pred eeeccCCee-EEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCC--CCcceeeeEEEeCCEEEEEEeccCCC
Q 035761 322 CIGTGGYGS-VYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRH--RNIVKLYGFCLHEKCMFLIYEYMEMG 398 (560)
Q Consensus 322 ~ig~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g 398 (560)
.++.|+... +|+....+|..+++|....... ..+..|..+++.+.. -.+.+++.+....+ +++||++.+.
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~-----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~ 97 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG-----GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA 97 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTTT-----CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC-----ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence 455555554 6677654467777776543210 123356666665532 23455666544344 6899999776
Q ss_pred CHHHHhhcCCc-----------------------ccCCCHHHHH-------H-------------HHHHHHHHHHHHHh-
Q 035761 399 SLFCILRTDEE-----------------------AVGLDWTKRV-------N-------------IVKGMAHALSYLHH- 434 (560)
Q Consensus 399 ~L~~~l~~~~~-----------------------~~~l~~~~~~-------~-------------i~~~ia~~l~~LH~- 434 (560)
.+.+++..... ...++..... . ....+...++.+.+
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 66544432110 0012211100 0 00111222233311
Q ss_pred --cCCCCeEEeCCCCCCeEeCCC----CcEEEeeecccccc
Q 035761 435 --HCTPPILHRDISSNNILLNSE----FEAFVADFGIARLL 469 (560)
Q Consensus 435 --~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg~~~~~ 469 (560)
...+.++|||+.+.||+++.+ +.+.++||+.+..-
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 123478999999999999875 67899999988753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.35 E-value=0.0016 Score=63.23 Aligned_cols=159 Identities=13% Similarity=0.100 Sum_probs=86.8
Q ss_pred cCHHHHHHHhcCCcc-----cceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCC--cce
Q 035761 305 ITFQDMIEATEDFDI-----KYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRN--IVK 377 (560)
Q Consensus 305 ~~~~~~~~~~~~~~~-----~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~ 377 (560)
++.+++...-..|.. .+.++.|....+|+....+| .+++|....... .+.+..|..+++.+...+ +.+
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~----~~~l~~e~~~l~~L~~~g~~vP~ 81 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE----KNDLPFFLGLMQHLAAKGLSCPL 81 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCC----HHHHHHHHHHHHHHHHCCCCCCc
Confidence 345555555555654 23466788899999987666 577888765211 123445677766653212 233
Q ss_pred eeeE------EEeCCEEEEEEeccCCCCHHH--------------HhhcC----Cccc----C-CCHHHHHH--------
Q 035761 378 LYGF------CLHEKCMFLIYEYMEMGSLFC--------------ILRTD----EEAV----G-LDWTKRVN-------- 420 (560)
Q Consensus 378 l~~~------~~~~~~~~lv~e~~~~g~L~~--------------~l~~~----~~~~----~-l~~~~~~~-------- 420 (560)
++.. ....+..+++++|++|..+.. .++.. .... . ..|.....
T Consensus 82 ~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~ 161 (322)
T 2ppq_A 82 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 161 (322)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred ccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence 3321 223466789999999854310 01110 0000 0 12322111
Q ss_pred ----HHHHHHHHHHHHHhc----CCCCeEEeCCCCCCeEeCCCCcEEEeeeccccc
Q 035761 421 ----IVKGMAHALSYLHHH----CTPPILHRDISSNNILLNSEFEAFVADFGIARL 468 (560)
Q Consensus 421 ----i~~~ia~~l~~LH~~----~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 468 (560)
+...+.+.++++++. ..++++|+|+.+.||+++++..+.++||+.+..
T Consensus 162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 162 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011244455666532 234789999999999998876567999997754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00087 Score=64.51 Aligned_cols=71 Identities=14% Similarity=0.093 Sum_probs=42.5
Q ss_pred cceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCc-ceeeeEEEeCCEEEEEEecc-CC
Q 035761 320 KYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNI-VKLYGFCLHEKCMFLIYEYM-EM 397 (560)
Q Consensus 320 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~ 397 (560)
.+.++.|....+|+. ..+++|+........ ....+|..+++.+...++ .+++++ ..+.-++++||+ ++
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~---~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY---INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGA 92 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C---CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce---eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCC
Confidence 567888999999998 467888775432111 112457777776643233 345543 333357899999 55
Q ss_pred CCH
Q 035761 398 GSL 400 (560)
Q Consensus 398 g~L 400 (560)
.++
T Consensus 93 ~~l 95 (301)
T 3dxq_A 93 QTM 95 (301)
T ss_dssp EEC
T ss_pred ccC
Confidence 433
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.24 E-value=0.0041 Score=60.49 Aligned_cols=142 Identities=14% Similarity=0.152 Sum_probs=80.5
Q ss_pred ceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCC--CCcceeeeE-----EEeCCEEEEEEe
Q 035761 321 YCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRH--RNIVKLYGF-----CLHEKCMFLIYE 393 (560)
Q Consensus 321 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~-----~~~~~~~~lv~e 393 (560)
..++ |....||+....+|+.+++|....... ....+..|..+++.+.. -.+.+++.. ....+..+++|+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~---~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC---CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence 3466 888899998877787899999863221 12345567777776632 123444442 223556788999
Q ss_pred ccCCCCHH-----HH---------hhc----CC--cccCCCHHHH----HHH---------------HHHHHHHHHHHHh
Q 035761 394 YMEMGSLF-----CI---------LRT----DE--EAVGLDWTKR----VNI---------------VKGMAHALSYLHH 434 (560)
Q Consensus 394 ~~~~g~L~-----~~---------l~~----~~--~~~~l~~~~~----~~i---------------~~~ia~~l~~LH~ 434 (560)
|++|..+. .+ +|. .. ....+++... ..+ ...+.+.++.+.+
T Consensus 108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~ 187 (328)
T 1zyl_A 108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA 187 (328)
T ss_dssp CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence 99874421 00 111 00 0011222211 001 1111122333332
Q ss_pred c----CCCCeEEeCCCCCCeEeCCCCcEEEeeeccccc
Q 035761 435 H----CTPPILHRDISSNNILLNSEFEAFVADFGIARL 468 (560)
Q Consensus 435 ~----~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 468 (560)
. ..+.++|+|+++.||+++ + .+.++||+.+..
T Consensus 188 ~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 188 HWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1 234689999999999999 4 889999988764
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.18 E-value=0.00057 Score=56.52 Aligned_cols=35 Identities=31% Similarity=0.282 Sum_probs=14.2
Q ss_pred CcEEECcCCcCcCCCCccCcCCCCCcEEEccCccc
Q 035761 127 LTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLL 161 (560)
Q Consensus 127 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 161 (560)
|+.|+|++|+|+.+.+..|..+++|+.|+|++|.+
T Consensus 33 l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 33 TTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp CSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred CCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 44444444444433333334444444444444433
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.08 E-value=0.00093 Score=67.73 Aligned_cols=71 Identities=23% Similarity=0.276 Sum_probs=47.0
Q ss_pred ceeeccCCeeEEEEEeCC--------CcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCc-ceeeeEEEeCCEEEEE
Q 035761 321 YCIGTGGYGSVYRARLPS--------GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNI-VKLYGFCLHEKCMFLI 391 (560)
Q Consensus 321 ~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv 391 (560)
+.|+.|....+|++...+ ++.+++|+...... ...+.+|..+++.+...++ .++++.+. + .+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~----~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v 150 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET----ESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRL 150 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC----HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEE
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc----HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEE
Confidence 457788889999998753 47889998743111 1244578888888743333 56666543 2 389
Q ss_pred EeccCCCC
Q 035761 392 YEYMEMGS 399 (560)
Q Consensus 392 ~e~~~~g~ 399 (560)
+||+++.+
T Consensus 151 ~e~l~G~~ 158 (429)
T 1nw1_A 151 EEYIPSRP 158 (429)
T ss_dssp ECCCCEEE
T ss_pred EEEeCCcc
Confidence 99998643
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.00 E-value=0.0014 Score=64.97 Aligned_cols=141 Identities=20% Similarity=0.249 Sum_probs=81.4
Q ss_pred ceeeccCCeeEEEEEeCC--------CcEEEEEEccchhhhhhhHHHHHHHHHHHhccC-CCCcceeeeEEEeCCEEEEE
Q 035761 321 YCIGTGGYGSVYRARLPS--------GKVVALKKLHRLETELASLESFQNEARLLSQIR-HRNIVKLYGFCLHEKCMFLI 391 (560)
Q Consensus 321 ~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 391 (560)
+.+..|-...+|++...+ ++.+++|+..... .....+.+|..+++.+. +.-..++++++. + .+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~--g~v 128 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL---QGVDSLVLESVMFAILAERSLGPQLYGVFP--E--GRL 128 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T--EEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc---chHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--ccE
Confidence 446668888999998752 4788898863311 22345568988888874 322355665543 2 289
Q ss_pred EeccCCCCHHHH-----------------hhcCCc--ccCCC--HHHHHHHHHHHHH-------------------HHHH
Q 035761 392 YEYMEMGSLFCI-----------------LRTDEE--AVGLD--WTKRVNIVKGMAH-------------------ALSY 431 (560)
Q Consensus 392 ~e~~~~g~L~~~-----------------l~~~~~--~~~l~--~~~~~~i~~~ia~-------------------~l~~ 431 (560)
|||++|..+..- +|.... ..... |.++.++..++.. .+++
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 999998554210 111100 11122 4555555544322 2333
Q ss_pred HHh----c-CCCCeEEeCCCCCCeEeCCC----CcEEEeeeccccc
Q 035761 432 LHH----H-CTPPILHRDISSNNILLNSE----FEAFVADFGIARL 468 (560)
Q Consensus 432 LH~----~-~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg~~~~ 468 (560)
|.+ . ....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 332 1 23368999999999999876 7899999998864
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0036 Score=61.26 Aligned_cols=32 Identities=25% Similarity=0.416 Sum_probs=28.1
Q ss_pred CCeEEeCCCCCCeEeCCCCcEEEeeecccccc
Q 035761 438 PPILHRDISSNNILLNSEFEAFVADFGIARLL 469 (560)
Q Consensus 438 ~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 469 (560)
+.++|+|+.+.||++++++.+.++||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 47899999999999998888999999877653
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.66 E-value=0.0069 Score=61.68 Aligned_cols=74 Identities=19% Similarity=0.163 Sum_probs=46.2
Q ss_pred cceeeccCCeeEEEEEeCC-CcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCc-ceeeeEEEeCCEEEEEEeccCC
Q 035761 320 KYCIGTGGYGSVYRARLPS-GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNI-VKLYGFCLHEKCMFLIYEYMEM 397 (560)
Q Consensus 320 ~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~ 397 (560)
.+.|+.|-...+|++...+ +..+++|+........ -...+|..+++.+...++ .++++.+ .+ .+||||+++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~---idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI---INREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC---SCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh---cCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCC
Confidence 3457788889999998765 4788888774322111 012478888888864444 4666665 23 259999987
Q ss_pred CCH
Q 035761 398 GSL 400 (560)
Q Consensus 398 g~L 400 (560)
.++
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.55 E-value=0.0069 Score=60.01 Aligned_cols=72 Identities=14% Similarity=0.066 Sum_probs=42.2
Q ss_pred ceeeccCCeeEEEEEeCC---------CcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCC-cceeeeEEEeCCEEEE
Q 035761 321 YCIGTGGYGSVYRARLPS---------GKVVALKKLHRLETELASLESFQNEARLLSQIRHRN-IVKLYGFCLHEKCMFL 390 (560)
Q Consensus 321 ~~ig~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~l 390 (560)
+.++.|....+|+....+ +..+++|+........ .....|.++++.+...+ +.++++.. ++ ++
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~---~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~ 111 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL---YNTISEFEVYKTMSKYKIAPQLLNTF--NG--GR 111 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT---SCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce---ecHHHHHHHHHHHHhcCCCCceEEec--CC--cE
Confidence 456778888999998654 2688888875432211 12346777777774333 34565443 32 68
Q ss_pred EEeccCCCC
Q 035761 391 IYEYMEMGS 399 (560)
Q Consensus 391 v~e~~~~g~ 399 (560)
||||+++..
T Consensus 112 v~e~i~G~~ 120 (369)
T 3c5i_A 112 IEEWLYGDP 120 (369)
T ss_dssp EEECCCSEE
T ss_pred EEEEecCCc
Confidence 999998754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.40 E-value=0.011 Score=52.72 Aligned_cols=139 Identities=17% Similarity=0.063 Sum_probs=87.6
Q ss_pred CCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCCce
Q 035761 398 GSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRT 477 (560)
Q Consensus 398 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 477 (560)
-+|.+.|...+. ++++.++..++.|.+++|.-+-... .-..+=+.|..|++..+|++.+.+ +.+.
T Consensus 33 vSL~eIL~~~~~--PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQ--PINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHHcCC--CcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc----------
Confidence 478888876543 4999999999999999986652110 111333457889999999988764 1110
Q ss_pred eeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccc------------------
Q 035761 478 LLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLL------------------ 539 (560)
Q Consensus 478 ~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~~~~~~~~~~~~~~------------------ 539 (560)
.....+.|||... ...+.+.=|||+|+++|.-+--..|-.....-+.++..++..|...
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~eE~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~ 174 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKENEERELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGL 174 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTEEECCCHHHHHHHHHHTTCCC----------------
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcccchhhCHHHHHHHHHHHhccccccccccccccccccc
Confidence 0112367888753 3456788999999999999985555444444555555555555433
Q ss_pred -------CCCCCCChhHHHhhc
Q 035761 540 -------DPRLPPPGDQMIRQG 554 (560)
Q Consensus 540 -------dp~~~p~~~~~~~~~ 554 (560)
.+.-+.+++++++-|
T Consensus 175 ~d~~~~~~~~~~~sl~~Vi~~C 196 (229)
T 2yle_A 175 GDEDEKRKISAIRSYRDVMKLC 196 (229)
T ss_dssp ----CCSCCCCCCSHHHHHHHH
T ss_pred ccccccccccCcCCHHHHHHHH
Confidence 235778888888765
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.38 E-value=0.14 Score=51.21 Aligned_cols=140 Identities=11% Similarity=0.090 Sum_probs=80.8
Q ss_pred ceeeccCCeeEEEEEeCC--------CcEEEEEEccchhhhhhhHHHHHHHHHHHhccC-CCCcceeeeEEEeCCEEEEE
Q 035761 321 YCIGTGGYGSVYRARLPS--------GKVVALKKLHRLETELASLESFQNEARLLSQIR-HRNIVKLYGFCLHEKCMFLI 391 (560)
Q Consensus 321 ~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 391 (560)
+.+..|-...+|+....+ ++.+++|+........ -...+|..+++.+. +.-..++++.+ .+ +.|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~---idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I 148 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF---YDSKVELDVFRYLSNINIAPNIIADF--PE--GRI 148 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC---CCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh---cCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEE
Confidence 446668888999998753 5788898865422111 12246777777774 22234555433 32 689
Q ss_pred EeccCCCCHHH-------H----------hhcC-------C---cccCCCHHHHHHHHHHH-------------------
Q 035761 392 YEYMEMGSLFC-------I----------LRTD-------E---EAVGLDWTKRVNIVKGM------------------- 425 (560)
Q Consensus 392 ~e~~~~g~L~~-------~----------l~~~-------~---~~~~l~~~~~~~i~~~i------------------- 425 (560)
|||++|..+.. . +|.. + ....--|.++.++..++
T Consensus 149 ~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l 228 (424)
T 3mes_A 149 EEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKI 228 (424)
T ss_dssp EECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHH
T ss_pred EEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHH
Confidence 99999865311 0 0100 0 00111244444443322
Q ss_pred HHHHHHHHhc---------------------CCCCeEEeCCCCCCeEeCCCCcEEEeeeccccc
Q 035761 426 AHALSYLHHH---------------------CTPPILHRDISSNNILLNSEFEAFVADFGIARL 468 (560)
Q Consensus 426 a~~l~~LH~~---------------------~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 468 (560)
...+++|.+. ....++|+|+.+.||+ +.++.+.++||..|..
T Consensus 229 ~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 229 LEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 2233333311 1235899999999999 7788999999998864
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=93.57 E-value=0.16 Score=45.12 Aligned_cols=126 Identities=6% Similarity=0.085 Sum_probs=85.0
Q ss_pred cCCCCcceeeeEEEeCCEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCC
Q 035761 370 IRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNN 449 (560)
Q Consensus 370 l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~N 449 (560)
..||+.++. .+-..++...+.|+.-+.+.=...++ .++..++++++.+|+...++++.. +|--+.|+|
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik------~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~N 109 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK------SFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDE 109 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG------GSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGG
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH------hcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecce
Confidence 368888876 56666776666665443222222232 278899999999999988776644 788899999
Q ss_pred eEeCCCCcEEEeeeccccccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccccccc
Q 035761 450 ILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSL 529 (560)
Q Consensus 450 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~~~~ 529 (560)
++++.++.+++.-.|+-..+.+ . ..++..=.-.+=+++..+++++..|+..-.....+
T Consensus 110 L~f~~~~~p~i~~RGik~~l~P-----------------~-----~~~ee~fL~qyKAliiall~~K~~Fe~l~~G~lel 167 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNVVDP-----------------L-----PVSEAEFLTRYKALVICAFNEKQSFDALVEGNLEL 167 (215)
T ss_dssp EEECTTSCEEESCCEETTTBSC-----------------C-----CCCHHHHHHHHHHHHHHHHCTTCCHHHHHHSCGGG
T ss_pred EEEcCCCCEEEEEccCccCCCC-----------------C-----CCCHHHHHHHHHHHHHHHHcCCCCHHHHHcChHhh
Confidence 9999999999988886544322 1 01111122346678888999999987555554444
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.30 E-value=0.31 Score=48.59 Aligned_cols=30 Identities=27% Similarity=0.419 Sum_probs=25.2
Q ss_pred CeEEeCCCCCCeEe------CCCCcEEEeeeccccc
Q 035761 439 PILHRDISSNNILL------NSEFEAFVADFGIARL 468 (560)
Q Consensus 439 ~ivH~dlk~~Nill------~~~~~~kl~Dfg~~~~ 468 (560)
.++|+|+.+.||++ +++..+.++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 35799999999999 4567799999998864
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.32 E-value=0.32 Score=30.82 Aligned_cols=15 Identities=40% Similarity=0.722 Sum_probs=7.0
Q ss_pred CcchhhhhHHHHHHH
Q 035761 247 KTIATGLVAIILAMV 261 (560)
Q Consensus 247 ~~~~~~~~~~~~~~v 261 (560)
..++.++++.+++++
T Consensus 11 ~~IA~gVVgGv~~~~ 25 (44)
T 2ks1_B 11 PSIATGMVGALLLLL 25 (44)
T ss_dssp SSSTHHHHHHHHHHH
T ss_pred ceEEeehhHHHHHHH
Confidence 345555554444433
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=90.29 E-value=0.037 Score=56.40 Aligned_cols=62 Identities=18% Similarity=0.116 Sum_probs=17.8
Q ss_pred cceeeccCCeeEEEEEeCC-CcEEEE------EEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEe
Q 035761 320 KYCIGTGGYGSVYRARLPS-GKVVAL------KKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLH 384 (560)
Q Consensus 320 ~~~ig~G~~g~Vy~~~~~~-~~~vav------K~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 384 (560)
.+.+| ||.||+|.+.. ..+||| |..+......+....|.+|..+++..+|||+++.+++...
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 44565 99999998864 367888 7766544444455678899999999999999999988754
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=89.89 E-value=1.1 Score=39.92 Aligned_cols=117 Identities=13% Similarity=0.121 Sum_probs=79.3
Q ss_pred CCCCcceeeeEEEeCCEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHH-HHHhcCCCCeEEeCCCCCC
Q 035761 371 RHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALS-YLHHHCTPPILHRDISSNN 449 (560)
Q Consensus 371 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~-~LH~~~~~~ivH~dlk~~N 449 (560)
.||++ -...-.+++...+.++.-+++.=...++. ++..++++++.+|+.... +++. -+|--++|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~------~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK------TTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT------SCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh------cCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence 68887 44445667777777776544433334432 788999999999988776 5554 4788899999
Q ss_pred eEeCCCCcEEEeeeccccccCCCCCCceeeccccCccCccccccCccCcchhH-HHHHHHHHHHHhCCCCCCccc
Q 035761 450 ILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDV-YSFGVVALEVLMGKHPGELLS 523 (560)
Q Consensus 450 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv-~s~G~il~el~~g~~P~~~~~ 523 (560)
+++|.++.+++.-.|.-..+. |.-. ...|. -.+=+++..++.++..|+..-
T Consensus 115 L~f~~~~~p~i~hRGi~~~lp-----------------P~e~------~ee~fl~qyKali~all~~K~~Fe~l~ 166 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKESLP-----------------PDEW------DDERLLREVKATVLALTEGEYRFDEYL 166 (219)
T ss_dssp EEECTTCCEEESCCEETTTBS-----------------SCSC------CHHHHHHHHHHHHHHHTTCSSCHHHHH
T ss_pred EEEeCCCcEEEEEcCCcccCC-----------------CCCC------CHHHHHHHHHHHHHHHHcCCCCHHHHH
Confidence 999999999998888654432 2210 11122 246667778888888776443
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.26 E-value=0.31 Score=30.83 Aligned_cols=32 Identities=25% Similarity=0.407 Sum_probs=18.1
Q ss_pred CcchhhhhHHHHHHHHHHHHHHhheeeEeccC
Q 035761 247 KTIATGLVAIILAMVAFLALIFGILIIRRRRD 278 (560)
Q Consensus 247 ~~~~~~~~~~~~~~v~~~~l~~~~~~~rr~r~ 278 (560)
.....+..+++.+++++++++.+++++.|+|+
T Consensus 8 s~~~~IA~gVVgGv~~~~ii~~~~~~~~RRr~ 39 (44)
T 2ks1_B 8 PKIPSIATGMVGALLLLLVVALGIGLFMRRRH 39 (44)
T ss_dssp SCSSSSTHHHHHHHHHHHHHHHHHHHHHHTTT
T ss_pred CCcceEEeehhHHHHHHHHHHHHHHHHhhhhH
Confidence 45556555555566667666655444444443
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.26 E-value=0.36 Score=30.47 Aligned_cols=6 Identities=50% Similarity=1.027 Sum_probs=2.2
Q ss_pred chhhhh
Q 035761 249 IATGLV 254 (560)
Q Consensus 249 ~~~~~~ 254 (560)
++.+++
T Consensus 12 IA~gVV 17 (44)
T 2l2t_A 12 IAAGVI 17 (44)
T ss_dssp HHHHHH
T ss_pred EEEeeh
Confidence 333333
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=87.57 E-value=0.28 Score=30.93 Aligned_cols=6 Identities=50% Similarity=1.132 Sum_probs=2.4
Q ss_pred eeEecc
Q 035761 272 IIRRRR 277 (560)
Q Consensus 272 ~~rr~r 277 (560)
|+|||+
T Consensus 34 ~~RRR~ 39 (44)
T 2jwa_A 34 LIKRRQ 39 (44)
T ss_dssp HHHHHC
T ss_pred heehhh
Confidence 334433
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=86.94 E-value=0.59 Score=29.50 Aligned_cols=21 Identities=5% Similarity=-0.001 Sum_probs=9.4
Q ss_pred chhhhhHHHHHHHHHHHHHHh
Q 035761 249 IATGLVAIILAMVAFLALIFG 269 (560)
Q Consensus 249 ~~~~~~~~~~~~v~~~~l~~~ 269 (560)
...+..+++.++++++++...
T Consensus 9 ~~aIA~gVVgGv~~v~ii~~~ 29 (44)
T 2l2t_A 9 TPLIAAGVIGGLFILVIVGLT 29 (44)
T ss_dssp SHHHHHHHHHHHHHHHHHHHH
T ss_pred cceEEEeehHHHHHHHHHHHH
Confidence 444444444445444444443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 560 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-58 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-58 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-57 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-56 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-54 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-52 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-52 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-51 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-51 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-51 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-50 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-50 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-50 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-50 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-49 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-49 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-48 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-47 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-47 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-47 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-47 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-46 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-46 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-46 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-46 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 9e-46 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-45 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-45 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-44 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-44 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-44 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-43 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-42 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-42 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-41 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-41 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-41 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-40 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-40 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-39 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-39 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-38 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-37 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-37 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-36 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-36 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-35 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-34 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-34 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-26 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-18 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-04 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-21 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-21 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-13 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-20 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-15 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-18 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-08 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-07 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 7e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 8e-13 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-11 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 6e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.003 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-10 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 8e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 9e-07 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 1e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 4e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 7e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.004 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 1e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 9e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 3e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 5e-04 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 3e-58
Identities = 61/235 (25%), Positives = 106/235 (45%), Gaps = 11/235 (4%)
Query: 313 ATEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIR 371
+DF+ +G G G V++ PSG V+A K +H LE + A E ++L +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH-LEIKPAIRNQIIRELQVLHECN 62
Query: 372 HRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSY 431
IV YG + + + E+M+ GSL +L+ +A + + + L+Y
Sbjct: 63 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTY 119
Query: 432 LHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELA 491
L I+HRD+ +NIL+NS E + DFG++ L S GT ++PE
Sbjct: 120 LREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFVGTRSYMSPERL 175
Query: 492 YTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRLPPP 546
+ + D++S G+ +E+ +G++P + + L+ D PP
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYP--IPPPDAKELELMFGCQVEGDAAETPP 228
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 8e-58
Identities = 63/250 (25%), Positives = 116/250 (46%), Gaps = 15/250 (6%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRN 374
+ IG+G +G+VY+ + VA+K L+ L++F+NE +L + RH N
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 375 IVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHH 434
I+ G+ + ++ ++ E SL+ L E + K ++I + A + YLH
Sbjct: 66 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHA 122
Query: 435 HCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTL--LAGTYGSIAPELAY 492
I+HRD+ SNNI L+ + + DFG+A + + S + L+G+ +APE+
Sbjct: 123 K---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 493 TM---VVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRLPPPGDQ 549
+ + DVY+FG+V E++ G+ P + ++ + L P L
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYS--NINNRDQIIFMVGRGYLSPDLSKVRSN 237
Query: 550 MIRQGIILIS 559
+ L++
Sbjct: 238 CPKAMKRLMA 247
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 1e-57
Identities = 65/247 (26%), Positives = 113/247 (45%), Gaps = 10/247 (4%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHR 373
ED+++ Y IGTG YG + R GK++ K+L A + +E LL +++H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 374 NIVKLYGFCLHE--KCMFLIYEYMEMGSLFCILRTDEEAVG-LDWTKRVNIVKGMAHALS 430
NIV+ Y + ++++ EY E G L ++ + LD + ++ + AL
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 431 YLHHH--CTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAP 488
H +LHRD+ N+ L+ + + DFG+AR+LN+D+S GT ++P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
Query: 489 ELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDL--LDPRLPPP 546
E M EK D++S G + E+ P + S L I+ + R
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFT--AFSQKELAGKIREGKFRRIPYRYSDE 241
Query: 547 GDQMIRQ 553
+++I +
Sbjct: 242 LNEIITR 248
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 9e-56
Identities = 61/241 (25%), Positives = 110/241 (45%), Gaps = 10/241 (4%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRN 374
E + +G G +G V+ VA+K L + S ++F EA L+ Q++H+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMSPDAFLAEANLMKQLQHQR 69
Query: 375 IVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHH 434
+V+LY E +++I EYME GSL L+ + L K +++ +A ++++
Sbjct: 70 LVRLYAVVTQEP-IYIITEYMENGSLVDFLK-TPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 435 HCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSN-RTLLAGTYGSIAPELAYT 493
+HRD+ + NIL++ +ADFG+ARL+ + R APE
Sbjct: 128 RN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 494 MVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDP-RLPPPGDQMIR 552
T K DV+SFG++ E++ ++ + + ++ P P Q++R
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMR 244
Query: 553 Q 553
Sbjct: 245 L 245
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 1e-54
Identities = 77/242 (31%), Positives = 123/242 (50%), Gaps = 13/242 (5%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASL-ESFQNEARLLSQIRH 372
EDF+I +G G +G+VY AR S ++ALK L + + E A + + E + S +RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYL 432
NI++LYG+ ++LI EY +G+++ L+ D + + +A+ALSY
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYC 122
Query: 433 HHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAY 492
H ++HRDI N+LL S E +ADFG + SS RT L GT + PE+
Sbjct: 123 HSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA--PSSRRTTLCGTLDYLPPEMIE 177
Query: 493 TMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDL-LDPRLPPPGDQMI 551
+ EK D++S GV+ E L+GK P E +++ K I ++ + +I
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPPFE--ANTYQETYKRISRVEFTFPDFVTEGARDLI 235
Query: 552 RQ 553
+
Sbjct: 236 SR 237
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 2e-52
Identities = 57/233 (24%), Positives = 98/233 (42%), Gaps = 9/233 (3%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRN 374
+ IG+G +G V+ + VA+K + S E F EA ++ ++ H
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE---GAMSEEDFIEEAEVMMKLSHPK 61
Query: 375 IVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHH 434
+V+LYG CL + + L++E+ME G L LRT + + + + +
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF--AAETLLGMCLDVCEG---MAY 116
Query: 435 HCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTL-LAGTYGSIAPELAYT 493
++HRD+++ N L+ V+DFG+ R + D + +PE+
Sbjct: 117 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176
Query: 494 MVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRLPPP 546
+ K DV+SFGV+ EV S+S ++ L PRL
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST 229
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 4e-52
Identities = 65/245 (26%), Positives = 107/245 (43%), Gaps = 13/245 (5%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHR 373
ED+D+ +G G YG V A + + VA+K + ++ + E+ + E + + H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-DMKRAVDCPENIKKEICINKMLNHE 63
Query: 374 NIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLH 433
N+VK YG +L EY G LF + D G+ + + YLH
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLH 120
Query: 434 HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTL--LAGTYGSIAPELA 491
I HRDI N+LL+ ++DFG+A + Y++ R L + GT +APEL
Sbjct: 121 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 492 YTM-VVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDP--RLPPPGD 548
E DV+S G+V +L G+ P + S S + L+P ++
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 237
Query: 549 QMIRQ 553
++ +
Sbjct: 238 ALLHK 242
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 1e-51
Identities = 57/233 (24%), Positives = 103/233 (44%), Gaps = 9/233 (3%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRN 374
+D +GTG +G V + VA+K + S + F EA+++ + H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE---GSMSEDEFIEEAKVMMNLSHEK 60
Query: 375 IVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHH 434
+V+LYG C ++ +F+I EYM G L LR + + + K + A+ YL
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLES 118
Query: 435 HCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTL-LAGTYGSIAPELAYT 493
LHRD+++ N L+N + V+DFG++R + D ++ PE+
Sbjct: 119 KQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 494 MVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRLPPP 546
+ K D+++FGV+ E+ ++S + + + + L P L
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE 228
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 4e-51
Identities = 58/234 (24%), Positives = 110/234 (47%), Gaps = 14/234 (5%)
Query: 314 TEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRH 372
+ + IG G G+VY A + +G+ VA+++++ + E NE ++ + ++
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL--QQQPKKELIINEILVMRENKN 76
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYL 432
NIV L ++++ EY+ GSL ++ +D + + + AL +L
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFL 132
Query: 433 HHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAY 492
H + ++HRDI S+NILL + + DFG + + S R+ + GT +APE+
Sbjct: 133 HSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 189
Query: 493 TMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRLPPP 546
K D++S G++A+E++ G+ P + + L + P L P
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPP----YLNENPLRALYLIATNGTPELQNP 239
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 4e-51
Identities = 64/241 (26%), Positives = 108/241 (44%), Gaps = 10/241 (4%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRN 374
E ++ +G G +G V+ VA+K L S E+F EA+++ ++RH
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP---GTMSPEAFLQEAQVMKKLRHEK 73
Query: 375 IVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHH 434
+V+LY E ++++ EYM GSL L+ E L + V++ +A ++Y+
Sbjct: 74 LVQLYAVVSEEP-IYIVTEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 435 HCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN-YDSSNRTLLAGTYGSIAPELAYT 493
+HRD+ + NIL+ VADFG+ARL+ + + R APE A
Sbjct: 132 MN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 188
Query: 494 MVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDL-LDPRLPPPGDQMIR 552
T K DV+SFG++ E+ + LD+ + + P P ++
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC 248
Query: 553 Q 553
Q
Sbjct: 249 Q 249
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 173 bits (439), Expect = 3e-50
Identities = 63/248 (25%), Positives = 106/248 (42%), Gaps = 20/248 (8%)
Query: 314 TEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHR-LETELASLESFQNEARLLSQIR 371
+ F IG G +G+VY AR + + +VVA+KK+ + + E R L ++R
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 372 HRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSY 431
H N ++ G L E +L+ EY + + + L + + G L+Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAY 130
Query: 432 LHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELA 491
LH H ++HRD+ + NILL+ + DFG A ++ +S GT +APE+
Sbjct: 131 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS----FVGTPYWMAPEVI 183
Query: 492 YTM---VVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNI---KLIDLLDPRLPP 545
M K DV+S G+ +E+ K P L + ++ S +I + L
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPP--LFNMNAMSALYHIAQNESPALQSGHWSE 241
Query: 546 PGDQMIRQ 553
+
Sbjct: 242 YFRNFVDS 249
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 3e-50
Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 13/205 (6%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRN 374
++ + IG G +G V G VA+K + T ++F EA +++Q+RH N
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA----QAFLAEASVMTQLRHSN 61
Query: 375 IVKLYGFCLHEK-CMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLH 433
+V+L G + EK ++++ EYM GSL LR+ +V L + + A+ YL
Sbjct: 62 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLE 120
Query: 434 HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYT 493
+ +HRD+++ N+L++ + A V+DFG+ + SS + APE
Sbjct: 121 GN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALRE 174
Query: 494 MVVTEKYDVYSFGVVALEVLMGKHP 518
+ K DV+SFG++ E+
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRV 199
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 172 bits (437), Expect = 4e-50
Identities = 78/262 (29%), Positives = 121/262 (46%), Gaps = 31/262 (11%)
Query: 306 TFQDMIEATEDFD---------IKYCIGTGGYGSVYRARLPS----GKVVALKKLHRLET 352
TF+D EA +F I+ IG G +G V L VA+K L T
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 353 ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVG 412
E F +EA ++ Q H N++ L G + +I E+ME GSL LR ++
Sbjct: 68 E-KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 413 LDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472
+ V +++G+A + YL +HRD+++ NIL+NS V+DFG++R L D
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 473 SSNRTLLA-----GTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSS 526
+S+ T + APE T DV+S+G+V EV+ G+ P ++
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT--- 238
Query: 527 SSLDKNIKLIDLLDPRLPPPGD 548
++++ D RLPPP D
Sbjct: 239 ---NQDVINAIEQDYRLPPPMD 257
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 4e-50
Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 13/211 (6%)
Query: 314 TEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRH 372
+ ++I +G G +G VY+A+ + + A K + E LE + E +L+ H
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE--ELEDYMVEIDILASCDH 68
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYL 432
NIVKL +E ++++ E+ G++ ++ E L ++ + K AL+YL
Sbjct: 69 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYL 126
Query: 433 HHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAY 492
H + I+HRD+ + NIL + + +ADFG++ R GT +APE+
Sbjct: 127 HDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM 183
Query: 493 TMV-----VTEKYDVYSFGVVALEVLMGKHP 518
K DV+S G+ +E+ + P
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPP 214
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 1e-49
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 317 FDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNI 375
FDI+ IG G + +VY+ + VA +L + + + F+ EA +L ++H NI
Sbjct: 13 FDIE--IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 376 VKLYGFCL----HEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSY 431
V+ Y +KC+ L+ E M G+L L+ + + + + + L +
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQF 127
Query: 432 LHHHCTPPILHRDISSNNILLNSE-FEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPEL 490
LH PPI+HRD+ +NI + + D G+A L +S + GT +APE+
Sbjct: 128 LHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK--RASFAKAVIGTPEFMAPEM 184
Query: 491 AYTMVVTEKYDVYSFGVVALEVLMGKHP 518
Y E DVY+FG+ LE+ ++P
Sbjct: 185 -YEEKYDESVDVYAFGMCMLEMATSEYP 211
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 2e-49
Identities = 57/244 (23%), Positives = 104/244 (42%), Gaps = 13/244 (5%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLH-RLETELASLESFQNEARLLSQIRH 372
EDF +G G + +V AR L + + A+K L R + + E ++S++ H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYL 432
VKLY ++ ++ Y + G L +R D T + AL YL
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYL 124
Query: 433 HHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTL--LAGTYGSIAPEL 490
H I+HRD+ NILLN + + DFG A++L+ +S GT ++PEL
Sbjct: 125 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 491 AYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDL-LDPRLPPPGDQ 549
+ D+++ G + +++ G P + + + + I ++ + P
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLPPFR--AGNEYLIFQKIIKLEYDFPEKFFPKARD 239
Query: 550 MIRQ 553
++ +
Sbjct: 240 LVEK 243
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 170 bits (431), Expect = 1e-48
Identities = 59/247 (23%), Positives = 108/247 (43%), Gaps = 18/247 (7%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHR 373
+ +DI +GTG +G V+R +G A K + + E+ + E + +S +RH
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHP 83
Query: 374 NIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLH 433
+V L+ + M +IYE+M G LF + +E + + V ++ + L ++H
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA--DEHNKMSEDEAVEYMRQVCKGLCHMH 141
Query: 434 HHCTPPILHRDISSNNILLNSEFEAFV--ADFGIARLLNYDSSNRTLLAGTYGSIAPELA 491
+ +H D+ NI+ ++ + DFG+ L+ S + GT APE+A
Sbjct: 142 ENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV-TTGTAEFAAPEVA 197
Query: 492 YTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIK-----LIDLLDPRLPPP 546
V D++S GV++ +L G P + +N+K + D +
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSP--FGGENDDETLRNVKSCDWNMDDSAFSGISED 255
Query: 547 GDQMIRQ 553
G IR+
Sbjct: 256 GKDFIRK 262
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 169 bits (429), Expect = 3e-48
Identities = 55/236 (23%), Positives = 100/236 (42%), Gaps = 13/236 (5%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHR 373
+ +DI +G+G +G V+R +G+V K ++ + +NE +++Q+ H
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT--PYPLDKYTVKNEISIMNQLHHP 86
Query: 374 NIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLH 433
++ L+ + M LI E++ G LF + E + + +N ++ L ++H
Sbjct: 87 KLINLHDAFEDKYEMVLILEFLSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMH 144
Query: 434 HHCTPPILHRDISSNNILLNSEFEAFV--ADFGIARLLNYDSSNRTLLAGTYGSIAPELA 491
H I+H DI NI+ ++ + V DFG+A LN D + T APE+
Sbjct: 145 EH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV-TTATAEFAAPEIV 200
Query: 492 YTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRLPPPG 547
V D+++ GV+ +L G P +N+K D
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSP--FAGEDDLETLQNVKRCDWEFDEDAFSS 254
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 1e-47
Identities = 62/265 (23%), Positives = 101/265 (38%), Gaps = 30/265 (11%)
Query: 315 EDFDIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRLETELASLESFQNEARLLS 368
+G G +G V A + VA+K L L E+ +E ++LS
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP-SAHLTEREALMSELKVLS 81
Query: 369 QI-RHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILR---------------TDEEAVG 412
+ H NIV L G C +I EY G L LR +++ +
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 413 LDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472
LD ++ +A +++L +HRD+++ NILL + DFG+AR + D
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKND 198
Query: 473 SSN--RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLD 530
S+ + +APE + V T + DV+S+G+ E+ S
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 531 KNIK--LIDLLDPRLPPPGDQMIRQ 553
K IK L P +++
Sbjct: 259 KMIKEGFRMLSPEHAPAEMYDIMKT 283
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 165 bits (419), Expect = 1e-47
Identities = 62/234 (26%), Positives = 104/234 (44%), Gaps = 14/234 (5%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHR 373
D +K+ +G G YG VY VA+K L + +E F EA ++ +I+H
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHP 73
Query: 374 NIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLH 433
N+V+L G C E ++I E+M G+L LR + + + + ++ A+ YL
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEYLE 132
Query: 434 HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNR-TLLAGTYGSIAPELAY 492
+HRD+++ N L+ VADFG++RL+ D+ APE
Sbjct: 133 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 189
Query: 493 TMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRLPPP 546
+ K DV++FGV+ E+ L + +L++ D R+ P
Sbjct: 190 YNKFSIKSDVWAFGVLLWEIATYGMS----PYPGIDLSQVYELLE-KDYRMERP 238
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 2e-47
Identities = 56/219 (25%), Positives = 98/219 (44%), Gaps = 15/219 (6%)
Query: 308 QDMIEATEDFDI-KYCIGTGGYGSVYRARL---PSGKVVALKKLHRLETELASLESFQNE 363
+ + ++ I +G G +GSV + VA+K L + TE A E E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQ-GTEKADTEEMMRE 59
Query: 364 ARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVK 423
A+++ Q+ + IV+L G C + + L+ E G L L E + + ++
Sbjct: 60 AQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLH 116
Query: 424 GMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSN---RTLLA 480
++ + YL +HRD+++ N+LL + A ++DFG+++ L D S R+
Sbjct: 117 QVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 481 GTYGSIAPELAYTMVVTEKYDVYSFGVVALEVL-MGKHP 518
APE + + DV+S+GV E L G+ P
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 212
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 3e-47
Identities = 52/202 (25%), Positives = 93/202 (46%), Gaps = 13/202 (6%)
Query: 323 IGTGGYGSVYRARLP---SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLY 379
+G+G +G+V + K VA+K L + A + EA ++ Q+ + IV++
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 380 GFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPP 439
G C E M L+ E E+G L L+ + + + +V ++ + YL
Sbjct: 75 GICEAESWM-LVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN--- 127
Query: 440 ILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSN---RTLLAGTYGSIAPELAYTMVV 496
+HRD+++ N+LL ++ A ++DFG+++ L D + +T APE
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 187
Query: 497 TEKYDVYSFGVVALEVLMGKHP 518
+ K DV+SFGV+ E
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQK 209
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 1e-46
Identities = 59/262 (22%), Positives = 110/262 (41%), Gaps = 39/262 (14%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPS------GKVVALKKLHRLETELASLESFQNEARLLS 368
E+ + +G+G +G V A VA+K L + + + E+ +E ++++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE-KADSSEREALMSELKMMT 95
Query: 369 QI-RHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRT--------------------D 407
Q+ H NIV L G C ++LI+EY G L LR+ +
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 408 EEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIAR 467
E+ L + + +A + +L +HRD+++ N+L+ + DFG+AR
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLAR 212
Query: 468 LLNYDSSNRTL--LAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVL-MGKHPGELLSS 524
+ DS+ +APE + + T K DV+S+G++ E+ +G +P
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP-----Y 267
Query: 525 SSSSLDKNIKLIDLLDPRLPPP 546
+D N + ++ P
Sbjct: 268 PGIPVDANFYKLIQNGFKMDQP 289
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 3e-46
Identities = 59/239 (24%), Positives = 102/239 (42%), Gaps = 14/239 (5%)
Query: 312 EATEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQI 370
E E + I +G G +G V+R S K K + T+ + E +L+
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ---VLVKKEISILNIA 58
Query: 371 RHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALS 430
RHRNI+ L+ + + +I+E++ +F + A L+ + V+ V + AL
Sbjct: 59 RHRNILHLHESFESMEELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQ 116
Query: 431 YLHHHCTPPILHRDISSNNILLNSEFEAFV--ADFGIARLLNYDSSNRTLLAGTYGSIAP 488
+LH H I H DI NI+ + + + +FG AR L + R L AP
Sbjct: 117 FLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-LFTAPEYYAP 172
Query: 489 ELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRLPPPG 547
E+ VV+ D++S G + +L G +P L+ ++ + +NI +
Sbjct: 173 EVHQHDVVSTATDMWSLGTLVYVLLSGINP--FLAETNQQIIENIMNAEYTFDEEAFKE 229
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (409), Expect = 4e-46
Identities = 60/233 (25%), Positives = 98/233 (42%), Gaps = 33/233 (14%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRLETELASLESFQNEARLLS 368
+ + IG G +G V++AR P +VA+K L E FQ EA L++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE-EASADMQADFQREAALMA 71
Query: 369 QIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILR---------------------TD 407
+ + NIVKL G C K M L++EYM G L LR +
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 408 EEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIAR 467
L +++ I + +A ++YL +HRD+++ N L+ +ADFG++R
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSR 188
Query: 468 LLNYDSSNR--TLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHP 518
+ + A + PE + T + DV+++GVV E+
Sbjct: 189 NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 6e-46
Identities = 57/243 (23%), Positives = 105/243 (43%), Gaps = 12/243 (4%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHR-LETELASLESFQNEARLLS-QIR 371
EDF + +G G +G V+ A + + A+K L + + +E E R+LS
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 372 HRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSY 431
H + ++ ++ +F + EY+ G L ++ D ++ + L +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQF 118
Query: 432 LHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELA 491
LH I++RD+ +NILL+ + +ADFG+ + + GT IAPE+
Sbjct: 119 LHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEIL 175
Query: 492 YTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPR-LPPPGDQM 550
D +SFGV+ E+L+G+ P L +I++ + PR L +
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSPFH--GQDEEELFHSIRMDNPFYPRWLEKEAKDL 233
Query: 551 IRQ 553
+ +
Sbjct: 234 LVK 236
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 9e-46
Identities = 60/263 (22%), Positives = 105/263 (39%), Gaps = 17/263 (6%)
Query: 295 EIAIWNYDGRITFQDMIEATEDFDIKY--CIGTGGYGSVYRARLPSGK----VVALKKLH 348
+++ N + Q ++ + + IG G +G VY L A+K L+
Sbjct: 5 DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 64
Query: 349 RLETELASLESFQNEARLLSQIRHRNIVKLYGFCLH-EKCMFLIYEYMEMGSLFCILRTD 407
R+ + F E ++ H N++ L G CL E ++ YM+ G L +R +
Sbjct: 65 RITDI-GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 123
Query: 408 EEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIAR 467
+ +A + + +HRD+++ N +L+ +F VADFG+AR
Sbjct: 124 TH--NPTVKDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178
Query: 468 LLN----YDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLS 523
+ N+T +A E T T K DV+SFGV+ E++ P
Sbjct: 179 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 238
Query: 524 SSSSSLDKNIKLIDLLDPRLPPP 546
++ ++ LL P P
Sbjct: 239 NTFDITVYLLQGRRLLQPEYCPD 261
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 3e-45
Identities = 60/245 (24%), Positives = 103/245 (42%), Gaps = 13/245 (5%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPS----GKVVALKKLHRLETELASLESFQNEARLLSQI 370
E ++ CIG G +G V++ S VA+K ++ + E F EA + Q
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD-SVREKFLQEALTMRQF 65
Query: 371 RHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALS 430
H +IVKL G E +++I E +G L LD + ++ AL+
Sbjct: 66 DHPHIVKLIGVI-TENPVWIIMELCTLGELRSF--LQVRKYSLDLASLILYAYQLSTALA 122
Query: 431 YLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNR-TLLAGTYGSIAPE 489
YL +HRDI++ N+L++S + DFG++R + + + + +APE
Sbjct: 123 YLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179
Query: 490 LAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDL-LDPRLPPPGD 548
T DV+ FGV E+LM ++ + + L + P PP
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 239
Query: 549 QMIRQ 553
++ +
Sbjct: 240 SLMTK 244
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 4e-45
Identities = 59/243 (24%), Positives = 101/243 (41%), Gaps = 20/243 (8%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPS----GKVVALKKLHR-LETELASLESFQNEARLLSQ 369
+D + +G G +G V R + VA+K L + ++ +++ F E +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 370 IRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHAL 429
+ HRN+++LYG M ++ E +GSL LR + L R +A +
Sbjct: 68 LDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGM 124
Query: 430 SYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSN---RTLLAGTYGSI 486
YL +HRD+++ N+LL + + DFG+ R L + + + +
Sbjct: 125 GYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 487 APELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSSSSLDKNIKLIDLLDPRLPP 545
APE T + D + FGV E+ G+ P + + + ID RLP
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI-----GLNGSQILHKIDKEGERLPR 236
Query: 546 PGD 548
P D
Sbjct: 237 PED 239
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 5e-45
Identities = 58/249 (23%), Positives = 101/249 (40%), Gaps = 22/249 (8%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSG---KVVALKKLHRLETELASLESFQNEARLLSQI- 370
D + IG G +G V +AR+ A+K++ ++ F E +L ++
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCKLG 68
Query: 371 RHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILR-------------TDEEAVGLDWTK 417
H NI+ L G C H ++L EY G+L LR + A L +
Sbjct: 69 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128
Query: 418 RVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRT 477
++ +A + YL +HRD+++ NIL+ + A +ADFG++R +T
Sbjct: 129 LLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYVKKT 184
Query: 478 LLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLID 537
+ +A E V T DV+S+GV+ E++ + + +K +
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 244
Query: 538 LLDPRLPPP 546
L P
Sbjct: 245 LEKPLNCDD 253
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (402), Expect = 5e-45
Identities = 54/244 (22%), Positives = 100/244 (40%), Gaps = 9/244 (3%)
Query: 314 TEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRH 372
+ +D + +GTG + V A + K+VA+K + + E S +NE +L +I+H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKH 66
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYL 432
NIV L ++LI + + G LF + E ++ + A+ YL
Sbjct: 67 PNIVALDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYL 123
Query: 433 HHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAY 492
H + + L+ + + ++DFG++++ + S T GT G +APE+
Sbjct: 124 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST-ACGTPGYVAPEVLA 182
Query: 493 TMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSS---SSLDKNIKLIDLLDPRLPPPGDQ 549
++ D +S GV+A +L G P + + L + +
Sbjct: 183 QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKD 242
Query: 550 MIRQ 553
IR
Sbjct: 243 FIRH 246
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 157 bits (398), Expect = 3e-44
Identities = 63/242 (26%), Positives = 108/242 (44%), Gaps = 14/242 (5%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHR-LETELASLESFQNEARLLSQIRH 372
+DF I +GTG +G V+ R +G+ A+K L + + L +E +E +LS + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYL 432
I++++G + +F+I +Y+E G LF +LR A L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS------QRFPNPVAKFYAAEVCLAL 117
Query: 433 HHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAY 492
+ + I++RD+ NILL+ + DFG A+ + L GT IAPE+
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP---DVTYTLCGTPDYIAPEVVS 174
Query: 493 TMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDL-LDPRLPPPGDQMI 551
T + D +SFG++ E+L G P S++ + I +L P ++
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYTP--FYDSNTMKTYEKILNAELRFPPFFNEDVKDLL 232
Query: 552 RQ 553
+
Sbjct: 233 SR 234
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 156 bits (395), Expect = 3e-44
Identities = 64/243 (26%), Positives = 112/243 (46%), Gaps = 17/243 (6%)
Query: 314 TEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHR-LETELASLESFQNEARLLSQIR 371
++ +++ +G GG V+ AR L + VA+K L L + + F+ EA+ + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 372 HRNIVKLYGFCLHE----KCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAH 427
H IV +Y E +++ EY++ +L I+ T+ + + + ++
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQ 122
Query: 428 ALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTL---LAGTYG 484
AL++ H + I+HRD+ NI++++ V DFGIAR + ++ T + GT
Sbjct: 123 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 485 SIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRLP 544
++PE A V + DVYS G V EVL G+ P S S+ D + P
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP--FTGDSPVSVAYQHVREDPIPPSAR 237
Query: 545 PPG 547
G
Sbjct: 238 HEG 240
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 4e-44
Identities = 69/240 (28%), Positives = 106/240 (44%), Gaps = 21/240 (8%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSG-----KVVALKKLHRLETELASLESFQNEARLLSQ 369
+ IG G +G VY+ L + VA+K L TE F EA ++ Q
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-KQRVDFLGEAGIMGQ 65
Query: 370 IRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHAL 429
H NI++L G K M +I EYME G+L LR E+ + V +++G+A +
Sbjct: 66 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR--EKDGEFSVLQLVGMLRGIAAGM 123
Query: 430 SYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSI--- 486
+ +HRD+++ NIL+NS V+DFG++R+L D +G I
Sbjct: 124 ---KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 487 APELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRLPPP 546
APE T DV+SFG+V EV+ S N +++ ++ P
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-------NHEVMKAINDGFRLP 233
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 5e-44
Identities = 57/262 (21%), Positives = 96/262 (36%), Gaps = 39/262 (14%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRN 374
++ IG G +G V+R + G+ VA+K E + E +RH N
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS---WFREAEIYQTVMLRHEN 58
Query: 375 IVKLYGFCLHE----KCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALS 430
I+ + ++L+ +Y E GSLF L + + + A L+
Sbjct: 59 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLA 114
Query: 431 YLHHHC-----TPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSN----RTLLAG 481
+LH P I HRD+ S NIL+ +AD G+A + + G
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 482 TYGSIAPELAYTMV------VTEKYDVYSFGVVALEVLMGKHPGE------------LLS 523
T +APE+ + ++ D+Y+ G+V E+ G + S
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234
Query: 524 SSSSSLDKNIKLIDLLDPRLPP 545
S + + L P +P
Sbjct: 235 DPSVEEMRKVVCEQKLRPNIPN 256
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 153 bits (387), Expect = 3e-43
Identities = 56/257 (21%), Positives = 102/257 (39%), Gaps = 25/257 (9%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASL-------ESFQNEARL 366
E+++ K +G G V R P+ K A+K + S E+ E +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 367 LSQIR-HRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGM 425
L ++ H NI++L FL+++ M+ G LF L E V L + I++ +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRAL 119
Query: 426 AHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGS 485
+ LH I+HRD+ NILL+ + + DFG + L+ + GT
Sbjct: 120 LEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLD-PGEKLREVCGTPSY 175
Query: 486 IAPELAYTMVV------TEKYDVYSFGVVALEVLMGKHP---GELLSSSSSSLDKNIKLI 536
+APE+ + ++ D++S GV+ +L G P + + + N +
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG 235
Query: 537 DLLDPRLPPPGDQMIRQ 553
++ +
Sbjct: 236 SPEWDDYSDTVKDLVSR 252
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 1e-42
Identities = 50/242 (20%), Positives = 98/242 (40%), Gaps = 18/242 (7%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHR----LETELASLESFQNEARLLSQ 369
+ +D +G+G + V + R +G A K + + S E + E +L +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 370 IRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHAL 429
I+H N++ L+ ++ + LI E + G LF L E L + + L
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEF---LKQIL 123
Query: 430 SYLHHHCTPPILHRDISSNNILLNSE----FEAFVADFGIARLLNYDSSNRTLLAGTYGS 485
+ +++ + I H D+ NI+L + DFG+A +++ + + GT
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEF 182
Query: 486 IAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRLPP 545
+APE+ + + D++S GV+ +L G P L + N+ ++
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP--FLGDTKQETLANVSAVNYEFEDEYF 240
Query: 546 PG 547
Sbjct: 241 SN 242
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 152 bits (384), Expect = 8e-42
Identities = 46/246 (18%), Positives = 86/246 (34%), Gaps = 14/246 (5%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESF----QNEARLLSQ 369
DF + IG GG+G VY R +GK+ A+K L + ++ E+ + L+S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 370 IRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHAL 429
IV + + I + M G L L + L
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF---SEADMRFYAAEIILGL 120
Query: 430 SYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPE 489
++H+ +++RD+ NILL+ ++D G+A + + ++ Y +
Sbjct: 121 EHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAP-EV 176
Query: 490 LAYTMVVTEKYDVYSFGVVALEVLMGKHP--GELLSSSSSSLDKNIKLIDLLDPRLPPPG 547
L + D +S G + ++L G P + + L P
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 236
Query: 548 DQMIRQ 553
++
Sbjct: 237 RSLLEG 242
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 148 bits (375), Expect = 2e-41
Identities = 51/205 (24%), Positives = 94/205 (45%), Gaps = 7/205 (3%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRN 374
E + IG G YG VY+A+ G+ ALKK+ + + + E +L +++H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 375 IVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHH 434
IVKLY +K + L++E+++ + + GL+ + + + + ++Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHD 118
Query: 435 HCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNR-TLLAGTYGSIAPELAYT 493
+LHRD+ N+L+N E E +ADFG+AR + + L +
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 494 MVVTEKYDVYSFGVVALEVLMGKHP 518
+ D++S G + E++ G
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPL 200
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 3e-41
Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 7/206 (3%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHR 373
E+F IG G YG VY+AR +G+VVALKK+ + E LL ++ H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 374 NIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLH 433
NIVKL E ++L++E++ + + G+ + + + L++ H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALT--GIPLPLIKSYLFQLLQGLAFCH 119
Query: 434 HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPE-LAY 492
H +LHRD+ N+L+N+E +ADFG+AR T T APE L
Sbjct: 120 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 493 TMVVTEKYDVYSFGVVALEVLMGKHP 518
+ D++S G + E++ +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRAL 202
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 3e-41
Identities = 54/242 (22%), Positives = 96/242 (39%), Gaps = 11/242 (4%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHR-LETELASLESFQNEARLLSQIRH 372
DFD +G G +G V R +G+ A+K L + + + E+R+L RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYL 432
+ L + + EY G LF L + + A +S L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER---VFTEERARFY---GAEIVSAL 118
Query: 433 HHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAY 492
+ + +++RDI N++L+ + + DFG+ + D + GT +APE+
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 493 TMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPR-LPPPGDQMI 551
D + GVV E++ G+ P + L + I + ++ PR L P ++
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHERLFELILMEEIRFPRTLSPEAKSLL 236
Query: 552 RQ 553
Sbjct: 237 AG 238
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 5e-41
Identities = 48/210 (22%), Positives = 94/210 (44%), Gaps = 12/210 (5%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALK---KLHRLETELASLESFQNEARLLSQI 370
+F +G+G +G+VY+ +P G+ V + K R T + + +EA +++ +
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 371 RHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALS 430
+ ++ +L G CL + LI + M G L E + +N +A ++
Sbjct: 69 DNPHVCRLLGICLTST-VQLITQLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMN 125
Query: 431 YLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTL--LAGTYGSIAP 488
YL ++HRD+++ N+L+ + + DFG+A+LL + +A
Sbjct: 126 YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 489 ELAYTMVVTEKYDVYSFGVVALEVLMGKHP 518
E + T + DV+S+GV E++
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGSK 212
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 1e-40
Identities = 52/211 (24%), Positives = 88/211 (41%), Gaps = 17/211 (8%)
Query: 316 DFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRN 374
+ IG G +G VY+A+L SG++VA+KK+ + E +++ ++ H N
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCN 74
Query: 375 IVKLYGFCLH------EKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHA 428
IV+L F E + L+ +Y+ L + + +
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 429 LSYLHHHCTPPILHRDISSNNILLNSEFEAF-VADFGIARLLNYDSSNRTLLAGTYGSIA 487
L+Y+H I HRDI N+LL+ + + DFG A+ L N + + Y
Sbjct: 135 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 191
Query: 488 PELAYTMVVTEKYDVYSFGVVALEVLMGKHP 518
+ T DV+S G V E+L+G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 1e-40
Identities = 50/219 (22%), Positives = 89/219 (40%), Gaps = 19/219 (8%)
Query: 315 EDFDIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRLETELASLESFQNEARLLS 368
E + +G G +G VY VA+K ++ + F NEA ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE-AASMRERIEFLNEASVMK 78
Query: 369 QIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVG-------LDWTKRVNI 421
+ ++V+L G + +I E M G L LR+ A+ +K + +
Sbjct: 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 422 VKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNR--TLL 479
+A ++YL+ + +HRD+++ N ++ +F + DFG+ R + R
Sbjct: 139 AGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195
Query: 480 AGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHP 518
++PE V T DV+SFGVV E+
Sbjct: 196 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 234
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 3e-40
Identities = 55/201 (27%), Positives = 96/201 (47%), Gaps = 11/201 (5%)
Query: 323 IGTGGYGSVYRAR-LPSGKVVALKKL---HRLETELASLESFQNEARLLSQIRHRNIVKL 378
+G G + +VY+AR + ++VA+KK+ HR E + + E +LL ++ H NI+ L
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 379 YGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTP 438
H+ + L++++ME I + ++ L + + L YLH H
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 120
Query: 439 PILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTM-VVT 497
ILHRD+ NN+LL+ +ADFG+A+ + T T APEL + +
Sbjct: 121 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179
Query: 498 EKYDVYSFGVVALEVLMGKHP 518
D+++ G + E+L+
Sbjct: 180 VGVDMWAVGCILAELLLRVPF 200
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (357), Expect = 7e-39
Identities = 48/238 (20%), Positives = 99/238 (41%), Gaps = 8/238 (3%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHR 373
+ ++ IG G YG+V++A+ + ++VALK++ + + S E LL +++H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 374 NIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLH 433
NIV+L+ +K + L++E+ + + + + L L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLG 115
Query: 434 HHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGT-YGSIAPELAY 492
+ +LHRD+ N+L+N E +A+FG+AR + T + L
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 493 TMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRLPPPGDQM 550
+ + D++S G + E+ P + L + +L+ P ++
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 8e-39
Identities = 53/228 (23%), Positives = 94/228 (41%), Gaps = 28/228 (12%)
Query: 315 EDFDIKYCIGTGGYGSVYRARLPS--------GKVVALKKLHRLETELASLESFQNEARL 366
+ + +G G +G V A VA+K L TE L +E +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEM 71
Query: 367 LSQI-RHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILR-------------TDEEAVG 412
+ I +H+NI+ L G C + +++I EY G+L L+ +
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 413 LDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472
L V+ +A + YL +HRD+++ N+L+ + +ADFG+AR +++
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 473 SSNRTLLA--GTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHP 518
+ +APE + + T + DV+SFGV+ E+
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS 236
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 1e-38
Identities = 65/257 (25%), Positives = 111/257 (43%), Gaps = 17/257 (6%)
Query: 313 ATEDFDIKYCIGTGGYGSVYRAR--LPSGKVVALKKLHRLETELASLESFQNEA---RLL 367
A + ++ IG G YG V++AR G+ VALK++ E S E R L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 368 SQIRHRNIVKLYGFCL-----HEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIV 422
H N+V+L+ C E + L++E+++ + + E G+ +++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP--GVPTETIKDMM 122
Query: 423 KGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGT 482
+ L +LH H ++HRD+ NIL+ S + +ADFG+AR+ ++ + + + T
Sbjct: 123 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS-VVVT 178
Query: 483 YGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPR 542
APE+ D++S G + E+ K SS L K + +I L
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR-GSSDVDQLGKILDVIGLPGEE 237
Query: 543 LPPPGDQMIRQGIILIS 559
P + RQ S
Sbjct: 238 DWPRDVALPRQAFHSKS 254
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 2e-38
Identities = 54/247 (21%), Positives = 94/247 (38%), Gaps = 23/247 (9%)
Query: 316 DFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRL----ETELASLESFQNEARLLSQI 370
+ + +G+GG+GSVY + VA+K + + EL + E LL ++
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 371 R--HRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHA 428
+++L + LI E E T+ L + + A
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEA 122
Query: 429 LSYLHHHCTPPILHRDISSNNILLN-SEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIA 487
+ + H+ +LHRDI NIL++ + E + DFG LL + T GT
Sbjct: 123 VRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSP 177
Query: 488 PE-LAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRLPPP 546
PE + Y V+S G++ +++ G P E ++ I+ R+
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE-------HDEEIIRGQVFFRQRVSSE 230
Query: 547 GDQMIRQ 553
+IR
Sbjct: 231 CQHLIRW 237
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 3e-38
Identities = 48/214 (22%), Positives = 86/214 (40%), Gaps = 9/214 (4%)
Query: 310 MIEATEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLS 368
+ + + IG G YG V A + VA+KK+ E + + E ++L
Sbjct: 3 VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ-TYCQRTLREIKILL 61
Query: 369 QIRHRNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHA 428
+ RH NI+ + + Y+ + L + L + +
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRG 121
Query: 429 LSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTL---LAGTYGS 485
L Y+H +LHRD+ +N+LLN+ + + DFG+AR+ + D + T
Sbjct: 122 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 486 IAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHP 518
APE+ T+ D++S G + E+L +
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 212
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 5e-37
Identities = 53/245 (21%), Positives = 94/245 (38%), Gaps = 24/245 (9%)
Query: 315 EDFDI-KYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQI-R 371
+D+ + +G G G V + + + ALK L + E L + +
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-------KARREVELHWRASQ 63
Query: 372 HRNIVKLYGFC----LHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAH 427
+IV++ KC+ ++ E ++ G LF ++ D + I+K +
Sbjct: 64 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIGE 122
Query: 428 ALSYLHHHCTPPILHRDISSNNILLNSEFE---AFVADFGIARLLNYDSSNRTLLAGTYG 484
A+ YLH I HRD+ N+L S+ + DFG A+ +S T T
Sbjct: 123 AIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP-CYTPY 178
Query: 485 SIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHP--GELLSSSSSSLDKNIKLIDLLDPR 542
+APE+ + D++S GV+ +L G P + S + I++ P
Sbjct: 179 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 238
Query: 543 LPPPG 547
Sbjct: 239 PEWSE 243
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 138 bits (348), Expect = 5e-37
Identities = 54/233 (23%), Positives = 93/233 (39%), Gaps = 16/233 (6%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHR-LETELASLESFQNEARLLSQIRH 372
+ FD +GTG +G V + SG A+K L + +L +E NE R+L +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 373 RNIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYL 432
+VKL ++++ EY+ G +F LR + YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 433 HHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAY 492
H +++RD+ N+L++ + V DFG A+ L GT ++APE+
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWTLCGTPEALAPEIIL 211
Query: 493 TMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRLPP 545
+ + D ++ GV+ E+ G P + + + I R P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP-----FFADQPIQIYEKIVSGKVRFPS 259
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 6e-37
Identities = 56/261 (21%), Positives = 95/261 (36%), Gaps = 27/261 (10%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR------LPSGKVVALKKLHRLETELASLESFQNEARLLS 368
+ + +G G +G V A + + VA+K L T L+
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 369 QIRHRNIVKLYGFCLHE-KCMFLIYEYMEMGSLFCILRT-------------DEEAVGLD 414
H N+V L G C + +I E+ + G+L LR+ D L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 415 WTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474
+ +A + +L +HRD+++ NILL+ + + DFG+AR + D
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 475 N--RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKN 532
+ +APE + V T + DV+SFGV+ E+ +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249
Query: 533 IKLIDLLDPRLPPPGDQMIRQ 553
+K + R P + Q
Sbjct: 250 LK--EGTRMRAPDYTTPEMYQ 268
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 7e-36
Identities = 58/241 (24%), Positives = 100/241 (41%), Gaps = 17/241 (7%)
Query: 315 EDFDIKYCIGTGGYGSVYRARL----PSGKVVALKKLHR--LETELASLESFQNEARLLS 368
E+F++ +GTG YG V+ R +GK+ A+K L + + + + E + E ++L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 369 QIRHR-NIVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAH 427
IR +V L+ E + LI +Y+ G LF L + + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR------ERFTEHEVQIYVGE 137
Query: 428 ALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGT---YG 484
+ L H I++RDI NILL+S + DFG+++ D + R Y
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197
Query: 485 SIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRLP 544
+ + D +S GV+ E+L G P + +S + + I +P P
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT-VDGEKNSQAEISRRILKSEPPYP 256
Query: 545 P 545
Sbjct: 257 Q 257
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 133 bits (336), Expect = 7e-36
Identities = 36/242 (14%), Positives = 83/242 (34%), Gaps = 24/242 (9%)
Query: 317 FDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNI 375
+ + IG+G +G +Y + +G+ VA+K E+++ ++
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVG 64
Query: 376 VKLYGFCLHEK-CMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHH 434
+ +C E ++ E + + + + M + Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYIHS 121
Query: 435 HCTPPILHRDISSNNILLNSE---FEAFVADFGIARLLNYDSSN-------RTLLAGTYG 484
+HRD+ +N L+ ++ DFG+A+ ++ L GT
Sbjct: 122 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 485 SIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRLP 544
+ + + + D+ S G V + +G P + +++ + + I P
Sbjct: 179 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ--GLKAATKRQKYERISEKKMSTP 236
Query: 545 PP 546
Sbjct: 237 IE 238
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 1e-35
Identities = 54/253 (21%), Positives = 99/253 (39%), Gaps = 25/253 (9%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHR 373
++ IG G +G V++AR +G+ VALKK+ + + E ++L ++H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 374 NIVKLYGFCL--------HEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGM 425
N+V L C + ++L++++ E + + L KRV M
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRV-----M 123
Query: 426 AHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS----NRTLLAG 481
L+ L++ ILHRD+ + N+L+ + +ADFG+AR + + T
Sbjct: 124 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 482 TYGSIAPE-LAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLD 540
T PE L D++ G + E+ ++ + LI L
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI-----MQGNTEQHQLALISQLC 238
Query: 541 PRLPPPGDQMIRQ 553
+ P +
Sbjct: 239 GSITPEVWPNVDN 251
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 132 bits (332), Expect = 3e-35
Identities = 38/244 (15%), Positives = 81/244 (33%), Gaps = 26/244 (10%)
Query: 317 FDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRN- 374
+ + IG G +G ++ L + + VA+K R ++E R +
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTG 62
Query: 375 IVKLYGFCLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHH 434
I +Y F L+ + + + + K M + +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK---FSVKTVAMAAKQMLARVQSIHE 119
Query: 435 HCTPPILHRDISSNNILLNSEF-----EAFVADFGIARLLNYDSSN-------RTLLAGT 482
+++RDI +N L+ +V DFG+ + + + L+GT
Sbjct: 120 KS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
Query: 483 YGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPR 542
++ + + D+ + G V + L G P + +++ + + I
Sbjct: 177 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ--GLKAATNKQKYERIGEKKQS 234
Query: 543 LPPP 546
P
Sbjct: 235 TPLR 238
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 130 bits (328), Expect = 2e-34
Identities = 42/226 (18%), Positives = 90/226 (39%), Gaps = 24/226 (10%)
Query: 299 WNYDG-RITFQDMIEATEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELAS 356
W+Y+ + + + +D+ + +G G Y V+ A + + + V +K L
Sbjct: 22 WDYESHVVEWGNQ----DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VK 72
Query: 357 LESFQNEARLLSQIR-HRNIVKLYGFCLH--EKCMFLIYEYMEMGSLFCILRTDEEAVGL 413
+ + E ++L +R NI+ L + L++E++ + +T L
Sbjct: 73 KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------L 126
Query: 414 DWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEF-EAFVADFGIARLLNYD 472
+ + AL Y H I+HRD+ +N++++ E + + D+G+A +
Sbjct: 127 TDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183
Query: 473 SSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHP 518
+A Y L + D++S G + ++ K P
Sbjct: 184 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 2e-34
Identities = 52/209 (24%), Positives = 88/209 (42%), Gaps = 7/209 (3%)
Query: 312 EATEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQI 370
E + +G+G YG+V A +G VA+KKL+R + E RLL +
Sbjct: 15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 74
Query: 371 RHRNIVKLYGFCLHEKCMFLIYE-YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHAL 429
RH N++ L ++ + + Y+ M + L + L + +V M L
Sbjct: 75 RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGL 134
Query: 430 SYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIAPE 489
Y+H HRD+ N+ +N + E + DFG+AR DS + +
Sbjct: 135 RYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLAR--QADSEMTGYVVTRWYRAPEV 189
Query: 490 LAYTMVVTEKYDVYSFGVVALEVLMGKHP 518
+ M T+ D++S G + E++ GK
Sbjct: 190 ILNWMRYTQTVDIWSVGCIMAEMITGKTL 218
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 3e-34
Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 15/213 (7%)
Query: 312 EATEDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQI 370
E E + +G+G YGSV A +G VA+KKL R + + E RLL +
Sbjct: 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 371 RHRNIVKLYGFC-----LHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGM 425
+H N++ L L E + ++ L I++ L ++ +
Sbjct: 75 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQI 130
Query: 426 AHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGS 485
L Y+H HRD+ +N+ +N + E + DFG+AR + D +A +
Sbjct: 131 LRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYR 185
Query: 486 IAPELAYTMVVTEKYDVYSFGVVALEVLMGKHP 518
+ M + D++S G + E+L G+
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (326), Expect = 5e-34
Identities = 56/248 (22%), Positives = 95/248 (38%), Gaps = 18/248 (7%)
Query: 315 EDFDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHR 373
+ + IG+G G V A + VA+KKL R + E L+ + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 374 NIVKLYGFCLHEKCM------FLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAH 427
NI+ L +K + +L+ E M+ I D + ++ M
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQMLC 130
Query: 428 ALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTLLAGTYGSIA 487
+ +LH I+HRD+ +NI++ S+ + DFG+AR S T T A
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRA 186
Query: 488 PELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLIDLLDPRLPPPG 547
PE+ M E D++S G + E++ K +K I+ + P
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFP-GRDYIDQWNKVIEQLGTPCPEFMKKL 245
Query: 548 DQMIRQGI 555
+R +
Sbjct: 246 QPTVRNYV 253
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 108 bits (270), Expect = 2e-26
Identities = 47/257 (18%), Positives = 95/257 (36%), Gaps = 28/257 (10%)
Query: 317 FDIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNI 375
+ + +G G + +V+ A+ + + VA+K + + E+ ++E +LL ++ +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADN 71
Query: 376 VKLYGFCLHE---------------KCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVN 420
K + + +++E + L I + + + L + K+
Sbjct: 72 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ-- 129
Query: 421 IVKGMAHALSYLHHHCTPPILHRDISSNNILLNSE-FEAFVADFGIARLLNYDSSNRT-- 477
I K + L Y+H C I+H DI N+L+ + IA L N +
Sbjct: 130 ISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 187
Query: 478 LLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSSSSSLDKNIKLID 537
T +PE+ D++S + E++ G E S K+ I
Sbjct: 188 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE--PDEGHSYTKDDDHIA 245
Query: 538 LLDPRLPPPGDQMIRQG 554
+ L ++R G
Sbjct: 246 QIIELLGELPSYLLRNG 262
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 95.1 bits (235), Expect = 1e-21
Identities = 48/178 (26%), Positives = 80/178 (44%), Gaps = 14/178 (7%)
Query: 6 NLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRM 65
NL L L+ N TL L+ L L+L+ N + P + LT+LT L + +N++
Sbjct: 220 NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQI 275
Query: 66 NGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLT 125
+ + + L L L+L+ N++ P + +LK L + L N + P + LT
Sbjct: 276 SN--ISPLAGLTALTNLELNENQLEDISPIS--NLKNLTYLTLYFNNISDISP--VSSLT 329
Query: 126 QLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGN 183
+L L NNK+ L N + + L G+N +S P + L + L L+
Sbjct: 330 KLQRLFFANNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 83.5 bits (205), Expect = 6e-18
Identities = 53/215 (24%), Positives = 89/215 (41%), Gaps = 15/215 (6%)
Query: 15 NHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIG 74
+ L +L+ L+ L + N + P LT L L++ N++ + +
Sbjct: 183 SSNKVSDISVLAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD--IGTLA 238
Query: 75 SLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYN 134
SL L LDL+ N+I P L L L + L N++ P L LT LT L +
Sbjct: 239 SLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNE 294
Query: 135 NKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLG 194
N+L+ P N L L L N +S P + L +L L + N ++ S L
Sbjct: 295 NQLEDISPI--SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLA 348
Query: 195 EFSCIDTVDLSMNNLSGGIPVF-VRKVPHLDVSGN 228
+ I+ + N +S P+ + ++ L ++
Sbjct: 349 NLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 55.4 bits (132), Expect = 7e-09
Identities = 49/231 (21%), Positives = 80/231 (34%), Gaps = 25/231 (10%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAI 60
+ L NL ++ S+N P L L++L + ++ N + P TL
Sbjct: 62 VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFN 119
Query: 61 ASNRMNGSI---------------LLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRS 105
+ + I +L L L + L +L L
Sbjct: 120 NQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLER 179
Query: 106 VDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSI 165
+D+S NK+ + LT L +L NN++ P + L L L N L
Sbjct: 180 LDISSNKVSDISVLA--KLTNLESLIATNNQISDITPL--GILTNLDELSLNGNQLKD-- 233
Query: 166 PSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVF 216
+ L L LDL+ N I+ P L + + + L N +S P+
Sbjct: 234 IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLA 282
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 54.2 bits (129), Expect = 2e-08
Identities = 30/138 (21%), Positives = 50/138 (36%), Gaps = 7/138 (5%)
Query: 98 GHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLG 157
L L S+ + N++ P LT L L++ N+L L + + L L L
Sbjct: 194 AKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLA 249
Query: 158 NNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFV 217
NN +S P + L +L L L N I+ I G + + +
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISN-ISPLAGLTALTNLELNENQLEDISPISNL 306
Query: 218 RKVPHLDVSGNQFGGEIP 235
+ + +L + N P
Sbjct: 307 KNLTYLTLYFNNISDISP 324
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 1e-05
Identities = 50/246 (20%), Positives = 87/246 (35%), Gaps = 22/246 (8%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASN 63
L + L + I + L+ L +N S N L P + +LT+L + + +N
Sbjct: 43 LDQVTTLQADRLG-IKSIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNN 98
Query: 64 RMNGSILLGIGSLKVL------------QVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQN 111
++ L + + +L+ +T+ + L + Q
Sbjct: 99 QIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQ 158
Query: 112 KLVGPIPSSLGHLTQLTTLN-MYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIG 170
G + L L LTTL + + L + L L NN +S P I
Sbjct: 159 LSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL 218
Query: 171 KLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPV-FVRKVPHLDVSGNQ 229
L L L+GN + L + + +DL+ N +S P+ + K+ L + NQ
Sbjct: 219 T--NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQ 274
Query: 230 FGGEIP 235
P
Sbjct: 275 ISNISP 280
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 7e-05
Identities = 42/247 (17%), Positives = 78/247 (31%), Gaps = 48/247 (19%)
Query: 28 LSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRN 87
L+E L ++ + L Q+TTL + + G+ L L ++ S N
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNN 76
Query: 88 EIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTT------------------ 129
++ P L +L L + ++ N++ P + T
Sbjct: 77 QLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134
Query: 130 --LNMYNNKLDGPIPPELMNCSKLRILKLGNNLLS-----------------GSIPSQIG 170
L + +N + + + L S S +
Sbjct: 135 NRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA 194
Query: 171 KLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVF--VRKVPHLDVSGN 228
KL L L + N I+ P + + +D + L+ N L I + + LD++ N
Sbjct: 195 KLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLK-DIGTLASLTNLTDLDLANN 251
Query: 229 QFGGEIP 235
Q P
Sbjct: 252 QISNLAP 258
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 2e-04
Identities = 15/80 (18%), Positives = 32/80 (40%), Gaps = 6/80 (7%)
Query: 75 SLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYN 134
+L L + + ++ + L + ++ + + + +L LT +N N
Sbjct: 20 ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 75
Query: 135 NKLDGPIPPELMNCSKLRIL 154
N+L P L N +KL +
Sbjct: 76 NQLTDITP--LKNLTKLVDI 93
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 89.8 bits (222), Expect = 2e-21
Identities = 25/168 (14%), Positives = 57/168 (33%), Gaps = 26/168 (15%)
Query: 323 IGTGGYGSVYRARLPSGKVVALKKLHRLETELASL--------ESFQNEARLLSQIRHRN 374
+G G +V+ +K T + F A ++ R
Sbjct: 8 MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67
Query: 375 IVKLYGFCLHEKCMF----LIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALS 430
+ KL G + + + ++ E ++ L+ + ++ + ++
Sbjct: 68 LQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV----------RVENPDEVLDMILEEVA 117
Query: 431 YLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSNRTL 478
+H I+H D+S N+L+ SE ++ DF + + + L
Sbjct: 118 KFYHRG---IVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGWREIL 161
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 92.4 bits (228), Expect = 3e-21
Identities = 52/258 (20%), Positives = 85/258 (32%), Gaps = 13/258 (5%)
Query: 5 RNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNR 64
+ LDL +N L L L L N + P L +L L ++ N+
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 65 MNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDL--SQNKLVGPIPSSLG 122
+ L K LQ L + NEI S L + V+L + K G +
Sbjct: 91 LKE---LPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 147
Query: 123 HLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSG 182
+ +L+ + + + + IP L L L L N ++ + + L L L LS
Sbjct: 148 GMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSF 204
Query: 183 NFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVR--KVPHLDVSGNQFGGEIPTTLAN 240
N I+ L + + L+ N L + + + N
Sbjct: 205 NSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFC- 263
Query: 241 VPPPHHKTIATGLVAIIL 258
PP + T + L
Sbjct: 264 --PPGYNTKKASYSGVSL 279
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 83.2 bits (204), Expect = 4e-18
Identities = 50/210 (23%), Positives = 80/210 (38%), Gaps = 5/210 (2%)
Query: 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIA 61
L+NL L L +N P L +L+ L LS N L L +L
Sbjct: 52 KNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENE 111
Query: 62 SNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSL 121
++ S+ G+ + V++ L + + G +K L + ++ + IP L
Sbjct: 112 ITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAFQGMKKLSYIRIADTNI-TTIPQGL 169
Query: 122 GHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLS 181
LT L++ NK+ L + L L L N +S + L L L+
Sbjct: 170 --PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLN 227
Query: 182 GNFINGKIPSQLGEFSCIDTVDLSMNNLSG 211
N + K+P L + I V L NN+S
Sbjct: 228 NNKLV-KVPGGLADHKYIQVVYLHNNNISA 256
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 69.3 bits (168), Expect = 2e-13
Identities = 41/199 (20%), Positives = 73/199 (36%), Gaps = 13/199 (6%)
Query: 9 HLDLSDNHFMGHIPPTLGRLSELKILNL--SLNSLVGNIPSNVGHLTQLTTLAIASNRMN 66
L + +N L+++ ++ L + G + +L+ + IA +
Sbjct: 104 ELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 163
Query: 67 GSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQ 126
+ G L L L N+I ++L L L + LS N + SL +
Sbjct: 164 T---IPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPH 220
Query: 127 LTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSG------SIPSQIGKLQELYYLDL 180
L L++ NNKL +P L + ++++ L NN +S P K + L
Sbjct: 221 LRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSL 279
Query: 181 SGNFINGKIPSQLGEFSCI 199
N + Q F C+
Sbjct: 280 FSNPVQ-YWEIQPSTFRCV 297
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.7 bits (218), Expect = 4e-20
Identities = 46/241 (19%), Positives = 71/241 (29%), Gaps = 3/241 (1%)
Query: 5 RNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNR 64
+ L N + L IL L N L + L L L ++ N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 65 MNGSIL-LGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGH 123
S+ L L L L R + P L L+ + L N L +
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151
Query: 124 LTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGN 183
L LT L ++ N++ L L L N ++ P L L L L N
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211
Query: 184 FINGKIPSQLGEFSCIDTVDLSMNNLSGGIPV--FVRKVPHLDVSGNQFGGEIPTTLANV 241
++ L + + L+ N + S ++ +P LA
Sbjct: 212 NLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLAGR 271
Query: 242 P 242
Sbjct: 272 D 272
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.5 bits (181), Expect = 2e-15
Identities = 41/184 (22%), Positives = 65/184 (35%), Gaps = 3/184 (1%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAI 60
L L L L P L+ L+ L L N+L L LT L +
Sbjct: 101 FHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFL 160
Query: 61 ASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSS 120
NR++ L L L L +N + P L L ++ L N L +
Sbjct: 161 HGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEA 220
Query: 121 LGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIG--KLQELYYL 178
L L L L + +N + + L+ + ++ + S+P ++ L+ L
Sbjct: 221 LAPLRALQYLRLNDNPWVCDCRARPL-WAWLQKFRGSSSEVPCSLPQRLAGRDLKRLAAN 279
Query: 179 DLSG 182
DL G
Sbjct: 280 DLQG 283
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 84.8 bits (208), Expect = 1e-18
Identities = 66/263 (25%), Positives = 106/263 (40%), Gaps = 51/263 (19%)
Query: 2 GRLRNLVHLDLSDNHFMG--HIPPTLGRLSELKILNLSLN-SLVGNIPSNVGHLTQLTTL 58
+ + +LDLS + IP +L L L L + +LVG IP + LTQL L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 59 AIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIP 118
I ++G+I + +K L LD S N + G++P ++ L L + N++ G IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 119 SSLGHLTQLTT-LNMYNNKLDGPIPPELMNCSKLRILK---------------------- 155
S G ++L T + + N+L G IPP N + +
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKI 226
Query: 156 ------------------------LGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPS 191
L NN + G++P + +L+ L+ L++S N + G+IP
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286
Query: 192 QLGEFSCIDTVDLSMNNLSGGIP 214
G D + N G P
Sbjct: 287 -GGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 53.6 bits (127), Expect = 2e-08
Identities = 50/222 (22%), Positives = 86/222 (38%), Gaps = 5/222 (2%)
Query: 26 GRLSELKILNLSLNSLVGN--IPSNVGHLTQLTTLAIASN-RMNGSILLGIGSLKVLQVL 82
+ + L+LS +L IPS++ +L L L I + G I I L L L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 83 DLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIP 142
++ + G+IP L +K L ++D S N L G +P S+ L L + N++ G IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 143 PELMNCSKLR--ILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCID 200
+ SKL + N L P+ L + + + + +
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKI 226
Query: 201 TVDLSMNNLSGGIPVFVRKVPHLDVSGNQFGGEIPTTLANVP 242
+ + G + + LD+ N+ G +P L +
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLK 268
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 49.7 bits (117), Expect = 4e-07
Identities = 39/132 (29%), Positives = 62/132 (46%), Gaps = 3/132 (2%)
Query: 95 STLGHLKWLRSVDLSQNKLVG--PIPSSLGHLTQLTTLNMYNN-KLDGPIPPELMNCSKL 151
T + ++DLS L PIPSSL +L L L + L GPIPP + ++L
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 152 RILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSG 211
L + + +SG+IP + +++ L LD S N ++G +P + + + N +SG
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 212 GIPVFVRKVPHL 223
IP L
Sbjct: 164 AIPDSYGSFSKL 175
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 45.9 bits (107), Expect = 7e-06
Identities = 12/46 (26%), Positives = 21/46 (45%), Gaps = 1/46 (2%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIP 46
+ +L+ L L++S N+ G I P G L + + N + P
Sbjct: 264 LTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANNKCLCGSP 308
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.7 bits (161), Expect = 8e-13
Identities = 45/268 (16%), Positives = 89/268 (33%), Gaps = 39/268 (14%)
Query: 9 HLDLSDNHFMGHIPPTLGRLSELKILNLSL-NSLVGNIPSNVGHLTQLTTLAIASNRMNG 67
LDL+ + P GRL ++ S + + ++ + ++++ +
Sbjct: 4 TLDLTGKNL---HPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEV 60
Query: 68 SILLGI-GSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLV--GPIPSSLGHL 124
S L GI LQ L L + I +TL L ++LS + + L
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 125 TQLTTLNMY-------------------------------NNKLDGPIPPELMNCSKLRI 153
++L LN+ N + + + +
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180
Query: 154 LKLGNNLLSGSIPSQIGKLQELYYLDLSG-NFINGKIPSQLGEFSCIDTVDLSMNNLSGG 212
+ +L + +L L +L LS I + +LGE + T+ + G
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240
Query: 213 IPVFVRKVPHLDVSGNQFGGEIPTTLAN 240
+ + +PHL ++ + F T+ N
Sbjct: 241 LQLLKEALPHLQINCSHFTTIARPTIGN 268
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 59.7 bits (144), Expect = 1e-11
Identities = 25/109 (22%), Positives = 45/109 (41%), Gaps = 4/109 (3%)
Query: 80 QVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDG 139
+VL L+ ++ ++ L L + +DLS N+L P+ L L L L +N L+
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALEN 57
Query: 140 PIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGK 188
+ + +L N L + + L L+L GN + +
Sbjct: 58 VDGVANLPRLQELLLC-NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 52.8 bits (126), Expect = 4e-09
Identities = 26/127 (20%), Positives = 47/127 (37%), Gaps = 12/127 (9%)
Query: 10 LDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSI 69
L L+ + L +L + L+LS N L P+ + L L + ++
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEV--LQASDNALEN 57
Query: 70 LLGIGSLKVLQVLDLSRNEI-GGSIPSTLGHLKWLRSVDLSQNKLVGP------IPSSLG 122
+ G+ +L LQ L L N + + L L ++L N L + L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
Query: 123 HLTQLTT 129
++ + T
Sbjct: 118 SVSSILT 124
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 50.5 bits (120), Expect = 2e-08
Identities = 30/120 (25%), Positives = 52/120 (43%), Gaps = 7/120 (5%)
Query: 57 TLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGP 116
L +A + ++L + L ++ LDLS N + P+ L L+ L + S N
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNA--LE 56
Query: 117 IPSSLGHLTQLTTLNMYNNKL-DGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQEL 175
+ +L +L L + NN+L L++C +L +L L N L +L E+
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.2 bits (96), Expect = 4e-05
Identities = 30/110 (27%), Positives = 47/110 (42%), Gaps = 7/110 (6%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAI 60
+ +L + HLDLS N PP L L L++L S N V +L +L L +
Sbjct: 16 LEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDN--ALENVDGVANLPRLQELLL 72
Query: 61 ASNRMNGSILLG-IGSLKVLQVLDLSRN---EIGGSIPSTLGHLKWLRSV 106
+NR+ S + + S L +L+L N + G L + S+
Sbjct: 73 CNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.5 bits (89), Expect = 3e-04
Identities = 19/94 (20%), Positives = 38/94 (40%), Gaps = 7/94 (7%)
Query: 152 RILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPS--QLGEFSCIDTVDLSMNNL 209
R+L L + L+ + + +L + +LDLS N + P+ L + D ++ N+
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENV 58
Query: 210 SGGIPVFVRKVPHLDVSGNQF-GGEIPTTLANVP 242
G + + L + N+ L + P
Sbjct: 59 DGVANLPRLQ--ELLLCNNRLQQSAAIQPLVSCP 90
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.0 bits (141), Expect = 3e-10
Identities = 49/179 (27%), Positives = 68/179 (37%), Gaps = 4/179 (2%)
Query: 5 RNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNR 64
++ L LS+N TL + L LNL G L L TL ++ N+
Sbjct: 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE--LTKLQVDGTLPVLGTLDLSHNQ 88
Query: 65 MNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHL 124
+ L +L L VLD+S N + L L L+ + L N+L P L
Sbjct: 89 LQSLP-LLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPT 147
Query: 125 TQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGN 183
+L L++ NN L L L L L N L +IP L + L GN
Sbjct: 148 PKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.4 bits (98), Expect = 6e-05
Identities = 11/54 (20%), Positives = 19/54 (35%), Gaps = 1/54 (1%)
Query: 85 SRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLD 138
+ N + L L+ L ++ L +N L IP L ++ N
Sbjct: 156 ANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (93), Expect = 3e-04
Identities = 14/65 (21%), Positives = 22/65 (33%), Gaps = 3/65 (4%)
Query: 120 SLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLD 179
+ + +N L +PP+L IL L NLL + + L L+
Sbjct: 5 EVSKVASHLEVNCDKRNLTA-LPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 180 LSGNF 184
L
Sbjct: 62 LDRAE 66
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.4 bits (85), Expect = 0.003
Identities = 11/41 (26%), Positives = 13/41 (31%), Gaps = 1/41 (2%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSL 41
+ L NL L L +N IP L L N
Sbjct: 168 LNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.2 bits (141), Expect = 7e-10
Identities = 21/91 (23%), Positives = 35/91 (38%), Gaps = 10/91 (10%)
Query: 79 LQVLDLSRNEIGGS-IPSTLGHLKWLRSVDLSQNKL----VGPIPSSLGHLTQLTTLNMY 133
+Q LD+ E+ + L L+ + V L L I S+L L LN+
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 134 NNKLDGPIPPELM-----NCSKLRILKLGNN 159
+N+L ++ K++ L L N
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.8 bits (127), Expect = 3e-08
Identities = 15/85 (17%), Positives = 31/85 (36%), Gaps = 9/85 (10%)
Query: 101 KWLRSVDLSQNKL----VGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELM-----NCSKL 151
LR + L+ + + ++L L L++ NN L +L+ L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 152 RILKLGNNLLSGSIPSQIGKLQELY 176
L L + S + ++ L++
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.7 bits (119), Expect = 3e-07
Identities = 15/91 (16%), Positives = 32/91 (35%), Gaps = 10/91 (10%)
Query: 55 LTTLAIASNRMNGSILLGI-GSLKVLQVLDLSRNEIGG----SIPSTLGHLKWLRSVDLS 109
+ +L I ++ + + L+ QV+ L + I S L L ++L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 110 QNKLVGPIPSSLGHL-----TQLTTLNMYNN 135
N+L + ++ L++ N
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.6 bits (116), Expect = 7e-07
Identities = 21/94 (22%), Positives = 35/94 (37%), Gaps = 13/94 (13%)
Query: 145 LMNCSKLRILKLGNNLLSG----SIPSQIGKLQELYYLDLSGNFINGKIPSQLGEF---- 196
S LR+L L + +S S+ + + L LDLS N + QL E
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 197 -SCIDTVDLSMNNLSGGIPVFVRKV----PHLDV 225
++ + L S + ++ + P L V
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRV 458
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.8 bits (114), Expect = 1e-06
Identities = 13/90 (14%), Positives = 34/90 (37%), Gaps = 5/90 (5%)
Query: 127 LTTLNMYNNKLDGPIPPELM-NCSKLRILKLGNNLLSG----SIPSQIGKLQELYYLDLS 181
+ +L++ +L EL+ + ++++L + L+ I S + L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 182 GNFINGKIPSQLGEFSCIDTVDLSMNNLSG 211
N + + + + + +L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 3e-05
Identities = 19/110 (17%), Positives = 36/110 (32%), Gaps = 27/110 (24%)
Query: 53 TQLTTLAIASNRMNG----SILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDL 108
+ L L +A ++ S+ + + L+ LDLS N +G + L +
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVES-------V 421
Query: 109 SQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELM----NCSKLRIL 154
Q L L +Y+ + L + LR++
Sbjct: 422 RQPG------------CLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 4e-05
Identities = 14/112 (12%), Positives = 29/112 (25%), Gaps = 26/112 (23%)
Query: 6 NLVHLDLSDNHF-MGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNR 64
++ LD+ L L + +++ L L +
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGL--------------------TEA 42
Query: 65 MNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHL-----KWLRSVDLSQN 111
I + L L+L NE+G + ++ + L
Sbjct: 43 RCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 5e-04
Identities = 17/100 (17%), Positives = 27/100 (27%), Gaps = 23/100 (23%)
Query: 6 NLVHLDLSDNHF----MGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIA 61
L L L+D + TL L+ L+LS N L + ++
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE-------SVR 422
Query: 62 SNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLK 101
L+ L L + L L+
Sbjct: 423 QPGCL------------LEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 53.7 bits (127), Expect = 3e-08
Identities = 21/93 (22%), Positives = 33/93 (35%), Gaps = 9/93 (9%)
Query: 84 LSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPP 143
N I S L +++S NKL+ +P+ L L N L +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPR---LERLIASFNHLAE-VPE 321
Query: 144 ELMNCSKLRILKLGNNLLSGSIPSQIGKLQELY 176
N L+ L + N L P +++L
Sbjct: 322 LPQN---LKQLHVEYNPLR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.1 bits (123), Expect = 8e-08
Identities = 26/110 (23%), Positives = 37/110 (33%), Gaps = 14/110 (12%)
Query: 99 HLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGN 158
L L N I S L LN+ NNKL +P +L L
Sbjct: 258 GLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALP---PRLERLIASF 313
Query: 159 NLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNN 208
N L+ +P L++ L + N + + P DL MN+
Sbjct: 314 NHLA-EVPELPQNLKQ---LHVEYNPLR-EFPDIPESVE-----DLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.4 bits (108), Expect = 5e-06
Identities = 23/118 (19%), Positives = 34/118 (28%), Gaps = 34/118 (28%)
Query: 9 HLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGS 68
N I L+ LN+S N L+ +P+
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR----------------- 305
Query: 69 ILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKL--VGPIPSSLGHL 124
L+ L S N + +P +LK L + N L IP S+ L
Sbjct: 306 ----------LERLIASFNHL-AEVPELPQNLKQL---HVEYNPLREFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.0 bits (102), Expect = 3e-05
Identities = 17/78 (21%), Positives = 31/78 (39%), Gaps = 9/78 (11%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASN 63
+L L++S+N + +P R L+ L S N L +P L L + N
Sbjct: 283 PPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHL-AEVPE---LPQNLKQLHVEYN 334
Query: 64 RMNGSILLGIGSLKVLQV 81
+ S++ L++
Sbjct: 335 PLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.3 bits (95), Expect = 2e-04
Identities = 21/112 (18%), Positives = 33/112 (29%), Gaps = 31/112 (27%)
Query: 131 NMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIP 190
Y N I L L + NN L +P+ +L+ L S N + ++P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLA-EVP 320
Query: 191 SQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHLDVSGNQFGG--EIPTTLAN 240
NL L V N +IP ++ +
Sbjct: 321 ELPQ-------------NLK-----------QLHVEYNPLREFPDIPESVED 348
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 48.5 bits (114), Expect = 6e-07
Identities = 39/216 (18%), Positives = 66/216 (30%), Gaps = 22/216 (10%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASN 63
L N + + ++ + T L + L+ + I V +L L L + N
Sbjct: 18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKDN 73
Query: 64 RMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGH 123
++ L + L + + +I + + S+L
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 124 LTQLTTLNMYNNKLDGPI--------------PPELMNCSKLRILKLGNNLLSGSIPSQI 169
L + L G L N SKL LK +N +S P +
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191
Query: 170 GKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLS 205
L L + L N I+ P L S + V L+
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 44.3 bits (103), Expect = 1e-05
Identities = 20/67 (29%), Positives = 31/67 (46%), Gaps = 4/67 (5%)
Query: 92 SIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKL 151
S + L +L L ++ NK+ P L L L +++ NN++ P L N S L
Sbjct: 164 SDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNL 219
Query: 152 RILKLGN 158
I+ L N
Sbjct: 220 FIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 8e-05
Identities = 35/217 (16%), Positives = 62/217 (28%), Gaps = 22/217 (10%)
Query: 28 LSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRN 87
L+ + +++ + L +TTL+ + + G+ L L L+L N
Sbjct: 18 LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKDN 73
Query: 88 EIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYN------------- 134
+I P + + K V I T T
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 135 -NKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQL 193
I + L S + + L +L L N I+ P L
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191
Query: 194 GEFSCIDTVDLSMNNLSGGIPV-FVRKVPHLDVSGNQ 229
+ V L N +S P+ + + ++ NQ
Sbjct: 192 ASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLT-NQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.001
Identities = 11/37 (29%), Positives = 17/37 (45%), Gaps = 2/37 (5%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLS 37
+ L NL+ + L +N P L S L I+ L+
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 47.5 bits (111), Expect = 9e-07
Identities = 37/153 (24%), Positives = 62/153 (40%), Gaps = 2/153 (1%)
Query: 79 LQVLDLSRNEIGGSIPSTL-GHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKL 137
L L+ NE+G L G L L ++L +N+L G P++ + + L + NK+
Sbjct: 31 TTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKI 90
Query: 138 DGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFS 197
+ +L+ L L +N +S +P L L L+L+ N N
Sbjct: 91 KEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC-NCHLAWFAE 149
Query: 198 CIDTVDLSMNNLSGGIPVFVRKVPHLDVSGNQF 230
+ L+ G P VR V D+ ++F
Sbjct: 150 WLRKKSLNGGAARCGAPSKVRDVQIKDLPHSEF 182
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 44.0 bits (102), Expect = 1e-05
Identities = 36/179 (20%), Positives = 59/179 (32%), Gaps = 27/179 (15%)
Query: 5 RNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNR 64
+ L L+DN G L L L + N+
Sbjct: 29 LHTTELLLNDNELGRISSDG-----------------------LFGRLPHLVKLELKRNQ 65
Query: 65 MNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHL 124
+ G +Q L L N+I L L++++L N++ +P S HL
Sbjct: 66 LTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHL 125
Query: 125 TQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGN 183
LT+LN+ +N + LR L PS K++++ DL +
Sbjct: 126 NSLTSLNLASNPFNCNCHLA-WFAEWLRKKSLNGGAARCGAPS---KVRDVQIKDLPHS 180
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.7 bits (110), Expect = 1e-06
Identities = 25/150 (16%), Positives = 50/150 (33%), Gaps = 14/150 (9%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAI 60
M + + L P L + +LN + + ++ +L +L +
Sbjct: 16 MSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNL 72
Query: 61 ASNRMNG--SILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIP 118
++NR+ + + L++L+LS NE+ L + L N L
Sbjct: 73 SNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132
Query: 119 SS-------LGHLTQLTTLNMYNNKLDGPI 141
+L L+ ++L PI
Sbjct: 133 DQSTYISAIRERFPKLLRLD--GHELPPPI 160
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.3 bits (101), Expect = 1e-05
Identities = 24/116 (20%), Positives = 40/116 (34%), Gaps = 7/116 (6%)
Query: 79 LQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLD 138
Q LDL L ++ + + ++ +L +LN+ NN+L
Sbjct: 24 QQALDLKGL----RSDPDLVAQNIDVVLNRRSSMAAT-LRIIEENIPELLSLNLSNNRLY 78
Query: 139 G--PIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQ 192
+ + L+IL L N L K +L L L GN ++ Q
Sbjct: 79 RLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQ 134
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.0 bits (90), Expect = 4e-04
Identities = 25/134 (18%), Positives = 44/134 (32%), Gaps = 6/134 (4%)
Query: 83 DLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIP 142
+L ++ + + L L L LN ++ +
Sbjct: 3 ELKPEQVE-QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSSMAAT-LR 58
Query: 143 PELMNCSKLRILKLGNNLLSG--SIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCID 200
N +L L L NN L + S + K L L+LSGN + + + ++
Sbjct: 59 IIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE 118
Query: 201 TVDLSMNNLSGGIP 214
+ L N+LS
Sbjct: 119 ELWLDGNSLSDTFR 132
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 47.3 bits (111), Expect = 1e-06
Identities = 26/195 (13%), Positives = 60/195 (30%), Gaps = 24/195 (12%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASN 63
+ +L + T L+ + + + + + + +L +T L + N
Sbjct: 23 FAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLNGN 78
Query: 64 RMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGH 123
++ + +LK L L L N++ S++ + + +
Sbjct: 79 KLTDIK--PLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQL 136
Query: 124 LTQLTTLNMYNNKLDGPI----------------PPELMNCSKLRILKLGNNLLSGSIPS 167
+ N + L +KL+ L L N +S + +
Sbjct: 137 ESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS-DLRA 195
Query: 168 QIGKLQELYYLDLSG 182
+ L+ L L+L
Sbjct: 196 -LAGLKNLDVLELFS 209
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.3 bits (105), Expect = 7e-06
Identities = 9/58 (15%), Positives = 20/58 (34%)
Query: 79 LQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNK 136
++ N + +D+S+ ++ L +L +L + YN K
Sbjct: 179 DELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 3e-04
Identities = 15/86 (17%), Positives = 25/86 (29%), Gaps = 3/86 (3%)
Query: 82 LDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPI 141
L L++N I + N L + L++ ++
Sbjct: 158 LWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLP 217
Query: 142 PPELMNCSKLRILKLGNNLLSGSIPS 167
L N KLR NL +P+
Sbjct: 218 SYGLENLKKLRARST-YNL--KKLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.001
Identities = 11/40 (27%), Positives = 15/40 (37%)
Query: 73 IGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNK 112
+LD+SR I L +LK LR+ K
Sbjct: 197 FHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.001
Identities = 9/42 (21%), Positives = 14/42 (33%), Gaps = 1/42 (2%)
Query: 1 MGRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNL-SLNSL 41
V LD+S L L +L+ + +L L
Sbjct: 197 FHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKL 238
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.8 bits (83), Expect = 0.004
Identities = 10/62 (16%), Positives = 21/62 (33%), Gaps = 4/62 (6%)
Query: 131 NMYNNKLDGPIPPE-LMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKI 189
N+ +N +P + S IL + + + L++L K+
Sbjct: 182 NLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN---LKKL 238
Query: 190 PS 191
P+
Sbjct: 239 PT 240
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 1e-04
Identities = 25/184 (13%), Positives = 60/184 (32%), Gaps = 14/184 (7%)
Query: 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASN 63
L + L + + L ++ L + V +L LT + ++N
Sbjct: 17 LAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNN 72
Query: 64 RMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGH 123
++ L + V +++ ++ + + + + ++L
Sbjct: 73 QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 132
Query: 124 LTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGN 183
L + + L G + +N S +N ++ P + L L LD+S N
Sbjct: 133 LELSSNTISDISALSGLTSLQQLNFS--------SNQVTDLKP--LANLTTLERLDISSN 182
Query: 184 FING 187
++
Sbjct: 183 KVSD 186
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.9 bits (92), Expect = 2e-04
Identities = 24/144 (16%), Positives = 49/144 (34%), Gaps = 9/144 (6%)
Query: 84 LSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPP 143
L+ I ++ R +DL K+ I + L Q ++ +N++
Sbjct: 3 LTAELIE-QAAQYTNAVR-DRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKLDGF 59
Query: 144 ELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFING----KIPSQLGEFSCI 199
+L+ L + NN + L +L L L+ N + + L + +
Sbjct: 60 P--LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYL 117
Query: 200 DTVDLSMNNLSGGIPVFVRKVPHL 223
+ + N + KVP +
Sbjct: 118 CILRNPVTNKKHYRLYVIYKVPQV 141
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.4 bits (95), Expect = 2e-04
Identities = 11/89 (12%), Positives = 26/89 (29%), Gaps = 5/89 (5%)
Query: 77 KVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKL----VGPIPSSLGHLTQLTTLNM 132
K L++ ++ + S+ + L ++ + LS N + + ++ L
Sbjct: 8 KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 133 YNNKLDGPIPPELMNCSKLRILKLGNNLL 161
+ L L L
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKL 95
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.5 bits (90), Expect = 9e-04
Identities = 9/84 (10%), Positives = 26/84 (30%), Gaps = 8/84 (9%)
Query: 101 KWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGP----IPPELMNCSKLRILKL 156
K L+ ++ + + L + + + N + + + + L I +
Sbjct: 8 KSLKLDAITTEDE-KSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 157 GNN---LLSGSIPSQIGKLQELYY 177
+ + IP + L +
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALL 90
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.1 bits (89), Expect = 0.001
Identities = 12/70 (17%), Positives = 22/70 (31%), Gaps = 6/70 (8%)
Query: 71 LGIGSLKVLQVLDLSRNEIGGSIPSTL-----GHLKWLRSVDLSQNKLVGPIPSSLGHLT 125
LQ L L NEI TL + L ++L+ N+ + +
Sbjct: 267 FSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF-SEEDDVVDEIR 325
Query: 126 QLTTLNMYNN 135
++ +
Sbjct: 326 EVFSTRGRGE 335
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.3 bits (87), Expect = 0.002
Identities = 12/70 (17%), Positives = 23/70 (32%), Gaps = 6/70 (8%)
Query: 120 SLGHLTQLTTLNMYNNKLDGPIPPELM-----NCSKLRILKLGNNLLSGSIPSQIGKLQE 174
S L TL + N+++ L L L+L N + +++E
Sbjct: 268 SKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF-SEEDDVVDEIRE 326
Query: 175 LYYLDLSGNF 184
++ G
Sbjct: 327 VFSTRGRGEL 336
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 37.9 bits (86), Expect = 0.003
Identities = 13/87 (14%), Positives = 23/87 (26%), Gaps = 4/87 (4%)
Query: 68 SILLGIGSLKVLQVLDLSRNEIGG----SIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGH 123
S+ + ++ + LS N IG + + K L + S
Sbjct: 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEA 81
Query: 124 LTQLTTLNMYNNKLDGPIPPELMNCSK 150
L L + KL +
Sbjct: 82 LRLLLQALLKCPKLHTVRLSDNAFGPT 108
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.4 bits (90), Expect = 3e-04
Identities = 20/133 (15%), Positives = 44/133 (33%), Gaps = 1/133 (0%)
Query: 62 SNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPS-TLGHLKWLRSVDLSQNKLVGPIPSS 120
+ L + + L L + + + L L LR++ + ++ L P +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 121 LGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDL 180
+L+ LN+ N L+ + S ++ GN L + + +E +
Sbjct: 76 FHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGV 135
Query: 181 SGNFINGKIPSQL 193
+ L
Sbjct: 136 PEQKLQCHGQGPL 148
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.6 bits (88), Expect = 5e-04
Identities = 23/144 (15%), Positives = 41/144 (28%), Gaps = 4/144 (2%)
Query: 6 NLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNV-GHLTQLTTLAIASNR 64
L + + + L L L + + ++ L +L L I +
Sbjct: 9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67
Query: 65 MNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPI-PSSLGH 123
+ L L+LS N + S+ L+ + LS N L L
Sbjct: 68 LRFVAPDAFHFTPRLSRLNLSFNAL-ESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQR 126
Query: 124 LTQLTTLNMYNNKLDGPIPPELMN 147
+ + KL L +
Sbjct: 127 WEEEGLGGVPEQKLQCHGQGPLAH 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 560 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.96 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.95 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.95 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.94 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.94 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.92 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.92 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.89 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.87 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.85 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.84 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.84 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.83 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.83 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.83 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.81 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.81 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.81 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.81 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.8 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.74 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.66 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.66 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.66 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.63 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.63 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.62 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.61 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.56 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.5 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.5 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.48 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.48 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.47 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.39 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.34 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.75 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.74 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.54 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.22 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 98.14 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 98.08 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.65 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.63 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.56 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.01 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.64 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.36 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-51 Score=397.46 Aligned_cols=236 Identities=24% Similarity=0.373 Sum_probs=208.6
Q ss_pred cCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
++|+..+.||+|+||.||+|.. .+|+.||||+++.... ...+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC--hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 4799999999999999999986 4699999999875432 234678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++|+|.+++... .+++.++..++.||+.||+|||++ |||||||||+|||++.++++||+|||+|+.+....
T Consensus 98 y~~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 98 YLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp CCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred ecCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 99999999988753 289999999999999999999999 99999999999999999999999999999876555
Q ss_pred CCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc--------------------ccccccccc
Q 035761 474 SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS--------------------SSSSLDKNI 533 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~--------------------~~~~~~~~~ 533 (560)
......+||+.|||||++.+..++.++||||+||++|||++|+.||...+. .+..+...+
T Consensus 171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 250 (293)
T d1yhwa1 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL 250 (293)
T ss_dssp CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHH
T ss_pred ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHH
Confidence 555667899999999999999999999999999999999999999964432 122345566
Q ss_pred ccccccCCCCCCChhHHHhhceeeec
Q 035761 534 KLIDLLDPRLPPPGDQMIRQGIILIS 559 (560)
Q Consensus 534 ~~~~~~dp~~~p~~~~~~~~~~~~~~ 559 (560)
+.|...||..||+++++++|+|+..+
T Consensus 251 ~~~L~~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 251 NRCLDMDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp HHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHccCChhHCcCHHHHhcCHhhCCC
Confidence 78888999999999999999999653
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-52 Score=393.31 Aligned_cols=236 Identities=32% Similarity=0.489 Sum_probs=207.2
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchh-hhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLE-TELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|++.+.||+|+||.||+|+.+ +++.||+|++.+.. ......+.+.+|+++++.++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46899999999999999999875 68899999987644 23344567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++|+|.+++..... +++.++..++.||++||+|||++ +||||||||+|||++.++.+||+|||+|+....
T Consensus 86 Ey~~~g~L~~~l~~~~~---l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~- 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS- 158 (263)
T ss_dssp ECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC-
T ss_pred eecCCCcHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC-
Confidence 99999999999986443 99999999999999999999999 999999999999999999999999999987543
Q ss_pred CCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------ccccccccccc
Q 035761 473 SSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNIKL 535 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~~~ 535 (560)
.......||+.|||||++.+..++.++|||||||++|||++|+.||+..+. .+..+.+.++.
T Consensus 159 -~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 237 (263)
T d2j4za1 159 -SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISR 237 (263)
T ss_dssp -CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred -CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 334456799999999999999999999999999999999999999975432 12234566677
Q ss_pred ccccCCCCCCChhHHHhhceeee
Q 035761 536 IDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 536 ~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
|...||..||+++++++|+|+..
T Consensus 238 ~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 238 LLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HccCCHhHCcCHHHHHcCcCcCC
Confidence 88899999999999999999853
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-52 Score=396.61 Aligned_cols=238 Identities=27% Similarity=0.383 Sum_probs=202.3
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
++|++.+.||+|+||.||+|+.+ +|+.||||++..... .+..+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 56899999999999999999874 689999999875432 2334568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+|+......
T Consensus 84 y~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ccCCCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999999997544 399999999999999999999999 99999999999999999999999999998764332
Q ss_pred --CCceeeccccCccCccccccCcc-CcchhHHHHHHHHHHHHhCCCCCCccccc--------------------ccccc
Q 035761 474 --SNRTLLAGTYGSIAPELAYTMVV-TEKYDVYSFGVVALEVLMGKHPGELLSSS--------------------SSSLD 530 (560)
Q Consensus 474 --~~~~~~~g~~~~~aPE~~~~~~~-~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------------~~~~~ 530 (560)
......+||+.|||||++.+..+ +.++||||+||++|||++|+.||...... +..+.
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 237 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 237 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHH
Confidence 22344679999999999988876 56799999999999999999999654421 12234
Q ss_pred cccccccccCCCCCCChhHHHhhceeeec
Q 035761 531 KNIKLIDLLDPRLPPPGDQMIRQGIILIS 559 (560)
Q Consensus 531 ~~~~~~~~~dp~~~p~~~~~~~~~~~~~~ 559 (560)
+.++.|...||..||+++++++|+|+..+
T Consensus 238 ~li~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 238 ALLHKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence 56677888899999999999999998754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-52 Score=398.26 Aligned_cols=242 Identities=28% Similarity=0.443 Sum_probs=194.5
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEe--CCEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLH--EKCMFLI 391 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv 391 (560)
++|++.+.||+|+||.||+|+.+ +|+.||||.+..........+.+.+|++++++++|||||++++++.+ ++..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999864 68999999997765444556779999999999999999999999965 4568999
Q ss_pred EeccCCCCHHHHhhcCC-cccCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEEeCCCCCCeEeCCCCcEEEeeeccccc
Q 035761 392 YEYMEMGSLFCILRTDE-EAVGLDWTKRVNIVKGMAHALSYLHHHC--TPPILHRDISSNNILLNSEFEAFVADFGIARL 468 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 468 (560)
|||+++|+|.+++.... ....+++.++..++.||+.||+|||+.. ..+||||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999986532 2234999999999999999999999871 11399999999999999999999999999998
Q ss_pred cCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc------------------cccccc
Q 035761 469 LNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS------------------SSSSLD 530 (560)
Q Consensus 469 ~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~------------------~~~~~~ 530 (560)
+...........||+.|||||++.+..++.++|||||||++|||+||+.||...+. .+.++.
T Consensus 164 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~ 243 (269)
T d2java1 164 LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELN 243 (269)
T ss_dssp C-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHH
T ss_pred cccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHH
Confidence 76554445567899999999999999999999999999999999999999975432 122355
Q ss_pred cccccccccCCCCCCChhHHHhhcee
Q 035761 531 KNIKLIDLLDPRLPPPGDQMIRQGII 556 (560)
Q Consensus 531 ~~~~~~~~~dp~~~p~~~~~~~~~~~ 556 (560)
+.++.|...||..||+++++++|+||
T Consensus 244 ~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 244 EIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 66678889999999999999999996
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-51 Score=394.85 Aligned_cols=237 Identities=25% Similarity=0.339 Sum_probs=202.5
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
+.|++.+.||+|+||.||+|+.+ +++.||||+++... ....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 46888999999999999999864 68999999987543 2334578899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++|+|.+++.... ..+++.++..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 90 y~~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 90 FCAGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp CCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred cCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence 999999999976532 2389999999999999999999999 99999999999999999999999999998754332
Q ss_pred CCceeeccccCccCccccc-----cCccCcchhHHHHHHHHHHHHhCCCCCCccccc--------------------ccc
Q 035761 474 SNRTLLAGTYGSIAPELAY-----TMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------------SSS 528 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~-----~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------------~~~ 528 (560)
.......||+.|||||++. +..|+.++||||+||++|||++|+.||...+.. +..
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~ 244 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSN 244 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHH
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHH
Confidence 2333467999999999974 456889999999999999999999999754321 122
Q ss_pred cccccccccccCCCCCCChhHHHhhceeee
Q 035761 529 LDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 529 ~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
+.+.++.|...||..||+++++++|+|+..
T Consensus 245 ~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 245 FKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 345567788899999999999999999974
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-50 Score=384.35 Aligned_cols=234 Identities=24% Similarity=0.371 Sum_probs=197.2
Q ss_pred CcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEe----CCEEEEE
Q 035761 317 FDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLH----EKCMFLI 391 (560)
Q Consensus 317 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv 391 (560)
|++.+.||+|+||.||+|... +++.||+|++..........+.+.+|++++++++|||||++++++.. +...++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 356678999999999999875 58899999987655444556789999999999999999999999875 3467999
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeC-CCCcEEEeeeccccccC
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLN-SEFEAFVADFGIARLLN 470 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~~~~~~ 470 (560)
|||+++|+|.+++..... +++.++..++.||++||+|||++ .++|+||||||+|||++ +++.+||+|||+|+...
T Consensus 91 mE~~~~g~L~~~l~~~~~---~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCcHHHHHhcccc---ccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 999999999999976443 89999999999999999999998 12399999999999996 57899999999998643
Q ss_pred CCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc--------------------cccccc
Q 035761 471 YDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS--------------------SSSSLD 530 (560)
Q Consensus 471 ~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~--------------------~~~~~~ 530 (560)
.......+||+.|||||++.+ .++.++||||+||++|||++|+.||..... ...++.
T Consensus 167 --~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 243 (270)
T d1t4ha_ 167 --ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK 243 (270)
T ss_dssp --TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHH
T ss_pred --CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHH
Confidence 233455689999999999875 589999999999999999999999964432 112345
Q ss_pred cccccccccCCCCCCChhHHHhhceee
Q 035761 531 KNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 531 ~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
+.++.|...||+.||+++++++|+|++
T Consensus 244 ~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 244 EIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 666778888999999999999999974
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-51 Score=401.40 Aligned_cols=236 Identities=24% Similarity=0.317 Sum_probs=203.4
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
.++|++.+.||+|+||.||+|+.. +|+.||+|+++.... ....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC-TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 467999999999999999999864 689999999875432 234467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHH-HCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 471 (560)
||+++|+|.+++..... +++.++..++.|++.||+|||+ + +|+||||||+|||++.++.+||+|||+|+....
T Consensus 84 Ey~~gg~L~~~l~~~~~---l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EcCCCCcHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 99999999999976443 9999999999999999999996 6 899999999999999999999999999987643
Q ss_pred CCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc--------------------------
Q 035761 472 DSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS-------------------------- 525 (560)
Q Consensus 472 ~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~-------------------------- 525 (560)
. .....+||+.|||||++.+..|+.++||||+||++|||++|+.||...+..
T Consensus 158 ~--~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 158 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp H--TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred C--ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 2 223457999999999999999999999999999999999999999643321
Q ss_pred -----------------------------------ccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 526 -----------------------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 526 -----------------------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
+.++.+.++.|...||..||+++++++|+|+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 112334566788899999999999999999864
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=389.04 Aligned_cols=232 Identities=26% Similarity=0.425 Sum_probs=190.7
Q ss_pred hcCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
.++|++.+.||+|+||.||+|+++ ..||||+++.........+.|.+|++++++++|||||+++|++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 467899999999999999999875 369999997655445567789999999999999999999998765 45799999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++|+|.+++...+. .+++.++..|+.|||+||+|||++ +||||||||+|||++.++.+||+|||+|+......
T Consensus 84 y~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 9999999999975433 389999999999999999999999 99999999999999999999999999998764322
Q ss_pred C--CceeeccccCccCcccccc---CccCcchhHHHHHHHHHHHHhCCCCCCccccc-----------------------
Q 035761 474 S--NRTLLAGTYGSIAPELAYT---MVVTEKYDVYSFGVVALEVLMGKHPGELLSSS----------------------- 525 (560)
Q Consensus 474 ~--~~~~~~g~~~~~aPE~~~~---~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~----------------------- 525 (560)
. ......||+.|||||++.+ ..++.++|||||||++|||+||+.||......
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 238 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTC
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccc
Confidence 2 2334579999999999864 34788999999999999999999999754421
Q ss_pred ccccccccccccccCCCCCCChhHHHhh
Q 035761 526 SSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 526 ~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
...+.+.+..|...||..||++++++++
T Consensus 239 ~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 239 PKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1123455566777788888888888765
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-50 Score=386.70 Aligned_cols=232 Identities=24% Similarity=0.354 Sum_probs=198.2
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchh-hhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLE-TELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|++.+.||+|+||.||+|+.+ +|+.||||++.+.. ......+.+.+|++++++++||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 56999999999999999999874 68999999997644 23345567999999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++|+|.+++...+. +++.++..++.|++.||+|||+. +||||||||+|||+++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~~~~---l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhccCC---CCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccC
Confidence 99999999999876543 99999999999999999999999 9999999999999999999999999999887533
Q ss_pred CC--CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------ccccccccc
Q 035761 473 SS--NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNI 533 (560)
Q Consensus 473 ~~--~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~ 533 (560)
.. .....+||+.|||||++.+..++.++||||+||++|||++|+.||...+. .+..+.+.+
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 241 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLV 241 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHH
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence 22 23345799999999999999999999999999999999999999975432 122344566
Q ss_pred ccccccCCCCCCChhHHHh
Q 035761 534 KLIDLLDPRLPPPGDQMIR 552 (560)
Q Consensus 534 ~~~~~~dp~~~p~~~~~~~ 552 (560)
+.|...||..||++++++.
T Consensus 242 ~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 242 EKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp HTTSCSSGGGSTTSGGGTC
T ss_pred HHHccCCHhHCcCHHHHcC
Confidence 7888899999999998533
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6e-50 Score=389.54 Aligned_cols=237 Identities=26% Similarity=0.349 Sum_probs=188.9
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
.+.|++.+.||+|+||.||+|+.+ +|+.||||++...... ...+.+.+|++++++++|||||++++++.+++..++||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 356899999999999999999875 6899999999765432 22356789999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeC---CCCcEEEeeecccccc
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLN---SEFEAFVADFGIARLL 469 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg~~~~~ 469 (560)
||+++|+|.+++...+. +++.++..++.||+.||+|||+. +|+||||||+||+++ +++.+||+|||+|+..
T Consensus 87 E~~~gg~L~~~l~~~~~---l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKGF---YTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHHTCSC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred eccCCCcHHHhhhcccC---CCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 99999999999976443 99999999999999999999999 999999999999994 5789999999999876
Q ss_pred CCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------cccc
Q 035761 470 NYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------SSSS 528 (560)
Q Consensus 470 ~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------~~~~ 528 (560)
... ......+||+.|||||++.+..++.++||||+||++|||++|+.||..... .+..
T Consensus 161 ~~~-~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 239 (307)
T d1a06a_ 161 DPG-SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS 239 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHH
T ss_pred cCC-CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHH
Confidence 533 233446799999999999999999999999999999999999999964431 1123
Q ss_pred cccccccccccCCCCCCChhHHHhhceeee
Q 035761 529 LDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 529 ~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
+.+.++.|...||..||+++++++|+|+..
T Consensus 240 ~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 240 AKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred HHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 455667788899999999999999999863
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.5e-50 Score=388.49 Aligned_cols=234 Identities=26% Similarity=0.365 Sum_probs=202.1
Q ss_pred cCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchh-hhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLE-TELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
+.|+..+.||+|+||.||+|+. .+|+.||||+++... ......+.+.+|++++++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 4588999999999999999986 468899999987544 23344567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++|++..++.... .+++.++..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 95 E~~~~g~l~~~~~~~~---~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp ECCSEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred EecCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 9999999987766543 399999999999999999999999 9999999999999999999999999999875432
Q ss_pred CCCceeeccccCccCcccccc---CccCcchhHHHHHHHHHHHHhCCCCCCcccc-------------------cccccc
Q 035761 473 SSNRTLLAGTYGSIAPELAYT---MVVTEKYDVYSFGVVALEVLMGKHPGELLSS-------------------SSSSLD 530 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~---~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-------------------~~~~~~ 530 (560)
....||+.|||||++.+ ..|+.++|||||||++|||++|+.||..... .+..+.
T Consensus 169 ----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~ 244 (309)
T d1u5ra_ 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFR 244 (309)
T ss_dssp ----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHH
T ss_pred ----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence 23569999999999864 4588999999999999999999999964432 123456
Q ss_pred cccccccccCCCCCCChhHHHhhceeee
Q 035761 531 KNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 531 ~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
..++.|...||..||+++++++|+|+..
T Consensus 245 ~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 245 NFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp HHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred HHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 6778888999999999999999999864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-49 Score=387.14 Aligned_cols=237 Identities=23% Similarity=0.310 Sum_probs=209.0
Q ss_pred cCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|++.+.||+|+||.||+|+. .+|+.||||++++... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 4699999999999999999986 4689999999976542 3344567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++|+|.+++...+. +++.++..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 85 ey~~gg~L~~~~~~~~~---~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLSRERV---FTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhhcccC---CcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 99999999999986543 89999999999999999999999 9999999999999999999999999999987655
Q ss_pred CCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------ccccccccccc
Q 035761 473 SSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNIKL 535 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~~~ 535 (560)
.......+||+.|||||++.+..|+.++||||+||++|||++|+.||...+. .+......++.
T Consensus 159 ~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~ 238 (337)
T d1o6la_ 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHh
Confidence 5555667899999999999999999999999999999999999999975442 22334566777
Q ss_pred ccccCCCCCCC-----hhHHHhhceee
Q 035761 536 IDLLDPRLPPP-----GDQMIRQGIIL 557 (560)
Q Consensus 536 ~~~~dp~~~p~-----~~~~~~~~~~~ 557 (560)
|...||..|+. +.++++|+|+.
T Consensus 239 ~L~~dP~~R~~~~~~~~~eil~Hp~f~ 265 (337)
T d1o6la_ 239 LLKKDPKQRLGGGPSDAKEVMEHRFFL 265 (337)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred hccCCchhhcccccccHHHHHcCcccc
Confidence 88899999994 89999999974
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-49 Score=386.53 Aligned_cols=239 Identities=29% Similarity=0.404 Sum_probs=189.4
Q ss_pred cCCcccceeeccCCeeEEEEEeCC-C---cEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPS-G---KVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFL 390 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 390 (560)
++|++.+.||+|+||.||+|.++. + ..||||++..... ....+.|.+|++++++++|||||+++|++..++..++
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT-EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccC-HHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 346667899999999999998753 2 3589998875443 2445679999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccC
Q 035761 391 IYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN 470 (560)
Q Consensus 391 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 470 (560)
||||+++|+|.+++..... .++|.++..++.|||+||+|||+. +|+||||||+|||++.++.+||+|||+|+.+.
T Consensus 105 v~Ey~~~g~L~~~~~~~~~--~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EEECCTTEEHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEecCCCcceeeeccccC--CCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEcc
Confidence 9999999999998876433 389999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCC-----ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc------------------cc
Q 035761 471 YDSSN-----RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS------------------SS 526 (560)
Q Consensus 471 ~~~~~-----~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~------------------~~ 526 (560)
..... .....||+.|||||.+.+..++.++|||||||++|||+| |+.||..... ..
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 259 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCP 259 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccch
Confidence 43222 112457899999999999999999999999999999998 8999975432 11
Q ss_pred cccccccccccccCCCCCCChhHHHhh--ceeeec
Q 035761 527 SSLDKNIKLIDLLDPRLPPPGDQMIRQ--GIILIS 559 (560)
Q Consensus 527 ~~~~~~~~~~~~~dp~~~p~~~~~~~~--~~~~~~ 559 (560)
..+.+++..|...||..||+++++++. .++.||
T Consensus 260 ~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p 294 (299)
T d1jpaa_ 260 SALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294 (299)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence 234566677888899999999998875 444443
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=380.02 Aligned_cols=231 Identities=28% Similarity=0.392 Sum_probs=188.2
Q ss_pred cCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
++|++.+.||+|+||.||+|.+++++.||||+++... ...+.|.+|++++++++|||||+++|+|..++..++||||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc---CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 4688899999999999999999889999999997543 2345799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
+++|+|.+++..... .+++.++..|+.|||+||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 82 ~~~g~L~~~l~~~~~--~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp CTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred cCCCcHHHHhhcccc--CCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 999999999876433 389999999999999999999999 999999999999999999999999999987654332
Q ss_pred C-ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc------------------cccccccccc
Q 035761 475 N-RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS------------------SSSSLDKNIK 534 (560)
Q Consensus 475 ~-~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~------------------~~~~~~~~~~ 534 (560)
. .....||+.|||||++.+..++.++|||||||++|||+| |++||..... ....+.+.++
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~ 236 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN 236 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHH
T ss_pred eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHH
Confidence 2 233568999999999999999999999999999999999 5666653321 1123456667
Q ss_pred cccccCCCCCCChhHHHhh
Q 035761 535 LIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 535 ~~~~~dp~~~p~~~~~~~~ 553 (560)
.|...||..||++++++++
T Consensus 237 ~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 237 HCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHccCCHhHCcCHHHHHHH
Confidence 7788899999999988875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.7e-49 Score=388.22 Aligned_cols=236 Identities=25% Similarity=0.338 Sum_probs=204.7
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
++|++.+.||+|+||.||+|+.+ +|+.||||++..... ...+.+.+|+.++++++|||||++++++.+++..++|||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE--SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH--HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch--hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 57999999999999999999864 689999999976442 334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCC--CCcEEEeeeccccccCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNS--EFEAFVADFGIARLLNY 471 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~~~~~~~ 471 (560)
|+++|+|.+++..... .+++.++..++.||+.||+|||++ +||||||||+|||++. ++.+||+|||+|+.+..
T Consensus 104 ~~~gg~L~~~l~~~~~--~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 104 FMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCCSCBHHHHHTCTTS--CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred cCCCCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 9999999999965432 399999999999999999999999 9999999999999964 57899999999988753
Q ss_pred CCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------cccccc
Q 035761 472 DSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------SSSSLD 530 (560)
Q Consensus 472 ~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------~~~~~~ 530 (560)
. .......||+.|||||++.+..++.++||||+||++|||++|+.||...+. .+..+.
T Consensus 179 ~-~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 257 (350)
T d1koaa2 179 K-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 257 (350)
T ss_dssp T-SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHH
T ss_pred c-cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 3 334456799999999999999999999999999999999999999974431 112334
Q ss_pred cccccccccCCCCCCChhHHHhhceeee
Q 035761 531 KNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 531 ~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
..++.|...||..||+++++++|+|+..
T Consensus 258 ~li~~~L~~dP~~R~t~~eil~hp~~~~ 285 (350)
T d1koaa2 258 DFIRKLLLADPNTRMTIHQALEHPWLTP 285 (350)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHHSTTTSC
T ss_pred HHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 5567788999999999999999999864
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-49 Score=380.01 Aligned_cols=237 Identities=24% Similarity=0.333 Sum_probs=205.2
Q ss_pred cCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhh----hhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETE----LASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMF 389 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 389 (560)
++|++.+.||+|+||.||+|+. .+|+.||||++++.... ....+.+.+|++++++++|||||++++++.+++..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 5799999999999999999987 46899999998754321 223567899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCC----cEEEeeecc
Q 035761 390 LIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEF----EAFVADFGI 465 (560)
Q Consensus 390 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg~ 465 (560)
+||||+++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++ .+|++|||+
T Consensus 90 iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhh
Confidence 9999999999999997644 399999999999999999999999 999999999999998776 499999999
Q ss_pred ccccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------
Q 035761 466 ARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS--------------------- 524 (560)
Q Consensus 466 ~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~--------------------- 524 (560)
|+...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...+.
T Consensus 164 a~~~~~~~-~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (293)
T d1jksa_ 164 AHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 242 (293)
T ss_dssp CEECTTSC-BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred hhhcCCCc-cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCC
Confidence 98875332 33345689999999999999999999999999999999999999975432
Q ss_pred cccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 525 SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 525 ~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
.+..+.+.++.|...||..||+++++++|+|+..
T Consensus 243 ~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 276 (293)
T d1jksa_ 243 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276 (293)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 1123445677888999999999999999999863
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-49 Score=372.13 Aligned_cols=231 Identities=26% Similarity=0.394 Sum_probs=199.9
Q ss_pred cCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
++|++.+.||+|+||.||+|++++++.||||+++.... ..+.|.+|++++++++||||++++|+|.+++..++||||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~---~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS---CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC---CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 57899999999999999999999899999999976442 245799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
+++|++.+++..... .+++..+.+++.|||+||+|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~~g~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 81 MANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp CTTEEHHHHHHSGGG--CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred cCCCcHHHhhhcccc--CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 999999999765433 389999999999999999999999 999999999999999999999999999987654333
Q ss_pred C-ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------------ccccccccc
Q 035761 475 N-RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------------SSSLDKNIK 534 (560)
Q Consensus 475 ~-~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------------~~~~~~~~~ 534 (560)
. .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||+..... ...+.+.++
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~ 235 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY 235 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHH
Confidence 2 233568999999999999999999999999999999998 89999755421 123456667
Q ss_pred cccccCCCCCCChhHHHhh
Q 035761 535 LIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 535 ~~~~~dp~~~p~~~~~~~~ 553 (560)
.|...||..||++++++.+
T Consensus 236 ~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 236 SCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HTTCSSGGGSCCHHHHHHH
T ss_pred HHccCCHhHCcCHHHHHHH
Confidence 7777788888888888876
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=381.80 Aligned_cols=235 Identities=26% Similarity=0.407 Sum_probs=196.7
Q ss_pred hcCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
.++|++.+.||+|+||.||+|.+++++.||||+++... ...+.|.+|++++++++|||||+++|++.+ +..++|||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E 87 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc---CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence 46788999999999999999999988999999997543 234579999999999999999999998865 45789999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++|+|.+++.... ...+++.++..|+.|||+||+|||+. +|+||||||+|||+++++.+||+|||+|+......
T Consensus 88 y~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 88 YMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp CCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred eCCCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCc
Confidence 999999999886543 23499999999999999999999999 99999999999999999999999999999875432
Q ss_pred C-CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCC-CCcccc------------------ccccccccc
Q 035761 474 S-NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHP-GELLSS------------------SSSSLDKNI 533 (560)
Q Consensus 474 ~-~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P-~~~~~~------------------~~~~~~~~~ 533 (560)
. ......||+.|||||++.+..++.++|||||||++|||+||..| |..... ....+.+.+
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li 243 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLM 243 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHH
Confidence 2 22335688999999999999999999999999999999996554 432221 122356667
Q ss_pred ccccccCCCCCCChhHHHh--hcee
Q 035761 534 KLIDLLDPRLPPPGDQMIR--QGII 556 (560)
Q Consensus 534 ~~~~~~dp~~~p~~~~~~~--~~~~ 556 (560)
+.|...||..||+++++++ +.|+
T Consensus 244 ~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 244 RLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 7788889999999999887 4554
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-48 Score=380.61 Aligned_cols=235 Identities=27% Similarity=0.387 Sum_probs=204.5
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchh-hhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLE-TELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|++.+.||+|+||.||+|+.+ +|+.||||+++... ......+.+.+|+.+++.++|||||++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46899999999999999999874 68999999997644 23345678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+++|++..++..... +++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~~~---~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQR---FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHHTSS---CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccccccc---ccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 99999999999886554 88999999999999999999999 9999999999999999999999999999886432
Q ss_pred CCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------ccccccccccc
Q 035761 473 SSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNIKL 535 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~~~ 535 (560)
....+||+.|||||++.+..++.++||||+||++|||++|+.||...+. ....+...++.
T Consensus 158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 234 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSR 234 (316)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 2345799999999999999999999999999999999999999975432 12234556677
Q ss_pred ccccCCCCCC-----ChhHHHhhceeee
Q 035761 536 IDLLDPRLPP-----PGDQMIRQGIILI 558 (560)
Q Consensus 536 ~~~~dp~~~p-----~~~~~~~~~~~~~ 558 (560)
|...||..|+ +++++++|+|+..
T Consensus 235 ~L~~dp~~R~~~~r~t~~~il~Hp~f~~ 262 (316)
T d1fota_ 235 LITRDLSQRLGNLQNGTEDVKNHPWFKE 262 (316)
T ss_dssp HTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred HhhhCHHhccccchhhHHHHHcCccccc
Confidence 7788998885 8999999999853
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.8e-48 Score=385.92 Aligned_cols=235 Identities=23% Similarity=0.319 Sum_probs=205.0
Q ss_pred cCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
++|++.+.||+|+||.||+|.. .+|+.||||+++.... ...+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP--LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 5699999999999999999986 4699999999876432 234578899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeC--CCCcEEEeeeccccccCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLN--SEFEAFVADFGIARLLNY 471 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfg~~~~~~~ 471 (560)
|+++|+|.+++.... ..+++.++..|+.||+.||+|||+. |||||||||+|||++ .++.+||+|||+|+.+..
T Consensus 107 ~~~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 107 FLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp CCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred cCCCChHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCC
Confidence 999999998876543 2389999999999999999999999 999999999999998 678999999999998764
Q ss_pred CCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------cccccc
Q 035761 472 DSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------SSSSLD 530 (560)
Q Consensus 472 ~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------~~~~~~ 530 (560)
. .......||+.|||||++.+..++.++||||+||++|||++|+.||..... .+.++.
T Consensus 182 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 260 (352)
T d1koba_ 182 D-EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 260 (352)
T ss_dssp T-SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred C-CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 3 334456799999999999999999999999999999999999999965431 122345
Q ss_pred cccccccccCCCCCCChhHHHhhceee
Q 035761 531 KNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 531 ~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
+.++.|...||..||+++++++|+|+.
T Consensus 261 ~li~~~L~~dp~~R~s~~eil~Hp~~~ 287 (352)
T d1koba_ 261 DFIKNLLQKEPRKRLTVHDALEHPWLK 287 (352)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHTSTTTS
T ss_pred HHHHHHccCChhHCcCHHHHhcCHhhC
Confidence 567888899999999999999999985
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-49 Score=381.97 Aligned_cols=233 Identities=25% Similarity=0.362 Sum_probs=197.0
Q ss_pred HhcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEE
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLI 391 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 391 (560)
..++|++.+.||+|+||.||+|.++ +++.||||+++... ...+.|.+|++++++++|||||+++|++.+++..++|
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 91 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc---chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence 3467888999999999999999875 58899999987543 2356799999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 471 (560)
|||+++|+|.+++.... ...+++..+..|+.|||.||+|||++ +|+||||||+|||+++++.+||+|||+|+....
T Consensus 92 ~E~~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp EECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred eecccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCC
Confidence 99999999999997643 23489999999999999999999999 999999999999999999999999999988654
Q ss_pred CCCC-ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-------------------ccccccc
Q 035761 472 DSSN-RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-------------------SSSSLDK 531 (560)
Q Consensus 472 ~~~~-~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-------------------~~~~~~~ 531 (560)
.... .....|++.|||||++.+..++.++|||||||++|||++|..||....+ ....+.+
T Consensus 168 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 247 (287)
T d1opja_ 168 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 247 (287)
T ss_dssp SSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred CCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHH
Confidence 3322 2234588999999999999999999999999999999997766532221 1123455
Q ss_pred ccccccccCCCCCCChhHHHh
Q 035761 532 NIKLIDLLDPRLPPPGDQMIR 552 (560)
Q Consensus 532 ~~~~~~~~dp~~~p~~~~~~~ 552 (560)
+++.|...||+.||+++++++
T Consensus 248 li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 248 LMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHH
Confidence 667778889999999888865
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=373.44 Aligned_cols=225 Identities=25% Similarity=0.366 Sum_probs=186.3
Q ss_pred ceeeccCCeeEEEEEeCC---CcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEeccCC
Q 035761 321 YCIGTGGYGSVYRARLPS---GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEYMEM 397 (560)
Q Consensus 321 ~~ig~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 397 (560)
+.||+|+||.||+|.+++ ++.||||+++.........+.|.+|++++++++|||||+++|+|..+ ..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 469999999999998643 46899999976554445567899999999999999999999999654 57899999999
Q ss_pred CCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCCC--
Q 035761 398 GSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSSN-- 475 (560)
Q Consensus 398 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-- 475 (560)
|+|.++++.... +++.++..++.|||+||+|||+. +||||||||+|||++.++.+||+|||+++.+......
T Consensus 92 g~L~~~l~~~~~---l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhhccC---CCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 999999986543 99999999999999999999999 9999999999999999999999999999876543222
Q ss_pred -ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc------------------ccccccccccc
Q 035761 476 -RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS------------------SSSSLDKNIKL 535 (560)
Q Consensus 476 -~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~------------------~~~~~~~~~~~ 535 (560)
.....||++|||||++.+..++.++|||||||++|||+| |+.||..... ....+.+++..
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~ 245 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNL 245 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHH
Confidence 123468999999999999999999999999999999998 9999975442 11234456677
Q ss_pred ccccCCCCCCChhHHHh
Q 035761 536 IDLLDPRLPPPGDQMIR 552 (560)
Q Consensus 536 ~~~~dp~~~p~~~~~~~ 552 (560)
|...||..||+++++..
T Consensus 246 cl~~dp~~RPs~~~i~~ 262 (277)
T d1xbba_ 246 CWTYDVENRPGFAAVEL 262 (277)
T ss_dssp HTCSSTTTSCCHHHHHH
T ss_pred HcCCCHhHCcCHHHHHH
Confidence 77889999999888753
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-48 Score=373.30 Aligned_cols=230 Identities=25% Similarity=0.346 Sum_probs=188.1
Q ss_pred cCCcccce-eeccCCeeEEEEEeC---CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEE
Q 035761 315 EDFDIKYC-IGTGGYGSVYRARLP---SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFL 390 (560)
Q Consensus 315 ~~~~~~~~-ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 390 (560)
++|.+.+. ||+|+||.||+|.++ ++..||||+++.... ....+.|.+|++++++++|||||+++|++..+ ..++
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~l 85 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALML 85 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcC-HHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEE
Confidence 45666674 999999999999764 355799999976443 34456899999999999999999999998754 5789
Q ss_pred EEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccC
Q 035761 391 IYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLN 470 (560)
Q Consensus 391 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 470 (560)
||||+++|+|.+++...+. .+++.++..++.|||+||+|||++ +|+||||||+||+++.++.+||+|||+|+.+.
T Consensus 86 vmE~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEECCTTEEHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCcHHHHhhcccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccc
Confidence 9999999999999865432 389999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCC---ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------------ccc
Q 035761 471 YDSSN---RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------------SSS 528 (560)
Q Consensus 471 ~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------------~~~ 528 (560)
..... .....||+.|||||++.+..++.++|||||||++|||+| |+.||...... ...
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~ 240 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPE 240 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHH
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHH
Confidence 43221 223468899999999999999999999999999999998 99999755421 112
Q ss_pred cccccccccccCCCCCCChhHHH
Q 035761 529 LDKNIKLIDLLDPRLPPPGDQMI 551 (560)
Q Consensus 529 ~~~~~~~~~~~dp~~~p~~~~~~ 551 (560)
+.+++..|...||..||++.++.
T Consensus 241 l~~li~~cl~~~p~~RPs~~~i~ 263 (285)
T d1u59a_ 241 LYALMSDCWIYKWEDRPDFLTVE 263 (285)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHH
Confidence 33445555666777777766664
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-47 Score=379.95 Aligned_cols=235 Identities=23% Similarity=0.320 Sum_probs=205.7
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchh-hhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLE-TELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
++|++.+.||+|+||.||+|+.+ +|+.||||++.+.. ......+.+.+|+.+++.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999874 69999999987543 23345567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYD 472 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 472 (560)
||+.+|+|.+++...+. +++.++..++.||+.||+|||+. +||||||||+|||++.++.+||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~~~~---l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhcCC---CCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 99999999999976543 99999999999999999999999 9999999999999999999999999999886532
Q ss_pred CCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------ccccccccccc
Q 035761 473 SSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNIKL 535 (560)
Q Consensus 473 ~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~~~ 535 (560)
.....||+.|||||++.+..++.++||||+||++|||++|+.||...+. .+..+.+.++.
T Consensus 195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 271 (350)
T d1rdqe_ 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHH
T ss_pred ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHH
Confidence 2345799999999999999999999999999999999999999975431 22345667778
Q ss_pred ccccCCCCC-----CChhHHHhhceeee
Q 035761 536 IDLLDPRLP-----PPGDQMIRQGIILI 558 (560)
Q Consensus 536 ~~~~dp~~~-----p~~~~~~~~~~~~~ 558 (560)
|...||..| |+++++++|+|+..
T Consensus 272 ~L~~dP~kR~~~~r~t~~ell~Hp~f~~ 299 (350)
T d1rdqe_ 272 LLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HhhhCHHhccccccccHHHHHcCccccC
Confidence 888898877 58999999999753
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-48 Score=376.15 Aligned_cols=237 Identities=22% Similarity=0.358 Sum_probs=204.1
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHHHHHHHHh-ccCCCCcceeeeEEEeCCEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQNEARLLS-QIRHRNIVKLYGFCLHEKCMFLI 391 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv 391 (560)
++|++.+.||+|+||+||+|+.+ +|+.||||++++... .....+.+..|..++. .++|||||++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57899999999999999999875 689999999975432 2334556667777665 68999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCC
Q 035761 392 YEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNY 471 (560)
Q Consensus 392 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 471 (560)
|||+++|+|.+++..... +++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~~~~---~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhccCC---CCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccc
Confidence 999999999999986543 89999999999999999999999 999999999999999999999999999987765
Q ss_pred CCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-----------------cccccccccc
Q 035761 472 DSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-----------------SSSSLDKNIK 534 (560)
Q Consensus 472 ~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------------~~~~~~~~~~ 534 (560)
.........||+.|+|||++.+..++.++||||+||++|||++|+.||...+. .+..+...++
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~ 235 (320)
T d1xjda_ 156 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLV 235 (320)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred ccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence 55555667899999999999999999999999999999999999999975432 1223455567
Q ss_pred cccccCCCCCCChh-HHHhhceee
Q 035761 535 LIDLLDPRLPPPGD-QMIRQGIIL 557 (560)
Q Consensus 535 ~~~~~dp~~~p~~~-~~~~~~~~~ 557 (560)
.|...||..||++. ++++|+|+.
T Consensus 236 ~~L~~dP~~R~s~~~~l~~hpff~ 259 (320)
T d1xjda_ 236 KLFVREPEKRLGVRGDIRQHPLFR 259 (320)
T ss_dssp HHSCSSGGGSBTTBSCGGGSGGGT
T ss_pred HhcccCCCCCcCHHHHHHhCchhc
Confidence 78888999999985 788998874
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-48 Score=379.39 Aligned_cols=236 Identities=25% Similarity=0.391 Sum_probs=194.8
Q ss_pred hcCCcccceeeccCCeeEEEEEeCC------CcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCC
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLPS------GKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEK 386 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 386 (560)
.++|++.+.||+|+||.||+|++.. ...||||.+...... .....+.+|+.+++++ +|||||+++|++.+++
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS-SEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCH-HHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 3678999999999999999998643 236999998754432 3345788999999998 8999999999999999
Q ss_pred EEEEEEeccCCCCHHHHhhcCCc--------------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCC
Q 035761 387 CMFLIYEYMEMGSLFCILRTDEE--------------------AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDIS 446 (560)
Q Consensus 387 ~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk 446 (560)
..++||||+++|+|.++++.... ...+++.+++.++.||++||+|||++ +|||||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCc
Confidence 99999999999999999976432 12489999999999999999999999 99999999
Q ss_pred CCCeEeCCCCcEEEeeeccccccCCCCCCc--eeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccc
Q 035761 447 SNNILLNSEFEAFVADFGIARLLNYDSSNR--TLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLS 523 (560)
Q Consensus 447 ~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~ 523 (560)
|+||+++.++.+||+|||+|+......... ....||+.|||||++.+..++.++|||||||++|||+| |+.||....
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999998765443322 23568999999999999999999999999999999998 899997544
Q ss_pred cc-------------------ccccccccccccccCCCCCCChhHHHhh
Q 035761 524 SS-------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 524 ~~-------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
.. ...+.++++.|...||..||++++++++
T Consensus 272 ~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 272 VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp CSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 21 1234556677778888888888888875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.2e-47 Score=365.69 Aligned_cols=236 Identities=23% Similarity=0.339 Sum_probs=202.6
Q ss_pred cCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhh-------hhhHHHHHHHHHHHhccC-CCCcceeeeEEEeC
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETE-------LASLESFQNEARLLSQIR-HRNIVKLYGFCLHE 385 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~ 385 (560)
++|++.+.||+|+||.||+|+. .+|+.||||+++..... ....+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6799999999999999999986 46899999998754311 223346889999999997 99999999999999
Q ss_pred CEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecc
Q 035761 386 KCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGI 465 (560)
Q Consensus 386 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 465 (560)
+..++||||+++|+|.++++... .+++.++..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchh
Confidence 99999999999999999997644 399999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCceeeccccCccCcccccc------CccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------
Q 035761 466 ARLLNYDSSNRTLLAGTYGSIAPELAYT------MVVTEKYDVYSFGVVALEVLMGKHPGELLSS--------------- 524 (560)
Q Consensus 466 ~~~~~~~~~~~~~~~g~~~~~aPE~~~~------~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~--------------- 524 (560)
++.+.... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.....
T Consensus 157 a~~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~ 235 (277)
T d1phka_ 157 SCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG 235 (277)
T ss_dssp CEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred eeEccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 99875433 3344679999999998763 3467899999999999999999999975542
Q ss_pred ------cccccccccccccccCCCCCCChhHHHhhceee
Q 035761 525 ------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 525 ------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
.+.++.+.++.|...||+.||+++++++|+|+.
T Consensus 236 ~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~ 274 (277)
T d1phka_ 236 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274 (277)
T ss_dssp TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHH
Confidence 112344556778888999999999999999985
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=373.62 Aligned_cols=239 Identities=26% Similarity=0.335 Sum_probs=198.2
Q ss_pred cCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
++|++.+.||+|+||.||+|.. .+|+.||||+++.........+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5789999999999999999986 568999999997654433445688999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+.++ +.+++.... ...+++.++..++.||+.||+|||++ +||||||||+|||++.++.+||+|||.|+......
T Consensus 82 ~~~~~-~~~~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQD-LKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEE-HHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCc-hhhhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99764 444443322 22399999999999999999999999 99999999999999999999999999998876555
Q ss_pred CCceeeccccCccCccccccCc-cCcchhHHHHHHHHHHHHhCCCCCCccccc---------------------------
Q 035761 474 SNRTLLAGTYGSIAPELAYTMV-VTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------------------- 525 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~~~-~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------------------- 525 (560)
.......||+.|+|||++.... ++.++||||+||++|||++|+.||...+..
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence 5555567999999999877765 478999999999999999999999643210
Q ss_pred -------------------ccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 526 -------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 526 -------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
+.++.+.++.|...||..||+++++++|+|+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~ 288 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhcc
Confidence 112234567788899999999999999999865
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.4e-47 Score=379.90 Aligned_cols=236 Identities=21% Similarity=0.239 Sum_probs=198.4
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhh-hhhhHHHHH---HHHHHHhccCCCCcceeeeEEEeCCEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLET-ELASLESFQ---NEARLLSQIRHRNIVKLYGFCLHEKCMF 389 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~---~e~~~l~~l~h~niv~l~~~~~~~~~~~ 389 (560)
++|++.+.||+|+||.||+|+.. +|+.||||++.+... .......+. +|+++++.++|||||++++++.+++..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57999999999999999999875 689999999875432 112222333 4467777889999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccccc
Q 035761 390 LIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL 469 (560)
Q Consensus 390 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 469 (560)
+||||+++|+|.+++..... +++.++..++.||+.||+|||+. +||||||||+|||++.++.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~~~~~---~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHGV---FSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhccc---ccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 99999999999999976543 89999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCcccc--------------------cccc
Q 035761 470 NYDSSNRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSS--------------------SSSS 528 (560)
Q Consensus 470 ~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~--------------------~~~~ 528 (560)
... ......||+.|||||++.. ..++.++||||+||++|||+||+.||..... .+..
T Consensus 158 ~~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 235 (364)
T d1omwa3 158 SKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 235 (364)
T ss_dssp SSS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHH
T ss_pred CCC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHH
Confidence 533 2334579999999999874 5689999999999999999999999964332 1223
Q ss_pred cccccccccccCCCCCCC-----hhHHHhhceeee
Q 035761 529 LDKNIKLIDLLDPRLPPP-----GDQMIRQGIILI 558 (560)
Q Consensus 529 ~~~~~~~~~~~dp~~~p~-----~~~~~~~~~~~~ 558 (560)
+...+..|...||..||+ ++++++|+|+.+
T Consensus 236 ~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 236 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270 (364)
T ss_dssp HHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred HHHHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence 456667788899999999 699999999853
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=374.09 Aligned_cols=234 Identities=25% Similarity=0.280 Sum_probs=193.9
Q ss_pred ccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhh---hhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 319 IKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETEL---ASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 319 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
..+.||+|+||+||+|+.+ +|+.||||+++...... ...+.+.+|++++++++|||||++++++..++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999864 68999999987543221 1124688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
++++++..+..... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 82 ~~~~~~~~~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIKDNSL---VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHTTCCS---SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred hcchHHhhhhhccc---CCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 99988776665433 389999999999999999999999 999999999999999999999999999988765555
Q ss_pred CceeeccccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCCCCCccccc----------------------------
Q 035761 475 NRTLLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKHPGELLSSS---------------------------- 525 (560)
Q Consensus 475 ~~~~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~---------------------------- 525 (560)
.....+||+.|+|||++.+. .++.++||||+||++|||++|+.||......
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhh
Confidence 55556799999999988654 5789999999999999999999999643210
Q ss_pred -----------------ccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 526 -----------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 526 -----------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
+..+.+.++.|...||+.||+++++++|+|+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence 112334567788889999999999999999874
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-47 Score=367.96 Aligned_cols=232 Identities=29% Similarity=0.378 Sum_probs=187.7
Q ss_pred cCCcccceeeccCCeeEEEEEeCCC-----cEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPSG-----KVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMF 389 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 389 (560)
++|+..+.||+|+||.||+|.++++ ..||||+++..... .....|.+|++++++++|||||+++|++.+.+..+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccCh-HHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 4688889999999999999987542 37999999754433 33457899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccccc
Q 035761 390 LIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL 469 (560)
Q Consensus 390 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 469 (560)
+||||+++|++.+++..... .++|.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEecccCcchhhhhcccc--cccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcc
Confidence 99999999999998875433 389999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCC---ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-------------------ccc
Q 035761 470 NYDSSN---RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-------------------SSS 527 (560)
Q Consensus 470 ~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-------------------~~~ 527 (560)
...... .....||+.|||||++.+..++.++|||||||++|||++|..||....+ ...
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 240 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS 240 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBH
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHH
Confidence 543222 2234589999999999999999999999999999999996555432211 112
Q ss_pred ccccccccccccCCCCCCChhHHHh
Q 035761 528 SLDKNIKLIDLLDPRLPPPGDQMIR 552 (560)
Q Consensus 528 ~~~~~~~~~~~~dp~~~p~~~~~~~ 552 (560)
.+.+++..|...||..||++.++++
T Consensus 241 ~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 241 AIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 3556677778889999999999876
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-47 Score=371.29 Aligned_cols=235 Identities=24% Similarity=0.286 Sum_probs=203.4
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 392 (560)
.++|++.+.||+|+||.||+|..+ +++.||||.++..... ...+.+|+++++.++|||||++++++.+++..++||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~---~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD---QVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH---HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc---HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 367899999999999999999875 6889999999764422 345789999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCC--CcEEEeeeccccccC
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSE--FEAFVADFGIARLLN 470 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~--~~~kl~Dfg~~~~~~ 470 (560)
||+++|+|.+++...+ ..+++.++..++.||+.||+|||+. +|+||||||+|||++.+ ..+||+|||+++...
T Consensus 81 E~~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 81 EFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred ecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccc
Confidence 9999999999997643 2389999999999999999999999 99999999999999854 579999999998764
Q ss_pred CCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------ccccc
Q 035761 471 YDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------SSSSL 529 (560)
Q Consensus 471 ~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------~~~~~ 529 (560)
.. .......+++.|+|||...+..++.++||||+||++|||++|+.||..... .+..+
T Consensus 156 ~~-~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 234 (321)
T d1tkia_ 156 PG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234 (321)
T ss_dssp TT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred cC-CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHH
Confidence 32 334446789999999999999999999999999999999999999975442 12234
Q ss_pred ccccccccccCCCCCCChhHHHhhceee
Q 035761 530 DKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 530 ~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
.+.++.|...||..||+++++++|+|+.
T Consensus 235 ~~li~~~L~~dp~~R~s~~eil~hp~~~ 262 (321)
T d1tkia_ 235 MDFVDRLLVKERKSRMTASEALQHPWLK 262 (321)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred HHHHHHHccCChhHCcCHHHHhcCHhhc
Confidence 5667788889999999999999999985
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=368.99 Aligned_cols=235 Identities=26% Similarity=0.364 Sum_probs=191.6
Q ss_pred cCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
++|++.+.||+|+||.||+|++++++.||||+++.... ..+.|.+|+.++++++|||||+++|++.+ +..++||||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey 92 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 92 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC---CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEe
Confidence 57899999999999999999998888999999975432 34679999999999999999999999854 567899999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
+++|++..++..... ..++|.+++.++.|||.||+|||++ +|+||||||+|||+++++++||+|||+|+.......
T Consensus 93 ~~~g~l~~~~~~~~~-~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 93 MSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp CTTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred cCCCchhhhhhhccc-ccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 999999999876432 3499999999999999999999999 999999999999999999999999999987643322
Q ss_pred -CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc-------------------cccccccccc
Q 035761 475 -NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS-------------------SSSSLDKNIK 534 (560)
Q Consensus 475 -~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-------------------~~~~~~~~~~ 534 (560)
......||+.|+|||++.+..++.++|||||||++|||++|..||..... ....+.+.+.
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 248 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC 248 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHHH
Confidence 23345689999999999999999999999999999999996656532221 1233556667
Q ss_pred cccccCCCCCCChhHHHh--hceee
Q 035761 535 LIDLLDPRLPPPGDQMIR--QGIIL 557 (560)
Q Consensus 535 ~~~~~dp~~~p~~~~~~~--~~~~~ 557 (560)
.|...||+.||++++++. +.|+.
T Consensus 249 ~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 249 QCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred HHcccCHhHCcCHHHHHHHHhhhhc
Confidence 778889999999999876 55554
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-47 Score=373.90 Aligned_cols=232 Identities=22% Similarity=0.306 Sum_probs=195.3
Q ss_pred cCCccc-ceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEe----CCE
Q 035761 315 EDFDIK-YCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLH----EKC 387 (560)
Q Consensus 315 ~~~~~~-~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~ 387 (560)
++|++. +.||+|+||.||+|+. .+++.||||+++.. ..+.+|++++.++ +|||||++++++.+ +..
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 568776 4699999999999986 56899999998643 2466899887655 89999999999875 456
Q ss_pred EEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCC---CCcEEEeeec
Q 035761 388 MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNS---EFEAFVADFG 464 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg 464 (560)
.++|||||++|+|.+++.... ...+++.++..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccc
Confidence 899999999999999997643 23499999999999999999999999 9999999999999985 4679999999
Q ss_pred cccccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc-------------------
Q 035761 465 IARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS------------------- 525 (560)
Q Consensus 465 ~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~------------------- 525 (560)
+|+...... ......||+.|||||++.+..|+.++||||+||++|||+||+.||......
T Consensus 160 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~ 238 (335)
T d2ozaa1 160 FAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 238 (335)
T ss_dssp TCEECCCCC-CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCT
T ss_pred eeeeccCCC-ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence 998765433 334467999999999999999999999999999999999999999654321
Q ss_pred ------ccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 526 ------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 526 ------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
+..+.+.++.|...||..||++++++.|+|+..
T Consensus 239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 277 (335)
T d2ozaa1 239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277 (335)
T ss_dssp THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence 112345567778889999999999999999854
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.2e-47 Score=367.10 Aligned_cols=237 Identities=25% Similarity=0.338 Sum_probs=199.1
Q ss_pred cCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEec
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYEY 394 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 394 (560)
++|++.+.||+|+||.||+|+.++|+.||||+++.........+.+.+|+.+|++++||||+++++++..++..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 57899999999999999999999999999999976554444557899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
+.++.+..+..... .+++.++..++.||+.||+|||+. +||||||||+|||++.++.+|++|||.+........
T Consensus 82 ~~~~~~~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHHTSTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHhhcC---CcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 98877777765443 399999999999999999999999 999999999999999999999999999988765555
Q ss_pred CceeeccccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCCCCCccccc----------------------------
Q 035761 475 NRTLLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKHPGELLSSS---------------------------- 525 (560)
Q Consensus 475 ~~~~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~---------------------------- 525 (560)
......+++.|+|||.+.+. .++.++||||+||++|||++|+.||...+..
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence 55556789999999998754 5689999999999999999999999643210
Q ss_pred ------------------ccccccccccccccCCCCCCChhHHHhhceee
Q 035761 526 ------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 526 ------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
+..+.+.++.|...||+.||+++++++|+|+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~ 285 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 01122346678889999999999999999985
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-47 Score=362.89 Aligned_cols=236 Identities=23% Similarity=0.291 Sum_probs=198.9
Q ss_pred cCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhh----hhhHHHHHHHHHHHhccC--CCCcceeeeEEEeCCE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETE----LASLESFQNEARLLSQIR--HRNIVKLYGFCLHEKC 387 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~ 387 (560)
++|++.+.||+|+||.||+|+. .+|+.||||++...... ......+.+|+.++++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5799999999999999999986 46899999998754311 111234668999999986 8999999999999999
Q ss_pred EEEEEeccCC-CCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCC-CcEEEeeecc
Q 035761 388 MFLIYEYMEM-GSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSE-FEAFVADFGI 465 (560)
Q Consensus 388 ~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~ 465 (560)
.++||||+.+ +++.+++.... .+++.++..++.||++||+|||+. +|+||||||+|||++.+ +.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccc
Confidence 9999999986 67888886543 399999999999999999999999 99999999999999854 7899999999
Q ss_pred ccccCCCCCCceeeccccCccCccccccCcc-CcchhHHHHHHHHHHHHhCCCCCCcccc-----------ccccccccc
Q 035761 466 ARLLNYDSSNRTLLAGTYGSIAPELAYTMVV-TEKYDVYSFGVVALEVLMGKHPGELLSS-----------SSSSLDKNI 533 (560)
Q Consensus 466 ~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~-~~~~Dv~s~G~il~el~~g~~P~~~~~~-----------~~~~~~~~~ 533 (560)
|+.... .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||..... .+.++.+.+
T Consensus 158 a~~~~~--~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~~~~~~~~~~~s~~~~~li 235 (273)
T d1xwsa_ 158 GALLKD--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLI 235 (273)
T ss_dssp CEECCS--SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCCCCCSSCCCHHHHHHH
T ss_pred ceeccc--ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHhhcccCCCCCCCHHHHHHH
Confidence 987543 23345679999999999987766 4678999999999999999999975432 234556777
Q ss_pred ccccccCCCCCCChhHHHhhceeee
Q 035761 534 KLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 534 ~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
+.|...||..||+++++++|+|+.+
T Consensus 236 ~~~L~~dp~~R~s~~eil~hp~~~~ 260 (273)
T d1xwsa_ 236 RWCLALRPSDRPTFEEIQNHPWMQD 260 (273)
T ss_dssp HHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred HHHccCCHhHCcCHHHHhcCHhhCC
Confidence 8899999999999999999999875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.9e-46 Score=358.87 Aligned_cols=235 Identities=26% Similarity=0.357 Sum_probs=187.6
Q ss_pred cCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCC----EE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEK----CM 388 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~ 388 (560)
++|++.+.||+|+||.||+|.. .+|+.||||+++.... .....+.+.+|+++++.++||||+++++++..++ ..
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 5799999999999999999986 4689999999976442 2344567999999999999999999999998654 47
Q ss_pred EEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccc
Q 035761 389 FLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARL 468 (560)
Q Consensus 389 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 468 (560)
++||||+++|+|.+++...+. +++.++..++.||+.||+|||+. +||||||||+|||++.++..+++|||.+..
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~~---l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEECCCCCEehhhhcccCC---CCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhh
Confidence 899999999999999876543 99999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCC---CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------
Q 035761 469 LNYDSS---NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSS--------------------- 524 (560)
Q Consensus 469 ~~~~~~---~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~--------------------- 524 (560)
...... .....+||+.|||||++.+..+++++||||+||++|||+||+.||.....
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 240 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSS
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccC
Confidence 543222 23345799999999999999999999999999999999999999975432
Q ss_pred cccccccccccccccCCCCCCChhHHHhhce
Q 035761 525 SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGI 555 (560)
Q Consensus 525 ~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~ 555 (560)
.+..+.+.++.|...||..||+..+.+.+.|
T Consensus 241 ~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l 271 (277)
T d1o6ya_ 241 LSADLDAVVLKALAKNPENRYQTAAEMRADL 271 (277)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred CCHHHHHHHHHHccCCHhHCHhHHHHHHHHH
Confidence 1122445556667778888874444444444
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-46 Score=365.78 Aligned_cols=232 Identities=23% Similarity=0.406 Sum_probs=189.5
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCc----EEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGK----VVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMF 389 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 389 (560)
++|++.+.||+|+||.||+|.+. +|+ +||||+++.... ....+.|.+|++++++++|||||+++|+|.++ ..+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence 45899999999999999999864 343 589998875432 34567899999999999999999999999875 467
Q ss_pred EEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccccc
Q 035761 390 LIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL 469 (560)
Q Consensus 390 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 469 (560)
+++||+.+|+|.+++..... .+++.++..++.|||+||+|||++ +||||||||+|||++.++.+||+|||+|+..
T Consensus 87 ~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEEECCTTCBHHHHHHHTSS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEEeccCCccccccccccc--CCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence 88999999999998876533 389999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCCC--ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------------ccc
Q 035761 470 NYDSSN--RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------------SSS 528 (560)
Q Consensus 470 ~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------------~~~ 528 (560)
...... .....||+.|||||++.+..++.++|||||||++|||+| |+.||+..... ...
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~ 241 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 241 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHH
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHH
Confidence 543332 233468999999999999999999999999999999998 89998754321 123
Q ss_pred cccccccccccCCCCCCChhHHHhh
Q 035761 529 LDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 529 ~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
+.++++.|...||..||++++++.+
T Consensus 242 ~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 242 VYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhCCCChhhCcCHHHHHHH
Confidence 4556677778899999999888875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=356.58 Aligned_cols=227 Identities=26% Similarity=0.397 Sum_probs=180.8
Q ss_pred cCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC-CEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHE-KCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e 393 (560)
++|++.+.||+|+||.||+|+++ |+.||||+++... ..+.+.+|++++++++||||++++|+|.++ +..++|||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 56888999999999999999985 7899999997533 235789999999999999999999999654 56799999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
|+++|+|.+++.... ...++|..+++|+.|||.||+|||+. +|+||||||+||+++.++.+|++|||+++....
T Consensus 82 y~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~-- 155 (262)
T d1byga_ 82 YMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-- 155 (262)
T ss_dssp CCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred ccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCC--
Confidence 999999999997543 22489999999999999999999999 999999999999999999999999999987543
Q ss_pred CCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccccc------------------cccccccc
Q 035761 474 SNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSSS------------------SSLDKNIK 534 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~~------------------~~~~~~~~ 534 (560)
......+++.|+|||++.+..+++++|||||||++|||+| |+.||+.....+ ..+.+.++
T Consensus 156 -~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~ 234 (262)
T d1byga_ 156 -TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMK 234 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHH
T ss_pred -CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHH
Confidence 2233467889999999999999999999999999999998 788887544311 12334445
Q ss_pred cccccCCCCCCChhHHHhh
Q 035761 535 LIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 535 ~~~~~dp~~~p~~~~~~~~ 553 (560)
.|...||..||++.+++++
T Consensus 235 ~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 235 NCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHcccCHhHCcCHHHHHHH
Confidence 5556666666666666553
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=360.57 Aligned_cols=233 Identities=27% Similarity=0.376 Sum_probs=181.1
Q ss_pred hcCCcccceeeccCCeeEEEEEeCC----CcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLPS----GKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMF 389 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 389 (560)
.++|++.+.||+|+||.||+|.+.. +..||||.++.... ....+.|.+|++++++++||||++++|++. ++..+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-DSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 3578999999999999999998643 35689999865433 344567999999999999999999999986 46789
Q ss_pred EEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccccc
Q 035761 390 LIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL 469 (560)
Q Consensus 390 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 469 (560)
+||||+++|++.+++..... .+++.++..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+|+..
T Consensus 84 iv~E~~~~g~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEEECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEEeccCCcHHhhhhccCC--CCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheec
Confidence 99999999999998775433 389999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCC-CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc------------------cccc
Q 035761 470 NYDSS-NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS------------------SSSL 529 (560)
Q Consensus 470 ~~~~~-~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~------------------~~~~ 529 (560)
..... ......||+.|+|||++.+..++.++|||||||++|||++ |++||...... ...+
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 238 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 238 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 54332 2334568999999999999999999999999999999998 89999755431 1123
Q ss_pred ccccccccccCCCCCCChhHHHhh
Q 035761 530 DKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 530 ~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
.++++.|...||..||++++++++
T Consensus 239 ~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 239 YSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHH
Confidence 445555666677777777776654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-46 Score=357.39 Aligned_cols=231 Identities=24% Similarity=0.357 Sum_probs=179.0
Q ss_pred cCCcccceeeccCCeeEEEEEeCC--C--cEEEEEEccchhh-hhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPS--G--KVVALKKLHRLET-ELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMF 389 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 389 (560)
++|++.+.||+|+||.||+|++.. + ..||||+++.... ..+..+.|.+|++++++++||||++++|++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 568999999999999999998632 2 3789999875432 33445689999999999999999999999965 4678
Q ss_pred EEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccccc
Q 035761 390 LIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLL 469 (560)
Q Consensus 390 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~ 469 (560)
+||||+++|++.+++..... .+++..++.++.|||+||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 87 lv~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhcccC--CCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhc
Confidence 99999999999988876433 399999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCCC---ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCccccc-------------------c
Q 035761 470 NYDSSN---RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSSS-------------------S 526 (560)
Q Consensus 470 ~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~~-------------------~ 526 (560)
...... .....|+..|+|||++.+..++.++|||||||++|||+| |+.||...+.. .
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 241 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCccccc
Confidence 543332 223457889999999999999999999999999999998 89999744321 1
Q ss_pred cccccccccccccCCCCCCChhHHH
Q 035761 527 SSLDKNIKLIDLLDPRLPPPGDQMI 551 (560)
Q Consensus 527 ~~~~~~~~~~~~~dp~~~p~~~~~~ 551 (560)
..+.+.+..|...||..||+++++.
T Consensus 242 ~~l~~li~~cl~~dp~~RPt~~ei~ 266 (273)
T d1u46a_ 242 QDIYNVMVQCWAHKPEDRPTFVALR 266 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHH
Confidence 1233445555666777777766654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-46 Score=363.38 Aligned_cols=238 Identities=24% Similarity=0.330 Sum_probs=193.4
Q ss_pred hcCCcccceeeccCCeeEEEEEe-CC-CcEEEEEEccchhhhhhhHHHHHHHHHHHhcc---CCCCcceeeeEEEe----
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARL-PS-GKVVALKKLHRLETELASLESFQNEARLLSQI---RHRNIVKLYGFCLH---- 384 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~---- 384 (560)
.++|++.+.||+|+||.||+|+. ++ ++.||||+++...........+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999986 34 56799999875443322233456777777665 89999999999863
Q ss_pred -CCEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeee
Q 035761 385 -EKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADF 463 (560)
Q Consensus 385 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 463 (560)
....+++|||+++|.+........ ..+++..+..++.|++.||+|||++ +||||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecch
Confidence 246899999999877755544332 3389999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc------------------
Q 035761 464 GIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS------------------ 525 (560)
Q Consensus 464 g~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~------------------ 525 (560)
|+++..... .......||+.|||||++.+..++.++||||+||++|||++|+.||...+..
T Consensus 161 g~~~~~~~~-~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 161 GLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hhhhhhccc-ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 999865432 2334567999999999999999999999999999999999999999644210
Q ss_pred --------------------------ccccccccccccccCCCCCCChhHHHhhceee
Q 035761 526 --------------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 526 --------------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
+..+.+.++.|...||+.||+++++++|+|+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~ 297 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGT
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhc
Confidence 11123356677888999999999999999985
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-45 Score=356.00 Aligned_cols=228 Identities=25% Similarity=0.393 Sum_probs=189.6
Q ss_pred cceeeccCCeeEEEEEeCCC----cEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEe-CCEEEEEEec
Q 035761 320 KYCIGTGGYGSVYRARLPSG----KVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLH-EKCMFLIYEY 394 (560)
Q Consensus 320 ~~~ig~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~ 394 (560)
.++||+|+||+||+|.+.++ ..||||+++... .....+.|.+|++++++++||||++++|++.+ ++..++||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 56899999999999987542 358999987543 23455789999999999999999999999876 5689999999
Q ss_pred cCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 035761 395 MEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDSS 474 (560)
Q Consensus 395 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 474 (560)
+++|+|.+++..... .+++.++++++.|+|+||.|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 111 ~~~g~l~~~~~~~~~--~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 111 MKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp CTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred eecCchhhhhccccc--cchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 999999999886543 378899999999999999999999 999999999999999999999999999987654322
Q ss_pred C----ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc-------------------cccccc
Q 035761 475 N----RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS-------------------SSSLDK 531 (560)
Q Consensus 475 ~----~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~-------------------~~~~~~ 531 (560)
. .....||+.|+|||.+.+..++.++||||||+++|||+||+.||....+. ...+.+
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~ 265 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 265 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHH
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHH
Confidence 2 22346899999999999999999999999999999999988777543221 123556
Q ss_pred ccccccccCCCCCCChhHHHhh
Q 035761 532 NIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 532 ~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
.+..|...||..||++++++++
T Consensus 266 li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 266 VMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHH
Confidence 6677788899999999988876
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.4e-46 Score=361.46 Aligned_cols=239 Identities=27% Similarity=0.379 Sum_probs=193.9
Q ss_pred HHHHhcCCcccceeeccCCeeEEEEEeC------CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEE
Q 035761 310 MIEATEDFDIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCL 383 (560)
Q Consensus 310 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 383 (560)
++.+.++|++.+.||+|+||.||+|+++ +++.||||+++.... ....+.|.+|++++++++||||+++++++.
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcC-hHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 3335578999999999999999999864 357899999975432 344567999999999999999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHhhcCC---------------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q 035761 384 HEKCMFLIYEYMEMGSLFCILRTDE---------------------EAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILH 442 (560)
Q Consensus 384 ~~~~~~lv~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH 442 (560)
..+..++||||+++|+|.+++.... ....+++.+++.|+.|+|.||+|||+. ++||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEe
Confidence 9999999999999999999986432 123489999999999999999999999 9999
Q ss_pred eCCCCCCeEeCCCCcEEEeeeccccccCCCCCC--ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCC-CCC
Q 035761 443 RDISSNNILLNSEFEAFVADFGIARLLNYDSSN--RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGK-HPG 519 (560)
Q Consensus 443 ~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~-~P~ 519 (560)
|||||+|||++.++.+||+|||+|+........ .....|++.|+|||.+.+..++.++|||||||++|||++|. +||
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 999999999999999999999999876433222 23456889999999999999999999999999999999985 567
Q ss_pred Cccccc------------------ccccccccccccccCCCCCCChhHHHh
Q 035761 520 ELLSSS------------------SSSLDKNIKLIDLLDPRLPPPGDQMIR 552 (560)
Q Consensus 520 ~~~~~~------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~ 552 (560)
...... ..++..++..|...||+.||++.++++
T Consensus 244 ~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 244 YGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp TTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 644321 112344455556667777777777654
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-45 Score=357.22 Aligned_cols=234 Identities=26% Similarity=0.412 Sum_probs=191.1
Q ss_pred cCCcccceeeccCCeeEEEEEeCC-Cc--EEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCCEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPS-GK--VVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEKCMFL 390 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 390 (560)
++|++.+.||+|+||.||+|.+++ |. .||||+++..... ...+.|.+|+++++++ +|||||+++|++.+++..++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccCh-HHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 578899999999999999998754 43 4788887644322 3455799999999998 79999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCC-------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCc
Q 035761 391 IYEYMEMGSLFCILRTDE-------------EAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFE 457 (560)
Q Consensus 391 v~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~ 457 (560)
||||+++|+|.++++... ....+++.++..++.|||+||.|||+. +|+||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCc
Confidence 999999999999997542 234599999999999999999999999 9999999999999999999
Q ss_pred EEEeeeccccccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCC-CCCCcccc------------
Q 035761 458 AFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGK-HPGELLSS------------ 524 (560)
Q Consensus 458 ~kl~Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~-~P~~~~~~------------ 524 (560)
+||+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|. +||...+.
T Consensus 166 ~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~ 244 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 244 (309)
T ss_dssp EEECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred eEEccccccccccccc-cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC
Confidence 9999999998654322 223446899999999999999999999999999999999965 56753331
Q ss_pred ------cccccccccccccccCCCCCCChhHHHhh
Q 035761 525 ------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 525 ------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
....+.+.+..|...||+.||++++++++
T Consensus 245 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 245 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 12234566677778889999999888875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-45 Score=356.57 Aligned_cols=237 Identities=24% Similarity=0.353 Sum_probs=185.6
Q ss_pred HhcCCcccceeeccCCeeEEEEEeC------CCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeC
Q 035761 313 ATEDFDIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLHE 385 (560)
Q Consensus 313 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 385 (560)
..++|++.+.||+|+||.||+|.+. +++.||||+++..... ...+.+.+|...+.++ +|+||+.+++++..+
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~-~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCc-HHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 3467999999999999999999853 3468999999754432 3345677888888776 789999999998765
Q ss_pred C-EEEEEEeccCCCCHHHHhhcCCc-------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeE
Q 035761 386 K-CMFLIYEYMEMGSLFCILRTDEE-------------AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNIL 451 (560)
Q Consensus 386 ~-~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nil 451 (560)
+ ..++||||+++|+|.++++.... ...+++.++..++.||++||+|||++ +||||||||+|||
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NIL 166 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNIL 166 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCcccee
Confidence 4 68999999999999999975432 23489999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeeeccccccCCCCC--CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhC-CCCCCcccc----
Q 035761 452 LNSEFEAFVADFGIARLLNYDSS--NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMG-KHPGELLSS---- 524 (560)
Q Consensus 452 l~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g-~~P~~~~~~---- 524 (560)
+++++.+||+|||+|+....... ......||+.|||||++.+..++.++|||||||++|||+|| ..||.....
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~ 246 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 246 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999987643332 23345799999999999999999999999999999999996 567764432
Q ss_pred ---------------cccccccccccccccCCCCCCChhHHHhh
Q 035761 525 ---------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 525 ---------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
....+.+.+..|...||..||++++++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 247 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 11234455666777899999999998876
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=351.51 Aligned_cols=198 Identities=26% Similarity=0.376 Sum_probs=162.2
Q ss_pred cCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCC----EEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEK----CMFL 390 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~l 390 (560)
.+|.+.+.||+|+||.||+|++ +|+.||||+++..... ......|+..++.++||||++++|++.+++ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~---~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH---HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh---HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4577788999999999999997 5899999998653321 112233455556789999999999998754 5799
Q ss_pred EEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEEeCCCCCCeEeCCCCcEEEeeecc
Q 035761 391 IYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHH-----CTPPILHRDISSNNILLNSEFEAFVADFGI 465 (560)
Q Consensus 391 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-----~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 465 (560)
||||+++|+|.+++++.. ++|.++.+++.|+|.||+|+|+. ..++||||||||+|||++.++.+||+|||+
T Consensus 79 v~Ey~~~g~L~~~l~~~~----l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEECCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEecccCCCHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 999999999999998642 89999999999999999999963 124999999999999999999999999999
Q ss_pred ccccCCCCC----CceeeccccCccCccccccCc------cCcchhHHHHHHHHHHHHhCCCCCC
Q 035761 466 ARLLNYDSS----NRTLLAGTYGSIAPELAYTMV------VTEKYDVYSFGVVALEVLMGKHPGE 520 (560)
Q Consensus 466 ~~~~~~~~~----~~~~~~g~~~~~aPE~~~~~~------~~~~~Dv~s~G~il~el~~g~~P~~ 520 (560)
++....... ......||++|||||++.+.. ++.++|||||||++|||+||..||.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~ 219 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCC
Confidence 987744322 223457999999999987643 6779999999999999999998874
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-44 Score=349.40 Aligned_cols=237 Identities=20% Similarity=0.291 Sum_probs=203.4
Q ss_pred cCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCEEEEEEe
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKCMFLIYE 393 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 393 (560)
++|++.+.||+|+||+||+|+. .+++.||||+++...........+.+|+.+++.++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5789999999999999999986 468999999997655444556788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 035761 394 YMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARLLNYDS 473 (560)
Q Consensus 394 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 473 (560)
++.++++..++...+. +++.++..++.|++.||+|||++ +||||||||+|||++.++.+||+|||.|+......
T Consensus 82 ~~~~~~l~~~~~~~~~---~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGD---LDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHTTTC---CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccccccc---cchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 9999999888775543 89999999999999999999999 99999999999999999999999999999876555
Q ss_pred CCceeeccccCccCccccccCc-cCcchhHHHHHHHHHHHHhCCCCCCcccccc--------------------------
Q 035761 474 SNRTLLAGTYGSIAPELAYTMV-VTEKYDVYSFGVVALEVLMGKHPGELLSSSS-------------------------- 526 (560)
Q Consensus 474 ~~~~~~~g~~~~~aPE~~~~~~-~~~~~Dv~s~G~il~el~~g~~P~~~~~~~~-------------------------- 526 (560)
.......+++.|+|||.+.... ++.++||||+||++|||++|+.||....+..
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
T d1unla_ 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence 5555556788999999887665 6889999999999999999999974322111
Q ss_pred ---------------------cccccccccccccCCCCCCChhHHHhhceee
Q 035761 527 ---------------------SSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 527 ---------------------~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
..+.+.++.|...||+.||+++++++|+|+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~ 287 (292)
T d1unla_ 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGS
T ss_pred ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhc
Confidence 0122345677888999999999999999985
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=350.86 Aligned_cols=236 Identities=25% Similarity=0.363 Sum_probs=192.7
Q ss_pred hcCCcccceeeccCCeeEEEEEeCC--------CcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEe
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLPS--------GKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLH 384 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 384 (560)
.++|++.+.||+|+||.||+|+... +..||||+++..... .....+.+|...+.++ +|||||+++++|.+
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccCh-HHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 3578899999999999999997532 347999999765433 3456788898888888 89999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHhhcCCc-------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeE
Q 035761 385 EKCMFLIYEYMEMGSLFCILRTDEE-------------AVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNIL 451 (560)
Q Consensus 385 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nil 451 (560)
++..++||||+++|+|.+++..... ...+++.++..++.|||.||+|||+. +||||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeeccccee
Confidence 9999999999999999999975431 23489999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeeeccccccCCCCCC--ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc----
Q 035761 452 LNSEFEAFVADFGIARLLNYDSSN--RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS---- 524 (560)
Q Consensus 452 l~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~---- 524 (560)
++.++.+||+|||+++........ .....|++.|+|||.+.+..|++++|||||||++|||++ |++||+....
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~ 247 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH
Confidence 999999999999999877543322 233568999999999999999999999999999999998 7888864431
Q ss_pred --------------cccccccccccccccCCCCCCChhHHHhh
Q 035761 525 --------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 525 --------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
....+.+.++.|...||..||+++++++.
T Consensus 248 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 290 (299)
T d1fgka_ 248 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290 (299)
T ss_dssp HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 12235566677788899999999888764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=352.15 Aligned_cols=235 Identities=27% Similarity=0.393 Sum_probs=195.7
Q ss_pred hcCCcccceeeccCCeeEEEEEe------CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhcc-CCCCcceeeeEEEeCC
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRLETELASLESFQNEARLLSQI-RHRNIVKLYGFCLHEK 386 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 386 (560)
.++|++.+.||+|+||.||+|++ .+++.||||+++.... ......+.+|+.+++++ +|||||+++|++.+++
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC-HHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 46788999999999999999975 2457899999976443 34456789999999999 7999999999999999
Q ss_pred EEEEEEeccCCCCHHHHhhcCC---------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeE
Q 035761 387 CMFLIYEYMEMGSLFCILRTDE---------------EAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNIL 451 (560)
Q Consensus 387 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nil 451 (560)
..++||||+++|+|.++++... ....+++.++..++.|||+||+|||++ ++|||||||+||+
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccc
Confidence 9999999999999999997643 123589999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeeeccccccCCCCCCc--eeeccccCccCccccccCccCcchhHHHHHHHHHHHHh-CCCCCCcccc----
Q 035761 452 LNSEFEAFVADFGIARLLNYDSSNR--TLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLM-GKHPGELLSS---- 524 (560)
Q Consensus 452 l~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~-g~~P~~~~~~---- 524 (560)
++.++.+|++|||.++......... ....||+.|+|||++.+..++.++|||||||++|||+| |.+||.....
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~ 257 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999999875433322 23568999999999999999999999999999999999 5665643332
Q ss_pred ---------------cccccccccccccccCCCCCCChhHHHh
Q 035761 525 ---------------SSSSLDKNIKLIDLLDPRLPPPGDQMIR 552 (560)
Q Consensus 525 ---------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~ 552 (560)
....+.+++..|...||..||+++++++
T Consensus 258 ~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 258 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1123455666777788888888888775
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-44 Score=356.56 Aligned_cols=233 Identities=24% Similarity=0.308 Sum_probs=191.7
Q ss_pred hcCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCC------
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEK------ 386 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 386 (560)
.++|++.+.||+|+||.||+|... +|+.||||+++.........+.+.+|+++|+.++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 357999999999999999999864 6999999999865544455677899999999999999999999997654
Q ss_pred EEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccc
Q 035761 387 CMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIA 466 (560)
Q Consensus 387 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~ 466 (560)
..++||||+ +++|..+.+.. .+++..+..++.||+.||+|||++ +||||||||+|||++.++.+|++|||+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccce
Confidence 469999999 55777777543 299999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCceeeccccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCCCCCcccc---------------------
Q 035761 467 RLLNYDSSNRTLLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKHPGELLSS--------------------- 524 (560)
Q Consensus 467 ~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~P~~~~~~--------------------- 524 (560)
+.... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||...+.
T Consensus 169 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (346)
T d1cm8a_ 169 RQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245 (346)
T ss_dssp EECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred eccCC---ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence 87643 23445799999999998764 568899999999999999999999965421
Q ss_pred ---------------------------cccccccccccccccCCCCCCChhHHHhhceee
Q 035761 525 ---------------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 525 ---------------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
.+..+.+.++.|...||+.||+++++++|+|+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~ 305 (346)
T d1cm8a_ 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 305 (346)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGT
T ss_pred hcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhC
Confidence 011223456778889999999999999999985
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-44 Score=351.87 Aligned_cols=238 Identities=21% Similarity=0.307 Sum_probs=193.3
Q ss_pred cCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC--------
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHE-------- 385 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------- 385 (560)
++|++.+.||+|+||+||+|+. ++|+.||||++..........+.+.+|++++++++|||++++++++...
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 6799999999999999999986 4799999999876554444556788999999999999999999998653
Q ss_pred CEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecc
Q 035761 386 KCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGI 465 (560)
Q Consensus 386 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 465 (560)
...++||||++++.+..+..... .++..++..++.||+.||.|||+. +|+||||||+|||++.++.+|++|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~~---~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCCCccchhhhccc---ccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecce
Confidence 45799999998877765554332 388999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCC----CceeeccccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCCCCCccccc---------------
Q 035761 466 ARLLNYDSS----NRTLLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------- 525 (560)
Q Consensus 466 ~~~~~~~~~----~~~~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------- 525 (560)
++.+..... .....+||+.|+|||++.+. .+++++||||+||++|||++|+.||......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 987643221 22335699999999998765 6889999999999999999999999643310
Q ss_pred ----------------------------------ccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 526 ----------------------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 526 ----------------------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
+..+.+.++.|...||+.||+++++++|+|+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 001123456788889999999999999999874
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-45 Score=354.02 Aligned_cols=236 Identities=23% Similarity=0.351 Sum_probs=196.7
Q ss_pred hcCCcccceeeccCCeeEEEEEeC------CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCCE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEKC 387 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 387 (560)
.++|++.+.||+|+||.||+|.+. +++.||||+++.... ......|.+|++++++++||||++++|++..+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC-HHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccC-hHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence 467899999999999999999763 357899999975443 3445678999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhcCC-------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEE
Q 035761 388 MFLIYEYMEMGSLFCILRTDE-------EAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFV 460 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 460 (560)
.++||||+++|+|.+++.... ....+++..+.+++.|+|+||.|||+. +|+||||||+|||++.++++||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEE
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEE
Confidence 999999999999999987532 123479999999999999999999999 9999999999999999999999
Q ss_pred eeeccccccCCCCCC--ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhC-CCCCCcccc-------------
Q 035761 461 ADFGIARLLNYDSSN--RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMG-KHPGELLSS------------- 524 (560)
Q Consensus 461 ~Dfg~~~~~~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g-~~P~~~~~~------------- 524 (560)
+|||+|+........ .....||+.|+|||.+.+..++.++||||||+++|||+|| +.||.....
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~ 254 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 254 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCC
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCC
Confidence 999999876433222 2234589999999999999999999999999999999998 477764432
Q ss_pred -----cccccccccccccccCCCCCCChhHHHhh
Q 035761 525 -----SSSSLDKNIKLIDLLDPRLPPPGDQMIRQ 553 (560)
Q Consensus 525 -----~~~~~~~~~~~~~~~dp~~~p~~~~~~~~ 553 (560)
....+.+.+..|...||..||+++++++.
T Consensus 255 ~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~ 288 (308)
T d1p4oa_ 255 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288 (308)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 11234556666777788888888888763
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-44 Score=354.52 Aligned_cols=236 Identities=22% Similarity=0.277 Sum_probs=193.4
Q ss_pred hcCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeCC----EE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHEK----CM 388 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~ 388 (560)
+++|++.+.||+|+||.||+|.. .+|+.||||++..... ....+.+++|+++|++++||||+++++++..+. ..
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTC-HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcC-hHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 35689999999999999999975 5799999999975442 344567889999999999999999999997653 23
Q ss_pred EEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccc
Q 035761 389 FLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIARL 468 (560)
Q Consensus 389 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 468 (560)
+++++|+.+|+|.+++... .+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.
T Consensus 86 ~~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 4445667799999999754 289999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC---CceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCcccc--------------------
Q 035761 469 LNYDSS---NRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSS-------------------- 524 (560)
Q Consensus 469 ~~~~~~---~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~-------------------- 524 (560)
...... .....+||+.|+|||++.. ..++.++||||+||++|||++|+.||.....
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence 643222 2344578999999999854 5578899999999999999999999964331
Q ss_pred ----------------------------cccccccccccccccCCCCCCChhHHHhhceee
Q 035761 525 ----------------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 525 ----------------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
.+..+...++.|...||..||+++++++|+|+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~ 299 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 299 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGT
T ss_pred hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhc
Confidence 112244567888899999999999999999975
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-44 Score=353.52 Aligned_cols=232 Identities=24% Similarity=0.265 Sum_probs=188.7
Q ss_pred CCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC------CEE
Q 035761 316 DFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHE------KCM 388 (560)
Q Consensus 316 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~ 388 (560)
+|+..++||+|+||+||+|+.. +|+.||||++..... ...+|++++++++||||+++++++... ...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 5778899999999999999875 689999999975432 234799999999999999999998653 357
Q ss_pred EEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCC-cEEEeeecccc
Q 035761 389 FLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEF-EAFVADFGIAR 467 (560)
Q Consensus 389 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~~~ 467 (560)
++||||+++|.+....+.......+++.++..++.||+.||+|||+. ||+||||||+|||++.++ .+||+|||+++
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchh
Confidence 89999998765444433222334499999999999999999999999 999999999999999775 89999999998
Q ss_pred ccCCCCCCceeeccccCccCcccccc-CccCcchhHHHHHHHHHHHHhCCCCCCccccc---------------------
Q 035761 468 LLNYDSSNRTLLAGTYGSIAPELAYT-MVVTEKYDVYSFGVVALEVLMGKHPGELLSSS--------------------- 525 (560)
Q Consensus 468 ~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~--------------------- 525 (560)
...... ......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||......
T Consensus 172 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 172 QLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp ECCTTS-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred hccCCc-ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 765332 3334579999999998765 57899999999999999999999999643310
Q ss_pred -------------------------ccccccccccccccCCCCCCChhHHHhhceee
Q 035761 526 -------------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 526 -------------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
+.++.+.++.|...||..||+++++++|+|+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~ 307 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 307 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhc
Confidence 11123355678888999999999999999975
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.4e-43 Score=346.32 Aligned_cols=229 Identities=18% Similarity=0.267 Sum_probs=192.4
Q ss_pred cCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccC-CCCcceeeeEEEeC--CEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIR-HRNIVKLYGFCLHE--KCMFL 390 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~l 390 (560)
++|++.+.||+|+||+||+|+. .+|+.||||+++... .+.+.+|+++|+.++ ||||+++++++... ...++
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 5799999999999999999987 468999999987533 346789999999995 99999999999754 56899
Q ss_pred EEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCC-cEEEeeecccccc
Q 035761 391 IYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEF-EAFVADFGIARLL 469 (560)
Q Consensus 391 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~~~~~ 469 (560)
||||+++|+|..+.+ .+++.++..++.||+.||+|||++ |||||||||+|||++.++ .+||+|||+|+..
T Consensus 110 v~e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 110 VFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp EEECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred EEeecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceec
Confidence 999999999977653 289999999999999999999999 999999999999998655 5899999999876
Q ss_pred CCCCCCceeeccccCccCccccccCc-cCcchhHHHHHHHHHHHHhCCCCCCccccc-----------------------
Q 035761 470 NYDSSNRTLLAGTYGSIAPELAYTMV-VTEKYDVYSFGVVALEVLMGKHPGELLSSS----------------------- 525 (560)
Q Consensus 470 ~~~~~~~~~~~g~~~~~aPE~~~~~~-~~~~~Dv~s~G~il~el~~g~~P~~~~~~~----------------------- 525 (560)
.... ......+|+.|+|||.+.+.. ++.++||||+||++|||++|+.||....+.
T Consensus 181 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 181 HPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp CTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred cCCC-cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 5432 334457899999999987654 789999999999999999999998643211
Q ss_pred --------------------------------ccccccccccccccCCCCCCChhHHHhhceeee
Q 035761 526 --------------------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIILI 558 (560)
Q Consensus 526 --------------------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~~ 558 (560)
+.++.+.++.|...||+.||+++++++|+|+..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~ 324 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 011223457788899999999999999999863
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-43 Score=350.05 Aligned_cols=233 Identities=24% Similarity=0.264 Sum_probs=186.9
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEe------CCE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLH------EKC 387 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~ 387 (560)
++|++.+.||+|+||+||+|+.. +|+.||||++..........+.+.+|+.+++.++||||+++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57999999999999999999875 69999999998655444555678899999999999999999999964 367
Q ss_pred EEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccc
Q 035761 388 MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIAR 467 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~ 467 (560)
.|+||||+.++.+ +.+.. .+++.++..++.||+.||+|||++ ||+||||||+|||++.++.++++|||+++
T Consensus 97 ~~iv~Ey~~~~l~-~~~~~-----~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLC-QVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHH-HHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHH-Hhhhc-----CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhh
Confidence 8999999976544 44432 289999999999999999999999 99999999999999999999999999988
Q ss_pred ccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc----------------------
Q 035761 468 LLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS---------------------- 525 (560)
Q Consensus 468 ~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~---------------------- 525 (560)
.... ........+|+.|+|||++.+..+++++||||+||++|||++|+.||...+..
T Consensus 168 ~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 168 TAGT-SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred cccc-ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 7543 23334557899999999999999999999999999999999999999533210
Q ss_pred -------------------------------------ccccccccccccccCCCCCCChhHHHhhceee
Q 035761 526 -------------------------------------SSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 526 -------------------------------------~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
+..+.+.++.|...||+.||+++++++|+|++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~ 315 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 315 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTG
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccC
Confidence 01123456678899999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=347.10 Aligned_cols=237 Identities=27% Similarity=0.383 Sum_probs=197.5
Q ss_pred cCCcccceeeccCCeeEEEEEe----CCCcEEEEEEccchhh--hhhhHHHHHHHHHHHhccCC-CCcceeeeEEEeCCE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL----PSGKVVALKKLHRLET--ELASLESFQNEARLLSQIRH-RNIVKLYGFCLHEKC 387 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~ 387 (560)
++|++.+.||+|+||.||+|+. .+|+.||||.+++... .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5699999999999999999975 2478999999875431 22234567899999999966 899999999999999
Q ss_pred EEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccc
Q 035761 388 MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIAR 467 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~ 467 (560)
.++||||+.+|+|.+++..... +.......++.||+.|++|+|+. +||||||||+||+++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~---~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhccc---ccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchh
Confidence 9999999999999999986554 78889999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC-CceeeccccCccCccccccC--ccCcchhHHHHHHHHHHHHhCCCCCCccccc-------------------
Q 035761 468 LLNYDSS-NRTLLAGTYGSIAPELAYTM--VVTEKYDVYSFGVVALEVLMGKHPGELLSSS------------------- 525 (560)
Q Consensus 468 ~~~~~~~-~~~~~~g~~~~~aPE~~~~~--~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~------------------- 525 (560)
.+..... ......|++.|+|||.+.+. .++.++||||+||++|||++|+.||......
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~ 257 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 257 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcc
Confidence 7643222 23345789999999998754 4678999999999999999999999755421
Q ss_pred --ccccccccccccccCCCCCC-----ChhHHHhhceee
Q 035761 526 --SSSLDKNIKLIDLLDPRLPP-----PGDQMIRQGIIL 557 (560)
Q Consensus 526 --~~~~~~~~~~~~~~dp~~~p-----~~~~~~~~~~~~ 557 (560)
+..+...++.|...||..|| +++++++|+|+.
T Consensus 258 ~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~ 296 (322)
T d1vzoa_ 258 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 296 (322)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGT
T ss_pred cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhc
Confidence 12244566777888999998 479999999974
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-43 Score=348.71 Aligned_cols=234 Identities=23% Similarity=0.287 Sum_probs=194.6
Q ss_pred hcCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceeeeEEEeC-----CE
Q 035761 314 TEDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLYGFCLHE-----KC 387 (560)
Q Consensus 314 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 387 (560)
.++|++.+.||+|+||+||+|+. .+|+.||||+++.........+.+.+|++++++++|||+|++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46799999999999999999986 5699999999986654445566788999999999999999999998643 34
Q ss_pred EEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEeeecccc
Q 035761 388 MFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVADFGIAR 467 (560)
Q Consensus 388 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~ 467 (560)
.+++++|+.+|+|.+++... .+++.++..++.||+.||+|||++ ||+||||||+|||++.++.+|++|||.+.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhc
Confidence 56778888999999999653 299999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCCCceeeccccCccCccccccC-ccCcchhHHHHHHHHHHHHhCCCCCCcccc----------------------
Q 035761 468 LLNYDSSNRTLLAGTYGSIAPELAYTM-VVTEKYDVYSFGVVALEVLMGKHPGELLSS---------------------- 524 (560)
Q Consensus 468 ~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~Dv~s~G~il~el~~g~~P~~~~~~---------------------- 524 (560)
.... ......|++.|+|||...+. .++.++||||+||++|||++|+.||...+.
T Consensus 170 ~~~~---~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (348)
T d2gfsa1 170 HTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246 (348)
T ss_dssp CCTG---GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred ccCc---ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhc
Confidence 6532 23345689999999987665 467899999999999999999999964321
Q ss_pred --------------------------cccccccccccccccCCCCCCChhHHHhhceee
Q 035761 525 --------------------------SSSSLDKNIKLIDLLDPRLPPPGDQMIRQGIIL 557 (560)
Q Consensus 525 --------------------------~~~~~~~~~~~~~~~dp~~~p~~~~~~~~~~~~ 557 (560)
.+..+.+.++.|...||..||+++++++|+|+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~ 305 (348)
T d2gfsa1 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 305 (348)
T ss_dssp CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred cchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhC
Confidence 112234567788899999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.2e-41 Score=326.58 Aligned_cols=199 Identities=20% Similarity=0.270 Sum_probs=171.1
Q ss_pred cCCcccceeeccCCeeEEEEEeC-CCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCC-CCcceeeeEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRLETELASLESFQNEARLLSQIRH-RNIVKLYGFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 392 (560)
++|++.+.||+|+||.||+|+.. +|+.||||++...... ..+.+|++.++.++| +|++.+++++..+...++||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 57899999999999999999864 6899999988654322 246778889998865 89999999999999999999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCC-----CCcEEEeeecccc
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNS-----EFEAFVADFGIAR 467 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Dfg~~~ 467 (560)
||+ +++|.+++..... .+++.++..++.|++.||+|||+. ||+||||||+||+++. ++.+||+|||+|+
T Consensus 81 e~~-~~~l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 81 DLL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp ECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred Eec-CCCHHHHHHhhcc--chhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeE
Confidence 999 6899999876443 389999999999999999999999 9999999999999974 5789999999998
Q ss_pred ccCCCCC-------CceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccc
Q 035761 468 LLNYDSS-------NRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLS 523 (560)
Q Consensus 468 ~~~~~~~-------~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~ 523 (560)
.+..... ......||+.|||||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~ 217 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 217 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCcc
Confidence 7643221 1233579999999999999999999999999999999999999997543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.8e-41 Score=327.12 Aligned_cols=226 Identities=17% Similarity=0.245 Sum_probs=180.8
Q ss_pred cCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCcceee-eEEEeCCEEEEEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNIVKLY-GFCLHEKCMFLIY 392 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~-~~~~~~~~~~lv~ 392 (560)
++|++.+.||+|+||.||+|++ .+|+.||||++...... +.+.+|+++++.++|++++..+ ++..+.+..++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 4699999999999999999986 46899999987654322 3477899999999877655554 5556778899999
Q ss_pred eccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCC---CCcEEEeeecccccc
Q 035761 393 EYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNS---EFEAFVADFGIARLL 469 (560)
Q Consensus 393 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~~~~~ 469 (560)
||+. |++.+.+.... ..+++.++..++.|++.||+|||++ +||||||||+|||++. +..+|++|||+|+.+
T Consensus 83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 83 ELLG-PSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp ECCC-CBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EEcC-Cchhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 9994 56666665433 2389999999999999999999999 9999999999999863 457999999999987
Q ss_pred CCCCCC-------ceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc-----------------
Q 035761 470 NYDSSN-------RTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS----------------- 525 (560)
Q Consensus 470 ~~~~~~-------~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~----------------- 525 (560)
...... .....||+.|||||++.+..++.++|||||||++|||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC
Confidence 543221 23357999999999999999999999999999999999999999654321
Q ss_pred --------ccccccccccccccCCCCCCChhHH
Q 035761 526 --------SSSLDKNIKLIDLLDPRLPPPGDQM 550 (560)
Q Consensus 526 --------~~~~~~~~~~~~~~dp~~~p~~~~~ 550 (560)
..++.+.+..|...+|..||+++++
T Consensus 237 ~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i 269 (299)
T d1ckia_ 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYL 269 (299)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHH
T ss_pred hhHhccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 1223455667778899999987654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.5e-37 Score=307.80 Aligned_cols=235 Identities=20% Similarity=0.245 Sum_probs=184.1
Q ss_pred cCCcccceeeccCCeeEEEEEe-CCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccC-----------CCCcceeeeEE
Q 035761 315 EDFDIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRLETELASLESFQNEARLLSQIR-----------HRNIVKLYGFC 382 (560)
Q Consensus 315 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~ 382 (560)
.+|++.+.||+|+||.||+|+. .+|+.||||+++... ...+.+.+|+.+++.++ |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 3589999999999999999986 469999999997543 22346778888888775 57899999988
Q ss_pred EeC--CEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEeCCCCCCeEeCCCCc--
Q 035761 383 LHE--KCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHH-HCTPPILHRDISSNNILLNSEFE-- 457 (560)
Q Consensus 383 ~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~-- 457 (560)
... ...+++++++..+..............+++..+..++.||+.||+|||+ . ||+||||||+|||++.++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTT
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccc
Confidence 653 4666777776665443333322333448999999999999999999998 6 9999999999999986653
Q ss_pred ----EEEeeeccccccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHHHHHHHhCCCCCCccccc--------
Q 035761 458 ----AFVADFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVVALEVLMGKHPGELLSSS-------- 525 (560)
Q Consensus 458 ----~kl~Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~il~el~~g~~P~~~~~~~-------- 525 (560)
++++|||.+...... ....+||+.|+|||++....++.++||||+||+++||++|+.||......
T Consensus 167 ~~~~~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp TEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ccceeeEeecccccccccc---cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 899999999865432 23456999999999999999999999999999999999999998633210
Q ss_pred ---------------------------------------------------------ccccccccccccccCCCCCCChh
Q 035761 526 ---------------------------------------------------------SSSLDKNIKLIDLLDPRLPPPGD 548 (560)
Q Consensus 526 ---------------------------------------------------------~~~~~~~~~~~~~~dp~~~p~~~ 548 (560)
...+.+.+..|...||..||+++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 01123345678899999999999
Q ss_pred HHHhhceeee
Q 035761 549 QMIRQGIILI 558 (560)
Q Consensus 549 ~~~~~~~~~~ 558 (560)
++++|+|+.+
T Consensus 324 e~L~Hp~f~~ 333 (362)
T d1q8ya_ 324 GLVNHPWLKD 333 (362)
T ss_dssp HHHTCGGGTT
T ss_pred HHhcCcccCC
Confidence 9999999863
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.96 E-value=6.9e-30 Score=249.79 Aligned_cols=224 Identities=29% Similarity=0.471 Sum_probs=182.2
Q ss_pred CCCEEEccCCcCcc--cCCCCCCCcCCCCEEEccC-CcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEE
Q 035761 6 NLVHLDLSDNHFMG--HIPPTLGRLSELKILNLSL-NSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVL 82 (560)
Q Consensus 6 ~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~-N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 82 (560)
+++.|+|++|++++ .+|..++++++|++|+|++ |++++.+|..|.++++|++|+|++|++.+..+..+..+.+|+.+
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence 57888888888876 3677888888888888876 77887788888888888888888888887777778888888888
Q ss_pred EeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCC-cEEECcCCcCcC----------------------
Q 035761 83 DLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQL-TTLNMYNNKLDG---------------------- 139 (560)
Q Consensus 83 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L-~~L~l~~n~l~~---------------------- 139 (560)
++++|.+...+|..+.+++.|+.+++++|.+++.+|..+..+.++ +.+++++|++++
T Consensus 131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~ 210 (313)
T d1ogqa_ 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLE 210 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEE
T ss_pred ccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 888888887778888888888888888888877777777766665 666666666654
Q ss_pred -CCCccCcCCCCCcEEEccCcccccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCcc--
Q 035761 140 -PIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVF-- 216 (560)
Q Consensus 140 -~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~-- 216 (560)
..|..+..+++|+.+++++|.+++.+ ..+..+++|+.|+|++|++++.+|..+.++++|+.|+|++|+|+|.+|..
T Consensus 211 ~~~~~~~~~~~~l~~l~~~~~~l~~~~-~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~ 289 (313)
T d1ogqa_ 211 GDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN 289 (313)
T ss_dssp ECCGGGCCTTSCCSEEECCSSEECCBG-GGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTT
T ss_pred ccccccccccccccccccccccccccc-cccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCccc
Confidence 34455667788999999999998654 46888999999999999999999999999999999999999999988873
Q ss_pred cccCCCCcCCCCCC
Q 035761 217 VRKVPHLDVSGNQF 230 (560)
Q Consensus 217 ~~~l~~l~l~~n~~ 230 (560)
+.+++.+++.+|+.
T Consensus 290 L~~L~~l~l~~N~~ 303 (313)
T d1ogqa_ 290 LQRFDVSAYANNKC 303 (313)
T ss_dssp GGGSCGGGTCSSSE
T ss_pred CCCCCHHHhCCCcc
Confidence 57888889999984
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=4.7e-28 Score=233.14 Aligned_cols=233 Identities=18% Similarity=0.145 Sum_probs=191.7
Q ss_pred CCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeecc-ccccccccccccCCCCCCCEEEe
Q 035761 6 NLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIA-SNRMNGSILLGIGSLKVLQVLDL 84 (560)
Q Consensus 6 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~-~n~i~~~~~~~~~~l~~L~~L~l 84 (560)
++++|+|++|+|+++.+.+|.++++|++|++++|++..+.+..+.++..++.+... .|.++...+..|.++++|++|++
T Consensus 33 ~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l 112 (284)
T d1ozna_ 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112 (284)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEec
Confidence 57889999999987777788899999999999999988888888888888888764 56777777888888999999999
Q ss_pred ecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccccc
Q 035761 85 SRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGS 164 (560)
Q Consensus 85 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 164 (560)
++|.+....+..+..+++|+.+++++|.++++.+..|..+++|+.|++++|++++..+..|.++++|+.+++++|++++.
T Consensus 113 ~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i 192 (284)
T d1ozna_ 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192 (284)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred CCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhcccccc
Confidence 99988877777888888899999999999877778888888999999999998887788888899999999999999888
Q ss_pred cchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCc-c-cccCCCCcCCCCCCCCcCCccc
Q 035761 165 IPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPV-F-VRKVPHLDVSGNQFGGEIPTTL 238 (560)
Q Consensus 165 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~-~-~~~l~~l~l~~n~~~~~~p~~~ 238 (560)
.|..|..+++|++|++++|++.+..+..|..+++|+.|++++|++.+..+. + ...++......+.+.|..|...
T Consensus 193 ~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C~~p~~l 268 (284)
T d1ozna_ 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRL 268 (284)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEESGGG
T ss_pred ChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccchHHHHHHHhCcCCCCceEeCCchHH
Confidence 888899999999999999999888888888889999999999998876653 1 1234445555566666544443
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.95 E-value=3.4e-28 Score=237.64 Aligned_cols=207 Identities=30% Similarity=0.449 Sum_probs=180.4
Q ss_pred CCCCEEEccCCccee--cCCccccCCCCCCeeeccc-cccccccccccCCCCCCCEEEeecCccCccCCCCcCCCCCccE
Q 035761 29 SELKILNLSLNSLVG--NIPSNVGHLTQLTTLAIAS-NRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRS 105 (560)
Q Consensus 29 ~~L~~L~L~~N~i~~--~~~~~~~~l~~L~~L~L~~-n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 105 (560)
.+++.|+|++|.+++ .+|..+.++++|++|+|++ |++.+.+|..|.++++|++|+|++|++.+..+..+..+..|+.
T Consensus 50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~ 129 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred EEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence 469999999999986 5789999999999999997 8999889999999999999999999999999999999999999
Q ss_pred EEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCC-cEEEccCcccccccc------------------
Q 035761 106 VDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKL-RILKLGNNLLSGSIP------------------ 166 (560)
Q Consensus 106 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~------------------ 166 (560)
+++++|.+.+.+|..+.+++.|+.+++++|.+.+.+|..+..+.++ +.+++++|++++..|
T Consensus 130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~ 209 (313)
T d1ogqa_ 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNML 209 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEE
T ss_pred cccccccccccCchhhccCcccceeecccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999999999999999999999999999988888776 778888888775444
Q ss_pred -----hhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCccc---ccCCCCcCCCCCCCCcCCc
Q 035761 167 -----SQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFV---RKVPHLDVSGNQFGGEIPT 236 (560)
Q Consensus 167 -----~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~~---~~l~~l~l~~n~~~~~~p~ 236 (560)
..+..+++|+.+++++|.+.+.++ .+..+++|+.|++++|++++.+|..+ ++++.|++++|++.|.+|.
T Consensus 210 ~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~ 286 (313)
T d1ogqa_ 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286 (313)
T ss_dssp EECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC
T ss_pred ccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC
Confidence 444556778888888888876544 57788899999999999998888765 5577789999999887654
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=2.1e-26 Score=218.99 Aligned_cols=204 Identities=26% Similarity=0.260 Sum_probs=183.0
Q ss_pred CCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEE
Q 035761 3 RLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVL 82 (560)
Q Consensus 3 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 82 (560)
+...+.++|.++++|+ .+|..+. ++|++|+|++|+|+++.+..|.++++|++|+|++|+|+.+. .+..+++|++|
T Consensus 8 ~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~--~~~~l~~L~~L 82 (266)
T d1p9ag_ 8 KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ--VDGTLPVLGTL 82 (266)
T ss_dssp CSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEE--CCSCCTTCCEE
T ss_pred ccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccccc--ccccccccccc
Confidence 4567788899999999 4676664 68999999999999888889999999999999999998543 46789999999
Q ss_pred EeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccc
Q 035761 83 DLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLS 162 (560)
Q Consensus 83 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 162 (560)
+|++|+++ ..+..+.++++|+.|++++|.+....+..+..+.+++.|++++|.++...+..+..+++|+.|++++|+++
T Consensus 83 ~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~ 161 (266)
T d1p9ag_ 83 DLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT 161 (266)
T ss_dssp ECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred cccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccccc
Confidence 99999999 56778999999999999999999888888999999999999999999888888899999999999999999
Q ss_pred cccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCcccccc
Q 035761 163 GSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGI 213 (560)
Q Consensus 163 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~ 213 (560)
+..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|++.+..
T Consensus 162 ~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC 211 (266)
T d1p9ag_ 162 ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC 211 (266)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred ccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCc
Confidence 888888999999999999999999 77888888999999999999988653
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=3.9e-26 Score=219.54 Aligned_cols=223 Identities=21% Similarity=0.185 Sum_probs=203.1
Q ss_pred CEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEee-c
Q 035761 8 VHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLS-R 86 (560)
Q Consensus 8 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~-~ 86 (560)
..++.++++++ .+|..+. +++++|+|++|+|+.+.+.+|.++++|+.|++++|++..+.+..+.++..++.+... .
T Consensus 14 ~~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~ 90 (284)
T d1ozna_ 14 VTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (284)
T ss_dssp CEEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccc
Confidence 46788999998 5666554 678999999999998888899999999999999999999999999999999999775 6
Q ss_pred CccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccccccc
Q 035761 87 NEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIP 166 (560)
Q Consensus 87 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 166 (560)
|.++...+..|.++++|++|++++|.+....+..+..+++|+.+++++|.++++.+..|..+++|+.|++++|++++..+
T Consensus 91 ~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~ 170 (284)
T d1ozna_ 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170 (284)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred cccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccch
Confidence 77887778899999999999999999987788889999999999999999998878889999999999999999998889
Q ss_pred hhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCccc---ccCCCCcCCCCCCCCc
Q 035761 167 SQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFV---RKVPHLDVSGNQFGGE 233 (560)
Q Consensus 167 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~~---~~l~~l~l~~n~~~~~ 233 (560)
..|.++++|+.+++++|++++..|..|..+++|+.|++++|.+.+..+..+ .+++.|++++|++.|.
T Consensus 171 ~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~ 240 (284)
T d1ozna_ 171 RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240 (284)
T ss_dssp TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred hhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCC
Confidence 999999999999999999999999999999999999999999998887655 5678899999999875
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.92 E-value=1.3e-24 Score=211.04 Aligned_cols=221 Identities=23% Similarity=0.232 Sum_probs=183.1
Q ss_pred CCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEe
Q 035761 5 RNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDL 84 (560)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l 84 (560)
+++++|+|++|+|+.+.+.+|.++++|++|++++|.+..+.|..|.++++|+.|++++|+++.+... + ...|+.|++
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~l~~~-~--~~~l~~L~~ 107 (305)
T d1xkua_ 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEK-M--PKTLQELRV 107 (305)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBCCSS-C--CTTCCEEEC
T ss_pred CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccCcCccc-h--hhhhhhhhc
Confidence 5799999999999977777899999999999999999988899999999999999999998854332 2 345667777
Q ss_pred ecCccCcc--------------------------CCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCc
Q 035761 85 SRNEIGGS--------------------------IPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLD 138 (560)
Q Consensus 85 ~~n~l~~~--------------------------~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 138 (560)
.+|.+... .+..+..+++|+.+++++|.++ .+|..+ +++|+.|++++|.++
T Consensus 108 ~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~ 184 (305)
T d1xkua_ 108 HENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT 184 (305)
T ss_dssp CSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCC
T ss_pred cccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-ccCccc--CCccCEEECCCCcCC
Confidence 77666522 2334667788999999999988 445443 578999999999999
Q ss_pred CCCCccCcCCCCCcEEEccCcccccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCcc--
Q 035761 139 GPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVF-- 216 (560)
Q Consensus 139 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~-- 216 (560)
+..+..|..++.++.|++++|.+++..+..+.++++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|+......
T Consensus 185 ~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~ 263 (305)
T d1xkua_ 185 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFC 263 (305)
T ss_dssp EECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSS
T ss_pred CCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhcc
Confidence 888889999999999999999999888899999999999999999998 56788999999999999999998654332
Q ss_pred -------cccCCCCcCCCCCCCC
Q 035761 217 -------VRKVPHLDVSGNQFGG 232 (560)
Q Consensus 217 -------~~~l~~l~l~~n~~~~ 232 (560)
..++..|++.+|++..
T Consensus 264 ~~~~~~~~~~L~~L~L~~N~~~~ 286 (305)
T d1xkua_ 264 PPGYNTKKASYSGVSLFSNPVQY 286 (305)
T ss_dssp CSSCCTTSCCCSEEECCSSSSCG
T ss_pred CcchhcccCCCCEEECCCCcCcc
Confidence 2457778999999864
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=7e-25 Score=208.39 Aligned_cols=202 Identities=25% Similarity=0.273 Sum_probs=180.1
Q ss_pred CCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEeecCccCccCCCCcCCCCCcc
Q 035761 25 LGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLR 104 (560)
Q Consensus 25 ~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 104 (560)
+.....+.+++.+++.++ .+|..+. ++|++|+|++|+|+++.+..|.++++|++|+|++|+|+.+ + .+..+++|+
T Consensus 6 ~~~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~ 80 (266)
T d1p9ag_ 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLG 80 (266)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCC
T ss_pred EcccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-ccccccccc
Confidence 345667788899999999 5676664 6899999999999988889999999999999999999954 3 367899999
Q ss_pred EEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccccccchhhccccccceeeccccc
Q 035761 105 SVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNF 184 (560)
Q Consensus 105 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 184 (560)
+|+|++|+++ ..+..+.++++|+.|++++|.+.+..+..+..+.+++.|++++|.++...+..+..+++|+.|++++|+
T Consensus 81 ~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~ 159 (266)
T d1p9ag_ 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (266)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred cccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccc
Confidence 9999999999 567789999999999999999998888899999999999999999998888888999999999999999
Q ss_pred cCCcCccccCCCceeeEEEccCCccccccCc-c--cccCCCCcCCCCCCCCc
Q 035761 185 INGKIPSQLGEFSCIDTVDLSMNNLSGGIPV-F--VRKVPHLDVSGNQFGGE 233 (560)
Q Consensus 185 l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~-~--~~~l~~l~l~~n~~~~~ 233 (560)
+++..+..|..+++|+.|+|++|.|+. +|. . +.+++.|++.||++.|.
T Consensus 160 l~~~~~~~~~~l~~L~~L~Ls~N~L~~-lp~~~~~~~~L~~L~L~~Np~~Cd 210 (266)
T d1p9ag_ 160 LTELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGNPWLCN 210 (266)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCCCSEEECCSCCBCCS
T ss_pred ccccCccccccccccceeecccCCCcc-cChhHCCCCCCCEEEecCCCCCCC
Confidence 998888999999999999999999994 554 2 36788999999999875
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=6.1e-24 Score=191.02 Aligned_cols=170 Identities=17% Similarity=0.217 Sum_probs=120.6
Q ss_pred cccceeeccCCeeEEEEEeCCCcEEEEEEccchhhh----------------hhhHHHHHHHHHHHhccCCCCcceeeeE
Q 035761 318 DIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETE----------------LASLESFQNEARLLSQIRHRNIVKLYGF 381 (560)
Q Consensus 318 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------~~~~~~~~~e~~~l~~l~h~niv~l~~~ 381 (560)
.+.+.||+|+||.||+|...+|+.||||+++..... ........+|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 457889999999999999889999999986532110 1112345678889999999999888765
Q ss_pred EEeCCEEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCCeEeCCCCcEEEe
Q 035761 382 CLHEKCMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHCTPPILHRDISSNNILLNSEFEAFVA 461 (560)
Q Consensus 382 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 461 (560)
. . .+++|||++++.+.+ ++......++.|++++++|||+. ||+||||||+|||++++ .++|+
T Consensus 83 ~--~--~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 E--G--NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp E--T--TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEEC
T ss_pred c--C--CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEE
Confidence 3 2 269999998865432 34445568999999999999999 99999999999999865 58999
Q ss_pred eeccccccCCCCCCceeeccccCccCccccccCccCcchhHHHHHHH
Q 035761 462 DFGIARLLNYDSSNRTLLAGTYGSIAPELAYTMVVTEKYDVYSFGVV 508 (560)
Q Consensus 462 Dfg~~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Dv~s~G~i 508 (560)
|||.|.....+... .........+ .+ +..+.|..++|+||..--
T Consensus 145 DFG~a~~~~~~~~~-~~l~rd~~~~-~~-~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 145 DFPQSVEVGEEGWR-EILERDVRNI-IT-YFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp CCTTCEETTSTTHH-HHHHHHHHHH-HH-HHHHHHCCCCCHHHHHHH
T ss_pred ECCCcccCCCCCcH-HHHHHHHHHH-HH-HHcCCCCCcccHHHHHHH
Confidence 99999775422111 1000000000 01 124567888999998543
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.89 E-value=4.7e-22 Score=192.84 Aligned_cols=222 Identities=19% Similarity=0.225 Sum_probs=184.2
Q ss_pred CCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEee
Q 035761 6 NLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLS 85 (560)
Q Consensus 6 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~ 85 (560)
..+.+|-++++++ .+|..+. +++++|+|++|+|+.+.+.+|.++++|++|++++|.+....+..|.++++|++|+++
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 3678999999999 5566664 689999999999997777789999999999999999998889999999999999999
Q ss_pred cCccCccCCCCcCCCCCccEEEccCCCccCC--------------------------CCccCCCCCCCcEEECcCCcCcC
Q 035761 86 RNEIGGSIPSTLGHLKWLRSVDLSQNKLVGP--------------------------IPSSLGHLTQLTTLNMYNNKLDG 139 (560)
Q Consensus 86 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~--------------------------~~~~~~~l~~L~~L~l~~n~l~~ 139 (560)
+|+|+. +|..+ ...|+.|++++|.+.+. .+..+..+++|+.+++++|.++.
T Consensus 88 ~n~l~~-l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~ 164 (305)
T d1xkua_ 88 KNQLKE-LPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT 164 (305)
T ss_dssp SSCCSB-CCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred CCccCc-Cccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccc
Confidence 999995 44433 24567777777766532 23345677889999999999884
Q ss_pred CCCccCcCCCCCcEEEccCcccccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCc--cc
Q 035761 140 PIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPV--FV 217 (560)
Q Consensus 140 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~--~~ 217 (560)
+|..+ +++|+.|++++|..+...+..|.+++.+++|++++|.+.+..+..+..+++|++|+|++|+|+..++. .+
T Consensus 165 -l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp~~l~~l 241 (305)
T d1xkua_ 165 -IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADH 241 (305)
T ss_dssp -CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTC
T ss_pred -cCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecccccccccccccccc
Confidence 44443 58999999999999988899999999999999999999988899999999999999999999854332 34
Q ss_pred ccCCCCcCCCCCCCCcCCc
Q 035761 218 RKVPHLDVSGNQFGGEIPT 236 (560)
Q Consensus 218 ~~l~~l~l~~n~~~~~~p~ 236 (560)
++++.|++++|+++.....
T Consensus 242 ~~L~~L~Ls~N~i~~i~~~ 260 (305)
T d1xkua_ 242 KYIQVVYLHNNNISAIGSN 260 (305)
T ss_dssp SSCCEEECCSSCCCCCCTT
T ss_pred cCCCEEECCCCccCccChh
Confidence 6788899999999865433
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.87 E-value=4.8e-22 Score=199.30 Aligned_cols=221 Identities=28% Similarity=0.356 Sum_probs=143.5
Q ss_pred CCCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeecccccccccc------------
Q 035761 2 GRLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSI------------ 69 (560)
Q Consensus 2 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~------------ 69 (560)
+.|++|++|+|++|+|+++.+ |+++++|++|++++|++.++. .+.++++|+.|++++|.+++..
T Consensus 63 ~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~L~~~~~~~~~~~~~~~~~~~~~~~ 138 (384)
T d2omza2 63 EYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADIT--PLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLE 138 (384)
T ss_dssp GGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCGGGTTCTTCSEEE
T ss_pred ccCCCCCEEeCcCCcCCCCcc--ccCCccccccccccccccccc--cccccccccccccccccccccccccccccccccc
Confidence 457788888888888875432 788888888888888887543 3777788888887776654211
Q ss_pred ---------------------------------------------------ccccCCCCCCCEEEeecCccCccCCCCcC
Q 035761 70 ---------------------------------------------------LLGIGSLKVLQVLDLSRNEIGGSIPSTLG 98 (560)
Q Consensus 70 ---------------------------------------------------~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 98 (560)
...+..+++++.|++++|.+++..| +.
T Consensus 139 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~l~~n~i~~~~~--~~ 216 (384)
T d2omza2 139 LSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP--LG 216 (384)
T ss_dssp EEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG--GG
T ss_pred cccccccccccccccccccccccccccchhhhhccccccccccccccccccccccccccccceeeccCCccCCCCc--cc
Confidence 0123344566666666666664332 34
Q ss_pred CCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCccccccc-------------
Q 035761 99 HLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSI------------- 165 (560)
Q Consensus 99 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~------------- 165 (560)
..++|+.|++++|.++. + ..+..+++|+.|++++|.+++.. .+..+++|+.|++++|++++..
T Consensus 217 ~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~ 292 (384)
T d2omza2 217 ILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNISPLAGLTALTNLEL 292 (384)
T ss_dssp GCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEEC
T ss_pred ccCCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCC--cccccccCCEeeccCcccCCCCccccccccccccc
Confidence 44556666666666552 2 24555556666666666555332 2445555555555555544321
Q ss_pred -------chhhccccccceeeccccccCCcCccccCCCceeeEEEccCCcccccc-CcccccCCCCcCCCCCCCCcC
Q 035761 166 -------PSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGI-PVFVRKVPHLDVSGNQFGGEI 234 (560)
Q Consensus 166 -------~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~-~~~~~~l~~l~l~~n~~~~~~ 234 (560)
...+..+++++.|++++|++++..+ +..+++|+.|++++|++++.. ...+++|+.|++++|++.+.+
T Consensus 293 ~~n~l~~~~~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~~l~~l~~l~~L~~L~l~~N~l~~l~ 367 (384)
T d2omza2 293 NENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDVSSLANLTNINWLSAGHNQISDLT 367 (384)
T ss_dssp CSSCCSCCGGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCBCG
T ss_pred cccccccccccchhcccCeEECCCCCCCCCcc--cccCCCCCEEECCCCCCCCChhHcCCCCCCEEECCCCcCCCCh
Confidence 2346778889999999999986543 778899999999999988633 123467888899999988754
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.85 E-value=5e-21 Score=191.77 Aligned_cols=219 Identities=26% Similarity=0.299 Sum_probs=181.0
Q ss_pred CCCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEE
Q 035761 3 RLRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVL 82 (560)
Q Consensus 3 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 82 (560)
.+.+|++|++++|.|+.+ +.+..+++|++|+|++|+|+++. .+.++++|++|++++|++.+.. .+.++++|+.|
T Consensus 42 ~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~L 115 (384)
T d2omza2 42 DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIADIT--PLANLTNLTGL 115 (384)
T ss_dssp HHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGTTCTTCCEE
T ss_pred HhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCCc--cccCCccccccccccccccccc--ccccccccccc
Confidence 356899999999999854 45889999999999999999653 3999999999999999998654 38899999999
Q ss_pred EeecCccCccC---------------------------------------------------------------CCCcCC
Q 035761 83 DLSRNEIGGSI---------------------------------------------------------------PSTLGH 99 (560)
Q Consensus 83 ~l~~n~l~~~~---------------------------------------------------------------~~~~~~ 99 (560)
++++|.+++.. ...+..
T Consensus 116 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (384)
T d2omza2 116 TLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAK 195 (384)
T ss_dssp ECCSSCCCCCGGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGGG
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhcccccccccccccccccccccccc
Confidence 99998876311 123455
Q ss_pred CCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccccccchhhccccccceee
Q 035761 100 LKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLD 179 (560)
Q Consensus 100 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 179 (560)
+++++.+++++|.+++..| +..+++|+.|++++|.++.. +.+..+++|+.|++++|.+++.. .+..+++|++|+
T Consensus 196 l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~ 269 (384)
T d2omza2 196 LTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA--PLSGLTKLTELK 269 (384)
T ss_dssp CTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEE
T ss_pred ccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCC--cccccccCCEee
Confidence 6889999999999996544 56678999999999999853 57889999999999999998654 378899999999
Q ss_pred ccccccCCcCc--------------------cccCCCceeeEEEccCCccccccC-cccccCCCCcCCCCCCCCc
Q 035761 180 LSGNFINGKIP--------------------SQLGEFSCIDTVDLSMNNLSGGIP-VFVRKVPHLDVSGNQFGGE 233 (560)
Q Consensus 180 l~~n~l~~~~~--------------------~~~~~~~~L~~l~l~~n~l~~~~~-~~~~~l~~l~l~~n~~~~~ 233 (560)
+++|++++..+ ..+..+++++.|++++|++++..+ ..+++++.|++++|++++.
T Consensus 270 l~~~~l~~~~~~~~~~~l~~l~~~~n~l~~~~~~~~~~~l~~L~ls~n~l~~l~~l~~l~~L~~L~L~~n~l~~l 344 (384)
T d2omza2 270 LGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVSDV 344 (384)
T ss_dssp CCSSCCCCCGGGTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCCC
T ss_pred ccCcccCCCCccccccccccccccccccccccccchhcccCeEECCCCCCCCCcccccCCCCCEEECCCCCCCCC
Confidence 99998875432 224566789999999999998654 4678899999999999864
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.84 E-value=2.7e-21 Score=173.71 Aligned_cols=175 Identities=23% Similarity=0.266 Sum_probs=110.7
Q ss_pred CCEEEccCCcceecCCccccCCCCCCeeecccccccc-ccccccCCCCCCCEEEeecCccCccCCCCcCCCCCccEEEcc
Q 035761 31 LKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNG-SILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLS 109 (560)
Q Consensus 31 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 109 (560)
.++++.++|+++ .+|..+. +++++|+|++|+|+. ..+..|.++++|++|+|++|.++...+..|..+++|++|+|+
T Consensus 10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 356777777777 4555443 567777777777764 345566677777777777777776666677777777777777
Q ss_pred CCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccccccchhhccccccceeeccccccCCcC
Q 035761 110 QNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKI 189 (560)
Q Consensus 110 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 189 (560)
+|+|+.+.+.+|.++++|++|+|++|+|+++.+..|..+++|++|+|++|.+...... ..-...++.+
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~-~~~~~~l~~~----------- 154 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL-AWFAEWLRKK----------- 154 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG-HHHHHHHHHH-----------
T ss_pred cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccch-HHHhhhhhhh-----------
Confidence 7777766666677777777777777777766666666667777777776666532211 1111223333
Q ss_pred ccccCCCceeeEEEccCCccccccCcccccCCCCcCCCCCCCCc
Q 035761 190 PSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHLDVSGNQFGGE 233 (560)
Q Consensus 190 ~~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~l~~n~~~~~ 233 (560)
.+..|.+++..|..++.++.+++..|.+.|.
T Consensus 155 -------------~l~~~~~~c~~p~~l~~~~l~~L~~n~l~C~ 185 (192)
T d1w8aa_ 155 -------------SLNGGAARCGAPSKVRDVQIKDLPHSEFKCS 185 (192)
T ss_dssp -------------CCSGGGCBBCSSTTTTTSBGGGSCTTTCCCC
T ss_pred -------------cccCCCeEeCCChhhcCCEeeecCHhhCcCC
Confidence 3444555555565566666667777777664
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.84 E-value=2e-20 Score=172.92 Aligned_cols=185 Identities=26% Similarity=0.308 Sum_probs=84.8
Q ss_pred CCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEe
Q 035761 5 RNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDL 84 (560)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l 84 (560)
.+|+.|++++|+|+.+ ..+..+++|++|++++|++++.. .+..+++|+.|++++|.++.. ..+.++++|+.+++
T Consensus 41 ~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~--~l~~l~~l~~l~~~~n~~~~i--~~l~~l~~L~~l~l 114 (227)
T d1h6ua2 41 DGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLA--PLKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDL 114 (227)
T ss_dssp HTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCG--GGTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEEC
T ss_pred CCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeeccc--ccccccccccccccccccccc--cccccccccccccc
Confidence 3455555555555432 22445555555555555554332 144555555555555544421 23444555555555
Q ss_pred ecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccccc
Q 035761 85 SRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGS 164 (560)
Q Consensus 85 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 164 (560)
++|..... ..+...+.++.+.++.+.+... ..+.++++|+.|++++|.+... ..+.++++|+.|++++|++++.
T Consensus 115 ~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~~l 188 (227)
T d1h6ua2 115 TSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKISDI 188 (227)
T ss_dssp TTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC
T ss_pred cccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccccc--hhhcccccceecccCCCccCCC
Confidence 55544421 1234444455555555544421 2234445555555555554422 2244455555555555555432
Q ss_pred cchhhccccccceeeccccccCCcCccccCCCceeeEEEcc
Q 035761 165 IPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLS 205 (560)
Q Consensus 165 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~ 205 (560)
+ .+.++++|++|+|++|++++..| +..+++|+.|+++
T Consensus 189 -~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~ls 225 (227)
T d1h6ua2 189 -S-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225 (227)
T ss_dssp -G-GGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEE
T ss_pred -h-hhcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEee
Confidence 1 24455555555555555543221 4445555555543
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.83 E-value=1.4e-20 Score=175.81 Aligned_cols=214 Identities=14% Similarity=0.024 Sum_probs=165.1
Q ss_pred CEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccc-cccccCCCCCCCEEEeec
Q 035761 8 VHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGS-ILLGIGSLKVLQVLDLSR 86 (560)
Q Consensus 8 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~-~~~~~~~l~~L~~L~l~~ 86 (560)
+.++.++++++ .+|+.+. +++++|+|++|+|+.+.+.+|.++++|++|+|++|.+... .+..|.+++++++|.+..
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 67888888888 5665543 5789999999999977777899999999999999988753 466788899999998764
Q ss_pred -CccCccCCCCcCCCCCccEEEccCCCccCCCCc-cCCCCCCCcEEECcCCcCcCCCCccCcCCC-CCcEEEccCccccc
Q 035761 87 -NEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPS-SLGHLTQLTTLNMYNNKLDGPIPPELMNCS-KLRILKLGNNLLSG 163 (560)
Q Consensus 87 -n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~n~l~~ 163 (560)
|++....+..|.++++|+.|++++|.+....+. .+..+..+..+..+++.+....+..|..++ .++.|++++|+++.
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~ 167 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 167 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred cccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccc
Confidence 678878888899999999999999998744332 344566676777788888866667777665 78889999999986
Q ss_pred ccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCcccccCCCCc
Q 035761 164 SIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHLD 224 (560)
Q Consensus 164 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~ 224 (560)
..+..|.....++.+++++|+++...+..|..+++|+.|++++|+++...+..+.+++.|.
T Consensus 168 i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~ 228 (242)
T d1xwdc1 168 IHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLR 228 (242)
T ss_dssp ECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEE
T ss_pred cccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccc
Confidence 5555554433344556788889866667788999999999999999976666676666653
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.83 E-value=7.7e-21 Score=170.63 Aligned_cols=173 Identities=22% Similarity=0.249 Sum_probs=144.7
Q ss_pred CCEEEccCCcCcccCCCCCCCcCCCCEEEccCCccee-cCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEee
Q 035761 7 LVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVG-NIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLS 85 (560)
Q Consensus 7 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~-~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~ 85 (560)
.++++.++++++ .+|..+. +++++|+|++|+|+. +.+..|.++++|+.|+|++|++....+..|..+++|++|+|+
T Consensus 10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 568999999999 5666554 789999999999975 557778999999999999999999999999999999999999
Q ss_pred cCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCccccccc
Q 035761 86 RNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSI 165 (560)
Q Consensus 86 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 165 (560)
+|+|+.+.++.|.++++|++|+|++|+|+++.+.+|..+++|++|+|++|.+.... ....-...++.+.+..|.++...
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~-~~~~~~~~l~~~~l~~~~~~c~~ 165 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC-HLAWFAEWLRKKSLNGGAARCGA 165 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG-GGHHHHHHHHHHCCSGGGCBBCS
T ss_pred cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccccc-chHHHhhhhhhhcccCCCeEeCC
Confidence 99999888999999999999999999999889999999999999999999988432 21111134566677778777666
Q ss_pred chhhccccccceeeccccccC
Q 035761 166 PSQIGKLQELYYLDLSGNFIN 186 (560)
Q Consensus 166 ~~~~~~l~~L~~L~l~~n~l~ 186 (560)
|..+ ..++.++|+.|.+.
T Consensus 166 p~~l---~~~~l~~L~~n~l~ 183 (192)
T d1w8aa_ 166 PSKV---RDVQIKDLPHSEFK 183 (192)
T ss_dssp STTT---TTSBGGGSCTTTCC
T ss_pred Chhh---cCCEeeecCHhhCc
Confidence 6544 45667778877775
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.83 E-value=5.8e-20 Score=171.59 Aligned_cols=201 Identities=16% Similarity=0.062 Sum_probs=166.4
Q ss_pred CCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCccee-cCCccccCCCCCCeeeccc-cccccccccccCCCCCCCEE
Q 035761 5 RNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVG-NIPSNVGHLTQLTTLAIAS-NRMNGSILLGIGSLKVLQVL 82 (560)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~-~~~~~~~~l~~L~~L~L~~-n~i~~~~~~~~~~l~~L~~L 82 (560)
+++++|+|++|.|+.+.+.+|.++++|++|+|++|.+.. +.+..|.+++++++|.+.+ |++....+..|.++++|++|
T Consensus 29 ~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l 108 (242)
T d1xwdc1 29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 108 (242)
T ss_dssp SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEE
T ss_pred CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccccccccccccccccccc
Confidence 479999999999998777889999999999999999875 4566799999999999865 68887888999999999999
Q ss_pred EeecCccCccCCC-CcCCCCCccEEEccCCCccCCCCccCCCCC-CCcEEECcCCcCcCCCCccCcCCCCCcEE-EccCc
Q 035761 83 DLSRNEIGGSIPS-TLGHLKWLRSVDLSQNKLVGPIPSSLGHLT-QLTTLNMYNNKLDGPIPPELMNCSKLRIL-KLGNN 159 (560)
Q Consensus 83 ~l~~n~l~~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L-~l~~n 159 (560)
++++|+++...+. .+..++.+..+..+++.+....+..|.+++ .++.|++++|+++.+.+..+ ..++++.+ ++++|
T Consensus 109 ~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~-~~~~l~~~~~l~~n 187 (242)
T d1xwdc1 109 LISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAF-NGTQLDELNLSDNN 187 (242)
T ss_dssp EEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTT-TTCCEEEEECTTCT
T ss_pred ccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccccccccc-cchhhhcccccccc
Confidence 9999999854332 345677788888888899877778888765 89999999999996555444 45565555 67888
Q ss_pred ccccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccC
Q 035761 160 LLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSM 206 (560)
Q Consensus 160 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~ 206 (560)
+++...+..|.++++|++|+|++|+|+...+..|.++++|+.+++.+
T Consensus 188 ~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 188 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN 234 (242)
T ss_dssp TCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred ccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence 99966677799999999999999999977777788888888877643
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.81 E-value=2.1e-20 Score=172.66 Aligned_cols=204 Identities=19% Similarity=0.285 Sum_probs=168.7
Q ss_pred CCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEeec
Q 035761 7 LVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSR 86 (560)
Q Consensus 7 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~ 86 (560)
+..++++.+.+++.. .+..+.+|++|++++|.|+.+ +.+.++++|+.|++++|++++..+ +.++++|++|++++
T Consensus 21 ~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~ 94 (227)
T d1h6ua2 21 AIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSG 94 (227)
T ss_dssp HHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCS
T ss_pred HHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--cccccccccccccc
Confidence 345677888888654 467889999999999999954 468999999999999999986544 89999999999999
Q ss_pred CccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccccccc
Q 035761 87 NEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIP 166 (560)
Q Consensus 87 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 166 (560)
|.++. + ..+.++++|+.+++++|...+. ..+...+.+..+.++.+.+... ..+..+++|+.|++++|.+++.
T Consensus 95 n~~~~-i-~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~-- 166 (227)
T d1h6ua2 95 NPLKN-V-SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL-- 166 (227)
T ss_dssp CCCSC-C-GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCC--
T ss_pred ccccc-c-cccccccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccccc--
Confidence 99984 3 3588999999999999998744 4477789999999999998744 4578889999999999999844
Q ss_pred hhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCc-ccccCCCCcCC
Q 035761 167 SQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPV-FVRKVPHLDVS 226 (560)
Q Consensus 167 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~-~~~~l~~l~l~ 226 (560)
..+.++++|+.|+|++|++++. + .+..+++|+.|++++|++++..|. .+++|+.|+++
T Consensus 167 ~~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 167 TPLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLT 225 (227)
T ss_dssp GGGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCGGGTTCTTCCEEEEE
T ss_pred hhhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCCcccccCCCCCEEEee
Confidence 3488999999999999999854 3 378999999999999999976552 45666666664
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.81 E-value=7.2e-20 Score=166.65 Aligned_cols=181 Identities=25% Similarity=0.339 Sum_probs=135.3
Q ss_pred EEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEeecCcc
Q 035761 10 LDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEI 89 (560)
Q Consensus 10 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~l 89 (560)
.+++.+.+++.++. ..+.+|++|++++|.++... .+..+++|++|+|++|+|++.. .+..+++|++|++++|+|
T Consensus 29 ~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i 102 (210)
T d1h6ta2 29 DNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKV 102 (210)
T ss_dssp HHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred HHhCcCccCCccCH--HHhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccc
Confidence 34556666544432 35678888888888887542 4778888888888888887543 367788888888888888
Q ss_pred CccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccccccchhh
Q 035761 90 GGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQI 169 (560)
Q Consensus 90 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 169 (560)
+. ++ .+.++++|+.|++++|.+.. + ..+.++++|+.+++++|.+++ +..+..+++|+.+++++|++++.. .+
T Consensus 103 ~~-l~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~--~l 174 (210)
T d1h6ta2 103 KD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV--PL 174 (210)
T ss_dssp CC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG--GG
T ss_pred cc-cc-cccccccccccccccccccc-c-ccccccccccccccccccccc--cccccccccccccccccccccccc--cc
Confidence 84 33 47788888888888888763 2 357788888888888888874 345677888888888888887532 37
Q ss_pred ccccccceeeccccccCCcCccccCCCceeeEEEccC
Q 035761 170 GKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSM 206 (560)
Q Consensus 170 ~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~ 206 (560)
.++++|+.|+|++|+++. ++ .+..+++|+.|+|++
T Consensus 175 ~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 175 AGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp TTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred cCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence 888888888888888874 44 578888888888764
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.81 E-value=1e-19 Score=165.69 Aligned_cols=165 Identities=27% Similarity=0.327 Sum_probs=142.9
Q ss_pred CCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEE
Q 035761 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLD 83 (560)
Q Consensus 4 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 83 (560)
+.+|++|++++|.+++.. .+..+++|++|+|++|+|+++. .+..+++|+.|++++|+|+.. + .+.++++|+.|+
T Consensus 45 L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~ 118 (210)
T d1h6ta2 45 LNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKDL-S-SLKDLKKLKSLS 118 (210)
T ss_dssp HHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCG-G-GGTTCTTCCEEE
T ss_pred hcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCcccccccccccccccc-c-cccccccccccc
Confidence 568999999999998643 3889999999999999999653 478999999999999999854 3 588999999999
Q ss_pred eecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCccccc
Q 035761 84 LSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSG 163 (560)
Q Consensus 84 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 163 (560)
+++|.+.. + ..+.+++.|+.+++++|.++. +..+..+++|+.+++++|++++. ..+.++++|+.|++++|++++
T Consensus 119 l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i--~~l~~l~~L~~L~Ls~N~i~~ 192 (210)
T d1h6ta2 119 LEHNGISD-I-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSKNHISD 192 (210)
T ss_dssp CTTSCCCC-C-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCB
T ss_pred cccccccc-c-ccccccccccccccccccccc--ccccccccccccccccccccccc--ccccCCCCCCEEECCCCCCCC
Confidence 99999883 3 468899999999999999984 34678899999999999999864 348899999999999999985
Q ss_pred ccchhhccccccceeeccc
Q 035761 164 SIPSQIGKLQELYYLDLSG 182 (560)
Q Consensus 164 ~~~~~~~~l~~L~~L~l~~ 182 (560)
++ .+.++++|++|+|++
T Consensus 193 -l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 193 -LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp -CG-GGTTCTTCSEEEEEE
T ss_pred -Ch-hhcCCCCCCEEEccC
Confidence 44 599999999999974
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.81 E-value=1e-19 Score=164.18 Aligned_cols=178 Identities=20% Similarity=0.293 Sum_probs=124.1
Q ss_pred EEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEeecCc
Q 035761 9 HLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNE 88 (560)
Q Consensus 9 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~ 88 (560)
.+.++.+.+++..+ ...++++++|++++|.|+.+ +.++.+++|++|+|++|++++..+ +.++++|++|++++|.
T Consensus 22 ~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~ 95 (199)
T d2omxa2 22 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ 95 (199)
T ss_dssp HHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred HHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCcccccccccccc
Confidence 34566666665432 34567788888888888743 346777888888888888775433 7778888888888887
Q ss_pred cCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCcccccccchh
Q 035761 89 IGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQ 168 (560)
Q Consensus 89 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 168 (560)
+.. ++ .+.+++.|+.|++++|.+... ..+..+++|+.|++++|++... +.+..+++|+.|++++|++++.. .
T Consensus 96 ~~~-~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~~l~--~ 167 (199)
T d2omxa2 96 IAD-IT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTDLK--P 167 (199)
T ss_dssp CCC-CG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCCG--G
T ss_pred ccc-cc-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhccc--ccccccccccccccccccccCCc--c
Confidence 773 33 377778888888888777643 3467778888888888877632 35777788888888888877432 3
Q ss_pred hccccccceeeccccccCCcCccccCCCceeeEE
Q 035761 169 IGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTV 202 (560)
Q Consensus 169 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l 202 (560)
+.++++|++|++++|++++. + .+.++++|+.|
T Consensus 168 l~~l~~L~~L~ls~N~i~~i-~-~l~~L~~L~~L 199 (199)
T d2omxa2 168 LANLTTLERLDISSNKVSDI-S-VLAKLTNLESL 199 (199)
T ss_dssp GTTCTTCCEEECCSSCCCCC-G-GGGGCTTCSEE
T ss_pred ccCCCCCCEEECCCCCCCCC-c-cccCCCCCCcC
Confidence 77778888888888887742 2 35666666654
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.80 E-value=3.7e-19 Score=160.43 Aligned_cols=161 Identities=27% Similarity=0.342 Sum_probs=139.2
Q ss_pred CCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEE
Q 035761 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLD 83 (560)
Q Consensus 4 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 83 (560)
+++|++|++++|.++.+ +.+..+++|++|+|++|++++..| +.++++|+.|++++|.+.... .+.++++|+.|+
T Consensus 39 l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~ 112 (199)
T d2omxa2 39 LDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADIT--PLANLTNLTGLT 112 (199)
T ss_dssp HTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG--GGTTCTTCSEEE
T ss_pred hcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCccccccccccccccccc--cccccccccccc
Confidence 67899999999999854 358899999999999999996543 999999999999999997543 488999999999
Q ss_pred eecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCCCCCcEEEccCccccc
Q 035761 84 LSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNCSKLRILKLGNNLLSG 163 (560)
Q Consensus 84 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 163 (560)
+++|.+... ..+..+++|+.|++++|++.. + ..+..+++|+.|++++|++++. ..+.++++|+.|++++|++++
T Consensus 113 l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l--~~l~~l~~L~~L~ls~N~i~~ 186 (199)
T d2omxa2 113 LFNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDL--KPLANLTTLERLDISSNKVSD 186 (199)
T ss_dssp CCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCC
T ss_pred ccccccccc--cccchhhhhHHhhhhhhhhcc-c-ccccccccccccccccccccCC--ccccCCCCCCEEECCCCCCCC
Confidence 999999843 458899999999999999984 3 3688999999999999999965 358999999999999999985
Q ss_pred ccchhhcccccccee
Q 035761 164 SIPSQIGKLQELYYL 178 (560)
Q Consensus 164 ~~~~~~~~l~~L~~L 178 (560)
. + .+.++++|+.|
T Consensus 187 i-~-~l~~L~~L~~L 199 (199)
T d2omxa2 187 I-S-VLAKLTNLESL 199 (199)
T ss_dssp C-G-GGGGCTTCSEE
T ss_pred C-c-cccCCCCCCcC
Confidence 3 3 58889998876
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.74 E-value=9.6e-17 Score=157.96 Aligned_cols=209 Identities=25% Similarity=0.308 Sum_probs=136.7
Q ss_pred CCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEee
Q 035761 6 NLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLS 85 (560)
Q Consensus 6 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~ 85 (560)
++++|||++|.++ .+|+. .++|++|+|++|+|+ .+|+.+ .+|+.|++++|+++.+ +. + .+.|++|+++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~l-~~-l--p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKAL-SD-L--PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSCC-CS-C--CTTCCEEECC
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccchh-hh-h--cccccccccc
Confidence 5788888888887 45643 467888888888888 556543 5678888888877633 21 1 1457788888
Q ss_pred cCccCccCCCCcCCCCCccEEEccCCCccCCC------------------CccCCCCCCCcEEECcCCcCcCCC------
Q 035761 86 RNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPI------------------PSSLGHLTQLTTLNMYNNKLDGPI------ 141 (560)
Q Consensus 86 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~------------------~~~~~~l~~L~~L~l~~n~l~~~~------ 141 (560)
+|.++ .+|. +..+++|+.|++++|.+.... ...+..++.++.|++++|.+....
T Consensus 107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~~ 184 (353)
T d1jl5a_ 107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSL 184 (353)
T ss_dssp SSCCS-SCCC-CTTCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCCTTC
T ss_pred ccccc-cccc-hhhhccceeeccccccccccccccccccchhhccccccccccccccccceecccccccccccccccccc
Confidence 88877 3443 566777888887777665221 122444566666666666554210
Q ss_pred ------------CccCcCCCCCcEEEccCccccccc------------------------------------------c-
Q 035761 142 ------------PPELMNCSKLRILKLGNNLLSGSI------------------------------------------P- 166 (560)
Q Consensus 142 ------------~~~~~~l~~L~~L~l~~n~l~~~~------------------------------------------~- 166 (560)
...+..++.|+.+++++|...... +
T Consensus 185 ~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~ 264 (353)
T d1jl5a_ 185 ESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPP 264 (353)
T ss_dssp CEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCSCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSEESCCCT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 112344556666666655443200 0
Q ss_pred -------------hhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCcccccCCCCcCCCCCCCCc
Q 035761 167 -------------SQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHLDVSGNQFGGE 233 (560)
Q Consensus 167 -------------~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~l~~n~~~~~ 233 (560)
.....+++|++|+|++|+|+ .+|. .+++|+.|++++|+|+ .+|..+.+++.|++++|++...
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~---~~~~L~~L~L~~N~L~-~l~~~~~~L~~L~L~~N~L~~l 339 (353)
T d1jl5a_ 265 NLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNHLA-EVPELPQNLKQLHVEYNPLREF 339 (353)
T ss_dssp TCCEEECCSSCCSEECCCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCS-CCCCCCTTCCEEECCSSCCSSC
T ss_pred hhcccccccCccccccccCCCCCEEECCCCccC-cccc---ccCCCCEEECCCCcCC-ccccccCCCCEEECcCCcCCCC
Confidence 00112468999999999998 4554 3578889999999998 5666778899999999998754
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.66 E-value=3.1e-17 Score=141.79 Aligned_cols=129 Identities=20% Similarity=0.160 Sum_probs=102.7
Q ss_pred CCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEeecCccCccCCCCcCCCCCc
Q 035761 24 TLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWL 103 (560)
Q Consensus 24 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 103 (560)
.|.+..+|++|+|++|+|+. ++..+..+++|+.|+|++|+|+.. ..|..+++|++|++++|+++...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCcccccccccc
Confidence 46777888999999999884 466678888999999999998854 358888999999999999986666666788999
Q ss_pred cEEEccCCCccCCCC-ccCCCCCCCcEEECcCCcCcCCCC---ccCcCCCCCcEEE
Q 035761 104 RSVDLSQNKLVGPIP-SSLGHLTQLTTLNMYNNKLDGPIP---PELMNCSKLRILK 155 (560)
Q Consensus 104 ~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~---~~~~~l~~L~~L~ 155 (560)
+.|++++|+++.... ..+..+++|++|++++|.++.... ..+..+|+|+.||
T Consensus 90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred ccceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 999999999874322 467888999999999999874321 2477889999887
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.66 E-value=3.6e-15 Score=146.43 Aligned_cols=203 Identities=23% Similarity=0.227 Sum_probs=138.0
Q ss_pred CCCCCEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEE
Q 035761 4 LRNLVHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLD 83 (560)
Q Consensus 4 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 83 (560)
+++|++|+|++|+|+ .+|+.+ .+|+.|++++|+++. +++. .+.|++|++++|.++.. | .+..+++|+.|+
T Consensus 57 ~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~-l~~l---p~~L~~L~L~~n~l~~l-p-~~~~l~~L~~L~ 126 (353)
T d1jl5a_ 57 PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEKL-P-ELQNSSFLKIID 126 (353)
T ss_dssp CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSSC-C-CCTTCTTCCEEE
T ss_pred CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccch-hhhh---ccccccccccccccccc-c-chhhhccceeec
Confidence 368999999999998 556543 578888899888873 3321 14688888888888743 3 356788888888
Q ss_pred eecCccCccC------------------CCCcCCCCCccEEEccCCCccCCC------------------CccCCCCCCC
Q 035761 84 LSRNEIGGSI------------------PSTLGHLKWLRSVDLSQNKLVGPI------------------PSSLGHLTQL 127 (560)
Q Consensus 84 l~~n~l~~~~------------------~~~~~~l~~L~~L~l~~n~l~~~~------------------~~~~~~l~~L 127 (560)
+++|.+.... ...+..++.++.|++++|.+.... ...+..++.|
T Consensus 127 l~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~L 206 (353)
T d1jl5a_ 127 VDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFL 206 (353)
T ss_dssp CCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCCTTCCEEECCSSCCSSCCCCTTCTTC
T ss_pred cccccccccccccccccchhhccccccccccccccccceecccccccccccccccccccccccccccccccccccccccc
Confidence 8888766221 123445566777777776654211 1123445666
Q ss_pred cEEECcCCcCcCCC----------------------C----------------------------------ccCcCCCCC
Q 035761 128 TTLNMYNNKLDGPI----------------------P----------------------------------PELMNCSKL 151 (560)
Q Consensus 128 ~~L~l~~n~l~~~~----------------------~----------------------------------~~~~~l~~L 151 (560)
+.+++++|...... + .....+++|
T Consensus 207 ~~l~l~~n~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~L 286 (353)
T d1jl5a_ 207 TTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSL 286 (353)
T ss_dssp CEEECCSSCCSSCCSCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSEECCCCTTC
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhcccccccCccccccccCCCC
Confidence 77776665443210 0 001124689
Q ss_pred cEEEccCcccccccchhhccccccceeeccccccCCcCccccCCCceeeEEEccCCccccccCcccccCCCCcC
Q 035761 152 RILKLGNNLLSGSIPSQIGKLQELYYLDLSGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHLDV 225 (560)
Q Consensus 152 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~l 225 (560)
++|++++|+|+ .+|. .+++|+.|+|++|+|+ .+|.. +.+|+.|++++|+++ .+|.....++.|.+
T Consensus 287 ~~L~Ls~N~l~-~lp~---~~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~~~~L~~L~~ 351 (353)
T d1jl5a_ 287 EELNVSNNKLI-ELPA---LPPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDIPESVEDLRM 351 (353)
T ss_dssp CEEECCSSCCS-CCCC---CCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCCCTTCCEEEC
T ss_pred CEEECCCCccC-cccc---ccCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCccccccCeeEC
Confidence 99999999998 5664 4689999999999998 55643 467999999999998 45655556666554
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.66 E-value=7.1e-17 Score=139.52 Aligned_cols=129 Identities=19% Similarity=0.125 Sum_probs=88.2
Q ss_pred cccCCCCCCeeeccccccccccccccCCCCCCCEEEeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCC
Q 035761 48 NVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQL 127 (560)
Q Consensus 48 ~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 127 (560)
.|.+..+|++|+|++|+|+.+ +..+..+++|+.|+|++|+|+.+ +.|..+++|++|++++|+++...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCcccccccccc
Confidence 356667788888888888744 55566777788888888887743 347777778888888888775555556667777
Q ss_pred cEEECcCCcCcCCCC-ccCcCCCCCcEEEccCccccccc---chhhccccccceee
Q 035761 128 TTLNMYNNKLDGPIP-PELMNCSKLRILKLGNNLLSGSI---PSQIGKLQELYYLD 179 (560)
Q Consensus 128 ~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~---~~~~~~l~~L~~L~ 179 (560)
+.|++++|+|+.... ..+..+++|+.|++++|.++... +..+..+|+|++||
T Consensus 90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred ccceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 777777777764321 35667777777777777776322 12456677777665
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.63 E-value=3.8e-16 Score=128.25 Aligned_cols=102 Identities=26% Similarity=0.291 Sum_probs=65.3
Q ss_pred CEEEccCCcCcccCCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEeecC
Q 035761 8 VHLDLSDNHFMGHIPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRN 87 (560)
Q Consensus 8 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n 87 (560)
|.|||++|+|+. ++ .+..+++|++|++++|+|+ .+|+.|..+++|+.|++++|+|+.. + .+..+++|++|++++|
T Consensus 1 R~L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCSS-CC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCCC-Cc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-C-ccccccccCeEECCCC
Confidence 467777777763 33 3677777777777777776 4556677777777777777777643 2 3666666666666666
Q ss_pred ccCccCC-CCcCCCCCccEEEccCCCcc
Q 035761 88 EIGGSIP-STLGHLKWLRSVDLSQNKLV 114 (560)
Q Consensus 88 ~l~~~~~-~~~~~l~~L~~L~l~~n~l~ 114 (560)
+|+.... ..+..+++|+.|++++|.++
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 6663321 34555666666666666655
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.63 E-value=4.4e-17 Score=155.25 Aligned_cols=212 Identities=18% Similarity=0.234 Sum_probs=158.3
Q ss_pred CCCcCCCCEEEccCCcceec-CCccccCCCCCCeeeccccccccccccccCCCCCCCEEEeecC-ccCcc-CCCCcCCCC
Q 035761 25 LGRLSELKILNLSLNSLVGN-IPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRN-EIGGS-IPSTLGHLK 101 (560)
Q Consensus 25 ~~~l~~L~~L~L~~N~i~~~-~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n-~l~~~-~~~~~~~l~ 101 (560)
.....+|++|||++|.++.. ++..+.++++|++|+|++|+++......+..+++|++|++++| .++.. +...+.+++
T Consensus 42 ~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~ 121 (284)
T d2astb2 42 HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121 (284)
T ss_dssp CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCT
T ss_pred hccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHH
Confidence 34557899999999988743 4455788999999999999998777888899999999999995 56532 122245689
Q ss_pred CccEEEccCC-CccCC-CCccCC-CCCCCcEEECcCCc--CcCC-CCccCcCCCCCcEEEccCc-ccccccchhhccccc
Q 035761 102 WLRSVDLSQN-KLVGP-IPSSLG-HLTQLTTLNMYNNK--LDGP-IPPELMNCSKLRILKLGNN-LLSGSIPSQIGKLQE 174 (560)
Q Consensus 102 ~L~~L~l~~n-~l~~~-~~~~~~-~l~~L~~L~l~~n~--l~~~-~~~~~~~l~~L~~L~l~~n-~l~~~~~~~~~~l~~ 174 (560)
+|++|+++++ .++.. ....+. ..++|+.|+++++. ++.. +...+.++++|+.|++++| .+++.....+..+++
T Consensus 122 ~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~ 201 (284)
T d2astb2 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNY 201 (284)
T ss_dssp TCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTT
T ss_pred hccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCc
Confidence 9999999986 44321 112222 35789999999763 4321 1223457899999999987 588778888999999
Q ss_pred cceeecccc-ccCCcCccccCCCceeeEEEccCCccc-cccCcccccCCCCcCCCCCCCCcCCcc
Q 035761 175 LYYLDLSGN-FINGKIPSQLGEFSCIDTVDLSMNNLS-GGIPVFVRKVPHLDVSGNQFGGEIPTT 237 (560)
Q Consensus 175 L~~L~l~~n-~l~~~~~~~~~~~~~L~~l~l~~n~l~-~~~~~~~~~l~~l~l~~n~~~~~~p~~ 237 (560)
|++|++++| .+++.....+.++++|+.|+++++ ++ +..+.....+++|.+..++++...++.
T Consensus 202 L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d~~l~~l~~~lp~L~i~~~~ls~~~~~~ 265 (284)
T d2astb2 202 LQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDGTLQLLKEALPHLQINCSHFTTIARPT 265 (284)
T ss_dssp CCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTTCHHHHHHHSTTSEESCCCSCCTTCSS
T ss_pred CCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CCHHHHHHHHHhCccccccCccCCCCCCCc
Confidence 999999995 677777777889999999999988 44 333334467888988888887654444
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.62 E-value=9.5e-16 Score=125.80 Aligned_cols=84 Identities=31% Similarity=0.518 Sum_probs=31.9
Q ss_pred CCCCCCEEEeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCC-CccCcCCCCCcE
Q 035761 75 SLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPI-PPELMNCSKLRI 153 (560)
Q Consensus 75 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~ 153 (560)
.+++|++|++++|+|+ .+|..+..+++|+.|++++|.|+. +| .+..+++|+.|++++|+|++.. ...+..+++|+.
T Consensus 18 ~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~ 94 (124)
T d1dcea3 18 QLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVL 94 (124)
T ss_dssp GGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCE
T ss_pred cCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCccCCCCCchhhcCCCCCCE
Confidence 3333333444433333 223333334444444444444432 11 2333444444444444443221 123334444444
Q ss_pred EEccCccc
Q 035761 154 LKLGNNLL 161 (560)
Q Consensus 154 L~l~~n~l 161 (560)
|++++|++
T Consensus 95 L~l~~N~i 102 (124)
T d1dcea3 95 LNLQGNSL 102 (124)
T ss_dssp EECTTSGG
T ss_pred EECCCCcC
Confidence 44444444
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.61 E-value=8.9e-18 Score=165.17 Aligned_cols=231 Identities=18% Similarity=0.216 Sum_probs=171.4
Q ss_pred CCCCCCEEEccCCcCcc----cCCCCCCCcCCCCEEEccCCcceec----------CCccccCCCCCCeeeccccccccc
Q 035761 3 RLRNLVHLDLSDNHFMG----HIPPTLGRLSELKILNLSLNSLVGN----------IPSNVGHLTQLTTLAIASNRMNGS 68 (560)
Q Consensus 3 ~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~N~i~~~----------~~~~~~~l~~L~~L~L~~n~i~~~ 68 (560)
+..+|+.|+|++|.|.. .+...+...++|+.|+++++..... +.+.+..+++|+.|+|++|.+...
T Consensus 29 ~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~ 108 (344)
T d2ca6a1 29 EDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPT 108 (344)
T ss_dssp HCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTT
T ss_pred hCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccccc
Confidence 35789999999999864 2345677889999999998754311 234456789999999999998753
Q ss_pred ----cccccCCCCCCCEEEeecCccCccCCC-------------CcCCCCCccEEEccCCCccCC----CCccCCCCCCC
Q 035761 69 ----ILLGIGSLKVLQVLDLSRNEIGGSIPS-------------TLGHLKWLRSVDLSQNKLVGP----IPSSLGHLTQL 127 (560)
Q Consensus 69 ----~~~~~~~l~~L~~L~l~~n~l~~~~~~-------------~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L 127 (560)
+...+...++|+.|++++|.++..... .....+.|+.|++++|.++.. +...+..++.|
T Consensus 109 ~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L 188 (344)
T d2ca6a1 109 AQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLL 188 (344)
T ss_dssp THHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTC
T ss_pred cccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhh
Confidence 334455678999999999987621111 113467899999999998632 23345668899
Q ss_pred cEEECcCCcCcCC-----CCccCcCCCCCcEEEccCcccccc----cchhhccccccceeeccccccCCcCcccc----C
Q 035761 128 TTLNMYNNKLDGP-----IPPELMNCSKLRILKLGNNLLSGS----IPSQIGKLQELYYLDLSGNFINGKIPSQL----G 194 (560)
Q Consensus 128 ~~L~l~~n~l~~~-----~~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~~~~~~----~ 194 (560)
+.|+|++|.++.. +...+..+++|+.|++++|.++.. +...+..+++|++|+|++|.|++.....+ .
T Consensus 189 ~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~ 268 (344)
T d2ca6a1 189 HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFS 268 (344)
T ss_dssp CEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhh
Confidence 9999999998732 334577889999999999998743 34567789999999999999976533333 2
Q ss_pred --CCceeeEEEccCCccccccCc--------ccccCCCCcCCCCCCCCc
Q 035761 195 --EFSCIDTVDLSMNNLSGGIPV--------FVRKVPHLDVSGNQFGGE 233 (560)
Q Consensus 195 --~~~~L~~l~l~~n~l~~~~~~--------~~~~l~~l~l~~n~~~~~ 233 (560)
..+.|+.|++++|+++..... ...+++.|++++|++...
T Consensus 269 ~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~~ 317 (344)
T d2ca6a1 269 KLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 317 (344)
T ss_dssp TCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTT
T ss_pred hccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCCc
Confidence 346799999999999753221 235788999999998643
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.56 E-value=1.7e-16 Score=151.11 Aligned_cols=220 Identities=15% Similarity=0.167 Sum_probs=159.2
Q ss_pred CCCCCCEEEccCCcCccc-CCCCCCCcCCCCEEEccCCcceecCCccccCCCCCCeeecccc-ccccc-cccccCCCCCC
Q 035761 3 RLRNLVHLDLSDNHFMGH-IPPTLGRLSELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASN-RMNGS-ILLGIGSLKVL 79 (560)
Q Consensus 3 ~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n-~i~~~-~~~~~~~l~~L 79 (560)
...+|++|||++|.++.. ....+..+++|++|+|++|.+++..+..+..+++|+.|+|+++ .++.. ....+.++++|
T Consensus 44 ~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L 123 (284)
T d2astb2 44 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL 123 (284)
T ss_dssp CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTC
T ss_pred cCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhc
Confidence 356899999999998743 3455788999999999999998777888999999999999995 66633 22334578999
Q ss_pred CEEEeecC-ccCcc-CCCCcC-CCCCccEEEccCCC--ccCC-CCccCCCCCCCcEEECcCC-cCcCCCCccCcCCCCCc
Q 035761 80 QVLDLSRN-EIGGS-IPSTLG-HLKWLRSVDLSQNK--LVGP-IPSSLGHLTQLTTLNMYNN-KLDGPIPPELMNCSKLR 152 (560)
Q Consensus 80 ~~L~l~~n-~l~~~-~~~~~~-~l~~L~~L~l~~n~--l~~~-~~~~~~~l~~L~~L~l~~n-~l~~~~~~~~~~l~~L~ 152 (560)
++|+++++ .++.. ....+. ..++|+.|+++++. ++.. +.....++++|++|++++| .+++.....+.++++|+
T Consensus 124 ~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~ 203 (284)
T d2astb2 124 DELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQ 203 (284)
T ss_dssp CEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCC
T ss_pred cccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCC
Confidence 99999996 45421 112232 34789999999763 3321 2233456899999999997 57766677889999999
Q ss_pred EEEccCc-ccccccchhhccccccceeeccccccCCc-CccccCCCceeeEEEccCCccccccCcccccCCCCcCC
Q 035761 153 ILKLGNN-LLSGSIPSQIGKLQELYYLDLSGNFINGK-IPSQLGEFSCIDTVDLSMNNLSGGIPVFVRKVPHLDVS 226 (560)
Q Consensus 153 ~L~l~~n-~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~l~ 226 (560)
.|++++| .+++.....+..+++|+.|+++++ ++.. .+.....+++|+ ++.++++...+..+.+-+...+.
T Consensus 204 ~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d~~l~~l~~~lp~L~---i~~~~ls~~~~~~~~~~~~~~iw 275 (284)
T d2astb2 204 HLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDGTLQLLKEALPHLQ---INCSHFTTIARPTIGNKKNQEIW 275 (284)
T ss_dssp EEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTTCHHHHHHHSTTSE---ESCCCSCCTTCSSCSSTTCCCBT
T ss_pred EEECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CCHHHHHHHHHhCcccc---ccCccCCCCCCCccCccccchhc
Confidence 9999995 688777778899999999999998 4322 222223455554 57777876655555444433333
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.50 E-value=4.6e-16 Score=152.73 Aligned_cols=212 Identities=19% Similarity=0.178 Sum_probs=156.9
Q ss_pred CCCCCCCCEEEccCCcCccc----------CCCCCCCcCCCCEEEccCCcceec----CCccccCCCCCCeeeccccccc
Q 035761 1 MGRLRNLVHLDLSDNHFMGH----------IPPTLGRLSELKILNLSLNSLVGN----IPSNVGHLTQLTTLAIASNRMN 66 (560)
Q Consensus 1 ~~~l~~L~~L~L~~n~l~~~----------~~~~~~~l~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~L~~n~i~ 66 (560)
+...++|+.|+++++..... +...+...++|++|+|++|.+... +...+...++|+.|++++|.+.
T Consensus 55 l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~ 134 (344)
T d2ca6a1 55 IASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLG 134 (344)
T ss_dssp TTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCH
T ss_pred HHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccccccccchhhhhcccccchheeccccccc
Confidence 35678999999998865422 123355678999999999998743 3344567899999999999875
Q ss_pred ccccc-------------ccCCCCCCCEEEeecCccCcc----CCCCcCCCCCccEEEccCCCccCC-----CCccCCCC
Q 035761 67 GSILL-------------GIGSLKVLQVLDLSRNEIGGS----IPSTLGHLKWLRSVDLSQNKLVGP-----IPSSLGHL 124 (560)
Q Consensus 67 ~~~~~-------------~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~-----~~~~~~~l 124 (560)
..... .....+.|+.|++++|.++.. +...+...+.|+.|+|++|.+... +...+..+
T Consensus 135 ~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~ 214 (344)
T d2ca6a1 135 PQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYC 214 (344)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGC
T ss_pred ccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcch
Confidence 32111 123567899999999998732 223455678999999999998631 34457788
Q ss_pred CCCcEEECcCCcCcCC----CCccCcCCCCCcEEEccCcccccccchhh----cc--ccccceeeccccccCCcCc----
Q 035761 125 TQLTTLNMYNNKLDGP----IPPELMNCSKLRILKLGNNLLSGSIPSQI----GK--LQELYYLDLSGNFINGKIP---- 190 (560)
Q Consensus 125 ~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~~~~~~----~~--l~~L~~L~l~~n~l~~~~~---- 190 (560)
++|+.|+|++|.++.. +...+..+++|++|++++|.|++.....+ .. .+.|++|++++|+|+....
T Consensus 215 ~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~ 294 (344)
T d2ca6a1 215 QELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLK 294 (344)
T ss_dssp TTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHH
T ss_pred hhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHH
Confidence 9999999999998632 34567889999999999999986544333 32 4679999999999875432
Q ss_pred cccC-CCceeeEEEccCCccccc
Q 035761 191 SQLG-EFSCIDTVDLSMNNLSGG 212 (560)
Q Consensus 191 ~~~~-~~~~L~~l~l~~n~l~~~ 212 (560)
..+. +.++|+.|++++|.+...
T Consensus 295 ~~l~~~~~~L~~L~l~~N~~~~~ 317 (344)
T d2ca6a1 295 TVIDEKMPDLLFLELNGNRFSEE 317 (344)
T ss_dssp HHHHHHCTTCCEEECTTSBSCTT
T ss_pred HHHHccCCCCCEEECCCCcCCCc
Confidence 2332 467899999999999754
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.50 E-value=1.1e-16 Score=143.20 Aligned_cols=112 Identities=26% Similarity=0.284 Sum_probs=54.0
Q ss_pred CccccCCCCCCeeeccccccccccccccCCCCCCCEEEeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCC
Q 035761 46 PSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLT 125 (560)
Q Consensus 46 ~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 125 (560)
|..+..+++|+.|+|++|+|+.+ ..+.++++|++|+|++|.|+ .++..+..+++|++|++++|+++.. ..+..++
T Consensus 41 ~~sl~~L~~L~~L~Ls~n~I~~i--~~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~ 115 (198)
T d1m9la_ 41 DATLSTLKACKHLALSTNNIEKI--SSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKLV 115 (198)
T ss_dssp HHHHHHTTTCCEEECSEEEESCC--CCHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHHH
T ss_pred hhHHhcccccceeECcccCCCCc--ccccCCccccChhhcccccc-ccccccccccccccccccccccccc--ccccccc
Confidence 34455555555555555555532 13445555555555555555 2333333334455555555555422 2244455
Q ss_pred CCcEEECcCCcCcCCCC-ccCcCCCCCcEEEccCcccc
Q 035761 126 QLTTLNMYNNKLDGPIP-PELMNCSKLRILKLGNNLLS 162 (560)
Q Consensus 126 ~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~ 162 (560)
+|+.|++++|+|+.... ..+..+++|+.|++++|++.
T Consensus 116 ~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 116 NLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp HSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred cccccccccchhccccccccccCCCccceeecCCCccc
Confidence 55555555555542211 23445555555555555544
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.48 E-value=1.2e-13 Score=118.06 Aligned_cols=138 Identities=17% Similarity=0.095 Sum_probs=78.3
Q ss_pred CccEEEccCCCccCCCCccCCCCCCCcEEECcCC-cCcCCCCccCcCCCCCcEEEccCcccccccchhhccccccceeec
Q 035761 102 WLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNN-KLDGPIPPELMNCSKLRILKLGNNLLSGSIPSQIGKLQELYYLDL 180 (560)
Q Consensus 102 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n-~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 180 (560)
..+.++++++.+. ..|..+..+++|++|++++| .|+.+.+..|.++++|+.|+|++|+|+.+.+..|..+++|++|+|
T Consensus 9 ~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L 87 (156)
T d2ifga3 9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL 87 (156)
T ss_dssp SSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred CCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceec
Confidence 3444556665555 34555566666666666544 366555556666666666666666666666666666777777777
Q ss_pred cccccCCcCccccCCCceeeEEEccCCccccccCc-cc---ccCCCCcCCCCCCCCcCCcccCCC
Q 035761 181 SGNFINGKIPSQLGEFSCIDTVDLSMNNLSGGIPV-FV---RKVPHLDVSGNQFGGEIPTTLANV 241 (560)
Q Consensus 181 ~~n~l~~~~~~~~~~~~~L~~l~l~~n~l~~~~~~-~~---~~l~~l~l~~n~~~~~~p~~~~~~ 241 (560)
++|+|+...+..|... +|+.|+|++|++.+.... ++ .......+..+++.|..|....+.
T Consensus 88 s~N~l~~l~~~~~~~~-~l~~L~L~~Np~~C~C~~~~l~~~~~~~~~~~~~~~~~C~~p~~l~~~ 151 (156)
T d2ifga3 88 SFNALESLSWKTVQGL-SLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHM 151 (156)
T ss_dssp CSSCCSCCCSTTTCSC-CCCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSSCSSCC
T ss_pred cCCCCcccChhhhccc-cccccccCCCcccCCchHHHHHHHHHhccCccCcCCcEECcChHHCcC
Confidence 7777764444444333 577777777777643321 11 112233344455666555444443
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.48 E-value=1.7e-16 Score=142.05 Aligned_cols=114 Identities=25% Similarity=0.281 Sum_probs=70.5
Q ss_pred cccccCCCCCCCEEEeecCccCccCCCCcCCCCCccEEEccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCccCcCC
Q 035761 69 ILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPPELMNC 148 (560)
Q Consensus 69 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 148 (560)
.+..+..+++|++|+|++|+|+. ++ .+.++++|+.|+|++|.|+ .++..+..+++|+.|++++|+++.. ..+..+
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l 114 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKL 114 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHH
T ss_pred hhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--cccccc
Confidence 34556667777777777777773 33 4666777777777777776 3444444455677777777766632 345566
Q ss_pred CCCcEEEccCcccccccc-hhhccccccceeeccccccCC
Q 035761 149 SKLRILKLGNNLLSGSIP-SQIGKLQELYYLDLSGNFING 187 (560)
Q Consensus 149 ~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~ 187 (560)
++|+.|++++|+++.... ..+..+++|+.|+|++|++..
T Consensus 115 ~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~ 154 (198)
T d1m9la_ 115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp HHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred ccccccccccchhccccccccccCCCccceeecCCCcccc
Confidence 666666666666663321 345666666666666666653
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.47 E-value=1.4e-13 Score=117.71 Aligned_cols=83 Identities=18% Similarity=0.171 Sum_probs=40.6
Q ss_pred CCEEEccCCcceecCCccccCCCCCCeeecccc-ccccccccccCCCCCCCEEEeecCccCccCCCCcCCCCCccEEEcc
Q 035761 31 LKILNLSLNSLVGNIPSNVGHLTQLTTLAIASN-RMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLS 109 (560)
Q Consensus 31 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n-~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 109 (560)
.+.++.+++++. ..|..+..+++|++|++++| .|+.+.+..|.++++|+.|+|++|+|+.+.+.+|..+++|++|+|+
T Consensus 10 ~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls 88 (156)
T d2ifga3 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (156)
T ss_dssp SSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence 344555555554 34444555555555555433 2444444445555555555555555554444444444444444444
Q ss_pred CCCcc
Q 035761 110 QNKLV 114 (560)
Q Consensus 110 ~n~l~ 114 (560)
+|+|+
T Consensus 89 ~N~l~ 93 (156)
T d2ifga3 89 FNALE 93 (156)
T ss_dssp SSCCS
T ss_pred CCCCc
Confidence 44444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.39 E-value=4.2e-15 Score=151.39 Aligned_cols=87 Identities=24% Similarity=0.288 Sum_probs=51.0
Q ss_pred CCCCCEEEccCCcCcc----cCCCCCCCcCCCCEEEccCCcceec----CCcccc-CCCCCCeeeccccccccc----cc
Q 035761 4 LRNLVHLDLSDNHFMG----HIPPTLGRLSELKILNLSLNSLVGN----IPSNVG-HLTQLTTLAIASNRMNGS----IL 70 (560)
Q Consensus 4 l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~N~i~~~----~~~~~~-~l~~L~~L~L~~n~i~~~----~~ 70 (560)
++++++|+|++|.|+. .++..+..+++|++|||++|.|+.. +...+. ...+|++|+|++|+++.. ++
T Consensus 26 l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~ 105 (460)
T d1z7xw1 26 LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLS 105 (460)
T ss_dssp HTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCcccccccccc
Confidence 4566777777776652 2234455667777777777766521 122222 224577777777776532 34
Q ss_pred cccCCCCCCCEEEeecCccC
Q 035761 71 LGIGSLKVLQVLDLSRNEIG 90 (560)
Q Consensus 71 ~~~~~l~~L~~L~l~~n~l~ 90 (560)
..+..+++|++|+|++|.|+
T Consensus 106 ~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 106 STLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp HHTTSCTTCCEEECCSSBCH
T ss_pred chhhccccccccccccccch
Confidence 45566677777777776653
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.34 E-value=1.9e-14 Score=146.43 Aligned_cols=231 Identities=19% Similarity=0.189 Sum_probs=139.8
Q ss_pred CCCCCCCEEEccCCcCccc----CCCCCC-CcCCCCEEEccCCcceec----CCccccCCCCCCeeeccccccccccc--
Q 035761 2 GRLRNLVHLDLSDNHFMGH----IPPTLG-RLSELKILNLSLNSLVGN----IPSNVGHLTQLTTLAIASNRMNGSIL-- 70 (560)
Q Consensus 2 ~~l~~L~~L~L~~n~l~~~----~~~~~~-~l~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~L~~n~i~~~~~-- 70 (560)
..+++|++|||++|.|+.. +...+. ...+|++|+|++|++++. ++..+..+++|++|+|++|+|.....
T Consensus 52 ~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~ 131 (460)
T d1z7xw1 52 RVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQL 131 (460)
T ss_dssp HTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHH
T ss_pred hcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhh
Confidence 3578899999999998632 233333 335799999999998743 45667889999999999998642100
Q ss_pred -------------------------------cccCCCCCCCEEEeecCc-----------------------------cC
Q 035761 71 -------------------------------LGIGSLKVLQVLDLSRNE-----------------------------IG 90 (560)
Q Consensus 71 -------------------------------~~~~~l~~L~~L~l~~n~-----------------------------l~ 90 (560)
..+.....++.++++++. +.
T Consensus 132 l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~ 211 (460)
T d1z7xw1 132 LCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVT 211 (460)
T ss_dssp HHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCB
T ss_pred hhhcccccccccccccccccccchhhhccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 000111233334333322 11
Q ss_pred ----------------------------c-----cCCCCcCCCCCccEEEccCCCccCC----CCccCCCCCCCcEEECc
Q 035761 91 ----------------------------G-----SIPSTLGHLKWLRSVDLSQNKLVGP----IPSSLGHLTQLTTLNMY 133 (560)
Q Consensus 91 ----------------------------~-----~~~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~ 133 (560)
. ...........|+.|++++|.+... ....+...+.++.++++
T Consensus 212 ~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~ 291 (460)
T d1z7xw1 212 SDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLA 291 (460)
T ss_dssp TTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECT
T ss_pred chhhhcccccccccccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccc
Confidence 0 0011123356789999999988632 12234557788888888
Q ss_pred CCcCcCCCCcc-----CcCCCCCcEEEccCcccccccchhh----ccccccceeeccccccCCc----CccccC-CCcee
Q 035761 134 NNKLDGPIPPE-----LMNCSKLRILKLGNNLLSGSIPSQI----GKLQELYYLDLSGNFINGK----IPSQLG-EFSCI 199 (560)
Q Consensus 134 ~n~l~~~~~~~-----~~~l~~L~~L~l~~n~l~~~~~~~~----~~l~~L~~L~l~~n~l~~~----~~~~~~-~~~~L 199 (560)
+|.++...... ......|+.+++++|.++......+ ...++|++|+|++|++++. ++..+. ..+.|
T Consensus 292 ~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L 371 (460)
T d1z7xw1 292 GNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVL 371 (460)
T ss_dssp TCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCC
T ss_pred cccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCC
Confidence 88876321111 1233577888888887765433333 3455788888888877543 222232 35667
Q ss_pred eEEEccCCccccccC----c---ccccCCCCcCCCCCCCC
Q 035761 200 DTVDLSMNNLSGGIP----V---FVRKVPHLDVSGNQFGG 232 (560)
Q Consensus 200 ~~l~l~~n~l~~~~~----~---~~~~l~~l~l~~n~~~~ 232 (560)
+.|+|++|+++.... . ..+++++|++++|+++.
T Consensus 372 ~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~ 411 (460)
T d1z7xw1 372 RVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 411 (460)
T ss_dssp CEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred CEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCH
Confidence 888888888774321 1 22567778888887754
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.75 E-value=1.2e-10 Score=99.67 Aligned_cols=121 Identities=18% Similarity=0.049 Sum_probs=69.8
Q ss_pred CCCEEEccCCcceecCCccccCCCCCCeeeccccccccccccccCCCCCCCEEEeecCccCccC--CCCcCCCCCccEEE
Q 035761 30 ELKILNLSLNSLVGNIPSNVGHLTQLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSI--PSTLGHLKWLRSVD 107 (560)
Q Consensus 30 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~--~~~~~~l~~L~~L~ 107 (560)
..+.|+++++... ..+..+..+..++..+|.+. ..+..+..+++|++|+|++|+|+... +..+..+++|+.|+
T Consensus 23 ~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~ 97 (162)
T d1koha1 23 SQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN 97 (162)
T ss_dssp SSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCC
T ss_pred hhCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccc
Confidence 3445555544322 22344444555555555443 33444456677777777777777432 23455677777777
Q ss_pred ccCCCccCCCCccCCCCCCCcEEECcCCcCcCCCCc-------cCcCCCCCcEEE
Q 035761 108 LSQNKLVGPIPSSLGHLTQLTTLNMYNNKLDGPIPP-------ELMNCSKLRILK 155 (560)
Q Consensus 108 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~-------~~~~l~~L~~L~ 155 (560)
|++|.|+...+-.+....+|+.|++++|.+...... .+..+|+|+.||
T Consensus 98 Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 98 LSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred cccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 777777744332333445677788888877754332 255677888775
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.74 E-value=1.7e-10 Score=98.79 Aligned_cols=121 Identities=21% Similarity=0.204 Sum_probs=71.3
Q ss_pred CCCeeeccccccccccccccCCCCCCCEEEeecCccCccCCCCcCCCCCccEEEccCCCccCCC--CccCCCCCCCcEEE
Q 035761 54 QLTTLAIASNRMNGSILLGIGSLKVLQVLDLSRNEIGGSIPSTLGHLKWLRSVDLSQNKLVGPI--PSSLGHLTQLTTLN 131 (560)
Q Consensus 54 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~--~~~~~~l~~L~~L~ 131 (560)
..+.|+++++... ..+..+..+..++..+|.+. .++..+.++++|++|+|++|+|+... +..+..+++|+.|+
T Consensus 23 ~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~ 97 (162)
T d1koha1 23 SQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN 97 (162)
T ss_dssp SSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCC
T ss_pred hhCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccc
Confidence 4555666655432 12333444444444444443 33344456777888888888877432 23455677888888
Q ss_pred CcCCcCcCCCCccCcCCCCCcEEEccCcccccccc-------hhhccccccceee
Q 035761 132 MYNNKLDGPIPPELMNCSKLRILKLGNNLLSGSIP-------SQIGKLQELYYLD 179 (560)
Q Consensus 132 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-------~~~~~l~~L~~L~ 179 (560)
|++|.|+...+-.+....+|+.|++++|+++.... ..+..+|+|+.||
T Consensus 98 Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 98 LSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred cccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 88888775433233344567788888887765433 2255677777765
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.54 E-value=2.2e-07 Score=85.82 Aligned_cols=150 Identities=13% Similarity=0.084 Sum_probs=100.2
Q ss_pred HHHHHHhcCCcccceeeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccC-CCCcceeeeEEEeCC
Q 035761 308 QDMIEATEDFDIKYCIGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIR-HRNIVKLYGFCLHEK 386 (560)
Q Consensus 308 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~ 386 (560)
.++...-+.|+..+..+.++.+.||+... +++.+++|+...... .....+.+|..++..+. +--+.+++.+...++
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~--~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~ 83 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDG 83 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcc--cchhhHHHHHHHHHHHhccCCCCcEEEEEecCC
Confidence 34555566776655544444568999875 466677888764332 12224567888877763 434677788888888
Q ss_pred EEEEEEeccCCCCHHHHhhcCCcccCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------
Q 035761 387 CMFLIYEYMEMGSLFCILRTDEEAVGLDWTKRVNIVKGMAHALSYLHHHC------------------------------ 436 (560)
Q Consensus 387 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------------------------------ 436 (560)
..++||+++++.++.+...... . ...++.++++.++.||+..
T Consensus 84 ~~~lv~~~l~G~~~~~~~~~~~-----~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T d1j7la_ 84 WSNLLMSEADGVLCSEEYEDEQ-----S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp EEEEEEECCSSEEHHHHTTTCS-----C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred ceEEEEEecccccccccccccc-----c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence 9999999999988765543211 1 2234555666666666321
Q ss_pred --------------------------CCCeEEeCCCCCCeEeCCCCcEEEeeeccccc
Q 035761 437 --------------------------TPPILHRDISSNNILLNSEFEAFVADFGIARL 468 (560)
Q Consensus 437 --------------------------~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 468 (560)
.+.++|+|+.|.||++++++.+.|.||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12379999999999999776667999998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.22 E-value=1.3e-06 Score=79.91 Aligned_cols=73 Identities=16% Similarity=0.094 Sum_probs=52.4
Q ss_pred eeccCC-eeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccC--CCCcceeeeEEEeCCEEEEEEeccCCCC
Q 035761 323 IGTGGY-GSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIR--HRNIVKLYGFCLHEKCMFLIYEYMEMGS 399 (560)
Q Consensus 323 ig~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~ 399 (560)
+..|.. +.||+....++..+++|....... ..+..|...++.+. .-.+.+++++..+++..++||+|+++.+
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 444554 579999988888888998654332 23566777777663 3336677888888888999999998865
Q ss_pred H
Q 035761 400 L 400 (560)
Q Consensus 400 L 400 (560)
+
T Consensus 93 ~ 93 (255)
T d1nd4a_ 93 L 93 (255)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=98.14 E-value=2.1e-07 Score=79.42 Aligned_cols=109 Identities=10% Similarity=0.097 Sum_probs=55.4
Q ss_pred cCCCCEEEccCC-cceec----CCccccCCCCCCeeeccccccccc----cccccCCCCCCCEEEeecCccCcc----CC
Q 035761 28 LSELKILNLSLN-SLVGN----IPSNVGHLTQLTTLAIASNRMNGS----ILLGIGSLKVLQVLDLSRNEIGGS----IP 94 (560)
Q Consensus 28 l~~L~~L~L~~N-~i~~~----~~~~~~~l~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~l~~n~l~~~----~~ 94 (560)
.++|++|+|+++ .++.. +...+...++|++|+|++|.+... +...+...+.|++|+|++|.|+.. +.
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~ 93 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 93 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence 355555555542 34311 222344455566666666655422 222333445666666666666531 22
Q ss_pred CCcCCCCCccEEEccCCCccCC-------CCccCCCCCCCcEEECcCCc
Q 035761 95 STLGHLKWLRSVDLSQNKLVGP-------IPSSLGHLTQLTTLNMYNNK 136 (560)
Q Consensus 95 ~~~~~l~~L~~L~l~~n~l~~~-------~~~~~~~l~~L~~L~l~~n~ 136 (560)
..+...++|++|+|++|++... +...+...++|+.|+++.+.
T Consensus 94 ~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 94 RSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 2445556666666666654422 22334445677777776553
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=98.08 E-value=3.4e-07 Score=78.02 Aligned_cols=112 Identities=13% Similarity=0.097 Sum_probs=74.9
Q ss_pred cCCCCCCeeecccc-ccccc----cccccCCCCCCCEEEeecCccCccC----CCCcCCCCCccEEEccCCCccCC----
Q 035761 50 GHLTQLTTLAIASN-RMNGS----ILLGIGSLKVLQVLDLSRNEIGGSI----PSTLGHLKWLRSVDLSQNKLVGP---- 116 (560)
Q Consensus 50 ~~l~~L~~L~L~~n-~i~~~----~~~~~~~l~~L~~L~l~~n~l~~~~----~~~~~~l~~L~~L~l~~n~l~~~---- 116 (560)
.+.++|++|+|+++ .++.. +...+...++|++|+|++|.++... ...+...+.|+.|+|++|.++..
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence 44578888888864 46432 3445667778888888888887322 22344567888888888887632
Q ss_pred CCccCCCCCCCcEEECcCCcCcCC-------CCccCcCCCCCcEEEccCccc
Q 035761 117 IPSSLGHLTQLTTLNMYNNKLDGP-------IPPELMNCSKLRILKLGNNLL 161 (560)
Q Consensus 117 ~~~~~~~l~~L~~L~l~~n~l~~~-------~~~~~~~l~~L~~L~l~~n~l 161 (560)
+...+...++|++|+|++|.+... +...+...++|+.|+++.+..
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 233566778888888888876532 233455667888888877654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.65 E-value=6.6e-05 Score=72.91 Aligned_cols=78 Identities=12% Similarity=0.110 Sum_probs=47.3
Q ss_pred cceeeccCCeeEEEEEeCC-CcEEEEEEccchh----h-hhhhHHHHHHHHHHHhcc-CC-C-CcceeeeEEEeCCEEEE
Q 035761 320 KYCIGTGGYGSVYRARLPS-GKVVALKKLHRLE----T-ELASLESFQNEARLLSQI-RH-R-NIVKLYGFCLHEKCMFL 390 (560)
Q Consensus 320 ~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~----~-~~~~~~~~~~e~~~l~~l-~h-~-niv~l~~~~~~~~~~~l 390 (560)
.+.||.|....||++...+ ++.++||.-.... . ..........|.+.++.+ .+ | .+.+++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3458999999999998654 6788999754211 0 011222345688888766 23 3 34455543 4455678
Q ss_pred EEeccCCCC
Q 035761 391 IYEYMEMGS 399 (560)
Q Consensus 391 v~e~~~~g~ 399 (560)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997644
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.63 E-value=2.2e-06 Score=72.79 Aligned_cols=111 Identities=18% Similarity=0.166 Sum_probs=62.3
Q ss_pred CCcCCCCEEEccC-Cccee----cCCccccCCCCCCeeeccccccccc----cccccCCCCCCCEEEeecCccCcc----
Q 035761 26 GRLSELKILNLSL-NSLVG----NIPSNVGHLTQLTTLAIASNRMNGS----ILLGIGSLKVLQVLDLSRNEIGGS---- 92 (560)
Q Consensus 26 ~~l~~L~~L~L~~-N~i~~----~~~~~~~~l~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~l~~n~l~~~---- 92 (560)
.+.++|++|+|++ +.|+. .+..++...++|++|+|++|.++.. +...+...++|+.|++++|.++..
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence 3456666666665 34441 1233345566677777777766532 223344556777777777766532
Q ss_pred CCCCcCCCCCccEEEc--cCCCccC----CCCccCCCCCCCcEEECcCCc
Q 035761 93 IPSTLGHLKWLRSVDL--SQNKLVG----PIPSSLGHLTQLTTLNMYNNK 136 (560)
Q Consensus 93 ~~~~~~~l~~L~~L~l--~~n~l~~----~~~~~~~~l~~L~~L~l~~n~ 136 (560)
+...+...++|+.++| ++|.+.. .+...+...++|+.|+++.+.
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred HHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCC
Confidence 2234556667776544 3455542 233445567778888776654
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.56 E-value=3.3e-06 Score=71.66 Aligned_cols=116 Identities=12% Similarity=0.109 Sum_probs=78.1
Q ss_pred ccccCCCCCCeeeccc-ccccc----ccccccCCCCCCCEEEeecCccCcc----CCCCcCCCCCccEEEccCCCccCC-
Q 035761 47 SNVGHLTQLTTLAIAS-NRMNG----SILLGIGSLKVLQVLDLSRNEIGGS----IPSTLGHLKWLRSVDLSQNKLVGP- 116 (560)
Q Consensus 47 ~~~~~l~~L~~L~L~~-n~i~~----~~~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~- 116 (560)
....+.++|++|+|++ +.++. .+...+...++|++|+|++|.++.. +...+...+.|+.|++++|.+...
T Consensus 11 ~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g 90 (166)
T d1io0a_ 11 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSG 90 (166)
T ss_dssp HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHH
T ss_pred HHHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchh
Confidence 3445678888899887 45653 2345566788889999998888742 223455667888899888887522
Q ss_pred ---CCccCCCCCCCcEEECc--CCcCcC----CCCccCcCCCCCcEEEccCcccc
Q 035761 117 ---IPSSLGHLTQLTTLNMY--NNKLDG----PIPPELMNCSKLRILKLGNNLLS 162 (560)
Q Consensus 117 ---~~~~~~~l~~L~~L~l~--~n~l~~----~~~~~~~~l~~L~~L~l~~n~l~ 162 (560)
+...+...++|+.++|+ +|.+.. .+...+...++|+.|+++.+...
T Consensus 91 ~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 91 ILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp HHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCCc
Confidence 33456677888876654 556652 23345667788888888877653
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.01 E-value=0.0015 Score=61.26 Aligned_cols=136 Identities=14% Similarity=0.130 Sum_probs=76.6
Q ss_pred CeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCCCCc--ceee-----eEEEeCCEEEEEEeccCCCCH
Q 035761 328 YGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRHRNI--VKLY-----GFCLHEKCMFLIYEYMEMGSL 400 (560)
Q Consensus 328 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lv~e~~~~g~L 400 (560)
--.||++...+|+.+++|..+.... ..+++..|...+..+....+ +..+ ......+..+.++++++|..+
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~---s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCC---CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence 3589999999999999998764321 23456677777776632221 1111 123446678899999986332
Q ss_pred ------------------HHHhhcCC--cccCCC-------------------HHHHHHHHHHHHHHHHHHHh----cCC
Q 035761 401 ------------------FCILRTDE--EAVGLD-------------------WTKRVNIVKGMAHALSYLHH----HCT 437 (560)
Q Consensus 401 ------------------~~~l~~~~--~~~~l~-------------------~~~~~~i~~~ia~~l~~LH~----~~~ 437 (560)
+....... ....++ ...+..+...+.+.++.+.. ...
T Consensus 112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p 191 (325)
T d1zyla1 112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT 191 (325)
T ss_dssp CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred CCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCC
Confidence 11111000 000111 11111122222333333322 224
Q ss_pred CCeEEeCCCCCCeEeCCCCcEEEeeeccccc
Q 035761 438 PPILHRDISSNNILLNSEFEAFVADFGIARL 468 (560)
Q Consensus 438 ~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 468 (560)
.++||+|+.+.|||++++ ..+.||+.+..
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 478999999999999754 45899998864
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.64 E-value=0.0041 Score=57.81 Aligned_cols=159 Identities=11% Similarity=0.021 Sum_probs=82.2
Q ss_pred cCHHHHHHHhcCCcccce-----eeccCCeeEEEEEeCCCcEEEEEEccchhhhhhhHHHHHHHHHHHhccCC-----CC
Q 035761 305 ITFQDMIEATEDFDIKYC-----IGTGGYGSVYRARLPSGKVVALKKLHRLETELASLESFQNEARLLSQIRH-----RN 374 (560)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~-----ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-----~n 374 (560)
++.+++....++|.+.+. |..|---..|+.+..+|+ +++|++....+ . +....|.+++..+.. |.
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~-~---~~l~~~~~~l~~L~~~g~pvp~ 77 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVE-K---NDLPFFLGLMQHLAAKGLSCPL 77 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC----C---CHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCC-H---HHHHHHHHHHHhhhhccccccc
Confidence 456777777788876443 345666788999877664 78898864321 1 233445666665532 22
Q ss_pred cceee-e--EEEeCCEEEEEEeccCCCCHHH--------------Hhhc----C--Cccc------------------CC
Q 035761 375 IVKLY-G--FCLHEKCMFLIYEYMEMGSLFC--------------ILRT----D--EEAV------------------GL 413 (560)
Q Consensus 375 iv~l~-~--~~~~~~~~~lv~e~~~~g~L~~--------------~l~~----~--~~~~------------------~l 413 (560)
.+... | +....+....++.++.+..... .++. . .... .-
T Consensus 78 pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (316)
T d2ppqa1 78 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 157 (316)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred cceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhh
Confidence 21111 0 1223455666777776633210 0000 0 0000 01
Q ss_pred CHHHHHHHHHHHHHHHHHHHh-cCCCCeEEeCCCCCCeEeCCCCcEEEeeeccccc
Q 035761 414 DWTKRVNIVKGMAHALSYLHH-HCTPPILHRDISSNNILLNSEFEAFVADFGIARL 468 (560)
Q Consensus 414 ~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~~~~ 468 (560)
........+..+...+.-.+. ....|+||+|+.+.||+++++...-+.||+.+..
T Consensus 158 ~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 158 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 111111222222222222221 2244799999999999999887778999998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.36 E-value=0.0052 Score=59.11 Aligned_cols=72 Identities=22% Similarity=0.211 Sum_probs=46.1
Q ss_pred ceeeccCCeeEEEEEeCCC--------cEEEEEEccchhhhhhhHHHHHHHHHHHhccC-CCCcceeeeEEEeCCEEEEE
Q 035761 321 YCIGTGGYGSVYRARLPSG--------KVVALKKLHRLETELASLESFQNEARLLSQIR-HRNIVKLYGFCLHEKCMFLI 391 (560)
Q Consensus 321 ~~ig~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 391 (560)
+.|+.|-.-.+|++..+++ +.|.+++.-.... .....+|..+++.+. +.-..++++++.. .+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~----~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I 119 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET----ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 119 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC----HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcch----hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence 4577788899999986543 4566666542221 123457888888874 4334466666532 589
Q ss_pred EeccCCCCH
Q 035761 392 YEYMEMGSL 400 (560)
Q Consensus 392 ~e~~~~g~L 400 (560)
+||+++..+
T Consensus 120 ~efi~g~~l 128 (395)
T d1nw1a_ 120 EEYIPSRPL 128 (395)
T ss_dssp ECCCCEEEC
T ss_pred EEEeccccC
Confidence 999987543
|